PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Agrafioti, P; Morin-Baxter, J; Tanagala, KKK; Dubey, S; Sims, P; Lalla, E; Momen-Heravi, F				Agrafioti, Panagiota; Morin-Baxter, Joshua; Tanagala, Kranthi K. K.; Dubey, Sunil; Sims, Peter; Lalla, Evanthia; Momen-Heravi, Fatemeh			Decoding the role of macrophages in periodontitis and type 2 diabetes using single-cell RNA-sequencing	FASEB JOURNAL			English	Article						macrophages; periodontitis; single-cell RNA-sequencing; type 2 diabetes	FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; COMPLICATIONS; EXPRESSION; GENE; MECHANISMS; GENOTYPES; RECEPTOR; DISEASE; TARGET	Macrophages are resident myeloid cells in the gingival tissue which control homeostasis and play a pivotal role in orchestrating the immune response in periodontitis. Cell heterogeneity and functional phenotypes of macrophage subpopulations in periodontitis remain elusive. Here, we isolated gingival tissue from periodontitis-affected and healthy sites of patients with and without type 2 diabetes mellitus (T2DM). We then used single-cell RNA-sequencing (scRNA-seq) to define the heterogeneity of tissue-resident macrophages in gingival tissue in health vs. periodontitis. scRNA-seq demonstrated an unforeseen gene expression heterogeneity among macrophages in periodontitis and showed transcriptional and signaling heterogeneity of identified subsets in an independent cohort of patients with periodontitis and T2DM. Our bioinformatic inferences indicated divergent expression profiles in macrophages driven by transcriptional regulators CIITA, RELA, RFX5, and RUNX2. Macrophages in periodontitis expressed both pro-inflammatory and anti-inflammatory markers and their polarization was not mutually exclusive. The majority of macrophages in periodontitis expressed the monocyte lineage marker CD14, indicating their bone marrow lineage. We also found high expression and activation of RELA, a subunit of the NF-kappa B transcription factor complex, in gingival macrophages of periodontitis patients with T2DM. Our data suggested that heterogeneity and hyperinflammatory activation of macrophages may be relevant to the pathogenesis and outcomes of periodontitis, and may be further augmented in patients with T2DM.	[Agrafioti, Panagiota; Tanagala, Kranthi K. K.; Dubey, Sunil; Lalla, Evanthia; Momen-Heravi, Fatemeh] Columbia Univ, Coll Dent Med, Div Periodont, Sect Oral Diagnost & Rehabil Sci, 630 W 168th St,PH7-200, New York, NY 10032 USA; [Agrafioti, Panagiota; Morin-Baxter, Joshua; Tanagala, Kranthi K. K.; Dubey, Sunil; Momen-Heravi, Fatemeh] Columbia Univ, Canc Biol & Immunol Lab, Irving Med Ctr, New York, NY 10032 USA; [Morin-Baxter, Joshua] Columbia Univ, Fu Fdn Sch Engn & Appl Sci, New York, NY 10032 USA; [Sims, Peter] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY 10032 USA; [Sims, Peter] Columbia Univ, Dept Biochem & Mol Biophys, Irving Med Ctr, New York, NY 10032 USA; [Momen-Heravi, Fatemeh] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Momen-Heravi, F (corresponding author), Columbia Univ, Coll Dent Med, Div Periodont, Sect Oral Diagnost & Rehabil Sci, 630 W 168th St,PH7-200, New York, NY 10032 USA.	fm2540@cumc.columbia.edu		Momen-Heravi, Fatemeh/0000-0003-4534-1450; Morin-Baxter, Joshua/0000-0001-9785-8844; DUBEY, SUNIL KUMAR/0000-0001-7107-9148	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR) [DE029546-01, KL2TR001874]	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR)	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE029546-01; HHS | NIH | National Center for Advancing Translational Sciences (NCATS), Grant/Award Number: KL2TR001874	Almubarak A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00330; Ambili R, 2005, J PERIODONTOL, V76, P1148, DOI 10.1902/jop.2005.76.7.1148; Arabaci Taner, 2010, Eur J Dent, V4, P454; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bagnati M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125736; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caetano AJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62810; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chinniah R, 2021, IMMUNOGENETICS, V73, P291, DOI 10.1007/s00251-021-01212-x; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Daryabor G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01582; Eke PI, 2020, PERIODONTOL 2000, V82, P257, DOI 10.1111/prd.12323; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Garcia-Alonso L, 2019, GENOME RES, V29, P1363, DOI 10.1101/gr.240663.118; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gyllenberg A, 2012, GENES IMMUN, V13, P632, DOI 10.1038/gene.2012.44; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jing CZ, 2020, P NATL ACAD SCI USA, V117, P15160, DOI 10.1073/pnas.2000943117; Jotwani R, 2010, ANN NY ACAD SCI, V1192, P278, DOI 10.1111/j.1749-6632.2009.05247.x; Kelley JB, 2019, METHODS, V157, P106, DOI 10.1016/j.ymeth.2018.11.002; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lalla E, 2000, PERIODONTOL 2000, V23, P50, DOI 10.1034/j.1600-0757.2000.2230104.x; Lalla E, 1998, J PERIODONTAL RES, V33, P387; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Laria A, 2016, J INFLAMM RES, V9, P1, DOI 10.2147/JIR.S82320; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Martinez A, 2007, ANN RHEUM DIS, V66, P325, DOI 10.1136/ard.2006.059428; Momen-Heravi F, 2021, J DENT RES, V100, P549, DOI 10.1177/0022034520979614; Navegantes KC, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1141-8; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Ohyama H, 1996, J PERIODONTOL, V67, P888, DOI 10.1902/jop.1996.67.9.888; Papapanou PN, 2018, J CLIN PERIODONTOL, V45, pS162, DOI 10.1111/jcpe.12946; Patel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7614; Sha H, 2017, MOL MED REP, V16, P3641, DOI 10.3892/mmr.2017.6992; Stein J, 2003, J PERIODONTAL RES, V38, P508, DOI 10.1034/j.1600-0765.2003.00683.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suryavanshi SV, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00798; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; Trizzino M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.aaz8836; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Yang JM, 2018, ARCH ORAL BIOL, V96, P234, DOI 10.1016/j.archoralbio.2017.03.006	46	5	6	8	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22136	10.1096/fj.202101198R	http://dx.doi.org/10.1096/fj.202101198R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032412				2022-12-26	WOS:000747987800045
J	Bratulic, S; Limeta, A; Maccari, F; Galeotti, F; Volpi, N; Levin, M; Nielsen, J; Gatto, F				Bratulic, Sinisa; Limeta, Angelo; Maccari, Francesca; Galeotti, Fabio; Volpi, Nicola; Levin, Max; Nielsen, Jens; Gatto, Francesco			Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISACCHARIDES; AGE	Plasma and urine glycosaminoglycans (GAGs) are long, linear sulfated polysaccharides that have been proposed as potential noninvasive biomarkers for several diseases. However, owing to the analytical complexity associated with the measurement of GAG concentration and disaccharide composition (the so-called GAGome), a reference study of the normal healthy GAGome is currently missing. Here, we prospectively enrolled 308 healthy adults and analyzed their free GAGomes in urine and plasma using a standardized ultra-high-performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry method together with comprehensive demographic and blood chemistry biomarker data. Of 25 blood chemistry biomarkers, we mainly observed weak correlations between the free GAGome and creatinine in urine and hemoglobin or erythrocyte counts in plasma. We found a higher free GAGome concentration - but not a more diverse composition - in males. Partitioned by gender, we also established reference intervals for all detectable free GAGome features in urine and plasma. Finally, we carried out a transference analysis in healthy individuals from two distinct geographical sites, including data from the Lifelines Cohort Study, which validated the reference intervals in urine. Our study is the first large-scale determination of normal free GAGomes reference intervals in plasma and urine and represents a critical resource for future physiology and biomarker research.	[Bratulic, Sinisa; Limeta, Angelo; Nielsen, Jens; Gatto, Francesco] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Maccari, Francesca; Galeotti, Fabio; Volpi, Nicola] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Levin, Max] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Levin, Max] Univ Gothenburg, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden; [Levin, Max] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden; [Nielsen, Jens] Biolnnovat Inst, Copenhagen N, Denmark; [Gatto, Francesco] Elypta AB, S-17165 Stockholm, Sweden	Chalmers University of Technology; Universita di Modena e Reggio Emilia; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital	Gatto, F (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.; Gatto, F (corresponding author), Elypta AB, S-17165 Stockholm, Sweden.	gatto@chalmers.se	Gatto, Francesco/AAA-6682-2020	Gatto, Francesco/0000-0002-9031-9562; Limeta, Angelo/0000-0002-6093-8426; Bratulic, Sinisa/0000-0002-1663-2227; Levin, Max/0000-0001-9676-5582	Knut and Alice Wallenberg Foundation; Cancerfonden; IngaBritt och Arne Lundbergs Forskningsstiftelse; European Union [849251]; EIT Healthy 2019 Digital Sandbox [2019-DS1001-6543]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Cancerfonden(Swedish Cancer Society); IngaBritt och Arne Lundbergs Forskningsstiftelse; European Union(European Commission); EIT Healthy 2019 Digital Sandbox	This work was supported by the Knut and Alice Wallenberg Foundation, Cancerfonden, and the IngaBritt och Arne Lundbergs Forskningsstiftelse (J. N.) and in part by the European Union's Horizon 2020 research and innovation programme under grant agreement No 849251 and the EIT Healthy 2019 Digital Sandbox (Grant No 2019-DS1001-6543) (Fr. G.).	Chen YH, 2018, NAT METHODS, V15, P881, DOI 10.1038/s41592-018-0086-z; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Gatto F, 2018, EUR UROL ONCOL, V1, P364, DOI 10.1016/j.euo.2018.04.015; Gatto F, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00253; Gatto F, 2016, CELL REP, V15, P1822, DOI 10.1016/j.celrep.2016.04.056; Ha X, 2020, GLYCOBIOLOGY, V30, P143, DOI 10.1093/glycob/cwz088; Hamad OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012889; Khan SA, 2018, MOL GENET METAB, V125, P44, DOI 10.1016/j.ymgme.2018.04.011; LARKING PW, 1987, BIOCHEM MED METAB B, V37, P246, DOI 10.1016/0885-4505(87)90033-8; LARKING PW, 1989, BIOCHEM MED METAB B, V42, P192, DOI 10.1016/0885-4505(89)90055-8; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02422; Schmidt EP, 2016, AM J RESP CRIT CARE, V194, P439, DOI 10.1164/rccm.201511-2281OC; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Sun XJ, 2015, ANAL CHEM, V87, P6220, DOI 10.1021/acs.analchem.5b00913; Tamburro D, 2021, J CHROMATOGR B, V1177, DOI 10.1016/j.jchromb.2021.122761; Tavianatou AG, 2019, FEBS J, V286, P2883, DOI 10.1111/febs.14777; Tomatsu Shunji, 2014, J Anal Bioanal Tech, V2014, P006; Volpi N, 2014, NAT PROTOC, V9, P541, DOI 10.1038/nprot.2014.026; Wang JY, 2002, P NATL ACAD SCI USA, V99, P14362, DOI 10.1073/pnas.222536599; Wei W, 2013, ANAL CHEM, V85, P5917, DOI 10.1021/ac400690g; Wei W, 2011, ANAL CHEM, V83, P3703, DOI 10.1021/ac2001077	22	1	1	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101575	10.1016/j.jbc.2022.101575	http://dx.doi.org/10.1016/j.jbc.2022.101575			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35007531	Green Published, gold			2022-12-26	WOS:000761371500005
J	Jiang, WR; Kakizaki, T; Fujihara, K; Miyata, S; Zhang, Y; Suto, T; Kato, D; Saito, S; Shibasaki, K; Ishizaki, Y; Isoda, K; Yokoo, H; Obinata, H; Hirano, T; Miyasaka, Y; Mashimo, T; Yanagawa, Y				Jiang, Weiru; Kakizaki, Toshikazu; Fujihara, Kazuyuki; Miyata, Shigeo; Zhang, Yue; Suto, Takashi; Kato, Daiki; Saito, Shigeru; Shibasaki, Koji; Ishizaki, Yasuki; Isoda, Koji; Yokoo, Hideaki; Obinata, Hideru; Hirano, Touko; Miyasaka, Yoshiki; Mashimo, Tomoji; Yanagawa, Yuchio			Impact of GAD65 and/or GAD67 deficiency on perinatal development in rats	FASEB JOURNAL			English	Article						GABA; GAD65; GAD67; knockout rats; phenotypes	GAMMA-AMINOBUTYRIC-ACID; MICE LACKING; MESSENGER-RNA; CLEFT-PALATE; GABA; EXPRESSION; ISOFORMS; RETINA; MOUSE; FETAL	GABA is a major neurotransmitter in the mammalian central nervous system. Glutamate decarboxylase (GAD) synthesizes GABA from glutamate, and two isoforms of GAD, GAD65, and GAD67, are separately encoded by the Gad2 and Gad1 genes, respectively. The phenotypes differ in severity between GAD single isoform-deficient mice and rats. For example, GAD67 deficiency causes cleft palate and/or omphalocele in mice but not in rats. In this study, to further investigate the functional roles of GAD65 and/or GAD67 and to determine the contribution of these isoforms to GABA synthesis during development, we generated various kinds of GAD isoform(s)-deficient rats and characterized their phenotypes. The age of death was different among Gad mutant rat genotypes. In particular, all Gad1(-/-); Gad2(-/-) rats died at postnatal day 0 and showed little alveolar space in their lungs, suggesting that the cause of their death was respiratory failure. All Gad1(-/-); Gad2(-/-) rats and 18% of Gad1(-/-); Gad2(+/-) rats showed cleft palate. In contrast, none of the Gad mutant rats including Gad1(-/-); Gad2(-/-) rats, showed omphalocele. These results suggest that both rat GAD65 and GAD67 are involved in palate formation, while neither isoform is critical for abdominal wall formation. The GABA content in Gad1(-/-); Gad2(-/-) rat forebrains and retinas at embryonic day 20 was extremely low, indicating that almost all GABA was synthesized from glutamate by GADs in the perinatal period. The present study shows that Gad mutant rats are a good model for further defining the role of GABA during development.	[Jiang, Weiru; Kakizaki, Toshikazu; Fujihara, Kazuyuki; Miyata, Shigeo; Zhang, Yue; Yanagawa, Yuchio] Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gumma 3718511, Japan; [Zhang, Yue] Dalian Med Univ, Dept Physiol, Liaoning Prov Key Lab Cerebral Dis, Dalian, Peoples R China; [Suto, Takashi; Kato, Daiki; Saito, Shigeru] Gunma Univ, Dept Anesthesiol, Grad Sch Med, Maebashi, Gumma, Japan; [Shibasaki, Koji; Ishizaki, Yasuki] Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gumma, Japan; [Isoda, Koji; Yokoo, Hideaki] Gunma Univ, Dept Human Pathol, Grad Sch Med, Maebashi, Gumma, Japan; [Obinata, Hideru; Hirano, Touko] Gunma Univ, Educ & Res Support Ctr, Lab Analyt Instruments, Grad Sch Med, Maebashi, Gumma, Japan; [Miyasaka, Yoshiki] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Suita, Osaka, Japan; [Mashimo, Tomoji] Univ Tokyo, Lab Anim Res Ctr, Inst Med Sci, Tokyo, Japan; [Shibasaki, Koji] Univ Nagasaki, Grad Sch Human Hlth Sci, Lab Neurochem, Nagasaki, Japan	Gunma University; Dalian Medical University; Gunma University; Gunma University; Gunma University; Gunma University; Osaka University; University of Tokyo; Nagasaki University	Yanagawa, Y (corresponding author), Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gumma 3718511, Japan.	yuchio@gunma-u.ac.jp		Miyasaka, Yoshiki/0000-0003-4020-9290	Japan Society for the Promotion of Science (KAKENHI) [16H06276, 19K06881]; Ministry of Education Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Collaborative Research Project of the Brain Research Institute, Niigata University	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Collaborative Research Project of the Brain Research Institute, Niigata University	Japan Society for the Promotion of Science (KAKENHI), Grant/Award Number: 16H06276 and 19K06881; Ministry of Education Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Collaborative Research Project of the Brain Research Institute, Niigata University	Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Chatron N, 2020, BRAIN, V143, P1447, DOI 10.1093/brain/awaa085; Chintagari NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014171; Colic L, 2018, J NEUROSCI, V38, P5067, DOI 10.1523/JNEUROSCI.1985-17.2018; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; Eliasson MJL, 1997, NEUROSCIENCE, V79, P863, DOI 10.1016/S0306-4522(97)00032-8; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fujihara K, 2021, FEBS OPEN BIO, V11, P340, DOI 10.1002/2211-5463.13065; Fujihara K, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01108-6; Fujii M, 2007, NEUROSCIENCE, V146, P1044, DOI 10.1016/j.neuroscience.2007.02.050; Glausier JR, 2015, BIOL PSYCHIAT, V77, P167, DOI 10.1016/j.biopsych.2014.05.010; Hanamura K, 2010, NEUROSCIENCE, V169, P1489, DOI 10.1016/j.neuroscience.2010.06.043; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; HOKOC JN, 1990, BRAIN RES, V532, P197, DOI 10.1016/0006-8993(90)91760-E; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jin N, 2008, GENE EXPR PATTERNS, V8, P397, DOI 10.1016/j.gep.2008.04.008; Kakizaki T, 2015, NEUROSCIENCE, V288, P86, DOI 10.1016/j.neuroscience.2014.12.030; Kakizaki T, 2021, FASEB J, V35, DOI 10.1096/fj.202001935R; Le TN, 2017, J NEUROSCI, V37, P8816, DOI 10.1523/JNEUROSCI.2125-16.2017; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Muller I, 2015, GENES BRAIN BEHAV, V14, P37, DOI 10.1111/gbb.12188; Neuray Caroline, 2020, Brain, V143, P2388, DOI 10.1093/brain/awaa178; Oda M, 2020, LAB INVEST, V100, P297, DOI 10.1038/s41374-019-0347-1; ROBERTS EUGENE, 1968, BRAIN RES, V8, P1, DOI 10.1016/0006-8993(68)90170-4; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Saito K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-40; SEILER N, 1974, BIOCHEM J, V144, P29, DOI 10.1042/bj1440029; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Suto T, 2019, J PAIN, V20, P600, DOI 10.1016/j.jpain.2018.11.008; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wang SJ, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0160-z; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wyszynski DF, 1996, CLEFT PALATE-CRAN J, V33, P406, DOI 10.1597/1545-1569(1996)033<0406:GONOCR>2.3.CO;2; Yamasaki EN, 1999, INT J DEV NEUROSCI, V17, P201, DOI 10.1016/S0736-5748(99)00002-7	40	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22123	10.1096/fj.202101389R	http://dx.doi.org/10.1096/fj.202101389R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972242				2022-12-26	WOS:000747987800033
J	Rasmussen, HO; Otzen, DE; Pedersen, JS				Rasmussen, Helena Ostergaard; Otzen, Daniel E.; Pedersen, Jan Skov			Induction, inhibition, and incorporation: Different roles for anionic and zwitterionic lysolipids in the fibrillation of the functional amyloid FapC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SURFACTANT INTERACTIONS; X-RAY-SCATTERING; ALPHA-SYNUCLEIN; MEMBRANE INTERACTIONS; LIPID-MEMBRANES; PEPTIDE; POLYPEPTIDE; CHOLESTEROL; AGGREGATION; MODEL	Amyloid proteins are widespread in nature both as pathological species involved in several diseases and as functional entities that can provide protection and storage for the organism. Lipids have been found in amyloid deposits from various amyloid diseases and have been shown to strongly affect the formation and structure of both pathological and functional amyloid proteins. Here, we investigate how fibrillation of the functional amyloid FapC from Pseudomonas is affected by two lysolipids, the zwitterionic lipid 1-myristoyl-2-hydroxy-sn-glycero-3phosphocholine and the anionic lipid 1-myristoyl-2-hydroxyand thioflavin T fluorescence measurements were performed simultaneously on the same sample to ensure reproducibility and allow a multimethod integrated analysis. We found that LPG strongly induces fibrillation around its critical micelle concentration (cmc) by promoting formation of large structures, which mature via accumulation of intermediate fibril structures with a large cross section. At concentrations above its cmc, LPG strongly inhibits fibrillation by locking FapC in a core-shell 3-phosphocholine induces fibrillation at concentrations above its cmc, not via strong interactions with FapC but by being incorporated during fibrillation and likely stabilizing the fibrillation nucleus to reduce the lag phase. Finally, we show that LPG is not incorporated into the fibril during assembly but rather can coat the final fibril. We conclude that lipids affect both the mechanism and outcome of fibrillation of functional amyloid, highlighting a role for lipid concentration and composition in the onset and mechanism of fibrillation in vivo.	[Rasmussen, Helena Ostergaard; Otzen, Daniel E.; Pedersen, Jan Skov] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark; [Rasmussen, Helena Ostergaard; Pedersen, Jan Skov] Aarhus Univ, Dept Chem, Aarhus C, Denmark; [Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Otzen, DE; Pedersen, JS (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark.; Pedersen, JS (corresponding author), Aarhus Univ, Dept Chem, Aarhus C, Denmark.; Otzen, DE (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark.	dao@inano.au.dk; jsp@chem.au.dk	Rasmussen, Helena Østergaard/GQI-2591-2022; Pedersen, Jan Skov/A-8346-2008	Rasmussen, Helena Østergaard/0000-0001-8384-656X; Pedersen, Jan Skov/0000-0002-7768-0206; Otzen, Daniel/0000-0002-2918-8989	Independent Research Fund Denmark, Natural Sciences [8021-00133B]	Independent Research Fund Denmark, Natural Sciences	The support from the Independent Research Fund Denmark, Natural Sciences (grant no.: 8021-00133B) is gratefully acknowledged (J. S. P.) .	Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Avdulov NA, 1997, J NEUROCHEM, V69, P1746; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Brown A, 2009, INT J MOL SCI, V10, P3457, DOI 10.3390/ijms10083457; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Chodankar S, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/32/326102; Christensen LFB, 2020, J BIOL CHEM, V295, P13031, DOI 10.1074/jbc.RA120.013396; Cooper A., 2005, BIOPHYS CHEM, V1st, P107; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Gellermann GP, 2006, BIOL CHEM, V387, P1267, DOI 10.1515/BC.2006.157; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HAYTER JB, 1983, COLLOID POLYM SCI, V261, P1022, DOI 10.1007/BF01421709; Hellstrand E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077235; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Jiang ZP, 2014, J MOL BIOL, V426, P4074, DOI 10.1016/j.jmb.2014.10.009; Jones EM, 2012, BIOCHEMISTRY-US, V51, P2539, DOI 10.1021/bi201857v; JOOSTEN JGH, 1990, PHYS REV A, V42, P2161, DOI 10.1103/PhysRevA.42.2161; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Koenig BW, 2005, BBA-BIOMEMBRANES, V1715, P65, DOI 10.1016/j.bbamem.2005.07.006; Korshavn KJ, 2017, J BIOL CHEM, V292, P4638, DOI 10.1074/jbc.M116.764092; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Li YL, 2008, J APPL CRYSTALLOGR, V41, P1134, DOI 10.1107/S0021889808031129; Majewski J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70208-6; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; MENDZ GL, 1995, EUR BIOPHYS J BIOPHY, V24, P39, DOI 10.1007/BF00216829; Morel B, 2018, PHYS CHEM CHEM PHYS, V20, P20597, DOI 10.1039/c8cp02685h; Mortensen HG, 2017, BIOPHYS J, V113, P2621, DOI 10.1016/j.bpj.2017.10.024; Nagaraj M, 2020, J MOL BIOL, V432, P2232, DOI 10.1016/j.jmb.2020.01.044; Najarzadeh Z, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2019.140263; Nielsen AD, 2005, BBA-PROTEINS PROTEOM, V1752, P124, DOI 10.1016/j.bbapap.2005.08.001; Norrild RK, 2021, BIOPHYS CHEM, V271, DOI 10.1016/j.bpc.2021.106549; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Oliver RC, 2014, LANGMUIR, V30, P13353, DOI 10.1021/la503458n; Otzen D, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033860; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Otzen D, 2010, PRION, V4, P256, DOI 10.4161/pri.4.4.13676; Otzen DE, 2009, J COLLOID INTERF SCI, V329, P273, DOI 10.1016/j.jcis.2008.10.021; Pedersen JN, 2020, CHEM SCI, V11, P699, DOI 10.1039/c9sc04831f; Pedersen JN, 2019, BBA-PROTEINS PROTEOM, V1867, P519, DOI 10.1016/j.bbapap.2018.11.007; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Pedersen JS, 1996, J APPL CRYSTALLOGR, V29, P646, DOI 10.1107/S0021889896006589; Pirc K, 2015, BBA-BIOMEMBRANES, V1848, P2002, DOI 10.1016/j.bbamem.2015.06.021; Rasmussen CB, 2019, PROTEIN SCI, V28, P633, DOI 10.1002/pro.3566; Rasmussen HO, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.129434; Rasmussen HO, 2021, BIOPHYS J, V120, P2262, DOI 10.1016/j.bpj.2021.03.031; Rocha S, 2012, BIOCHEM BIOPH RES CO, V420, P136, DOI 10.1016/j.bbrc.2012.02.129; Rouse SL, 2018, J MOL BIOL, V430, P3685, DOI 10.1016/j.jmb.2018.05.004; Saboury AA, 2003, J THERM ANAL CALORIM, V72, P93, DOI 10.1023/A:1023955300221; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sciacca MF, 2020, ACS CHEM NEUROSCI, V11, P4336, DOI 10.1021/acschemneuro.0c00588; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2; Sharma S, 2021, BIOPHYS CHEM, V278, DOI 10.1016/j.bpc.2021.106665; Soria MA, 2017, BIOPHYS J, V113, P37, DOI 10.1016/j.bpj.2017.05.039; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Sun Y, 2015, SOFT MATTER, V11, P7769, DOI 10.1039/c5sm01231g; TERASAWA S, 1975, J PHYS CHEM-US, V79, P2345, DOI 10.1021/j100589a004; TURRO NJ, 1995, LANGMUIR, V11, P2525, DOI 10.1021/la00007a035; Wei Y, 2016, PHYS CHEM CHEM PHYS, V18, P29847, DOI 10.1039/c6cp04431j; WENDER M, 1991, Neuropatologia Polska, V29, P87; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Zhang XX, 2017, BIOCHEMISTRY-US, V56, P376, DOI 10.1021/acs.biochem.6b01016; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	72	0	0	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101569	10.1016/j.jbc.2022.101569	http://dx.doi.org/10.1016/j.jbc.2022.101569			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35007533	gold, Green Published			2022-12-26	WOS:000761371500002
J	Zhang, X; Wang, YQ; Yao, HY; Deng, SW; Gao, T; Shang, L; Chen, XC; Cui, XJ; Zeng, J				Zhang, Xiao; Wang, Yaoqing; Yao, Haoya; Deng, Senwen; Gao, Ting; Shang, Lin; Chen, Xiaocui; Cui, Xiaojuan; Zeng, Jia			Peroxisomal beta-oxidation stimulates cholesterol biosynthesis in the liver in diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; ACTIVATED RECEPTOR-ALPHA; ACYL-COA THIOESTERASES; ACETYL-COA; RAT-LIVER; CARNITINE ACYLTRANSFERASES; ERUCIC-ACID; METABOLISM; ACETATE; HEPATOCYTES	Although diabetes normally causes an elevation of cholesterol biosynthesis and induces hypercholesterolemia in animals and human, the mechanism linking diabetes to the dysregulation of cholesterol biosynthesis in the liver is not fully understood. As liver peroxisomal beta-oxidation is induced in the diabetic state and peroxisomal oxidation of fatty acids generates free acetate, we hypothesized that peroxisomal beta-oxidation might play a role in liver cholesterol biosynthesis in diabetes. Here, we used erucic acid, a specific substrate for peroxisomal beta-oxidation, and 10,12-tricosadiynoic acid, a specific inhibitor for peroxisomal beta-oxidation, to specifically induce and suppress peroxisomal beta-oxidation. Our results suggested that induction of peroxisomal beta-oxidation increased liver cholesterol biosynthesis in streptozotocin-induced diabetic mice. We found that excessive oxidation of fatty acids by peroxisomes generated considerable free acetate in the liver, which was used as a precursor for cholesterol biosynthesis. In addition, we show that specific inhibition of peroxisomal beta-oxidation decreased cholesterol biosynthesis by reducing acetate formation in the liver in diabetic mice, demonstrating a crosstalk between peroxisomal beta-oxidation and cholesterol biosynthesis. Based on these results, we propose that induction of peroxisomal beta-oxidation serves as a mechanism for a fatty acidinduced upregulation in cholesterol biosynthesis and also plays a role in diabetes-induced hypercholesterolemia.	[Zhang, Xiao; Wang, Yaoqing; Yao, Haoya; Deng, Senwen; Gao, Ting; Shang, Lin; Chen, Xiaocui; Cui, Xiaojuan; Zeng, Jia] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China	Hunan University of Science & Technology	Zeng, J (corresponding author), Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China.	zengj@hnu.edu.cn			National Natural Science Fund of P. R. China [30900024]; Hunan University of Science and Technology; Project of graduate innovation in Hunan province [CX20190814]	National Natural Science Fund of P. R. China(National Natural Science Foundation of China (NSFC)); Hunan University of Science and Technology; Project of graduate innovation in Hunan province	This work was supported by the National Natural Science Fund of P. R. China (30900024), Distinguished Professor Funds from Hunan University of Science and Technology, and Project of graduate innovation in Hunan province (CX20190814).	Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; Antonenkov VD, 2004, AM J PHYSIOL-CELL PH, V287, pC1623, DOI 10.1152/ajpcell.00142.2004; Asayama K, 1999, MOL CELL BIOCHEM, V194, P227, DOI 10.1023/A:1006930513476; ASAYAMA K, 1991, DIABETES RES CLIN PR, V11, P89, DOI 10.1016/0168-8227(91)90096-V; Bieber L L, 1981, Methods Enzymol, V71 Pt C, P351; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADY RO, 1950, J BIOL CHEM, V187, P589; BREMER J, 1982, J LIPID RES, V23, P243; Carre P, 2014, OCL OILS FAT CROP LI, V21, DOI 10.1051/ocl/2013054; CARROLL KK, 1959, CAN J BIOCHEM PHYS, V37, P803; CASSADER M, 1993, ATHEROSCLEROSIS, V99, P47, DOI 10.1016/0021-9150(93)90049-Z; CENEDELLA RJ, 1969, LIPIDS, V4, P155, DOI 10.1007/BF02531936; Chen XC, 2020, J BIOL CHEM, V295, P10168, DOI 10.1074/jbc.RA120.013583; CHOI YR, 1977, J BIOL CHEM, V252, P7930; CHUNG BH, 1980, J LIPID RES, V21, P284; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; DUPONT J, 1966, LIPIDS, V1, P415, DOI 10.1007/BF02532545; FERRE P, 1983, BIOCHEM J, V214, P937, DOI 10.1042/bj2140937; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Ginsberg HN, 1998, AM J CARDIOL, V81, p32B, DOI 10.1016/S0002-9149(98)00035-6; Grant RW, 2002, AM J MED, V112, P603, DOI 10.1016/S0002-9343(02)01103-8; Gu Y., 2020, OBES MED, V18; Haffner SM, 1999, AM J CARDIOL, V83, p17F; HANDLER JA, 1988, EUR J BIOCHEM, V176, P477, DOI 10.1111/j.1432-1033.1988.tb14305.x; HASHIMOTO F, 1995, BIOCHEM PHARMACOL, V49, P1213, DOI 10.1016/0006-2952(95)00041-W; He AY, 2020, MOL CELL, V79, P30, DOI 10.1016/j.molcel.2020.05.007; Honda A, 1998, J LIPID RES, V39, P44; HORIE S, 1981, J BIOCHEM, V90, P1691, DOI 10.1093/oxfordjournals.jbchem.a133645; HOTTA S, 1954, J BIOL CHEM, V206, P835; HOTTA S, 1952, J BIOL CHEM, V198, P895; HOVIK R, 1991, J LIPID RES, V32, P993; Hu C, 2018, DIABETES, V67, P3, DOI 10.2337/dbi17-0013; Hunt MC, 2008, PROG LIPID RES, V47, P405, DOI 10.1016/j.plipres.2008.05.001; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; KING MT, 1988, METHOD ENZYMOL, V166, P70; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; KONDRUP J, 1985, BIOCHIM BIOPHYS ACTA, V835, P147, DOI 10.1016/0005-2760(85)90041-4; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; KWONG LK, 1991, DIABETES, V40, P1630, DOI 10.2337/diabetes.40.12.1630; Lazarow P B, 1981, Methods Enzymol, V72, P315; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MURTHY VK, 1973, METABOLISM, V22, P81, DOI 10.1016/0026-0495(73)90032-2; NAKANISHI Y, 1994, J BIOCHEM-TOKYO, V115, P328, DOI 10.1093/oxfordjournals.jbchem.a124337; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; NILSSON A, 1974, FEBS LETT, V45, P282, DOI 10.1016/0014-5793(74)80862-8; PEARSON DJ, 1964, NATURE, V202, P91, DOI 10.1038/202091a0; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REITZ R C, 1979, Progress in Lipid Research, V18, P87, DOI 10.1016/0163-7827(79)90007-9; ROGNSTAD R, 1991, BIOCHEM J, V279, P147, DOI 10.1042/bj2790147; SCHAFER HF, 1992, CLIN BIOCHEM, V25, P325, DOI 10.1016/0009-9120(92)80008-5; Scoppola A, 2001, ATHEROSCLEROSIS, V156, P357, DOI 10.1016/S0021-9150(00)00660-2; THOMAS H, 1989, BIOCHEM PHARMACOL, V38, P4291, DOI 10.1016/0006-2952(89)90528-5; THOMASSEN MS, 1982, BIOCHEM J, V206, P195, DOI 10.1042/bj2060195; TUBBS PK, 1964, BIOCHEM J, V93, P550, DOI 10.1042/bj0930550; VAMECQ J, 1987, J BIOCHEM-TOKYO, V102, P225, DOI 10.1093/oxfordjournals.jbchem.a122035; VANBRUGGEN JT, 1954, J BIOL CHEM, V209, P635; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; WILLIAMS.DH, 1968, BIOCHEM J, V108, P353, DOI 10.1042/bj1080353; YOSHINO G, 1988, ATHEROSCLEROSIS, V73, P191, DOI 10.1016/0021-9150(88)90041-X; Yuan CX, 2015, CHROMATOGRAPHIA, V78, P273, DOI 10.1007/s10337-014-2826-2; Zeng J, 2017, J BIOL CHEM, V292, P3800, DOI 10.1074/jbc.M116.763532	63	2	2	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101572	10.1016/j.jbc.2022.101572	http://dx.doi.org/10.1016/j.jbc.2022.101572			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35007532	Green Published, gold			2022-12-26	WOS:000761371500011
J	Demissew, A; Animut, A; Kibret, S; Tsegaye, A; Hawaria, D; Degefa, T; Getachew, H; Lee, MC; Yan, GY; Yewhalaw, D				Demissew, Assalif; Animut, Abebe; Kibret, Solomon; Tsegaye, Arega; Hawaria, Dawit; Degefa, Teshome; Getachew, Hallelujah; Lee, Ming-Chieh; Yan, Guiyun; Yewhalaw, Delenasaw			Evidence of pyrethroid resistance in Anopheles amharicus and Anopheles arabiensis from Arjo-Didessa irrigation scheme, Ethiopia	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; GAMBIAE COMPLEX; DETOXIFICATION GENES; VECTOR; IMPACT; QUADRIANNULATUS; IDENTIFICATION; TOLERANCE	Background Indoor residual spraying and insecticide-treated nets are among the key malaria control intervention tools. However, their efficacy is declining due to the development and spread of insecticide resistant vectors. In Ethiopia, several studies reported resistance of An. arabiensis to multiple insecticide classes. However, such data is scarce in irrigated areas of the country where insecticides, pesticides and herbicides are intensively used. Susceptibility of An. gambiae s.l. to existing and new insecticides and resistance mechanisms were assessed in Arjo-Didessa sugarcane plantation area, southwestern Ethiopia. Methods Adult An. gambiae s.l. reared from larval/pupal collections of Arjo-Didessa sugarcane irrigation area and its surrounding were tested for their susceptibility to selected insecticides. Randomly selected An. gambiae s.l. (dead and survived) samples were identified to species using species-specific polymerase chain reaction (PCR) and were further analyzed for the presence of knockdown resistance (kdr) alleles using allele-specific PCR. Results Among the 214 An. gambiae s.l. samples analyzed by PCR, 89% (n = 190) were An. amharicus and 9% (n = 20) were An. arabiensis. Mortality rates of the An. gambiae s.l. exposed to deltamethrin and alphacypermethrin were 85% and 86.8%, respectively. On the other hand, mortalities against pirmiphos-methyl, bendiocarb, propoxur and clothianidin were 100%, 99%, 100% and 100%, respectively. Of those sub-samples (An. amharicus and An. arabiensis) examined for presence of kdr gene, none of them were found to carry the L1014F (West African) allelic mutation. Conclusion Anopheles amharicus and An. arabiensis from Arjo-Didessa sugarcane irrigation area were resistant to pyrethroids which might be synergized by extensive use of agricultural chemicals. Occurrence of pyrethroid resistant malaria vectors could challenge the ongoing malaria control and elimination program in the area unless resistance management strategies are implemented. Given the resistance of An. amharicus to pyrethroids, its behavior and vectorial capacity should be further investigated.	[Demissew, Assalif] Ambo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Ambo, Ethiopia; [Demissew, Assalif; Animut, Abebe] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Kibret, Solomon; Lee, Ming-Chieh; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Tsegaye, Arega] Jimma Univ, Coll Nat Sci, Dept Biol, Jimma, Ethiopia; [Tsegaye, Arega; Hawaria, Dawit; Degefa, Teshome; Getachew, Hallelujah; Yewhalaw, Delenasaw] Jimma Univ, Trop & Infect Dis Res Ctr TIDRC, Jimma, Ethiopia; [Hawaria, Dawit] Yirgalem Hosp Med Coll, Yirgalem, Ethiopia; [Hawaria, Dawit; Degefa, Teshome; Getachew, Hallelujah; Yewhalaw, Delenasaw] Jimma Univ, Fac Hlth Sci, Sch Med Lab Sci, Jimma, Ethiopia; [Getachew, Hallelujah] Arbaminch Coll Hlth Sci, Dept Med Lab Sci, Arba Minch, Ethiopia	Ambo University; Addis Ababa University; University of California System; University of California Irvine; Jimma University; Jimma University; Jimma University	Demissew, A (corresponding author), Ambo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Ambo, Ethiopia.; Demissew, A (corresponding author), Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	assalifd@yahoo.com		Demissew, Assalif/0000-0001-7054-0641; Degefa, Teshome/0000-0002-3518-2372; Lee, Ming-Chieh/0000-0002-2462-6089; Logita, Dawit Hawaria/0000-0001-8975-894X; Kibret, Solomon/0000-0003-1793-6908	National Institutes of Health (NIH) [D43TW001505, R01A1050243, U19AI129326]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was financially supported by National Institutes of Health (NIH) (Grant No.:D43TW001505, R01A1050243 and U19AI129326). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abuelmaali SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080549; Agossa FR., 2018, PARASITE VECTOR, V11, P1; Agossa FR., 2018, MALARIA J, V17, P1; Akogbeto MC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-22; Alemayehu E, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2342-y; [Anonymous], 2009, IMPORTANCE IRRIGATED; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Chabi J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1462-0; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Chouaibou MS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1481-5; Coetzee M, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-3144-9; Dagg K, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2685-2; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; Davies T. G. E., 2009, Bayer CropScience Journal, V62, P159; Demissew A, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03416-0; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Fettene M, 2003, J MED ENTOMOL, V40, P112, DOI 10.1603/0022-2585-40.1.112; Fodjo BK, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2874160; Gilbert L.I., 2010, INSECT CONTROL BIOL; Haile GG., 2015, ACAD J AGRI RES, DOI [DOI 10.15413/AJAR.2015.0141, 10.15413/ajar.2015.0141]; Hancock PA, 2018, P NATL ACAD SCI USA, V115, P5938, DOI 10.1073/pnas.1801826115; Hawaria D., 2019, MALARIA J, V18, P1; Hawaria D, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-019-0620-y; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Hien AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173098; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; Jeanrenaud ACSN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215552; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Massebo F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-44; Matowo J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-193; Matowo NS, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03331-4; Messenger L., 2017, MALARIA J, V11, P1; Mzilahowa T, 2008, MED VET ENTOMOL, V22, P258, DOI 10.1111/j.1365-2915.2008.00736.x; Nkya Theresia E, 2014, Tanzan J Health Res, V16, P329; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Nkya TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0480-z; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Oliver SV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192551; Orondo PW, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04833-z; Oxborough RM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2888-6; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reid MC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1162-4; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007; Riveron JM., 2018, MALARIA ELIMINATION, P149, DOI [10.5772/intechopen.78375, DOI 10.5772/INTECHOPEN.78375]; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Singh OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-59; Tabbabi A, 2019, TROP BIOMED, V36, P542; Uragayala S, 2018, TROP MED INT HEALTH, V23, P605, DOI 10.1111/tmi.13056; Uragayala S, 2015, INDIAN J MED RES, V142, P64, DOI 10.4103/0971-5916.176624; Wanjala CL, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00055; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WHO, 2016, WORLD MAL REP 2016; WHO, 2016, APPROPRIATE MONITORI; Wilkins L, 2007, METHODS ANOPHELES RE; World Health Organization, 2006, PEST THEIR APPL CONT; Yadouleton A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-60; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Zahar AR, 1985, VBC53 WHO	62	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261713	10.1371/journal.pone.0261713	http://dx.doi.org/10.1371/journal.pone.0261713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030201	gold, Green Published			2022-12-26	WOS:000812798500014
J	Lim, K; Rolston, M; Barnum, S; Wademan, C; Leverenz, H				Lim, Kahui; Rolston, Matthew; Barnum, Samantha; Wademan, Cara; Leverenz, Harold			A biogeographic 16S rRNA survey of bacterial communities of ureolytic biomineralization from California public restrooms	PLOS ONE			English	Article							SP-NOV.; BIOFILM FORMATION; UREASE ACTIVITY; GEN. NOV.; CALCITE; SOIL; INACTIVATION; STABILITY; ALKALINE; STORAGE	In this study, we examined the total bacterial community associated with ureolytic biomineralization from urine drainage systems. Biomineral samples were obtained from 11 California Department of Transportation public restrooms fitted with waterless, low-flow, or conventional urinals in 2019. Following high throughput 16S rRNA Illumina sequences processed using the DADA2 pipeline, the microbial diversity assessment of 169 biomineral and urine samples resulted in 3,869 reference sequences aggregated as 598 operational taxonomic units (OTUs). Using PERMANOVA testing, we found strong, significant differences between biomineral samples grouped by intrasystem sampling location and urinal type. Biomineral microbial community profiles and alpha diversities differed significantly when controlling for sampling season. Observational statistics revealed that biomineral samples obtained from waterless urinals contained the largest ureC/16S gene copy ratios and were the least diverse urinal type in terms of Shannon indices. Waterless urinal biomineral samples were largely dominated by the Bacilli class (86.1%) compared to low-flow (41.3%) and conventional samples (20.5%), and had the fewest genera that account for less than 2.5% relative abundance per OTU. Our findings are useful for future microbial ecology studies of urine source-separation technologies, as we have established a comparative basis using a large sample size and study area.	[Lim, Kahui; Leverenz, Harold] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Rolston, Matthew] Univ Calif Davis, Dept Med Microbiol & Immunol, Host Microbe Syst Biol Core Facil, Davis, CA 95616 USA; [Barnum, Samantha; Wademan, Cara] Univ Calif Davis, Dept Med & Epidemiol, Real Time PCR Res & Diagnost Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Lim, K (corresponding author), Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA.	kalim@ucdavis.edu		Lim, Kahui/0000-0002-3790-4770	California Department of Transportation [65A0734]	California Department of Transportation	This research was funded by the California Department of Transportation under Agreement Number 65A0734. The grant was awarded to Harold Leverenz. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	allassignmenthelp, ALPHA DIVERSITY EXPL; Anbu P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1869-2; Bachmeier KL, 2002, J BIOTECHNOL, V93, P171, DOI 10.1016/S0168-1656(01)00393-5; Baird R.B., 2017, STANDARD METHODS EXA, V23; benjjneb, DADA2 PIPELINE TUTOR; Broomfield RJ, 2009, J MED MICROBIOL, V58, P1367, DOI 10.1099/jmm.0.012419-0; Burbank MB, 2012, GEOMICROBIOL J, V29, P389, DOI 10.1080/01490451.2011.575913; Buttigieg PL, 2014, FEMS MICROBIOL ECOL, V90, P543, DOI 10.1111/1574-6941.12437; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Canaveras JC, 2006, NATURWISSENSCHAFTEN, V93, P27, DOI 10.1007/s00114-005-0052-3; CHIN WT, 1961, ANAL CHEM, V33, P1757, DOI 10.1021/ac60180a039; Cho Sun-Ja, 2016, Journal of Ecology and Environment, V40, P10, DOI 10.1186/s41610-016-0004-1; Cotta MA, 2004, ANAEROBE, V10, P191, DOI 10.1016/j.anaerobe.2004.04.001; CRAMER WN, 1983, APPL ENVIRON MICROB, V45, P760, DOI 10.1128/AEM.45.3.760-765.1983; Demiriz M., 2006, APPL SCI; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Doyle JD, 2002, WATER RES, V36, P3925, DOI 10.1016/S0043-1354(02)00126-4; Espinosa-Ortiz EJ, 2019, NAT REV UROL, V16, P35, DOI 10.1038/s41585-018-0120-z; Fischer MA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02064; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fujita Y, 2010, ENVIRON SCI TECHNOL, V44, P7652, DOI 10.1021/es101752p; Gat D, 2016, ENVIRON SCI TECHNOL, V50, P616, DOI 10.1021/acs.est.5b04033; github, GITHUB S4HTSHTSTREAM; github, GITHUB MSETTLESDBCAM; Goosse P, 2009, GWA, P567; GRIFFITH DP, 1978, KIDNEY INT, V13, P372, DOI 10.1038/ki.1978.55; Habbadi K, 2020, J APPL MICROBIOL, V128, P828, DOI 10.1111/jam.14523; Hai B, 2009, APPL ENVIRON MICROB, V75, P4993, DOI 10.1128/AEM.02917-08; Harrns C., TISSIERELLA CREATINO; Holling N, 2014, INFECT IMMUN, V82, P1616, DOI 10.1128/IAI.01652-13; HU LT, 1990, J BACTERIOL, V172, P3073, DOI 10.1128/jb.172.6.3073-3080.1990; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jin D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00385; Jin D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01006; Keshri J, 2013, MICROBIOL RES, V168, P165, DOI 10.1016/j.micres.2012.09.005; Kim YJ, 2010, INT J SYST EVOL MICR, V60, P1401, DOI 10.1099/ijs.0.009720-0; Kvarnstrom E., 2006, OSANRES PUBL SER, V64; Lahr RH, 2016, ENVIRON SCI TECHNOL, V50, P11619, DOI 10.1021/acs.est.6b02094; Legendre P., 2012, NUMERICAL ECOLOGY; Li WJ, 2007, INT J SYST EVOL MICR, V57, P1424, DOI 10.1099/ijs.0.64749-0; Li XB, 2016, ANTIMICROB AGENTS CH, V60, P2993, DOI 10.1128/AAC.00203-16; Lim K., 2021, BIORXIV; Lindgren M, 1999, URINSORTING TOILETSC; Liu CM, 2013, MBIO, V4, DOI 10.1128/mBio.00076-13; Liu YT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205112; Lv ZP, 2019, APPL MICROBIOL BIOT, V103, P519, DOI 10.1007/s00253-018-9444-0; Maciejewska M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01181; Mahdy A., 2020, BIORESOUR TECHNOL RE, V9, DOI DOI 10.1016/J.BITEB.2019.100359; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mesbah NM, 2007, MICROB ECOL, V54, P598, DOI 10.1007/s00248-006-9193-y; Mestre M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01590; Mortensen BM, 2011, J APPL MICROBIOL, V111, P338, DOI 10.1111/j.1365-2672.2011.05065.x; Muller T, 2006, CURR MICROBIOL, V52, P400, DOI 10.1007/s00284-005-0370-x; Oshiki M, 2018, MICROBES ENVIRON, V33, P230, DOI [10.1264/jsme2.ME17188, 10.1264/jsme2.me17188]; Prywer J, 2017, CURR MED CHEM, V24, P292, DOI 10.2174/0929867323666161028154545; Qiao NH, 2018, ANTON LEEUW INT J G, V111, P945, DOI 10.1007/s10482-017-0993-5; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rahmati E, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw272; RESNICK MI, 1981, UROL CLIN N AM, V8, P265; ROSSAU R, 1987, INT J SYST BACTERIOL, V37, P198, DOI 10.1099/00207713-37-3-198; Rubin BER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070460; Schultz L. N., 2016, ROLE BACTERIA UROLOG, P41; Shu M, 2003, INFECT IMMUN, V71, P7188, DOI 10.1128/IAI.71.12.7188-7192.2003; Sun W, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01644; Udert KM, 2003, WA SCI TECHNOL, V3, P71, DOI 10.2166/ws.2003.0010; Vaz-Moreira I, 2010, INT J SYST EVOL MICR, V60, P144, DOI 10.1099/ijs.0.009498-0; Vinneras B, 2008, WATER RES, V42, P4067, DOI 10.1016/j.watres.2008.06.014; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; ZANTUA MI, 1977, SOIL BIOL BIOCHEM, V9, P135, DOI 10.1016/0038-0717(77)90050-5; Zheng Q, 2019, SOIL BIOL BIOCHEM, V136, DOI 10.1016/j.soilbio.2019.107521	70	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262425	10.1371/journal.pone.0262425	http://dx.doi.org/10.1371/journal.pone.0262425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030221	gold, Green Published			2022-12-26	WOS:000812798500044
J	Wang, Z; Liu, YY; Wei, LY; Ji, JS; Liu, Y; Liu, RY; Zha, YX; Chang, XY; Zhang, L; Liu, Q; Zhang, Y; Zeng, J; Dong, T; Xu, XY; Zhou, LJ; He, J; Deng, Y; Zhong, B; Wu, XP				Wang, Zhuo; Liu, Yuanyuan; Wei, Luyi; Ji, John S.; Liu, Yang; Liu, Runyou; Zha, Yuxin; Chang, Xiaoyu; Zhang, Lun; Liu, Qian; Zhang, Yu; Zeng, Jing; Dong, Ting; Xu, Xinyin; Zhou, Lijun; He, Jun; Deng, Ying; Zhong, Bo; Wu, Xianping			What are the risk factors of hospital length of stay in the novel coronavirus pneumonia (COVID-19) patients? A survival analysis in southwest China	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; PRIMARY-CARE; IMPACT; WUHAN	Background The global epidemic of novel coronavirus pneumonia (COVID-19) has resulted in substantial healthcare resource consumption. Since patients' hospital length of stay (LoS) is at stake in the process, an investigation of COVID-19 patients' LoS and its risk factors becomes urgent for a better understanding of regional capabilities to cope with COVID-19 outbreaks. Methods First, we obtained retrospective data of confirmed COVID-19 patients in Sichuan province via National Notifiable Diseases Reporting System (NNDRS) and field surveys, including their demographic, epidemiological, clinical characteristics and LoS. Then we estimated the relationship between LoS and the possibly determinant factors, including demographic characteristics of confirmed patients, individual treatment behavior, local medical resources and hospital grade. The Kaplan-Meier method and the Cox Proportional Hazards Model were applied for single factor and multi-factor survival analysis. Results From January 16, 2020 to March 4, 2020, 538 human cases of COVID-19 infection were laboratory-confirmed, and were hospitalized for treatment, including 271 (50%) patients aged >= 45, 285 (53%) males, and 450 patients (84%) with mild symptoms. The median LoS was 19 (interquartile range (IQR): 14-23, range: 3-41) days. Univariate analysis showed that age and clinical grade were strongly related to LoS (P<0.01). Adjusted multivariate analysis showed that the longer LoS was associated with those aged >= 45 (Hazard ratio (HR): 0.74, 95% confidence interval (CI): 0.60-0.91), admission to provincial hospital (HR: 0.73, 95% CI: 0.54-0.99), and severe illness (HR: 0.66, 95% CI: 0.48-0.90). By contrast, the shorter LoS was linked with residential areas with more than 5.5 healthcare workers per 1,000 population (HR: 1.32, 95% CI: 1.05-1.65). Neither gender factor nor time interval from illness onset to diagnosis showed significant impact on LoS. Conclusions Understanding COVID-19 patients' hospital LoS and its risk factors is critical for governments' efficient allocation of resources in respective regions. In areas with older and more vulnerable population and in want of primary medical resources, early reserving and strengthening of the construction of multi-level medical institutions are strongly suggested to cope with COVID-19 outbreaks.	[Wang, Zhuo; Liu, Yang; Liu, Runyou; Zha, Yuxin; Chang, Xiaoyu; Zhang, Lun; Liu, Qian; Zhang, Yu; Zeng, Jing; Dong, Ting; Xu, Xinyin; Zhou, Lijun; He, Jun; Deng, Ying; Zhong, Bo; Wu, Xianping] Sichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Liu, Yuanyuan; Wei, Luyi] Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Liu, Yuanyuan; Wei, Luyi] Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China; [Ji, John S.] Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China	Sichuan University; Sichuan University; Tsinghua University	Zhong, B; Wu, XP (corresponding author), Sichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China.	zhongbo1969@163.com; wwwuxp@163.com	Zeng, jing/AGY-9325-2022; Zhou, Li/GSE-4531-2022; Ji, John/AAT-4219-2021; liu, yuanyuan/GWZ-5838-2022	Zeng, jing/0000-0002-4736-4210; Ji, John/0000-0002-5002-118X; 	Chengdu Science and Technology Bureau [2020YF05-00296-SN]; Science and Technology Bureau of Sichuan province (COVID-19 science and technology emergency project) [2020YFS0015]; Sichuan Provincial Leading Group Office for Talent Work (Sichuan provincial "Tianfu ten thousand talents plan" fund in 2018); China National Natural Science Funding [82041033]; Science and Technology Department of Chengdu [2020-YF05-00296-SN]	Chengdu Science and Technology Bureau; Science and Technology Bureau of Sichuan province (COVID-19 science and technology emergency project); Sichuan Provincial Leading Group Office for Talent Work (Sichuan provincial "Tianfu ten thousand talents plan" fund in 2018); China National Natural Science Funding(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Chengdu	The funding of the project No. 2020YF05-00296-SN is from Chengdu Science and Technology Bureau. Yuanyuan Liu is the leader of this project, who receives funding award. This funding has nothing to do with any commercial companies. Chengdu Science and Technology Bureau didn't play any role in study design, data collection and analysis, decesion to publish, and preparation of the manuscript. This research was supported by the Grants from Science and Technology Bureau of Sichuan province (COVID-19 science and technology emergency project, No. 2020YFS0015), Sichuan Provincial Leading Group Office for Talent Work (Sichuan provincial "Tianfu ten thousand talents plan" fund in 2018) and China National Natural Science Funding (No.82041033), Science and Technology Department of Chengdu (No. 2020-YF05-00296-SN).	[Anonymous], 2020, CHINA DAILY; C.Massonnaud, 2020, medRxiv, DOI 10.1101/2020.03.16.20036939; Epidemiology Working Group for Ncip Epidemic Response CCfDC Prevention, 2020, ZHONGHUA LIU XING BI, V41; General Office of National Health Commission of the People's Republic of China, 2020, CHINAS MED, V15, P1494; George B, 2014, J NUCL CARDIOL, V21, P686, DOI 10.1007/s12350-014-9908-2; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Health Commission of Sichuan Province, 2020, HLTH RES; Krist AH, 2020, ANN FAM MED, V18, P349, DOI 10.1370/afm.2557; Lee K, 2009, GLOB INST, P1; Lin S, 2020, MAYO CLIN PROC, V95, P1831, DOI 10.1016/j.mayocp.2020.06.050; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Liu XF, 2020, J INFECTION, V81, pE95, DOI 10.1016/j.jinf.2020.04.008; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m641; MEDBOX, 2020, COVID 19; Milenkovic M, 2006, HEALTHCARE COST UTIL; Mitchell S, 2020, PALLIATIVE MED, V34, P1182, DOI 10.1177/0269216320947623; Moriconi D, 2020, OBES RES CLIN PRACT, V14, P205, DOI 10.1016/j.orcp.2020.05.009; National Health Commission of the People's Republic of China, 2020, GUID COR VIR DIS 201; Park M, 2020, EUR J IMMUNOL, V50, P308, DOI 10.1002/eji.202070035; Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033; Thai PQ, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001259; Rees EM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01726-3; Romeyke T, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.926694; Sarti TD, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/S1679-49742020000200024, 10.5123/s1679-49742020000200024]; Sichuan Provincial Bureau of Statistics, 2018, STAT YB SICH PROV; Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P139, DOI 10.3760/cma.j.issn.0254-6450.2020.02.002; The Central People's Government of the People's Republic of China, 2019, NOT COMPL BAS PUBL H; The People's Government of Sichuan Province, 2020, 41 EX M SICH PROV PE; The People's Government of Sichuan Province, 2020, 10 QUEST 1 LEV EM RE; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wikipedia, 2020, SICH; WINTAC, 2020, WORKPL READ SKILLS T; World Health Organization, RAP HOSP READ CHECKL; World Health Organization, 2020, NOV COR COVID 19 SIT; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Wu J, 2020, CLIN INFECT DIS, V71, P706, DOI 10.1093/cid/ciaa199; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; YIN H., 2019, J MED INFORM, V40, P1, DOI [10.3969/j.issn.1673-6036.2019.08.001, DOI 10.3969/J.ISSN.1673-6036.2019.08.001]; Zhang Longhao, 2020, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V37, P236, DOI 10.7507/1001-5515.202002034; Zheng H, 2020, BRIT J ANAESTH, V125, pE378, DOI 10.1016/j.bja.2020.07.001; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490	42	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261216	10.1371/journal.pone.0261216	http://dx.doi.org/10.1371/journal.pone.0261216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030181	Green Published, gold			2022-12-26	WOS:000812798500008
J	Hilpmann, S; Bader, M; Steudtner, R; Muller, K; Stumpf, T; Cherkouk, A				Hilpmann, Stephan; Bader, Miriam; Steudtner, Robin; Mueller, Katharina; Stumpf, Thorsten; Cherkouk, Andrea			Microscopic and spectroscopic bioassociation study of uranium(VI) with an archaeal Halobacterium isolate	PLOS ONE			English	Article							FLUORESCENCE SPECTROSCOPY; SALT; COMPLEXATION; SPECIATION; DIVERSITY; U(VI)	The safe disposal of high-level radioactive waste in a deep geological repository is a huge social and technical challenge. So far, one of the less considered factors needed for a long-term risk assessment, is the impact of microorganisms occurring in the different host rocks. Even under the harsh conditions of salt formations different bacterial and archaeal species were found, e. g. Halobacterium sp. GP5 1-1, which has been isolated from a German rock salt sample. The interactions of this archaeon with uranium(VI), one of the radionuclides of major concern for the long-term storage of high-level radioactive waste, were investigated. Different spectroscopic techniques, as well as microscopy, were used to examine the occurring mechanisms on a molecular level leading to a more profound process understanding. Batch experiments with different uranium(VI) concentrations showed that the interaction is not only a simple, but a more complex combination of different processes. With the help of in situ attenuated total reflection Fourier-transform infrared spectroscopy the association of uranium(VI) onto carboxylate groups was verified. In addition, time-resolved laser-induced luminescence spectroscopy revealed the formation of phosphate and carboxylate species within the cell pellets as a function of the uranium(VI) concentration and incubation time. The association behavior differs from another very closely related halophilic archaeon, especially with regard to uranium(VI) concentrations. This clearly demonstrates the importance of studying the interactions of different, at first sight very similar, microorganisms with uranium(VI). This work provides new insights into the microbe-uranium(VI) interactions at highly saline conditions relevant to the long-term storage of radioactive waste in rock salt.	[Hilpmann, Stephan; Bader, Miriam; Steudtner, Robin; Mueller, Katharina; Stumpf, Thorsten; Cherkouk, Andrea] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany; [Bader, Miriam] Forsch Inst Leder & Kunststoffbahnen gGmbH, Freiberg, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Cherkouk, A (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany.	a.cherkouk@hzdr.de	Müller, Katharina/B-8238-2014	Müller, Katharina/0000-0002-0038-1638; Hilpmann, Stephan/0000-0001-7906-6851	iCross project [02NUK053E]; Helmholtz Association [SO-093]	iCross project; Helmholtz Association(Helmholtz Association)	SH was partly funded by the iCross project with the grant number 02NUK053E (German Federal Ministry of Education and Research -BMBF) and SO-093 (Helmholtz Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; Andrei AS, 2012, FEMS MICROBIOL LETT, V330, P1, DOI 10.1111/j.1574-6968.2012.02526.x; [Anonymous], 2020, NUCL POWER REACTORS; Bader M, 2018, WECHSELWIRKUNG HALOP; Bader M, 2018, ENVIRON SCI TECHNOL, V52, P12895, DOI 10.1021/acs.est.8b02667; Bader M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190953; Bader M, 2017, J HAZARD MATER, V327, P225, DOI 10.1016/j.jhazmat.2016.12.053; Barkleit A, 2008, APPL SPECTROSC, V62, P798, DOI 10.1366/000370208784909607; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Drobot B, 2016, ANAL CHEM, V88, P3548, DOI 10.1021/acs.analchem.5b03958; Drobot B, 2015, CHEM SCI, V6, P964, DOI 10.1039/c4sc02022g; Faybishenko B., 2016, INT APPROACHES DEEP, V5th; Fendrihan S., 2007, LIFE EXTREM ENV, V5, P125; Frols S, 2012, ENVIRON MICROBIOL, V14, P3159, DOI 10.1111/j.1462-2920.2012.02895.x; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; Gonzales E, 2006, OECD PAP; Gruber C, 2004, EXTREMOPHILES, V8, P431, DOI 10.1007/s00792-004-0403-6; Guillaumont R., 2003, UPDATE CHEM THERMODY; Hunsche U, 1999, ENG GEOL, V52, P271, DOI 10.1016/S0013-7952(99)00011-3; Jaakkola ST, 2016, ENVIRON MICROBIOL, V18, P565, DOI 10.1111/1462-2920.13130; Jaakkola ST, 2016, TRENDS MICROBIOL, V24, P148, DOI 10.1016/j.tim.2015.12.002; Jones DL, 2015, CHEM SCI, V6, P5133, DOI 10.1039/c5sc00661a; Li B, 2010, J INORG BIOCHEM, V104, P718, DOI 10.1016/j.jinorgbio.2010.03.004; Lloyd Jr, 2002, RADIOACTIV ENVIRONM, V2, P313; Madden T., 2013, NCBI HDB; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; Meinrath G, 1996, RADIOCHIM ACTA, V74, P81; Merroun ML, 2003, BIOMETALS, V16, P331, DOI 10.1023/A:1020612600726; Muller K, 2008, INORG CHEM, V47, P10127, DOI 10.1021/ic8005103; Muller K, 2012, GEOCHIM COSMOCHIM AC, V76, P191, DOI 10.1016/j.gca.2011.10.004; Nuclear Energy Agency (NEA) report, 2018, MICROBIAL INFLUENCE; Opel K, 2007, RADIOCHIM ACTA, V95, P143, DOI 10.1524/ract.2007.95.3.143; Quiles F, 2000, VIB SPECTROSC, V23, P231, DOI 10.1016/S0924-2031(00)00067-9; Reitz T, 2011, U 6 BIOACCUMULATION; Selenska-Pobell S, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P483, DOI 10.1007/978-3-642-05062-6_17; Stan-Lotter H., 2019, MODEL ECOSYSTEMS EXT, P169; Steudtner R, 2011, RADIOCHIM ACTA, V99, P687, DOI 10.1524/ract.2011.1861; Steudtner R, 2010, J RADIOANAL NUCL CH, V284, P421, DOI 10.1007/s10967-010-0489-5; Swanson JS., 2021, MICROBIOLOGY NUCL WA, P97; Vreeland RH, 1998, EXTREMOPHILES, V2, P321, DOI 10.1007/s007920050075	40	1	1	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262275	10.1371/journal.pone.0262275	http://dx.doi.org/10.1371/journal.pone.0262275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025937	gold, Green Published			2022-12-26	WOS:000796264200055
J	Cohen, DA; Talarowski, M; Awomolo, O; Han, B; Williamson, S; McKenzie, TL				Cohen, Deborah A.; Talarowski, Meghan; Awomolo, Olaitan; Han, Bing; Williamson, Stephanie; McKenzie, Thomas L.			Increased mask adherence after important politician infected with COVID-19	PLOS ONE			English	Article								Objectives To quantify changes in adherence to mask and distancing guidelines in outdoor settings in Philadelphia, PA before and after President Trump announced he was infected with COVID-19. Methods We used Systematic Observation of Masking Adherence and Distancing (SOMAD) to assess mask adherence in parks, playgrounds, and commercial streets in the 10 City Council districts in Philadelphia PA. We compared adherence rates between August and September 2020 and after October 2, 2020. Results Disparities in mask adherence existed by age group, gender, and race/ethnicity, with females wearing masks correctly more often than males, seniors having higher mask use than other age groups, and Asians having higher adherence than other race/ethnicities. Correct mask use did not increase after the City released additional mask guidance in September but did after Oct 2. Incorrect mask use also decreased, but the percentage not having masks at all was unchanged. Conclusions Vulnerability of leadership appears to influence population behavior. Public health departments likely need more resources to effectively and persuasively communicate critical safety messages related to COVID-19 transmission.	[Cohen, Deborah A.] Kaiser Permanente Southern Calif Res & Evaluat, Pasadena, CA 91101 USA; [Talarowski, Meghan; Awomolo, Olaitan] Studio Ludo, Philadelphia, PA USA; [Han, Bing; Williamson, Stephanie] RAND Corp, Santa Monica, CA USA; [McKenzie, Thomas L.] San Diego State Univ, San Diego, CA 92182 USA	Kaiser Permanente; RAND Corporation; California State University System; San Diego State University	Cohen, DA (corresponding author), Kaiser Permanente Southern Calif Res & Evaluat, Pasadena, CA 91101 USA.	Deborah.a.cohen@kp.org		/0000-0002-1506-3739	NHLBI [R01HL145145]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by NHLBI #R01HL145145 (PI is DC).	[Anonymous], 2015, MINORITY MARKETING I, DOI [10.1007/978-3-319-17392-4_24, DOI 10.1007/978-3-319-17392-4_24]; Banholzer N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252827; Chen HQ, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00672-w; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Chu Q, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047231; Cohen DA, 2021, PREV MED REP, V23, DOI 10.1016/j.pmedr.2021.101449; Cowell AJ, 2009, ETHNIC HEALTH, V14, P75, DOI 10.1080/13557850802257715; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; Fowler JH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248849; Fraser MR, 2021, J PUBLIC HEALTH MAN, V27, pS106, DOI 10.1097/PHH.0000000000001289; Gandhi M, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2026913; Green LW, 2002, J HEALTH COMMUN, V7, P245, DOI 10.1080/10810730290001710; Honein MA., 2020, MMWR, V4; Ibrahim JK, 2007, AM J PUBLIC HEALTH, V97, P1383, DOI 10.2105/AJPH.2006.097006; McKenzie TL, 2016, RES Q EXERCISE SPORT, V87, P334, DOI 10.1080/02701367.2016.1234302; McKenzie TL, 2015, RES Q EXERCISE SPORT, V86, P13, DOI 10.1080/02701367.2015.991264; Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893; Porco TC, 2020, MEDRXIV; Teslya A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003166; van den Broek-Altenburg E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250302; Wiese AD, 2021, CLIN INFECT DIS, V73, pE141, DOI 10.1093/cid/ciaa834; Worby CJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17922-x	22	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261398	10.1371/journal.pone.0261398	http://dx.doi.org/10.1371/journal.pone.0261398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020749	Green Published, gold			2022-12-26	WOS:000834207700016
J	Djebbari, F; Rampotas, A; Panitsas, F; Lim, WY; Lees, C; Tsagkaraki, I; Gomes, AR; Prideaux, S; Chen, L; Prodger, C; Khera, A; Gray, N; Ellis, L; Sangha, G; Eyre, TA; Moore, S; Kothari, J; Ramasamy, K				Djebbari, Faouzi; Rampotas, Alexandros; Panitsas, Fotios; Lim, Wen Yuen; Lees, Charlotte; Tsagkaraki, Ismini; Gomes, Ana Rita; Prideaux, Steve; Chen, Lucia; Prodger, Catherine; Khera, Akhil; Gray, Nicola; Ellis, Lauren; Sangha, Gina; Eyre, Toby A.; Moore, Sally; Kothari, Jaimal; Ramasamy, Karthik			Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients	PLOS ONE			English	Article							GERIATRIC ASSESSMENT; DEXAMETHASONE; LENALIDOMIDE	The management of myeloma in the elderly is shifting its focus towards reducing the risk of under-treating fit patients and the risk of over-treating frail patients. Frailty assessment is required in this patient group in order to individualise treatment decisions. In addition to the proven prognostic values of the International Myeloma Working Group (IMWG) frailty score and the revised Myeloma Co-morbidity Index (R-MCI), a new easy-to-use frailty-based risk profile score (high-risk (i.e. frail), medium risk (i.e. intermediate-fitness) and low-risk (i.e. fit)) named Myeloma Risk Profile (MRP) was shown to be predictive of survival in the clinical trial setting. In this retrospective real-world study, we set out to evaluate the frailty characteristics and clinical outcomes according to the different MRP scoring algorithm categories (frail vs. intermediate vs fit), in a high risk cohort of elderly newly diagnosed myeloma patients treated with the fixed-duration triplet therapy VCD (bortezomib with cyclophosphamide and dexamethasone). Clinical outcomes included: reason for treatment discontinuation, overall response rate (ORR), overall survival (OS), progression-free survival (PFS), and adverse events (AEs). Out of 100 patients, 62 were frail, 27 were intermediate and 11 were fit, according to MRP scores. To enable meaningful comparisons between comparable numbers, subgroups analyses for ORR, OS, PFS, and AEs focused on frail (n = 62) versus intermediate or fit (n = 38) patients. The proportion of patients in each subgroup who were able to complete the planned course of treatment was (frail: 43.5% vs. intermediate or fit: 55.3%). A higher proportion in the frail subgroup discontinued therapy due to progressive disease (19.4% vs. 2.6%). Discontinuation due to toxicity was comparable across subgroups (14.5% vs. 15.8%), ORR in the total cohort was 75%, and this was comparable between subgroups (frail: 74.2% vs. intermediate or fit: 76.3%). There was a trend for a shorter median OS in the frail subgroup but without a statistical significance: (frail vs. intermediate or fit): (46 months vs. not reached, HR: 1.94, 95% CI 0.89-4.2, p = 0.094). There was no difference in median PFS between subgroups: (frail vs. intermediate or fit): (11.8 vs. 9.9 months, HR: 0.99, 95% CI: 0.61-1.61, P = 0.982). This cohort demonstrated a higher incidence rate of AEs in frail patients compared to those in the intermediate or fit group: patients with at least one any grade toxicity (85.5% vs. 71.1%), patients with at least one >= G3 AE (37.1% vs. 21.1%). In conclusion, our study is to the first to evaluate clinical outcomes according to MRP in a high risk real-world cohort of patients treated exclusively with the proteasome inhibitor-based VCD therapy. Our study demonstrated a trend for worse OS in addition to worse AE outcomes in the frail group, but no difference in PFS with this fixedduration therapy. MRP is an easy-to-use tool in clinical practice; its prognostic value was validated in the real-world in a large cohort of patients from the Danish Registry. Further evaluation of MRP in the real-world when continuous therapies are used, can further support the generalisability of its prognostic value in elderly myeloma patients.	[Djebbari, Faouzi; Rampotas, Alexandros; Lim, Wen Yuen; Gomes, Ana Rita; Prodger, Catherine; Khera, Akhil; Sangha, Gina; Eyre, Toby A.; Moore, Sally; Kothari, Jaimal; Ramasamy, Karthik] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England; [Panitsas, Fotios] Laikon Gen Hosp, Dept Haematol, Athens, Greece; [Lees, Charlotte] Royal Berkshire NHS Fdn Trust, Reading, Berks, England; [Tsagkaraki, Ismini] Buckinghamshire Healthcare NHS Trust, Aylesbury, Bucks, England; [Prideaux, Steve] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England; [Chen, Lucia] Milton Keynes Univ Hosp NHS Fdn Trust, Milton Keynes, Bucks, England; [Gray, Nicola] Wexham Pk Hosp, Slough, Berks, England; [Ellis, Lauren] Frimley Hlth NHS Fdn Trust, Frimley, England	Oxford University Hospitals NHS Foundation Trust; Laiko General Hospital; Royal Berkshire Hospital	Djebbari, F (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England.	faouzi.djebbari@ouh.nhs.uk		DJEBBARI, Faouzi/0000-0001-9578-7632; Rampotas, Alexandros/0000-0002-2681-5860; Ramasamy, Karthik/0000-0003-3385-3707; Sangha, Gina/0000-0002-8433-8994				[Anonymous], 2009, COMMON TERMINOLOGY C; Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; Cancer Research UK, CANC STAT MYEL INC S; Cook G, 2019, LANCET HAEMATOL, V6, pE154, DOI 10.1016/S2352-3026(18)30220-5; Engelhardt M, 2020, HAEMATOLOGICA, V105, P1183, DOI 10.3324/haematol.2019.242958; Engelhardt M, 2017, HAEMATOLOGICA, V102, P910, DOI 10.3324/haematol.2016.162693; Engelhardt M, 2016, HAEMATOLOGICA, V101, P1110, DOI 10.3324/haematol.2016.148189; Facon T, 2019, NEW ENGL J MED, V380, P2104, DOI 10.1056/NEJMoa1817249; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Mateos MV, 2018, NEW ENGL J MED, V378, P518, DOI 10.1056/NEJMoa1714678; Palumbo A, 2015, BLOOD, V125, P2068, DOI 10.1182/blood-2014-12-615187; Redder L, 2021, BRIT J HAEMATOL, V193, P119, DOI 10.1111/bjh.16806; Zweegman S, 2019, LANCET HAEMATOL, V6, pE117, DOI 10.1016/S2352-3026(19)30011-0	13	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262388	10.1371/journal.pone.0262388	http://dx.doi.org/10.1371/journal.pone.0262388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015781	Green Published, gold			2022-12-26	WOS:000814820600013
J	Fayed, A; Wahabi, HA; Esmaeil, S; Elkouny, R; Elmorshedy, H; Bakhsh, H				Fayed, Amel; Wahabi, Hayfaa A.; Esmaeil, Samia; Elkouny, Roaa; Elmorshedy, Hala; Bakhsh, Hanadi			Independent effect of gestational weight gain and prepregnancy obesity on pregnancy outcomes among Saudi women: A sub-cohort analysis from Riyadh mother and baby cohort study (RAHMA)	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; RISK; ASSOCIATION; PREVALENCE; DELIVERY; IMPACT; BIRTH	Background Gestational weight gain (GWG) and prepregnancy obesity are garnering more attention as determining factors of pregnancy outcomes when it comes to the wellbeing of both the mother and her baby. This study was conducted to describe the pattern of GWG among participants of Riyadh Mother and Baby Multicenter Cohort Study (RAHMA) and to investigate the detrimental effects of excessive GWG and prepregnancy obesity on pregnancy outcomes. Methods RAHMA is a multicentre cohort study conducted in three hospitals in Riyadh, Saudi Arabia. Participants were categorized according to the Institute of Medicine into inadequate, adequate, and excessive GWG, and stratified by body mass index (BMI) into under/normal weight, overweight, and obese. To examine the independent effect of maternal prepregnancy obesity and GWG, a multivariate regression model was used and adjusted odds ratio (AOR) and 95% Confidence Interval (CI) for each outcome were calculated. Results A total of 7029 participants were included in this study; 31.8% had adequate GWG, 25.9% had excessive GWG and 42.3% had inadequate GWG, while 29.7% had normal BMI, 33.3% were overweight, 34.8% were obese, and 2.2% were underweight. Excessive GWG was independently associated with increased risk of hypertensive events, (AOR = 1.77, 95% CI 1.20-2.63). Obesity was associated with higher risk of gestational diabetes (AOR 2.11, 95% CI 1.76-2.53), hypertensive events (AOR 2.06, 95% CI 1.48-3.01), and delivery by emergency caesarean section (AOR = 1.63, 95% CI 1.35-1.97). Infants of obese women had increased odds of macrosomia (AOR 3.11, 95% CI 1.94-4.99) and lower odds of low birth weight (AOR = 0.68, 95% CI 0.53-0.88). Conclusion In comparison to excessive GWG, which increases the risk of hypertensive events during pregnancy, prepregnancy obesity is associated with more adverse outcomes including GDM, hypertensive events in pregnancy and emergency CS.	[Fayed, Amel; Elmorshedy, Hala; Bakhsh, Hanadi] Princess Nourah Bint Abdulrahman Univ, Coll Med, Clin Sci Dept, Riyadh, Saudi Arabia; [Wahabi, Hayfaa A.; Esmaeil, Samia] King Saud Univ, Res Chair Evidence Based Healthcare & Knowledge T, Riyadh, Saudi Arabia; [Wahabi, Hayfaa A.] King Saud Univ Med City & Coll Med, Dept Family & Community Med, Riyadh, Saudi Arabia; [Elkouny, Roaa] AlFaisal Univ, Coll Med, Riyadh, Saudi Arabia	Princess Nourah bint Abdulrahman University; King Saud University; King Saud University; Alfaisal University	Wahabi, HA (corresponding author), King Saud Univ, Res Chair Evidence Based Healthcare & Knowledge T, Riyadh, Saudi Arabia.; Wahabi, HA (corresponding author), King Saud Univ Med City & Coll Med, Dept Family & Community Med, Riyadh, Saudi Arabia.	umlena@yahoo.com	Fayed, Amel/H-8588-2016	Fayed, Amel/0000-0003-3395-0486; Elkouny, Roaa/0000-0002-5344-5017	Center for Promising Research in Social Research and Women's Studies, Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University	Center for Promising Research in Social Research and Women's Studies, Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University(Princess Nourah bint Abdulrahman University)	The authors would like to thank the Center for Promising Research in Social Research and Women's Studies, Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University for funding this Project in 2020. Award/Grant number is not applicable. The funder did not play any role in collection of data, decision to publish or preparation of the manuscript.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Alsheef MA, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4071892; American College of Obstetricians and Gynecologists Committee on Practice BulletinsObstetrics, 2016, Obstet Gynecol, V128, pe155, DOI 10.1097/AOG.0000000000001711; [Anonymous], 2020, Obstet Gynecol, V135, P246, DOI 10.1097/AOG.0000000000003607; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bahadoer S, 2015, EUR J OBSTET GYN R B, V193, P51, DOI 10.1016/j.ejogrb.2015.06.031; Beta J, 2019, ULTRASOUND OBST GYN, V54, P308, DOI 10.1002/uog.20279; Beyerlein A, 2010, OBSTET GYNECOL, V116, P1111, DOI 10.1097/AOG.0b013e3181f1ad8b; Beyerlein A, 2009, AM J CLIN NUTR, V90, P1552, DOI 10.3945/ajcn.2009.28026; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; Bodnar LM, 2010, AM J CLIN NUTR, V91, P1642, DOI 10.3945/ajcn.2009.29008; Bogaerts A, 2015, OBSTET GYNECOL, V125, P566, DOI 10.1097/AOG.0000000000000677; Catalano PM, 2017, BMJ-BRIT MED J, V356, DOI [10.1136/bmj.j1, 10.1136/bmj.j1631]; Chen CN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041221; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Corp S., 2019, STATA STAT SOFTWARE; Cutland CL, 2017, VACCINE, V35, P6492, DOI 10.1016/j.vaccine.2017.01.049; Deputy NP, 2015, OBSTET GYNECOL, V125, P773, DOI 10.1097/AOG.0000000000000739; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Durst JK, 2016, AM J PERINAT, V33, P849, DOI 10.1055/s-0036-1579650; El-Gilany AH, 2009, OBESITY FACTS, V2, P217, DOI 10.1159/000226597; Fallatah Anas M, 2019, Med Arch, V73, P425, DOI 10.5455/medarh.2019.73.425-432; Fernandez-Twinn DS, 2019, DIABETOLOGIA, V62, P1789, DOI 10.1007/s00125-019-4951-9; Frolova AI, 2018, AM J PERINAT, V35, P59, DOI 10.1055/s-0037-1605574; Gaillard R, 2013, OBESITY, V21, P1046, DOI 10.1002/oby.20088; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Guo YF, 2019, CAN J PUBLIC HEALTH, V110, P657, DOI 10.17269/s41997-019-00250-z; Haugen M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-201; Heude B, 2012, MATERN CHILD HLTH J, V16, P355, DOI 10.1007/s10995-011-0741-9; Hillesund E R, 2018, BMC Res Notes, V11, P282, DOI 10.1186/s13104-018-3396-4; IBM, 2021, CIT IBM SPSS STAT EA; Institute of M., 2009, WEIGHT GAIN PREGNANC; Institute of Medicine Committee on Nutritional Status During P Lactation, 1990, NUTR PREGNANCY 1; Jain AP, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.018; Kominiarek MA, 2018, OBSTET GYNECOL, V132, P875, DOI 10.1097/AOG.0000000000002854; Kominiarek MA, 2017, AM J OBSTET GYNECOL, V217, P642, DOI 10.1016/j.ajog.2017.05.040; Li CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136850; Lim S, 2015, OBES REV, V16, P972, DOI 10.1111/obr.12312; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12863; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; Mastroeni MF, 2017, MATERN CHILD HLTH J, V21, P705, DOI 10.1007/s10995-016-2156-0; Mohammadi M, 2019, J MATERN-FETAL NEO M, V32, P3818, DOI 10.1080/14767058.2018.1473366; Morgan ES, 2012, INT J OBSTET ANESTH, V21, P253, DOI 10.1016/j.ijoa.2012.01.002; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; O'Dwyer V, 2013, J OBSTET GYNAECOL, V33, P671, DOI 10.3109/01443615.2013.821461; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293; Santos S, 2019, BJOG-INT J OBSTET GY, V126, P984, DOI 10.1111/1471-0528.15661; Tieu J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006674.pub3; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; Voerman E, 2019, JAMA-J AM MED ASSOC, V321, P1702, DOI 10.1001/jama.2019.3820; Wahabi H, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6655942; Wahabi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150297; Wahabi HA, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2957429; World Health Organization, HLTH TOP OB	58	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262437	10.1371/journal.pone.0262437	http://dx.doi.org/10.1371/journal.pone.0262437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015784	Green Published, gold			2022-12-26	WOS:000814820600017
J	Lin, JG; Xia, LZ; Oyang, LD; Liang, JX; Tan, SM; Wu, NY; Yi, P; Pan, Q; Rao, S; Han, YQ; Tang, YY; Su, M; Luo, X; Yang, YQ; Chen, XH; Yang, LX; Zhou, YJ; Liao, QJ				Lin, Jinguan; Xia, Longzheng; Oyang, Linda; Liang, Jiaxin; Tan, Shiming; Wu, Nayiyuan; Yi, Pin; Pan, Qing; Rao, Shan; Han, Yaqian; Tang, Yanyan; Su, Min; Luo, Xia; Yang, Yiqing; Chen, Xiaohui; Yang, Lixia; Zhou, Yujuan; Liao, Qianjin			The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity	ONCOGENE			English	Article							BREAST-CANCER; RESISTANCE; OXALIPLATIN; APOPTOSIS; TRANSCRIPTION; ALDOLASE; INSIGHTS	Cancer metabolic reprogramming enhances its malignant behaviors and drug resistance, which is regulated by POU domain transcription factors. This study explored the effect of POU domain class 2 transcription factor 1 (POU2F1) on metabolic reprogramming in colon cancer. The POU2F1 expression was analyzed in GEO dataset, TCGA cohorts and human colon cancer tissues by bioinformatics and immunohistochemistry. The effects of altered POU2F1 expression on proliferation, glucose metabolism and oxaliplatin sensitivity of colon cancer cells were tested. The impacts of POU2F1 on aldolase A (ALDOA) expression and malignant behaviors of colon cancer cells were examined. We found that up-regulated POU2F1 expression was associated with worse prognosis and oxaliplatin resistance in colon cancer. POU2F1 enhanced the proliferation, aerobic glycolysis and the pentose phosphate pathway (PPP) activity, but reduced oxidative stress and apoptosis in colon cancer cells, dependent on up-regulating ALDOA expression. Mechanistically, POU2F1 directly bound to the ALDOA promoter to enhance the ALDOA promoter activity in colon cancer cells. Moreover, activation of the POU2F1-ALDOA axis decreased the sensitivity to oxaliplatin in colon cancer cells. These data indicate that the POU2F1-ALDOA axis promotes the progression and oxaliplatin resistance by enhancing metabolic reprogramming in colon cancer. Our findings suggest that the POU2F1-ALDOA axis may be new therapeutic targets to overcome oxaliplatin resistance in colon cancer.	[Lin, Jinguan; Xia, Longzheng; Oyang, Linda; Liang, Jiaxin; Tan, Shiming; Wu, Nayiyuan; Yi, Pin; Pan, Qing; Rao, Shan; Han, Yaqian; Tang, Yanyan; Su, Min; Luo, Xia; Yang, Yiqing; Chen, Xiaohui; Yang, Lixia; Zhou, Yujuan; Liao, Qianjin] Cent South Univ, Hunan Canc Hosp, Hunan Key Lab Canc Metab, Changsha 410013, Hunan, Peoples R China; [Lin, Jinguan; Xia, Longzheng; Oyang, Linda; Liang, Jiaxin; Tan, Shiming; Wu, Nayiyuan; Yi, Pin; Pan, Qing; Rao, Shan; Han, Yaqian; Tang, Yanyan; Su, Min; Luo, Xia; Yang, Yiqing; Chen, Xiaohui; Yang, Lixia; Zhou, Yujuan; Liao, Qianjin] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha 410013, Hunan, Peoples R China; [Yi, Pin; Pan, Qing] Univ South China, Hengyang 421001, Hunan, Peoples R China; [Zhou, Yujuan; Liao, Qianjin] Hunan Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China	Central South University; Central South University; University of South China	Zhou, YJ; Liao, QJ (corresponding author), Cent South Univ, Hunan Canc Hosp, Hunan Key Lab Canc Metab, Changsha 410013, Hunan, Peoples R China.; Zhou, YJ; Liao, QJ (corresponding author), Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha 410013, Hunan, Peoples R China.; Zhou, YJ; Liao, QJ (corresponding author), Hunan Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.	yujany_zhou@163.com; march-on@126.com			National Natural Science Foundation of China [82173142, 81972636, 81872281, 81772842]; Natural Science Foundation of Hunan Province [2020JJ5336, 2019JJ40175, 2019JJ40183, 2018JJ1013]; Research Project of Health Commission of Hunan Province [202203034978, 202109031837, 20201020]; China Hunan Provincial Science and Technology Department [2018SK7005]; Ascend Foundation of National Cancer Center [NCC2018b68]; Hunan Cancer Hospital Climb Plan [ZX2020001-3, YF2020002]; Fundamental Research Funds for the Central Universities of Central South University [2019zzts832, 2019zzts833]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Research Project of Health Commission of Hunan Province; China Hunan Provincial Science and Technology Department; Ascend Foundation of National Cancer Center; Hunan Cancer Hospital Climb Plan; Fundamental Research Funds for the Central Universities of Central South University	This work was supported in part by grants from the following sources: the National Natural Science Foundation of China (82173142, 81972636, 81872281, 81772842), the Natural Science Foundation of Hunan Province (2020JJ5336, 2019JJ40175, 2019JJ40183, 2018JJ1013), the Research Project of Health Commission of Hunan Province (202203034978, 202109031837, 20201020), China Hunan Provincial Science and Technology Department (2018SK7005), Ascend Foundation of National Cancer Center (NCC2018b68), and Supported By Hunan Cancer Hospital Climb Plan (ZX2020001-3, YF2020002) and By the Fundamental Research Funds for the Central Universities of Central South University (2019zzts832, 2019zzts833).	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Benson AB, 2018, J NATL COMPR CANC NE, V16, P359, DOI 10.6004/jnccn.2018.0021; Bidkhori G, 2018, P NATL ACAD SCI USA, V115, pE11874, DOI 10.1073/pnas.1807305115; Blondy S, 2020, CANCER SCI, V111, P3142, DOI 10.1111/cas.14532; Bu PC, 2018, CELL METAB, V27, P1249, DOI 10.1016/j.cmet.2018.04.003; Cao PH, 2019, INT J BIOL SCI, V15, P1676, DOI 10.7150/ijbs.35265; Chen Q, 2020, LEUKEMIA, V34, P2736, DOI 10.1038/s41375-020-0801-5; Cheng CY, 2018, BIOMED PHARMACOTHER, V108, P194, DOI 10.1016/j.biopha.2018.09.031; Costanzo P, 1999, FEBS LETT, V454, P61, DOI 10.1016/S0014-5793(99)00775-9; Dai Ling, 2018, Cancer Manag Res, V10, P1799, DOI 10.2147/CMAR.S157925; Fan JJ, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16039234; Fionda C, 2019, CANCERS, V11, DOI 10.3390/cancers11060810; Gold DA, 2014, MOL BIOL EVOL, V31, P3136, DOI 10.1093/molbev/msu243; Herbert K, 2019, GENE DEV, V33, P310, DOI 10.1101/gad.314633.118; Jiang ZH, 2018, J CELL MOL MED, V22, P4377, DOI 10.1111/jcmm.13732; Kawai K, 2017, INT J ONCOL, V50, P525, DOI 10.3892/ijo.2016.3814; Kondaveeti Y, 2015, CANCER LETT, V364, P44, DOI 10.1016/j.canlet.2015.04.025; Kuo CC, 2019, THERANOSTICS, V9, P2526, DOI 10.7150/thno.32915; Li QG, 2016, MOL CANCER RES, V14, P830, DOI 10.1158/1541-7786.MCR-16-0032; Lopez-Bertoni H, 2020, CANCER RES, V80, P1644, DOI 10.1158/0008-5472.CAN-19-1624; Maddox J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003048; Mou JJ, 2018, BIOMED PHARMACOTHER, V103, P729, DOI 10.1016/j.biopha.2018.04.099; Ortmayr K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09695-9; Pages F, 2020, ANN ONCOL, V31, P921, DOI 10.1016/j.annonc.2020.03.310; Pankratova EV, 1998, FEBS LETT, V426, P81, DOI 10.1016/S0014-5793(98)00316-0; Park JS, 2020, NATURE, V578, P621, DOI 10.1038/s41586-020-1998-1; Petr MA, 2020, TRENDS CELL BIOL, V30, P117, DOI 10.1016/j.tcb.2019.12.001; Pierce CJ, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-00247-1; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Sau A, 2018, ACS APPL MATER INTER, V10, P4582, DOI 10.1021/acsami.7b18837; Schworer S, 2019, CELL METAB, V29, P576, DOI 10.1016/j.cmet.2019.01.015; Shakya A, 2009, NAT CELL BIOL, V11, P320, DOI 10.1038/ncb1840; Sharpe DJ, 2014, ONCOTARGET, V5, P8803, DOI 10.18632/oncotarget.2492; Tantin D, 2013, DEVELOPMENT, V140, P2857, DOI 10.1242/dev.095927; Tharp ME, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14055-8; Vazquez-Arreguin K, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007687; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wazir U, 2019, CANCER GENOM PROTEOM, V16, P121, DOI 10.21873/cgp.20117; Wu D, 2020, BIOCHEM BIOPH RES CO, V533, P533, DOI 10.1016/j.bbrc.2020.09.003; Yu JW, 2019, MED SCI MONITOR, V25, P1204, DOI 10.12659/MSM.912109; Yu LL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14437-3; Zheng PL, 2018, CELL RES, V28, P833, DOI 10.1038/s41422-018-0065-z; Zhu HY, 2017, AM J CANCER RES, V7, P1665	43	4	5	7	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2022	41	7					1024	1039		10.1038/s41388-021-02148-y	http://dx.doi.org/10.1038/s41388-021-02148-y		JAN 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YX7EK	34997215	Green Published, hybrid			2022-12-26	WOS:000740148300001
J	Bajos, N; Spire, A; Silberzan, L				Bajos, Nathalie; Spire, Alexis; Silberzan, Lena		EPICOV Study Grp	The social specificities of hostility toward vaccination against Covid-19 in France	PLOS ONE			English	Article							HEALTH; WOMEN; HESITANCY; REFUSAL; GENDER; IMPACT; RISKS	Equal Access to the COVID-19 vaccine for all remains a major public health issue. The current study compared the prevalence of vaccination reluctance in general and COVID-19 vaccine hesitancy and social and health factors associated with intentions to receive the vaccine. A random socio-epidemiological population-based survey was conducted in France in November 2020, in which 85,855 adults participants were included in this study. We used logistic regressions to study being "not at all in favor" to vaccination in general, and being "certainly not willing to get vaccinated against Covid-19. Our analysis highlighted a gendered reluctance toward vaccination in general but even more so regarding vaccination against COVID-19 (OR = 1.88 (95% CI: 1.79-1.97)). We also found that people at the bottom of the social hierarchy, in terms of level of education, financial resources, were more likely to refuse the COVID-19 vaccine (from OR = 1.22 (95% CI:1.10-1.35) for respondents without diploma to OR = 0.52 (95% CI:0.47-0.57) for High school +5 or more years level). People from the French overseas departments, immigrants and descendants of immigrants, were all more reluctant to the Covid-19 vaccine (first-generation Africa/Asia immigrants OR = 1.16 (95% CI:1.04-1.30)) versus OR = 2.19 (95% CI:1.96-2.43) for the majority population). Finally, our analysis showed that those who reported not trusting the government were more likely to be Covid-19 vaccine-reluctant (OR = 3.29 (95% CI: 3.13-3.45)). Specific campaigns should be thought beforehand to reach women and people at the bottom of the social hierarchy to avoid furthering social inequalities in terms of morbidity and mortality.	[Bajos, Nathalie; Spire, Alexis; Silberzan, Lena] INSERM, IRIS, EHESS, CNRS, Aubervilliers, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bajos, N (corresponding author), INSERM, IRIS, EHESS, CNRS, Aubervilliers, France.	nathalie.bajos@inserm.fr	Bajos, Nathalie/M-4170-2018	Bajos, Nathalie/0000-0001-8073-9056; Spire, Alexis/0000-0002-2589-9804; , Lena Silberzan/0000-0002-3482-1128	European Research Council (ERC) under the European Union [856478]	European Research Council (ERC) under the European Union(European Research Council (ERC))	NB has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. [856478]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, FRANCE 24; Bajos N., 2020, PUBLIC GLOBAL HLTH, DOI [10.1101/2020.10.07.20208595, DOI 10.1101/2020.10.07.20208595]; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Benet T., 2021, COVIPREV; Bergeron H., 2020, COVID 19 CRISE ORGAN, DOI [10.3917/scpo.berge.2020.01, DOI 10.3917/SCPO.BERGE.2020.01]; Bryden GM, 2018, VACCINE, V36, P1227, DOI 10.1016/j.vaccine.2017.12.068; Byrne T, 2021, VACCINE, V39, P7108, DOI 10.1016/j.vaccine.2021.09.066; Callaghan T, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.113638; Conis E, 2013, B HIST MED, V87, P407, DOI 10.1353/bhm.2013.0047; Connor J, 2020, SOC SCI MED, V266, DOI 10.1016/j.socscimed.2020.113364; Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003; Dubbin LA, 2013, SOC SCI MED, V93, P113, DOI 10.1016/j.socscimed.2013.06.014; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Gengler AM, 2014, J HEALTH SOC BEHAV, V55, P342, DOI 10.1177/0022146514544172; Hacquin A-S., 2020, PSYARXIV, DOI [10.31234/osf.io/r8h6z, DOI 10.31234/OSF.IO/R8H6Z]; Hsu HE, 2020, MMWR-MORBID MORTAL W, V69, P864, DOI 10.15585/mmwr.mm6927a3; Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812; J. WARSZAWSKI, 2021, medRxiv, DOI 10.1101/2021.02.24.21252316; Kazemian S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254127; Kricorian K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256122; Lachenal G., 2014, MEDICAMENT QUI DEVAI; Larson H, 2018, STATE VACCINE CONFID, V10, DOI DOI 10.2875/241099; Latkin CA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246970; Lin C, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010016; Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1; Lunz Trujillo K, US NEWS WORLD REP; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Maxfield S, 2010, GEND MANAG, V25, P586, DOI 10.1108/17542411011081383; Meleis AI, 2016, J WOMENS HEALTH, V25, P329, DOI 10.1089/jwh.2015.5717; Milner A, 2020, LANCET PUBLIC HEALTH, V5, pE419, DOI 10.1016/S2468-2667(20)30162-6; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Peretti-Watel Patrick, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289; Pogue K, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040582; Reich JA, 2014, GENDER SOC, V28, P679, DOI 10.1177/0891243214532711; Robertson E, 2021, BRAIN BEHAV IMMUN, V94, P41, DOI 10.1016/j.bbi.2021.03.008; Roederer T, 2021, LANCET PUBLIC HEALTH, V6, pE202, DOI 10.1016/S2468-2667(21)00001-3; Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8; Siegrist M, 2000, RISK ANAL, V20, P195, DOI 10.1111/0272-4332.202020; Singh-Manoux A, 2005, SOC SCI MED, V60, P2129, DOI 10.1016/j.socscimed.2004.08.070; Smith N, 2019, INFORM COMMUN SOC, V22, P1310, DOI 10.1080/1369118X.2017.1418406; Wachtler Benjamin, 2020, J Health Monit, V5, P3, DOI 10.25646/7059; Ward JK, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113414; Ward JK, 2019, NAT IMMUNOL, V20, P1257, DOI 10.1038/s41590-019-0488-9; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8; Zintel S., 2021, SSRN ELECT J, DOI [10.2139/ssrn.3803323, DOI 10.2139/SSRN.3803323]	45	11	11	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262192	10.1371/journal.pone.0262192	http://dx.doi.org/10.1371/journal.pone.0262192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990482	Green Submitted, Green Published, gold			2022-12-26	WOS:000815783800019
J	Cerrejon, C; Valeria, O; Munoz, J; Fenton, NJ				Cerrejon, Carlos; Valeria, Osvaldo; Munoz, Jesus; Fenton, Nicole J.			Small but visible: Predicting rare bryophyte distribution and richness patterns using remote sensing-based ensembles of small models	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOSYSTEM BASED MANAGEMENT; FOREST MANAGEMENT; BOREAL FOREST; GAP ANALYSIS; SAMPLE-SIZE; DIVERSITY; MIXEDWOOD; CLIMATE; MOSS	In Canadian boreal forests, bryophytes represent an essential component of biodiversity and play a significant role in ecosystem functioning. Despite their ecological importance and sensitivity to disturbances, bryophytes are overlooked in conservation strategies due to knowledge gaps on their distribution, which is known as the Wallacean shortfall. Rare species deserve priority attention in conservation as they are at a high risk of extinction. This study aims to elaborate predictive models of rare bryophyte species in Canadian boreal forests using remote sensing-derived predictors in an Ensemble of Small Models (ESMs) framework. We hypothesize that high ESMs-based prediction accuracy can be achieved for rare bryophyte species despite their low number of occurrences. We also assess if there is a spatial correspondence between rare and overall bryophyte richness patterns. The study area is located in western Quebec and covers 72,292 km(2). We selected 52 bryophyte species with <30 occurrences from a presence-only database (214 species, 389 plots in total). ESMs were built from Random Forest and Maxent techniques using remote sensing-derived predictors related to topography and vegetation. Lee's L statistic was used to assess and map the spatial relationship between rare and overall bryophyte richness patterns. ESMs yielded poor to excellent prediction accuracy (AUC > 0.5) for 73% of the modeled species, with AUC values > 0.8 for 19 species, which confirmed our hypothesis. In fact, ESMs provided better predictions for the rarest bryophytes. Likewise, our study revealed a spatial concordance between rare and overall bryophyte richness patterns in different regions of the study area, which have important implications for conservation planning. This study demon-strates the potential of remote sensing for assessing and making predictions on inconspicuous and rare species across the landscape and lays the basis for the eventual inclusion of bryophytes into sustainable development planning.	[Cerrejon, Carlos; Valeria, Osvaldo; Fenton, Nicole J.] Univ Quebec Abitibi Temiscamingue, Inst Rech Sur Forets, Boul Univ, Rouyn Noranda, PQ, Canada; [Valeria, Osvaldo] Univ Mayor, Fac Ciencias, Hemera Ctr Observac Tierra, Santiago, Chile; [Munoz, Jesus] Real Jardin Bot RJB CSIC, Madrid, Spain	University of Quebec; University Quebec Abitibi-Temiscamingue; Universidad Mayor; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Cerrejon, C (corresponding author), Univ Quebec Abitibi Temiscamingue, Inst Rech Sur Forets, Boul Univ, Rouyn Noranda, PQ, Canada.	carlos.cerrejonlozano@uqat.ca			Environmental Damages Fund, Environment and Climate Change Canada	Environmental Damages Fund, Environment and Climate Change Canada	This research was funded by Environmental Damages Fund, Environment and Climate Change Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amirkhiz RG, 2021, LANDSCAPE ECOL, V36, P1039, DOI 10.1007/s10980-021-01217-7; Austin M.P., 1986, P45; Barbe M, 2017, CAN FIELD NAT, V131, P258, DOI 10.22621/cfn.v131i3.1901; Barbe M, 2017, BIODIVERS CONSERV, V26, P943, DOI 10.1007/s10531-016-1281-9; Bartels SF, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00858; Bennie J, 2008, ECOL MODEL, V216, P47, DOI 10.1016/j.ecolmodel.2008.04.010; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Bergeron Y, 2007, FOREST CHRON, V83, P326, DOI 10.5558/tfc83326-3; Bivand RS, 2015, J STAT SOFTW, V63, P1; Bond-Lamberty B, 2007, OECOLOGIA, V151, P584, DOI 10.1007/s00442-006-0619-5; Boudreault C, 2002, CAN J FOREST RES, V32, P1080, DOI [10.1139/x02-027, 10.1139/X02-027]; Boudreault C, 2018, CAN J FOREST RES, V48, P821, DOI 10.1139/cjfr-2017-0352; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Caners RT, 2013, FOREST ECOL MANAG, V289, P489, DOI 10.1016/j.foreco.2012.09.044; Castonguay J., 2016, THESIS U QUEBEC MONT; Cerrejon C., 2021, MENDELEY DATA, VV3, DOI 10.17632/9mtcx3jnxz.3; Cerrejon C, 2021, DIVERS DISTRIB, V27, P948, DOI 10.1111/ddi.13244; Cerrejon C, 2020, ECOL INDIC, V119, DOI 10.1016/j.ecolind.2020.106826; Chaieb C, 2015, FORESTS, V6, P1195, DOI 10.3390/f6041195; Chefaoui RM, 2011, ANIM BIODIV CONSERV, V34, P229; climate weather, 2010, ENV CANADA; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cole HA, 2008, CAN J FOREST RES, V38, P1867, DOI 10.1139/X08-036; Couvreur JM, 2016, INT J AGRON, V2016, DOI 10.1155/2016/5365412; Delso A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91651-z; Dimiceli C., 2015, NASA EOSDIS LAND PRO, DOI [10.5067/MODIS/MOD44B.006., DOI 10.5067/MODIS/MOD44B.006, 10.5067/MODIS/ MOD44B.006.]; ESRI (Environmental Systems Research Institute), 2016, ARCGIS DESKT 10 5; Faubert J., 2011, CARNETS BRYOL, V1, P29; Faubert J., 2010, BRYOPHYTES RARES QU; Faubert J., 2012, ESP CES PRIORITAIRES, V2, P53; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P882, DOI 10.1016/j.patrec.2005.10.012; Ficken CD, 2019, SCI TOTAL ENVIRON, V693, DOI 10.1016/j.scitotenv.2019.133647; Franch B, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11060632; Frego KA, 2007, FOREST ECOL MANAG, V242, P65, DOI 10.1016/j.foreco.2007.01.030; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Gignac LD, 2001, BRYOLOGIST, V104, P410, DOI 10.1639/0007-2745(2001)104[0410:BAIOCC]2.0.CO;2; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hespanhol H, 2015, ECOL EVOL, V5, P5443, DOI 10.1002/ece3.1796; Hespanhol H, 2011, PLANT ECOL DIVERS, V4, P251, DOI 10.1080/17550874.2011.616546; Hijmans R.J., 2020, RASTER GEOGRAPHIC DA; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; Hylander K, 2002, ECOL APPL, V12, P797, DOI 10.1890/1051-0761(2002)012[0797:EBSABS]2.0.CO;2; Jiang YB, 2014, ECOL INDIC, V38, P72, DOI 10.1016/j.ecolind.2013.10.024; Jiang YB, 2013, J VEG SCI, V24, P214, DOI 10.1111/j.1654-1103.2012.01453.x; Jiang ZY, 2007, PROC SPIE, V6679, DOI 10.1117/12.734933; Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14; Lee S.I., 2001, J GEOGR SYST, V15, P369, DOI [10.1007/s101090100064, DOI 10.1007/S101090100064]; Lomba A, 2010, BIOL CONSERV, V143, P2647, DOI 10.1016/j.biocon.2010.07.007; Mansuy N, 2018, GEODERMA REG, V15, DOI 10.1016/j.geodrs.2018.e00194; MARGULES CR, 1989, BIOL CONSERV, V50, P219, DOI 10.1016/0006-3207(89)90011-6; Mateo RG, 2016, SCI REP-UK, V6, DOI 10.1038/srep25546; Mateo RG, 2011, REV CHIL HIST NAT, V84, P217, DOI 10.4067/S0716-078X2011000200008; McCune JL, 2020, ECOL EVOL, V10, P5001, DOI 10.1002/ece3.6254; Mols T, 2013, BIODIVERS CONSERV, V22, P1537, DOI 10.1007/s10531-013-0492-6; Moreira EF, 2017, BIOTA NEOTROP, V17, DOI [10.1590/1676-0611-BN-2016-0294, 10.1590/1676-0611-bn-2016-0294]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Natural Resources Canada, 2017, STAT CAN FOR ANN REP; Newmaster SG, 2005, DIVERS DISTRIB, V11, P57, DOI 10.1111/j.1366-9516.2005.00123.x; Newmaster SG, 2002, CAN J FOREST RES, V32, P38, DOI 10.1139/x01-163; Pearce J, 1998, RESTOR ECOL, V6, P238, DOI 10.1046/j.1526-100X.1998.00636.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pocs Tamas, 1996, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Botanica, V67, P109; Pouteau R, 2012, ECOL INFORM, V9, P37, DOI 10.1016/j.ecoinf.2012.03.003; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; R Core Team, 2021, R LANG ENV STAT; Raabe S, 2010, FOREST ECOL MANAG, V260, P1956, DOI 10.1016/j.foreco.2010.08.042; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rowntree JK, 2011, IN VITRO CELL DEV-PL, V47, P55, DOI 10.1007/s11627-010-9326-3; Roy PS, 1996, J BIOSCIENCES, V21, P723, DOI 10.1007/BF02703148; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; Saucier J., 2003, ZONES VEGETATION DOM; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Sousa-Silva R, 2014, GLOB ECOL CONSERV, V2, P226, DOI 10.1016/j.gecco.2014.09.011; Spiers JA, 2018, BIODIVERS CONSERV, V27, P2931, DOI 10.1007/s10531-018-1578-y; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W., 2020, R PACKAGE VERSION 34; Turetsky MR, 2012, NEW PHYTOL, V196, P49, DOI 10.1111/j.1469-8137.2012.04254.x; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Usher M.B., 1986, P3; Vanderpoorten A., 2009, BRYOPHYTE BIOL, P487, DOI DOI 10.1017/CBO9780511754807.013; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Vellak K, 2005, BIODIVERS CONSERV, V14, P3255, DOI 10.1007/s10531-004-0445-1; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zhang P., 2019, THESIS UTRECHT U; Zimmermann NE, 2007, J APPL ECOL, V44, P1057, DOI 10.1111/j.1365-2664.2007.01348.x	102	0	0	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0260543	10.1371/journal.pone.0260543	http://dx.doi.org/10.1371/journal.pone.0260543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990454	Green Published, gold			2022-12-26	WOS:000815783800004
J	Souza, MLF; de Sousa, JV; Guerreiro, JF				Ferreira Souza Junior, Mauro Lucio; de Sousa, Jaime Viana; Guerreiro, Joao Farias			Analysis of coding variants in the human FTO gene from the gnomAD database	PLOS ONE			English	Article							OBESITY; ASSOCIATION; CHILDHOOD	Single nucleotide polymorphisms (SNPs) in the first intron of the FTO gene reported in 2007 continue to be the known variants with the greatest effect on adiposity in different human populations. Coding variants in the FTO gene, on the other hand, have been little explored, although data from complete sequencing of the exomes of various populations are available in public databases and provide an excellent opportunity to investigate potential functional variants in FTO. In this context, this study aimed to track nonsynonymous variants in the exons of the FTO gene in different population groups employing the gnomAD database and analyze the potential functional impact of these variants on the FTO protein using five publicly available pathogenicity prediction programs. The findings revealed 345 rare mutations, of which 321 are missense (93%), 19 are stop gained (5.6%) and five mutations are located in the splice region (1.4%). Of these, 134 (38.8%) were classified as pathogenic, 144 (41.7%) as benign and 67 (19.5%) as unknown. The available data, however, suggest that these variants are probably not associated with BMI and obesity, but instead, with other diseases. Functional studies are, therefore, required to identify the role of these variants in disease genesis.	[Ferreira Souza Junior, Mauro Lucio; Guerreiro, Joao Farias] Fed Univ Para, Inst Biol Sci, Lab Human & Med Genet, Belem, Para, Brazil; [de Sousa, Jaime Viana] Fed Rural Univ Amazon, Capanema Campus, Capanema, PA, Brazil	Universidade Federal do Para	Guerreiro, JF (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Human & Med Genet, Belem, Para, Brazil.	joao.guerreiro53@gmail.com		Guerreiro, Joao/0000-0003-1979-3656; Souza, Mauro Lucio/0000-0002-4161-0281	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [88887.465295/2019-00, 001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received support from Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior 001, Process Number: 88887.465295/2019-00 (awarded to MLFSJ). No additional external funding was received.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almen MS, 2013, INT J OBESITY, V37, P424, DOI 10.1038/ijo.2012.57; [Anonymous], 2020, AM J MED GENET A, V182, P1999, DOI 10.1002/ajmg.a.61819; Araujo GS, 2016, BIOINFORMATICS, V32, P1247, DOI 10.1093/bioinformatics/btv708; Babenko V, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0491-x; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Caglayan AO, 2016, J HUM GENET, V61, P395, DOI 10.1038/jhg.2015.160; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Deliard S, 2013, OBESITY, V21, P159, DOI 10.1002/oby.20147; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kim HS, 2017, GUT, V66, P1926, DOI 10.1136/gutjnl-2016-311921; Kolackov K, 2016, ADV CLIN EXP MED, V25, P33, DOI 10.17219/acem/60645; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landfors M, 2016, FERTIL STERIL, V105, P1170, DOI 10.1016/j.fertnstert.2016.01.002; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Mao LY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4262-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Pshennikova Vera G, 2019, ScientificWorldJournal, V2019, P5198931, DOI 10.1155/2019/5198931; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rohena L, 2016, AM J MED GENET A, V170, P1023, DOI 10.1002/ajmg.a.37515; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Walters-Sen LC, 2015, MOL GENET GENOM MED, V3, P99, DOI 10.1002/mgg3.116; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zheng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067039	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0248610	10.1371/journal.pone.0248610	http://dx.doi.org/10.1371/journal.pone.0248610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990463	gold, Green Published			2022-12-26	WOS:000815783800001
J	Gray, AD; Bernhardt, E				Gray, Austin D.; Bernhardt, Emily			Are nitrogen and carbon cycle processes impacted by common stream antibiotics? A comparative assessment of single vs. mixture exposures	PLOS ONE			English	Article							WASTE-WATER CONTAMINANTS; MICROBIAL RESPIRATION; UNITED-STATES; PHARMACEUTICALS; GENE; RESTORATION; REDUCTASE; DENITRIFICATION; SUSCEPTIBILITY; ANTIMICROBIALS	A variety of antibiotics are ubiquitous in all freshwater ecosystems that receive wastewater. A wide variety of antibiotics have been developed to kill problematic bacteria and fungi through targeted application, and their use has contributed significantly to public health and livestock management. Unfortunately, a substantial fraction of the antibiotics applied to humans, pets and livestock end up in wastewater, and ultimately many of these chemicals enter freshwater ecosystems. The effect of adding chemicals that are intentionally designed to kill microbes, on freshwater microbial communities remains poorly understood. There are reasons to be concerned, as microbes play an essential role in nutrient uptake, carbon fixation and denitrification in freshwater ecosystems. Chemicals that reduce or alter freshwater microbial communities might reduce their capacity to degrade the excess nutrients and organic matter that characterize wastewater. We performed a laboratory experiment in which we exposed microbial community from unexposed stream sediments to three commonly detected antibiotics found in urban wastewater and urban streams (sulfamethoxazole, danofloxacin, and erythromycin). We assessed how the form and concentration of inorganic nitrogen, microbial carbon, and nitrogen cycling processes changed in response to environmentally relevant doses (10 mu g/ L) of each of these antibiotics individually and in combination. We expected to find that all antibiotics suppressed rates of microbial mineralization and nitrogen transformations and we anticipated that this suppression of microbial activity would be greatest in the combined treatment. Contrary to our expectations we measured few significant changes in microbially mediated functions in response to our experimental antibiotic dosing. We found no difference in functional gene abundance of key nitrogen cycling genes nosZ, mcrA, nirK, and amoA genes, and we measured no treatment effects on NO3- uptake or N2O, N-2, CH4, CO2 production over the course of our seven-day experiment. In the mixture treatment, we measured significant increases in NH4+ concentrations over the first 24 hours of the experiment, which were indistinguishable from controls within six hours. Our results suggest remarkable community resistance to pressure antibiotic exposure poses on naive stream sediments.	[Gray, Austin D.] Univ North Carolina Greensboro, Dept Biol, Greensboro, NC 27412 USA; [Gray, Austin D.; Bernhardt, Emily] Duke Univ, Dept Biol, French Sci Ctr, Durham, NC 27706 USA; [Gray, Austin D.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	University of North Carolina; University of North Carolina Greensboro; Duke University; Virginia Polytechnic Institute & State University	Gray, AD (corresponding author), Univ North Carolina Greensboro, Dept Biol, Greensboro, NC 27412 USA.; Gray, AD (corresponding author), Duke Univ, Dept Biol, French Sci Ctr, Durham, NC 27706 USA.; Gray, AD (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA.	austindg@vt.edu	Bernhardt, Emily S/D-9940-2011; Gray, Austin/HDM-0092-2022; Gray, Austin/GSN-9971-2022	Bernhardt, Emily S/0000-0003-3031-621X; Gray, Austin/0000-0002-6090-6328; 	Society of Environmental Toxicology and Chemistry Student Training Exchange Opportunity Award or (STEO); North Carolina Sea Grant	Society of Environmental Toxicology and Chemistry Student Training Exchange Opportunity Award or (STEO); North Carolina Sea Grant	AG Society of Environmental Toxicology and Chemistry Student Training Exchange Opportunity Award or (STEO) https://awards.setac.org/student-training-exchange-opportunity/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also supported by North Carolina Sea Grant.	Al-Odaini NA, 2013, INT J ENVIRON AN CH, V93, P245, DOI 10.1080/03067319.2011.592949; Angle JC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01753-4; [Anonymous], 2004, USEPA REP C IMP CONT; Ashfaq M, 2020, ADV ENV POLL RES, V1, P331, DOI 10.1016/B978-0-12-818882-8.00021-8; Baran W, 2011, J HAZARD MATER, V196, P1, DOI 10.1016/j.jhazmat.2011.08.082; Barnes KK, 2008, SCI TOTAL ENVIRON, V402, P192, DOI 10.1016/j.scitotenv.2008.04.028; Bernhardt ES, 2017, FRONT ECOL ENVIRON, V15, P84, DOI 10.1002/fee.1450; Blaszczak JR, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2318; Brigham J. S, 2018, THESIS U N CAROLINA; Bunch AR, 2011, ECOTOXICOLOGY, V20, P97, DOI 10.1007/s10646-010-0560-6; Carreira C, 2018, PEERJ, V6, DOI 10.7717/peerj.5603; Chen Z, 2007, AQUAT TOXICOL, V81, P256, DOI 10.1016/j.aquatox.2006.12.008; Conkle JL, 2012, J ENVIRON SCI HEAL A, V47, P1381, DOI 10.1080/10934529.2012.672315; Cordova-Kreylos AL, 2007, ISME J, V1, P585, DOI 10.1038/ismej.2007.71; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DeVries SL, 2016, CURR POLLUT REP, V2, P51, DOI 10.1007/s40726-016-0027-3; Du Jingru, 2015, Journal of Water and Environment Technology, V13, P37, DOI 10.2965/jwet.2015.37; Fenton CS, 2015, IRISH VET J, V68, DOI 10.1186/s13620-015-0051-4; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Gonzalez-Pleiter M, 2013, WATER RES, V47, P2050, DOI 10.1016/j.watres.2013.01.020; Goolsby D. A., 2000, EOS, V81, P321, DOI DOI 10.1029/00EO00244; Gray A., 2020, THESIS U N CAROLINA; Gray A, 2021, J ENVIRON HEALTH SCI, V19, P1313, DOI 10.1007/s40201-021-00688-9; Gray AD, 2020, SCI TOTAL ENVIRON, V710, DOI 10.1016/j.scitotenv.2019.136286; Greaver TL, 2016, NAT CLIM CHANGE, V6, P836, DOI [10.1038/NCLIMATE3088, 10.1038/nclimate3088]; Grimm NB, 2005, J N AM BENTHOL SOC, V24, P626, DOI 10.1899/04-027.1; Haggard BE, 2009, J ENVIRON QUAL, V38, P343, DOI 10.2134/jeq2007.0540; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Ji GD, 2012, ECOL ENG, V44, P269, DOI 10.1016/j.ecoleng.2012.04.007; Kaushal SS, 2008, ECOL APPL, V18, P789, DOI 10.1890/07-1159.1; Kim A, 2018, MICROB DRUG RESIST, V24, P1226, DOI 10.1089/mdr.2017.0137; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Lee CM, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6924-y; Lee SS, 2016, ENVIRON SCI TECHNOL, V50, P9727, DOI 10.1021/acs.est.6b03717; Lofton DD, 2007, BIOGEOCHEMISTRY, V86, P77, DOI 10.1007/s10533-007-9146-7; Ma DY, 2006, SCI TOTAL ENVIRON, V367, P273, DOI 10.1016/j.scitotenv.2005.10.014; McDermott PF, 2003, INT J TOXICOL, V22, P135, DOI 10.1080/10915810305089; McDowell RW, 2009, NEW ZEAL J MAR FRESH, V43, P985, DOI 10.1080/00288330909510055; McMillan SK, 2014, J AM WATER RESOUR AS, V50, P626, DOI 10.1111/jawr.12205; Patel M, 2019, CHEM REV, V119, P3510, DOI 10.1021/acs.chemrev.8b00299; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Rocca JD, 2015, ISME J, V9, P1693, DOI 10.1038/ismej.2014.252; Roose-Amsaleg C, 2016, ENVIRON SCI POLLUT R, V23, P4000, DOI 10.1007/s11356-015-4943-3; Rosi EJ, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2041; Rosi-Marshall EJ, 2013, ECOL APPL, V23, P583, DOI 10.1890/12-0491.1; Rosi-Marshall EJ, 2012, ECOSYSTEMS, V15, P867, DOI 10.1007/s10021-012-9553-z; Rossi N. A., 2019, COMMUN BIOL, V2, P1; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Santana LMBM, 2017, SCI TOTAL ENVIRON, V595, P920, DOI 10.1016/j.scitotenv.2017.03.020; Sobota DJ, 2013, FRONT ECOL ENVIRON, V11, P82, DOI 10.1890/110216; Sweeney MT, 2017, J VET DIAGN INVEST, V29, P224, DOI 10.1177/1040638716683212; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023; Toth JD, 2011, SOIL BIOL BIOCHEM, V43, P2470, DOI 10.1016/j.soilbio.2011.09.004; Underwood JC, 2011, ENVIRON SCI TECHNOL, V45, P3096, DOI 10.1021/es103605e; Vaksmaa A, 2017, APPL MICROBIOL BIOT, V101, P1631, DOI 10.1007/s00253-016-8065-8; Van Metre PC, 2016, J ENVIRON QUAL, V45, P1696, DOI 10.2134/jeq2015.12.0591; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Yan TF, 2003, ENVIRON MICROBIOL, V5, P13, DOI 10.1046/j.1462-2920.2003.00393.x	59	3	3	15	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0261714	10.1371/journal.pone.0261714	http://dx.doi.org/10.1371/journal.pone.0261714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986185	gold, Green Published			2022-12-26	WOS:000765956200013
J	Guo, Q; Sun, YH; Zhang, JT; Li, Y				Guo, Qi; Sun, Yuhan; Zhang, Jiangtao; Li, Yun			Variation of phenotypic and physiological traits of Robinia pseudoacacia L. from 20 provenances	PLOS ONE			English	Article							BLACK LOCUST PLANTATION; LOESS PLATEAU; POPULATIONS; FOREST; FRUIT; TREE; SEED	To select elite Robinia pseudoacacia L. germplasm resources for production, 13 phenotypes and three physiological indicators of 214 seedlings from 20 provenances were systematically evaluated and analyzed. The leaf phenotypic and physiological coefficients of variation among the genotypes ranged from 3.741% to 19.599% and from 8.260% to 42.363%, respectively. The Kentucky provenance had the largest coefficient of variation (18.541%). The average differentiation coefficients between and within provenances were 34.161% and 38.756%, respectively. These close percentages showed that R. pseudoacacia presented high genetic variation among and within provenances, which can be useful for assisted migration and breeding programs. Furthermore, based on the results of correlations, principal component analysis and cluster analysis, breeding improvements targeting R. pseudoacacia's ornamental value, food value, and stress resistance of were performed. Forty and 30 excellent individuals, accounting for 18.692% and 14.019%, respectively, of the total resources. They were ultimately screened, after comprehensively taking into considering leaf phenotypic traits including compound leaf length, leaflet number and leaflet area and physiological characteristics including proline and soluble protein contents. These selected individuals could provide a base material for improved variety conservation and selection.	[Guo, Qi] Henan Univ Sci & Technol, Coll Agr Tree Peony, Luoyang, Henan, Peoples R China; [Guo, Qi; Sun, Yuhan; Li, Yun] Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China; [Guo, Qi; Sun, Yuhan; Li, Yun] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Guo, Qi; Sun, Yuhan; Li, Yun] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Zhang, Jiangtao] Henan Acad Forestry, Zhengzhou, Peoples R China	Henan University of Science & Technology; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Li, Y (corresponding author), Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China.; Li, Y (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.; Li, Y (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.; Zhang, JT (corresponding author), Henan Acad Forestry, Zhengzhou, Peoples R China.	hnlky@163.com; yunli@bjfu.edu.cn		Li, Yun/0000-0002-8426-565X	Youth Science Foundation of Henan Province [202300410136]; National Nature Science Foundation of China [31570677]; National Key R&D Program of China [2017YFD0600503]; National Forestry and Grassland Administration of Science and Technology Development Center Project [2016007]	Youth Science Foundation of Henan Province; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Forestry and Grassland Administration of Science and Technology Development Center Project	Qi Guo: Youth Science Foundation of Henan Province (202300410136), Yun Li: National Nature Science Foundation of China (31570677), Yun Li: National Key R&D Program of China (2017YFD0600503), Yun Li: National Forestry and Grassland Administration of Science and Technology Development Center Project (2016007).	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Balapanov I, 2019, SCI HORTIC-AMSTERDAM, V253, P322, DOI 10.1016/j.scienta.2019.04.014; Bessega C, 2015, GENETICA, V143, P31, DOI 10.1007/s10709-014-9810-5; Carletti G, 2021, J FORESTRY RES, V32, P263, DOI 10.1007/s11676-019-00913-0; COHEN JI, 1991, SCIENCE, V253, P866, DOI 10.1126/science.253.5022.866; Dini-Papanastasi O, 2008, FORESTRY, V81, P91, DOI 10.1093/forestry/cpm047; [董承光 Dong Chengguang], 2016, [植物遗传资源学报, Journal of Plant Genetic Resources], V17, P438; [董胜君 Dong Shengjun], 2018, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V49, P686; El-Soda M, 2014, TRENDS PLANT SCI, V19, P390, DOI 10.1016/j.tplants.2014.01.001; Feng Qiuhong, 2020, Biodiversity Science, V28, P314, DOI 10.17520/biods.2019091; Fu M., 2018, FOREST RESOURCES MAN, P35, DOI [10.13466/j.cnki.lyzygl.2018.02.007, DOI 10.13466/J.CNKI.LYZYGL.2018.02.007]; Ge S., 1988, Scientia Silvae Sinicae, V24, P399; Granata MU, 2020, FLORA, V268, DOI 10.1016/j.flora.2020.151626; Gu J, 2006, THESIS HEBEI AGR U, DOI [10. 7666/d.y933406, DOI 10.7666/D.Y933406]; Gu WanChun, 2007, World Forestry Research, V20, P66; [郭琪 Guo Qi], 2019, [分子植物育种, Molecular Plant Breeding], V17, P4479; Guo Q, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092492; [郝蕾 Hao Lei], 2015, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V29, P112; Hawkins TS, 2009, J NAT CONSERV, V17, P123, DOI 10.1016/j.jnc.2008.12.007; [何清伟 He Qingwei], 2020, [四川农业大学学报, Journal of Sichuan Agricultural University], V38, P135; Hong T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208899; Huang TianCai, 2011, Biodiversity Science, V19, P319, DOI 10.3724/SP.J.1003.2011.08206; Huntley JC, 1990, SILVICS N AM, V2; Jiang R, 2011, J NORTHEAST FOR UNIV, V39, P23, DOI [10.3969/j.issn.1000-5382.2011.05.003, DOI 10.3969/J.ISSN.1000-5382.2011.05.003]; Jiang RongBo, 2011, Journal of Northeast Forestry University, V39, P9; Keeler H., 1907, OUR NATIVE TREES IDE, P186; [李斌 Li Bin], 2014, [植物遗传资源学报, Journal of Plant Genetic Resources], V15, P477; [李鸿雁 Li Hongyan], 2017, [植物遗传资源学报, Journal of Plant Genetic Resources], V18, P620; Li JM, 2008, GENETICA, V133, P227, DOI 10.1007/s10709-007-9204-z; Li M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0772-x; Li Y, 2017, J SHANXI AGR ENCES, V45, P1061, DOI [10.3969/j.issn.1002-2481.2017.07.04, DOI 10.3969/J.ISSN.1002-2481.2017.07.04]; Li ZhongXi, 2015, Acta Agriculturae Shanghai, V31, P63; Lian YJ, 2019, J FUJIAN FORESTRY SC, V42, P55, DOI DOI 10.13428/J.CNKI.FJLK.2019.02.013; Liu Na, 2020, Plant Science Journal, V38, P378, DOI 10.11913/PSJ.2095-0837.2020.30378; Lv JB, 2020, IND CROP PROD, V145, DOI 10.1016/j.indcrop.2020.112157; Nezhad MS, 2011, LIFE SCI J, V8, P440; Ou HanBiao, 2020, Southwest China Journal of Agricultural Sciences, V33, P637, DOI 10.16213/j.cnki.scjas.2020.3.026; Pan YY, 2020, TREE GENET GENOMES, V16, DOI 10.1007/s11295-020-1420-z; [庞发虎 Pang Fahu], 2010, [生态学报, Acta Ecologica Sinica], V30, P3188; [彭祥 Peng Xiang], 2018, [分子植物育种, Molecular Plant Breeding], V16, P5731; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pritchard HW, 2014, FOREST ECOL MANAG, V333, P88, DOI 10.1016/j.foreco.2014.08.012; Qiu LP, 2010, PLANT SOIL, V332, P207, DOI 10.1007/s11104-010-0286-5; Santiso X, 2015, TREE PHYSIOL, V35, P1118, DOI 10.1093/treephys/tpv081; Su Leyi, 2016, Journal of Plant Resources and Environment, V25, P76, DOI 10.3969/j.issn.674-7895.2016.04.10; [孙芳 SUN Fang], 2009, [植物遗传资源学报, Journal of Plant Genetic Resources], V10, P91; Sun YuHan, 2013, Journal of Northeast Forestry University, V41, P14; SURLES SE, 1989, CAN J FOREST RES, V19, P471, DOI 10.1139/x89-073; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tateno R, 2007, FOREST ECOL MANAG, V241, P84, DOI 10.1016/j.foreco.2006.12.026; Tian F, 2000, PHARM BIOL, V38, P229, DOI 10.1076/1388-0209(200007)3831-SFT229; Wang HongLing, 2019, Journal of Jiangsu Forestry Science & Technology, V46, P22, DOI 10.3969/j.issn.1001-7380.2019.05.004; Wang Kai, 2014, Bulletin of Botanical Research, V34, P634, DOI 10.7525/j.issn.1673-5102.2014.05.009; Wang XL, 2021, GENET RESOUR CROP EV, V68, P3219, DOI 10.1007/s10722-021-01182-9; Wen Shan-Na, 2017, Bulletin of Botanical Research, V37, P288, DOI 10.7525/j.issn.1673-5102.2017.02.018; Wen Y, 2012, SILVAE GENET, V61, P287, DOI 10.1515/sg-2012-0036; [解新明 Xie Xinming], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P31; Xie YangJiao, 2017, Guangxi Zhiwu / Guihaia, V37, P348; Xu YD, 2019, CATENA, V174, P316, DOI 10.1016/j.catena.2018.11.009; Xue D, 2018, HUBEI FORESTRY SCI T, V47, P20; Xun S, 2009, J SHANDONG FOR SCI T, V39, P92, DOI 10.3969/j.issn.1002-2724.2009.01.038; Yang M, 2004, ACTA GENET SIN, V31, P1440, DOI 10.1016/j.jce.2003.10; Yang Xiaoxia, 2016, Journal of Plant Resources and Environment, V25, P80, DOI 10.3969/j.issn.1674-7895.2016.03.10; Zhang DL, 1990, SHANDONG FOR SCI TEC, V2, P16; Zhang GuoJun, 2013, Journal of Beijing Forestry University, V35, P8; Zhang JG, 2015, ECOHYDROLOGY, V8, P137, DOI 10.1002/eco.1495; [张双 Zhang Shuang], 2017, [园艺学报, Acta Horticulturae Sinica], V44, P1609; [张燕 Zhang Yan], 2016, [分子植物育种, Molecular Plant Breeding], V14, P239; Zhou L, 2013, THESIS HENAN AGR U, DOI [10.7666/d.Y2691005, DOI 10.7666/D.Y2691005]; Zhou XinHua, 2021, Journal of South China Agricultural University, V42, P116, DOI 10.7671/j.issn.1001-411X.202003001	70	0	0	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262278	10.1371/journal.pone.0262278	http://dx.doi.org/10.1371/journal.pone.0262278			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986177	gold, Green Published			2022-12-26	WOS:000765956200035
J	Kim, MJ; Chu, KB; Lee, HA; Quan, FS; Kong, HH; Moon, EK				Kim, Min-Jeong; Chu, Ki-Back; Lee, Hae-Ahm; Quan, Fu-Shi; Kong, Hyun-Hee; Moon, Eun-Kyung			Detection of Acanthamoeba spp. using carboxylesterase antibody and its usage for diagnosing Acanthamoeba-keratitis	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; GENUS ACANTHAMOEBA; CONTACT-LENS; IDENTIFICATION; MOUSE; WALL; PCR	Contact lens usage has contributed to increased incidence rates of Acanthamoeba keratitis (AK), a serious corneal infection that can lead to blindness. Since symptoms associated with AK closely resemble those incurred by bacterial or fungal keratitis, developing a diagnostic method enabling rapid detection with a high degree of Acanthamoeba-specificity would be beneficial. Here, we produced a polyclonal antibody targeting the carboxylesterase (CE) superfamily protein secreted by the pathogenic Acanthamoeba and evaluated its diagnostic potential. Western blot analysis revealed that the CE antibody specifically interacts with the cell lysates and conditioned media of pathogenic Acanthamoeba, which were not observed from the cell lysates and conditioned media of human corneal epithelial (HCE) cells, Fusarium solani, Staphylococcus aureus, and Pseudomonas aeruginosa. High titers of A. castellanii-specific antibody production were confirmed sera of immunized mice via ELISA, and these antibodies were capable of detecting A. castellanii from the cell lysates and their conditioned media. The specificity of the CE antibody was further confirmed on A. castellanii trophozoites and cysts co-cultured with HCE cells, F. solani, S. aureus, and P. aeruginosa using immunocytochemistry. Additionally, the CE antibody produced in this study successfully interacted with 7 different Acanthamoeba species. Our findings demonstrate that the polyclonal CE antibody specifically detects multiple species belong to the genus Acanthamoeba, thus highlighting its potential as AK diagnostic tool.	[Kim, Min-Jeong; Chu, Ki-Back] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Lee, Hae-Ahm; Quan, Fu-Shi] Kyung Hee Univ, Med Res Ctr Bioreact React Oxygen Species, Seoul, South Korea; [Lee, Hae-Ahm; Quan, Fu-Shi] Kyung Hee Univ, Sch Med, Grad Sch, Biomed Sci Inst, Seoul, South Korea; [Quan, Fu-Shi; Moon, Eun-Kyung] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea; [Kong, Hyun-Hee] Dong A Univ, Coll Med, Dept Parasitol, Busan, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Dong A University	Moon, EK (corresponding author), Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea.	ekmoon@khu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MIST) [2020R1A2C1005345]	National Research Foundation of Korea (NRF) - Korea government (MIST)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MIST) (No. 2020R1A2C1005345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh H, 2001, CORNEA, V20, P622, DOI 10.1097/00003226-200108000-00013; CHYNN EW, 1995, OPHTHALMOLOGY, V102, P1369, DOI 10.1016/S0161-6420(95)30862-7; de Lacerda AG, 2021, OPHTHAL PHYSL OPT, V41, P116, DOI 10.1111/opo.12752; Duarte JL, 2013, EXP PARASITOL, V135, P9, DOI 10.1016/j.exppara.2013.05.013; Fanselow N, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10030323; Fuerst PA, 2015, J EUKARYOT MICROBIOL, V62, P69, DOI 10.1111/jeu.12186; Furihata T, 2004, DRUG METAB DISPOS, V32, P1170, DOI 10.1124/dmd.104.000620; Goh JWY, 2018, CORNEA, V37, P480, DOI 10.1097/ICO.0000000000001497; Hammersmith KM, 2006, CURR OPIN OPHTHALMOL, V17, P327, DOI 10.1097/01.icu.0000233949.56229.7d; Hatfield MJ, 2016, CHEM-BIOL INTERACT, V259, P327, DOI 10.1016/j.cbi.2016.02.011; HOSOKAWA M, 1995, DRUG METAB DISPOS, V23, P1022; Ikeda Y, 2012, OPHTHALMOLOGY, V119, P1111, DOI 10.1016/j.ophtha.2011.12.023; Jercic MI, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3302-5; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Ledee DR, 1996, INVEST OPHTH VIS SCI, V37, P544; Lee HA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250342; Lian JH, 2018, PROTEIN CELL, V9, P178, DOI 10.1007/s13238-017-0437-z; Lorenzo-Morales J, 2015, PARASITE, V22, DOI 10.1051/parasite/2015010; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Mascarenhas J, 2014, AM J OPHTHALMOL, V157, P56, DOI 10.1016/j.ajo.2013.08.032; Moan EK, 2018, KOREAN J PARASITOL, V56, P553, DOI 10.3347/kjp.2018.56.6.553; Park SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239867; Pfister DR, 1996, AM J OPHTHALMOL, V121, P119, DOI 10.1016/S0002-9394(14)70576-8; PUSSARD M, 1977, PROTISTOLOGICA, V13, P557; Riviere D, 2006, J MICROBIOL METH, V64, P78, DOI 10.1016/j.mimet.2005.04.008; Schuster FL, 2006, CLIN INFECT DIS, V42, P1260, DOI 10.1086/503037; SEAL DV, 1993, J MED MICROBIOL, V39, P1, DOI 10.1099/00222615-39-1-1; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Stothard DR, 1998, J EUKARYOT MICROBIOL, V45, P45, DOI 10.1111/j.1550-7408.1998.tb05068.x; Szentmary N, 2019, J CURR OPHTHALMOL, V31, P16, DOI 10.1016/j.joco.2018.09.008; Turner ML, 2005, INT J PARASITOL, V35, P981, DOI 10.1016/j.ijpara.2005.03.015; Walochnik J, 2000, APPL ENVIRON MICROB, V66, P4408, DOI 10.1128/AEM.66.10.4408-4413.2000; Xuan YH, 2008, KOREAN J PARASITOL, V46, P157, DOI 10.3347/kjp.2008.46.3.157; Yoder JS, 2012, OPHTHAL EPIDEMIOL, V19, P221, DOI 10.3109/09286586.2012.681336; Zamora A, 2014, Surg Neurol Int, V5, P68, DOI 10.4103/2152-7806.132239	36	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262223	10.1371/journal.pone.0262223	http://dx.doi.org/10.1371/journal.pone.0262223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986189	gold, Green Published			2022-12-26	WOS:000765956200025
J	Hemminki, K; Forsti, A; Hemminki, A; Ljungberg, B; Hemminki, O				Hemminki, Kari; Foersti, Asta; Hemminki, Akseli; Ljungberg, Borje; Hemminki, Otto			Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; EUROPEAN ASSOCIATION; UROLOGY GUIDELINES; SURGICAL-TREATMENT; TOBACCO USE; TRENDS; MORTALITY; END; IMMIGRANTS	Survival has improved in bladder cancer but few studies have considered extended periods or covered populations for which medical care is essentially free of charge. We analyzed survival in urothelial cancer (UC, of which vast majority are bladder cancers) in Finland and Sweden over a 50-year period (1967-2016) using data from the NORDCAN database. Finland and Sweden are neighboring countries with largely similar health care systems but higher economic resources and health care expenditure in Sweden. We present results on 1- and 5-year relative survival rates, and additionally provide a novel measure, the difference between 1- and 5-year relative survival, indicating how well survival was maintained between these two periods. Over the 50-year period the median diagnostic age has increased by several years and the incidence in the very old patients has increased vastly. Relative 1- year survival rates increased until early 1990s in both countries, and with minor gains later reaching about 90% in men and 85% in women. Although 5-year survival also developed favorably until early 1990s, subsequent gains were small. Over time, age specific differences in male 1-year survival narrowed but remained wide in 5-year survival. For women, age differences were larger than for men. The limitations of the study were lack of information on treatment and stage. In conclusion, challenges are to improve 5-year survival, to reduce the gender gap and to target specific care to the most common patient group, those of 70 years at diagnosis. The most effective methods to achieve survival gains are to target control of tobacco use, emphasis on early diagnosis with prompt action at hematuria, upfront curative treatment and awareness of high relapse requiring regular cystoscopy follow up.	[Hemminki, Kari] Charles Univ Pilsen, Fac Med, Biomed Ctr, Plzen, Czech Republic; [Hemminki, Kari] German Canc Res Ctr, Div Canc Epidemiol, Neuenheimer Feld, Heidelberg, Germany; [Foersti, Asta] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Germany; [Foersti, Asta] German Canc Res Ctr, German Canc Consortium DKTK, Div Pediat Neu Rooncol, Heidelberg, Germany; [Hemminki, Akseli; Hemminki, Otto] Univ Helsinki, Translat Immunol Res Program, Canc Gene Therapy Grp, Helsinki, Finland; [Hemminki, Akseli] Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Hemminki, Otto] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Hemminki, Otto] Univ Helsinki, Helsinki, Finland; [Hemminki, Otto] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol Oncol, Toronto, ON, Canada; [Hemminki, Otto] Univ Toronto, Toronto, ON, Canada	Charles University Prague; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Umea University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Hemminki, K (corresponding author), Charles Univ Pilsen, Fac Med, Biomed Ctr, Plzen, Czech Republic.; Hemminki, K (corresponding author), German Canc Res Ctr, Div Canc Epidemiol, Neuenheimer Feld, Heidelberg, Germany.	K.Hemminki@dkfz.de		Hemminki, Kari/0000-0002-2769-3316	European Union's Horizon 2020 research and innovation programme [856620]; Finnish Cancer Organizations [6-5156-32]; Helsinki University Central Hospital [TYH2019215, TYH2018306]; Paivikki and Sakari Sohlberg Foundation [10-6623-11]	European Union's Horizon 2020 research and innovation programme; Finnish Cancer Organizations; Helsinki University Central Hospital; Paivikki and Sakari Sohlberg Foundation	Supported by the European Union's Horizon 2020 research and innovation programme, grant No 856620, Finnish Cancer Organizations (6-5156-32), Helsinki University Central Hospital (TYH2019215 and TYH2018306) and Paivikki and Sakari Sohlberg Foundation (10-6623-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon-Ching JB, 2019, CLIN GENITOURIN CANC, V17, P436, DOI 10.1016/j.clgc.2019.07.011; Babjuk M, 2019, EUR UROL, V76, P639, DOI 10.1016/j.eururo.2019.08.016; Brown KF, 2018, BRIT J CANCER, V118, P1130, DOI 10.1038/s41416-018-0029-6; Cai QL, 2020, TRANSL ANDROL UROL, V9, P153, DOI 10.21037/tau.2020.02.24; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Ebrahimi H, 2019, J UROLOGY, V201, P893, DOI 10.1097/JU.0000000000000025; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Engholm G, 2010, ACTA ONCOL, V49, P545, DOI 10.3109/02841861003739322; Engholm G, 2010, ACTA ONCOL, V49, P655, DOI 10.3109/02841860903575299; Fahmy NM, 2006, EUR UROL, V50, P1176, DOI 10.1016/j.eururo.2006.05.046; Feldman AS, 2022, UROL ONCOL-SEMIN ORI, V40, P442, DOI 10.1016/j.urolonc.2021.01.013; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Haggstrom C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016606; Hemminki K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253236; Hemminki K, 2022, EUR J CANCER PREV, V31, P228, DOI 10.1097/CEJ.0000000000000694; Hemminki K, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08371-w; Hemminki K, 2014, EUR J PUBLIC HEALTH, V24, P64, DOI 10.1093/eurpub/cku102; Hussain SK, 2008, ANN ONCOL, V19, P156, DOI 10.1093/annonc/mdm413; Inoue-Choi M, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz036; Jahnson S, 2016, SCAND J UROL, V50, P14, DOI 10.3109/21681805.2015.1085089; Jancke G, 2017, SCAND J UROL, V51, P124, DOI 10.1080/21681805.2017.1298156; Ji JG, 2012, INT J CANCER, V131, P2085, DOI 10.1002/ijc.27462; Kim M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1161-9; Kohlmann W., 1993, LYNCH SYNDROME, DOI [10.1093/ajh/6.9.794 8110434, DOI 10.1093/AJH/6.9.7948110434]; Liu XD, 2015, INT J CANCER, V137, P903, DOI 10.1002/ijc.29440; Malmstrom PU, 2019, SCAND J UROL, V53, P193, DOI 10.1080/21681805.2019.1632380; Malmstrom PU, 1996, J UROLOGY, V155, P1903, DOI 10.1016/S0022-5347(01)66042-7; Marcos-Gragera R, 2015, EUR J CANCER, V51, P2217, DOI 10.1016/j.ejca.2015.07.028; Moller P, 2018, GUT, V67, P1306, DOI 10.1136/gutjnl-2017-314057; Mousavi SM, 2010, EUR J CANCER PREV, V19, P275, DOI 10.1097/CEJ.0b013e3283387728; Nielsen ME, 2014, CANCER-AM CANCER SOC, V120, P86, DOI 10.1002/cncr.28397; Nilsson S, 2001, ACTA ONCOL, V40, P371, DOI 10.1080/02841860151116466; Oosterlinck W, 2002, EUR UROL, V41, P105, DOI 10.1016/S0302-2838(01)00026-4; Patja K, 2009, SCAND J PUBLIC HEALT, V37, P153, DOI 10.1177/1403494808100277; Radkiewicz C, 2020, CLIN GENITOURIN CANC, V18, P26, DOI 10.1016/j.clgc.2019.10.020; Rink M, 2013, EUR UROL, V63, P724, DOI 10.1016/j.eururo.2012.08.025; Roupret M, 2018, EUR UROL, V73, P111, DOI 10.1016/j.eururo.2017.07.036; Sjostrom C, 2018, SCAND J UROL, V52, P186, DOI 10.1080/21681805.2018.1462254; Storm HH, 2010, ACTA ONCOL, V49, P694, DOI 10.3109/02841861003631495; Sunela KL, 2014, BJU INT, V113, P228, DOI 10.1111/bju.12242; Tellini R, 2021, EUR UROL ONCOL, V4, P580, DOI 10.1016/j.euo.2020.10.006; Teoh JYC, 2020, EUR UROL, V78, P893, DOI 10.1016/j.eururo.2020.09.006; Thorstenson A, 2014, SCAND J UROL, V48, P231, DOI 10.3109/21681805.2013.864698; Welch HG, 2019, NEW ENGL J MED, V381, P1378, DOI 10.1056/NEJMsr1905447; Wischhusen JW, 2020, CANCER EPIDEM BIOMAR, V29, P193, DOI 10.1158/1055-9965.EPI-19-0213; Witjes JA, 2021, EUR UROL, V79, P82, DOI 10.1016/j.eururo.2020.03.055; Yu HY, 2020, MUTAGENESIS, V35, P207, DOI 10.1093/mutage/gez022; Zang Y, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2108	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261124	10.1371/journal.pone.0261124	http://dx.doi.org/10.1371/journal.pone.0261124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982793	Green Submitted, gold, Green Published			2022-12-26	WOS:000834805700006
J	Kim, HJ; Ryou, JH; Choi, KT; Kim, SM; Kim, JT; Han, DH				Kim, Hee Jin; Ryou, Jae Hyun; Choi, Kang Ta; Kim, Sun Mi; Kim, Jee Taek; Han, Doug Hyun			Deficits in color detection in patients with Alzheimer disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; DEMENTIA; TESTS	Deficits in color vision and related retinal changes hold promise as early screening biomarkers in patients with Alzheimer's disease. This study aimed to determine a cut-off score that can screen for Alzheimer's dementia using a novel color vision threshold test named the red, green, and blue (RGB) modified color vision plate test (RGB-vision plate). We developed the RGB-vision plate consisting of 30 plates in which the red and green hues of Ishihara Plate No.22 were sequentially adjusted. A total of 108 older people participated in the mini-mental state examination (MMSE), Ishihara plate, and RGB-vision plate. For the analyses, the participants were divided into two groups: Alzheimer's dementia (n = 42) and healthy controls (n = 38). K-means cluster analysis and ROC curve analysis were performed to identify the most appropriate cut-off score. As a result, the cut-off screening score for Alzheimer's dementia on the RGB-vision plate was set at 25, with an area under the curve of 0.773 (p<0.001). Moreover, there was a negative correlation between the RGB-vision plate thresholds and MMSE scores (r = -0.36, p = 0.02). In conclusion, patients with Alzheimer's dementia had a deficit in color vision. The RGB-vision plate is a potential early biomarker that may adequately detect Alzheimer's dementia.	[Kim, Hee Jin; Ryou, Jae Hyun; Choi, Kang Ta; Kim, Sun Mi; Han, Doug Hyun] Chung Ang Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Jee Taek] Chung Ang Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Han, DH (corresponding author), Chung Ang Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	hduk70@gmail.com		Choi, Gangta/0000-0001-5402-2158; Han, Doug Hyun/0000-0002-8314-0767; Kim, Heejin/0000-0002-8529-4786	Chung Ang University	Chung Ang University	This research was supported by the Chung Ang University Research Scholarship Grant in 2020.	Al-Qazzaz NK, 2014, SCI WORLD J, DOI 10.1155/2014/906038; Arnaoutoglou NA, 2017, INT PSYCHOGERIATR, V29, P1355, DOI 10.1017/S1041610217000096; Arvanitakis Z, 2019, JAMA-J AM MED ASSOC, V322, P1589, DOI 10.1001/jama.2019.4782; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Barbur J.L., 2010, ENCY EYE, P323, DOI 10.1016/B978-0-12-374203-2.00233-5; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Birch J, 1997, OPHTHAL PHYSL OPT, V17, P403, DOI 10.1111/j.1475-1313.1997.tb00072.x; Borson S, 2013, ALZHEIMERS DEMENT, V9, P151, DOI 10.1016/j.jalz.2012.08.008; BOYCOTT BB, 1969, PHILOS T ROY SOC B, V255, P109, DOI 10.1098/rstb.1969.0004; Bull ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034724; Byun MS, 2021, JAMA OPHTHALMOL, V139, P548, DOI 10.1001/jamaophthalmol.2021.0320; Chang LYL, 2014, ALZHEIMERS DEMENT, V10, P251, DOI 10.1016/j.jalz.2013.06.004; Choo IH, 2007, ALZ DIS ASSOC DIS, V21, P77, DOI 10.1097/WAD.0b013e3180687418; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; CRONINGOLOMB A, 1993, NEUROBIOL AGING, V14, P471, DOI 10.1016/0197-4580(93)90105-K; Danesh-Meyer HV, 2006, NEUROLOGY, V67, P1852, DOI 10.1212/01.wnl.0000244490.07925.8b; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; DEMARCO P, 1992, J OPT SOC AM A, V9, P1465, DOI 10.1364/JOSAA.9.001465; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; Gietl Anton Franz, 2015, Rev Med Suisse, V11, P1944; HARDY LH, 1954, AMA ARCH OPHTHALMOL, V51, P216, DOI 10.1001/archopht.1954.00920040218009; Henry MS, 2013, INT J GERIATR PSYCH, V28, P331, DOI 10.1002/gps.3829; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; Huna-Baron R, 2013, GRAEF ARCH CLIN EXP, V251, P585, DOI 10.1007/s00417-012-2073-x; Kim SM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254357; Ko F, 2018, JAMA NEUROL, V75, P1198, DOI 10.1001/jamaneurol.2018.1578; Kwon YC, 1989, KOR NEUROPSYCHIAT AS, V28, P125; La Morgia C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00710; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lorentz WJ, 2002, CAN J PSYCHIAT, V47, P723, DOI 10.1177/070674370204700803; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Martinez-Domingo MA, 2019, OPT EXPRESS, V27, P17954, DOI 10.1364/OE.27.017954; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Polo V, 2017, EYE, V31, P1034, DOI 10.1038/eye.2017.23; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Shabani A, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.1894; Siddiqui QA, 2010, SAUDI MED J, V31, P895; Tuijl JP, 2012, INT J GERIATR PSYCH, V27, P755, DOI 10.1002/gps.2776; van Staden D, 2018, AFR VIS EYE HEALTH J, V77, DOI 10.4102/aveh.v77i1.370; Zhang Y, 2021, TRANSL NEURODEGENER, V10, DOI 10.1186/s40035-021-00230-9; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	44	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262226	10.1371/journal.pone.0262226	http://dx.doi.org/10.1371/journal.pone.0262226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982795	Green Published, gold			2022-12-26	WOS:000834805700022
J	Lee, MF; Chiang, CH; Lin, SJ; Wu, CS; Chen, YH				Lee, Mey-Fann; Chiang, Chu-Hui; Lin, Shyh-Jye; Wu, Chi-Sheng; Chen, Yi-Hsing			Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; GRASS-POLLEN; ENVIRONMENTAL AEROALLERGENS; IMMUNOTHERAPY; PREVALENCE; MECHANISMS; EFFICACY; COVID-19	Allergic airway disease is the most common chronic airway inflammatory disorder in developed countries. House dust mite, cockroach, and mold are the leading allergens in most tropical and subtropical countries, including Taiwan. As allergen avoidance is difficult for patients allergic to these perennial indoor allergens, allergen-specific immunotherapy (ASIT) is the only available allergen-specific and disease-modifying treatment. However, for patients sensitized to multiple allergens, ASIT using each corresponding allergen is cumbersome. In the present study, we developed a recombinant L. lactis vaccine against the three most common indoor aeroallergens and investigated its effectiveness for preventing respiratory allergy and safety in mice. Three recombinant clones of Der p 2 (mite), Per a 2 (roach), and Cla c 14 (mold) were constructed individually in pNZ8149 vector and then electroporated into host strain L.lactis NZ3900. BALB/c mice were fed with the triple vaccine 5 times per week for 4 weeks prior to sensitization. The effectiveness and safety profile were then determined. Oral administration of the triple vaccine significantly alleviated allergen-induced airway hyper-responsiveness in the vaccinated mice. The allergen-specific IgG2a was upregulated. IL-4 and IL-13 mRNA expressions as well as inflammatory cell infiltration in the lungs decreased significantly in the vaccinated groups. No body weight loss or abnormal findings in the liver and kidneys were found in any of the groups of mice. This is the first report to describe a triple-aeroallergen vaccine using a food-grade lactococcal expression system. We developed a convenient oral delivery system and intend to extend this research to develop a vaccination that can be self-administered at home by patients.	[Lee, Mey-Fann] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chiang, Chu-Hui] Natl Pingtung Univ Sci & Technol, Dept Plant Med, Pingtung, Taiwan; [Lin, Shyh-Jye] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Wu, Chi-Sheng; Chen, Yi-Hsing] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Hsing] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan	Taichung Veterans General Hospital; National Pingtung University Science & Technology; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, YH (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, YH (corresponding author), Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan.	ysanne@vghtc.gov.tw		Chen, Yi-Hsing/0000-0002-8135-9554	Taichung Veterans General Hospital [TCVGH-1077313C, 1087316C]	Taichung Veterans General Hospital	This study was supported by grants from Taichung Veterans General Hospital (TCVGH-1077313C and 1087316C).	[Anonymous], 2000, AIR IOMUCOTAOAAI; Bousquet PJ, 2007, ALLERGY, V62, P301, DOI 10.1111/j.1398-9995.2006.01293.x; Cianferoni A, 2020, PEDIAT ALLERG IMM-UK, V31, P96, DOI 10.1111/pai.13367; Clavel R, 1998, ALLERGY, V53, P493, DOI 10.1111/j.1398-9995.1998.tb04086.x; de Bot CMA, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-59; Demoly P, 2021, J ALLERGY CLIN IMMUN, V147, P1020, DOI 10.1016/j.jaci.2020.07.036; Dougherty JA, 2021, ANN PHARMACOTHER, V55, P344, DOI 10.1177/1060028020944370; Dunlop JH, 2020, J INVEST MED, V68, P1152, DOI 10.1136/jim-2020-001422; Huang Hung-Wei, 2006, Acta Paediatr Taiwan, V47, P127; Jalbert I, 2015, CURR OPIN ALLERGY CL, V15, P476, DOI 10.1097/ACI.0000000000000205; Krishna MT, 2021, J ALLER CL IMM-PRACT, V9, P709, DOI 10.1016/j.jaip.2020.11.038; Lee MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201281; Lee MF, 2016, ANN ALLERG ASTHMA IM, V117, P535, DOI 10.1016/j.anai.2016.09.432; Luo WT, 2021, ALLERGY, V76, P589, DOI 10.1111/all.14597; Lupinek Christian, 2016, Curr Treat Options Allergy, V3, P189; Garcia-Menaya JM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.570721; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Okamoto Y, 2019, PEDIAT ALLERG IMM-UK, V30, P66, DOI 10.1111/pai.12984; Orgel K, 2019, CLIN EXP ALLERGY, V49, P461, DOI 10.1111/cea.13305; Pfaar O, 2021, ALLERGY, V76, P648, DOI 10.1111/all.14453; Roberts G, 2018, ALLERGY, V73, P765, DOI 10.1111/all.13317; SABBAH A, 1994, ALLERGY, V49, P309, DOI 10.1111/j.1398-9995.1994.tb02273.x; Saito S, 2020, MOL IMMUNOL, V125, P63, DOI 10.1016/j.molimm.2020.06.019; Schauberger EM J.M.B., 2020, MIDDLETONS ALLERGY P, V9, P1676; Su HJ, 2001, ENVIRON RES, V85, P135, DOI 10.1006/enrs.2000.4113; Sun XX, 2019, ASIAN PAC J ALLERGY, V37, P57, DOI 10.12932/AP-160817-0137; Tang RB, 2020, J CHIN MED ASSOC, V83, P109, DOI 10.1097/JCMA.0000000000000231; TREDE NS, 1989, ALLERGY, V44, P272, DOI 10.1111/j.1398-9995.1989.tb01069.x; URBANEK R, 1990, EUR J PEDIATR, V149, P545, DOI 10.1007/BF01957689; Valenta R, 2017, IMMUNOL LETT, V189, P19, DOI 10.1016/j.imlet.2017.04.015; Valenta R, 2016, J ALLERGY CLIN IMMUN, V137, P351, DOI 10.1016/j.jaci.2015.12.1299; van den Berg H, 2010, IMMUNOBIOLOGY, V215, P163, DOI 10.1016/j.imbio.2009.01.012; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0; Yang JM, 2020, J ALLERGY CLIN IMMUN, V146, P790, DOI 10.1016/j.jaci.2020.08.008; Zolkipli Z, 2015, J ALLERGY CLIN IMMUN, V136, P1541, DOI 10.1016/j.jaci.2015.04.045	35	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261333	10.1371/journal.pone.0261333	http://dx.doi.org/10.1371/journal.pone.0261333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972127	Green Published, gold			2022-12-26	WOS:000773555700030
J	Palukuri, MV; Marcotte, EM				Palukuri, Meghana Venkata; Marcotte, Edward M.			Super.Complex: A supervised machine learning pipeline for molecular complex detection in protein-interaction networks	PLOS ONE			English	Article								Characterization of protein complexes, i.e. sets of proteins assembling into a single larger physical entity, is important, as such assemblies play many essential roles in cells such as gene regulation. From networks of protein-protein interactions, potential protein complexes can be identified computationally through the application of community detection methods, which flag groups of entities interacting with each other in certain patterns. Most community detection algorithms tend to be unsupervised and assume that communities are dense network subgraphs, which is not always true, as protein complexes can exhibit diverse network topologies. The few existing supervised machine learning methods are serial and can potentially be improved in terms of accuracy and scalability by using better-suited machine learning models and parallel algorithms. Here, we present Super.Complex, a distributed, supervised AutoML-based pipeline for overlapping community detection in weighted networks. We also propose three new evaluation measures for the outstanding issue of comparing sets of learned and known communities satisfactorily. Super.Complex learns a community fitness function from known communities using an AutoML method and applies this fitness function to detect new communities. A heuristic local search algorithm finds maximally scoring communities, and a parallel implementation can be run on a computer cluster for scaling to large networks. On a yeast protein-interaction network, Super.Complex outperforms 6 other supervised and 4 unsupervised methods. Application of Super.Complex to a human protein-interaction network with similar to 8k nodes and similar to 60k edges yields 1,028 protein complexes, with 234 complexes linked to SARS-CoV-2, the COVID-19 virus, with 111 uncharacterized proteins present in 103 learned complexes. Super.Complex is generalizable with the ability to improve results by incorporating domain-specific features. Learned community characteristics can also be transferred from existing applications to detect communities in a new application with no known communities. Code and interactive visualizations of learned human protein complexes are freely available at: https://sites.google.com/view/supercomplex/super-complex-v3-0.	[Palukuri, Meghana Venkata] Univ Texas Austin, Oden Inst Computat Engn & Sci, Austin, TX 78712 USA; [Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Palukuri, MV (corresponding author), Univ Texas Austin, Oden Inst Computat Engn & Sci, Austin, TX 78712 USA.; Marcotte, EM (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA.	meghana.palukuri@utexas.edu; marcotte@utexas.edu		Palukuri, Meghana/0000-0002-6529-6127	Welch Foundation [F-1515]; National Institutes of Health [R35 GM122480, R01 HD085901, R21 HD103588]	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge funding from the Welch Foundation (F-1515) and National Institutes of Health (R35 GM122480, R01 HD085901, R21 HD103588) to E.M.M. The funders' websites are https://www.welch1.org/and https://www.nih.gov/respectively.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Borgeson BC., 2016, THESIS; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Dong YD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194124; Drew K, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167490; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; KARP RM, 1980, NETWORKS, V10, P143, DOI 10.1002/net.3230100205; Lee C., 2010, ARXIV10021827PHYS; Li H, 2019, GENOME RES, V29, P2034, DOI 10.1101/gr.251983.119; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Mete M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S19; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Olson Randy., 2019, ZENODO; Palukuri M., 2019, TACCSTER 2019 P; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Shi L, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S5; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; van Dongen SM., 2000, GRAPH CLUSTERING FLO; Wainberg M, 2021, NAT GENET, V53, P638, DOI 10.1038/s41588-021-00840-z; Wilson L.A., 2014, P 2014 ANN C EXTR SC, P40, DOI [DOI 10.1145/2616498.2616534, 10.1145/2616498.2616534]; Wu J., 2018 37 CHIN CONTR C, P8205; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yu FY, 2014, BMC SYST BIOL, V8, DOI [10.1186/1752-0509-8-S3-S5, 10.1186/1752-0509-8-S3-S4]; Zhou ZW, 2016, IEEE INT C BIOINFORM, P1296, DOI 10.1109/BIBM.2016.7822705	32	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262056	10.1371/journal.pone.0262056	http://dx.doi.org/10.1371/journal.pone.0262056			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972161	gold, Green Published, Green Submitted			2022-12-26	WOS:000773555700088
J	Thompson, HR; Pavlovic, A; D'Agostino, E; Napier, MD; Konty, K; Day, SE				Thompson, Hannah R.; Pavlovic, Andjelka; D'Agostino, Emily; Napier, Melanie D.; Konty, Kevin; Day, Sophia E.			The association between student body mass index and tests of flexibility assessed by the FITNESSGRAM (R): New York City public school students, 2017-18	PLOS ONE			English	Article							HEALTH-RELATED FITNESS; PHYSICAL-ACTIVITY; YOUTH FITNESS; MOTOR COMPETENCE; VALIDITY; CHILDREN; ADOLESCENTS; SURVEILLANCE; RELIABILITY; PREVALENCE	FITNESSGRAM (R) is the most widely used criterion-referenced tool to assess/report on student health-related fitness across the US. Potential weight-related biases with the two most common tests of musculoskeletal fitness-the trunk extension and Back-Saver Sit-and-Reach (sit-and-reach)-have been hypothesized, though have not been studied. To determine the association between musculoskeletal fitness test performance and weight status, we use data from 571,133 New York City public school 4(th)-12(th) grade students (85% non-White; 75% qualified for free or reduced-price meals) with valid/complete 2017-18 FITNESSGRAM (R) data. Adjusted logistic mixed effects models with a random effect for school examined the association between weight status and whether a student was in the Healthy Fitness Zone (HFZ; met sex- and age-specific criterion-referenced standards) for the trunk extension and sit-and-reach. Compared to students with normal weight, the odds of being in the HFZ for trunk extension were lower for students with underweight (OR = 0.77; 95% CI: 0.741, 0.795) and higher for students with overweight (OR = 1.10; 95% CI: 1.081, 1.122) and obesity (OR = 1.11; 95% CI: 1.090, 1.13). The odds of being in the HFZ for sit-and-reach were lower for students with underweight OR = 0.85; 95% CI: 0.826, 0.878), overweight (OR = 0.83; 95% CI: 0.819, 0.844) and obesity (OR = 0.65; 95% CI: 0.641, 0.661). Students with overweight and obesity perform better on the trunk extension, yet worse on the sit-and-reach, compared to students with normal weight. Teachers, administrators, and researchers should be aware of the relationship of BMI with student performance in these assessments.	[Thompson, Hannah R.] Univ Calif Berkeley, Sch Publ Hlth, Community Hlth Sci, Berkeley, CA 94720 USA; [Pavlovic, Andjelka] Cooper Inst, Div Youth Educ, Dallas, TX USA; [D'Agostino, Emily] Duke Univ, Dept Populat Hlth Sci, Dept Family Med & Community Hlth, Sch Med, Durham, NC USA; [Napier, Melanie D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Konty, Kevin; Day, Sophia E.] New York City Dept Hlth & Mental Hyg, Off Sch Hlth, New York, NY USA	University of California System; University of California Berkeley; Cooper Institute; Duke University; University of North Carolina; University of North Carolina Chapel Hill; New York City Department of Health & Mental Hygiene	Thompson, HR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Community Hlth Sci, Berkeley, CA 94720 USA.	ThompsonH@Berkeley.edu		Thompson, Hannah/0000-0003-0214-5003	National Heart Lung and Blood Institute (NHLBI) [1K01HL151805]	National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded, in part, by the National Heart Lung and Blood Institute (NHLBI), Grant 1K01HL151805.	Ajisafe T, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00142; Alvarez-Bueno C, 2020, J SPORT SCI, V38, P582, DOI 10.1080/02640414.2020.1720496; Artero EG, 2010, SCAND J MED SCI SPOR, V20, P418, DOI 10.1111/j.1600-0838.2009.00959.x; Aryana M, 2012, AM HEART J, V163, P302, DOI 10.1016/j.ahj.2011.10.020; Bai Y, 2015, J PEDIATR-US, V167, P662, DOI 10.1016/j.jpeds.2015.05.035; Barnett LM, 2016, SPORTS MED, V46, P1663, DOI 10.1007/s40279-016-0495-z; Berkson SS, 2013, J SCHOOL HEALTH, V83, P21, DOI 10.1111/j.1746-1561.2012.00743.x; Burns RD., 2014, ADV PHYS ED, V4; Cattuzzo MT, 2016, J SCI MED SPORT, V19, P123, DOI 10.1016/j.jsams.2014.12.004; cdc, NATL HLTH STAT REPOR; Centers for Disease Control and Prevention (CDC), OV OB; Chaddock-Heyman L, 2014, MONOGR SOC RES CHILD, V79, P25, DOI 10.1111/mono.12129; Chen G., 2018, PUBLIC SCH REV DIVER; Chen WY, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5107-4; Day SE, 2020, OBESITY, V28, P638, DOI 10.1002/oby.22732; Day SE, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130439; Institute of Medicine, 2013, ED STUD BOD TAK PHYS; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Konty KJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227185; Lang JJ, 2018, J SCI MED SPORT, V21, P383, DOI 10.1016/j.jsams.2017.08.002; Lee EY, 2020, J EXERC SCI FIT, V18, P129, DOI 10.1016/j.jesf.2020.04.002; Mayorga-Vega D, 2015, J SPORT SCI MED, V14, P536; Moreau CE, 2001, J MANIP PHYSIOL THER, V24, P110, DOI 10.1067/mmt.2001.112563; Morrow JR, 2013, AM J PREV MED, V44, P439, DOI 10.1016/j.amepre.2013.01.008; Morrow JR, 2010, RES Q EXERCISE SPORT, V81, pS24, DOI 10.1080/02701367.2010.10599691; Morrow James R Jr, 2009, Res Q Exerc Sport, V80, P696; Morrow JR, 2009, RES Q EXERCISE SPORT, V80, P1; Muyor JM, 2014, INT J SPORTS MED, V35, P664, DOI 10.1055/s-0033-1353217; NYC FITNESSGRAM: Assessment Protocol, FITNESSGRAM ASS MOD; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Pate R., 2012, HLTH OUTCOMES YOUTH, V7; PATE RR, 1993, RES Q EXERCISE SPORT, V64, P17, DOI 10.1080/02701367.1993.10608774; Patterson P, 2001, RES Q EXERCISE SPORT, V72, P117, DOI 10.1080/02701367.2001.10608941; Pereira SA, 2011, INT J PEDIATR OBES, V6, P53, DOI 10.3109/17477161003792549; Plowman S., 2013, FITNESSGRAM REFERENC, V4th; Plowman S A, 1992, Exerc Sport Sci Rev, V20, P221; Saint-Maurice PF, 2015, J SPORT MED PHYS FIT, V55, P1252; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; State of Childhood Obesity, OB RAT HIGH SCH STUD; Thompson HR, 2019, J SCHOOL HEALTH, V89, P629, DOI 10.1111/josh.12788; Tucker JS, 2014, J PHYS ACT HEALTH, V11, P1006, DOI 10.1123/jpah.2011-0431; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Weihrauch-Bluher S, 2018, CURR OBES REP, V7, P254, DOI 10.1007/s13679-018-0320-0; Welk GJ, 2011, AM J PREV MED, V41, pS63, DOI 10.1016/j.amepre.2011.07.012; Zhu WM, 2011, AM J PREV MED, V41, pS68, DOI 10.1016/j.amepre.2011.07.001	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262083	10.1371/journal.pone.0262083	http://dx.doi.org/10.1371/journal.pone.0262083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972179	gold, Green Published			2022-12-26	WOS:000773555700092
J	Liao, XW; Li, HA; Guo, Y; Yang, F; Chen, YS; He, XJ; Li, HY; Xia, W; Mao, ZW; Sun, HZ				Liao, Xiangwen; Li, Huinan; Guo, Yu; Yang, Fang; Chen, Yushou; He, Xiaojun; Li, Hongyan; Xia, Wei; Mao, Zong -Wan; Sun, Hongzhe			Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE DETERMINANTS; GLOBAL REGULATOR; CCPA; RESISTANCE; IDENTIFICATION; TRANSCRIPTION; HOMEOSTASIS; AFFINITY; SYSTEM; MGRA	Catabolite control protein A (CcpA) of the human pathogen Staphylococcus aureus is an essential DNA regulator for carbon catabolite repression and virulence, which facilitates bacterial survival and adaptation to a changing environment. Here, we report that copper (II) signaling mediates the DNA-binding capability of CcpA in vitro and in vivo. Copper (II) catalyzes the oxidation of two cysteine residues (Cys216 and Cys242) in CcpA to form intermolecular disulfide bonds between two CcpA dimers, which results in the formation and dissociation of a CcpA tetramer of CcpA from its cognate DNA promoter. We further demonstrate that the two cysteine residues on CcpA are important for S. aureus to resist host innate immunity, indi-cating that S. aureus CcpA senses the redox-active copper (II) ions as a natural signal to cope with environmental stress. Together, these findings reveal a novel regulatory mechanism for CcpA activity through copper (II)-mediated oxidation.	[Liao, Xiangwen; Li, Huinan; Guo, Yu; Yang, Fang; He, Xiaojun; Xia, Wei; Mao, Zong -Wan] Sun Yat Sen Univ, Sch Chem, MOE Key Lab Bioinorgan & Synthet Chem, Guangzhou, Peoples R China; [Liao, Xiangwen; Chen, Yushou] Jiangxi Sci & Technol Normal Univ, Sch Pharm, Nanchang, Jiangxi, Peoples R China; [Guo, Yu] Chinese Acad Sci, Guangdong Key Lab Marine Mat Med,South China Sea, Innovat Acad South China Sea Ecol & Environm Engn, CAS Key Lab Trop Marine Bio Resources & Ecol, Guangzhou, Peoples R China; [Guo, Yu] Southern Marine Sci & Engn Guangdong Lab, Guangzhou, Peoples R China; [Sun, Hongzhe] Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China	Sun Yat Sen University; Jiangxi Science & Technology Normal University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Southern Marine Science & Engineering Guangdong Laboratory; University of Hong Kong	Xia, W; Mao, ZW (corresponding author), Sun Yat Sen Univ, Sch Chem, MOE Key Lab Bioinorgan & Synthet Chem, Guangzhou, Peoples R China.; Sun, HZ (corresponding author), Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China.	xiawei5@mail.sysu.edu.cn; cesmzw@mail.sysu.edu.cn; hsun@hku.hk	何, 晓俊/GSJ-1063-2022; /D-3123-2009	/0000-0001-6697-6899	National Nat-ural Science Foundation of China [21837006, 22022706, 22077142, 91953117, 21877131]; Natural Science Foundation of Guang-dong Province, China [2019A1515011156]; Ministry of Educa-tion of China [IRT-17R111]; Fundamental Research Funds for the Central Universities	National Nat-ural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guang-dong Province, China(National Natural Science Foundation of Guangdong Province); Ministry of Educa-tion of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Acknowledgments-This work was supported by the National Nat-ural Science Foundation of China (21837006, 22022706, 22077142, 91953117 and 21877131) , Natural Science Foundation of Guang-dong Province, China (2019A1515011156) , the Ministry of Educa-tion of China (IRT-17R111) , and the Fundamental Research Funds for the Central Universities.	Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Chen WH, 2017, J AM CHEM SOC, V139, P3790, DOI 10.1021/jacs.6b13317; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Hao ZY, 2014, NAT CHEM BIOL, V10, P21, DOI [10.1038/NCHEMBIO.1380, 10.1038/nchembio.1380]; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Huang Q, 2020, ACS INFECT DIS, V6, P347, DOI 10.1021/acsinfecdis.9b00465; Ji QJ, 2012, J BIOL CHEM, V287, P21102, DOI 10.1074/jbc.M112.359737; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krishnamoorthy L, 2016, NAT CHEM BIOL, V12, P586, DOI [10.1038/NCHEMBIO.2098, 10.1038/nchembio.2098]; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Liao XW, 2017, CHEM SCI, V8, P8061, DOI 10.1039/c7sc02251d; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Pidwill GR, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.620339; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Riquelme SA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00385; Schumacher MA, 2006, J BIOL CHEM, V281, P6793, DOI 10.1074/jbc.M509977200; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Schumacher MA, 2011, NUCLEIC ACIDS RES, V39, P2931, DOI 10.1093/nar/gkq1177; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2008, INFECT IMMUN, V76, P5093, DOI 10.1128/IAI.00724-08; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Sitthisak S, 2007, MICROBIOL-SGM, V153, P4274, DOI 10.1099/mic.0.2007/009860-0; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Tao X, 2020, CCS CHEM, V2, P946, DOI 10.31635/ccschem.020.202000219; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Tiwari N, 2020, P NATL ACAD SCI USA, V117, P10989, DOI 10.1073/pnas.1921307117; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Xiao T, 2018, NAT CHEM BIOL, V14, P655, DOI 10.1038/s41589-018-0062-z; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350	44	1	1	9	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101587	10.1016/j.jbc.2022.101587	http://dx.doi.org/10.1016/j.jbc.2022.101587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35032550	gold, Green Published			2022-12-26	WOS:000791267400011
J	Kitajima, Y; Hashizume, NS; Saiki, C; Ide, R; Imai, T				Kitajima, Yoichiro; Hashizume, Nana Sato; Saiki, Chikako; Ide, Ryoji; Imai, Toshio			Effect of dexmedetomidine on cardiorespiratory regulation in spontaneously breathing adult rats	PLOS ONE			English	Article							RESPIRATORY DRIVE; VENTILATION; NEWBORN; PATTERN; SEDATION	Purpose We examined the cardiorespiratory effect of dexmedetomidine, an alpha(2)- adrenoceptor/imidazoline 1 (I-1) receptor agonist, in spontaneously breathing adult rats. Methods Male rats (226-301 g, n = 49) under isoflurane anesthesia had their tail vein cannulated for drug administration and their tail artery cannulated for analysis of mean arterial pressure (MAP), pulse rate (PR), and arterial blood gases (PaO2, PaCO2, pH). After recovery, one set of rats received normal saline for control recording and was then divided into three experimental groups, two receiving dexmedetomidine (5 or 50 mu g.kg(-1)) and one receiving normal saline (n = 7 per group). Another set of rats was divided into four groups receiving dexmedetomidine (50 mu g.kg(-1)) followed 5 min later by 0.5 or 1 mg.kg(-1) atipamezole (selective alpha(2)-adrenoceptor antagonist) or efaroxan (alpha(2)-adrenoceptor/I-1 receptor antagonist) (n = 6 or 8 per group). Recordings were performed 15 min after normal saline or dexmedetomidine administration. Results Compared with normal saline, dexmedetomidine (5 and 50 mu g.kg(-1)) decreased respiratory frequency (f(R), p = 0.04 and < 0.01, respectively), PR (both p < 0.01), and PaO2 (p = 0.04 and < 0.01), and increased tidal volume (both p = 0.049). Dexmedetomidine at 5 mu g.kg(-1) did not significantly change minute ventilation (V-E) (p = 0.87) or MAP (p = 0.24), whereas dexmedetomidine at 50 mu g.kg(-1) significantly decreased V '(E) (p = 0.03) and increased MAP (p < 0.01). Only dexmedetomidine at 50 mu g.kg(-1) increased PaCO2 (p < 0.01). Dexmedetomidine (5 and 50 mu g.kg(-1)) significantly increased blood glucose (p < 0.01), and dexmedetomidine at 50 mu g.kg(-1) increased hemoglobin (p = 0.04). Supplemental atipamezole or efaroxan administration similarly prevented the 50 mu g.kg(-1) dexmedetomidine-related cardiorespiratory changes. Principal conclusion These results suggest that dexmedetomidine-related hypoventilation and hypertension are observed simultaneously and occur predominantly through activation of alpha(2)-adrenoceptors, but not I-1 receptors, in spontaneously breathing adult rats.	[Kitajima, Yoichiro; Hashizume, Nana Sato; Saiki, Chikako; Ide, Ryoji; Imai, Toshio] Nippon Dent Univ Sch Life Dent Tokyo, Dept Physiol, Tokyo, Japan; [Kitajima, Yoichiro; Hashizume, Nana Sato; Saiki, Chikako; Ide, Ryoji; Imai, Toshio] Nippon Dent Univ Tokyo, Dept Physiol, Sch Life Dent Tokyo, Tokyo, Japan	Nippon Dental University; Nippon Dental University	Saiki, C (corresponding author), Nippon Dent Univ Tokyo, Dept Physiol, Sch Life Dent Tokyo, Tokyo, Japan.	chikako@tky.ndu.ac.jp	Hashizume, Nana/AGK-3208-2022; Ide, Ryoji/AAV-6129-2020	bei dao, yue yi lang/0000-0001-9644-8712	Nippon Dental University, School of Life dentistry at Tokyo	Nippon Dental University, School of Life dentistry at Tokyo	The authors thank Takashi Hashimoto (Bio Research Center Co., Ltd, Nagoya, Japan) and Eishi Nakamura for their technical assistance; and Mina Ooka Takahashi for her assistance in preparing the manuscript. This study is dedicated to the late Professor Ken Yaegaki, Department of Oral Health, The Nippon Dental University, School of Life dentistry at Tokyo.	BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; Bousquet P, 2020, PHARMACOL REV, V72, P50, DOI 10.1124/pr.118.016311; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; El-Mas MM, 2004, J APPL PHYSIOL, V97, P1237, DOI 10.1152/japplphysiol.00401.2004; Ernsberger Paul, 1997, American Journal of Physiology, V273, pR1572; Fan TWV, 2013, BRIT J ORAL MAX SURG, V51, P428, DOI 10.1016/j.bjoms.2012.08.013; Fernandes FC, 2006, RESP PHYSIOL NEUROBI, V154, P342, DOI 10.1016/j.resp.2006.02.002; Filbey WA, 2014, SLEEP, V37, P871, DOI 10.5665/sleep.3650; HADDAD GG, 1979, J APPL PHYSIOL, V46, P998, DOI 10.1152/jappl.1979.46.5.998; HOFFMAN WE, 1991, ANESTHESIOLOGY, V75, P328, DOI 10.1097/00000542-199108000-00022; Horvath G, 1996, LIFE SCI, V59, P1247, DOI 10.1016/0024-3205(96)00448-1; Kubin L, 2008, RESP PHYSIOL NEUROBI, V164, P64, DOI 10.1016/j.resp.2008.04.012; LINDERKAMP O, 1978, EUR J PEDIATR, V129, P73, DOI 10.1007/BF00442366; Mason KP, 2013, RADIOLOGY, V267, P911, DOI 10.1148/radiol.13121232; McMullan S, 2010, RESP PHYSIOL NEUROBI, V174, P37, DOI 10.1016/j.resp.2010.07.009; Mortola JP, 2019, RESP PHYSIOL NEUROBI, V261, P48, DOI 10.1016/j.resp.2018.12.005; Mortola JP, 2004, EUR J APPL PHYSIOL, V91, P119, DOI 10.1007/s00421-003-0978-0; Mortola JP, 1996, RESP PHYSIOL, V106, P21, DOI 10.1016/0034-5687(96)00064-3; MORTOLA JP, 1985, J COMP PHYSIOL B, V155, P171, DOI 10.1007/BF00685210; Mortola JP, 1998, CAN J PHYSIOL PHARM, V76, P937, DOI 10.1139/cjpp-76-10-11-937; Nguyen Viet, 2017, Anesthesiol Clin, V35, P233, DOI 10.1016/j.anclin.2017.01.009; Pavlin EG., 1986, HDB PHYSL SECTION 3, VII, P793; Peever J, 2017, CURR BIOL, V27, pR1237, DOI 10.1016/j.cub.2017.10.026; Saiki C, 2003, CAN J PHYSIOL PHARM, V81, P9, DOI 10.1139/Y03-001; Sanders RD, 2005, ANESTH ANALG, V100, P1295, DOI 10.1213/01.ANE.0000149595.41576.B3; Sato N, 2017, PEDIATR ANESTH, V27, P506, DOI 10.1111/pan.13107; SEVERINGHAUS JW, 1966, J APPL PHYSIOL, V21, P1108, DOI 10.1152/jappl.1966.21.3.1108; Sy GY, 2006, AUTON NEUROSCI-BASIC, V128, P19, DOI 10.1016/j.autneu.2005.12.003; Takahashi T, 2015, J ANESTH, V29, P396, DOI 10.1007/s00540-014-1943-2; Tamiya J, 2014, PEDIATR ANESTH, V24, P1245, DOI 10.1111/pan.12530; Thomas AJ, 2000, DEV BRAIN RES, V120, P181, DOI 10.1016/S0165-3806(00)00008-0; Tsuzawa K, 2015, NEUROSCI LETT, V597, P117, DOI 10.1016/j.neulet.2015.04.035; Uusalo P, 2021, ACTA ANAESTH SCAND, V65, P1447, DOI 10.1111/aas.13970; Weerink MAS, 2017, CLIN PHARMACOKINET, V56, P893, DOI 10.1007/s40262-017-0507-7	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262263	10.1371/journal.pone.0262263	http://dx.doi.org/10.1371/journal.pone.0262263			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030204	Green Published, gold			2022-12-26	WOS:000812798500034
J	Adedini, SA; Abatan, SM; Ogunsakin, AD; Alex-Ojei, CA; Babalola, BI; Shittu, SB; Odusina, EK; Ntoimo, LFC				Adedini, Sunday A.; Abatan, Sunday Matthew; Ogunsakin, Adesoji Dunsin; Alex-Ojei, Christiana Alake; Babalola, Blessing Iretioluwa; Shittu, Sarafa Babatunde; Odusina, Emmanuel Kolawole; Ntoimo, Lorretta Favour C.			Comparing the timeliness and adequacy of antenatal care uptake between women who married as child brides and adult brides in 20 sub-Saharan African countries	PLOS ONE			English	Article							TEENAGE PREGNANCY; FAMILY-STRUCTURE; HEALTH; MORTALITY; DETERMINANTS; INFANT; ASSOCIATION; SERVICES; CONTEXT	Context Considering the persistent poor maternal and child health outcomes in sub-Saharan Africa (SSA), this study undertook a comparative analysis of the timing and adequacy of antenatal care uptake between women (aged 20-24 years) who married before age 18 and those who married at age 18 or above. Method Data came from Demographic and Health Surveys of 20 SSA countries. We performed binary logistic regression analysis on pooled data of women aged 20-24 (n = 33,630). Results Overall, the percentage of child brides in selected countries was 57.1%, with the lowest prevalence found in Rwanda (19.1%) and the highest rate in Chad (80.9%). Central and West African countries had the highest prevalence of child marriage compared to other sub-regions. Bivariate results indicate that a lower proportion of child brides (50.0%) had 4+ ANC visits compared to the adult brides (60.9%) and a lower percentage of them (34.0%) initiated ANC visits early compared to the adult brides (37.5%). After controlling for country of residence and selected socio-economic and demographic characteristics, multivariable results established significantly lower odds of having an adequate/prescribed number of ANC visits among women who married before age 15 (OR: 0.63, CI: 0.57-0.67, p<0.001), and women who married at ages 15-17 (OR: 0.81, CI: 0.75-0.84, p<0.001) compared to those who married at age 18+. Similar results were established between age at first marriage and timing of first ANC visit. Other interesting results emerged that young women who married earlier than age 18 and those who married at age 18+ differ significantly by several socio-economic and demographic characteristics. Conclusion Efforts to improve maternal and child health outcomes in SSA must give attention to address the underutilization and late start of antenatal care uptake among child brides.	[Adedini, Sunday A.; Abatan, Sunday Matthew; Ogunsakin, Adesoji Dunsin; Alex-Ojei, Christiana Alake; Babalola, Blessing Iretioluwa; Shittu, Sarafa Babatunde; Odusina, Emmanuel Kolawole; Ntoimo, Lorretta Favour C.] Fed Univ Oye Ekiti, Demog & Social Stat Dept, Fac Social Sci, Oye Ekiti, Nigeria; [Adedini, Sunday A.] Univ Witwatersrand, Sch Publ Hlth, Programme Demog & Populat Studies, Johannesburg, South Africa; [Adedini, Sunday A.] Univ Witwatersrand, Schools Social Sci, Programme Demog & Populat Studies, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Adedini, SA (corresponding author), Fed Univ Oye Ekiti, Demog & Social Stat Dept, Fac Social Sci, Oye Ekiti, Nigeria.; Adedini, SA (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Programme Demog & Populat Studies, Johannesburg, South Africa.; Adedini, SA (corresponding author), Univ Witwatersrand, Schools Social Sci, Programme Demog & Populat Studies, Johannesburg, South Africa.	sunday.adedini@fuoye.edu.ng	Adedini, Sunday/GZM-8362-2022; Adedini, Sunday/AAM-6790-2021	Adedini, Sunday/0000-0003-0378-1941				Adedini, 2016, MATERNAL HLTH NIGERI; Adedini SA., 2014, GENDER BEHAV, V12, P6050; Adedini SA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23499; Adedini SA, 2015, J BIOSOC SCI, V47, P165, DOI 10.1017/S0021932013000734; Adhikari R., 2018, J HLTH PROMOTION, V6, P49; Akinyemi JO, 2016, TROP MED INT HEALTH, V21, P1572, DOI 10.1111/tmi.12779; Al-Eisawi Z, 2021, PUBLIC UNDERST SCI, V30, P319, DOI 10.1177/0963662520968468; Alex-Ojei CA, 2020, MIDWIFERY, V82, DOI 10.1016/j.midw.2019.102619; Alkema L, 2019, TRENDS MATERNAL MORT; Awasthi MS, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/3467308; Ayoade MA., 2020, GEOJOURNAL, P1; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Banke-Thomas OE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1246-3; Bwana VM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214807; Chung HW, 2018, J ADOLESCENCE, V69, P180, DOI 10.1016/j.adolescence.2018.10.007; de Groot R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5166-6; Delprato M, 2017, ANN GLOB HEALTH, V83, P557, DOI 10.1016/j.aogh.2017.10.005; Dey A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204810; Efendi F, 2017, WOMEN HEALTH, V57, P614, DOI 10.1080/03630242.2016.1181136; Godha D, 2013, J ADOLESCENT HEALTH, V52, P552, DOI 10.1016/j.jadohealth.2013.01.021; Jarnkvist K, 2019, MARRIAGE FAM REV, V55, P38, DOI 10.1080/01494929.2018.1458002; Kaphagawani NC, 2017, GLOB PUBLIC HEALTH, V12, P694, DOI 10.1080/17441692.2016.1229354; Kidman R, 2017, INT J EPIDEMIOL, V46, P662, DOI 10.1093/ije/dyw225; Koski A, 2017, POPUL DEV REV, V43, P7, DOI 10.1111/padr.12035; Mobolaji JW, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08714-5; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; Nour NM, 2006, EMERG INFECT DIS, V12, P1644, DOI 10.3201/eid1211.060510; Odimegwu C., 2014, GENDER BEHAV, V12, P5843; Odimegwu C, 2018, J PSYCHOL AFR, V28, P479, DOI 10.1080/14330237.2018.1544390; Okedo-Alex IN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031890; Omariba DWR, 2007, POPUL RES POLICY REV, V26, P299, DOI 10.1007/s11113-007-9031-z; Omariba DWR, 2007, J MARRIAGE FAM, V69, P528, DOI 10.1111/j.1741-3737.2007.00381.x; Raj A, 2010, ARCH DIS CHILD, V95, P931, DOI 10.1136/adc.2009.178707; Schaffnit SB, 2021, GLOB PUBLIC HEALTH, V16, P1820, DOI 10.1080/17441692.2020.1837911; Schaffnit SB, 2019, SEX REPROD HLTH MATT, V27, P93, DOI 10.1080/09688080.2019.1571304; Sekine K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222643; Shimamoto K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1499-x; Shimamoto K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0591-3; Singh P, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03607-w; Spagnoletti BRM, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1991-y; Stanton K, 2013, WORLD J PREV MED, V1, P22; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; Tekelab T., 2014, SCI TECHNOL ARTS RES, V3, P108, DOI [10.4314/star.v3i1.17, DOI 10.4314/STAR.V3I1.17]; Thapa DK, 2013, SOC SCI MED, V93, P1, DOI 10.1016/j.socscimed.2013.06.003; Trhas TB., 2020, ADV PUBLIC HLTH, V2020; Uthman OA, 2009, J TROP PEDIATRICS, V55, P109, DOI 10.1093/tropej/fmn093; Wahhaj Z., 2015, SCH EC DISCUSSION PA; Wall LL, 1998, STUD FAMILY PLANN, V29, P341, DOI 10.2307/172248; Westoff C. F., 2003, DHS COMP REPORT; WHO, CHILD MARR 39 000 EV; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Yaya S, 2019, BMC INT HEALTH HUM R, V19, DOI 10.1186/s12914-019-0219-1	52	1	1	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262688	10.1371/journal.pone.0262688	http://dx.doi.org/10.1371/journal.pone.0262688			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025949	gold, Green Published			2022-12-26	WOS:000796264200095
J	Ahn, TR; Jeong, YM; Park, SH; Jeon, JY; Lee, SW; Shim, YS				Ahn, Tae Ran; Jeong, Yu Mi; Park, So Hyun; Jeon, Ji Young; Lee, Sheen-Woo; Shim, Young Sup			Analysis of critical report notification from musculoskeletal radiology in a tertiary academic medical institution with a regional trauma center	PLOS ONE			English	Article							INCIDENTAL FINDINGS; ACTIONABLE FINDINGS; COMMUNICATION; IMPACT; MRI; DISCREPANCIES; POPULATION; FRACTURES; ERRORS	Purpose We aimed to analyze the prevalence, causes, and clinical settings of 4-year critical radiologic reports (CRRs) notified from the musculoskeletal section of the radiology department. Then, we investigated the communication outcomes. Methods This study was approved by our institutional review board. We retrospectively included 175 musculoskeletal CRRs from our database between January 2017 and December 2020. The CRRs were analyzed by two musculoskeletal radiologists, who categorized the CRRs by clinical setting (emergency department(ED) patient, outpatient, and inpatient), body part, type of image modality, reason for CRR, incidental lesion, and clinical outcome. The clinical outcome was retrieved from the electronic medical records. Results The 175 musculoskeletal CRRs accounted for 5.4% of the CRRs (n = 3217) available in the study period. Most CRRs (94.9%, 166/175) corresponded to the musculoskeletal system, while the remaining ones (5.1%, 9/175) corresponded to the non-musculoskeletal system. In addition, the spine, extremities, and thoracic cage accounted for 52.6%, 40.6%, and 1.7% of the musculoskeletal CRRs, respectively. Moreover, most patients presented to the ED (50.3%, 88/175), followed by inpatients (30.9%, 54/175), and outpatients (18.9%, 33/175). The CRR reasons included missed fracture (54.3%), suspected malignancy (16%), clinical emergency (10.3%), unexpected infection/inflammation (11.4%), and others (8%). Furthermore, 11 (6.3%) incidental lesions were not related to the primary imaging purpose. Referring clinicians actively acknowledged 80% of the CRRs. The loss to follow-up action was the highest in the ED patients (35.2%, 31/88; p < 0.001), being significantly higher than that in outpatients (6.1%, 2/33) and inpatients (3.7%, 2/54). Conclusion Missed fractures were the most common cause of musculoskeletal CRRs. ED showed prevalence in musculoskeletal CRRs and reflected the highest loss to follow-up action. ED physicians should pay more attention to CRRs to enhance patient care.	[Ahn, Tae Ran; Jeong, Yu Mi; Park, So Hyun; Jeon, Ji Young; Lee, Sheen-Woo; Shim, Young Sup] Gachon Univ, Dept Radiol, Gil Med Ctr, Coll Med, Incheon, South Korea; [Lee, Sheen-Woo] Catholic Univ Korea, Eunpyeong St Marys Hosp, Dept Radiol, Coll Med, Seoul, South Korea	Gachon University; Catholic University of Korea	Jeong, YM (corresponding author), Gachon Univ, Dept Radiol, Gil Med Ctr, Coll Med, Incheon, South Korea.	youme34@gilhospital.com		Jeong, Yu Mi/0000-0002-3880-0156; Ahn, Tae Ran/0000-0001-6524-6341				Anthony SG, 2011, RADIOLOGY, V259, P802, DOI 10.1148/radiol.11101396; Baker JC, 2014, SEMIN ROENTGENOL, V49, P169, DOI 10.1053/j.ro.2014.01.001; Booth TC, 2016, BRIT J GEN PRACT, V66, P346, DOI 10.3399/bjgp16X685777; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; Fayad LM, 2007, RADIOGRAPHICS, V27, P1723, DOI 10.1148/rg.276075033; Gaetke-Udager K, 2014, ABDOM IMAGING, V39, P776, DOI 10.1007/s00261-014-0108-y; Guly HR, 2001, EMERG MED J, V18, P263, DOI 10.1136/emj.18.4.263; Guss DA, 2014, J EMERG MED, V46, P560, DOI 10.1016/j.jemermed.2013.11.067; Harvey HB, 2015, J AM COLL RADIOL, V12, P376, DOI 10.1016/j.jacr.2014.08.013; Hegenscheid K, 2013, EUR RADIOL, V23, P816, DOI 10.1007/s00330-012-2636-6; jointcommission, 2021, NAT PAT SAF GOALS; Lacson R, 2014, AM J ROENTGENOL, V203, P933, DOI 10.2214/AJR.14.13064; Lakhani P, 2010, J AM COLL RADIOL, V7, P782, DOI 10.1016/j.jacr.2010.05.025; Larson PA, 2014, J AM COLL RADIOL, V11, P552, DOI 10.1016/j.jacr.2013.12.016; Lumbreras B, 2010, BRIT J RADIOL, V83, P276, DOI 10.1259/bjr/98067945; Mehta P, 2017, SEMIN ULTRASOUND CT, V38, P439, DOI 10.1053/j.sult.2017.04.001; Mellnick V, 2016, J AM COLL RADIOL, V13, P1233, DOI 10.1016/j.jacr.2016.04.020; Mounts J, 2011, CLIN PEDIATR, V50, P183, DOI 10.1177/0009922810384725; Pinto Antonio, 2018, Acta Biomed, V89, P111, DOI 10.23750/abm.v89i1-S.7015; Quattrocchi CC, 2013, INSIGHTS IMAGING, V4, P301, DOI 10.1007/s13244-013-0234-z; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Sahraian S, 2020, J DIGIT IMAGING, V33, P348, DOI 10.1007/s10278-019-00286-0; Scepi M, 2005, AM J EMERG MED, V23, P918, DOI 10.1016/j.ajem.2005.07.003; Tranovich MJ, 2019, WEST J EMERG MED, V20, P626, DOI 10.5811/westjem.2019.1.41375; Tuncel SA, 2015, KOREAN J RADIOL, V16, P866, DOI 10.3348/kjr.2015.16.4.866; Visser JJ, 2020, EUR J RADIOL, V129, DOI 10.1016/j.ejrad.2020.109109; Waite S, 2018, CLIN IMAG, V51, P266, DOI 10.1016/j.clinimag.2018.05.025; Wei CJ, 2006, ACTA RADIOL, V47, P710, DOI 10.1080/02841850600806340; WOODRING JH, 1992, J TRAUMA, V33, P698, DOI 10.1097/00005373-199211000-00019	29	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262511	10.1371/journal.pone.0262511	http://dx.doi.org/10.1371/journal.pone.0262511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025970	gold, Green Published			2022-12-26	WOS:000796264200077
J	ElMokhallalati, Y; Alaloul, E; Shatat, M; Shneewra, T; El Massri, S; Shaer, O; Relton, S; Abu-Odah, H; Allsop, MJ				ElMokhallalati, Yousuf; Alaloul, Enas; Shatat, Mohammed; Shneewra, Tasneem; El Massri, Saad; Shaer, Omar; Relton, Samuel; Abu-Odah, Hammoda; Allsop, Matthew J.			The Symptom Burden and Quality of Life in Cancer Patients in the Gaza Strip, Palestine: A Cross-Sectional Study	PLOS ONE			English	Article							ARABIC VERSION; ASSESSMENT SCALE; VALIDATION; CARE	Objectives Cancer is the second leading cause of death in the Gaza Strip, Palestine, but there is an absence of evidence systematically assessing symptom burden and quality of life (QoL) using validated tools. Our objective was to assess associations between socio-demographic and disease-related characteristics, symptom burden and QoL in a sample of cancer patients accessing outpatient services in the Gaza Strip. Design A cross-sectional, descriptive survey using interviews and medical record review involving patients with cancer accessing oncology outpatient services at Al Rantisi Hospital and European Gaza Hospital (EGH) in the Gaza Strip was employed. Socio-demographic and disease-related data, the Lebanese version of the Memorial Symptom Assessment Scale (MSAS-Leb), and the Arabic version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) were collected. Multiple linear regression was used to judge the relative influence of determinants of QoL. Results Of 414 cancer patients approached, 385 patients consented to participation. The majority were women (64.7%) with a mean age of 52 years (SD = 16.7). Common cancer diagnoses were breast (32.2%), haematological (17.9%) and colorectal (9.1%). The median number of symptoms was 10 (IQR 1.5-18.5). Mean overall QoL was 70.5 (SD 19.9) with common physical and psychological symptoms identified. A higher burden of symptoms was associated with marital status, education and income. Limited access to both opioids and psychological support were reported. Conclusions A high symptom burden was identified in outpatients with cancer. Increasing provision and access to supportive care for physical and psychological symptoms should be prioritised alongside exploring routine assessment of symptom burden and QoL.	[ElMokhallalati, Yousuf; Alaloul, Enas; Relton, Samuel; Allsop, Matthew J.] Univ Leeds, Leeds Inst Hlth Sci, Sch Med, Leeds, W Yorkshire, England; [Shatat, Mohammed; Shneewra, Tasneem] Minist Hlth, Gaza, Palestine; [El Massri, Saad; Shaer, Omar] Islamic Univ, Fac Med, Gaza, Palestine; [Abu-Odah, Hammoda] Hong Kong Polytech Univ, Sch Nursing, Hung Hom, Hong Kong, Peoples R China	University of Leeds; Hong Kong Polytechnic University	Allsop, MJ (corresponding author), Univ Leeds, Leeds Inst Hlth Sci, Sch Med, Leeds, W Yorkshire, England.	m.j.allsop@leeds.ac.uk	ABU-ODAH, Hammoda/AAW-7822-2021	ABU-ODAH, Hammoda/0000-0002-8874-2599; shaer, omar/0000-0002-0583-4800; Relton, Samuel/0000-0003-0634-4587; Allsop, Matthew/0000-0002-7399-0194				Abu-Odah H, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00558-5; AlKhaldi M, 2020, GLOB PUBLIC HEALTH, V15, P1244, DOI 10.1080/17441692.2020.1781914; Awad MA, 2008, ANN NY ACAD SCI, V1138, P146, DOI 10.1196/annals.1414.021; Basch E, 2017, JAMA-J AM MED ASSOC, V318, P197, DOI 10.1001/jama.2017.7156; Basch E, 2016, J CLIN ONCOL, V34, P557, DOI 10.1200/JCO.2015.63.0830; Batra A, 2021, SUPPORT CARE CANCER, V29, P3299, DOI 10.1007/s00520-020-05827-w; Bener Abdulbari, 2017, J Family Med Prim Care, V6, P824, DOI 10.4103/jfmpc.jfmpc_17_17; De Lima L, 2014, J PAIN SYMPTOM MANAG, V48, P649, DOI 10.1016/j.jpainsymman.2013.12.237; Deek MP, 2018, AM J CLIN ONCOL-CANC, V41, P362, DOI 10.1097/COC.0000000000000293; Elshami M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08553-4; Halahleh K, 2018, LANCET ONCOL, V19, pE359, DOI 10.1016/S1470-2045(18)30323-1; Hamad B, 2016, J US CHINA MEDICAL S, P13; Holland JC, 2003, J CLIN ONCOL, V21, p253S, DOI 10.1200/JCO.2003.09.133; Huijer HA, 2015, J PAIN SYMPTOM MANAG, V50, P559, DOI 10.1016/j.jpainsymman.2014.08.014; Huijer HAS, 2013, QUAL LIFE RES, V22, P1473, DOI 10.1007/s11136-012-0261-0; Huljer HAS, 2013, EUR J PSYCHOL, V9, P8, DOI 10.5964/ejop.v9i1.444; Jassim G, 2020, NEUROPSYCH DIS TREAT, V16, P3045, DOI 10.2147/NDT.S263190; Kim YC, 2015, CANCER MED-US, V4, P1196, DOI 10.1002/cam4.471; Kirkova J, 2010, PALLIATIVE MED, V24, P330, DOI 10.1177/0269216309356380; Lang-Rollin I, 2018, DIALOGUES CLIN NEURO, V20, P13; Mikati D, 2021, DECONSTRUCTING PALLI; Ministry of Health, 2016, CANC REPORT GAZA STR; Nayak MG, 2017, INDIAN J PALLIAT CAR, V23, P445, DOI 10.4103/IJPC.IJPC_82_17; Odonkor CA, 2017, PAIN MED, V18, P363, DOI 10.1093/pm/pnw143; Park BW, 2012, YONSEI MED J, V53, P118, DOI 10.3349/ymj.2012.53.1.118; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Samara AM, 2018, APPL CANC RES, V38, P15; Schmidt H, 2015, J PAIN SYMPTOM MANAG, V49, P118, DOI 10.1016/j.jpainsymman.2014.04.007; Selby Peter, 2018, Res Involv Engagem, V4, P25, DOI 10.1186/s40900-018-0109-z; Shamallakh AN, 2017, LANCET, V390, P21; Surbone A., 2010, MASCC POSITION STATE, V18, P255; Tranmer JE, 2003, J PAIN SYMPTOM MANAG, V25, P420, DOI 10.1016/S0885-3924(03)00074-5; United Nations Development Programme, 2020, BRIEFING NOTE COUNTR; United Nations Office for the Coordination of Humanitarian Affairs, DATA CASUALTIES; Wang XS, 2010, BRAIN BEHAV IMMUN, V24, P968, DOI 10.1016/j.bbi.2010.03.009; Weis J, 2015, BREAST CARE, V10, P84, DOI 10.1159/000381969; WHO, 2020, WHOQOL MEAS QUAL LIF; World Health Organization, 2019, RIGHT HLTH 2018; World Health Organization, 2018, CANC PRESS RELEASE N; Wozniak K, 2014, MENOPAUSE REV, V13, P253, DOI 10.5114/pm.2014.45002; Zambroski Cheryl Hoyt, 2005, Eur J Cardiovasc Nurs, V4, P198, DOI 10.1016/j.ejcnurse.2005.03.010	41	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262512	10.1371/journal.pone.0262512	http://dx.doi.org/10.1371/journal.pone.0262512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025966	Green Published, gold			2022-12-26	WOS:000796264200078
J	Kanguya, T; Koyuncu, A; Sharma, A; Kusanathan, T; Mubanga, M; Chi, BH; Vinikoor, MJ; Mubiana-Mbewe, M				Kanguya, Tukiya; Koyuncu, Aybueke; Sharma, Anjali; Kusanathan, Thankian; Mubanga, Martha; Chi, Benjamin H.; Vinikoor, Michael J.; Mubiana-Mbewe, Mwangelwa			Identifying barriers to ART initiation and adherence: An exploratory qualitative study on PMTCT in Zambia	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; MALE INVOLVEMENT; ANTIRETROVIRAL THERAPY; HIV CARE; PREVENTION; PREGNANCY; WOMEN; RETENTION; PROGRAMS	Background Though antiretroviral therapy (ART) is widely available, HIV positive pregnant women in Zambia are less likely to start and remain on therapy throughout pregnancy and after delivery. This study sought to understand readiness to start ART among HIV pregnant women from the perspectives of both women and men in order to suggest more holistic programs to support women to continue life-long ART after delivery. Methods We conducted a qualitative study with HIV positive pregnant women before and after ART initiation, and men with female partners, to understand readiness to start lifelong ART. We conducted 28 in-depth interviews among women and 2 focus group discussions among male partners. Data were transcribed verbatim and analyzed in NVivo 12 using thematic analysis. Emerging themes from the data were organized using the social ecological framework. Results Men thought of their female partners as young and needing their supervision to initiate and stay on ART. Women agreed that disclosure and partner support were necessary preconditions to ART initiation and adherence and, expressed fear of divorce as a prominent barrier to disclosure. Maternal love and desire to look after one's children instilled a sense of responsibility among women which motivated them to overcome individual, interpersonal and health system level barriers to initiation and adherence. Women preferred adherence strategies that were discrete, the effectiveness of which, depended on women's intrinsic motivation. Conclusion The results support current policies in Zambia to encourage male engagement in ART care. To appeal to male partners, messaging on ART should be centered on emphasizing the importance of male involvement to ensure women remain engaged in ART care. Programs aimed at supporting postpartum ART adherence should design messages that appeal to both men's role in couples' joint decision-making and women's maternal love as motivators for adherence.	[Kanguya, Tukiya; Koyuncu, Aybueke; Sharma, Anjali; Mubanga, Martha; Mubiana-Mbewe, Mwangelwa] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Kusanathan, Thankian] Univ Zambia, Dept Gender Studies, Lusaka, Zambia; [Chi, Benjamin H.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Vinikoor, Michael J.] Univ Alabama Birmingham, Birmingham, AL USA	University of Zambia; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham	Kanguya, T; Koyuncu, A (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	Tukiya.Kanguya@cidrz.org; akoyuncu@berkeley.edu			President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control andPrevention (CDC) [U01GH000530]	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control andPrevention (CDC)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR; https://www.state.gov/pepfar/) through the United States Centers for Disease Control andPrevention (CDC) under the terms of cooperative agreement number U01GH000530 (Funding recipient MMM). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton P., 2001, CURR SOCIOL, V49, P23, DOI [DOI 10.1177/0011392101496005, 10.1177/0011392101496005]; Auvinen J, 2010, PSYCHOL HEALTH MED, V15, P288, DOI 10.1080/13548501003615290; Buregyeya E, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1276-x; Chadambuka A, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4611-2; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Fernandez MI, 2011, AIDS CARE, V23, P1492, DOI 10.1080/09540121.2011.565020; Gill MM, 2017, AIDS PATIENT CARE ST, V31, P153, DOI 10.1089/apc.2016.0234; Golden SD, 2012, HEALTH EDUC BEHAV, V39, P364, DOI 10.1177/1090198111418634; Hampanda K, 2021, SOC SCI MED, V283, DOI 10.1016/j.socscimed.2021.114029; Harvey SM, 2002, J SEX RES, V39, P284, DOI 10.1080/00224490209552152; Hershow RB, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25293; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Hommann K., 2019, WHICH WAY LIVABLE PR, DOI [10.1596/978-1-4648-1405-1, DOI 10.1596/978-1-4648-1405-1]; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Kululanga LI, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-36; LeCompte MD., 1999, DESIGNING CONDUCTING; Loomba Foundation, 2015, GLOB WID REP 2015 GL; Lusaka (Province Zambia), POPULATION STAT CHAR; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; Millennium Development Goals United Nations General Assembly Special Session World Health Organization, 2010, PMTCT STRAT VIS 2010; Ministry of Health Zambia, 2019, ZAMB POP BAS HIV IMP; Morfaw Frederick, 2013, Syst Rev, V2, P5, DOI 10.1186/2046-4053-2-5; Mubiana-Mbewe M, 2021, AIDS BEHAV, V25, P992, DOI 10.1007/s10461-020-03060-4; Musheke M, 2013, AIDS PATIENT CARE ST, V27, P231, DOI 10.1089/apc.2012.0341; Naigino R, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0367-5; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Orne-Gliemann J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-197; Patel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168057; Peacock D., 2008, MEN CARE CONTEXT HIV; Simuyemba MC, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-019-2700-1; Takah NF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207060; The Republic of Zambia Ministry of Health, ELIMINATION MOTHER T; The World Bank, 2018, 124032ZM WORLD BANK; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; Vermeulen E, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0853-8	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262392	10.1371/journal.pone.0262392	http://dx.doi.org/10.1371/journal.pone.0262392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025923	Green Published, gold			2022-12-26	WOS:000796264200065
J	Li, WT; Huang, DJ; Wang, B; Hou, XM; Zhang, R; Yan, M; Lia, WB				Li, Weitai; Huang, Dengjing; Wang, Bo; Hou, Xuemei; Zhang, Rui; Yan, Mei; Lia, Weibiao			Changes of starch and sucrose content and related gene expression during the growth and development of Lanzhou lily bulb	PLOS ONE			English	Article							METABOLISM; CARBON; BIOSYNTHESIS; RHIZOSPHERE; LEAVES; ACIDS	As the main forms of carbohydrates, starch and sucrose play a vital role in the balance and coordination of various carbohydrates. Lanzhou lily is the most popular edible lily in China, mainly distributed in the central region of Gansu. To clarify the relationship between carbohydrate metabolism and bulb development of Lanzhou lily, so as to provide a basis for the promotion of the growth and development in Lanzhou lily and its important economic value, we studied lily bulbs in the squaring stage, flowering stage, half withering stage and withering stage. The plant height, fresh weight of mother and daughter bulbs continued to increase during the whole growth period and fresh weight of stem and leaf began to decrease in the half withering stage. The content of starch, sucrose and total soluble sugar in the lily mother bulb accumulated mostly in the flowering, withering and half withering stages, respectively. Starch, sucrose and total soluble sugar accumulated in the daughter bulb with the highest concentration during the withering stage. In the transcription level, sucrose synthase (SuSy1) and sucrose invertase (INV2) expressed the highest in squaring stage, and the expression was significantly higher in the mother bulb than in the daughter bulb. In flowering stage, the expression levels of soluble starch synthase (SSS1), starch-branching enzyme (SBE) and adenosine diphosphate-glucose pyrophosphorylase (AGP1) genes were higher in the mother bulb than in the daughter bulb. Altogether, our results indicate that starch and sucrose are important for the bulb growth and development of Lanzhou lily.	[Li, Weitai; Huang, Dengjing; Wang, Bo; Hou, Xuemei; Zhang, Rui; Yan, Mei; Lia, Weibiao] Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China	Gansu Agricultural University	Lia, WB (corresponding author), Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China.	liaowb@gsau.edu.cn			National Natural Science Foundation of China [31860568, 31560563, 31160398]; National Key Research and Development Program [2018YFD1000800]; Research Fund of Higher Education of Gansu, China [2018C-14]; Post-Doctoral Foundation of China [20100470887, 2012T50828]; Natural Science Foundation of Gansu Province, China [1606RJZA073, 1606RJZA077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Research Fund of Higher Education of Gansu, China; Post-Doctoral Foundation of China(China Postdoctoral Science Foundation); Natural Science Foundation of Gansu Province, China	This work was supported by the National Natural Science Foundation of China (Nos. 31860568, 31560563 and 31160398); the National Key Research and Development Program (2018YFD1000800); the Research Fund of Higher Education of Gansu, China (No. 2018C-14); the Post-Doctoral Foundation of China (Nos. 20100470887 and 2012T50828) and the Natural Science Foundation of Gansu Province, China (Nos. 1606RJZA073 and 1606RJZA077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2019, RUSS J PLANT PHYSL+, V66, P41, DOI 10.1134/S1021443719010023; Cao X, 2020, PLANT DIS, V104, P291, DOI 10.1094/PDIS-02-19-0374-PDN; Chang L, 2013, SCI HORTIC-AMSTERDAM, V161, P118, DOI 10.1016/j.scienta.2013.07.005; Du F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4303-4; Du YL, 2020, PLANT PHYSIOL BIOCH, V146, P1, DOI 10.1016/j.plaphy.2019.11.003; Durand M, 2018, PLANTA, V247, P587, DOI 10.1007/s00425-017-2807-4; Angeles-Nunez JG, 2010, PLANTA, V232, P701, DOI 10.1007/s00425-010-1207-9; Gao MP, 2018, GENE, V649, P99, DOI 10.1016/j.gene.2018.01.075; Gao SP, 2018, PLANT CELL TISS ORG, V135, P143, DOI 10.1007/s11240-018-1451-4; Ghobadi M, 2013, IND CROP PROD, V50, P29, DOI 10.1016/j.indcrop.2013.07.009; Gu JH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093092; Guidi L, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00174; Hua CP, 2019, HORTSCIENCE, V54, P253, DOI [10.21273/HORTSCI13527-18, 10.21273/hortsci13527-18]; Huang DJ, 2021, POSTHARVEST BIOL TEC, V176, DOI 10.1016/j.postharvbio.2021.111520; Jiang LL, 2013, TRANSGENIC RES, V22, P1133, DOI 10.1007/s11248-013-9717-4; Kuai J, 2014, PLANT SCI, V223, P79, DOI 10.1016/j.plantsci.2014.03.010; Li GH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01369; Li WM, 2020, ACTA PHYSIOL PLANT, V42, DOI 10.1007/s11738-020-03115-y; Li WM, 2020, J SCI FOOD AGR, V100, P5603, DOI 10.1002/jsfa.10613; Li XY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0358-4; LingFei X, 2009, SCI HORTIC-AMSTERDAM, V119, P458, DOI 10.1016/j.scienta.2008.08.026; Mukerjea R, 2002, CARBOHYD RES, V337, P1015, DOI 10.1016/S0008-6215(02)00067-8; Mukherjee S, 2015, PLANT SCI, V240, P143, DOI 10.1016/j.plantsci.2015.09.010; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Shen JL, 2019, SCI HORTIC-AMSTERDAM, V253, P99, DOI 10.1016/j.scienta.2019.04.010; Shin KS, 2002, SCI HORTIC-AMSTERDAM, V96, P195, DOI 10.1016/S0304-4238(02)00087-0; Tetlow IJ, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7040081; Tian XH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227921; Wang FX, 2018, APPL BIOCHEM BIOTECH, V186, P535, DOI 10.1007/s12010-018-2750-2; Wang HR., 2017, BIOTECHNOL J INT, V20, P1; Wu Y, 2019, J PLANT GROWTH REGUL, V38, P359, DOI 10.1007/s00344-018-9844-5; Wu Y, 2016, J ZHEJIANG UNIV-SC B, V17, P892, DOI 10.1631/jzus.B1600231; Yan ZQ, 2019, SCI HORTIC-AMSTERDAM, V250, P121, DOI 10.1016/j.scienta.2019.02.038; Yang PP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01508; Zhang CS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01425; Zhang YJ, 2015, RUSS J PLANT PHYSL+, V62, P334, DOI 10.1134/S1021443715030206; Zhang YB, 2018, CROP PROT, V110, P73, DOI 10.1016/j.cropro.2018.02.028; Zhang YB, 2015, J VIROL METHODS, V220, P13, DOI 10.1016/j.jviromet.2015.03.021; Zou HG., 2003, NO HORT, P60, DOI [10.21273/HORTSCI11463-16, DOI 10.21273/HORTSCI11463-16]	39	5	5	16	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262506	10.1371/journal.pone.0262506	http://dx.doi.org/10.1371/journal.pone.0262506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015792	Green Published, gold			2022-12-26	WOS:000814820600030
J	Madrazo, E; Gonzalez-Novo, R; Ortiz-Placin, C; de Lacoba, MG; Gonzalez-Murillo, A; Ramirez, M; Redondo-Munoz, J				Madrazo, Elena; Gonzalez-Novo, Raquel; Ortiz-Placin, Candido; Garcia de Lacoba, Mario; Gonzalez-Murillo, Africa; Ramirez, Manuel; Redondo-Munoz, Javier			Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells	ONCOGENE			English	Article							MIGRATION; KINASE; CXCR4; INFILTRATION; CHROMATIN; PATHOGENESIS; PHOSPHORYLATION; DEFORMATION; STRATEGIES; ORIGINS	T-acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that comprises the accumulation of malignant T-cells. Despite current therapies, failure to conventional treatments and relapse are frequent in children with T-ALL. It is known that the chemokine CXCL12 modulates leukemia survival and dissemination; however, our understanding of molecular mechanisms used by T-ALL cells to infiltrate and respond to leukemia cells-microenvironment interactions is still vague. In the present study, we showed that CXCL12 promoted H3K9 methylation in cell lines and primary T-ALL cells within minutes. We thus identified that CXCL12-mediated H3K9 methylation affected the global chromatin configuration and the nuclear mechanics of T-ALL cells. Importantly, we characterized changes in the genomic profile of T-ALL cells associated with rapid CXCL12 stimulation. We showed that blocking CXCR4 and protein kinase C (PKC) impaired the H3K9 methylation induced by CXCL12 in T-ALL cells. Finally, blocking H3K9 methyltransferases reduced the efficiency of T-ALL cells to deform their nuclei, migrate across confined spaces, and home to spleen and bone marrow in vivo models. Together, our data show novel functions for CXL12 as a master regulator of nuclear deformability and epigenetic changes in T-ALL cells, and its potential as a promising pharmacological target against T-ALL dissemination.	[Madrazo, Elena; Gonzalez-Novo, Raquel; Ortiz-Placin, Candido; Redondo-Munoz, Javier] Ctr Invest Biol Margarita Salas CIB Margarita Sal, Dept Mol Med, Madrid, Spain; [Garcia de Lacoba, Mario] Ctr Invest Biol Margarita Salas CIB Margarita Sal, Bioinformat & Biostat Unit, Madrid, Spain; [Gonzalez-Murillo, Africa; Ramirez, Manuel] Hosp Univ Nino Jesus, Dept Paediat Haematol & Oncol, Madrid, Spain; [Gonzalez-Murillo, Africa; Ramirez, Manuel] Hlth Res Inst La Princesa, Madrid, Spain		Redondo-Munoz, J (corresponding author), Ctr Invest Biol Margarita Salas CIB Margarita Sal, Dept Mol Med, Madrid, Spain.	Javier.redondo@cib.csic.es	; Gonzalez, Africa/M-3426-2014	Gonzalez-Novo, Raquel/0000-0002-3796-2751; Redondo-Munoz, Javier/0000-0003-0607-2171; Ortiz Placin, Candido/0000-0003-0529-4047; Gonzalez, Africa/0000-0001-7747-1204	FPI Scholarship 2018 (Ministerio de Ciencia e Innovacion/MICINN); FPI Scholarship 2018 (Agencia Estatal de Investigacion/AEI); FPI Scholarship 2018 (Fondo Europeo de Desarrollo Regional/FEDER); undergraduate fellowship "Beca de Introduccion a la Investigacion" (Asociacion Espanola Contra el Cancer); Asociacion Pablo Ugarte; Gilead Sciences International Scholar in Hematology/Oncology (Gilead); 2020 Leonardo Grant for Researchers and Cultural Creators (BBVA Foundation); Ministerio de Ciencia e Innovacion/MICINN [SAF2017-86327-R]; Agencia Estatal de Investigacion/AEI [SAF2017-86327-R]; Fondo Europeo de Desarrollo Regional/FEDER [SAF2017-86327-R]	FPI Scholarship 2018 (Ministerio de Ciencia e Innovacion/MICINN); FPI Scholarship 2018 (Agencia Estatal de Investigacion/AEI); FPI Scholarship 2018 (Fondo Europeo de Desarrollo Regional/FEDER); undergraduate fellowship "Beca de Introduccion a la Investigacion" (Asociacion Espanola Contra el Cancer); Asociacion Pablo Ugarte; Gilead Sciences International Scholar in Hematology/Oncology (Gilead); 2020 Leonardo Grant for Researchers and Cultural Creators (BBVA Foundation); Ministerio de Ciencia e Innovacion/MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia Estatal de Investigacion/AEI; Fondo Europeo de Desarrollo Regional/FEDER(European CommissionSpanish Government)	The authors thank the Microscopy Unit and the Flow Cytometry Core Unit of Instituto de Investigacion Biosanitaria Gregorio Maranon (IiSGM) for assistance with confocal, videomicroscopy and flow cytometry analyses. The UCM-Genomic CAI Unit for their assistance with the microarray experiments. We thank Dr. Ignacio Casal, Joaquin Teixido, Alicia Garcia-Arroyo and Maria Montoya for insightful and critical comments. This research was supported by a FPI Scholarship 2018 (Ministerio de Ciencia e Innovacion/MICINN, Agencia Estatal de Investigacion/AEI y Fondo Europeo de Desarrollo Regional/FEDER) to R. G.N.; an undergraduate fellowship "Beca de Introduccion a la Investigacion" (Asociacion Espanola Contra el Cancer) to C.O.P.; and by grants from Asociacion Pablo Ugarte to M.R., Gilead Sciences International Scholar in Hematology/Oncology (Gilead), 2020 Leonardo Grant for Researchers and Cultural Creators (BBVA Foundation) and SAF2017-86327-R (Ministerio de Ciencia e Innovacion/MICINN, Agencia Estatal de Investigacion/AEI y Fondo Europeo de Desarrollo Regional/FEDER) to J.R.M.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Almamun M, 2015, EPIGENETICS-US, V10, P882, DOI 10.1080/15592294.2015.1078050; Alsadeq A, 2017, HAEMATOLOGICA, V102, P346, DOI 10.3324/haematol.2016.147744; Altman A, 2016, ANNU REV IMMUNOL, V34, P511, DOI 10.1146/annurev-immunol-041015-055347; Apaolaza I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00555-y; Bao Y, 2019, ONCOGENE, V38, P881, DOI 10.1038/s41388-018-0452-4; Barbieri F, 2016, EXPERT OPIN DRUG DIS, V11, P1093, DOI 10.1080/17460441.2016.1233176; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; Bradstock KF, 2000, LEUKEMIA, V14, P882, DOI 10.1038/sj.leu.2401729; Cancilla D, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01672; Cannon JL, 2017, ONCOTARGET, V8, P84626, DOI 10.18632/oncotarget.21394; Melo RDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085926; Crazzolara R, 2001, BRIT J HAEMATOL, V115, P545, DOI 10.1046/j.1365-2141.2001.03164.x; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Edens LJ, 2017, MOL BIOL CELL, V28, P1389, DOI 10.1091/mbc.E16-11-0786; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Frishman-Levy L, 2017, BRIT J HAEMATOL, V176, P157, DOI 10.1111/bjh.14411; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Gomez AM, 2015, BLOOD CELL MOL DIS, V55, P220, DOI 10.1016/j.bcmd.2015.07.001; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Hong ZX, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01060-y; Irianto J, 2017, BIOPHYS J, V112, P446, DOI 10.1016/j.bpj.2016.09.047; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; Jost TR, 2016, J LEUKOCYTE BIOL, V99, P1077, DOI 10.1189/jlb.5MA0915-394R; Jung HJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.15; Kato I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027042; Kidiyoor GR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18580-9; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Kuang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061807; Lai YS, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.37; Le Berre M, 2012, INTEGR BIOL-UK, V4, P1406, DOI 10.1039/c2ib20056b; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lu CW, 2020, CANCER LETT, V476, P87, DOI 10.1016/j.canlet.2020.02.004; Madrazo E, 2018, CANCERS, V10, DOI 10.3390/cancers10090325; Makhija E, 2016, P NATL ACAD SCI USA, V113, pE32, DOI 10.1073/pnas.1513189113; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nava MM, 2020, CELL, V181, P800, DOI 10.1016/j.cell.2020.03.052; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Passaro D, 2015, CANCER CELL, V27, P769, DOI 10.1016/j.ccell.2015.05.003; Perim AD, 2015, CELL MOL LIFE SCI, V72, P1715, DOI 10.1007/s00018-014-1830-x; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Pfeifer CR, 2019, ADV EXP MED BIOL, V1146, P117, DOI 10.1007/978-3-030-17593-1_8; Pfeifer CR, 2018, MOL BIOL CELL, V29, P1948, DOI 10.1091/mbc.E18-02-0079; Pitt LA, 2015, CANCER CELL, V27, P755, DOI 10.1016/j.ccell.2015.05.002; Poli A, 2018, FASEB J, V32, P681, DOI 10.1096/fj.201700690R; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Randhawa S, 2016, BRIT J HAEMATOL, V174, P425, DOI 10.1111/bjh.14075; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Redondo-Munoz J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00156; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Scupoli MT, 2008, HAEMATOLOGICA, V93, P524, DOI 10.3324/haematol.12098; Sison EAR, 2015, ONCOTARGET, V6, P30902, DOI 10.18632/oncotarget.5094; Song ZY, 2019, ONCOGENE, V38, P1560, DOI 10.1038/s41388-018-0519-2; Stephens AD, 2019, CURR OPIN CELL BIOL, V58, P76, DOI 10.1016/j.ceb.2019.02.006; Stephens AD, 2017, MOL BIOL CELL, V28, P1984, DOI 10.1091/mbc.E16-09-0653; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Vadillo E, 2018, BLOOD REV, V32, P36, DOI 10.1016/j.blre.2017.08.006; Vargas P, 2014, JOVE-J VIS EXP, DOI 10.3791/51099; Velazquez-Avila M, 2019, LEUKEMIA, V33, P1337, DOI 10.1038/s41375-018-0333-4; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wei SY, 2014, J MOL CELL BIOL, V6, P458, DOI 10.1093/jmcb/mju050; Yokoyama M, 2017, ONCOTARGET, V8, P21315, DOI 10.18632/oncotarget.15528; Zhang XH, 2016, NUCLEIC ACIDS RES, V44, P3031, DOI 10.1093/nar/gkv1348	66	1	1	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1324	1336		10.1038/s41388-021-02168-8	http://dx.doi.org/10.1038/s41388-021-02168-8		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	34999734	Green Published			2022-12-26	WOS:000740423700002
J	Kan, TT; Zhang, SP; Zhou, ST; Zhang, Y; Zhao, Y; Gao, YH; Zhang, T; Gao, F; Wang, X; Zhao, LJ; Yang, MS				Kan, Tongtong; Zhang, Shupeng; Zhou, Shengtao; Zhang, Ya; Zhao, Yun; Gao, Yinghua; Zhang, Tao; Gao, Feng; Wang, Xin; Zhao, Linjie; Yang, Mengsu			Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence	ONCOGENE			English	Article							GENE-EXPRESSION PROFILES; STEM-CELLS; HETEROGENEITY; MECHANISMS; GROWTH; PROGRESSION; RESISTANCE; CYR61	Epithelial ovarian cancers (EOCs) are sensitive to chemotherapy but will ultimately relapse and develop drug resistance. The origin of EOC recurrence has been elusive due to intra-tumor heterogeneity. Here we performed single-cell RNA sequencing (scRNA-seq) in 13,369 cells from primary, untreated peritoneal metastasis, and relapse tumors. We used time-resolved analysis to chart the developmental sequence of cells from the metastatic tumors, then traced the earliest replanting cells back to the primary tumors. We discovered seven distinct subpopulations in primary tumors where the CYR61(+) "stress" subpopulation was identified as the relapse-initiators. Furthermore, a subpopulation of RGS5(+) cancer-associated fibroblasts (CAFs) was found to strongly support tumor metastasis. The combined CYR61/RGS5 expression scores significantly correlated with the relapse-free-survival of EOC patients and can be used as predictors of EOC recurrence. Our study provides insights into the mechanism of EOC recurrence and presents CYR61(+) relapse-initiating cells as potential therapeutic targets to prevent EOC relapse.	[Kan, Tongtong; Gao, Feng; Wang, Xin; Yang, Mengsu] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Kan, Tongtong] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Zhang, Shupeng; Zhang, Ya; Gao, Yinghua] Shandong First Med Univ, Affiliated Hosp 2, Dept Pathol, Tai An, Shandong, Peoples R China; [Zhou, Shengtao; Zhao, Linjie] Sichuan Univ, West China Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ,Dept Obstet & Gynecol,West China Hosp, Chengdu, Peoples R China; [Zhou, Shengtao; Zhao, Linjie] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr, State Key Lab Biotherapy, Chengdu, Peoples R China; [Zhao, Yun] Taian Tumor Prevent & Treatment Hosp, Dept Pathol, Tai An, Shandong, Peoples R China; [Zhang, Tao] Shandong Univ, Sch Publ Hlth, Dept Biostat, Jinan, Peoples R China; [Yang, Mengsu] City Univ Hong Kong, Shenzhen Res Inst, Key Lab Biochip Technol, Shenzhen, Peoples R China	City University of Hong Kong; Academy of Military Medical Sciences - China; Shandong First Medical University & Shandong Academy of Medical Sciences; Sichuan University; Sichuan University; Shandong University; City University of Hong Kong	Kan, TT; Yang, MS (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China.; Kan, TT (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.; Yang, MS (corresponding author), City Univ Hong Kong, Shenzhen Res Inst, Key Lab Biochip Technol, Shenzhen, Peoples R China.	tongtongkan@hotmail.com; bhmyang@cityu.edu.hk		Gao, Feng/0000-0002-0500-5527; Wang, Xin/0000-0002-5122-2418; Zhou, Shengtao/0000-0001-8322-5536	General Research Fund [CityU_11319516]; Research Impact Fund of Hong Kong Research Grant Council [R1020-18F]; Guangdong Frontier and Key Technology Development Fund of Guangdong Province, PR China [2017B020226001]; Knowledge Innovation Program of Shenzhen Municipality, PR China [JCYJ20170818095453642, JCYJ20180307123759162]	General Research Fund; Research Impact Fund of Hong Kong Research Grant Council; Guangdong Frontier and Key Technology Development Fund of Guangdong Province, PR China; Knowledge Innovation Program of Shenzhen Municipality, PR China	We thank Dr Junhai Wang from Taian Tumor Prevention and Treatment Hospital for assistance with IHC. This work was supported by grants from the General Research Fund (CityU_11319516) and the Research Impact Fund (R1020-18F) of Hong Kong Research Grant Council, the Guangdong Frontier and Key Technology Development Fund (2017B020226001) of Guangdong Province, PR China, and the Knowledge Innovation Program (JCYJ20170818095453642 and JCYJ20180307123759162) of Shenzhen Municipality, PR China.	Abal M, 2003, CURR CANCER DRUG TAR, V3, P193, DOI 10.2174/1568009033481967; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Corrado G, 2017, EXPERT REV ANTICANC, V17, P1147, DOI 10.1080/14737140.2017.1398088; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; Dan S, 2002, CANCER RES, V62, P1139; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Gery S, 2005, CLIN CANCER RES, V11, P7243, DOI 10.1158/1078-0432.CCR-05-0231; Goveia J, 2020, CANCER CELL, V37, P21, DOI 10.1016/j.ccell.2019.12.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hellinger JW, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01074; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hoang-Minh LB, 2018, EMBO J, V37, DOI 10.15252/embj.201798772; Hyun HB, 2018, MOLECULES, V23, DOI 10.3390/molecules23020209; Kan TT, 2020, ONCOGENE, V39, P4227, DOI 10.1038/s41388-020-1288-2; Khalique L, 2007, J PATHOL, V211, P286, DOI 10.1002/path.2112; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; KOHN KW, 1994, J CELL BIOCHEM, V54, P440, DOI 10.1002/jcb.240540411; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Landen CN, 2010, MOL CANCER THER, V9, P3186, DOI 10.1158/1535-7163.MCT-10-0563; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Li XP, 2018, EXP THER MED, V16, P730, DOI 10.3892/etm.2018.6274; Lin JPA, 2012, CANCER IMMUNOL IMMUN, V61, P677, DOI 10.1007/s00262-011-1135-y; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maity G, 2019, MOL CANCER THER, V18, P788, DOI 10.1158/1535-7163.MCT-18-0899; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Pantel Klaus, 2014, Bonekey Rep, V3, P584, DOI 10.1038/bonekey.2014.79; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vasey PA, 2003, BRIT J CANCER, V89, pS23, DOI 10.1038/sj.bjc.6601497; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Zembutsu H, 2002, CANCER RES, V62, P518; Zhang YQ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.057; Zlobec I, 2007, J CLIN PATHOL, V60, P1112, DOI 10.1136/jcp.2006.044537	50	5	5	7	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					895	906		10.1038/s41388-021-02139-z	http://dx.doi.org/10.1038/s41388-021-02139-z		JAN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34992217				2022-12-26	WOS:000739823800001
J	Min, HK; Choi, J; Lee, SY; Lee, AR; Min, BM; Cho, ML; Park, SH				Min, Hong Ki; Choi, JeongWon; Lee, Seon-Yeong; Lee, A. Ram; Min, Byung-Moo; Cho, Mi-La; Park, Sung-Hwan			Vitronectin-derived bioactive peptide prevents spondyloarthritis by modulating Th17/Treg imbalance in mice with curdlan-induced spondyloarthritis	PLOS ONE			English	Article							REGULATORY T-CELLS; ANKYLOSING-SPONDYLITIS; RADIOGRAPHIC PROGRESSION; TH17 CELLS; BISPHOSPHONATES; PATHOGENESIS; EXPRESSION	Purpose Spondyloarthritis (SpA) is a systemic inflammatory arthritis mediated mainly by interleukin (IL)-17. The vitronectin-derived bioactive peptide, VnP-16, exerts an anti-osteoporotic effect via beta 1 and alpha v beta 3 integrin signaling. SpA is associated with an increased risk of osteoporosis, and we investigated the effect of VnP-16 in mice with SpA. Methods SpA was induced by curdlan in SKG ZAP-70(W163C) mice, which were treated with vehicle, celecoxib, VnP-16, or VnP-16+celecoxib. The clinical score, arthritis score, spondylitis score, and proinflammatory cytokine expression of the spine were evaluated by immunohistochemical staining. Type 17 helper T cell (Th17) and regulatory T cell (Treg) differentiation in the spleen was evaluated by flow cytometry and in the spine by confocal staining. Splenocyte expression of signal transducer and activator of transcription (STAT) 3 and pSTAT3 was evaluated by in vitro Western blotting. Results The clinical score was significantly reduced in the VnP16+celecoxib group. The arthritis and spondylitis scores were significantly lower in the VnP-16 and VnP16+celecoxib groups than the vehicle group. In the spine, the levels of IL-1 beta, IL-6, tumor necrosis factor-alpha, and IL-17 expression were reduced and Th17/Treg imbalance was regulated in the VnP-16 alone and VnP-16+celecoxib groups. Flow cytometry of splenocytes showed increased polarization of Tregs in the VnP-16+celecoxib group. In vitro, VnP-16 suppressed pSTAT3. Conclusions VnP-16 plus celecoxib prevented SpA progression in a mouse model by regulating the Th17/Treg imbalance and suppressing the expression of proinflammatory cytokines.	[Min, Hong Ki] Konkuk Univ, Med Ctr, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Choi, JeongWon; Lee, Seon-Yeong; Lee, A. Ram; Cho, Mi-La; Park, Sung-Hwan] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Lee, A. Ram; Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea; [Min, Byung-Moo] Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Oral Biochem, Seoul, South Korea; [Min, Byung-Moo] Seoul Natl Univ, Sch Dent, Dent Res Inst, Program Canc & Dev Biol, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Lab Immune Network, Conversant Res Consortium Immunol Dis, Seoul, South Korea; [Park, Sung-Hwan] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Catholic University of Korea; Catholic University of Korea; Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Catholic University of Korea	Cho, ML; Park, SH (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Lab Immune Network, Conversant Res Consortium Immunol Dis, Seoul, South Korea.; Park, SH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	iammila@catholic.ac.kr; rapark@catholic.ac.kr	Min, Hong Ki/AHE-4068-2022	Min, Hong Ki/0000-0003-1147-1046	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare of the Republic of Korea [HI20C1496]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare of the Republic of Korea	This research was funded by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare of the Republic of Korea (grant number HI20C1496, grant receiver : SH Park). The funder had no role on the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya M, 2010, J CLIN INVEST, V120, P4445, DOI 10.1172/JCI43796; Baraliakos X, 2014, ANN RHEUM DIS, V73, P1819, DOI 10.1136/annrheumdis-2013-203425; Baraliakos X, 2019, ANN RHEUM DIS, V78, P1220, DOI 10.1136/annrheumdis-2018-214983; Bertoni A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020485; Briot K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000052; Cairns AP, 2005, ANN RHEUM DIS, V64, P338, DOI 10.1136/ard.2004.022871; Dotan I, 2020, MED RES REV, V40, P245, DOI 10.1002/med.21601; Du F, 2016, CELL REP, V16, P1339, DOI 10.1016/j.celrep.2016.06.065; Haibel H, 2003, RHEUMATOLOGY, V42, DOI 10.1093/rheumatology/keg256; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Jo S, 2021, RHEUMATOLOGY, V60, P3923, DOI 10.1093/rheumatology/keaa846; Jo S, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1582-3; Jung YK, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e2; Karmacharya P, 2020, ARTHRITIS RHEUMATOL, V72, P733, DOI 10.1002/art.41206; Klann JE, 2018, J IMMUNOL, V200, P4012, DOI 10.4049/jimmunol.1800112; Koo BS, 2020, ANN RHEUM DIS, V79, P1327, DOI 10.1136/annrheumdis-2019-216741; Li XY, 2013, J CLIN IMMUNOL, V33, P151, DOI 10.1007/s10875-012-9774-0; Magrey Marina, 2010, Curr Rheumatol Rep, V12, P332, DOI 10.1007/s11926-010-0122-1; Marijnissen RJ, 2011, ARTHRITIS RHEUM-US, V63, P2939, DOI 10.1002/art.30469; McGonagle DG, 2019, ANN RHEUM DIS, V78, P1167, DOI 10.1136/annrheumdis-2019-215356; Min HK, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1774-x; Min HK, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0942-5; Min SK, 2018, CELL DEATH DIFFER, V25, P268, DOI 10.1038/cdd.2017.153; Molnar C, 2018, ANN RHEUM DIS, V77, P63, DOI 10.1136/annrheumdis-2017-211544; Park JW, 2019, ARTHRITIS RHEUMATOL, V71, P82, DOI 10.1002/art.40661; Reppert S, 2015, EUR J IMMUNOL, V45, P1426, DOI 10.1002/eji.201445150; Roelofs AJ, 2010, CURR PHARM DESIGN, V16, P2950; Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; Ruutu M, 2012, ARTHRITIS RHEUM-US, V64, P2211, DOI 10.1002/art.34423; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sieper J, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.13; Smith JA, 2014, ARTHRITIS RHEUMATOL, V66, P231, DOI 10.1002/art.38291; Stolwijk C, 2016, ARTHRIT CARE RES, V68, P1320, DOI 10.1002/acr.22831; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; Tanaka T, 2014, CANCER IMMUNOL RES, V2, P288, DOI 10.1158/2326-6066.CIR-14-0022; Toussirot E, 2007, CURR OPIN RHEUMATOL, V19, P340; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wanders A, 2005, ARTHRITIS RHEUM-US, V52, P1756, DOI 10.1002/art.21054; Ward MM, 2019, ARTHRITIS RHEUMATOL, V71, P1599, DOI 10.1002/art.41042; Weiss RJ, 2010, J RHEUMATOL, V37, P2247, DOI 10.3899/jrheum.100363; WILL R, 1989, LANCET, V2, P1483; Zhang JR, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00214; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhao Z, 2019, CLIN RHEUMATOL, V38, P465, DOI 10.1007/s10067-018-4284-y	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262183	10.1371/journal.pone.0262183	http://dx.doi.org/10.1371/journal.pone.0262183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986165	gold, Green Published			2022-12-26	WOS:000765956200021
J	Xu, C; Liu, SJ; Yang, F; Zhang, KY; Li, Y; Zhao, XL; Zhang, JY; Lu, T; Lu, SQ; Jiang, Y; Qin, WJ; Shi, CH; Zhang, R; Yang, AG; Zhao, AZ; Han, DH; Wen, WH				Xu, Chao; Liu, Shaojie; Yang, Fa; Zhang, Keying; Li, Yu; Zhao, Xiaolong; Zhang, Jiayu; Lu, Tong; Lu, Shiqi; Jiang, Yao; Qin, Weijun; Shi, Changhong; Zhang, Rui; Yang, An-Gang; Zhao, Aizhi; Han, Donghui; Wen, Weihong			Antibody-drug conjugates targeting CD248(+) myofibroblasts effectively alleviate renal fibrosis in mice	FASEB JOURNAL			English	Article						antibody-drug conjugate (ADC); CD248; myofibroblasts; renal fibrosis; specific killing	INTERSTITIAL MYOFIBROBLASTS; ENDOSIALIN; CELL; FIBROBLASTS; MECHANISMS; MARKER; APOPTOSIS; DELIVERY; PROTEINS; PROTECTS	Myofibroblasts, or activated fibroblasts, play a critical role in the process of renal fibrosis. Targeting myofibroblasts to inhibit their activation or induce specific cell death has been considered to be an effective strategy to attenuate renal fibrosis. However, specific biomarkers for myofibroblasts are needed to ensure the efficacy of these strategies. Here, we verified that CD248 was mainly expressed in myofibroblasts in patients with chronic kidney disease, which was inversely correlated with renal function. The same result was also confirmed in renal fibrotic mice induced by unilateral ureteral obstruction and aristolochic acid nephropathy. By using an antibody-drug conjugate (ADC) named IgG78-DM1, in which maytansinoid (DM1) was linked to a fully human antibody IgG78 through an uncleavable SMCC linker, we demonstrated that it could effectively bind with and kill CD248(+) fibroblasts in vitro and alleviate renal fibrosis in mice models. Besides, we confirmed that IgG78-DM1 had qualified biosafety in vivo. Our results confirmed that CD248 can be used as a specific marker for myofibroblasts, and specific killing of CD248(+) myofibroblasts by IgG78-DM1 has excellent anti-fibrotic effect in renal fibrotic mice. Our study expanded the application of ADC and provided a novel strategy for the treatment of renal fibrosis.	[Xu, Chao; Liu, Shaojie; Yang, Fa; Zhang, Keying; Li, Yu; Zhao, Xiaolong; Zhang, Jiayu; Lu, Tong; Jiang, Yao; Qin, Weijun; Han, Donghui] Air Force Mil Med Univ, Xijing Hosp, Dept Urol, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Lu, Shiqi; Wen, Weihong] Northwestern Polytech Univ, Inst Med Res, 127 West Youyi Rd, Xian 710072, Shaanxi, Peoples R China; [Shi, Changhong] Air Force Mil Med Univ, Lab Anim Ctr, Xian, Peoples R China; [Zhang, Rui; Yang, An-Gang] Air Force Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian, Peoples R China; [Zhao, Aizhi] OriMAbs Ltd, Newark, DE USA	Air Force Military Medical University; Northwestern Polytechnical University; Air Force Military Medical University	Han, DH (corresponding author), Air Force Mil Med Univ, Xijing Hosp, Dept Urol, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.; Wen, WH (corresponding author), Northwestern Polytech Univ, Inst Med Res, 127 West Youyi Rd, Xian 710072, Shaanxi, Peoples R China.	906812205@qq.com; weihongwen@nwpu.edu.cn	温, 家琦/GYV-3177-2022	Xu, Chao/0000-0001-8462-8337	National Natural Science Foundation of China [81772734]; Innovation Capability Support Program of Shaanxi [2020PT-021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Capability Support Program of Shaanxi	This work was partly supported by grants from the National Natural Science Foundation of China (No. 81772734), and the Innovation Capability Support Program of Shaanxi (Program No. 2020PT-021)	Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Ashley SL, 2016, AM J RESP CELL MOL, V54, P482, DOI 10.1165/rcmb.2015-0148OC; Bagley RG, 2008, MICROVASC RES, V76, P180, DOI 10.1016/j.mvr.2008.07.008; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; Chau CH, 2019, LANCET, V394, P793, DOI 10.1016/S0140-6736(19)31774-X; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Christian S, 2001, J BIOL CHEM, V276, P7408, DOI 10.1074/jbc.M009604200; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Hinz B, 2020, NAT REV RHEUMATOL, V16, P11, DOI 10.1038/s41584-019-0324-5; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Kuppe C, 2021, NATURE, V589, P281, DOI 10.1038/s41586-020-2941-1; Lax S, 2007, FEBS LETT, V581, P3550, DOI 10.1016/j.febslet.2007.06.063; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Li QH, 2019, J CELL MOL MED, V23, P1951, DOI 10.1111/jcmm.14097; Li R, 2020, J CONTROL RELEASE, V320, P32, DOI 10.1016/j.jconrel.2020.01.017; Li R, 2020, APOPTOSIS, V25, P105, DOI 10.1007/s10495-019-01583-3; Luo JW, 2019, ACS NANO, V13, P3910, DOI 10.1021/acsnano.8b06924; Luyckx VA, 2021, NAT REV NEPHROL, V17, P15, DOI 10.1038/s41581-020-00363-6; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Modi S, 2020, NEW ENGL J MED, V382, P610, DOI 10.1056/NEJMoa1914510; Morton RL, 2021, NAT REV NEPHROL, V17, P5, DOI 10.1038/s41581-020-00376-1; Munoz-Felix JM, 2015, PHARMACOL THERAPEUT, V156, P44, DOI 10.1016/j.pharmthera.2015.10.003; O'Shannessy Daniel J., 2016, Sarcoma, V2016, P5213628, DOI 10.1155/2016/5213628; Pai CH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73194-x; Poosti F, 2016, ONCOTARGET, V7, P54240, DOI 10.18632/oncotarget.11095; Poosti F, 2015, FASEB J, V29, P1029, DOI 10.1096/fj.14-258459; Rouleau C, 2008, CLIN CANCER RES, V14, P7223, DOI 10.1158/1078-0432.CCR-08-0499; Safiri S, 2019, ANN RHEUM DIS, V78, P1463, DOI 10.1136/annrheumdis-2019-215920; Shitara K, 2020, NEW ENGL J MED, V382, P2419, DOI 10.1056/NEJMoa2004413; Smith SW, 2011, KIDNEY INT, V80, P200, DOI 10.1038/ki.2011.103; Smith SW, 2015, NEPHRON, V131, P265, DOI 10.1159/000438754; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Teicher Beverly A, 2019, Oncotarget, V10, P993, DOI 10.18632/oncotarget.26590; Thomas A, 2016, LANCET ONCOL, V17, pE254, DOI 10.1016/S1470-2045(16)30030-4; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yang F, 2020, CANCER RES, V80, P3892, DOI 10.1158/0008-5472.CAN-19-2691; Zhao H, 2020, FASEB J, V34, P12599, DOI 10.1096/fj.202000949R; Zhou J, 2021, MOL PHARMACEUT, V18, P1373, DOI 10.1021/acs.molpharmaceut.0c01182	43	1	1	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22102	10.1096/fj.202101441R	http://dx.doi.org/10.1096/fj.202101441R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972243				2022-12-26	WOS:000747987800004
J	Yamauchi, I; Sakane, Y; Yamashita, T; Hakata, T; Sugawa, T; Fujita, H; Okamoto, K; Taura, D; Hirota, K; Ueda, Y; Fujii, T; Yasoda, A; Inagaki, N				Yamauchi, Ichiro; Sakane, Yoriko; Yamashita, Takafumi; Hakata, Takuro; Sugawa, Taku; Fujita, Haruka; Okamoto, Kentaro; Taura, Daisuke; Hirota, Keisho; Ueda, Yohei; Fujii, Toshihito; Yasoda, Akihiro; Inagaki, Nobuya			Thyroid hormone economy in mice overexpressing iodothyronine deiodinases	FASEB JOURNAL			English	Article						hydrodynamic gene delivery; hypothyroidism; iodothyronine deiodinase; thyroid hormone action; thyroid hormone economy	IN-VITRO EXPRESSION; CONSUMPTIVE HYPOTHYROIDISM; TARGETED DISRUPTION; TYPE-3 DEIODINASE; THYROXINE; RESISTANCE; SELENOCYSTEINE; INACTIVATION; ASSOCIATION; CONVERSION	In peripheral tissues, triiodothyronine (T3) production and consequent thyroid hormone actions are mainly regulated by iodothyronine deiodinases (DIOs) classified into 3 types: D1, D2, and D3. We aimed to investigate the effects of peripheral DIOs on thyroid hormone economy independent of the hypothalamus-pituitary-thyroid axis. We cloned coding sequences of human DIOs with FLAG-tag and HiBiT-tag sequences into a pcDNA3.1 vector. To obtain full-length proteins, we modified these vectors by cloning the selenocysteine insertion sequence of each DIO (SECIS vectors). Western blot analyses and HiBiT lytic assay using HEK293T cells revealed that SECIS vectors expressed full-length proteins with substantial activity. Subsequently, in vivo transfections of pLIVE-based SECIS vectors into male C57BL/6J mice were performed by hydrodynamic gene delivery to generate mice overexpressing DIOs predominantly in the liver (D1, D2, and D3 mice). After 7 days from transfections, mice were analyzed to clarify phenotypes. To summarize, serum thyroid hormone levels did not change in D1 mice but D2 mice had higher serum free T3 levels. D3 mice developed hypothyroidism with higher serum reverse T3 (rT3) levels. Transfections with levothyroxine administration suggested that thyroid hormone action was upregulated in D2 mice. Our DIO-overexpressing mice provided insights on the physiological properties of upregulated DIOs: D2 augments local thyroid hormone action and recruits T3 into the circulation: D3 decreases circulating T3 and T4 levels with elevated rT3, leading to consumptive hypothyroidism. As D3 mice are expected to be a novel hypothyroidism model, they can contribute to progress in the field of thyroid hormone economy and action.	[Yamauchi, Ichiro; Sakane, Yoriko; Yamashita, Takafumi; Hakata, Takuro; Sugawa, Taku; Fujita, Haruka; Okamoto, Kentaro; Taura, Daisuke; Ueda, Yohei; Fujii, Toshihito; Inagaki, Nobuya] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan; [Sakane, Yoriko] Sugawa Clin, Kyoto, Japan; [Yamashita, Takafumi] Kishiwada City Hosp, Metab & Endocrinol Div Internal Med, Osaka, Japan; [Hirota, Keisho] Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Kyoto, Japan; [Yasoda, Akihiro] Natl Hosp Org, Clin Res Inst, Kyoto Med Ctr, Kyoto, Japan	Kyoto University; Kyoto University	Yamauchi, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	ichiroy@kuhp.kyoto-u.ac.jp		Yamauchi, Ichiro/0000-0002-4236-502X	MEXT | Japan Society for the Promotion of Science (JSPS) [19K18006]; Japan Foundation for Applied Enzymology	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19K18006; Japan Foundation for Applied Enzymology	Abdulrahman RM, 2010, J CLIN ENDOCR METAB, V95, P3758, DOI 10.1210/jc.2009-2507; BERRY MJ, 1992, ENDOCRINOLOGY, V131, P1848, DOI 10.1210/en.131.4.1848; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2014, THYROID, V24, P88, DOI 10.1089/thy.2013.0109; Castagna MG, 2017, J CLIN ENDOCR METAB, V102, P1623, DOI 10.1210/jc.2016-2587; Christoffolete MA, 2006, ENDOCRINOLOGY, V147, P1735, DOI 10.1210/en.2005-1300; CLARK OH, 1976, ENDOCRINOLOGY, V99, P988, DOI 10.1210/endo-99-4-988; Endo T, 2013, AM J PHYSIOL-ENDOC M, V305, pE660, DOI 10.1152/ajpendo.00067.2013; Endo T, 2012, AM J PHYSIOL-ENDOC M, V302, pE1569, DOI 10.1152/ajpendo.00572.2011; Franca MM, 2021, THYROID, V31, P202, DOI 10.1089/thy.2020.0253; Galton VA, 2014, ENDOCRINOLOGY, V155, P4081, DOI 10.1210/en.2014-1184; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; GOLDBERG RC, 1950, ENDOCRINOLOGY, V46, P72, DOI 10.1210/endo-46-1-72; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Howard D, 2011, J CLIN ENDOCR METAB, V96, P1966, DOI 10.1210/jc.2010-2104; Huang SA, 2000, NEW ENGL J MED, V343, P185, DOI 10.1056/NEJM200007203430305; Huang SA, 2002, J CLIN ENDOCR METAB, V87, P4457, DOI 10.1210/jc.2002-020627; ISHII H, 1981, J CLIN ENDOCR METAB, V52, P1211, DOI 10.1210/jcem-52-6-1211; Jaeschke H, 2018, THYROID, V28, P1372, DOI 10.1089/thy.2018.0041; Kappers MHW, 2011, J CLIN ENDOCR METAB, V96, P3087, DOI 10.1210/jc.2011-1172; Kim BW, 2003, J CLIN ENDOCR METAB, V88, P594, DOI 10.1210/jc.2002-020921; Kwon MM, 2015, CELL REP, V13, P1521, DOI 10.1016/j.celrep.2015.10.021; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Maia AL, 2005, J CLIN INVEST, V115, P2524, DOI 10.1172/JCI25083; MAIA AL, 1995, ENDOCRINOLOGY, V136, P4842, DOI 10.1210/en.136.11.4842; MANDEL SJ, 1992, J CLIN ENDOCR METAB, V75, P1133, DOI 10.1210/jc.75.4.1133; Markossian S, 2018, THYROID, V28, P139, DOI 10.1089/thy.2017.0389; Maynard MA, 2014, NEW ENGL J MED, V370, P1327, DOI 10.1056/NEJMoa1308893; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Miyamura N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms16017; Ohba K, 2016, ENDOCRINOLOGY, V157, P1660, DOI 10.1210/en.2015-1848; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013; Razavi SA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49247-1; Ruppe MD, 2005, THYROID, V15, P1369, DOI 10.1089/thy.2005.15.1369; SALVATORE D, 1995, J CLIN INVEST, V96, P2421, DOI 10.1172/JCI118299; Salvatore D, 1996, ENDOCRINOLOGY, V137, P3308, DOI 10.1210/en.137.8.3308; Salvatore D, 1996, J CLIN INVEST, V98, P962, DOI 10.1172/JCI118880; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; Schneider MJ, 2006, ENDOCRINOLOGY, V147, P580, DOI 10.1210/en.2005-0739; VISSER TJ, 1982, P NATL ACAD SCI-BIOL, V79, P5080, DOI 10.1073/pnas.79.16.5080; Yamashita T, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa008; Yamauchi I, 2022, CLIN ENDOCRINOL, V96, P236, DOI 10.1111/cen.14591; Yamauchi I, 2018, ENDOCRINE, V59, P353, DOI 10.1007/s12020-017-1495-y	45	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22141	10.1096/fj.202101288RR	http://dx.doi.org/10.1096/fj.202101288RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34981562				2022-12-26	WOS:000747987800012
J	Chiavarina, B; Ronca, R; Otaka, Y; Sutton, RB; Rezzola, S; Yokobori, T; Chiodelli, P; Souche, R; Pourquier, D; Maraver, A; Faa, G; Khellaf, L; Turtoi, E; Oyama, T; Gofflot, S; Bellahcene, A; Detry, O; Delvenne, P; Castronovo, V; Nishiyama, M; Turtoi, A				Chiavarina, Barbara; Ronca, Roberto; Otaka, Yukihiro; Sutton, Roger Bryan; Rezzola, Sara; Yokobori, Takehiko; Chiodelli, Paola; Souche, Regis; Pourquier, Didier; Maraver, Antonio; Faa, Gavino; Khellaf, Lakhdar; Turtoi, Evgenia; Oyama, Tetsunari; Gofflot, Stephanie; Bellahcene, Akeila; Detry, Olivier; Delvenne, Philippe; Castronovo, Vincent; Nishiyama, Masahiko; Turtoi, Andrei			Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma	ONCOGENE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; SARCOMA-VIRUS; CELLS; HETEROGENEITY; EXPRESSION; SORAFENIB; INHIBITOR; TARGETS; PROTEIN; VEGF	Cancer-associated fibroblasts (CAF) are important constituents of the tumor microenvironment (TME) and are major drivers of tumorigenesis. Yet, therapies aiming at eliminating CAF have failed to cure patients. This setback has raised questions regarding whether CAF exclusively favour cancer progression, or if they may also assume tumor-suppressor functions. In the present study, we used proteomics and single cell RNA-sequencing analysis to examine the CAF landscape in hepatocellular carcinoma (HCC). We thereby unveil three major CAF populations in HCC, one of which specifically expressing the prolargin protein. This CAF subpopulation (further termed as CAF_Port) shared a strong transcriptomic signature with portal liver fibroblasts. We further show that CAF_Port deposit prolargin in the TME and that its levels are lower in tumors as compared to the peritumoral region. Mechanistically, aggressive cancer cells degraded prolargin using matrix metalloprotease activity. Survival analysis of 188 patients revealed that high prolargin protein levels correlate with good patient outcome (HR = 0.37; p = 0.01). In vivo, co-injection of cancer cells with fibroblasts silenced for prolargin, led to faster tumor development (5-fold; p = 0.01), mainly due to stronger angiogenesis. Using protein-protein interaction study and structural modelling, we further demonstrate that prolargin binds and inhibits the activity of several pro-agiogenic proteins, including hepatocyte and fibroblast growth factors. In conclusion, prolargin is angiogenesis modulator and CAF-derived tumor suppressor in HCC. Stabilizing prolargin levels in the CAF_Port subpopulation may revert their tumor-antagonizing properties, warranting exploration in further pre-clinical studies.	[Chiavarina, Barbara; Souche, Regis; Pourquier, Didier; Turtoi, Evgenia; Turtoi, Andrei] INSERM, Tumor Microenvironm & Resistance Treatment Lab, Inst Rech Cancerol Montpellier, U1194, Montpellier, France; [Chiavarina, Barbara; Souche, Regis; Maraver, Antonio; Turtoi, Evgenia; Turtoi, Andrei] Univ Montpellier, Montpellier, France; [Chiavarina, Barbara; Souche, Regis; Pourquier, Didier; Maraver, Antonio; Khellaf, Lakhdar; Turtoi, Evgenia; Turtoi, Andrei] Inst Reg Canc Montpellier ICM Val dAurelle, Montpellier, France; [Ronca, Roberto; Rezzola, Sara; Chiodelli, Paola] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Otaka, Yukihiro; Nishiyama, Masahiko] Gunma Univ, Dept Mol Pharmacol & Oncol, Grad Sch Med, Gunma, Japan; [Otaka, Yukihiro; Yokobori, Takehiko; Nishiyama, Masahiko; Turtoi, Andrei] Gunma Univ Initiat Adv Res GIAR, Gunma, Japan; [Sutton, Roger Bryan] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Yokobori, Takehiko] Gunma Univ Maebashi, Grad Sch Med, Dept Gen Surg Sci, Gunma, Japan; [Maraver, Antonio] INSERM, Oncogen Pathways Lung Canc Lab, Inst Rech Cancerol Montpellier, U1194, Montpellier, France; [Faa, Gavino] Univ Cagliari, Univ Hosp San Giovanni Dio AOU Cagliari, Dept Pathol, Cagliari, Italy; [Oyama, Tetsunari] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gumma, Japan; [Gofflot, Stephanie] Univ Liege, BIOTHEQUE, Liege, Belgium; [Bellahcene, Akeila; Castronovo, Vincent] Univ Liege, Metastasis Res Lab, GIGA Canc, Liege, Belgium; [Detry, Olivier] Univ Liege, Univ Hosp, Dept Abdominal Surg, Liege, Belgium; [Delvenne, Philippe] Univ Liege, Univ Hosp, Dept Pathol, Liege, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); University of Brescia; Gunma University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Cagliari; Gunma University; University of Liege; University of Liege; University of Liege; University of Liege	Chiavarina, B; Turtoi, A (corresponding author), INSERM, Tumor Microenvironm & Resistance Treatment Lab, Inst Rech Cancerol Montpellier, U1194, Montpellier, France.; Chiavarina, B; Turtoi, A (corresponding author), Univ Montpellier, Montpellier, France.; Chiavarina, B; Turtoi, A (corresponding author), Inst Reg Canc Montpellier ICM Val dAurelle, Montpellier, France.; Turtoi, A (corresponding author), Gunma Univ Initiat Adv Res GIAR, Gunma, Japan.	barbara.chiavarina@inserm.fr; andrei.turtoi@inserm.fr	Detry, Olivier/I-9333-2019; Ronca, Roberto/AAC-6470-2022	Detry, Olivier/0000-0002-9436-6673; Ronca, Roberto/0000-0001-8979-7068; Chiavarina, Barbara/0000-0003-1444-174X; Turtoi, Andrei/0000-0003-3813-6635; Maraver, Antonio/0000-0002-5527-5680; Otaka, Yukihiro/0000-0002-9162-7188	University of Liege; National Fund for Scientific Research (FNRS); Gunma University (GIAR Research Program for Omics-Based Medical Science); Fondation de France grant [00078461]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [MFAG 18459, 23151]; Fondazione Umberto Veronesi fellowship; LabEx MabImprove Starting Grant; Fondation Contre le Cancer	University of Liege(University of Liege); National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Gunma University (GIAR Research Program for Omics-Based Medical Science); Fondation de France grant; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi fellowship(Fondazione Umberto Veronesi); LabEx MabImprove Starting Grant; Fondation Contre le Cancer	The authors acknowledge the experimental support of Naima Maloujahmoum (Metastasis Research Laboratory, University of Liege), Susumu Rokudai (Department of Molecular Pharmacology and Oncology, Gunma University), and Tadashi Handa (Pathology Dept. Gunma University). The authors are particularly thankful to Arnaud Blomme (Metastasis Research Laboratory, University of Liege) and Touko Hirano (Laboratory for Analytical Instruments, Gunma University Graduate School of Medicine) for the help concerning the MS analysis of patient material. The authors thank the Small Animal Imaging Platform of Montpellier (IPAM, http://www.ipam.cnrs.fr/) for the help with animal experiments. AT is thankful to Jacques Colinge (Bioinformatics and Systems Biology group, IRCM, Montpellier) for his R teachings and to Peter Friedl (The University of Texas MD Anderson Cancer Center, Houston, Texas, USA) for the helpful discussions. This work was supported with grants from the University of Liege, National Fund for Scientific Research (FNRS), Gunma University (GIAR Research Program for Omics-Based Medical Science). BC is supported by a Fondation de France grant (No. 00078461). RR is supported by Associazione Italiana per la Ricerca sul Cancro (AIRC), grant number MFAG 18459 and IG 2019 -ID. 23151; SR is supported by Fondazione Umberto Veronesi fellowship. AT is a senior research fellow of the French National Institute of Health and Medical Research (INSERM) and is supported by LabEx MabImprove Starting Grant. OD is supported by a grant from the "Fondation Contre le Cancer". No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Cabello-Aguilar S, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa183; Catenacci DVT, 2015, J CLIN ONCOL, V33, P4284, DOI 10.1200/JCO.2015.62.8719; Chang PH, 2012, CANCER RES, V72, P4652, DOI 10.1158/0008-5472.CAN-12-0877; Chiavarina B, 2017, CURR MED CHEM, V24, P2846, DOI 10.2174/0929867324666170428104311; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; DeFilippis RA, 2012, CANCER DISCOV, V2, P826, DOI 10.1158/2159-8290.CD-12-0107; Dobie R, 2019, CELL REP, V29, P1832, DOI 10.1016/j.celrep.2019.10.024; DOLBERG DS, 1984, NATURE, V309, P552, DOI 10.1038/309552a0; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fields GB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01278; Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Guo DJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03032-0; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma LC, 2019, CANCER CELL, V36, P418, DOI 10.1016/j.ccell.2019.08.007; Maris P, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001871; Morse MA, 2019, CLIN CANCER RES, V25, P912, DOI 10.1158/1078-0432.CCR-18-1254; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Nwosu ZC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0872-6; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2007, CANCER BIOL THER, V6, P618, DOI 10.4161/cbt.6.4.4255; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ramisch S, 2014, P NATL ACAD SCI USA, V111, P17875, DOI 10.1073/pnas.1413638111; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Ronca R, 2018, CURR OPIN ONCOL, V30, P45, DOI 10.1097/CCO.0000000000000420; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Turtoi A, 2011, J PROTEOME RES, V10, P3160, DOI 10.1021/pr200212r; Turtoi A, 2011, AM J PATHOL, V178, P12, DOI 10.1016/j.ajpath.2010.08.004; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Waltregny D, 1998, J NATL CANCER I, V90, P1000, DOI 10.1093/jnci/90.13.1000; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Winer A, 2018, MOL CANCER THER, V17, P1147, DOI 10.1158/1535-7163.MCT-17-0646	45	2	2	5	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2022	41	10					1410	1420		10.1038/s41388-021-02171-z	http://dx.doi.org/10.1038/s41388-021-02171-z		JAN 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZN2JO	35031773				2022-12-26	WOS:000742613600003
J	Louha, S; Herman, C; Gupta, M; Patel, D; Kelley, J; Oh, JHM; Guru, J; Lemoine, JF; Chang, MA; Venkatachalam, U; Rogier, E; Talundzic, E				Louha, Swarnali; Herman, Camelia; Gupta, Mansi; Patel, Dhruviben; Kelley, Julia; Oh, Je-Hoon M.; Guru, Janani; Lemoine, Jean F.; Chang, Michelle A.; Venkatachalam, Udhayakumar; Rogier, Eric; Talundzic, Eldin			Evaluation of a parasite-density based pooled targeted amplicon deep sequencing (TADS) method for molecular surveillance of Plasmodium falciparum drug resistance genes in Haiti	PLOS ONE			English	Article							CHLOROQUINE; MUTATIONS	Sequencing large numbers of individual samples is often needed for countrywide antimalarial drug resistance surveillance. Pooling DNA from several individual samples is an alternative cost and time saving approach for providing allele frequency (AF) estimates at a population level. Using 100 individual patient DNA samples of dried blood spots from a 2017 nationwide drug resistance surveillance study in Haiti, we compared codon coverage of drug resistance-conferring mutations in four Plasmodium falciparum genes (crt, dhps, dhfr, and mdr1), for the same deep sequenced samples run individually and pooled. Samples with similar real-time PCR cycle threshold (Ct) values (+/- 1.0 Ct value) were combined with ten samples per pool. The sequencing success for samples in pools were higher at a lower parasite density than the individual samples sequence method. The median codon coverage for drug resistance-associated mutations in all four genes were greater than 3-fold higher in the pooled samples than in individual samples. The overall codon coverage distribution for pooled samples was wider than the individual samples. The sample pools with < 40 parasites/mu L blood showed more discordance in AF calls for dhfr and mdr1 between the individual and pooled samples. This discordance in AF estimation may be due to low amounts of parasite DNA, which could lead to variable PCR amplification efficiencies. Grouping samples with an estimated >= 40 parasites/mu L blood prior to pooling and deep sequencing yielded the expected population level AF. Pooling DNA samples based on estimates of > 40 parasites/mu L prior to deep sequencing can be used for rapid genotyping of a large number of samples for these four genes and possibly other drug resistant markers in population-based studies. As Haiti is a low malaria transmission country with very few mixed infections and continued chloroquine sensitivity, the pooled sequencing approach can be used for routine national molecular surveillance of resistant parasites.	[Louha, Swarnali; Gupta, Mansi; Oh, Je-Hoon M.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA; [Herman, Camelia; Kelley, Julia] Ctr Dis Control & Prevent Fdn, Atlanta, GA USA; [Patel, Dhruviben] Williams Consulting LLC, Atlanta, GA USA; [Patel, Dhruviben; Kelley, Julia; Chang, Michelle A.; Venkatachalam, Udhayakumar; Rogier, Eric; Talundzic, Eldin] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Ctr Global Hlth, Atlanta, GA USA; [Guru, Janani] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Lemoine, Jean F.] MSPP, Programme Natl Controle Malaria, Port Au Prince, Haiti	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia Institute of Technology	Louha, S (corresponding author), Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA.	qxu5@cdc.gov		Louha, Swarnali/0000-0002-0777-8507	Advanced Molecular Detection Initiative at the CDC; Oak Ridge Institute for Science and Education; CDC OAMD program	Advanced Molecular Detection Initiative at the CDC; Oak Ridge Institute for Science and Education(General Electric); CDC OAMD program	We acknowledge support from the Advanced Molecular Detection (https://www.cdc.gov/amd/index.html) Initiative at the CDC. SL and JM is supported by The Oak Ridge Institute for Science and Education (https://orise.orau.gov) and funded by the CDC OAMD program. DP is employed by Williams Consulting LLC (https://www.williamsconsultingllc.com), which provided support in the form of salary for DP. CH was supported by the CDC Foundation (https://www.cdcfoundation.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerele D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179178; Anand S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33735; Assefa A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2874-z; Boncy PJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0753-9; Brazeau NF, 2019, AM J TROP MED HYG, V101, P1139, DOI 10.4269/ajtmh.19-0142; Carter TE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-275; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Daniels RF, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03439-7; Druetz T, 2022, J INFECT DIS, V225, P1611, DOI 10.1093/infdis/jiab259; Druetz T, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2553-5; ElBadry MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-426; Hamre KES, 2020, AM J TROP MED HYG, V103, P2217, DOI 10.4269/ajtmh.20-0833; Hutchins RJ, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.00261-19, 10.1128/jcm.00261-19]; Kofler R, 2016, MOL ECOL RESOUR, V16, P118, DOI 10.1111/1755-0998.12432; Lemoine JF, 2017, AM J TROP MED HYG, V97, P43, DOI 10.4269/ajtmh.16-0902; Lerch A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4260-y; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Morton LC, 2016, AM J TROP MED HYG, V95, P811, DOI 10.4269/ajtmh.16-0214; Ngondi JM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1886-9; Rhodes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113501; Robin JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24067; Rogier E, 2020, EMERG INFECT DIS, V26, P902, DOI 10.3201/eid2605.190556; Scott CR, 2020, J PEDIATR-US, V216, P204, DOI 10.1016/j.jpeds.2019.09.036; Talundzic E, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02474-17; Talundzic E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-31; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Taylor SM, 2013, J INFECT DIS, V208, P1998, DOI 10.1093/infdis/jit392; Tessema SK, 2022, J INFECT DIS, V225, P1227, DOI 10.1093/infdis/jiaa527; Vincent JP, 2018, EMERG INFECT DIS, V24, P2124, DOI 10.3201/eid2411.180738; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zhu SJ, 2018, BIOINFORMATICS, V34, P9, DOI 10.1093/bioinformatics/btx530; Zilinskas J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104992	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262616	10.1371/journal.pone.0262616	http://dx.doi.org/10.1371/journal.pone.0262616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030215	Green Published, gold			2022-12-26	WOS:000812798500060
J	Smalling, RV; Bechard, ME; Duryea, J; Kingsley, PJ; Roberts, ER; Marnett, LJ; Bilbao, D; Stauffer, SR; McDonald, OG				Smalling, Rana, V; Bechard, Matthew E.; Duryea, Jeff; Kingsley, Philip J.; Roberts, Evan R.; Marnett, Lawrence J.; Bilbao, Daniel; Stauffer, Shaun R.; McDonald, Oliver G.			Aminopyridine analogs selectively target metastatic pancreatic cancer	ONCOGENE			English	Article							DISTANT METASTASIS; 6-AMINONICOTINAMIDE; HETEROGENEITY; ADENOCARCINOMA; METABOLISM; CELLS	Metastatic outgrowth is supported by metabolic adaptations that may differ from the primary tumor of origin. However, it is unknown if such adaptations are therapeutically actionable. Here we report a novel aminopyridine compound that targets a unique Phosphogluconate Dehydrogenase (PGD)-dependent metabolic adaptation in distant metastases from pancreatic cancer patients. Compared to structurally similar analogs, 6-aminopicolamine (6AP) potently and selectively reversed PGD-dependent metastatic properties, including intrinsic tumorigenic capacity, excess glucose consumption, and global histone hyperacetylation. 6AP acted as a water-soluble prodrug that was converted into intracellular bioactive metabolites that inhibited PGD in vitro, and 6AP monotherapy demonstrated anti-metastatic efficacy with minimal toxicity in vivo. Collectively, these studies identify 6AP and possibly other 6-aminopyridines as well-tolerated prodrugs with selectivity for metastatic pancreatic cancers. If unique metabolic adaptations are a common feature of metastatic or otherwise aggressive human malignancies, then such dependencies could provide a largely untapped pool of druggable targets for patients with advanced cancers.	[Smalling, Rana, V; Bechard, Matthew E.; McDonald, Oliver G.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA; [Duryea, Jeff; Roberts, Evan R.; Bilbao, Daniel; McDonald, Oliver G.] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Pathol & Lab Med, Miller Sch Med, Miami, FL 33136 USA; [Kingsley, Philip J.; Marnett, Lawrence J.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN USA; [Stauffer, Shaun R.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN USA; [Stauffer, Shaun R.] Cleveland Clin, Ctr Therapeut Discovery, Cleveland, OH USA	Vanderbilt University; University of Miami; Vanderbilt University; Vanderbilt University; Cleveland Clinic Foundation	McDonald, OG (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA.; McDonald, OG (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Dept Pathol & Lab Med, Miller Sch Med, Miami, FL 33136 USA.	ogm443@miami.edu		McDonald, Oliver/0000-0002-6602-7535; Kingsley, Philip/0000-0002-5470-4340	National Institutes of Health [R01 CA222594, 5P30 DK058404]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants R01 CA222594 (OGM) and 5P30 DK058404 (OGM).	Balachandran VP, 2019, GASTROENTEROLOGY, V156, P2056, DOI 10.1053/j.gastro.2018.12.038; Bechard ME, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17839-5; Bechard ME, 2018, ONCOGENE, V37, P5248, DOI 10.1038/s41388-018-0346-5; Bergers G, 2021, NAT REV CANCER, V21, P162, DOI 10.1038/s41568-020-00320-2; Bryant KL, 2019, NAT MED, V25, P628, DOI 10.1038/s41591-019-0368-8; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Daneshmandi S, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108831; DIETRICH LS, 1958, J BIOL CHEM, V233, P964; Embuscado EE, 2005, CANCER BIOL THER, V4, P548, DOI 10.4161/cbt.4.5.1663; Fendt SM, 2020, CANCER DISCOV, V10, P1797, DOI 10.1158/2159-8290.CD-20-0844; Golan T, 2019, NEW ENGL J MED, V381, P317, DOI 10.1056/NEJMoa1903387; Hayashi A, 2021, NAT REV GASTRO HEPAT, V18, P469, DOI 10.1038/s41575-021-00463-z; HERKEN H, 1976, N-S ARCH PHARMACOL, V293, P245, DOI 10.1007/BF00507347; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Iacobuzio-Donahue CA, 2020, NAT CANCER, V1, P3, DOI 10.1038/s43018-019-0002-1; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; JOHNSON WJ, 1955, SCIENCE, V122, P834, DOI 10.1126/science.122.3174.834; Ju HQ, 2016, CANCER LETT, V379, P1, DOI 10.1016/j.canlet.2016.05.024; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kinsey CG, 2019, NAT MED, V25, P620, DOI 10.1038/s41591-019-0367-9; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; KOHLER E, 1970, FEBS LETT, V6, P225, DOI 10.1016/0014-5793(70)80063-1; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; McDonald OG, 2020, MOL CELL ONCOL, V7, DOI 10.1080/23723556.2020.1825910; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Recouvreux MV, 2020, J EXP MED, V217, DOI 10.1084/jem.20200388; Reiter JG, 2018, SCIENCE, V361, P1033, DOI 10.1126/science.aat7171; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Soares Kevin C, 2014, J Vis Exp, P51677, DOI 10.3791/51677; Storz P, 2020, GASTROENTEROLOGY, V158, P2072, DOI 10.1053/j.gastro.2020.02.059; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Walker DL, 1999, BIOCHEM PHARMACOL, V58, P1057, DOI 10.1016/S0006-2952(99)00179-3; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoshida T, 2020, BIOCHEM BIOPH RES CO, V522, P633, DOI 10.1016/j.bbrc.2019.11.130	40	1	1	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2022	41	10					1518	1525		10.1038/s41388-022-02183-3	http://dx.doi.org/10.1038/s41388-022-02183-3		JAN 2022	8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZN2JO	35031771	Green Accepted			2022-12-26	WOS:000742613600002
J	Choi, SW				Choi, Seung-Whan			Outlier analysis: Natural resources and immigration policy	PLOS ONE			English	Article							FOREIGN DIRECT-INVESTMENT; POLITICS; WAR	This replication underlines the importance of outlier diagnostics since many researchers have long neglected influential observations in OLS regression analysis. In his article, entitled "Primary Resources, Secondary Labor," Shin finds that advanced democracies with increased natural resource wealth, particularly from oil and natural gas production, are more likely to restrict low-skill immigration policy. By performing outlier diagnostics, this replication shows that Shin's findings are a statistical artifact. When one outlying country, Norway, is removed from the sample data, I observe almost no significant and negative relationship between oil wealth and immigration policy. When two outlying countries are excluded, the effect of oil wealth completely disappears. Robust regression analysis, a widely used remedial method for outlier problems, confirms the results of my outlier diagnostics.	[Choi, Seung-Whan] Univ Illinois, Dept Polit Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Choi, SW (corresponding author), Univ Illinois, Dept Polit Sci, Chicago, IL 60607 USA.	whanchoi@uic.edu			Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago	Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago	Seung-Whan Choi appreciates the Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago for financial support towards the open access publishing fee for this article.	Achen CH, 2002, ANNU REV POLIT SCI, V5, P423, DOI 10.1146/annurev.polisci.5.112801.080943; [Anonymous], 2015, STAT BAS REF MAN 14; Ashworth S, 2008, AM POLIT SCI REV, V102, P269, DOI 10.1017/S0003055408080167; Bilgin MH, 2021, SINGAP ECON REV, V66, P685, DOI 10.1142/S0217590819500164; Cederman LE, 2007, AM POLIT SCI REV, V101, P173, DOI 10.1017/S0003055407070086; Choi SW, 2008, FOREIGN POL ANAL-US, V4, P83, DOI 10.1111/j.1743-8594.2008.00059.x; Choi SW, 2009, Q J POLIT SCI, V4, P183, DOI 10.1561/100.00009035; Clarke KA, 2008, AM POLIT SCI REV, V102, P387, DOI 10.1017/S0003055408080131; Crabtree C, 2017, BRIT J POLIT SCI, V47, P229, DOI 10.1017/S0007123415000344; Fearon JD, 2007, AM POLIT SCI REV, V101, P187, DOI 10.1017/S0003055407070219; Gilens M, 2014, PERSPECT POLIT, V12, P564, DOI 10.1017/S1537592714001595; Grytten O., 2016, EC HIST NORWAY; Gujarati D. N., 2009, BASIC ECONOMETRICS; Hamilton L., 2004, STAT STATA; Imai K, 2020, J POLIT, V82, P714, DOI 10.1086/707059; JACKMAN RW, 1987, J POLIT, V49, P242, DOI 10.2307/2131143; Kerner A, 2014, INT STUD QUART, V58, P804, DOI 10.1111/isqu.12147; Park J, 2014, INT STUD QUART, V58, P118, DOI 10.1111/isqu.12114; Powell EN, 2014, BRIT J POLIT SCI, V44, P123, DOI 10.1017/S0007123412000531; Ray JL, 2003, CONFLICT MANAG PEACE, V20, P1; Replication King G., 1995, REPLICATION PS POLIT, V28, P444; Schmitter P., 1971, INTEREST C POLITICAL; Shin AJ, 2019, INT STUD QUART, V63, P805, DOI 10.1093/isq/sqz033; Welsch R, 1980, REGRESSION DIAGNOSTI; Zigerell L.J., 2015, RES POLITICS, V2, P1	25	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261533	10.1371/journal.pone.0261533	http://dx.doi.org/10.1371/journal.pone.0261533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025888	gold, Green Published			2022-12-26	WOS:000796264200018
J	Christersson, C; Held, C; Modica, A; Westerbergh, J; Batra, G				Christersson, Christina; Held, Claes; Modica, Angelo; Westerbergh, Johan; Batra, Gorav			Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study	PLOS ONE			English	Article							AORTIC-VALVE IMPLANTATION; HEART-DISEASE; EUROPEAN-SOCIETY; TASK-FORCE; WARFARIN; GUIDELINES; MANAGEMENT; EDOXABAN; STENOSIS; EPIDEMIOLOGY	Aims To describe the prevalence of atrial fibrillation (AF), use of oral anticoagulants (OAC) and change in antithrombotic treatment patterns during follow-up after valve intervention with a biological prosthesis or valvuloplasty. Methods and results All patients with history of AF or new-onset AF discharged alive after valvular intervention (biological prosthesis or valvuloplasty) between 2010-2016 in Sweden were included (n = 7,362). Information about comorbidities was collected from national patient registers. Exposure to OAC was based on pharmacy dispensation data. In total 4,800 (65.2%) patients had a history of AF, and 2,562 (34.8%) patients developed new-onset AF, with 999 (39.0%) developing new-onset AF within 3 months after intervention. The proportion of patients with biological valve prosthesis was higher in patients with new-onset AF compared to history of AF (p<0.001). CHA(2)DS(2)-VASc score >= 2 was observed in 83.1% and 75.5% patients with history of AF and new-onset AF, respectively. Warfarin was more frequently dispensed than NOAC at discharge in patients with history of AF (43.9% vs 7.3%), and in patients with new-onset AF (36.6% vs 17.1%). Almost half of the AF population was not dispensed on any OAC at discharge (48.8% in patients with history of AF and 46.3% in patients with new-onset AF). Conclusion In this real world study of patients with AF and recent valvular intervention, risk of new-onset AF after valvular intervention is high emphasizing need for frequent rhythm monitoring after intervention. A considerable undertreatment with OAC was observed despite being indicated for the majority of the patients. Warfarin was the OAC most frequently dispensed.	[Christersson, Christina; Batra, Gorav] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Held, Claes] Uppsala Univ, Dept Med Sci Cardiol, Uppsala Clin Res Ctr, Uppsala, Sweden; [Modica, Angelo] Pfizer AB, Sollentuna, Sweden; [Westerbergh, Johan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Uppsala University; Uppsala University; Pfizer; Uppsala University	Christersson, C (corresponding author), Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden.	christina.christersson@medsci.uu.se		Christersson, Christina/0000-0001-9116-8084	Pfizer; Bristol Myers Squibb	Pfizer(Pfizer); Bristol Myers Squibb(Bristol-Myers Squibb)	This study was funded by Pfizer and Bristol Myers Squibb via institutional research collaboration to and administered by Uppsala Clinical Research Center. Uppsala University receives institutional funding from other pharmaceutical companies, regulatory authorities, and contract research organizations, including Pfizer and Bristol Myers Squibb, for performance of pharmacoepidemiology studies.	Abraham NS, 2015, PATIENT PREFER ADHER, V9, P1657, DOI 10.2147/PPA.S91553; Alwafi H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69492-z; Avezum A, 2015, CIRCULATION, V132, P624, DOI 10.1161/CIRCULATIONAHA.114.014807; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Brennan JM, 2012, J AM COLL CARDIOL, V60, P971, DOI 10.1016/j.jacc.2012.05.029; Carnicelli AP, 2017, CIRCULATION, V135, P1273, DOI 10.1161/CIRCULATIONAHA.116.026714; Chopard R, 2015, JACC-CARDIOVASC INTE, V8, P1346, DOI 10.1016/j.jcin.2015.06.010; Christersson C, 2020, HEART, V106, P838, DOI 10.1136/heartjnl-2019-315453; Clark DM, 1997, J AM COLL CARDIOL, V30, P1039, DOI 10.1016/S0735-1097(97)00254-4; Collet JP, 2018, AM HEART J, V200, P44, DOI 10.1016/j.ahj.2018.03.008; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dangas GD, 2016, J AM COLL CARDIOL, V68, P2671, DOI 10.1016/j.jacc.2016.09.958; Evans M, 2016, J AM COLL CARDIOL, V67, P1687, DOI 10.1016/j.jacc.2016.01.050; Girerd N, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000385; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guimaraes HP, 2020, NEW ENGL J MED, V383, P2117, DOI 10.1056/NEJMoa2029603; Haastrup SB, 2018, BASIC CLIN PHARMACOL, V123, P452, DOI 10.1111/bcpt.13024; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Levy F, 2006, AM J CARDIOL, V98, P809, DOI 10.1016/j.amjcard.2006.03.067; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Maggioni AP, 2020, AM HEART J, V220, P12, DOI 10.1016/j.ahj.2019.10.017; Maura G, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026645; McCarthy PM, 2020, J THORAC CARDIOV SUR, V159, P2245, DOI 10.1016/j.jtcvs.2019.06.062; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Ryan R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007768.pub3; Simons LA, 2016, CURR MED RES OPIN, V32, P1857, DOI 10.1080/03007995.2016.1218325; Steffel J, 2018, EUROPACE, V20, P1231, DOI 10.1093/europace/euy054; Tarantini G, 2017, EUR HEART J, V38, P1285, DOI 10.1093/eurheartj/ehw456; Tarantini G, 2016, JACC-CARDIOVASC INTE, V9, P937, DOI 10.1016/j.jcin.2016.01.037; Thomas KL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006475; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Vahanian A, 2021, EUR HEART J, DOI [10.1093/ejcts/ezac209, 10.1093/eurheartj/ehab395, 10.1093/ejcts/ezab389]; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Van Mieghem NM, 2021, NEW ENGL J MED, V385, P2150, DOI 10.1056/NEJMoa2111016; Van Mieghem NM, 2018, AM HEART J, V205, P63, DOI 10.1016/j.ahj.2018.07.006; Yankelson L, 2014, AM J CARDIOL, V114, P1861, DOI 10.1016/j.amjcard.2014.09.025	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262580	10.1371/journal.pone.0262580	http://dx.doi.org/10.1371/journal.pone.0262580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025950	Green Published, gold			2022-12-26	WOS:000796264200089
J	Heron, P; Spanakis, P; Crosland, S; Johnston, G; Newbronner, E; Wadman, R; Walker, L; Gilbody, S; Peckham, E				Heron, Paul; Spanakis, Panagiotis; Crosland, Suzanne; Johnston, Gordon; Newbronner, Elizabeth; Wadman, Ruth; Walker, Lauren; Gilbody, Simon; Peckham, Emily			Loneliness among people with severe mental illness during the COVID-19 pandemic: Results from a linked UK population cohort study	PLOS ONE			English	Article							PERCEIVED SOCIAL SUPPORT; RISK-FACTORS; SCHIZOPHRENIA; PSYCHOSIS; PARTICIPATION; EXPERIENCE; NETWORKS	Aim/Goal/Purpose Population surveys underrepresent people with severe mental ill health. This paper aims to use multiple regression analyses to explore perceived social support, loneliness and factor associations from self-report survey data collected during the Covid-19 pandemic in a sample of individuals with severe mental ill health. Design/Methodology/Approach We sampled an already existing cohort of people with severe mental ill health. Researchers contacted participants by phone or by post to invite them to take part in a survey about how the pandemic restrictions had impacted health, Covid-19 experiences, perceived social support, employment and loneliness. Loneliness was measured by the three item UCLA loneliness scale. Findings In the pandemic sub-cohort, 367 adults with a severe mental ill health diagnosis completed a remote survey. 29-34% of participants reported being lonely. Loneliness was associated with being younger in age (adjusted OR = -.98, p = .02), living alone (adjusted OR = 2.04, p = .01), high levels of social and economic deprivation (adjusted OR = 2.49, p = .04), and lower perceived social support (B = -5.86, p < .001). Living alone was associated with lower perceived social support. Being lonely was associated with a self-reported deterioration in mental health during the pandemic (adjusted OR = 3.46, 95%CI 2.03-5.91). Practical implications Intervention strategies to tackle loneliness in the severe mental ill health population are needed. Further research is needed to follow-up the severe mental ill health population after pandemic restrictions are lifted to understand perceived social support and loneliness trends. Originality Loneliness was a substantial problem for the severe mental ill health population before the Covid-19 pandemic but there is limited evidence to understand perceived social support and loneliness trends during the pandemic.	[Heron, Paul; Spanakis, Panagiotis; Crosland, Suzanne; Newbronner, Elizabeth; Wadman, Ruth; Walker, Lauren; Gilbody, Simon; Peckham, Emily] Univ York, Mental Hlth & Addict Res Grp, York, N Yorkshire, England; [Gilbody, Simon] Hull York Med Sch, York, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK	Heron, P (corresponding author), Univ York, Mental Hlth & Addict Res Grp, York, N Yorkshire, England.	paul.heron@york.ac.uk	Gilbody, Simon/AAY-3720-2021	Gilbody, Simon/0000-0002-8236-6983; Johnston, Gordon/0000-0003-4483-8932; Heron, Paul/0000-0003-3529-5737	Medical Research Council [MR/V028529]; Wellcome Trust through the Centre for Future Health at the University of York [204829]; UK Research and Innovation [ES/S004459/1]; NIHR Yorkshire and Humberside Applied Research Collaboration	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust through the Centre for Future Health at the University of York(Wellcome Trust); UK Research and Innovation(UK Research & Innovation (UKRI)); NIHR Yorkshire and Humberside Applied Research Collaboration	This study is supported by the Medical Research Council, https://mrc.ukri.org/, (grant reference MR/V028529) (author SG,EP) and links with the Closing the Gap cohort, which was partfunded by the Wellcome Trust, https://wellcome.org/, (reference 204829) (author SG,EP) through the Centre for Future Health at the University of York, UK Research and Innovation, https://www.york.ac.uk/future-health/, (reference ES/S004459/1) (author SG,EP), and the YYY, https://www.arc-yh.nihr.ac.uk/about-us (author RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour C, 2021, J PSYCHOPATHOL BEHAV, V43, P174, DOI 10.1007/s10862-020-09841-4; Badcock JC, 2020, CLIN PSYCHOL-SCI PR, V27, DOI 10.1111/cpsp.12345; Bu F, 2020, Public Health, V186, P31, DOI 10.1016/j.puhe.2020.06.036; Cacioppo JT, 2018, LANCET, V391, P426, DOI 10.1016/S0140-6736(18)30142-9; Chrostek A, 2016, COMPR PSYCHIAT, V70, P190, DOI 10.1016/j.comppsych.2016.07.015; COHEN CI, 1993, HOSP COMMUNITY PSYCH, V44, P951; Eglit GML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194021; Gayer-Anderson C, 2013, EPIDEMIOL PSYCH SCI, V22, P131, DOI 10.1017/S2045796012000406; Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Kliem S, 2015, J CLIN EPIDEMIOL, V68, P551, DOI 10.1016/j.jclinepi.2014.11.003; Lamster F, 2017, COMPR PSYCHIAT, V74, P35, DOI 10.1016/j.comppsych.2016.12.007; Marwaha S, 2004, SOC PSYCH PSYCH EPID, V39, P337, DOI 10.1007/s00127-004-0762-4; Matthews T, 2019, PSYCHOL MED, V49, P268, DOI 10.1017/S0033291718000788; Mishu MP, 2019, SOC PSYCH PSYCH EPID, V54, P887, DOI 10.1007/s00127-018-1639-2; Moller P, 2000, SCHIZOPHRENIA BULL, V26, P217, DOI 10.1093/oxfordjournals.schbul.a033442; Office of National Statistics, 2018, MEAS LON GUID US NAT; Prince JD, 2018, J NERV MENT DIS, V206, P136, DOI 10.1097/NMD.0000000000000768; Roe D, 2011, SCHIZOPHR RES, V131, P133, DOI 10.1016/j.schres.2011.05.023; Schwartz C, 2009, ISR J PSYCHIATR REL, V46, P120; Shioda A, 2016, J PSYCHIATR MENT HLT, V23, P399, DOI 10.1111/jpm.12318; Spanakis P, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.732735; Stain HJ, 2012, AUST NZ J PSYCHIAT, V46, P879, DOI 10.1177/0004867412449060; Sundermann O, 2014, SOC PSYCH PSYCH EPID, V49, P359, DOI 10.1007/s00127-013-0754-3; Tremeau F, 2016, PSYCHIAT RES, V246, P211, DOI 10.1016/j.psychres.2016.09.043; Valtorta NK, 2018, EUR J PREV CARDIOL, V25, P1387, DOI 10.1177/2047487318792696; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; van der Werf M, 2010, SCHIZOPHR RES, V122, P193, DOI 10.1016/j.schres.2010.05.020; Varga TV, 2021, LANCET REG HEALTH-EU, V2, DOI 10.1016/j.lanepe.2020.100020; Wang JY, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1736-5; Weiner A, 2010, COMMUNITY MENT HLT J, V46, P389, DOI 10.1007/s10597-009-9279-3; What Works Wellbeing, 2020, HAS COV 19 ASS LOCKD	33	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262363	10.1371/journal.pone.0262363	http://dx.doi.org/10.1371/journal.pone.0262363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025915	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000796264200063
J	Lungu, P; Njelesani, E; Sukwa, T; Ngalamika, O; Munsaka, S; Kilembe, W; Lakhi, S; Mwaba, P				Lungu, Patrick; Njelesani, Evarist; Sukwa, Thomas; Ngalamika, Owen; Munsaka, Sody; Kilembe, William; Lakhi, Shabir; Mwaba, Peter			Immune correlates of Mycobacterium Tuberculosis patients in Zambia stratified by HIV serostatus and level of immunity-a cross-sectional analytical laboratory based study	PLOS ONE			English	Article							INFECTION; RESPONSES; TH1	Background People living with HIV (PLHIV) co-infected with tuberculosis (TB) have a distinct clinical presentation and poorer treatment outcomes compared to HIV-seronegative TB patients. Excluding low CD4 count, innate immune factors associated with TB are not fully elucidated. We, therefore, characterised and compared the expression of IL-6, TNF-alpha, IFN-gamma, and IL-10 in whole blood of treatment naive TB patients stimulated with heat-killed Mycobacterium tuberculosis stratified by HIV status and the level of CD4 count. Results We recruited 39 HIV seropositive and 31 HIV seronegative TB patients. Median (IQR) age was 35(28-42) years and 31(25-36) years respectively, and a majority had pulmonary tuberculosis i.e. 38(95%) and 30(97%), respectively. The two groups were significantly different in the distribution of CD4 count, 563 [465-702.5 cells/mm3] vs 345 [157-483 cell/mm3] in HIV negative vs HIV positive respectively p = <0.001. Post stimulation, the expression of IL-6 in HIV negative TB patients was significantly higher than in the HIV positive 16,757366 [8,827-23,686 pg/ml] vs. 9,508 [5,514-15,008 pg/ml], respectively; p = 0.0360. TNF-alpha and IFN-gamma were highly expressed in HIV negative TB patients compared to the HIV positive though not statistically significant. We only observed higher expression of IL-6 in HIV negative patients in comparison to the HIV positive when stratified by level of CD4 counts as < 500 and >= 500 cell/mm(3) for both cohorts. 21,953 [8,990-24,206 pg/ml] vs 9,505 [5,400-15,313 pg/ml], p value = 0.0585 in patients with CD4 count < 500 cell/mm(3) and 13,168 [7,087-22,584 pg/ml] vs 10,413 [7,397-14,806 pg/ml], p value = 0.3744 for patients with CD4 count of >= 500 cell/mm(3) respectively. We found a positive pairwise correlation between TNF-alpha -alpha and IL-6 in both HIV positive and HIV negative patients, r = 0.61 (95% CI 0.36-0.72; p < 0.0001) and r = 0.48 (95% CI 0.15-0.68; p = 0.005) respectively. The IFN gamma/IL-10 ratio was higher in HIV negative when compared to HIV positive individuals, 0.052 [0.0-0.28] vs 0.007 [0-0.32] respectively; p = 0.05759. IL-6 independently reduced the probability of TB/HIV, Adjusted odds ratio 0.99, p value 0.007. Conclusions This study suggests that HIV seronegative TB patients have a higher pro-inflammatory response to MTB than HIV seropositive TB patients. Further, it also shows that the level of CD4 influences immunomodulation. The findings suggest that the difference in cytokine expression may be responsible for the distinct patterns of TB presentation between HIV positive and HIV negative patient.	[Lungu, Patrick; Lakhi, Shabir] Univ Zambia, Dept Internal Med, Sch Med, Lusaka, Zambia; [Njelesani, Evarist; Sukwa, Thomas; Mwaba, Peter] Lusaka Apex Med Univ, Fac Med, Lusaka, Zambia; [Njelesani, Evarist; Sukwa, Thomas; Mwaba, Peter] Lusaka Apex Med Univ, Directorate Postgrad Studies, Lusaka, Zambia; [Ngalamika, Owen] Univ Zambia, Sch Med, Dept Internal Med, Lusaka, Zambia; [Munsaka, Sody] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Kilembe, William] Ctr Family Hlth Res Zambia, Lusaka, Zambia	University of Zambia; University of Zambia; University of Zambia	Lungu, P (corresponding author), Univ Zambia, Dept Internal Med, Sch Med, Lusaka, Zambia.	lungupatrick99@gmail.com		, owen/0000-0002-0648-4128	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE); DELTAS Africa Initiative [DEL-15-006]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trus [107752/Z/15/Z]; UK government	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE); DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trus(Wellcome Trust); UK government	This work was supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant #DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant #107752/Z/15/Z] and the UK government.	Babu H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01965; Basingnaa A, 2019, DISEASES-BASEL, V7, DOI 10.3390/diseases7010002; Bastard M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193491; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; BREEN EC, 1990, J IMMUNOL, V144, P480; Domingo-Gonzalez R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0018-2016; Ellis PK., 2017, CD4 COUNT TUBERCULOS, V2015; Fekadu G, 2020, ANN MED SURG, V60, P531, DOI 10.1016/j.amsu.2020.11.032; Garcuia JI., 2020, SCI REP-UK, V10, P1, DOI DOI 10.1038/S41598-019-56847-4; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Henn L, 1999, MEM I OSWALDO CRUZ, V94, P377, DOI 10.1590/S0074-02761999000300017; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Khan Taj Ali, 2016, Chemother Res Pract, V2016, P7295390, DOI 10.1155/2016/7295390; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-125; Morou A, 2014, CURR OPIN HIV AIDS, V9, P446, DOI 10.1097/COH.0000000000000094; Naidoo K, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/585919; Narazaki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113528; Neta R, 1992, Immunol Ser, V56, P499; Osei E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234878; Osuji FN, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0490-9; Scheller J., 2011, BIOCH BIOPHYSICA ACT, V1813, P878, DOI [DOI 10.1016/J.BBAMCR.2011.01.034, 10.1016/j.bbamcr.2011.01.034]; Skolimowska KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046481; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Waitt CJ, 2011, J INFECT DIS, V204, P358, DOI 10.1093/infdis/jir265; WHO, 2018, GLOBAL TUBERCULOSIS; World Health Organization, 2020, TUB GLOB REP	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262454	10.1371/journal.pone.0262454	http://dx.doi.org/10.1371/journal.pone.0262454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025927	gold, Green Published			2022-12-26	WOS:000796264200071
J	Mamo, SA; Teshome, GS; Tesfaye, T; Goshu, AT				Mamo, Seifu Awgchew; Teshome, Girum Sebsibie; Tesfaye, Tewodros; Goshu, Abel Tibebu			Perinatal asphyxia and associated factors among neonates admitted to a specialized public hospital in South Central Ethiopia: A retrospective cross-sectional study	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; BIRTH ASPHYXIA; RISK-FACTORS; PREVALENCE; MORTALITY; NEWBORNS; PARTOGRAPH; ZONE	Introduction Perinatal asphyxia continues to be a significant clinical concern around the world as the consequences can be devastating. World Health Organization data indicates perinatal asphyxia is encountered amongst 6-10 newborns per 1000 live full-term birth, and the figures are higher for low and middle-income countries. Nevertheless, studies on the prevalence of asphyxia and the extent of the problem in poorly resourced southern Ethiopian regions are limited. This study aimed to determine the magnitude of perinatal asphyxia and its associated factors. Methods A retrospective cross-sectional study design was used from March to April 2020. Data was collected from charts of neonates who were admitted to NICU from January 2016 to December 31, 2019. Result The review of 311 neonates' medical records revealed that 41.2% of the neonates experienced perinatal asphyxia. Preeclampsia during pregnancy (AOR = 6.2, 95%CI:3.1-12.3), antepartum hemorrhage (AOR = 4.5, 95%CI:2.3-8.6), gestational diabetes mellitus (AOR = 4.2, 95%CI:1.9-9.2), premature rupture of membrane (AOR = 2.5, 95%CI:1.33-4.7) fetal distress (AOR = 3,95%CI:1.3-7.0) and meconium-stained amniotic fluid (AOR = 7.7, 95%CI: 3.1-19.3) were the associated factors. Conclusion Substantial percentages of neonates encounter perinatal asphyxia, causing significant morbidity and mortality. Focus on early identification and timely treatment of perinatal asphyxia in hospitals should, therefore, be given priority.	[Mamo, Seifu Awgchew; Goshu, Abel Tibebu] Wachemo Univ, Dept Pediat Nursing, Coll Med & Hlth Sci, Hosaena, Ethiopia; [Teshome, Girum Sebsibie; Tesfaye, Tewodros] Addis Ababa Univ, Sch Nursing & Midwifery, Coll Hlth Sci, Addis Ababa, Ethiopia; [Goshu, Abel Tibebu] Haramaya Univ, Sch Nursing & Midwifery, Coll Hlth & Med Sci, Harar, Ethiopia	Addis Ababa University; Haramaya University	Goshu, AT (corresponding author), Haramaya Univ, Sch Nursing & Midwifery, Coll Hlth & Med Sci, Harar, Ethiopia.	ABTI2222@gmail.com		Goshu, Abel/0000-0003-0818-4169				Abdo RA, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2696-6; Alemu A, 2019, PEDIATR HEALTH MED T, V10, P69, DOI 10.2147/PHMT.S196265; Allanson ER, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0472-9; [Anonymous], 2017, J BIOSCI MED; [Anonymous], 2020, ETHIOPIAN J REPROD H, V12, P1; Antonucci RPA., 2014, ROLE CLIN PATHOLOGIC; Aslam HM, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0094-2; Berglund S, 2010, ACTA OBSTET GYN SCAN, V89, P39, DOI 10.3109/00016340903418751; Berhe AK, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1667-7; Borna Sedigheh, 2004, BMC Pregnancy Childbirth, V4, P15, DOI 10.1186/1471-2393-4-15; Dibaba B, 2021, J MULTIDISCIP HEALTH, V14, P271, DOI 10.2147/JMDH.S269744; Ekwochi U, 2017, CLIN MED INSIGHTS-PE, V11, DOI 10.1177/1179556517746646; Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF, 2019, ETH MIN DEM HLTH SUR, P11; FDRE Ministry of Health, 2016, NAT REPR HLTH STRAT, P100; Federal Ministry of Health, 2014, NEONATAL INTENSIVE C, P137; Gebregziabher GT, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/4367248; Gebreheat G, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5351010; Goldenberg RL, 2016, CLIN PERINATOL, V43, P439, DOI 10.1016/j.clp.2016.04.004; Gudayu TW, 2017, AFR HEALTH SCI, V17, P1, DOI 10.4314/ahs.v17i1.2; Haan M WJ., 2006, DEVELOPMENTAL SCI, V9, P350, DOI [10.1111/j.1467-7687.2006.00499.x, DOI 10.1111/J.1467-7687.2006.00499.X]; Hagos AA, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2734-4; Haile Y, 2020, J PREGNANCY, V2020, DOI 10.1155/2020/3943498; Hug L, 2019, LANCET GLOB HEALTH, V7, pE710, DOI 10.1016/S2214-109X(19)30163-9; Ilah B., 2015, SUBSAHARAN AFR J MED, V2, P64, DOI [DOI 10.4103/2384-5147.157421, 10.4103/2384-5147.157421]; Kiyani AN, 2014, IRAN J PEDIATR, V24, P637; Markos M, 2020, J PREGNANCY, V2020, DOI 10.1155/2020/3631808; Maternal and Child Health Directorate FMoH, 2015, NAT STRAT NEWB CHILD, P10; Mehta VEA., 2019, INT J CONT PEDIAT, V6; Mitao M., 2016, Asian Pacific Journal of Reproduction, V5, P72; Muche AA, 2020, MIDWIFERY, V87, DOI 10.1016/j.midw.2020.102713; Neil Abdurashid Ibrahim, 2017, Clinics in Mother and Child Health, V14, P279; Nguanboonmak ASS, 2019, THAI JOUR OBST GYNAE, V27, P29; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Royal College of Obstetricians and Gynaecologists, 2011, ANT HAEM GREEN TOP G, P1; Samba A, 2017, OBSTET GYNECOLOGY IN, V7, P1; Selvakumar RVC., 2017, INT J SCI STUDY, V5, P63; Silte Zone Health department, 2021, 2019 20 FISC YEAR AN; Simiyu IN, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0876-y; Solayman M., 2017, KYAMC J, V8, P43, DOI DOI 10.3329/KYAMCJ.V8I1.33873; Suleiman B M, 2012, West Afr J Med, V31, P102; Tasew Hagos, 2018, BMC Res Notes, V11, P496, DOI 10.1186/s13104-018-3611-3; Tekelab T, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1012-x; Tette EMA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232406; Usman F, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2541; Utomo MTE., 2011, FOLIA MEDICA INDONES, V47, P1; Wakgari N, 2015, AFR HEALTH SCI, V15, P552, DOI 10.4314/ahs.v15i2.30; WHO, 2018, MCEE WHO METH DAT SO; WHO, 2018, GLOB ACT PLAN HLTH L, P37; Woday A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226891; Wood S, 2021, J MATERN-FETAL NEO M, V34, P1448, DOI 10.1080/14767058.2019.1638901; Workineh Y, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03793; Wosenu L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203763; Woticha EW, 2019, DIABETES METAB SYND, V13, P1827, DOI 10.1016/j.dsx.2019.04.005; Yisma E, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-17	54	0	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262619	10.1371/journal.pone.0262619	http://dx.doi.org/10.1371/journal.pone.0262619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025979	gold, Green Published			2022-12-26	WOS:000796264200094
J	Zofkie, AC; Garner, WH; Schell, RC; Ragsdale, AS; McIntire, DD; Roberts, SW; Spong, CY				Zofkie, Amanda C.; Garner, W. Holt; Schell, Rachel C.; Ragsdale, Alexandra S.; McIntire, Donald D.; Roberts, Scott W.; Spong, Catherine Y.			An evidence-based definition of anemia for singleton, uncomplicated pregnancies	PLOS ONE			English	Article							SEVERE MATERNAL MORBIDITY; IRON	Background The definition for anemia in pregnancy is outdated, derived from Scandinavian studies in the 1970's to 1980's. To identity women at risk of blood transfusion, a common cause of Severe Maternal Morbidity, a standard definition of anemia in pregnancy in a modern, healthy United States cohort is needed. Objective To define anemia in pregnancy in a United States population including a large county vs. private hospital population using uncomplicated patients. Materials and methods Inclusion criteria were healthy women with the first prenatal visit before 20 weeks. Exclusion criteria included preterm birth, preeclampsia, hypertension, diabetes, short interval pregnancy (<18 months), multiple gestation, abruption, and fetal demise. All women had iron fortification (Ferrous sulfate 325 mg daily) recommended. The presentation to care and pre-delivery hematocrits were obtained, and the percentiles determined. A total of 2000 patients were included, 1000 from the public county hospital and 1000 from the private hospital. Each cohort had 250 patients in each 2011, 2013, 2015, and 2018. The cohorts were compared for differences in the fifth percentile for each antepartum epoch. Student's t-test and chi-squared statistical tests were used for analysis, p-value of <= 0.05 was considered significant. Results In the public and private populations, 777 and 785 women presented in the first trimester while 223 and 215 presented in the second. The women at the private hospital were more likely to be older, Caucasian race, nulliparous, and present earlier to care. The fifth percentile was compared between the women in the private and public hospitals and were clinically indistinguishable. When combining the cohorts, the fifth percentile for hemoglobin/hematocrit was 11 g/dL/32.8% in the first trimester, 10.3 g/dL/30.6% in the second trimester, and 10.0 g/dL/30.2% pre-delivery. Conclusions Fifth percentile determinations were made from a combined cohort of normal, uncomplicated pregnancies to define anemia in pregnancy. Comparison of two different cohorts confirms that the same definition for anemia is appropriate regardless of demographics or patient mix.	[Zofkie, Amanda C.; Garner, W. Holt; Schell, Rachel C.; Ragsdale, Alexandra S.; McIntire, Donald D.; Roberts, Scott W.; Spong, Catherine Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Maternal Fetal Med Div, Parkland Hlth & Hosp Syst, Dallas, TX 75225 USA; [Zofkie, Amanda C.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Maternal Fetal Med Div, St Louis, MO 63110 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Zofkie, AC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Maternal Fetal Med Div, Parkland Hlth & Hosp Syst, Dallas, TX 75225 USA.; Zofkie, AC (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, Maternal Fetal Med Div, St Louis, MO 63110 USA.	azofkie@gmail.com		mcintire, donald/0000-0002-9799-7905; Garner, William Holt/0000-0003-2714-0938; Ragsdale, Alexandra/0000-0002-5126-3260				American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V112, P201, DOI 10.1097/AOG.0b013e3181809c0d; [Anonymous], 1998, MMWR RECOMM REP, V47; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P400; Hoyert DL, 2021, NCHS HLTH E STATS; JOHNSONSPEAR MA, 1994, AM J CLIN NUTR, V60, P117, DOI 10.1093/ajcn/60.1.117; Kilpatrick SK, 2016, AM J OBSTET GYNECOL, V215, pB17, DOI 10.1016/j.ajog.2016.07.050; Nijboer JMM, 2007, J TRAUMA, V62, P1310, DOI 10.1097/TA.0b013e3180341f54; PERRY GS, 1992, J NUTR, V122, P1417, DOI 10.1093/jn/122.7.1417; Puolakka J, 1980, Acta Obstet Gynecol Scand Suppl, V95, P43; Sienas L, 2013, OBSTET GYNECOL SURV, V68, P594, DOI 10.1097/OGX.0b013e3182a2d51c; Sjostedt J E, 1977, Acta Obstet Gynecol Scand, V56, P3, DOI 10.1111/aogs.1977.56.s60.3; Svanberg B, 1975, Acta Obstet Gynecol Scand Suppl, V48, P87; TAYLOR DJ, 1982, BRIT J OBSTET GYNAEC, V89, P1011, DOI 10.1111/j.1471-0528.1982.tb04656.x; Weatherall MS, 1997, CLIN LAB HAEMATOL, V19, P183, DOI 10.1046/j.1365-2257.1997.00076.x; WHO Guidelines Approved by the Guidelines Review Committee, 2016, WHO RECOMMENDATIONS; World Health Organization, 2001, CLIN US BLOOD MED OB	18	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262436	10.1371/journal.pone.0262436	http://dx.doi.org/10.1371/journal.pone.0262436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025925	Green Published, gold			2022-12-26	WOS:000796264200069
J	Gabri, AC; Galanti, MR; Orsini, N; Magnusson, C				Gabri, Alexander Carl; Galanti, Maria Rosaria; Orsini, Nicola; Magnusson, Cecilia			Changes in cannabis policy and prevalence of recreational cannabis use among adolescents and young adults in Europe-An interrupted time-series analysis	PLOS ONE			English	Article							MEDICAL MARIJUANA; PUBLIC-HEALTH; RISK; LAWS; LEGALIZATION; IMPACT	Background Cannabis policy varies greatly across European countries, but evidence of how such policy impacts on recreational cannabis use among young people is conflicting. This study aimed to clarify this association by investigating how changes in cannabis legislation influenced cannabis use. Methods Available data on self-reports of recreational cannabis use among individuals aged 15-34 years was retrieved from EMCDDA. Information on cannabis policy changes was categorized as more lenient (decriminalisation or depenalisation) or stricter (criminalisation, penalisation). Countries that had implemented changes in cannabis legislation or had information on prevalence of use for at least eight calendar years, were eligible for inclusion. We used interrupted time-series linear models to investigate changes in country-specific trajectories of prevalence over calendar time and in relation to policy changes. Results Data from Belgium, Czech Republic, Germany, Italy, Netherlands, Norway, Portugal, Slovakia, Spain, Sweden and United Kingdom, for 1994-2017 was available for analyses. Cannabis use varied considerably over the study period and between countries. On average, use was stable or weakly increasing in countries where legislation was not changed or changed at the extremes of the study period (+0.08 percent per year [95% CI -0.01, 0.17 percent]). In contrast, the pooled average use decreased after changes in legislation, regardless of whether it had become more lenient (-0.22 [-1.21, 0.77]) or stricter (-0.44 [-0.91, 0.03]). Conclusions Our findings do not support any considerable impact of cannabis legislation on the prevalence of recreational cannabis use among youth and young adults in Europe.	[Gabri, Alexander Carl; Galanti, Maria Rosaria; Orsini, Nicola; Magnusson, Cecilia] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Galanti, Maria Rosaria; Orsini, Nicola; Magnusson, Cecilia] Ctr Epidemiol & Community Med, Reg Stockholm, Stockholm, Sweden	Karolinska Institutet	Gabri, AC (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.	alexander.gabri@stud.ki.se		Gabri, Alexander/0000-0001-6435-9491				Arria AM, 2015, PSYCHOL ADDICT BEHAV, V29, P564, DOI 10.1037/adb0000108; Beck F., 2007, SANT PUBLIQUE, V19; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Cambron C, 2020, PREV SCI, V21, P508, DOI 10.1007/s11121-019-01072-8; Castillo-Carniglia A, 2020, ADDICTION, V115, P2089, DOI 10.1111/add.15058; Cecho R, 2017, CENT EUR J PUBL HEAL, V25, P261, DOI 10.21101/cejph.a5019; Cerda M, 2017, INT J DRUG POLICY, V42, P118, DOI 10.1016/j.drugpo.2017.02.007; Cerda M, 2012, DRUG ALCOHOL DEPEN, V120, P22, DOI 10.1016/j.drugalcdep.2011.06.011; Chatwin C, 2017, INT J DRUG POLICY, V49, P80, DOI 10.1016/j.drugpo.2015.12.017; Choo EK, 2014, J ADOLESCENT HEALTH, V55, P160, DOI 10.1016/j.jadohealth.2014.02.018; Cox C, 2018, HEALTH POLICY, V122, P205, DOI 10.1016/j.healthpol.2018.01.009; Csete J, 2016, LANCET, V387, P1427, DOI 10.1016/S0140-6736(16)00619-X; Ebbert JO, 2018, MAYO CLIN PROC, V93, P1842, DOI 10.1016/j.mayocp.2018.09.005; EMCDDA, 2019, EUR DRUG REP; European Monitoring Centre for Drugs and Drug Addiction, 2019, STAT B 2019 PREV DRU; European Monitoring Centre for Drugs and Drug Addiction, 2002, HDB SURV DRUG US GEN; European Monitoring Centre for Drugs and Drug Addiction, 2018, CANN LEG EUR OV; Farrelly MC, 2001, J HEALTH ECON, V20, P51, DOI 10.1016/S0167-6296(00)00067-9; Grotenhermen F, 2007, CHEM BIODIVERS, V4, P1744, DOI 10.1002/cbdv.200790151; Grucza RA, 2018, INT J DRUG POLICY, V59, P67, DOI 10.1016/j.drugpo.2018.06.016; Hughes B, 2018, ADDICTION, V113, P2155, DOI 10.1111/add.14372; Kalant H, 2010, ADDICTION, V105, P1146, DOI 10.1111/j.1360-0443.2009.02830.x; Kotlaja MM, 2019, INT J OFFENDER THER, V63, P1082, DOI 10.1177/0306624X18814184; Laqueur H, 2020, INT J DRUG POLICY, V80, DOI 10.1016/j.drugpo.2020.102748; MacCoun R, 1997, SCIENCE, V278, P47, DOI 10.1126/science.278.5335.47; Maxwell JC, 2016, J ADDICT MED, V10, P3, DOI 10.1097/ADM.0000000000000188; Meier MH, 2015, DRUG ALCOHOL DEPEN, V156, P207, DOI 10.1016/j.drugalcdep.2015.09.010; Melchior M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025880; Mokwena K, 2019, AFR J PRIM HEALTH CA, V11, DOI 10.4102/phcfm.v11i1.2136; Olfson M, 2018, AM J PSYCHIAT, V175, P47, DOI [10.1176/appi.ajp.2017.17040413, 10.1176/appi.ajp.2017.17070808]; Pardo B, 2014, INT J DRUG POLICY, V25, P727, DOI 10.1016/j.drugpo.2014.05.010; Sagar KA, 2018, INT REV PSYCHIATR, V30, P251, DOI 10.1080/09540261.2018.1460334; Shi YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143562; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; UNESCO, 1968, ECN72020CRP19 WHO; unodc, 2020, WORLD DRUG REPORT 20; Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278; Waldheim K., 1973, COMMENTARY SINGLE CO; Williams J, 2014, J HEALTH ECON, V36, P20, DOI 10.1016/j.jhealeco.2014.03.006	39	6	6	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261885	10.1371/journal.pone.0261885	http://dx.doi.org/10.1371/journal.pone.0261885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020763	Green Published, gold			2022-12-26	WOS:000834207700028
J	Mason, B; Piel, AK; Modry, D; Petrzelkova, KJ; Stewart, FA; Pafao, B				Mason, Bethan; Piel, Alex K.; Modry, David; Petrzelkova, Klara J.; Stewart, Fiona A.; Pafao, Barbora			Association of human disturbance and gastrointestinal parasite infection of yellow baboons in western Tanzania	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; FECAL EGG COUNTS; ENTAMOEBA-HISTOLYTICA INFECTION; PAPIO-CYNOCEPHALUS; MOLECULAR-IDENTIFICATION; INTESTINAL PARASITES; STRONGYLOIDES SPP.; NATIONAL-PARK; WORM BURDEN; GROUP-SIZE	Human disturbance is an ongoing threat to many wildlife species, manifesting as habitat destruction, resource overuse, or increased disease exposure, among others. With increasing human: non-human primate (NHP) encounters, NHPs are increasingly susceptible to human-introduced diseases, including those with parasitic origins. As such, epidemiology of parasitic disease is becoming an important consideration for NHP conservation strategies. To investigate the relationship between parasite infections and human disturbance we studied yellow baboons (Papio cynocephalus) living outside of national park boundaries in western Tanzania, collecting 135 fresh faecal samples from nine troops occupying areas with varying levels of human disturbance. We fixed all samples in 10% formalin and later evaluated parasite prevalence and abundance (of isotrichid ciliates and Strongylida). We identified seven protozoan and four helminth taxa. Taxa showed varied relationships with human disturbance, baboon troop size and host age. In four taxa, we found a positive association between prevalence and troop size. We also report a trend towards higher parasite prevalence of two taxa in less disturbed areas. To the contrary, high levels of human disturbance predicted increased abundance of isotrichid ciliates, although no relationship was found between disturbance and Strongylida abundance. Our results provide mixed evidence that human disturbance is associated with NHP parasite infections, highlighting the need to consider monitoring parasite infections when developing NHP conservation strategies.	[Mason, Bethan; Modry, David] Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic; [Mason, Bethan; Petrzelkova, Klara J.; Pafao, Barbora] Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic; [Piel, Alex K.; Stewart, Fiona A.] UCL, Dept Anthropol, London, England; [Piel, Alex K.; Stewart, Fiona A.] Greater Mahale Ecosyst Res & Conservat GMERC Proj, Busongola, Tanzania; [Modry, David; Petrzelkova, Klara J.] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Modry, David] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources CINeZ, Dept Vet Sci, Prague, Czech Republic; [Stewart, Fiona A.] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England	Masaryk University Brno; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of London; University College London; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech University of Life Sciences Prague; Liverpool John Moores University	Mason, B (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.; Mason, B (corresponding author), Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic.; Piel, AK (corresponding author), UCL, Dept Anthropol, London, England.; Piel, AK (corresponding author), Greater Mahale Ecosyst Res & Conservat GMERC Proj, Busongola, Tanzania.	bethanmason@sky.com; a.piel@ucl.ac.uk		Mason, Bethan/0000-0003-4344-7243; Piel, Alexander/0000-0002-4674-537X				Alvarado-Villalobos MA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2532-7; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ANDERSON RM, 1985, T ROY SOC TROP MED H, V79, P812, DOI 10.1016/0035-9203(85)90128-2; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Barelli C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67959-7; Barelli C, 2015, INT J PRIMATOL, V36, P209, DOI 10.1007/s10764-015-9815-7; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benavides JA, 2012, AM J PHYS ANTHROPOL, V147, P52, DOI 10.1002/ajpa.21627; Bentley-Condit VK, 2009, AM J PRIMATOL, V71, P432, DOI 10.1002/ajp.20670; Bhattacharjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127626; Blickley JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050462; Bradley BJ, 2008, J ZOOL, V275, P333, DOI 10.1111/j.1469-7998.2008.00431.x; Cabaret J, 1998, PARASITE, V5, P137, DOI 10.1051/parasite/1998052137; Chapman CA, 2006, AM J PRIMATOL, V68, P397, DOI 10.1002/ajp.20233; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2007, AM J PHYS ANTHROPOL, V134, P240, DOI 10.1002/ajpa.20664; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Chomitz KM, 2007, AT LOGGERHEADS: AGRICULTURAL EXPANSION, POVERTY REDUCTION, AND ENVIRONMENT IN THE TROPICAL FORESTS, P1, DOI 10.1596/978-0-8213-6735-3; COHEN S, 1992, PSYCHOL SCI, V3, P301, DOI 10.1111/j.1467-9280.1992.tb00677.x; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Deere JR, 2021, BEHAV ECOL SOCIOBIOL, V75, DOI 10.1007/s00265-021-03030-3; Deere JR, 2019, PARASITOLOGY, V146, P1116, DOI [10.1017/S0031182018001397, 10.1017/s0031182018001397]; DOYLE PW, 1990, J CLIN MICROBIOL, V28, P116, DOI 10.1128/JCM.28.1.116-121.1990; EAST IJ, 1988, INT J PARASITOL, V18, P863, DOI 10.1016/0020-7519(88)90130-0; Ebbert MA, 2015, PARASITOLOGY, V142, P958, DOI 10.1017/S0031182015000104; Ellis S, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1991; Fehlmann G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14871-2; Fotedar R, 2007, CLIN MICROBIOL REV, V20, P511, DOI 10.1128/CMR.00004-07; Furtbauer I, 2020, HORM BEHAV, V126, DOI 10.1016/j.yhbeh.2020.104846; Ghai RR, 2015, P ROY SOC B-BIOL SCI, V282, P181, DOI 10.1098/rspb.2015.1436; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002641; Gillespie TR, 2006, INT J PRIMATOL, V27, P1129, DOI 10.1007/s10764-006-9064-x; Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290.x; Gillespie TR, 2005, J APPL ECOL, V42, P699, DOI 10.1111/j.1365-2664.2005.01049.x; Hahn NE, 2003, INT J PRIMATOL, V24, P271, DOI 10.1023/A:1023092915171; Hasegawa D., 2018, PARASITES APES ATLAS, P164; Hasegawa H., 2018, PARASITES APES ATLAS, P83; Hasegawa H., 2018, PARASITES APES ATLAS, P20, DOI [10.1016/j.exppara.2018.06.009 29959915, DOI 10.1016/J.EXPPARA.2018.06.00929959915]; Hasegawa H, 2010, PARASITOL INT, V59, P407, DOI 10.1016/j.parint.2010.05.007; Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222; Hilser H, 2014, FOLIA PRIMATOL, V85, P265, DOI 10.1159/000363740; Hoffman TS, 2011, INT J PRIMATOL, V32, P308, DOI 10.1007/s10764-010-9467-6; Holechek JL, 2017, RANGELAND ECOL MANAG, V70, P273, DOI 10.1016/j.rama.2016.09.004; Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035; Howells ME, 2011, AM J PRIMATOL, V73, P173, DOI 10.1002/ajp.20884; Hussain Shaik, 2013, PLoS One, V8, pe63685, DOI 10.1371/journal.pone.0063685; Jirku-Pomajbikova K, 2016, PARASITOLOGY, V143, P741, DOI 10.1017/S0031182016000263; Kalousova B, 2014, INT J PRIMATOL, V35, P463, DOI 10.1007/s10764-014-9753-9; Kigwangalla HA, 2019, GAZETTE UNITED REPUB, V38; Klein SL, 2003, PHYSIOL BEHAV, V79, P441, DOI 10.1016/S0031-9384(03)00163-X; Kleinschmidt LM, 2018, J MED PRIMATOL, V47, P201, DOI 10.1111/jmp.12338; Lane-DeGraaf KE, 2014, AM J PRIMATOL, V76, P159, DOI 10.1002/ajp.22218; MacIntosh AJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051144; Makunga J. E., 2017, Open Journal of Forestry, V7, P285, DOI 10.4236/ojf.2017.72018; Martínez-Mota Rodolfo, 2018, Therya, V9, P161, DOI 10.12933/therya-18-572; Mpasiwakomu AR., 2017, HURIA J OPEN U TANZA, V24, P150; Muller-Klein N, 2019, FUNCT ECOL, V33, P1088, DOI 10.1111/1365-2435.13313; MullerGraf CDM, 1996, PARASITOLOGY, V112, P489, DOI 10.1017/S0031182000076952; Murray S, 2000, J ZOO WILDLIFE MED, V31, P176, DOI 10.1638/1042-7260(2000)031[0176:IPOBPC]2.0.CO;2; MYERS BJ, 1971, T AM MICROSC SOC, V90, P80, DOI 10.2307/3224900; NORTON GW, 1987, FOLIA PRIMATOL, V48, P78, DOI 10.1159/000156287; Pafco B, 2019, MOL ECOL, V28, P4786, DOI 10.1111/mec.15257; Pafco B, 2017, PARASITOL RES, V116, P3401, DOI 10.1007/s00436-017-5667-8; Papkou A, 2016, ZOOLOGY, V119, P330, DOI 10.1016/j.zool.2016.02.001; Patterson JEH, 2013, PARASITOLOGY, V140, P803, DOI 10.1017/S0031182012002259; Petrzelkova KJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89283-4; Piel AK, 2017, J HUM EVOL, V112, P57, DOI 10.1016/j.jhevol.2017.08.016; Pomajbikova K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002140; Post D.G., 1982, International Journal of Primatology, V3, P403, DOI 10.1007/BF02693741; Poulsen JR, 2001, J TROP ECOL, V17, P787, DOI 10.1017/S0266467401001602; R Core Team, 2020, R LANG ENV STAT COMP; Ragazzo LJ, 2018, VET PARASITOL, V249, P98, DOI 10.1016/j.vetpar.2017.12.002; Raichlen DA, 2005, J HUM EVOL, V49, P452, DOI 10.1016/j.jhevol.2005.05.005; Rimbach R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0110; Rothman JM, 2012, INT J PRIMATOL, V33, P542, DOI 10.1007/s10764-011-9568-x; Sa RM, 2013, AM J PRIMATOL, V75, P1032, DOI 10.1002/ajp.22170; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Scanlan PD, 2014, FEMS MICROBIOL ECOL, V90, P326, DOI 10.1111/1574-6941.12396; Schneider-Crease I, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22684; Schovancova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081374; Schuster FL, 2008, CLIN MICROBIOL REV, V21, P626, DOI 10.1128/CMR.00021-08; Seivwright LJ, 2004, J HELMINTHOL, V78, P69, DOI 10.1079/JOH2003220; Sheather A. L., 1923, Journal of Comparative Pathology and Therapeutics, V36, P266; Shutt-Phillips K, 2021, GEN COMP ENDOCR, V312, DOI 10.1016/j.ygcen.2021.113859; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Stear MJ, 1995, PARASITE IMMUNOL, V17, P643, DOI 10.1111/j.1365-3024.1995.tb01010.x; Stensvold CR, 2009, TRENDS PARASITOL, V25, P23, DOI 10.1016/j.pt.2008.09.010; Stoner KE, 1996, CONSERV BIOL, V10, P539, DOI 10.1046/j.1523-1739.1996.10020539.x; Thompson RCA, 2013, INT J PARASITOL, V43, P1079, DOI 10.1016/j.ijpara.2013.06.007; Tomley FM, 2009, PHILOS T R SOC B, V364, P2637, DOI 10.1098/rstb.2009.0133; Tonukari NJ, 2004, ELECTRON J BIOTECHN, V7, P5, DOI 10.2225/vol7-issue1-fulltext-i02; Vadlamudi Raja S, 2006, Clin Mol Allergy, V4, P8, DOI 10.1186/1476-7961-4-8; Vlckova K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01202; WARNICK LD, 1992, CORNELL VET, V82, P453; Weyher AH, 2006, INT J PRIMATOL, V27, P1519, DOI 10.1007/s10764-006-9089-1; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0	98	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262481	10.1371/journal.pone.0262481	http://dx.doi.org/10.1371/journal.pone.0262481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020760	Green Accepted, gold, Green Published			2022-12-26	WOS:000834207700043
J	Acquah, GE; Hernandez-Allica, J; Thomas, CL; Dunham, SJ; Towett, EK; Drake, LB; Shepherd, KD; McGrath, SP; Haefele, SM				Acquah, Gifty E.; Hernandez-Allica, Javier; Thomas, Cathy L.; Dunham, Sarah J.; Towett, Erick K.; Drake, Lee B.; Shepherd, Keith D.; McGrath, Steve P.; Haefele, Stephan M.			Portable X-ray fluorescence (pXRF) calibration for analysis of nutrient concentrations and trace element contaminants in fertilisers	PLOS ONE			English	Article							CADMIUM CONTENT; SOILS; XRF; APPLICABILITY; SPECTROMETRY	With the increasing popularity of local blending of fertilisers, the fertiliser industry faces issues regarding quality control and fertiliser adulteration. Another problem is the contamination of fertilisers with trace elements that have been shown to subsequently accumulate in the soil and be taken up by plants, posing a danger to the environment and human health. Conventional characterisation methods necessary to ensure the quality of fertilisers and to comply with local regulations are costly, time consuming and sometimes not even accessible. Alternatively, using a wide range of unamended and intentionally amended fertilisers this study developed empirical calibrations for a portable handheld X-ray fluorescence (pXRF) spectrometer, determined the reliability for estimating the macro and micro nutrients and evaluated the use of the pXRF for the high-throughput detection of trace element contaminants in fertilisers. The models developed using pXRF for Mg, P, S, K, Ca, Mn, Fe, Zn and Mo had R-2 values greater or equal to 0.97. These models also performed well on validation, with R-2 values greater or equal to 0.97 (except for Fe, R-val(2 )= 0.55) and slope values ranging from 0.81 to 1.44. A second set of models were developed with a focus on trace elements in amended fertilisers. The R-2 values of calibration for Co, Ni, As, Se, Cd and Pb were greater than or equal to 0.80. At concentrations up to 1000 mg kg(-1), good validation statistics were also obtained; R-2 values ranged from 0.97-0.99, except in one instance. The regression coefficients of the validation also had good prediction in the range of 0-100 mg kg(-1) (R-2 values were from 0.78-0.99), but not as well at lower concentrations up to 20 mg kg(-1) (R-2 values ranged from 0.10-0.99), especially for Cd. This study has demonstrated that pXRF can measure several major (P, Ca) and micro (Mn, Fe, Cu) nutrients, as well as trace elements and potential contaminants (Cr, Ni, As) in fertilisers with high accuracy and precision. The results obtained in this study is good, especially considering that loose powders were scanned for a maximum of 90 seconds without the use of a vacuum pump.	[Acquah, Gifty E.; Hernandez-Allica, Javier; Thomas, Cathy L.; Dunham, Sarah J.; McGrath, Steve P.; Haefele, Stephan M.] Rothamsted Res, Dept Sustainable Agr Sci, Harpenden, Herts, England; [Towett, Erick K.; Shepherd, Keith D.] World Agroforestry ICRAF, Nairobi, Kenya; [Drake, Lee B.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; CGIAR; World Agroforestry (ICRAF); University of New Mexico	Acquah, GE (corresponding author), Rothamsted Res, Dept Sustainable Agr Sci, Harpenden, Herts, England.	gifty.acquah@rothamsted.ac.uk	McGrath, Steve P/B-5127-2008; Dunham, Sarah/C-3331-2017; Shepherd, Keith/N-6627-2016; Haefele, Stephan/E-1256-2017	McGrath, Steve P/0000-0003-0952-8947; Dunham, Sarah/0000-0003-4701-199X; Shepherd, Keith/0000-0001-7144-3915; Acquah, Gifty/0000-0003-4269-0903; Thomas, Cathy/0000-0002-6320-9923; Haefele, Stephan/0000-0003-0389-8373	UK-BBSRC [BBS/E/C/000I0310]; Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS); Innovative Solutions for Decision Agriculture Ltd (iSDA)	UK-BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS); Innovative Solutions for Decision Agriculture Ltd (iSDA)	SPM and SMH were funded by the Institute Strategic Programme grant, "Soils to Nutrition", UK-BBSRC grant number BBS/E/C/000I0310. This work was also supported by the Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS) and Innovative Solutions for Decision Agriculture Ltd (iSDA), a social enterprise with a mission to improve smallholder farmer profitability across Africa. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bold T., 2015, LOW QUALITY LOW RETU; Brent RN, 2017, J ENVIRON CHEM ENG, V5, P768, DOI 10.1016/j.jece.2016.12.056; Bruker, 2010, APEXZ SAINT SADABS; EPA, 1988, 6200 USEPA; Guerra MBB, 2018, J BRAZIL CHEM SOC, V29, P1086, DOI 10.21577/0103-5053.20170229; Hall WL., 2014, J AOAC INT, V97; Hasikova J, 2014, PROCEDIA ENGINEER, V83, P455, DOI 10.1016/j.proeng.2014.09.078; Higueras P, 2012, J GEOCHEM EXPLOR, V113, P3, DOI 10.1016/j.gexplo.2011.02.005; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Jang M, 2010, ENVIRON GEOCHEM HLTH, V32, P207, DOI 10.1007/s10653-009-9276-z; JONES KC, 1992, ENVIRON SCI TECHNOL, V26, P834, DOI 10.1021/es00028a026; Lucas-Tooth HJ., 1961, METALLURGIA, V64, P149; Mackey EA, 2007, ANAL BIOANAL CHEM, V387, P2401, DOI 10.1007/s00216-007-1124-3; Makinen E, 2006, WATER AIR SOIL POLL, V171, P95, DOI 10.1007/s11270-005-9017-6; MCGRATH SP, 1985, J SCI FOOD AGR, V36, P794, DOI 10.1002/jsfa.2740360906; McLaren TI, 2012, SOIL SCI SOC AM J, V76, P1446, DOI 10.2136/sssaj2011.0355; McLaren TI, 2012, SOIL SCI SOC AM J, V76, P1436, DOI 10.2136/sssaj2011.0354; Mortvedt JJ, 1996, FERT RES, V43, P55, DOI 10.1007/BF00747683; Nazaroff AJ, 2010, J ARCHAEOL SCI, V37, P885, DOI 10.1016/j.jas.2009.11.019; NICHOLSON FA, 1994, ENVIRON SCI TECHNOL, V28, P2170, DOI 10.1021/es00061a027; Paltridge NG, 2012, PLANT SOIL, V361, P251, DOI 10.1007/s11104-011-1104-4; Perroy RL, 2014, SCI TOTAL ENVIRON, V487, P72, DOI 10.1016/j.scitotenv.2014.03.102; Rademaker K, 2013, GEOLOGY, V41, P779, DOI 10.1130/G34313.1; Radu T, 2009, J HAZARD MATER, V171, P1168, DOI 10.1016/j.jhazmat.2009.06.062; Resende LV, 2016, TALANTA, V147, P485, DOI 10.1016/j.talanta.2015.10.007; Rouillon M, 2016, ENVIRON POLLUT, V214, P255, DOI 10.1016/j.envpol.2016.03.055; Sanabria J., 2013, QUALITY FERTILISER T; Smolders E., 2013, REVISITING UPDATING, P14; Stockmann U, 2016, CATENA, V139, P220, DOI 10.1016/j.catena.2016.01.007; Towett EK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242821; Towett EK, 2016, X-RAY SPECTROM, V45, P117, DOI 10.1002/xrs.2678; Trendov N., 2019, FAO YB FISHERY AQUAC, DOI DOI 10.30875/E36CFD60-EN; Vanhoof C, 2013, X-RAY SPECTROM, V42, P224, DOI 10.1002/xrs.2485; Weindorf DC, 2012, ENVIRON MONIT ASSESS, V184, P217, DOI 10.1007/s10661-011-1961-6	34	0	0	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262460	10.1371/journal.pone.0262460	http://dx.doi.org/10.1371/journal.pone.0262460			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015770	gold, Green Published			2022-12-26	WOS:000814820600023
J	Kim, KY; Kim, KM				Kim, Kyong Young; Kim, Kyoung Min			Similarities and differences between bone quality parameters, trabecular bone score and femur geometry	PLOS ONE			English	Article							FRACTURE RISK; OSTEOPOROTIC FRACTURES; MINERAL DENSITY; UNITED-STATES; FEMORAL-NECK; HIP; TBS; WOMEN; MICROARCHITECTURE; STRENGTH	Bone quality is a critical factor that, along with bone quantity, determines bone strength. Image-based parameters are used for assessing bone quality non-invasively. The trabecular bone score (TBS) is used to assess quality of trabecular bone and femur geometry for cortical bone. Little is known about the associations between these two bone quality parameters and whether they show differences in the relationships with age and body mass index (BMI). We investigated the associations between the trabecular bone score (TBS) and femur cortical geometry. Areal bone mineral density (BMD) was assessed using dual energy X-ray absorptiometry (DXA) and the TBS was assessed using iNsight software and, femur geometry using APEX (Hologic). A total of 452 men and 517 women aged 50 years and older with no medical history of a condition affecting bone metabolism were included. Z-scores for TBS and cortical thickness were calculated using the age-specific mean and SD for each parameter. A 'discrepancy group' was defined as patients whose absolute Z-score difference between TBS and cortical thickness was > 1 point. TBS and cortical thickness correlated negatively with age both in men and women, but the associations were stronger in women. Regarding the associations with BMI, TBS provided significant negative correlation with BMI in the range of BMI > 25 kg/m(2). By contrast, cortical thickness correlated positively with BMI for all BMI ranges. These bone quality-related parameters, TBS and cortical thickness, significantly correlated, but discordance between these two parameters was observed in about one-third of the men and women (32.7% and 33.4%, respectively). Conclusively, image-based bone quality parameters for trabecular and cortical bone exhibit both similarities and differences in terms of their associations with age and BMI. These different profiles in TBS and FN cortical thickness might results in different risk profiles for the vertebral fractures or hip fractures in a certain percentage of people.	[Kim, Kyong Young] Gyeongsang Natl Univ, Dept Internal Med, Changwon Hosp, Chang Won, South Korea; [Kim, Kyoung Min] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Kyoung Min] Seoul Natl Univ, Coll Med, Seongnam, South Korea; [Kim, Kyoung Min] Yonsei Univ, Yongin Severance Hosp, Dept Internal Med, Div Endocrinol,Coll Med, Yongin, South Korea	Gyeongsang National University; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System	Kim, KM (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.; Kim, KM (corresponding author), Seoul Natl Univ, Coll Med, Seongnam, South Korea.; Kim, KM (corresponding author), Yonsei Univ, Yongin Severance Hosp, Dept Internal Med, Div Endocrinol,Coll Med, Yongin, South Korea.	kyoungmin.kim@yonsei.ac.kr						Albala C, 1996, INT J OBESITY, V20, P1027; Ayoub ML, 2016, J CLIN DENSITOM, V19, P544, DOI 10.1016/j.jocd.2016.03.004; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beck T., 2002, HIP STRUCTURAL ANAL, P11; Beck TJ, 2009, J BONE MINER RES, V24, P1369, DOI [10.1359/JBMR.090307, 10.1359/jbmr.090307]; Boutroy S, 2013, OSTEOPOROSIS INT, V24, P77, DOI 10.1007/s00198-012-2188-2; Broy SB, 2015, J CLIN DENSITOM, V18, P287, DOI 10.1016/j.jocd.2015.06.005; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Carda S, 2009, CEREBROVASC DIS, V28, P191, DOI 10.1159/000226578; Cohen A, 2013, J CLIN ENDOCR METAB, V98, P2562, DOI 10.1210/jc.2013-1047; Crabtree NJ, 2002, OSTEOPOROSIS INT, V13, P48, DOI 10.1007/s198-002-8337-y; Danielson ME, 2013, OSTEOPOROSIS INT, V24, P1379, DOI 10.1007/s00198-012-2066-y; Fink HA, 2008, J CLIN DENSITOM, V11, P250, DOI 10.1016/j.jocd.2007.12.018; Hans D, 2011, J BONE MINER RES, V26, P2762, DOI 10.1002/jbmr.499; Harvey NC, 2015, BONE, V78, P216, DOI 10.1016/j.bone.2015.05.016; Hong AR, 2019, J BONE MINER METAB, V37, P835, DOI 10.1007/s00774-018-0980-6; Iki M, 2014, J BONE MINER RES, V29, P399, DOI 10.1002/jbmr.2048; Kaptoge S, 2008, J BONE MINER RES, V23, P1892, DOI [10.1359/jbmr.080802, 10.1359/JBMR.080802]; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; KOHRT WM, 1995, J BONE MINER RES, V10, P1303, DOI 10.1002/jbmr.5650100906; Leib E, 2014, BONE, V62, P51, DOI 10.1016/j.bone.2013.12.015; Link Thomas M, 2004, Curr Osteoporos Rep, V2, P47, DOI 10.1007/s11914-004-0003-5; Lloyd M, 1998, NEW ENGL J MED, V339, P202; Martineau P, 2015, SEMIN NUCL MED, V45, P458, DOI 10.1053/j.semnuclmed.2015.02.001; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; MAZESS RB, 1990, J BONE MINER RES, V5, P645; Moayyeri Alireza, 2005, BMC Endocr Disord, V5, P3, DOI 10.1186/1472-6823-5-3; Mounach A., 2009, SEMIN ARTHRITIS RHEU; Paschalis EP, 2011, CLIN ORTHOP RELAT R, V469, P2170, DOI 10.1007/s11999-010-1751-4; Poole KES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038466; Pothuaud L, 2008, BONE, V42, P775, DOI 10.1016/j.bone.2007.11.018; Romagnoli E, 2016, ENDOCRINE, V54, P342, DOI 10.1007/s12020-016-0857-1; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Syed Zeba, 2002, J Obstet Gynaecol Can, V24, P476; Valderrabano RJ, 2017, J CLIN ENDOCR METAB, V102, P2199, DOI 10.1210/jc.2017-00266; Woodson G, 2000, J CLIN DENSITOM, V3, P319, DOI 10.1385/JCD:3:4:319; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0260924	10.1371/journal.pone.0260924	http://dx.doi.org/10.1371/journal.pone.0260924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015756	gold, Green Published			2022-12-26	WOS:000814820600001
J	Jorga, SD; Dessie, YL; Kedir, MR; Donacho, DO				Jorga, Sime Daba; Dessie, Yohannes Lulu; Kedir, Mohammed Reshad; Donacho, Dereje Oljira			Prevalence of Tungiasis and its risk factors of among children of Mettu woreda, southwest Ethiopia, 2020	PLOS ONE			English	Article							TUNGA-PENETRANS; COMMUNITIES	Tungiasis is caused by the flea tunga penetrans and results in painful skin lesions, skin infections, and permanent disability. However, limited information is available that shows the magnitude of the problem and its risk factors that help for intervention in Ethiopia. The goal of this study was to determine the prevalence and risk factors of tungiasis in children aged 5 to 14 in Mettu woreda in 2020. A community based cross sectional study was conducted among randomly selected kebeles of Mettu woreda, in Southwest Ethiopia. To select study participants, multistage sampling was used. The data were collected through physical examination of the children, interview of parents/guardians of the children, and observation of the home environment using checklists and questionnaires. The descriptive analysis was done for socio-demographic characteristics, prevalence of tungiasis, and housing conditions. A logistic regression analysis was performed, and variables in multivariable regression reported odds ratios and their 95% confidence intervals once the variables were identified using a p-value of 0.05 as a risk factor of statistical significance. The prevalence of tungiasis among children 5-14 years of age in Mettu rural woreda was 52 percent (n = 821). As a risk factor, large family size (AOR: 2.9, 95% CI: 2.13, 4.40); school attendance (AOR: 1.5, 95% CI: 1.02, 2.18), floor inside the house (AOR: 3.8, 95% CI: 1.76, 8.43); having sleeping bed (AOR: 0.16, 95% CI: 0.03, 0.82); access to protected water sources (AOR: 0.24, 95% CI: 0.15, 0.39); access to improved toilet facilities(AOR: 0.63: 95% CI: 0.44, 0.89); access to electric services (AOR: 0.30, 95% CI: 0.15, 0.62); and lack of own farmland (AOR: 0.36, 95% CI: 0.26, 0.50) were found. Therefore, planning and implementation of interventions focus on those risk factors that are particularly important. Water, sanitation and hygiene interventions, and livelihood improvement interventions are required to solve the problem in the setting.	[Jorga, Sime Daba; Kedir, Mohammed Reshad] Mettu Univ, Coll Hlth Sci, Dept Publ Hlth, Metu, Ethiopia; [Dessie, Yohannes Lulu] Mettu Univ, Coll Hlth Sci, Dept Nursing, Metu, Ethiopia; [Donacho, Dereje Oljira] Mettu Univ, Coll Hlth Sci, Dept Hlth Informat, Jimma, Ethiopia; [Donacho, Dereje Oljira] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia	Jimma University	Donacho, DO (corresponding author), Mettu Univ, Coll Hlth Sci, Dept Hlth Informat, Jimma, Ethiopia.; Donacho, DO (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia.	dodbau3687@gmail.com	Donacho, Dereje Oljira/AAS-7401-2021	Donacho, Dereje Oljira/0000-0001-6145-2914				[Anonymous], JIGGERS REMOVAL PROG; CSA Ethiopia, 2013, POPULATION PROJECTIO, P118; Feldmeier H, 2013, EUR J CLIN MICROBIOL, V32, P19, DOI 10.1007/s10096-012-1725-4; Feldmeier H, 2003, EMERG INFECT DIS, V9, P949; Feldmeier H, 2013, TRAVEL MED INFECT DI, V11, P357, DOI 10.1016/j.tmaid.2013.10.001; Feldmeier H, 2009, B WORLD HEALTH ORGAN, V87, P152, DOI 10.2471/BLT.07.047308; Franck Sabine, 2003, Travel Med Infect Dis, V1, P159, DOI 10.1016/j.tmaid.2003.09.005; Girma M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3373-5; Heukelbach J, 2004, B WORLD HEALTH ORGAN, V82, P563; Heukelbach J, 2007, J INFECT DEV COUNTR, V1; IBM Corp. Released, 2011, IBM SPSS STAT WINDOW; Karunamoorthi K, 2013, PARASITOL RES, V112, P3635, DOI 10.1007/s00436-013-3551-8; Lauritsen JM., 2004, EPIDATA VERSION 3 1; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mazengia AL, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/7521751; Muehlen M, 2006, T ROY SOC TROP MED H, V100, P371, DOI 10.1016/j.trstmh.2005.06.033; Mutebi F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004126; Obebe OO, 2020, PATHOG GLOB HEALTH, V114, P360, DOI 10.1080/20477724.2020.1813489; Pilger D, 2008, PARASITOL RES, V102, P875, DOI 10.1007/s00436-007-0840-0; Ramaswamy V., 2016, INT J INTEGR MED SCI, V3, P211, DOI DOI 10.16965/IJIMS; Sachse MM, 2007, J EUR ACAD DERMATOL, V21, P11, DOI 10.1111/j.1468-3083.2006.01888.x; Ugbomoiko US, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000087; Ugbomoiko US, 2007, INT J DERMATOL, V46, P475, DOI 10.1111/j.1365-4632.2007.03245.x; Wafula ST, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.77.8916; Walker SL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005808; Winter B, 2009, J INFECT DEV COUNTR, V3, P458, DOI 10.3855/jidc.418	26	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262168	10.1371/journal.pone.0262168	http://dx.doi.org/10.1371/journal.pone.0262168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986188	Green Published, gold			2022-12-26	WOS:000765956200020
J	Kudzia, P; Jackson, E; Dumas, G				Kudzia, Pawel; Jackson, Erika; Dumas, Genevieve			Estimating body segment parameters from three-dimensional human body scans	PLOS ONE			English	Article							INERTIAL PARAMETERS; RELIABILITY; SENSITIVITY; VALIDATION; VOLUME; TRUNK; MODEL; ACCURACY; KINECT; ERROR	Body segment parameters are inputs for a range of applications. Participant-specific estimates of body segment parameters are desirable as this requires fewer prior assumptions and can reduce outcome measurement errors. Commonly used methods for estimating participant-specific body segment parameters are either expensive and out of reach (medical imaging), have many underlying assumptions (geometrical modelling) or are based on a specific subset of a population (regression models). Our objective was to develop a participant-specific 3D scanning and body segmentation method that estimates body segment parameters without any assumptions about the geometry of the body, ethnic background, and gender, is low-cost, fast, and can be readily available. Using a Microsoft Kinect Version 2 camera, we developed a 3D surface scanning protocol that enabled the estimation of participant-specific body segment parameters. To evaluate our system, we performed repeated 3D scans of 21 healthy participants (10 male, 11 female). We used open source tools to segment each body scan into 16 segments (head, torso, abdomen, pelvis, left and right hand, forearm, upper arm, foot, shank and thigh) and wrote custom software to estimate each segment's mass, mass moment of inertia in the three principal orthogonal axes relevant to the center of the segment, longitudinal length, and center of mass. We compared our body segment parameter estimates to those obtained using two comparison methods and found that our system was consistent in estimating total body volume between repeated scans (male p = 0.1194, female p = 0.2240), estimated total body mass without significant differences when compared to our comparison method and a medical scale (male p = 0.8529, female p = 0.6339), and generated consistent and comparable estimates across a range of the body segment parameters of interest. Our work here outlines and provides the code for an inexpensive 3D surface scanning method for estimating a range of participant-specific body segment parameters.	[Kudzia, Pawel] Simon Fraser Univ, Dept Engn Sci, Burnaby, BC, Canada; [Kudzia, Pawel; Jackson, Erika; Dumas, Genevieve] Queens Univ, Dept Mech & Mat Engn, Kingston, ON, Canada	Simon Fraser University; Queens University - Canada	Kudzia, P (corresponding author), Simon Fraser Univ, Dept Engn Sci, Burnaby, BC, Canada.; Kudzia, P (corresponding author), Queens Univ, Dept Mech & Mat Engn, Kingston, ON, Canada.	pawel.kudzia5@gmail.com		Kudzia, Pawel/0000-0002-6667-2913	NSERC Canada [A6858]	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	G.D received funding from NSERC Canada Discovery Grant A6858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad O., 2017, P 3DBODY TECH 2017 8; Andrews JG, 1996, J BIOMECH, V29, P651, DOI 10.1016/0021-9290(95)00118-2; Arena SL, 2017, J APPL BIOMECH, V33, P76, DOI 10.1123/jab.2016-0029; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bourgeois B, 2017, EUR J CLIN NUTR, V71, P1329, DOI 10.1038/ejcn.2017.142; Buffa R, 2015, SENSORS-BASEL, V15, P12342, DOI 10.3390/s150612342; Chambers AJ, 2010, CLIN BIOMECH, V25, P131, DOI 10.1016/j.clinbiomech.2009.10.015; Chandler RF., 1975, INVESTIGATION INERTI; Cheng CK, 2000, CLIN BIOMECH, V15, P559, DOI 10.1016/S0268-0033(00)00016-4; Chiu CY, 2016, INT J SPORTS MED, V37, P1117, DOI 10.1055/s-0042-112589; Chiu CY, 2016, IET SCI MEAS TECHNOL, V10, P553, DOI 10.1049/iet-smt.2015.0252; Cignoni p, 2008, P 6 EUR IT CHAPT C S; Clarkson S., 2012, P 3 INT C 3D BOD SCA, P153; Clauser C., 1969, WEIGHT VOLUME CTR MA, DOI DOI 10.21236/AD0710622; Damavandi M, 2009, MED ENG PHYS, V31, P880, DOI 10.1016/j.medengphy.2009.03.008; Das AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179264; Das B, 1996, APPL ERGON, V27, P157, DOI 10.1016/0003-6870(96)00008-7; Deffeyes J., 2005, ISBS C P ARCH; Dembia Christopher, 2014, F1000Res, V3, P223, DOI 10.12688/f1000research.5292.2; DEMPSTER WILFRED TAYLOR, 1955, U S A F WRIGHT AIR DEVELOPMENT CENTER TECH REPT, V55/159, P1; Durkin JL, 2006, ANN BIOMED ENG, V34, P1483, DOI 10.1007/s10439-006-9088-6; EBERLY D, 1991, CVGIP-GRAPH MODEL IM, V53, P550, DOI 10.1016/1049-9652(91)90005-5; Espitia-Contreras A, 2014, 2014 IEEE VIRTUAL REALITY (VR), P71, DOI 10.1109/VR.2014.6802056; Gerke O, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050334; HATZE H, 1980, J BIOMECH, V13, P833, DOI 10.1016/0021-9290(80)90171-2; Ho WH, 2013, MED SCI SPORT EXER, V45, P1759, DOI 10.1249/MSS.0b013e3182923b2a; Jackson E, 2017, BODY SEGMENT INERTIA; JENSEN RK, 1978, J BIOMECH, V11, P349, DOI 10.1016/0021-9290(78)90069-6; Kongsro J, 2014, COMPUT ELECTRON AGR, V109, P32, DOI 10.1016/j.compag.2014.08.008; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kowalski M, 2015, 2015 INTERNATIONAL CONFERENCE ON 3D VISION, P318, DOI 10.1109/3DV.2015.43; Kudzia P, 2015, ESTIMATING BODY SEGM; Kwon YH, 1996, J APPL BIOMECH, V12, P413, DOI 10.1123/jab.12.4.413; Lachat E, 2015, INT ARCH PHOTOGRAMM, V40-5, P93, DOI 10.5194/isprsarchives-XL-5-W4-93-2015; Laschowski B, 2016, SPORTS ENG, V19, P155, DOI 10.1007/s12283-016-0200-3; McIlwain J, 1998, SLICER COMPUTER SOFT; Narang YS, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034168; Pandis P, 2017, P I MECH ENG H, V231, P1064, DOI 10.1177/0954411917727031; Pataky TC, 2003, CLIN BIOMECH, V18, P364, DOI 10.1016/S0268-0033(03)00015-9; Pearsall DJ, 1996, ANN BIOMED ENG, V24, P198, DOI 10.1007/BF02667349; Pearsall DJ, 1999, GAIT POSTURE, V9, P173, DOI 10.1016/S0966-6362(99)00011-9; Peyer KE, 2015, PEERJ, V3, DOI 10.7717/peerj.831; Rao G, 2006, J BIOMECH, V39, P1531, DOI 10.1016/j.jbiomech.2005.04.014; Sarbolandi H, 2015, COMPUT VIS IMAGE UND, V139, P1, DOI 10.1016/j.cviu.2015.05.006; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e509; Silva MPT, 2004, GAIT POSTURE, V19, P35, DOI 10.1016/S0966-6362(03)00013-4; Smith SHL, 2018, MED ENG PHYS, V62, P36, DOI 10.1016/j.medengphy.2018.10.001; Soileau L, 2016, EUR J CLIN NUTR, V70, P475, DOI 10.1038/ejcn.2015.132; Stancic I, 2013, MEASUREMENT, V46, P716, DOI 10.1016/j.measurement.2012.09.010; Sunaga Y, 2016, APPL ERGON, V55, P173, DOI 10.1016/j.apergo.2016.02.010; van Soest AJ, 2004, J MOTOR BEHAV, V36, P419, DOI 10.3200/JMBR.36.4.419-424; Wasenmuller O, 2017, LECT NOTES COMPUT SC, V10117, P34, DOI 10.1007/978-3-319-54427-4_3; Wicke J, 2003, J APPL BIOMECH, V19, P3, DOI 10.1123/jab.19.1.3; Wicke J, 2014, J BIOMECH, V47, P1869, DOI 10.1016/j.jbiomech.2014.03.020; Wicke J, 2010, J APPL BIOMECH, V26, P26, DOI 10.1123/jab.26.1.26; Winter D. A, 2009, BIOMECHANICS MOTOR C; Yang L, 2015, IEEE SENS J, V15, P4275, DOI 10.1109/JSEN.2015.2416651; Zatsiorsky VM., 2002, KINETICS HUMAN MOTIO	58	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262296	10.1371/journal.pone.0262296	http://dx.doi.org/10.1371/journal.pone.0262296			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986175	gold, Green Published, Green Submitted			2022-12-26	WOS:000765956200037
J	Kurihara, T; Terada, M; Numasawa, S; Kusagawa, Y; Maeo, S; Kanehisa, H; Isaka, T				Kurihara, Toshiyuki; Terada, Masafumi; Numasawa, Shun; Kusagawa, Yuki; Maeo, Sumiaki; Kanehisa, Hiroaki; Isaka, Tadao			Effects of age and sex on association between toe muscular strength and vertical jump performance in adolescent populations	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; FLEXOR STRENGTH; CHILDREN; MUSCLES; HEIGHT; FLEXIBILITY; SOCCER	Toe muscular strength plays an important role in enhancing athletic performance because the forefoot is the only part of the body touching the ground. In general, muscular strength increases with age throughout adolescence, and sex-related difference in muscular strength becomes evident during childhood and adolescence. However, toe muscular strength is known to be levelled off after late adolescence in both sexes. For adolescent populations, therefore, the association of toe muscular strength with physical performance might differ with age and/or sex. This study aimed to investigate differences in relationships between toe muscular strength and vertical jump performance across sex and age in adolescent populations. The maximum isometric strength of the toe muscles and vertical jump height (VJ) were assessed in 479 junior high school students (JH) aged 12-14 years (243 boys and 236 girls) and 465 high school students (HS) aged 15-18 years (265 boys and 200 girls). Two types of measurements were performed to evaluate the toe muscular strength: toe gripping strength (TGS) with the metatarsophalangeal joint in the plantar flexed position and toe push strength (TPS) with the metatarsophalangeal joint in the dorsiflexed position. TGS and TPS were normalized to body weight. Two-way ANOVA showed that TGS had significant main effects of sex (boys > girls) and age (HS > JH) while TPS only had a significant main effect of sex (boys > girls). When the effects of sex and age were separately analyzed, VJ was significantly correlated with TGS in JH girls, HS girls, and JH boys (r = 0.253-0.269, p < 0.05), but not in HS boys (r = 0.062, p = 0.3351). These results suggest that toe muscular strength is relatively weakly associated with vertical jump performance in adolescent boys and girls, but the association would not be established in high school boys.	[Kurihara, Toshiyuki] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan; [Terada, Masafumi; Maeo, Sumiaki; Kanehisa, Hiroaki; Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Numasawa, Shun] Osaka Basketball Assoc, Med Comm, Osaka, Japan; [Kusagawa, Yuki] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan	Ritsumeikan University; Ritsumeikan University; Ritsumeikan University	Kurihara, T (corresponding author), Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan.	t-kuri-a@st.ritsumei.ac.jp		Kusagawa, Yuki/0000-0003-4446-4723; Kurihara, Toshiyuki/0000-0001-9726-1255	JSPS KAKENHI [17K01540, 17H04756]; Japan Sports Agency	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Sports Agency	This work was supported by JSPS KAKENHI Grant Number 17K01540 and 17H04756, and Fund for Female Athletes Development and Support Projects in 2018-2019 by Japan Sports Agency.	BALE P, 1992, J SPORT MED PHYS FIT, V32, P142; Felser S, 2016, SCAND J MED SCI SPOR, V26, P165, DOI 10.1111/sms.12429; Focke A, 2013, EUR J SPORT SCI, V13, P518, DOI 10.1080/17461391.2012.756069; Goldmann JP, 2013, J SPORT SCI, V31, P424, DOI 10.1080/02640414.2012.736627; Goldmann JP, 2012, J ANAT, V221, P187, DOI 10.1111/j.1469-7580.2012.01524.x; Guimaraes E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020776; Hawley VS, 2022, J STRENGTH COND RES, V36, P1860, DOI 10.1519/JSC.0000000000003733; Isaacs LD, 1998, PERCEPT MOTOR SKILL, V86, P659, DOI 10.2466/pms.1998.86.2.659; Kanehisa H, 1995, EUR J APPL PHYSIOL O, V72, P150, DOI 10.1007/BF00964130; Laffaye G, 2016, BIOL SPORT, V33, P29, DOI 10.5604/20831862.1180169; Lloyd RS, 2011, J STRENGTH COND RES, V25, P1889, DOI 10.1519/JSC.0b013e3181e7faa8; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; MANN R, 1964, J BONE JOINT SURG AM, V46, P469, DOI 10.2106/00004623-196446030-00001; McKay MJ, 2017, NEUROLOGY, V88, P36, DOI 10.1212/WNL.0000000000003466; Morita N, 2018, EUR J APPL PHYSIOL, V118, P1003, DOI 10.1007/s00421-018-3827-x; Naka H, 2005, J BONE MINER METAB, V23, P463, DOI 10.1007/s00774-005-0629-0; Nariyama K, 2001, AM J HUM BIOL, V13, P356, DOI 10.1002/ajhb.1059; Otsuka M., 2015, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V174, P307; Philippaerts RM, 2006, J SPORT SCI, V24, P221, DOI 10.1080/02640410500189371; Rodriguez-Rosell D, 2017, J STRENGTH COND RES, V31, P196, DOI 10.1519/JSC.0000000000001476; Rouis M, 2015, J SPORT MED PHYS FIT, V55, P1502; Rowley KM, 2015, MED PROBL PERFORM AR, V30, P152, DOI 10.21091/mppa.2015.3029; Smith G, 2012, J SPORT SCI, V30, P1521, DOI 10.1080/02640414.2012.713501; Stefanyshyn DJ, 2000, MED SCI SPORT EXER, V32, P471, DOI 10.1097/00005768-200002000-00032; Taylor MJD, 2010, J SPORT SCI, V28, P867, DOI 10.1080/02640411003770212; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Unger CL, 2000, J STRENGTH COND RES, V14, P373; Uritani D, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-28; van Werkhoven H, 2017, J BIOMECH, V57, P27, DOI 10.1016/j.jbiomech.2017.03.014; Vanezis A, 2005, ERGONOMICS, V48, P1594, DOI 10.1080/00140130500101262; Yamauchi J, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109719; Yuasa Y, 2018, J HUM KINET, V64, P47, DOI 10.1515/hukin-2017-0183	32	1	1	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262100	10.1371/journal.pone.0262100	http://dx.doi.org/10.1371/journal.pone.0262100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972181	gold, Green Published			2022-12-26	WOS:000773555700097
J	Liu, N; Shapira, P; Yue, XX; Guan, JC				Liu, Na; Shapira, Philip; Yue, Xiaoxu; Guan, Jiancheng			Mapping technological innovation dynamics in artificial intelligence domains: Evidence from a global patent analysis	PLOS ONE			English	Article							DIGITAL TRANSFORMATION; NETWORKS; TRENDS	Artificial intelligence (AI) is emerging as a technology at the center of many political, economic, and societal debates. This paper formulates a new AI patent search strategy and applies this to provide a landscape analysis of AI innovation dynamics and technology evolution. The paper uses patent analyses, network analyses, and source path link count algorithms to examine AI spatial and temporal trends, cooperation features, cross-organization knowledge flow and technological routes. Results indicate a growing yet concentrated, non-collaborative and multi-path development and protection profile for AI patenting, with cross-organization knowledge flows based mainly on interorganizational knowledge citation links.	[Liu, Na] Shandong Technol & Business Univ, Sch Management, Yantai, Peoples R China; [Shapira, Philip] Univ Manchester, Alliance Manchester Business Sch, Manchester Inst Innovat Res, Manchester, Lancs, England; [Shapira, Philip] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Yue, Xiaoxu] Tsinghua Univ, Sch Publ Policy & Management, Beijing, Peoples R China; [Guan, Jiancheng] Univ Chinese Acad Sci, Sch Econ & Management, Beijing, Peoples R China	Shandong Technology & Business University; University of Manchester; Alliance Manchester Business School; University System of Georgia; Georgia Institute of Technology; Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shapira, P (corresponding author), Univ Manchester, Alliance Manchester Business Sch, Manchester Inst Innovat Res, Manchester, Lancs, England.; Shapira, P (corresponding author), Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA.	pshapira@manchester.ac.uk		Shapira, Philip/0000-0003-2488-5985	National Natural Science Foundation of China [72174112, 71874176]; Taishan Scholars Program of Shandong Province [Tsqn201909149]; Biotechnology and Biological Sciences Research Council [BB/M017702/1]; Partnership for the Organization of Innovation and New Technologies (Social Science and Humanities Research Council of Canada) [895-2018-1006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong Province; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Partnership for the Organization of Innovation and New Technologies (Social Science and Humanities Research Council of Canada)	NL: grant number 72174112, National Natural Science Foundation of China, http://www.nsfc.gov.cn; grant number Tsqn201909149, Taishan Scholars Program of Shandong Province. PS: grant number BB/M017702/1, Biotechnology and Biological Sciences Research Council, https://bbsrc.ukri.org/; grant number 895-2018-1006, Partnership for the Organization of Innovation and New Technologies (Social Science and Humanities Research Council of Canada), https://www.4point0.ca.JG: grant number 71874176, National Natural Science Foundation of China, http://www.nsfc.gov.cn.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi HHN, 2020, IEEE ACCESS, V8, P81633, DOI 10.1109/ACCESS.2020.2988815; Albino V, 2014, APPL ENERG, V135, P836, DOI 10.1016/j.apenergy.2014.08.012; [Anonymous], 2019, TECHN TRENDS 2019 AR; [Anonymous], 2020, FORTUNEBUSINESSINSIG; Ardito L, 2018, TECHNOL FORECAST SOC, V136, P317, DOI 10.1016/j.techfore.2017.04.022; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Crawford K., 2021, ATLAS; de Paulo AF, 2020, TECHNOL FORECAST SOC, V159, DOI 10.1016/j.techfore.2020.120054; de Rassenfosse G, 2013, RES POLICY, V42, P720, DOI 10.1016/j.respol.2012.11.002; Duguet E, 2005, ECON INNOV NEW TECH, V14, P375, DOI 10.1080/1043859042000307347; Dwivedi YK, 2021, INT J INFORM MANAGE, V57, DOI 10.1016/j.ijinfomgt.2019.08.002; Ernst H, 2001, RES POLICY, V30, P143, DOI 10.1016/S0048-7333(99)00098-0; Evangelista A, 2020, COMPUT IND, V118, DOI 10.1016/j.compind.2020.103221; Frietsch R, 2010, SCIENTOMETRICS, V82, P185, DOI 10.1007/s11192-009-0082-2; Fujii H, 2018, ECON ANAL POLICY, V58, P60, DOI 10.1016/j.eap.2017.12.006; Goralski MA, 2020, INT J MANAG EDUC-OXF, V18, DOI 10.1016/j.ijme.2019.100330; Griliches Z., 1986, VALUE PATENTS INDICA; Guan JC, 2016, RES POLICY, V45, P97, DOI 10.1016/j.respol.2015.08.002; Hinze S, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P215; Huang Y, 2015, SCIENTOMETRICS, V105, P2005, DOI 10.1007/s11192-015-1638-y; HUMMON NP, 1989, SOC NETWORKS, V11, P39, DOI 10.1016/0378-8733(89)90017-8; Jaffe AB, 2017, J ASSOC INF SCI TECH, V68, P1360, DOI 10.1002/asi.23731; Jeong HJ, 2020, INT J TECHNOL MANAGE, V82, P132; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Liu JS, 2019, SCIENTOMETRICS, V119, P379, DOI 10.1007/s11192-019-03034-x; Liu JS, 2012, J AM SOC INF SCI TEC, V63, P528, DOI 10.1002/asi.21692; Liu N, 2021, SCIENTOMETRICS, V126, P3153, DOI 10.1007/s11192-021-03868-4; Liu N, 2016, ENERG POLICY, V91, P220, DOI 10.1016/j.enpol.2016.01.020; Lu LYY, 2016, TECHNOL FORECAST SOC, V103, P71, DOI 10.1016/j.techfore.2015.10.018; Magistretti S, 2019, BUS HORIZONS, V62, P819, DOI 10.1016/j.bushor.2019.08.004; Martinelli A, 2012, RES POLICY, V41, P414, DOI 10.1016/j.respol.2011.10.012; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Miller T, 2019, ARTIF INTELL, V267, P1, DOI 10.1016/j.artint.2018.07.007; Mrvar A, 2016, COMPLEX ADAPT SYST M, V4, DOI 10.1186/s40294-016-0017-8; Nagaoka S, 2010, HBK ECON, V2, P1083, DOI 10.1016/S0169-7218(10)02009-5; O'Meara S, 2019, NATURE, V572, P427, DOI 10.1038/d41586-019-02360-7; OECD, 2021, POL OBS; OECD, 2009, MEAS CAP; PatentSight, EXC DAT QUAL FDN REL; Porter AL, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P587; Russell S, 2015, NATURE, V521, P415, DOI 10.1038/521415a; Shapira P, 2017, SCIENTOMETRICS, V112, P1439, DOI 10.1007/s11192-017-2452-5; Suh Y, 2019, TECHNOL FORECAST SOC, V146, P595, DOI 10.1016/j.techfore.2018.01.037; Tseng CY, 2013, INNOV-ORGAN MANAG, V15, P463, DOI 10.5172/impp.2013.15.4.463; Van Roy V., 2019, 433 GLO; Verspagen B, 2007, ADV COMPLEX SYST, V10, P93, DOI 10.1142/S0219525907000945; Vial G, 2019, J STRATEGIC INF SYST, V28, P118, DOI 10.1016/j.jsis.2019.01.003; Warner KSR, 2019, LONG RANGE PLANN, V52, P326, DOI 10.1016/j.lrp.2018.12.001; Wu F, 2020, NAT MACH INTELL, V2, P312, DOI 10.1038/s42256-020-0183-4; Xie ZQ, 2013, WORLD PAT INF, V35, P20, DOI 10.1016/j.wpi.2012.10.005	51	0	0	29	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262050	10.1371/journal.pone.0262050	http://dx.doi.org/10.1371/journal.pone.0262050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972173	Green Published, gold			2022-12-26	WOS:000773555700087
J	Mekonnen, SA; Gezehagn, A; Berju, A; Haile, B; Dejene, H; Nigatu, S; Molla, W; Jemberu, WT				Mekonnen, Sefinew Alemu; Gezehagn, Agegnehu; Berju, Adugna; Haile, Belete; Dejene, Haileyesus; Nigatu, Seleshe; Molla, Wassie; Jemberu, Wudu Temesgen			Health and economic burden of foodborne zoonotic diseases in Amhara region, Ethiopia	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; PREVALENCE; MEAT; SUSCEPTIBILITY; SALMONELLA; CATTLE	Diseases from food of animal origin are common health problems in Ethiopia. A cross-sectional study was carried out to estimate health and economic burden, and to identify demographic factors associated with community awareness of foodborne zoonotic diseases in Amhara region, Ethiopia. Data was collected from 435 households in three towns: Gondar, Lalibela and Debark. A retrospective data was also collected from health records in each town. The health burden due to zoonotic diseases was estimated at 0.2, 0.1 and 1.3 DALYs per household per year and at 73.2, 146.6 and 1,689.5 DALYs out of 100,000 populations per year in Gondar, Lalibela and Debark, respectively. The overall health burden due to foodborne zoonotic diseases (aggregated over the 435 households in the three towns) was estimated to be 89.9 DALYs per 100,000 populations per year. The economic impact of foodborne zoonotic diseases in the three towns of Amhara regional state was 278.98 Ethiopian Birr (ETB) (1ETB = 0.025 US Dollar) per household per year and 121,355.68 ETB per year. Costs of preventive measures followed by costs of patients' time made the highest contribution while costs of diagnosis made the lowest contribution to the total economic burden of foodborne zoonotic diseases. From a total of 435 respondents, 305 (70.1%) had known the presence of zoonotic diseases. Level of education, number of families in the house and income were highly associated with awareness of zoonosis. Although majority of respondents had known zoonotic diseases exists (70.1%) and disease can be acquired from animal source food (63.2%), the health and economic burden associated to foodborne zoonotic diseases are still high. Therefore, changing mindset and practical training aiming in controlling foodborne zoonotic diseases may be suggested to the community in the health improvement extension service.	[Mekonnen, Sefinew Alemu; Berju, Adugna; Haile, Belete; Dejene, Haileyesus; Nigatu, Seleshe; Molla, Wassie; Jemberu, Wudu Temesgen] Univ Gondar, Coll Vet Med & Anim Sci, Dept Vet Epidemiol & Publ Hlth, Gondar, Ethiopia; [Gezehagn, Agegnehu] Cent Gondar Zone Anim Quarantine Ctr, Gondar, Ethiopia	University of Gondar	Mekonnen, SA (corresponding author), Univ Gondar, Coll Vet Med & Anim Sci, Dept Vet Epidemiol & Publ Hlth, Gondar, Ethiopia.	asefinew@gmail.com	Dejene, Haileyesus/GLT-9623-2022; Molla, Wassie/GYD-3081-2022	Dejene, Haileyesus/0000-0002-2196-9334; Jemberu, Wudu Temesgen/0000-0002-3769-307X	University of Gondar, Ethiopia [383/10/2019]	University of Gondar, Ethiopia	This study was financially supported by University of Gondar, Ethiopia with grant Ref. number 383/10/2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2020, J TROP MED-US, V2020, DOI 10.1155/2020/4674235; Abegaz GA, 2018, 113 ETH DEV RES I ED; Aklilu Addis, 2015, BMC Res Notes, V8, P17, DOI 10.1186/s13104-014-0967-x; [Anonymous], 2010, 50833GLB WORLD BANK, V1; [Anonymous], 2012, MAPPING POVERTY LIKE; [Anonymous], 2013, POPULATION PROJECTIO; [Anonymous], 2006, CONTROL NEGLECTED ZO; [Anonymous], 1999, HUMAN POPULATION CEN; [Anonymous], 2017, WHO METHODS DATA SOU; Ashwani Kumar, 2011, Ethiopian Veterinary Journal, V15, P15; Bayleyegn Molla, 2004, Ethiopian Journal of Health Development, V18, P208; Cascio A, 2011, CLIN MICROBIOL INFEC, V17, P336, DOI 10.1111/j.1469-0691.2010.03451.x; Cleaveland S, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0168; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; Dargatz DA, 2003, J APPL MICROBIOL, V95, P753, DOI 10.1046/j.1365-2672.2003.02034.x; Grace D, 2012, TROP ANIM HEALTH PRO, V44, pS67, DOI 10.1007/s11250-012-0209-y; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; Haagsma JA, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0042-4; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kemunto N, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3443-8; Leta S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-310; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Meloni D, 2009, INT J FOOD MICROBIOL, V129, P166, DOI 10.1016/j.ijfoodmicro.2008.11.014; Mengesha D, 2009, BERL MUNCH TIERARZTL, V122, P20, DOI 10.2376/0005-9366-122-20; Menghistu HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209974; Molyneux D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-106; Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Pieracci EG, 2016, ONE HEALTH, V2, P131, DOI 10.1016/j.onehlt.2016.09.001; Potts KS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020354; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Seimenis A, 2012, VET ITAL, V48, P5; Seleshe S, 2014, KOREAN J FOOD SCI AN, V34, P7, DOI [10.5851/kosfa.2013.34.1.7, 10.5851/kosfa.2014.34.1.7]; Shitaye JE, 2006, VET MED-CZECH, V51, P512, DOI 10.17221/5585-VETMED; Sisay Girma, 2012, Ethiopian Veterinary Journal, V16, P15; Tadesse Getachew, 2015, BMC Res Notes, V8, P163, DOI 10.1186/s13104-015-1127-7; Tadesse G, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0270-y; Tassew H, 2010, ETHIOP J HEALTH SCI, V20, P137; Torgerson PR, 2018, ONE HEALTH-AMSTERDAM, V5, P40, DOI 10.1016/j.onehlt.2017.11.003; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	43	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262032	10.1371/journal.pone.0262032	http://dx.doi.org/10.1371/journal.pone.0262032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972156	gold, Green Published			2022-12-26	WOS:000773555700086
J	Sacchetti, S; McGlone, F; Cazzato, V; Mirams, L				Sacchetti, Sofia; McGlone, Francis; Cazzato, Valentina; Mirams, Laura			The off-line effect of affective touch on multisensory integration and tactile perceptual accuracy during the somatic signal detection task	PLOS ONE			English	Article							DYSMORPHIC CONCERN; UNMYELINATED AFFERENTS; PLEASANT TOUCH; VIBROTACTILE; STROKING; FEEL; PSYCHOPHYSICS; BRAIN	Affective touch refers to the emotional and motivational facets of tactile sensation and has been linked to the activation of a specialised system of mechanosensory afferents (the CT system), that respond optimally to slow caress-like touch. Affective touch has been shown to play an important role in the building of the bodily self: the multisensory integrated global awareness of one's own body. Here we investigated the effects of affective touch on subsequent tactile awareness and multisensory integration using the Somatic Signal Detection Task (SSDT). During the SSDT, participants were required to detect near-threshold tactile stimulation on their cheek, in the presence/absence of a concomitant light. Participants repeated the SSDT twice, before and after receiving a touch manipulation. Participants were divided into two groups: one received affective touch (CT optimal; n = 32), and the second received non-affective touch (non-CT optimal; n = 34). Levels of arousal (skin conductance levels, SCLs) and mood changes after the touch manipulation were also measured. Affective touch led to an increase in tactile accuracy, as indicated by less false reports of touch and a trend towards higher tactile sensitivity during the subsequent SSDT. Conversely, non-affective touch was found to induce a partial decrease in the correct detection of touch possibly due to a desensitization of skin mechanoreceptors. Both affective and non-affective touch induced a more positive mood and higher SCLs in participants. The increase in SCLs was greater after affective touch. We conclude that receiving affective touch enhances the sense of bodily self therefore increasing perceptual accuracy and awareness. Higher SCLs are suggested to be a possible mediator linking affective touch to a greater tactile accuracy. Clinical implications are discussed.	[Sacchetti, Sofia; McGlone, Francis; Cazzato, Valentina; Mirams, Laura] Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England	Liverpool John Moores University; University of Liverpool	Sacchetti, S (corresponding author), Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England.	S.V.Sacchetti@2017.ljmu.ac.uk	Cazzato, Valentina/GLV-4402-2022	Sacchetti, Sofia/0000-0002-8130-983X; Cazzato, Valentina/0000-0001-9826-7798; Mirams, Laura/0000-0002-5176-1200	Early Career Researcher PhD Studentship bursary from Liverpool John Moores University	Early Career Researcher PhD Studentship bursary from Liverpool John Moores University	This work was supported by an Early Career Researcher PhD Studentship bursary from Liverpool John Moores University.	Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Boucsein W., 2012, SPRINGER SCI BUSINES; Cabrera A, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1596; Case LK, 2016, J NEUROSCI, V36, P5850, DOI 10.1523/JNEUROSCI.1130-15.2016; Ciaunica A, 2017, EMBODIMENT, ENACTION, AND CULTURE: INVESTIGATING THE CONSTITUTION OF THE SHARED WORLD, P173; Clausen L, 2011, J PSYCHOPATHOL BEHAV, V33, P101, DOI 10.1007/s10862-010-9207-4; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Croy I, 2016, BEHAV BRAIN RES, V297, P37, DOI 10.1016/j.bbr.2015.09.038; Crucianelli L, 2018, CORTEX, V104, P180, DOI 10.1016/j.cortex.2017.04.018; Crucianelli Laura, 2013, Front Psychol, V4, P703, DOI 10.3389/fpsyg.2013.00703; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Fairhurst MT, 2014, PSYCHOL SCI, V25, P1124, DOI 10.1177/0956797614527114; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Garner D.M, 2004, EATING DISORDER INVE; Gazzola V, 2012, P NATL ACAD SCI USA, V109, pE1657, DOI 10.1073/pnas.1113211109; Gentsch A., 2016, AFFECTIVE TOUCH NEUR, P355; GESCHEIDER GA, 1985, J ACOUST SOC AM, V78, P534, DOI 10.1121/1.392475; Haggarty CJ, 2020, EUR J NEUROSCI, V51, P1844, DOI 10.1111/ejn.14637; Harjunen VJ, 2017, PERS INDIV DIFFER, V107, P88, DOI 10.1016/j.paid.2016.11.047; Harris JA, 2007, J NEUROSCI, V27, P7136, DOI 10.1523/JNEUROSCI.2102-07.2007; Hasson D., 2005, International Electronic Journal of Health Education, V8, P178; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Howell D. C., 2012, CENGAGE LEARNING; Jenkinson PM, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa034; Jorgensen L, 2001, AUST NZ J PSYCHIAT, V35, P124, DOI 10.1046/j.1440-1614.2001.00860.x; Katzer A, 2012, J ABNORM PSYCHOL, V121, P530, DOI 10.1037/a0026536; Krahe C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32865-6; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Lloyd DM, 2008, J PSYCHOSOM RES, V64, P21, DOI 10.1016/j.jpsychores.2007.06.004; Lloyd DM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00207; Lloyd DM, 2011, NEUROPSYCHOLOGIA, V49, P3430, DOI 10.1016/j.neuropsychologia.2011.08.018; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Lush P, 2020, COLLABRA-PSYCHOL, V6, DOI 10.1525/collabra.325; Macmillan N. A., 2004, DETECTION THEORY USE; Mancuso SG, 2010, AUST NZ J PSYCHIAT, V44, P535, DOI 10.3109/00048671003596055; Marotta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168489; Marshall AG, 2019, ELIFE, V8, DOI 10.7554/eLife.51642; Mayo LM, 2018, BIOL PSYCHOL, V137, P83, DOI 10.1016/j.biopsycho.2018.07.001; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; McKenzie KJ, 2010, PERCEPTION, V39, P839, DOI 10.1068/p6401; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; Mirams L, 2017, EXP BRAIN RES, V235, P2591, DOI 10.1007/s00221-017-4998-0; Mirams L, 2012, Q J EXP PSYCHOL, V65, P926, DOI 10.1080/17470218.2011.636823; Mirams L, 2010, EXP BRAIN RES, V202, P787, DOI 10.1007/s00221-010-2185-7; Morrison I, 2016, HUM BRAIN MAPP, V37, P1308, DOI 10.1002/hbm.23103; Morrison I, 2012, CURR BIOL, V22, pR77, DOI 10.1016/j.cub.2011.11.032; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; OHNHAUS EE, 1975, PAIN, V1, P379, DOI 10.1016/0304-3959(75)90075-5; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oosthuizen P, 1998, AUST NZ J PSYCHIAT, V32, P129, DOI 10.3109/00048679809062719; Panagiotopoulou E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13345-9; Pawling R, 2017, BIOL PSYCHOL, V129, P186, DOI 10.1016/j.biopsycho.2017.08.057; Pawling R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173457; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Porges S.W., 1993, BODY PERCEPTION QUES, V10, P2009; Ree A, 2019, BIOL PSYCHOL, V140, P55, DOI 10.1016/j.biopsycho.2018.11.006; Russo V, 2020, NEUROSCI BIOBEHAV R, V108, P445, DOI 10.1016/j.neubiorev.2019.09.037; Sacchetti S., 2021, PSYCHOL RES-PSYCH FO; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Triscoli C, 2017, BIOL PSYCHOL, V128, P71, DOI 10.1016/j.biopsycho.2017.07.007; Triscoli C, 2017, PHYSIOL BEHAV, V177, P169, DOI 10.1016/j.physbeh.2017.05.006; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; van Stralen HE, 2011, PHILOS T R SOC B, V366, P3142, DOI 10.1098/rstb.2011.0163; van Stralen HE, 2014, COGNITION, V131, P147, DOI 10.1016/j.cognition.2013.11.020; VERRILLO RT, 1985, J ACOUST SOC AM, V77, P225, DOI 10.1121/1.392263; von Mohr M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13355-7; Wald A., 2004, COURIER CORPORATION; Watkins RH, 2021, J NEUROPHYSIOL, V125, P232, DOI 10.1152/jn.00587.2020; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002	79	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261060	10.1371/journal.pone.0261060	http://dx.doi.org/10.1371/journal.pone.0261060			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972120	Green Published, Green Accepted, gold			2022-12-26	WOS:000773555700021
J	Blanchflower, DG; Bryson, A				Blanchflower, David G.; Bryson, Alex			Further decoding the mystery of American pain: The importance of work	PLOS ONE			English	Article							UNHAPPINESS	A recent paper showed that, whereas we expect pain to rise with age due to accumulated injury, physical wear and tear, and disease, the elderly in America report less pain than those in midlife. Further exploration revealed this pattern was confined to the less educated. The authors called this the 'mystery of American pain' since pain appears to rise with age in other countries irrespective of education. Revisiting this issue with the same cross-sectional data we show that what matters in explaining pain through to age 65 is whether one is working or not. The incidence of pain across the life-course is nearly identical for workers in America and elsewhere, but it is greater for non-working Americans than it is for non-workers elsewhere. As in other countries, pain is hump-shaped in age among those Americans out of work but rises a little over the life-course for those in work. Furthermore, these patterns are apparent within educational groups. We show that, if one ascribes age-specific employment rates from other OECD countries to Americans, the age profile of pain in the United States is more similar to that found elsewhere in the OECD. This is because employment rates are lower in the United States than elsewhere between ages 30 and 60: the simulation reduces the pain contribution of these non-workers to overall pain in America, so it looks somewhat similar to pain elsewhere. We conclude that what matters in explaining pain over the life-course is whether one is working or not and once that is accounted for, the patterns are consistent across the United States and the rest of the OECD.	[Blanchflower, David G.; Bryson, Alex] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Bryson, Alex] Univ London, Inst Social Res, London, England	Dartmouth College; University of London	Bryson, A (corresponding author), Univ London, Inst Social Res, London, England.	a.bryson@ucl.ac.uk		Blanchflower, David/0000-0002-2856-7039; Bryson, Alex/0000-0003-1529-2010				Aaronson S, 2014, BROOKINGS PAP ECO AC, P197; Abraham Katharine G., 2018, 24333 NBER; Blanchflower D. G, 2021, NOT WORKING HAVE ALL; Blanchflower DG, 2020, REV BEHAV ECON, V7, P197, DOI 10.1561/105.00000120; Blanchflower DG, 2020, J ECON BEHAV ORGAN, V176, P461, DOI 10.1016/j.jebo.2020.04.022; Blanchflower DG, 2019, J ECON LIT, V57, P385, DOI 10.1257/jel.20171492; Bloom N, 2012, AM ECON REV, V102, P167, DOI 10.1257/aer.102.1.167; Case A, 2020, DEATHS OF DESPAIR AND THE FUTURE OF CAPITALISM, P1; Case A, 2020, P NATL ACAD SCI USA, V117, P24785, DOI 10.1073/pnas.2012350117; Case A, 2017, BROOKINGS PAP ECO AC, P397; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; El-Jahel L., 2020, DOES MONETARY POLCY; Feenstra RC, 2018, REV INT ECON, V26, P1053, DOI 10.1111/roie.12370; Graham C, 2021, SOC SCI MED, V270, DOI 10.1016/j.socscimed.2020.113612; Graham C, 2019, J POPUL ECON, V32, P665, DOI 10.1007/s00148-018-0687-y; Hudomiet P., 2021, J EC BEHAV ORG; Inst Med, 2011, RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH, P1; Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X; Krueger AB, 2017, BROOKINGS PAP ECO AC, P1, DOI 10.1353/eca.2017.0012; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Piper A., 2021, 28863 NBER; Sadun Raffaella, 2016, HARVARD BUSINESS SCH, DOI 10.3386/w22327.; Winkelmann L, 1998, ECONOMICA, V65, P1, DOI 10.1111/1468-0335.00111	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261891	10.1371/journal.pone.0261891	http://dx.doi.org/10.1371/journal.pone.0261891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025882	Green Submitted, Green Published, gold			2022-12-26	WOS:000796264200031
J	Chu, AMY; Chan, TWC; So, MKP				Chu, Amanda M. Y.; Chan, Thomas W. C.; So, Mike K. P.			Learning from work-from-home issues during the COVID-19 pandemic: Balance speaks louder than words	PLOS ONE			English	Article							SLEEP QUALITY; STRESS; FAMILY; IMPACT; PRODUCTIVITY; SATISFACTION; WORKPLACE; OUTCOMES; SUPPORT; MINDSET	During the 2019 novel coronavirus disease (COVID-19) pandemic, many employees have switched to working from home. Despite the findings of previous research that working from home can improve productivity, the scale, nature, and purpose of those studies are not the same as in the current situation with the COVID-19 pandemic. We studied the effects that three stress relievers of the work-from-home environment-company support, supervisor's trust in the subordinate, and work-life balance-had on employees' psychological well-being (stress and happiness), which in turn influenced productivity and engagement in non-work-related activities during working hours. In order to collect honest responses on sensitive questions or negative forms of behavior including stress and non-work-related activities, we adopted the randomized response technique in the survey design to minimize response bias. We collected a total of 500 valid responses and analyzed the results with structural equation modelling. We found that among the three stress relievers, work-life balance was the only significant construct that affected psychological well-being. Stress when working from home promoted non-work-related activities during working hours, whereas happiness improved productivity. Interestingly, non-work-related activities had no significant effect on productivity. The research findings provide evidence that management's maintenance of a healthy work-life balance for colleagues when they are working from home is important for supporting their psychosocial well-being and in turn upholding their work productivity.	[Chu, Amanda M. Y.] Educ Univ Hong Kong, Dept Social Sci, Tai Po, Hong Kong, Peoples R China; [Chan, Thomas W. C.; So, Mike K. P.] Hong Kong Univ Sci & Technol, Dept Informat Syst Business Stat & Operat Managem, Clear Water Bay, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); Hong Kong University of Science & Technology	Chu, AMY (corresponding author), Educ Univ Hong Kong, Dept Social Sci, Tai Po, Hong Kong, Peoples R China.	amandachu@eduhk.hk		Chu, Amanda/0000-0002-9543-747X; Chan, Wing Chun/0000-0002-3412-4234	Hong Kong University of Science and Technology research grant "Big Data Analytics on Social Research" [CEF20BM04]	Hong Kong University of Science and Technology research grant "Big Data Analytics on Social Research"	This work was partially supported by the Hong Kong University of Science and Technology research grant "Big Data Analytics on Social Research" (grant number CEF20BM04). The funding recipient was MKPS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altena E, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13052; Azeem S.M., 2014, INT J HUMAN RESOURCE, V4, P18; Barrero JM., 2020, SSRN ELECT J; Bayrak T, 2012, TELEMAT INFORMAT, V29, P286, DOI 10.1016/j.tele.2011.10.002; Beck MJ, 2020, TRANSPORT POLICY, V99, P95, DOI 10.1016/j.tranpol.2020.08.004; Belanger F, 2002, COMMUN ACM, V45, P64, DOI 10.1145/502269.502299; Bell A.S., 2012, E J APPL PSYCHOL, V8, P25, DOI DOI 10.7790/EJAP.V8I1.320; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bentley TA, 2016, APPL ERGON, V52, P207, DOI 10.1016/j.apergo.2015.07.019; Bialowolski P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230562; Casper A, 2017, EUR J WORK ORGAN PSY, V26, P798, DOI 10.1080/1359432X.2017.1374947; Chaiprasit K, 2011, PROCD SOC BEHV, V25, DOI 10.1016/j.sbspro.2011.10.540; Chanana N, 2021, J PUBLIC AFF, V21, DOI 10.1002/pa.2508; Chong ACY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060970; Chu AMY, 2020, STAT METHODS MED RES, V29, P894, DOI 10.1177/0962280219847492; Chu AMY, 2015, COMMUN ASSOC INF SYS, V37, P510; Colligan TW, 2006, J WORKPLACE BEHAV HE, V21, P89, DOI 10.1300/J490v21n02_07; Cooper CD, 2002, J ORGAN BEHAV, V23, P511, DOI 10.1002/job.145; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crosbie T., 2004, SOC POLICY SOC, V3, P223, DOI DOI 10.1017/S1474746404001733; Crum AJ, 2017, ANXIETY STRESS COPIN, V30, P379, DOI 10.1080/10615806.2016.1275585; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; Delanoeije J, 2019, HUM RELAT, V72, P1843, DOI 10.1177/0018726718823071; Derks D, 2016, HUM RELAT, V69, P1045, DOI 10.1177/0018726715601890; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; dos Santos PM, 2021, COMMUN STAT-SIMUL C, DOI 10.1080/03610918.2021.1888122; Endicott J, 1997, PSYCHOPHARMACOL BULL, V33, P13; Fadinger H., 2020, COVID EC VETTED REAL; Fisher-Mcauley Gwenith, 2003, MODELING RELATIONSHI; Ford D., 2020, CBC NEWS; FORD JK, 1986, PERS PSYCHOL, V39, P291, DOI 10.1111/j.1744-6570.1986.tb00583.x; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gefen D., 2000, COMMUN ASSOC INF SYS, V4, DOI [10.17705/1cais.00407, DOI 10.17705/1CAIS.00407, 10.17705/1CAIS.00407]; Gefen D, 2005, COMMUN ASSOC INF SYS, V16, P91, DOI 10.17705/1CAIS.01605; Green N., 2020, NZ J EMPLOY RELATION, V45; Gupta R, 2020, INDIAN J PSYCHIAT, V62, P370, DOI 10.4103/psychiatry.IndianJPsychiatry_523_20; Haar JM, 2014, J VOCAT BEHAV, V85, P361, DOI 10.1016/j.jvb.2014.08.010; Halkos G, 2010, INT J PRODUCT PERFOR, V59, P415, DOI 10.1108/17410401011052869; Hill EJ, 2001, FAM RELAT, V50, P49, DOI 10.1111/j.1741-3729.2001.00049.x; Hoffman KE, 2020, INT J RADIAT ONCOL, V108, P370, DOI 10.1016/j.ijrobp.2020.06.062; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Javed A, 2019, J ADV NURS, V75, P2820, DOI 10.1111/jan.14167; Kelliher C, 2010, HUM RELAT, V63, P83, DOI 10.1177/0018726709349199; Kjellberg A, 2010, WORK, V36, P9, DOI 10.3233/WOR-2010-1003; Knudsen HK, 2007, SOC SCI MED, V64, P1997, DOI 10.1016/j.socscimed.2007.02.020; Kossek EE., 2015, WORKPLACE FLEXIBILIT, V1, DOI [10.1093/oxfordhb/9780199337538.001.0001/oxfordhb-9780199337538-e-19, DOI 10.1093/OXFORDHB/9780199337538.001.0001/OXFORDHB-9780199337538-E-19]; Kowalski KB, 2005, BENCHMARKING, V12, P236, DOI 10.1108/14635770510600357; Kramer A., 2020, J VOCAT BEHAV, V119; Kruse K., 2012, FORBES; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; McBride DL, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4001; Nakrosiene A, 2019, INT J MANPOWER, V40, P87, DOI 10.1108/IJM-07-2017-0172; Oravec JA, 2002, COMMUN ACM, V45, P60, DOI 10.1145/502269.502298; Oswald AJ, 2015, J LABOR ECON, V33, P789, DOI 10.1086/681096; Pee LG, 2008, INFORM MANAGE-AMSTER, V45, P120, DOI 10.1016/j.im.2008.01.004; Petreanu V, 2013, PROCD SOC BEHV, V92, P420, DOI 10.1016/j.sbspro.2013.08.695; Robertson I, 2011, WELL-BEING: PRODUCTIVITY AND HAPPINESS AT WORK, P1, DOI 10.1057/9780230306738; Rohail I., 2020, FDN U J PSYCHOL, V4, P5; Russell JoyceE.A, 2013, WASH POST; Sgroi Daniel, 2015, SOC MARK FDN; Simpser A, 2017, SSRN ELECT J; Staples D. S., 2001, Journal of End User Computing, V13, P3, DOI 10.4018/joeuc.2001040101; Steiger JH, 1980, ANN M PSYCH SOC 1980; Sull C., 2020, MIT SLOAN MANAGE REV, V61, P1; Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206; TANAKA JS, 1985, BRIT J MATH STAT PSY, V38, P197, DOI 10.1111/j.2044-8317.1985.tb00834.x; Tiwari A, 2021, INT J INFECT DIS, V103, P97, DOI 10.1016/j.ijid.2020.11.143; Toniolo-Barrios M, 2021, BUS HORIZONS, V64, P189, DOI 10.1016/j.bushor.2020.09.004; Versey HS, 2015, DEV PSYCHOL, V51, P1672, DOI 10.1037/a0039607; Vyas L, 2021, POLICY DES PRACT, V4, P59, DOI 10.1080/25741292.2020.1863560; Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417; Wang J, 2001, J Occup Health Psychol, V6, P283, DOI 10.1037/1076-8998.6.4.283; West S. G., 1995, STRUCTURAL EQUATION, P56; Wong LC, 2014, RES SOCIAL WORK PRAC, V24, P356, DOI 10.1177/1049731513498622; Wright T A, 2000, J Occup Health Psychol, V5, P84, DOI 10.1037/1076-8998.5.1.84	76	7	7	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261969	10.1371/journal.pone.0261969	http://dx.doi.org/10.1371/journal.pone.0261969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025893	Green Published, gold			2022-12-26	WOS:000796264200039
J	Glatz, M; Riedl, R; Glatz, W; Schneider, M; Wedrich, A; Bolz, M; Strauss, RW				Glatz, Marlene; Riedl, Regina; Glatz, Wilfried; Schneider, Mona; Wedrich, Andreas; Bolz, Matthias; Strauss, Rupert W.			Blindness and visual impairment in Central Europe	PLOS ONE			English	Article							QUALITY-OF-LIFE; REGISTERED BLINDNESS; DIABETIC-RETINOPATHY; VISION IMPAIRMENT; ADULT-POPULATION; TRENDS; PREVALENCE; IMPACT; REGISTRATION; MORTALITY	Purpose To assess the prevalence and causes of visual impairment and blindness in a Central European country. The findings may have implications for the planning of further research and development of therapies in order to prevent blindness. Setting Department of Ophthalmology, Medical University of Graz, Austria. Design Retrospective, epidemiological study. Methods The database of the Main Confederation of Austrian Social Insurances was searched for patients with visual impairment, legal blindness or deaf-blindness. This database gathers data from patients of all insurance providers in the country who receive care due to visual impairment and blindness. To determine the prevalence of these conditions, the number of all entries recorded in February 2019 was evaluated. Additionally, all new entries between (January 1(st),) 2017, and (December 31(st),) 2018, were analysed for distinct characteristics, such as sex, the cause of blindness/visual impairment, and age. Since health care allowances can provide a considerable source of income (459.90Euro-936.90Euro per month), good coverage of practically all patients who are blind and visually impaired in the country can be assumed. Results On February 2(nd), 2019, 17,730 patients with visual impairments, blindness or deaf-blindness were registered in Austria, resulting in a prevalence of these diagnoses of 0.2% in the country. During the observational period from 2017 to 2018, 4040 persons met the inclusion criteria. Of these, 2877 were female (65.3%), and 1527 were male (34.7%). The mean age was 75.7 18.0 years (median 82). Most patients (n = 3675, 83.4%) were of retirement age, while 729 (16.6%) were working-age adults or minors. In total, an incidence of 25.0 (95% confidence limit (CL) 24.3-25.8) per 100,000 person-years was observed from 2017 to 2018. A higher incidence was observed for females (32.2, 95% CL 31.0-33.3) than for males (17.7, 95% CL 16.8-18.5). Incidences where higher for males in lower age groups (e.g. 10-14 years: rate ratio RR = 2.7, 95% CL 1.1-6.8), and higher for females in higher age groups (e.g. 70-74 years: RR = 0.6, 95% CL 0.5-0.8). In total, the most frequent diagnoses were macular degeneration (1075 persons, 24.4%), other retinal disorders (493 persons, 11.2%) and inherited retinal and choroidal diseases (IRDs) (186 persons, 4.2%). Persons with IRDs were significantly younger compared to persons with macular degeneration or retinal disorders (IRDs: median 57, range 2-96 vs 83, 5-98 and 82, 1-98 years, p<0.001). For persons of retirement age, macular degeneration, other retinal disorders and glaucoma were the three most frequent diagnoses. In contrast, among working-aged adults and children, IRDs were the leading cause of visual impairment and blindness (103 persons, 14.1%). Conclusion These data show that IRDs are the leading cause of blindness and visual impairment in working-aged persons and children in Austria. Thus, these findings suggest to draw attention to enhance further research in the fields of emerging therapies for IRDs.	[Glatz, Marlene; Glatz, Wilfried; Schneider, Mona; Wedrich, Andreas; Strauss, Rupert W.] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Riedl, Regina] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Bolz, Matthias; Strauss, Rupert W.] Kepler Univ Clin Linz, Dept Ophthalmol, Linz, Austria; [Strauss, Rupert W.] Inst Mol & Clin Ophthalmol, Basel, Switzerland; [Strauss, Rupert W.] Moorfields Eye Hosp, London, England; [Strauss, Rupert W.] UCL, Inst Ophthalmol, London, England	Medical University of Graz; Medical University of Graz; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Strauss, RW (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.; Strauss, RW (corresponding author), Kepler Univ Clin Linz, Dept Ophthalmol, Linz, Austria.; Strauss, RW (corresponding author), Inst Mol & Clin Ophthalmol, Basel, Switzerland.; Strauss, RW (corresponding author), Moorfields Eye Hosp, London, England.; Strauss, RW (corresponding author), UCL, Inst Ophthalmol, London, England.	r.strauss@medunigraz.at	Bolz, Matthias/HCI-0622-2022					Abou-Gareeb I, 2001, Ophthalmic Epidemiol, V8, P39, DOI 10.1076/opep.8.1.39.1540; Avisar R, 2006, ISRAEL MED ASSOC J, V8, P880; Bamashmus MA, 2004, EYE, V18, P257, DOI 10.1038/sj.eye.6700606; Barry RJ, 2005, BRIT J OPHTHALMOL, V89, P995, DOI 10.1136/bjo.2004.059915; Berdeaux G, 2007, OPHTHAL EPIDEMIOL, V14, P80, DOI 10.1080/09286580600899691; Bertelsen M, 2015, ACTA OPHTHALMOL, V93, P134, DOI 10.1111/aos.12467; Bourne RRA, 2018, BRIT J OPHTHALMOL, V102, P575, DOI 10.1136/bjophthalmol-2017-311258; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Chakravarthy U, 2017, OPHTHAL EPIDEMIOL, V24, P239, DOI 10.1080/09286586.2017.1281426; Chaumet-Riffaud AE, 2017, AM J OPHTHALMOL, V177, P169, DOI 10.1016/j.ajo.2017.02.016; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Crewe JM, 2013, BRIT J OPHTHALMOL, V97, P1579, DOI 10.1136/bjophthalmol-2013-303993; Crewe JM, 2011, CLIN EXP OPHTHALMOL, V39, P336, DOI 10.1111/j.1442-9071.2010.02466.x; Cruciani F, 2011, CLIN TER, V162, pE35; Cruciani F, 2010, CLIN TER, V161, pE11; Finger RP, 2011, BRIT J OPHTHALMOL, V95, P1061, DOI 10.1136/bjo.2010.194712; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Galvin O, 2020, CLIN OPHTHALMOL, V14, P707, DOI 10.2147/OPTH.S241928; Gilbert C, 2003, BMJ-BRIT MED J, V327, P760, DOI 10.1136/bmj.327.7418.760; Gruntman AM, 2018, FASEB J, V32, P1733, DOI 10.1096/fj.201700982R; Kelliher C, 2006, BRIT J OPHTHALMOL, V90, P367, DOI 10.1136/bjo.2005.075861; Kellner U, 2012, Klin Monbl Augenheilkd, V229, P171, DOI 10.1055/s-0031-1280461; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Malik ANJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001496; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Munier A, 1998, BRIT J OPHTHALMOL, V82, P630, DOI 10.1136/bjo.82.6.630; Nemeth J, 2019, EUR J OPHTHALMOL, V29, P129, DOI 10.1177/1120672118819397; Quartilho A, 2016, EYE, V30, P602, DOI 10.1038/eye.2015.288; Rosenberg T, 1996, ACTA OPHTHALMOL SCAN, V74, P395; Scholl HPN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2838; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Wong EYH, 2008, OPHTHAL EPIDEMIOL, V15, P339, DOI 10.1080/09286580802227394; Wong TY, 2018, OPHTHALMOLOGY, V125, P1608, DOI 10.1016/j.ophtha.2018.04.007; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Yong VK, 2006, OPHTHAL EPIDEMIOL, V13, P35, DOI 10.1080/09286580500473779; Zatic T, 2015, BRIT J OPHTHALMOL, V99, P832, DOI 10.1136/bjophthalmol-2014-305824; Zheng Yingfeng, 2012, Indian J Ophthalmol, V60, P428, DOI 10.4103/0301-4738.100542	39	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261897	10.1371/journal.pone.0261897	http://dx.doi.org/10.1371/journal.pone.0261897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025896	gold, Green Published			2022-12-26	WOS:000796264200032
J	Jung, H; Ko, RE; Ko, MG; Jeon, K				Jung, Hohyung; Ko, Ryoung-Eun; Ko, Myeong Gyun; Jeon, Kyeongman			Trends of in-hospital cardiac arrests in a single tertiary hospital with a mature rapid response system	PLOS ONE			English	Article							MEDICAL EMERGENCY TEAM; CARDIOPULMONARY-RESUSCITATION; NEW-ZEALAND; OUTCOMES; IMPLEMENTATION; EPIDEMIOLOGY; ANTECEDENTS; AUSTRALIA; DEATHS; CARE	Background Most studies on rapid response system (RRS) have simply focused on its role and effectiveness in reducing in-hospital cardiac arrests (IHCAs) or hospital mortality, regardless of the predictability of IHCA. This study aimed to identify the characteristics of IHCAs including predictability of the IHCAs as our RRS matures for 10 years, to determine the best measure for RRS evaluation. Methods Data on all consecutive adult patients who experienced IHCA and received cardiopulmonary resuscitation in general wards between January 2010 and December 2019 were reviewed. IHCAs were classified into three groups: preventable IHCA (P-IHCA), non-preventable IHCA (NP-IHCA), and inevitable IHCA (I-IHCA). The annual changes of three groups of IHCAs were analyzed with Poisson regression models. Results Of a total of 800 IHCA patients, 149 (18.6%) had P-IHCA, 465 (58.1%) had NP-IHCA, and 186 (23.2%) had I-IHCA. The number of the RRS activations increased significantly from 1,164 in 2010 to 1,560 in 2019 (P = 0.009), and in-hospital mortality rate was significantly decreased from 9.20/1,000 patients in 2010 to 7.23/1000 patients in 2019 (P = 0.009). The trend for the overall IHCA rate was stable, from 0.77/1,000 patients in 2010 to 1.06/1,000 patients in 2019 (P = 0.929). However, while the incidence of NP-IHCA (P = 0.927) and I-IHCA (P = 0.421) was relatively unchanged over time, the incidence of P-IHCA decreased from 0.19/1,000 patients in 2010 to 0.12/1,000 patients in 2019 (P = 0.025). Conclusions The incidence of P-IHCA could be a quality metric to measure the clinical outcomes of RRS implementation and maturation than overall IHCAs.	[Jung, Hohyung; Ko, Ryoung-Eun; Jeon, Kyeongman] Sungkyunkwan Univ, Dept Crit Care Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Ko, Myeong Gyun] Sungkyunkwan Univ, Intens Care Unit, Samsung Med Ctr, Nursing Dept,Sch Med, Seoul, South Korea; [Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med,Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Dept Crit Care Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.; Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med,Samsung Med Ctr, Seoul, South Korea.	kjeon@skku.edu	Jeon, Kyeongman/F-5963-2019	Jeon, Kyeongman/0000-0002-4822-1772; Jung, Hohyung/0000-0002-5536-5483	Samsung Medical Center grant [SMO1200901]	Samsung Medical Center grant(Samsung)	This work was supported by a Samsung Medical Center grant (SMO1200901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett J, 2018, INTERN MED J, V48, P264, DOI 10.1111/imj.13676; Boniatti MM, 2014, CRIT CARE MED, V42, P26, DOI 10.1097/CCM.0b013e31829e53b9; Calzavacca P, 2008, INTENS CARE MED, V34, P2112, DOI 10.1007/s00134-008-1229-y; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Egol A, 1999, CRIT CARE MED, V27, P633; Fennessy G, 2016, INTERN MED J, V46, P1172, DOI 10.1111/imj.13039; Field RA, 2014, RESUSCITATION, V85, P1418, DOI 10.1016/j.resuscitation.2014.08.024; Findlay GSH, 2012, REPORT NATL CONFIDEN; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Galhotra S, 2007, QUAL SAF HEALTH CARE, V16, P260, DOI 10.1136/qshc.2007.022210; Georgiou L, 2019, INT J EMERG MED, V12, DOI 10.1186/s12245-019-0225-z; Herod R, 2014, RESUSCITATION, V85, P1083, DOI 10.1016/j.resuscitation.2014.04.010; Hodgetts TJ, 2002, RESUSCITATION, V54, P115, DOI 10.1016/S0300-9572(02)00098-9; Johnson Mae, 2017, BMJ Qual Improv Rep, V6, DOI 10.1136/bmjquality.u213254.w6626; Jones D, 2017, BRIT J HOSP MED, V78, P137, DOI 10.12968/hmed.2017.78.3.137; Kause J, 2004, RESUSCITATION, V62, P275, DOI 10.1016/j.resuscitation.2004.05.016; Kurita T, 2020, AM J EMERG MED, V38, P1327, DOI 10.1016/j.ajem.2019.10.028; Lee DS, 2015, CRIT CARE MED, V43, P1439, DOI 10.1097/CCM.0000000000000989; Lim SY, 2011, J CRIT CARE, V26, P373, DOI 10.1016/j.jcrc.2010.08.019; Lyons PG, 2018, RESUSCITATION, V128, P191, DOI 10.1016/j.resuscitation.2018.05.013; MCGRATH RB, 1987, ANN EMERG MED, V16, P1365, DOI 10.1016/S0196-0644(87)80420-1; Moriarty JP, 2014, INT J QUAL HEALTH C, V26, P49, DOI 10.1093/intqhc/mzt091; Na SJ, 2020, CRIT CARE MED, V48, pE1029, DOI 10.1097/CCM.0000000000004571; Peberdy MA, 2007, CIRCULATION, V116, P2481, DOI 10.1161/CIRCULATIONAHA.107.186227; Santamaria J, 2010, CRIT CARE MED, V38, P445, DOI 10.1097/CCM.0b013e3181cb0ff1; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; Smith AF, 1998, RESUSCITATION, V37, P133, DOI 10.1016/S0300-9572(98)00056-2; Smith RL, 2014, CRIT CARE MED, V42, P322, DOI 10.1097/CCM.0b013e3182a27413; Song JU, 2012, INTENS CARE MED, V38, P1505, DOI 10.1007/s00134-012-2594-0; Subbe CP, 2019, RESUSCITATION, V141, P1, DOI 10.1016/j.resuscitation.2019.05.012; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Winters BD, 2013, ANN INTERN MED, V158, P417, DOI 10.7326/0003-4819-158-5-201303051-00009	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262541	10.1371/journal.pone.0262541	http://dx.doi.org/10.1371/journal.pone.0262541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025978	Green Published, gold			2022-12-26	WOS:000796264200081
J	Kruger, D; Lahoud, N; Yako, YY; Dever, J; Smith, M				Kruger, Deirdre; Lahoud, Nicola; Yako, Yandiswa Y.; Dever, John; Smith, Martin			Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; RISK-FACTORS; PLATELET COUNT; CANCER; SURVIVAL; THROMBOCYTOSIS; MARKERS	Background/Objectives Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy associated with high metastatic risk. Prognosis remains poor even after resection. Previously our group identified biomarkers that improved diagnostic accuracy in PDAC beyond the established diagnostic tumour marker, CA19-9. Risk factors, symptoms and circulating biomarkers associated with a PDAC diagnosis may differ from those that alter disease progression and metastasis. This study aimed at assessing the risk factors, presenting symptoms and potential prognostic biomarkers in PDAC and determine their relationship with PDAC stage and/ or metastatic status. Methods Seventy-two PDAC patients with imaging available for TNM staging at presentation were enrolled following informed consent. Demographic and clinical data were captured. Blood was collected and 38 cytokines/angiogenic factors measured. Nonparametric association tests, univariate and multivariate logistic regression were performed using STATA version 14.2. A p-value <= 0.05 was considered significant and odds ratios reported for effect size. Results Most risk factors and symptoms did not differ across the stages of cancer. Although male gender and smoking are risk factors for PDAC, the majority of study patients with metastatic PDAC were non-smoking females. In addition to CA19-9, the platelet count (p<0.01), IL-15 (p = 0.02) and GM-CSF (p<0.01) were significant, independent negative predictors of metastatic PDAC. Moreover, using specific cut-off values in a combined panel, the odds in a patient with all three biomarker levels below the cut-offs is 21 times more likely to have metastatic PDAC (p<0.0001). Conclusions Platelet count, IL-15 and GM-CSF are potential prognostic indicators of metastatic disease in PDAC patients from our local South African population.	[Kruger, Deirdre; Lahoud, Nicola; Yako, Yandiswa Y.; Dever, John; Smith, Martin] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Surg, Johannesburg, South Africa; [Dever, John; Smith, Martin] Chris Hani Baragwanath Acad Hosp, Dept Gen Surg, Hepatopancreatbiliary Unit, Johannesburg, South Africa; [Yako, Yandiswa Y.] Walter Sisulu Univ, Fac Hlth Sci, Dept Human Biol, Mthatha, South Africa	University of Witwatersrand; Walter Sisulu University	Kruger, D (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Surg, Johannesburg, South Africa.	Deirdre.Kruger@wits.ac.za		Kruger, Deirdre/0000-0002-3604-7682	MS. MRC CERCP15 Pancreas South African Medical Research Council	MS. MRC CERCP15 Pancreas South African Medical Research Council	MS. MRC CERCP15 Pancreas South African Medical Research Council www.samrc.ac.za MS conceived the study design, data interpretation, critically revised the manuscript and approved the final version.	Adamska A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071338; Aktekin Ali, 2019, Ann Hepatobiliary Pancreat Surg, V23, P155, DOI 10.14701/ahbps.2019.23.2.155; Almadi MA, 2013, SAUDI J GASTROENTERO, V19, P278, DOI 10.4103/1319-3767.121036; [Anonymous], 2004, N S W Public Health Bull, V15, P107; Arnaoutakis GJ, 2011, J GASTROINTEST SURG, V15, P1611, DOI 10.1007/s11605-011-1605-8; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Camara SN, 2016, J HUAZHONG U SCI-MED, V36, P295, DOI 10.1007/s11596-016-1583-x; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Chen S, 2018, ONCOTARGETS THER, V11, P59, DOI 10.2147/OTT.S147715; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Decoster C, 2016, ONCOTARGET, V7, P45634, DOI 10.18632/oncotarget.9861; Dominguez I, 2008, WORLD J SURG, V32, P1051, DOI 10.1007/s00268-007-9423-6; Evans J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004215; Gomez-Olive FX, 2017, GLOB HEART, V12, P81, DOI 10.1016/j.gheart.2017.01.007; He XY, 2014, WORLD J GASTROENTERO, V20, P11241, DOI 10.3748/wjg.v20.i32.11241; Hong IS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.64; Illes D, 2016, PANCREATOLOGY, V16, P266, DOI 10.1016/j.pan.2015.12.005; Keane MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005720; Kinney T, 2010, SURG CLIN N AM, V90, P235, DOI 10.1016/j.suc.2009.12.003; Kolodecik T, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00415; Kruger D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221169; Largillier R, 2008, ANN ONCOL, V19, P2012, DOI 10.1093/annonc/mdn424; Mann DV, 2000, EUR J SURG ONCOL, V26, P474, DOI 10.1053/ejso.1999.0925; Maraz A, 2013, ANTICANCER RES, V33, P1725; Marrelli D, 2009, AM J SURG, V198, P333, DOI 10.1016/j.amjsurg.2008.12.031; Martin HL, 2014, INTERN MED J, V44, P676, DOI 10.1111/imj.12453; Midha S, 2016, CANCER LETT, V381, P269, DOI 10.1016/j.canlet.2016.07.022; Mitsunaga S, 2016, PANCREAS, V45, P110, DOI 10.1097/MPA.0000000000000465; Miyamoto R, 2017, PANCREAS, V46, P35, DOI 10.1097/MPA.0000000000000697; Paniccia R, 2015, VASC HEALTH RISK MAN, V11, P133, DOI 10.2147/VHRM.S44469; Porta Miquel, 2005, Clin Transl Oncol, V7, P189, DOI 10.1007/BF02712816; Qi Q, 2015, PANCREATOLOGY, V15, P145, DOI 10.1016/j.pan.2014.12.004; Raptis DA, 2010, SURG-J R COLL SURG E, V8, P239, DOI 10.1016/j.surge.2010.03.001; Scarton L, 2018, CANCERS, V10, DOI 10.3390/cancers10070235; Schlesinger M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0669-2; Schulte A, 2014, EUR J CANCER, V50, P997, DOI 10.1016/j.ejca.2013.12.014; Schwarz RE, 1999, LANCET, V353, P2158, DOI 10.1016/S0140-6736(05)75597-5; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Stravodimou A, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/289563; Taucher S, 2003, THROMB HAEMOSTASIS, V89, P1098; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Voutsadakis IA, 2014, WORLD J GASTRO ONCOL, V6, P34, DOI 10.4251/wjgo.v6.i2.34; Wang L, 2015, INT J CLIN EXP MED, V8, P21215; Wei EK, 2010, J CLIN ONCOL, V28, P4052, DOI 10.1200/JCO.2009.26.9324; World Health Organization, 2014, CANC FACT SHEET; Xiao YY, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6250-8; Xiao YY, 2016, CANCER MED-US, V5, P881, DOI 10.1002/cam4.644; Yako YY, 2017, PANCREATOLOGY, V17, P438, DOI 10.1016/j.pan.2017.03.003; Yuan Y, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1139-5	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262439	10.1371/journal.pone.0262439	http://dx.doi.org/10.1371/journal.pone.0262439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020761	gold, Green Published			2022-12-26	WOS:000834207700041
J	Papaj, K; Spychalska, P; Kapica, P; Fischer, A; Nowak, J; Bzowka, M; Sellner, M; Lill, MA; Smiesko, M; Gora, A				Papaj, Katarzyna; Spychalska, Patrycja; Kapica, Patryk; Fischer, Andre; Nowak, Jakub; Bzowka, Maria; Sellner, Manuel; Lill, Markus A.; Smiesko, Martin; Gora, Artur			Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease	PLOS ONE			English	Article							CORONAVIRUS	Based on previous large-scale in silico screening several factor Xa inhibitors were proposed to potentially inhibit SARS-CoV-2 M-pro. In addition to their known anticoagulants activity this potential inhibition could have an additional therapeutic effect on patients with COVID-19 disease. In this study we examined the binding of the Apixaban, Betrixaban and Rivaroxaban to the SARS-CoV-2 M-pro with the use of the MicroScale Thermophoresis technique. Our results indicate that the experimentally measured binding affinity is weak and the therapeutic effect due to the SARS-CoV-2 M-pro inhibition is rather negligible.	[Papaj, Katarzyna; Spychalska, Patrycja; Kapica, Patryk; Bzowka, Maria; Gora, Artur] Silesian Tech Univ, Biotechnol Ctr, Tunneling Grp, Gliwice, Poland; [Fischer, Andre; Sellner, Manuel; Lill, Markus A.; Smiesko, Martin] Univ Basel, Dept Pharmaceut Sci, Computat Pharm, Basel, Switzerland; [Nowak, Jakub] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland	Silesian University of Technology; University of Basel; Jagiellonian University	Gora, A (corresponding author), Silesian Tech Univ, Biotechnol Ctr, Tunneling Grp, Gliwice, Poland.	a.gora@tunnelinggroup.pl	Nowak, Jakub Stanislaw/AFZ-0547-2022; Bzówka, Maria/ABG-2897-2020; Gora, Artur/D-5041-2012	Nowak, Jakub Stanislaw/0000-0001-6536-2940; Bzówka, Maria/0000-0001-6802-8753; Gora, Artur/0000-0003-2530-6957	Plastic Omnium Auto Sp. z o.o.	Plastic Omnium Auto Sp. z o.o.	KP, PS, PK, MB, AG -Plastic Omnium Auto Sp. z o.o. for support of the experimental part of this work. AF, MS1, MAL, MS2 -NVIDIA Corporation with the donation of a Titan Xp GPU used for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani RA, 2020, AM J CARDIOVASC DRUG, V20, P525, DOI 10.1007/s40256-020-00438-6; [Anonymous], 2019, SCHRODINGER RELEASE; Augusto Chaves O., 2021, BIORXIV; Biembengut IV, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200179; Billett HH, 2020, THROMB HAEMOSTASIS, V120, P1691, DOI 10.1055/s-0040-1720978; Bosch FTM, 2021, THROMB RES, V205, P106, DOI 10.1016/j.thromres.2021.07.008; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Bzowka M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093099; Chan NC, 2015, VASC HEALTH RISK MAN, V11, P343, DOI 10.2147/VHRM.S63060; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489; Du LY, 2007, BIOCHEM BIOPH RES CO, V359, P174, DOI 10.1016/j.bbrc.2007.05.092; Fischer A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042065; Fischer A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103626; Foerster KI, 2020, CLIN PHARMACOKINET, V59, P967, DOI 10.1007/s40262-020-00879-x; Gahlawat A, 2020, J CHEM INF MODEL, V60, P5781, DOI 10.1021/acs.jcim.0c00546; Ghosh AK, 2016, J MED CHEM, V59, P5172, DOI 10.1021/acs.jmedchem.5b01697; Gorlinger K, 2020, ANESTH ANALG, V131, P1324, DOI 10.1213/ANE.0000000000005147; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Jakowenko N, 2020, THROMB RES, V196, P276, DOI 10.1016/j.thromres.2020.09.002; Jimenez-Alberto A, 2020, COMPUT BIOL CHEM, V88, DOI 10.1016/j.compbiolchem.2020.107325; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Kabir AA, 2021, OPEN MED-WARSAW, V16, P1486, DOI 10.1515/med-2021-0354; Kanhed AM, 2021, MOL DIVERS, V25, P383, DOI 10.1007/s11030-020-10130-1; Kneller DW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16954-7; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Lee J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19662-4; Mazzini S, 2020, MOLECULES, V25, DOI 10.3390/molecules25163745; Pathak N, 2021, ACS NANO, V15, P857, DOI 10.1021/acsnano.0c07383; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shaw DE, 2014, INT CONF HIGH PERFOR, P41, DOI 10.1109/SC.2014.9; Siddiqui F, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619847524; Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817; Tungol A, 2011, J MANAGE CARE PHARM, V17, P685, DOI 10.18553/jmcp.2011.17.9.685; Ullrich S, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127377; World Health Organisation, COR DIS COVID 19 SIT; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405	37	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262482	10.1371/journal.pone.0262482	http://dx.doi.org/10.1371/journal.pone.0262482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015795	Green Published, gold			2022-12-26	WOS:000814820600027
J	Cho, HC; Huang, YL; Hung, JT; Hung, TH; Cheng, KC; Liu, YH; Kuo, MW; Wang, SH; Yu, AL; Yu, J				Cho, Huan-Chieh; Huang, Yenlin; Hung, Jung-Tung; Hung, Tsai-Hsien; Cheng, Kai-Chun; Liu, Yun-Hen; Kuo, Ming-Wei; Wang, Sheng-Hung; Yu, Alice L.; Yu, John			Puf-A promotes cancer progression by interacting with nucleophosmin in nucleolus	ONCOGENE			English	Article							CELL-CYCLE; TRANSCRIPTION FACTOR; RIBOSOME BIOGENESIS; BINDING-SITE; LUNG-CANCER; P53; TARGET; EXPRESSION; PROLIFERATION; RECOGNITION	Previously, we identified Puf-A as a novel member of Puf-family RNA-binding proteins; however, its biological functions remain obscure. Analysis of tumor samples of non-small cell lung cancer (NSCLC) showed that high Puf-A expression correlated with high histology grade and abnormal p53 status. Kaplan-Meier curve for overall survival revealed high expression of Puf-A to predict poor prognosis in stage I NSCLC. Among patients with colorectal cancer, high Puf-A expression also showed an adverse impact on overall survival. In lung cancer cell lines, downregulation of p53 increased Puf-A expression, and upregulation of p53 dampened its expression. However, luciferase reporter assays indicated that PUF-A locus harbored the p53-response element, but regulated Puf-A transcription indirectly. In vivo suppression of p53 in CCSP-rtTA/TetO-Cre/LSL-Kras(G12D)/p53(flox/flox) conditional mutant mice accelerated the progression of the Kras(G12D)-driven lung cancer, along with enhanced expression of Puf-A. Importantly, intranasal delivery of shPuf-A to the inducible Kras(G12D)/p53(flox/flox) mice suppressed tumor progression. Puf-A silencing led to marked decreases in the 80S ribosomes, along with decrease in S6 and L5 in the cytoplasm and accumulation in the nucleolus. Based on immunofluorescence staining and immunoprecipitation studies, Puf-A interacted with NPM1 in nucleolus. Puf-A silencing resulted in NPM1 translocation from nucleolus to nucleoplasm and this disruption of NPM1 localization was reversed by a rescue experiment. Mechanistically, Puf-A silencing altered NPM1 localization, leading to the retention of ribosomal proteins in nucleolus and diminished ribosome biogenesis, followed by cell-cycle arrest/cell death. Puf-A is a potential theranostic target for cancer therapy and an important player in cancer progression.	[Cho, Huan-Chieh; Huang, Yenlin; Hung, Jung-Tung; Hung, Tsai-Hsien; Cheng, Kai-Chun; Kuo, Ming-Wei; Wang, Sheng-Hung; Yu, Alice L.; Yu, John] Chang Gung Mem Hosp Linkou, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Huang, Yenlin] Chang Gung Mem Hosp Linkou, Dept Anat Pathol, Taoyuan, Taiwan; [Liu, Yun-Hen] Chang Gung Mem Hosp Linkou, Dept Surg, Taoyuan, Taiwan; [Yu, Alice L.] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Yu, Alice L.] Univ Calif San Diego, Med Ctr, Dept Pediat, San Diego, CA 92103 USA; [Yu, John] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; University of California System; University of California San Diego; Academia Sinica - Taiwan	Yu, J (corresponding author), Chang Gung Mem Hosp Linkou, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan.	johnyu@gate.sinica.edu.tw		Yu, John/0000-0002-3237-4272	Ministry of Science and Technology of Taiwan [MOST 106-3114-B-182A-001, MOST 107-2321-B-182A-005, MOST 108-2321-B-182A-004, MOST 109-2321-B-182A-005]; CGMH at Linkou of Taiwan [CMRPG3H1342, OMRPG3C0047-OMRPG3C0048, CMRPG3J0311-CMRPG3J0313]; CGMH fellowship	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); CGMH at Linkou of Taiwan; CGMH fellowship	This work was supported by Ministry of Science and Technology of Taiwan (MOST 106-3114-B-182A-001, MOST 107-2321-B-182A-005, MOST 108-2321-B-182A-004, and MOST 109-2321-B-182A-005); and CGMH at Linkou of Taiwan (CMRPG3H1342, OMRPG3C0047-OMRPG3C0048 to JY and CMRPG3J0311-CMRPG3J0313 to JTH). HCC is a recipient of CGMH fellowship.	Ando K, 2017, J CELL BIOL, V216, P1795, DOI 10.1083/jcb.201608095; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bursac S, 2014, BBA-MOL BASIS DIS, V1842, P817, DOI 10.1016/j.bbadis.2013.08.014; Chang HY, 2011, CANCER RES, V71, P1126, DOI 10.1158/0008-5472.CAN-10-1831; Chen SY, 2018, J DRUG TARGET, V26, P27, DOI 10.1080/1061186X.2017.1332066; Cho HC, 2011, CANCER RES, V71, P7250, DOI 10.1158/0008-5472.CAN-11-0903; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fan CC, 2013, TUMOR BIOL, V34, P2557, DOI 10.1007/s13277-013-0801-4; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Fischer M, 2016, CELL CYCLE, V15, P2852, DOI 10.1080/15384101.2016.1205393; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P6070, DOI 10.1093/nar/gkw523; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P164, DOI 10.1093/nar/gkv927; Fischer M, 2015, ONCOTARGET, V6, P41402, DOI 10.18632/oncotarget.6356; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kiankhooy A, 2014, ANN THORAC SURG, V98, P1175, DOI 10.1016/j.athoracsur.2014.05.061; Kreft L, 2017, NUCLEIC ACIDS RES, V45, pW490, DOI 10.1093/nar/gkx376; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuo MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004980; Li SH, 2017, J ORAL PATHOL MED, V46, P175, DOI 10.1111/jop.12482; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Liu GY, 2017, J CELL BIOCHEM, V118, P4697, DOI 10.1002/jcb.26135; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Ponkratova D., 2020, BIOL B REV, V10, P266; Qiu C, 2014, P NATL ACAD SCI USA, V111, P18554, DOI 10.1073/pnas.1407634112; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Sawazaki H, 2017, WORLD J UROL, V35, P1081, DOI 10.1007/s00345-016-1977-1; SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x; Sinn HP, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3111-1; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Stepinski D, 2018, HISTOCHEM CELL BIOL, V150, P607, DOI 10.1007/s00418-018-1706-5; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Xie DY, 2014, ONCOL REP, V32, P2517, DOI 10.3892/or.2014.3538; Xie M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13280; Zhu CQ, 2014, TRANSL LUNG CANCER R, V3, P149, DOI 10.3978/j.issn.2218-6751.2014.06.09	51	2	2	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2022	41	8					1155	1165		10.1038/s41388-021-02138-0	http://dx.doi.org/10.1038/s41388-021-02138-0		JAN 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZC9WS	34999733	hybrid, Green Published			2022-12-26	WOS:000740423400001
J	DiNatale, A; Kaur, R; Qian, C; Zhang, JY; Marchioli, M; Ipe, D; Castelli, M; McNair, CM; Kumar, G; Meucci, O; Fatatis, A				DiNatale, Anthony; Kaur, Ramanpreet; Qian, Chen; Zhang, Jieyi; Marchioli, Michael; Ipe, Darin; Castelli, Maria; McNair, Chris M.; Kumar, Gaurav; Meucci, Olimpia; Fatatis, Alessandro			Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy	ONCOGENE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; STEM-CELLS; CHEMOKINE CX3CL1; TUMOR-CELLS; ADHESION; BONE; PLASTICITY; MIGRATION; SALL4; PLURIPOTENCY	Metastasis-initiating cells (MICs) display stem cell-like features, cause metastatic recurrences and defy chemotherapy, which leads to patients' demise. Here we show that prostate and breast cancer patients harbor contingents of tumor cells with high expression of CX3CR1, OCT4a (POU5F1), and NANOG. Impairing CX3CR1 expression or signaling hampered the formation of tumor spheroids by cell lines from which we isolated small subsets co-expressing CX3CR1 and stemness-related markers, similarly to patients' tumors. These rare CX3CR1(High) cells show transcriptomic profiles enriched in pathways that regulate pluripotency and endowed with metastasis-initiating behavior in murine models. Cancer cells lacking these features (CX3CR1(Low)) were capable of re-acquiring CX3CR1-associated features over time, implying that MICs can continuously emerge from non-stem cancer cells. CX3CR1 expression also conferred resistance to docetaxel, and prolonged treatment with docetaxel selected CX3CR1(High) phenotypes with de-enriched transcriptomic profiles for apoptotic pathways. These findings nominate CX3CR1 as a novel marker of stem-like tumor cells and provide conceptual ground for future development of approaches targeting CX3CR1 signaling and (re)expression as therapeutic means to prevent or contain metastasis initiation.	[DiNatale, Anthony; Kaur, Ramanpreet; Qian, Chen; Zhang, Jieyi; Marchioli, Michael; Ipe, Darin; Castelli, Maria; Meucci, Olimpia; Fatatis, Alessandro] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA 19102 USA; [McNair, Chris M.; Kumar, Gaurav] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [McNair, Chris M.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Canc Informat, Philadelphia, PA 19107 USA; [Meucci, Olimpia] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Program Immune Cell Regulat & Targeting, Philadelphia, PA 19107 USA; [Fatatis, Alessandro] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Program Translat & Cellular Oncol, Philadelphia, PA 19107 USA; [Kaur, Ramanpreet] Champ Oncol, 1330 Piccard Dr, Rockville, MD 20850 USA; [Qian, Chen] Cedars Sinai, Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA; [Castelli, Maria] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Drexel University; Jefferson University; Jefferson University; Jefferson University; Jefferson University; Cedars Sinai Medical Center; University of Pennsylvania; Pennsylvania Medicine	Fatatis, A (corresponding author), Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA 19102 USA.; Fatatis, A (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Program Translat & Cellular Oncol, Philadelphia, PA 19107 USA.	af39@drexel.edu	Qian, Chen/GWV-0990-2022	DiNatale, Anthony/0000-0003-3221-7506; Meucci, Olimpia/0000-0001-8333-4804	NCI [R01-CA202929]; DoD [BC150659]; Wallace H. Coulter Foundation; Pennsylvania Breast Cancer Coalition; Breast Cancer Alliance; Sidney Kimmel Cancer Center (SKCC) Support Grant [5P30CA056036-21]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DoD(United States Department of Defense); Wallace H. Coulter Foundation; Pennsylvania Breast Cancer Coalition; Breast Cancer Alliance; Sidney Kimmel Cancer Center (SKCC) Support Grant	This work was supported by NCI grant R01-CA202929 (AF and OM), DoD grant BC150659 (AF), Wallace H. Coulter Foundation (AF and OM), Pennsylvania Breast Cancer Coalition (AF), Exceptional Project Grant from Breast Cancer Alliance (AF), and the Sidney Kimmel Cancer Center (SKCC) Support Grant 5P30CA056036-21 (AF). We would like to thank: Dr. Meenhard Herlyn (Wistar Institute, Philadelphia, PA) and Dr. Edward Hartsough (Pharmacology and Physiology, Drexel University College of Medicine) for providing the WM793 and 1205Lu human melanoma cell lines; Dr. Edward Hartsough (Pharmacology and Physiology, Drexel University College of Medicine) and Dr. Josep Domingo-Domenech (Cancer Biology, SKCC at Thomas Jefferson University) for helpful discussions; Dr. Paolo Fortina, Professor of Cancer Biology and Director of the Cancer Genomics and Translational Research/Pathology core services at SKCC for consultation and advice with RNA Sequencing; Ms. Shannon Cremin (Translational Research Project Manager), Ms. Danielle Wentworth (Biorepository Manager) and the SKCC Biorepository of Thomas Jefferson University for providing the human specimens used in this study. The authors are also grateful to Dr. Bradley Nash (Director, Office of Scientific Communications, Department of Pharmacology and Physiology, Drexel University College of Medicine) for critically reading and editing the manuscript.	Agarwal N, 2014, ANN ONCOL, V25, P1700, DOI 10.1093/annonc/mdu038; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Annett S, 2018, PHARMACOL THERAPEUT, V187, P13, DOI 10.1016/j.pharmthera.2018.02.001; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cabrera MC, 2015, WORLD J STEM CELLS, V7, P27, DOI 10.4252/wjsc.v7.i1.27; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; Celia-Terrassa T, 2018, NAT CELL BIOL, V20, P868, DOI 10.1038/s41556-018-0145-9; Celia-Terrassa T, 2016, GENE DEV, V30, P892, DOI 10.1101/gad.277681.116; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chandrakesan P, 2016, J Carcinog Mutagen, V7; Chen W, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1740936; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Chimento A, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00807; Do DV, 2013, GENE DEV, V27, P1378, DOI 10.1101/gad.221176.113; Das PK, 2020, STEM CELL REV REP, V16, P397, DOI 10.1007/s12015-019-09942-y; Dillekas H, 2019, CANCER MED-US, V8, P5574, DOI 10.1002/cam4.2474; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Er EE, 2018, NAT CELL BIOL, V20, P966, DOI 10.1038/s41556-018-0138-8; Erreni M, 2010, EUR J CANCER, V46, P3383, DOI 10.1016/j.ejca.2010.07.022; Esposito M, 2014, PHARMACOL THERAPEUT, V141, P222, DOI 10.1016/j.pharmthera.2013.10.006; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Francescone R, 2021, CANCER DISCOV, V11, P446, DOI 10.1158/2159-8290.CD-20-0775; Ganesh K, 2021, NAT MED, V27, P34, DOI 10.1038/s41591-020-01195-4; Gassenmaier M, 2013, STEM CELLS, V31, P1467, DOI 10.1002/stem.1407; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Gravina GL, 2015, PROSTATE, V75, P1227, DOI 10.1002/pros.23007; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Gupta PB, 2019, CELL STEM CELL, V24, P65, DOI 10.1016/j.stem.2018.11.011; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huang LY, 2017, BIOCHEM BIOPH RES CO, V493, P1510, DOI 10.1016/j.bbrc.2017.10.006; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Igntiadis M, 2008, EUR J CANCER, V44, P2726, DOI 10.1016/j.ejca.2008.09.033; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jamieson WL, 2008, CANCER RES, V68, P1715, DOI 10.1158/0008-5472.CAN-07-1315; Jamieson-Gladney WL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3016; JavanMoghadam-Kamrani S, 2008, CELL CYCLE, V7, P2434, DOI 10.4161/cc.6364; Jiao XM, 2019, CANCER RES, V79, P4801, DOI 10.1158/0008-5472.CAN-19-1167; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Karatas OF, 2016, PROSTATE, V76, P434, DOI 10.1002/pros.23137; Kato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046576; Kim J, 2016, ONCOGENE, V35, P1334, DOI 10.1038/onc.2015.205; Kim M, 2012, MOL CANCER RES, V10, P11, DOI 10.1158/1541-7786.MCR-11-0256; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; King KM, 2009, CURR ONCOL, V16, P149; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Li WZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14364-2; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu AF, 2013, CHIN J CANCER, V32, P483, DOI 10.5732/cjc.012.10282; Liu Y, 2021, CLIN TRANSL ONCOL, V23, P378, DOI 10.1007/s12094-020-02431-6; Locatelli M, 2010, EUR CYTOKINE NETW, V21, P27, DOI 10.1684/ecn.2009.0184; Lombardo Y, 2015, JOVE-J VIS EXP, DOI 10.3791/52671; Main HG, 2017, ONCOGENE, V36, P3025, DOI 10.1038/onc.2016.456; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Micalizzi DS, 2017, GENE DEV, V31, P1827, DOI 10.1101/gad.305805.117; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Morein D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00952; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Obenauf AC, 2015, TRENDS CANCER, V1, P76, DOI 10.1016/j.trecan.2015.07.009; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Palmeri Laura, 2008, Ther Clin Risk Manag, V4, P1047; Pasello M, 2020, SEMIN CANCER BIOL, V60, P57, DOI 10.1016/j.semcancer.2019.10.004; Pein M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15188-x; Putzer BM, 2017, ADV DRUG DELIVER REV, V120, P89, DOI 10.1016/j.addr.2017.07.013; Qian C, 2018, MOL CANCER RES, V16, P1844, DOI 10.1158/1541-7786.MCR-18-0302; Quayle LA, 2018, CLIN EXP METASTAS, V35, P831, DOI 10.1007/s10585-018-9946-2; Qureshi-Baig K, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0602-2; Ramsey DM, 2013, BIOORG MED CHEM LETT, V23, P20, DOI 10.1016/j.bmcl.2012.10.138; Rao S, 2010, BIOL BLOOD MARROW TR, V16, pS187, DOI 10.1016/j.bbmt.2009.12.111; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Riihimaki M, 2018, CANCER MED-US, V7, P5534, DOI 10.1002/cam4.1697; Shahriari K, 2017, ONCOGENE, V36, P2846, DOI 10.1038/onc.2016.436; Shen F, 2016, MOL CANCER RES, V14, P518, DOI 10.1158/1541-7786.MCR-16-0013; Shen Y, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw023; Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Singh SK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19643-0; Stojic L, 2018, NUCLEIC ACIDS RES, V46, P5950, DOI 10.1093/nar/gky437; Tatetsu H, 2016, GENE, V584, P111, DOI 10.1016/j.gene.2016.02.019; Thankamony AP, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00079; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wada A, 2015, ONCOL REP, V33, P2935, DOI 10.3892/or.2015.3941; Walcher L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01280; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Wang YJ, 2015, AM J PHYSIOL-CELL PH, V309, pC709, DOI 10.1152/ajpcell.00212.2015; Weber MR, 2016, THROMB RES, V140, pS27, DOI 10.1016/S0049-3848(16)30095-0; Worrede A, 2019, PHARMACOL THERAPEUT, V199, P117, DOI 10.1016/j.pharmthera.2019.03.007; Yang JC, 2018, BIOMARK RES, V6, DOI 10.1186/s40364-017-0115-6; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yang XP, 2007, CIRC RES, V101, P1001, DOI 10.1161/CIRCRESAHA.107.160812; Yao X, 2014, UROL ONCOL-SEMIN ORI, V32, P162, DOI 10.1016/j.urolonc.2012.12.006; Yuan S, 2019, CANCER DISCOV, V9, P837, DOI 10.1158/2159-8290.CD-19-0015; Zhang WJ, 2021, CELL, V184, P2471, DOI 10.1016/j.cell.2021.03.011; Zhao Wenxiu, 2017, Cancer Transl Med, V3, P87, DOI 10.4103/ctm.ctm_69_16; Zhao Y, 2018, SEMIN CANCER BIOL, V53, P139, DOI 10.1016/j.semcancer.2018.08.002; Zheng DQ, 1999, CANCER RES, V59, P1655	114	0	0	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1337	1351		10.1038/s41388-021-02174-w	http://dx.doi.org/10.1038/s41388-021-02174-w		JAN 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	34999735	Green Accepted			2022-12-26	WOS:000740423700003
J	Abdelaleem, OO; Mohammed, SR; El Sayed, HS; Hussein, SK; Ali, DY; Abdelwahed, MY; Gaber, SN; Hemeda, NF; Abd El-Hmid, RG				Abdelaleem, Omayma O.; Mohammed, Shereen Rashad; El Sayed, Hassan S.; Hussein, Sherin Khamis; Ali, Doaa Y.; Abdelwahed, Mostafa Y.; Gaber, Sylvana N.; Hemeda, Nada F.; Abd El-Hmid, Rehab G.			Serum miR-34a-5p and miR-199a-3p as new biomarkers of neonatal sepsis	PLOS ONE			English	Article							MICRORNA-34A SUPPRESSES AUTOPHAGY; ACUTE LUNG INJURY; KAPPA-B; EPITHELIAL-CELLS; DOWN-REGULATION; PROLIFERATION; EXPRESSION; BETA; PCR	Background Neonatal sepsis is a serious condition. Recent clinical studies have indicated that micro-RNAs (miRNAs) are key players in the pathogenesis of sepsis, which could be used as bio-markers for this condition. Patients and methods A total of 90 neonates with sepsis and 90 healthy neonates were enrolled in this study. qRT-PCR was performed to measure the expression levels of serum miR-34a-5p and miR-199a-3p. Results miR-34a-5p and miR-199a-3p serum levels were significantly reduced in neonates with sepsis compared with those in healthy neonates (P = 0.006 and P = 0.001, respectively). Significant correlations of miR-34a-5p and miR-199a-3p with each of TLC, RDW, RBS, and Creactive protein (CRP) as well as SNAPII were observed, indicating their associations with the severity of neonatal sepsis. Conclusion miR-34a-5p and miR-199a-3p may be useful as novel biomarkers in neonatal sepsis and may provide a new direction for its treatment.	[Abdelaleem, Omayma O.; Mohammed, Shereen Rashad; El Sayed, Hassan S.] Fayoum Univ, Fac Med, Dept Med Biochem & Mol Biol, Al Fayyum, Egypt; [Hussein, Sherin Khamis; Abd El-Hmid, Rehab G.] Fayoum Univ, Fac Med, Dept Pediat, Al Fayyum, Egypt; [Ali, Doaa Y.] Fayoum Univ, Fac Med, Dept Clin Pathol, Al Fayyum, Egypt; [Abdelwahed, Mostafa Y.] Fayoum Univ, Fac Med, Dept Physiol, Al Fayyum, Egypt; [Gaber, Sylvana N.] Fayoum Univ, Fac Med, Dept Microbiol & Immunol, Al Fayyum, Egypt; [Hemeda, Nada F.] Fayoum Univ, Fac Agr, Dept Genet, Al Fayyum, Egypt	Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University	Abdelaleem, OO (corresponding author), Fayoum Univ, Fac Med, Dept Med Biochem & Mol Biol, Al Fayyum, Egypt.	dr.omayma@yahoo.com						Agrawal A, 2003, IMMUNOLOGY, V108, P539, DOI 10.1046/j.1365-2567.2003.01608.x; Cai ZG, 2012, CAN J PHYSIOL PHARM, V90, P37, DOI [10.1139/Y11-095, 10.1139/y11-095]; Chen M, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/8874854; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen Z, 2019, INT J BIOL SCI, V15, P2627, DOI 10.7150/ijbs.37133; Cheng DL, 2018, BIOMED PHARMACOTHER, V105, P1276, DOI 10.1016/j.biopha.2018.06.063; Chiesa C, 2004, CLIN CHEM, V50, P279, DOI 10.1373/clinchem.2003.025171; CLSI, 2020, PERFORMANCE STANDARD, V30th, DOI 10.1108/08876049410065598; Coldewey SM, 2013, DIS MODEL MECH, V6, P1031, DOI 10.1242/dmm.012435; de Prost N, 2013, CRIT CARE, V17, DOI 10.1186/cc13022; Delanghe JR, 2015, CLIN CHIM ACTA, V451, P46, DOI 10.1016/j.cca.2015.01.031; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Di Martino MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090005; Fatmi A, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00217-8; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gantier MP, 2010, J INTERF CYTOK RES, V30, P283, DOI 10.1089/jir.2010.0037; He XB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/945169; Huang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094382; Jia XQ, 2012, CELL BIOCHEM BIOPHYS, V62, P237, DOI 10.1007/s12013-011-9263-8; Khan AA, 2013, BLOOD, V121, P4473, DOI 10.1182/blood-2012-06-435412; Lange T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183435; Liu HJ, 2017, MOL MED REP, V16, P4355, DOI 10.3892/mmr.2017.7036; Liu XJ, 2015, AM J NEPHROL, V42, P168, DOI 10.1159/000439185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Misso G, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.47; Pang JQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.462; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Satar M, 2012, TURKISH J PEDIATR, V54, P449; Shen XM, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00497-6; Solayman MHM, 2016, MOL BIOTECHNOL, V58, P179, DOI 10.1007/s12033-015-9912-z; Song AF, 2020, EUR REV MED PHARMACO, V24, P11675, DOI 10.26355/eurrev_202011_23812; Song L, 2017, INFLAMMATION, V40, P927, DOI 10.1007/s10753-017-0537-1; Szilagyi Bernadett, 2019, EJIFCC, V30, P128; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang D, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9781; Wang LN, 2013, EXP THER MED, V5, P1101, DOI 10.3892/etm.2013.937; Wangyang YF, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180982; Xia WZ, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001293; Xie MX, 2019, J AUTOIMMUN, V102, P96, DOI 10.1016/j.jaut.2019.04.018; Xiong A, 2019, HLA, V94, P493, DOI 10.1111/tan.13677; Yin X, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01071; Yuan J, 2020, CHEM-BIOL INTERACT, V322, DOI 10.1016/j.cbi.2020.109027	44	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262339	10.1371/journal.pone.0262339	http://dx.doi.org/10.1371/journal.pone.0262339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990478	gold, Green Published			2022-12-26	WOS:000815783800028
J	Yang, L; Sun, JG; Yan, CY; Wu, JY; Wang, YY; Ren, QT; Wang, S; Ma, X; Zhao, L; Sun, JS				Yang, Lin; Sun, Jinge; Yan, Congyu; Wu, Junyi; Wang, Yaya; Ren, Qiuting; Wang, Shen; Ma, Xu; Zhao, Ling; Sun, Jinsheng			Regeneration of duckweed (Lemna turonifera) involves genetic molecular regulation and cyclohexane release	PLOS ONE			English	Article							ORGANIC-COMPOUND EMISSIONS; PLANT-REGENERATION; ROOT; INDUCTION; CELLS	Plant regeneration is important for vegetative propagation, detoxification and the obtain of transgenic plant. We found that duckweed regeneration could be enhanced by regenerating callus. However, very little is known about the molecular mechanism and the release of volatile organic compounds (VOCs). To gain a global view of genes differently expression profiles in callus and regenerating callus, genetic transcript regulation has been studied. Auxin related genes have been significantly down-regulated in regenerating callus. Cytokinin signal pathway genes have been up-regulated in regenerating callus. This result suggests the modify of auxin and cytokinin balance determines the regenerating callus. Volatile organic compounds release has been analysised by gas chromatography/ mass spectrum during the stage of plant regeneration, and 11 kinds of unique volatile organic compounds in the regenerating callus were increased. Cyclohexane treatment enhanced duckweed regeneration by initiating root. Moreover, Auxin signal pathway genes were down-regulated in callus treated by cyclohexane. All together, these results indicated that cyclohexane released by regenerating callus promoted duckweed regeneration. Our results provide novel mechanistic insights into how regenerating callus promotes regeneration.	[Yang, Lin; Sun, Jinge; Yan, Congyu; Wu, Junyi; Wang, Yaya; Ren, Qiuting; Wang, Shen; Ma, Xu; Sun, Jinsheng] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Zhao, Ling] Nankai Univ, Coll Life Sci, Dept Plant Biol & Ecol, Tianjin, Peoples R China	Tianjin Normal University; Nankai University	Sun, JS (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	skysjs@tjnu.edu.cn		Wang, Shen/0000-0002-5113-9067; Sun, Jinsheng/0000-0002-3013-4822	National Natural Science Foundation of China [32071620]; Tianjin Natural Science Foundation of Tianjin [S20QNK618]; Postgraduate Innovative Research Projects of Tianjin [2020YJSS133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation of Tianjin; Postgraduate Innovative Research Projects of Tianjin	Funded studies Initials of the authors who received each award: L.Yang., JG. Sun Grant numbers awarded to each author: 86185 dollars, 9276 dollars and 785 dollars The full name of each funder: Present research has been supported by National Natural Science Foundation of China (No. 32071620), Tianjin Natural Science Foundation of Tianjin (S20QNK618), The Postgraduate Innovative Research Projects of Tianjin (2020YJSS133) URL of each funder website: N/A Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? Yes.	An D, 2019, P NATL ACAD SCI USA, V116, P18893, DOI 10.1073/pnas.1910401116; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Azizi P, 2015, MECH DEVELOP, V135, P1, DOI 10.1016/j.mod.2014.11.001; Binglian Z., 2003, CHINESE SCI BULL, V48, P8; Cheng F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01020; Feher A, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00536; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hao Guo., 2020, OJNS, V8, P85; Hirota A, 2007, PLANT CELL, V19, P2156, DOI 10.1105/tpc.107.050674; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Ikeuchi M, 2017, PLANT PHYSIOL, V175, P1158, DOI 10.1104/pp.17.01035; Ikeuchi M, 2016, DEVELOPMENT, V143, P1442, DOI 10.1242/dev.134668; Jud W, 2016, PLANT CELL ENVIRON, V39, P1204, DOI 10.1111/pce.12643; Karunadasa SS, 2020, NEW PHYTOL, V227, P50, DOI 10.1111/nph.16519; Lardon R, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01274-9; Li J, 2004, PLANT CELL REP, V22, P457, DOI 10.1007/s00299-003-0724-4; Liu JC, 2014, PLANT CELL, V26, P1081, DOI 10.1105/tpc.114.122887; Loreto F, 2006, PLANT CELL ENVIRON, V29, P1820, DOI 10.1111/j.1365-3040.2006.01561.x; Motte H, 2014, BIOTECHNOL ADV, V32, P107, DOI 10.1016/j.biotechadv.2013.12.002; Pi LM, 2015, DEV CELL, V33, P576, DOI 10.1016/j.devcel.2015.04.024; Raghava T., 2009, Karnataka Journal of Agricultural Sciences, V22, P1023; RAM NVR, 1984, Z PFLANZENPHYSIOL, V113, P315; Romanov GA, 2018, NEW PHYTOL, V218, P41, DOI 10.1111/nph.14991; Sagare AP, 2000, PLANT SCI, V160, P139, DOI 10.1016/S0168-9452(00)00377-0; Shim S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78324-z; Shimotohno A, 2018, GENE DEV, V32, P1085, DOI 10.1101/gad.314096.118; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; WANG Y, 1994, J PLANT PHYSIOL, V144, P710, DOI 10.1016/S0176-1617(11)80666-8; Yang L, 2020, AQUAT TOXICOL, V229, DOI 10.1016/j.aquatox.2020.105579; Yang L, 2013, PLANT CELL TISS ORG, V113, P407, DOI 10.1007/s11240-012-0280-0; Yao J, 2020, PLANT CELL TISS ORG, V143, P189, DOI 10.1007/s11240-020-01909-z; Zhang GF, 2019, NAT PLANTS, V5, P491, DOI 10.1038/s41477-019-0408-x; Zhang RM, 2012, J ARID ENVIRON, V87, P212, DOI 10.1016/j.jaridenv.2012.04.008; Zuo ZJ, 2012, BIOCHEM SYST ECOL, V40, P19, DOI 10.1016/j.bse.2011.09.007; Zuo ZJ, 2018, ECOTOX ENVIRON SAFE, V161, P214, DOI 10.1016/j.ecoenv.2018.05.095	39	0	0	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0254265	10.1371/journal.pone.0254265	http://dx.doi.org/10.1371/journal.pone.0254265			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990448	gold, Green Published			2022-12-26	WOS:000815783800002
J	Portnoy, S; Cohen, S; Ratzon, NZ				Portnoy, Sigal; Cohen, Shlomit; Ratzon, Navah Z.			Correlations between body postures and musculoskeletal pain in guitar players	PLOS ONE			English	Article							PROFESSIONAL ORCHESTRAL MUSICIANS; PREVALENCE; KINEMATICS; DISORDERS; INJURY	Background The guitar-playing community is the largest group at risk of developing playing related musculoskeletal disorders. A thorough investigation of the relationships between the various risk factors and players' report on musculoskeletal pain using objective and accurate means of assessment has yet to be reported. Purpose (a) to explore the correlations between demographic characteristics, anthropometric measurements, playing habits, and personal habits of guitar player and their complaints of musculoskeletal pain, (b) explore the correlations between the upper body kinematics of guitar players during playing the guitar and their complaints of musculoskeletal pain, and (c) compare the upper body kinematics of guitar players during playing the guitar while sitting versus standing. Methods Twenty-five guitar players (27.54.6 years old) filled out questionnaires regarding their guitar-playing habits, and the Standardized Nordic Questionnaires for the analysis of musculoskeletal symptoms. Kinematics of their torso and upper limbs were tracked while they played a tune twice, once while sitting and once while standing. Results We found moderate correlations between the number of painful joints in the last year and factors, such as physical comfort while playing, years of playing, and position during playing. During standing, lower back pain severity correlated with the rotation range of the torso, while during sitting, it moderately correlated with the average radial-ulnar deviation of the right wrist. During sitting, we found higher anterior and right tilt of the torso, combined with greater abduction of the right shoulder, higher flexion in the left shoulder and higher radial deviation in the left wrist. Conclusion Our results point to several risk factors, related both to playing habits but also to playing posture, which should be considered by the guitar players in order to prevent playing-related musculoskeletal disorders.	[Portnoy, Sigal; Cohen, Shlomit; Ratzon, Navah Z.] Tel Aviv Univ, Sackler Fac Med, Dept Occupat Therapy, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Portnoy, S (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Occupat Therapy, Tel Aviv, Israel.	portnoys@tauex.tau.ac.il						Ackermann B, 2012, MED PROBL PERFORM AR, V27, P181; Ackermann BJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00913; Ajidahun AT, 2019, MUZIKI, V16, P7, DOI 10.1080/18125980.2019.1606675; Brandfonbrener AG, 2003, HAND CLIN, V19, P231, DOI 10.1016/S0749-0712(02)00100-2; Brown W, 2022, INT J OCCUP SAF ERGO, V28, P536, DOI 10.1080/10803548.2020.1796039; Creech JA., 2021, SHOULDER IMPINGEMENT; Cruder C, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2440-4; Fjellman-Wiklund A, 2006, MUSCULOSKELETAL GEN; Fotiadis DG, 2013, MED PROBL PERFORM AR, V28, P91; Foxman Irina, 2006, AAOHN J, V54, P309; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gohil K., 2016, INT J THER APPL, V32, P100, DOI [10.20530/ijta_32_100-103, DOI 10.20530/IJTA_32_100]; Haj A, 2019, CLIN BIOMECH, V61, P192, DOI 10.1016/j.clinbiomech.2018.12.022; Hulshof CTJ, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106157; Kochem FB, 2018, J MANIP PHYSIOL THER, V41, P540, DOI 10.1016/j.jmpt.2018.05.001; Kok LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191772; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Laird RA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-229; Levanon Y, 2010, GAIT POSTURE, V32, P469, DOI 10.1016/j.gaitpost.2010.07.003; Moreira-Silva I, 2016, WORKPLACE HEALTH SAF, V64, P210, DOI 10.1177/2165079916629688; Paarup HM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-223; Paarup HM., 2011, BMC MUSCULOSKEL DIS, P12, DOI [10.1186/1471-2474-12-12, DOI 10.1186/1471-2474-12-12]; Perez-Carrillo A, 2019, FRONT COMP SCI-SWITZ, V1, DOI 10.3389/fcomp.2019.00008; Price K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-210; Rigg JL, 2003, MED PROBL PERFORM AR, V18, P150; Silva AG, 2015, MED PROBL PERFORM AR, V30, P8, DOI 10.21091/mppa.2015.1002; Steinmetz A, 2015, CLIN RHEUMATOL, V34, P965, DOI 10.1007/s10067-013-2470-5; Steinmetz A, 2010, J MANIP PHYSIOL THER, V33, P603, DOI 10.1016/j.jmpt.2010.08.006; Storm Seneca A, 2006, Phys Med Rehabil Clin N Am, V17, P893, DOI 10.1016/j.pmr.2006.08.003; Turner-Stokes L, 1999, CLIN BIOMECH, V14, P426, DOI 10.1016/S0268-0033(98)00110-7; Woldendorp KH, 2018, INT ARCH OCC ENV HEA, V91, P215, DOI 10.1007/s00420-017-1264-5; Zuhdi N, 2020, MED PROBL PERFORM AR, V35, P167, DOI 10.21091/mppa.2020.3022	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262207	10.1371/journal.pone.0262207	http://dx.doi.org/10.1371/journal.pone.0262207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982777	Green Published, gold			2022-12-26	WOS:000834805700021
J	Galbussera, AA; Mandelli, S; Rosso, S; Zanetti, R; Rossi, M; Giacomin, A; Detoma, P; Riva, E; Tettamanti, M; Della Porta, MG; Lucca, U				Galbussera, Alessia A.; Mandelli, Sara; Rosso, Stefano; Zanetti, Roberto; Rossi, Marianna; Giacomin, Adriano; Detoma, Paolo; Riva, Emma; Tettamanti, Mauro; Della Porta, Matteo G.; Lucca, Ugo			Mild anemia and 11-to 15-year mortality risk in young-old and old-old: Results from two population-based cohort studies	PLOS ONE			English	Article							HEMOGLOBIN CONCENTRATION; PREVALENCE; COMMUNITY; HEALTH; AGE; HOSPITALIZATION; DEFINITION; ADULTS; IMPACT	Background Mild anemia is a frequent although often overlooked finding in old age. Nevertheless, in recent years anemia has been linked to several adverse outcomes in the elderly population. Objective of the study was to investigate the association of mild anemia (hemoglobin concentrations: 10.0-11.9/12.9 g/dL in women/men) with all-cause mortality over 11-15 years and the effect of change in anemia status on mortality in young-old (65-84 years) and old-old (80+ years). Methods The Health and Anemia and Monzino 80-plus are two door-to-door, prospective population-based studies that included residents aged 65-plus years in Biella municipality and 80-plus years in Varese province, Italy. No exclusion criteria were used. Results Among 4,494 young-old and 1,842 old-old, mortality risk over 15/11 years was significantly higher in individuals with mild anemia compared with those without (young-old: fully-adjusted HR: 1.35, 95%CI, 1.15-1.58; old-old: fully-adjusted HR: 1.28, 95%CI, 1.14-1.44). Results were similar in the disease-free subpopulation (age, sex, education, smoking history, and alcohol consumption adjusted HR: 1.54, 95%CI, 1.02-2.34). Both age groups showed a dose-response relationship between anemia severity and mortality (P for trend <0.0001). Mortality risk was significantly associated with chronic disease and chronic kidney disease mild anemia in both age groups, and with vitamin B-12/folate deficiency and unexplained mild anemia in young-old. In participants with two hemoglobin determinations, seven-year mortality risk was significantly higher in incident and persistent anemic cases compared to constant non-anemic individuals in both age groups. In participants without anemia at baseline also hemoglobin decline was significantly associated with an increased mortality risk over seven years in both young-old and old-old. Limited to the Monzino 80-plus study, the association remained significant also when the risk was further adjusted also for time-varying covariates and time-varying anemia status over time. Conclusions Findings from these two large prospective population-based studies consistently suggest an independent, long-term impact of mild anemia on survival at older ages.	[Galbussera, Alessia A.; Mandelli, Sara; Riva, Emma; Tettamanti, Mauro; Lucca, Ugo] Ist Ric Farmacol Mario Negri IRCCS, Lab Geriatr Neuropsychiat, Dept Neurosci, Milan, Italy; [Rosso, Stefano; Zanetti, Roberto] Ctr Epidemiol & Prevent Oncol Piedmont, Piedmont Canc Registry, Turin, Italy; [Rossi, Marianna; Della Porta, Matteo G.] Humanitas Res Hosp, Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy; [Rossi, Marianna; Della Porta, Matteo G.] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Giacomin, Adriano] Azienda Sanitaria Locale, Epidemiol Unit, Biella, Italy; [Detoma, Paolo] Osped Inferm Biella, Lab Anal, Biella, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione IRCCS Istituto Nazionale Tumori Milan; Humanitas University	Lucca, U (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Lab Geriatr Neuropsychiat, Dept Neurosci, Milan, Italy.	lucca@marionegri.it	Galbussera, Alessia Antonella/ABG-3036-2020	Galbussera, Alessia Antonella/0000-0003-0163-1034; Della Porta, Matteo Giovanni/0000-0002-6915-5970	Cariplo Foundation, Milan, Italy [2016-0860]; Italian Ministry of Health, Italy [RF 2016-02364918]; Italo Monzino Foundation, Milano, Italy	Cariplo Foundation, Milan, Italy(Fondazione Cariplo); Italian Ministry of Health, Italy(Ministry of Health, Italy); Italo Monzino Foundation, Milano, Italy	This study was supported by Cariplo Foundation, Milan, Italy (Project #2016-0860) and Italian Ministry of Health, Italy (Ricerca Finalizzata 2016 -Project #RF 2016-02364918). The Monzino 80-plus Study is being supported by a research grant from Italo Monzino Foundation, Milano, Italy. Present and past funders of the studies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication.	da Silva CLA, 2013, CAD SAUDE PUBLICA, V29, P2241, DOI [10.1590/0102-311X00183712, 10.1590/0102-311x00183712]; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; BURCH GE, 1980, AM HEART J, V100, P407, DOI 10.1016/0002-8703(80)90157-X; Carmel R, 2001, BLOOD REV, V15, P9, DOI 10.1054/blre.2001.0146; Chaves PHM, 2004, J AM GERIATR SOC, V52, P1811, DOI 10.1111/j.1532-5415.2004.52502.x; Culleton BF, 2006, BLOOD, V107, P3841, DOI 10.1182/blood-2005-10-4308; DALLMAN PR, 1984, AM J CLIN NUTR, V39, P437, DOI 10.1093/ajcn/39.3.437; den Elzen WPJ, 2009, CAN MED ASSOC J, V181, P151, DOI 10.1503/cmaj.090040; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; Dong X, 2008, J GERONTOL A-BIOL, V63, P873, DOI 10.1093/gerona/63.8.873; Ershler WB, 2005, VALUE HEALTH, V8, P629, DOI 10.1111/j.1524-4733.2005.00058.x; Girelli D, 2018, HEMASPHERE, V2, DOI 10.1097/HS9.0000000000000040; Goodnough LT, 2014, AM J HEMATOL, V89, P88, DOI 10.1002/ajh.23598; Groopman JE, 1999, JNCI-J NATL CANCER I, V91, P1616, DOI 10.1093/jnci/91.19.1616; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Istituto Nazionale di Statistica, GEOD IST IT; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Jia WP, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.613426; Lucca U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001920; Lucca U, 2015, ALZHEIMERS DEMENT, V11, P258, DOI 10.1016/j.jalz.2014.05.1750; Lucca U, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-54; Malcovati L, 2017, BLOOD, V129, P3371, DOI 10.1182/blood-2017-01-763425; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; MCLENNAN WJ, 1973, Q J MED, V42, P1; Merchant AA, 2012, BRIT J HAEMATOL, V156, P173, DOI 10.1111/j.1365-2141.2011.08920.x; Nissenson Allen R, 2005, J Manag Care Pharm, V11, P565; Nissenson AR, 2003, ARCH INTERN MED, V163, P1400, DOI 10.1001/archinte.163.12.1400; Nutritional Anaemias, 1968, WHO TECH REP SER, V405, P5; Paltiel O, 2009, CAN MED ASSOC J, V181, P129, DOI 10.1503/cmaj.091199; Patel KV, 2007, BLOOD, V109, P4663, DOI 10.1182/blood-2006-10-055384; Patel KV, 2009, BRIT J HAEMATOL, V145, P514, DOI 10.1111/j.1365-2141.2009.07659.x; Penninx BWJH, 2006, J GERONTOL A-BIOL, V61, P474, DOI 10.1093/gerona/61.5.474; Riva E, 2009, HAEMATOL-HEMATOL J, V94, P22, DOI 10.3324/haematol.13449; Robinson B, 2003, J AM GERIATR SOC, V51, pS14; Rossi M., 2021, BLOOD, V138(21):2093-2105, DOI DOI 10.1182/BLOOD.2021011320, Patent No. 20210113202021; Semba RD, 2007, AGING CLIN EXP RES, V19, P259; Shavelle RM, 2012, INT J HEMATOL, V95, P248, DOI 10.1007/s12185-012-1007-z; Stauder R, 2018, BLOOD, V131, P505, DOI 10.1182/blood-2017-07-746446; Tang WHW, 2008, J AM COLL CARDIOL, V51, P569, DOI 10.1016/j.jacc.2007.07.094; Tettamanti M, 2010, HAEMATOL-HEMATOL J, V95, P1849, DOI 10.3324/haematol.2010.023101; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP AG 2017 HI; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WHO, 2011, WHO TECH REP SER, V959, P1; Wilson A, 2004, AM J MED, V116, P50, DOI 10.1016/j.amjmed.2003.12.012; Wouters HJCM, 2019, HAEMATOLOGICA, V104, P468, DOI 10.3324/haematol.2018.195552; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zakai NA, 2013, AM J HEMATOL, V88, P5, DOI 10.1002/ajh.23336	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261899	10.1371/journal.pone.0261899	http://dx.doi.org/10.1371/journal.pone.0261899			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972180	gold, Green Published			2022-12-26	WOS:000773555700066
J	Suardi, A; Saia, S; Alfano, V; Rezaei, N; Cetera, P; Bergonzoli, S; Pari, L				Suardi, Alessandro; Saia, Sergio; Alfano, Vincenzo; Rezaei, Negar; Cetera, Paola; Bergonzoli, Simone; Pari, Luigi			Pruning harvesting with modular towed chipper: Little effect of the machine setting and configuration on performance despite strong impact on wood chip quality	PLOS ONE			English	Article							HELICAL CHIPPERS; KNIFE WEAR; RESIDUES; SYSTEM	Pruning residues can have a high quality as feedstock for energy purposes and are largely available in Europe. However, it is still an untapped resource. Such scarce use is due to the need to optimize their supply chain in term of collection machines and the associate cost of collection. A modular chipper (prototype PC50) for pruning harvest was developed. Such prototype is adaptable to various harvesting logistics and may produce a higher quality woodchip compared with the one produced by shredders available in the market. In this work, we tested the performance and quality of the product delivered by the prototype PC50 in various conditions and plant species, after a modulation of the machine settings (counter-rotating toothed rollers [CRR] speed), loading systems ([LS], either big bag or container), and knife types ([KT], either discontinuous hoe shaped knives or continuous helicoidal knives). To take into account of the covariates in the experiment (Cropping season and plant species), LSmeans were computed to have an unbiased estimate of the treatments means. The modulation of LS and KT scarcely affected the performance of the machine. In particular, the choice of the KT affected the field efficiency when the LS was a Tilting box but not a Big Bag. Whereas the continuous knife resulted in a 97% higher material capacity compared to hoe shape knives, the last of which the amount of short sized (<16 mm) fractions compared to helicoidal knives. No role of the CCR was found on the machine performance, but increasing CRR speed reduced the chip apparent bulk density and the fraction chips with a size <8 mm.	[Suardi, Alessandro; Alfano, Vincenzo; Bergonzoli, Simone; Pari, Luigi] Res Ctr Engn & Agrofood Proc CREA IT, Council Agr Res & Econ, Rome, Italy; [Saia, Sergio] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Rezaei, Negar] Natl Res Council CNR Res Inst Terr Ecosyst IRET, Porano, TR, Italy; [Cetera, Paola] Univ Sassari, Dipartimento Agr, Sassari, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Pisa; University of Sassari	Saia, S (corresponding author), Univ Pisa, Dept Vet Sci, Pisa, Italy.	sergio.saia@unipi.it	Cetera, Paola/AAN-9007-2020; Cetera, Paola/GZG-8644-2022; Saia, Sergio/K-7535-2012	Cetera, Paola/0000-0002-7568-2718; Cetera, Paola/0000-0002-7568-2718; Saia, Sergio/0000-0001-5465-8500; Alfano, Vincenzo/0000-0001-6256-3931	European Horizon 2020 project Magic [727698]	European Horizon 2020 project Magic	This study has been produced with the data collected during the EuroPruning project (Development and implementation of a new and non-existent logistics chain for biomass from pruning); and the European Horizon 2020 project Magic (grant number 727698). The ideas expressed do not represent either those of the European Commission or the Italian Ministry of Agriculture (MiPAAF).	Abdallah R, 2011, BIOMASS BIOENERG, V35, P843, DOI 10.1016/j.biombioe.2010.11.009; Acampora A, 2013, RENEW ENERG, V53, P350, DOI 10.1016/j.renene.2012.12.009; [Anonymous], 2016, ISO33101; [Anonymous], 2010, 151491 EN; [Anonymous], 2015, 178282015 ISO; [Anonymous], 2009, 147741 EN, P1; Assirelli A, 2013, T ASABE, V56, P829; Assirelli A., 2012, INFORM AGRARIO, P32; Bergonzoli S, 2020, ENERGIES, V13, DOI 10.3390/en13051265; Bodria L., 2006, EDAGRICOLE; Civitarese V, 2015, CROAT J FOR ENG, V36, P101; Creutzig F, 2015, GCB BIOENERGY, V7, P916, DOI 10.1111/gcbb.12205; Dauve J J., 2015, EFF BR MINDFULNESS I, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; DiBlasi C, 1997, BIOMASS BIOENERG, V12, P321, DOI 10.1016/S0961-9534(96)00073-6; Dyjakon A., 2014, AGR ENG, V18, P29, DOI [10.14654/ir.2014.151.054, DOI 10.14654/IR.2014.151.054]; Eurostat, 2019, EUR GRAIN MAIZ CORN; Facello A, 2013, BIOMASS BIOENERG, V59, P468, DOI 10.1016/j.biombioe.2013.07.012; Garcia-Galindo D., 2016, EUROPEAN BIOMASS C E, DOI [10.5071/24thEUBCE2016-1BO.9.1, DOI 10.5071/24THEUBCE2016-1BO.9.1]; Kuptz D., 2015, INT J ENG TAYLOR FRA, V26, P60, DOI 10.1080/14942119.2015.1021529; Magagnotti N, 2013, BIORESOURCE TECHNOL, V128, P697, DOI 10.1016/j.biortech.2012.10.149; Palmieri N, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083466; Pari L, 2017, BIOMASS BIOENERG, V107, P398, DOI 10.1016/j.biombioe.2017.09.014; Pari L., 2018, BEST AVAILABLE TECHN; Pari L., 2019, AGR BYPRODUCTS VALOR, P60; Pari L, 2018, ENERGIES, V11, DOI 10.3390/en11071622; Pari L, 2018, ENERGIES, V11, DOI 10.3390/en11061365; Pari L, 2018, BIOMASS BIOENERG, V112, P121, DOI 10.1016/j.biombioe.2018.01.002; Pari L, 2017, BIOMASS BIOENERG, V107, P1, DOI 10.1016/j.biombioe.2017.09.007; Picchi G., 2011, 19 EUR BIOM C EXH BE, P430, DOI [10.2478/S31756-009-0109-4.6, DOI 10.2478/S31756-009-0109-4.6]; Prando D, 2014, PAPERS OF THE 22ND EUROPEAN BIOMASS CONFERENCE: SETTING THE COURSE FOR A BIOBASED ECONOMY, P655; Rackl M, 2016, BIOMASS BIOENERG, V88, P106, DOI 10.1016/j.biombioe.2016.03.011; Recchia L, 2009, BIOMASS BIOENERG, V33, P149, DOI 10.1016/j.biombioe.2008.05.003; Saia S, 2020, MYCORRHIZA, V30, P133, DOI 10.1007/s00572-019-00927-w; Santangelo E, 2015, IND CROP PROD, V75, P85, DOI 10.1016/j.indcrop.2015.07.013; Scarlat N, 2010, WASTE MANAGE, V30, P1889, DOI 10.1016/j.wasman.2010.04.016; Spinelli R, 2012, T ASABE, V55, P21; Spinelli R, 2015, SUPPLY WOOD BIOMASS, P54; Spinelli R, 2014, BIOMASS BIOENERG, V62, P117, DOI 10.1016/j.biombioe.2014.01.007; Spinelli R, 2012, SCAND J FOREST RES, V27, P393, DOI 10.1080/02827581.2011.644577; Spinelli R, 2012, APPL ENERG, V89, P374, DOI 10.1016/j.apenergy.2011.07.049; Spinelli R, 2010, BIOSYST ENG, V105, P316, DOI 10.1016/j.biosystemseng.2009.11.011; Spinelli R, 2010, BIORESOURCE TECHNOL, V101, P730, DOI 10.1016/j.biortech.2009.08.039; Suardi A, 2020, ENERGIES, V13, DOI 10.3390/en13071713; Suardi A, 2020, ENERGIES, V13, DOI 10.3390/en13071572; Suardi A, 2019, ENERGIES, V12, DOI 10.3390/en12163086; Velazquez-Marti B, 2009, BIOSYST ENG, V104, P184, DOI 10.1016/j.biosystemseng.2009.06.017; Wegener J, 2013, T ASABE, V56, P363; Wegener J, 2012, APPL ENG AGRIC, V28, P491; Wegener JK, 2014, BIOMASS BIOENERG, V66, P151, DOI 10.1016/j.biombioe.2014.01.029	49	2	2	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261810	10.1371/journal.pone.0261810	http://dx.doi.org/10.1371/journal.pone.0261810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972130	Green Published, gold			2022-12-26	WOS:000773555700056
J	Chen, PY; Chuang, PN; Chiang, CH; Chang, HH; Lu, CW; Huang, KC				Chen, Pei-Yun; Chuang, Pei-Ni; Chiang, Chien-Hsieh; Chang, Hao-Hsiang; Lu, Chia-Wen; Huang, Kuo-Chin			Impact of Coronavirus Infectious Disease (COVID-19) pandemic on willingness of immunization-A community-based questionnaire study	PLOS ONE			English	Article								Background Coronavirus infectious disease 2019 (COVID-19) has had a great impact on global health, but with relatively few confirmed cases in Taiwan. People in Taiwan showed excellent cooperation with the government for disease prevention and faced social and behavioral changes during this period. This study aimed to investigate people's knowledge of COVID-19, attitudes and practices regarding vaccinations for influenza, pneumococcus and COVID-19. Methods We conducted a community-based, cross-sectional questionnaire survey from September 2020 to October 2020 among adults in northern Taiwan. The four-part questionnaire included questions on sociodemographic characteristics, knowledge, attitude, and practice toward COVID-19. Results Among a total of 410 respondents, 58.5% were categorized as having "good knowledge" responding to COVID-19. Among the total respondents, 86.6% were willing to receive influenza or pneumococcal vaccines, and 76% of them acted to receive COVID-19 immunization once the vaccine became available. Compared with the respondents with poor knowledge of COVID-19, those with good knowledge had a more positive attitude toward receiving influenza or pneumococcal immunization (OR 3.26, 95% CI = 1.74-6.12). Conclusions Participants with good knowledge of COVID-19 had greater intent to receive immunization for influenza or pneumococcal vaccine. The promotion of correct knowledge of both COVID-19 and immunization preparations is necessary.	[Chen, Pei-Yun; Huang, Kuo-Chin] Natl Taiwan Univ Hosp, Dept Family Med, Bei Hu Branch, Taipei, Taiwan; [Chen, Pei-Yun; Chuang, Pei-Ni; Chiang, Chien-Hsieh; Chang, Hao-Hsiang; Lu, Chia-Wen; Huang, Kuo-Chin] Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Pei-Yun; Chuang, Pei-Ni; Chiang, Chien-Hsieh; Chang, Hao-Hsiang; Lu, Chia-Wen; Huang, Kuo-Chin] Natl Taiwan Univ Hosp, Training Ctr Travel Med, Taipei, Taiwan; [Chuang, Pei-Ni] Natl Taiwan Univ, Dept Family Med, BioMed Pk Hosp, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Huang, KC (corresponding author), Natl Taiwan Univ Hosp, Dept Family Med, Bei Hu Branch, Taipei, Taiwan.; Huang, KC (corresponding author), Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan.; Huang, KC (corresponding author), Natl Taiwan Univ Hosp, Training Ctr Travel Med, Taipei, Taiwan.	bretthuang@ntu.edu.tw		HUANG, KUO-CHIN/0000-0002-6029-5520; Chen, Pei-Yun/0000-0001-8970-8248; Lu, Chia-Wen/0000-0001-7555-1737; Chiang, Chien-Hsieh/0000-0003-0894-4498; Chang, Hao-Hsiang/0000-0001-5836-0728	Centers for Disease Control, Taiwan [JK108026]	Centers for Disease Control, Taiwan	This study has been partially sponsored by the Centers for Disease Control, Taiwan (JK108026) and there was no additional external funding received for this study.	Chang CM, 2020, PEERJ, V8, DOI 10.7717/peerj.9360; Cheng SY, 2021, J GASTROEN HEPATOL, V36, P1614, DOI 10.1111/jgh.15325; Feyissa GT, 2020, AFR J REPROD HEALTH, V24, P24, DOI 10.29063/ajrh2020/v24i2s.3; FocusTaiwan, INFL IMM PROGR TAIW; Johns Hopkins University, 2021, COVID 19 DASHB CTR S; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Sari DK, 2021, J COMMUN HEALTH, V46, P182, DOI 10.1007/s10900-020-00866-0; Shahid Z, 2020, J AM GERIATR SOC, V68, P926, DOI 10.1111/jgs.16472; Song JY, 2020, NEW ENGL J MED, V382, P1858, DOI 10.1056/NEJMc2001801; Taiwan Centers for Disease Control, SEASONAL INFLUENZA V; Taiwan Centers for Disease Control, CURR IMM SCHED TAIW; Taiwan Centers for Disease Control, ANN REP IMM COV TAIW; Taiwan Centers for Disease Control, TAIW CDC GUIDL COVID; Taiwan Centers for Disease Control, 2020, COVID 19 CUM CAS; Taiwan Centers for Disease Control, SEV INFL INF REL MOR; Taiwan Ministry of Health and Welfare, 2020, MAJ POL COMB COVID 1; TaiwanCentersforDiseaseControl, PRESS REL TAIW CTR D; Uyeki TM, 2017, ANN INTERN MED, V167, pITC33, DOI 10.7326/AITC201709050; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; World Health Organization (WHO), INFL UPD 2020; Zhang NN, 2020, CELL, V182, P1271, DOI 10.1016/j.cell.2020.07.024; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3	24	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262660	10.1371/journal.pone.0262660	http://dx.doi.org/10.1371/journal.pone.0262660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030220	gold, Green Published			2022-12-26	WOS:000812798500063
J	Sekulic, A; Yoo, S; Kudchadkar, R; Guillen, J; Rogers, G; Chang, ALS; Guenthner, S; Raskin, B; Dawson, K; Mun, Y; Chu, L; McKenna, E; Lacouture, M				Sekulic, Aleksandar; Yoo, Simon; Kudchadkar, Ragini; Guillen, Julie; Rogers, Gary; Chang, Anne Lynn S.; Guenthner, Scott; Raskin, Bernard; Dawson, Keith; Mun, Yong; Chu, Laura; McKenna, Edward; Lacouture, Mario			Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry	PLOS ONE			English	Article							MOHS MICROGRAPHIC SURGERY; NONMELANOMA SKIN-CANCER; SURGICAL EXCISION; SYSTEMIC THERAPY; CLINICAL-TRIAL; VISMODEGIB; NEOADJUVANT; FACE; RECURRENCE; AUSTRALIA	Background Limited information is available regarding real-world treatment patterns and their effectiveness and safety in patients with locally advanced basal cell carcinoma, including patients not typically represented in clinical trials. The purpose of the current study was to describe how clinicians diagnose and treat locally advanced basal cell carcinoma in the United States. Methods This prospective, multicenter, observational registry study included patients with newly diagnosed, Hedgehog pathway inhibitor-naive locally advanced basal cell carcinoma without basal cell carcinoma nevus syndrome (n = 433) treated at 75 US academic and community practices, including dermatology, Mohs surgery, and medical oncology sites. The main outcomes of this study were treatment patterns and associated effectiveness and safety for patients with locally advanced basal cell carcinoma in real-world settings. Results Determination of locally advanced basal cell carcinoma was mainly based on lesion size (79.6% of patients), histopathology (54.3%), extent of involvement (49.0%), and location (46.2%). Within 90 days of determination of locally advanced disease, 115 patients (26.6%) received vismodegib, 251 (58.0%) received surgery/other (non-vismodegib) treatment, and 67 (15.5%) had not yet received treatment (observation). Vismodegib-treated patients had a higher prevalence of high-risk clinical features predictive for locoregional recurrence than those with non-vismodegib treatment or observation. Clinical response rate was 85.1% with vismodegib and 94.9% with non-vismodegib treatment (primarily surgery). The most common adverse events with vismodegib were ageusia/dysgeusia, muscle spasms, alopecia, and weight loss. Rates of cutaneous squamous cell cancers were comparable between vismodegib and non-vismodegib treatment. Conclusions This prospective observational study offers insight on real-world practice, treatment selection, and outcomes for a nationally representative sample of US patients with locally advanced basal cell carcinoma. For patients with lesions that were not amenable to surgery, vismodegib treatment was associated with effectiveness and safety that was consistent with that observed in clinical trials.	[Sekulic, Aleksandar] Mayo Clin, Dermatol, Scottsdale, AZ 85259 USA; [Yoo, Simon] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA; [Kudchadkar, Ragini] Emory Univ, Winship Canc Inst, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Guillen, Julie] Univ Calif San Francisco, UCSF Dermatol & Laser Surg Ctr, San Francisco, CA 94143 USA; [Rogers, Gary] Tufts Univ New England Med Ctr, Surg Dermatol, Boston, MA USA; [Chang, Anne Lynn S.] Stanford Univ, Dermatol, Sch Med, Stanford, CA USA; [Guenthner, Scott] Indiana Clin Trials Ctr, Dermatol Ctr Indiana, Plainfield, IN USA; [Raskin, Bernard] Univ Calif Los Angeles, Sch Med, Dermatol, Los Angeles, CA USA; [Dawson, Keith; McKenna, Edward] Genentech Inc, Med Affairs, San Francisco, CA USA; [Mun, Yong] Genentech Inc, Biostat, San Francisco, CA USA; [Chu, Laura] Genentech Inc, Oncol, San Francisco, CA USA; [Lacouture, Mario] Mem Sloan Kettering Canc Ctr, Dermatol, 1275 York Ave, New York, NY 10021 USA	Mayo Clinic; Mayo Clinic Phoenix; Northwestern University; Feinberg School of Medicine; Emory University; University of California System; University of California San Francisco; Tufts Medical Center; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Memorial Sloan Kettering Cancer Center	Sekulic, A (corresponding author), Mayo Clin, Dermatol, Scottsdale, AZ 85259 USA.	sekulic@mayo.edu			F. Hoffmann-La Roche/Genentech, Inc.	F. Hoffmann-La Roche/Genentech, Inc.	F. Hoffmann-La Roche/Genentech, Inc. funded the RegiSONIC study and participated in the study design; data collection, analysis, and interpretation; preparation and revision of the manuscript; and decision to submit the manuscript for publication.	Alam M, 2011, J AM ACAD DERMATOL, V64, P839, DOI 10.1016/j.jaad.2010.06.028; Alcalay J, 2015, J DRUGS DERMATOL, V14, P219; Ally MS, 2014, J AM ACAD DERMATOL, V71, P904, DOI 10.1016/j.jaad.2014.05.020; [Anonymous], 2021, ALZHEIMERS DEMENT, V17, P327, DOI 10.1002/alz.12328; Basset-Seguin N, 2017, EUR J CANCER, V86, P334, DOI 10.1016/j.ejca.2017.08.022; Basset-Seguin N, 2015, LANCET ONCOL, V16, P729, DOI 10.1016/S1470-2045(15)70198-1; Berchick ER., 2019, HLTH INSURANCE COVER; Bhutani T, 2017, J AM ACAD DERMATOL, V77, P713, DOI 10.1016/j.jaad.2017.03.038; Chang ALS, 2013, JAMA DERMATOL, V149, P639, DOI 10.1001/jamadermatol.2013.30; Chren MM, 2013, J INVEST DERMATOL, V133, P1188, DOI 10.1038/jid.2012.403; Chren MM, 2011, ARCH DERMATOL, V147, P540, DOI 10.1001/archdermatol.2011.109; Fecher LA, 2013, CURR TREAT OPTION ON, V14, P237, DOI 10.1007/s11864-013-0233-9; Ganti AK, 2011, CANCER TREAT REV, V37, P440, DOI 10.1016/j.ctrv.2010.12.002; Goppner D, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/650258; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P445, DOI 10.1016/j.jaad.2005.04.083; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P452, DOI 10.1016/j.jaad.2005.04.087; Lewin Jesse M, 2015, F1000Prime Rep, V7, P53, DOI 10.12703/P7-53; Lo Muzio L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-32; Maciel PC, 2014, AN BRAS DERMATOL, V89, P594, DOI 10.1590/abd1806-4841.20142742; Maly TJ, 2014, J DRUGS DERMATOL, V13, P528; Marzuka Alexander G., 2015, Yale Journal of Biology and Medicine, V88, P167; Migden MR, 2015, LANCET ONCOL, V16, P716, DOI 10.1016/S1470-2045(15)70100-2; Mohan SV, 2014, CURR DERMATOL REP, V3, P40, DOI 10.1007/s13671-014-0069-y; Mohan SV, 2016, JAMA DERMATOL, V152, P527, DOI 10.1001/jamadermatol.2015.4330; Mosterd K, 2008, LANCET ONCOL, V9, P1149, DOI 10.1016/S1470-2045(08)70260-2; National Institute of Mental Health, 2018, MENT HLTH INF STAT; Pandeya N, 2005, AM J EPIDEMIOL, V161, P748, DOI 10.1093/aje/kwi098; Peris K, 2015, FUTURE ONCOL, V11, P703, DOI 10.2217/fon.14.281; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Sekulic A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3286-5; Sekulic A, 2015, J AM ACAD DERMATOL, V72, P1021, DOI 10.1016/j.jaad.2015.03.021; Sekulic A, 2013, CURR OPIN ONCOL, V25, P218, DOI 10.1097/CCO.0b013e32835ff438; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Smeets NWJ, 2004, LANCET, V364, P1766, DOI 10.1016/S0140-6736(04)17399-6; The National Institute of Mental Health, 2020, MENT ILLN; van Loo E, 2014, EUR J CANCER, V50, P3011, DOI 10.1016/j.ejca.2014.08.018; Weinstock MA, 2011, SEMIN CUTAN MED SURG, V30, pS10, DOI 10.1016/j.sder.2011.11.004	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262151	10.1371/journal.pone.0262151	http://dx.doi.org/10.1371/journal.pone.0262151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030185	gold, Green Published			2022-12-26	WOS:000812798500031
J	Sarpong-Kumankomah, S; Knox, KB; Kelly, ME; Hunter, G; Popescu, B; Nichol, H; Kopciuk, K; Ntanda, H; Gailer, J				Sarpong-Kumankomah, Sophia; Knox, Katherine B.; Kelly, Michael E.; Hunter, Gary; Popescu, Bogdan; Nichol, Helen; Kopciuk, Karen; Ntanda, Henry; Gailer, Jurgen			Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age	PLOS ONE			English	Article							ERYTHROCYTE FRAGILITY; OXIDATIVE STRESS; SERUM; IRON; DIAGNOSIS; PROTEOME; METALS; ZINC	Advanced analytical methods play an important role in quantifying serum disease biomarkers. The problem of separating thousands of proteins can be reduced by analyzing for a 'sub-proteome', such as the 'metalloproteome', defined as all proteins that contain bound metals. We employed size exclusion chromatography (SEC) coupled to an inductively coupled plasma atomic emission spectrometer (ICP-AES) to analyze plasma from multiple sclerosis (MS) participants (n = 21), acute ischemic stroke (AIS) participants (n = 17) and healthy controls (n = 21) for Fe, Cu and Zn-metalloproteins. Using ANOVA analysis to compare the mean peak areas among the groups revealed no statistically significant differences for ceruloplasmin (p = 0.31), a 2 macroglobulin (p = 0.51) and transferrin (p = 0.31). However, a statistically significant difference was observed for the haptoglobin-hemoglobin (Hp-Hb) complex (p = 0.04), being driven by the difference between the control group and AIS (p = 0.012), but not with the MS group (p = 0.13), based on Dunnes test. A linear regression model for Hp-Hb complex with the groups now adjusted for age found no statistically significant differences between the groups (p = 0.95), but was suggestive for age (p = 0.057). To measure the strength of association between the Hp-Hb complex and age without possible modifications due to disease, we calculated the Spearman rank correlation in the healthy controls. The latter revealed a positive association (r = 0.39, 95% Confidence Interval = (-0.05, 0.83), which suggests that either the removal of Hp-Hb complexes from the blood circulation slows with age or that the release of Hb from red blood cells increases with age. We also observed that the Fe-peak corresponding to the Hp-Hb complex eluted similar to 100 slater in similar to 14% of all study samples, which was not correlated with age or disease diagnosis, but is consistent with the presence of the smaller Hp (1-1) isoform in 15% of the population.	[Sarpong-Kumankomah, Sophia; Gailer, Jurgen] Univ Calgary, Dept Chem, Calgary, AB, Canada; [Knox, Katherine B.] Univ Saskatchewan, Coll Med, Dept Phys Med & Rehabil, Saskatoon, SK, Canada; [Kelly, Michael E.] Univ Saskatchewan, Coll Med, Div Neurosurg, Saskatoon, SK, Canada; [Hunter, Gary] Univ Saskatchewan, Coll Med, Div Neurol, Saskatoon, SK, Canada; [Popescu, Bogdan; Nichol, Helen] Univ Saskatchewan, Dept Anat Physiol & Pharmacol, Saskatoon, SK, Canada; [Kopciuk, Karen] Univ Calgary, Dept Math & Stat, Calgary, AB, Canada; [Kopciuk, Karen] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Kopciuk, Karen] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Kopciuk, Karen] Canc Control Alberta, Canc Epidemiol & Prevent Res, Calgary, AB, Canada; [Ntanda, Henry] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada	University of Calgary; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Gailer, J (corresponding author), Univ Calgary, Dept Chem, Calgary, AB, Canada.	jgailer@ucalgary.ca		Gailer, Juergen/0000-0002-8264-8243	Royal University Hospital Foundation [G21548]; Saskatchewan Research Chair in Clinical Stroke Research - Heart & Stroke Foundation; Saskatchewan Health Research Foundation; University of Saskatchewan's College of Medicine	Royal University Hospital Foundation; Saskatchewan Research Chair in Clinical Stroke Research - Heart & Stroke Foundation; Saskatchewan Health Research Foundation; University of Saskatchewan's College of Medicine	The project was funded by a grant from the Royal University Hospital Foundation G21548 to H. Nichol (PI) and M.E. Kelly, the Saskatchewan Research Chair in Clinical Stroke Research which is funded by the Heart & Stroke Foundation, the Saskatchewan Health Research Foundation and the University of Saskatchewan's College of Medicine.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Bale BF, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00141; BARTOSZ G, 1991, GERONTOLOGY, V37, P33, DOI 10.1159/000213251; Bredholt M, 2016, ASN NEURO, V8, DOI 10.1177/1759091416651511; Bridle TG, 2021, MOLECULES, V26, DOI 10.3390/molecules26113408; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Carelli-Alinovi C, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00276; Chaichana KL, 2007, STROKE, V38, P3266, DOI 10.1161/STROKEAHA.107.490003; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; da Silva MAO, 2010, EXPERT REV PROTEOMIC, V7, P387, DOI [10.1586/epr.10.16, 10.1586/EPR.10.16]; di Masi A, 2020, MOL ASPECTS MED, V73, DOI 10.1016/j.mam.2020.100851; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1318, DOI 10.1001/archneurol.2012.1282; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; Ferenci P, 2017, HAND CLINIC, V142, P171, DOI 10.1016/B978-0-444-63625-6.00014-8; Geyer PE, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20156297; Gomes FP, 2019, MASS SPECTROM REV, V38, P445, DOI 10.1002/mas.21599; Gonzalez-Dominguez R, 2014, METALLOMICS, V6, P292, DOI 10.1039/c3mt00301a; Hood L. A., 2008, PHYS BIOL ATOMS MED, P337; Kodali P, 2012, METALLOMICS, V4, P1077, DOI 10.1039/c2mt20092a; Kumar Arun, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P6, DOI 10.1016/S2221-1691(11)60058-0; Langlois MR, 1996, CLIN CHEM, V42, P1589; Manley SA, 2009, J BIOL INORG CHEM, V14, P61, DOI 10.1007/s00775-008-0424-1; Manley SA, 2009, EXPERT REV PROTEOMIC, V6, P251, DOI [10.1586/epr.09.44, 10.1586/EPR.09.44]; Melo TM, 2003, BIOL TRACE ELEM RES, V93, P1, DOI 10.1385/BTER:93:1-3:1; Miller K, 2020, J CHROMATOGR B, V1147, DOI 10.1016/j.jchromb.2020.122147; Moitra S, 2014, AM J IND MED, V57, P1064, DOI 10.1002/ajim.22336; Pan MX, 2017, AGING DIS, V8, P519, DOI 10.14336/AD.2017.0710; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Popescu BF, 2017, ACTA NEUROPATHOL, V134, P45, DOI 10.1007/s00401-017-1696-8; Popescu BFG, 2009, CEREBELLUM, V8, P340, DOI 10.1007/s12311-009-0102-z; Popescu BFG, 2011, CNS NEUROSCI THER, V17, P256, DOI 10.1111/j.1755-5949.2010.00149.x; Pushie MJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74698-2; Sarpong-Kumankomah S, 2019, J INORG BIOCHEM, V201, DOI 10.1016/j.jinorgbio.2019.110802; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Sussulini A, 2010, ANAL CHEM, V82, P5859, DOI 10.1021/ac101063t; Tham M, 2021, ANN NEUROL, V89, P498, DOI 10.1002/ana.25974; Vardi M, 2012, CURR DIABETES REP, V12, P274, DOI 10.1007/s11892-012-0265-8; Wang P, 2017, AGEING RES REV, V35, P265, DOI 10.1016/j.arr.2016.10.003; Zhang T, 2018, EUR NEUROL, V79, P154, DOI 10.1159/000487648; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009	45	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262160	10.1371/journal.pone.0262160	http://dx.doi.org/10.1371/journal.pone.0262160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020753	gold, Green Published			2022-12-26	WOS:000834207700034
J	Seravalli, V; Strambi, N; D'Arienzo, A; Magni, F; Bernardi, L; Morucchio, A; Di Tommaso, M				Seravalli, Viola; Strambi, Noemi; D'Arienzo, Alessandra; Magni, Francesco; Bernardi, Ludovico; Morucchio, Anna; Di Tommaso, Mariarosaria			Patient's experience with the Arabin cervical pessary during pregnancy: A questionnaire survey	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; SINGLETON PREGNANCY; TWIN PREGNANCIES; RANDOMIZED-TRIAL; WOMEN; PREVENTION; MULTICENTER; PECEP; RISK	Introduction The cervical pessary is used in women with precocious cervical ripening to prevent preterm birth. Up to now however, there have been no systematic studies on compliance and tolerance, which vary among different study cohorts. Material and methods A questionnaire was administered to 166 women treated with the Arabin cervical pessary in one center. Data were analysed about the patient's experience before insertion (adequacy of information received), during treatment (follow-up, impact on daily life, perceived discomfort, side effects) and at the time of removal (pain, if the patient's expectations had been met regarding the treatment). Results Information received before the insertion of the Arabin cervical pessary was considered adequate in 163/166 (98.2%) women. An increase in vaginal discharge was experienced by 70/ 166 (42.2%) women. Discomfort or other side effects were reported in 13.8% and 16.3% of cases, respectively. Overall, 77% of women reported an improved quality of life and 94% considered the follow-up during pregnancy adequate. Removal was moderately painful for 58/166 (35%) of women. Patient's expectations regarding the treatment were exceeded in the majority of cases (75.3%). In a final step, we compared our results to previous studies regarding the use of the pessary in singleton and twin pregnancies. Conclusion Although some trials report high rates of non-compliant patients, this could not be confirmed by our study. In contrast, most women reported having a positive experience and that they were motivated to continue the treatment when they were continuously followed by experienced clinicians.	[Seravalli, Viola; Strambi, Noemi; D'Arienzo, Alessandra; Magni, Francesco; Bernardi, Ludovico; Morucchio, Anna; Di Tommaso, Mariarosaria] Univ Florence, Dept Hlth Sci, Florence, Italy	University of Florence	Di Tommaso, M (corresponding author), Univ Florence, Dept Hlth Sci, Florence, Italy.	mariarosaria.ditommaso@unifi.it		DI TOMMASO, MARIAROSARIA/0000-0001-8248-929X				Arabin B, 2006, ULTRASOUND OBST GYN, V27, P377, DOI 10.1002/uog.2694; Arabin B, 2013, ULTRASOUND OBST GYN, V42, P390, DOI 10.1002/uog.12540; Arabin B, 2003, J PERINAT MED, V31, P122, DOI 10.1515/JPM.2003.017; Barbone AS, 2020, ULTRASOUND OBST GYN, V55, P557, DOI 10.1002/uog.20375; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Cannie MM, 2013, ULTRASOUND OBST GYN, V42, P426, DOI 10.1002/uog.12507; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Dang VQ, 2019, OBSTET GYNECOL, V133, P459, DOI 10.1097/AOG.0000000000003136; Di Renzo GC, 2017, J MATERN-FETAL NEO M, V30, P2011, DOI 10.1080/14767058.2017.1323860; Di Tommaso M, 2016, J OBSTET GYNAECOL, V36, P715, DOI 10.3109/01443615.2016.1148127; Diez-Izquierdo A, 2018, ENVIRON RES, V160, P547, DOI 10.1016/j.envres.2017.10.033; Dugoff L, 2018, ULTRASOUND OBST GYN, V51, P573, DOI 10.1002/uog.18908; Englund-Ogge L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1446; Franca MS, 2021, OBSTET GYNECOL INT J, V12, P94; Garn JV, 2015, MATERN CHILD HLTH J, V19, P811, DOI 10.1007/s10995-014-1576-y; Goya M, 2016, AM J OBSTET GYNECOL, V214, P145, DOI 10.1016/j.ajog.2015.11.012; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Hoffman MK, 2020, LANCET, V395, P285, DOI 10.1016/S0140-6736(19)32973-3; Hui SYA, 2013, AM J PERINAT, V30, P283, DOI 10.1055/s-0032-1322550; Ivandic J, 2020, J MATERN-FETAL NEO M, V33, P1370, DOI 10.1080/14767058.2018.1519018; Jones KR, 2007, J REHABIL RES DEV, V44, P305, DOI 10.1682/JRRD.2006.05.0051; Kyvernitakis I, 2019, GEBURTSH FRAUENHEILK, V79, P1171, DOI 10.1055/a-1007-8613; Liem S, 2013, LANCET, V382, P1341, DOI 10.1016/S0140-6736(13)61408-7; Makrides M, 2019, NEW ENGL J MED, V381, P1035, DOI 10.1056/NEJMoa1816832; Middleton P, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub3; Nicolaides KH, 2016, NEW ENGL J MED, V374, P1044, DOI 10.1056/NEJMoa1511014; Nicolaides KH, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.051; Norman JE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003506; Saccone G, 2017, JAMA-J AM MED ASSOC, V318, P2317, DOI 10.1001/jama.2017.18956; Simmonds LA, 2020, BJOG-INT J OBSTET GY, V127, P975, DOI 10.1111/1471-0528.16168; Souka AP, 2019, ULTRASOUND OBST GYN, V53, P396, DOI 10.1002/uog.19050	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261830	10.1371/journal.pone.0261830	http://dx.doi.org/10.1371/journal.pone.0261830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020768	gold, Green Published			2022-12-26	WOS:000834207700025
J	Feichtinger, X; Heimel, P; Tangl, S; Keibl, C; Nurnberger, S; Schanda, JE; Hercher, D; Kocijan, R; Redl, H; Grillari, J; Fialka, C; Mittermayr, R				Feichtinger, Xaver; Heimel, Patrick; Tangl, Stefan; Keibl, Claudia; Nurnberger, Sylvia; Schanda, Jakob Emanuel; Hercher, David; Kocijan, Roland; Redl, Heinz; Grillari, Johannes; Fialka, Christian; Mittermayr, Rainer			Improved biomechanics in experimental chronic rotator cuff repair after shockwaves is not reflected by bone microarchitecture	PLOS ONE			English	Article							EXTRACORPOREAL SHOCKWAVE; WAVE THERAPY; TENDON; DEGENERATION; IMAGE; PROLIFERATION; OSTEOPOROSIS; EXPRESSION; TISSUES; CELLS	Purpose The aim of this study was to investigate the effect of extracorporeal shockwave therapy (ESWT) on bone microstructure as well as the bone-tendon-interface and the musculo-tendinous transition zone to explain the previously shown improved biomechanics in a degenerative rotator cuff tear animal model. This study hypothesized that biomechanical improvements related to ESWT are a result of improved bone microstructure and muscle tendon properties. Methods In this controlled laboratory study unilateral supraspinatus (SSP) tendon detachment was performed in 48 male Sprague-Dawley rats. After a degeneration period of three weeks, SSP tendon was reconstructed transosseously. Rats were randomly assigned into three groups (n = 16 per group): control (noSW); intraoperative shockwave treatment (IntraSW); intra- and postoperative shockwave treatment (IntraPostSW). Eight weeks after SSP repair, all rats were sacrificed and underwent bone microstructure analysis as well as histological and immunohistochemical analyses. Results With exception of cortical porosity at the tendon area, bone microstructure analyses revealed no significant differences between the three study groups regarding cortical and trabecular bone parameters. Cortical Porosity at the Tendon Area was lowest in the IntraPostSW (p <= 0.05) group. Histological analyses showed well-regenerated muscle and tendon structures in all groups. Immunohistochemistry detected augmented angiogenesis at the musculo-tendinous transition zone in both shockwave groups indicated by CD31 positive stained blood vessels. Conclusion In conclusion, bone microarchitecture changes are not responsible for previously described improved biomechanical results after shockwave treatment in rotator cuff repair in rodents. Immunohistochemical analysis showed neovascularization at the musculo-tendinous transition zone within ESWT-treated animals. Further studies focusing on neovascularization at the musculo-tendinous transition zone are necessary to explain the enhanced biomechanical and functional properties observed previously.	[Feichtinger, Xaver; Heimel, Patrick; Keibl, Claudia; Nurnberger, Sylvia; Schanda, Jakob Emanuel; Hercher, David; Redl, Heinz; Grillari, Johannes; Mittermayr, Rainer] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Feichtinger, Xaver; Schanda, Jakob Emanuel; Fialka, Christian; Mittermayr, Rainer] AUVA Trauma Ctr Vienna Meidling, Vienna, Austria; [Feichtinger, Xaver] Herz Jesu Krankenhaus, Dept Orthopaed Surg 2, Vienna, Austria; [Feichtinger, Xaver; Heimel, Patrick; Tangl, Stefan; Keibl, Claudia; Nurnberger, Sylvia; Schanda, Jakob Emanuel; Hercher, David; Redl, Heinz; Grillari, Johannes; Mittermayr, Rainer] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Heimel, Patrick; Tangl, Stefan] Med Univ Vienna, Univ Clin Dent, Dept Oral Surg, Karl Donath Lab Hard Tissue & Biomat Res, Vienna, Austria; [Nurnberger, Sylvia] Med Univ Vienna, Dept Orthopaed & Trauma Surg, Div Trauma Surg, Vienna, Austria; [Kocijan, Roland] Hanusch Hosp, Med Dept 1, Ludwig Boltzmann Inst Osteol, Vienna, Austria; [Kocijan, Roland; Fialka, Christian; Mittermayr, Rainer] Sigmund Freud Univ, Med Fac, Ctr Musculoskeletal Syst, Vienna, Austria	Ludwig Boltzmann Institute; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital	Feichtinger, X (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.; Feichtinger, X (corresponding author), AUVA Trauma Ctr Vienna Meidling, Vienna, Austria.; Feichtinger, X (corresponding author), Herz Jesu Krankenhaus, Dept Orthopaed Surg 2, Vienna, Austria.; Feichtinger, X (corresponding author), Austrian Cluster Tissue Regenerat, Vienna, Austria.	xaver.feichtinger@gmail.com		Hercher, David/0000-0001-5928-9492; Tangl, Stefan/0000-0002-9023-4745	Medical Scientific Fund of the Mayor of the City of Vienna	Medical Scientific Fund of the Mayor of the City of Vienna	This work was supported by the Medical Scientific Fund of the Mayor of the City of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpantaki K, 2005, J BONE JOINT SURG AM, V87A, P1580, DOI 10.2106/JBJS.D.02840; BranEs J, 2012, SHOULDER ELB, V4, P163, DOI [10.1111/j.1758-5740.2012.00178.x, DOI 10.1111/J.1758-5740.2012.00178.X]; Buchmann S, 2011, ARCH ORTHOP TRAUM SU, V131, P429, DOI 10.1007/s00402-010-1246-5; Cheng JH, 2015, INT J SURG, V24, P143, DOI 10.1016/j.ijsu.2015.06.059; Cho NS, 2010, AM J SPORT MED, V38, P664, DOI 10.1177/0363546509350081; Chona DV, 2017, J SHOULDER ELB SURG, V26, P2054, DOI 10.1016/j.jse.2017.07.015; Chow DHK, 2012, AM J SPORT MED, V40, P2862, DOI 10.1177/0363546512461596; Chung SW, 2011, AM J SPORT MED, V39, P2099, DOI 10.1177/0363546511415659; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dungel P, 2014, LASER SURG MED, V46, P773, DOI 10.1002/lsm.22299; Feichtinger X, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02394-6; Feichtinger X, 2019, AM J SPORT MED, V47, P2158, DOI 10.1177/0363546519854760; Feichtinger X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22844-2; FRITSCH H, 1989, STAIN TECHNOL, V64, P75, DOI 10.3109/10520298909108049; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Haffner N, 2016, INJURY, V47, P1506, DOI 10.1016/j.injury.2016.04.010; Hausdorf J, 2011, ARCH ORTHOP TRAUM SU, V131, P303, DOI 10.1007/s00402-010-1166-4; Holfeld J, 2014, INFLAMMATION, V37, P65, DOI 10.1007/s10753-013-9712-1; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339; KANNUS P, 1995, J BONE MINER RES, V10, P1263; Killian ML, 2015, AM J SPORT MED, V43, P2401, DOI 10.1177/0363546515596408; Kim HM, 2010, J BONE JOINT SURG AM, V92A, P829, DOI 10.2106/JBJS.H.01746; Kim JY, 2012, KNEE SURG SPORT TR A, V20, P2567, DOI 10.1007/s00167-012-1923-8; Kirchhoff C, 2010, AM J SPORT MED, V38, P564, DOI 10.1177/0363546509354989; Kisch T, 2016, J SURG RES, V201, P440, DOI 10.1016/j.jss.2015.11.049; Meyer DC, 2004, J SHOULDER ELB SURG, V13, P333, DOI 10.1016/j.jse.2003.12.016; Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e; Moya D, 2018, J BONE JOINT SURG AM, V100, P251, DOI 10.2106/JBJS.17.00661; Notarnicola A, 2018, J BIOL REG HOMEOS AG, V32, P185; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider KH, 2016, ACTA BIOMATER, V29, P125, DOI 10.1016/j.actbio.2015.09.038; Song FL, 2017, CELL PHYSIOL BIOCHEM, V41, P875, DOI 10.1159/000460005; Thomopoulos S, 2002, J ORTHOP RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Trantalis JN, 2008, ARTHROSCOPY, V24, P727, DOI 10.1016/j.arthro.2008.03.009; van der Jagt OP, 2011, J BONE JOINT SURG AM, V93A, P38, DOI 10.2106/JBJS.I.01535; van der Jagt OP, 2009, J ORTHOP RES, V27, P1528, DOI 10.1002/jor.20910; van der Worp H, 2013, KNEE SURG SPORT TR A, V21, P1451, DOI 10.1007/s00167-012-2009-3; Wang CJ, 2007, AM J SPORT MED, V35, P972, DOI 10.1177/0363546506298109; Weihs AM, 2014, J BIOL CHEM, V289, P27090, DOI 10.1074/jbc.M114.580936; Xu TT, 2017, MOL MED REP, V16, P8755, DOI 10.3892/mmr.2017.7735; Yu L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1404650	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262294	10.1371/journal.pone.0262294	http://dx.doi.org/10.1371/journal.pone.0262294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986173	Green Published, gold			2022-12-26	WOS:000765956200036
J	Slanzon, GS; Ridenhour, BJ; Moore, DA; Sischo, WM; Parrish, LM; Trombetta, SC; McConnel, CS				Slanzon, Giovana S.; Ridenhour, Benjamin J.; Moore, Dale A.; Sischo, William M.; Parrish, Lindsay M.; Trombetta, Sophie C.; McConnel, Craig S.			Fecal microbiome profiles of neonatal dairy calves with varying severities of gastrointestinal disease	PLOS ONE			English	Article							CALF DIARRHEA; BIFIDOBACTERIA; DYSBIOSIS; DIAGNOSIS	Gastrointestinal disease (GI) is the most common illness in pre-weaned dairy calves. Studies have associated the fecal microbiome composition with health status, but it remains unclear how the microbiome changes across different levels of GI disease and breeds. Our objective was to associate the clinical symptoms of GI disease with the fecal microbiome. Fecal samples were collected from calves (n = 167) of different breeds (Holstein, Jersey, Jersey-cross and beef-cross) from 4-21 d of age. Daily clinical evaluations assessed health status. Calves with loose or watery feces were diagnosed with diarrhea and classified as bright-sick (BS) or depressed-sick (DS) according to behavior. Calves with normal or semiformed feces and no clinical illness were classified as healthy (H). One hundred and three fecal samples were obtained from consistently healthy calves and 64 samples were from calves with diarrhea (n = 39 BS; n = 25 DS). The V3-V4 region of 16S rRNA gene was sequenced and analyzed. Differences were identified by a linear-mixed effects model with a negative binomial error. DS and Jersey calves had a higher relative abundance of Streptococcus gallolyticus relative to H Holstein calves. In addition, DS calves had a lower relative abundance of Bifidobacterium longum and an enrichment of Escherichia coli. Species of the genus Lactobacillus, such as an unclassified Lactobacillus, Lactobacillus reuteri, and Lactobacillus salivarius were enriched in calves with GI disease. Moreover, we created a model to predict GI disease based on the fecal microbiome composition. The presence of Eggerthella lenta, Bifidobacterium longum, and Collinsella aerofaciens were associated with a healthy clinical outcome. Although lactobacilli are often associated with beneficial probiotic properties, the presence of E. coli and Lactobacillus species had the highest coefficients positively associated with GI disease prediction. Our results indicate that there are differences in the fecal microbiome of calves associated with GI disease severity and breed specificities.	[Slanzon, Giovana S.; Moore, Dale A.; Sischo, William M.; Parrish, Lindsay M.; Trombetta, Sophie C.; McConnel, Craig S.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Ridenhour, Benjamin J.] Univ Idaho, Coll Sci, Dept Math & Stat Sci, Moscow, ID 83843 USA	Washington State University; Idaho; University of Idaho	Slanzon, GS (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA.	giovana.slanzon@wsu.edu	Slanzon, Giovana/GQQ-7384-2022; Slanzon, Giovana/F-5136-2017	Slanzon, Giovana/0000-0002-3629-8844; Ridenhour, Benjamin/0000-0001-8271-4629	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2019-68008-29897]; USDA National Institute of Food and Agriculture; Animal Health & Disease Research Capacity Grant project [1014680]; WSU CVM Caldwell Endowment; American Jersey Cattle Association	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Animal Health & Disease Research Capacity Grant project; WSU CVM Caldwell Endowment; American Jersey Cattle Association	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2019-68008-29897 from the USDA National Institute of Food and Agriculture, the USDA National Institute of Food and Agriculture, Animal Health & Disease Research Capacity Grant project 1014680, the WSU CVM Caldwell Endowment, and the American Jersey Cattle Association.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 1995, J DAIRY SCI, V78, P2838, DOI 10.3168/jds.S0022-0302(95)76914-4; Ahl D, 2016, ACTA PHYSIOL, V217, P300, DOI 10.1111/apha.12695; Alipour MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28733-y; Allard G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0747-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amin N, 2021, COMPUT STRUCT BIOTEC, V19, P989, DOI 10.1016/j.csbj.2021.01.035; Anderson D. C., 2003, Professional Animal Scientist, V19, P399; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204; Aust V, 2013, J ANIM PHYSIOL AN N, V97, P1091, DOI 10.1111/jpn.12019; Aw W, 2019, MICROB BIOTECHNOL, V12, P1097, DOI 10.1111/1751-7915.13460; Barden M, 2020, ANIM MICROBIOME, V2, DOI 10.1186/s42523-020-00049-1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergamaschi M, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00888-9; Bharti R, 2021, BRIEF BIOINFORM, V22, P178, DOI 10.1093/bib/bbz155; Boudry G, 2017, J DAIRY SCI, V100, P2471, DOI 10.3168/jds.2016-11890; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Castro JJ, 2016, J DAIRY SCI, V99, P9703, DOI 10.3168/jds.2016-11007; Caswell JL, 2012, VET CLIN N AM-FOOD A, V28, P419, DOI 10.1016/j.cvfa.2012.07.004; Cho YI, 2014, J VET SCI, V15, P1, DOI 10.4142/jvs.2014.15.1.1; Constable PD, 2004, J VET INTERN MED, V18, P8, DOI 10.1892/0891-6640(2004)18&lt;8:AUITTO&gt;2.0.CO;2; Constable PD, 2009, VET CLIN N AM-FOOD A, V25, P101, DOI 10.1016/j.cvfa.2008.10.012; Deelen SM, 2014, J DAIRY SCI, V97, P3838, DOI 10.3168/jds.2014-7939; DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750; Dicksved J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046399; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169851; Mokhtari EB, 2021, Arxiv, DOI arXiv:2104.01679; Fernandez S, 2020, BENEF MICROBES, V11, P477, DOI 10.3920/BM2019.0167; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fujiwara S, 1997, APPL ENVIRON MICROB, V63, P506, DOI 10.1128/AEM.63.2.506-512.1997; Gomez DE, 2017, J VET INTERN MED, V31, P928, DOI 10.1111/jvim.14695; Gomez DE, 2019, VET CLIN N AM-FOOD A, V35, P485, DOI 10.1016/j.cvfa.2019.08.002; Guzman CE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74677-7; Hagey JV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01093; Hennessy M, 2021, J DAIRY SCI, V104, P7225, DOI 10.3168/jds.2020-19108; Hristov S., 2011, Biotechnology in Animal Husbandry, V27, P1417, DOI 10.2298/BAH1104417H; Hulbert LE, 2016, J DAIRY SCI, V99, P3199, DOI 10.3168/jds.2015-10198; Islam M, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.601061; LARSON LL, 1977, J DAIRY SCI, V60, P989, DOI 10.3168/jds.S0022-0302(77)83975-1; Lowe GL, 2019, J DAIRY SCI, V102, P5389, DOI 10.3168/jds.2018-15701; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Malmuthuge N, 2019, APPL ENVIRON MICROB, V85, DOI [10.1128/AEM.02534-18, 10.1128/aem.02534-18]; Maynou G, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00159; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meganck V, 2015, PREV VET MED, V118, P64, DOI 10.1016/j.prevetmed.2014.11.007; National Center for Biotechnology Information (NCBI), 1988, US; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Okada S, 2018, LARGE ANIM REV, V24, P139; Oultram J, 2015, VET REC, V177, DOI 10.1136/vr.103320; Paz HA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01206; Penati M, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.650150; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rosa F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191599; Sato H, 2010, J VET MED SCI, V72, P1551, DOI 10.1292/jvms.10-0162; Sayers RG, 2016, J DAIRY SCI, V99, P4647, DOI 10.3168/jds.2015-10600; Smith DR, 2012, VET CLIN N AM-FOOD A, V28, P465, DOI 10.1016/j.cvfa.2012.07.010; Uetake K, 2013, ANIM SCI J, V84, P101, DOI 10.1111/asj.12019; USDA, 2017, HLTH MAN PRACT US DA; Waller D.G., 2018, MED PHARM THERAPEUTI, P581, DOI [DOI 10.1016/B978-0-7020-7167-6.00046-4, 10.1016/B978-0-7020-7167-6.00051-8]; Xiao YP, 2017, ASIAN AUSTRAL J ANIM, V30, P1456, DOI 10.5713/ajas.16.0746	63	5	5	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262317	10.1371/journal.pone.0262317	http://dx.doi.org/10.1371/journal.pone.0262317			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982792	gold, Green Published			2022-12-26	WOS:000834805700030
J	Raab, M; Pfadenhauer, LM; Doumbouya, D; Froeschl, G				Raab, Manuel; Pfadenhauer, Lisa M.; Doumbouya, Dansira; Froeschl, Guenter			Clinical presentations, diagnostics, treatments and treatment costs of children and adults with febrile illness in a tertiary referral hospital in south-eastern Guinea: A retrospective longitudinal cohort study	PLOS ONE			English	Article							EBOLA-VIRUS DISEASE; WEST-AFRICA; SYSTEMATIC ANALYSIS; TYPHOID-FEVER; HEALTH; LEPTOSPIROSIS; PREVALENCE; RESISTANCE; CARE	BackgroundFebrile illness is frequent among patients in the tropics. It is caused by a wide variety of common diseases such as malaria or gastrointestinal infections but also by less common but highly contagious pathogens with epidemic potential. This study describes the clinical features of adult and paediatric patients with febrile illness in in the largest tertiary referral hospital in south-eastern Guinea, a region at high risk for viral haemorrhagic fever outbreaks. The study further compares their diagnostic characteristics, treatments and outcomes with non-febrile patients in order to contribute to the local epidemiology of febrile illness. MethodsWe used retrospective data collection to record demographic and clinical data of all incoming patients during a study period of three months. For the follow-up study of inpatients, we retrospectively reviewed patient charts for diagnostic characteristics, diagnoses and outcomes. ResultsOf the 4317 incoming patients during the study period, 9.5% had a febrile illness. The most used diagnostic measures to identify causative agents in febrile patients were point-of-care tests and most treatments relied on antibiotics. Most common discharge diagnoses for febrile inpatients were malaria (9.6% adults, 56.7% children), salmonella gastroenteritis/typhoid (10.6% adults, 7.8% children) and respiratory infection/pneumonia (5.3% adults, 18.7% children). Inpatient mortality for children was significantly higher in febrile than non-febrile children (18.5% vs. 5.1%, p<0.001) and considerably higher in febrile than non-febrile adults (29.8% vs. 25.0%, p = 0.404). ConclusionsMalaria, respiratory infection and gastroenteritis are considered the main causes for febrile illness. The wide reliance on rapid diagnostic tests to diagnose febrile patients not only risks to over- or under-diagnose certain diseases but also leaves the possibility of highly infectious diseases in febrile patients unexplored. Furthermore, the heavy reliance on antibiotics risks to cause antimicrobial resistance. High mortality rates in febrile patients, especially children, should be of concern to public health authorities.	[Raab, Manuel; Froeschl, Guenter] Univ Hosp LMU, Div Infect Dis & Trop Med, Munich, Germany; [Pfadenhauer, Lisa M.] Ludwig Maximilian Univ Munich, Inst Med Informat Biometry & Epidemiol, Pettenkofer Sch Publ Hlth, Munich, Germany; [Doumbouya, Dansira] Paediat Serv, Hopital Reg Nzerekore, Nzerekore, Guinea	University of Munich; University of Munich	Raab, M (corresponding author), Univ Hosp LMU, Div Infect Dis & Trop Med, Munich, Germany.	manuel.j.raab@gmail.com		Raab, Manuel/0000-0002-4247-9588	MeCuM International Scholarship by the Medical Department of the Ludwig-Maximilians-Universitat (LMU), Munich	MeCuM International Scholarship by the Medical Department of the Ludwig-Maximilians-Universitat (LMU), Munich	MR was supported financially through MeCuM International Scholarship by the Medical Department of the Ludwig-Maximilians-Universitat (LMU), Munich. The scholarship covered travel and living expenses during the research period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhulimhen-Iyoha BI., 2012, NIGER J PAEDIAT, V39; Agence Nationale de Securite Sanitaire (ANSS), 2021, REUN HEBD INF EP; Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109; [Anonymous], INF B EB VIR DIS OUT; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Bausch DG, 2001, VECTOR-BORNE ZOONOT, V1, P269, DOI 10.1089/15303660160025903; Bernabe KJ, 2017, INT J ANTIMICROB AG, V50, P629, DOI 10.1016/j.ijantimicag.2017.07.002; Berzosa P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2481-4; Bisoffi Z, 2013, LANCET GLOB HEALTH, V1, pE11, DOI 10.1016/S2214-109X(13)70013-5; Boozary AS, 2014, JAMA-J AM MED ASSOC, V312, P1859, DOI 10.1001/jama.2014.14387; Butenko A M, 1996, Med Parazitol (Mosk), P40; Camara I., 2020, J PUBLIC HLTH EPIDEM, V12, P318, DOI DOI 10.21203/RS.3.RS-25099/V1; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Crump JA., 2017, MAJOR INFECT DIS, VThird, DOI [10.1596/978-1-4648-0524-0_ch14, DOI 10.1596/978-1-4648-0524-0_CH14]; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847; de Vries SG, 2014, INT J INFECT DIS, V28, P47, DOI 10.1016/j.ijid.2014.06.013; de Wit E, 2016, EMERG INFECT DIS, V22, P323, DOI 10.3201/eid2202.151656; Endy T., 2020, HUNTERS TROPICAL MED, P325, DOI [10.1016/B978-0-323-55512-8.00036-3, DOI 10.1016/B978-0-323-55512-8.00036-3]; Fairhead J, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005783; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Gilson L, 2005, BMJ-BRIT MED J, V331, P762, DOI 10.1136/bmj.331.7519.762; Hartley MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005356; Jentes ES, 2010, AM J TROP MED HYG, V83, P388, DOI 10.4269/ajtmh.2010.09-0688; Kansiime C, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.84.2692; Keita M., 2014, ANN DERMATOL VENER, V141, pS356; Kerneis S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000548; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Leach MA, 2008, SOC SCI MED, V66, P2157, DOI 10.1016/j.socscimed.2008.01.039; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Magassouba N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12101062; Magombedze G, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3158-0; Mamady K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-436; Mawazo A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4340-y; Maze MJ, 2018, CLIN MICROBIOL INFEC, V24, P808, DOI 10.1016/j.cmi.2018.02.011; Mfuh KO, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2711-4; Mhalu G, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4030-4; Ministry of Health Guinea., 2013, GUID THER NAT; Naidenova EV., EBOLA VIRUS DIS OUTB; Ohanu ME, 2019, MALAWI MED J, V31, P184, DOI 10.4314/mmj.v31i3.4; Okoroiwu HU, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237313; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pierce J, 2020, INT J INFECT DIS, V96, P621, DOI 10.1016/j.ijid.2020.05.126; Pigott DM, 2017, LANCET, V390, P2662, DOI 10.1016/S0140-6736(17)32092-5; Prasad N, 2015, AM J TROP MED HYG, V93, P178, DOI 10.4269/ajtmh.14-0646; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Raab M, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009487; Raab M, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05573-8; Raab M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8433-2; Racsa LD, 2016, CLIN INFECT DIS, V62, P214, DOI 10.1093/cid/civ792; Rojek A, 2017, LANCET INFECT DIS, V17, pE280, DOI 10.1016/S1473-3099(17)30234-7; Roth E, KEY CONSIDERATIONS 2; Roth E, 2020, VIROLOGIE, V24, P61, DOI 10.1684/vir.2020.0839; Sardan J-POde., 2003, MED CINE INHOSPITALI; Stoler J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2025-x; Tadesse BT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2713-1; Tropenmedizin B-N-I fur, 2021, MISS MAD POSS TROTZ; Wasihun AG, 2015, INT J INFECT DIS, V35, P96, DOI 10.1016/j.ijid.2015.04.014; WHO, SENSITIVITY SPECIFIC; World Health Organization, 2016, CLIN MAN PAT VIR HAE; World Health Organization (WHO), IMAI DISTR CLIN MAN; Zimmermann S, 2007, INT J ANTIMICROB AG, V29, pS49, DOI 10.1016/S0924-8579(07)70159-0; Zunt JR, 2018, LANCET NEUROL, V17, P1061, DOI 10.1016/S1474-4422(18)30387-9	67	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262084	10.1371/journal.pone.0262084	http://dx.doi.org/10.1371/journal.pone.0262084			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007283	gold, Green Published, Green Submitted			2022-12-26	WOS:000741060700001
J	Ali, H; Din, JU; Bosso, L; Hameed, S; Kabir, M; Younas, M; Nawaz, MA				Ali, Hussain; Din, Jaffar Ud; Bosso, Luciano; Hameed, Shoaib; Kabir, Muhammad; Younas, Muhammad; Nawaz, Muhammad Ali			Expanding or shrinking? range shifts in wild ungulates under climate change in Pamir-Karakoram mountains, Pakistan	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HINDU-KUSH; BLUE SHEEP; PSEUDOIS-NAYAUR; SNOW LEOPARD; RIVER-BASIN; DISTRIBUTIONS; CONSERVATION; HIMALAYAS; PREY	Climate change is expected to impact a large number of organisms in many ecosystems, including several threatened mammals. A better understanding of climate impacts on species can make conservation efforts more effective. The Himalayan ibex (Capra ibex sibirica) and blue sheep (Pseudois nayaur) are economically important wild ungulates in northern Pakistan because they are sought-after hunting trophies. However, both species are threatened due to several human-induced factors, and these factors are expected to aggravate under changing climate in the High Himalayas. In this study, we investigated populations of ibex and blue sheep in the Pamir-Karakoram mountains in order to (i) update and validate their geographical distributions through empirical data; (ii) understand range shifts under climate change scenarios; and (iii) predict future habitats to aid long-term conservation planning. Presence records of target species were collected through camera trapping and sightings in the field. We constructed Maximum Entropy (MaxEnt) model on presence record and six key climatic variables to predict the current and future distributions of ibex and blue sheep. Two representative concentration pathways (4.5 and 8.5) and two-time projections (2050 and 2070) were used for future range predictions. Our results indicated that ca. 37% and 9% of the total study area (Gilgit-Baltistan) was suitable under current climatic conditions for Himalayan ibex and blue sheep, respectively. Annual mean precipitation was a key determinant of suitable habitat for both ungulate species. Under changing climate scenarios, both species will lose a significant part of their habitats, particularly in the Himalayan and Hindu Kush ranges. The Pamir-Karakoram ranges will serve as climate refugia for both species. This area shall remain focus of future conservation efforts to protect Pakistan's mountain ungulates.	[Ali, Hussain; Hameed, Shoaib; Kabir, Muhammad] Quaid I Azam Univ, Dept Zool, Islamabad, Pakistan; [Din, Jaffar Ud; Younas, Muhammad] Snow Leopard Trust, Pakistan Program, Islamabad, Pakistan; [Bosso, Luciano] Univ Napoli Federico II, Dipartimento Agr, Wildlife Res Unit, Portici, Italy; [Nawaz, Muhammad Ali] Qatar Univ, Dept Biol & Environm Sci, Environm Sci Program, Doha, Qatar	Quaid I Azam University; University of Naples Federico II; Qatar University	Nawaz, MA (corresponding author), Qatar Univ, Dept Biol & Environm Sci, Environm Sci Program, Doha, Qatar.	nawazma@gmail.com	Nawaz, Muhammad Ali/GQY-8578-2022; Din, Jaffar Ud/D-7748-2017	Nawaz, Muhammad Ali/0000-0001-5632-9014; Bosso, Luciano/0000-0002-9472-3802	Snow Leopard Trust; Pakistan Snow Leopard and Ecosystem Protection Program [9231]	Snow Leopard Trust; Pakistan Snow Leopard and Ecosystem Protection Program	This study received support from the following sources: Snow Leopard Trust (awarded to MAN); and Pakistan Snow Leopard and Ecosystem Protection Program (grant number 9231, awarded to MAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellanas B, 2018, FOREST ECOL MANAG, V424, P136, DOI 10.1016/j.foreco.2018.04.050; Ahlburg DA., 2013, KO IMPACT POPULATION; Ahmad Z, 2012, ENVIRON MONIT ASSESS, V184, P5255, DOI 10.1007/s10661-011-2337-7; Akhtar M, 2008, J HYDROL, V355, P148, DOI 10.1016/j.jhydrol.2008.03.015; Ali H, 2019, ORYX, V53, P329, DOI 10.1017/S0030605317000229; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2015, READING A CAPRA SIBI; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat4858; Archis JN, 2018, PEERJ, V6, DOI 10.7717/peerj.4647; Aryal A, 2016, ECOL EVOL, V6, P4065, DOI 10.1002/ece3.2196; Ashraf A, 2012, GEOMAT NAT HAZ RISK, V3, P113, DOI 10.1080/19475705.2011.615344; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Bagchi S, 2010, OECOLOGIA, V164, P1075, DOI 10.1007/s00442-010-1690-5; Balakrishnan B., 2018, ENV INFORM SYSTEMS C, P555; Bhattacharya T, 2012, MAMM STUDY, V37, P173, DOI 10.3106/041.037.0302; Bischof R, 2014, J ZOOL, V293, P40, DOI 10.1111/jzo.12100; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Byeon DH, 2018, J ASIA-PAC BIODIVERS, V11, P325, DOI 10.1016/j.japb.2018.06.002; Ciach M, 2018, INT J BIOMETEOROL, V62, P2173, DOI 10.1007/s00484-018-1619-y; Dani Ahmad Hasan, 2001, HIST NO AREAS PAKIST; Dolezal J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24881; Eckstein D, 2017, J GER BONN; Edenhofer O., 2014, CONTRIBUTION WORKING; El-Gabbas A, 2018, ECOL EVOL, V8, P2196, DOI 10.1002/ece3.3834; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fedosenko Alexander K., 2001, Mammalian Species, V675, P1, DOI 10.1644/1545-1410(2001)675<0001:CS>2.0.CO;2; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Forsythe N, 2017, NAT CLIM CHANGE, V7, P664, DOI 10.1038/NCLIMATE3361; Gomes VHF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18927-1; Hess R., 1997, P239; Hewitt K, 2005, MT RES DEV, V25, P332, DOI 10.1659/0276-4741(2005)025[0332:TKAGEA]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Holt CDS, 2018, ECOL INFORM, V48, P97, DOI 10.1016/j.ecoinf.2018.09.005; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Ishaq S., 2015, Journal of Mountain Area Research, V1, P53; Joshi S, 2013, ENVIRON MANAGE, V52, P639, DOI 10.1007/s00267-013-0062-4; Kabir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187027; Khan B, 2016, J KING SAUD UNIV SCI, V28, P216, DOI 10.1016/j.jksus.2015.02.007; Khan MZ, 2014, INT J AGRIC BIOL, V16, P1050; Khan N, 2018, WATER-SUI, V10, DOI 10.3390/w10121793; Khattak RH, 2019, PAK J ZOOL; Kulkarni A, 2013, MT RES DEV, V33, P142, DOI 10.1659/MRD-JOURNAL-D-11-00131.1; Kumar P, 2015, GEOPHYS RES LETT, V42, P1818, DOI 10.1002/2015GL063392; Laws AN, 2017, CURR OPIN INSECT SCI, V23, P28, DOI 10.1016/j.cois.2017.06.010; Li J, 2016, BIOL CONSERV, V203, P188, DOI 10.1016/j.biocon.2016.09.026; Looney R, 2012, CONTEMP SOUTH ASIA, V20, P225, DOI 10.1080/09584935.2012.670203; Lu XM, 2016, ARCT ANTARCT ALP RES, V48, P461, DOI 10.1657/AAAR0015-069; Luo ZH, 2015, ECOL APPL, V25, P24, DOI 10.1890/13-1499.1; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Maurer JM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7266; Mishra C, 2004, J APPL ECOL, V41, P344, DOI 10.1111/j.0021-8901.2004.00885.x; Mohammadi S, 2019, ECOL INFORM, V52, P7, DOI 10.1016/j.ecoinf.2019.04.003; Morelli T.L., 2017, CLIMATE CHANGE RESPO, V4, P8, DOI [10.1186/s40665-017-0036-5, DOI 10.1186/S40665-017-0036-5]; Morelli TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159909; Murray BD, 2013, ECOLOGY, V94, P1317, DOI 10.1890/12-1582.1; Niittynen P, 2018, ECOGRAPHY, V41, P1024, DOI 10.1111/ecog.03348; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Rehman A., 2015, J EC SUSTAIN DEV, V6, P39; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Roa AL., 2003, NASSD BACKGROUND PAP; Roberts T.J, 1997, MAMMALS PAKISTAN; Salick J, 2014, J ETHNOBIOL, V34, P276, DOI 10.2993/0278-0771-34.3.276; Schaller G. B., 1977, Mountain monarchs. Wild sheep and goats of the Himalaya.; Schaller G.B., 1973, J BOMBAY NAT HIST SO, V69, P523; Schild A, 2008, MT RES DEV, V28, P328, DOI 10.1659/mrd.mp009; Schneider UA, 2011, AGR SYST, V104, P204, DOI 10.1016/j.agsy.2010.11.003; Smeraldo S, 2017, J NAT CONSERV, V37, P12, DOI 10.1016/j.jnc.2017.02.008; Sony RK, 2018, ECOL ENG, V120, P355, DOI 10.1016/j.ecoleng.2018.06.017; Tahir AA, 2015, SCI TOTAL ENVIRON, V505, P748, DOI 10.1016/j.scitotenv.2014.10.065; Tahir AA, 2011, J HYDROL, V409, P104, DOI 10.1016/j.jhydrol.2011.08.035; UHLIG H, 1978, ARCTIC ALPINE RES, V10, P519, DOI 10.2307/1550785; Virk AT., 2003, NASSD BACKGROUND PAP; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; WILSON P, 1981, BIOL CONSERV, V21, P55, DOI 10.1016/0006-3207(81)90068-9; Wiltshire AJ, 2014, CRYOSPHERE, V8, P941, DOI 10.5194/tc-8-941-2014; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Zain O.F., 2010, PAKISTAN J SOC SCI, V30, P181	88	10	10	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260031	10.1371/journal.pone.0260031	http://dx.doi.org/10.1371/journal.pone.0260031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972110	gold, Green Published			2022-12-26	WOS:000773555700011
J	Hagabimana, A; Omolo, J; El-Khatib, Z; Rwagasore, E; Benemariya, N; Nsekuye, O; Kabeja, A; Balisanga, H; Umutoni, A; Musafili, A; Ndagijimana, A				Hagabimana, Aphrodis; Omolo, Jared; El-Khatib, Ziad; Rwagasore, Edson; Benemariya, Noella; Nsekuye, Olivier; Kabeja, Adeline; Balisanga, Helene; Umutoni, Angela; Musafili, Aimable; Ndagijimana, Albert			Baseline knowledge and attitudes on COVID-19 among hotels' staff: A cross-sectional study in Kigali, Rwanda	PLOS ONE			English	Article								Background The World Health Organization declared coronavirus disease 2019 (COVID-19) as a global pandemic on the 11(th) of March, 2020. Hotels and other public establishments have been associated with higher transmission rates. Sensitisation of staff and strengthening of Infection Prevention and Control (IPC) practices in such settings are important interventions. This study assessed the baseline knowledge and attitudes on COVID-19 among hotels' representatives in Kigali, Rwanda. Methods A cross-sectional study was conducted among hotels' staff in Kigali in July 2020. A structured questionnaire was self-administered to 104 participants. Baseline knowledge and attitudes were assessed using a number of pre-test questions and mean scores were used to dichotomise the participants' responses as satisfactory or unsatisfactory. Results All of the 104 hotels' staff completed the self-administered questionnaires. Sixty-seven percent (n = 70) were male and 58% (n = 60) were aged between 30 and 44 years. The satisfactory rate of correct answers was 63%2.4 (n = 66) on knowledge and 68%+/- 1.7 (n = 71) on attitudes evaluation. Participants with University education were more likely to have satisfactory knowledge (AOR: 2.6, 95% C.I: 1.07-6.58) than those with secondary education or less. The staff working in the front-office (AOR: 0.05; 95% CI 0.01-0.54) and housekeeping (AOR: 0.09; 95% C.I: 0.01-0.87) were less likely to have satisfactory attitudes than those working in the administration. Conclusions Hotels' staff based in the capital of Rwanda have shown satisfactory knowledge and attitudes regarding appropriate IPC practices for preventing the COVID-19 transmission. Educational interventions are needed to improve their knowledge and attitudes for better prevention in this setting.	[Hagabimana, Aphrodis; Omolo, Jared; Benemariya, Noella; Nsekuye, Olivier; Ndagijimana, Albert] Univ Rwanda, Dept Epidemiol & Biostat, Rwanda Field Epidemiol & Lab Training Program, Kigali, Rwanda; [Hagabimana, Aphrodis] Kigeme Dist Hosp, Kirehe, Rwanda; [El-Khatib, Ziad] Univ Global Hlth Equ, Bill & Joyce Cumming Inst Global Hlth, Kigali, Rwanda; [El-Khatib, Ziad] Karolinska Inst, Dept Global Publ Hlth, Solna, Sweden; [El-Khatib, Ziad] Univ Quebec Abitibi Temiscamingue, World Hlth Programme, Rouyn Noranda, PQ, Canada; [Rwagasore, Edson; Kabeja, Adeline; Balisanga, Helene; Umutoni, Angela] Rwanda Biomed Ctr, Publ Hlth Surveillance & Epidem Response, Kigali, Rwanda; [Musafili, Aimable] Univ Rwanda, Coll Med & Hlth Sci, Sch Med & Pharm, Dept Pediat & Child Hlth, Kigali, Rwanda	University of Rwanda; Karolinska Institutet; University of Quebec; University Quebec Abitibi-Temiscamingue; Rwanda Biomedical Center; University of Rwanda	Hagabimana, A (corresponding author), Univ Rwanda, Dept Epidemiol & Biostat, Rwanda Field Epidemiol & Lab Training Program, Kigali, Rwanda.; Hagabimana, A (corresponding author), Kigeme Dist Hosp, Kirehe, Rwanda.	hagaba01@gmail.com		Nsekuye, Olivier/0000-0002-9238-4691				Adebowale OO, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248189; Ceylan Z, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138817; Ge HP, 2020, EUR J CLIN MICROBIOL, V39, P1011, DOI 10.1007/s10096-020-03874-z; Health W., 2020, OPERATIONAL CONSIDER, V2008, P1, DOI [10.1016/j.jinf.2021.06.018, DOI 10.1016/J.JINF.2021.06.018]; Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798; Krisiunas Edward, 2020, J Diabetes Sci Technol, V14, P748, DOI 10.1177/1932296820930032; Mendez-Brito A, 2021, J INFECTION, V83, P281, DOI 10.1016/j.jinf.2021.06.018; Mirowsky J, 2005, LOND REV EDUC, V3, P205, DOI 10.1080/14748460500372366; Nachega Jean B, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa695; National Institute of Statistics of Rwanda, 2014, RWAND DEM HLTH SURV; Nsanzabaganwa C., 2020, RWANDA PUBLIC HLTH B, V2, P22; Odetokun IA, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040243; Rwanda Development Board, 2012, RWAND SKILLS SURV 20; Rwanda Development Board, 2020, GUID HOSP SECT BUS R, P1; Rwanda Ministry of Health, 2020, COV 19 CLIN MAN GUID; Rwanda Ministry of Health (MOH), RWAND PUBL HLTH B, V2, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2020, ANTIGEN DETECTION DI; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261744	10.1371/journal.pone.0261744	http://dx.doi.org/10.1371/journal.pone.0261744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972131	Green Published, gold			2022-12-26	WOS:000773555700051
J	Nguyen, TTT; Ramachandran, S; Hill, MJ; Cerione, RA				Nguyen, Thuy-Tien T.; Ramachandran, Sekar; Hill, Matthew J.; Cerione, Richard A.			High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-TYPE GLUTAMINASE; ACTIVATION LOOP; CANCER; METABOLISM; MECHANISM; EXPRESSION; INHIBITORS	The mitochondrial enzyme glutaminase C (GAC) is upregulated in many cancer cells to catalyze the first step in glutamine metabolism, the hydrolysis of glutamine to glutamate. The dependence of cancer cells on this transformed metabolic pathway highlights GAC as a potentially important therapeutic target. GAC acquires maximal catalytic activity upon binding to anionic activators such as inorganic phosphate. To delineate the mechanism of GAC activation, we used the tryptophan substitution of tyrosine 466 in the catalytic site of the enzyme as a fluorescent reporter for glutamine binding in the presence and absence of phosphate. We show that in the absence of phosphate, glutamine binding to the Y466W GAC tetramer exhibits positive cooperativity. A high-resolution X-ray structure of tetrameric Y466W GAC bound to glutamine suggests that cooperativity in substrate binding is coupled to tyrosine 249, located at the edge of the catalytic site (i.e., the "lid"), adopting two distinct conformations. In one dimer within the GAC tetramer, the lids are open and glutamine binds weakly, whereas, in the adjoining dimer, the lids are closed over the substrates, resulting in higher affinity interactions. When crystallized in the presence of glutamine and phosphate, all four subunits of the Y466W GAC tetramer exhibited bound glutamine with closed lids. Glutamine can bind with high affinity to each subunit, which subsequently undergo simultaneous catalysis. These findings explain how the regulated transitioning of GAC between different conformational states ensures that maximal catalytic activity is reached in cancer cells only when an allosteric activator is available.	[Nguyen, Thuy-Tien T.; Ramachandran, Sekar; Hill, Matthew J.; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA; [Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14850 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA.; Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14850 USA.	rac1@cornell.edu		Nguyen, Thuy-Tien/0000-0003-1676-733X; Hill, Matthew/0000-0003-1207-2880	National Institutes of Health [GM122575, CA201402]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr Marc Antonyak, Dr Shawn Milano, and Cody Aplin for valuable discussions. This study was supported by the National Institutes of Health grants GM122575 and CA201402. This study is dedicated to the memory of our dear colleague Jon Erickson. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GODFREY S, 1977, J BIOL CHEM, V252, P1927; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kenny J, 2003, PROTEIN EXPRES PURIF, V31, P140, DOI 10.1016/S1046-5928(03)00161-X; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Li YX, 2020, J BIOL CHEM, V295, P1328, DOI 10.1074/jbc.RA119.010314; Li YX, 2016, J BIOL CHEM, V291, P20900, DOI 10.1074/jbc.M116.720268; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Lukey MJ, 2019, CELL REP, V29, P76, DOI 10.1016/j.celrep.2019.08.076; Lukey MJ, 2017, DRUG DISCOV TODAY, V22, P796, DOI 10.1016/j.drudis.2016.12.003; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Mendez-Lucas A, 2020, NAT METAB, V2, P335, DOI 10.1038/s42255-020-0195-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOREHOUSE RF, 1981, BIOCHEM J, V193, P709, DOI 10.1042/bj1930709; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Stalnecker CA, 2017, J BIOL CHEM, V292, P6095, DOI 10.1074/jbc.M116.758219; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEILMALHERBE H, 1969, J NEUROCHEM, V16, P855, DOI 10.1111/j.1471-4159.1969.tb08973.x; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xiang LS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1291-5; Xu LF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2012748118; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025	37	2	2	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101564	10.1016/j.jbc.2022.101564	http://dx.doi.org/10.1016/j.jbc.2022.101564			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	34999118	Green Published, gold			2022-12-26	WOS:000761371500006
J	Xing, J; He, YC; Wang, KY; Wan, PZ; Zhai, XY				Xing, Jia; He, Yu-Chen; Wang, Kai-Yue; Wan, Peng-Zhi; Zhai, Xiao-Yue			Involvement of YTHDF1 in renal fibrosis progression via up-regulating YAP	FASEB JOURNAL			English	Article						m6A modification; renal fibrosis; YAP; YTHDF1	MESENCHYMAL TRANSITION; METHYLATION; M(6)A; DIFFERENTIATION; TRANSLATION	Renal fibrosis is a progressive, fatal renal disease characterized by the aberrant accumulation of myofibroblasts that produce excess extracellular matrix (ECM) in the renal interstitium and glomeruli. Yes-associated protein (YAP) has been regarded as a crucial modulator in myofibroblast transformation, but its upstream regulator remains a mystery. In the present study investigating the participation of m6A methylation during renal fibrosis through bioinformatics analysis, we identified YTHDF1, a modulator of m6A methylation, as a key contributor for renal fibrosis because it was highly expressed in human fibrotic kidneys and had a significant correction with YAP. Their co-localization in human fibrotic kidneys was additionally shown by immunofluorescence. We then found that YTHDF1 was also up-regulated in fibrotic mouse kidneys induced by unilateral ureteral obstruction (UUO), high-dose folic acid administration, or the unilateral ischemia-reperfusion injury, further supporting a causal role of YTHDF1 during renal fibrosis. Consistent with this notion, YTHDF1 knockdown alleviated the progression of renal fibrosis both in cultured cells induced by transforming growth factor-beta administration and in the UUO mouse model. Meanwhile, YAP was accordingly down-regulated when YTHDF1 was inhibited. Furthermore, the specific binding of YTHDF1 to YAP mRNA was detected using RNA Binding Protein Immunoprecipitation, and the up-regulation of fibrotic related molecules in cultured cells induced by YTHDF1 over-expression plasmid was attenuated by YAP siRNA. Taken together, our data highlight the potential utility of YTHDF1 as an indicator for renal fibrosis and suggest that YTHDF1 inhibition might be a promising therapeutic strategy to alleviate renal fibrosis via downregulating YAP.	[Xing, Jia; Wang, Kai-Yue; Zhai, Xiao-Yue] China Med Univ, Dept Histol & Embryol, Shenyang, Peoples R China; [He, Yu-Chen] China Med Univ, Hosp 1, Dept Vasc Surg, Shenyang, Peoples R China; [Wan, Peng-Zhi] China Med Univ, Hosp 1, Dept Nephrol, Shenyang, Peoples R China; [Zhai, Xiao-Yue] China Med Univ, Inst Nephropathol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Zhai, XY (corresponding author), China Med Univ, Dept Histol & Embryol, Shenyang, Peoples R China.	xyzhai@cmu.edu.cn		Xing, Jia/0000-0001-7521-9806	National Natural Scientific Foundation of China [31971115]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (NSFC. 31971115)	Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Brennan EP, 2017, MOL ASPECTS MED, V58, P102, DOI 10.1016/j.mam.2017.05.001; Bruggenwirth IMA, 2020, AM J TRANSPLANT, V20, P931, DOI 10.1111/ajt.15689; Chang YT, 2016, J CLIN INVEST, V126, P721, DOI 10.1172/JCI82819; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chen B, 2019, MOL BIOL REP, V46, P2567, DOI 10.1007/s11033-019-04655-4; Chen XW, 2014, J CLIN INVEST, V124, P3295, DOI 10.1172/JCI71668; Feng ZH, 2018, J CELL MOL MED, V22, P2558, DOI 10.1111/jcmm.13491; Flores JV, 2017, STEM CELL REP, V8, P112, DOI 10.1016/j.stemcr.2016.11.014; Han B, 2020, EMBO REP, V21, DOI 10.15252/embr.201949229; He YC, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.12.65; Jin D, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0830-6; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Leaf IA, 2017, NEPHROL DIAL TRANSPL, V32, P89, DOI 10.1093/ndt/gfw388; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li LJ, 2018, MOL IMMUNOL, V93, P55, DOI 10.1016/j.molimm.2017.11.009; Li X, 2020, OXID MED CELL LONGEV, V2020, P1; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liu JH, 2018, KIDNEY BLOOD PRESS R, V43, P1677, DOI 10.1159/000494745; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lv WS, 2018, EUR J PHARMACOL, V820, P65, DOI 10.1016/j.ejphar.2017.12.016; Martinez-Klimova E, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040141; METZKURSCHEL U, 1990, RENAL FAILURE, V12, P93, DOI 10.3109/08860229009087124; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Piersma B, 2015, AM J PATHOL, V185, P3326, DOI 10.1016/j.ajpath.2015.08.011; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Shi Y, 2020, FASEB J, V34, P10286, DOI 10.1096/fj.201902544RR; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tong JY, 2018, FRONT MED-PRC, V12, P481, DOI 10.1007/s11684-018-0654-8; Wang JH, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/3120391; Wanna-udom S, 2020, BIOCHEM BIOPH RES CO, V524, P150, DOI 10.1016/j.bbrc.2020.01.042; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z; Xu LY, 2019, J AM SOC NEPHROL, V30, P1825, DOI 10.1681/ASN.2019010068; Zhang JX, 2021, MOL THER, V29, P3436, DOI 10.1016/j.ymthe.2021.06.008	39	3	3	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22144	10.1096/fj.202100172RR	http://dx.doi.org/10.1096/fj.202100172RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34990050				2022-12-26	WOS:000747987800008
J	Kinsella, HM; Hostnik, LD; Snyder, HA; Mazur, SE; Kamr, AM; Burns, TA; Mossbarger, JC; Toribio, RE				Kinsella, Hannah M.; Hostnik, Laura D.; Snyder, Hailey A.; Mazur, Sarah E.; Kamr, Ahmed M.; Burns, Teresa A.; Mossbarger, John C.; Toribio, Ramiro E.			Comparison of insulin sensitivity between healthy neonatal foals and horses using minimal model analysis	PLOS ONE			English	Article							BIOCHEMISTRY REFERENCE VALUES; GLUCOSE DYNAMICS; CLINICAL PATHOLOGY; CELL-FUNCTION; FETAL FOAL; SECRETION; DIET; HEMATOLOGY; RESISTANCE; RESPONSES	The equine neonate is considered to have impaired glucose tolerance due to delayed maturation of the pancreatic endocrine system. Few studies have investigated insulin sensitivity in newborn foals using dynamic testing methods. The objective of this study was to assess insulin sensitivity by comparing the insulin-modified frequently sampled intravenous glucose tolerance test (I-FSIGTT) between neonatal foals and adult horses. This study was performed on healthy neonatal foals (n = 12), 24 to 60 hours of age, and horses (n = 8), 3 to 14 years of age using dextrose (300 mg/kg IV) and insulin (0.02 IU/kg IV). Insulin sensitivity (SI), acute insulin response to glucose (AIRg), glucose effectiveness (Sg), and disposition index (DI) were calculated using minimal model analysis. Proxy measurements were calculated using fasting insulin and glucose concentrations. Nonparametric statistical methods were used for analysis and reported as median and interquartile range (IQR). SI was significantly higher in foals (18.3 L.min(-1).mu IU-1 [13.4-28.4]) compared to horses (0.9 L.min(-1).mu IU-1 [0.5-1.1]); (p < 0.0001). DI was higher in foals (12 x 10(3) [8 x 10(3)-14 x 10(3)]) compared to horses (4 x 10(2) [2 x 10(2)-7 x 10(2)]); (p < 0.0001). AIRg and Sg were not different between foals and horses. The modified insulin to glucose ratio (MIRG) was lower in foals (1.72 mu IUinsulin2/10.L.mg(glucose) [1.43-2.68]) compared to horses (3.91 mu IU (2)(insulin)/10.L.mg(glucose) [2.57-7.89]); (p = 0.009). The homeostasis model assessment of beta cell function (HOMA-BC%) was higher in horses (78.4% [43-116]) compared to foals (23.2% [17.8-42.2]); (p = 0.0096). Our results suggest that healthy neonatal foals are insulin sensitive in the first days of life, which contradicts current literature regarding the equine neonate. Newborn foals may be more insulin sensitive immediately after birth as an evolutionary adaptation to conserve energy during the transition to extrauterine life.	[Kinsella, Hannah M.; Hostnik, Laura D.; Snyder, Hailey A.; Mazur, Sarah E.; Kamr, Ahmed M.; Burns, Teresa A.; Toribio, Ramiro E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Kamr, Ahmed M.] Univ Sadat City, Fac Vet Med, Sadat City, Egypt; [Mossbarger, John C.] Midland Acres Inc, Bloomingburg, OH USA	University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); University of Sadat City	Hostnik, LD (corresponding author), Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA.	hostnik.2@osu.edu	Toribio, Ramiro/H-7838-2013	Toribio, Ramiro/0000-0002-9063-540X; Kinsella, Hannah/0000-0001-7809-6100	Ohio State University College of Veterinary Medicine Equine Intramural Funds [520519]	Ohio State University College of Veterinary Medicine Equine Intramural Funds	This work was supported by The Ohio State University College of Veterinary Medicine Equine Intramural Funds (Grant #520519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2018, J VET INTERN MED, V32, P1731, DOI 10.1111/jvim.15245; Axon JE, 2008, VET CLIN N AM-EQUINE, V24, P357, DOI 10.1016/j.cveq.2008.03.005; Bamford NJ, 2016, EQUINE VET J, V48, P368, DOI 10.1111/evj.12434; Bamford NJ, 2014, DOMEST ANIM ENDOCRIN, V47, P101, DOI 10.1016/j.domaniend.2013.11.001; Banse HE, 2014, J VET DIAGN INVEST, V26, P527, DOI 10.1177/1040638714536560; Barsnick RJIM, 2011, J VET INTERN MED, V25, P123, DOI 10.1111/j.1939-1676.2010.0636.x; Barton MH, 2020, VET CLIN N AM-EQUINE, V36, P73, DOI 10.1016/j.cveq.2019.11.003; Berryhill EH, 2019, VET J, V246, P1, DOI 10.1016/j.tvjl.2019.01.013; Bertin FR, 2017, EQUINE VET J, V49, P570, DOI 10.1111/evj.12703; Bertin FR, 2016, J VET INTERN MED, V30, P1726, DOI 10.1111/jvim.14529; Borer KE, 2012, EQUINE VET J, V44, P444, DOI 10.1111/j.2042-3306.2011.00475.x; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Bradbery AN, 2021, ANIM REPROD SCI, V227, DOI 10.1016/j.anireprosci.2021.106720; Carslake HB, 2017, J VET INTERN MED, V31, P568, DOI 10.1111/jvim.14657; Dunbar LK, 2016, J VET INTERN MED, V30, P885, DOI 10.1111/jvim.13934; Forhead AJ, 2004, J ENDOCRINOL, V181, P459, DOI 10.1677/joe.0.1810459; Fowden A L, 1982, J Reprod Fertil Suppl, V32, P529; Fowden AL, 2012, EQUINE VET J, V44, P130, DOI 10.1111/j.2042-3306.2011.00505.x; FOWDEN AL, 1995, REPROD FERT DEVELOP, V7, P351, DOI 10.1071/RD9950351; FOWDEN AL, 1980, J ENDOCRINOL, V87, P293, DOI 10.1677/joe.0.0870293; Fowden AL, 1999, EXP PHYSIOL, V84, P697, DOI 10.1017/S0958067099018503; FOWDEN AL, 1984, EQUINE VET J, V16, P286, DOI 10.1111/j.2042-3306.1984.tb01928.x; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; FOWDEN AL, 1991, J REPROD FERTIL, P537; Frank N, 2005, J ANIM SCI, V83, P2509; Hackett ES, 2010, J VET INTERN MED, V24, P617, DOI 10.1111/j.1939-1676.2010.0481.x; Hoffman RM, 2003, J ANIM SCI, V81, P2333; Holdstock NB, 2012, EQUINE VET J, V44, P30, DOI 10.1111/j.2042-3306.2011.00447.x; Holdstock NB, 2004, J ENDOCRINOL, V181, P469, DOI 10.1677/joe.0.1810469; Hollis AR, 2008, J VET INTERN MED, V22, P1223, DOI 10.1111/j.1939-1676.2008.0174.x; Inzucchi SE, 2006, NEW ENGL J MED, V355, P1903, DOI 10.1056/NEJMcp060094; Jacob SI, 2018, EQUINE VET J, V50, P249, DOI 10.1111/evj.12745; Kao LS, 2006, J PERINATOL, V26, P730, DOI 10.1038/sj.jp.7211593; Kinsella HM, 2021, J VET INTERN MED, V35, P550, DOI 10.1111/jvim.16024; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Kronfeld DS, 2005, JAVMA-J AM VET MED A, V226, P712, DOI 10.2460/javma.2005.226.712; Lindase S, 2018, DOMEST ANIM ENDOCRIN, V64, P49, DOI 10.1016/j.domaniend.2018.03.006; LUMSDEN JH, 1980, CAN J COMP MED, V44, P32; LUMSDEN JH, 1980, CAN J COMP MED, V44, P24; Madigan JE, 1991, MANUAL NEONATAL MED, P201; Ousey J C, 1997, Equine Vet J Suppl, P104; Pratt SE, 2005, J VET INTERN MED, V19, P883, DOI 10.1892/0891-6640(2005)19[883:ROMFAO]2.0.CO;2; Quinn RW, 2008, J EQUINE VET SCI, V28, P728, DOI 10.1016/j.jevs.2008.10.020; Rings LM, 2019, J VET INTERN MED, V33, P2752, DOI 10.1111/jvim.15641; Silver M, 1987, J Reprod Fertil Suppl, V35, P607; SMYTH GB, 1993, AUST VET J, V70, P129, DOI 10.1111/j.1751-0813.1993.tb06103.x; Spurlock S, 1990, EQUINE CLIN NEONATOL, P684; Stewart-Hunt L, 2010, EQUINE VET J, V42, P355, DOI 10.1111/j.2042-3306.2010.00255.x; Toth F, 2009, EQUINE VET J, V41, P844, DOI 10.2746/042516409X439661; Toth F, 2008, AM J VET RES, V69, P82, DOI 10.2460/ajvr.69.1.82; Trahair J F, 1997, Equine Vet J Suppl, P40; Treiber KH, 2005, J ANIM SCI, V83, P2357; Warnken T, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0828-z	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262584	10.1371/journal.pone.0262584	http://dx.doi.org/10.1371/journal.pone.0262584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030228	Green Published, gold			2022-12-26	WOS:000812798500056
J	Forray, A; Mele, A; Byatt, N; Londono Tobon, A; Gilstad-Hayden, K; Hunkle, K; Hong, S; Lipkind, H; Fiellin, DA; Callaghan, K; Yonkers, KA				Forray, Ariadna; Mele, Amanda; Byatt, Nancy; Londono Tobon, Amalia; Gilstad-Hayden, Kathryn; Hunkle, Karen; Hong, Suyeon; Lipkind, Heather; Fiellin, David A.; Callaghan, Katherine; Yonkers, Kimberly A.			Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics	PLOS ONE			English	Article							MEDICATION-ASSISTED TREATMENT; PRIMARY-CARE PROVIDERS; COLLABORATIVE CARE; PROJECT ECHO; METHADONE-MAINTENANCE; HEPATITIS-C; BUPRENORPHINE; MANAGEMENT; DEPRESSION; BARRIERS	Introduction The prevalence of opioid use disorder (OUD) in pregnancy increased nearly five-fold over the past decade. Despite this, obstetric providers are less likely to treat pregnant women with medication for OUD than non-obstetric providers (75% vs 91%). A major reason is many obstetricians feel unprepared to prescribe medication for opioid use disorder (MOUD). Education and support may increase prescribing and overall comfort in delivering care for pregnant women with OUD, but optimal models of education and support are yet to be determined. Methods and analysis We describe the rationale and conduct of a matched-pair cluster randomized clinical trial to compare the effectiveness of two models of support for reproductive health clinicians to provide care for pregnant and postpartum women with OUD. The primary outcomes of this trial are patient treatment engagement and retention in OUD treatment. This study compares two support models: 1) a collaborative care approach, based upon the Massachusetts Office-Based-Opioid Treatment Model, that provides practice-level training and support to providers and patients through the use of care managers, versus 2) a telesupport approach based on the Project Extension for Community Healthcare Outcomes, a remote education model that provides mentorship, guided practice, and participation in a learning community, via video conferencing. Discussion This clustered randomized clinical trial aims to test the effectiveness of two approaches to support practitioners who care for pregnant women with an OUD. The results of this trial will help determine the best model to improve the capacity of obstetrical providers to deliver treatment for OUD in prenatal clinics.	[Forray, Ariadna; Mele, Amanda; Gilstad-Hayden, Kathryn; Hunkle, Karen; Hong, Suyeon] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Byatt, Nancy; Yonkers, Kimberly A.] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Byatt, Nancy; Callaghan, Katherine] Univ Massachusetts, Sch Med, Dept Ob Gyn, Worcester, MA USA; [Byatt, Nancy] Univ Massachusetts, Sch Med, Dept Populat & Quantitat Hlth Sci, Worcester, MA USA; [Londono Tobon, Amalia] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Lipkind, Heather] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Fiellin, David A.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Fiellin, David A.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Fiellin, David A.] Yale Sch Publ Hlth, New Haven, CT USA	Yale University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Brown University; Yale University; Yale University; Yale University; Yale University	Forray, A (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.	ariadna.forray@yale.edu		Hong, Suyeon/0000-0003-0200-7479; Mele, Amanda/0000-0002-9893-3225	Patient Centered Outcomes Research Institution (PCORI) [MAT-2018C2-12891]; Andrea Brandau Program Officer Patient-Centered Outcomes Research Institute (PCORI),Washington, DC	Patient Centered Outcomes Research Institution (PCORI); Andrea Brandau Program Officer Patient-Centered Outcomes Research Institute (PCORI),Washington, DC	This work was supported by PatientCentered Outcomes Research Institution (PCORI) grant number MAT-2018C2-12891) awarded to AF and KY. PCORI had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results. LT performed this work while employed by Yale University and Lifespan/Brown University; however, she is now employed by the Division of Intramural Research, National Institute of Minority Health and Health Disparities, National Institutes of Health. The contents and views in this manuscript are those of the authors and should not be construed to represent the views of the National Institutes of Health. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder Contact: Andrea Brandau Program Officer Patient-Centered Outcomes Research Institute (PCORI) 1828 L Street, NW 9th Floor, Washington, DC 20036 Office: 202.370.9394 abrandau@pcori.orghttps://www.pcori.org/people/andrea-brandau-	Alford DP, 2011, ARCH INTERN MED, V171, P425, DOI 10.1001/archinternmed.2010.541; Andraka-Christou B, 2018, INT J DRUG POLICY, V54, P9, DOI 10.1016/j.drugpo.2017.11.021; Arora S, 2007, PUBLIC HEALTH REP, V122, P74, DOI 10.1177/00333549071220S214; Arora S, 2007, ACAD MED, V82, P154, DOI 10.1097/ACM.0b013e31802d8f68; Arora S, 2014, ACAD MED, V89, P30, DOI 10.1097/ACM.0000000000000051; Bachhuber MA, 2017, MED CARE, V55, P985, DOI 10.1097/MLR.0000000000000803; Barry DT, 2009, J GEN INTERN MED, V24, P218, DOI 10.1007/s11606-008-0881-9; Bhat A, 2017, PSYCHIAT SERV, V68, P17, DOI 10.1176/appi.ps.201600002; Brogly SB, 2018, OBSTET GYNECOL, V132, P916, DOI 10.1097/AOG.0000000000002881; Carey EP, 2016, J REHABIL RES DEV, V53, P147, DOI 10.1682/JRRD.2014.10.0247; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; CHAPPEL JN, 1985, J STUD ALCOHOL, V46, P48, DOI 10.15288/jsa.1985.46.48; Cleveland LM, 2020, ADDICTION, V115, P2079, DOI 10.1111/add.15054; Colleran K, 2012, DIABETES EDUCATOR, V38, P386, DOI 10.1177/0145721712441523; Coventry PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108114; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0; DeFlavio JR, 2015, RURAL REMOTE HEALTH, V15; Edgington E. S., 1987, RANDOMIZATION TESTS; Falletta L, 2018, CHILD ABUSE NEGLECT, V79, P125, DOI 10.1016/j.chiabu.2018.01.026; Fals-Stewart W, 2000, J CONSULT CLIN PSYCH, V68, P134, DOI 10.1037/0022-006X.68.1.134; Fullerton CA, 2014, PSYCHIAT SERV, V65, P146, DOI 10.1176/appi.ps.201300235; Gail MH, 1996, STAT MED, V15, P1069, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.3.CO;2-H; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gordon AJ, 2011, PSYCHOL ADDICT BEHAV, V25, P215, DOI 10.1037/a0022776; Guille C, 2017, AM J PSYCHIAT, V174, P208, DOI 10.1176/appi.ajp.2016.16060710; Haight SC, 2018, MMWR-MORBID MORTAL W, V67, P845, DOI 10.15585/mmwr.mm6731a1; Hand DJ, 2017, FERTIL STERIL, V108, P222, DOI 10.1016/j.fertnstert.2017.06.011; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Huffman JC, 2014, PSYCHOSOMATICS, V55, P109, DOI 10.1016/j.psym.2013.09.002; Huhn AS, 2017, J SUBST ABUSE TREAT, V78, P1, DOI 10.1016/j.jsat.2017.04.005; Hutchinson E, 2014, ANN FAM MED, V12, P128, DOI 10.1370/afm.1595; Jones HE, 2008, AM J ADDICTION, V17, P372, DOI 10.1080/10550490802266276; Jones HE, 2013, SUBST ABUS, V34, P89, DOI 10.1080/08897077.2012.752779; Jumah NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011774; Kampman K, 2015, NATL PRACTICE GUIDEL; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katzman JG, 2014, J CONTIN EDUC HEALTH, V34, P68, DOI 10.1002/chp.21210; Kermack A, 2017, J SUBST ABUSE TREAT, V74, P1, DOI 10.1016/j.jsat.2016.10.005; Khatri K, 2013, J HEALTH CARE POOR U, V24, P850, DOI 10.1353/hpu.2013.0093; Kim S C, 2001, Clin Nurs Res, V10, P314; Klaman SL, 2017, J ADDICT MED, V11, P178, DOI 10.1097/ADM.0000000000000308; Komaromy M, 2017, PSYCHIAT SERV, V68, P873, DOI 10.1176/appi.ps.201600471; Komaromy M, 2016, SUBST ABUS, V37, P20, DOI 10.1080/08897077.2015.1129388; Krans EE, 2018, ADDICT BEHAV, V86, P124, DOI 10.1016/j.addbeh.2018.05.016; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; LaBelle CT, 2016, J SUBST ABUSE TREAT, V60, P6, DOI 10.1016/j.jsat.2015.06.010; Luoma JB, 2007, ADDICT BEHAV, V32, P1331, DOI 10.1016/j.addbeh.2006.09.008; MacAfee L, 2017, DRUG ALCOHOL DEPEN, V171, pE125, DOI 10.1016/j.drugalcdep.2016.08.347; Maly RC, 1998, J AM GERIATR SOC, V46, P889, DOI 10.1111/j.1532-5415.1998.tb02725.x; Martin CE, 2015, J ADDICT MED, V9, P99, DOI 10.1097/ADM.0000000000000095; Mascola MA, 2017, OBSTET GYNECOL, V130, pE81, DOI 10.1097/AOG.0000000000002235; Mazurek MO, 2017, CLIN PEDIATR, V56, P247, DOI 10.1177/0009922816648288; McMurphy S, 2006, AM J HEALTH BEHAV, V30, P544, DOI 10.5993/AJHB.30.5.11; McRae-Clark AL, 2011, PSYCHOPHARMACOLOGY, V218, P49, DOI 10.1007/s00213-011-2376-3; Melville JL, 2014, OBSTET GYNECOL, V123, P1237, DOI 10.1097/AOG.0000000000000231; Meyer M, 2015, PREV MED, V80, P18, DOI 10.1016/j.ypmed.2015.07.015; Mittal L, 2017, SUBST ABUS, V38, P261, DOI 10.1080/08897077.2015.1129525; Moeckli J, 2017, J RURAL HEALTH, V33, P323, DOI 10.1111/jrh.12200; Patrick SW, 2019, SUBST ABUS, V40, P356, DOI 10.1080/08897077.2018.1488336; Rich KM, 2018, CURR HIV-AIDS REP, V15, P266, DOI 10.1007/s11904-018-0396-x; Saia K, 2017, ADDICT SCI CLIN PRAC, V12, DOI 10.1186/s13722-016-0070-9; Sobell LC, 1996, DRUG ALCOHOL DEPEN, V42, P49, DOI 10.1016/0376-8716(96)01263-X; Sockalingam S, 2018, ACAD PSYCHIATR, V42, P451, DOI 10.1007/s40596-017-0735-z; Substance Abuse and Mental Health Services Administration, 2016, COLLABORATIVE APPROA; Sutter MB, 2017, OBSTET GYN CLIN N AM, V44, P95, DOI 10.1016/j.ogc.2016.11.004; Suzuki Joji, 2014, J Opioid Manag, V10, P159, DOI 10.5055/jom.2014.0204; Thota AB, 2012, AM J PREV MED, V42, P525, DOI 10.1016/j.amepre.2012.01.019; Walley AY, 2008, J GEN INTERN MED, V23, P1393, DOI 10.1007/s11606-008-0686-x; Watkins KE, 2017, JAMA INTERN MED, V177, P1480, DOI 10.1001/jamainternmed.2017.3947; Wilder C, 2015, DRUG ALCOHOL DEPEN, V149, P225, DOI 10.1016/j.drugalcdep.2015.02.012; Williams ES, 1999, MED CARE, V37, P1140, DOI 10.1097/00005650-199911000-00006; Zhou C, 2016, ACAD MED, V91, P1439, DOI 10.1097/ACM.0000000000001328	74	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261751	10.1371/journal.pone.0261751	http://dx.doi.org/10.1371/journal.pone.0261751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025898	gold, Green Published			2022-12-26	WOS:000796264200027
J	Liu, WQ; Yang, QF; Xu, ZE; Hu, Y; Wang, YM; Liu, ZQ; Zhao, QQ; Wang, ZC; Wei, H; Hua, ZY				Liu, Weiqin; Yang, Qifen; Xu, Zhen-e; Hu, Ya; Wang, Yongming; Liu, Zhenqiu; Zhao, Qianqian; Wang, Zhuangcheng; Wei, Hong; Hua, Ziyu			Impact of the COVID-19 pandemic on neonatal admissions in a tertiary children's hospital in southwest China: An interrupted time-series study	PLOS ONE			English	Article								Background The unprecedented coronavirus disease 2019 (COVID-19) pandemic has caused millions of infections worldwide and represents a significant challenge facing modern health care systems. This study was conducted to investigate the impact of lockdown measures in a tertiary Children's Hospital in southwest China, which might be used to predict long-term effects related to health-seeking behavior of parents/caregivers. Methods This study included newborns enrolled over a span of 86 weeks between January 4, 2019, and August 27, 2020. We designated two time periods for analysis purposes: a stable pre-COVID period(55 weeks between January 4, 2019, and January 23, 2020) and a COVID-impacted period (31 weeks between January 24, 2020, and August 27, 2020). An interrupted time-series analysis was employed to compare changes and trends in hospital admissions and disease spectra before and after the period of nonpharmaceutical interventions (NPIs). Furthermore, this study was conducted to evaluate whether the health-seeking behavior of parents/caregivers was influenced by pandemic factors. Results Overall, 16,640 infants were admitted to the neonatology department during the pre-COVID period (n = 12,082) and the COVID-impacted period (n = 4,558). The per week neonatal admissions consistently decreased following the first days of NPIs (January 24, 2020). The average weekly admission rates of 220/week pre-COVID period and 147/week COVID-impacted period. There was an evident decrease in the volume of admissions for all disease spectra after the intervention, whereas the decrease of patients complaining about pathological jaundice-related conditions was statistically significant (p<0.05). In the COVID-impacted period, the percentage of patients who suffered from respiratory system diseases, neonatal encephalopathy, and infectious diseases decreased, while the percentage of pathological jaundice-related conditions and gastrointestinal system diseases increased. The neonatal mortality rates (NMRs) increased by 8.7% during the COVID-impacted period compared with the pre-COVID period. Conclusions In summary, there was a significant decline in neonatal admissions in a tertiary care hospital during the COVID-19 Pandemic and the associated NPIs. Additionally, this situation had a remarkable impact on disease spectra and health-seeking behavior of parents/caregivers. We, therefore, advise continuing follow-ups and monitoring the main health indicators in vulnerable populations affected by this Pandemic over time.	[Liu, Weiqin; Xu, Zhen-e; Hu, Ya; Wang, Yongming; Liu, Zhenqiu; Zhao, Qianqian; Wei, Hong; Hua, Ziyu] Chongqing Med Univ, Key Lab Child Dev & Disorders, Natl Clin Res Ctr Child Hlth & Disorders, Childrens Hosp,Minist Educ,Dept Neonatol, Chongqing, Peoples R China; [Liu, Weiqin; Xu, Zhen-e; Hu, Ya; Wang, Yongming; Liu, Zhenqiu; Zhao, Qianqian; Wei, Hong; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Yang, Qifen] Southwest Univ, Sch Life Sci, Chongqing, Peoples R China; [Wang, Zhuangcheng] Chongqing Univ, Engn Res Ctr, Childrens Med Big Data Intelligent Applicat, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Southwest University - China; Chongqing University	Hua, ZY (corresponding author), Chongqing Med Univ, Key Lab Child Dev & Disorders, Natl Clin Res Ctr Child Hlth & Disorders, Childrens Hosp,Minist Educ,Dept Neonatol, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Pediat, Chongqing, Peoples R China.	h_ziyu@126.com			Clinical Research Project of Children's Hospital of Chongqing Medical University [YBXM 2019007]	Clinical Research Project of Children's Hospital of Chongqing Medical University	this study was supported by grants from the Clinical Research Project of Children's Hospital of Chongqing Medical University (YBXM 2019007), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angoulvant F, 2021, CLIN INFECT DIS, V72, P319, DOI 10.1093/cid/ciaa710; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ezeh OK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013350; Gazzin S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010299; Hartnett KP, 2020, MMWR-MORBID MORTAL W, V69, P699, DOI 10.15585/mmwr.mm6923e1; Hegyi T, 2019, J MATERN-FETAL NEO M, V32, P2721, DOI 10.1080/14767058.2018.1448380; Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609; Li M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237420; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liang XH, 2020, WORLD J CLIN CASES, V8, P2959, DOI 10.12998/wjcc.v8.i14.2959; Liu TC, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000102; Melnick ER, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1924; Mengistu BA, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02031-x; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Piroozi Bakhtiar, 2018, Med J Islam Repub Iran, V32, P121, DOI 10.14196/mjiri.32.121; Riordan SM, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00376; TEAM, 2014, LANG ENV STAT COMP; Tsioufis K, 2020, CLIN RES CARDIOL, V109, P1483, DOI 10.1007/s00392-020-01682-1; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yang LL, 2020, CELL STEM CELL, V27, P125, DOI 10.1016/j.stem.2020.06.015	25	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262202	10.1371/journal.pone.0262202	http://dx.doi.org/10.1371/journal.pone.0262202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025931	Green Published, gold			2022-12-26	WOS:000796264200054
J	Parkin, ET; Hammond, JE; Owens, L; Hodges, MD				Parkin, Edward T.; Hammond, Jessica E.; Owens, Lauren; Hodges, Matthew D.			The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein	PLOS ONE			English	Article							BRAIN GLUCOSE-METABOLISM; ALZHEIMERS; CLEAVAGE	The amyloid cascade hypothesis proposes that excessive accumulation of amyloid beta-peptides is the initiating event in Alzheimer's disease. These neurotoxic peptides are generated from the amyloid precursor protein via sequential cleavage by beta- and gamma-secretases in the 'amyloidogenic' proteolytic pathway. Alternatively, the amyloid precursor protein can be processed via the 'non-amyloidogenic' pathway which, through the action of the alpha-secretase a disintegrin and metalloproteinase (ADAM) 10, both precludes amyloid beta-peptide formation and has the additional benefit of generating a neuroprotective soluble amyloid precursor protein fragment, sAPP alpha. In the current study, we investigated whether the orphan drug, dichloroacetate, could alter amyloid precursor protein proteolysis. In SH-SY5Y neuroblastoma cells, dichloroacetate enhanced sAPP alpha generation whilst inhibiting beta-secretase processing of endogenous amyloid precursor protein and the subsequent generation of amyloid beta-peptides. Over-expression of the amyloid precursor protein partly ablated the effect of dichloroacetate on amyloidogenic and non-amyloidogenic processing whilst over-expression of the beta-secretase only ablated the effect on amyloidogenic processing. Similar enhancement of ADAM-mediated amyloid precursor protein processing by dichloroacetate was observed in unrelated cell lines and the effect was not exclusive to the amyloid precursor protein as an ADAM substrate, as indicated by dichloroacetate-enhanced proteolysis of the Notch ligand, Jagged1. Despite altering proteolysis of the amyloid precursor protein, dichloroacetate did not significantly affect the expression/activity of alpha-, beta- or gamma-secretases. In conclusion, dichloroacetate can inhibit amyloidogenic and promote non-amyloidogenic proteolysis of the amyloid precursor protein. Given the small size and blood-brain-barrier permeability of the drug, further research into its mechanism of action with respect to APP proteolysis may lead to the development of therapies for slowing the progression of Alzheimer's disease.	[Parkin, Edward T.; Hammond, Jessica E.; Owens, Lauren; Hodges, Matthew D.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England	Lancaster University	Parkin, ET (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	e.parkin@lancaster.ac.uk	Hodges, Matthew/GZB-0433-2022	Parkin, Edward/0000-0003-3270-3184; Owens, Lauren/0000-0001-9460-6609; Hammond, Jessica/0000-0002-1465-4844; Hodges, Matthew David John/0000-0002-6815-751X	Bramall Foundation	Bramall Foundation	Y EP received funding for this research from the Bramall Foundation (https://www.bramallfoundation.org) (no grant number available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEMAYOR E, 1984, J NEUROCHEM, V42, P38, DOI 10.1111/j.1471-4159.1984.tb09694.x; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Chowdhury F, 2016, NANO LETT, V16, P3892, DOI 10.1021/acs.nanolett.6b01403; CURRY SH, 1985, CLIN PHARMACOL THER, V37, P89, DOI 10.1038/clpt.1985.17; Dai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092962; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Findlay JA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00382; Guo L., 2016, J ALZHEIMERS DIS JAD; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harting TP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178744; He WX, 2014, J BIOL CHEM, V289, P20630, DOI 10.1074/jbc.M114.579862; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Klose K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257403; KURODA Y, 1984, PEDIATR RES, V18, P936, DOI 10.1203/00006450-198418100-00005; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Miquel E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034776; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Pajuelo-Reguera D, 2015, INT J ONCOL, V46, P2409, DOI 10.3892/ijo.2015.2953; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Parr-Sturgess CA, 2010, BIOCHEM J, V432, P283, DOI 10.1042/BJ20100321; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STACPOOLE PW, 1988, ANN INTERN MED, V108, P58, DOI 10.7326/0003-4819-108-1-58; STACPOOLE PW, 1978, NEW ENGL J MED, V298, P526, DOI 10.1056/NEJM197803092981002; Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989; Stapoole PW, 2008, ADV DRUG DELIVER REV, V60, P1478, DOI 10.1016/j.addr.2008.02.014; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Sun WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016207; Warburg O., 1923, BIOCHEM Z, V152, P319; Xu JS, 2016, BBA-MOL BASIS DIS, V1862, P1084, DOI 10.1016/j.bbadis.2016.03.001	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0255715	10.1371/journal.pone.0255715	http://dx.doi.org/10.1371/journal.pone.0255715			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025874	Green Submitted, Green Published, gold			2022-12-26	WOS:000796264200002
J	da Silva, AAP; Franquelino, AR; Teodoro, PE; Montanari, R; Faria, GA; da Silva, CHR; da Silva, DB; Ribeiro, WA; Muchalak, F; Souza, KMC; da Silva, MHP; Teodoro, LPR				Pereira da Silva, Arlindo Ananias; Franquelino, Adriano Roberto; Teodoro, Paulo Eduardo; Montanari, Rafael; Faria, Glaucia Amorim; Ribeiro da Silva, Cristovao Henrique; Bortoloto da Silva, Dayane; Junior, Walter Aparecido Ribeiro; Muchalak, Franciele; Cruz Souza, Kassia Maria; Prudencio da Silva, Marcos Henrique; Teodoro, Larissa Pereira Ribeiro			The fewer, the better fare: Can the loss of vegetation in the Cerrado drive the increase in dengue fever cases infection?	PLOS ONE			English	Article							AEDES-AEGYPTI; DEFORESTATION; MALARIA; POLICIES; IMPACT	Several studies have reported the relationship of deforestation with increased incidence of infectious diseases, mainly due to the deregulation caused in these environments. The purpose of this study was to answer the following questions: a) is increased loss of vegetation related to dengue cases in the Brazilian Cerrado? b) how do different regions of the tropical savanna biome present distinct patterns for total dengue cases and vegetation loss? c) what is the projection of a future scenario of deforestation and an increased number of dengue cases in 2030? Thus, this study aimed to assess the relationship between loss of native vegetation in the Cerrado and dengue infection. In this paper, we quantify the entire deforested area and dengue infection cases from 2001 to 2019. For data analyses, we used Poisson generalized linear model, descriptive statistics, cluster analysis, non-parametric statistics, and autoregressive integrated moving average (ARIMA) models to predict loss of vegetation and fever dengue cases for the next decade. Cluster analysis revealed the formation of four clusters among the states. Our results showed significant increases in loss of native vegetation in all states, with the exception of Piaui. As for dengue cases, there were increases in the states of Minas Gerais, SAo Paulo, and Mato Grosso. Based on projections for 2030, Minas Gerais will register about 4,000 dengue cases per 100,000 inhabitants, Sao Paulo 750 dengue cases per 100,000 inhabitants, and Mato Grosso 500 dengue cases per 100,000 inhabitants. To reduce these projections, Brazil will need to control deforestation and implement public health, environmental and social policies, requiring a joint effort from all spheres of society.	[Pereira da Silva, Arlindo Ananias; Teodoro, Paulo Eduardo; Montanari, Rafael; Faria, Glaucia Amorim; Bortoloto da Silva, Dayane] Sao Paulo State Univ Unesp, Grad Program Agron Cropping Syst, Ilha Solteira, SP, Brazil; [Franquelino, Adriano Roberto] Sao Paulo State Univ Unesp, Sch Sci & Technol, Grad Program Geog, Presidente Prudente, SP, Brazil; [Teodoro, Paulo Eduardo; Teodoro, Larissa Pereira Ribeiro] Fed Univ Mato Grosso UFMS, Chapadao do Sul, MS, Brazil; [Ribeiro da Silva, Cristovao Henrique] Fed Univ Acre UFAC, Rio Branco, AC, Brazil; [Junior, Walter Aparecido Ribeiro] State Univ Londrina Uel, Grad Program Agron, Londrina, PR, Brazil; [Muchalak, Franciele] Univ Sao Paulo, Grad Program Sci Nucl Energy Agr, Ctr Energia Nucl Agr, Piracicaba, Brazil; [Cruz Souza, Kassia Maria] Sao Paulo State Univ Unesp, Sch Engn, Ilha Solteira, SP, Brazil; [Prudencio da Silva, Marcos Henrique] Fed Univ Mato Grosso UFMS, Grad Program Geog, Tres Lagoas, MS, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul; Universidade Federal do Acre (UFAC); Universidade Estadual de Londrina; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul	Teodoro, PE (corresponding author), Sao Paulo State Univ Unesp, Grad Program Agron Cropping Syst, Ilha Solteira, SP, Brazil.; Teodoro, PE (corresponding author), Fed Univ Mato Grosso UFMS, Chapadao do Sul, MS, Brazil.	eduteodoro@hotmail.com		Silva, Dayane Bortoloto/0000-0002-3264-0390; Cruz Souza, Kassia Maria/0000-0001-7192-1040; ANANIAS PEREIRA DA SILVA RIBEIRO, OTAVIO/0000-0002-3093-6796; Ribeiro Junior, Walter Aparecido/0000-0002-6612-0924; Franquelino, Adriano/0000-0002-2100-1809; TEODORO, PAULO/0000-0002-8236-542X	Universidade Estadual Paulista "Julio de Mesquita Filho" (UNESP), Universidade Federal de Mato Grosso do Sul (UFMS); Conselho Nacional de Desenvolvimento Cienti'Filho" (UNESP), Universidade Federal de Mato Grosso do Sul (UFMS) [303767/2020-0]; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso [71/019.039/2021]; Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior -Brazil [001]; Universidade Estadual Paulista "Julio de Mesquita Filho" (UNESP); Universidade Federal de Mato Grosso do Sul (UFMS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303767/2020-0]; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) [71/019.039/2021]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001]	Universidade Estadual Paulista "Julio de Mesquita Filho" (UNESP), Universidade Federal de Mato Grosso do Sul (UFMS); Conselho Nacional de Desenvolvimento Cienti'Filho" (UNESP), Universidade Federal de Mato Grosso do Sul (UFMS); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso; Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior -Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Estadual Paulista "Julio de Mesquita Filho" (UNESP); Universidade Federal de Mato Grosso do Sul (UFMS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to thank the Universidade Estadual Paulista Julio de Mesquita Filho (UNESP), Universidade Federal de Mato Grosso do Sul (UFMS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) -Grant number 303767/2020-0 and Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) process number 71/019.039/2021. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) -Financial Code 001.	Abdulsalam FI, 2021, GEOSPATIAL HEALTH, V16, DOI 10.4081/gh.2021.1012; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barros FSM, 2015, AM J TROP MED HYG, V93, P939, DOI 10.4269/ajtmh.15-0042; Bauhoff S, 2020, WORLD DEV, V127, DOI 10.1016/j.worlddev.2019.104734; Beck MW, 2018, J STAT SOFTW, V85, DOI 10.18637/jss.v085.i11; Box GEP., 1970, BOXTIME SER ANAL FOR; BRASIL MdaS, 2021, SEMANAS EPIDEMIOL GI; Burkett-Cadena ND, 2018, BASIC APPL ECOL, V26, P101, DOI 10.1016/j.baae.2017.09.012; Castro MC, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000526; Chiaravalloti Neto Francisco, 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P279, DOI 10.1590/S0037-86821997000400002; da Silva CA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72571-w; Cavalcanti LPD, 2007, REV SAUDE PUBL, V41, P638, DOI 10.1590/S0034-89102006005000041; Dunnington D., 2018, GGSPATIAL SPATIAL DA; Ellwanger JH, 2020, AN ACAD BRAS CIENC, V92, DOI 10.1590/0001-3765202020191375; Garrett RD, 2018, GLOBAL ENVIRON CHANG, V53, P233, DOI 10.1016/j.gloenvcha.2018.09.011; Gottwalt A., 2013, COLUMBIA U J GLOBAL, V3, pArticl, DOI [10.7916/thejgh.v3i2.4864, DOI 10.7916/THEJGH.V3I2.4864]; Grantham HS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19493-3; Guegan JF, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab8dd7; Gupta SK, 2021, J HYDROL ENG, V26, DOI 10.1061/(ASCE)HE.1943-5584.0002010; Hartig F, 2017, RESIDUAL DIAGNOSTICS, P121; HOFHANSL F. P., 2008, ZUGLEICH KATALOGE OB, V88, P237; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Hyndman R. J, 2017, FORECAST FORECASTING; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Inácio-Silva Marcela, 2017, Hoehnea, V44, P464, DOI 10.1590/2236-8906-08/2017; INPE, 2021, PROJ PRODESPROJETO E; Instituto Brasileiro de Geografia e Estatistica IBGE, 2020, BDIA BANC DAD INF AM; Kalbus A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0242685; Kassambara A., 2017, EXTRACT VISUALIZE RE; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; MacDonald AJ, 2019, P NATL ACAD SCI USA, V116, P22212, DOI 10.1073/pnas.1905315116; Maracahipes-Santos L, 2018, ACTA BOT BRAS; McLeod AI, 2015, PACKAGE KENDALL; Metcalfe AV., 2009, COWPERTWAIT PSP INTR, DOI [10.1007/978-0-387-88698-5, DOI 10.1007/978-0-387-88698-5]; Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nava A, 2017, ILAR J, V58, P393, DOI 10.1093/ilar/ilx034; Newbold P, 1993, DEV TIME SERIES ANAL, P9; Norma-Rashid Y., 2014, BASIC APPL ASPECTS B, P235; OPAS OP-A de S, 2020, OMS AF QUE COVID 19; Pebesma E, 2018, R J, V10, P439; Pereira R.H.M., 2021, GEOBR DOWNLOAD OFFIC; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Pires MO, 2020, BRAZILIAN POLIT SCI; Pohlert T., 2016, NONPARAMETRIC TREND; Ranathunge T, 2021, BIOL CONTROL, V160, DOI 10.1016/j.biocontrol.2021.104638; Rathnayaka RMGS, 2021, MED VET ENTOMOL, V35, P495, DOI 10.1111/mve.12513; Ribeiro JF., 1998, CERRADO AMBIENTE FLO, P87; Rosa IMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077231; Sawyer D., 2018, ECOSYSTEM PROFILE CE; Schrama M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69858-3; SILVA CMDA, 2018, VARIA HIST RIA, P34; Simes DA., 2008, OCORRNCIA TOXORHYNCH; Team RC, 2017, R LANG ENV STAT COMP, P1; Trigueiro ERORORGE, 2020, J ENVIRON MANAGE, V275, DOI 10.1016/j.jenvman.2020.111243; Warnes G.R., 2009, GPLOTS VARIOUS R PRO, V2, P1; Weterings R, 2015, J ASIA-PAC ENTOMOL, V18, P1, DOI 10.1016/j.aspen.2014.10.008; WHO WHO, 2019, GLOB TUB REP; WHO WHO, 2021, COR DIS COVID 19 DAS; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450	60	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262473	10.1371/journal.pone.0262473	http://dx.doi.org/10.1371/journal.pone.0262473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025976	Green Published, gold			2022-12-26	WOS:000796264200074
J	Kang, SH; Do, JY; Kim, JC				Kang, Seok Hui; Do, Jun Young; Kim, Jun Chul			Impedance-derived phase angle is associated with muscle mass, strength, quality of life, and clinical outcomes in maintenance hemodialysis patients	PLOS ONE			English	Article							HEALTH SURVEY SF-36; KIDNEY-DISEASE; VALIDITY; SARCOPENIA; PREDICTOR; SURVIVAL	Introduction We aimed to evaluate the association between the phase angle and muscle mass, muscle strength, physical performance tests, quality-of-life scales, mood scales, or patient and hospitalization-free survival rates in hemodialysis (HD) patients. Methods We included 83 HD patients. The patients were divided into tertiles based on phase angle value. The phase angle was measured using a bioimpedance analysis machine. Thigh muscle area per height squared (TMA/Ht(2)), handgrip strength (HGS), nutritional indicators, physical performance, quality-of-life, depression or anxiety status, and the presence of hospitalization or death regardless of cause were evaluated. Results In our study, no significant differences were observed in the serum albumin level and body mass index according to tertiles of phase angle. The phase angle tertiles were associated with TMA/Ht(2) and HGS. The phase angle was also associated with physical performance measurements and depression or anxiety status. Subgroup analyses according to sex, age, and diabetes mellitus showed similar trends to those of the total cohort. Furthermore, the hospitalization-free survival rate and patient survival rate were favorable in patients with high values for the phase angle. Conclusion The present study demonstrated that the phase angle is associated with muscle mass, strength, physical performance, quality-of-life scale, and hospitalization-free survival in maintenance HD patients.	[Kang, Seok Hui; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Kim, Jun Chul] CHA Univ, CHA Gumi Med Ctr, Dept Internal Med, Div Nephrol, Gumi, Gyeongsangbuk D, South Korea	Yeungnam University; Yeungnam University Hospital; Pochon Cha University	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.; Kim, JC (corresponding author), CHA Univ, CHA Gumi Med Ctr, Dept Internal Med, Div Nephrol, Gumi, Gyeongsangbuk D, South Korea.	jydo@med.yu.ac.kr; truedoc1@hanmail.net			Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea)	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (JYD).	Abad S, 2011, NEFROLOGIA, V31, P670, DOI 10.3265/Nefrologia.pre2011.Sep.10999; Bansal N, 2018, AM J KIDNEY DIS, V72, P662, DOI 10.1053/j.ajkd.2018.03.030; Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39; Beberashvilil I, 2014, EUR J CLIN NUTR, V68, P683, DOI 10.1038/ejcn.2014.67; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chertow GM, 1997, KIDNEY INT, V52, P1617, DOI 10.1038/ki.1997.493; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gibson AL, 2008, AM J CLIN NUTR, V87, P332, DOI 10.1093/ajcn/87.2.332; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Huang R, 2020, J RENAL NUTR, V30, P119, DOI 10.1053/j.jrn.2019.06.006; Jin DC, 2015, KIDNEY RES CLIN PRAC, V34, P132, DOI 10.1016/j.krcp.2015.08.004; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Kang SH, 2020, KIDNEY BLOOD PRESS R, V45, P419, DOI 10.1159/000506986; Kang SH, 2013, CLIN NEPHROL, V79, P261, DOI 10.5414/CN107693; Kooman JP, 2013, NEPHROL DIAL TRANSPL, V28, P48, DOI 10.1093/ndt/gfs451; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Lee JE, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7298-8; Lee K, 2019, KOREAN J RADIOL, V20, P205, DOI 10.3348/kjr.2018.0479; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; MacFarlane DJ, 2006, AM J HUM BIOL, V18, P418, DOI 10.1002/ajhb.20503; Maggiore Q, 1996, KIDNEY INT, V50, P2103, DOI 10.1038/ki.1996.535; Markaki AG, 2019, PSYCHOL HEALTH MED, V24, P1213, DOI 10.1080/13548506.2019.1612074; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mushnick R, 2003, KIDNEY INT, V64, pS53, DOI 10.1046/j.1523-1755.64.s87.22.x; Oliveira CMC, 2010, J RENAL NUTR, V20, P314, DOI 10.1053/j.jrn.2010.01.008; Park HJ, 2007, TOHOKU J EXP MED, V211, P321, DOI 10.1620/tjem.211.321; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pupim LB, 2004, KIDNEY INT, V66, P2054, DOI 10.1111/j.1523-1755.2004.00978.x; Saitoh M, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-02102-2; Schubert MM, 2019, CLIN PHYSIOL FUNCT I, V39, P150, DOI 10.1111/cpf.12550; Steiber AL, 2004, J RENAL NUTR, V14, P191, DOI 10.1053/j.jrn.2004.08.004; Tan RS, 2019, J RENAL NUTR, V29, P295, DOI 10.1053/j.jrn.2018.09.001; TIETZ NW, 1992, CLIN CHEM, V38, P1167; United States renal data system, 2020, USRDS ANN DAT REP EP; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; World Health Organization, GLOBAL RECOMMENDATIO	38	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261070	10.1371/journal.pone.0261070	http://dx.doi.org/10.1371/journal.pone.0261070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020730	Green Published, gold			2022-12-26	WOS:000834207700011
J	Holden, CA; Bailey, JP; Taylor, JE; Martin, F; Beckett, P; McAinsh, M				Holden, Claire Anne; Bailey, John Paul; Taylor, Jane Elizabeth; Martin, Frank; Beckett, Paul; McAinsh, Martin			Know your enemy: Application of ATR-FTIR spectroscopy to invasive species control	PLOS ONE			English	Article							SEXUAL REPRODUCTION; FALLOPIA-JAPONICA; SPP.; EVOLUTION; L.; HYBRIDIZATION; POLYGONACEAE; POPULATIONS; DIVERSITY; TRANSPORT	1. Extreme weather and globalisation leave our climate vulnerable to invasion by alien species, which have negative impacts on the economy, biodiversity, and ecosystem services. Rapid and accurate identification is key to the control of invasive alien species. However, visually similar species hinder conservation efforts, for example hybrids within the Japanese Knotweed complex. 2. We applied the novel method of ATR-FTIR spectroscopy combined with chemometrics (mathematics applied to chemical data) to historic herbarium samples, taking 1580 spectra in total. Samples included five species from within the interbreeding Japanese Knotweed complex (including three varieties of Japanese Knotweed), six hybrids and five species from the wider Polygonaceae family. Spectral data from herbarium specimens were analysed with several chemometric techniques: support vector machines (SVM) for differentiation between plant types, supported by ploidy levels; principal component analysis loadings and spectral biomarkers to explore differences between the highly invasive Reynoutria japonica var. japonica and its non-invasive counterpart Reynoutria japonica var. compacta; hierarchical cluster analysis (HCA) to investigate the relationship between plants within the Polygonaceae family, of the Fallopia, Reynoutria, Rumex and Fagopyrum genera. 3. ATR-FTIR spectroscopy coupled with SVM successfully differentiated between plant type, leaf surface and geographical location, even in herbarium samples of varying age. Differences between Reynoutria japonica var. japonica and Reynoutria japonica var. compacta included the presence of two polysaccharides, glucomannan and xyloglucan, at higher concentrations in Reynoutria japonica var. japonica than Reynoutria japonica var. compacta. HCA analysis indicated that potential genetic linkages are sometimes masked by environmental factors; an effect that can either be reduced or encouraged by altering the input parameters. Entering the absorbance values for key wavenumbers, previously highlighted by principal component analysis loadings, favours linkages in the resultant HCA dendrogram corresponding to expected genetic relationships, whilst environmental associations are encouraged using the spectral fingerprint region. 4. The ability to distinguish between closely related interbreeding species and hybrids, based on their spectral signature, raises the possibility of using this approach for determining the origin of Japanese knotweed infestations in legal cases where the clonal nature of plants currently makes this difficult and for the targeted control of species and hybrids. These techniques also provide a new method for supporting biogeographical studies.	[Holden, Claire Anne; Taylor, Jane Elizabeth; McAinsh, Martin] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Bailey, John Paul] Univ Leicester, Dept Genet & Genome Biol, Leicester, England; [Martin, Frank] Biocel Ltd, Kingston Upon Hull, England; [Beckett, Paul] Phlorum Ltd, Brighton, England	Lancaster University; University of Leicester	Holden, CA (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	c.holden6@lancaster.ac.uk		Holden, Claire/0000-0002-7831-8671; McAinsh, Martin Robert/0000-0003-4294-6470; Taylor, Jane Elizabeth/0000-0002-1467-7149				Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Bagcioglu M, 2017, METHODS ECOL EVOL, V8, P870, DOI 10.1111/2041-210X.12697; Bailey J, 2003, PLANT INVASIONS: ECOLOGICAL THREATS AND MANAGEMENT SOLUTIONS, P183; Bailey J. P., 2000, Watsonia, V23, P93; Bailey JP, 2009, BIOL INVASIONS, V11, P1189, DOI 10.1007/s10530-008-9381-4; Ben-Ari G, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P163, DOI 10.1016/B978-0-12-381466-1.00011-0; Bielczynski LW, 2017, PLANT PHYSIOL, V175, P1634, DOI 10.1104/pp.17.00904; Buitrago MF, 2016, ISPRS J PHOTOGRAMM, V111, P22, DOI 10.1016/j.isprsjprs.2015.11.003; Butler HJ, 2020, ANAL LETT, V53, P536, DOI 10.1080/00032719.2019.1658199; Butler HJ, 2018, ANALYST, V143, P6121, DOI 10.1039/c8an01384e; Butler HJ, 2017, VIB SPECTROSC, V90, P46, DOI 10.1016/j.vibspec.2017.03.004; Butler HJ, 2015, ANAL METHODS-UK, V7, P4059, DOI [10.1039/C5AY00377F, 10.1039/c5ay00377f]; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Carvalho LC, 2016, ANAL METHODS-UK, V8, P5658, DOI [10.1039/C6AY01325B, 10.1039/c6ay01325b]; Demir P, 2015, SPECTROCHIM ACTA A, V135, P757, DOI 10.1016/j.saa.2014.07.025; DESILVA DLR, 1986, NEW PHYTOL, V104, P41, DOI 10.1111/j.1469-8137.1986.tb00632.x; Desjardins SD., 2015, EVOLUTIONARY STUDIES; Di Giambattista L, 2011, ANAL BIOANAL CHEM, V399, P2771, DOI 10.1007/s00216-011-4654-7; Du CW, 2013, SENSOR ACTUAT B-CHEM, V188, P1167, DOI 10.1016/j.snb.2013.08.023; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Euring D, 2012, TREES-STRUCT FUNCT, V26, P1933, DOI 10.1007/s00468-012-0761-0; Fennell M, 2018, PEERJ, V6, DOI 10.7717/peerj.5246; Festa G, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1292; Gillies S, 2016, INVAS PLANT SCI MANA, V9, P71, DOI 10.1614/IPSM-D-15-00039.1; Gniwotta F, 2005, PLANT PHYSIOL, V139, P519, DOI 10.1104/pp.104.053579; Grevstad FS, 2018, BIOL BIOL CONTROL KN; Grimsby JL, 2007, AM J BOT, V94, P957, DOI 10.3732/ajb.94.6.957; Holden CA, 2021, BMC PLANT BIOL, V21, DOI 10.1186/s12870-021-03293-y; Hollingsworth ML, 1998, MOL ECOL, V7, P1681, DOI 10.1046/j.1365-294x.1998.00498.x; Hollingsworth ML, 2000, BOT J LINN SOC, V133, P463, DOI 10.1111/j.1095-8339.2000.tb01589.x; Huang YP, 2018, J FOOD ENG, V222, P185, DOI 10.1016/j.jfoodeng.2017.11.030; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Inamura A, 2000, J PLANT RES; Jones D, 2018, BIOL INVASIONS, V20, P2091, DOI 10.1007/s10530-018-1684-5; Jones IM, 2020, J APPL ENTOMOL, V144, P710, DOI 10.1111/jen.12792; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kang SH, 2008, COLLOID SURFACE A, V318, P275, DOI 10.1016/j.colsurfa.2008.01.004; Kanter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061518; Kim SW, 2004, PLANT CELL REP, V23, P246, DOI 10.1007/s00299-004-0811-1; Lavoie C, 2017, BIOL INVASIONS, V19, P2319, DOI 10.1007/s10530-017-1444-y; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Liu N, 2020, PLANT CELL ENVIRON, V43, P662, DOI 10.1111/pce.13691; Long F, 2021, RENEW SUST ENERG REV, V148, DOI 10.1016/j.rser.2021.111269; Mandak B, 2003, ANN BOT-LONDON, V92, P265, DOI 10.1093/aob/mcg141; Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133; McNear DH, 2010, PHYTOCHEMISTRY, V71, P188, DOI 10.1016/j.phytochem.2009.10.023; Milne RI, 2000, MOL ECOL, V9, P541, DOI 10.1046/j.1365-294x.2000.00906.x; Minnes R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04678-6; Moody ML, 2007, BIOL INVASIONS, V9, P559, DOI 10.1007/s10530-006-9058-9; Morais CLM, 2020, NAT PROTOC, V15, P2143, DOI 10.1038/s41596-020-0322-8; Morais CLM, 2019, NAT PROTOC, V14, P1546, DOI 10.1038/s41596-019-0150-x; Morais CLM, 2018, J BRAZIL CHEM SOC, V29, P472, DOI 10.21577/0103-5053.20170159; Morais CLM, 2017, ANAL METHODS-UK, V9, P2964, DOI [10.1039/c7ay00428a, 10.1039/C7AY00428A]; Mounger J, EPIGENETICS SUCCESS, DOI [10.32942/OSF.IO/69PM8, DOI 10.32942/OSF.IO/69PM8]; Nadeem MA, 2017, REV AGR ENV BIOTECHN, DOI [10.1080/13102818.2017.1400401, DOI 10.1080/13102818.2017.1400401]; Nishinari K, 2007, COMPREHENSIVE GLYCOS, P613; Ord J, 2016, ANALYST, V141, P2896, DOI [10.1039/c6an00392c, 10.1039/C6AN00392C]; Parepa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2632; Pashley CH, 2007, CLONAL DIVERSITY BRI; Pashley CH, 2003, USE MOL MARKERS STUD; Pichancourt JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032323; Raba DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138080; Rahman MM, 2019, SPECTROCHIM ACTA A, V214, P269, DOI 10.1016/j.saa.2019.02.011; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Ringelmann A, 2009, PLANTA, V230, P95, DOI 10.1007/s00425-009-0924-4; Santo P, 2017, J BUILD SURV APPRAIS, V6, P211; Schuster TM, 2015, TAXON, V64, P1188, DOI 10.12705/646.5; Sharma S, 2018, J APPL SPECTROSC+, V85, P771, DOI 10.1007/s10812-018-0717-2; Skolik P, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1852-5; Skolik P, 2019, PLANTA, V249, P925, DOI 10.1007/s00425-018-3060-1; Snow AA, 1999, MOL ECOL, V8, P605, DOI 10.1046/j.1365-294x.1999.00596.x; Spalding K, 2018, VIB SPECTROSC, V99, P50, DOI 10.1016/j.vibspec.2018.08.019; Taiz L., 2015, Plant physiology and development; Talari ACS, 2017, APPL SPECTROSC REV, V52, P456, DOI 10.1080/05704928.2016.1230863; Tiwari G, 2013, POSTHARVEST BIOL TEC, V86, P221, DOI 10.1016/j.postharvbio.2013.07.009; Traore M, 2018, WOOD SCI TECHNOL, V52, P487, DOI 10.1007/s00226-017-0967-9; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Trevisan J, 2013, BIOINFORMATICS, V29, P1095, DOI 10.1093/bioinformatics/btt084; USDA Plants Database, PLANT PROF POL BOH D; Usman K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42029-9; Van den Ende W, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00247; Wang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182161; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Williams F., 2010, VM10066 CABI; Yang Y, 2018, CURR OPIN BIOTECH, V49, P191, DOI 10.1016/j.copbio.2017.09.003; Zhang Y-Y, 2016, INVASION GENETICS, P328, DOI [10.1002/, DOI 10.1002/9781119072799.CH19]; Zika PF, 2003, RHODORA, V105, P143	88	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1							e0261742	10.1371/journal.pone.0261742	http://dx.doi.org/10.1371/journal.pone.0261742			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6S2ZW	34995300	Green Published, gold			2022-12-26	WOS:000892861900001
J	Zhao, JZ; Zhao, Y; Ma, XW; Feng, HL; Cui, RM				Zhao, Jiazheng; Zhao, Yi; Ma, Xiaowei; Feng, Helin; Cui, Rongmin			Immunological and prognostic significance of novel ferroptosis-related genes in soft tissue sarcoma	PLOS ONE			English	Article							EXPRESSION; IMMUNOTHERAPY; SURVIVAL; REVEAL; CELLS	Background Ferroptosis has exhibited great potential in the treatment of cancer and has gained widespread attention in soft tissue sarcoma (STS). The aim was to explore the immunological and prognostic significance of novel ferroptosis-related genes in STS. Methods We identified ferroptosis-related differentially expressed genes (DEGs) in STS to construct the networks of enrichment analysis and protein-protein interaction. Subsequently, hub genes with prognostic significance were localized and a series of prognostic and immune analyses were performed. Results 40 ferroptosis-related DEGs were identified, of which HELLS, STMN1 EPAS1, CXCL2, NQO1, and IL6 were classified as hub genes and were associated with the prognosis in STS patients. In the results of the immune analysis, PDCD1, CTLA4, TIGIT, IDO1 and CD27 exhibited consistent intense correlations as immune checkpoint genes, as well as macrophage, neutrophil, cytotoxic cell, dendritic cell, interdigitating dendritic cell and plasmacytoid dendritic cell as immune cells. EPAS1 and HELLS might be independent prognostic factors for STS patients, and separate prognostic models were constructed by using them. Conclusions We recognized novel ferroptosis-related genes with prognostic value in STS. Furthermore, we searched out potential immune checkpoints and critical immune cells.	[Zhao, Jiazheng; Zhao, Yi; Ma, Xiaowei; Feng, Helin] Hebei Med Univ, Dept Orthoped, Hosp 4, Shijiazhuang, Hebei, Peoples R China; [Cui, Rongmin] Hebei Med Univ, Dept Operating Room, Hosp 4, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University	Cui, RM (corresponding author), Hebei Med Univ, Dept Operating Room, Hosp 4, Shijiazhuang, Hebei, Peoples R China.	rongmincui0311@163.com		Feng, Helin/0000-0002-7260-5485	Project of the Natural Science Foundation of Hebei Province [H2019206309]	Project of the Natural Science Foundation of Hebei Province	This work was supported by grants from the Project of the Natural Science Foundation of Hebei Province [H2019206309] for HF.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MML, 2015, INT J CLIN EXP PATHO, V8, P2795; Atherton MJ, 2020, VET COMP ONCOL, V18, P447, DOI 10.1111/vco.12595; Ayodele O, 2020, CURR ONCOL, V27, P17, DOI 10.3747/co.27.5407; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Burugu S, 2018, SEMIN CANCER BIOL, V52, P39, DOI 10.1016/j.semcancer.2017.10.001; Callegaro D, 2017, CANCER-AM CANCER SOC, V123, P2802, DOI 10.1002/cncr.30721; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Coley W B, 1891, Ann Surg, V14, P199, DOI 10.1097/00000658-189112000-00015; Dancsok AR, 2019, MODERN PATHOL, V32, P1772, DOI 10.1038/s41379-019-0312-y; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Fanzani A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081718; Ferrari A, 2016, PROG TUMOR RES, V43, P128, DOI 10.1159/000447083; Gamboa AC, 2020, CA-CANCER J CLIN, V70, P200, DOI 10.3322/caac.21605; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hu XQ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923749; Huang WJ, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.629868; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Jafarzadeh N, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08734-3; Jiang YQ, 2017, THERANOSTICS, V7, P3293, DOI 10.7150/thno.19988; Klein S, 2019, CANCER IMMUNOL IMMUN, V68, P973, DOI 10.1007/s00262-019-02339-3; Law CT, 2019, HEPATOLOGY, V69, P2013, DOI 10.1002/hep.30414; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lu T, 2021, MOL THER-ONCOLYTICS, V21, P134, DOI 10.1016/j.omto.2021.02.011; Miwa S, 2017, IMMUNOTHERAPY-UK, V9, P1331, DOI 10.2217/imt-2017-0101; Nabeshima A, 2015, BRIT J CANCER, V112, P547, DOI 10.1038/bjc.2014.637; Nakazawa MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10539; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Pollack SM, 2018, J CLIN ONCOL, V36, P125, DOI 10.1200/JCO.2017.75.1610; Qin S, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1091-2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang R, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00946-7; Thapa D, 2014, CANCER RES, V74, P5644, DOI 10.1158/0008-5472.CAN-14-0562; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang R, 2020, CANCER SCI, V111, P406, DOI 10.1111/cas.14262; Zhang X, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101211; Zheng BX, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0560-1; Zhou N, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa021; Zhu MMT, 2020, CANCER TREAT REV, V91, DOI 10.1016/j.ctrv.2020.102115; Zhu TY, 2021, J ADV RES, V28, P7, DOI 10.1016/j.jare.2020.06.006; Zou Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09277-9	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262234	10.1371/journal.pone.0262234	http://dx.doi.org/10.1371/journal.pone.0262234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982796	gold, Green Published			2022-12-26	WOS:000834805700023
J	Hirakata, T; Huang, TX; Hiratsuka, Y; Yamamoto, S; Inoue, A; Murakami, A				Hirakata, Toshiaki; Huang, Tianxiang; Hiratsuka, Yoshimune; Yamamoto, Shutaro; Inoue, Akira; Murakami, Akira			Clinical patterns of rhegmatogenous retinal detachment during the first state of emergency for the COVID-19 pandemic in a Tokyo center	PLOS ONE			English	Article								The coronavirus disease 2019 (COVID-19) pandemic is disturbing and overwhelming a regular medical care in the world. We evaluated the clinical characteristics of patients with primary rhegmatogenous retinal detachment (RRD) during the state of emergency for COVID-19 pandemic in Japan. We also reviewed measures against the COVID-19 pandemic in our institute with a focus on RRD treatment. Retrospectively, patients who underwent initial RRD surgery during the state of emergency between April 7, 2020 and May 25, 2020 were included. For comparison, we recruited patients who underwent surgery for initial RRD during the same period in the last 2 years (2018 and 2019). Data related to the number of surgeries, age, gender, macular detachment, proliferative vitreoretinopathy (PVR), preoperative visual acuity, surgical techniques, the time between the onset and hospitalization and/or surgery of the 2020 cohort were analyzed and compared with those of the 2018 and 2019 cohorts. Furthermore, we reviewed measures taken against COVID-19 in our institute. The number of RRD patients during the state of emergency tended to be lower than that within the last 2 years. Relatively lesser female (vs. male) patients were observed in the 2020 cohort than in the last 2 years (P = 0.084). In contrast, among all cohorts, no significant differences were observed in the incidence of macula-off and PVR, preoperative visual acuity, and the time period between symptom onset and hospitalization and/or surgery. This is the first report to show the clinical patterns of RRD during COVID-19 pandemic in Japan. Despite the state of emergency for the COVID-19 pandemic, no delay in the patient's initial visit to the hospital and surgery was observed. Further studies, including multicenter researches, are important for investigating the influence of COVID-19 on urgent ocular diseases.	[Hirakata, Toshiaki; Huang, Tianxiang; Hiratsuka, Yoshimune; Yamamoto, Shutaro; Inoue, Akira; Murakami, Akira] Juntendo Univ, Dept Ophthalmol, Fac Med, Tokyo, Japan	Juntendo University	Hirakata, T (corresponding author), Juntendo Univ, Dept Ophthalmol, Fac Med, Tokyo, Japan.	t-hirakata@juntendo.ac.jp			MEXT/JSPS KAKENHI [19K23851, 20K18395]; Japan Agency for Medical Research and Development [20dk0310108]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from MEXT/JSPS KAKENHI (19K23851 and 20K18395 to T.H.), and the Japan Agency for Medical Research and Development (20dk0310108 to Y. H.). Then, these funding helped English proofreading fee and publication fee. So, these funders had no role in study design, data collection and analysis, decision to publish, but had role in the preparation of the manuscript.	Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI DOI 10.1016/j.idm.2020.04.001; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Gao ZR, 2021, J MICROBIOL IMMUNOL, V54, P12, DOI 10.1016/j.jmii.2020.05.001; Gariano RF, 2004, AM FAM PHYSICIAN, V69, P1691; Hiroi U., 2020, J CITY PLAN INST JPN, V55, P902, DOI [10.11361/journalcpij.55.902, DOI 10.11361/JOURNALCPIJ.55.902]; Jasani KM, 2021, EUR J OPHTHALMOL, V31, P2876, DOI 10.1177/1120672120965480; Katafuchi Yuya, 2021, Econ Disaster Clim Chang, V5, P71, DOI 10.1007/s41885-020-00077-w; Kuniya T, 2020, INFECT DIS MODEL, V5, P580, DOI 10.1016/j.idm.2020.08.004; Mitry D, 2013, BRIT J OPHTHALMOL, V97, P149, DOI 10.1136/bjophthalmol-2012-302330; Ogden RS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235871; Paital B, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138914; Patel LG, 2021, OPHTHALMOLOGY, V128, P686, DOI 10.1016/j.ophtha.2020.10.009; Siddiqui MAR, 2010, ACTA OPHTHALMOL, V88, pe352, DOI 10.1111/j.1755-3768.2009.01771.x; Tirupathi Raghavendra, 2020, Infez Med, V28, P57; Vroon J, 2018, BIOMECH MODEL MECHAN, V17, P975, DOI 10.1007/s10237-018-1006-y; Wong L.E., 2020, NEJM CATAL INNOV CAR, DOI 10.1056/CAT.20.0193	16	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261779	10.1371/journal.pone.0261779	http://dx.doi.org/10.1371/journal.pone.0261779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972153	gold, Green Published			2022-12-26	WOS:000773555700053
J	Tizzani, M; Munoz-Gomez, V; De Nardi, M; Paolotti, D; Munoz, O; Ceschi, P; Viltrop, A; Capua, I				Tizzani, Michele; Munoz-Gomez, Violeta; De Nardi, Marco; Paolotti, Daniela; Munoz, Olga; Ceschi, Piera; Viltrop, Arvo; Capua, Ilaria			Integrating digital and field surveillance as complementary efforts to manage epidemic diseases of livestock: African swine fever as a case study	PLOS ONE			English	Article							INFORMATION-SEEKING; WIKIPEDIA; ATTITUDES; KNOWLEDGE	SARS-CoV-2 has clearly shown that efficient management of infectious diseases requires a top-down approach which must be complemented with a bottom-up response to be effective. Here we investigate a novel approach to surveillance for transboundary animal diseases using African Swine (ASF) fever as a model. We collected data both at a population level and at the local level on information-seeking behavior respectively through digital data and targeted questionnaire-based surveys to relevant stakeholders such as pig farmers and veterinary authorities. Our study shows how information-seeking behavior and resulting public attention during an epidemic, can be identified through novel data streams from digital platforms such as Wikipedia. Leveraging attention in a critical moment can be key to providing the correct information at the right moment, especially to an interested cohort of people. We also bring evidence on how field surveys aimed at local workers and veterinary authorities remain a crucial tool to assess more in-depth preparedness and awareness among front-line actors. We conclude that these two tools should be used in combination to maximize the outcome of surveillance and prevention activities for selected transboundary animal diseases such as ASF.	[Tizzani, Michele; Paolotti, Daniela] Inst Sci Interchange Fdn, Turin, Italy; [Munoz-Gomez, Violeta; De Nardi, Marco] SAFOSO, Liebefeld, Switzerland; [Munoz-Gomez, Violeta] Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland; [Munoz, Olga] One Hlth Ctr Excellence, Gainesville, FL USA; [Munoz, Olga; Ceschi, Piera; Capua, Ilaria] Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Viltrop, Arvo] Estonian Univ Life Sci, Tartu, Estonia	University of Zurich; Estonian University of Life Sciences	Tizzani, M (corresponding author), Inst Sci Interchange Fdn, Turin, Italy.; Munoz-Gomez, V (corresponding author), SAFOSO, Liebefeld, Switzerland.; Munoz-Gomez, V (corresponding author), Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland.	mt.tizzani@isi.it; violetamunozgomez@hotmail.com		Capua, Ilaria/0000-0002-7072-2581; Tizzani, Michele/0000-0003-3068-5111; Munoz, Violeta/0000-0001-5874-0317	Leonardo Fellowship Program; Circular Health Initiative at University of Florida; Lagrange Project of the Institute for Scientific Interchange Foundation - Fondazione CRT of Torino; Zurich Insurance Company	Leonardo Fellowship Program; Circular Health Initiative at University of Florida; Lagrange Project of the Institute for Scientific Interchange Foundation - Fondazione CRT of Torino; Zurich Insurance Company	IC acknowledges the Leonardo Fellowship Program, and the Circular Health Initiative at University of Florida (https://onehealth.ifas.ufl.edu/activities/circular-health-program/circular-health/).DP and MT acknowledge the support from the Lagrange Project of the Institute for Scientific Interchange Foundation (https://www. isi.it/en/lagrange-project/project) funded by Fondazione CRT (https://www.fondazionecrt.it/en/fondazione-crt.html) of Torino (https://www.fondazionecrt.it/).MDN and VM acknowledge the support of the Zurich Insurance Company (www.zurich.com) for funding the fieldwork in Estonia. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Al Baghal T, 2021, EPJ DATA SCI, V10, DOI 10.1140/epjds/s13688-021-00286-7; Al Baghal T, 2020, SOC SCI COMPUT REV, V38, P517, DOI 10.1177/0894439319828011; Belgian Federal Agency for the Safety of the Food Chain (FASFC), 2019, AFRICAN SWINE FEVER; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brigo F, 2015, EPILEPTIC DISORD, V17, P460, DOI 10.1684/epd.2015.0772; Busch F, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.637487; Castillo-Contreras R, 2018, SCI TOTAL ENVIRON, V615, P282, DOI 10.1016/j.scitotenv.2017.09.277; Chenais E, 2019, PORCINE HEALTH MANAG, V5, DOI 10.1186/s40813-018-0109-2; Choi S, 2020, SOC SCI COMPUT REV, V38, P91, DOI 10.1177/0894439318788618; Costard S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17074; Dixon LK, 2020, ANNU REV ANIM BIOSCI, V8, P221, DOI 10.1146/annurev-animal-021419-083741; E-estonia, 2020, E EST WE HAV BUILD D; Fanelli A, 2021, TRANSBOUND EMERG DIS; FAO, ASF SIT UPD AFR SWIN; FAO OIE, 2020, GLOB CONTR AFR SWIN; Galindo I, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050103; Gozzi N, 2020, J MED INTERNET RES, V22, DOI 10.2196/21597; Honnibal M, 2017, SPCY2 NATURAL LANGUA; Jabaley CS, 2019, AM J RESP CRIT CARE, V199, P531, DOI 10.1164/rccm.201809-1649LE; Jori F., 2021, UNDERSTANDING COMBAT, P197, DOI [10.3920/978-90-8686-910-7_8, DOI 10.3920/978-90-8686-910-7_8]; Krentel A, 2006, TROP MED INT HEALTH, V11, P1731, DOI 10.1111/j.1365-3156.2006.01720.x; Kristian M, 2017, WORKSH ASF MAN WILD; Leetaru Kalev, 2013, ISA ANN CONV; Lewis N., 2017, INT ENCY MEDIA EFFEC, P1, DOI [10.1002/9781118783764.wbieme0156, DOI 10.1002/9781118783764.WBIEME0156]; Liu L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3252-8; Liu Q, 2020, J MED INTERNET RES, V22, DOI 10.2196/19118; Mason-D'Croz D, 2020, NAT FOOD, V1, DOI 10.1038/s43016-020-0057-2; Matibag Gino C., 2007, Environmental Health and Preventive Medicine, V12, P84, DOI 10.1007/BF02898154; Munoz-Gomez V, 2021, VET MED SCI, V7, P1786, DOI 10.1002/vms3.578; Nurmoja I, 2017, TRANSBOUND EMERG DIS, V64, P2034, DOI 10.1111/tbed.12614; Nurmoja I, 2020, PREV VET MED, V181, DOI 10.1016/j.prevetmed.2018.10.001; OIE, 2010, STAND GROUP EXP AFR; pandas development team, 2020, T PANDAS DEV PANDAS; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Probst C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170054; Sanchez-Cordon PJ, 2018, VET J, V233, P41, DOI 10.1016/j.tvjl.2017.12.025; Schulz K, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020336; Seabold S, 2010, P 9 PYTHON SCI C; Sidana S, 2018, IEEE T KNOWL DATA EN, V30, P1467, DOI 10.1109/TKDE.2018.2795606; Stier S, 2020, SOC SCI COMPUT REV, V38, P503, DOI 10.1177/0894439319843669; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; Tizzoni M., 2018, 346411 BIORXIV, DOI [10.1101/346411, DOI 10.1101/346411]; Tizzoni M, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007633, 10.1371/journal.pcbi.1007633.r001, 10.1371/journal.pcbi.1007633.r002, 10.1371/journal.pcbi.1007633.r003, 10.1371/journal.pcbi.1007633.r004]; USDA APHIS, USDA STAT CONF AFR S	44	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0252972	10.1371/journal.pone.0252972	http://dx.doi.org/10.1371/journal.pone.0252972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972117	Green Published, gold, Green Accepted			2022-12-26	WOS:000773555700002
J	Wu, H; Niu, CY; Qu, YX; Sun, XY; Wang, KW				Wu, Han; Niu, Canyang; Qu, Yaxuan; Sun, Xiaoying; Wang, KeWei			Selective activation of TRPA1 ion channels by nitrobenzene skin sensitizers DNFB and DNCB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAPTEN-INDUCED COLITIS; ALPHA,BETA-UNSATURATED ALDEHYDES; INFLAMMATORY RESPONSE; RECEPTOR; ITCH; EXPRESSION; DERMATITIS; INDUCTION; MEDIATORS; REVEALS	2, 4-dinitrofluorobenzene (DNFB) and 2, 4-dinitrochlorobenzene (DNCB) are well known as skin sensitizers that can cause dermatitis. DNFB has shown to more potently sensitize skin; however, how DNFB and DNCB cause skin inflammation at a molecular level and why this difference in their sensiti-zation ability is observed remain unknown. In this study, we aimed to identify the molecular targets and mechanisms on which DNFB and DNCB act. We used a fluorescent calcium imaging plate reader in an initial screening assay before patch-clamp recordings for validation. Molecular docking in combination with site-directed mutagenesis was then carried out to investigate DNFB and DNCB binding sites in the TRPA1 ion channel that may be selectively activated by these tow sensitizers. We found that DNFB and DNCB selectively activated TRPA1 channel with EC50 values of 2.3 +/- 0.7 mu M and 42.4 +/- 20.9 mu M, respectively. Single-channel recordings revealed that DNFB and DNCB increase the probability of channel opening and act on three residues (C621, E625, and Y658) critical for TRPA1 activation. Our findings may not only help explain the molecular mechanism underlying the dermatitis and pruritus caused by chemicals such as DNFB and DNCB, but also provide a molecular tool 7.5-fold more potent than the current TRPA1 activator allyl isothiocyanate (AITC) used for investigating TRPA1 channel pharmacology and pathology.	[Wu, Han; Niu, Canyang; Qu, Yaxuan; Sun, Xiaoying; Wang, KeWei] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China; [Sun, Xiaoying; Wang, KeWei] Qingdao Univ, Inst Innovat Drugs, Qingdao, Peoples R China	Qingdao University; Qingdao University	Sun, XY; Wang, KW (corresponding author), Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China.; Sun, XY; Wang, KW (corresponding author), Qingdao Univ, Inst Innovat Drugs, Qingdao, Peoples R China.	xiaoyingsun@qdu.edu.cn; wangkw@qdu.edu.cn			National Natural Science Foundation of China [81903734, 81973299]; Ministry of Science and Technology of China [2018ZX09711001-004-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We are grateful to Drs Fan Yang, Xiaowen Tang and Mr Heng Zhang for assistance and discussion in the molecular docking. This work was supported by National Natural Science Foundation of China (81903734 and 81973299) and the Ministry of Science and Technology of China (2018ZX09711001-004-006) .	Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Bailon E, 2011, INFLAMM BOWEL DIS, V17, P2087, DOI 10.1002/ibd.21586; Barry DM, 2018, NEUROSCI BULL, V34, P156, DOI 10.1007/s12264-017-0125-2; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bertin S, 2017, GUT, V66, P1584, DOI 10.1136/gutjnl-2015-310710; Bourane S, 2015, SCIENCE, V350, P550, DOI 10.1126/science.aac8653; Caterina MJ, 2014, ACS CHEM NEUROSCI, V5, P1107, DOI 10.1021/cn5000919; Danso-Abeam D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-79; Deng ZQ, 2018, NAT STRUCT MOL BIOL, V25, P252, DOI 10.1038/s41594-018-0037-5; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Gao ZR, 2019, NEURON, V101, P45, DOI 10.1016/j.neuron.2018.11.010; GARCIAPEREZ A, 1978, CONTACT DERMATITIS, V4, P125, DOI 10.1111/j.1600-0536.1978.tb03756.x; Gouin O, 2017, PROTEIN CELL, V8, P644, DOI 10.1007/s13238-017-0395-5; Grandclement C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151031; Heber S, 2019, J NEUROSCI, V39, P3845, DOI 10.1523/JNEUROSCI.3048-18.2019; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hsieh GC, 1996, FASEB J, V10, P1284; Ibarra Y, 2013, MOL PHARMACOL, V83, P1120, DOI 10.1124/mol.112.084194; Ishibashi T, 2008, ACTA OTO-LARYNGOL, V128, P1286, DOI 10.1080/00016480801938958; Kang SM, 2017, J DERMATOL SCI, V88, P126, DOI 10.1016/j.jdermsci.2017.05.009; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kim S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1047; Landsteiner K, 1941, J EXP MED, V73, P431, DOI 10.1084/jem.73.3.431; Li MW, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106696; Li YX, 2018, INT ARCH ALLERGY IMM, V175, P220, DOI 10.1159/000486958; Lin J, 2018, CELL SIGNAL, V49, P39, DOI 10.1016/j.cellsig.2018.05.007; Luo JL, 2018, J ALLERGY CLIN IMMUN, V141, P608, DOI 10.1016/j.jaci.2017.05.051; Mandadi S, 2008, CURR NEUROPHARMACOL, V6, P21, DOI 10.2174/157015908783769680; Mohania D, 2017, ADV EXP MED BIOL, V996, P71, DOI 10.1007/978-3-319-56017-5_7; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oh MH, 2013, J IMMUNOL, V191, P5371, DOI 10.4049/jimmunol.1300300; Parenti A, 2016, BRIT J PHARMACOL, V173, P953, DOI 10.1111/bph.13392; Dien PH, 2012, NAT PROD RES, V26, P2107, DOI 10.1080/14786419.2011.619186; Rijnierse A, 2006, EUR J PHARMACOL, V548, P150, DOI 10.1016/j.ejphar.2006.07.010; Rijnierse A, 2006, AM J PHYSIOL-GASTR L, V291, pG969, DOI 10.1152/ajpgi.00146.2006; Rijnierse A, 2006, J IMMUNOL, V176, P4375, DOI 10.4049/jimmunol.176.7.4375; Rodriguez AL, 2010, MOL PHARMACOL, V78, P1105, DOI 10.1124/mol.110.067207; Saarnilehto M, 2014, ALLERGY, V69, P1424, DOI 10.1111/all.12488; Sandor Z, 2016, BASIC CLIN PHARMACOL, V119, P341, DOI 10.1111/bcpt.12574; Southall MD, 2003, J PHARMACOL EXP THER, V304, P217, DOI 10.1124/jpet.102.040675; [Sun Xiaomei 孙晓梅], 2017, [Journal of Chinese Pharmaceutical Sciences, 中国药学], V26, P675; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; TINGLE MD, 1990, INT ARCH ALLER A IMM, V91, P160, DOI 10.1159/000235108; Toth BI, 2014, BRIT J PHARMACOL, V171, P2568, DOI 10.1111/bph.12569; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Yogianti F, 2014, J INVEST DERMATOL, V134, P2610, DOI 10.1038/jid.2014.188; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245; Zeng D, 2021, LIFE SCI, V266, DOI 10.1016/j.lfs.2020.118906	52	1	1	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101555	10.1016/j.jbc.2021.101555	http://dx.doi.org/10.1016/j.jbc.2021.101555			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1YB	34973335	gold, Green Published			2022-12-26	WOS:000761423400009
J	Ahmed, HGMD; Naeem, M; Zeng, YW; Rashid, MAR; Ullah, A; Saeed, A; Qadeer, A				Ahmed, Hafiz Ghulam Muhu-Din; Naeem, Muhammad; Zeng, Yawen; Rashid, Muhammad Abdul Rehman; Ullah, Aziz; Saeed, Amjad; Qadeer, Abdul			Genome-wide association mapping for high temperature tolerance in wheat through 90k SNP array using physiological and yield traits	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; SINGLE-NUCLEOTIDE POLYMORPHISM; CELL-MEMBRANE STABILITY; BREAD WHEAT; HEAT TOLERANCE; WINTER-WHEAT; SPRING WHEAT; DROUGHT; QTL; GENOTYPES	Dissecting the genetic basis of physiological and yield traits against tolerance to heat stress is an essential in wheat breeding programs to boost up the wheat yield for sustainable food security. Herein, a genome-wide association study (GWAS) was performed to reveal the genetic basis of heat tolerance using high-density Illumina 90K Infinium SNPs array through physiological and yield indices. These indices were phenotyped on a diverse panel of foreign and domestic genotypes of Pakistan, grown in normal and heat-stressed environments. Based on STRUCTURE analysis, the studied germplasm clustered into four sub-population. Highly significant variations with a range of moderate (58.3%) to high (77.8%) heritability was observed under both conditions. Strong positive correlation existed among physiological and yield related attributes. A total of 320 significant (-log10 P >= 3) marker-trait associations (MTAs) were identified for the observed characters. Out of them 169 and 151 MTAs were recorded in normal and heat stress environments, respectively. Among the MTA loci, three (RAC875_c103017_302, Tdurum_contig42087_1199, and Tdurum_contig46877_488 on chromosomes 4B, 6B, and 7B respectively), two (BobWhite_c836_422 and BS00010616_51) and three (Kukri_rep_c87210_361, D_GA8KES401BNLTU_253 and Tdurum_contig1015_131) on chromosomes 5A, 1B, and 3D at the positions 243.59cM, 77.82cM and 292.51cM) showed pleiotropic effects in studied traits under normal, heat-stressed and both conditions respectively. The present study not only authenticated the numerous previously reported MTAs for examined attributes but also revealed novel MTAs under heat-stressed conditions. Identified SNPs will be beneficial in determining the novel genes in wheat to develop the heat tolerant and best yielded genotypes to fulfill the wheat requirement for the growing population.	[Ahmed, Hafiz Ghulam Muhu-Din; Naeem, Muhammad] Islamia Univ Bahawalpur, Fac Agr & Environm, Dept Plant Breeding & Genet, Bahawalpur, Pakistan; [Zeng, Yawen] Yunnan Acad Agr Sci, Biotechnol & Germplasm Resources Inst, Kunming, Yunnan, Peoples R China; [Rashid, Muhammad Abdul Rehman] Govt Coll Univ Faisalabad, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Ullah, Aziz] Univ Sargodha, Dept Plant Breeding & Genet, Sargodha, Pakistan; [Saeed, Amjad] Islamia Univ Bahawalpur, Fac Agr & Environm, Dept Forestry Range & Wildlife Management, Bahawalpur, Pakistan; [Qadeer, Abdul] Univ Agr Faisalabad, Inst Soil & Environm Sci, Soil Fertil & Plant Nutr Lab, Faisalabad, Pakistan	Islamia University of Bahawalpur; Yunnan Academy of Agricultural Sciences; Government College University Faisalabad; University of Sargodha; Islamia University of Bahawalpur; University of Agriculture Faisalabad	Ahmed, HGMD (corresponding author), Islamia Univ Bahawalpur, Fac Agr & Environm, Dept Plant Breeding & Genet, Bahawalpur, Pakistan.; Zeng, YW (corresponding author), Yunnan Acad Agr Sci, Biotechnol & Germplasm Resources Inst, Kunming, Yunnan, Peoples R China.	ghulam.muhudin@iub.edu.pk; zengyw1967@126.com	Ahmed, Hafiz/GWR-3787-2022; Rashid, Muhammad Abdul Rehman/R-5982-2018	Rashid, Muhammad Abdul Rehman/0000-0002-4941-3469; Ahmed, Hafiz GMD/0000-0001-9104-3791	China Agriculture Research System of MOF and MARA [CARS-05-01A-04]; Major science and technology projects in Yunnan Province [202102AE090014]	China Agriculture Research System of MOF and MARA(Ministry of Oceans & Fisheries (MOF), Republic of Korea); Major science and technology projects in Yunnan Province	Funding was supported by China Agriculture Research System of MOF and MARA (CARS-05-01A-04) Major science and technology projects in Yunnan Province (202102AE090014).	Acuna-Galindo MA, 2015, CROP SCI, V55, P477, DOI 10.2135/cropsci2013.11.0793; Ahmed HGMD, 2021, J KING SAUD UNIV SCI, V33, DOI 10.1016/j.jksus.2021.101628; Ahmed HGMD, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11081646; Ahmed HGMD, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10090392; Ahmed HGMD, 2020, SAUDI J BIOL SCI, V27, P2116, DOI 10.1016/j.sjbs.2020.06.019; Ahmed HGMD, 2019, J INTEGR AGR, V18, P2483, DOI 10.1016/S2095-3119(18)62083-0; Ahmed HGMD, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11092584; Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; [Anonymous], 2015, RSTUD; Aslani F., 2012, Asian Journal of Agricultural Sciences, V4, P72; Bahar B, 2008, NOT BOT HORTI AGROBO, V36, P34; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Bennett D, 2012, THEOR APPL GENET, V125, P1473, DOI 10.1007/s00122-012-1927-2; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Dixon J., 2009, WHEAT FACTS FUTURES; Dodig D, 2012, INT J MOL SCI, V13, P6167, DOI 10.3390/ijms13056167; Dreisigacker S, 2013, LAB MANUAL ICAR CIMM; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; ElBasyoni I, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9091606; Epure DG, 2017, AGROLIFE SCI J, V6, P104; Mason RE, 2010, EUPHYTICA, V174, P423, DOI 10.1007/s10681-010-0151-x; Fiaz S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115585; Guo J., 2020, GENOME WIDE ASS STUD; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; IBM-SPSS, 2012, IBM SPSS STAT VERS 2; Khan A. A., 2014, Journal of Agricultural Research (Lahore), V52, P11; Khan A, 2021, SAUDI J BIOL SCI, V28, P7404, DOI 10.1016/j.sjbs.2021.08.050; Khan A, 2018, PAK J BOT, V50, P481; Kumar S, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.549743; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li L, 2019, PLANT CELL ENVIRON, V42, P2540, DOI 10.1111/pce.13577; Li W, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10091481; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lozada DN, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2005-2; Maulana F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01272; Mohammadi M, 2011, AUST J CROP SCI, V5, P487; Mondal S, 2015, EUPHYTICA, V201, P123, DOI 10.1007/s10681-014-1193-2; Moriondo M, 2011, CLIMATIC CHANGE, V104, P679, DOI 10.1007/s10584-010-9871-0; Muller J., 1991, AGR METEOROL, V14, P311; Nasri R., 2014, Indian Journal of Fundamental and Applied Life Sciences, V4, P188; Ni ZF, 2018, CROP J, V6, P32, DOI 10.1016/j.cj.2017.09.005; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Payne R., 2008, GUIDE ANOVA DESIGN G; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Qaseem MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199121; Rahimi Y, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2165-4; Rehman SU, 2016, CROP PASTURE SCI, V67, P712, DOI 10.1071/CP15385; Somssich M, 2016, DEVELOPMENT, V143, P3238, DOI 10.1242/dev.133645; Sorkheh K, 2008, GENET MOL BIOL, V31, P805, DOI 10.1590/S1415-47572008000500001; Sukumaran S, 2018, THEOR APPL GENET, V131, P999, DOI 10.1007/s00122-018-3066-x; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; Talukder SK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0097-4; Thomelin P, 2016, P PLANT AN GEN C PAG; Vijayalakshmi K, 2010, MOL BREEDING, V26, P163, DOI 10.1007/s11032-009-9366-8; Wang SS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01166; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu QH, 2016, EUPHYTICA, V208, P337, DOI 10.1007/s10681-015-1603-0; Yang DL, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0399-9; Zameer R, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.794305; Zhai HJ, 2018, THEOR APPL GENET, V131, P539, DOI 10.1007/s00122-017-3017-y; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8	62	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262569	10.1371/journal.pone.0262569	http://dx.doi.org/10.1371/journal.pone.0262569			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030233	gold, Green Published			2022-12-26	WOS:000812798500055
J	El Mouzan, M; Assiri, A; Al Sarkhy, A; Alasmi, M; Saeed, A; Al-Hussaini, A; AlSaleem, B; Al Mofarreh, M				El Mouzan, Mohammad; Assiri, Asaad; Al Sarkhy, Ahmed; Alasmi, Mona; Saeed, Anjum; Al-Hussaini, Abdulrahman; AlSaleem, Badr; Al Mofarreh, Mohammad			Viral dysbiosis in children with new-onset celiac disease	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; BACTERIOPHAGES; INFECTION; SUSCEPTIBILITY; RESPONSES; VIRUSES; TRIGGER; VIROME	Viruses are common components of the intestinal microbiome, modulating host bacterial metabolism and interacting with the immune system, with a possible role in the pathogenesis of immune-mediated diseases such as celiac disease (CeD). The objective of this study was to characterize the virome profile in children with new-onset CeD. We used metagenomic analysis of viral DNA in mucosal and fecal samples from children with CeD and controls and performed sequencing using the Nextera XT library preparation kit. Abundance log2 fold changes were calculated using differential expression and linear discriminant effect size. Shannon alpha and Bray-Curtis beta diversity were determined. A total of 40 children with CeD and 39 controls were included. We found viral dysbiosis in both fecal and mucosal samples. Examples of significantly more abundant species in fecal samples of children with CeD included Human polyomavirus 2, Enterobacteria phage mEpX1, and Enterobacteria phage mEpX2; whereas less abundant species included Lactococcus phages ul36 and Streptococcus phage Abc2. In mucosal samples however, no species were significantly associated with CeD. Shannon alpha diversity was not significantly different between CeD and non-CeD groups and Bray-Curtis beta diversity showed no significant separation between CeD and non-CeD samples in either mucosal or stool samples, whereas separation was clear in all samples. We identified significant viral dysbiosis in children with CeD, suggesting a potential role in the pathogenesis of CeD indicating the need for further studies.	[El Mouzan, Mohammad; Assiri, Asaad; Al Sarkhy, Ahmed; Alasmi, Mona; Saeed, Anjum] King Saud Univ, Dept Pediat Gastroenterol, Riyadh, Saudi Arabia; [El Mouzan, Mohammad; Assiri, Asaad; Al Sarkhy, Ahmed; Alasmi, Mona; Saeed, Anjum] King Saud Univ, King Saud Univ Med City, Dept Pediat, Riyadh, Saudi Arabia; [Assiri, Asaad] King Saud Univ, Dept Pediat, Prince Abdullah Bin Khalid Celiac Dis Res Chair, Riyadh, Saudi Arabia; [Al-Hussaini, Abdulrahman] King Fahad Med City, Div Pediat Gastroenterol, Childrens Specialist Hosp, Riyadh, Saudi Arabia; [Al-Hussaini, Abdulrahman] Al Faisal Univ, Fac Med, Riyadh, Saudi Arabia; [AlSaleem, Badr] King Fahad Med City, Div Gastroenterol, Children Hosp, Pediat Intestinal Failure & Parenteral Nutr Progr, Riyadh, Saudi Arabia; [Al Mofarreh, Mohammad] Al Mofarreh PolyClin, Dept Gastroenterol, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Fahad Medical City; Alfaisal University; King Fahad Medical City	El Mouzan, M (corresponding author), King Saud Univ, Dept Pediat Gastroenterol, Riyadh, Saudi Arabia.; El Mouzan, M (corresponding author), King Saud Univ, King Saud Univ Med City, Dept Pediat, Riyadh, Saudi Arabia.	melmouzan@ksu.edu.sa			Deanship of Scientific Research at King Saud University [RGP-1441-007]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciations to the Deanship of Scientific Research at King Saud University for funding this work through Research Group No (RGP-1441-007).	Ahlmann-Eltze C, 2019, GGSIGNIF SIGNIFICANC; Al-Hussaini A, 2018, SAUDI J GASTROENTERO, V24, P268, DOI 10.4103/sjg.SJG_551_17; Al-Hussaini A, 2017, J PEDIATR GASTR NUTR, V65, P646, DOI 10.1097/MPG.0000000000001681; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Carding SR, 2017, ALIMENT PHARM THER, V46, P800, DOI 10.1111/apt.14280; Collado MC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-232; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Cinova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016169; Corouge M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121776; Dalmasso M, 2014, TRENDS MICROBIOL, V22, P399, DOI 10.1016/j.tim.2014.02.010; De Palma G, 2010, J LEUKOCYTE BIOL, V87, P765, DOI 10.1189/jlb.0709471; Duerr DM, 2004, J VIROL METHODS, V116, P177, DOI 10.1016/j.jviromet.2003.11.012; Easha S, 2006, CELL MOL LIFE SCI, V63, P865, DOI 10.1007/s00018-005-5454-z; El Mouzan M, 2022, DIGEST DIS SCI, V67, P216, DOI 10.1007/s10620-021-06823-8; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fulci V, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22084127; Granito A, 2005, ALIMENT PHARM THER, V21, P881, DOI 10.1111/j.1365-2036.2005.02417.x; Hamzeh-Mivehroud M, 2008, EUR J PHARM BIOPHARM, V70, P577, DOI 10.1016/j.ejpb.2008.06.005; Handley SA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0287-y; Hasan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097699; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kahrs CR, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l231; Kassambara A., 2020, GGPUBRGGPLOT2 BASED; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lerner A, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7060173; Lindfors K, 2020, GUT, V69, P1416, DOI 10.1136/gutjnl-2019-319809; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mills S, 2013, GUT MICROBES, V4, P4, DOI 10.4161/gmic.22371; Miskin DP, 2015, CURR OPIN NEUROL, V28, P288, DOI 10.1097/WCO.0000000000000201; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Nieuwenhuizen WF, 2003, LANCET, V361, P2152, DOI 10.1016/S0140-6736(03)13695-1; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ottesen A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0894-1; Perez-Brocal V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.9; Ponnusamy D, 2016, P NATL ACAD SCI USA, V113, P722, DOI 10.1073/pnas.1523817113; Saeed A, 2017, SAUDI MED J, V38, P895, DOI 10.15537/smj.2017.9.20808; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Wagner J, 2013, INFLAMM BOWEL DIS, V19, P1598, DOI 10.1097/MIB.0b013e318292477c; Wang WW, 2015, INFLAMM BOWEL DIS, V21, P1419, DOI 10.1097/MIB.0000000000000344; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262108	10.1371/journal.pone.0262108	http://dx.doi.org/10.1371/journal.pone.0262108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030192	Green Published, gold			2022-12-26	WOS:000812798500030
J	LaCourse, SM; Seko, E; Wood, R; Bundi, W; Ouma, GS; Agaya, J; Richardson, BA; John-Stewart, G; Wandiga, S; Cangelosi, GA				LaCourse, Sylvia M.; Seko, Evans; Wood, Rachel; Bundi, Wilfred; Ouma, Gregory S.; Agaya, Janet; Richardson, Barbra A.; John-Stewart, Grace; Wandiga, Steve; Cangelosi, Gerard A.			Diagnostic performance of oral swabs for non-sputum based TB diagnosis in a TB/HIV endemic setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MTB/RIF ULTRA	Objective We evaluated diagnostic performance of oral swab analysis (OSA) for tuberculosis (TB) in a high HIV/TB burden setting in Kenya. Methods In this cross-sectional study, buccal swabs and sputum were collected from 100 participants with suspected TB in outpatient clinics in Kenya at enrollment and subsequent morning visits. Buccal swabs underwent IS6110-targeted qPCR analysis. Sputum was evaluated by Xpert MTB/RIF (Xpert) and culture. Diagnostic performance of OSA for TB diagnosis was evaluated relative to a combined reference of sputum Xpert and culture. Results Among 100 participants, 54% were living with HIV (PLHIV). Twenty percent (20/100) of participants had confirmed TB (19/20 [95%] culture-positive, 17/20 [85%] Xpert-positive). Overall buccal swab sensitivity was 65.0% (95% CI 40.8-84.6%) vs. sputum Xpert/culture and 76.5% (95% CI 50.1-93.2%) vs. sputum Xpert alone. Specificity was 81.3% (95% CI 71.0-89.1%) and 81.9% (95% CI 72.0-89.5%) compared to sputum Xpert/culture and Xpert alone, respectively. Sensitivity among PLHIV (n = 54) with suspected TB was 83.3% (95% CI 35.9-99.6%) vs. sputum Xpert/culture and 100% (95% CI 47.8-100.0%) vs. sputum Xpert alone. Among participants with TB, mean OSA threshold quantitation cycle (Cq) value was lower (stronger signal) at subsequent morning compared to enrolment visit (33.4 SD 3.7 vs. 35.2 SD +/- 2.9, p = 0.009). Conclusions In this pilot study, results confirm M. tuberculosis DNA is detectable in oral swabs including among PLHIV with fair diagnostic performance. Further work is needed to optimize OSA and evaluate its utility in diverse settings.	[LaCourse, Sylvia M.; John-Stewart, Grace] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [LaCourse, Sylvia M.; Richardson, Barbra A.; John-Stewart, Grace; Cangelosi, Gerard A.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Seko, Evans; Bundi, Wilfred; Ouma, Gregory S.; Agaya, Janet; Wandiga, Steve] Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Wood, Rachel; Cangelosi, Gerard A.] Univ Washington, Dept Environm & Occupat Hlth, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [John-Stewart, Grace; Cangelosi, Gerard A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	LaCourse, SM (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.; LaCourse, SM (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	sylvial2@uw.edu			National Institute of Allergy and Infectious Diseases (NIAID); University of Washington/Fred Hutch Center for AIDS Research (CFAR) [NIH/NIAID K23AI120793]; CFAR New Investigator Award [AI027757]; NIH/NIAID [R01AI139254]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington/Fred Hutch Center for AIDS Research (CFAR); CFAR New Investigator Award; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases (NIAID), and the University of Washington/Fred Hutch Center for AIDS Research (CFAR) (NIH/NIAID K23AI120793 and CFAR New Investigator Award AI027757 to SML, NIH/NIAID R01AI139254 to GAC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the design, collection of data, data analysis, and interpretation or decision to submit the manuscript to this journal.	[Anonymous], 2011, GUID INT TUB CAS FIN; Datta S, 2017, LANCET GLOB HEALTH, V5, pE760, DOI 10.1016/S2214-109X(17)30201-2; Denkinger CM, 2015, J INFECT DIS, V211, pS29, DOI 10.1093/infdis/jiu821; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Horne DJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub4; Joint United Nations Programme on HIV/AIDS, 2015, GLOBAL REPORT UNAIDS; Kenya Ministry of Health, KEN TUB SURV 2017; Lima F, 2020, J CLIN TUBER OTH MYC, V19, DOI 10.1016/j.jctube.2020.100148; Luabeya AK, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01847-18; Modi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167685; Nicol MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47302-5; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Song YH, 2021, INFECT DRUG RESIST, V14, P89, DOI 10.2147/IDR.S284157; Wood RC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251422; Wood RC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08668; World Health Organization, 2021, 10 THREATS GLOB HLTH; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262123	10.1371/journal.pone.0262123	http://dx.doi.org/10.1371/journal.pone.0262123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025930	Green Published, gold			2022-12-26	WOS:000796264200047
J	Carrignon, S; Bentley, RA; Silk, M; Fefferman, NH				Carrignon, Simon; Bentley, R. Alexander; Silk, Matthew; Fefferman, Nina H.			How social learning shapes the efficacy of preventative health behaviors in an outbreak	PLOS ONE			English	Article							DISCRETE-CHOICE; BINARY CHOICE; DIFFUSION; IDENTIFICATION; PERSISTENCE; KNOWLEDGE; NETWORKS; COVID-19; INSIGHTS; MODELS	The global pandemic of COVID-19 revealed the dynamic heterogeneity in how individuals respond to infection risks, government orders, and community-specific social norms. Here we demonstrate how both individual observation and social learning are likely to shape behavioral, and therefore epidemiological, dynamics over time. Efforts to delay and reduce infections can compromise their own success, especially when disease risk and social learning interact within sub-populations, as when people observe others who are (a) infected and/or (b) socially distancing to protect themselves from infection. Simulating socially-learning agents who observe effects of a contagious virus, our modelling results are consistent with with 2020 data on mask-wearing in the U.S. and also concur with general observations of cohort induced differences in reactions to public health recommendations. We show how shifting reliance on types of learning affect the course of an outbreak, and could therefore factor into policy-based interventions incorporating age-based cohort differences in response behavior.	[Carrignon, Simon; Bentley, R. Alexander] Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA; [Carrignon, Simon; Bentley, R. Alexander] Univ Tennessee, Ctr Dynam Social Complex DySoC, Knoxville, TN 37996 USA; [Silk, Matthew] Univ Exeter, Ctr Ecol & Conservat, Exeter, Devon, England; [Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Fefferman, Nina H.] Univ Tennessee, Dept Math, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Exeter; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Carrignon, S (corresponding author), Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA.; Carrignon, S (corresponding author), Univ Tennessee, Ctr Dynam Social Complex DySoC, Knoxville, TN 37996 USA.	scarrign@utk.edu	Bentley, R Alexander/GWZ-8982-2022	Bentley, R. Alexander/0000-0001-9086-2197; Carrignon, Simon/0000-0002-4416-1389; Silk, Matthew/0000-0002-8318-5383	NSF [2028710]	NSF(National Science Foundation (NSF))	This material is based upon work supported by the NSF under award #2028710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcidiacono P, 2011, ANNU REV ECON, V3, P363, DOI 10.1146/annurev-economics-111809-125038; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Bansal Shweta, 2010, Journal of Biological Dynamics, V4, P478, DOI 10.1080/17513758.2010.503376; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Becker J, 2017, P NATL ACAD SCI USA, V114, pE5070, DOI 10.1073/pnas.1615978114; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Bentley A, 2011, SIMPLICITY-DES TECHN, P1; Bentley RA, 2014, BEHAV BRAIN SCI, V37, P63, DOI 10.1017/S0140525X13000289; Blume LE, 2015, J POLIT ECON, V123, P444, DOI 10.1086/679496; Brock W.A., 2001, HDB ECONOMETRICS, V5, P3297, DOI DOI 10.1016/S1573-4412(01)05007-3; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; Brock WA, 2007, J ECONOMETRICS, V140, P52, DOI 10.1016/j.jeconom.2006.09.002; Brock WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111022; Caiado CCS, 2016, J THEOR BIOL, V405, P5, DOI 10.1016/j.jtbi.2015.12.013; Centola D, 2013, CIRCULATION, V127, P2135, DOI 10.1161/CIRCULATIONAHA.112.101816; Cheung BY, 2011, PSYCHOL SCI, V22, P147, DOI 10.1177/0956797610394661; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Donker T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000715; E.Bendavid, 2020, medRxiv, DOI 10.1101/2020.05.23.20111419; Fineberg HV, 2013, JAMA-J AM MED ASSOC, V310, P85, DOI 10.1001/jama.2013.7518; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gharzai LA, 2020, ADV RADIAT ONCOL, V5, P679, DOI 10.1016/j.adro.2020.04.009; Gibson MA, 2015, EVOL ANTHROPOL, V24, P3, DOI 10.1002/evan.21432; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Greene H., 2003, ECONOMETRIC ANAL; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; Guiteras R, 2015, SCIENCE, V348, P903, DOI 10.1126/science.aaa0491; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Henrich J, 2001, AM ANTHROPOL, V103, P992, DOI 10.1525/aa.2001.103.4.992; Hogset H, 2010, ECON DEV CULT CHANGE, V58, P563, DOI 10.1086/650424; Hoppitt W., 2013, SOCIAL LEARNING INTR, DOI DOI 10.23943/PRINCETON/9780691150703.001.0001/UPSO-9780691150703; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; Hyndman RJ, 1996, AM STAT, V50, P120, DOI 10.2307/2684423; Inglehart RF, 2008, WEST EUR POLIT, V31, P130, DOI 10.1080/01402380701834747; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Jennings MK, 1996, PUBLIC OPIN QUART, V60, P228, DOI 10.1086/297749; Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154; KEINAN G, 1987, J PERS SOC PSYCHOL, V52, P639, DOI 10.1037/0022-3514.52.3.639; Kendal RL, 2018, TRENDS COGN SCI, V22, P651, DOI 10.1016/j.tics.2018.04.003; Knoll LJ, 2017, J ADOLESCENCE, V60, P53, DOI 10.1016/j.adolescence.2017.07.002; Kronbichler A, 2020, INT J INFECT DIS, V98, P180, DOI 10.1016/j.ijid.2020.06.052; Lavela Sherri L, 2012, Top Spinal Cord Inj Rehabil, V18, P306, DOI 10.1310/sci1804-306; Lerman K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147617; Li J, 2009, J APPL ECONOMET, V24, P257, DOI 10.1002/jae.1035; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Maharaj S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-679; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Marchant R, 2020, ARXIV PREPRINT ARXIV; McAdams D, 2021, ANNU REV ECON, V13, P539, DOI 10.1146/annurev-economics-082120-122900; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1023/A:1009905800005; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Miller D., 1992, BUS HORIZONS, V35, P24, DOI 10.1016/0007-6813(92)90112-M; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Pedro SA, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.574514; R Development Core Team, 2018, LANG ENV STAT COMP; Rendell L, 2011, PHILOS T R SOC B, V366, P1118, DOI 10.1098/rstb.2010.0376; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rogers E.M., 1995, DIFFUSION INNOVATION, V4th ed.; Ruck DJ, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.190725; Ruck DJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8680; Ruck DJ, 2021, EARLY WARNING VULNER; Russell Timothy W, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.12.2000256; Sanger-Katz, 2020, NEW YORK TIMES; Schrock JM, 2020, EVOL HUM BEHAV, V41, P44, DOI 10.1016/j.evolhumbehav.2019.09.002; Sears DO, 1999, J POLIT, V61, P1, DOI 10.2307/2647773; Surian D, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6045; Tizzoni M, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007633, 10.1371/journal.pcbi.1007633.r001, 10.1371/journal.pcbi.1007633.r002, 10.1371/journal.pcbi.1007633.r003, 10.1371/journal.pcbi.1007633.r004]; Toxvaerd F., 2020, CAMBRIDGE WORKING PA, DOI DOI 10.17863/CAM.52489; Trueblood J., 2020, TALE 2 CRISES FINANC; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Weaver JB, 2010, AM J PUBLIC HEALTH, V100, P1520, DOI 10.2105/AJPH.2009.180521; Weitz JS, 2020, P NATL ACAD SCI USA, V117, P32764, DOI 10.1073/pnas.2009911117; Weng LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02522; World Health Organization, 2020, 64 WHO; Yamey G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1643; Young HP, 2009, AM ECON REV, V99, P1899, DOI 10.1257/aer.99.5.1899; Zhang JW, 2019, ANNU REV SOCIOL, V45, P91, DOI 10.1146/annurev-soc-073117-041421	83	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262505	10.1371/journal.pone.0262505	http://dx.doi.org/10.1371/journal.pone.0262505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015794	gold, Green Published			2022-12-26	WOS:000814820600029
J	Maruyama, M; Furukawa, Y; Kinoshita, M; Mukaiyama, A; Akiyama, S; Yoshimura, T				Maruyama, Michiyo; Furukawa, Yuko; Kinoshita, Masato; Mukaiyama, Atsushi; Akiyama, Shuji; Yoshimura, Takashi			Adenylate kinase 1 overexpression increases locomotor activity in medaka fish	PLOS ONE			English	Article							EXPRESSION; HEART	Maintenance of the energy balance is indispensable for cell survival and function. Adenylate kinase (Ak) is a ubiquitous enzyme highly conserved among many organisms. Ak plays an essential role in energy regulation by maintaining adenine nucleotide homeostasis in cells. However, its role at the whole organism level, especially in animal behavior, remains unclear. Here, we established a model using medaka fish (Oryzias latipes) to examine the function of Ak in environmental adaptation. Medaka overexpressing the major Ak isoform Ak1 exhibited increased locomotor activity compared to that of the wild type. Interestingly, this increase was temperature dependent. Our findings suggest that cellular energy balance can modulate locomotor activity.	[Maruyama, Michiyo; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Integrat Physiol, Nagoya, Aichi, Japan; [Maruyama, Michiyo; Furukawa, Yuko; Yoshimura, Takashi] Nagoya Univ, Inst Transformat BioMol WPI ITbM, Nagoya, Aichi, Japan; [Kinoshita, Masato] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto, Japan; [Mukaiyama, Atsushi; Akiyama, Shuji] Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, Okazaki, Aichi, Japan; [Mukaiyama, Atsushi; Akiyama, Shuji] SOKENDAI Grad Univ Adv Studies, Dept Funct Mol Sci, Okazaki, Aichi, Japan	Nagoya University; Nagoya University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Integrat Physiol, Nagoya, Aichi, Japan.; Yoshimura, T (corresponding author), Nagoya Univ, Inst Transformat BioMol WPI ITbM, Nagoya, Aichi, Japan.	takashiy@agr.nagoya-u.ac.jp		Maruyama, Michiyo/0000-0002-8821-5756; Mukaiyama, Atsushi/0000-0002-6736-631X; AKIYAMA, Shuji/0000-0002-7184-189X	JSPS KAKENHI [19H05643]; Sasakawa Scientific Research Grant from The Japan Science Society	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sasakawa Scientific Research Grant from The Japan Science Society	This work was supported by a JSPS KAKENHI "Grant-in-Aid for Scientific Research (S)" (19H05643) for T.Y. and the Sasakawa Scientific Research Grant from The Japan Science Society for M.M. There was no additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaszczyk JW., 2020, METABOLITES, P1, DOI [10.3390/metabo11010001, DOI 10.3390/METABO11010001]; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200; Fontinha BM, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001012; Fukamachi S, 2009, GENE, V442, P81, DOI 10.1016/j.gene.2009.04.010; Horiguchi T, 2020, J MED INVESTIG, V67, P51, DOI 10.2152/jmi.67.51; Ionescu MI, 2019, PROTEIN J, V38, P120, DOI 10.1007/s10930-019-09811-0; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Klepinin A, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00660; Nakayama T, 2020, P NATL ACAD SCI USA, V117, P9594, DOI 10.1073/pnas.2000278117; Nakayama T, 2019, NAT ECOL EVOL, V3, P845, DOI 10.1038/s41559-019-0866-6; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; Panayiotou C, 2014, INT J BIOCHEM CELL B, V49, P75, DOI 10.1016/j.biocel.2014.01.014; Pucar D, 2000, J BIOL CHEM, V275, P41424, DOI 10.1074/jbc.M007903200; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Xie MY, 2020, BIOL REPROD, V103, P1121, DOI 10.1093/biolre/ioaa134	20	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0257967	10.1371/journal.pone.0257967	http://dx.doi.org/10.1371/journal.pone.0257967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982774	Green Submitted, gold, Green Published			2022-12-26	WOS:000834805700001
J	Young-Xu, Y; Smith, J; Nealon, J; Mahmud, SM; Van Aalst, R; Thommes, EW; Neupane, N; Lee, JKH; Chit, A				Young-Xu, Yinong; Smith, Jeremy; Nealon, Joshua; Mahmud, Salaheddin M.; Van Aalst, Robertus; Thommes, Edward W.; Neupane, Nabin; Lee, Jason K. H.; Chit, Ayman			Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans	PLOS ONE			English	Article							MORTALITY BENEFITS; PEOPLE; RISK; HOSPITALIZATIONS	Background Prior studies have established those elderly patients with chronic obstructive pulmonary disease (COPD) are at elevated risk for developing influenza-associated complications such as hospitalization, intensive-care admission, and death. This study sought to determine whether influenza vaccination could improve survival among elderly patients with COPD. Materials/Methods This study included Veterans (age >= 65 years) diagnosed with COPD that received care at the United States Veterans Health Administration (VHA) during four influenza seasons, from 2012-2013 to 2015-2016. We linked VHA electronic medical records and Medicare administrative files to Centers for Disease Control and Prevention National Death Index cause of death records as well as influenza surveillance data. A multivariable time-dependent Cox proportional hazards model was used to compare rates of mortality of recipients of influenza vaccination to those who did not have records of influenza vaccination. We estimated hazard ratios (HRs) adjusted for age, gender, race, socioeconomic status, comorbidities, and healthcare utilization. Results Over a span of four influenza seasons, we included 1,856,970 person-seasons of observation where 1,199,275 (65%) had a record of influenza vaccination and 657,695 (35%) did not have a record of influenza vaccination. After adjusting for comorbidities, demographic and socioeconomic characteristics, influenza vaccination was associated with reduced risk of death during the most severe periods of influenza seasons: 75% all-cause (HR = 0.25; 95% CI: 0.24-0.26), 76% respiratory causes (HR = 0.24; 95% CI: 0.21-0.26), and 82% pneumonia/influenza cause (HR = 0.18; 95% CI: 0.13-0.26). A significant part of the effect could be attributed to "healthy vaccinee" bias as reduced risk of mortality was also found during the periods when there was no influenza activity and before patients received vaccination: 30% all-cause (HR = 0.70; 95% CI: 0.65-0.75), 32% respiratory causes (HR = 0.68; 95% CI: 0.60-0.78), and 51% pneumonia/influenza cause (HR = 0.49; 95% CI: 0.31-0.78). However, as a falsification study, we found that influenza vaccination had no impact on hospitalization due to urinary tract infection (HR = 0.97; 95% CI: 0.80-1.18). Conclusions Among elderly patients with COPD, influenza vaccination was associated with reduced risk for all-cause and cause-specific mortality.	[Young-Xu, Yinong; Smith, Jeremy; Neupane, Nabin] Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA; [Young-Xu, Yinong] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH 03755 USA; [Nealon, Joshua] Sanofi Pasteur, Med Evidence Generat, Lyon, France; [Mahmud, Salaheddin M.] Univ Manitoba, Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Van Aalst, Robertus] Univ Groningen, Fac Med Sci, Groningen, Netherlands; [Van Aalst, Robertus; Thommes, Edward W.; Chit, Ayman] Sanofi Pasteur, Swiftwater, PA USA; [Thommes, Edward W.] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada; [Lee, Jason K. H.; Chit, Ayman] Univ Toronto, Leslie & Sch Pharm, Toronto, ON, Canada; [Lee, Jason K. H.] Sanofi Pasteur, Toronto, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; Sanofi-Aventis; Sanofi France; University of Manitoba; University of Groningen; Sanofi-Aventis; University of Guelph; University of Toronto; Sanofi-Aventis	Young-Xu, Y (corresponding author), Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA.; Young-Xu, Y (corresponding author), Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH 03755 USA.	Yinong.Young-Xu@va.gov		Lee, Jason/0000-0001-8875-607X; van Aalst, Robertus/0000-0003-3025-7811	Sanofi Pasteur	Sanofi Pasteur	Funding Statement: YYX, JS, and NN report having received grant funds from Sanofi Pasteur that were awarded to the Veterans Education and Research Association of Northern New England Inc. The funder provided support in the form of salaries for authors JN, RVA, EWT, JKL, and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], OV INFL SURV US; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Campitelli MA, 2010, VACCINE, V29, P240, DOI 10.1016/j.vaccine.2010.10.049; cdc.gov, US; cms.gov, **DROPPED REF**; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; healthquality.va.gov, **DROPPED REF**; Huang HH, 2019, J MICROBIOL IMMUNOL, V52, P22, DOI 10.1016/j.jmii.2017.08.014; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Man William D-C, 2015, ERJ Open Res, V1; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Mulpuru S, 2019, CHEST, V155, P69, DOI 10.1016/j.chest.2018.10.044; National Center for Health Statistics, 2013, NAT DEATH IND US GUI; Olubowale OT, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004966; Petersen LA, 2010, HEALTH SERV RES, V45, P762, DOI 10.1111/j.1475-6773.2010.01107.x; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Simonsen L, 2009, VACCINE, V27, P6300, DOI 10.1016/j.vaccine.2009.07.008; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; va.gov, **DROPPED REF**; World Health Organization, 2017, VACCINES BIOL; World Health Organization, 2003, 56 WORLD HLTH ASS RE; Young-Xu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169344	27	0	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262072	10.1371/journal.pone.0262072	http://dx.doi.org/10.1371/journal.pone.0262072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982781	gold, Green Published			2022-12-26	WOS:000834805700015
J	Zawadzka, A; Janczewska, A; Kobus-Cisowska, J; Dziedzinski, M; Siwulski, M; Czarniecka-Skubina, E; Stuper-Szablewska, K				Zawadzka, Agnieszka; Janczewska, Anna; Kobus-Cisowska, Joanna; Dziedzinski, Marcin; Siwulski, Marek; Czarniecka-Skubina, Ewa; Stuper-Szablewska, Kinga			The effect of light conditions on the content of selected active ingredients in anatomical parts of the oyster mushroom (Pleurotus ostreatus L.)	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; EDIBLE MUSHROOMS; GROWTH	This study aimed to evaluate the effect of cultivation conditions in the context of light on the retention of selected vitamins, minerals and polyphenols in the stem and cap of the oyster mushroom (Pleurotus ostreatus L.). Additionally, the effect of the retention of bioactive components on the antioxidant activity of mushroom extracts was evaluated, taking into account the morphological part. Oyster mushrooms grown in the light of 200 lux had higher riboflavin content compared to mushrooms exposed to the light of lower intensity. The thiamine content of the mushrooms dropped with decreasing light intensity during cultivation. The content of biologically active compounds was found to be equal in the stem and the cap. In the case of riboflavin, it was shown that its contents in cap fractions, irrespective of the cultivation method, was statistically significantly higher than in stems. The mineral composition of caps and stems differed from each other. No differences in Zn and Cu content between the morphological parts of the mushroom studied were found. However, it was shown that the stems, regardless of the type of light, contained less iron, magnesium and sodium. Thus, it was observed that limited light exposure caused an increase in the content of total polyphenolic compounds, which did not correlate with antioxidant activity. There was no effect of the light on the antioxidant activity of mushrooms. It was also shown that stem extracts had higher antioxidant activity compared to the extracts obtained from the caps. This findings point to the possibility and potentail of use both fraction of mushrooms in the new food products development.	[Zawadzka, Agnieszka; Janczewska, Anna; Kobus-Cisowska, Joanna; Dziedzinski, Marcin] Poznan Univ Life Sci, Dept Gastron Sci & Funct Foods, Poznan, Poland; [Siwulski, Marek] Poznan Univ Life Sci, Dept Vegetable Crops, Poznan, Poland; [Czarniecka-Skubina, Ewa] Warsaw Univ Life Sci, Dept Food Gastron & Food Hyg, Warsaw, Poland; [Stuper-Szablewska, Kinga] Poznan Univ Life Sci, Dept Chem, Poznan, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences; Warsaw University of Life Sciences; Poznan University of Life Sciences	Kobus-Cisowska, J (corresponding author), Poznan Univ Life Sci, Dept Gastron Sci & Funct Foods, Poznan, Poland.	joanna.kobus-cisowska@up.poznan.pl	Dziedziński, Marcin/AAK-4211-2020; Czarniecka-Skubina, Ewa/L-8758-2019	Czarniecka-Skubina, Ewa/0000-0001-6557-5436; Dziedzinski, Marcin/0000-0003-1069-0095; Stuper-Szablewska, Kinga/0000-0002-9011-8592	Ministry of Education and Science (MEiN) [DWD/4/44/2020]; Poznan University of Life Sciences (UPP) [DWD/4/44/2020]	Ministry of Education and Science (MEiN); Poznan University of Life Sciences (UPP)	The publication was co-financed within the agreement between Ministry of Education and Science (MEiN) and Poznan University of Life Sciences (UPP), grant number DWD/4/44/2020 from 23.11.2020r. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monem NM, 2020, BIOCHEM BIOPHYS REP, V24, DOI 10.1016/j.bbrep.2020.100852; Augustin J., 2007, BOCZNIAK OSTRYGOWATY, P170; Bernas E, 2006, ACTA SCI POLON-TECHN, V5, P5; Bolaniran Tolulope, 2021, Transactions of the Royal Society of South Africa, V76, DOI 10.1080/0035919X.2021.1947921; Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3; Das AK, 2021, MOLECULES, V26, DOI 10.3390/molecules26092463; Espinosa-Paez E, 2021, LWT-FOOD SCI TECHNOL, V148, DOI 10.1016/j.lwt.2021.111727; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; Fogarasi M, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10121972; Girmay Z, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0265-1; Gonzalez A, 2020, FOOD FUNCT, V11, P7400, DOI 10.1039/d0fo01746a; jun Jang myoung, 2014, [Journal of Mushrooms, 한국버섯학회지], V12, P258, DOI 10.14480/JM.2014.12.4.258; Kobus-Cisowska J, 2020, CIENC RURAL, V50, DOI 10.1590/0103-8478cr20190371; Kulczynski B, 2016, ACTA SCI POLON-TECHN, V15, P267, DOI 10.17306/J.AFS.2016.3.26; Mahari WAW, 2020, J HAZARD MATER, V400, DOI 10.1016/j.jhazmat.2020.123156; Manthou E, 2019, LWT-FOOD SCI TECHNOL, V111, P506, DOI 10.1016/j.lwt.2019.05.062; Muszynska B., 2015, MEDICINA INTERNACIA, V26, P146; Panek M, 2019, MYCOL PROG, V18, P1173, DOI 10.1007/s11557-019-01515-0; Salata A, 2018, ACTA SCI POL-HORTORU, V17, P185, DOI 10.24326/asphc.2018.2.16; Sarikurkcu C, 2008, BIORESOURCE TECHNOL, V99, P6651, DOI 10.1016/j.biortech.2007.11.062; Sarma D., 2018, J PHARMACOGN PHYTOCH, V7, P2694; Wu CY, 2016, INT J MED MUSHROOMS, V18, P589, DOI 10.1615/IntJMedMushrooms.v18.i7.40; YUSEF HM, 1967, MYCOPATH MYCOL APPL, V33, P81, DOI 10.1007/BF02053439; Zhou S, 2016, FUNGAL BIOL-UK, V120, P852, DOI 10.1016/j.funbio.2016.03.007	24	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262279	10.1371/journal.pone.0262279	http://dx.doi.org/10.1371/journal.pone.0262279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982785	Green Published, gold			2022-12-26	WOS:000834805700026
J	Chang, YP; Zhang, B; Du, MF; Geng, ZC; Wei, JZ; Guan, RB; An, SH; Zhao, WL				Chang, Yanpeng; Zhang, Bo; Du, Mengfang; Geng, Zichen; Wei, Jizhen; Guan, Ruobing; An, Shiheng; Zhao, Wenli			The vital hormone 20-hydroxyecdysone controls ATP production by upregulating binding of trehalase 1 with ATP synthase subunit alpha in Helicoverpa armigera	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; DEVELOPING OVARIES; MIDGUT; BIOSYNTHESIS; SILKWORM; INSECT; METAMORPHOSIS; LOCALIZATION; PURIFICATION; METABOLISM	Trehalose is the major "blood sugar" of insects and it plays a crucial role in energy supply and as a stress protectant. The hydrolysis of trehalose occurs only under the enzymatic control of trehalase (Treh), which plays important roles in growth and development, energy supply, chitin biosynthesis, and abiotic stress responses. Previous reports have revealed that the vital hormone 20-hydroxyecdysone (20E) regulates Treh, but the detailed mechanism underlying 20E regulating Treh remains unclear. In this study, we investigated the function of HaTreh1 in Helicoverpa armigera larvae. The results showed that the transcript levels and enzymatic activity of HaTreh1 were elevated during molting and metamorphosis stages in the epidermis, midgut, and fat body, and that 20E upregulated the transcript levels of HaTreh1 through the classical nuclear receptor complex EcR-B1/USP1. HaTreh1 is a mitochondria protein. We also found that knockdown of HaTreh1 in the fifth- or sixth-instar larvae resulted in weight loss and and glutathione-S-transferase (GST) pull-down experiments demonstrated that HaTreh1 bound with ATP synthase subunit alpha (HaATPs-alpha) and that this binding increased under 20E treatment. In addition, 20E enhanced the transcript level of HaATPs-alpha and ATP content. Finally, the knockdown of HaTreh1 or HaATPs-alpha decreased the induction effect of 20E on ATP content. Altogether, these findings demonstrate that 20E controls ATP production by up-regulating the binding of HaTreh1 to HaATPs-alpha in H. armigera.	[Chang, Yanpeng; Zhang, Bo; Du, Mengfang; Geng, Zichen; Wei, Jizhen; Guan, Ruobing; An, Shiheng; Zhao, Wenli] Henan Agr Univ, Coll Plant Protect, State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China	Henan Agricultural University	Zhao, WL (corresponding author), Henan Agr Univ, Coll Plant Protect, State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China.	zhaowenli19900218@163.com		Zhao, Wenli/0000-0002-8658-817X	National Natural Science Foundation of China [31772536, 31970472]; National Science Fund of Henan Province for Distinguished Young Scholar [202300410191]; Basic Research Project of the Key Scientific Research Projects of Universities in Henan Province [21zx013]; Henan Agricultural Research System [S2014-11-G06]; Key Scientific Research Projects of Universities in Henan Province [22A210005]; Henan Youth Talent Support Project [2022HYTP030]; Natural Science Youth Innovation Fund of Henan Agricultural University [KJCX2018A02, KJCX2017A10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund of Henan Province for Distinguished Young Scholar; Basic Research Project of the Key Scientific Research Projects of Universities in Henan Province; Henan Agricultural Research System; Key Scientific Research Projects of Universities in Henan Province; Henan Youth Talent Support Project; Natural Science Youth Innovation Fund of Henan Agricultural University	The work was supported by National Natural Science Foundation of China (31772536 and 31970472), National Science Fund of Henan Province for Distinguished Young Scholar (202300410191), Basic Research Project of the Key Scientific Research Projects of Universities in Henan Province (21zx013), Henan Agricultural Research System (Grant S2014-11-G06), Key Scientific Research Projects of Universities in Henan Province (22A210005), Henan Youth Talent Support Project (2022HYTP030), and Natural Science Youth Innovation Fund of Henan Agricultural University (KJCX2018A02 and KJCX2017A10).	Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRANDT NR, 1979, CAN J BIOCHEM CELL B, V57, P145, DOI 10.1139/o79-018; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; Cai MJ, 2012, APOPTOSIS, V17, P1327, DOI 10.1007/s10495-012-0761-y; CANDY DJ, 1961, BIOCHEM J, V78, P531, DOI 10.1042/bj0780531; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; CHANG PL, 1975, J HISTOCHEM CYTOCHEM, V23, P800, DOI 10.1177/23.11.1194670; Chen CH, 2017, P NATL ACAD SCI USA, V114, pE7121, DOI 10.1073/pnas.1704999114; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; Denton D, 2012, CELL DEATH DIFFER, V19, P1299, DOI 10.1038/cdd.2012.43; Du MF, 2012, J INSECT PHYSIOL, V58, P699, DOI 10.1016/j.jinsphys.2012.02.002; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Frison M, 2007, FEBS LETT, V581, P4010, DOI 10.1016/j.febslet.2007.07.036; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Gu JH, 2009, J INSECT PHYSIOL, V55, P997, DOI 10.1016/j.jinsphys.2009.07.003; Hu J, 2016, PEST MANAG SCI, V72, P1433, DOI 10.1002/ps.4185; Huang Junyi, 2006, Journal of Insect Biotechnology and Sericology, V75, P1; Kamei Y, 2011, J INSECT PHYSIOL, V57, P608, DOI 10.1016/j.jinsphys.2010.10.001; Kang XL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008331; Kh S. D., 2021, COMP BIOCHEM PHYS B, V255; Kozlova T, 2000, TRENDS ENDOCRIN MET, V11, P276, DOI 10.1016/S1043-2760(00)00282-4; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; Lam CK, 2013, CIRC RES, V112, P79, DOI 10.1161/CIRCRESAHA.112.279935; Li Juan, 2014, Acta Entomologica Sinica, V57, P1155; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Li YN, 2020, J INSECT SCI, V20, DOI 10.1093/jisesa/ieaa108; Matassini C, 2020, MOLECULES, V25, DOI 10.3390/molecules25133013; Mitsumasu K, 2008, ZOOL SCI, V25, P693, DOI 10.2108/zsj.25.693; OGISO M, 1984, GEN COMP ENDOCR, V55, P387, DOI 10.1016/0016-6480(84)90008-X; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; REED W D, 1971, Archives of Biochemistry and Biophysics, V145, P392, DOI 10.1016/0003-9861(71)90052-X; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Shi JF, 2016, INSECT BIOCHEM MOLEC, V77, P52, DOI 10.1016/j.ibmb.2016.07.012; SHIMADA S, 1979, J COMP PHYSIOL, V131, P333, DOI 10.1007/BF00688808; Silva MCP, 2009, INSECT MOL BIOL, V18, P769, DOI 10.1111/j.1365-2583.2009.00920.x; Singtripop T, 2000, INSECT BIOCHEM MOLEC, V30, P847, DOI 10.1016/S0965-1748(00)00057-6; STRANG RHC, 1980, INSECT BIOCHEM, V10, P155, DOI 10.1016/0020-1790(80)90067-0; TAKIGUCHI M, 1992, BIOCHEM J, V288, P19, DOI 10.1042/bj2880019; Tan YA, 2014, ARCH INSECT BIOCHEM, V86, P107, DOI 10.1002/arch.21166; Tang B, 2017, PESTIC BIOCHEM PHYS, V137, P81, DOI 10.1016/j.pestbp.2016.10.003; Tang B, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0297-2; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; VALAITIS AP, 1993, INSECT BIOCHEM MOLEC, V23, P599, DOI 10.1016/0965-1748(93)90033-O; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Wang K, 2020, PLANT MOL BIOL, V102, P589, DOI 10.1007/s11103-020-00965-5; Wegener G, 2003, J EXP BIOL, V206, P1233, DOI 10.1242/jeb.00217; Wei JZ, 2018, INSECT SCI, V25, P655, DOI 10.1111/1744-7917.12451; Zhang L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00750; Zhao XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35204; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	57	1	1	5	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101565	10.1016/j.jbc.2022.101565	http://dx.doi.org/10.1016/j.jbc.2022.101565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	34999119	gold, Green Published			2022-12-26	WOS:000761371500009
J	Biehl, LM; Farowski, F; Hilpert, C; Nowag, A; Kretzschmar, A; Jazmati, N; Tsakmaklis, A; Wieters, I; Khodamoradi, Y; Wisplinghoff, H; Vehreschild, MJGT				Biehl, Lena M.; Farowski, Fedja; Hilpert, Catharina; Nowag, Angela; Kretzschmar, Anne; Jazmati, Nathalie; Tsakmaklis, Anastasia; Wieters, Imke; Khodamoradi, Yascha; Wisplinghoff, Hilmar; Vehreschild, Maria J. G. T.			Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot study	PLOS ONE			English	Article							BACTERIA; CULTURE	Background The understanding of longitudinal changes in the urinary microbiota of healthy women and its relation to intestinal microbiota is limited. Methods From a cohort of 15 premenopausal women without known urogenital disease or current symptoms, we collected catheter urine (CU), vaginal and periurethral swabs, and fecal samples on four visits over six months. Additionally, ten participants provided CU and midstream urine (MU) to assess comparability. Urine was subjected to expanded culture. 16S rRNA gene sequencing was performed on all urine, fecal, and selected vaginal and periurethral samples. Sequence reads were processed (DADA2 pipeline) and analyzed using QIIME 2 and R. Results Relative abundances of urinary microbiota were variable over 6-18 months. The degree of intraindividual variability of urinary microbiota was higher than that found in fecal samples. Still, nearly half of the observed beta diversity of all urine samples could be attributed to differences between volunteers (R-2 = 0.48, p = 0.001). After stratification by volunteer, time since last sexual intercourse was shown to be a factor significantly contributing to beta diversity (R-2 = 0.14, p = 0.001). We observed a close relatedness of urogenital microbial habitats and a clear distinction from intestinal microbiota in the overall betadiversity analysis. Microbiota compositions derived from MU differed only slightly from CU compositions. Within this analysis of low-biomass samples, we identified contaminating sequences potentially stemming from sequencing reagents. Conclusions Results from our longitudinal cohort study confirmed the presence of a rather variable individual urinary microbiota in premenopausal women. These findings from catheter urine complement previous observations on temporal dynamics in voided urine. The higher intraindividual variability of urinary microbiota as compared to fecal microbiota will be a challenge for future studies investigating associations with urogenital diseases and aiming at identifying pathogenic microbiota signatures.	[Biehl, Lena M.; Farowski, Fedja; Hilpert, Catharina; Tsakmaklis, Anastasia; Vehreschild, Maria J. G. T.] Univ Cologne, Fac Med, Cologne, Germany; [Biehl, Lena M.; Farowski, Fedja; Hilpert, Catharina; Tsakmaklis, Anastasia; Vehreschild, Maria J. G. T.] Univ Cologne, Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Biehl, Lena M.; Farowski, Fedja; Vehreschild, Maria J. G. T.] German Ctr Infect Res, Bonn, Germany; [Farowski, Fedja; Wieters, Imke; Khodamoradi, Yascha; Vehreschild, Maria J. G. T.] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Internal Med, Infect Dis, Frankfurt, Germany; [Nowag, Angela; Kretzschmar, Anne; Jazmati, Nathalie; Wisplinghoff, Hilmar] Wisplinghoff Labs, Cologne, Germany; [Nowag, Angela; Jazmati, Nathalie; Wisplinghoff, Hilmar] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Wisplinghoff, Hilmar] Witten Herdecke Univ, Inst Virol & Med Microbiol, Witten, Germany	University of Cologne; University of Cologne; German Center for Infection Research; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Cologne	Vehreschild, MJGT (corresponding author), Univ Cologne, Fac Med, Cologne, Germany.; Vehreschild, MJGT (corresponding author), Univ Cologne, Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany.; Vehreschild, MJGT (corresponding author), German Ctr Infect Res, Bonn, Germany.; Vehreschild, MJGT (corresponding author), Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Internal Med, Infect Dis, Frankfurt, Germany.	maria.vehreschild@kgu.de	Vehreschild, Maria/HGB-6948-2022	Biehl, Lena/0000-0001-7613-8119; Khodamoradi, Yascha/0000-0001-5972-0967	German Research Foundation [BI 1899/1-1]	German Research Foundation(German Research Foundation (DFG))	This study was supported by a study grant from the German Research Foundation (DFG -https://www.dfg.de/), grant number BI 1899/1-1, awarded to Lena M. Biehl. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammitzboll N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81790-8; Anderson M, 2004, J CLIN MICROBIOL, V42, P753, DOI 10.1128/JCM.42.2.753-758.2004; Bajic P, 2020, EUR UROL FOCUS, V6, P376, DOI 10.1016/j.euf.2018.08.001; Bao YG, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.14; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Burnett LA, 2021, NEUROUROL URODYNAM, V40, P1479, DOI 10.1002/nau.24707; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chen YB, 2020, J UROLOGY, V204, P303, DOI 10.1097/JU.0000000000000910; Faria MMP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0557-7; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Gottschick C, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0305-3; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Hooton TM, 2013, NEW ENGL J MED, V369, P1883, DOI 10.1056/NEJMoa1302186; Illumina, 2016, TRUSIGHT CARD SEQ KI; Karstens L, 2018, NAT REV UROL, V15, P735, DOI 10.1038/s41585-018-0104-z; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Komesu YM, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.08.011; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Magruder M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13467-w; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morand A, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00675-18; Mueller ER, 2017, CURR OPIN UROL, V27, P282, DOI 10.1097/MOU.0000000000000396; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Perez-Carrasco V, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.617002; Popovic VB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29054-w; Price TK, 2020, BJOG-INT J OBSTET GY, V127, P193, DOI 10.1111/1471-0528.15920; Price TK, 2020, MBIO, V11, DOI 10.1128/mBio.00475-20; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2020, R LANG ENV STAT COMP; Siddiqui H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-244; Thomas-White K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03968-5; Vaughan MH, 2021, J UROLOGY, V206, P1222, DOI 10.1097/JU.0000000000001940; Whiteside SA, 2015, NAT REV UROL, V12, P81, DOI 10.1038/nrurol.2014.361; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262095	10.1371/journal.pone.0262095	http://dx.doi.org/10.1371/journal.pone.0262095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030190	gold, Green Published			2022-12-26	WOS:000812798500029
J	Mohamed, EA; Rashed, EA; Gaber, T; Karam, O				Mohamed, Esraa A.; Rashed, Essam A.; Gaber, Tarek; Karam, Omar			Deep learning model for fully automated breast cancer detection system from thermograms	PLOS ONE			English	Article								Breast cancer is one of the most common diseases among women worldwide. It is considered one of the leading causes of death among women. Therefore, early detection is necessary to save lives. Thermography imaging is an effective diagnostic technique which is used for breast cancer detection with the help of infrared technology. In this paper, we propose a fully automatic breast cancer detection system. First, U-Net network is used to automatically extract and isolate the breast area from the rest of the body which behaves as noise during the breast cancer detection model. Second, we propose a two-class deep learning model, which is trained from scratch for the classification of normal and abnormal breast tissues from thermal images. Also, it is used to extract more characteristics from the dataset that is helpful in training the network and improve the efficiency of the classification process. The proposed system is evaluated using real data (A benchmark, database (DMR-IR)) and achieved accuracy = 99.33%, sensitivity = 100% and specificity = 98.67%. The proposed system is expected to be a helpful tool for physicians in clinical use.	[Mohamed, Esraa A.; Rashed, Essam A.] Suez Canal Univ, Fac Sci, Dept Math, Ismailia, Egypt; [Rashed, Essam A.] Nagoya Inst Technol, Dept Elect & Mech Engn, Nagoya, Aichi, Japan; [Gaber, Tarek] Univ Salford, Sch Sci Engn & Environm, Manchester, Lancs, England; [Gaber, Tarek] Suez Canal Univ, Fac Comp & Informat, Ismailia, Egypt; [Karam, Omar] British Univ Egypt BUE, Fac Informat & Comp Sci, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Nagoya Institute of Technology; University of Salford; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); British University in Egypt	Gaber, T (corresponding author), Univ Salford, Sch Sci Engn & Environm, Manchester, Lancs, England.; Gaber, T (corresponding author), Suez Canal Univ, Fac Comp & Informat, Ismailia, Egypt.	t.m.a.gaber@salford.ac.uk	Karam, Oliver/N-6216-2014; Rashed, Essam A./F-4320-2012; Gaber, Tarek/B-9472-2011	Karam, Oliver/0000-0001-6606-1736; Rashed, Essam A./0000-0001-6571-9807; Gaber, Tarek/0000-0003-4065-4191				Abdel-Nasser M, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8010100; AlFayez F, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10020551; Ali MAS, 2015, ACSIS-ANN COMPUT SCI, V5, P255, DOI 10.15439/2015F318; Araujo MC, 2014, EXPERT SYST APPL, V41, P6728, DOI 10.1016/j.eswa.2014.04.027; Figueiredo AAA, 2019, COMPUT METH PROG BIO, V172, P65, DOI 10.1016/j.cmpb.2019.02.004; Cabioglu C, 2020, 8 INT WORK C BIOINFO; Cuevas A, 2004, COMPUT STAT DATA AN, V47, P111, DOI 10.1016/j.csda.2003.10.021; de Freitas Barbosa V.A., 2020, DEEP LEARNING DATA A, P99; Dey N, 2021, P INT C DATA SCI APP; Dongola N, 2018, MEDSCAPE; Ekici S, 2020, MED HYPOTHESES, V137, DOI 10.1016/j.mehy.2019.109542; Fernandes SL, 2019, IEEE CONSUM ELECTR M, V8, P31, DOI 10.1109/MCE.2019.2923926; Francis SV, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0023-3; Gaber T, 2003, IEEE COMP SOC 7 IT C; Gaber T, 2015, IEEE ENG MED BIO, P4254, DOI 10.1109/EMBC.2015.7319334; Globocan, 2019, ALL CANC; Hankare P., 2016, INT RES J ENG TECHNO, P1061; Hossam A., 2018, J ENG SCI, V46, P12, DOI 10.21608/jesaun.2017.114377; Irfan R, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11071212; Kingma DP., 2014, ADAM METHOD STOCHAST; Kundu R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256630; Loberg M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0525-z; Mahmoudzadeh E, 2015, INFRARED PHYS TECHN, V72, P19, DOI 10.1016/j.infrared.2015.06.012; Mambou SJ, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18092799; Milosevic M, 2014, EXCLI J, V13, P1204; Pramanik S, 2015, 2015 INTERNATIONAL SYMPOSIUM ON ADVANCED COMPUTING AND COMMUNICATION (ISACC), P205, DOI 10.1109/ISACC.2015.7377343; Rajinikanth V., 2021, P 2021 IEEE 7 INT C, DOI [10.1109/ICBSII51839.2021.9445166, DOI 10.1109/ICBSII51839.2021.9445166]; Rajinikanth V., 2021, P 2021 7 INT C BIOSI, P1, DOI [10.1109/icbsii51839.2021.9445134, DOI 10.1109/ICBSII51839.2021.9445134]; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Ruder S., 2017, ARXIV; Santana Maíra Araújo de, 2018, Res. Biomed. Eng., V34, P45, DOI 10.1590/2446-4740.05217; Schaul T., 2012, ARXIV12061106V2; Silva LF, 2014, J MED IMAG HEALTH IN, V4, P92, DOI 10.1166/jmihi.2014.1226; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Tahoun M, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10238422; Tong GF, 2018, OPTIK, V174, P460, DOI 10.1016/j.ijleo.2018.08.086; Walker D., 2012, NATURAL MED J; Wehle H., 2007, MACHINE LEARNING DEE; Yao XL, 2014, ASIAN BIOMED, V8, P11, DOI 10.5372/1905-7415.0801.257; Zejmo M, 2017, J PHYS CONF SER, V783, DOI 10.1088/1742-6596/783/1/012060; Zuluaga-Gomez J., 2019, Journal of Medical Engineering & Technology, V43, DOI 10.1080/03091902.2019.1664672; Zuluaga-Gomez J., 2019, ARXIV191013757V1	42	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262349	10.1371/journal.pone.0262349	http://dx.doi.org/10.1371/journal.pone.0262349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030211	gold, Green Published			2022-12-26	WOS:000812798500040
J	Degroote, S; Vandekerckhove, L; Vogelaers, D; Vanden Bulcke, C				Degroote, Sophie; Vandekerckhove, Linos; Vogelaers, Dirk; Vanden Bulcke, Charlotte			Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting	PLOS ONE			English	Article							GENERIC ANTIRETROVIRAL DRUGS; QUALITY-OF-LIFE; COST-EFFECTIVENESS; DE-SIMPLIFICATION; ADHERENCE; THERAPY; EMTRICITABINE; TENOFOVIR; VALIDATION; EFAVIRENZ	Background The use of single-tablet regimens (STRs) in HIV treatment is ubiquitous. However, reintroducing the (generic) components as multi-tablet regimens (MTRs) could be an interesting cost-reducing strategy. It is essential to involve patient-reported outcome measures (PROs) to examine the effects of such an approach. Hence, this study compared PROs of people living with HIV taking an STR versus a MTR in a real world setting. Materials and methods This longitudinal study included 188 people living with HIV. 132 remained on a MTR and 56 switched to an STR. At baseline, months 1-3-6-12-18 and 24, participants filled in questionnaires on health-related quality of life (HRQoL), depressive symptoms, HIV symptoms, neurocognitive complaints (NCC), treatment satisfaction and adherence. Generalized linear mixed models and generalized estimation equations mixed models were built. Results Clinical parameters and PROs of the two groups were comparable at baseline. Neurocognitive complaints and treatment satisfaction did differ over time among the groups. In the STR-group, the odds of having NCC increased monthly by 4,1% as compared to the MTR-group (p = 0.035). Moreover, people taking an STR were more satisfied with their treatment after 6 months: the median change score was high: 24 (IQR 7,5-29). Further, treatment satisfaction showed a contrary evolution in the groups: the estimated state score of the STR-group increased by 3,3 while it decreased by 0,2 in the MTR-group (p = 0.003). No differences over time between the groups were observed with regard to HRQoL, HIV symptoms, depressive symptoms and adherence. Conclusions Neurocognitive complaints were more frequently reported among people on an STR versus MTR. This finding contrasts with the higher treatment satisfaction in the STR-group over time. The long-term effects of both PROs should guide the decision-making on STRs vs. (generic) MTRs.	[Degroote, Sophie; Vandekerckhove, Linos; Vanden Bulcke, Charlotte] Ghent Univ Hosp, Dept Gen Internal Med, Ghent, Belgium; [Vandekerckhove, Linos] Univ Ghent, Dept Internal Med & Paediat, Ghent, Belgium; [Vogelaers, Dirk] AZ Delta, Dept Gen Internal Med, Roeselare, Belgium; [Vogelaers, Dirk] Ghent Univ Hosp, Dept Phys Med & Rehabil, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital	Degroote, S (corresponding author), Ghent Univ Hosp, Dept Gen Internal Med, Ghent, Belgium.	sophie.degroote@uzgent.be			Gilead Sciences to Ghent University Hospital [KW/1592/CIZ/001/013/001]	Gilead Sciences to Ghent University Hospital	This research was supported by a restricted grant from Gilead Sciences to Ghent University Hospital (KW/1592/CIZ/001/013/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; Altice F, 2019, PATIENT PREFER ADHER, V13, P475, DOI 10.2147/PPA.S192735; Amusan P, 2020, J NEUROVIROL, V26, P743, DOI 10.1007/s13365-020-00870-z; Angeletti C, 2014, HIV MED, V15, P165, DOI 10.1111/hiv.12097; Arribas JR, 2014, LANCET INFECT DIS, V14, P581, DOI 10.1016/S1473-3099(14)70782-0; Beck AT, 2002, BECK DEPRESSION INVE; Clay PG, 2018, AIDS RES THER, V15, DOI 10.1186/s12981-018-0204-0; Cohen J, 2020, AIDS RES THER, V17, DOI 10.1186/s12981-020-00268-1; Colombo GL, 2014, THER CLIN RISK MANAG, V10, P9, DOI 10.2147/TCRM.S49428; Colombo GL, 2013, CLINICOECONOMIC OUTC, V5, P59, DOI 10.2147/CEOR.S38977; Colombo GL, 2011, CLINICOECONOMIC OUTC, V3, P197, DOI 10.2147/CEOR.S24130; Costa JD, 2019, AIDS CARE, V31, P572, DOI 10.1080/09540121.2019.1576841; Cotte L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170661; Cutrell James, 2016, Fed Pract, V33, p24S; DeJesus E, 2009, JAIDS-J ACQ IMM DEF, V51, P163, DOI 10.1097/QAI.0b013e3181a572cf; dos Santos SF, 2020, AIDS CARE, V32, P1268, DOI 10.1080/09540121.2020.1736258; Engelhard Esther A N, 2016, Drugs Real World Outcomes, V3, P223; Engsig FN, 2014, JAIDS-J ACQ IMM DEF, V66, P407, DOI 10.1097/QAI.0000000000000199; European AIDS Clinical Society (EACS), 2020, EACS GUID 10 0; Gianotti N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182007; Hemmige V, 2018, AIDS CARE, V30, P1017, DOI 10.1080/09540121.2018.1442554; Hill A, 2014, J INT AIDS SOC, V17, P8, DOI 10.7448/IAS.17.4.19497; Hirnschall G, 2013, ANN INTERN MED, V158, P776, DOI 10.7326/0003-4819-158-10-201305210-00015; Hodder SL, 2010, AIDS PATIENT CARE ST, V24, P87, DOI 10.1089/apc.2009.0259; Jacomet C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117214; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Kapadia SN, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118816919; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Krentz Hartmut, 2019, J Int Assoc Provid AIDS Care, V18, p2325958218822304, DOI 10.1177/2325958218822304; Lazarus JV, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0640-4; Mannheimer SB, 2006, AIDS CARE, V18, P853, DOI 10.1080/09540120500465160; Mondi A., EFFECTIVENESS SINGLE; Olalla J, 2018, BMC PHARMACOL TOXICO, V19, DOI 10.1186/s40360-018-0252-z; Raffi F, 2015, J ANTIMICROB CHEMOTH, V70, P2121, DOI 10.1093/jac/dkv083; Alguero MR, 2020, J INT AIDS SOC, V23, P55; Rwagitinywa J, 2017, FUND CLIN PHARMACOL, V31, P27; Rwagitinywa J, 2018, FUND CLIN PHARMACOL, V32, P450, DOI 10.1111/fcp.12363; Sasse A., 2020, EP AIDS HIV INF BELG; Scheerder G., 2020, ANTWERP; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Stoll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023946; Suarez-Garcia I, 2020, J ANTIMICROB CHEMOTH, V75, P466, DOI 10.1093/jac/dkz439; Sweet DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147821; UNAIDS, 2014, UND FAST TRACK ACC A; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Woodcock A, 2001, QUAL LIFE RES, V10, P517, DOI 10.1023/A:1013050904635; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750	48	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262533	10.1371/journal.pone.0262533	http://dx.doi.org/10.1371/journal.pone.0262533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025957	Green Published, gold			2022-12-26	WOS:000796264200080
J	Knebel, A; Kampe, A; Carlson, R; Rohn, K; Tipold, A				Knebel, Anna; Kaempe, Annika; Carlson, Regina; Rohn, Karl; Tipold, Andrea			Th17 cell-mediated immune response in a subpopulation of dogs with idiopathic epilepsy	PLOS ONE			English	Article							INTERNATIONAL VETERINARY EPILEPSY; REGULATORY T-CELLS; BLOOD-BRAIN-BARRIER; INFANTILE SPASMS; INCREASED EXPRESSION; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; STATUS EPILEPTICUS; SEIZURE DISORDERS; CANINE EPILEPSY	Background Canine idiopathic epilepsy (IE) is a common neurological disease with severe impact on the owners and the dog's quality of life. A subpopulation of dogs with IE does not respond to antiseizure drugs (non-responder). Th17 cells (T helper cells) and their proinflammatory Interleukin-17 (IL-17) are part of the immune system and previous studies showed their involvement in the pathogenesis of several autoimmune diseases. Non-responder might have an abnormal immune response against structures of the central nervous system. To discover a new aetiology of canine IE and thereby optimising the therapy of intractable IE, this prospective study aimed to investigate Th17 cells and IL-17 in dogs with IE. The underlying hypothesis was that in some dogs with IE a Th17 cell-mediated immune response could be detectable. Methods 57 dogs with IE and 10 healthy dogs (control group, C) were enrolled in the study. EDTA blood was taken to measure Th17 cells by flow cytometry. IL-17 was measured in 35 cerebrospinal fluid (CSF) and 33 serum samples using an enzyme-linked immunosorbent assay (ELISA). It was investigated whether there was a significant increase of stimulated Th17 cells in blood samples or of IL-17 in serum and CSF samples of dogs with IE in comparison to C. Correlations between the amount of Th17 cells/mu L or IL-17 and different clinical parameters e.g. seizure frequency, seizure type, seizure severity or treatment response were evaluated. Additionally, Th17 cells/mu L were randomly controlled of 17 dogs with IE and were examined for changes over time and in relation to treatment response. Results Ten dogs with IE had strongly elevated stimulated Th17 cells/mu L within the blood (>100 Th17 cells/mu L). A slight positive correlation between stimulated Th17 cells/mu L and seizure severity (p = 0.046; rSpear = 0.27) was proven in these dogs. In addition, 4/10 dogs with elevated Th17 levels experienced cluster seizures and status epilepticus in comparison to 9% of the dogs with non-elevated Th17 levels (<100 Th17 cells/mu L). Dogs with IE had significantly higher IL-17 values in CSF and serum samples compared to C (p<0.001; p<0.002; respectively). Conclusion In single dogs with IE, strongly increased amounts of Th17 cells were detectable and dogs with elevated Th17 cells seemed to have a greater risk for experiencing a combination of cluster seizures and status epilepticus. Therefore, an underlying Th17-cell mediated immune response was suspected and hence anti-inflammatory drugs could be indicated in these single cases with intractable epilepsy.	[Knebel, Anna; Kaempe, Annika; Carlson, Regina; Tipold, Andrea] Univ Vet Med, Dept Small Anim Med & Surg, Hannover, Germany; [Rohn, Karl] Univ Vet Med Hannover, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Knebel, A (corresponding author), Univ Vet Med, Dept Small Anim Med & Surg, Hannover, Germany.	anna.knebel@tiho-hannover.de			Gkf -Die Gesellschaft zur Forderung kynologischer Forschung e.V. (Society for the Support of Cynological Research e.V., Bonn, Germany); Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	Gkf -Die Gesellschaft zur Forderung kynologischer Forschung e.V. (Society for the Support of Cynological Research e.V., Bonn, Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	The authors received financial support from the Gkf -Die Gesellschaft zur Forderung kynologischer Forschung e.V. (Society for the Support of Cynological Research e.V., Bonn, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing.	Andrea Fischer KJ., 2013, IDIOPATHISCHE EPILEP; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Baram TZ, 1996, PEDIATRICS, V97, P375; BARAN H, 1994, BRAIN RES, V646, P201, DOI 10.1016/0006-8993(94)90078-7; Bateman SW, 1999, J AM VET MED ASSOC, V215, P1463; Berendt M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0461-2; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bien CG, 2005, BRAIN, V128, P454, DOI 10.1093/brain/awh415; Brauer C, 2011, VET J, V187, P272, DOI 10.1016/j.tvjl.2009.10.023; Brenner T, 2013, EPILEPSIA, V54, P1028, DOI 10.1111/epi.12127; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Risio L, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0462-1; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dhote F, 2007, TOXICOLOGY, V238, P166, DOI 10.1016/j.tox.2007.05.032; Eriksson C, 2000, J NEUROSCI RES, V60, P266, DOI 10.1002/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P; Esendagli G, 2013, J NEUROIMMUNOL, V255, P81, DOI 10.1016/j.jneuroim.2012.10.009; Freundt-Revilla J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0784-3; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Golubovic SB, 2017, J VET EMERG CRIT CAR, V27, P288, DOI 10.1111/vec.12604; Gozubatik-Celik G, 2017, EPILEPSY RES, V135, P131, DOI 10.1016/j.eplepsyres.2017.06.008; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He JJ, 2013, J NEUROPATH EXP NEUR, V72, P152, DOI 10.1097/NEN.0b013e318281262e; HRACHOVY RA, 1983, J PEDIATR-US, V103, P641, DOI 10.1016/S0022-3476(83)80606-4; Hu MH, 2014, CLIN EXP IMMUNOL, V175, P268, DOI 10.1111/cei.12219; Hulsmeyer VI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0463-0; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Jamshidian A, 2013, J NEUROIMMUNOL, V262, P106, DOI 10.1016/j.jneuroim.2013.06.007; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; Kim JS, 2013, CELL MOL LIFE SCI, V70, P2271, DOI 10.1007/s00018-012-1163-6; Knebel A, 2022, VET IMMUNOL IMMUNOP, V243, DOI 10.1016/j.vetimm.2021.110366; Kol A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148568; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Mackay MT, 2004, NEUROLOGY, V62, P1668, DOI 10.1212/01.WNL.0000127773.72699.C8; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Mao LY, 2013, EPILEPSIA, V54, pe142, DOI 10.1111/epi.12337; McKnight K, 2005, NEUROLOGY, V65, P1730, DOI 10.1212/01.wnl.0000187129.66353.13; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moynes DM, 2014, BRAIN BEHAV IMMUN, V41, P1, DOI 10.1016/j.bbi.2014.03.004; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Ohta H, 2014, J VET MED SCI, V76, P409, DOI 10.1292/jvms.13-0008; Ong MS, 2014, JAMA NEUROL, V71, P569, DOI 10.1001/jamaneurol.2014.188; Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8; Packer RMA, 2017, PHYSIOL BEHAV, V177, P27, DOI 10.1016/j.physbeh.2017.04.008; Packer RMA, 2015, VET REC, V176, DOI 10.1136/vr.102934; Palace J, 2000, J NEUROL NEUROSUR PS, V69, P711, DOI 10.1136/jnnp.69.6.711; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PODELL M, 1993, J VET INTERN MED, V7, P318, DOI 10.1111/j.1939-1676.1993.tb01025.x; Potschka H, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0465-y; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; RASMUSSEN T, 1958, NEUROLOGY, V8, P435, DOI 10.1212/WNL.8.6.435; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rentzos M, 2010, ACTA NEUROL SCAND, V122, P425, DOI 10.1111/j.1600-0404.2010.01333.x; Riikonen R, 2004, J CHILD NEUROL, V19, P401, DOI 10.1177/088307380401900601; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Hernandez AS, 2009, REUMATOL CLIN, V5, P1, DOI 10.1016/j.reuma.2008.11.012; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Stadhouders R, 2018, J AUTOIMMUN, V87, P1, DOI 10.1016/j.jaut.2017.12.007; Tecellioglu M, 2018, IRISH J MED SCI, V187, P1057, DOI 10.1007/s11845-018-1777-2; Tizard I. R., 2013, VET IMMUNOLOGY; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Ueno M, 2016, BRAIN TUMOR PATHOL, V33, P89, DOI 10.1007/s10014-016-0255-7; van den Berg WB, 2013, SEMIN ARTHRITIS RHEU, V43, P158, DOI 10.1016/j.semarthrit.2013.04.006; Veiga-Parga T, 2016, VET PATHOL, V53, P737, DOI 10.1177/0300985816629719; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; Vezzani A, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022699; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; Vincent A, 2010, CURR OPIN NEUROL, V23, P144, DOI 10.1097/WCO.0b013e32833735fe; Volk HA, 2016, VET REC, V178, P394, DOI 10.1136/vr.i1999; Voutsinos-Porche B, 2004, NEUROBIOL DIS, V17, P385, DOI 10.1016/j.nbd.2004.07.023; Walker LSK, 2004, IMMUNOLOGY, V111, P129, DOI 10.1111/j.0019-2805.2003.01788.x; Wang Y, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0742-3; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wirrell E, 2005, CAN J NEUROL SCI, V32, P409, DOI 10.1017/S0317167100004388; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Zambrano-Zaragoza Jose Francisco, 2014, Int J Inflam, V2014, P651503, DOI 10.1155/2014/651503; Zimmermann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057307	91	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262285	10.1371/journal.pone.0262285	http://dx.doi.org/10.1371/journal.pone.0262285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025939	gold, Green Published			2022-12-26	WOS:000796264200056
J	Meijer, TS; Dieters, JHN; de Leede, EM; de Geus-Oei, LF; Vuijk, J; Martini, CH; van Erkel, AR; Lutjeboer, J; van der Meer, RW; Tijl, FGJ; Kapiteijn, E; Vahrmeijer, AL; Burgmans, MC				Meijer, T. Susanna; Dieters, Jan H. N.; de Leede, Eleonora M.; de Geus-Oei, Lioe-Fee; Vuijk, Jaap; Martini, Christian H.; van Erkel, Arian R.; Lutjeboer, Jacob; van der Meer, Rutger W.; Tijl, Fred G. J.; Kapiteijn, Ellen; Vahrmeijer, Alexander L.; Burgmans, Mark C.			Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer	PLOS ONE			English	Article							PHARMACOLOGICAL EVALUATION; CHEMOTHERAPY; RESECTION; INFUSION; MANAGEMENT; MELANOMA; SURVIVAL; TRENDS	Purpose Percutaneous hepatic perfusion with melphalan (M-PHP) is increasingly used in patients with liver metastases from various primary tumors, yet data on colorectal liver metastases (CRLM) are limited. The aim of this study was to prospectively evaluate the efficacy and safety of M-PHP in patients with CRLM. Materials and methods Prospective, single-center, single-arm phase II study of M-PHP with hemofiltration in patients with unresectable CRLM. Proven, extrahepatic metastatic disease was one of the exclusion criteria. Primary outcomes were overall response rate (ORR) and best overall response (BOR). Secondary outcomes were overall survival (OS), progression-free survival (PFS), hepatic PFS (hPFS), and safety. Results A total of 14 M-PHP procedures were performed in eight patients between March 2014 and December 2015. All patients (median age 56 years, ranging from 46 to 68) had received (extensive) systemic chemotherapy before entering the study. The ORR was 25.0%, with two out of eight patients showing partial response as BOR. Median OS was 17.3 months (ranging from 2.6 to 30.9) with a one-year OS of 50.0%. Median PFS and hPFS were 4.4 and 4.5 months, respectively. No serious adverse events occurred. Grade 3/4 hematologic adverse events were observed in the majority of patients, though all were transient and well-manageable. Conclusion M-PHP is a safe procedure with only limited efficacy in patients with unresectable CRLM who already showed progression of disease after receiving one or more systemic treatment regimens.	[Meijer, T. Susanna; Dieters, Jan H. N.; de Geus-Oei, Lioe-Fee; van Erkel, Arian R.; Lutjeboer, Jacob; van der Meer, Rutger W.; Burgmans, Mark C.] Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands; [de Leede, Eleonora M.; Vahrmeijer, Alexander L.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [de Geus-Oei, Lioe-Fee] Univ Twente, Biomed Photon Imaging Grp, Enschede, Netherlands; [Martini, Christian H.] Leiden Univ Med Ctr, Dept Anesthesiol, Leiden, Netherlands; [Tijl, Fred G. J.] Leiden Univ Med Ctr, Dept Extra Corporal Circulat, Leiden, Netherlands; [Kapiteijn, Ellen] Leiden Univ Med Ctr, Dept Med Oncol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Meijer, TS (corresponding author), Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands.	t.s.meijer@lumc.nl	Burgmans, Mark C/B-4478-2013	Burgmans, Mark C/0000-0001-5258-291X; de Geus-Oei, Lioe-Fee/0000-0003-1817-2743; Kapiteijn, Ellen/0000-0002-4814-6426	Leiden University Medical Center	Leiden University Medical Center	YES -The Leiden University Medical Center received financial support and in kind contributions from Delcath Systems Inc. for conducting studies on M-PHP. No grant number applies. The sponsor did not play any rol in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER K, 1983, RECENT RESULTS CANC, V86, P99; AUSMAN RK, 1961, NEW YORK STATE J MED, V61, P3993; Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burgmans MC, 2016, CARDIOVASC INTER RAD, V39, P801, DOI 10.1007/s00270-015-1276-z; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; de Leede EM, 2017, CARDIOVASC INTER RAD, V40, P1196, DOI 10.1007/s00270-017-1630-4; de Ridder JAM, 2016, EUR J CANCER, V59, P13, DOI 10.1016/j.ejca.2016.02.003; DEBRAUW LM, 1991, CANCER RES, V51, P1694; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hackl C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-810; HAFSTROM LR, 1994, SURG ONCOL, V3, P103, DOI 10.1016/0960-7404(94)90005-1; House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040; Hughes MS, 2016, ANN SURG ONCOL, V23, P1309, DOI 10.1245/s10434-015-4968-3; Karydis I, 2018, J SURG ONCOL, V117, P1170, DOI 10.1002/jso.24956; Leonard GD, 2005, J CLIN ONCOL, V23, P2038, DOI 10.1200/JCO.2005.00.349; Leporrier J, 2006, BRIT J SURG, V93, P465, DOI 10.1002/bjs.5278; Mambrini A, 2006, IN VIVO, V20, P751; Marinelli A, 1998, RECENT RES CANCER, V147, P83; Marquardt S, 2019, EUR RADIOL, V29, P1882, DOI 10.1007/s00330-018-5729-z; Meijer TS, 2021, ANN SURG ONCOL, V28, P1130, DOI 10.1245/s10434-020-08741-x; Meijer TS, 2019, DIAGN INTERV RADIOL, V25, P451, DOI 10.5152/dir.2019.18138; Meijer TS, 2019, CARDIOVASC INTER RAD, V42, P841, DOI 10.1007/s00270-019-02177-x; Miao N, 2008, ANN SURG ONCOL, V15, P815, DOI 10.1245/s10434-007-9781-1; Pingpank JF, 2005, J CLIN ONCOL, V23, P3465, DOI 10.1200/JCO.2005.00.927; Rothbarth J, 2003, BRIT J SURG, V90, P1391, DOI 10.1002/bjs.4308; Savier E, 2003, ARCH SURG-CHICAGO, V138, P325, DOI 10.1001/archsurg.138.3.325; van Iersel LBJ, 2008, ANN ONCOL, V19, P1127, DOI 10.1093/annonc/mdn032; Vogl TJ, 2014, ROFO-FORTSCHR RONTG, V186, P937, DOI 10.1055/s-0034-1366081	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261939	10.1371/journal.pone.0261939	http://dx.doi.org/10.1371/journal.pone.0261939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025911	gold, Green Published			2022-12-26	WOS:000796264200036
J	Zawierucha, K; Trzebny, A; Buda, J; Bagshaw, E; Franzetti, A; Dabert, M; Ambrosini, R				Zawierucha, Krzysztof; Trzebny, Artur; Buda, Jakub; Bagshaw, Elizabeth; Franzetti, Andrea; Dabert, Miroslawa; Ambrosini, Roberto			Trophic and symbiotic links between obligate-glacier water bears (Tardigrada) and cryoconite microorganisms	PLOS ONE			English	Article							GUT MICROBIOTA; ICE WORM; SP-NOV.; COMMUNITY; HOLES; PREFERENCES; EVOLUTION; BACTERIA	Insights into biodiversity and trophic webs are important for understanding ecosystem functions. Although the surfaces of glaciers are one of the most productive and biologically diverse parts of the cryosphere, the links between top consumers, their diet and microbial communities are poorly understood. In this study, for the first time we investigated the relationships between bacteria, fungi and other microeukaryotes as they relate to tardigrades, microscopic metazoans that are top consumers in cryoconite, a biologically rich and productive biogenic sediment found on glacier surfaces. Using metabarcoding (16S rDNA for bacteria, ITS1 for fungi, and 18S rDNA for other microeukaryotes), we analyzed the microbial community structures of cryoconite and compared them with the community found in both fully fed and starved tardigrades. The community structure of each microbial group (bacteria, fungi, microeukaryotes) were similar within each host group (cryoconite, fully fed tardigrades and starved tardigrades), and differed significantly between groups, as indicated by redundancy analyses. The relative number of operational taxonomic units (ZOTUs, OTUs) and the Shannon index differed significantly between cryoconite and tardigrades. Species indicator analysis highlighted a group of microbial taxa typical of both fully fed and starved tardigrades (potential commensals), like the bacteria of the genera Staphylococcus and Stenotrophomonas, as well as a group of taxa typical of both cryoconite and fully fed tardigrades (likely part of the tardigrade diet; bacteria Flavobacterium sp., fungi Preussia sp., algae Trebouxiophyceae sp.). Tardigrades are consumers of bacteria, fungi and other microeukaryotes in cryoconite and, being hosts for diverse microbes, their presence can enrich the microbiome of glaciers.	[Zawierucha, Krzysztof; Buda, Jakub] Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Poznan, Poland; [Trzebny, Artur; Dabert, Miroslawa] Adam Mickiewicz Univ, Fac Biol, Mol Biol Tech Lab, Poznan, Poland; [Bagshaw, Elizabeth] Cardiff Univ, Sch Earth & Environm Sci, Cardiff, Wales; [Franzetti, Andrea] Univ Milano Bicocca, Earth & Environm Sci Dept, Milan, Italy; [Ambrosini, Roberto] Univ Milan, Dept Environm Sci & Policy, Milan, Italy	Adam Mickiewicz University; Adam Mickiewicz University; Cardiff University; University of Milano-Bicocca; University of Milan	Zawierucha, K (corresponding author), Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Poznan, Poland.	k.p.zawierucha@gmail.com		Zawierucha, Krzysztof/0000-0002-0754-1411; Trzebny, Artur/0000-0002-0831-7243; Dabert, Miroslawa/0000-0001-5930-3346	National Science Centre in Poland [OPUS 2018/31/B/NZ8/00198]	National Science Centre in Poland(National Science Centre, Poland)	The studies on the role and diet of microinvertebrates in cryoconite ecosystems are supported via grant OPUS 2018/31/B/NZ8/00198 financed by National Science Centre in Poland. Grant recipient: Krzysztof Zawierucha The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzoni RS, 2017, J MAPS, V13, P870, DOI 10.1080/17445647.2017.1394227; Bagshaw EA, 2013, ARCT ANTARCT ALP RES, V45, P440, DOI 10.1657/1938-4246-45.4.440; Beligala D.H., 2017, ADV MICROBIOL-IRVINE, V7, P790, DOI [10.4236/aim.2017.711063, DOI 10.4236/AIM.2017.711063]; Boesgaard TM, 2001, ZOOL ANZ, V240, P253, DOI 10.1078/0044-5231-00033; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Bryndova M, 2020, ZOOL J LINN SOC-LOND, V188, P865; Buda J, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138112; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cook J, 2016, PROG PHYS GEOG, V40, P66, DOI 10.1177/0309133315616574; Dabert M., 2015, MITT HAMB ZOOL MUS I, V17, P233; Darcy JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023742; Dastych Hieronymus, 2003, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V100, P73; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; Di Marino E, 2007, NOVA HEDWIGIA, V84, P429, DOI 10.1127/0029-5035/2007/0084-0429; Dial CR, 2012, MOL PHYLOGENET EVOL, V63, P577, DOI 10.1016/j.ympev.2012.01.008; Edgar R. C., 2018, BIORXIV389833, DOI [10.1101/389833, DOI 10.1101/389833]; Edgar R. C., 2016, BIORXIV, DOI DOI 10.1101/074252; Edgar R.C., 2017, UNBIAS ATTEMPT CORRE, DOI [10.1101/124149, DOI 10.1101/124149]; Edgar RC, 2018, PEERJ, V6, DOI 10.7717/peerj.4652; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards A, 2013, FUNGAL ECOL, V6, P168, DOI 10.1016/j.funeco.2012.11.001; EDWARDS JS, 1970, CAN ENTOMOL, V102, P1169, DOI 10.4039/Ent1021169-9; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Garraffoni ARS, 2019, MAR BIODIVERS, V49, P2199, DOI 10.1007/s12526-019-00983-7; Gawor J, 2016, EXTREMOPHILES, V20, P403, DOI 10.1007/s00792-016-0831-0; GERDEL R. W., 1960, TRANS AMER MICROSC SOC, V79, P256, DOI 10.2307/3223732; Glockner FO, 2017, J BIOTECHNOL, V261, P169, DOI 10.1016/j.jbiotec.2017.06.1198; Greven Hartmut, 2005, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V102, P11; Guidetti R, 2012, ZOOMORPHOLOGY, V131, P127, DOI 10.1007/s00435-012-0149-0; Guil N, 2013, SYST BIODIVERS, V11, P181, DOI 10.1080/14772000.2013.798370; Hannon GJ., 2010, FASTX TOOLKIT; Hess S, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix104; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Jaromerska TN, 2021, BIOGEOSCIENCES, V18, P1543, DOI 10.5194/bg-18-1543-2021; Kaczmarek L, 2020, MOL PHYLOGENET EVOL, V145, DOI 10.1016/j.ympev.2019.106730; Kaltenpoth M, 2020, ANNU REV ENTOMOL, V65, P145, DOI 10.1146/annurev-ento-011019-025025; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kisielewska G, 2015, EUR J PROTISTOL, V51, P138, DOI 10.1016/j.ejop.2014.12.003; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kosztyla P, 2016, ZOOL J LINN SOC-LOND, V178, P765, DOI 10.1111/zoj.12409; Lerner A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01630; Lewin GR, 2016, ANNU REV MICROBIOL, V70, P235, DOI 10.1146/annurev-micro-102215-095748; Ma Y, 2019, BIOCHEM BIOPH RES CO, V516, P120, DOI 10.1016/j.bbrc.2019.05.085; Margesin R, 2007, INT J SYST EVOL MICR, V57, P2179, DOI 10.1099/ijs.0.65111-0; Matuszewska M, 2020, TRENDS MICROBIOL, V28, P465, DOI 10.1016/j.tim.2019.12.007; McInnes SJ, 2003, POLAR BIOL, V26, P79, DOI 10.1007/s00300-002-0449-9; Murakami T, 2018, ENVIRON MICROBIOL, V20, P4170, DOI 10.1111/1462-2920.14420; Murakami T, 2017, MICROBES ENVIRON, V32, P32, DOI 10.1264/jsme2.ME16158; Murakami T, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv003; Nelson DR, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P347, DOI 10.1016/B978-0-12-385026-3.00017-6; Nesvorna M, 2019, MICROB ECOL, V77, P488, DOI 10.1007/s00248-018-1224-y; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ono M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85462-5; Pantucek R, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01746-17; Perini L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00557; Pittino F, 2018, ANN GLACIOL, V59, P1, DOI 10.1017/aog.2018.16; Prochazkova L, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz064; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2020, R LANG ENV STAT COMP; Reese AT, 2018, MBIO, V9, DOI 10.1128/mBio.01294-18; Rozwalak P, 2022, SCI TOTAL ENVIRON, V807, DOI 10.1016/j.scitotenv.2021.150874; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; Sommers P, 2019, POLAR BIOL, V42, P1973, DOI 10.1007/s00300-019-02572-7; Stibal M, 2020, NAT ECOL EVOL, V4, P686, DOI 10.1038/s41559-020-1163-0; Takeuchi N, 2001, MEM NATL I POLAR RES, V54, P495; Takeuchi N, 2014, BULL GLACIOL RES, V32, P85, DOI 10.5331/bgr.32.85; Takeuchi N, 2010, ANN GLACIOL, V51, P9, DOI 10.3189/172756411795932010; Terashima M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01481; Vecchi M, 2018, MICROB ECOL, V76, P467, DOI 10.1007/s00248-017-1134-4; Vecchi M, 2016, ZOOL J LINN SOC-LOND, V178, P846, DOI 10.1111/zoj.12446; Vonnahme TR, 2016, BIOGEOSCIENCES, V13, P659, DOI 10.5194/bg-13-659-2016; Wagg C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12798-y; Wang B, 2020, GLOBAL CHANGE BIOL, V26, P960, DOI 10.1111/gcb.14841; Waterworth SC, 2020, MBIO, V11, DOI 10.1128/mBio.02430-19; Wilson BJ, 2004, CAN J BOT, V82, P607, DOI 10.1139/B04-030; Xia JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-266; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yoshida Y., 2019, HORIZONTAL GENE TRAN, P203; Zawierucha K, 2021, J ZOOL, V313, P18, DOI 10.1111/jzo.12832; Zawierucha K, 2019, AQUAT ECOL, V53, P543, DOI 10.1007/s10452-019-09707-2; Zawierucha K, 2018, LIMNOLOGY, V19, P141, DOI 10.1007/s10201-017-0528-9	82	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262039	10.1371/journal.pone.0262039	http://dx.doi.org/10.1371/journal.pone.0262039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020747	Green Published, gold, Green Accepted			2022-12-26	WOS:000834207700033
J	Kwon, OJ; Zhang, BY; Jia, DY; Zhang, L; Wei, X; Zhou, ZC; Liu, DL; Huynh, KT; Zhang, K; Zhang, YQ; Labhart, P; Sboner, A; Barbieri, C; Haffner, MC; Creighton, CJ; Xin, L				Kwon, Oh-Joon; Zhang, Boyu; Jia, Deyong; Zhang, Li; Wei, Xing; Zhou, Zhicheng; Liu, Deli; Khoi Trung Huynh; Zhang, Kai; Zhang, Yiqun; Labhart, Paul; Sboner, Andrea; Barbieri, Chris; Haffner, Michael C.; Creighton, Chad J.; Xin, Li			Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130	ONCOGENE			English	Article							TO-LUMINAL DIFFERENTIATION; ANDROGEN-RECEPTOR; ACCELERATES INITIATION; CHRONIC INFLAMMATION; GENE-EXPRESSION; MOUSE MODEL; CANCER; HYPERPLASIA; TISSUE; PROGRESSION	Macrophages are increased in human benign prostatic hyperplasia and prostate cancer. We generate a Pb-Csf1 mouse model with prostate-specific overexpression of macrophage colony-stimulating factor (M-Csf/Csf1). Csf1 overexpression promotes immune cell infiltration into the prostate, modulates the macrophage polarity in a lobe-specific manner, and induces senescence and low-grade prostatic intraepithelial neoplasia (PIN). The Pb-Csf1 prostate luminal cells exhibit increased stem cell features and undergo an epithelial-to-mesenchymal transition. Human prostate cancer patients with high CSF-1 expression display similar transcriptional alterations with the Pb-Csf1 model. P53 knockout alleviates senescence but fails to progress PIN lesions. Ablating epithelial Gp130 but not Il1r1 substantially blocks PIN lesion formation. The androgen receptor (AR) is downregulated in Pb-Csf1 mice. ChIP-Seq analysis reveals altered AR binding in 2482 genes although there is no significant widespread change in global AR transcriptional activity. Collectively, our study demonstrates that increased macrophage infiltration causes PIN formation but fails to transform prostate cells.	[Kwon, Oh-Joon; Jia, Deyong; Zhang, Li; Wei, Xing; Zhou, Zhicheng; Zhang, Kai; Xin, Li] Univ Washington, Dept Urol, Seattle, WA 98109 USA; [Zhang, Boyu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Liu, Deli; Sboner, Andrea; Barbieri, Chris] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Liu, Deli; Sboner, Andrea; Barbieri, Chris] Weill Cornell Med, Dept Urol, New York, NY USA; [Khoi Trung Huynh] Univ Washington, Dept Biol, Seattle, WA 98109 USA; [Zhang, Yiqun; Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Labhart, Paul] Act Motif, San Diego, CA USA; [Haffner, Michael C.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98109 USA; [Xin, Li] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine; Cornell University; Cornell University; University of Washington; University of Washington Seattle; Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xin, L (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98109 USA.; Xin, L (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.	xin18@uw.edu	Jia, Deyong/GSJ-0327-2022; Jia, Deyong/GQP-9611-2022; Zhang, YiQun/HCI-2427-2022	Jia, Deyong/0000-0003-2034-0363; Kwon, Oh-Joon/0000-0001-9067-0240; Zhang, Yiqun/0000-0001-5058-5623	 [R01CA190378];  [R01DK092202];  [R01DK107436]	; ; 	We thank Dr. Fen Wang for the ARR2PB-Cre mice, Dr. Rodger McEver for the Gp130fl/fl mice, and Dr. Richard Stanley for the mouse Csf-1 cDNA. This work is supported by R01CA190378, R01DK092202 and R01DK107436 (L.X.).	Barron DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013751; Becerra-Diaz M, 2018, J IMMUNOL, V201, P2923, DOI 10.4049/jimmunol.1800352; Birbach A, 2011, NEOPLASIA, V13, P692, DOI 10.1593/neo.11524; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chen TS, 2000, CANCER RES, V60, P2132; Cioni B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18313-y; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Debelec-Butuner B, 2014, MOL CARCINOGEN, V53, P85, DOI 10.1002/mc.21948; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Elkahwaji JE, 2007, PROSTATE, V67, P14, DOI 10.1002/pros.20445; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Fong L, 1997, J IMMUNOL, V159, P3113; Graham TR, 2010, BREAST CANCER RES TR, V123, P139, DOI 10.1007/s10549-009-0623-7; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gurel B, 2014, CANCER EPIDEM BIOMAR, V23, P847, DOI 10.1158/1055-9965.EPI-13-1126; Haverkamp JM, 2011, PROSTATE, V71, P1139, DOI 10.1002/pros.21327; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hmadcha A, 1999, J EXP MED, V190, P1595, DOI 10.1084/jem.190.11.1595; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Kazma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051680; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Kirma N, 2004, CANCER RES, V64, P4162, DOI 10.1158/0008-5472.CAN-03-2971; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Kwon OJ, 2016, STEM CELL RES, V16, P682, DOI 10.1016/j.scr.2016.04.009; Kwon OJ, 2014, P NATL ACAD SCI USA, V111, pE592, DOI 10.1073/pnas.1318157111; Leach DA, 2017, MOL CELL ENDOCRINOL, V439, P261, DOI 10.1016/j.mce.2016.09.010; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Liu G, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0386-7; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Maggio M, 2005, J Endocrinol Invest, V28, P116; Maggio M, 2006, J ANDROL, V27, P725, DOI 10.2164/jandrol.106.000141; Malinen M, 2017, NUCLEIC ACIDS RES, V45, P619, DOI 10.1093/nar/gkw855; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; ORMANDY CJ, 1992, INT J CANCER, V50, P777, DOI 10.1002/ijc.2910500519; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Platz EA, 2017, CANCER EPIDEM BIOMAR, V26, P1549, DOI 10.1158/1055-9965.EPI-17-0503; Schlomm T, 2016, EUR UROL, V69, P1157, DOI 10.1016/j.eururo.2016.02.024; Shinohara DB, 2013, PROSTATE, V73, P1007, DOI 10.1002/pros.22648; Simons BW, 2015, J PATHOL, V235, P478, DOI 10.1002/path.4472; Sorrentino C, 2011, CLIN CANCER RES, V17, P1571, DOI 10.1158/1078-0432.CCR-10-2804; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Traish A, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120549; Valdez JM, 2012, CELL STEM CELL, V11, P676, DOI 10.1016/j.stem.2012.07.003; Vignozzi L, 2012, J ENDOCRINOL, V214, P31, DOI 10.1530/JOE-12-0142; Vignozzi L, 2012, J ENDOCRINOL, V212, P71, DOI 10.1530/JOE-11-0289; Wang XH, 2012, J BIOL CHEM, V287, P18376, DOI 10.1074/jbc.M112.355164; Wang ZW, 2017, J PATHOL, V243, P457, DOI 10.1002/path.4985; Zhang BY, 2016, MOL CELL, V63, P976, DOI 10.1016/j.molcel.2016.07.025; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	60	2	2	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1309	1323		10.1038/s41388-021-02169-7	http://dx.doi.org/10.1038/s41388-021-02169-7		JAN 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	34999736	Green Accepted			2022-12-26	WOS:000740423700001
J	Hedlund, L; Jensen, P				Hedlund, Louise; Jensen, Per			Effects of stress during commercial hatching on growth, egg production and feather pecking in laying hens	PLOS ONE			English	Article							EARLY FEED RESTRICTION; BROILER-CHICKENS; HEAT-STRESS; CANNIBALISM; BEHAVIOR; THERMOTOLERANCE; TEMPERATURE; SELECTION; EXPOSURE	Every year, billions of egg layer chicks around the world are hatched under highly stressful, industrial circumstances. Here, it is investigated how the stressful procedure in the commercial hatchery, including incubation, hatching, processing, and transport affects the chicks with regards to traits relevant for the egg production industry. These traits were compared to those of a control group hatched in a small incubator and handled gently och quietly in a quiet room without any processing and transport. The chicks were weighed at hatch and at eight additional time points: 4 days, 1 week (w), 2 w, 3 w, 5 w, 8 w, 20 w and 25 w of age. Feather pecking was studied at 15 w of age and damages to the feathers and injuries on the comb and wattle were assessed at 25 w of age. From 19 w of age, eggs were collected on three days per week, counted and weighed. Chicks from a commercial hatchery had a lower hatch weight than control chicks (p<0.001). At 20 w of age, the weight of the commercial hatched chicks was still numerically lower, although this did not reach statistical significance. Commercially hatched chicks tended to show more feather pecking behaviour at 15 w of age compared to control chicks (p<0.1), although feather condition at 25 w of age showed the opposite pattern. Regarding production, commercially hatched chickens laid fewer (p<0.05) and smaller (p<0.05) eggs than chicks hatched and handled under calm circumstances. From this experiment, it is concluded that the stressful experience in the commercial hatchery has an overall negative effect on traits relevant for the industry.	[Hedlund, Louise; Jensen, Per] Linkoping Univ, IFM Biol, Linkoping, Sweden	Linkoping University	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, Linkoping, Sweden.	per.jensen@liu.se			FORMAS [2016-01728]	FORMAS(Swedish Research Council Formas)	P.J. recieved funding from FORMAS, grant No. 2016-01728, http://formas.se.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan O, 2000, BRIT POULTRY SCI, V41, P489, DOI 10.1080/713654965; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P145, DOI 10.1016/0168-1591(84)90104-7; BLOKHUIS HJ, 1992, BRIT POULTRY SCI, V33, P17, DOI 10.1080/00071669208417440; Bolhuis JE, 2009, PHYSIOL BEHAV, V97, P470, DOI 10.1016/j.physbeh.2009.03.021; Camm EJ, 2001, DEV BRAIN RES, V132, P141, DOI 10.1016/S0165-3806(01)00305-4; de Haas EN, 2013, POULTRY SCI, V92, P2259, DOI 10.3382/ps.2012-02996; Deng C, 2002, ANIM BEHAV, V63, P697, DOI 10.1006/anbe.2001.1942; Eriksen MS, 2003, BRIT POULTRY SCI, V44, P690, DOI 10.1080/00071660310001643660; FAO, FOOD AGR ORG UN; GEBHARDTHENRICH SG, 1995, POULTRY SCI, V74, P402, DOI 10.3382/ps.0740402; Giersberg MF, 2017, ANIMALS, V7, DOI 10.3390/ani7120097; Glatz PC, 2001, ASIAN AUSTRAL J ANIM, V14, P553, DOI 10.5713/ajas.2001.553; Hassan SM, 2003, POULTRY SCI, V82, P1163, DOI 10.1093/ps/82.7.1163; Hedlund L, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11041083; Hedlund L, 2021, POULTRY SCI, V100, P1, DOI 10.1016/j.psj.2020.10.015; Hedlund L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38817-y; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Hollemans MS, 2018, POULTRY SCI, V97, P2534, DOI 10.3382/ps/pey106; Jensen AB, 2006, APPL ANIM BEHAV SCI, V99, P287, DOI 10.1016/j.applanim.2005.10.017; Jensen P, 2014, APPL ANIM BEHAV SCI, V157, P1, DOI 10.1016/j.applanim.2014.02.009; Johnsen PF, 1998, APPL ANIM BEHAV SCI, V60, P25, DOI 10.1016/S0168-1591(98)00149-X; JOZSA R, 1979, GEN COMP ENDOCR, V39, P158, DOI 10.1016/0016-6480(79)90221-1; Kesar Alpana Goel, 2014, Int J Appl Basic Med Res, V4, P3, DOI 10.4103/2229-516X.125666; Kjaer JB, 2001, APPL ANIM BEHAV SCI, V71, P229, DOI 10.1016/S0168-1591(00)00184-2; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; NORGAARDNIELSEN G, 1993, APPL ANIM BEHAV SCI, V38, P345, DOI 10.1016/0168-1591(93)90032-K; Riber AB, 2007, APPL ANIM BEHAV SCI, V106, P39, DOI 10.1016/j.applanim.2006.07.012; Riedstra B, 2004, ANIM BEHAV, V67, P1037, DOI 10.1016/j.anbehav.2003.10.009; Riedstra B, 2002, APPL ANIM BEHAV SCI, V77, P127, DOI 10.1016/S0168-1591(02)00031-X; Rodenburg TB, 2004, APPL ANIM BEHAV SCI, V86, P291, DOI 10.1016/j.applanim.2004.02.007; Shinder D, 2002, J THERM BIOL, V27, P517, DOI 10.1016/S0306-4565(02)00025-6; Tumova E, 2002, CZECH J ANIM SCI, V47, P418; Urdaneta-Rincon M, 2002, POULTRY SCI, V81, P679, DOI 10.1093/ps/81.5.679; Yahav S, 1996, POULTRY SCI, V75, P402, DOI 10.3382/ps.0750402; Zhan XA, 2007, POULTRY SCI, V86, P654, DOI 10.1093/ps/86.4.654	36	3	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262307	10.1371/journal.pone.0262307	http://dx.doi.org/10.1371/journal.pone.0262307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982788	Green Published, gold			2022-12-26	WOS:000834805700029
J	Leddy, AM; Gottert, A; Haberland, N; Hove, J; West, RL; Pettifor, A; Lippman, SA; Kahn, K; Mathebula, R; Rebombo, D; Gomez-Olive, X; Twine, R; Peacock, D; Pulerwitz, J				Leddy, Anna M.; Gottert, Ann; Haberland, Nicole; Hove, Jennifer; West, Rebecca L.; Pettifor, Audrey; Lippman, Sheri A.; Kahn, Kathleen; Mathebula, Rhandzekile; Rebombo, Dumisani; Gomez-Olive, Xavier; Twine, Rhian; Peacock, Dean; Pulerwitz, Julie			Shifting gender norms to improve HIV service uptake: Qualitative findings from a large-scale community mobilization intervention in rural South Africa	PLOS ONE			English	Article							YOUNG-ADULTS; CONDOM USE; PREVENTION; MASCULINITY; CARE; MEN; COMMUNICATION; ENGAGEMENT; ATTITUDES; VIOLENCE	Background Interventions to improve HIV service uptake are increasingly addressing inequitable and restrictive gender norms. Yet comparatively little is known about which gender norms are most salient for HIV testing and treatment and how changing these specific norms translates into HIV service uptake. To explore these questions, we implemented a qualitative study during a community mobilization trial targeting social barriers to HIV service uptake in South Africa. Methods We conducted 55 in-depth interviews in 2018, during the final months of a three-year intervention in rural Mpumalanga province. Participants included 25 intervention community members (48% women) and 30 intervention staff/community-opinion-leaders (70% women). Data were analyzed using an inductive-deductive approach. Results We identified three avenues for gender norms change which, when coupled with other strategies, were described to support HIV service uptake: (1) Challenging norms around male toughness/avoidance of help-seeking, combined with information on the health and preventive benefits of early antiretroviral therapy (ART), eased men's fears of a positive diagnosis and facilitated HIV service uptake. (2) Challenging norms about men's expected control over women, combined with communication and conflict resolution skill-building, encouraged couple support around HIV service uptake. (3) Challenging norms around women being solely responsible for the family's health, combined with information about sero-discordance and why both members of the couple should be tested, encouraged men to test for HIV rather than relying on their partner's results. Facility-level barriers such as long wait times continued to prevent some men from accessing care. Conclusions Despite continued facility-level barriers, we found that promoting critical reflection around several specific gender norms, coupled with information (e.g., benefits of ART) and skill-building (e.g., communication), were perceived to support men's and women's engagement in HIV services. There is a need to identify and tailor programming around specific gender norms that hinder HIV service uptake.	[Leddy, Anna M.; West, Rebecca L.; Lippman, Sheri A.] Univ Calif San Francisco, Dept Med, Div Prevent Sci, San Francisco, CA 94143 USA; [Gottert, Ann; Haberland, Nicole; Pulerwitz, Julie] Populat Council, Project SOAR, Washington, DC USA; [Gottert, Ann; Haberland, Nicole; Pulerwitz, Julie] Populat Council, Project SOAR, New York, NY USA; [Hove, Jennifer; Pettifor, Audrey; Lippman, Sheri A.; Kahn, Kathleen; Gomez-Olive, Xavier; Twine, Rhian] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Pettifor, Audrey] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Mathebula, Rhandzekile; Rebombo, Dumisani] Sonke Gender Justice, Johannesburg, South Africa; [Peacock, Dean] Promundo, Washington, DC USA; [Rebombo, Dumisani] Yanani Community Project, Johannesburg, South Africa	University of California System; University of California San Francisco; Population Council; Population Council; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill	Leddy, AM (corresponding author), Univ Calif San Francisco, Dept Med, Div Prevent Sci, San Francisco, CA 94143 USA.	anna.leddy@ucsf.edu		Leddy, Anna/0000-0002-1508-4193; Pettifor, Audrey/0000-0002-3387-0817	Project SOAR through the United States President's Emergency Plan for AIDS Relief (PEPFAR) [AID-OAA-A-14-00060]; United States Agency for International Development (USAID)	Project SOAR through the United States President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The manuscript and related analyses were supported by Project SOAR (Cooperative AgreementAID-OAA-A-14-00060) (PI: NH), made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR)and United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this paper are the sole responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, or the United States Government.	Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Antle BF, 2011, J FAM SOC WORK, V14, P387, DOI 10.1080/10522158.2011.616482; Berkowitz A. D., 2003, SOCIAL NORMS APPROAC, P259; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Colvin CJ, 2019, LANCET HIV, V6, pE191, DOI 10.1016/S2352-3018(19)30032-3; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Darbes LA, 2019, JAIDS-J ACQ IMM DEF, V80, P404, DOI [10.1097/QAI.0000000000001948, 10.1097/qai.0000000000001948]; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; El-Bassel N, 2010, JAIDS-J ACQ IMM DEF, V55, pS98, DOI 10.1097/QAI.0b013e3181fbf407; Fleming PJ, 2016, CULT HEALTH SEX, V18, P1251, DOI 10.1080/13691058.2016.1183045; Fleming PJ, 2016, AIDS, V30, P157, DOI 10.1097/QAD.0000000000000899; Fleming PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118639; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Gottert A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237084; Gottert A, 2018, AIDS BEHAV, V22, P1858, DOI 10.1007/s10461-017-1706-9; Harichund C, 2019, AIDS CARE, V31, P186, DOI 10.1080/09540121.2018.1503638; Harichund C, 2018, AIDS BEHAV, V22, P560, DOI 10.1007/s10461-017-1848-9; Harrison A, 2006, J URBAN HEALTH, V83, P709, DOI 10.1007/s11524-006-9077-y; Heise L, 2019, LANCET, V393, P2440, DOI 10.1016/S0140-6736(19)30652-X; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Kalichman SC, 2007, AIDS CARE, V19, P20, DOI 10.1080/09540120600984003; Kaufman MR, 2008, AIDS CARE, V20, P434, DOI 10.1080/09540120701867057; Kerrigan D, 2019, JAIDS-J ACQ IMM DEF, V82, P141, DOI 10.1097/QAI.0000000000002123; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Leddy A, 2016, AIDS CARE, V28, P228, DOI 10.1080/09540121.2015.1080792; Leddy AM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7192-4; Levy JK, 2020, LANCET GLOB HEALTH, V8, pE225, DOI 10.1016/S2214-109X(19)30495-4; Lippman SA, 2020, INT AIDS SOC C SAN F; Lippman SA, 2020, JAIDS-J ACQ IMM DEF, V83, pE9, DOI 10.1097/QAI.0000000000002197; Lippman SA, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25182; Lippman SA, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0541-0; Lippman SA, 2017, JAIDS-J ACQ IMM DEF, V74, pS44, DOI 10.1097/qai.0000000000001207; Lippman SA, 2016, SOC SCI MED, V157, P127, DOI 10.1016/j.socscimed.2016.04.002; Lippman SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078208; Lippman SA, 2012, SEX TRANSM DIS, V39, P209, DOI 10.1097/OLQ.0b013e31823b1937; Mburu G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1061; Minnis AM, 2015, INT J WOMENS HEALTH, V7, P517, DOI 10.2147/IJWH.S77398; Mooney AC, 2017, AIDS EDUC PREV, V29, P274, DOI 10.1521/aeap.2017.29.3.274; National Department of Health South Africa, 2018, NAT HIV SELF SCREEN; Orr N, 2017, JAIDS-J ACQ IMM DEF, V74, pS69, DOI 10.1097/qai.0000000000001204; Pettifor A, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100327; Pettifor A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25134; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; President's Emergency Plan for ARP, 2020, MENSTAR STRAT; Pulerwitz J, 2019, AIDS BEHAV, V23, pS162, DOI 10.1007/s10461-019-02603-8; Scientific Software Development, 2018, ATLAS TI, V8; Sikweyiya YM, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24631; Sileo KM, 2019, AIDS CARE, V31, P1435, DOI 10.1080/09540121.2019.1595509; Sileo KM, 2018, AIDS BEHAV, V22, P2468, DOI 10.1007/s10461-018-2160-z; Sonke Gender Justice, 2012, BUSHB ON MAN CAN COM; Stephenson R, 2013, AIDS BEHAV, V17, P2352, DOI 10.1007/s10461-012-0223-0; Strebel A, 2006, SAHARA J, V3, P516; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; UNAIDS, 2019, UNAIDS DAT 2019; UNAIDS, 2017, BLIND SPOT REACH MEN; van den Berg W, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001811	57	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260425	10.1371/journal.pone.0260425	http://dx.doi.org/10.1371/journal.pone.0260425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972113	gold, Green Published			2022-12-26	WOS:000773555700014
J	Ma, XM; Liu, Q; Zhang, ZD; Zhang, ZW; Zhou, ZY; Jiang, Y; Huang, XR				Ma, Xuemei; Liu, Qiang; Zhang, Zhidong; Zhang, Zewen; Zhou, Zeyu; Jiang, Yu; Huang, Xuanrui			Effects of photosynthetic models on the calculation results of photosynthetic response parameters in young Larix principis-rupprechtii Mayr. plantation	PLOS ONE			English	Article							LIGHT-RESPONSE; CANOPY PHOTOSYNTHESIS; LEAF PHOTOSYNTHESIS; CURVES; ACCLIMATION; RESPIRATION; EFFICIENCY; EXCHANGE; CONDUCTANCE; IRRADIANCE	Accurately predicting the crown photosynthesis of trees is necessary for better understanding the C circle in terrestrial ecosystem. However, modeling crown for individual tree is still challenging with the complex crown structure and changeable environmental conditions. This study was conducted to explore model in modeling the photosynthesis light response curve of the tree crown of young Larix principis-rupprechtii Mayr. Plantation. The rectangular hyperbolic model (RHM), non-rectangular hyperbolic model (NRHM), exponential model (EM) and modified rectangular hyperbolic model (MRHM) were used to model the photosynthetic light response curves. The fitting accuracy of these models was tested by comparing determinants coefficients (R-2), mean square errors (MSE) and Akaike information criterion (AIC). The results showed that the mean value of R-2 of MRHM (R-2 = 0.9687) was the highest, whereas MSE value (MSE = 0.0748) and AIC value (AIC = -39.21) were the lowest. The order of fitting accuracy of the four models for P-n-PAR response curve was as follows: MRHM > EM > NRHM > RHM. In addition, the light saturation point (LSP) obtained by MRHM was slightly lower than the observed values, whereas the maximum net photosynthetic rates (P-max) modeled by the four models were close to the measured values. Therefore, MRHM was superior to other three models in describing the photosynthetic response curve, the accurate values were that the quantum efficiency (alpha), maximum net photosynthetic rate (P-max), light saturation point (LSP), light compensation point (LCP) and respiration rate (R-d) were 0.06, 6.06 mu mol.m(-2)s(-1), 802.68 mu mol.m(-2)s(-1), 10.76 mu mol.m(-2)s(-1) and 0.60 mu mol.m(-2)s(-1). Moreover, the photosynthetic response parameters values among different layers were also significant. Our findings have critical implications for parameter calibration of photosynthetic models and thus robust prediction of photosynthetic response in forests.	[Ma, Xuemei; Liu, Qiang; Zhang, Zhidong; Zhang, Zewen; Zhou, Zeyu; Jiang, Yu; Huang, Xuanrui] Hebei Agr Univ, Coll Forestry, Baoding, Hebei, Peoples R China; [Ma, Xuemei] Anyang Inst Technol, Anyang, Henan, Peoples R China	Hebei Agricultural University; Anyang Institute of Technology	Liu, Q; Huang, XR (corresponding author), Hebei Agr Univ, Coll Forestry, Baoding, Hebei, Peoples R China.	qiangliu2015@126.com; hxr1962@163.com			Asia-Pacific Network for Sustainable Forest Management and Rehabilitation (APFNet) project [2021SP2-CHN]; National Science Foundation of China [32071795]; Talent Special Scientific Research Fund of Hebei Agricultural University [YJ201942]	Asia-Pacific Network for Sustainable Forest Management and Rehabilitation (APFNet) project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talent Special Scientific Research Fund of Hebei Agricultural University	This research was funded by the Asia-Pacific Network for Sustainable Forest Management and Rehabilitation (APFNet) project (No.2021SP2-CHN), the National Science Foundation of China (No.32071795) and Talent Special Scientific Research Fund of Hebei Agricultural University (YJ201942).	Akhkha A, 2001, PLANTA, V214, P135, DOI 10.1007/s004250100599; Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; BASSMAN JH, 1991, TREE PHYSIOL, V8, P145, DOI 10.1093/treephys/8.2.145; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Chai SF., 2015, J GUANG 11 ACAD SCI, V31, P286, DOI [10.13657/j.cnki.gxkxyxb.20151126.001, DOI 10.13657/J.CNKI.GXKXYXB.20151126.001]; Chen Wei-Ying, 2012, Chinese Journal of Plant Ecology, V36, P1277, DOI 10.3724/SP.J.1258.2012.01277; Chen ZY, 2011, PHOTOSYNTHETICA, V49, P467, DOI 10.1007/s11099-011-0056-5; Cox PM, 1998, J HYDROL, V212, P79, DOI 10.1016/S0022-1694(98)00203-0; Di XY, 2014, BIOCHEM SYST ECOL, V54, P71, DOI 10.1016/j.bse.2013.12.035; Dias-Filho Moacyr Bernardino, 2002, Sci. agric. (Piracicaba, Braz.), V59, P65, DOI 10.1590/S0103-90162002000100009; Gardiner ES, 2001, TREE PHYSIOL, V21, P1103, DOI 10.1093/treephys/21.15.1103; HENLEY WJ, 1993, J PHYCOL, V29, P729, DOI 10.1111/j.0022-3646.1993.00729.x; Huang LiangShuai, 2017, Journal of Nanjing Forestry University (Natural Sciences Edition), V41, P193; Jin S, 2003, FOREST ECOL MANAG, V184, P125, DOI 10.1016/S0378-1127(03)00205-6; Johnson G, 2011, METHODS MOL BIOL, V775, P311, DOI 10.1007/978-1-61779-237-3_17; Kubiske ME, 1996, TREE PHYSIOL, V16, P351; Kull O, 1998, FUNCT ECOL, V12, P767, DOI 10.1046/j.1365-2435.1998.00257.x; Kyei-Boahen S, 2003, PHOTOSYNTHETICA, V41, P301, DOI 10.1023/B:PHOT.0000011967.74465.cc; Lang Y, 2013, PHOTOSYNTHETICA, V51, P370, DOI 10.1007/s11099-013-0036-z; Larocque GR, 2002, ECOL MODEL, V148, P213, DOI 10.1016/S0304-3800(01)00442-2; Liu Q, 2018, CAN J FOREST RES, V48, P1085, DOI 10.1139/cjfr-2018-0151; Liu Q, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68429-w; Liu Q, 2018, FORESTS, V9, DOI 10.3390/f9090522; Liu Qiang, 2016, Yingyong Shengtai Xuebao, V27, P2789, DOI 10.13287/j.1001-9332.201609.008; Lobo FD, 2013, PHOTOSYNTHETICA, V51, P445, DOI 10.1007/s11099-013-0045-y; Luo YQ, 2000, AGR FOREST METEOROL, V100, P35, DOI 10.1016/S0168-1923(99)00085-4; Ma YanJun, 2010, Acta Agrestia Sinica, V18, P183; MARSHALL B, 1980, J EXP BOT, V31, P29, DOI 10.1093/jxb/31.1.29; Moreno-Sotomayor A, 2002, J PLANT PHYSIOL, V159, P819, DOI 10.1078/0176-1617-00809; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; Pinto H, 2016, PLANT CELL ENVIRON, V39, P514, DOI 10.1111/pce.12636; Posada JM, 2009, ANN BOT-LONDON, V103, P795, DOI 10.1093/aob/mcn265; Quan XK, 2018, FOREST ECOL MANAG, V411, P166, DOI 10.1016/j.foreco.2018.01.024; Rascher U, 2000, PLANT CELL ENVIRON, V23, P1397, DOI 10.1046/j.1365-3040.2000.00650.x; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Shang LQ., 2018, CHIN AGR SCI B, V485, P67; STEELE JH, 1962, LIMNOL OCEANOGR, V7, P137, DOI 10.4319/lo.1962.7.2.0137; Thornley J. H. M., 1976, Mathematical models in plant physiology.; [王海珍 Wang Haizhen], 2017, [生态学报, Acta Ecologica Sinica], V37, P2315; Wilson KB, 2001, PLANT CELL ENVIRON, V24, P571, DOI 10.1046/j.0016-8025.2001.00706.x; Xu ZF, 2012, EUR J FOREST RES, V131, P811, DOI 10.1007/s10342-011-0554-9; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; Ye ZP, 2008, PHOTOSYNTHETICA, V46, P637, DOI 10.1007/s11099-008-0110-0; Ye Zi-Piao, 2008, Zhiwu Shengtai Xuebao, V32, P1356, DOI 10.3773/j.issn.1005-264x.2008.06.016; Ye ZP., 2009, J JINGGANGSHAN U SCI, V30, P9; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Zhang GY, 2006, J CHEM TECHNOL BIOT, V81, P1185, DOI 10.1002/jctb.1510; Zhang N, 2020, AGR FOREST METEOROL, V291, DOI 10.1016/j.agrformet.2020.108098; Zhang XQ, 2003, FOREST ECOL MANAG, V173, P201, DOI 10.1016/S0378-1127(02)00015-4; Zhang YunQi, 2019, Journal of Beijing Forestry University, V41, P32; Zheng T, 2017, AGR FOREST METEOROL, V236, P48, DOI 10.1016/j.agrformet.2017.01.008; Zhu SZ., 2016, J SHANXI U NAT SCI E, V39, P184, DOI [10.13451/j.cnki.shanxi.univ(nat.sci.).2016.04.028, DOI 10.13451/J.CNKI.SHANXI.UNIV(NAT.SCI.).2016.04.028]; Zu YG, 2011, PHOTOSYNTHETICA, V49, P448, DOI 10.1007/s11099-011-0057-4	54	1	1	12	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261683	10.1371/journal.pone.0261683	http://dx.doi.org/10.1371/journal.pone.0261683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972150	gold, Green Published			2022-12-26	WOS:000773555700046
J	Zhang, JQ; Liu, WB; Li, GY; Xu, CP; Nie, XQ; Qin, DD; Wang, QZ; Lu, XK; Liu, JQ; Li, L				Zhang, Jiaqi; Liu, Wenbo; Li, Guangyue; Xu, Chengpeng; Nie, Xiaoqing; Qin, Dandan; Wang, Qizhi; Lu, Xukun; Liu, Jianqiao; Li, Lei			BCAS2 is involved in alternative splicing and mouse oocyte development	FASEB JOURNAL			English	Article						alternative splicing; BCAS2; follicle; oogenesis; PRP19 complex	POLY(A)-BINDING PROTEIN EPAB; PRP19P-ASSOCIATED COMPLEX; MOLECULAR CONTROL; GENE-EXPRESSION; SPLICEOSOME; ACTIVATION; PRP19; IDENTIFICATION; COMPONENTS; CHROMATIN	Alternative splicing (AS) is an important mechanism to regulate organogenesis and fertility. Breast carcinoma amplified sequence 2 (BCAS2) is one of the core components of the PRP19 complex, a multiple function complex including splicing, and it is involved in the initiation of meiosis through regulating AS in male mice. However, the role of BCAS2 in mouse oogenesis remains largely unknown. In this study, we found that BCAS2 was highly expressed in the oocytes of primordial follicles. Vasa-Cre-mediated deletion of Bcas2 caused poor oocyte quality, abnormal oogenesis and follicular development. The deletion of Bcas2 in mouse oocytes caused alteration in 991 AS events that corresponded to 706 genes, including Pabpc1l, Nobox, Zfp207, Mybl2, Prc1, and Spc25, which were associated with oogenesis and spindle assembly. Moreover, the disruption of BCAS2 led to degradation of PRP19 core proteins in mouse oocytes. These results suggested that BCAS2 was involved in the AS of functional genes through PRP19 complex during mouse oocyte development.	[Zhang, Jiaqi; Liu, Wenbo; Xu, Chengpeng; Nie, Xiaoqing; Qin, Dandan; Wang, Qizhi; Lu, Xukun; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Zhang, Jiaqi; Xu, Chengpeng; Nie, Xiaoqing; Wang, Qizhi] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Wenbo; Liu, Jianqiao] Guangzhou Med Univ, Ctr Reprod Med, Dept Obstet & Gynecol, Key Lab Major Obstet Dis Guangdong Prov,Affiliate, Guangzhou, Peoples R China; [Liu, Wenbo; Liu, Jianqiao] Guangzhou Med Univ, Key Lab Reprod Med Guangdong Prov, Affiliated Hosp 3, Guangzhou, Peoples R China; [Li, Guangyue] Northeast Forestry Univ, Coll Life Sci, Key Lab Saline Alkali Vegetat Ecol Restorat, Minist Educ, Harbin, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Medical University; Guangzhou Medical University; Northeast Forestry University - China	Li, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.	lil@ioz.ac.cn		Li, Lei/0000-0001-5478-5681	National Key R&D Program of China [2018YFC1004500, 2021YFC2700300]; National Natural Science Foundation of China [31801241, 31930033, 31771633, 81971452]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Key R&D Program of China (2018YFC1004500 and 2021YFC2700300) and the National Natural Science Foundation of China (31801241, 31930033, 31771633, and 81971452)	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chanarat S, 2013, BBA-MOL CELL RES, V1833, P2126, DOI 10.1016/j.bbamcr.2013.05.023; Chen HR, 1999, P NATL ACAD SCI USA, V96, P5406, DOI 10.1073/pnas.96.10.5406; Chen PH, 2013, RNA, V19, P208, DOI 10.1261/rna.034835.112; Chou MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130706; Do DV, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0032-3; de Moura TR, 2018, MOL CELL, V69, P979, DOI 10.1016/j.molcel.2018.02.022; Fan XY, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3001017; Gagliardi M, 2016, METHODS MOL BIOL, V1480, P73, DOI 10.1007/978-1-4939-6380-5_7; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Guzeloglu-Kayisli O, 2012, BIOCHEM J, V446, P47, DOI 10.1042/BJ20120467; Hamid FM, 2014, BIOCHEM SOC T, V42, P1168, DOI 10.1042/BST20140066; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hofmann JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074851; Huang CW., 2016, SCI REP-UK, V6; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kuo PC, 2009, CANCER RES, V69, P8877, DOI 10.1158/0008-5472.CAN-09-2023; Lee S, 2002, CANCER LETT, V188, P121, DOI 10.1016/S0304-3835(02)00055-1; Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Liu L, 2013, REPROD FERT DEVELOP, V25, P463, DOI 10.1071/RD12310; Liu WB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14182; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Nagasaki K, 1999, CANCER LETT, V140, P219, DOI 10.1016/S0304-3835(99)00091-9; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Oktem O, 2010, HUM REPROD, V25, P2944, DOI 10.1093/humrep/deq275; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salmeron-Hernandez A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040966; Sanchez F, 2012, BBA-MOL BASIS DIS, V1822, P1896, DOI 10.1016/j.bbadis.2012.05.013; Seli E, 2005, P NATL ACAD SCI USA, V102, P367, DOI 10.1073/pnas.0408378102; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Sibley CR, 2014, BIOCHEM SOC T, V42, P1196, DOI 10.1042/BST20140102; Supek F, 2021, TRENDS GENET, V37, P657, DOI 10.1016/j.tig.2020.11.002; Tan JH, 2009, MOL HUM REPROD, V15, P1, DOI 10.1093/molehr/gan069; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Trincado JL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1417-1; Wan L, 2014, J BIOL CHEM, V289, P6619, DOI 10.1074/jbc.M113.543439; Wan RX, 2020, ANNU REV BIOCHEM, V89, P333, DOI 10.1146/annurev-biochem-013118-111024; Wan RX, 2019, CURR OPIN STRUC BIOL, V59, P124, DOI 10.1016/j.sbi.2019.07.010; Wang LP, 2020, BRIT J CANCER, V123, P1796, DOI 10.1038/s41416-020-01086-y; Xu QH, 2015, DEVELOPMENT, V142, P3943, DOI 10.1242/dev.129841; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yu LP, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.196931; Yu SS, 2019, BLOOD, V133, P805, DOI 10.1182/blood-2018-09-876599	56	1	1	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22128	10.1096/fj.202101279R	http://dx.doi.org/10.1096/fj.202101279R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972250				2022-12-26	WOS:000747987800026
J	Aikawa, T; Maehara, N; Ichihara, Y; Masuya, H; Nakamura, K; Anbutsu, H				Aikawa, Takuya; Maehara, Noritoshi; Ichihara, Yu; Masuya, Hayato; Nakamura, Katsunori; Anbutsu, Hisashi			Cytoplasmic incompatibility in the semivoltine longicorn beetle Acalolepta fraudatrix (Coleoptera: Cerambycidae) double infected with Wolbachia	PLOS ONE			English	Article							CALLOSOBRUCHUS-CHINENSIS COLEOPTERA; MONOCHAMUS-ALTERNATUS COLEOPTERA; JAPANESE PINE SAWYER; PHYLOGENETIC ANALYSIS; BACTERIAL SYMBIONT; BEAN BEETLE; ENDOSYMBIONTS; POPULATIONS; PREVALENCE; DIVERSITY	Wolbachia are obligatory endosymbiotic alpha-proteobacteria found in many arthropods. They are maternally inherited, and can induce reproductive alterations in the hosts. Despite considerable recent progress in studies on the associations between Wolbachia and various taxonomic groups of insects, none of the researches have revealed the effects of Wolbachia on longicorn beetles as the host insect. Acalolepta fraudatrix is a forest longicorn beetle that is distributed in East Asia. In this study, the relationship between Wolbachia and A. fraudatrix was investigated. Out of two populations of A. fraudatrix screened for Wolbachia using the genes ftsZ, wsp, and 16S rRNA, only one of the populations showed detection of all three genes indicating the presence of Wolbachia. Electron microscopy and fluorescent in situ hybridization also confirmed that the A. fraudatrix population was infected with Wolbachia. Sequencing the wsp genes derived from single insects revealed that two strains of Wolbachia coexisted in the insects based on the detection of two different sequences of the wsp gene. We designated these strains as wFra1 and wFra2. The bacterial titers of wFra1 were nearly 2-fold and 3-fold higher than wFra2 in the testes and ovaries, respectively. The two strains of Wolbachia in the insects were completely eliminated by rearing the insects on artificial diets containing 1% concentration of tetracycline for 1 generation. Reciprocal crosses between Wolbachia-infected and Wolbachia-uninfected A. fraudatrix demonstrated that only eggs produced by the crosses between Wolbachia-infected males and Wolbachia-uninfected females did not hatch, indicating that Wolbachia infecting A. fraudatrix causes cytoplasmic incompatibility in the host insect. This is the first report showing the effect of Wolbachia on reproductive function in a longicorn beetle, A. fraudatrix.	[Aikawa, Takuya; Nakamura, Katsunori] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate, Japan; [Maehara, Noritoshi] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki, Japan; [Ichihara, Yu] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto, Japan; [Masuya, Hayato] Forestry & Forest Prod Res Inst, Dept Mushroom Sci & Forest Microbiol, Tsukuba, Ibaraki, Japan; [Anbutsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Computat Bio Big Data Open Innovat Lab, Shinjuku Ku, Tokyo, Japan; [Anbutsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Anbutsu, Hisashi] Waseda Univ, Res Org Nano & Life Innovat, Shinjuku Ku, Tokyo, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Waseda University	Aikawa, T (corresponding author), Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate, Japan.	taikawa@ffpri.affrc.go.jp		Aikawa, Takuya/0000-0001-9407-2184	Japan Society for the Promotion of Science [16H04944, 19H03004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	TA received KAKENHI grants (Nos. 16H04944 and 19H03004) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/index.html).The funder had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2020, NEMATOLOGY, V22, P713, DOI 10.1163/15685411-00003334; Aikawa T, 2014, APPL ENTOMOL ZOOL, V49, P337, DOI 10.1007/s13355-014-0256-0; Aikawa T, 2009, P ROY SOC B-BIOL SCI, V276, P3791, DOI 10.1098/rspb.2009.1022; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bourtzis K., 2008, INSECT SYMBIOSIS VOL, V3; Bourtzis K, 2003, INSECT SYMBIOSIS, V1; Breeuwer J.A.J., 1992, Insect Molecular Biology, V1, P25, DOI 10.1111/j.1365-2583.1993.tb00074.x; Caputo B, 2020, PEST MANAG SCI, V76, P1324, DOI 10.1002/ps.5643; Crawford JE, 2020, NAT BIOTECHNOL, V38, P482, DOI 10.1038/s41587-020-0471-x; Czarnetzki AB, 2004, ENVIRON MICROBIOL, V6, P35, DOI 10.1046/j.1462-2920.2003.00537.x; Dobson SL, 2003, TRENDS PARASITOL, V19, P128, DOI 10.1016/S1471-4922(03)00002-3; Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023; Gill WM, 2000, NEW PHYTOL, V147, P381, DOI 10.1046/j.1469-8137.2000.00707.x; Glowska E, 2015, INFECT GENET EVOL, V30, P140, DOI 10.1016/j.meegid.2014.12.019; Haselkorn TS, 2010, FLY, V4, P80, DOI 10.4161/fly.4.1.10883; Hayashi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155794; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; HOLDEN PR, 1993, MOL GEN GENET, V240, P213, DOI 10.1007/BF00277059; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Ijichi N, 2002, APPL ENVIRON MICROB, V68, P4074, DOI 10.1128/AEM.68.8.4074-4080.2002; da Silva LMI, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10010039; Kajtoch L, 2018, PEERJ, V6, DOI 10.7717/peerj.4471; Kaur R, 2021, CELL HOST MICROBE, V29, P879, DOI 10.1016/j.chom.2021.03.006; Kawai M, 2006, ENVIRON ENTOMOL, V35, P569, DOI 10.1603/0046-225X-35.2.569; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; Kittayapong P, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007771; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Kondo N, 2002, MOL ECOL, V11, P167, DOI 10.1046/j.0962-1083.2001.01432.x; Kondo N, 1999, ZOOL SCI, V16, P955, DOI 10.2108/zsj.16.955; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lo N, 2007, INT J SYST EVOL MICR, V57, P654, DOI 10.1099/ijs.0.64515-0; Maehara N, 2020, ECOL EVOL, V10, P14320, DOI 10.1002/ece3.7033; Mains JW, 2019, J MED ENTOMOL, V56, P1296, DOI 10.1093/jme/tjz051; Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Morimoto K., 2007, ICONOGRAPHIA INSECTO, VII; Nakamura S., 2019, FOOD PLANTS ECOLOGY; Nakamura Y, 2012, APPL ENTOMOL ZOOL, V47, P273, DOI 10.1007/s13355-012-0120-z; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; ONEILL SL, 2018, GATES OPEN RES, V0002; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Plewa R, 2018, ARTHROPOD SYST PHYLO, V76, P123; Riegler M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P547, DOI 10.1007/0-387-30745-1_22; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Russell JA, 2012, MYRMECOL NEWS, V16, P7; Sanguin H, 2006, ENVIRON MICROBIOL, V8, P289, DOI 10.1111/j.1462-2920.2005.00895.x; Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894; Shoda-Kagaya E., 2008, PINE WILT DIS, P184; Shoemaker DD, 2002, P ROY SOC B-BIOL SCI, V269, P2257, DOI 10.1098/rspb.2002.2100; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tagami Y, 2004, INSECT MOL BIOL, V13, P359, DOI 10.1111/j.0962-1075.2004.00492.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Yonezawa K., 1988, BIOMETRY; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zhao BG., 2008, PINE WILT DIS; Zhong Y, 2014, MICROB ECOL, V68, P463, DOI 10.1007/s00248-014-0425-2; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	70	2	2	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261928	10.1371/journal.pone.0261928	http://dx.doi.org/10.1371/journal.pone.0261928			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030199	gold, Green Published			2022-12-26	WOS:000812798500020
J	Guo, X; Gupta, A; Sampat, A; Zhai, CW				Guo, Xi; Gupta, Abhineet; Sampat, Anand; Zhai, Chengwei			A stochastic contact network model for assessing outbreak risk of COVID-19 in workplaces	PLOS ONE			English	Article							INFECTIOUS-DISEASE; ATTACK RATE; TRANSMISSION; SPREAD; STATES; CHINA	The COVID-19 pandemic has drastically shifted the way people work. While many businesses can operate remotely, a large number of jobs can only be performed on-site. Moreover as businesses create plans for bringing workers back on-site, they are in need of tools to assess the risk of COVID-19 for their employees in the workplaces. This study aims to fill the gap in risk modeling of COVID-19 outbreaks in facilities like offices and warehouses. We propose a simulation-based stochastic contact network model to assess the cumulative incidence in workplaces. First-generation cases are introduced as a Bernoulli random variable using the local daily new case rate as the success rate. Contact networks are established through randomly sampled daily contacts for each of the first-generation cases and successful transmissions are established based on a randomized secondary attack rate (SAR). Modification factors are provided for SAR based on changes in airflow, speaking volume, and speaking activity within a facility. Control measures such as mask wearing are incorporated through modifications in SAR. We validated the model by comparing the distribution of cumulative incidence in model simulations against real-world outbreaks in workplaces and nursing homes. The comparisons support the model's validity for estimating cumulative incidences for short forecasting periods of up to 15 days. We believe that the current study presents an effective tool for providing short-term forecasts of COVID-19 cases for workplaces and for quantifying the effectiveness of various control measures. The open source model code is made available at github.com/abhineetgupta/covid-workplace-risk.	[Guo, Xi; Gupta, Abhineet; Sampat, Anand; Zhai, Chengwei] One Concern Inc, Menlo Pk, CA 94025 USA		Guo, X; Gupta, A (corresponding author), One Concern Inc, Menlo Pk, CA 94025 USA.	cguo@oneconcern.com; abhineet@oneconcern.com	Gupta, Abhineet/GOE-6159-2022	Gupta, Abhineet/0000-0002-7992-9458; Zhai, Chengwei/0000-0002-8508-9838; Sampat, Anand/0000-0002-3409-6827	One Concern, Inc.	One Concern, Inc.	One Concern, Inc. provided support in the form of salaries for authors [XG, AG, AS, CZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	American Society of Microbiology (ASM), 2021, SUPPL SHORT IMP COVI; Asadi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38808-z; Azimi P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015482118; Azuma K, 2020, ENVIRON HEALTH PREV, V25, DOI 10.1186/s12199-020-00904-2; Bazant MZ, 2021, MEDRXIV; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Bohmer MM, 2020, LANCET INFECT DIS, V20, P920, DOI 10.1016/S1473-3099(20)30314-5; Bradbury Shelly, 2020, DENVER POST; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; Byambasuren Oyungerel, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P223, DOI 10.3138/jammi-2020-0030; Caglar D., 2021, BUSINESS NEEDS TIGHT; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Centers for Disease Control and Prevention, 2020, THE WELL; Centers for Medicare and Medicaid Services-Division of Nursing Homes/Quality Safety and Oversight Group/Center for Clinical Standards and Quality, 2021, COVID 19 NURS HOM DA; Chande A, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01000-9; Chaw L, 2020, MEDRXIV; Cheng H-Y, 2020, HIGH TRANSMISSIBILIT, DOI [10.1101/2020.03.18.20034561, DOI 10.1101/2020.03.18.20034561]; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Ferretti L., 2020, TIMING COVID 19 TRAN, DOI [DOI 10.1101/2020.09.04.20188516, 10.1101/2020.09.04.20188516, 10.2139/ssrn.3716879, DOI 10.1101/2020.09.04.20188516V2]; Fox MD, 2021, MMWR-MORBID MORTAL W, V70, P118, DOI 10.15585/mmwr.mm7004a3; Gabrel C S, 2000, Adv Data, P1; Gambell T, 2020, US CO ARE PLANNING S; Gandhi M, 2021, MED-CAMBRIDGE, V2, P29, DOI 10.1016/j.medj.2020.12.008; Genois M, 2015, NETW SCI, V3, P326, DOI 10.1017/nws.2015.10; Griffin RH, 2012, EVOL ECOL, V26, P779, DOI 10.1007/s10682-011-9526-2; Hamidi S, 2020, HEALTH PLACE, V64, DOI 10.1016/j.healthplace.2020.102378; Hamner L, 2020, MMWR-MORBID MORTAL W, V69, P606, DOI 10.15585/mmwr.mm6919e6; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hijnen D, 2020, EMERG INFECT DIS, V26, P1935, DOI 10.3201/eid2608.201235; James A, 2020, MMWR-MORBID MORTAL W, V69, P632, DOI 10.15585/mmwr.mm6920e2; Jenness SM, 2020, MEDRXIV; Karia Rutu, 2020, SN Compr Clin Med, V2, P1798, DOI 10.1007/s42399-020-00498-4; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kerr CC, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009149; Klepac P, 2020, MEDRXIV; Koh WC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240205; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Labcorp, 2021, GET MY COVID 19 TEST; Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012; Lau H, 2021, PULMONOLOGY, V27, P110, DOI 10.1016/j.pulmoe.2020.05.015; Lerman, 2020, WASH POST; Li W, 2020, CLIN INFECT DIS, V71, P1943, DOI 10.1093/cid/ciaa450; Liu F, 2021, INDOOR AIR, V31, P369, DOI 10.1111/ina.12737; Liu F, 2020, SCI BULL, V65, P1297, DOI 10.1016/j.scib.2020.04.043; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lund S., 2021, FUTURE WORK COVID 19; Lund S., 2020, WHATS NEXT REMOTE WO; Lund SusanWan-LaeCheng, 2020, WHAT 800 EXECUTIVES; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Mentus C, 2020, MEDRXIV; Mizumoto K, 2020, INT J INFECT DIS, V97, P96, DOI 10.1016/j.ijid.2020.05.091; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Mossong J, 2020, POLYMOD SOCIAL CONTA; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Murray MT, 2020, MMWR-MORBID MORTAL W, V69, P1542, DOI 10.15585/mmwr.mm6942a4; Nissen K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76442-2; Noorimotlagh Z, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110612; O'Connor L., 2020, MOD HEALTHCARE; Olsson C, 2021, MICROCOVID PROJECT; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Pang Q., 2020, ANHUI J PREV MED, V26, P130; Park SY, 2020, EMERG INFECT DIS, V26, P1666, DOI 10.3201/eid2608.201274; Pollock AM, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4851; Prentiss M., 2020, MEDRXIV; Pung R, 2020, LANCET, V395, P1039, DOI 10.1016/S0140-6736(20)30528-6; Qian H, 2021, INDOOR AIR, V31, P639, DOI 10.1111/ina.12766; Ridenhour B, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2013.301704; Sanghvi A., 2020, REIMAGINING OFFICE W; Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932; Shao SY, 2021, J AEROSOL SCI, V151, DOI 10.1016/j.jaerosci.2020.105661; Shen Y, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa231; Singer BJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81814-3; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Steinberg J, 2020, MMWR-MORBID MORTAL W, V69, P1015, DOI 10.15585/mmwr.mm6931a2; Tao J, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100166; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640, 10.1101/2020.12.21.20248640(2020]; Tyson A, 2020, PEW RES CTR; Vella F, 2020, EUR REV MED PHARMACO, V24, P7889, DOI 10.26355/eurrev_202007_22296; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Wang R, 2020, J PHYS CHEM LETT, V11, P10007, DOI 10.1021/acs.jpclett.0c02765; Weitz JS, 2021, COVID 19 EVENT RISK; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Wu J, 2020, CLIN INFECT DIS, V71, P2099, DOI 10.1093/cid/ciaa557; Xiao Y, 2020, ARXIV200610666 PHYS; Yu C, 2020, VIRULENCE, V11, P1006, DOI 10.1080/21505594.2020.1802194; Zhang XA, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101620; Zhang Y., 2020, ZHONGHUA LIU XING BI, V41, P649	89	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262316	10.1371/journal.pone.0262316	http://dx.doi.org/10.1371/journal.pone.0262316			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030206	Green Published, gold			2022-12-26	WOS:000812798500039
J	Simar, C; Petit, R; Bozga, N; Leroy, A; Cebolla, AM; Petieau, M; Bontempi, G; Cheron, G				Simar, Cedric; Petit, Robin; Bozga, Nichita; Leroy, Axelle; Cebolla, Ana-Maria; Petieau, Mathieu; Bontempi, Gianluca; Cheron, Guy			Riemannian classification of single-trial surface EEG and sources during checkerboard and navigational images in humans	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; ELECTROMAGNETIC TOMOGRAPHY; POTENTIALS; ALGORITHMS; COMPONENTS; SIGNALS; CORTEX	Objective Different visual stimuli are classically used for triggering visual evoked potentials comprising well-defined components linked to the content of the displayed image. These evoked components result from the average of ongoing EEG signals in which additive and oscillatory mechanisms contribute to the component morphology. The evoked related potentials often resulted from a mixed situation (power variation and phase-locking) making basic and clinical interpretations difficult. Besides, the grand average methodology produced artificial constructs that do not reflect individual peculiarities. This motivated new approaches based on single-trial analysis as recently used in the brain-computer interface field. Approach We hypothesize that EEG signals may include specific information about the visual features of the displayed image and that such distinctive traits can be identified by state-of-the-art classification algorithms based on Riemannian geometry. The same classification algorithms are also applied to the dipole sources estimated by sLORETA. Main results and significance We show that our classification pipeline can effectively discriminate between the display of different visual items (Checkerboard versus 3D navigational image) in single EEG trials throughout multiple subjects. The present methodology reaches a single-trial classification accuracy of about 84% and 93% for inter-subject and intra-subject classification respectively using surface EEG. Interestingly, we note that the classification algorithms trained on sLORETA sources estimation fail to generalize among multiple subjects (63%), which may be due to either the average head model used by sLORETA or the subsequent spatial filtering failing to extract discriminative information, but reach an intra-subject classification accuracy of 82%.	[Simar, Cedric; Petit, Robin; Bozga, Nichita; Bontempi, Gianluca] Univ Libre Bruxelles ULB, Fac Sci, Comp Sci Dept, Machine Learning Grp, Brussels, Belgium; [Petit, Robin] Vrije Univ Brussel, Univ Libre Bruxelles, Interuniv Inst Bioinformat Brussels, Brussels, Belgium; [Leroy, Axelle; Cebolla, Ana-Maria; Petieau, Mathieu; Cheron, Guy] Univ Libre Bruxelles ULB, Neurosci Inst, Lab Neurophysiol & Movement Biomech, Brussels, Belgium; [Cheron, Guy] Univ Mons Hainaut, Lab Electrophysiol, Mons, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; University of Mons	Simar, C (corresponding author), Univ Libre Bruxelles ULB, Fac Sci, Comp Sci Dept, Machine Learning Grp, Brussels, Belgium.	cedric.simar@ulb.be	Bontempi, Gianluca/HII-4838-2022; Simar, Cédric/GRJ-1406-2022	Simar, Cedric/0000-0002-6412-4163; Bozga, Nichita/0000-0002-8538-0262	Brain & Society foundation	Brain & Society foundation	The authors thank the fund Leibu and the Brain & Society foundation for their support as well as T. D'Angelo, M. Dufief, E. Hortmanns, E. Pecoraro, and E. Toussaint for expert technical assistance.	Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; Baijot S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120167; Barachant A., 2014, MEG DECODING USING R; Barachant A, 2013, NEUROCOMPUTING, V112, P172, DOI 10.1016/j.neucom.2012.12.039; Barachant A, 2012, IEEE T BIO-MED ENG, V59, P920, DOI 10.1109/TBME.2011.2172210; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blum S, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00141; Cebolla AM, 2011, NEUROIMAGE, V54, P1297, DOI 10.1016/j.neuroimage.2010.08.060; Cebolla AM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02133; Cecotti H, 2017, INT J PSYCHOPHYSIOL, V111, P156, DOI 10.1016/j.ijpsycho.2016.07.500; Chen YL, 2010, IEEE T SIGNAL PROCES, V58, P5016, DOI 10.1109/TSP.2010.2053029; Cheron G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-75; Cheron G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082371; Chevallier S, 2021, NEUROINFORMATICS, V19, P93, DOI 10.1007/s12021-020-09473-9; Congedo M, 2017, IEEE ENG MED BIO, P3198, DOI 10.1109/EMBC.2017.8037537; Coon WG, 2016, J NEUROSCI METH, V271, P76, DOI 10.1016/j.jneumeth.2016.06.024; DAWSON GD, 1954, ELECTROEN CLIN NEURO, V6, P65, DOI 10.1016/0013-4694(54)90007-3; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2015, J NEUROSCI METH, V250, P3, DOI 10.1016/j.jneumeth.2014.10.003; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Freunberger R, 2009, HUM BRAIN MAPP, V30, P3417, DOI 10.1002/hbm.20766; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Guan S, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/5627156; Hanslmayr S, 2007, CEREB CORTEX, V17, P1, DOI 10.1093/cercor/bhj129; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Iemi L, 2019, ELIFE, V8, DOI 10.7554/eLife.43620; Jones E., 2001, SCIPY OPEN SOURCE SC; Kalaganis FP, 2020, IEEE T BIO-MED ENG, V67, P245, DOI 10.1109/TBME.2019.2912066; Kappenman Emily S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P110; Karch JD, 2015, NEUROIMAGE, V118, P538, DOI 10.1016/j.neuroimage.2015.04.038; KOLES ZJ, 1991, ELECTROEN CLIN NEURO, V79, P440, DOI 10.1016/0013-4694(91)90163-X; Korczowski L, 2015, IEEE ENG MED BIO, P1769, DOI 10.1109/EMBC.2015.7318721; KURITATASHIMA S, 1991, ELECTROEN CLIN NEURO, V80, P161, DOI 10.1016/0168-5597(91)90118-H; Langeslag SJE, 2018, BRAIN RES, V1678, P297, DOI 10.1016/j.brainres.2017.10.031; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Leroy A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69448-3; Leroy A, 2018, NEUROSCIENCE, V373, P92, DOI 10.1016/j.neuroscience.2018.01.022; Leroy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178817; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aab2f2; Majidov I, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19071736; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Moakher M, 2005, SIAM J MATRIX ANAL A, V26, P735, DOI 10.1137/S0895479803436937; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Navarro-Sune X, 2017, IEEE T BIO-MED ENG, V64, P1138, DOI 10.1109/TBME.2016.2592820; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Pernet CR, 2021, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.610388; Pernet CR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00322; Potvin O, 2017, NEUROIMAGE, V156, P43, DOI 10.1016/j.neuroimage.2017.04.035; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rey HG, 2015, CURR OPIN NEUROBIOL, V31, P148, DOI 10.1016/j.conb.2014.10.009; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Shigihara Y, 2016, NEUROIMAGE, V134, P532, DOI 10.1016/j.neuroimage.2016.03.078; Stewart AX, 2014, J NEUROSCI METH, V228, P1, DOI 10.1016/j.jneumeth.2014.02.014; Tomberg C, 1996, J PHYSIOL-LONDON, V496, P559, DOI 10.1113/jphysiol.1996.sp021707; TOMBERG C, 1994, NEUROSCI LETT, V168, P123, DOI 10.1016/0304-3940(94)90431-6; Tuzel O, 2008, IEEE T PATTERN ANAL, V30, P1713, DOI 10.1109/TPAMI.2008.75; Vidal M, 2004, COGNITIVE BRAIN RES, V19, P244, DOI 10.1016/j.cogbrainres.2003.12.006; Wang J, 2018, COMPUT BIOL MED, V97, P161, DOI 10.1016/j.compbiomed.2018.04.022; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu JC, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab839e; Yger F, 2017, IEEE T NEUR SYS REH, V25, P1753, DOI 10.1109/TNSRE.2016.2627016; Zeng H, 2016, IEEE T NEUR NET LEAR, V27, P2301, DOI 10.1109/TNNLS.2015.2475618	73	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262417	10.1371/journal.pone.0262417	http://dx.doi.org/10.1371/journal.pone.0262417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030232	gold, Green Published			2022-12-26	WOS:000812798500043
J	Humphries, H; Upfold, M; Mahlase, G; Mdladla, M; Gengiah, TN; Karim, QA				Humphries, Hilton; Upfold, Michele; Mahlase, Gethwana; Mdladla, Makhosazana; Gengiah, Tanuja N.; Karim, Quarraisha Abdool			Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision	PLOS ONE			English	Article							ACTING REVERSIBLE CONTRACEPTION; HEALTH-CARE PROVIDERS; SOUTH-AFRICA; PREEXPOSURE PROPHYLAXIS; MISCONCEPTIONS; PERSPECTIVES; MYTHS; RISK; GAPS	Preventing new HIV infections, especially amongst young women, is key to ending the HIV epidemic especially in sub-Saharan Africa. Potent antiretroviral (ARV) drugs used as pre-exposure prophylaxis (PrEP) are currently being formulated as long-acting implantable devices, or nanosuspension injectables that release drug at a sustained rate providing protection from acquiring HIV. PrEP as implants (PrEP Implants) offers an innovative and novel approach, expanding the HIV prevention toolbox. Feedback from providers and future users in the early clinical product development stages may identify modifiable characteristics which can improve acceptability and uptake of new technologies. Healthcare workers (HCWs) perspectives and lessons learned during the rollout of contraceptive implants will allow us to understand what factors may impact the roll-out of PrEP implants. We conducted eighteen interviews with HCWs (9 Nurses and 9 Community Healthcare Workers) in rural KwaZulu-Natal, South Africa. HCWs listed the long-acting nature of the contraceptive implant as a key benefit, helping to overcome healthcare system barriers like heavy workloads and understaffing. However, challenges like side effects, migration of the implant, stakeholder buy-in and inconsistent training on insertion and removal hampered the roll-out of the contraceptive implant. For PrEP implants, HCWs preferred long-acting products that were palpable and biodegradable. Our findings highlighted that the characteristics of PrEP implants that are perceived to be beneficial by HCWs may not align with that of potential users, potentially impacting the acceptability and uptake of PrEP implants. Further our data highlight the need for sustained and multi-pronged approaches to training HCWs and introducing new health technologies into communities. Finding a balance between the needs of HCWs that accommodate their heavy workloads, limited resources at points of delivery of care and the needs and preferences of potential users need to be carefully considered in the development of PrEP implants.	[Humphries, Hilton; Upfold, Michele; Mahlase, Gethwana; Mdladla, Makhosazana; Gengiah, Tanuja N.; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa	University of Kwazulu Natal	Humphries, H (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.	Hilton.humphries@caprisa.org	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Humphries, Hilton/0000-0001-8503-4127; Gengiah, Tanuja/0000-0002-3405-5128	South African Medical Research Council Special initiative grant [00251]; Department of Science and Innovation-National Research Foundation Centre of Excellence in HIV Prevention	South African Medical Research Council Special initiative grant; Department of Science and Innovation-National Research Foundation Centre of Excellence in HIV Prevention	Funding: Funding for the study was provided by South African Medical Research Council Special initiative grant (00251), and partial support from the Department of Science and Innovation-National Research Foundation Centre of Excellence in HIV Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Beesham I, 2021, AFR J REPROD HEALTH, V25, P41, DOI 10.29063/ajrh2021/v25i1.5; Bekker LG, 2018, LANCET HIV, V5, pE68, DOI 10.1016/S2352-3018(17)30156-X; Blackstone SR, 2017, INT Q COMMUNITY HEAL, V37, P79, DOI 10.1177/0272684X16685254; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Brown A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7312-1; Bukenya D, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-018-0214-y; Dunbar MS, 2018, SEX HEALTH, V15, P513, DOI 10.1071/SH18061; Garrett CC, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0227-9; IAVI, 2021, EV ACC PATHW LONG AC; Ismail H, 2006, J FAM PLAN REPROD H, V32, P157, DOI 10.1783/147118906777888413; Karim SSAA, 2019, CAPRISA 018 PHASE 3; Kerrigan D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190487; Kharsany ABM, 2018, LANCET HIV, V5, pE427, DOI 10.1016/S2352-3018(18)30104-8; Kharsany ABM, 2015, JAIDS-J ACQ IMM DEF, V70, P289, DOI 10.1097/QAI.0000000000000761; Kriel Y, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0749-y; Krogstad EA, 2019, AIDS PATIENT CARE ST, V33, P157, DOI 10.1089/apc.2018.0177; Mansoor LE, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25381; Montgomery ET, 2019, JAIDS-J ACQ IMM DEF, V80, P542, DOI 10.1097/QAI.0000000000001960; Morrison CS, 2007, AIDS, V21, P85, DOI 10.1097/QAD.0b013e3280117c8b; Mullick S, 2017, SAMJ S AFR MED J, V107, P812, DOI [10.7196/SAMJ.2017.v107i10.12849, 10.7196/samj.2017.v107i10.12849]; Mwaisaka J, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09849-1; Nanda K, 2015, WOMENS HEALTH, V11, P729, DOI 10.2217/whe.15.84; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Ontiri S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091543; Patel RC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21396; Pillay D, 2017, SAMJ S AFR MED J, V107, P827, DOI [10.7196/SAMJ.2017.v107i10.12822, 10.7196/samj.2017.v107i10.12822]; Pleaner M, 2017, SAMJ S AFR MED J, V107, P933, DOI [10.7196/samj.2017.v107i11.12805, 10.7196/SAMJ.2017.v107i11.12805]; Ralph LJ, 2015, LANCET INFECT DIS, V15, P181, DOI 10.1016/S1473-3099(14)71052-7; Rees H, 2017, SAMJ S AFR MED J, V107, P939, DOI [10.7196/SAMJ.2017.v107i11.12903, 10.7196/samj.2017.v107i11.12903]; Roberts K, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0707-y; Russo JA, 2013, J ADOLESCENT HEALTH, V52, pS14, DOI 10.1016/j.jadohealth.2013.02.003; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Staveteig S., 2015, DHS ANAL STUDIES, V54; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Thomson KA, 2016, CURR OPIN HIV AIDS, V11, P18, DOI 10.1097/COH.0000000000000207; UNAIDS, 2019, WOM HIV SPOTL AD GIR, P120	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262043	10.1371/journal.pone.0262043	http://dx.doi.org/10.1371/journal.pone.0262043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025908	Green Published, gold			2022-12-26	WOS:000796264200041
J	Marbaniang, SP; Chungkham, HS; Lhungdim, H				Marbaniang, Strong P.; Chungkham, Holendro Singh; Lhungdim, Hemkhothang			A structured additive modeling of diabetes and hypertension in Northeast India	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RISK-FACTORS; PREVALENCE; ASSOCIATION; OBESITY; ALTITUDE	Background Multiple factors are associated with the risk of diabetes and hypertension. In India, they vary widely even from one district to another. Therefore, strategies for controlling diabetes and hypertension should appropriately address local risk factors and take into account the specific causes of the prevalence of diabetes and hypertension at sub-population levels and in specific settings. This paper examines the demographic and socioeconomic risk factors as well as the spatial disparity of diabetes and hypertension among adults aged 15-49 years in Northeast India. Methods The study used data from the Indian Demographic Health Survey, which was conducted across the country between 2015 and 2016. All men and women between the ages of 15 and 49 years were tested for diabetes and hypertension as part of the survey. A Bayesian geo-additive model was used to determine the risk factors of diabetes and hypertension. Results The prevalence rates of diabetes and hypertension in Northeast India were, respectively, 6.38% and 16.21%. The prevalence was higher among males, urban residents, and those who were widowed/divorced/separated. The functional relationship between household wealth index and diabetes and hypertension was found to be an inverted U-shape. As the household wealth status increased, its effect on diabetes also increased. However, interestingly, the inverse was observed in the case of hypertension, that is, as the household wealth status increased, its effect on hypertension decreased. The unstructured spatial variation in diabetes was mainly due to the unobserved risk factors present within a district that were not related to the nearby districts, while for hypertension, the structured spatial variation was due to the unobserved factors that were related to the nearby districts. Conclusion Diabetes and hypertension control measures should consider both local and non-local factors that contribute to the spatial heterogeneity. More importance should be given to efforts aimed at evaluating district-specific factors in the prevalence of diabetes within a region.	[Marbaniang, Strong P.; Lhungdim, Hemkhothang] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India; [Marbaniang, Strong P.] Sankardev Coll, Dept Stat, Shillong, Meghalaya, India; [Chungkham, Holendro Singh] Indian Stat Inst, North East Ctr, Tezpur, Assam, India; [Chungkham, Holendro Singh] Stockholm Univ, Stress Res Inst, Stockholm, Sweden	International Institute for Population Sciences; Stockholm University	Marbaniang, SP (corresponding author), Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India.; Marbaniang, SP (corresponding author), Sankardev Coll, Dept Stat, Shillong, Meghalaya, India.	strongmarbaniang@yahoo.com	Marbaniang, Strong P/AAN-9493-2021; Chungkham, Holendro Singh/G-6804-2012	Marbaniang, Strong P/0000-0001-5347-1867; Chungkham, Holendro Singh/0000-0002-6016-8943				Adebayo SB, 2019, HIV AIDS REV, V18, P247, DOI 10.5114/hivar.2019.83852; Akhtar S, 2017, J SOC HEAL DIABETES, V5, P028, DOI [10.4103/2321- 0656.194001, DOI 10.4103/2321-0656.194001]; Anjana RM, 2017, LANCET DIABETES ENDO, V5, P585, DOI 10.1016/S2213-8587(17)30174-2; Astell-Burt T, 2014, INT J OBESITY, V38, P156, DOI 10.1038/ijo.2013.64; Astell-Burt T, 2014, DIABETES CARE, V37, P197, DOI 10.2337/dc13-1325; Baek TH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2175-6; Bansal Sushil K, 2012, J Cardiovasc Dis Res, V3, P117, DOI 10.4103/0975-3583.95365; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; Borah PK, 2020, INDIAN HEART J, V72, P398, DOI 10.1016/j.ihj.2020.08.003; Campbell Amy P, 2017, Diabetes Spectr, V30, P76, DOI 10.2337/ds16-0084; Carbone S, 2019, VASC HEALTH RISK MAN, V15, P89, DOI 10.2147/VHRM.S168946; Carbone S, 2017, MAYO CLIN PROC, V92, P266, DOI 10.1016/j.mayocp.2016.11.001; Constant AF., 2016, HYPERTENSION CARDIOV, P351, DOI [10.1007/978-3-319-39599-9, DOI 10.1007/978-3-319-39599-9]; DHS, 2017, DHS PROGR IND STAND; GADM, 2021, US; Ghosh K, 2020, J PUBLIC HEALTH-HEID, V28, P535, DOI 10.1007/s10389-019-01072-6; Ghosh S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010085; Ghosh S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029714; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Gupta R, 2019, J HUM HYPERTENS, V33, P575, DOI 10.1038/s41371-018-0117-3; Hanna JM, 1999, HUM BIOL, V71, P553; Haynes-Maslow L, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4658-0; Hazarika N C, 2003, J Assoc Physicians India, V51, P567; Hernandez AM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3865; Hossain F, 2019, INDIAN J HUM DEV, V13, P221; Husain K, 2014, WORLD J CARDIOL, V6, P245, DOI 10.4330/wjc.v6.i5.245; IIPS and ICF, 2020, NATL FAMILY HLTH SUR; International Diabetes Federation, 2019, ADV GUID IDF DIAB AT; Kandala NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101103; Kandala NB, 2013, AM J HYPERTENS, V26, P382, DOI 10.1093/ajh/hps063; Nam KD, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03383; Koissi M-C, 2013, AFRICAN POPUL STUD, V20, P1; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Li GJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4802-x; Lin XL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71908-9; Marbaniang SP., 2020, CHILD CARE PRACT, DOI [10.1080/13575279.2020.1812534, DOI 10.1080/13575279.2020.1812534]; Marbaniang SP, 2021, DIABETES METAB SYND, V15, DOI 10.1016/j.dsx.2021.102227; Marbaniang SP, 2021, CLIN EPIDEMIOL GLOB, V11, DOI 10.1016/j.cegh.2021.100764; Mayilvaganan M., 2020, TAWANG, DOI [10.1007/978-981-15-4346-3, DOI 10.1007/978-981-15-4346-3]; Mingji C, 2015, HEART, V101, P1054, DOI 10.1136/heartjnl-2014-307158; Mungreiphy N.K., 2011, J ANTHR, V127, P119, DOI [10.1155/2011/78147, DOI 10.1155/2011/748147, 10.1155/2011/748147.]; Ngangbam S, 2019, J HEALTH MANAG, V21, P234, DOI 10.1177/0972063419835118; Ngianga-Bakwin K., 2004, AFRICAN POPUL STUD S, V19, P199; Rasiah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-886; Sabri S, 2005, Med J Malaysia, V60, P416; SEAR AM, 1982, J BIOSOC SCI, V14, P213, DOI 10.1017/S0021932000014036; Singh S, 2020, J DIABETES METAB DIS, V19, P523, DOI 10.1007/s40200-020-00545-w; Sobngwi E, 2002, INT J OBESITY, V26, P1009, DOI 10.1038/sj.ijo.0802008; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; van der Sande MAB, 2001, J HUM HYPERTENS, V15, P733, DOI 10.1038/sj.jhh.1001259; Wei C, 2016, EATER; World Health Organization, 2019, HYPERTENSION; Zaccardi F, 2017, DIABETOLOGIA, V60, P240, DOI 10.1007/s00125-016-4162-6; Zaman Forhad Akhtar, 2014, J Nat Sci Biol Med, V5, P383, DOI 10.4103/0976-9668.136195; Zeileis, 2019, BAMLSS LEGO TOOLBOX; Zhiwen T., 2018, J CHENGDU MED COLL, V13	58	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262560	10.1371/journal.pone.0262560	http://dx.doi.org/10.1371/journal.pone.0262560			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025967	gold, Green Published			2022-12-26	WOS:000796264200086
J	Mir, AA; Kearfott, KJ; Celebi, FV; Rafique, M				Mir, Adil Aslam; Kearfott, Kimberlee Jane; Celebi, Fatih Vehbi; Rafique, Muhammad			Imputation by feature importance (IBFI): A methodology to envelop machine learning method for imputing missing patterns in time series data	PLOS ONE			English	Article							SOIL RADON; EARTHQUAKE PRECURSOR; MULTIPLE IMPUTATION; METEOROLOGICAL PARAMETERS; ENVIRONMENTAL PARAMETERS; NORTHERN PAKISTAN; GAS; GROUNDWATER; AIR; PREDICTION	A new methodology, imputation by feature importance (IBFI), is studied that can be applied to any machine learning method to efficiently fill in any missing or irregularly sampled data. It applies to data missing completely at random (MCAR), missing not at random (MNAR), and missing at random (MAR). IBFI utilizes the feature importance and iteratively imputes missing values using any base learning algorithm. For this work, IBFI is tested on soil radon gas concentration (SRGC) data. XGBoost is used as the learning algorithm and missing data are simulated using R for different missingness scenarios. IBFI is based on the physically meaningful assumption that SRGC depends upon environmental parameters such as temperature and relative humidity. This assumption leads to a model obtained from the complete multivariate series where the controls are available by taking the attribute of interest as a response variable. IBFI is tested against other frequently used imputation methods, namely mean, median, mode, predictive mean matching (PMM), and hot-deck procedures. The performance of the different imputation methods was assessed using root mean squared error (RMSE), mean squared log error (MSLE), mean absolute percentage error (MAPE), percent bias (PB), and mean squared error (MSE) statistics. The imputation process requires more attention when multiple variables are missing in different samples, resulting in challenges to machine learning methods because some controls are missing. IBFI appears to have an advantage in such circumstances. For testing IBFI, Radon Time Series Data (RTS) has been used and data was collected from 1st March 2017 to the 11th of May 2018, including 4 seismic activities that have taken place during the data collection time.	[Mir, Adil Aslam; Celebi, Fatih Vehbi] Ankara Yildirim Beyazit Univ, Dept Comp Engn, Ayvali, Kecioren Ankara, Turkey; [Mir, Adil Aslam] Univ Azad Jammu & Kashmir, Dept Comp Sci & Informat Technol, Muzaffarabad, Azad Kashmir, Pakistan; [Kearfott, Kimberlee Jane] Univ Michigan, Dept Nucl Engn & Radiol Sci, Ann Arbor, MI 48109 USA; [Rafique, Muhammad] Univ Azad Jammu & Kashmir Muzaffarabad, Dept Phys, King Abdullah Campus, Azad Kashmir, Pakistan	University of Azad Jammu & Kashmir; University of Michigan System; University of Michigan; University of Azad Jammu & Kashmir	Mir, AA (corresponding author), Ankara Yildirim Beyazit Univ, Dept Comp Engn, Ayvali, Kecioren Ankara, Turkey.; Mir, AA (corresponding author), Univ Azad Jammu & Kashmir, Dept Comp Sci & Informat Technol, Muzaffarabad, Azad Kashmir, Pakistan.	adilmir300@gmail.com		Rafique, Muhammad/0000-0002-5216-9380	 [6453/AJK/NRPU/RD/HEC/2016]		Muhammad Rafique Higher Education Commision, Pakistan Grant No: 6453/AJK/NRPU/R&D/HEC/2016 under NRPU scheme to principal investigator MR. www.hec.gov.pk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino F, 2019, RADIAT PROT DOSIM, V186, P428, DOI 10.1093/rpd/ncz245; Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; Arora BR, 2017, J ASIAN EARTH SCI, V149, P49, DOI 10.1016/j.jseaes.2017.06.033; Ayturan YA., 2018, INT J ENV POLLUTION, V1, P58; Banks D, 1998, SCI TOTAL ENVIRON, V222, P71, DOI 10.1016/S0048-9697(98)00291-5; Barkat A, 2018, APPL GEOCHEM, V97, P197, DOI 10.1016/j.apgeochem.2018.08.016; Barkat A, 2017, GEOCHEM J, V51, P337, DOI 10.2343/geochemj.2.0473; Blomberg AJ, 2019, J AIR WASTE MANAGE, V69, P266, DOI 10.1080/10962247.2018.1523071; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Choubey VM, 2009, SCI TOTAL ENVIRON, V407, P5877, DOI 10.1016/j.scitotenv.2009.08.010; Cigolini C, 2009, J VOLCANOL GEOTH RES, V184, P381, DOI 10.1016/j.jvolgeores.2009.04.019; Crockett RGM, 2006, SCI TOTAL ENVIRON, V364, P138, DOI 10.1016/j.scitotenv.2005.08.003; Dubinchuk V, 1993, GEOCHEMICAL PRECURSO; Fichman M, 2003, ORGAN RES METHODS, V6, P282, DOI 10.1177/1094428103255532; Field R W, 2001, Rev Environ Health, V16, P151; Fujiyoshi R, 2006, SCI TOTAL ENVIRON, V370, P224, DOI 10.1016/j.scitotenv.2006.07.007; Ghosh D, 2009, J APPL GEOPHYS, V69, P67, DOI 10.1016/j.jappgeo.2009.06.001; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; HAUKSSON E, 1981, J GEOPHYS RES, V86, P9397, DOI 10.1029/JB086iB10p09397; IGARASHI G, 1995, SCIENCE, V269, P60, DOI 10.1126/science.269.5220.60; Inan S, 2012, NAT HAZARDS, V62, P575, DOI 10.1007/s11069-012-0096-6; Janik M, 2018, SCI TOTAL ENVIRON, V630, P1155, DOI 10.1016/j.scitotenv.2018.02.233; Jerez JM, 2010, ARTIF INTELL MED, V50, P105, DOI 10.1016/j.artmed.2010.05.002; Joenssen DW., 2012, INT WORKSHOP MACHINE; Junger WL, 2015, ATMOS ENVIRON, V102, P96, DOI 10.1016/j.atmosenv.2014.11.049; Kawabata K, 2020, J HYDROL, V584, DOI 10.1016/j.jhydrol.2020.124712; KEARFOTT KJ, 1989, HEALTH PHYS, V56, P169, DOI 10.1097/00004032-198902000-00004; KEARFOTT KJ, 1992, HEALTH PHYS, V63, P674, DOI 10.1097/00004032-199212000-00008; Kleinke K, 2018, METHODOLOGY-EUR, V14, P3, DOI 10.1027/1614-2241/a000141; KLUSMAN RW, 1981, B SEISMOL SOC AM, V71, P211; Kowarik A, 2016, J STAT SOFTW, V74, DOI 10.18637/jss.v074.i07; Kraner HW., 1964, NATURAL RAD ENV; Krewski D, 2006, J TOXICOL ENV HEAL A, V69, P533, DOI 10.1080/15287390500260945; Kumar U, 2010, STOCH ENV RES RISK A, V24, P751, DOI 10.1007/s00477-009-0361-8; Lakshminarayan K., 1996, IMPUTATION MISSING D; Levintal E, 2020, SCI TOTAL ENVIRON, V722, DOI 10.1016/j.scitotenv.2020.137857; Li P, 2015, JAMA-J AM MED ASSOC, V314, P1966, DOI 10.1001/jama.2015.15281; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Mital U, 2020, FRONT WATER, V2, DOI 10.3389/frwa.2020.00020; Negarestani A, 2003, APPL RADIAT ISOTOPES, V58, P269, DOI 10.1016/S0969-8043(02)00304-4; Negarestani A, 2002, J ENVIRON RADIOACTIV, V62, P225, DOI 10.1016/S0265-931X(01)00165-5; OLGUIN MT, 1993, SCI TOTAL ENVIRON, V130, P43, DOI 10.1016/0048-9697(93)90058-E; Perrier F, 2009, SCI TOTAL ENVIRON, V407, P2361, DOI 10.1016/j.scitotenv.2008.12.018; PORSTENDORFER J, 1994, HEALTH PHYS, V67, P283, DOI 10.1097/00004032-199409000-00011; Qin YS, 2007, APPL INTELL, V27, P79, DOI 10.1007/s10489-006-0032-0; R Core Team, 2013, R LANG ENV STAT COMP; Rafique M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59881-9; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; RUBIN DB, 1986, J BUS ECON STAT, V4, P87, DOI 10.2307/1391390; Rubin DB, 2004, MULTIPLE IMPUTATION; Sahoo SK, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-017-6434-0; Salgado Catia M., 2016, SECONDARY ANAL ELECT; Schlomer GL, 2010, J COUNS PSYCHOL, V57, P1, DOI 10.1037/a0018082; Schouten RM, 2018, J STAT COMPUT SIM, V88, P2909, DOI 10.1080/00949655.2018.1491577; SHENBER MA, 1992, SCI TOTAL ENVIRON, V119, P243, DOI 10.1016/0048-9697(92)90267-V; Singh M., 1988, Journal of Association of Exploration Geophysicists, V9, P85; Smetanova I, 2010, J RADIOANAL NUCL CH, V283, P101, DOI 10.1007/s10967-009-0128-1; Smith BJ, 2007, STAT MED, V26, P4619, DOI 10.1002/sim.2884; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Sundal AV, 2008, SCI TOTAL ENVIRON, V389, P418, DOI 10.1016/j.scitotenv.2007.09.001; Tareen ADK, 2019, APPL RADIAT ISOTOPES, V154, DOI 10.1016/j.apradiso.2019.108861; Tareen ADK, 2019, J ENVIRON RADIOACTIV, V203, P48, DOI 10.1016/j.jenvrad.2019.03.003; Toutain JP, 1999, TECTONOPHYSICS, V304, P1, DOI 10.1016/S0040-1951(98)00295-9; Van Buuren S., 2018, FLEXIBLE IMPUTATION, DOI [DOI 10.1201/9780429492259, 10.1201/9780429492259]; van Buuren S, 2011, J STAT SOFTW, V45, P1; Duong VH, 2021, ENVIRON POLLUT, V282, DOI 10.1016/j.envpol.2021.116973; VIRK HS, 1994, GEOPHYS RES LETT, V21, P737, DOI 10.1029/94GL00310; WAKITA H, 1980, SCIENCE, V207, P882, DOI 10.1126/science.207.4433.882; Walia V, 2005, TERR ATMOS OCEAN SCI, V16, P775, DOI 10.3319/TAO.2005.16.4.775(GIG); Woith H, 2015, EUR PHYS J-SPEC TOP, V224, P611, DOI 10.1140/epjst/e2015-02395-9; Xie D, 2012, ATMOS ENVIRON, V60, P453, DOI 10.1016/j.atmosenv.2012.07.006; Yitshak-Sade M, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.05.059; Yuan YC., 2000, P 25 ANN SAS USERS G; Zakaria NA., 2018, URBANISM ARHITECTURA, V9, P159; Zmazek B, 2003, APPL RADIAT ISOTOPES, V58, P697, DOI 10.1016/S0969-8043(03)00094-0	77	5	5	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262131	10.1371/journal.pone.0262131	http://dx.doi.org/10.1371/journal.pone.0262131			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025953	Green Published, gold			2022-12-26	WOS:000796264200049
J	Fjaestad, KY; Romer, AMA; Goitea, V; Johansen, AZ; Thorseth, ML; Carretta, M; Engelholm, LH; Grontved, L; Junker, N; Madsen, DH				Fjaestad, Klaire Yixin; Romer, Anne Mette Askehoj; Goitea, Victor; Johansen, Astrid Zedlitz; Thorseth, Marie-Louise; Carretta, Marco; Engelholm, Lars Henning; Grontved, Lars; Junker, Niels; Madsen, Daniel Hargbol			Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment	ONCOGENE			English	Article							NERVOUS-SYSTEM; OPEN-LABEL; PROPRANOLOL; CELLS; PEMBROLIZUMAB; COMBINATION; MANAGEMENT; SUPPRESSES; PHENOTYPE; MORTALITY	The development of immune checkpoint inhibitors (ICI) marks an important breakthrough of cancer therapies in the past years. However, only a limited fraction of patients benefit from such treatments, prompting the search for immune modulating agents that can improve the therapeutic efficacy. The nonselective beta blocker, propranolol, which for decades has been prescribed for the treatment of cardiovascular conditions, has recently been used successfully to treat metastatic angiosarcoma. These results have led to an orphan drug designation by the European Medicines Agency for the treatment of soft tissue sarcomas. The anti-tumor effects of propranolol are suggested to involve the reduction of cancer cell proliferation as well as angiogenesis. Here, we show that oral administration of propranolol delays tumor progression of MCA205 fibrosarcoma model and MC38 colon cancer model and increases the survival rate of tumor bearing mice. Propranolol works by reducing tumor angiogenesis and facilitating an anti-tumoral microenvironment with increased T cell infiltration and reduced infiltration of myeloid-derived suppressor cells (MDSCs). Using T cell deficient mice, we demonstrate that the full anti-tumor effect of propranolol requires the presence of T cells. Flow cytometry-based analysis and RNA sequencing of FACS-sorted cells show that propranolol treatment leads to an upregulation of PD-L1 on tumor associated macrophages (TAMs) and changes in their chemokine expression profile. Lastly, we observe that the co-administration of propranolol significantly enhances the efficacy of anti-CTLA4 therapy. Our results identify propranolol as an immune modulating agent, which can improve immune checkpoint inhibitor therapies in soft tissue sarcoma patients and potentially in other cancers.	[Fjaestad, Klaire Yixin; Romer, Anne Mette Askehoj; Johansen, Astrid Zedlitz; Thorseth, Marie-Louise; Carretta, Marco; Madsen, Daniel Hargbol] Copenhagen Univ Hosp Herlev & Gentofte, Natl Ctr Canc Immune Therapy CCIT DK, Dept Oncol, Herlev, Denmark; [Fjaestad, Klaire Yixin; Thorseth, Marie-Louise; Madsen, Daniel Hargbol] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Romer, Anne Mette Askehoj] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Goitea, Victor; Grontved, Lars] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Engelholm, Lars Henning] Univ Copenhagen, Biotech Res & Innovat Ctr, Finsen Lab, Copenhagen, Denmark; [Junker, Niels] Copenhagen Univ Hosp Herlev & Gentofte, Dept Oncol, Herlev, Denmark	University of Copenhagen; Roskilde University; University of Southern Denmark; University of Copenhagen	Madsen, DH (corresponding author), Copenhagen Univ Hosp Herlev & Gentofte, Natl Ctr Canc Immune Therapy CCIT DK, Dept Oncol, Herlev, Denmark.; Madsen, DH (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark.	daniel.hargboel.madsen@regionh.dk	Johansen, Astrid/CAF-7679-2022	Askehoj Romer, Anne Mette/0000-0002-5408-7020; Madsen, Daniel Hargboel/0000-0002-3183-6201; Fjaestad, Klaire Yixin/0000-0002-0141-6898; Grontved, Lars/0000-0002-6735-8483; Thorseth, Marie-Louise/0000-0001-7978-5549; Engelholm, Lars/0000-0002-6616-1232; Goitea, Victor/0000-0002-1564-4111; CARRETTA, MARCO/0000-0002-8135-7188	Lundbeck Foundation [R307-2018-3326]; Danish Cancer Society [R231-A14035, R231-A13832]; Independent Research Fund Denmark; department of Oncology, Herlev Hospital	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Independent Research Fund Denmark; department of Oncology, Herlev Hospital	This work was supported by the Lundbeck Foundation (R307-2018-3326) (to DHM), Danish Cancer Society (R231-A14035 and R231-A13832 (to DHM and LHE)), the Independent Research Fund Denmark (to LG), and department of Oncology, Herlev Hospital.	Agac D, 2018, BRAIN BEHAV IMMUN, V74, P176, DOI 10.1016/j.bbi.2018.09.004; Amaya Clarissa N, 2018, Oncoscience, V5, P109, DOI 10.18632/oncoscience.413; Awad RM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01977; Baghba R, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-0530-4; Bai RL, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-00209-0; Banavali S, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.499; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Barnes TA, 2017, BRIT J CANCER, V117, P451, DOI 10.1038/bjc.2017.220; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Barton AL, 2015, J PEDIATR-US, V166, P115, DOI 10.1016/j.jpeds.2014.08.067; Brohee L, 2015, ONCOTARGET, V6, P11264, DOI 10.18632/oncotarget.3595; Bucsek MJ, 2017, CANCER RES, V77, P5639, DOI 10.1158/0008-5472.CAN-17-0546; Casali PG, 2014, ANN ONCOL, V25, P102, DOI 10.1093/annonc/mdu254; Chandran S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00787; Cole SW, 2015, NAT REV CANCER, V15, P563, DOI 10.1038/nrc3978; D'Angelo SP, 2018, LANCET ONCOL, V19, P416, DOI 10.1016/S1470-2045(18)30006-8; Daher C, 2019, CANCER IMMUNOL RES, V7, P1849, DOI 10.1158/2326-6066.CIR-18-0833; Eng JWL, 2014, CANCER IMMUNOL IMMUN, V63, P1115, DOI 10.1007/s00262-014-1617-9; Enot DP, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1462431; Fares Charlene M, 2019, Am Soc Clin Oncol Educ Book, V39, P147, DOI 10.1200/EDBK_240837; Field CS, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1376154; Gandhi S, 2021, CLIN CANCER RES, V27, P87, DOI 10.1158/1078-0432.CCR-20-2381; Hoang NT, 2018, CANCER MANAG RES, V10, P1089, DOI 10.2147/CMAR.S159641; Hou AH, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00783; Idos GE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60255-4; Jin MZ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00280-x; Jurberg AD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01440; Kamiya A, 2019, NAT NEUROSCI, V22, P1289, DOI 10.1038/s41593-019-0430-3; Kokolus KM, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1405205; Liu YT, 2020, CLIN CANCER RES, V26, P970, DOI [10.1158/1078-0432.CCR-19-1040z, 10.1158/1078-0432.CCR-19-1040]; Magnon C, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975643; Makale MT, 2017, BIOCYBERN BIOMED ENG, V37, P443, DOI 10.1016/j.bbe.2017.05.001; Mohammadpour H, 2019, J CLIN INVEST, V129, P5537, DOI 10.1172/JCI129502; Mravec B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217958; Nagaraja AS, 2013, J CLIN INVEST, V123, P558, DOI 10.1172/JCI67887; Neophytou CM, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00899; Pantziarka Pan, 2018, Ecancermedicalscience, V12, ped82, DOI 10.3332/ecancer.2018.ed82; Pantziarka P, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.680; Pasquier E, 2016, EBIOMEDICINE, V6, P87, DOI 10.1016/j.ebiom.2016.02.026; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Peranzoni E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01590; Qiao GX, 2019, CANCER IMMUNOL IMMUN, V68, P11, DOI 10.1007/s00262-018-2243-8; Rains Steven L, 2017, Oncoscience, V4, P95, DOI 10.18632/oncoscience.357; Srinivasan AV, 2019, ANN INDIAN ACAD NEUR, V22, P21, DOI 10.4103/aian.AIAN_201_18; Tawbi HA, 2017, LANCET ONCOL, V18, P1493, DOI 10.1016/S1470-2045(17)30624-1; Vaddepally RK, 2020, CANCERS, V12, DOI 10.3390/cancers12030738; Wagner Michael J, 2018, J Exp Pharmacol, V10, P51, DOI 10.2147/JEP.S146211; Wesolowski R, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-10; Wieduwild E, 2020, J EXP MED, V217, DOI 10.1084/jem.20190554; Wood Laura S, 2020, JCO Oncol Pract, V16, p15s, DOI 10.1200/JOP.19.00647; Zhong SL, 2016, EUR J CANCER PREV, V25, P440, DOI 10.1097/CEJ.0000000000000192; Zhou L, 2016, J IMMUNOL, V196, P3460, DOI 10.4049/jimmunol.1501677	52	8	8	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1364	1375		10.1038/s41388-021-02170-0	http://dx.doi.org/10.1038/s41388-021-02170-0		JAN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	35017664	Green Published, hybrid			2022-12-26	WOS:000741240600002
J	Kavanaugh, DW; Porrini, C; Dervyn, R; Ramarao, N				Kavanaugh, Devon W.; Porrini, Constance; Dervyn, Rozenn; Ramarao, Nalini			The pathogenic biomarker alcohol dehydrogenase protein is involved in Bacillus cereus virulence and survival against host innate defence	PLOS ONE			English	Article							NITRIC-OXIDE; BACTEREMIA; BIOFILM; STRAINS; FRANCE; HLYII; GENE	Bacillus cereus is a spore forming bacteria recognized among the leading agents responsible for foodborne outbreaks in Europe. B. cereus is also gaining notoriety as an opportunistic human pathogen inducing local and systemic infections. The real incidence of such infection is likely underestimated and information on genetic and phenotypic characteristics of the incriminated strains is generally scarce. We have recently analyzed a large strain collection of varying pathogenic potential. Screening for biomarkers to differentiate among clinical and non-clinical strains, a gene encoding an alcohol dehydrogenase-like protein was identified among the leading candidates. This family of proteins has been demonstrated to be involved in the virulence of several bacterial species. The relevant gene was knocked out to elucidate its function with regards to resistance to host innate immune response, both in vitro and in vivo. Our results demonstrate that the adhB gene plays a significant role in resistance to nitric oxide and oxidative stress in vitro, as well as its pathogenic ability with regards to in vivo toxicity. These properties may explain the pathogenic potential of strains carrying this newly identified virulence factor.	[Kavanaugh, Devon W.; Porrini, Constance; Dervyn, Rozenn; Ramarao, Nalini] Univ Paris Saclay, Micalis Inst, AgroParisTech, INRAE, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Ramarao, N (corresponding author), Univ Paris Saclay, Micalis Inst, AgroParisTech, INRAE, Jouy En Josas, France.	nalini.ramarao@inrae.fr	Rama Rao, Nalini/GRR-7800-2022	Kavanaugh, Devon/0000-0001-8831-8248				Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; Callejas-Negrete OA, 2015, MICROBIOL RES, V172, P57, DOI 10.1016/j.micres.2014.11.006; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bakker BM, 2000, J BACTERIOL, V182, P4730, DOI 10.1128/JB.182.17.4730-4737.2000; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Cadot C, 2010, J CLIN MICROBIOL, V48, P1358, DOI 10.1128/JCM.02123-09; Chin MP, 2010, CHEM RES TOXICOL, V23, P778, DOI 10.1021/tx900415k; Cormontagne D, 2021, TOXINS, V13, DOI 10.3390/toxins13020123; Darrigo C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163321; Dervyn R, 2022, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.788757; Duport C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01550; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Gaur AH, 2001, CLIN INFECT DIS, V32, P1456, DOI 10.1086/320154; Glasset B, 2016, EUROSURVEILLANCE, V21, P18, DOI 10.2807/1560-7917.ES.2016.21.48.30413; Glasset B, 2021, FOOD MICROBIOL, V98, DOI 10.1016/j.fm.2021.103759; Glasset B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194346; Guillemet E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29349; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Hagan CT, 2018, ADV CANCER RES, V139, P35, DOI 10.1016/bs.acr.2018.05.003; Haydar A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01063; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; Kamar R, 2013, J CLIN MICROBIOL, V51, P320, DOI 10.1128/JCM.02848-12; Kavanaugh DW, 2022, CLIN MICROBIOL INFEC, V28, DOI 10.1016/j.cmi.2021.05.035; KELLY JM, 1990, MOL GEN GENET, V222, P323, DOI 10.1007/BF00633836; Leclerc M, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.00558-21; Lotte R, 2017, EMERG INFECT DIS, V23, P845, DOI 10.3201/eid2305.161788; Madeira JP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00342; Martinez-Blanch JF, 2009, INT J FOOD MICROBIOL, V135, P15, DOI 10.1016/j.ijfoodmicro.2009.07.013; Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Plapp BV, 2015, CHEM-BIOL INTERACT, V234, P85, DOI 10.1016/j.cbi.2014.12.040; Porrini C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105079; Porrini C, 2020, BIOL CHEM, V401, P547, DOI 10.1515/hsz-2019-0368; Ramarao N., 2015, MOL MED MICROBIOL, V2, P1041, DOI [10.1016/B978-0-12-397169-2.00059-7, DOI 10.1016/B978-0-12-397169-2.00059-7]; Ramarao N, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20092667; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Ramarao N, 2014, AM J INFECT CONTROL, V42, P694, DOI 10.1016/j.ajic.2014.01.025; Rubach JK, 2003, BIOCHEMISTRY-US, V42, P2907, DOI 10.1021/bi0272656; Saliola M, 1995, MOL GEN GENET, V249, P665, DOI 10.1007/BF00418036; Tran SL, 2013, FEMS MICROBIOL LETT, V347, P1, DOI 10.1111/1574-6968.12209; SUN HW, 1992, J MOL EVOL, V34, P522, DOI 10.1007/BF00160465; Taneja B, 1999, PROTEIN ENG, V12, P815, DOI 10.1093/protein/12.10.815; THORN JM, 1995, J MOL BIOL, V249, P785, DOI 10.1006/jmbi.1995.0337; Tran SL, 2020, TOXINS, V12, DOI 10.3390/toxins12090593; Tran SL, 2013, J INVERTEBR PATHOL, V113, P205, DOI 10.1016/j.jip.2013.04.001; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Tran SL, 2010, J BACTERIOL, V192, P2638, DOI 10.1128/JB.01315-09; Veysseyre F, 2015, MED MALADIES INFECT, V45, P436, DOI 10.1016/j.medmal.2015.09.011; Zaki MH, 2005, J PHARMACOL SCI, V98, P117, DOI 10.1254/jphs.CRJ05004X	53	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0259386	10.1371/journal.pone.0259386	http://dx.doi.org/10.1371/journal.pone.0259386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982789	Green Published, gold			2022-12-26	WOS:000834805700002
J	Ohara-Nemoto, Y; Shimoyama, Y; Ono, T; Sarwar, MT; Nakasato, M; Sasaki, M; Nemoto, TK				Ohara-Nemoto, Yuko; Shimoyama, Yu; Ono, Toshio; Sarwar, Mohammad Tanvir; Nakasato, Manami; Sasaki, Minoru; Nemoto, Takayuki K.			Expanded substrate specificity supported by P1' and P2' residues enables bacterial dipeptidyl-peptidase 7 to degrade bioactive peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS; CRYSTAL-STRUCTURE; PERIODONTITIS; PROTEASE; BACTEREMIA; DPP11; RISK; IV	Dipeptide production from extracellular proteins is crucial for Porphyromonas gingivalis, a pathogen related to chronic periodontitis, because its energy production is entirely dependent on the metabolism of amino acids predominantly incorporated as dipeptides. These dipeptides are produced by periplasmic dipeptidyl-peptidase (DPP)4, DPP5, DPP7, and DPP11. Although the substrate specificities of these four DPPs cover most amino acids at the penultimate position from the N terminus (P1), no DPP is known to cleave penultimate Gly, Ser, Thr, or His. Here, we report an expanded substrate preference of bacterial DPP7 that covers those residues. MALDI-TOF mass spectrometry analysis demonstrated that DPP7 effi- ciently degraded incretins and other gastrointestinal peptides, which were successively cleaved at every second residue, including Ala, Gly, Ser, and Gln, as well as authentic hydrophobic residues. Intravenous injection of DPP7 into mice orally administered glucose caused declines in plasma glucagon-like peptide-1 and insulin, accompanied by increased blood glucose levels. A newly developed coupled enzyme reaction system that uses synthetic fluorogenic peptides revealed that the P1' and P2' residues of substrates significantly elevated kcat values, providing an expanded substrate preference. This activity enhancement was most effective toward the substrates with nonfavorable but nonrepulsive P1 residues in DPP7. Enhancement of k(cat) by prime-side residues was also observed in DPP11 but not DPP4 and DPP5. Based on this expanded substrate specificity, we demonstrate that a combination of DPPs enables proteolytic liberation of all types of N-terminal dipeptides and ensures P. gingivalis growth and pathogenicity.& nbsp;	[Ohara-Nemoto, Yuko; Ono, Toshio; Sarwar, Mohammad Tanvir; Nemoto, Takayuki K.] Nagasaki Univ, Dept Oral Mol Biol, Course Med & Dent Sci, Grad Sch Biomed Sci, Nagasaki, Japan; [Shimoyama, Yu; Sasaki, Minoru] Iwate Med Univ, Dept Microbiol, Div Mol Microbiol, Yahaba, Iwate, Japan; [Nakasato, Manami] Iwate Med Univ, Dept Conservat Dent, Div Periodontol, Sch Dent, Morioka, Iwate, Japan; [Sarwar, Mohammad Tanvir] Islamic Univ, Fac Biol Sci, Dept Appl Nutr & Food Technol, Kushtia 7003, Bangladesh	Nagasaki University; Iwate Medical University; Iwate Medical University; Islamic University	Nemoto, TK (corresponding author), Nagasaki Univ, Dept Oral Mol Biol, Course Med & Dent Sci, Grad Sch Biomed Sci, Nagasaki, Japan.	tnemoto@nagasaki-u.ac.jp		Shimoyama, Yu/0000-0002-4143-6519; Ohara-Nemoto, Yuko/0000-0002-2822-7296	Japan Society for the Promotion of Science KAKENHI [JP19K10045, JP19K10071, JP19K19005]; Kyushu Dental Association	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyushu Dental Association	Funding and additional information-This study was supported by the Japan Society for the Promotion of Science KAKENHI grants (JP19K10045 to T. K. N., JP19K10071 to Y. O.-N., and JP19K19005 to M. N.) and a grant from the Kyushu Dental Association (to T. K. N.) .	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Banbula A, 2000, INFECT IMMUN, V68, P1176, DOI 10.1128/IAI.68.3.1176-1182.2000; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; Bezerra GA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03220-y; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gallwitz B, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00389; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Genco RJ, 2010, NAT REV CARDIOL, V7, P479, DOI 10.1038/nrcardio.2010.120; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; Hack K, 2017, J THROMB HAEMOST, V15, P487, DOI 10.1111/jth.13605; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Keane FM, 2011, FEBS J, V278, P1316, DOI 10.1111/j.1742-4658.2011.08051.x; Kshirsagar AV, 2007, BLOOD PURIFICAT, V25, P125, DOI 10.1159/000096411; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; MENTLEIN R, 1988, FEBS LETT, V234, P251, DOI 10.1016/0014-5793(88)80092-9; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Nemoto TK, 2021, MOL ORAL MICROBIOL, V36, P145, DOI 10.1111/omi.12317; Nemoto TK, 2018, ANAL BIOCHEM, V548, P78, DOI 10.1016/j.ab.2018.02.008; Nemoto TK, 2016, J BIOL CHEM, V291, P5913, DOI 10.1074/jbc.M115.687566; Nemoto TK, 2016, JPN DENT SCI REV, V52, P22, DOI 10.1016/j.jdsr.2015.08.002; Ohara-Nemoto Y, 2020, FEMS MICROBIOL LETT, V367, DOI 10.1093/femsle/fnaa204; Ohara-Nemoto Y, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny221; Ohara-Nemoto Y, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00277-17; Ohara-Nemoto Y, 2014, J BIOL CHEM, V289, P5436, DOI 10.1074/jbc.M113.527333; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Rea D, 2017, EUR J MED CHEM, V139, P482, DOI 10.1016/j.ejmech.2017.08.024; Rouf SMA, 2013, FEBS OPEN BIO, V3, P177, DOI 10.1016/j.fob.2013.03.004; Rouf SMA, 2013, BIOCHIMIE, V95, P824, DOI 10.1016/j.biochi.2012.11.019; Sakamoto Y., 2014, SCI; Sarwar MT, 2020, BIOL CHEM, V401, P629, DOI 10.1515/hsz-2019-0387; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; SUIDO H, 1986, J DENT RES, V65, P1335, DOI 10.1177/00220345860650111101; Tabeta K, 2014, JPN DENT SCI REV, V50, P55, DOI 10.1016/j.jdsr.2014.03.001; Takahashi N, 2002, ORAL MICROBIOL IMMUN, V17, P50, DOI 10.1046/j.0902-0055.2001.00089.x; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; TANGLARSEN J, 1995, J PERIODONTAL RES, V30, P390, DOI 10.1111/j.1600-0765.1995.tb01292.x; Teixeira FB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00327	47	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101585	10.1016/j.jbc.2022.101585	http://dx.doi.org/10.1016/j.jbc.2022.101585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35032549	Green Published, gold			2022-12-26	WOS:000791267400012
J	Soundararajan, R; Varanasi, SM; Patil, SS; Srinivas, S; Hernandez-Cuervo, H; Czachor, A; Bulkhi, A; Fukumoto, J; Galam, L; Lockey, RF; Kolliputi, N				Soundararajan, Ramani; Varanasi, Sai Manasa; Patil, Sahebgowda Sidramagowda; Srinivas, Sriraja; Hernandez-Cuervo, Helena; Czachor, Alexander; Bulkhi, Adeeb; Fukumoto, Jutaro; Galam, Lakshmi; Lockey, Richard F.; Kolliputi, Narasaiah			Lung fibrosis is induced in ADAR2 overexpressing mice via HuR-induced CTGF signaling	FASEB JOURNAL			English	Article						ADAR2; CTGF; HuR; lung fibrosis; Delta ECS mice	TISSUE GROWTH FACTOR/CCN2; MESSENGER-RNA; ADENOSINE-DEAMINASE; PULMONARY-FIBROSIS; BINDING PROTEIN; GLUR-B; GENE; INJURY; EXPRESSION; STABILITY	Adenosine deaminase acting on RNA 2 (ADAR2), an RNA editing enzyme is involved in a site-selective modification of adenosine (A) to inosine (I) in double-stranded RNA (dsRNA). Its role in the lungs is unknown. The phenotypic characterization of Adarb1 mice that lacked ADAR2 auto-regulation due to the deletion of editing complementary sequence (ABCS mice) determined the functional role of ADAR2 in the lungs. ADAR2 protein expression increased in the Delta ECS mice. These mice display immune cell infiltration and alveolar disorganization. The lung wet by dry ratio indicates there is no lung edema in Delta ECS mice. Bronchoalveolar lavage (BAL) analysis of ABCS mice reveals a significant increase in neutrophils. Interestingly, Delta ECS mice spontaneously develop lung fibrosis as indicated by Sirius red staining of collagen fibers in the lung sections and a significant increase in hydroxyproline level in their lungs. ADAR2 expression increased significantly in a bleomycin mouse model, implicating a role of ADAR2 in lung fibrosis. Furthermore, there is a likely possibility that the genetically modified ARCS mice does not model the physiological or pathophysiological process of lung fibrosis. Nevertheless, this model is useful in interrogating the role of ADAR2 in the lungs. The CtemRNA and connective tissue growth factor (CTGF) protein significantly increased in ABCS lungs and occurs in bronchial epithelial cells. There is a significant increase in Human antigen R (ELAVL1; HuR) protein levels in ABCS lungs and suggests a role in stabilizing Ctgf m RNA. Lung mechanics such as total respiratory resistance, Newtonian resistance and tissue damping were increased, whereas inspiratory capacity was decreased in the Delta ECS mice. Taken together, these data indicate that overexpression of ADAR2 causes spontaneous lung fibrosis via HuR-mediated CTGF signaling and implicate a role for ADAR2 auto-regulation in lung homeostasis. The identification of ADAR2 target genes in Delta ECS mice would facilitate a mechanistic understanding of the role of ADAR2 in the lungs and provide a therapeutic strategy for lung fibrosis.	[Soundararajan, Ramani; Varanasi, Sai Manasa; Patil, Sahebgowda Sidramagowda; Srinivas, Sriraja; Hernandez-Cuervo, Helena; Czachor, Alexander; Bulkhi, Adeeb; Fukumoto, Jutaro; Galam, Lakshmi; Lockey, Richard F.; Kolliputi, Narasaiah] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Srinivas, Sriraja] Auburn Univ, Dept Drug Discovery & Dev, Auburn, AL 36849 USA; [Hernandez-Cuervo, Helena] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Czachor, Alexander] Jagiellonian Univ Med Coll, Dept Med, Krakow, Poland; [Bulkhi, Adeeb] Umm Al Qura Univ, Coll Med, Dept Internal Med, Mecca, Saudi Arabia	State University System of Florida; University of South Florida; Auburn University System; Auburn University; State University System of Florida; University of South Florida; Jagiellonian University; Collegium Medicum Jagiellonian University; Umm Al Qura University	Kolliputi, N (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	nkollipu@usf.edu	Bulkhi, Adeeb A/AAD-8924-2019	Bulkhi, Adeeb A/0000-0001-5857-7097	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01 HL105932]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01 HL105932	Anantharaman A, 2017, FEBS LETT, V591, P2890, DOI 10.1002/1873-3468.12795; Anantharaman A, 2017, NUCLEIC ACIDS RES, V45, P4189, DOI 10.1093/nar/gkw1304; Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Ben-Shoshan SO, 2017, RNA BIOL, V14, P587, DOI 10.1080/15476286.2016.1203501; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Cortes A, 2015, MED RES REV, V35, P85, DOI 10.1002/med.21324; Cox R, 2015, AM J RESP CELL MOL, V53, P422, DOI 10.1165/rcmb.2014-0339OC; Cronstein Bruce N, 2011, F1000 Biol Rep, V3, P21, DOI 10.3410/B3-21; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; Fukumoto J, 2019, AM J PHYSIOL-CELL PH, V316, pC492, DOI 10.1152/ajpcell.00330.2018; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galam L, 2016, AM J PHYSIOL-LUNG C, V310, pL572, DOI 10.1152/ajplung.00417.2015; Galam L, 2015, FREE RADICAL BIO MED, V84, P196, DOI 10.1016/j.freeradbiomed.2015.03.036; Gerber A, 1997, RNA, V3, P453; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hasko G, 2005, TRENDS PHARMACOL SCI, V26, P511, DOI 10.1016/j.tips.2005.08.004; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Horowitz JC, 2006, SEMIN RESP CRIT CARE, V27, P600, DOI 10.1055/s-2006-957332; Kaljas Y, 2017, CELL MOL LIFE SCI, V74, P555, DOI 10.1007/s00018-016-2357-0; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065; Kondo S, 2006, ONCOGENE, V25, P1099, DOI 10.1038/sj.onc.1209129; Kutryb-Zajac B, 2019, J MOL CELL CARDIOL, V128, P62, DOI 10.1016/j.yjmcc.2019.01.004; Lagishetty V, 2014, AM J PHYSIOL-CELL PH, V306, pC999, DOI 10.1152/ajpcell.00064.2013; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; LeRoy E C, 1990, Eur Cytokine Netw, V1, P215; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Moreno E, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00106; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Narala VR, 2018, AM J PHYSIOL-LUNG C, V314, pL860, DOI 10.1152/ajplung.00365.2017; Neumark N, 2020, AM J PHYSIOL-LUNG C, V319, pL887, DOI 10.1152/ajplung.00451.2020; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; OConnell MA, 1997, J BIOL CHEM, V272, P473; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Tashiro J, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00118; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; WAGNER RW, 1990, MOL CELL BIOL, V10, P5586, DOI 10.1128/MCB.10.10.5586; Wang GL, 2015, AM J PATHOL, V185, P3224, DOI 10.1016/j.ajpath.2015.08.002; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Woodhoo A, 2012, HEPATOLOGY, V56, P1870, DOI 10.1002/hep.25828	67	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22143	10.1096/fj.202101511R	http://dx.doi.org/10.1096/fj.202101511R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34985777				2022-12-26	WOS:000747987800009
J	Litwinek, D; Boreczek, J; Gambus, H; Buksa, K; Berski, W; Kowalczyk, M				Litwinek, Dorota; Boreczek, Jakub; Gambus, Halina; Buksa, Krzysztof; Berski, Wiktor; Kowalczyk, Magdalena			Developing lactic acid bacteria starter cultures for wholemeal rye flour bread with improved functionality, nutritional value, taste, appearance and safety	PLOS ONE			English	Article							MICROBIAL ECOLOGY; LACTOBACILLUS-PLANTARUM; SOURDOUGH FERMENTATIONS; GENETIC DIVERSITY; IN-VITRO; WHEAT; PCR; MICROORGANISMS; TECHNOLOGY; DYNAMICS	Starter cultures composed of lactic acid bacteria (LAB) were developed based on the genotypic and phenotypic characterisation of isolates belonging to dominant groups of bacteria in spontaneous rye wholemeal sourdoughs. Combinations of strains have been evaluated on an industrial scale in the sourdough fermentation process. Wholemeal rye bread was prepared using sourdoughs obtained with 3 new starter cultures, and compared to bread made using the commercial culture (LV2). All newly developed cultures used for the preparation of wholemeal rye bread allowed to obtain better quality products as compared to the LV2 based bread. The best results were obtained when the culture containing Lactiplantibacillus plantarum 2MI8 and exopolysaccharide (EPS)-producing Weissella confusa/cibaria 6PI3 strains was applied. The addition of yeast during sourdough breads production, especially the one prepared from mentioned above starter culture, significantly improved their organoleptic properties, their volume and crumb moisture was increased, and also the crumb acidity and hardness was reduced. Fermentation of rye wholemeal dough, especially without the yeast addition, resulted in a significant reduction in the content of higher inositol phosphates as compared to the applied flour, which is associated with improved bioavailability of minerals. The results of this study prove that the investigated new starter cultures can be successfully applied in wholemeal rye bread production.	[Litwinek, Dorota; Gambus, Halina; Buksa, Krzysztof; Berski, Wiktor] Agr Univ Krakow, Fac Food Technol, Dept Carbohydrate Technol & Cereal Proc, Krakow, Poland; [Boreczek, Jakub; Kowalczyk, Magdalena] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Agricultural University Krakow; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Berski, W (corresponding author), Agr Univ Krakow, Fac Food Technol, Dept Carbohydrate Technol & Cereal Proc, Krakow, Poland.; Kowalczyk, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	rrberski@cyf-kr.edu.pl; mk@ibb.waw.pl	Kowalczyk, Magdalena/GLV-6664-2022	Kowalczyk, Magdalena/0000-0001-8070-2368; Boreczek, Jakub/0000-0002-7750-0121; Berski, Wiktor/0000-0002-0183-933X	Applied Research Programme of the National Centre for Research and Development [PBS2/B8/12/2014]	Applied Research Programme of the National Centre for Research and Development	The work of DL, JB, HG, KB and MK was supported by the Applied Research Programme of the National Centre for Research and Development (https://www.gov.pl/web/ncbr) [Grant: PBS2/B8/12/2014 (FunCHLEB)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondio M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01733; Ahsyee RS, 2013, ARCH BIOL SCI, V65, P595, DOI 10.2298/ABS1302595A; Ajith J., 2017, INT J FOOD SCI NUTR, V2, P192; [Anonymous], 1989, PNA741081989; [Anonymous], 2012, 4322012 EU; AOAC, 2000, OFF METH AN, DOI [DOI 10.1007/978-3-642-31241-0, 10.3109/15563657608988149]; Arendt EK, 2007, FOOD MICROBIOL, V24, P165, DOI 10.1016/j.fm.2006.07.011; Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Battcock M, 1998, FOOD AGR ORG FAO AGR, V134; Bocker G., 1990, GETREIDE MEHL BROT, V44, P269; Boreczek J, 2020, MICROBIOLOGYOPEN, V9, DOI 10.1002/mbo3.1009; Buksa K, 2021, FOOD CHEM, V362, DOI 10.1016/j.foodchem.2021.130221; Buksa K, 2020, CEREAL CHEM, V97, P642, DOI 10.1002/cche.10280; Cardoso RVC, 2019, FOOD CHEM, V280, P123, DOI 10.1016/j.foodchem.2018.12.063; Chen QC, 2003, J CHROMATOGR A, V1018, P41, DOI 10.1016/j.chroma.2003.08.040; Choi YJ, 2008, FOOD SCI BIOTECHNOL, V17, P1139; Cieslikowski T, 2003, J CLIN MICROBIOL, V41, P1673, DOI 10.1128/JCM.41.4.1673-1680.2003; Cocolin L, 2005, INT J FOOD MICROBIOL, V103, P167, DOI 10.1016/j.ijfoodmicro.2004.12.027; Corsetti A, 2007, FOOD RES INT, V40, P539, DOI 10.1016/j.foodres.2006.11.001; DAESCHEL MA, 1987, FEMS MICROBIOL LETT, V46, P357, DOI 10.1111/j.1574-6968.1987.tb02472.x; De Bellis P, 2015, INT J FOOD MICROBIOL, V197, P30, DOI 10.1016/j.ijfoodmicro.2014.12.017; De Vuyst L, 2014, FOOD MICROBIOL, V37, P11, DOI 10.1016/j.fm.2013.06.002; Decock P, 2005, TRENDS FOOD SCI TECH, V16, P113, DOI 10.1016/j.tifs.2004.04.012; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P7827, DOI 10.1128/AEM.02955-13; Fadda C, 2014, COMPR REV FOOD SCI F, V13, P473, DOI 10.1111/1541-4337.12064; Fernandez-Pelaez J, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10121962; Fessard A, 2017, FERMENTATION-BASEL, V3, DOI 10.3390/fermentation3030038; Ganzle MG, 2009, INT J FOOD MICROBIOL, V134, P29, DOI 10.1016/j.ijfoodmicro.2009.05.018; Ganzle MG., 2006, HDB SAUERTEIG, P109; Gobbetti M, 2014, FOOD MICROBIOL, V37, P30, DOI 10.1016/j.fm.2013.04.012; Gupta RK, 2015, J FOOD SCI TECH MYS, V52, P676, DOI 10.1007/s13197-013-0978-y; Hadaegh H, 2017, J FOOD QUALITY, DOI 10.1155/2017/7825203; Huys G., 2013, HDB SOURDOUGH BIOTEC, P105, DOI [10.1007/978-1-4614-5425-0_5, DOI 10.1007/978-1-4614-5425-0_5]; Katina K, 2006, LWT-FOOD SCI TECHNOL, V39, P479, DOI 10.1016/j.lwt.2005.03.013; Kawka A., 2010, YWNO NAUKA TECHNOL J, V70, P44; Kowalczyk M, 2015, UPDATES METABOLISM L, DOI [10.1002/9781118868386.ch1, DOI 10.1002/9781118868386.CH1]; Kowalczyk M, 2012, J DAIRY RES, V79, P26, DOI 10.1017/S0022029911000677; Lavermicocca P, 2016, FOOD HYGIENE AND TOXICOLOGY IN READY-TO-EAT FOODS, P275, DOI 10.1016/B978-0-12-801916-0.00016-9; LITWINEK D, 2017, YWNOC NAUKA TECHNOL, V24, P76, DOI DOI 10.15193/ZNTJ/2017/113/212; Litwinek D., 2018, YWNO NAUKA TECHNOL J, V1, P50; Meija L, 2019, WHOLE GRAINS THEIR B, P169; Muhialdin BJ, 2020, MOLECULES, V25, DOI 10.3390/molecules25112655; Pereira DIA, 2003, APPL ENVIRON MICROB, V69, P4743, DOI 10.1128/AEM.69.8.4743-4752.2003; Petrova P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041118; Piasecka-Jowiak K., 2016, KWART POST PY MIKROB, V55, P268; Ribotta PD, 2007, J FOOD ENG, V78, P913, DOI 10.1016/j.jfoodeng.2005.11.032; Ricciardi A, 2009, J APPL MICROBIOL, V107, P1528, DOI 10.1111/j.1365-2672.2009.04335.x; Rosca I, 2018, INT J BIOL MACROMOL, V107, P1765, DOI 10.1016/j.ijbiomac.2017.10.048; Rosenquist H, 2000, FOOD MICROBIOL, V17, P241, DOI 10.1006/fmic.1999.0313; Ruas-Madiedo P, 2005, J DAIRY SCI, V88, P843, DOI 10.3168/jds.S0022-0302(05)72750-8; Ruimy R, 2001, INFECT IMMUN, V69, P584, DOI 10.1128/IAI.69.1.584-588.2001; SANDBERG AS, 1987, J NUTR, V117, P2061, DOI 10.1093/jn/117.12.2061; Simpson PJ, 2002, APPL ENVIRON MICROB, V68, P765, DOI 10.1128/AEM.68.2.765-771.2002; Slukova M, 2021, CZECH J FOOD SCI, V39, P3, DOI 10.17221/203/2020-CJFS; Sugihara T.F., 1971, APPL MICROBIOL, V21, P459, DOI DOI 10.1128/AM.21.3.459-465.1971; Teixeira CG, 2021, PROBIOTICS ANTIMICRO, V13, P915, DOI 10.1007/s12602-021-09751-1; Torino MI, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00834; Torrieri E, 2014, LWT-FOOD SCI TECHNOL, V56, P508, DOI 10.1016/j.lwt.2013.12.005; Van Kerrebroeck S, 2017, TRENDS FOOD SCI TECH, V68, P152, DOI 10.1016/j.tifs.2017.08.016; Vauterin L., 1992, EUROPEAN MICROBIOLOG, V1, P37; Ventimiglia G, 2015, FOOD MICROBIOL, V51, P57, DOI 10.1016/j.fm.2015.04.011; Venturi M, 2012, INT J FOOD MICROBIOL, V156, P122, DOI 10.1016/j.ijfoodmicro.2012.03.011; Weckx S, 2010, FOOD MICROBIOL, V27, P1000, DOI 10.1016/j.fm.2010.06.005; Xiong T, 2011, AFR J BIOTECHNOL, V10, P7518; Zaccardelli M., 2012, Agricultural Sciences, V3, P98, DOI 10.4236/as.2012.31013	65	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261677	10.1371/journal.pone.0261677	http://dx.doi.org/10.1371/journal.pone.0261677			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030182	Green Published, gold			2022-12-26	WOS:000812798500013
J	Dreyling, C; Hasselmann, M				Dreyling, Clara; Hasselmann, Martin			The dynamics of mitochondrial-linked gene expression among tissues and life stages in two contrasting strains of laying hens	PLOS ONE			English	Article							SKELETAL-MUSCLE; METABOLISM; MODEL; PHOSPHORYLATION; GAPDH; SPAN; TOR	The cellular energy metabolism is one of the most conserved processes, as it is present in all living organisms. Mitochondria are providing the eukaryotic cell with energy and thus their genome and gene expression has been of broad interest for a long time. Mitochondrial gene expression changes under different conditions and is regulated by genes encoded in the nucleus of the cell. In this context, little is known about non-model organisms and we provide the first large-scaled gene expression analysis of mitochondrial-linked genes in laying hens. We analysed 28 mitochondrial and nuclear genes in 100 individuals in the context of five life-stages and strain differences among five tissues. Our study showed that mitochondrial gene expression increases during the productive life span, and reacts tissue and strain specific. In addition, the strains react different to potential increased oxidative stress, resulting from the increase in mitochondrial gene expression. The results suggest that the cellular energy metabolism as part of a complex regulatory system is strongly affected by the productive life span in laying hens and thus partly comparable to model organisms. This study provides a starting point for further analyses in this field on non-model organisms, especially in laying-hens.	[Dreyling, Clara; Hasselmann, Martin] Univ Hohenheim, Inst Anim Sci, Dept Livestock Populat Genom, Stuttgart, Germany	University Hohenheim	Dreyling, C (corresponding author), Univ Hohenheim, Inst Anim Sci, Dept Livestock Populat Genom, Stuttgart, Germany.	clara.heumann-kiesler@uni-hohenheim.de			Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [HA 5499/9-1]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (Project number HA 5499/9-1) and was a part of the Research Unit 2601: Inositol phosphates and myo-inositol in the domestic fowl: Exploring the interface of genetics, physiology, microbiome, and nutrition.	Aghanoori MR, 2019, MOL METAB, V20, P149, DOI 10.1016/j.molmet.2018.11.008; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; BASSON ABK, 1982, COMP BIOCHEM PHYS A, V71, P369, DOI 10.1016/0300-9629(82)90420-0; Bhattacharya TK, 2015, BRIT POULTRY SCI, V56, P398, DOI 10.1080/00071668.2015.1041098; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; BROWN DR, 1988, J ANIM SCI, V66, P1347; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Clavier A, 2016, APOPTOSIS, V21, P239, DOI 10.1007/s10495-015-1209-y; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551; Elser JJ, 2012, CURR OPIN BIOTECH, V23, P833, DOI 10.1016/j.copbio.2012.03.001; Feroze-Merzoug F, 2002, BIOTECHNIQUES, V32, P776, DOI 10.2144/02324st03; Gulbins E, 2003, EXP PHYSIOL, V88, P85, DOI 10.1113/eph8802503; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heumann-Kiesler C, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11030825; Hong YH, 2012, POULTRY SCI, V91, P1081, DOI 10.3382/ps.2011-01948; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lassiter K, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00126; Lenth R, 2020, EMMEANS TESTS LINEAR; Li YJ, 2009, AM J PHYSIOL-CELL PH, V296, pC25, DOI 10.1152/ajpcell.00094.2008; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lopez-Mejia IC, 2015, CURR OPIN CELL BIOL, V33, P19, DOI 10.1016/j.ceb.2014.10.006; Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Matalon O, 2014, CURR OPIN STRUC BIOL, V26, P113, DOI 10.1016/j.sbi.2014.06.001; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474; Omotoso AO, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99566-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Santos AL, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1941285; Sarle W. S, 1983, CUBIC CLUSTERING CRI; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sommerfeld V, 2020, POULTRY SCI, V99, P6797, DOI 10.1016/j.psj.2020.08.064; Sommerfeld V, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10101736; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Waveren C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-18; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348	56	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262613	10.1371/journal.pone.0262613	http://dx.doi.org/10.1371/journal.pone.0262613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025974	Green Published, gold			2022-12-26	WOS:000796264200092
J	Johnson, EW; McRae, SB				Johnson, Emily W.; McRae, Susan B.			Interclutch variability in egg characteristics in two species of rail: Is maternal identity encoded in eggshell patterns?	PLOS ONE			English	Article							INTRASPECIFIC BROOD PARASITISM; CONSPECIFIC NEST PARASITISM; PHOTOGRAPHIC IDENTIFICATION; MOORHENS; EVOLUTION; REJECTION; RESPONSES; BIRDS; COLOR	Maternal signatures are present in the eggs of some birds, but quantifying interclutch variability within populations remains challenging. Maternal assignment of eggs with distinctive appearances could be used to non-invasively identify renesting females, including hens returning among years, as well as to identify cases of conspecific brood parasitism. We explored whether King Rail (Rallus elegans) eggs with shared maternity could be matched based on eggshell pattern. We used NaturePatternMatch (NPM) software to match egg images taken in the field in conjunction with spatial and temporal data on nests. Since we had only a small number of marked breeders, we analyzed similar clutch images from a study of Eurasian Common Moorhens (Gallinula chloropus chloropus) with color-banded breeders for which parentage at many nests had been verified genetically to validate the method. We ran 66 King Rail clutches (n = 338 eggs) and 58 Common Moorhen clutches (n = 364 eggs) through NPM. We performed non-metric multidimensional scaling and permutational analysis of variance using the best egg match output from NPM. We also explored whether eggs could be grouped by clutch using a combination of egg dimensions and pattern data derived from NPM using linear discriminant analyses. We then scrutinized specific matches returned by NPM for King Rail eggs to determine whether multiple matches between the same clutches might reveal maternity among nests and inform our understanding of female laying behavior. To do this, we ran separate NPM analyses for clutches photographed over several years from two spatially distant parts of the site. With these narrower datasets, we were able to identify four instances where hens likely returned to breed among years, four likely cases of conspecific brood parasitism, and a within-season re-nesting attempt. Thus, the matching output was helpful in identifying congruent egg patterns among clutches when used in conjunction with spatial and temporal data, revealing previously unrecognized site fidelity, within-season movements, and reproductive interference by breeding females. Egg pattern data in combination with nest mapping can be used to inform our understanding of female reproductive effort, success, and longevity in King Rails. These methods may also be applied to other secretive birds and species of conservation concern.	[Johnson, Emily W.; McRae, Susan B.] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	McRae, SB (corresponding author), East Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	mcraes@ecu.edu		McRae, Susan/0000-0003-3209-4710	U.S. Fish and Wildlife Service, Refuge System Inventory and Monitoring program through a Piedmont South Atlantic Coast Cooperative Ecosystems Studies Unit [F19AC00629]; E. Alexander Bergstrom Memorial Research Award from the Association of Field Ornithologists	U.S. Fish and Wildlife Service, Refuge System Inventory and Monitoring program through a Piedmont South Atlantic Coast Cooperative Ecosystems Studies Unit; E. Alexander Bergstrom Memorial Research Award from the Association of Field Ornithologists	This study was conducted with support from the U.S. Fish and Wildlife Service, Refuge System Inventory and Monitoring program through a Piedmont South Atlantic Coast Cooperative Ecosystems Studies Unit (http://www.cesu.psu.edu/unit_portals/PSAC_portal.htm) agreement to SBM (F19AC00629), and an E. Alexander Bergstrom Memorial Research Award from the Association of Field Ornithologists (https://afonet.org/grants-awards/bergstrom/) to EWJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2001, AM NAT, V158, P599, DOI 10.1086/324113; BAERENDS G P, 1982, Behaviour, V82, P1; Birkhead T.R., 2016, MOST PERFECT THING I; BIRKHEAD TR, 1978, ANIM BEHAV, V26, P321, DOI 10.1016/0003-3472(78)90050-7; Brackett CL, 2013, CONSERV GENET RESOUR, V5, P1189, DOI 10.1007/s12686-013-9999-0; Caves EM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0598; Clauser AJ, 2016, WATERBIRDS, V39, P268; Cooper T., 2008, KING RAIL RALLUS ELE; FREEMAN S, 1988, OSTRICH, V59, P49, DOI 10.1080/00306525.1988.9633694; GASTON AJ, 1993, ANIM BEHAV, V45, P301, DOI 10.1006/anbe.1993.1034; Gomez J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248021; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Gosler AG, 2000, P ROY SOC B-BIOL SCI, V267, P2469, DOI 10.1098/rspb.2000.1307; Hanley D, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2592; Hoque S., 2011, INT J BIOSCI BIOTECH, V3, P45; Ishikawa S, 2010, FEBS LETT, V584, P770, DOI 10.1016/j.febslet.2009.12.041; JACKSON WM, 1992, AUK, V109, P435; Jamieson IG, 2000, AUK, V117, P250, DOI 10.1642/0004-8038(2000)117[0250:HROCBP]2.0.CO;2; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kolts JR, 2017, ECOL EVOL, V7, P1101, DOI 10.1002/ece3.2761; Kolts JR, 2014, THESIS E CAROLINA U; Lahti DC, 2002, ANIM BEHAV, V63, P1135, DOI 10.1006/anbe.2002.3009; Long SL, 2017, HERPETOL CONSERV BIO, V12, P350; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lyon BE, 2015, ANIM BEHAV, V103, P117, DOI 10.1016/j.anbehav.2015.02.010; MCRAE SB, 1995, ANIM BEHAV, V49, P1073, DOI 10.1006/anbe.1995.0136; McRae SB, 1998, BEHAV ECOL, V9, P93, DOI 10.1093/beheco/9.1.93; McRae SB, 1996, ANIM BEHAV, V52, P225, DOI 10.1006/anbe.1996.0169; McRae SB, 1997, J ANIM ECOL, V66, P143, DOI 10.2307/6017; McRae SB, 1997, IBIS, V139, P701; McRae SB, 1996, BEHAV ECOL SOCIOBIOL, V38, P115, DOI 10.1007/s002650050224; McRae SB, 2011, ECOL EVOL, V1, P317, DOI 10.1002/ece3.26; MONTEVECCHI WA, 1976, BEHAVIOUR, V58, P26, DOI 10.1163/156853976X00226; Quach L, 2021, J EXP ZOOL PART B, V336, P595, DOI 10.1002/jez.b.22945; R Core Team, 2021, R LANG ENV STAT; Schroeder KM, 2018, WILSON J ORNITHOL, V130, P1036, DOI 10.1676/1559-4491.130.4.1036; Sezer M, 2009, BIOL RES, V42, P99, DOI [/S0716-97602009000100010, 10.4067/S0716-97602009000100010]; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Soto FA, 2012, COGN AFFECT BEHAV NE, V12, P220, DOI 10.3758/s13415-011-0070-x; Sparks NHC, 2011, AVIAN BIOL RES, V4, P162, DOI 10.3184/175815511X13228269481875; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Stoddard MC, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0197; Stoddard MC, 2017, SCIENCE, V356, P1249, DOI 10.1126/science.aaj1945; Stoddard MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5117; Stoddard MC, 2011, AVIAN BIOL RES, V4, P196, DOI 10.3184/175815511X13207484398647; Sulc M., 2020, PREPRINT; Town C, 2013, ECOL EVOL, V3, P1902, DOI 10.1002/ece3.587; TSCHANZ BEAT, 1959, BEHAVIOUR, V14, P1, DOI 10.1163/156853959X00018; Van Perlo, 1998, RAILS GUIDE RAILS CR; VICTORIA JK, 1972, IBIS, V114, P367, DOI 10.1111/j.1474-919X.1972.tb00834.x; Yom-Tov Y, 2001, IBIS, V143, P133, DOI 10.1111/j.1474-919X.2001.tb04177.x; YOMTOV Y, 1980, BIOL REV, V55, P93, DOI 10.1111/j.1469-185X.1980.tb00689.x	53	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261868	10.1371/journal.pone.0261868	http://dx.doi.org/10.1371/journal.pone.0261868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025922	gold, Green Published			2022-12-26	WOS:000796264200030
J	Namasivayam, P; Bui, DT; Low, C; Barnett, T; Bridgman, H; Marsh, P; Lee, S				Namasivayam, Pathmavathy; Bui, Dung T.; Low, Christine; Barnett, Tony; Bridgman, Heather; Marsh, Pauline; Lee, Simone			Use of telehealth in the provision of after-hours palliative care services in rural and remote Australia: A scoping review protocol	PLOS ONE			English	Review							CAREGIVERS; SUPPORT; TOOLS	Introduction After-hours services are essential in ensuring patients with life limiting illness and their caregivers are supported to enable continuity of care. Telehealth is a valuable approach to meeting after-hours support needs of people living with life-limiting illness, their families, and caregivers in rural and remote communities. It is important to explore the provision of after-hours palliative care services using telehealth to understand the reach of these services in rural and remote Australia. A preliminary search of databases failed to reveal any scoping or systematic reviews of telehealth in after-hours palliative care services in rural or remote Australia. Aim To review and map the available evidence about the use of telehealth in providing after-hours palliative care services in Australian rural and remote communities. Methods The proposed scoping review will be conducted using the Arksey and O'Malley methodological framework and in accordance with the Joanna Briggs Institute methodology for scoping reviews. The reporting of the scoping review will be guided by the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). This review will consider research and evaluation of after-hours services using telehealth for palliative care stakeholders in rural and remote Australia. Peer reviewed studies and grey literature published in English from 2000 to May 2021 will be included. Scopus, Web of Science, CINAHL Complete, Embase via Ovid, PsycINFO via Ovid, Emcare via Ovid, Medline via Ovid, and grey literature will be searched for relevant articles. Titles and abstracts will be screened by two independent reviewers for assessment against the inclusion criteria. Data will be extracted and analysed by two reviewers using an adapted data extraction tool and thematic analysis techniques. Diagrams, tables, and summary narratives will be used to map, summarise and thematically group the characteristics of palliative care telehealth services in rural and remote Australia, including stakeholders' perceptions and benefits and challenges of the services.	[Namasivayam, Pathmavathy; Bui, Dung T.] Univ Tasmania, Sch Nursing, Hobart, Tas, Australia; [Bui, Dung T.; Low, Christine; Barnett, Tony; Bridgman, Heather; Marsh, Pauline; Lee, Simone] Univ Tasmania, Sch Hlth Sci, Ctr Rural Hlth, Newnham, Tas, Australia	University of Tasmania; University of Tasmania	Bui, DT (corresponding author), Univ Tasmania, Sch Hlth Sci, Ctr Rural Hlth, Newnham, Tas, Australia.	dungtrung.bui@utas.edu.au		Namasivayam, Pathmavathy/0000-0003-0761-223X; Bui, Trung Dung/0000-0002-9907-8240; Low, Christine/0000-0002-4247-6467				Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Armstrong K., 2016, HLTH FUTURE AUSTR; Australian Bureau of Statistics, 2017, AUSTR DEM STAT; Australian Bureau of Statistics, 2014, AUSTR HIST POP STAT; Australian Department of Health, TEL PIL PROGR; Australian Department of Health, MOD MON MOD INT; Australian Department of Health and Human Services, TASM MOD SERV DEL PA; Australian Institute of Health and Welfare, 2018, OLD AUSTR GLANC; Australian Institute of Health and Welfare, RURAL REMOTE HEALTH; Australian Institute of Health and Welfare, PALL CAR SERV AUSTR; Baird-Bower D, 2016, INT J PALLIAT NURS, V22, P286, DOI 10.12968/ijpn.2016.22.6.286; Bradford NK, 2016, RURAL REMOTE HEALTH, V16; Bradford N, 2012, J PEDIATR ONCOL NURS, V29, P141, DOI 10.1177/1043454212446023; CareSearch, RUR REM SPEC POP INT; Chi NC, 2015, J TELEMED TELECARE, V21, P37, DOI 10.1177/1357633X14562734; Chiang LC, 2012, INT J NURS STUD, V49, P1230, DOI 10.1016/j.ijnurstu.2012.04.013; Chih MY, 2013, PALLIATIVE MED, V27, P533, DOI 10.1177/0269216312457213; Ciechomski L, 2009, ASIA-PAC J HEALTH MA, V4, P57; CRANA plus, 2015, CRANA PLUS POS PAP P; Crawford M., 2017, GEN REPORT PERFORMAN; Cromwell D., 2003, CAN NATL PALLIATIVE; Demiris G, 2012, J PALLIAT MED, V15, P653, DOI 10.1089/jpm.2011.0488; Demiris G, 2007, CLIN GERONTOLOGIST, V31, P43, DOI 10.1300/J018v31n01_04; Dionne-Odom JN, 2018, J PAIN SYMPTOM MANAG, V55, P1519, DOI 10.1016/j.jpainsymman.2018.02.009; Disalvo D, 2021, PALLIATIVE MED, V35, P1385, DOI 10.1177/02692163211024451; Grindrod A, 2018, ANN PALLIAT MED, V7, pS73, DOI 10.21037/apm.2018.04.01; Johnston Bridget M, 2020, HRB Open Res, V3, P9, DOI 10.12688/hrbopenres.13006.1; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; National Rural Health Alliance, 2012, PALL CAR RUR REM ARE; Oliver DP, 2010, AM J HOSP PALLIAT ME, V27, P465, DOI 10.1177/1049909110362402; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Palliative Care Australia, 2018, PALL CAR SERV DEV GU; Palliative Care Australia, 2017, PALL CAR AUSTR SUBM; Palliative Care Australia, 2020, CALLS PALL CAR REF P; Palliative Care Tasmania, PALL CAR; Palliative Care team, 2012, AFT HOURS PALL CAR F; Peters M.D.J., 2020, JBI MANUAL EVIDENCE, DOI [DOI 10.46658/JBIMES-20-01, 10.46658/JBIMES-20-12,%20JBI,%202020, DOI 10.46658/JBIMES-20-12]; Phillips JL, 2008, J PAIN SYMPTOM MANAG, V36, P11, DOI 10.1016/j.jpainsymman.2007.08.017; Royal Australian Coffege of General Practitioners, 2016, GP LED PALL CAR RUR; Snoswell CL, 2020, AUST HEALTH REV, V44, P737, DOI 10.1071/AH20183; The Australian Department of Health, 2015, TEL; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; Victoria Department of Health Human Services, 2013, HOURS PALL CAR PIL P; Wadhwa A, 2006, MED EDUC, V40, P759, DOI 10.1111/j.1365-2929.2006.02534.x; Wenham S, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3012001; WHO, 2019, TEL WHO; Wilkes Lesley, 2004, Aust J Rural Health, V12, P95, DOI 10.1111/j.1440-1854.2004.00568.x; World Health Organization, PALL CAR; Zheng YQ, 2016, TELEMED E-HEALTH, V22, P288, DOI 10.1089/tmj.2015.0090	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261962	10.1371/journal.pone.0261962	http://dx.doi.org/10.1371/journal.pone.0261962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025895	Green Published, Green Accepted, gold			2022-12-26	WOS:000796264200037
J	Rybak, B; Krawczyk, B; Furmanek-Blaszk, B; Wysocka, M; Fordon, M; Ziolkowski, P; Meissner, W; Stepniewska, K; Sikorska, K				Rybak, Bartosz; Krawczyk, Beata; Furmanek-Blaszk, Beata; Wysocka, Magdalena; Fordon, Magdalena; Ziolkowski, Pawel; Meissner, Wlodzimierz; Stepniewska, Katarzyna; Sikorska, Katarzyna			Antibiotic resistance, virulence, and phylogenetic analysis of Escherichia coli strains isolated from free-living birds in human habitats	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; HIGH-PATHOGENICITY ISLAND; MOLECULAR EPIDEMIOLOGY; CTX-M; PREVALENCE; GENES; BACTERIA; BLOOD; WATER; ENVIRONMENT	Wild birds can be colonized by bacteria, which are often resistant to antibiotics and have various virulence profiles. The aim of this study was to analyze antibiotic resistance mechanisms and virulence profiles in relation to the phylogenetic group of E. co/i strains that were isolated from the GI tract of wildfowl. Out of 241 faecal samples, presence of E. co/i resistant to a cephalosporin (ESBLIAmpC) was estimated for 33 isolates (13,7%). Based on the analysis of the coexistence of 4 genes encoding ESBLs/AmpC (bla(CTX-M), bla(TEM), bla(SHV), bla(AmpC)) and class 1 and 2 integrons genes (intl1, intl2) a subset of two resistance profiles was observed among the investigated E. coli isolates carrying bla(AmpC), bla(SHV), and bla(CTX-M), bla(TEM), class 1 and 2 integrons, respectively. The E. coli isolates were categorized into 4 phylogenetic groups A (39.4%), B2 (24.25%), D (24.25%) and B1 (12.1%). The pathogenic B2 and D groups were mainly typical for the Laridae family. Among the 28 virulence factors (Vfs) detected in pathogenic phylogenetic groups B2 and D, 7 were exclusively found in those groups (sfa, vat, tosA, tosB, h/y, usp, cm), while 4 VFs (fecA, fyuA, irp2, kspMTII) showed a statistically significant association (P <= 0.05) with phylogroups A and B1. Our results indicated that strains belonging to commensal phylogroups A/B1 possess extensive iron acquisition systems (93,9%) and autotransporters (60,6%), typical for pathogens, hence we suggest that these strains evolve towards higher levels of virulence. This study, which is a point assessment of the virulence and drug resistance potential of wild birds, confirms the importance of taking wild birds as a reservoir of strains that pose a growing threat to humans. The E. coli analyzed in our study derive from different phylogenetic groups and possess an arsenal of antibiotic resistance genes and virulence factors that contribute to their ability to cause diseases.	[Rybak, Bartosz] Med Univ Gdansk, Inst Maritime & Trop Med, Dept Environm Toxicol, Fac Hlth Sci, Gdansk, Poland; [Krawczyk, Beata; Wysocka, Magdalena; Fordon, Magdalena] Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, Gdansk, Poland; [Furmanek-Blaszk, Beata; Ziolkowski, Pawel] Univ Gdansk, Fac Biol, Dept Microbiol, Gdansk, Poland; [Meissner, Wlodzimierz; Stepniewska, Katarzyna] Univ Gdansk, Dept Vertebrate Ecol & Zool, Avian Ecophysiol Unit, Gdansk, Poland; [Sikorska, Katarzyna] Med Univ Gdansk, Fac Hlth Sci, Dept Trop Med & Parasitol, Natl Ctr Trop Med,Inst Maritime & Trop Med, Gdynia, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Krawczyk, B (corresponding author), Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, Gdansk, Poland.	beata.krawczyk@pg.edu.pl			Statutory Research Programme in Gdansk University of Technology [4914/E-359/M/2019 Ds-033143]	Statutory Research Programme in Gdansk University of Technology	Financial support within the framework of Statutory Research Programme in Gdansk University of Technology: 4914/E-359/M/2019 Ds-033143 for Beata Krawczyk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala L, 2016, MICROB ECOL, V72, P861, DOI 10.1007/s00248-015-0718-0; Atterby C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190380; Baraniak A, 2002, ANTIMICROB AGENTS CH, V46, P151, DOI 10.1128/AAC.46.1.151-159.2002; Binkowski LJ, 2013, ENVIRON POLLUT, V178, P336, DOI 10.1016/j.envpol.2013.03.030; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bonnedahl J, 2014, UPSALA J MED SCI, V119, P113, DOI 10.3109/03009734.2014.905663; Briongos-Figuero LS, 2012, INT J CLIN PRACT, V66, P891, DOI 10.1111/j.1742-1241.2012.02991.x; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2002, ANTIMICROB AGENTS CH, V46, P1269, DOI 10.1128/AAC.46.5.1269-1272.2002; Carniel E, 1996, J BACTERIOL, V178, P6743, DOI 10.1128/jb.178.23.6743-6751.1996; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; De Souza GM, 2019, INFECT DRUG RESIST, V12, P3595, DOI 10.2147/IDR.S228612; De Vries A, 2016, GGDENDRO CREATE DEND; Dobiasova H, 2013, FEMS MICROBIOL ECOL, V85, P604, DOI 10.1111/1574-6941.12149; Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x; Dynowska M, 2013, B VET I PULAWY, V57, P323, DOI 10.2478/bvip-2013-0056; Dzidic S, 2008, FOOD TECHNOL BIOTECH, V46, P11; Edelstein M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; EWINS PJ, 1994, HYDROBIOLOGIA, V279, P39, DOI 10.1007/BF00027839; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Gao QQ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-143; Ge XKZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112048; Goldstein A, 2015, J COMPUT GRAPH STAT, V24, P44, DOI 10.1080/10618600.2014.907095; Gophna U, 2001, FEMS MICROBIOL LETT, V196, P57, DOI 10.1111/j.1574-6968.2001.tb10540.x; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gordon DM, 2003, MICROBIOL-SGM, V149, P3575, DOI 10.1099/mic.0.26486-0; Gronthal T, 2018, EUROSURVEILLANCE, V23, P13, DOI 10.2807/1560-7917.ES.2018.23.27.1700497; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guerra B, 2003, J ANTIMICROB CHEMOTH, V52, P489, DOI 10.1093/jac/dkg362; Handrova L, 2019, J ENVIRON SCI HEAL B, V54, P605, DOI 10.1080/03601234.2019.1608103; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Infante B, 2005, INT J ANTIMICROB AG, V25, P308, DOI 10.1016/j.ijantimicag.2004.12.004; Izdebski R, 2013, ANTIMICROB AGENTS CH, V57, P309, DOI 10.1128/AAC.01656-12; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Johnson JR, 2008, J CLIN MICROBIOL, V46, P4078, DOI 10.1128/JCM.00980-08; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Jorgensen SL, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00333-18; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Krawczyk B, 2015, EUR J CLIN MICROBIOL, V34, P1135, DOI 10.1007/s10096-015-2331-z; Krawczyk B, 2007, J MICROBIOL METH, V71, P114, DOI 10.1016/j.mimet.2007.08.010; Krawczyk B, 2006, J CLIN MICROBIOL, V44, P2327, DOI 10.1128/JCM.00052-06; Krawczyk B, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050318; Krawczyk B, 2017, J APPL GENET, V58, P415, DOI 10.1007/s13353-017-0393-6; Leverstein-van Hall MA, 2002, J CLIN MICROBIOL, V40, P3038, DOI 10.1128/JCM.40.8.3038-3040.2002; Literak I, 2012, MICROB DRUG RESIST, V18, P567, DOI 10.1089/mdr.2012.0075; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Liu BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073947; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Machado E, 2005, ANTIMICROB AGENTS CH, V49, P1823, DOI 10.1128/AAC.49.5.1823-1829.2005; Martinez-Martinez Luis, 2014, Enferm Infecc Microbiol Clin, V32 Suppl 4, P4, DOI 10.1016/S0213-005X(14)70168-5; Michalik M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192899; Mitchell NM, 2015, APPL ENVIRON MICROB, V81, P1177, DOI 10.1128/AEM.03524-14; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Ong CLY, 2008, J BACTERIOL, V190, P1054, DOI 10.1128/JB.01523-07; Picozzi S, 2013, UROL ANNALS, V5, P25, DOI 10.4103/0974-7796.106962; Pietsch M, 2017, VET MICROBIOL, V200, P130, DOI 10.1016/j.vetmic.2015.11.028; Radhouani H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00023; Roderova M, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02147; Sarowska J, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0290-0; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Searle LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117906; Shobrak MY, 2014, BRAZ J MICROBIOL, V45, P1199, DOI 10.1590/S1517-83822014000400010; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Skurnik D, 2005, ANTIMICROB AGENTS CH, V49, P3062, DOI 10.1128/AAC.49.7.3062-3065.2005; Sledzinska Anna, 2006, Przegl Epidemiol, V60, P27; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Smits JEG, 2013, COMP IMMUNOL MICROB, V36, P333, DOI 10.1016/j.cimid.2012.11.007; Smolders A, 2014, LAKE RESERV MANAGE, V30, P23, DOI 10.1080/10402381.2013.866997; Solo-Gabriele HM, 2000, APPL ENVIRON MICROB, V66, P230, DOI 10.1128/AEM.66.1.230-237.2000; Stedt J, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0166-3; Stojowska K, 2009, POL J MICROBIOL, V58, P247; The European Committee on Antimicrobial Susceptibility Testing, 2020, BREAKP TABL INT MICS; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; van der Westhuizen WA, 2012, AVIAN PATHOL, V41, P33, DOI 10.1080/03079457.2011.631982; Vounba P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214304; Wang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147740; Washburn BE, 2013, CONDOR, V115, P67, DOI 10.1525/cond.2013.110185; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Yair Y, 2018, CURR TOP MICROBIOL, V416, P163, DOI 10.1007/82_2018_109	88	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262236	10.1371/journal.pone.0262236	http://dx.doi.org/10.1371/journal.pone.0262236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020771	Green Published, gold			2022-12-26	WOS:000834207700037
J	Shartaj, M; Suter, JF; Warziniack, T				Shartaj, Mostafa; Suter, Jordan F.; Warziniack, Travis			Summer crowds: An analysis of USFS campground reservations during the COVID-19 pandemic	PLOS ONE			English	Article							UNITED-STATES	During the COVID-19 pandemic, US public land managers faced the challenge of catering to large increases in camping demand, while maintaining social distancing guidelines. In this paper, we use multivariate linear regression to analyze weekly changes in reservations to US Forest Service (USFS) campgrounds between 2019 and 2020. The regression models estimate the impact of local COVID infection rates, public health restrictions, and spatial spillovers from proximity to National Parks (NPs), metropolitan areas and wildfire on camping demand. Our sample includes 1,688 individual USFS campgrounds from across the contiguous US. The results illustrate the dramatic increases in camping on USFS land that occurred in the summer of 2020 and demonstrate that increases in local infection rates led to significant increases in camping nights reserved in the summer. The results also illustrate that the increase in camping nights reserved at USFS campgrounds was particularly dramatic for campgrounds located near large metropolitan areas and near NPs that saw increases in overall recreational visits. These results point to the important role that public lands played during the pandemic and can help guide public land resource allocations for campground maintenance and operation.	[Shartaj, Mostafa; Suter, Jordan F.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Warziniack, Travis] US Forest Serv, Rocky Mt Res Stn, Ft Collins, CO USA	Colorado State University; United States Department of Agriculture (USDA); United States Forest Service	Shartaj, M (corresponding author), Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA.	mostafa.shartaj@colostate.edu		Warziniack, Travis/0000-0002-9431-2288	US National Forest Service, National Center for Natural Resource Economics Research [19-JV-11221636-164]	US National Forest Service, National Center for Natural Resource Economics Research	Author Initials: JFS, MS Grant Number awarded: 19-JV-11221636-164 Funder: US National Forest Service, National Center for Natural Resource Economics Research The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LM, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142396; Blahna Dale J., 2020, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P9; Craig CA, 2021, ANN TOURISM RES, V89, DOI 10.1016/j.annals.2020.103071; Department of Health and Social Care, 2020, DET METH SOURC COVID; Gellman J, 2021, WILDFIRE SMOKE OUTDO; Geng DH, 2021, J FORESTRY RES, V32, P553, DOI 10.1007/s11676-020-01249-w; Goodman-Bacon A, 2020, SURV RES METHODS-GER, V14, P153, DOI 10.18148/srm/2020.v14i2.7723; Jenkins ME, 2020, ADDRESSING MAINTENAN; Kupfer JA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13169366; Landry CE, 2021, APPL ECON PERSPECT P, V43, P443, DOI 10.1002/aepp.13119; Moreland A, 2020, MMWR-MORBID MORTAL W, V69, P1198, DOI 10.15585/mmwr.mm6935a2; Morse JW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243697; National Interagency Fire Center, 2021, FIRE INF STAT; National Interagency Fire Center, 2021, WILDL FIR OP DAT; National Park Service, 2020, CURRENT YEAR MONTHLY; Oster AM, 2020, MMWR-MORBID MORTAL W, V69, P1127, DOI 10.15585/mmwr.mm6933e2; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Rice W.L., UNDERSTANDING DRIVER, DOI [10.31235/osf.io/97qa4, DOI 10.31235/OSF.IO/97QA4]; Romano S, 2021, RES SOC ADMIN PHARM, V17, P1876, DOI 10.1016/j.sapharm.2020.05.024; USA FACTS, 2021, US COVID 19 CAS DEAT; Volenec ZM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251799; Yi SH, 2020, MMWR-MORBID MORTAL W, V69, P1730, DOI 10.15585/mmwr.mm6946a3	22	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261833	10.1371/journal.pone.0261833	http://dx.doi.org/10.1371/journal.pone.0261833			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020759	gold, Green Published			2022-12-26	WOS:000834207700026
J	Yamagishi, T; Saito, A; Kawakami, Y				Yamagishi, Takaki; Saito, Akira; Kawakami, Yasuo			Determinants of whole-body maximal aerobic performance in young male and female athletes: The roles of lower extremity muscle size, strength and power	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; LEG EXTENSION POWER; OXYGEN-CONSUMPTION; STROKE VOLUME; VENTILATORY THRESHOLD; INCREMENTAL EXERCISE; CURVATURE CONSTANT; CYCLE ERGOMETRY; SEX-DIFFERENCES; THIGH	This study sought to determine whether lower extremity muscle size, power and strength could be a determinant of whole-body maximal aerobic performance in athletes. 20 male and 19 female young athletes (18 +/- 4 years) from various sporting disciplines participated in this study. All athletes performed a continuous ramp-incremental cycling to exhaustion for the determination of peak oxygen uptake ((V) over dotO(2peak): the highest (V) over dotO(2) over a 15-s period) and maximal power output (MPO: power output corresponding to (V) over dotO(2pe)(ak)). Axial scanning of the right leg was performed with magnetic resonance imaging, and anatomical cross-sectional areas (CSAs) of quadriceps femoris (QF) and hamstring muscles at 50% of thigh length were measured. Moreover, bilateral leg extension power and unilateral isometric knee extension and flexion torque were determined. All variables were normalised to body mass, and six independent variables ((V) over dotO(2peak), CSAs of thigh muscles, leg extension power and knee extension and flexion torque) were entered into a forward stepwise multiple regression model with MPO being dependent variable for males and females separately. In the males, (V) over dot(2)(peak), was chosen as the single predictor of MPO explaining 78% of the variance. In the females, MPO was attributed to, in the order of importance, (V) over dotO(2peak), (p < 0.001) and the CSA of QF (p = 0.011) accounting for 84% of the variance. This study suggests that while oxygen transport capacity is the main determinant of MPO regardless of sex, thigh muscle size also has a role in whole-body maximal aerobic performance in female athletes.	[Yamagishi, Takaki; Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Yamagishi, Takaki] Japan Inst Sport Sci, Dept Sport Sci, Tokyo, Japan; [Saito, Akira] Kyushu Sangyo Univ, Ctr Hlth & Sports Sci, Fukuoka, Japan; [Kawakami, Yasuo] Waseda Univ, Human Performance Lab, Comprehens Res Org, Tokyo, Japan	Waseda University; Waseda University	Kawakami, Y (corresponding author), Waseda Univ, Fac Sport Sci, Saitama, Japan.; Kawakami, Y (corresponding author), Waseda Univ, Human Performance Lab, Comprehens Res Org, Tokyo, Japan.	ykawa@waseda.jp	Kawakami, Yasuo/AFM-0651-2022	Kawakami, Yasuo/0000-0003-0588-4039; Yamagishi, Takaki/0000-0002-5499-8182	Go for the World! Saitama Young Athletes Development Program, Saitama prefecture; Human Performance Laboratory, Comprehensive Research Organization, Waseda University	Go for the World! Saitama Young Athletes Development Program, Saitama prefecture; Human Performance Laboratory, Comprehensive Research Organization, Waseda University	This work was supported by Go for the World! Saitama Young Athletes Development Program, Saitama prefecture; and the Human Performance Laboratory, Comprehensive Research Organization, Waseda University. One of our funders (Go for the World! Saitama Young Athletes Development Program, Saitama prefecture) played a role in participant recruitment.	Adami A, 2013, EUR J APPL PHYSIOL, V113, P2647, DOI 10.1007/s00421-013-2705-9; Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2004-821000; Ansdell P, 2020, EXP PHYSIOL, V105, P2007, DOI 10.1113/EP088548; Ansdell P, 2020, J PHYSIOL-LONDON, V598, P5717, DOI 10.1113/JP280031; Ansdell P, 2019, J PHYSIOL-LONDON, V597, P5577, DOI 10.1113/JP278699; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Boone J, 2016, APPL PHYSIOL NUTR ME, V41, P55, DOI 10.1139/apnm-2015-0261; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Cook DB, 1998, INT J NEUROSCI, V95, P183, DOI 10.3109/00207459809003340; di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z; Ema R, 2014, INT J SPORTS MED, V35, P293, DOI 10.1055/s-0033-1349138; ERICSON MO, 1986, EUR J APPL PHYSIOL, V55, P229, DOI 10.1007/BF02343792; Ferretti G, 2014, EUR J APPL PHYSIOL, V114, P2007, DOI 10.1007/s00421-014-2911-0; Froyd C, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00399; GLEDHILL N, 1994, MED SCI SPORT EXER, V26, P1116; GREEN S, 1993, SPORTS MED, V15, P312, DOI 10.2165/00007256-199315050-00003; Guette M, 2005, CHRONOBIOL INT, V22, P541, DOI 10.1081/CBI-200062407; Hodgson MD, 2018, J APPL PHYSIOL, V125, P304, DOI 10.1152/japplphysiol.00722.2017; Hug F, 2006, INT J SPORTS MED, V27, P456, DOI 10.1055/s-2005-865787; Hunter SK, 2016, EXP PHYSIOL, V101, P250, DOI 10.1113/EP085370; IVY JL, 1980, J APPL PHYSIOL, V48, P523, DOI 10.1152/jappl.1980.48.3.523; Jacobs RA, 2011, J APPL PHYSIOL, V111, P1422, DOI 10.1152/japplphysiol.00625.2011; Kordi M, 2018, EUR J APPL PHYSIOL, V118, P637, DOI 10.1007/s00421-018-3807-1; Lanferdini FJ, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00979; Lavie CJ, 2004, AM J CARDIOL, V93, P588, DOI 10.1016/j.amjcard.2003.11.023; LORTIE G, 1985, EUR J APPL PHYSIOL O, V54, P471, DOI 10.1007/BF00422954; Maeo S, 2018, MED SCI SPORT EXER, V50, P1629, DOI 10.1249/MSS.0000000000001611; Marcora SM, 2010, EUR J APPL PHYSIOL, V109, P763, DOI 10.1007/s00421-010-1418-6; Mattu AT, 2020, SCAND J MED SCI SPOR, V30, P472, DOI 10.1111/sms.13590; McNulty KL, 2020, SPORTS MED, V50, P1813, DOI 10.1007/s40279-020-01319-3; Midgley AW, 2006, SPORTS MED, V36, P117, DOI 10.2165/00007256-200636020-00003; Miura A, 2002, EUR J APPL PHYSIOL, V87, P238, DOI 10.1007/s00421-002-0623-3; Morales-Alamo D, 2015, J PHYSIOL-LONDON, V593, P4631, DOI 10.1113/JP270487; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Mortensen SP, 2005, J PHYSIOL-LONDON, V566, P273, DOI 10.1113/jphysiol.2005.086025; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Murias JM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00143; Noakes TD, 2008, BRIT J SPORT MED, V42, P551, DOI 10.1136/bjsm.2008.046821; Noakes TD, 2008, BRIT J SPORT MED, V42, P574, DOI 10.1136/bjsm.2008.046771; Noakes TD, 2004, BRIT J SPORT MED, V38, P511, DOI 10.1136/bjsm.2003.009860; Oliveira RB, 2011, CLINICS, V66, P203, DOI 10.1590/S1807-59322011000200004; Raghuveer G, 2020, CIRCULATION, V142, pE101, DOI 10.1161/CIR.0000000000000866; Roels B, 2005, BRIT J SPORT MED, V39, P965, DOI 10.1136/bjsm.2005.020404; Ronnestad BR, 2010, EUR J APPL PHYSIOL, V108, P965, DOI 10.1007/s00421-009-1307-z; Souza KM, 2015, APPL PHYSIOL NUTR ME, V40, P895, DOI 10.1139/apnm-2015-0090; Vucetic V, 2015, J STRENGTH COND RES, V29, P1057, DOI 10.1519/JSC.0000000000000725; Warburton DER, 2008, J APPL PHYSIOL, V104, P276, DOI 10.1152/japplphysiol.00595.2007a; Yamaguchi T, 2005, J STRENGTH COND RES, V19, P677; Yoshiga CC, 2003, J SPORT SCI, V21, P905, DOI 10.1080/0264041031000140437; Zhang JG, 2003, EUR J APPL PHYSIOL, V90, P109, DOI 10.1007/s00421-003-0860-0; Zhou B, 2001, MED SCI SPORT EXER, V33, P1849, DOI 10.1097/00005768-200111000-00008	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262507	10.1371/journal.pone.0262507	http://dx.doi.org/10.1371/journal.pone.0262507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020757	Green Published, gold			2022-12-26	WOS:000834207700045
J	Maharaj, AS; Parker, J; Hopkins, JP; Gournis, E; Bogoch, II; Rader, B; Astley, CM; Ivers, NM; Hawkins, JB; Lee, L; Tuite, AR; Fisman, DN; Brownstein, JS; Lapointe-Shaw, L				Maharaj, Arjuna S.; Parker, Jennifer; Hopkins, Jessica P.; Gournis, Effie; Bogoch, Isaac I.; Rader, Benjamin; Astley, Christina M.; Ivers, Noah M.; Hawkins, Jared B.; Lee, Liza; Tuite, Ashleigh R.; Fisman, David N.; Brownstein, John S.; Lapointe-Shaw, Lauren			Comparison of longitudinal trends in self-reported symptoms and COVID-19 case activity in Ontario, Canada	PLOS ONE			English	Article								Background Limitations in laboratory diagnostic capacity impact population surveillance of COVID-19. It is currently unknown whether participatory surveillance tools for COVID-19 correspond to government-reported case trends longitudinally and if it can be used as an adjunct to laboratory testing. The primary objective of this study was to determine whether self-reported COVID-19-like illness reflected laboratory-confirmed COVID-19 case trends in Ontario Canada. Methods We retrospectively analyzed longitudinal self-reported symptoms data collected using an online tool-Outbreaks Near Me (ONM)-from April 20th, 2020, to March 7th, 2021 in Ontario, Canada. We measured the correlation between COVID-like illness among respondents and the weekly number of PCR-confirmed COVID-19 cases and provincial test positivity. We explored contemporaneous changes in other respiratory viruses, as well as the demographic characteristics of respondents to provide context for our findings. Results Between 3,849-11,185 individuals responded to the symptom survey each week. No correlations were seen been self-reported CLI and either cases or test positivity. Strong positive correlations were seen between CLI and both cases and test positivity before a previously documented rise in rhinovirus/enterovirus in fall 2020. Compared to participatory surveillance respondents, a higher proportion of COVID-19 cases in Ontario consistently came from low-income, racialized and immigrant areas of the province- these groups were less well represented among survey respondents. Interpretation Although digital surveillance systems are low-cost tools that have been useful to signal the onset of viral outbreaks, in this longitudinal comparison of self-reported COVID-like illness to Ontario COVID-19 case data we did not find this to be the case. Seasonal respiratory virus transmission and population coverage may explain this discrepancy.	[Maharaj, Arjuna S.; Parker, Jennifer] Univ Toronto, Temerty Fac Med, Doctor Med Program, Toronto, ON, Canada; [Hopkins, Jessica P.] Publ Hlth Ontario, Toronto, ON, Canada; [Hopkins, Jessica P.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Hopkins, Jessica P.; Gournis, Effie; Tuite, Ashleigh R.; Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gournis, Effie] Toronto Publ Hlth, Toronto, ON, Canada; [Bogoch, Isaac I.; Fisman, David N.; Lapointe-Shaw, Lauren] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bogoch, Isaac I.; Lapointe-Shaw, Lauren] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Rader, Benjamin; Astley, Christina M.; Hawkins, Jared B.; Brownstein, John S.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA; [Rader, Benjamin] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Astley, Christina M.] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Astley, Christina M.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Ivers, Noah M.] Womens Coll Res Inst, Toronto, ON, Canada; [Ivers, Noah M.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Lee, Liza] Publ Hlth Agcy Canada, Ctr Immunizat & Resp Infect Dis, Ottawa, ON, Canada; [Brownstein, John S.] Harvard Med Sch, Dept Pediat & Biomed Informat, Boston, MA 02115 USA	University of Toronto; McMaster University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Boston Children's Hospital; Boston University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Public Health Agency of Canada; Harvard University; Harvard Medical School	Maharaj, AS (corresponding author), Univ Toronto, Temerty Fac Med, Doctor Med Program, Toronto, ON, Canada.	a.maharaj@mail.utoronto.ca		Parker, Jennifer/0000-0003-2206-4120; Maharaj, Arjuna/0000-0002-2155-7014	UofT COVID action initiative; Center for Disease Control and Prevention; Ending Pandemics; Flu Lab; Public Health Agency of Canada	UofT COVID action initiative; Center for Disease Control and Prevention; Ending Pandemics; Flu Lab; Public Health Agency of Canada	This study is funded by the UofT COVID action initiative (LL-S), URL: https://medicine.utoronto.ca/eligibility-update-toronto-covid-19-action-initiative Outbreaks Near Me is funded by the Center for Disease Control and Prevention, Ending Pandemics and Flu Lab. CDC: https://www.cdc.gov Ending Pandemics: https://endingpandemics.org Flu Lab: https://theflulab.org FluWatchers is funded by the Public Health Agency of Canada. PHAC: https://www.canada.ca/en/public-health.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FORWARD SORTATION AR; Baltrusaitis K, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3322-3; Baltrusaitis Kristin, 2017, JMIR Public Health Surveill, V3, pe18, DOI 10.2196/publichealth.7304; Brownstein John S, 2017, JMIR Public Health Surveill, V3, pe83, DOI 10.2196/publichealth.7344; Centers for Disease Control and Prevention, 2020, CORONAVIRUS DIS 2019; Chan ANT, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2016259; Desjardins MR, 2020, LANCET REG HEALTH-W, V4, DOI 10.1016/j.lanwpc.2020.100024; Guttmann A., 2020, COVID 19 IMMIGRANTS, P1; ISO, 2019, 860112019 ISO; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; King JA, 2021, CAN MED ASSOC J, V193, pE1, DOI 10.1503/cmaj.202065; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Lapointe-Shaw L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239886; Lessler J, 2021, SCIENCE, V372, P1092, DOI 10.1126/science.abh2939; Liu M, 2020, CAN MED ASSOC J, V192, pE1540, DOI 10.1503/cmaj.201860; Luo Hongxing, 2020, JMIR Public Health Surveill, V6, pe18576, DOI 10.2196/18576; Nomura S, 2020, LANCET REG HEALTH-W, V1, DOI 10.1016/j.lanwpc.2020.100011; Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006; Rader B, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa076; Reses HE, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11683-y; Reses HE., 2020, MEDRXIV, DOI 10.02.20195479; Sharfstein JM, 2020, JAMA-J AM MED ASSOC, V323, P1437, DOI 10.1001/jama.2020.3864; Statistics Canada, 2016, DAT PROD 2016 CENS; Statistics Canada, 2019, STAT CANADA, DOI [10.25318/1710000501-eng%0Ahttps://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501, DOI 10.25318/1710000501-ENG%0AHTTPS://WWW150.STATCAN.GC.CA/T1/TBL1/EN/TV.ACTION?PID=1710000501]; Statistics Canada, 2021, CENS PROGR; Sudre Carole Helene, 2020, medRxiv, DOI 10.1101/2020.12.15.20248096; van den Wijngaard C, 2008, EMERG INFECT DIS, V14, P917, DOI 10.3201/eid1406.071467; Yoneoka D, 2020, LANCET REG HEALTH-W, V3, DOI 10.1016/j.lanwpc.2020.100016	28	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262447	10.1371/journal.pone.0262447	http://dx.doi.org/10.1371/journal.pone.0262447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015778	Green Published, gold			2022-12-26	WOS:000814820600019
J	Zhang, YH; Van Laer, AO; Baicu, CF; Neff, LS; Hoffman, S; Katz, MR; Zeigler, SM; Zile, MR; Bradshaw, AD				Zhang, Yuhua; Van Laer, An O.; Baicu, Catalin F.; Neff, Lily S.; Hoffman, Stanley; Katz, Marc R.; Zeigler, Sanford M.; Zile, Michael R.; Bradshaw, Amy D.			Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF	PLOS ONE			English	Article							HEART-FAILURE; COLLAGEN; FIBROSIS; SPARC; STIFFNESS; MATRIX	Heart failure is a leading cause of hospitalizations and mortality worldwide. Heart failure with a preserved ejection fraction (HFpEF) represents a significant clinical challenge due to the lack of available treatment modalities for patients diagnosed with HFpEF. One symptom of HFpEF is impaired diastolic function that is associated with increases in left ventricular stiffness. Increases in myocardial fibrillar collagen content is one factor contributing to increases in myocardial stiffness. Cardiac fibroblasts are the primary cell type that produce fibrillar collagen in the heart. However, relatively little is known regarding phenotypic changes in cardiac fibroblasts in HFpEF myocardium. In the current study, cardiac fibroblasts were established from left ventricular epicardial biopsies obtained from patients undergoing cardiovascular interventions and divided into three categories: Referent control, hypertension without a heart failure designation (HTN (-) HFpEF), and hypertension with heart failure (HTN (+) HFpEF). Biopsies were evaluated for cardiac myocyte cross-sectional area (CSA) and collagen volume fraction. Primary fibroblast cultures were assessed for differences in proliferation and protein expression of collagen I, Membrane Type 1-Matrix Metalloproteinase (MT1-MMP), and a smooth muscle actin (aSMA). Biopsies from HTN (-) HFpEF and HTN (+) HFpEF exhibited increases in myocyte CSA over referent control although only HTN (+) HFpEF exhibited significant increases in fibrillar collagen content. No significant changes in proliferation or aSMA was detected in HTN (-) HFpEF or HTN (+) HFpEF cultures versus referent control. Significant increases in production of collagen I was detected in HF (-) HFpEF fibroblasts, whereas significant decreases in MT1-MMP levels were measured in HTN (+) HFpEF cells. We conclude that epicardial biopsies provide a viable source for primary fibroblast cultures and that phenotypic differences are demonstrated by HTN (-) HFpEF and HTN (+) HFpEF cells versus referent control.	[Zhang, Yuhua; Van Laer, An O.; Baicu, Catalin F.; Neff, Lily S.; Zile, Michael R.; Bradshaw, Amy D.] Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Hoffman, Stanley] Med Univ South Carolina, Dept Med, Div Rheumatol, Charleston, SC 29425 USA; [Katz, Marc R.; Zeigler, Sanford M.] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Zile, Michael R.; Bradshaw, Amy D.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Bradshaw, AD (corresponding author), Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA.; Bradshaw, AD (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA.	bradshad@musc.edu			NIH [5R01-HL123478-01, T32GM132055]; National Defense Science and Engineering Graduate (NDSEG) Fellowship Program - Air Force Research Laboratory (AFRL) [FA9550-21-F-0003]; Office of Naval Research (ONR); Army Research Office (ARO); Department of Veterans Affairs [CX001608]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate (NDSEG) Fellowship Program - Air Force Research Laboratory (AFRL); Office of Naval Research (ONR)(Office of Naval Research); Army Research Office (ARO); Department of Veterans Affairs(US Department of Veterans Affairs)	YES: This work was partially supported by NIH grant 5R01-HL123478-01 to MRZ, NIH T32GM132055 and a FA9550-21-F-0003 through the National Defense Science and Engineering Graduate (NDSEG) Fellowship Program, sponsored by the Air Force Research Laboratory (AFRL), the Office of Naval Research (ONR) and the Army Research Office (ARO) to LSN and by the Department of Veterans Affairs under grants CX001608 to ADB and MRZ.	Ali SR, 2014, CIRC RES, V115, P625, DOI 10.1161/CIRCRESAHA.115.303794; Baicu CF, 2012, AM J PHYSIOL-HEART C, V303, pH1128, DOI 10.1152/ajpheart.00482.2012; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; McDonald LT, 2018, AM J PHYSIOL-HEART C, V315, pH92, DOI 10.1152/ajpheart.00719.2017; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Nagaraju CK, 2019, J AM COLL CARDIOL, V73, P2267, DOI 10.1016/j.jacc.2019.02.049; Pakshir P, 2018, MATRIX BIOL, V68-69, P81, DOI 10.1016/j.matbio.2018.01.019; Riley HJ, 2021, AM J PHYSIOL-HEART C, V320, pH604, DOI 10.1152/ajpheart.00552.2020; Spruill LS, 2007, AM J PHYSIOL-CELL PH, V293, pC1362, DOI 10.1152/ajpcell.00545.2006; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Trombetta-eSilva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079715; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	17	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262479	10.1371/journal.pone.0262479	http://dx.doi.org/10.1371/journal.pone.0262479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015787	Green Published, gold			2022-12-26	WOS:000814820600026
J	Emery, T; Koops, JC				Emery, Tom; Koops, Judith C.			The impact of COVID-19 on fertility behaviour and intentions in a middle income country	PLOS ONE			English	Article							GENDER SURVEY; GENERATIONS; TIME	The COVID Pandemic may affect fertility behaviour and intentions in many ways. Restrictions on service provision reduce access to family planning services and increase fertility in the short term. By contrast, the economic uncertainty brought about by the pandemic and its impact on mental health and well-being may reduce fertility. These various pathways have been explored in the context of high income countries such as the United States and Western Europe, but little is known about middle income countries. In this paper we asses the impact of the COVID pandemic on fertility intentions and behaviour in the Republic of Moldova, a middle income country in Eastern Europe, using the Generations and Gender Survey. This survey was conducted partially before and partially after the onset of the pandemic in 2020, allowing for detailed comparisons of individual circumstances. The results indicate that the pandemic reduced the used of intrauterine devices, and increased the use of male condoms, but with no overall decrease in contraceptive use. Conversely individuals interviewed after the onset of the pandemic were 34.5% less likely to be trying to conceive, although medium term fertility intentions were unchanged. Indicators therefore suggest that in the medium term fertility intentions may not be affected by the pandemic but restricted access to contraception requiring medical consultation and a decrease in short-term fertility intentions could disrupt short term family planning.	[Emery, Tom] Erasmus Univ, Dept Publ Adm, Rotterdam, Netherlands; [Koops, Judith C.] Univ Groningen, Netherlands Interdisciplinary Demog Inst NIDI KNA, Groningen, Netherlands	Erasmus University Rotterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); University of Groningen	Emery, T (corresponding author), Erasmus Univ, Dept Publ Adm, Rotterdam, Netherlands.	tom@odissei-data.nl	Koops, Judith Christel/GOH-0134-2022; Koops, Judith Christel/GOH-0019-2022	Koops, Judith Christel/0000-0002-7449-3480; 	UNFPA Moldova; National Bureau of Statistics of the Republic of Moldova; Ministry of Health, Labour and Social Protection of the Republic of Moldova	UNFPA Moldova; National Bureau of Statistics of the Republic of Moldova; Ministry of Health, Labour and Social Protection of the Republic of Moldova	Particular thanks to the UNFPA Moldova, National Bureau of Statistics of the Republic of Moldova and the Ministry of Health, Labour and Social Protection of the Republic of Moldova for support in conducting the Gender and Generations Programme in the conduct of the study. This analysis in this paper was conducted in collaboration with the UNFPA Moldova and the Ministry of Health, Labour and Social Protection of the Republic of Moldova in response to the onset of the COVID-19 Pandemic during the fieldwork of the Moldovan GGS in 2020. Both parties reviewed and provided comments on earlier and current versions of the analysis. The contents of this publication do not necessarily reflect the views or policies of the UNFPA Moldova and the Ministry of Health, Labour and Social Protection.	Aassve A, 2020, SCIENCE, V369, P370, DOI 10.1126/science.abc9520; Alburez-Gutierrez D., 2019, DEMOGRAPHY DIGITAL E; Dasgupta Aisha, 2020, Gates Open Res, V4, P102, DOI 10.12688/gatesopenres.13148.1; Dommermuth L, 2015, ADV LIFE COURSE RES, V24, P34, DOI 10.1016/j.alcr.2015.02.001; Eeckhaut MCW, 2014, PERSPECT SEX REPRO H, V46, P149, DOI 10.1363/46e1914; Fishbein M, 2011, PREDICTING AND CHANGING BEHAVIOR: THE REASONED ACTION APPROACH, P1; Fokkema T, 2016, DEMOGR RES, V34, P498, DOI 10.4054/DemRes.2016.34.18; Gauthier A, 2018, LONGITUD LIFE COURSE, V9, P456, DOI 10.14301/llcs.v9i4.500; Ito Katsuya, 2017, International Economic Journal, V31, P462; Jacob L, 2020, J SEX MED, V17, P1229, DOI 10.1016/j.jsxm.2020.05.001; Janevic T, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-69; Lappegard T, 2020, COVID 19 COULD GENER; Lindberg L.D, 2020, CONTINUING IMPACTS C; Luppi F, 2020, DEMOGR RES, V43, P1399, DOI 10.4054/DemRes.2020.43.47; Matchan L, 2020, BOSTON GLOBE; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Prodan M., 2016, IMPACT MIGRATION LAB; Settersten RA, 2020, ADV LIFE COURSE RES, V45, DOI 10.1016/j.alcr.2020.100360; Vignoli Daniele, 2020, Genus, V76, P28, DOI 10.1186/s41118-020-00094-3; Vikat A, 2007, DEMOGR RES, V17, P389, DOI 10.4054/DemRes.2007.17.14; Voicu M, 2021, EUR SOC, V23, pS199, DOI 10.1080/14616696.2020.1822537; Wilde, 2020, COVID 19 FUTURE US F; Zhu CF, 2020, INT J GYNECOL OBSTET, V151, P399, DOI 10.1002/ijgo.13366	23	1	1	11	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261509	10.1371/journal.pone.0261509	http://dx.doi.org/10.1371/journal.pone.0261509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990459	gold, Green Published			2022-12-26	WOS:000815783800008
J	Yuen, JG; Marshilok, AC; Benziger, PT; Yan, S; Cello, J; Stackhouse, CA; Kisslinger, K; Bock, DC; Takeuchi, ES; Takeuchi, KJ; Wang, L; Babu, S; Itzkowitz, G; Thanassi, D; Knopf, DA; Shroyer, KR				Yuen, John G.; Marshilok, Amy C.; Benziger, Peter Todd; Yan, Shan; Cello, Jeronimo; Stackhouse, Chavis A.; Kisslinger, Kim; Bock, David C.; Takeuchi, Esther S.; Takeuchi, Kenneth J.; Wang, Lei; Babu, Sruthi; Itzkowitz, Glen; Thanassi, David; Knopf, Daniel A.; Shroyer, Kenneth R.			Dry heat sterilization as a method to recycle N95 respirator masks: The importance of fit	PLOS ONE			English	Article							ISOTACTIC POLYPROPYLENE; FILTRATION EFFICIENCY; PERFORMANCE; DECONTAMINATION; VIRUSES; LEVEL	In times of crisis, including the current COVID-19 pandemic, the supply chain of filtering facepiece respirators, such as N95 respirators, are disrupted. To combat shortages of N95 respirators, many institutions were forced to decontaminate and reuse respirators. While several reports have evaluated the impact on filtration as a measurement of preservation of respirator function after decontamination, the equally important fact of maintaining proper fit to the users' face has been understudied. In the current study, we demonstrate the complete inactivation of SARS-CoV-2 and preservation of fit test performance of N95 respirators following treatment with dry heat. We apply scanning electron microscopy with energy dispersive X-ray spectroscopy (SEM/EDS), X-ray diffraction (XRD) measurements, Raman spectroscopy, and contact angle measurements to analyze filter material changes as a consequence of different decontamination treatments. We further compared the integrity of the respirator after autoclaving versus dry heat treatment via quantitative fit testing and found that autoclaving, but not dry heat, causes the fit of the respirator onto the users face to fail, thereby rendering the decontaminated respirator unusable. Our findings highlight the importance to account for both efficacy of disinfection and mask fit when reprocessing respirators to for clinical redeployment.	[Yuen, John G.; Babu, Sruthi; Shroyer, Kenneth R.] SUNY Stony Brook, Renaissance Sch Med, Dept Pathol, Stony Brook, NY 11794 USA; [Marshilok, Amy C.; Yan, Shan; Bock, David C.; Takeuchi, Esther S.; Takeuchi, Kenneth J.; Wang, Lei] Brookhaven Natl Lab, Interdisciplinary Sci Dept, Upton, NY 11973 USA; [Marshilok, Amy C.; Yan, Shan; Stackhouse, Chavis A.; Bock, David C.; Takeuchi, Esther S.; Takeuchi, Kenneth J.; Wang, Lei] SUNY Stony Brook, Inst Electrochem Stored Energy, Stony Brook, NY 11794 USA; [Marshilok, Amy C.; Takeuchi, Esther S.; Takeuchi, Kenneth J.] SUNY Stony Brook, Dept Mat Sci & Chem Engn, Stony Brook, NY 11794 USA; [Benziger, Peter Todd; Cello, Jeronimo; Thanassi, David] SUNY Stony Brook, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA; [Cello, Jeronimo; Thanassi, David] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Stackhouse, Chavis A.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Kisslinger, Kim] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Itzkowitz, Glen] SUNY Stony Brook, Off Dean, Renaissance Sch Med, Stony Brook, NY 11794 USA; [Knopf, Daniel A.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Shroyer, KR (corresponding author), SUNY Stony Brook, Renaissance Sch Med, Dept Pathol, Stony Brook, NY 11794 USA.; Knopf, DA (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	Daniel.Knopf@stonybrook.edu; Kenneth.Shroyer@stonybrookmedicine.edu	Kisslinger, Kim/F-4485-2014	Yuen, John/0000-0002-1569-3298	DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19; Coronavirus CARES Act; U.S. DOE Office of Science Facility, at Brookhaven National Laboratory [DE-SC0012704]; NIH; NIH New York Consortium for the Advancement of Postdoctoral Scholars (IRACDANYCAPS) [K12-GM102778]	DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19(United States Department of Energy (DOE)); Coronavirus CARES Act; U.S. DOE Office of Science Facility, at Brookhaven National Laboratory(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH New York Consortium for the Advancement of Postdoctoral Scholars (IRACDANYCAPS)	Contact angle, Raman spectroscopy, and electron microscopy characterization were supported by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act (https://science.osti.gov/nvbl).Electron microscopy data were collected at Center for Functional Nanomaterials, which is a U.S. DOE Office of Science Facility, at Brookhaven National Laboratory under Contract No. DE-SC0012704 (https://www.bnl.gov).C.A.S.acknowledges support from the NIH Institutional Research and Academic Career Development Award and New York Consortium for the Advancement of Postdoctoral Scholars (IRACDANYCAPS), award K12-GM102778 (https://www.nigms.nih.gov).	3M, 2021, DEC 3M FILT FAC RESP; [Anonymous], 2013, CONTACT ANGLE WETTIN; Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Campos RK, 2020, ACS NANO, V14, P14017, DOI 10.1021/acsnano.0c06565; CHEN CC, 1992, AM IND HYG ASSOC J, V53, P566, DOI 10.1202/0002-8894(1992)053<0566:APTFFA>2.0.CO;2; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Cohen J, 2020, PREV MED, V141, DOI 10.1016/j.ypmed.2020.106263; Control CfD, PREV IMPL FILT FAC R; FDA, 2020, REC SPONS REQ EUAS D; Fischer RJ, 2020, EMERG INFECT DIS, V26, P2253, DOI 10.3201/eid2609.201524; Fisher EM, 2011, J APPL MICROBIOL, V110, P287, DOI 10.1111/j.1365-2672.2010.04881.x; Grinshpun SA, 2020, J HOSP INFECT, V105, P608, DOI 10.1016/j.jhin.2020.06.030; Guo XM, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11101698; Hager E, 2018, FORENSIC CHEM, V9, P44, DOI 10.1016/j.forc.2018.05.001; Halvorsen T., 1998, ITI062 TSI; He XJ, 2013, AEROSOL SCI TECH, V47, P1180, DOI 10.1080/02786826.2013.829209; Hiejima Y, 2017, MACROMOLECULES, V50, P5867, DOI 10.1021/acs.macromol.7b00229; Jatta M, 2021, AM J INFECT CONTROL, V49, P8, DOI 10.1016/j.ajic.2020.06.194; Jayaweera M, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109819; Kumar A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243965; Liao L, 2020, ACS NANO, V14, P6348, DOI 10.1021/acsnano.0c03597; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Lysik D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133199; Martin S B Jr, 2000, Appl Occup Environ Hyg, V15, P609; Mehrotra Preeti, 2020, JAMA Health Forum, V1, pe200553, DOI 10.1001/jamahealthforum.2020.0553; Meselson M, 2020, NEW ENGL J MED, V382, P2063, DOI 10.1056/NEJMc2009324; Mondelli MU, 2021, LANCET INFECT DIS, V21, pE112, DOI 10.1016/S1473-3099(20)30678-2; Nielsen AS, 2002, POLYMER, V43, P2671, DOI 10.1016/S0032-3861(02)00053-8; Qian YG, 1998, AM IND HYG ASSOC J, V59, P128, DOI 10.1080/15428119891010389; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Safety O Administration H, 2021, ADM H APPENDIX 19101; TSI, 2005, ITI041 TSI; Wang XQ, 2001, J APPL POLYM SCI, V82, P1330, DOI 10.1002/app.1968; Yim WJ, 2020, ACS APPL MATER INTER, V12, P54473, DOI 10.1021/acsami.0c17333	34	0	0	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0257963	10.1371/journal.pone.0257963	http://dx.doi.org/10.1371/journal.pone.0257963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986162	Green Published, gold, Green Submitted			2022-12-26	WOS:000765956200002
J	Han, WT; Liu, MY; Han, D; Li, MQ; Toure, AA; Wang, ZF; Besschetnova, A; Patalano, S; Macoska, JA; Gao, S; He, HH; Cai, CM				Han, Wanting; Liu, Mingyu; Han, Dong; Li, Muqing; Toure, Anthia A.; Wang, Zifeng; Besschetnova, Anna; Patalano, Susan; Macoska, Jill A.; Gao, Shuai; He, Housheng Hansen; Cai, Changmeng			RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition	ONCOGENE			English	Article							NEUROENDOCRINE PHENOTYPE; LINEAGE PLASTICITY; INCREASED SURVIVAL; MECHANISMS; PHOSPHORYLATION; DIFFERENTIATION; DEMETHYLATION; METASTASIS; EXPRESSION; GENOMICS	Genomic loss of RB1 is a common alteration in castration-resistant prostate cancer (CRPC) and is associated with poor patient outcomes. RB1 loss is also a critical event that promotes the neuroendocrine transdifferentiation of prostate cancer (PCa) induced by the androgen receptor (AR) signaling inhibition (ARSi). The loss of Rb protein disrupts the Rb-E2F repressor complex and thus hyperactivates E2F transcription activators. While the impact of Rb inactivation on PCa progression and linage plasticity has been previously studied, there is a pressing need to fully understand underlying mechanisms and identify vulnerabilities that can be therapeutically targeted in Rb-deficient CRPC. Using an integrated cistromic and transcriptomic analysis, we have characterized Rb activities in multiple CRPC models by identifying Rb-directly regulated genes and revealed that Rb has distinct binding sites and targets in CRPC with different genomic backgrounds. Significantly, we show that E2F1 chromatin binding and transcription activity in Rb-deficient CRPC are highly dependent on LSD1/KDM1A, and that Rb inactivation sensitizes CRPC tumor to the LSD1 inhibitor treatment. These results provide new molecular insights into Rb activity in PCa progression and suggest that targeting LSD1 activity with small molecule inhibitors may be a potential treatment strategy to treat Rb-deficient CRPC.	[Han, Wanting; Liu, Mingyu; Han, Dong; Li, Muqing; Toure, Anthia A.; Wang, Zifeng; Besschetnova, Anna; Patalano, Susan; Macoska, Jill A.; Gao, Shuai; Cai, Changmeng] Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA; [Han, Wanting; Liu, Mingyu; Li, Muqing; Toure, Anthia A.; Wang, Zifeng; Besschetnova, Anna; Patalano, Susan; Macoska, Jill A.; Gao, Shuai; Cai, Changmeng] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [He, Housheng Hansen] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [He, Housheng Hansen] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Cai, CM (corresponding author), Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA.; Cai, CM (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	changmeng.cai@umb.edu	Han, Wanting/GQA-5728-2022; Han, Wanting/AEX-5349-2022	Han, Wanting/0000-0002-2173-3647; Besschetnova, Anna/0000-0003-3623-1997; Gao, Shuai/0000-0002-7304-8801; Macoska, Jill/0000-0001-8471-2221; Han, Dong/0000-0002-6224-855X	NIH [R00 CA166507, R01 CA211350, U54 CA156734]; DOD [W81XWH-16-1-0445, W81XWH-19-1-0361, W81XWH-21-1-0267, W81XWH-19-1-0777]; CIHR [142246, 152863, 152864, 159567]; Terry Fox Frontiers Program [1090 P3]; Integrative Biosciences Program at the University of Massachusetts Boston; CSM (College of Science and Mathematics) Dean's Doctoral Research Fellowship from the University of Massachusetts Boston	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox Frontiers Program; Integrative Biosciences Program at the University of Massachusetts Boston; CSM (College of Science and Mathematics) Dean's Doctoral Research Fellowship from the University of Massachusetts Boston	This work is supported by grants from NIH (R00 CA166507 and R01 CA211350 to CC, U54 CA156734 to JAM), DOD (W81XWH-16-1-0445, W81XWH-19-1-0361, and W81XWH-21-1-0267 to CC, W81XWH-19-1-0777 to SG), CIHR (142246, 152863, 152864, and 159567 to HHH), and Terry Fox Frontiers Program Project Grants (1090 P3 to HHH). MLiu was supported by the graduate fellowship from the Integrative Biosciences Program at the University of Massachusetts Boston. WH and ZW were supported by CSM (College of Science and Mathematics) Dean's Doctoral Research Fellowship from the University of Massachusetts Boston. HHH holds Joey and Toby Tanenbaum Brazilian Ball Chair in Prostate Cancer.	Abida W, 2019, P NATL ACAD SCI USA, V116, P11428, DOI 10.1073/pnas.1902651116; Beltran H, 2019, CLIN CANCER RES, V25, P6916, DOI 10.1158/1078-0432.CCR-19-1423; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Berger A, 2019, J CLIN INVEST, V129, P3924, DOI 10.1172/JCI127961; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Chen WS, 2019, CLIN CANCER RES, V25, P4290, DOI 10.1158/1078-0432.CCR-19-0404; Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446; Coleman DJ, 2020, NEOPLASIA, V22, P253, DOI 10.1016/j.neo.2020.04.002; Conteduca V, 2019, EUR J CANCER, V121, P7, DOI 10.1016/j.ejca.2019.08.011; Danza G, 2012, MOL CANCER RES, V10, P230, DOI 10.1158/1541-7786.MCR-11-0296; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Fang Y, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0811-9; Gao S, 2020, NAT GENET, V52, P1011, DOI 10.1038/s41588-020-0681-7; Gao S, 2019, CELL RES, V29, P770, DOI 10.1038/s41422-019-0203-2; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo HY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08133-6; He Y, 2018, ONCOGENE, V37, P534, DOI 10.1038/onc.2017.353; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Korenchuk S, 2001, IN VIVO, V15, P163; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Laurent B, 2015, MOL CELL, V57, P957, DOI 10.1016/j.molcel.2015.01.010; Lin TP, 2016, ONCOTARGET, V7, P26137, DOI 10.18632/oncotarget.8433; Mandigo AC, 2021, CANCER DISCOV, V11, P2334, DOI 10.1158/2159-8290.CD-20-1114; Mateo J, 2020, J CLIN INVEST, V130, P1743, DOI [10.1172/JCI132031, 10.1172/JCl132031]; McNair C, 2018, J CLIN INVEST, V128, P341, DOI 10.1172/JCI93566; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Nyquist MD, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107669; Pfitzenmaier J, 2003, J BONE MINER RES, V18, P1882, DOI 10.1359/jbmr.2003.18.10.1882; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rubin MA, 2020, MOL CELL, V80, P562, DOI 10.1016/j.molcel.2020.10.033; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sehrawat A, 2018, P NATL ACAD SCI USA, V115, pE4179, DOI 10.1073/pnas.1719168115; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Yuan HR, 2020, CANCER CELL, V38, P350, DOI 10.1016/j.ccell.2020.05.022; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zhang XT, 2015, CLIN CANCER RES, V21, P4698, DOI 10.1158/1078-0432.CCR-15-0157; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2019, EMBO J, V38, DOI 10.15252/embj.201899599	51	3	3	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					852	864		10.1038/s41388-021-02135-3	http://dx.doi.org/10.1038/s41388-021-02135-3		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34975152	Green Accepted			2022-12-26	WOS:000737109100001
J	Saha, I; Durand-Morat, A; Nalley, LL; Alam, MJ; Nayga, R				Saha, Indrani; Durand-Morat, Alvaro; Nalley, Lawton Lanier; Alam, Mohammad Jahangir; Nayga, Rodolfo			Rice quality and its impacts on food security and sustainability in Bangladesh	PLOS ONE			English	Article							SENSORY EVALUATION; CONSUMERS; MARKET	Rice market efficiency is important for food security in countries where rice is a staple. We assess the impact of rice quality on rice prices, food security, and environmental sustainability in Bangladesh. We find that while price varies as expected for most quality attributes, it is unaffected by a broken percentage below 24.9 percent. This reveals a potential inefficiency, considering the average 5 percent broken rate observed in the market. An increase in the broken rate of milled rice within the limits supported by our findings can, ceteris paribus, increase rice rations by 4.66 million a year, or conversely, yield the current number of rice rations using 170.79 thousand fewer hectares and cutting emissions by 1.48 million metric tons of CO2 equivalent. Thus, producing rice based on quality assessment can improve food security and its sustainability.	[Saha, Indrani; Durand-Morat, Alvaro; Nalley, Lawton Lanier] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Alam, Mohammad Jahangir] Bangladesh Agr Univ, Dept Agribusiness & Mkt, Mymensingh, Bangladesh; [Nayga, Rodolfo] Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA	University of Arkansas System; University of Arkansas Fayetteville; Bangladesh Agricultural University (BAU); Texas A&M University System; Texas A&M University College Station	Durand-Morat, A (corresponding author), Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA.	adurand@uark.edu		Durand-Morat, Alvaro/0000-0002-8036-2217; Alam, Mohammad Jahangir/0000-0003-3412-9438	University of Arkansas Chancelor's Innovation and Collaboration Grant [IFA2019-019]	University of Arkansas Chancelor's Innovation and Collaboration Grant	DTY This study was funded by the University of Arkansas Chancelor's Innovation and Collaboration Grant #IFA2019-019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairagi S, 2017 AGR APPL EC ASS; Bangladesh Bureau of Statistics, 2021, AGR EST MAJ CROPS; Bangladesh Standards and Testing Institution, 1981, BANGL STAND SPEC GRA; Bruce RM, 2018, CEREAL CHEM, V95, P889, DOI 10.1002/cche.10107; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Choudhury N., 1992, CONSUMER DEMAND RICE, P117; Cuevas RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150345; Custodio MC, 2019, TRENDS FOOD SCI TECH, V92, P122, DOI 10.1016/j.tifs.2019.07.039; Custodio MC, 2016, GLOB FOOD SECUR-AGR, V9, P19, DOI 10.1016/j.gfs.2016.05.005; Custodio MC, 2016, RAPID VALUE CHAIN AS, DOI [10.13140/RG.2.2.27642.13768, DOI 10.13140/RG.2.2.27642.13768]; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; Demont M, 2012, FOOD QUAL PREFER, V23, P63, DOI 10.1016/j.foodqual.2011.07.005; Department of Food and Public Distribution of India, UN SPEC FOOD GRAINS; Diagne M, 2017, AFR J AGRIC RESOUR E, V12, P99; Food and Agriculture Organization, FAOSTAT FOOD BAL; Giraud G, 2013, INT FOOD AGRIBUS MAN, V16, P1; Islam S., 2017, THREAT FOOD SECURITY; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Meresa A, 2020, INT J FOOD SCI, V2020, DOI 10.1155/2020/8810553; Ministry of Food of Bangladesh, 2001, 28 FMRSP MIN FOOD BA; Mottaleb KA, 2016, J AGRIC APPL ECON, V48, P298, DOI 10.1017/aae.2016.18; Rahman A, 2017, 2017 2ND INTERNATIONAL CONFERENCE ON ELECTRICAL & ELECTRONIC ENGINEERING (ICEEE); Roser M., 2019, HUNGER UNDERNOURISHM; Rutsaert P, 2013, REALIZING AFRICA'S RICE PROMISE, P294, DOI 10.1079/9781845938123.0294; Sayeed K. A., 2018, RICE PRICES GROWTH P; Shew AM, 2019, ENVIRON SCI POLICY, V95, P46, DOI 10.1016/j.envsci.2019.02.004; Skorbiansky SR, 2018, RCS18L01 USDA EC RES; South Asian Network on Economic Modeling (SANEM), 2021, COVID 19 FALL POV LI; Tomlins K, 2007, J SCI FOOD AGR, V87, P1564, DOI 10.1002/jsfa.2889; Tomlins KI, 2005, FOOD QUAL PREFER, V16, P79, DOI 10.1016/j.foodqual.2004.02.002; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; United States Department of Agriculture, GLOBAL AGR INFORM NE; United States Department of Agriculture, 2020, RIC INSP HDB; USDA, PROD SUPPL DISTR; Vagsholm I, 2020, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.00016; World Bank, 2019, BANGL POV ASS FAC OL, DOI [10.1596/32754, DOI 10.1596/32754]; World Bank, BANGL INT POV MAP; Yunus M., 2019, INT FOOD POLICY RES, V3, DOI [10.2499/p15738coll2.133124, DOI 10.2499/P15738COLL2.133124]; Zaman ZU., 2001, REV AGR ECON, V57, P121	41	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261118	10.1371/journal.pone.0261118	http://dx.doi.org/10.1371/journal.pone.0261118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972112	gold, Green Published			2022-12-26	WOS:000773555700023
J	Yari, A; Khoshsabegheh, HY; Zarezadeh, Y; Ardalan, A; Boubakran, MS; Ostadtaghizadeh, A; Motlagh, ME				Yari, Arezoo; Khoshsabegheh, Homa Yousefi; Zarezadeh, Yadolah; Ardalan, Ali; Boubakran, Mohsen Soufi; Ostadtaghizadeh, Abbas; Motlagh, Mohamad Esmaeil			Behavioral, health- related and demographic risk factors of death in floods: A case-control study	PLOS ONE			English	Article							FLASH-FLOOD; FATALITIES; CIRCUMSTANCES; VULNERABILITY; FRANCE; LIFE; PREPAREDNESS; PERCEPTION; RESIDENTS; AUSTRALIA	During the first half of 2019, many provinces of Iran were affected by floods, which claimed the lives of 82 people. The present study aimed to investigate the behavioral, health related and demographic risk factors associated with deaths due to floods. We measured the odds ratio and investigated the contribution and significance of the factors in relation to mortality. This case-control study was conducted in the cities affected by flood in Iran. Data were collected on the flood victims using a questionnaire. Survivors, a member of the flood victim's family, were interviewed. In total, 77 subjects completed the survey in the case group, and 310 subjects completed the survey in the control group. The findings indicated that factors such as the age of less than 18 years, low literacy, being trapped in buildings/cars, and risky behaviors increased the risk of flood deaths. Regarding the behavioral factors, perceived/real swimming skills increased the risk of flood deaths although it may seem paradoxical. This increment is due to increased self confidence in time of flood. On the other hand, skills and abilities such as evacuation, requesting help, and escape decreased the risk of flood deaths. According to the results, the adoption of support strategies, protecting vulnerable groups, and improving the socioeconomic status of flood-prone areas could prevent and reduce the risk of flood deaths.	[Yari, Arezoo; Zarezadeh, Yadolah] Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran; [Khoshsabegheh, Homa Yousefi; Ardalan, Ali; Ostadtaghizadeh, Abbas] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Emergencies & Disasters, Tehran, Iran; [Khoshsabegheh, Homa Yousefi] Minist Hlth & Med Educ, Disaster Risk Management Off, Tehran, Iran; [Boubakran, Mohsen Soufi] Urmia Univ, Dept Mech Engn, Orumiyeh, Iran; [Motlagh, Mohamad Esmaeil] Ahvaz Jundishapur Univ Med Sci, Dept Pediat, Ahvaz, Iran	Kurdistan University of Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Urmia University; Ahvaz Jundishapur University of Medical Sciences (AJUMS)	Ostadtaghizadeh, A (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Emergencies & Disasters, Tehran, Iran.; Motlagh, ME (corresponding author), Ahvaz Jundishapur Univ Med Sci, Dept Pediat, Ahvaz, Iran.	ostadtaghizadeh@gmail.com; Dr.motlagh.ms@gmail.com		Ostadtaghizadeh, Abbas/0000-0001-5260-6221	Deputy for Health at Ministry of Health and Medical Education (MOHE) in IRAN [IR.MUK.REC.1398.223]	Deputy for Health at Ministry of Health and Medical Education (MOHE) in IRAN	This study (no: IR.MUK.REC.1398.223.) was conducted with the financial support of the Deputy for Health at Ministry of Health and Medical Education (MOHE) in IRAN. The funding body did not have any other roles in the study design, collection, analysis, and interpretation of data and in writing the manuscript.	Ardalan A., 2019, NATL FLOOD REPORT RE; Ashley ST, 2008, J APPL METEOROL CLIM, V47, P805, DOI 10.1175/2007JAMC1611.1; Becker JS, 2015, WEATHER CLIM SOC, V7, P321, DOI 10.1175/WCAS-D-14-00030.1; Benadusi M, 2014, J CONTING CRISIS MAN, V22, P174, DOI 10.1111/1468-5973.12050; Brazdova M, 2014, NAT HAZARD EARTH SYS, V14, P1663, DOI 10.5194/nhess-14-1663-2014; Brons R, 2006, HANDBOOK ON DROWNING: PREVENTION, RESCUE, TREATMENT, P533; Coates L, 1999, AUST GEOGR, V30, P391, DOI 10.1080/00049189993657; Di Mauro M, 2012, NAT HAZARDS, V63, P1083, DOI 10.1007/s11069-012-0207-4; Diakakis M, 2018, INT J DISAST RISK RE, V28, P404, DOI 10.1016/j.ijdrr.2018.03.018; DUCLOS P, 1991, EUR J EPIDEMIOL, V7, P365, DOI 10.1007/BF00145001; Egli T., 2002, NONSTRUCTURAL FLOOD; FitzGerald G, 2010, EMERG MED AUSTRALAS, V22, P180, DOI 10.1111/j.1742-6723.2010.01284.x; Grothmann T, 2006, NAT HAZARDS, V38, P101, DOI 10.1007/s11069-005-8604-6; Haynes K, 2017, ENVIRON SCI POLICY, V76, P165, DOI 10.1016/j.envsci.2017.07.003; Ibrahim NF, 2017, INT J GEOMATE, V12, P107; IFRC The International Federation of Red Cross and Red Crescent Societies, 2011, WORLD DISASTERS REPO; Jackson TL., 2009, IMPACTS INCREASING R; Jongman B, 2015, P NATL ACAD SCI USA, V112, pE2271, DOI 10.1073/pnas.1414439112; Jonkman SN, 2008, J FLOOD RISK MANAG, V1, P43, DOI 10.1111/j.1753-318X.2008.00006.x; Jonkman SN, 2005, DISASTERS, V29, P75, DOI 10.1111/j.0361-3666.2005.00275.x; Jonkman SN, 2003, DC12336; Keim ME., 2009, FLOODS KOENIG SCHULT, P529; Kelman I., 2004, FLOOD RISK NET NEWSL, V1, P3; King D., 2000, J CONTING CRISIS MAN, V8, P223, DOI [10.1111/1468-5973.00143, DOI 10.1111/1468-5973.00143]; Kundzewicz ZW, 2005, EXTREME WEATHER EVENTS AND PUBLIC HEALTH RESPONSES, P197, DOI 10.1007/3-540-28862-7_19; Lee S, 2015, WATER POLICY, V17, P1045, DOI 10.2166/wp.2015.089; Lindell MK, 2000, RISK ANAL, V20, P13, DOI 10.1111/0272-4332.00002; Llewellyn M, 2006, SURG CLIN N AM, V86, P557, DOI 10.1016/j.suc.2006.02.006; Lowe D, 2013, INT J ENV RES PUB HE, V10, P7015, DOI [10.3390/ijerph10127015, 10.3390/ijerph110100030]; Lumbroso DM, 2011, NAT HAZARD EARTH SYS, V11, P2321, DOI 10.5194/nhess-11-2321-2011; Majdzadeh R., 2004, APPL RES METHODOLOGY, DOI [10.1081/clt-200042550, DOI 10.1081/CLT-200042550]; Martinez D, 2019, MEDWAVE, V19, DOI 10.5867/medwave.2019.10.7716; Miceli R, 2008, J ENVIRON PSYCHOL, V28, P164, DOI 10.1016/j.jenvp.2007.10.006; Netemeyer RG., 2003, SCALING PROCEDURES I, DOI [10.1007/BF03325000, DOI 10.1007/BF03325000]; Paul BK, 2016, NAT HAZARDS, V83, P1703, DOI 10.1007/s11069-016-2384-z; Pereira S, 2016, RISK ANAL, V36, P1188, DOI 10.1111/risa.12516; Pourhoseingholi Mohamad Amin, 2012, Gastroenterol Hepatol Bed Bench, V5, P79; Priest S., 2009, BUILDING MODEL ESTIM; Priest SJ, 2007, BUILDING MODEL ESTIM; Rae E, 2016, NONP REV RES P BUSHF; Salvati P, 2018, SCI TOTAL ENVIRON, V610, P867, DOI 10.1016/j.scitotenv.2017.08.064; Samir KC, 2013, ECOL SOC, V18, DOI 10.5751/ES-05095-180108; Shabanikiya H, 2014, NAT HAZARDS, V73, P1119, DOI 10.1007/s11069-014-1124-5; Sharif HO, 2015, NAT HAZARDS REV, V16, DOI 10.1061/(ASCE)NH.1527-6996.0000145; Sharif HO., 2010, SECURITY, V2, P325, DOI [10.1080/19439962.2010.506596, DOI 10.1080/19439962.2010.506596]; Shaw R., 2004, DISASTER PREV MANAG, V13, P39, DOI [10.1108/09653560410521689, DOI 10.1108/09653560410521689]; Terpstra T, 2008, INT J WATER RESOUR D, V24, P555, DOI 10.1080/07900620801923385; Thieken AH, 2007, HYDROLOG SCI J, V52, P1016, DOI 10.1623/hysj.52.5.1016; Vinet F, 2012, NAT HAZARDS, V61, P1179, DOI 10.1007/s11069-011-9975-5; Wallingford H., 2006, FINAL REPORT PREPARE; World Health Organization (WHO, 2002, FLOODS CLIM CHANG AD; Yadollahie M, 2019, INT J OCCUP ENV MED, V10, P54, DOI 10.15171/ijoem.2019.1681; Yari A, 2019, THESIS TEHRAN U MED; Yari A, 2020, J ENVIRON HEALTH SCI, V18, P1643, DOI 10.1007/s40201-020-00511-x; Yari A, 2019, INT J DISAST RISK RE, V40, DOI 10.1016/j.ijdrr.2019.101258	55	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262005	10.1371/journal.pone.0262005	http://dx.doi.org/10.1371/journal.pone.0262005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972162	Green Published, gold			2022-12-26	WOS:000773555700082
J	Cai, BX; Liao, CY; He, DX; Chen, JM; Han, JH; Lu, JY; Qin, KQ; Liang, WX; Wu, XL; Liu, ZG; Wu, YL				Cai, Binxiang; Liao, Chunyan; He, Danxue; Chen, Jingmeng; Han, Jiahuai; Lu, Jiaying; Qin, Kaiqi; Liang, Wenxu; Wu, Xiaoling; Liu, Zuguo; Wu, Yalin			Gasdermin E mediates photoreceptor damage by all-trans-retinal in the mouse retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-LIKE PROTEIN; INFLAMMATORY CASPASES; CELL-DEATH; PYROPTOSIS; APOPTOSIS; RETINOPATHY; METABOLISM; CLEAVAGE; DISEASE; ROD	The breakdown of all-trans-retinal (atRAL) clearance is closely associated with photoreceptor cell death in dry age related macular degeneration (AMD) and autosomal recessive Stargardt's disease (STGD1), but its mechanisms remain elusive. Here, we demonstrate that activation of gasdermin E (GSDME) but not gasdermin D promotes atRAL-induced photoreceptor damage by activating pyroptosis and aggravating apoptosis through a mitochondria-mediated caspase-3-dependent signaling pathway. Activation of c-Jun N-terminal kinase was identified as one of the major causes of mitochondrial membrane rupture in atRAL-loaded photoreceptor cells, resulting in the release of cytochrome c from mitochondria to the cytosol, where it stimulated caspase-3 activation required for cleavage of GSDME. Aggregation of the N-terminal fragment of GSDME in the mitochondria revealed that GSDME was likely to penetrate mitochondrial membranes in photoreceptor cells after atRAL exposure. ABC (subfamily A, member 4) and all-trans-retinol dehydrogenase 8 are two key proteins responsible for clearing atRAL in the retina. Abca4(-/-)Rdh8(-/-) mice exhibit serious defects in atRAL clearance upon light exposure and serve as an acute model for dry AMD and STGD1. We found that N-terminal fragment of GSDME was distinctly localized in the photoreceptor outer nuclear layer of light-exposed Abca4(-/-)Rdh8(-/-)mice. Of note, degeneration and caspase-3 activation in photoreceptors were significantly alleviated in Abca4(-/-)Rdh8(-/-)Gsdme(-/-) mice after exposure to light. The results of this study indicate that GSDME is a common causative factor of photoreceptor pyroptosis and apoptosis arising from atRAL overload, suggesting that repressing GSDME may represent a potential treatment of photoreceptor atrophy in dry AMD and STGD1.	[Cai, Binxiang; Liao, Chunyan; He, Danxue; Lu, Jiaying; Qin, Kaiqi; Liang, Wenxu; Wu, Xiaoling; Liu, Zuguo; Wu, Yalin] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Eye Inst,Dept Ophthalmol, Fujian Engn & Res Ctr Eye Regenerat Med,Xiangan H, Xiamen, Fujian, Peoples R China; [Chen, Jingmeng] Xiamen Univ, Sch Med, Xiamen, Fujian, Peoples R China; [Han, Jiahuai] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Biol, Sch Life Sci, Xiamen, Fujian, Peoples R China; [Wu, Yalin] Xiamen Univ, Xiamen Eye Ctr, Sch Med, Xiamen, Fujian, Peoples R China; [Wu, Yalin] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Xiamen University; Xiamen University	Wu, YL (corresponding author), Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Eye Inst,Dept Ophthalmol, Fujian Engn & Res Ctr Eye Regenerat Med,Xiangan H, Xiamen, Fujian, Peoples R China.; Wu, YL (corresponding author), Xiamen Univ, Xiamen Eye Ctr, Sch Med, Xiamen, Fujian, Peoples R China.; Wu, YL (corresponding author), Xiamen Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China.	yalinw@xmu.edu.cn			China National Natural Science Foundation [82171064, 81870671]; Guangdong Basic and Applied Basic Research Foundation [2021A1515011391]; Basic Research Program of Shenzhen [JCYJ20180306173025004]; XMU Training Program of Innovation and Entrepreneurship for Undergraduates	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation; Basic Research Program of Shenzhen; XMU Training Program of Innovation and Entrepreneurship for Undergraduates	This work was supported in part by grants from China National Natural Science Foundation (grant nos.: 82171064 and 81870671 to Y. W.), Guangdong Basic and Applied Basic Research Foundation (grant no.: 2021A1515011391 to Y. W.), the Basic Research Program of Shenzhen (grant no.: JCYJ20180306173025004 to Y. W.), and XMU Training Program of Innovation and Entrepreneurship for Undergraduates.	Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chen C, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015779; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Erkes DA, 2020, CANCER DISCOV, V10, P254, DOI 10.1158/2159-8290.CD-19-0672; Gao Z, 2018, J BIOL CHEM, V293, P14507, DOI 10.1074/jbc.RA118.002447; Green DR, 2019, CELL, V177, P1094, DOI 10.1016/j.cell.2019.04.024; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hou JW, 2020, NAT CELL BIOL, V22, P1264, DOI 10.1038/s41556-020-0575-z; Jiang MX, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00349-0; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kesavardhana S, 2020, ANNU REV IMMUNOL, V38, P567, DOI 10.1146/annurev-immunol-073119-095439; Kiser PD, 2016, ANNU REV VIS SCI, V2, P197, DOI 10.1146/annurev-vision-111815-114407; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Li J, 2016, TOXICOLOGY, V371, P41, DOI 10.1016/j.tox.2016.10.005; Liao CY, 2020, J BIOL CHEM, V295, P6958, DOI 10.1074/jbc.RA120.013189; Liu X, 2016, INVEST OPHTH VIS SCI, V57, P1017, DOI 10.1167/iovs.15-18429; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Orning P, 2019, J EXP MED, V216, P2453, DOI 10.1084/jem.20190545; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2; Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	39	3	3	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101553	10.1016/j.jbc.2021.101553	http://dx.doi.org/10.1016/j.jbc.2021.101553			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34973334	gold, Green Published			2022-12-26	WOS:000761395300008
J	Lee, H; Sun, R; Niehrs, C				Lee, Hyeyoon; Sun, Rui; Niehrs, Christof			Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN; ENDOCYTOSIS; ORGANIZER; MEMBRANE; LGR5	Signaling by bone morphogenetic proteins (BMPs) plays pivotal roles in embryogenesis, adult tissue homeostasis, and disease. Recent studies revealed that the well-established WNT agonist R-spondin 2 (RSPO2) is also a BMP receptor (BMP receptor type 1A) antagonist, with roles in early Xenopus embryogenesis and human acute myeloid leukemia (AML). To uncouple the BMP antagonist function from the WNT agonist function and to promote development of AML therapeutics, here we identified a 10-mer peptide (RW) derived from the thrombospondin 1 domain of RSPO2, which specifically prevents binding between RSPO2 and BMP receptor type 1A without altering WNT signaling. We also show that a corresponding RW dendrimer (RWd) exhibiting improved half-life relieves inhibition of BMP receptor signaling by RSPO2 in human AML cells, reduces cell growth, and induces differentiation. Moreover, microinjection of RWd in Xenopus embryos ventralizes the dorsoventral embryonic patterning by upregulating BMP signaling without affecting WNT signaling. Our study corroborates the function of RSPO2 as a BMP receptor antagonist and provides a proof of concept for pharmacologically uncoupling BMP antagonist from WNT agonist functions of RSPO2 using the inhibitor peptide RWd with enhanced target selectivity and limited side effects.	[Lee, Hyeyoon; Sun, Rui; Niehrs, Christof] Deutsch Krebsforschungszentrum DKFZ, Div Mol Embryol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Niehrs, Christof] Inst Mol Biol IMB, Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Molecular Biology (IMB)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Mol Embryol, DKFZ ZMBH Alliance, Heidelberg, Germany.; Niehrs, C (corresponding author), Inst Mol Biol IMB, Mainz, Germany.	niehrs@dkfz-heidelberg.de			Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB1324-B01]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) to C. N. (grant no.: SFB1324-B01).	Antebi YE, 2017, CELL, V170, P1184, DOI 10.1016/j.cell.2017.08.015; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chang CB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021923; Chartier C, 2016, CANCER RES, V76, P713, DOI 10.1158/0008-5472.CAN-15-0561; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Cui J, 2021, J MED CHEM, V64, P12572, DOI 10.1021/acs.jmedchem.1c00395; Cunningham AD, 2017, CURR OPIN STRUC BIOL, V44, P59, DOI 10.1016/j.sbi.2016.12.009; Davenport AP, 2020, NAT REV DRUG DISCOV, V19, P389, DOI 10.1038/s41573-020-0062-z; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; De Kouchkovsky I, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.50; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dubey R, 2020, ELIFE, V9, DOI 10.7554/eLife.54469; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Han T, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms15945; Hao HX, 2016, CANCERS, V8, DOI 10.3390/cancers8060054; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ilmer M, 2015, CANCER RES, V75, P1883, DOI 10.1158/0008-5472.CAN-14-1327; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim JE, 2012, J BIOMED MATER RES A, V100A, P1488, DOI 10.1002/jbm.a.34089; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Klauzinska M, 2012, J CELL PHYSIOL, V227, P1960, DOI 10.1002/jcp.22924; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lebensohn AM, 2018, ELIFE, V7, DOI 10.7554/eLife.33126; Lee H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19373-w; Li Ming, 2008, Yichuan, V30, P885, DOI 10.3724/SP.J.1005.2008.00885; Lowery JW, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7290686; Lu HY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00315-3; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Nanki K, 2018, CELL, V174, P856, DOI 10.1016/j.cell.2018.07.027; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Peng WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083110; de Vega MJP, 2007, CURR TOP MED CHEM, V7, P33; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Sadler Kristen, 2002, J Biotechnol, V90, P195; Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Salik B, 2020, CANCER CELL, V38, P263, DOI 10.1016/j.ccell.2020.05.014; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shimer AL, 2009, INJURY, V40, P32; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Sun Aihua, 2013, Zhejiang Da Xue Xue Bao Yi Xue Ban, V42, P125; Sun R, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109559; Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z; Szenker-Ravi E, 2018, NATURE, V557, P564, DOI 10.1038/s41586-018-0118-y; Tong Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49758-x; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Yu SM, 2021, BIOCONJUGATE CHEM, V32, P376, DOI 10.1021/acs.bioconjchem.1c00008; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787; Zhang HB, 2019, J CELL BIOCHEM, V120, P5813, DOI 10.1002/jcb.27867; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang YC, 2020, ANNU REV PHYSIOL, V82, P251, DOI 10.1146/annurev-physiol-021119-034500; Zylbersztejn F, 2018, EXP HEMATOL, V61, P36, DOI 10.1016/j.exphem.2018.02.005	66	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101586	10.1016/j.jbc.2022.101586	http://dx.doi.org/10.1016/j.jbc.2022.101586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1JE	35032551	gold, Green Published			2022-12-26	WOS:000761380200004
J	Marcum, RD; Hsieh, J; Giljen, M; Justice, E; Daffern, N; Zhang, YB; Radhakrishnan, I				Marcum, Ryan Dale; Hsieh, Joseph; Giljen, Maksim; Justice, Emily; Daffern, Nicolas; Zhang, Yongbo; Radhakrishnan, Ishwar			A capped Tudor domain within a core subunit of the Sin3L/Rpd3L histone deacetylase complex binds to nucleic acid G-quadruplexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS-SUPPRESSOR; RNA-BINDING; CARCINOMA METASTASIS; NMR-SPECTROSCOPY; GENE-EXPRESSION; TORSION ANGLES; PROTEIN; SIN3; FAMILY; BRMS1	Chromatin-modifying complexes containing histone deacetylase (HDAC) activities play critical roles in the regulation of gene transcription in eukaryotes. These complexes are thought to lack intrinsic DNA-binding activity, but according to a well-established paradigm, they are recruited via protein-protein interactions by gene-specific transcription factors and post-translational histone modifications to their sites of action on the genome. The mammalian Sin3L/Rpd3L complex, comprising more than a dozen different polypeptides, is an ancient HDAC complex found in diverse eukaryotes. The subunits of this complex harbor conserved domains and motifs of unknown structure and function. Here, we show that Sds3, a constitutively-associated subunit critical for the proper func-tioning of the Sin3L/Rpd3L complex, harbors a type of Tudor domain that we designate the capped Tudor domain. Unlike canonical Tudor domains that bind modified histones, the Sds3 capped Tudor domain binds to nucleic acids that can form higher-order structures such as G-quadruplexes and shares similarities with the knotted Tudor domain of the Esa1 histone acetyltransferase that was previously shown to bind single-stranded RNA. Our findings expand the range of macromole-cules capable of recruiting the Sin3L/Rpd3L complex and draw attention to potentially new biological roles for this HDAC complex.	[Marcum, Ryan Dale; Hsieh, Joseph; Giljen, Maksim; Justice, Emily; Daffern, Nicolas; Zhang, Yongbo; Radhakrishnan, Ishwar] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Radhakrishnan, I (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	i-radhakrishnan@northwestern.edu	Radhakrishnan, Ishwar/AHA-7392-2022	Radhakrishnan, Ishwar/0000-0002-0195-9710; Hsieh, Joseph/0000-0002-3828-2192; Zhang, Yongbo/0000-0002-8216-1371	American Heart Association [17GRNT33680167, 16PRE27260041]	American Heart Association(American Heart Association)	This work was supported by grants from the American Heart Association to I. R. (17GRNT33680167) and R. D. M. (16PRE27260041) and to Northwestern University for providing J. H., M. G., and E. J. with funds for undergraduate research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams GE, 2018, BIOCHEM J, V475, P3921, DOI 10.1042/BCJ20170314; Adrian M, 2012, METHODS, V57, P11, DOI 10.1016/j.ymeth.2012.05.003; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Banks CAS, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.080; Banks CAS, 2018, MOL CELL PROTEOMICS, V17, P1432, DOI 10.1074/mcp.TIR118.000661; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bowman GD, 2015, CHEM REV, V115, P2274, DOI 10.1021/cr500350x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Chung WJ, 2015, P NATL ACAD SCI USA, V112, P2729, DOI 10.1073/pnas.1418718112; Clark MD, 2015, P NATL ACAD SCI USA, V112, pE3669, DOI 10.1073/pnas.1504021112; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Gong C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6406; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; He Y, 2009, NUCLEIC ACIDS RES, V37, P2142, DOI 10.1093/nar/gkp051; Hirschi A, 2016, RNA, V22, P1250, DOI 10.1261/rna.057265.116; Hoffmann RF, 2016, NUCLEIC ACIDS RES, V44, P152, DOI 10.1093/nar/gkv900; Holm L, 2020, METHODS MOL BIOL, V2112, P29, DOI 10.1007/978-1-0716-0270-6_3; Hurst DR, 2012, CANCER METAST REV, V31, P641, DOI 10.1007/s10555-012-9363-y; Hurst DR, 2011, FEBS LETT, V585, P3185, DOI 10.1016/j.febslet.2011.07.045; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee W, 2019, J BIOMOL NMR, V73, P213, DOI 10.1007/s10858-019-00255-3; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Lohr F, 1996, J MAGN RESON SER B, V112, P259, DOI 10.1006/jmrb.1996.0140; Maity A, 2020, NUCLEIC ACIDS RES, V48, P3315, DOI 10.1093/nar/gkaa008; Manley James L, 2013, Cold Spring Harb Protoc, V2013, P156, DOI 10.1101/pdb.prot072934; Marcum RD, 2019, J BIOL CHEM, V294, P13928, DOI 10.1074/jbc.RA119.009780; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Moser MA, 2014, CHROMOSOMA, V123, P67, DOI 10.1007/s00412-013-0441-x; Do NQ, 2017, NUCLEIC ACIDS RES, V45, P7487, DOI 10.1093/nar/gkx274; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Porro A, 2014, CELL REP, V6, P765, DOI 10.1016/j.celrep.2014.01.022; Saintome C, 2016, NUCLEIC ACIDS RES, V44, P2926, DOI 10.1093/nar/gkw003; Salas-Armenteros I, 2017, EMBO J, V36, P3532, DOI 10.15252/embj.201797208; Seraj MJ, 2000, CANCER RES, V60, P2764; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi XZ, 2012, BIOCHEM J, V446, P349, DOI 10.1042/BJ20120563; Shimojo H, 2008, J MOL BIOL, V378, P987, DOI 10.1016/j.jmb.2008.03.021; Silveira AC, 2009, CANCER LETT, V276, P32, DOI 10.1016/j.canlet.2008.10.024; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Smith KT, 2012, MOL CELL PROTEOMICS, V11, P1815, DOI 10.1074/mcp.M112.020255; Smith PW, 2009, CANCER LETT, V276, P196, DOI 10.1016/j.canlet.2008.11.024; Varshney D, 2020, NAT REV MOL CELL BIO, V21, P459, DOI 10.1038/s41580-020-0236-x; Vermeulen M, 2004, MOL CELL BIOL, V24, P2364, DOI 10.1128/MCB.24.6.2364-2372.2004; WANG Y, 1992, BIOCHEMISTRY-US, V31, P8112, DOI 10.1021/bi00150a002; Xu C., 2015, HISTONE RECOGNITION, P49; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Zimmermann RC, 2020, CANCER METAST REV, V39, P755, DOI 10.1007/s10555-020-09871-0	70	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101558	10.1016/j.jbc.2021.101558	http://dx.doi.org/10.1016/j.jbc.2021.101558			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34979096	Green Published, gold			2022-12-26	WOS:000761395300006
J	Zheng, Y; Zhang, LK; Jin, L; Zhang, PF; Li, FY; Guo, M; Gao, Q; Zeng, Y; Li, MZ; Zeng, WX				Zheng, Yi; Zhang, Lingkai; Jin, Long; Zhang, Pengfei; Li, Fuyuan; Guo, Ming; Gao, Qiang; Zeng, Yao; Li, Mingzhou; Zeng, Wenxian			Unraveling three-dimensional chromatin structural dynamics during spermatogonial differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-RANGE INTERACTIONS; STEM-CELLS; 3D GENOME; HI-C; TRANSCRIPTION FACTORS; PROMOTER CONTACTS; SUPER-ENHANCERS; GENE-REGULATION; ARCHITECTURE; REORGANIZATION	Spermatogonial stem cells (SSCs) are able to undergo both self-renewal and differentiation. Unlike self-renewal, which replenishes the SSC and progenitor pool, differentiation is an irreversible process committing cells to meiosis. Although the preparations for meiotic events in differentiating spermatogonia (Di-SG) are likely to be accompanied by alterations in chromatin structure, the three-dimensional chromatin architectural differences between SSCs and Di-SG, and the higher-order chromatin dynamics during spermatogonial differentiation, have not been systematically investigated. Here, we performed in situ high-throughput chromosome conformation capture, RNA-seq, and chromatin immunoprecipitation-sequencing analyses on porcine undifferentiated spermatogonia (which consist of SSCs and progenitors) and Di-SG. We identified that Di-SG exhibited less compact chromatin structural organization, weakened compartmentalization, and diminished topologically associating domains in comparison with undifferentiated spermatogonia, suggesting that diminished higher-order chromatin architecture in meiotic cells, as shown by recent reports, might be preprogrammed in Di-SG. Our data also revealed that A/B compartments, representing open or closed chromatin regions respectively, and topologically associating domains were related to dynamic gene expression during spermatogonial differentiation. Furthermore, we unraveled the contribution of promoter-enhancer interactions to pre meiotic transcriptional regulation, which has not been accomplished in previous studies due to limited cell input and resolution. Together, our study uncovered the three-dimensional chromatin structure of SSCs/progenitors and Di-SG, as well as the interplay between higher-order chromatin architecture and dynamic gene expression during spermatogonial differentiation. These findings provide novel insights into the mechanisms for SSC self-renewal and differentiation and have implications for diagnosis and treatment of male sub-/infertility.	[Zheng, Yi; Zhang, Lingkai; Zhang, Pengfei; Li, Fuyuan; Guo, Ming; Gao, Qiang; Zeng, Yao; Zeng, Wenxian] Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Yangling, Shaanxi, Peoples R China; [Jin, Long; Li, Mingzhou] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China	Northwest A&F University - China; Sichuan Agricultural University	Zeng, WX (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Yangling, Shaanxi, Peoples R China.; Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China.	mingzhou.li@sicau.edu.cn; zengwenxian2015@126.com	Zeng, Wen/GPS-8058-2022	Zheng, Yi/0000-0003-0152-2671	National Natural Science Foundation of China [31772605, 32002178]; First-class University and Academic Program from Northwest AF University [Z102021906]; Open Fund of Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province [SNDK-KF-201804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); First-class University and Academic Program from Northwest AF University; Open Fund of Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province	This study was supported by National Natural Science Foundation of China to W. Z. (Grant No. 31772605) and Y. Zh. (Grant No. 32002178), the First-class University and Academic Program from Northwest A&F University to W. Z. (Grant No. Z102021906), and the Open Fund of Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province to Y. Zh. (Grant No. SNDK-KF-201804).	Alavattam KG, 2019, NAT STRUCT MOL BIOL, V26, P175, DOI 10.1038/s41594-019-0189-y; Belton JM, 2012, METHODS, V58, P268, DOI 10.1016/j.ymeth.2012.05.001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Bryant JM, 2013, JOVE-J VIS EXP, DOI 10.3791/50648; Caldeira-Brant AL, 2020, REPRODUCTION, V159, P437, DOI 10.1530/REP-19-0254; Chen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0183-x; Cheng KR, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101596; Chiarini-Garcia H, 2002, REPRODUCTION, V123, P567, DOI 10.1530/reprod/123.4.567; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1170, DOI 10.1095/biolreprod65.4.1170; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Culty M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110544; De Rooij DG, 2000, J ANDROL, V21, P776; de Rooij DG, 2003, CYTOGENET GENOME RES, V103, P267, DOI 10.1159/000076812; de Rooij DG, 2017, DEVELOPMENT, V144, P3022, DOI 10.1242/dev.146571; De Rooij DG, 2012, J ANDROL, V33, P1085, DOI 10.2164/jandrol.112.016832; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Du ZH, 2017, NATURE, V547, P232, DOI 10.1038/nature23263; Fayomi AP, 2018, STEM CELL RES, V29, P207, DOI 10.1016/j.scr.2018.04.009; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Guo JT, 2017, CELL STEM CELL, V21, P533, DOI 10.1016/j.stem.2017.09.003; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Han K, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00277; He MN, 2018, INT J BIOL SCI, V14, P1571, DOI 10.7150/ijbs.25328; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03279-9; Hug CB, 2017, CELL, V169, P216, DOI 10.1016/j.cell.2017.03.024; Jan SZ, 2017, DEVELOPMENT, V144, P3659, DOI 10.1242/dev.152413; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Jin C, 2017, REPRODUCTION, V154, P615, DOI 10.1530/REP-17-0302; JOHNSON L, 1980, BIOL REPROD, V22, P1233, DOI 10.1093/biolreprod/22.5.1233; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Ke YW, 2017, CELL, V170, P367, DOI 10.1016/j.cell.2017.06.029; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Kubota H, 2018, BIOL REPROD, V99, P52, DOI 10.1093/biolre/ioy077; Lau XZ, 2020, DEV CELL, V54, P548, DOI 10.1016/j.devcel.2020.07.018; Law NC, 2020, ANDROLOGY-US, V8, P852, DOI 10.1111/andr.12810; Lei QJ, 2020, STEM CELL REP, V15, P1140, DOI 10.1016/j.stemcr.2020.10.006; Lesch BJ, 2016, NAT GENET, V48, P888, DOI 10.1038/ng.3591; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindsly S, 2021, NUCLEUS-PHILA, V12, P58, DOI 10.1080/19491034.2021.1910437; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08084; Lord T, 2020, DEV CELL, V52, P399, DOI 10.1016/j.devcel.2020.01.014; Lord T, 2017, REPRODUCTION, V154, pR55, DOI 10.1530/REP-17-0034; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luo ZY, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101034; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; Maezawa S, 2018, NUCLEIC ACIDS RES, V46, P593, DOI 10.1093/nar/gkx1052; Makela JA, 2019, REPRODUCTION, V158, pR169, DOI 10.1530/REP-18-0476; Manku G, 2015, REPRODUCTION, V149, pR139, DOI 10.1530/REP-14-0431; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mulder CL, 2016, HUM REPROD UPDATE, V22, P561, DOI 10.1093/humupd/dmw017; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Niedenberger BA, 2015, REPRODUCTION, V149, P329, DOI 10.1530/REP-14-0653; Niimi Y, 2019, DEV BIOL, V445, P103, DOI 10.1016/j.ydbio.2018.11.003; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Patel L, 2019, NAT STRUCT MOL BIOL, V26, P164, DOI 10.1038/s41594-019-0187-0; Paulsen J, 2019, NAT GENET, V51, P835, DOI 10.1038/s41588-019-0392-0; Rajapakse I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002543; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ron G, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-023863, 10.1038/s41467-017-02386-3]; Rowley MJ, 2017, MOL CELL, V67, P837, DOI 10.1016/j.molcel.2017.07.022; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Sato T, 2015, STEM CELL REP, V5, P75, DOI 10.1016/j.stemcr.2015.05.011; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Seaman L, 2018, BIOINFORMATICS, V34, P104, DOI 10.1093/bioinformatics/btx484; Shami AN, 2020, DEV CELL, V54, P529, DOI 10.1016/j.devcel.2020.05.010; Sharma S, 2019, HUM REPROD UPDATE, V25, P275, DOI 10.1093/humupd/dmz006; Siersbaek R, 2017, MOL CELL, V66, P420, DOI 10.1016/j.molcel.2017.04.010; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Stadhouders R, 2018, NAT GENET, V50, P238, DOI 10.1038/s41588-017-0030-7; Suzuki S, 2019, BIOL REPROD, V101, P617, DOI 10.1093/biolre/ioz088; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Tan K, 2020, CURR OPIN CELL BIOL, V67, P71, DOI 10.1016/j.ceb.2020.07.005; Tan K, 2019, CELL STEM CELL, V24, P201, DOI 10.1016/j.stem.2019.01.010; Vara C, 2019, CELL REP, V28, P352, DOI 10.1016/j.celrep.2019.06.037; Visser L, 2011, FERTIL STERIL, V95, P1020, DOI 10.1016/j.fertnstert.2010.11.067; Voigt AL, 2021, FASEB J, V35, DOI 10.1096/fj.202002799R; Wang Y, 2019, MOL CELL, V73, P547, DOI 10.1016/j.molcel.2018.11.019; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Yang F, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12933; Yardimci GG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1658-7; Zhang PF, 2020, ANDROLOGY-US, V8, P1923, DOI 10.1111/andr.12870; Zheng Y, 2018, DNA REPAIR, V70, P55, DOI 10.1016/j.dnarep.2018.08.027; Zheng Y, 2017, REPRODUCTION, V154, P181, DOI 10.1530/REP-17-0173	91	3	3	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101559	10.1016/j.jbc.2021.101559	http://dx.doi.org/10.1016/j.jbc.2021.101559			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34979097	gold, Green Submitted, Green Published			2022-12-26	WOS:000761395300010
J	Sempore, WY; Ouedraogo, N; Gandema, S; Henni, S; Ilboudo, A; Yameogo, TM; Abraham, P				Sempore, Wendsendate Yves; Ouedraogo, Nafi; Gandema, Salifou; Henni, Samir; Ilboudo, Alassane; Yameogo, Tene Marceline; Abraham, Pierre			The "Walking Estimated Limitation Stated by History" (WELSH) visual tool is applicable and accurate to determine walking capacity, even in people with low literacy level	PLOS ONE			English	Article							IMPAIRMENT QUESTIONNAIRE; VALIDATION; TRANSLATION; DISTANCES; TREADMILL	Determination of the self-reported walking capacity by interview or standardized questionnaire is important. However, the existing questionnaires require the patient to be able to read and write in a specific language. We recently proposed the WELSH (Walking Estimated Limitation Stated by History) tool to be administrable to illiterate people. The main objective was to assess the applicability of WELSH tool in the community and in a large group. We performed a prospective study in the city of Bobo-Dioulasso in Burkina Faso during June 2020. We recruited 630 interviewers among medical students. They were trained to administer the WELSH, and to conduct a 6-minute walk test. We performed a Pearson's "r" correlation between the WELSH and maximal walking distance (MWD). Of the 1723 participants available for the analysis, 757 (43.9%: 41.6-46.3) never went to school or attended only elementary school. The percentage of questionnaires with participant filling-in errors corrected by the investigator decreased with the decrease in educational level (p<0.001). The average WELSH score was 53 +/- 22 and the average MWD was 383 +/- 142 meters. The Spearman correlation coefficient between the WELSH score and the MWD was r = 0.567 (p<0.001). Correlations ranged from 0.291 to 0.576 in males and females, (all p values < 0.05) and in different levels of education, with the highest coefficients found in illiterate people. The WELSH is feasible on the community by a wide variety of interviewers. It correlates with the MWD estimated by the 6-minutes' walk test even for people with little or no schooling.	[Sempore, Wendsendate Yves; Abraham, Pierre] Inst Natl Sante Publ, Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Sempore, Wendsendate Yves; Henni, Samir; Abraham, Pierre] Ctr Hosp Univ Angers, Vasc Med Dept, Angers, France; [Sempore, Wendsendate Yves; Abraham, Pierre] Univ Angers, CNRS, Inst MitoVasc, INSERM 1083,UMR 6015, Angers, France; [Ouedraogo, Nafi] Ctr Hosp Univ Souro Sanou, Physiol, Bobo Dioulasso, Burkina Faso; [Gandema, Salifou] Ctr Hosp Univ Souro Sanou, Phys Med & Funct Rehabil Dept, Bobo Dioulasso, Burkina Faso; [Ilboudo, Alassane; Yameogo, Tene Marceline] Ctr Hosp Univ Souro Sanou, Dept Internal Med, Bobo Dioulasso, Burkina Faso	Centre Muraz; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Abraham, P (corresponding author), Ctr Hosp Univ Angers, Vasc Med Dept, Angers, France.; Abraham, P (corresponding author), Univ Angers, CNRS, Inst MitoVasc, INSERM 1083,UMR 6015, Angers, France.	piabraham@chu-angers.fr						Abraham P, 2014, EUR J VASC ENDOVASC, V47, P319, DOI 10.1016/j.ejvs.2013.11.010; Cucato GG, 2016, ARQ BRAS CARDIOL, V106, P49, DOI 10.5935/abc.20160004; Fisher R. A., 1946, Statistical methods for research workers.; Frans FA, 2013, J VASC SURG, V57, P720, DOI 10.1016/j.jvs.2012.09.044; Gernigon M., 2015, NOUVELLES APPROCHES; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; Mahe G, 2011, EUR J VASC ENDOVASC, V41, P104, DOI 10.1016/j.ejvs.2010.10.002; Manfredini F, 2004, EUR J VASC ENDOVASC, V28, P303, DOI 10.1016/j.ejvs.2004.05.005; McDermott MM, 1998, J VASC SURG, V28, P1072, DOI 10.1016/S0741-5214(98)70034-5; Myers SA, 2008, J VASC SURG, V47, P550, DOI 10.1016/j.jvs.2007.10.052; Ouedraogo N, 2013, J VASC SURG, V58, P981, DOI 10.1016/j.jvs.2013.03.039; Ouedraogo N, 2011, J VASC SURG, V54, P133, DOI 10.1016/j.jvs.2010.11.129; Ritti-Dias RM, 2009, ARQ BRAS CARDIOL, V92, P143, DOI 10.1590/S0066-782X2009000200011; Sagar SP, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/190641; Sempore WY, 2019, CARDIOVASC J AFR, V30, P341, DOI 10.5830/CVJA-2019-032; Tew GA, 2014, VASC MED, V19, P27, DOI 10.1177/1358863X14520870; Verspaget M, 2009, EUR J VASC ENDOVASC, V37, P56, DOI 10.1016/j.ejvs.2008.10.001; Yan BP, 2011, VASC MED, V16, P167, DOI 10.1177/1358863X11404934; Zhang X., 2021, BMC PUBLIC HEALTH, V21	19	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0260875	10.1371/journal.pone.0260875	http://dx.doi.org/10.1371/journal.pone.0260875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025876	gold, Green Published			2022-12-26	WOS:000796264200008
J	Chauhan, BS				Chauhan, Bhagirath Singh			The world's first glyphosate-resistant case of Avena fatua L. and Avena sterilis ssp. ludoviciana (Durieu) Gillet & Magne and alternative herbicide options for their control	PLOS ONE			English	Article							WILD; TRANSLOCATION	Avena fatua and A. ludoviciana (commonly known as wild oats) are the most problematic winter grass species in fallows and winter crops in the northeast region of Australia. A series of experiments were conducted to evaluate the performance of glyphosate and alternative post-emergence herbicides on A. fatua and A. ludoviciana. This study reports the world's first glyphosate-resistant (GR) biotypes of A. fatua and A. ludoviciana. The glyphosate dose required to kill 50% of the plants (LD50) and to reduce 50% of the biomass (GR(50)) for the GR biotype of A. fatua was 556 g a.e./ha and 351 g a.e./ha, respectively. These values for A. ludoviciana were 848 g a.e./ha and 289 g a.e./ha. Regardless of the growth stage (3-4 or 6-7 leaf stages), clethodim (120 g a.i./ha), haloxyfop (78 g a.i./ha), pinoxaden (20 g a.i./ha), and propaquizafop (30 g a.i./ha) were the best alternative herbicide options for the control of A. fatua and A. ludoviciana. The efficacy of butroxydim (45 g a.i./ha), clodinafop (120 g a.i./ha), imazamox + imazapyr (36 g a.i./ha), and paraquat (600 g a.i./ha) reduced at the advanced growth stage. Glufosinate (750 g a.i./ha), flamprop (225 g a.i./ha), and pyroxsulam + halauxifen (20 g a.i./ha) did not provide effective control of Avena species. This study identified alternative herbicide options to manage GR biotypes of A. fatua and A. ludoviciana.	[Chauhan, Bhagirath Singh] Univ Queensland, Ctr Crop Sci, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia; [Chauhan, Bhagirath Singh] Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia; [Chauhan, Bhagirath Singh] Chaudhary Charan Singh Haryana Agr Univ, Dept Agron, Hisar, Haryana, India	University of Queensland; University of Queensland; CCS Haryana Agricultural University	Chauhan, BS (corresponding author), Univ Queensland, Ctr Crop Sci, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia.; Chauhan, BS (corresponding author), Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia.; Chauhan, BS (corresponding author), Chaudhary Charan Singh Haryana Agr Univ, Dept Agron, Hisar, Haryana, India.	b.chauhan@uq.edu.au						Beckie HJ, 2008, WEED TECHNOL, V22, P530, DOI 10.1614/WT-07-175.1; Broster J. C., 2011, Plant Protection Quarterly, V26, P22; Chauhan BS, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208311; Desai HS, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10091266; Genstat, 2019, GENSTAT WINDOWS, V20th; HARKER KN, 1991, WEED SCI, V39, P650, DOI 10.1017/S0043174500088524; Heap I, INT SURVEY HERBICIDE; Kumaratilake AR, 2005, WEED SCI, V53, P10, DOI 10.1614/WS-03-140R; Llewellyn Rick., 2016, IMPACT WEEDS AUSTR G; Mahajan G, 2021, WEED SCI, V69, P485, DOI 10.1017/wsc.2021.25; Mahajan G, 2021, WEED SCI, V69, P362, DOI 10.1017/wsc.2021.7; Mahajan G, 2021, AGRON J, V113, P42, DOI 10.1002/agj2.20507; Nugent T, 1999, MANAGING WILD OATS; Owen MJ, 2016, CROP PASTURE SCI, V67, P520, DOI 10.1071/CP15295; Ramsey RJL, 2002, PESTIC BIOCHEM PHYS, V73, P1, DOI 10.1016/S0048-3575(02)00017-2; Sahil, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234648; Thomas G. A., 1997, Sustainable crop production in the sub-tropics: an Australian perspective., P195; VanGessel MJ, 2001, WEED SCI, V49, P703, DOI 10.1614/0043-1745(2001)049[0703:RPRHFD]2.0.CO;2; Vila-Aiub MM, 2007, WEED SCI, V55, P566, DOI 10.1614/WS-07-053.1; Webb A. A., 1997, Sustainable crop production in the sub-tropics: an Australian perspective., P8	20	1	1	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262494	10.1371/journal.pone.0262494	http://dx.doi.org/10.1371/journal.pone.0262494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020774	Green Published, gold			2022-12-26	WOS:000834207700044
J	Mumoli, N; Dentali, F; Conte, G; Colombo, A; Capra, R; Porta, C; Rotiroti, G; Zuretti, F; Cei, M; Tangianu, F; Evangelista, I; Vitale, J; Mazzone, A; Giarretta, I				Mumoli, Nicola; Dentali, Francesco; Conte, Giulia; Colombo, Alessandra; Capra, Riccardo; Porta, Cesare; Rotiroti, Giuseppe; Zuretti, Francesca; Cei, Marco; Tangianu, Flavio; Evangelista, Isabella; Vitale, Jose; Mazzone, Antonino; Giarretta, Igor			Upper extremity deep vein thrombosis in COVID-19: Incidence and correlated risk factors in a cohort of non-ICU patients	PLOS ONE			English	Article							VENOUS THROMBOSIS; PULMONARY-EMBOLISM; ANTICOAGULATION	Background Venous thromboembolism is a frequent complication of COVID-19 infection. Less than 50% of pulmonary embolism (PE) is associated with the evidence of deep venous thrombosis (DVT) of the lower extremities. DVT may also occur in the venous system of the upper limbs especially if provoking conditions are present such as continuous positive airway pressure (CPAP). The aim of this study was to evaluate the incidence of UEDVT in patients affected by moderate-severe COVID-19 infection and to identify potential associated risk factors for its occurrence. Methods We performed a retrospective analysis of all patients affected by moderate-severe COVID-19 infection admitted to our unit. In accordance with the local protocol, all patients had undergone a systematic screening for the diagnosis of UEDVT, by vein compression ultrasonography (CUS). All the patients were receiving pharmacological thromboprophylaxis according to international guidelines recommendations. Univariate and multivariate analyses were used to identify risk factors associated with UEDVT. Results 257 patients were included in the study, 28 patients were affected by UEDVT with an incidence of 10.9% (95% CI, 7.1-14.7). At univariate analysis UEDVT appeared to be significantly associated (p< 0.05) with pneumonia, ARDS, Pa02/Fi02, D-dimer value higher than the age adjusted cut off value and need for CPAP ventilation. Multivariate analysis showed a significant association between UEDVT and the need for CPAP ventilation (OR 5.95; 95% IC 1.33-26.58). Increased mortality was found in patients affected by UEDVT compared to those who were not (OR 3.71; 95% CI, 1.41-9.78). Conclusions UEDVT can occur in COVID-19 patients despite adequate prophylaxis especially in patients undergoing helmet CPAP ventilation. Further studies are needed to identify the correct strategy to prevent DVT in these patients.	[Mumoli, Nicola; Conte, Giulia; Colombo, Alessandra; Capra, Riccardo; Porta, Cesare; Rotiroti, Giuseppe; Cei, Marco; Evangelista, Isabella; Vitale, Jose; Mazzone, Antonino] ASST Ovest Milanese, Dept Internal Med, Magenta, MI, Italy; [Dentali, Francesco] Insubria Univ, Dept Med & Surg, Varese, Italy; [Zuretti, Francesca; Tangianu, Flavio; Giarretta, Igor] ASST Sette Laghi, Dept Internal Med, Varese, Italy	University of Insubria	Mumoli, N (corresponding author), ASST Ovest Milanese, Dept Internal Med, Magenta, MI, Italy.	nimumoli@tiscali.it	Mumoli, Nicola/J-4652-2019	Mumoli, Nicola/0000-0001-7166-5630				Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Ageno W, 2019, THROMB HAEMOSTASIS, V119, P1365, DOI 10.1055/s-0039-1688828; Amirfarzan H, 2021, PULMONOLOGY, V27, P413, DOI 10.1016/j.pulmoe.2021.01.008; [Anonymous], 2020, SURV STRAT COVID 19; [Anonymous], COVID 19 TREATMENT G; Arnhjort T, 2007, EUR J INTERN MED, V18, P304, DOI 10.1016/j.ejim.2006.12.005; Ashish A, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000692; Bleker SM, 2016, J THROMB HAEMOST, V14, P973, DOI 10.1111/jth.13291; Cabrini L, 2020, LANCET, V395, P685, DOI 10.1016/S0140-6736(20)30359-7; Chang H, 2021, J VASC SURG-VENOUS L, V9, P597, DOI 10.1016/j.jvsv.2020.09.010; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Cuker A, 2021, BLOOD ADV, V5, P872, DOI 10.1182/bloodadvances.2020003763; Demelo-Rodriguez P, 2020, THROMB RES, V192, P23, DOI 10.1016/j.thromres.2020.05.018; Edler C, 2020, INT J LEGAL MED, V134, P1275, DOI 10.1007/s00414-020-02317-w; Flinterman LE, 2008, J THROMB HAEMOST, V6, P1262, DOI 10.1111/j.1538-7836.2008.03017.x; Gazzaruso C, 2020, NUTR METAB CARDIOVAS, V30, P1914, DOI 10.1016/j.numecd.2020.07.040; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta N, 2019, THROMB RES, V181, P77, DOI 10.1016/j.thromres.2019.07.013; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Ibrahim EH, 2002, CRIT CARE MED, V30, P771, DOI 10.1097/00003246-200204000-00008; Isma N, 2010, THROMB RES, V125, pE335, DOI 10.1016/j.thromres.2010.03.005; Kollias A, 2020, BRIT J HAEMATOL, V189, P846, DOI 10.1111/bjh.16727; Kucher N, 2011, NEW ENGL J MED, V364, P861, DOI 10.1056/NEJMcp1008740; Levy MM, 2011, ANN VASC SURG, V25, P442, DOI 10.1016/j.avsg.2011.01.005; Linnemann B, 2008, THROMB HAEMOSTASIS, V100, P440, DOI 10.1160/TH08-03-0196; Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Lopes RD, 2021, LANCET, V397, P2253, DOI 10.1016/S0140-6736(21)01203-4; MacIntyre NR, 2019, RESP CARE, V64, P617, DOI 10.4187/respcare.06635; Marietta M, 2020, BLOOD TRANSFUS-ITALY, V18, P167, DOI 10.2450/2020.0083-20; Marinella MA, 2000, HEART LUNG, V29, P113; Marongiu F, 2020, J THROMB HAEMOST, V18, P1511, DOI 10.1111/jth.14818; Newton DH, 2017, J VASC SURG-VENOUS L, V5, P18, DOI 10.1016/j.jvsv.2016.08.002; (NICE) NIfHaCE, 2021, COVID 19 RAPID GUIDE; Owens CA, 2010, J VASC INTERV RADIOL, V21, P779, DOI 10.1016/j.jvir.2010.02.021; Porfidia A, 2020, J THROMB THROMBOLYS, V50, P355, DOI 10.1007/s11239-020-02044-4; Poston JT, 2020, JAMA-J AM MED ASSOC, V323, P1839, DOI 10.1001/jama.2020.4914; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; Righini M, 2009, J THROMB HAEMOST, V7, P406, DOI 10.1111/j.1538-7836.2008.03264.x; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Sakr Y, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00741-0; Santoliquido A, 2020, J THROMB HAEMOST, V18, P2358, DOI 10.1111/jth.14992; Sholzberg M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2400; Smadja DM, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.747527; Spencer FA, 2007, AM J MED, V120, P678, DOI 10.1016/j.amjmed.2006.06.046; Stein PD, 2005, AM J MED, V118, P978, DOI 10.1016/j.amjmed.2005.03.012; Tadlock MD, 2015, AM J SURG, V209, P959, DOI 10.1016/j.amjsurg.2014.09.027; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Voicu S, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.608788; Zhang L, 2020, CIRCULATION, V142, P114, DOI 10.1161/CIRCULATIONAHA.120.046702	53	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262522	10.1371/journal.pone.0262522	http://dx.doi.org/10.1371/journal.pone.0262522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020777	gold, Green Published			2022-12-26	WOS:000834207700048
J	Asim, M; Hameed, W; Saleem, S				Asim, Muhammad; Hameed, Waqas; Saleem, Sarah			Do empowered women receive better quality antenatal care in Pakistan? An analysis of demographic and health survey data	PLOS ONE			English	Article							VIOLENCE; AFRICA; AGENCY	Introduction Quality antenatal care is a window of opportunity for improving maternal and neonatal outcomes. Numerous studies have shown a positive effect of women empowerment on improved coverage of maternal and reproductive health services, including antenatal care (ANC). However, there is scarce evidence on the association between women's empowerment and improved ANC services both in terms of coverage and quality. Addressing this gap, this paper examines the relationship between multi-dimensional measures of women empowerment on utilization of quality ANC (service coverage and consultation) in Pakistan. Methods We used Pakistan Demographic and Health Survey 2017-18 (PDHS) data which comprises of 6,602 currently married women aged between 15-49 years who had a live birth in the past five years preceding the survey. Our exposure variables were three-dimensional measures of women empowerment (social independence, decision making, and attitude towards domestic violence), and our outcome variables were quality of antenatal coverage [i.e. a composite binary measure based on skilled ANC (trained professional), timeliness (1st ANC visit during first trimester), sufficiency of ANC visits (4 or more)] and quality of ANC consultation (i.e. receiving at least 7 or more essential antenatal components out of 8). Data were analysed in Stata 16.0 software. Descriptive statistics were used to describe sample characteristics and binary logistic regression was employed to assess the association between empowerment and quality of antenatal care. Results We found that 41.4% of the women received quality ANC coverage and 30.6% received quality ANC consultations during pregnancy. After controlling for a number of socio-economic and demographic factors, all three measures of women's empowerment independently showed a positive relationship with both outcomes. Women with high autonomy (i.e. strongly opposed the notion of violence) in the domain of attitude to violence are 1.66 (95% CI 1.30-2.10) and 1.45 (95% CI 1.19-1.75) and times more likely to receive antenatal coverage and quality ANC consultations respectively, compared with women who ranked low on attitude to violence. Women who enjoy high social independence had 1.87 (95% CI 1.44-2.43) and 2.78 (95% CI 2.04-3.79) higher odds of quality antenatal coverage and consultations respectively, as compared with their counterparts. Similarly, women who had high autonomy in household decision making 1.98 (95% CI 1.60-2.44) and 1.56 (95% CI 2.17-1.91) were more likely to receive quality antenatal coverage and consultation respectively, as compared to women who possess low autonomy in household decision making. Conclusion The quality of ANC coverage and consultation with service provider is considerably low in Pakistan. Women's empowerment related to social independence, gendered beliefs about violence, and decision-making have an independent positive association with the utilisation of quality antenatal care. Thus, efforts directed towards empowering women could be an effective strategy to improve utilisation of quality antenatal care in Pakistan.	[Asim, Muhammad; Hameed, Waqas; Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University	Hameed, W (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.	waqas.hameed1@gmail.com						Afulani PA, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4476-4; Agha S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0979-8; Ali PA, 2015, TRAUMA VIOLENCE ABUS, V16, P299, DOI 10.1177/1524838014526065; Ali Tazeen Saeed, 2007, JPMA Journal of the Pakistan Medical Association, V57, P27; Arsenault C, 2018, LANCET GLOB HEALTH, V6, pE1186, DOI 10.1016/S2214-109X(18)30389-9; Benova L, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000779; Bin Nisar Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-305; Carvajal-Aguirre L, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020501; Ewerling F, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020434; Freedman LP, 2014, LANCET, V384, pE42, DOI 10.1016/S0140-6736(14)60859-X; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Ghuman SJ, 2006, SOC SCI RES, V35, P1, DOI 10.1016/j.ssresearch.2004.06.001; Gladstone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120566; Hanmer L, 2016, FEM ECON, V22, P237, DOI 10.1080/13545701.2015.1091087; Jewkes R, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001849; Kabeer N, 1999, DEV CHANGE, V30, P435, DOI 10.1111/1467-7660.00125; Khatiwada J, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03309-9; Kishor S., 1997, EMPOWERMENT WOMEN EG; Lamiday SP., 2019, JURNAL BERKALA EPIDE, V7; Lassi Zohra S, 2019, F1000Res, V8, P200, DOI 10.12688/f1000research.17828.1; Lincetto O, 2006, ANTENATAL CARE OPPOR; Mahmud KT, 2019, J POVERTY, V23, P365, DOI 10.1080/10875549.2019.1577324; Merrell LK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218172; Miedema SS, 2018, WORLD DEV, V110, P453, DOI 10.1016/j.worlddev.2018.05.031; Na MZ, 2015, PUBLIC HEALTH NUTR, V18, P3155, DOI 10.1017/S1368980015002621; Nadeem M, 2021, J INTERPERS VIOLENCE, V36, pNP11717, DOI 10.1177/0886260519889942; PDHS, 2018, PAK DEM HLTH SURV 20; Pratley P, 2016, SOC SCI MED, V169, P119, DOI 10.1016/j.socscimed.2016.08.001; Rowther AA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144926; Sado L, 2014, SOC SCI MED, V114, P169, DOI 10.1016/j.socscimed.2014.05.047; Sathar ZA., 1986, DELAYED MARRIAGES PA, V25, P535; Sebayang SK, 2019, WOMEN HEALTH, V59, P1155, DOI 10.1080/03630242.2019.1593282; Sharifa Begum, 2009, Bangladesh Development Studies, V32, P69; Shibre G, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0768-8; Shimamoto K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0591-3; Tikmani SS, 2019, SEMIN PERINATOL, V43, P297, DOI 10.1053/j.semperi.2019.03.020; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; WHO, 2016, WHO TECH REP SER, V997, P1; WHO, 2015, STAT IN REPR MAT NEW; World Health Organization UNICEF UNFPA World Bank Group United Nation Population Division, 2019, TRENDS MAT MORT 2000; Zakar R, 2012, J INTERPERS VIOLENCE, V27, P3268, DOI 10.1177/0886260512441257; Zaky HHM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/403402	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262323	10.1371/journal.pone.0262323	http://dx.doi.org/10.1371/journal.pone.0262323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990479	Green Published, gold			2022-12-26	WOS:000815783800023
J	Radford-Smith, DE; Patel, PJ; Irvine, KM; Russell, A; Siskind, D; Anthony, DC; Powell, EE; Probert, F				Radford-Smith, Daniel E.; Patel, Preya J.; Irvine, Katharine M.; Russell, Anthony; Siskind, Dan; Anthony, Daniel C.; Powell, Elizabeth E.; Probert, Fay			Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism	PLOS ONE			English	Article							CLINICAL-PRACTICE; ASSOCIATIONS; SEVERITY; GLYCA	Non-alcoholic fatty liver disease (NAFLD) and depression are common disorders and have bidirectional contributing relationships to metabolic syndrome. We aimed to determine whether a fasting serum signature of recent, self-reported depressive symptoms could be identified in a heterogeneous NAFLD cohort using nuclear magnetic resonance (NMR)-based metabolomics integrated with clinical chemistry. Serum nuclear magnetic resonance (NMR) metabolite profiles and corresponding clinical chemistry were compared between patients with depressive symptoms in the last 12-months (n = 81) and patients without recent depressive symptoms (n = 137 controls) using multivariate statistics. Orthogonal partial least squares discriminant analysis (OPLS-DA) of the biochemical and metabolomic data identified NAFLD patients with recent depression with a cross-validated accuracy of 61.5%, independent of age, sex, medication, and other comorbidities. This led to the development of a diagnostic algorithm with AUC 0.83 for future testing in larger clinical cohorts. Serum triglycerides, VLDL cholesterol, and the inflammatory biomarker GlycA were key metabolites increased in patients with recent depressive symptoms, while serum glutamine level was reduced. Here, serum NMR metabolite analysis provides a link between disturbed lipid metabolism, inflammation, and active mental health issues in NAFLD, irrespective of disease severity.	[Radford-Smith, Daniel E.; Anthony, Daniel C.] Univ Oxford, Dept Pharmacol, Oxford, England; [Radford-Smith, Daniel E.; Probert, Fay] Univ Oxford, Dept Chem, Oxford, England; [Radford-Smith, Daniel E.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Patel, Preya J.] UCL, Inst Liver & Digest Hlth, London, England; [Patel, Preya J.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Irvine, Katharine M.; Powell, Elizabeth E.] Univ Queensland, Ctr Liver Dis Res, Brisbane, Qld, Australia; [Irvine, Katharine M.] Univ Queensland, Mater Res, Brisbane, Qld, Australia; [Russell, Anthony] Princess Alexandra Hosp, Dept Diabet & Endocrinol, Brisbane, Qld, Australia; [Russell, Anthony] Univ Queensland, Ctr Hlth Serv Res, Brisbane, Qld, Australia; [Siskind, Dan] Univ Queensland, Sch Clin Med, Woolloongabba, Qld, Australia; [Siskind, Dan] Metro South Addict & Mental Hlth Serv, Woolloongabba, Qld, Australia; [Powell, Elizabeth E.] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia	University of Oxford; University of Oxford; University of Oxford; University of London; University College London; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Queensland; Mater Research; University of Queensland; University of Queensland; University of Queensland	Radford-Smith, DE (corresponding author), Univ Oxford, Dept Pharmacol, Oxford, England.; Radford-Smith, DE (corresponding author), Univ Oxford, Dept Chem, Oxford, England.; Radford-Smith, DE (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England.	daniel.radford-smith@pharm.ox.ac.uk	Anthony, Daniel/F-7765-2010; Russell, Anthony/A-8807-2011; Siskind, Dan/A-9812-2014	Anthony, Daniel/0000-0003-1380-6655; Russell, Anthony/0000-0001-7886-8844; Probert, Fay/0000-0002-8580-2023; Siskind, Dan/0000-0002-2072-9216	Lincoln College, University of Oxford; Oxford University Press Clarendon Scholarship; Newton Abraham Studentship, University of Oxford	Lincoln College, University of Oxford; Oxford University Press Clarendon Scholarship; Newton Abraham Studentship, University of Oxford	Lincoln College, University of Oxford (Daniel Radford-Smith): General financial support for DPhil (bursary and laboratory bench fees). Oxford University Press Clarendon Scholarship (Daniel Radford-Smith): General financial support for DPhil (bursary and laboratory bench fees). Newton Abraham Studentship, University of Oxford (Daniel Radford-Smith): General financial support for DPhil (bursary and laboratory bench fees). No other funds contributed to this study. All other authors do not declare any funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bot M, 2020, BIOL PSYCHIAT, V87, P409, DOI 10.1016/j.biopsych.2019.08.016; Brunoni AR, 2020, J AFFECT DISORDERS, V271, P39, DOI 10.1016/j.jad.2020.03.074; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Dekker RL, 2011, J CARD FAIL, V17, P755, DOI 10.1016/j.cardfail.2011.04.016; Hashimoto K, 2016, ACTA NEUROPSYCHIATR, V28, P173, DOI 10.1017/neu.2015.59; Huckvale S, 2021, J CLIN PSYCHIAT, V82, DOI 10.4088/JCP.20m13245; Jia HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23441; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kim D, 2019, ALIMENT PHARM THER, V50, P590, DOI 10.1111/apt.15395; Labenz C, 2020, HEPATOL COMMUN, V4, P1293, DOI 10.1002/hep4.1541; Liu YZ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-106; Malhi GS, 2018, LANCET, V392, P2299, DOI 10.1016/S0140-6736(18)31948-2; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Mazidi M, 2021, AM J CLIN NUTR, V114, P1028, DOI 10.1093/ajcn/nqab132; Meessen ECE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11123000; Milaneschi Y, 2019, MOL PSYCHIATR, V24, P18, DOI 10.1038/s41380-018-0017-5; Otvos JD, 2015, CLIN CHEM, V61, P714, DOI 10.1373/clinchem.2014.232918; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Patel FJ, 2018, HEPATOL COMMUN, V2, P897, DOI 10.1002/hep4.1208; Penninx BWJH, 2018, DIALOGUES CLIN NEURO, V20, P63; Probert F, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab084; Probert F, 2018, J CROHNS COLITIS, V12, P1326, DOI 10.1093/ecco-jcc/jjy101; Pu JC, 2021, MOL PSYCHIATR, V26, P4265, DOI 10.1038/s41380-020-0645-4; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Simon GE, 2010, GEN HOSP PSYCHIAT, V32, P583, DOI 10.1016/j.genhosppsych.2010.09.010; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; Tomeno W, 2015, J GASTROEN HEPATOL, V30, P1009, DOI 10.1111/jgh.12897; Wang L, 2007, FASEB J, V21, P1227, DOI 10.1096/fj.06-7495com; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Youssef NA, 2013, LIVER INT, V33, P1062, DOI 10.1111/liv.12165; Zimmerman M, 2006, J CLIN PSYCHIAT, V67, P1536, DOI 10.4088/JCP.v67n1007	31	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261555	10.1371/journal.pone.0261555	http://dx.doi.org/10.1371/journal.pone.0261555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990473	gold, Green Published			2022-12-26	WOS:000815783800010
J	Lia, M; Horn, LC; Sodeikat, P; Hockel, M; Aktas, B; Wolf, B				Lia, Massimiliano; Horn, Lars-Christian; Sodeikat, Paulina; Hoeckel, Michael; Aktas, Bahriye; Wolf, Benjamin			The diagnostic value of core needle biopsy in cervical cancer: A retrospective analysis	PLOS ONE			English	Article							RADICAL HYSTERECTOMY SPECIMENS; PARAMETRIAL INVOLVEMENT; STAGE-IB; CARCINOMA; IDENTIFICATION; MANAGEMENT; RESECTION; INVASION; FEATURES	Cervical carcinoma is a major cause of morbidity and mortality among women worldwide. Histological subtype, lymphovascular space invasion and tumor grade could have a prognostic and predictive value for patients' outcome and the knowledge of these histologic characteristics may influence clinical decision making. However, studies evaluating the diagnostic value of various biopsy techniques regarding these parameters of cervical cancer are scarce. We reviewed 318 cases of cervical carcinoma with available pathology reports from preoperative core needle biopsy (CNB) assessment and from final postoperative evaluation of the hysterectomy specimen. Setting the postoperative comprehensive pathological evaluation as reference, we analysed CNB assessment of histological tumor characteristics. In addition, we performed multivariable logistic regression to identify factors influencing the accuracy in identifying LVSI and tumor grade. CNB was highly accurate in discriminating histological subtype. Sensitivity and specificity were 98.8% and 89% for squamous cell carcinoma, 92.9% and 96.6% for adenocarcinoma, 33.3% and 100% in adenosquamous carcinoma respectively. Neuroendocrine carcinoma was always recognized correctly. The accuracy of the prediction of LVSI was 61.9% and was positively influenced by tumor size in preoperative magnetic resonance imaging and negatively influenced by strong peritumoral inflammation. High tumor grade (G3) was diagnosed accurately in 73.9% of cases and was influenced by histological tumor type. In conclusion, CNB is an accurate sampling technique for histological classification of cervical cancer and represents a reasonable alternative to other biopsy techniques.	[Lia, Massimiliano; Sodeikat, Paulina; Hoeckel, Michael; Aktas, Bahriye; Wolf, Benjamin] Univ Hosp Leipzig, Dept Gynecol & Obstet, Leipzig, Germany; [Horn, Lars-Christian] Univ Hosp Leipzig, Div Gynecol Breast & Perinatal Pathol, Leipzig, Germany	Leipzig University; Leipzig University	Lia, M (corresponding author), Univ Hosp Leipzig, Dept Gynecol & Obstet, Leipzig, Germany.	massimiliano.lia@medizin.uni-leipzig.de		Aktas, Bahriye/0000-0002-5474-051X				AGO, 2014, INT GERM GUIDL DIAGN; Andrade Juliano Ribeiro de, 2018, J. bras. pneumol., V44, P307, DOI [10.1590/s1806-37562017000000259, 10.1590/S1806-37562017000000259]; Bai HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25992; Bidus MA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.02.017; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cibula D, 2018, INT J GYNECOL CANCER, V28, P641, DOI 10.1097/IGC.0000000000001216; Covens A, 2002, GYNECOL ONCOL, V84, P145, DOI 10.1006/gyno.2001.6493; Creasman WT, 2004, GYNECOL ONCOL, V92, P525, DOI 10.1016/j.ygyno.2003.11.020; DELGADO G, 1989, GYNECOL ONCOL, V35, P314, DOI 10.1016/0090-8258(89)90070-X; Eggen T, 2007, INT J GYNECOL PATHOL, V26, P447, DOI 10.1097/pgp.0b013e3180341111; Fischerova D, 2008, INT J GYNECOL CANCER, V18, P833, DOI 10.1111/j.1525-1438.2007.01015.x; Frumovitz M, 2009, OBSTET GYNECOL, V114, P93, DOI 10.1097/AOG.0b013e3181ab474d; Haesen J, 2021, GYNECOL ONCOL, V162, P539, DOI 10.1016/j.ygyno.2021.06.026; Hockel M, 2019, LANCET ONCOL, V20, P1316, DOI 10.1016/S1470-2045(19)30389-4; Hockel M, 2017, EUR J CANCER, V70, P99, DOI 10.1016/j.ejca.2016.10.016; Hockel M, 2014, LANCET ONCOL, V15, P445, DOI 10.1016/S1470-2045(14)70060-9; Hockel M, 2009, LANCET ONCOL, V10, P683, DOI 10.1016/S1470-2045(09)70100-7; Horn LC, 2019, J CANCER RES CLIN, V145, P457, DOI 10.1007/s00432-018-2793-3; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Hutchcraft ML, 2019, GYNECOL ONCOL, V153, P255, DOI 10.1016/j.ygyno.2019.01.026; Kim MK, 2012, INT J GYNECOL CANCER, V22, P1214, DOI 10.1097/IGC.0b013e31825fb63b; KINNEY WK, 1995, GYNECOL ONCOL, V57, P3, DOI 10.1006/gyno.1995.1091; Knuttel FM, 2016, BRIT J SURG, V103, P644, DOI 10.1002/bjs.10128; Koh WJ, 2019, J NATL COMPR CANC NE, V17, P64, DOI 10.6004/jnccn.2019.0001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mascilini F, 2020, INT J GYNECOL CANCER, V30, P128, DOI 10.1136/ijgc-2019-000734; McCluggage WG, 2018, INT J GYNECOL PATHOL, V37, P205, DOI 10.1097/PGP.0000000000000412; Paja M, 2019, EUR RADIOL, V29, P4889, DOI 10.1007/s00330-019-06038-6; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; R Core Team, 2020, R LANG ENV STAT COMP; Ronsini C, 2021, GYNECOL ONCOL, V162, P299, DOI 10.1016/j.ygyno.2021.06.002; Sartori E, 2007, GYNECOL ONCOL, V107, pS170, DOI 10.1016/j.ygyno.2007.07.026; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Silva AL, 2005, GYNECOL OBSTET INVES, V59, P92, DOI 10.1159/000082522; Stoler M., 2014, WHO CLASSIFICATION T, V4th, P172; Tottrup M, 2020, J CLIN ULTRASOUND, V48, P134, DOI 10.1002/jcu.22769; Wagner AE, 2013, GYNECOL ONCOL, V129, P517, DOI 10.1016/j.ygyno.2013.03.008; Wenzel HHB, 2020, GYNECOL ONCOL, V158, P282, DOI 10.1016/j.ygyno.2020.04.705; Widschwendter P, 2019, ARCH GYNECOL OBSTET, V300, P1709, DOI 10.1007/s00404-019-05341-3; Wolf B, 2017, GYNECOL ONCOL, V146, P292, DOI 10.1016/j.ygyno.2017.05.007	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262257	10.1371/journal.pone.0262257	http://dx.doi.org/10.1371/journal.pone.0262257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986187	Green Published, gold, Green Submitted			2022-12-26	WOS:000765956200031
J	Matsushima-Nishiwaki, R; Yamada, N; Hattori, Y; Hosokawa, Y; Tachi, J; Hori, T; Kozawa, O				Matsushima-Nishiwaki, Rie; Yamada, Noriko; Hattori, Yuria; Hosokawa, Yui; Tachi, Junko; Hori, Takamitsu; Kozawa, Osamu			SERMs (selective estrogen receptor modulator), acting as estrogen receptor beta agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-alpha-induced migration via specific inhibition of AKT signaling pathway	PLOS ONE			English	Article							LIGANDS; CANCER; DISCOVERY; WOMEN; RISK	Selective estrogen receptor modulator (SERM) interacts with estrogen receptors and acts as both an agonist or an antagonist, depending on the target tissue. SERM is widely used as a safer hormone replacement therapeutic medicine for postmenopausal osteoporosis. Regarding hepatocellular carcinoma (HCC), accumulating evidence indicates gender differences in the development, and that men are at higher morbidity risk than premenopausal women, suggesting that estrogen protects against HCC. However, it remains unclear whether SERM affects the HCC progression. Previously, we have shown that transforming growth factor (TGF)-alpha promotes the migration of HCC cells via p38 mitogen-activated protein kinases (MAPK), c-Jun N-terminal kinase and AKT. In the present study, we investigated whether SERM such as tamoxifen, raloxifene and bazedoxifene, affects the HCC cell migration using human HCC-derived HuH7 cells. Raloxifene and bazedoxifene but not tamoxifen, significantly suppressed the TGF-alpha-induced HuH7 cell migration. ERB041 and DPN, estrogen receptor (ER) beta agonists, inhibited the TGF-alpha-induced cell migration whereas PPT, an ER alpha agonist, did not show the suppressive effect on the cell migration. ERB041 attenuated the TGF-alpha-induced phosphorylation of AKT without affecting the phosphorylation of p38 MAPK and c-Jun N-terminal kinase. Raloxifene and bazedoxifene also inhibited the phosphorylation of AKT by TGF-alpha. Furthermore, PHTPP, an ER beta antagonist, significantly reversed the suppression by both raloxifene and bazedoxifene of the TGF-alpha-induced cell migration. Taken together, our results strongly indicate that raloxifene and bazedoxifene, SERMs, suppress the TGF-alpha-induced migration of HCC cells through ER beta-mediated inhibition of the AKT signaling pathway.	[Matsushima-Nishiwaki, Rie; Yamada, Noriko; Hattori, Yuria; Hosokawa, Yui; Tachi, Junko; Hori, Takamitsu; Kozawa, Osamu] Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan	Gifu University	Kozawa, O (corresponding author), Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan.	okkasugai@yahoo.co.jp			Japan Society for the Promotion of Science KAKENHI [JP20K08283, JP25460989]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI (https://www.jsps.go.jp/) [grant numbers; JP20K08283 to RM-N and JP25460989 to OK] form the Ministry of Education, Culture, Sports, Science and Technology of Japan The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An KC, 2016, ASIAN SPINE J, V10, P787, DOI 10.4184/asj.2016.10.4.787; Badawy AAG, 2015, APMIS, V123, P823, DOI 10.1111/apm.12431; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Cocciadiferro L, 2017, J STEROID BIOCHEM, V172, P222, DOI 10.1016/j.jsbmb.2016.05.023; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Di Maio M, 2006, ANN NY ACAD SCI, V1089, P252, DOI 10.1196/annals.1386.007; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Ge Y, 2020, CANCER LETT, V477, P41, DOI 10.1016/j.canlet.2020.02.003; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Hassan MM, 2017, CLIN GASTROENTEROL H, V15, P1791, DOI 10.1016/j.cgh.2017.05.036; Hernandez-Silva CD, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00544; Huang PX, 2014, J CELL MOL MED, V18, P218, DOI 10.1111/jcmm.12153; JASKIEWICZ K, 1995, ANTICANCER RES, V15, P559; Kur P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082620; Ladenheim MR, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000107; Lee TK, 2005, CARCINOGENESIS, V26, P681, DOI 10.1093/carcin/bgi002; Liu PA, 2017, ONCOTARGET, V8, P68131, DOI 10.18632/oncotarget.19245; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Long DL, 2013, ARTHRITIS RHEUM-US, V65, P1561, DOI 10.1002/art.37922; Ma HY, 2019, CANCER SCI, V110, P950, DOI 10.1111/cas.13940; Ma WJ, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6168-1; Maczis MA, 2018, J LIPID RES, V59, P2297, DOI 10.1194/jlr.M085191; Martinkovich S, 2014, CLIN INTERV AGING, V9, P1437, DOI 10.2147/CIA.S66690; Matsushima-Nishiwaki R, 2017, BBA-MOL BASIS DIS, V1863, P1629, DOI 10.1016/j.bbadis.2017.04.021; Matsushima-Nishiwaki R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151907; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pinkerton JV, 2014, J STEROID BIOCHEM, V142, P142, DOI 10.1016/j.jsbmb.2013.12.011; Ren JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153863; Shanle EK, 2010, ADV DRUG DELIVER REV, V62, P1265, DOI 10.1016/j.addr.2010.08.001; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Ulitzky L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145212; Villa E, 2002, ANN NY ACAD SCI, V963, P37; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Wu Eric M, 2018, Hepatoma Res, V4, DOI 10.20517/2394-5079.2018.87; Xu BB, 2017, J DIABETES COMPLICAT, V31, P773, DOI 10.1016/j.jdiacomp.2016.12.010; Yamada N, 2019, BIOMED REP, V11, P19, DOI 10.3892/br.2019.1215; Yang PC, 2016, WORLD J HEPATOL, V8, P1309, DOI 10.4254/wjh.v8.i31.1309; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Zhang Y, 2014, WORLD J GASTROENTERO, V20, P142, DOI 10.3748/wjg.v20.i1.142	44	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262485	10.1371/journal.pone.0262485	http://dx.doi.org/10.1371/journal.pone.0262485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007301	Green Published, gold			2022-12-26	WOS:000741060700012
J	Nan, G; Zhao, SH; Wang, T; Chao, D; Tian, RF; Wang, WJ; Fu, X; Lin, P; Guo, T; Wang, B; Sun, XX; Chen, X; Chen, ZN; Wang, SJ; Cui, HY				Nan, Gang; Zhao, Shu-Hua; Wang, Ting; Chao, Dong; Tian, Ruo-Fei; Wang, Wen-Jing; Fu, Xin; Lin, Peng; Guo, Ting; Wang, Bin; Sun, Xiu-Xuan; Chen, Xi; Chen, Zhi-Nan; Wang, Shi-Jie; Cui, Hong-Yong			CD147 supports paclitaxel resistance via interacting with RanBP1	ONCOGENE			English	Article							OVARIAN-CANCER CELLS; TAXOL RESISTANCE; BETA; INHIBITION; APOPTOSIS; MUTATIONS; CHEMOSENSITIVITY; HAB18G/CD147; MECHANISMS; EXPRESSION	Though the great success of paclitaxel, the variable response of patients to the drug limits its clinical utility and the precise mechanisms underlying the variable response to paclitaxel remain largely unknown. This study aims to verify the role and the underlying mechanisms of CD147 in paclitaxel resistance. Immunostaining was used to analyze human non-small-cell lung cancer (NSCLC) and ovarian cancer tissues. RNA-sequencing was used to identify downstream effectors. Annexin V-FITC/propidium iodide and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were used to detect apoptosis. Co-immunoprecipitation (Co-IP), fluorescence resonance energy transfer (FRET) and surface plasmon resonance (SPR) were performed to determine protein interactions. Fluorescence recovery after photobleaching (FRAP) was performed to measure the speed of microtubule turnover. Xenograft tumor model was established to evaluate sensitivity of cancer cells to paclitaxel in vivo. In vitro and in vivo assays showed that silencing CD147 sensitized the cancer cells to paclitaxel treatment. CD147 protected cancer cells from paclitaxel-induced caspase-3 mediated apoptosis regardless of p53 status. Truncation analysis showed that the intracellular domain of CD147 (CD147(ICD)) was indispensable for CD147-regulated sensitivity to paclitaxel. Via screening the interacting proteins of CD147(ICD), Ran binding protein 1 (RanBP1) was identified to interact with CD147(ICD) via its C-terminal tail. Furthermore, we showed that RanBP1 mediated CD147-regulated microtubule stability and dynamics as well as response to paclitaxel treatment. These results demonstrated that CD147 regulated paclitaxel response by interacting with the C-terminal tail of RanBP1 and targeting CD147 may be a promising strategy for preventing paclitaxel resistant.	[Nan, Gang; Tian, Ruo-Fei; Wang, Wen-Jing; Fu, Xin; Lin, Peng; Guo, Ting; Wang, Bin; Sun, Xiu-Xuan; Chen, Zhi-Nan; Wang, Shi-Jie; Cui, Hong-Yong] Fourth Mil Med Univ, Natl Translat Sci Ctr Mol Med, Xian 710032, Peoples R China; [Nan, Gang; Tian, Ruo-Fei; Wang, Wen-Jing; Fu, Xin; Lin, Peng; Guo, Ting; Wang, Bin; Sun, Xiu-Xuan; Chen, Zhi-Nan; Wang, Shi-Jie; Cui, Hong-Yong] Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China; [Zhao, Shu-Hua] Fourth Mil Med Univ, Xijing Hosp, Dept Obstet & Gynecol, Xian 710032, Peoples R China; [Wang, Ting] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Chao, Dong] 940th Hosp Joint Logist Support Force Chinese Peo, Dept Thorac Surg, Lanzhou 730050, Peoples R China; [Chen, Xi] Northwest Univ, Coll Chem & Mat Sci, Xian 710127, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Northwest University Xi'an	Chen, ZN; Wang, SJ; Cui, HY (corresponding author), Fourth Mil Med Univ, Natl Translat Sci Ctr Mol Med, Xian 710032, Peoples R China.; Chen, ZN; Wang, SJ; Cui, HY (corresponding author), Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China.	znchen@fmmu.edu.cn; kola_519@163.com; cui-hongyong@163.com		Chen, Zhi-Nan/0000-0001-5512-4623	National Key Research and Development Program of China [2018YFA0109000]; National Postdoctoral Program for Innovative Talents [BX20180376]; State Key Laboratory of Cancer Biology [CBSKL2019ZZ16]; Discipline Promotion Foundation of Xijing Hospital [XJZT18MJ92]; Natural Science Foundation of Shaanxi Province [2020SF-252]; Basic Research Plan of Natural Science in Shaanxi Province [2020JM-326]; National Natural Science Foundation of China [31601127, 82103360, 82173244]	National Key Research and Development Program of China; National Postdoctoral Program for Innovative Talents; State Key Laboratory of Cancer Biology; Discipline Promotion Foundation of Xijing Hospital; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Basic Research Plan of Natural Science in Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (2018YFA0109000), the National Postdoctoral Program for Innovative Talents (BX20180376), the State Key Laboratory of Cancer Biology (CBSKL2019ZZ16), the Discipline Promotion Foundation of Xijing Hospital (XJZT18MJ92), the Natural Science Foundation of Shaanxi Province (2020SF-252), the Basic Research Plan of Natural Science in Shaanxi Province (2020JM-326) and the National Natural Science Foundation of China (31601127, 82103360 and 82173244). We thank Ms Rui-Rui Yao and Ms. Wen Wen for paraffin section, Ms Tian-Jiao Zhang for mouse model establishment.	Als AB, 2007, CLIN CANCER RES, V13, P4407, DOI 10.1158/1078-0432.CCR-07-0109; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Cavazza T, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00082; Chen YK, 2009, CANCER LETT, V278, P113, DOI 10.1016/j.canlet.2009.01.004; Cui HY, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00677-2; Cui HY, 2016, ONCOTARGET, V7, P5613, DOI 10.18632/oncotarget.6723; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Fan XY, 2019, AM J TRANSL RES, V11, P3543; Fruehauf J P, 1994, Contrib Gynecol Obstet, V19, P39; Gao J, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0920-9; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Gou XC, 2009, CANCER SCI, V100, P837, DOI 10.1111/j.1349-7006.2009.01113.x; Gulluni F, 2017, CANCER CELL, V32, P444, DOI 10.1016/j.ccell.2017.09.002; He LF, 2001, MOL CANCER THER, V1, P3; Hu Yun, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P192, DOI 10.3969/j.issn.1672-7347.2011.03.002; Inoue S, 2001, Hum Cell, V14, P211; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kanakkanthara A, 2013, CANCER TREAT REV, V39, P161, DOI 10.1016/j.ctrv.2012.07.005; Kang MJ, 2013, PROTEOMICS, V13, P1714, DOI 10.1002/pmic.201200511; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kuang YH, 2008, J PROTEOME RES, V7, P4784, DOI 10.1021/pr800355b; Kuang YH, 2009, CANCER LETT, V276, P189, DOI 10.1016/j.canlet.2008.11.010; Li Y, 2009, HISTOPATHOLOGY, V54, P677, DOI 10.1111/j.1365-2559.2009.03280.x; Liang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102496; Lounsbury KM, 1997, J BIOL CHEM, V272, P551; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Muramatsu T, 2016, J BIOCHEM, V159, P481, DOI 10.1093/jb/mvv127; Nami B, 2018, CANCERS, V10, DOI 10.3390/cancers10080274; Newman JR, 2008, ARCH OTOLARYNGOL, V134, P1218, DOI 10.1001/archotol.134.11.1218; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Strobel T, 1996, P NATL ACAD SCI USA, V93, P14094, DOI 10.1073/pnas.93.24.14094; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Wang SJ, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01647-2; Wu B, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.251; Xu J, 2007, HEPATOLOGY, V45, P269, DOI 10.1002/hep.21465; Yau KC, 2020, CELL CYCLE, V19, P1899, DOI 10.1080/15384101.2020.1782036; Yin SH, 2007, MOL CANCER THER, V6, P2798, DOI 10.1158/1535-7163.MCT-06-0791; Yin SH, 2012, PHARM RES-DORDR, V29, P2994, DOI 10.1007/s11095-012-0794-5; Yin SH, 2010, MOL CANCER THER, V9, P327, DOI 10.1158/1535-7163.MCT-09-0674; Yong YL, 2019, J PATHOL, V249, P255, DOI 10.1002/path.5316; Yu Y, 2015, CANCER CELL, V28, P82, DOI 10.1016/j.ccell.2015.05.009; Zheng YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02811-7; Zou W, 2007, CANCER LETT, V248, P211, DOI 10.1016/j.canlet.2006.07.005	47	1	1	5	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2022	41	7					983	996		10.1038/s41388-021-02143-3	http://dx.doi.org/10.1038/s41388-021-02143-3		JAN 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YX7EK	34974521	hybrid, Green Published			2022-12-26	WOS:000736941300002
J	Mercier, MR; Galivanche, AR; Brand, JP; Pathak, N; Medvecky, MJ; Varthi, AG; Rubin, LE; Grauer, JN				Mercier, Michael R.; Galivanche, Anoop R.; Brand, Jordan P.; Pathak, Neil; Medvecky, Michael J.; Varthi, Arya G.; Rubin, Lee E.; Grauer, Jonathan N.			COVID-positive ankle fracture patients are at increased odds of perioperative surgical complications following open reduction internal fixation surgery	PLOS ONE			English	Article							DATABASE; OUTCOMES	Introduction Ankle fractures have continued to occur through the COVID pandemic and, regardless of patient COVID status, often need operative intervention for optimizing long-term outcomes. For healthcare optimization, patient counseling, and care planning, understanding if COVID-positive patients undergoing ankle fracture surgery are at increased risk for perioperative adverse outcomes is of interest. Methods The COVID-19 Research Database contains recent United States aggregated insurance claims. Patients who underwent ankle fracture surgery from April 1st, 2020 to June 15th, 2020 were identified. COVID status was identified by ICD coding. Demographics, comorbidities, and postoperative complications were extracted based on administrative data. COVID-positive versus negative patients were compared with univariate analyses. Propensity-score matching was done on the basis of age, sex, and comorbidities. Multivariate regression was then performed to identify risk factors independently associated with the occurrence of 30-day postoperative adverse events. Results In total, 9,835 patients undergoing ankle fracture surgery were identified, of which 57 (0.58%) were COVID-positive. COVID-positive ankle fracture patients demonstrated a higher prevalence of comorbidities, including: chronic kidney disease, diabetes, hypertension, and obesity (p<0.05 for each). After propensity matching and controlling for all preoperative variables, multivariate analysis found that COVID-positive patients were at increased risk of any adverse event (odds ratio [OR] = 3.89, p = 0.002), a serious adverse event (OR = 5.48, p = 0.002), and a minor adverse event (OR = 3.10, p = 0.021). Discussion COVID-positive patients will continue to present with ankle fractures requiring operative intervention. Even after propensity matching and controlling for patient factors, COVID-positive patients were found to be at increased risk of 30-day perioperative adverse events. Not only do treatment teams need to be protected from the transmission of COVID in such situations, but the increased incidence of perioperative adverse events needs to be considered.	[Mercier, Michael R.; Galivanche, Anoop R.; Brand, Jordan P.; Pathak, Neil; Medvecky, Michael J.; Varthi, Arya G.; Rubin, Lee E.; Grauer, Jonathan N.] Yale Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA	Yale University	Grauer, JN (corresponding author), Yale Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA.	jonathan.grauer@yale.edu		Grauer, Jonathan/0000-0002-2626-7278				Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Basques BA, 2015, CLIN ORTHOP RELAT R, V473, P1133, DOI 10.1007/s11999-014-4005-z; Blouhos K, 2020, FRONT SURG, V7, DOI 10.3389/fsurg.2020.00033; Campbell KH, 2020, JAMA-J AM MED ASSOC, V323, P2520, DOI 10.1001/jama.2020.8904; COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X; DALY PJ, 1987, ACTA ORTHOP SCAND, V58, P539, DOI 10.3109/17453678709146395; Eckerle I, 2020, LANCET, V396, P514, DOI 10.1016/S0140-6736(20)31482-3; Ellis RJ, 2018, SURGERY, V164, P173, DOI 10.1016/j.surg.2017.12.021; Fu MC., 2017, FOOT ANKLE ORTHOP, DOI [10.1177/2473011417695254, DOI 10.1177/2473011417695254]; Kadiakia AR., 2016, MILLERS REV ORTHOPAE, V7th, P483; Martinez DA, 2020, JAMA-J AM MED ASSOC, V324, P392, DOI 10.1001/jama.2020.11374; Mi BB, 2020, J BONE JOINT SURG AM, V102, P750, DOI 10.2106/JBJS.20.00390; Perfetti DC, 2015, J ARTHROPLASTY, V30, P547, DOI 10.1016/j.arth.2014.10.035; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Pugely AJ, 2015, J BONE JOINT SURG AM, V97A, P1799, DOI 10.2106/JBJS.O.00134; Pugely AJ, 2015, J BONE JOINT SURG AM, V97A, P1278, DOI 10.2106/JBJS.N.01260; Randhawa AK, 2020, JAMA-J AM MED ASSOC, V323, P2334, DOI 10.1001/jama.2020.8097; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rowe S., 2020, DATAVANT; Sivasundaram L, 2016, CURR ORTHOP PRACT, V27, P673, DOI 10.1097/BCO.0000000000000431; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; SooHoo NF, 2009, J BONE JOINT SURG AM, V91A, P1042, DOI 10.2106/JBJS.H.00653; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Suleyman G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12270; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Xie JF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5619; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]	30	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262115	10.1371/journal.pone.0262115	http://dx.doi.org/10.1371/journal.pone.0262115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972190	Green Published, gold			2022-12-26	WOS:000773555700099
J	Youssouf, AS; Hasbullah, NF; Saidin, N; Habaebi, MH; Parthiban, R; Zin, MRB; Elsheikh, EAA; Suliman, FM				Youssouf, Abdouraouf Said; Hasbullah, Nurul Fadzlin; Saidin, Norazlina; Habaebi, Mohamed Hadi; Parthiban, Rajendran; Zin, Muhammad Rawi Bin Mohamed; Elsheikh, Elfatih A. A.; Suliman, F. M.			Induced electron radiation effect on the performance of inter-satellite optical wireless communication	PLOS ONE			English	Article							IRRADIATION; LINK; PHOTODIODES; RADIOS; DPSK	This paper provides the details of a study on the effects of electron radiation on the Performance of Inters-satellite Optical Wireless Communication (IsOWC). Academia and industry focus on solutions that can improve performance and reduce the cost of IsWOC systems. Spacecraft, space stations, satellites, and astronauts are exposed to an increased level of radiation when in space, so it is essential to evaluate the risks and performance effects associated with extended radiation exposures in missions and space travel in general. This investigation focuses on LEO, especially in the near-equatorial radiation environment. Radiation experiments supported with simulations have made it possible to obtain and evaluate the electron radiation impact on optoelectronics at the device level and system level performances. The electron radiation has induced a system degradation of 70%. This result demonstrates the importance of such an investigation to predict and take necessary and suitable reliable quality service for future space missions.	[Youssouf, Abdouraouf Said; Hasbullah, Nurul Fadzlin; Saidin, Norazlina; Habaebi, Mohamed Hadi] Int Islamic Univ Malaysia, Dept Elect & Comp Engn, Kuala Lumpur, Malaysia; [Parthiban, Rajendran] Monash Univ Malaysia, Sch Engn, Dept Elect & Comp Engn, Subang Jaya, Malaysia; [Zin, Muhammad Rawi Bin Mohamed] Nucl Malaysia, Radiat Proc Technol Div, Bangi, Malaysia; [Elsheikh, Elfatih A. A.; Suliman, F. M.] King Khalid Univ, Coll Engn, Dept Elect Engn, Abha, Saudi Arabia	International Islamic University Malaysia; Monash University; Monash University Sunway; King Khalid University	Hasbullah, NF (corresponding author), Int Islamic Univ Malaysia, Dept Elect & Comp Engn, Kuala Lumpur, Malaysia.	nfadzlinh@iium.edu.my	Salih, Dr. Fakher Eldin/AED-1124-2022; Parthiban, Rajendran/A-4999-2008	Salih, Dr. Fakher Eldin/0000-0002-9771-1559; Youssouf, Abdouraouf Said/0000-0003-4584-5042; Parthiban, Rajendran/0000-0003-0983-9796	King Khalid University [R.G.P.1/219/42]	King Khalid University	The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through Research Group Program under grant number: R.G.P.1/219/42. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyildiz IF, 2019, AD HOC NETW, V86, P166, DOI 10.1016/j.adhoc.2018.12.004; Alimenti F, 2020, IEEE ACCESS, V8, P106785, DOI 10.1109/ACCESS.2020.3000675; Arora H, 2017, J OPT COMMUN, V38, P63, DOI 10.1515/joc-2016-0017; Bourqui ML, 2008, MICROELECTRON RELIAB, V48, P1202, DOI 10.1016/j.microrel.2008.07.012; Boutillier M, 2007, IEEE T NUCL SCI, V54, P1110, DOI 10.1109/TNS.2007.894715; Boutillier M, 2006, MICROELECTRON RELIAB, V46, P1715, DOI 10.1016/j.microrel.2006.07.049; C. Systems, 2020, MASS DISTR ANT SYST, P2; Chaudhary S., 2017, EMPIRICAL EVALUATION, P1; Chaudhary S., 2012, HIGH SPEED INTERSATE; Chaudhary S, 2019, OPT QUANT ELECTRON, V51, DOI 10.1007/s11082-019-1864-2; Dang SP, 2020, NAT ELECTRON, V3, P20, DOI 10.1038/s41928-019-0355-6; El Nasr-Storey SS, 2013, IEEE T NUCL SCI, V60, P2518, DOI 10.1109/TNS.2013.2251356; Gregory M, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.3.031202; Heine F, 2010, IEEE MILIT COMMUN C, P1583, DOI 10.1109/MILCOM.2010.5680175; Hou R, 2013, LASER ENG, V25, P67; Hou R., 2012, 2012 S PHOT OPT SOPO; Johnston AH, 2003, IEEE T NUCL SCI, V50, P689, DOI 10.1109/TNS.2003.812926; Johnston AH, 2001, IEEE T NUCL SCI, V48, P1713, DOI 10.1109/23.960362; Johnston AH, 2013, IEEE T NUCL SCI, V60, P2054, DOI 10.1109/TNS.2013.2259504; Kaur P, 2015, PROCEDIA COMPUT SCI, V58, P572, DOI 10.1016/j.procs.2015.08.075; Kaur S, 2019, OPTO-ELECTRON REV, V27, P10, DOI 10.1016/j.opelre.2018.11.002; Kaushal H, 2017, IEEE COMMUN SURV TUT, V19, P57, DOI 10.1109/COMST.2016.2603518; Li YJ, 2018, OPT COMMUN, V407, P239, DOI 10.1016/j.optcom.2017.08.061; Lim HC, 2020, J ASTRON SPACE SCI, V37, P11, DOI 10.5140/JASS.2020.37.1.11; Lischka H, 1996, RADECS 95 - THIRD EUROPEAN CONFERENCE ON RADIATION AND ITS EFFECTS ON COMPONENTS AND SYSTEMS, P560, DOI 10.1109/RADECS.1995.509837; Liu Y, 2017, J LIGHTWAVE TECHNOL, V35, P3825, DOI 10.1109/JLT.2017.2717920; Liu Y, 2016, OPT COMMUN, V363, P97, DOI 10.1016/j.optcom.2015.10.064; Liu Y, 2015, OPTIK, V126, P2588, DOI 10.1016/j.ijleo.2015.06.032; Liu Y, 2015, OPT COMMUN, V350, P276, DOI 10.1016/j.optcom.2015.04.025; Nabila A, 2019, 2019 INTERNATIONAL CONFERENCE ON WIRELESS TECHNOLOGIES, EMBEDDED AND INTELLIGENT SYSTEMS (WITS); Olantera L, 2019, IEEE T NUCL SCI, V66, P1663, DOI 10.1109/TNS.2019.2902624; Pedroza G, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072672; Phifer C. C., 2004, SAND20044725, P1; Popescu O, 2017, IEEE ACCESS, V5, P12618, DOI 10.1109/ACCESS.2017.2721948; Rinaldi F., 2020, NONTERRESTRIAL NETWO; Samsuzzaman M, 2018, IEEE ACCESS, V6, P54282, DOI 10.1109/ACCESS.2018.2871209; Sharma A, 2020, OPTIK INT J LIGHT EL; Sharma V, 2013, OPT COMMUN, V286, P99, DOI 10.1016/j.optcom.2012.08.055; Smutny B., 2006, COLLECTION TECHNICAL, V2, P1141; Specification T., 2019, 38811 3GPP TR; Su YT, 2019, IEEE WIREL COMMUN, V26, P55, DOI 10.1109/MWC.2019.1800299; Suparta W, 2018, J AEROSP TECHNOL MAN, V10, DOI 10.5028/jatm.v10.815; Suparta W, 2017, ASTROPHYS SPACE SCI, V362, DOI 10.1007/s10509-017-3082-3; You L, 2020, IEEE J SEL AREA COMM, V38, P1851, DOI 10.1109/JSAC.2020.3000803; Zhang S., COMPUT NETW, V174	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0259649	10.1371/journal.pone.0259649	http://dx.doi.org/10.1371/journal.pone.0259649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972119	Green Published, gold			2022-12-26	WOS:000773555700008
J	Hanna, DA; Moore, CM; Liu, L; Yuan, XJ; Dominic, IM; Fleischhacker, AS; Hamza, I; Ragsdale, SW; Reddi, AR				Hanna, David A.; Moore, Courtney M.; Liu, Liu; Yuan, Xiaojing; Dominic, Iramofu M.; Fleischhacker, Angela S.; Hamza, Iqbal; Ragsdale, Stephen W.; Reddi, Amit R.			Heme oxygenase-2 (HO-2) binds and buffers labile ferric heme in human embryonic kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; THIOL/DISULFIDE REDOX SWITCH; REGULATORY MOTIFS; TRANSCRIPTIONAL ACTIVATION; BILIVERDIN REDUCTASE; MOLECULAR-MECHANISM; CARBON-MONOXIDE; REV-ERB; PROTEIN; DEGRADATION	Heme oxygenases (HOs) detoxify heme by oxidatively degrading it into carbon monoxide, iron, and biliverdin, which is reduced to bilirubin and excreted. Humans express two isoforms of HO: the inducible HO-1, which is upregulated in response to excess heme and other stressors, and the constitutive HO-2. Much is known about the regulation and physiological function of HO-1, whereas comparatively little is known about the role of HO-2 in regulating heme homeostasis. The biochemical necessity for expressing constitutive HO-2 is dependent on whether heme is sufficiently abundant and accessible as a substrate under conditions in which HO-1 is not induced. By measuring labile heme, total heme, and bilirubin in human embryonic kidney HEK293 cells with silenced or overexpressed HO-2, as well as various HO-2 mutant alleles, we found that endogenous heme is too limiting a substrate to observe HO-2-dependent heme degradation. Rather, we discovered a novel role for HO-2 in the binding and buffering of heme. Taken together, in the absence of excess heme, we propose that HO-2 regulates heme homeostasis by acting as a heme buffering factor that controls heme bioavailability. When heme is in excess, HO-1 is induced, and both HO-2 and HO-1 can provide protection from heme toxicity via enzymatic degradation. Our results explain why catalytically inactive mutants of HO-2 are cytoprotective against oxidative stress. Moreover, the change in bioavailable heme due to HO-2 overexpression, which selectively binds ferric over ferrous heme, is consistent with labile heme being oxidized, thereby providing new insights into heme trafficking and signaling.	[Hanna, David A.; Moore, Courtney M.; Dominic, Iramofu M.; Reddi, Amit R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Liu, Liu; Fleischhacker, Angela S.; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, Dept Cell Biol & Mol Genet, College Pk, MD USA; [Reddi, Amit R.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Reddi, Amit R.] Georgia Inst Technol, Parker Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Reddi, AR (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Reddi, AR (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.; Reddi, AR (corresponding author), Georgia Inst Technol, Parker Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.	amit.reddi@chemistry.gatech.edu		Dominic, Iramofu/0000-0002-1511-5981; Hanna, David/0000-0003-0726-8707	US National Institutes of Health [ES025661, DK125740, R35-GM141758]; US National Science Foundation [1552791]; Georgia Institute of Technology Blanchard and Vasser-Woolley fellowships	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Georgia Institute of Technology Blanchard and Vasser-Woolley fellowships	Funding and additional information-The research was supported by the US National Institutes of Health (ES025661 to A. R. R. and I. H., DK125740 to I. H., and R35-GM141758 to S. W. R.) , a US Na-tional Science Foundation grant 1552791 (to A. R. R.) , and the Georgia Institute of Technology Blanchard and Vasser-Woolley fellowships (to A. R. R.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abshire JR, 2017, P NATL ACAD SCI USA, V114, pE2068, DOI 10.1073/pnas.1615195114; ALAM J, 1989, J BIOL CHEM, V264, P6371; Atamna H, 2015, METALLOMICS, V7, P309, DOI 10.1039/c4mt00246f; Ayer A, 2016, PHYSIOL REV, V96, P1449, DOI 10.1152/physrev.00003.2016; Bal W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045832; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Barr I, 2012, P NATL ACAD SCI USA, V109, P1919, DOI 10.1073/pnas.1114514109; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Brewitz HH, 2015, CHEMBIOCHEM, V16, P2216, DOI 10.1002/cbic.201500331; Burton MJ, 2016, P NATL ACAD SCI USA, V113, P3785, DOI 10.1073/pnas.1600211113; Campbell NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28488-6; Carter EL, 2017, J BIOL CHEM, V292, P11280, DOI 10.1074/jbc.M117.783118; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chambers IG, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2020.118881; Chen AJ, 2018, ANAL CHEM, V90, P3395, DOI 10.1021/acs.analchem.7b05046; Chiabrando D, 2014, HAEMATOLOGICA, V99, P973, DOI 10.3324/haematol.2013.091991; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; Chien HC, 2016, DRUG METAB DISPOS, V44, P356, DOI 10.1124/dmd.115.066647; Constantin M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/859235; Dai Y, 2020, J BIOL CHEM, V295, P8145, DOI 10.1074/jbc.RA120.013802; Davydov R, 2016, BIOCHEMISTRY-US, V55, P62, DOI 10.1021/acs.biochem.5b00943; Desmard M, 2007, ANTIOXID REDOX SIGN, V9, P2139, DOI 10.1089/ars.2007.1803; Donegan RK, 2019, FREE RADICAL BIO MED, V133, P88, DOI 10.1016/j.freeradbiomed.2018.08.005; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Doty RT, 2015, J CLIN INVEST, V125, P4681, DOI 10.1172/JCI83054; Duffy SP, 2010, MOL CELL BIOL, V30, P5318, DOI 10.1128/MCB.00690-10; Fang YJ, 2017, CELL RES, V27, P1083, DOI 10.1038/cr.2017.85; Fleischhacker AS, 2020, J BIOL CHEM, V295, P5177, DOI 10.1074/jbc.RA120.012803; Fleischhacker AS, 2018, ANTIOXID REDOX SIGN, V29, P1841, DOI 10.1089/ars.2017.7368; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Funes SC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01467; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Gray LT, 2019, CELL CHEM BIOL, V26, P1681, DOI 10.1016/j.chembiol.2019.10.003; Hanna DA, 2018, J BIOL CHEM, V293, P12378, DOI 10.1074/jbc.RA118.002125; Hanna DA, 2017, BIOCHEMISTRY-US, V56, P1815, DOI 10.1021/acs.biochem.7b00007; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Hill-Kapturczak N, 2007, ANTIOXID REDOX SIGN, V9, P2197, DOI 10.1089/ars.2007.1798; Hopp MT, 2020, ANAL CHEM, V92, P9429, DOI 10.1021/acs.analchem.0c00415; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Ishikawa K, 1998, J BIOL CHEM, V273, P4317, DOI 10.1074/jbc.273.8.4317; Jazwa A, 2010, CURR DRUG TARGETS, V11, P1517, DOI 10.2174/1389450111009011517; Kathiresan M, 2014, P NATL ACAD SCI USA, V111, P17468, DOI 10.1073/pnas.1409692111; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; KEYSE SM, 1990, MOL CELL BIOL, V10, P4967, DOI 10.1128/MCB.10.9.4967; Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031; Kim YS, 2005, FREE RADICAL BIO MED, V39, P558, DOI 10.1016/j.freeradbiomed.2005.04.009; Kochert BA, 2019, J BIOL CHEM, V294, P8259, DOI 10.1074/jbc.RA119.008592; Kuhl T, 2014, CHEMBIOCHEM, V15, P2024, DOI 10.1002/cbic.201402218; Kumar D, 2005, J AM CHEM SOC, V127, P8204, DOI 10.1021/ja0446956; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Leung GCH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2104008118; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Linnenbaum M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035483; Liu L, 2020, J BIOL CHEM, V295, P17227, DOI 10.1074/jbc.RA120.014919; Liu YR, 2006, FREE RADICAL BIO MED, V40, P960, DOI 10.1016/j.freeradbiomed.2005.07.021; Lundvig DMS, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00081; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MAINES MD, 1986, J BIOL CHEM, V261, P411; Martinez-Guzman O, 2020, J CELL SCI, V133, DOI 10.1242/jcs.237917; Matsui T, 2010, INORG CHEM, V49, P3602, DOI 10.1021/ic901869t; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mestre-Fos S, 2020, J BIOL CHEM, V295, P14855, DOI 10.1074/jbc.RA120.014332; Michener JK, 2012, P NATL ACAD SCI USA, V109, P19504, DOI 10.1073/pnas.1212287109; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Muller M, 1996, CHEMEQL 20 PROGRAM C; Munoz-Sanchez J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/604981; Ong WY, 2005, J ALZHEIMERS DIS, V8, P183; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pek RH, 2019, ELIFE, V8, DOI 10.7554/eLife.49503; Ponka P, 2017, TRENDS BIOCHEM SCI, V42, P395, DOI 10.1016/j.tibs.2017.01.006; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Prawan A, 2005, ANTIOXID REDOX SIGN, V7, P1688, DOI 10.1089/ars.2005.7.1688; Quigley JG, 2005, BLOOD CELL MOL DIS, V35, P189, DOI 10.1016/j.bcmd.2005.01.005; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Reddi AR, 2007, J AM CHEM SOC, V129, P12815, DOI 10.1021/ja073902+; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sanematsu K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22807; Sankar SB, 2018, J BIOL CHEM, V293, P11358, DOI 10.1074/jbc.RA117.001050; Sarkar A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016717118; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schaefer B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188344; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Song YQ, 2015, ACS CHEM BIOL, V10, P1610, DOI 10.1021/cb5009734; Stec DE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/593530; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Sweeny EA, 2018, J BIOL CHEM, V293, P14557, DOI 10.1074/jbc.RA118.004169; Swenson SA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030579; TRAKSHEL GM, 1986, J BIOL CHEM, V261, P1131; TRAKSHEL GM, 1986, ARCH BIOCHEM BIOPHYS, V251, P175, DOI 10.1016/0003-9861(86)90064-0; Treanor B, 2005, J MICROSC-OXFORD, V217, P36, DOI 10.1111/j.0022-2720.2005.01430.x; Tregidgo C, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937212; Videira MAM, 2018, MOL MICROBIOL, V109, P385, DOI 10.1111/mmi.14060; Wang MC, 2015, PROTEOMICS, V15, P3163, DOI 10.1002/pmic.201400441; Wegiel B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00047; WESTALL JC, 1976, ABSTR PAP AM CHEM S, V172, P8; YAMAMOTO M, 1982, BIOCHEM BIOPH RES CO, V105, P985, DOI 10.1016/0006-291X(82)91067-1; YAMAMOTO M, 1983, BIOCHEM BIOPH RES CO, V115, P225, DOI 10.1016/0006-291X(83)90993-2; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Yoshida T, 2000, J INORG BIOCHEM, V82, P33, DOI 10.1016/S0162-0134(00)00156-2; Yuan XJ, 2016, P NATL ACAD SCI USA, V113, pE5144, DOI 10.1073/pnas.1609865113; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; Zhang L, 1998, MOL CELL BIOL, V18, P3819, DOI 10.1128/MCB.18.7.3819; Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431	113	3	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101549	10.1016/j.jbc.2021.101549	http://dx.doi.org/10.1016/j.jbc.2021.101549			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1QM	34973332	gold, Green Published			2022-12-26	WOS:000761402800002
J	Liu, JL; Yu, LD; Castro, L; Yan, YT; Clayton, NP; Bushel, P; Flagler, ND; Scappini, E; Dixon, D				Liu, Jingli; Yu, Linda; Castro, Lysandra; Yan, Yitang; Clayton, Natasha P.; Bushel, Pierre; Flagler, Norris D.; Scappini, Erica; Dixon, Darlene			Short-term tetrabromobisphenol A exposure promotes fibrosis of human uterine fibroid cells in a 3D culture system through TGF-beta signaling	FASEB JOURNAL			English	Article						extracellular matrix; fibrosis; tetrabromobisphenol A; TGFB; uterine fibroid	BROMINATED FLAME-RETARDANTS; BISPHENOL-A; TOXICOKINETICS; INDUCTION; LEIOMYOMA; RATS	Tetrabromobisphenol A (TBBPA), a derivative of BPA, is a ubiquitous environmental contaminant with weak estrogenic properties. In women, uterine fibroids are highly prevalent estrogen-responsive tumors often with excessive accumulation of extracellular matrix (ECM) and may be the target of environmental estrogens. We have found that BPA has profibrotic effects in vitro, in addition to previous reports of the in vivo fibrotic effects of BPA in mouse uterus. However, the role of TBBPA in fibrosis is unclear. To investigate the effects of TBBPA on uterine fibrosis, we developed a 3D human uterine leiomyoma (ht-UtLM) spheroid culture model. Cell proliferation was evaluated in 3D ht-UtLM spheroids following TBBPA (10(-6)-200 mu M) administration at 48 h. Fibrosis was assessed using a Masson's Trichrome stain and light microscopy at 7 days of TBBPA (10(-3) mu M) treatment. Differential expression of ECM and fibrosis genes were determined using RT2 Profiler (TM) PCR arrays. Network and pathway analyses were conducted using Ingenuity Pathway Analysis. The activation of pathway proteins was analyzed by a transforming growth factor-beta (TGFB) protein array. We found that TBBPA increased cell proliferation and promoted fibrosis in 3D ht-UtLM spheroids with increased deposition of collagens. TBBPA upregulated the expression of profibrotic genes and corresponding proteins associated with the TGFB pathway. TBBPA activated TGFB signaling through phosphorylation of TGFBR1 and downstream effectors-small mothers against decapentaplegic -2 and -3 proteins (SMAD2 and SMAD3). The 3D ht-UtLM spheroid model is an effective system for studying environmental agents on human uterine fibrosis. TBBPA can promote fibrosis in uterine fibroid through TGFB/SMAD signaling.	[Liu, Jingli; Yu, Linda; Castro, Lysandra; Yan, Yitang; Dixon, Darlene] NIEHS, Div Natl Toxicol Program DNTP, Mechanist Toxicol Branch MTB, NIH, Res Triangle Pk, NC 27709 USA; [Clayton, Natasha P.; Flagler, Norris D.] NIEHS, Cellular & Mol Pathogenesis Branch, DNTP, NIH, Res Triangle Pk, NC 27709 USA; [Bushel, Pierre] NIEHS, Biostat & Computat Biol Branch, Div Intramural Res DIR, NIH, Res Triangle Pk, NC 27709 USA; [Scappini, Erica] NIEHS, Signal Transduct Lab, DIR, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dixon, D (corresponding author), NIEHS, Mol Pathogenesis Grp, MTB, NIH, 111 TW Alexander Dr,Bldg 101,South Campus, Res Triangle Pk, NC 27709 USA.	dixon@niehs.nih.gov	Liu, Jingli/ABU-8123-2022; Liu, Jingli/GQH-2490-2022		HHS | National Institutes of Health (NIH) [ES021196--27]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: ES021196--27	Abdallah MA, 2016, ENVIRON INT, V94, P235, DOI 10.1016/j.envint.2016.05.026; Akiyama E, 2015, ENVIRON RES, V140, P157, DOI 10.1016/j.envres.2015.03.035; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bastos PM, 2008, CHEMOSPHERE, V70, P1196, DOI 10.1016/j.chemosphere.2007.08.019; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Ciebiera M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112435; Clayton NP, 2018, TOXICOL PATHOL, V46, P653, DOI 10.1177/0192623318789069; Debenest T, 2010, COMP BIOCHEM PHYS C, V152, P407, DOI 10.1016/j.cbpc.2010.06.009; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dunnick JK, 2015, TOXICOL PATHOL, V43, P464, DOI 10.1177/0192623314557335; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Elswefy SES, 2016, INT J EXP PATHOL, V97, P369, DOI 10.1111/iep.12207; Evans P, 2007, AM FAM PHYSICIAN, V75, P1503; Farini A, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00403; Fini JB, 2012, TOXICOL SCI, V125, P359, DOI 10.1093/toxsci/kfr312; Flake GP, 2018, CURR OBSTET GYNECOL, V7, P97, DOI 10.1007/s13669-018-0241-7; Flake GP, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/285103; Frangogiannis NG, 2020, J EXP MED, V217, DOI 10.1084/jem.20190103; Gyorfi AH, 2018, MATRIX BIOL, V68-69, P8, DOI 10.1016/j.matbio.2017.12.016; Hakk H, 2003, ENVIRON INT, V29, P801, DOI 10.1016/S0160-4120(03)00109-0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Howard PH, 2013, ENVIRON SCI TECHNOL, V47, P5259, DOI 10.1021/es4004075; Hu YY, 2016, TOXICOL LETT, V250, P1, DOI 10.1016/j.toxlet.2016.03.008; Kendziorski JA, 2015, REPROD TOXICOL, V58, P119, DOI 10.1016/j.reprotox.2015.08.001; Kicinski M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-86; Kim UJ, 2014, ENVIRON POLLUT, V184, P193, DOI 10.1016/j.envpol.2013.08.034; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; Knudsen GA, 2014, TOXICOL REP, V1, P214, DOI 10.1016/j.toxrep.2014.03.005; Li J, 2010, TOXICOL IN VITRO, V24, P201, DOI 10.1016/j.tiv.2009.09.008; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lyche JL, 2015, ENVIRON INT, V74, P170, DOI 10.1016/j.envint.2014.09.006; McCormick JM, 2010, AQUAT TOXICOL, V100, P255, DOI 10.1016/j.aquatox.2010.07.019; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Newbold RR, 2007, REPROD TOXICOL, V24, P253, DOI 10.1016/j.reprotox.2007.07.006; NTP, TECHN REP TOX STUD T; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Samuelsen M, 2001, CELL BIOL TOXICOL, V17, P139, DOI 10.1023/A:1011974012602; Schauer UMD, 2006, TOXICOL SCI, V91, P49, DOI 10.1093/toxsci/kfj132; Song KH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.10.33; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; Xie J, 2018, LAB INVEST, V98, P1575, DOI 10.1038/s41374-018-0117-5; Yoshida K, 2018, CANCERS, V10, DOI 10.3390/cancers10060183; Yu YJ, 2019, ENVIRON POLLUT, V253, P909, DOI 10.1016/j.envpol.2019.07.067; Yu YJ, 2016, CHEMOSPHERE, V146, P189, DOI 10.1016/j.chemosphere.2015.12.027	45	0	0	8	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22101	10.1096/fj.202101262R	http://dx.doi.org/10.1096/fj.202101262R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032343	Green Published			2022-12-26	WOS:000747987800007
J	Ren, LY; Zeng, FC; Deng, JZ; Bai, Y; Chen, K; Chen, L; Sun, L				Ren, Lingyan; Zeng, Fanchun; Deng, Jiezhong; Bai, Yun; Chen, Kun; Chen, Long; Sun, Li			Inflammatory osteoclasts-derived exosomes promote bone formation by selectively transferring lncRNA LIOCE into osteoblasts to interact with and stabilize Osterix	FASEB JOURNAL			English	Article						exosomes; inflammatory osteoclasts; lncRNA; osteoblasts	BIOLOGY; CELLS	Bone loss is a hallmark of inflammatory bone diseases caused by aberrantly activated osteoclasts (OCLs). Studies have shown that OCLs exhibit various phenotypes and functions due to variations in the source(s) of precursor cells, cytokine expressions, and microenvironment-dependent factors. During these conditions, inflammatory osteoclasts (iOCLs) lose their immune-suppressive effect relative to OCLs under physiological conditions. This induces TNF alpha-producing CD4(+) T cells in an antigen-dependent manner and finally leads to cascade amplification of iOCLs. OCL-derived exosomes have been reported to regulate OCL formation and inhibit the osteoblast activity. However, the specific function and mechanism of iOCL-derived exosomes on osteoblast have not been studied yet. In the present study, we compare the osteoblast promoting activities of iOCL-derived exosomes and OCL-derived exosomes. We found that iOCLs exosomes specifically target osteoblasts through ephrinA2/EphA2. Mechanistically, the lncRNA LIOCE is enriched in iOCL exosomes and promotes the osteoblast activity after being incorporated into osteoblasts. Furthermore, our results revealed that exosomal lncRNA LIOCE stabilizes osteogenic transcription factor Osterix by interacting and reducing the ubiquitination level of Osterix. This study demonstrated that the bone loss is alleviated in the inflammatory osteolysis mice model after injection of iOCL exosomes encapsulating lncRNA LIOCE. The role of exosomes encapsulating lncRNA LIOCE in promoting bone formation was well established in the rat bone repair model. Our results indicate that iOCL-derived exosomal lncRNA LIOCE promotes bone formation by upregulating Osx expression, and thus, the exosomes encapsulating lncRNA LIOCE may be an effective strategy to increase bone formation in osteoporosis and other bone metabolic disorders.	[Ren, Lingyan; Sun, Li] Guizhou Univ, Med Coll, Guiyang 550025, Peoples R China; [Ren, Lingyan; Chen, Long; Sun, Li] Guizhou Prov Peoples Hosp, Dept Orthoped, Guiyang, Peoples R China; [Ren, Lingyan] Guizhou Prov Peoples Hosp, Antenatal Diag Ctr, Guiyang, Peoples R China; [Zeng, Fanchun] Chongqing Univ, Bioengn Coll, Chongqing, Peoples R China; [Deng, Jiezhong; Bai, Yun] Army Med Univ, Southwest Hosp, Dept Orthoped Surg, Mil Med Univ 3, Chongqing, Peoples R China; [Chen, Kun] Guizhou Prov Peoples Hosp, Ctr Lab, Guiyang, Peoples R China	Guizhou University; Chongqing University; Army Medical University	Sun, L (corresponding author), Guizhou Univ, Med Coll, Guiyang 550025, Peoples R China.	lisun@gzu.edu.cn			Nature Science Foundation of China [81960401]; Basic Research Plan of Guizhou Province [[2019]1429, [2021]394]; NHC Key Laboratory of Pulmonary Immunological Diseases; Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences [2019PT320003]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Plan of Guizhou Province; NHC Key Laboratory of Pulmonary Immunological Diseases; Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences	This work was funded by grants from the Nature Science Foundation of China (81960401), Basic Research Plan of Guizhou Province ([2019]1429) ([2021]394), and NHC Key Laboratory of Pulmonary Immunological Diseases. This work was also supported by the Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences (2019PT320003)	Alves CH, 2016, CLIN REV ALLERG IMMU, V51, P27, DOI 10.1007/s12016-015-8522-7; Baassiri A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041398; Buchwald ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038199; Chen Z, 2019, NAT REV RHEUMATOL, V15, P9, DOI 10.1038/s41584-018-0109-2; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Cully M, 2021, NAT REV DRUG DISCOV, V20, P6, DOI 10.1038/d41573-020-00220-y; Dai JJ, 2020, AM J PHYSIOL-CELL PH, V319, pC21, DOI 10.1152/ajpcell.00039.2020; Dou C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21499; Drissi H, 2016, J CELL BIOCHEM, V117, P1753, DOI 10.1002/jcb.25560; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; He CJ, 2018, THERANOSTICS, V8, P237, DOI 10.7150/thno.21945; Ibanez L, 2016, J BONE MINER RES, V31, P1899, DOI 10.1002/jbmr.2868; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kiesel JR, 2009, J IMMUNOL, V182, P5477, DOI 10.4049/jimmunol.0803897; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Li Y, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0080-7; Liang LY, 2019, ONCOGENE, V38, P6567, DOI 10.1038/s41388-019-0931-2; Liu WJ, 2020, J CELL MOL MED, V24, P9786, DOI 10.1111/jcmm.15560; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Ma QY, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12068; Madel MB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01408; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Oryan A, 2015, BIOMED ENVIRON SCI, V28, P57, DOI 10.3967/bes2015.006; Park SY, 2020, BLOOD, V135, P2071, DOI 10.1182/blood.2019002227; Patil S, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.584118; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Speziani C, 2007, EUR J IMMUNOL, V37, P747, DOI 10.1002/eji.200636534; Sun WJ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.15; Sun Y, 2019, NAT METAB, V1, P485, DOI 10.1038/s42255-019-0053-8; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Wakkach A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00640; Xiao YL, 2015, STEM CELL REP, V4, P984, DOI 10.1016/j.stemcr.2015.04.012; Yang JX, 2020, CELL SIGNAL, V70, DOI 10.1016/j.cellsig.2019.109504; Yousefi H, 2020, ONCOGENE, V39, P953, DOI 10.1038/s41388-019-1040-y; Yu LJ, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12056; Yuan FL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00628	39	3	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22115	10.1096/fj.202101106RR	http://dx.doi.org/10.1096/fj.202101106RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032415	hybrid			2022-12-26	WOS:000747987800014
J	Nakatoh, T; Osaki, T; Tanimoto, S; Jahan, MGS; Kawakami, T; Chihara, K; Sakai, N; Yumura, S				Nakatoh, Tsukasa; Osaki, Takuji; Tanimoto, Sohma; Jahan, Md Golam Sarowar; Kawakami, Tomohisa; Chihara, Kentaro; Sakai, Nobuyuki; Yumura, Shigehiko			Cell behaviors within a confined adhesive area fabricated using novel micropatterning methods	PLOS ONE			English	Article							DICTYOSTELIUM CELLS; DYNAMICS; MIGRATION; CULTURE; TOOL	In the field of cell and tissue engineering, there is an increasing demand for techniques to spatially control the adhesion of cells to substrates of desired sizes and shapes. Here, we describe two novel methods for fabricating a substrate for adhesion of cells to a defined area. In the first method, the surface of the coverslip or plastic dish was coated with Lipidure, a non-adhesive coating material, and air plasma was applied through a mask with holes, to confer adhesiveness to the surface. In the second method, after the surface of the coverslip was coated with gold by sputtering and then with Lipidure; the Lipidure coat was locally removed using a novel scanning laser ablation method. These methods efficiently confined cells within the adhesive area and enabled us to follow individual cells for a longer duration, compared to the currently available commercial substrates. By following single cells within the confined area, we were able to observe several new aspects of cell behavior in terms of cell division, cell-cell collisions, and cell collision with the boundary between adhesive and non-adhesive areas.	[Nakatoh, Tsukasa; Tanimoto, Sohma; Jahan, Md Golam Sarowar; Sakai, Nobuyuki; Yumura, Shigehiko] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan; [Osaki, Takuji; Kawakami, Tomohisa; Chihara, Kentaro] Shoyo Sangyo Co Ltd, Chuo Ku, Osaka, Japan; [Jahan, Md Golam Sarowar] Univ Rajshahi, Dept Biochem & Mol Biol, Rajshahi, Bangladesh	Yamaguchi University; University of Rajshahi	Yumura, S (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan.	yumura@yamaguchi-u.ac.jp		Yumura, Shigehiko/0000-0001-8249-0100; Jahan, Sarowar/0000-0002-5740-9726				ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Allen GM, 2020, CELL SYST, V11, P286, DOI 10.1016/j.cels.2020.08.008; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Belotti Yuri, 2021, Communicative & Integrative Biology, V14, P5, DOI 10.1080/19420889.2021.1872917; Bhatia SN, 1999, BIOMED MICRODEVICES, V2, P131, DOI 10.1023/A:1009949704750; Bruckner DB, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016602118; CARTER SB, 1967, EXP CELL RES, V48, P189, DOI 10.1016/0014-4827(67)90298-4; Delince MJ, 2016, LAB CHIP, V16, P3276, DOI 10.1039/c6lc00649c; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; HARRIS A, 1973, EXP CELL RES, V77, P285, DOI 10.1016/0014-4827(73)90579-X; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Jahan MGS, 2017, EUR J CELL BIOL, V96, P515, DOI 10.1016/j.ejcb.2017.06.004; Jeon H, 2014, J BIOMED MATER RES B, V102, P1580, DOI 10.1002/jbm.b.33158; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Karmakar R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236171; Khalili AA, 2015, INT J MOL SCI, V16, P18149, DOI 10.3390/ijms160818149; KLEINFELD D, 1988, J NEUROSCI, V8, P4098; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Li D, 2018, P NATL ACAD SCI USA, V115, P10678, DOI 10.1073/pnas.1807543115; Lober J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09172; Masters T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044261; Mohammed D, 2019, NAT PHYS, V15, P858, DOI 10.1038/s41567-019-0543-3; Oakes PW, 2018, P NATL ACAD SCI USA, V115, P2646, DOI 10.1073/pnas.1715869115; Pervin S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39678-1; Pervin S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26337-0; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Ricoult SG, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00040; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e; Ruprecht V, 2017, J CELL SCI, V130, P51, DOI 10.1242/jcs.196162; Schreiber C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2009959118; Taira R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17477-w; Talukder MSU, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041058; Tanaka Y, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050473; Tanvir MIO, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051229; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Thery Manuel, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5255; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; To Y, 2007, ACTA BIOMATER, V3, P1024, DOI 10.1016/j.actbio.2007.05.010; Tschumperlin DJ, 2013, PHYSIOLOGY, V28, P380, DOI 10.1152/physiol.00024.2013; Uchida KSK, 2004, J CELL SCI, V117, P1443, DOI 10.1242/jcs.01015; Vignaud T, 2012, J CELL SCI, V125, P2134, DOI 10.1242/jcs.104901; Welle A, 2002, BIOMED MICRODEVICES, V4, P33, DOI 10.1023/A:1014267712144; Yamato M, 2003, J BIOMED MATER RES A, V67A, P1065, DOI 10.1002/jbm.a.10078; Yang KC, 2013, J BIOMED MATER RES A, V101, P2273, DOI 10.1002/jbm.a.34547; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; YUMURA S, 1995, CELL STRUCT FUNCT, V20, P185, DOI 10.1247/csf.20.185; Yumura S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22055	49	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262632	10.1371/journal.pone.0262632	http://dx.doi.org/10.1371/journal.pone.0262632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030217	Green Published, gold			2022-12-26	WOS:000812798500061
J	Wetsch, O; Strasburg, M; McQuigg, J; Boone, MD				Wetsch, Olivia; Strasburg, Miranda; McQuigg, Jessica; Boone, Michelle D.			Is overwintering mortality driving enigmatic declines? Evaluating the impacts of trematodes and the amphibian chytrid fungus on an anuran from hatching through overwintering	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; BATRACHOCHYTRIUM-DENDROBATIDIS; RANA-PIPIENS; WOOD FROG; ACRIS-BLANCHARDI; CRICKET FROGS; LEOPARD FROG; CHYTRIDIOMYCOSIS; LARVAL; PARASITE	Emerging infectious diseases are increasing globally and are an additional challenge to species dealing with native parasites and pathogens. Therefore, understanding the combined effects of infectious agents on hosts is important for species' conservation and population management. Amphibians are hosts to many parasites and pathogens, including endemic trematode flatworms (e.g., Echinostoma spp.) and the novel pathogenic amphibian chytrid fungus (Batrachochytrium dendrobatidis [Bd]). Our study examined how exposure to trematodes during larval development influenced the consequences of Bd pathogen exposure through critical life events. We found that prior exposure to trematode parasites negatively impacted metamorphosis but did not influence the effect of Bd infection on terrestrial growth and survival. Bd infection alone, however, resulted in significant mortality during overwintering-an annual occurrence for most temperate amphibians. The results of our study indicated overwintering mortality from Bd could provide an explanation for enigmatic declines and highlights the importance of examining the long-term consequences of novel parasite exposure.	[Wetsch, Olivia; Strasburg, Miranda; McQuigg, Jessica; Boone, Michelle D.] Miami Univ, Dept Biol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Wetsch, O (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	wetschoe@miamioh.edu		Strasburg, Miranda/0000-0002-9709-7595; Wetsch, Olivia/0000-0002-3126-6528	Miami University Department of Biology	Miami University Department of Biology	All authors and experimental materials were funded by Miami University Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Beasley VR, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P75; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BERVEN KA, 1981, EVOLUTION, V35, P707, DOI 10.1111/j.1558-5646.1981.tb04931.x; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; Blaustein AR, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10030081; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Burrow AK, 2017, ECOL EVOL, V7, P9196, DOI 10.1002/ece3.3255; Cabrera-Guzman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070121; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Crawford JA, 2017, J FISH WILDL MANAG, V8, P344, DOI 10.3996/012017-JFWM-003; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Davidson C, 2007, ENVIRON SCI TECHNOL, V41, P1771, DOI 10.1021/es0611947; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Ebert T.A., 1999, PLANT ANIMAL POPULAT; Ferguson LV, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163873; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; FORMANOWICZ DR, 1981, HERPETOLOGICA, V37, P125; Fried B, 1997, PARASITOL RES, V83, P666, DOI 10.1007/s004360050316; Garner TWJ, 2011, GLOBAL CHANGE BIOL, V17, P667, DOI 10.1111/j.1365-2486.2010.02272.x; GILBERT M, 1994, J HERPETOL, V28, P465, DOI 10.2307/1564959; Gosner K. L., 1960, Herpetologica, V16, P183; Hentges VA, 2010, WETLANDS, V30, P501, DOI 10.1007/s13157-010-0058-2; Hoskins TD, 2019, CHEMOSPHERE, V220, P845, DOI 10.1016/j.chemosphere.2018.12.112; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; James SM, 2003, AM SOC TEST MATER, V1443, P169, DOI 10.1520/STP11182S; Johnson Pieter T. J., 2009, P249, DOI 10.1007/978-0-387-09577-6_11; Klaus A, 2017, INT J PARASITOL-PAR, V6, P320, DOI 10.1016/j.ijppaw.2017.09.005; Koprivnikar J, 2010, ECOL APPL, V20, P2263, DOI 10.1890/09-1558.1; Koprivnikar J, 2006, CAN J ZOOL, V84, P1623, DOI 10.1139/Z06-158; KURAMOTO M, 1978, EVOLUTION, V32, P287, DOI 10.1111/j.1558-5646.1978.tb00644.x; LaFonte BE, 2013, J EXP BIOL, V216, P3700, DOI 10.1242/jeb.088104; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lehtinen Richard M., 2011, Herpetological Review, V42, P504; Leung B, 2017, DIVERS DISTRIB, V23, P1372, DOI 10.1111/ddi.12636; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Maniero GD, 1997, J COMP PHYSIOL B, V167, P256, DOI 10.1007/s003600050072; McCallum Malcolm L., 2011, Herpetology Notes, V4, P25; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Orlofske SA, 2013, COMP BIOCHEM PHYS A, V164, P529, DOI 10.1016/j.cbpa.2012.12.013; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Pearl CA, 2009, ECOHEALTH, V6, P209, DOI 10.1007/s10393-009-0237-x; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rumschlag SL, 2018, DIS AQUAT ORGAN, V131, P13, DOI 10.3354/dao03277; Rumschlag SL, 2015, HERPETOLOGICA, V71, P169, DOI 10.1655/HERPETOLOGICA-D-13-00070; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Schell, 1985, TREMATODES N AM N ME; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; SEMLITSCH RD, 1987, ECOLOGY, V68, P1003, DOI 10.2307/1938371; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Steiner Sheldon L., 2008, Herpetological Review, V39, P193; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Taylor CN, 2004, CAN J ZOOL, V82, P701, DOI [10.1139/z04-037, 10.1139/Z04-037]; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Trauth S.E., 1990, Arkansas Academy of Science Proceedings, V44, P107; Vonesh JR, 2002, OECOLOGIA, V133, P325, DOI 10.1007/s00442-002-1039-9; WILBUR HM, 1978, EVOLUTION, V32, P264, DOI 10.1111/j.1558-5646.1978.tb00642.x; Wuerthner VP, 2017, J ANIM ECOL, V86, P921, DOI 10.1111/1365-2656.12665	66	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262561	10.1371/journal.pone.0262561	http://dx.doi.org/10.1371/journal.pone.0262561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030210	gold, Green Published			2022-12-26	WOS:000812798500054
J	Alkhodari, M; Khandoker, AH				Alkhodari, Mohanad; Khandoker, Ahsan H.			Detection of COVID-19 in smartphone-based breathing recordings: A pre-screening deep learning tool	PLOS ONE			English	Article							NEURAL-NETWORKS; RESPIRATORY-DISEASES; DATA AUGMENTATION; LUNG SOUNDS; CT IMAGES; CLASSIFICATION; FRAMEWORK; TERM; DIAGNOSIS; MODEL	This study was sought to investigate the feasibility of using smartphone-based breathing sounds within a deep learning framework to discriminate between COVID-19, including asymptomatic, and healthy subjects. A total of 480 breathing sounds (240 shallow and 240 deep) were obtained from a publicly available database named Coswara. These sounds were recorded by 120 COVID-19 and 120 healthy subjects via a smartphone microphone through a website application. A deep learning framework was proposed herein that relies on hand-crafted features extracted from the original recordings and from the mel-frequency cepstral coefficients (MFCC) as well as deep-activated features learned by a combination of convolutional neural network and bi-directional long short-term memory units (CNN-BiLSTM). The statistical analysis of patient profiles has shown a significant difference (p-value: 0.041) for ischemic heart disease between COVID-19 and healthy subjects. The Analysis of the normal distribution of the combined MFCC values showed that COVID-19 subjects tended to have a distribution that is skewed more towards the right side of the zero mean (shallow: 0.59 +/- 1.74, deep: 0.65 +/- 4.35, p-value: <0.001). In addition, the proposed deep learning approach had an overall discrimination accuracy of 94.58% and 92.08% using shallow and deep recordings, respectively. Furthermore, it detected COVID-19 subjects successfully with a maximum sensitivity of 94.21%, specificity of 94.96%, and area under the receiver operating characteristic (AUROC) curves of 0.90. Among the 120 COVID-19 participants, asymptomatic subjects (18 subjects) were successfully detected with 100.00% accuracy using shallow recordings and 88.89% using deep recordings. This study paves the way towards utilizing smartphone-based breathing sounds for the purpose of COVID-19 detection. The observations found in this study were promising to suggest deep learning and smartphone-based breathing sounds as an effective pre-screening tool for COVID-19 alongside the current reverse-transcription polymerase chain reaction (RT-PCR) assay. It can be considered as an early, rapid, easily distributed, time-efficient, and almost no-cost diagnosis technique complying with social distancing restrictions during COVID-19 pandemic.	[Alkhodari, Mohanad; Khandoker, Ahsan H.] Khalifa Univ, Healthcare Engn Innovat Ctr HEIC, Dept Biomed Engn, Abu Dhabi, U Arab Emirates	Khalifa University of Science & Technology	Alkhodari, M (corresponding author), Khalifa Univ, Healthcare Engn Innovat Ctr HEIC, Dept Biomed Engn, Abu Dhabi, U Arab Emirates.	mohanad.alkhodari@ku.ac.ae		Alkhodari, Mohanad/0000-0002-5248-6327	Healthcare Engineering Innovation Center (HEIC) at Khalifa University, Abu Dhabi, UAE [8474000132]; Department of Education and Knowledge (ADEK), Abu Dhabi, UAE [29934]	Healthcare Engineering Innovation Center (HEIC) at Khalifa University, Abu Dhabi, UAE; Department of Education and Knowledge (ADEK), Abu Dhabi, UAE	This work was supported by a grant (award number: 8474000132) from the Healthcare Engineering Innovation Center (HEIC) at Khalifa University, Abu Dhabi, UAE, and by grant (award number: 29934) from the Department of Education and Knowledge (ADEK), Abu Dhabi, UAE.	Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Akram T, 2021, PATTERN ANAL APPL, V24, P951, DOI 10.1007/s10044-020-00950-0; Alkhodari M, 2021, IEEE J BIOMED HEALTH, V25, P746, DOI 10.1109/JBHI.2020.3002336; Alkhodari M, 2021, COMPUT METH PROG BIO, V200, DOI 10.1016/j.cmpb.2021.105940; Anders RL, 2021, NURS FORUM, V56, P89, DOI 10.1111/nuf.12514; Andres E, 2018, J Med Life, V11, P89; Bagad P., 2020, ARXIV PREPRINT ARXIV; Barrett KE., 2016, GANONGS REV MEDICAL; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Brown C, 2020, KDD '20: PROCEEDINGS OF THE 26TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P3474, DOI 10.1145/3394486.3412865; Campos-Taberner M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74215-5; CHATTERJEE S, 1986, COMMUN STAT THEORY, V15, P3227, DOI 10.1080/03610928608829305; Chilazi M., 2021, INTERMEDIATE LONG TE; Christian B., 2016, ALGORITHMS LIVE COMP; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Deshpande G., 2020, ARXIV PREPRINT ARXIV; Diaz-Escobar J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255886; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Faezipour M, 2020, TELEMED E-HEALTH, V26, P1202, DOI 10.1089/tmj.2020.0114; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Fraiwan L, 2021, BIOCYBERN BIOMED ENG, V41, P1, DOI [10.1016/j.bbe.2020.11.003, 10.1016/j.bbe.2020.11.0030208-5216/]; Fraiwan L, 2020, IEEE ACCESS, V8, P77255, DOI 10.1109/ACCESS.2020.2989442; Fraiwan M, 2021, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03184-y; GROENEVELD RA, 1984, STATISTICIAN, V33, P391, DOI 10.2307/2987742; Gurung A, 2011, RESP MED, V105, P1396, DOI 10.1016/j.rmed.2011.05.007; Han J, ARXIV PREPRINT ARXIV; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; HUANG Y, 2020, MEDRXIV; Hui H, 2020, MEDRXIV; Indian institute of science, PROJ COSW IISC; Jain R, 2021, APPL INTELL, V51, P1690, DOI 10.1007/s10489-020-01902-1; Jiang YF, 2021, IEEE J BIOMED HEALTH, V25, P441, DOI 10.1109/JBHI.2020.3042523; KATZ MJ, 1988, COMPUT BIOL MED, V18, P145, DOI 10.1016/0010-4825(88)90041-8; Kaushik H, 2021, CMC-COMPUT MATER CON, V69, P3459, DOI 10.32604/cmc.2021.017337; Khan MA, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21217286; Khan MA, 2021, COMPUT ELECTR ENG, V90, DOI 10.1016/j.compeleceng.2020.106960; Khasawneh N, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21175940; Laguarta J, 2020, IEEE OPEN J ENG MED, V1, P275, DOI 10.1109/OJEMB.2020.3026928; Lella KK, 2022, ALEX ENG J, V61, P1319, DOI 10.1016/j.aej.2021.06.024; Li C, 2020, IEEE J BIOMED HEALTH, V24, P3585, DOI 10.1109/JBHI.2020.3036722; Liang T, 2020, HDB COVID 19 PREVENT; Lim J, 2020, KOREAN J INTERN MED, V35, P741, DOI 10.3904/kjim.2020.257; Majid A, 2021, CMC-COMPUT MATER CON, V69, P319, DOI 10.32604/cmc.2021.016816; Mehta S, 2021, LANCET RESP MED, V9, P226, DOI 10.1016/S2213-2600(21)00068-0; Manshouri NM, 2022, COGN NEURODYNAMICS, V16, P239, DOI 10.1007/s11571-021-09695-w; Meng LW, 2020, IEEE J BIOMED HEALTH, V24, P3576, DOI 10.1109/JBHI.2020.3034296; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Mohammad-Rahimi H, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.638011; Mohammed EA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95042-2; Mouawad Pauline, 2021, SN Comput Sci, V2, P34, DOI 10.1007/s42979-020-00422-6; Nanni L, 2020, ECOL INFORM, V57, DOI 10.1016/j.ecoinf.2020.101084; Nikulin M.S., 1996, GUIDE CHI SQUARED TE, V280; Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9; Noda A, 2020, INTERNAL MED, V59, P3213, DOI 10.2169/internalmedicine.5565-20; O'Flynn-Magee K, 2021, TEACH LEARN NURS, V16, P3, DOI 10.1016/j.teln.2020.07.007; Organization WH, 2021, KUMEU COURIER; Ozkaya U., 2020, BIG DATA ANALYTICS A, P281, DOI DOI 10.1007/978-3-030-55258-9_17; Padma TV, 2021, NATURE, V592, P500, DOI 10.1038/d41586-021-00996-y; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Pramono RXA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213659; Qian N, 1999, NEURAL NETWORKS, V12, P145, DOI 10.1016/S0893-6080(98)00116-6; Quatieri TF, 2020, IEEE OPEN J ENG MED, V1, P203, DOI 10.1109/OJEMB.2020.2998051; Rabiner L.R., 2010, THEORY APPL DIGITAL; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rubin GD, 2020, CHEST, V158, P106, DOI 10.1016/j.chest.2020.04.003; Sait U, 2021, APPL SOFT COMPUT, V109, DOI 10.1016/j.asoc.2021.107522; Salamon J, 2017, IEEE SIGNAL PROC LET, V24, P279, DOI 10.1109/LSP.2017.2657381; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma N, 2020, INTERSPEECH, P4811, DOI 10.21437/Interspeech.2020-2768; Shi LK, 2019, IEEE ACCESS, V7, P139438, DOI 10.1109/ACCESS.2019.2943492; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Shuvo SB, 2021, IEEE J BIOMED HEALTH, V25, P2595, DOI 10.1109/JBHI.2020.3048006; Wang B, 2020, RESPIRATION, V99, P755, DOI 10.1159/000509610; Wang LD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76550-z; Wang SH, 2022, CMC-COMPUT MATER CON, V70, P2797, DOI 10.32604/cmc.2022.020140; Wang XG, 2020, IEEE T MED IMAGING, V39, P2615, DOI 10.1109/TMI.2020.2995965; WHO, 2019, REP WHO CHIN JOINT M; World Health Organization, REP WHO CHIN JOINT M; World Health Organization, COVID 19 WEEKL EP UP; Wu DF, 2020, IEEE J BIOMED HEALTH, V24, P3529, DOI 10.1109/JBHI.2020.3030224; Zhang NR, 2020, J MED VIROL, V92, P408, DOI 10.1002/jmv.25674; Zhang YD, 2021, CMC-COMPUT MATER CON, V69, P3145, DOI 10.32604/cmc.2021.018040; Zhao WT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93832-2; Zheng F, 2001, J COMPUT SCI TECHNOL, V16, P582, DOI 10.1007/BF02943243	87	8	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262448	10.1371/journal.pone.0262448	http://dx.doi.org/10.1371/journal.pone.0262448			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025945	Green Published, gold			2022-12-26	WOS:000796264200070
J	Athamneh, K; Alneyadi, A; Alsadik, A; Wong, TS; Ashraf, SS				Athamneh, Khawlah; Alneyadi, Aysha; Alsadik, Aya; Wong, Tuck Seng; Ashraf, Syed Salman			Efficient degradation of various emerging pollutants by wild type and evolved fungal DyP4 peroxidases	PLOS ONE			English	Article							DYE-DECOLORIZING PEROXIDASE; PHOTOCATALYTIC ACTIVITY; WASTE-WATER; 2-MERCAPTOBENZOTHIAZOLE; PHOTODEGRADATION; G-C3N4; REMOVAL; MICROPOLLUTANTS; IDENTIFICATION; FABRICATION	The accumulation of emerging pollutants in the environment remains a major concern as evidenced by the increasing number of reports citing their potential risk on environment and health. Hence, removal strategies of such pollutants remain an active area of investigation. One way through which emerging pollutants can be eliminated from the environment is by enzyme-mediated bioremediation. Enzyme-based degradation can be further enhanced via advanced protein engineering approaches. In the present study a sensitive and robust bioanalytical liquid chromatography-tandem mass spectrometry (LCMSMS)-based approach was used to investigate the ability of a fungal dye decolorizing peroxidase 4 (DyP4) and two of its evolved variants-that were previously shown to be H2O2 tolerant-to degrade a panel of 15 different emerging pollutants. Additionally, the role of a redox mediator was examined in these enzymatic degradation reactions. Our results show that three emerging pollutants (2-mercaptobenzothiazole (MBT), paracetamol, and furosemide) were efficiently degraded by DyP4. Addition of the redox mediator had a synergistic effect as it enabled complete degradation of three more emerging pollutants (methyl paraben, sulfamethoxazole and salicylic acid) and dramatically reduced the time needed for the complete degradation of MBT, paracetamol, and furosemide. Further investigation was carried out using pure MBT to study its degradation by DyP4. Five potential transformation products were generated during the enzymatic degradation of MBT, which were previously reported to be produced during different bioremediation approaches. The current study provides the first instance of the application of fungal DyP4 peroxidases in bioremediation of emerging pollutants.	[Athamneh, Khawlah; Alsadik, Aya; Ashraf, Syed Salman] Khalifa Univ, Dept Biol, Coll Arts & Sci, Abu Dhabi, U Arab Emirates; [Alneyadi, Aysha] UAE Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates; [Wong, Tuck Seng] Univ Sheffield, Dept Chem & Biol Engn, Sir Robert Hadfield Bldg, Sheffield, S Yorkshire, England; [Wong, Tuck Seng] Univ Sheffield, Adv Biomfg Ctr, Sir Robert Hadfield Bldg, Sheffield, S Yorkshire, England; [Wong, Tuck Seng] Natl Ctr Genet Engn & Biotechnol, Khlong Luang, Pathum Thani, Thailand; [Ashraf, Syed Salman] Khalifa Univ Sci & Technol, Ctr Biotechnol BTC, Abu Dhabi, U Arab Emirates	Khalifa University of Science & Technology; United Arab Emirates University; University of Sheffield; University of Sheffield; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Khalifa University of Science & Technology	Ashraf, SS (corresponding author), Khalifa Univ, Dept Biol, Coll Arts & Sci, Abu Dhabi, U Arab Emirates.; Ashraf, SS (corresponding author), Khalifa Univ Sci & Technol, Ctr Biotechnol BTC, Abu Dhabi, U Arab Emirates.	syed.ashraf@ku.ac.ae		Wong, Tuck Seng/0000-0001-7689-9057; Alsadik, Aya/0000-0003-4195-4735	Khalifa University [CIRA-2020-046, FSU-2019-09]; EPSRC [EP/E036252/1]; Open Project Funding of the State Key Laboratory of Bioreactor Engineering; Royal Academy of Engineering (the Leverhulme Trust Senior Research Fellowship) [LTSRF1819\15\21]; NSTDA Visiting Professorship	Khalifa University; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Open Project Funding of the State Key Laboratory of Bioreactor Engineering; Royal Academy of Engineering (the Leverhulme Trust Senior Research Fellowship); NSTDA Visiting Professorship	Generous support (CIRA-2020-046 and FSU-2019-09) to SSA from Khalifa University is graciously acknowledged. We also thank EPSRC (EP/E036252/1), the Open Project Funding of the State Key Laboratory of Bioreactor Engineering (to TSW), the Royal Academy of Engineering (the Leverhulme Trust Senior Research Fellowship; to TSW; LTSRF1819\15\21) and the NSTDA Visiting Professorship (to TSW) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessa AHA, 2019, BIORESOUR BIOPROCESS, V6, DOI 10.1186/s40643-019-0255-7; Allaoui A, 2010, J PHOTOCH PHOTOBIO A, V212, P153, DOI 10.1016/j.jphotochem.2010.04.010; Almaqdi KA, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-019-0574-y; Alneyadi AH, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010031; Alneyadi AH, 2016, CHEM ENG J, V303, P529, DOI 10.1016/j.cej.2016.06.017; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bilal M, 2019, ENVIRON INT, V124, P336, DOI 10.1016/j.envint.2019.01.011; Catucci G, 2020, BIOTECHNOL APPL BIOC, V67, P751, DOI 10.1002/bab.2015; Colpa DI, 2014, J IND MICROBIOL BIOT, V41, P1, DOI 10.1007/s10295-013-1371-6; de Eugenio LI, 2021, J FUNGI, V7, DOI 10.3390/jof7050325; DeWever H, 1997, ENVIRON TOXICOL CHEM, V16, P843, DOI 10.1002/etc.5620160502; Dong HH, 2018, COMPOS SCI TECHNOL, V164, P267, DOI 10.1016/j.compscitech.2018.05.047; Duan ZH, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0648-6; Engels H.W., 2011, ULLMANNS ENCY IND CH, DOI DOI 10.1002/14356007.A23_365.PUB3; Esmaile N, 2022, INT J ENVIRON AN CH, V102, P4019, DOI 10.1080/03067319.2020.1779241; Feng GQ, 2021, J HAZARD MATER, V420, DOI 10.1016/j.jhazmat.2021.126602; Fernandez-Fueyo E, 2015, APPL MICROBIOL BIOT, V99, P8927, DOI 10.1007/s00253-015-6665-3; Fiehn O, 1998, WATER RES, V32, P1075, DOI 10.1016/S0043-1354(97)00332-1; Gavrilescu M, 2015, NEW BIOTECHNOL, V32, P147, DOI 10.1016/j.nbt.2014.01.001; Gomes IB, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-00086-y; Grabarczyk L, 2020, ENVIRON SCI POLLUT R, V27, P26103, DOI 10.1007/s11356-020-08881-3; Haroune N, 2004, APPL ENVIRON MICROB, V70, P6315, DOI 10.1128/AEM.70.10.6315-6319.2004; Husain M, 2008, CRIT REV ENV SCI TEC, V38, P1, DOI 10.1080/10643380701501213; San-Martin MI, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.139155; Jiang P, 2021, WATER RES, V188, DOI 10.1016/j.watres.2020.116542; Kanaujiya DK, 2019, CURR POLLUT REP, V5, P112, DOI 10.1007/s40726-019-00110-x; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; Kotthoff L, 2019, MOLECULES, V24, DOI 10.3390/molecules24040753; Lauber C, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0463-5; LeFevre GH, 2016, ENVIRON SCI TECHNOL, V50, P6762, DOI 10.1021/acs.est.5b04716; Li R, 2022, CHEM ENG J, V427, DOI 10.1016/j.cej.2021.131458; Liao CY, 2018, ENVIRON SCI TECHNOL, V52, P5007, DOI 10.1021/acs.est.7b05493; Mead JA, 2009, MOL CELL PROTEOMICS, V8, P696, DOI 10.1074/mcp.M800192-MCP200; Miguez L, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111646; Morsi R, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11060904; Morsi R, 2020, SCI TOTAL ENVIRON, V714, DOI 10.1016/j.scitotenv.2020.136572; Ofrydopoulou A, 2022, SCI TOTAL ENVIRON, V802, DOI 10.1016/j.scitotenv.2021.149860; Patel M, 2019, CHEM REV, V119, P3510, DOI 10.1021/acs.chemrev.8b00299; Qin YY, 2019, APPL SURF SCI, V481, P1313, DOI 10.1016/j.apsusc.2019.03.244; Rajhans G, 2020, J APPL MICROBIOL, V129, P1633, DOI 10.1111/jam.14731; Redouane-Salah Z, 2018, J ENVIRON CHEM ENG, V6, P1783, DOI 10.1016/j.jece.2018.02.011; Robinson PK, 2015, ESSAYS BIOCHEM, V59, P1, DOI [10.1042/bse0590001, 10.1042/BSE0590001]; Saez-Jimenez V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124750; Savelli B, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101247; Serdechnova M, 2014, PHYS CHEM CHEM PHYS, V16, P25152, DOI 10.1039/c4cp03867c; Sorahan T, 2009, OCCUP ENVIRON MED, V66, P269, DOI 10.1136/oem.2008.041400; Teodosiu C, 2018, J CLEAN PROD, V197, P1210, DOI 10.1016/j.jclepro.2018.06.247; Umamaheswari B, 2017, J HAZARD MATER, V321, P773, DOI 10.1016/j.jhazmat.2016.09.061; Vasilachi IC, 2021, WATER-SUI, V13, DOI 10.3390/w13020181; Yu XN, 2020, NEW J CHEM, V44, P15908, DOI 10.1039/d0nj04057f; Zajickova Z, 2008, J HETEROCYCLIC CHEM, V45, P303, DOI 10.1002/jhet.5570450201; Zhou MJ, 2021, CHEMOSPHERE, V268, DOI 10.1016/j.chemosphere.2020.128839; Zhu Z, 2018, J PHOTOCH PHOTOBIO A, V358, P284, DOI 10.1016/j.jphotochem.2018.03.027; Zhu Z, 2017, ACS SUSTAIN CHEM ENG, V5, P10614, DOI 10.1021/acssuschemeng.7b02595; Zhu Z, 2015, RSC ADV, V5, P40726, DOI 10.1039/c5ra06209h	55	3	3	11	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262492	10.1371/journal.pone.0262492	http://dx.doi.org/10.1371/journal.pone.0262492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025977	Green Accepted, gold, Green Published			2022-12-26	WOS:000796264200075
J	Horton, MK; McCurdy, S; Shao, X; Bellesis, K; Chinn, T; Schaefer, C; Barcellos, LF				Horton, Mary K.; McCurdy, Shannon; Shao, Xiaorong; Bellesis, Kalliope; Chinn, Terrence; Schaefer, Catherine; Barcellos, Lisa F.			Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY; LIFE-EVENTS; DISEASES	Background Adverse childhood experiences (ACEs) are linked to numerous health conditions but understudied in multiple sclerosis (MS). This study's objective was to test for the association between ACEs and MS risk and several clinical outcomes. Methods We used a sample of adult, non-Hispanic MS cases (n = 1422) and controls (n = 1185) from Northern California. Eighteen ACEs were assessed including parent divorce, parent death, and abuse. Outcomes included MS risk, age of MS onset, Multiple Sclerosis Severity Scale score, and use of a walking aid. Logistic and linear regression estimated odds ratios (ORs) (and beta coefficients) and 95% confidence intervals (CIs) for ACEs operationalized as any/none, counts, individual events, and latent factors/patterns. Results Overall, more MS cases experienced >= 1 ACE compared to controls (54.5% and 53.8%, respectively). After adjusting for sex, birthyear, and race, this small difference was attenuated (OR = 1.01, 95% CI: 0.87, 1.18). There were no trends of increasing or decreasing odds of MS across ACE count categories. Consistent associations between individual ACEs between ages 0-10 and 11-20 years and MS risk were not detected. Factor analysis identified five latent ACE factors, but their associations with MS risk were approximately null. Age of MS onset and other clinical outcomes were not associated with ACEs after multiple testing correction. Conclusion Despite rich data and multiple approaches to operationalizing ACEs, no consistent and statistically significant effects were observed between ACEs with MS. This highlights the challenges of studying sensitive, retrospective events among adults that occurred decades before data collection.	[Horton, Mary K.; Shao, Xiaorong; Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA; [Horton, Mary K.; Barcellos, Lisa F.] Univ Calif Berkeley, Computat Biol Grad Grp, Berkeley, CA 94720 USA; [McCurdy, Shannon] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Bellesis, Kalliope; Chinn, Terrence; Schaefer, Catherine] Kaiser Permanente Div Res, Oakland, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Kaiser Permanente	Horton, MK (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA.; Horton, MK (corresponding author), Univ Calif Berkeley, Computat Biol Grad Grp, Berkeley, CA 94720 USA.	mary.horton@berkeley.edu		Horton, Mary/0000-0002-0854-4219	National Institute of Neurological Disorders and Stroke [R01 NS 049510, F31 NS 108668]; National Institute of Allergy and Infectious Diseases [R01 AI 076544]; National Institute of Environmental Health Sciences [R01 ES 017080]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Neurological Disorders and Stroke [grant numbers R01 NS 049510 to L.F.B. and F31 NS 108668 to M.K.H.] (https://www.ninds.nih.gov/); the National Institute of Allergy and Infectious Diseases [grant number R01 AI 076544 to L.F.B.] (https://www.niaid.nih.gov/); and National Institute of Environmental Health Sciences [grant number R01 ES 017080 to L.F.B.] (https://www.niehs.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ATLAS MS 2013 MAPPIN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bick J, 2012, DEV PSYCHOPATHOL, V24, P1417, DOI 10.1017/S0954579412000806; Briggs FBS, 2014, J EPIDEMIOL COMMUN H, V68, P622, DOI 10.1136/jech-2013-203184; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Castagne R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25170; CODDINGTON RD, 1972, J PSYCHOSOM RES, V16, P7, DOI 10.1016/0022-3999(72)90018-9; Danese A, 2017, ANNU REV PSYCHOL, V68, P517, DOI 10.1146/annurev-psych-010416-044208; DeQuattro K, 2020, ARTHRIT CARE RES, V72, P525, DOI 10.1002/acr.23878; Dube SR, 2009, PSYCHOSOM MED, V71, P243, DOI 10.1097/PSY.0b013e3181907888; Feldman CH, 2019, J RHEUMATOL, V46, P1589, DOI 10.3899/jrheum.190009; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Giano Z, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09411-z; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; Jordan M., 2006, PATTERN RECOGN, DOI [10.1641/B580519, DOI 10.1641/B580519]; Kenealy PM, 2002, J INT NEUROPSYCH SOC, V8, P855, DOI 10.1017/S1355617702860143; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; Merrick MT, 2018, JAMA PEDIATR, V172, P1038, DOI 10.1001/jamapediatrics.2018.2537; Montgomery S, 2017, ANN NEUROL, V82, P554, DOI 10.1002/ana.25036; Morris G, 2019, MOL NEUROBIOL, V56, P5866, DOI 10.1007/s12035-019-1498-1; Muller S, 2013, MULT SCLER J, V19, P225, DOI 10.1177/1352458512450352; Nielsen NM, 2014, MULT SCLER J, V20, P1609, DOI 10.1177/1352458514528761; Nielsen NM, 2005, AM J EPIDEMIOL, V162, P774, DOI 10.1093/aje/kwi280; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; R Core Team, 2018, R LANG ENV STAT COMP; Raiche G, 2013, METHODOLOGY-EUR, V9, P23, DOI 10.1027/1614-2241/a000051; Rhead B, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000097; Riise T, 2011, NEUROLOGY, V76, P1866, DOI 10.1212/WNL.0b013e31821d74c5; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Shaw MT, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00242; Spitzer C, 2012, PSYCHOSOM MED, V74, P312, DOI 10.1097/PSY.0b013e31824c2013; Turney K, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1118; Ventura RE, 2017, MULT SCLER J, V23, P1554, DOI 10.1177/1352458516679894	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262093	10.1371/journal.pone.0262093	http://dx.doi.org/10.1371/journal.pone.0262093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025951	gold, Green Published			2022-12-26	WOS:000796264200043
J	Pradhan, U; Oofuvong, M; Karnjanawanichkul, O; Pakpirom, J				Pradhan, Ujal; Oofuvong, Maliwan; Karnjanawanichkul, Orarat; Pakpirom, Jatuporn			Risk predictive tools of perioperative drug hypersensitivity reaction: A case-control study	PLOS ONE			English	Article							ALLERGIC REACTIONS; ANAPHYLAXIS; ANESTHESIA; EPIDEMIOLOGY; GUIDELINES; DIAGNOSIS	Objective We aimed to determine the risk factors of perioperative drug hypersensitivity reaction (DHR) and develop a predictive score for use in clinical practice. Methods A case-control study was conducted in patients who underwent anesthesia at a tertiary hospital in Thailand, between 2015-2018. DHR cases were graded clinically from 1 to 4 according to the World Federation of Societies of Anesthesiologists by two anesthesiologists. Controls were randomly matched with cases (ratio 2:1) by age group and month and type of surgery. Patient and anesthesia-related factors and agents given intraoperatively were recorded. A risk score was derived from the coefficients of the significant predictors of the final multivariate logistic regression model. Risk scores, adjusted odds ratios (OR) for perioperative DHR and 95% confidence intervals (CI) were determined. Results Overall, 325 cases and 650 controls were recruited. The severity of DHR was grade 1 (72.9%), grade 2 (24%), and grade 3 (3.1%). Our risk predictive tools for perioperative DHR provided a sensitivity of 62% and specificity of 65%. Predictive scores of subgroups of moderate to severe DHR showed high specificity (80%) but low sensitivity (47%). Common predictors of overall DHR and moderate to severe DHR were history of drug allergy to 2 or more drug categories (score 2.5-3.5), being allergic to analgesics (score 2.5-4.0), and intraoperative morphine use (score of 1). The sole predictor of high-risk perioperative DHR (score >= 3.5) was airway management with an endotracheal tube intubation (OR 5.6, 95% CI 2.2-14.4) whereas history of allergic rhinitis (OR 11.7, 95% CI 1.3-105.1) was a predictor of high-risk moderate to severe DHR (score >= 2.5). Conclusions Our predictive tool for perioperative DHR provided a modest predictive ability. History of drug allergies, rhinitis, morphine use and endotracheal intubation were significant risk factors of DHR after adjusting for age and type of surgery.	[Pradhan, Ujal; Oofuvong, Maliwan; Karnjanawanichkul, Orarat; Pakpirom, Jatuporn] Prince Songkla Univ, Dept Anesthesiol, Fac Med, Hat Yai, Thailand	Prince of Songkla University	Oofuvong, M (corresponding author), Prince Songkla Univ, Dept Anesthesiol, Fac Med, Hat Yai, Thailand.	oomaliwa@gmail.com	Pakpirom, Jatuporn/HHZ-0838-2022	Oofuvong, Maliwan/0000-0001-5840-5965	Faculty of Medicine, PSU, Thailand [6123784]	Faculty of Medicine, PSU, Thailand	MO received Grant number 6123784 from Faculty of Medicine, PSU, Thailand URL http://medinfo.psu.ac.th/The sponsors do not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of research assistants [43,000 baht], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Antunes J, 2014, ALLERGOL IMMUNOPATH, V42, P348, DOI 10.1016/j.aller.2013.08.001; Athar M., 2016, J CURR RES SCI MED, V2, P3, DOI [10.4103/2455-3069.184114, DOI 10.4103/2455-3069.184114]; Baldo BA, 2012, ANAESTH INTENS CARE, V40, P216, DOI 10.1177/0310057X1204000204; Berroa F, 2015, ANESTH ANALG, V121, P117, DOI 10.1213/ANE.0000000000000776; Bhole MV, 2012, BRIT J ANAESTH, V108, P903, DOI 10.1093/bja/aes162; Burlacu Crina L, 2008, Ther Clin Risk Manag, V4, P381; Chen XX, 2016, SINGAP MED J, V57, P126, DOI 10.11622/smedj.2016053; Cho YJ, 2016, EUR J ANAESTH, V33, P368, DOI 10.1097/EJA.0000000000000373; Dewachter P, 2011, CURR OPIN ANESTHESIO, V24, P320, DOI 10.1097/ACO.0b013e3283466c13; Gelincik A, 2013, ANN ALLERG ASTHMA IM, V110, P96, DOI 10.1016/j.anai.2012.11.018; Gurrieri C, 2011, ANESTH ANALG, V113, P1202, DOI 10.1213/ANE.0b013e31822d45ac; Harper NJN, 2018, BRIT J ANAESTH, V121, P159, DOI 10.1016/j.bja.2018.04.014; Harper NJN, 2009, ANAESTHESIA, V64, P199, DOI 10.1111/j.1365-2044.2008.05733.x; Hepner DL, 2003, ANESTH ANALG, V97, P1381, DOI 10.1213/01.ANE.0000082993.84883.7D; Montanez MI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00614; Kambali S., 2012, CHEST, V142, p315A, DOI [10.1378/chest.1390428, DOI 10.1378/CHEST.1390428]; Kroigaard M, 2007, ACTA ANAESTH SCAND, V51, P655, DOI 10.1111/j.1399-6576.2007.01313.x; Kuhlen JL, 2016, J ALLER CL IMM-PRACT, V4, P697, DOI 10.1016/j.jaip.2016.02.008; Lertnawapan Ratchaya, 2011, Allergology International, V60, P283, DOI 10.2332/allergolint.10-OA-0256; Mertes PM, 2011, J INVEST ALLERG CLIN, V21, P442; Mertes PM, 2019, BRIT J ANAESTH, V123, pE16, DOI 10.1016/j.bja.2019.01.027; Mirone Corrado, 2015, Clin Mol Allergy, V13, P11, DOI 10.1186/s12948-015-0017-9; Pawankar R, 2013, WAO WHITE BOOK ALLER; Pfutzner Wolfgang, 2018, Allergo J Int, V27, P126, DOI 10.1007/s40629-018-0071-1; Rangkakulnuwat P, 2020, ASIAN PAC J ALLERGY, V38, P31, DOI 10.12932/AP-210318-0284; Reddy JI, 2015, ANESTHESIOLOGY, V122, P39, DOI 10.1097/ALN.0000000000000512; Simons FER, 2011, WORLD ALLERGY ORGAN, V4, P13, DOI 10.1097/WOX.0b013e318211496c; Stefanutto TB, 2005, SOUTH AFR J ANAESTH, V11, P36, DOI 10.1080/22201173.2005.10872392; Thienthong Somboon, 2005, J Med Assoc Thai, V88 Suppl 7, pS128; Volcheck GW, 2019, J ALLER CL IMM-PRACT, V7, P2134, DOI 10.1016/j.jaip.2019.05.033; Ye YM, 2015, ALLERGY ASTHMA IMMUN, V7, P22, DOI 10.4168/aair.2015.7.1.22; Yim R., 2016, WORLD FED SOC ANAEST	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262362	10.1371/journal.pone.0262362	http://dx.doi.org/10.1371/journal.pone.0262362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025954	Green Published, gold			2022-12-26	WOS:000796264200062
J	Thavarajah, D; Lawrence, TJ; Powers, SE; Kay, J; Thavarajah, P; Shipe, E; McGee, R; Kumar, S; Boyles, R				Thavarajah, Dil; Lawrence, Tristan J.; Powers, Sarah E.; Kay, Joshua; Thavarajah, Pushparajah; Shipe, Emerson; McGee, Rebecca; Kumar, Shiv; Boyles, Rick			Organic dry pea (Pisum sativum L.) biofortification for better human health	PLOS ONE			English	Article							NITROGEN-FIXATION; WHOLE FOOD; PERFORMANCE; CULINARIS; LENTIL; IRON; ZINC	A primary criticism of organic agriculture is its lower yield and nutritional quality compared to conventional systems. Nutritionally, dry pea (Pisum sativum L.) is a rich source of low digestible carbohydrates, protein, and micronutrients. This study aimed to evaluate dry pea cultivars and advanced breeding lines using on-farm field selections to inform the development of biofortified organic cultivars with increased yield and nutritional quality. A total of 44 dry pea entries were grown in two USDA-certified organic on-farm locations in South Carolina (SC), United States of America (USA) for two years. Seed yield and protein for dry pea ranged from 61 to 3833 kg ha(-1) and 12.6 to 34.2 g/100 g, respectively, with low heritability estimates. Total prebiotic carbohydrate concentration ranged from 14.7 to 26.6 g/100 g. A 100-g serving of organic dry pea provides 73.5 to 133% of the recommended daily allowance (%RDA) of prebiotic carbohydrates. Heritability estimates for individual prebiotic carbohydrates ranged from 0.27 to 0.82. Organic dry peas are rich in minerals [iron (Fe): 1.9-26.2 mg/100 g; zinc (Zn): 1.1-7.5 mg/100 g] and have low to moderate concentrations of phytic acid (PA:18.8-516 mg/100 g). The significant cultivar, location, and year effects were evident for grain yield, thousand seed weight (1000-seed weight), and protein, but results for other nutritional traits varied with genotype, environment, and interactions. "AAC Carver," "Jetset," and "Mystique" were the best-adapted cultivars with high yield, and "CDC Striker," "Fiddle," and "Hampton" had the highest protein concentration. These cultivars are the best performing cultivars that should be incorporated into organic dry pea breeding programs to develop cultivars suitable for organic production. In conclusion, organic dry pea has potential as a winter cash crop in southern climates. Still, it will require selecting diverse genetic material and location sourcing to develop improved cultivars with a higher yield, disease resistance, and nutritional quality.	[Thavarajah, Dil; Lawrence, Tristan J.; Powers, Sarah E.; Kay, Joshua; Thavarajah, Pushparajah; Shipe, Emerson] Clemson Univ, Plant & Environm Sci, Pulse Qual & Nutr Breeding, Biosyst Res Complex, Clemson, SC 29634 USA; [McGee, Rebecca] Washington State Univ, Grain Legume Genet & Physiol Res Unit, USDA ARS, Pullman, WA USA; [Kumar, Shiv] Int Ctr Agr Res Dry Areas ICARDA, Biodivers & Crop Improvement Program, Rabat, Morocco; [Boyles, Rick] PeeDee Res & Educ Ctr, Plant & Environm Sci, Florence, SC USA	Clemson University; United States Department of Agriculture (USDA); Washington State University; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Thavarajah, D (corresponding author), Clemson Univ, Plant & Environm Sci, Pulse Qual & Nutr Breeding, Biosyst Res Complex, Clemson, SC 29634 USA.	dthavar@clemson.edu		Thavarajah, Dil/0000-0002-4251-7476; Kay, Joshua/0000-0002-3639-6508; Kumar, Shiv/0000-0001-8407-3562; Powers, Sarah/0000-0001-7392-8043	Organic Agriculture Research and Extension Initiative (OREI) of the United States Department of Agriculture, National Institute of Food and Agriculture [2018-5130028431, 2018-02799]; USDA-ARS Pulse Health Initiative; Specialty Crop Block Grant Program of the U.S. Department of Agriculture [AM180100XXXXG026]; USDA National Institute of Food and Agriculture [1022664]; Good Food Institute	Organic Agriculture Research and Extension Initiative (OREI) of the United States Department of Agriculture, National Institute of Food and Agriculture; USDA-ARS Pulse Health Initiative; Specialty Crop Block Grant Program of the U.S. Department of Agriculture; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Good Food Institute	Funding support for this project was provided by the Organic Agriculture Research and Extension Initiative (OREI) (award no. 2018-5130028431/proposal no. 2018-02799) of the United States Department of Agriculture, National Institute of Food and Agriculture (DT and RB), and the USDA-ARS Pulse Health Initiative (DT); the Specialty Crop Block Grant Program of the U.S. Department of Agriculture through grant AM180100XXXXG026 (DT); the USDA National Institute of Food and Agriculture, [Hatch] project [1022664] (DT); and the Good Food Institute (DT). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the USDA.	Amarakoon D, 2015, J FOOD COMPOS ANAL, V37, P67, DOI 10.1016/j.jfca.2014.09.001; Amarakoon D, 2012, J FOOD COMPOS ANAL, V27, P8, DOI 10.1016/j.jfca.2012.05.007; Baird JM, 2009, CAN J PLANT SCI, V89, P1089, DOI 10.4141/CJPS08226; Bouis H, 2018, WORLD REV NUTR DIET, V118, P112, DOI 10.1159/000484342; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Clark A., 2008, MANAGING COVER CROP; Crowder DW, 2015, P NATL ACAD SCI USA, V112, P7611, DOI 10.1073/pnas.1423674112; FAO, 2020, FAOSTAT FAOSTATS CRO; Georgieva N, 2017, BIOL AGRIC HORTIC, V33, P225, DOI 10.1080/01448765.2017.1303791; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gollner G, 2019, NUTR CYCL AGROECOSYS, V115, P391, DOI 10.1007/s10705-019-10021-4; Holdsworth WL, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.17; Jha AB, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010073; Johnson CR, 2013, FOOD RES INT, V51, P107, DOI 10.1016/j.foodres.2012.11.025; Johnson CR., 2015, J FOOD COMPOS ANAL, V44; Johnson N, 2020, PLANTS PEOPLE PLANET, V2, P310, DOI 10.1002/ppp3.10103; Johnson N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93475-3; Kniss AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165851; Kniss AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161673; Kumar J, 2016, J AGR FOOD CHEM, V64, P6383, DOI 10.1021/acs.jafc.6b02171; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Linda MiloOhr, 2020, FOOD TECHNOLOGY MAGA, V74; Muir JG, 2009, J AGR FOOD CHEM, V57, P554, DOI 10.1021/jf802700e; Murphy KM, 2007, FIELD CROP RES, V102, P172, DOI 10.1016/j.fcr.2007.03.011; Ntatsi G, 2019, ARCH AGRON SOIL SCI, V65, P294, DOI 10.1080/03650340.2018.1501155; PEOPLES MB, 1995, PLANT SOIL, V174, P3, DOI 10.1007/BF00032239; Powers S, 2021, G3-GENES GENOM GENET, V11, DOI 10.1093/g3journal/jkab227; Powers S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75804-0; Powers SE, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01489; Powers SE., 2019, FRONT PLANT SCI, P10, DOI [10.3389/fpls.2019.00010, DOI 10.3389/FPLS.2019.00010]; Ray H, 2014, CROP SCI, V54, P1698, DOI 10.2135/cropsci2013.08.0568; Reganold JP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.221, 10.1038/nplants.2015.221]; SAS Institute Inc, 2013, US GUID; Thavarajah D., 2015, PHENOMICS CROP PLANT, P223; Thavarajah D, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6030034; Thavarajah D, 2011, EUPHYTICA, V180, P123, DOI 10.1007/s10681-011-0365-6; Thavarajah D, 2009, J AGR FOOD CHEM, V57, P5413, DOI 10.1021/jf900786e; Thavarajah P, 2009, J AGR FOOD CHEM, V57, P9044, DOI 10.1021/jf901636p; Trewavas A, 2001, NATURE, V410, P409, DOI 10.1038/35068639; USAPulses, PROC INF TECHN MAN; USDA, 2016, USDA ORG AGR PROGR; Vandemark G, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00112; Wang N, 2009, LWT-FOOD SCI TECHNOL, V42, P842, DOI 10.1016/j.lwt.2008.10.007; Wiebe L, 2017, CAN J PLANT SCI, V97, P298, DOI 10.1139/cjps-2016-0141	45	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261109	10.1371/journal.pone.0261109	http://dx.doi.org/10.1371/journal.pone.0261109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025919	gold, Green Published			2022-12-26	WOS:000796264200011
J	Akther, T; Nur, T				Akther, Taslima; Nur, Tasnima			A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use	PLOS ONE			English	Article							FAKE NEWS; TECHNOLOGY; BEHAVIOR; INTENTIONS; HESITANCY; PEOPLE	The aim of this study is to investigate the key factors influencing the acceptance of COVID-19 vaccines and develop a model based on the theory of reasoned action, belief in conspiracy theory, awareness, perceived usefulness, and perceived ease of use. The authors created and distributed a self-administered online questionnaire using Google Forms. Data were collected from 351 respondents ranging in age from 19 to 30 years, studying at the graduate and postgraduate levels at various public universities in Bangladesh. The Partial Least Squares Structural Equation Modeling (PLS-SEM) method was used to analyze the data. The results indicate that belief in conspiracy theory undermines COVID-19 vaccine acceptance, thereby negatively impacting the individual attitudes, subjective norms, and acceptance. Individual awareness, on the other hand, has a strong positive influence on the COVID-19 vaccine acceptance. Furthermore, the perceived usefulness of vaccination and the perceived ease of obtaining the vaccine positively impact attitude and the acceptance of immunization. Individuals' positive attitudes toward immunization and constructive subjective norms have a positive impact on vaccine acceptance. This study contributes to the literature by combining the theory of reasoned action with conspiracy theory, awareness, perceived usefulness, and perceived ease of use to understand vaccine acceptance behavior. Authorities should focus on campaigns that could reduce misinformation and conspiracy surrounding COVID-19 vaccination. The perceived usefulness of vaccination to prevent pandemics and continue normal education will lead to vaccination success. Furthermore, the ease with which people can obtain the vaccine and that it is free of cost will encourage students to get vaccinated to protect themselves, their families, and society.	[Akther, Taslima] Jagannath Univ, Fac Business Studies, Dept Accounting & Informat Syst, Dhaka, Bangladesh; [Nur, Tasnima] Inst Chartered Accountants Bangladesh, Dhaka, Bangladesh		Akther, T (corresponding author), Jagannath Univ, Fac Business Studies, Dept Accounting & Informat Syst, Dhaka, Bangladesh.	taslima@ais.jnu.ac.bd	Akther, Taslima/AAC-1670-2021	Akther, Taslima/0000-0002-8764-2692				Ajzen I, 1998, PSYCHOL HEALTH, V13, P735, DOI 10.1080/08870449808407426; Ajzen I., 1980, UNDERSTANDING ATTITU; [Anonymous], 2021, LIST U BANGLADESH WI; [Anonymous], 2021, CORONAVIRUS DIS COVI; [Anonymous], 2021, DHAKA TRIBUNE; [Anonymous], 2021, WHO DIRECTOR GEN OPE; [Anonymous], 2021, NAMING CORONAVIRUS D; [Anonymous], 2021, COVID 19 VACCINES AD; [Anonymous], 2021, BANGLADESH COVID 19; [Anonymous], 2021, ORIGIN SARS COV 2; [Anonymous], 2021, PROTHOMALO; [Anonymous], 2021, NOVEL CORONAVIRUS 20; Aylward RB, 2005, AM J PUBLIC HEALTH, V95, P773, DOI 10.2105/AJPH.2004.055897; Bertin P, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565128; Bhattacharjee S., 2020, 1 DRAFT CASE STUDY U; Biglan A, 2000, AM J COMMUN PSYCHOL, V28, P269, DOI 10.1023/A:1005155903801; Bogart LM, 2010, JAIDS-J ACQ IMM DEF, V53, P648, DOI 10.1097/QAI.0b013e3181c57dbc; Brotherton R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00279; Carleton RA, 1996, CIRCULATION, V93, P1768, DOI 10.1161/01.CIR.93.9.1768; CARLSON M, 1988, J PERS SOC PSYCHOL, V55, P211, DOI 10.1037/0022-3514.55.2.211; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL 4, P151; Cookson D, 2021, GROUP PROCESS INTERG, V24, P759, DOI 10.1177/1368430221993907; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Dinev T, 2007, J ASSOC INF SYST, V8, P386, DOI 10.17705/1jais.00133; Douglas KM, 2021, GROUP PROCESS INTERG, V24, P270, DOI 10.1177/1368430220982068; Douglas KM, 2019, POLIT PSYCHOL, V40, P3, DOI 10.1111/pops.12568; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Eri Y, 2005, IEEE INT C MANAGEMEN; Fishbein M., 1975, BELIEF ATTITUDE INTE; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Freeman D, 2022, PSYCHOL MED, V52, P3127, DOI [10.1017/S0033291720005188, 10.1017/S0033291721002609]; GEISSER S, 1974, BIOMETRIKA, V61, P101, DOI 10.1093/biomet/61.1.101; Greene S.R., 2003, ANN M ASS STUD HIGH, P213; Hair J. F., 2017, HDB MARKET RES, V26, P1, DOI [DOI 10.1007/978-3-319-57413-4_15, DOI 10.1007/978-3-319-05542-8_15-1]; Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382; Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014; HILL RJ, 1977, CONTEMP SOCIOL, V6, P244, DOI 10.2307/2065853; Hornsey MJ, 2018, HEALTH PSYCHOL, V37, P307, DOI 10.1037/hea0000586; Hussain SF, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0195-3; Islam MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251605; Islam MS, 2021, MEDRXIV, DOI 2021.02.16.21251802; Jolley D, 2020, BRIT J SOC PSYCHOL, V59, P628, DOI 10.1111/bjso.12394; Jolley D, 2019, BRIT J SOC PSYCHOL, V58, P534, DOI 10.1111/bjso.12311; Jolley D, 2017, J APPL SOC PSYCHOL, V47, P459, DOI 10.1111/jasp.12453; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Jolley D, 2014, BRIT J PSYCHOL, V105, P35, DOI 10.1111/bjop.12018; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Lane S, 2018, VACCINE, V36, P3861, DOI 10.1016/j.vaccine.2018.03.063; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lavorgna L, 2018, MULT SCLER RELAT DIS, V25, P175, DOI 10.1016/j.msard.2018.07.046; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Mathieson K, 1991, INFORM SYST RES, V2, P173, DOI 10.1287/isre.2.3.173; Orosz G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01525; Piaget J., 1975, EQUILIBRIUM COGNITIV; Ramayah T, 2009, COMPUT HUM BEHAV, V25, P1222, DOI 10.1016/j.chb.2009.06.007; Ramayah T., 2004, GADJAH MADA INT J BU, V6, P405, DOI DOI 10.22146/GAMAIJB.5556; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Reynolds, 2002, PEDAGOGY CRITICAL AP, V2, P229, DOI DOI 10.1215/15314200-2-2-229; Ringle CM, 2013, J BUS RES, V66, P1318, DOI 10.1016/j.jbusres.2012.02.031; Ritchie H., 2021, OUR WORLD DATA; Rogers E.M., 2010, DIFFUSION INNOVATION; Sallam M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052407; Shammi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04063; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Shmueli L, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10816-7; Siu-cheung Chan, 2004, Journal of Global Information Management, V12, P21, DOI 10.4018/jgim.2004070102; Snell Jr W.E, 1998, SEX MARITAL THER, V13, P191, DOI [10.1080/02674659808406559, DOI 10.1080/02674659808406559]; Stecula DA, 2020, HARV KENNEDY SCH HKS, DOI [10.37016/mr-2020-007, DOI 10.37016/MR-2020-007]; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Suresh A., 2021, PUBLIC AWARENESS ACC; Swami V, 2010, APPL COGNITIVE PSYCH, V24, P749, DOI 10.1002/acp.1583; TAYLOR S, 1995, INFORM SYST RES, V6, P144, DOI 10.1287/isre.6.2.144; Terry DJ, 1996, PERS SOC PSYCHOL B, V22, P776, DOI 10.1177/0146167296228002; Tsui L, 2000, REV HIGH EDUC, V23, P421; Waszak PM, 2018, HEALTH POLICY TECHN, V7, P115, DOI 10.1016/j.hlpt.2018.03.002; Xu FJ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11205798	82	12	12	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261869	10.1371/journal.pone.0261869	http://dx.doi.org/10.1371/journal.pone.0261869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020764	gold, Green Published			2022-12-26	WOS:000834207700027
J	Dueker, ND; Beecham, A; Wang, LY; Dong, CH; Sacco, RL; Blanton, SH; Rundek, T				Dueker, Nicole D.; Beecham, Ashley; Wang, Liyong; Dong, Chuanhui; Sacco, Ralph L.; Blanton, Susan H.; Rundek, Tatjana			Rare variants in previously identified linkage regions associated with carotid plaque in Dominican Republic families	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; ISCHEMIC-STROKE; CANDIDATE GENES; HEART-DISEASE; RISK; LOCI; ATHEROSCLEROSIS; METAANALYSIS	Carotid plaque is a subclinical measure of atherosclerosis. We have previously shown measures of carotid plaque to be heritable in a sample of 100 Dominican families and found evidence for linkage and association of common variants (CVs) on 7q36, 11p15, 14q32 and 15q23 with plaque presence. Our current study aimed to refine these regions further and identify rare variants (RVs) influencing plaque presence. Therefore, we performed targeted sequencing of the one LOD unit down region on 7q36, 11p15, 14q32 and 15q23 in 12 Dominican families with evidence for linkage to plaque presence. Gene-based RV analyses were performed using the Sequence Association Test for familial data (F-SKAT) under two filtering algorithms; 1. all exonic RVs and 2. non-synonymous RVs. Replication analyses were performed using a sample of 22 Dominican families and 556 unrelated Dominicans with Exome Array data. To identify additional non-synonymous RVs influencing plaque, we looked for co-segregation of RVs with plaque in each of the sequenced families. Our most strongly associated gene with evidence for replication was AMPD3 which showed suggestive association with plaque presence in the sequenced families (exonic RV p = 0.003, nonsynonymous RV p = 0.005) and replication families (exonic RV p = 0.04, nonsynonymous RV p = 0.02). Examination of the sequenced family pedigrees revealed two missense variants on chromosome 11 which co-segregated with plaque presence in one of our families; rs61751342 (located in DENND2B), and rs61760882 (located in RNF141). The rs61751342 missense variant is an eQTL for SCUBE2 in the atrial appendage. Notably, SCUBE2 encodes a protein which interacts with vascular endothelial growth factor (VEGF) receptor 2 to regulate VEGF-induced angiogenesis, thus providing biologic plausibility for this gene in atherosclerosis. In conclusion, using targeted sequencing of previously-identified linkage regions, we have identified suggestive evidence for the role of RVs in carotid plaque pathogenesis.	[Dueker, Nicole D.; Beecham, Ashley; Wang, Liyong; Blanton, Susan H.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Wang, Liyong; Sacco, Ralph L.; Blanton, Susan H.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA; [Dong, Chuanhui; Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA; [Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Dept Publ Hlth Sci, Miller Sch Med, Miami, FL 33136 USA; [Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Rundek, T (corresponding author), Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.; Rundek, T (corresponding author), Univ Miami, Dept Publ Hlth Sci, Miller Sch Med, Miami, FL 33136 USA.; Rundek, T (corresponding author), Univ Miami, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL 33136 USA.	trundek@med.miami.edu			National Institutes of Health/National Institute for Neurological Disorders and Stroke [R01NS040807, R01NS29993]; Evelyn F. McKnight Brain Institute	National Institutes of Health/National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Evelyn F. McKnight Brain Institute	This work was supported by grants from the National Institutes of Health/National Institute for Neurological Disorders and Stroke (R01NS040807 and R01NS29993) and the Evelyn F. McKnight Brain Institute.	Abdullah MHN, 2012, J CARDIOL, V60, P192, DOI 10.1016/j.jjcc.2012.05.009; Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Calabresi L, 2003, ARTERIOSCL THROM VAS, V23, P1724, DOI 10.1161/01.ATV.0000094961.74697.54; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Dong CH, 2012, ATHEROSCLEROSIS, V223, P177, DOI 10.1016/j.atherosclerosis.2012.03.025; Dong CH, 2010, STROKE, V41, P2750, DOI 10.1161/STROKEAHA.110.596981; Dueker ND, 2018, G3-GENES GENOM GENET, V8, P659, DOI 10.1534/g3.117.300358; Dueker ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167202; Elkind MSV, 2006, STROKE, V37, P13, DOI 10.1161/01.STR.0000195048.86810.5b; Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708; Feng AF, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0608-0; Festa A, 1999, STROKE, V30, P1566, DOI 10.1161/01.STR.30.8.1566; Franceschini N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07340-5; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hunt KJ, 2002, STROKE, V33, P2775, DOI 10.1161/01.STR.0000043827.03966.EF; Jeff JM, 2013, ANN HUM GENET, V77, P321, DOI 10.1111/ahg.12023; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kuipers AL, 2019, ATHEROSCLEROSIS, V291, P19, DOI 10.1016/j.atherosclerosis.2019.10.008; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin YC, 2017, ARTERIOSCL THROM VAS, V37, P144, DOI 10.1161/ATVBAHA.116.308546; Moskau S, 2005, STROKE, V36, P5, DOI 10.1161/01.STR.0000149936.33498.83; Pott J, 2017, ATHEROSCLEROSIS, V259, P32, DOI 10.1016/j.atherosclerosis.2017.02.018; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Sacco RL, 2007, ETHNIC DIS, V17, P351; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Smolenski RT, 2014, CARDIOVASC DRUG THER, V28, P183, DOI 10.1007/s10557-013-6506-5; Tardif JC, 2010, EUR HEART J SUPPL, V12, pC2, DOI 10.1093/eurheartj/suq014; ten Sande JN, 2016, HEART RHYTHM, V13, P905, DOI 10.1016/j.hrthm.2015.12.006; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Wang LY, 2015, HUM GENET, V134, P1127, DOI 10.1007/s00439-015-1592-z; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yan Q, 2015, HUM HERED, V79, P60, DOI 10.1159/000375409	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0250799	10.1371/journal.pone.0250799	http://dx.doi.org/10.1371/journal.pone.0250799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020748	gold, Green Published			2022-12-26	WOS:000834207700003
J	Zhu, ZL; Middleton, B; Pindilli, E; Johnson, D; Johnson, K; Covington, S				Zhu, Zhiliang; Middleton, Beth; Pindilli, Emily; Johnson, Darren; Johnson, Kurt; Covington, Scott			Conservation of carbon resources and values on public lands: A case study from the National Wildlife Refuge System	PLOS ONE			English	Article							OLD-GROWTH FORESTS; STORAGE; RATES; FIRE	Public lands in the United States are those land areas managed by federal, state, and county governments for public purposes such as preservation and recreation. Protecting carbon resources and increasing carbon sequestration capacity are compatible with public land management objectives for healthy and resilient habitats, i.e., managing habitats for the benefit of wildlife and ecosystem services can simultaneously capture and store carbon. To evaluate the effect of public land management on carbon storage and review carbon management as part of the land management objectives, we used existing data of carbon stock and net ecosystem carbon balance in a study of the National Wildlife Refuge System (NWRS), a public land management program of the U.S. Fish and Wildlife Service (Service). Total carbon storage of the 364 refuges studied was 16.6 PgC, with a mean value 42,981 gCm(-2). We used mixed modeling with Bonferroni adjustment techniques to analyze the effect of time since refuge designation on carbon storage. In general, older refuges store more carbon per unit area than younger refuges. In addition to the age factor, carbon resources are variable by regions and habitat types protected in the refuges. Mean carbon stock and the rate of sequestration are higher within refuges than outside refuges, but the statistical comparison of 364 refuges analyzed in this study was not significant. We also used the social cost of carbon to analyze the annual benefits of sequestrating carbon in these publicly managed lands in the United States, which is over $976 million per year in avoided CO2 emissions via specific conservation management actions. We examine case studies of management, particularly with respect to Service cooperation activities with The Conservation Fund (TCF) Go Zero (R) Program, Trust for Public Land (TPL) and individuals. Additional opportunities exist in improving techniques to maximize carbon resources in refuges, while continuing to meet the core purpose and need of the NWRS.	[Zhu, Zhiliang] US Geol Survey, 959 Natl Ctr, Reston, VA 22092 USA; [Middleton, Beth; Johnson, Darren] US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA USA; [Pindilli, Emily] US Geol Survey, Sci & Decis Ctr, USGS Northeast Reg, Reston, VA USA; [Johnson, Kurt; Covington, Scott] US Fish & Wildlife Serv, Falls Church, VA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Zhu, ZL (corresponding author), US Geol Survey, 959 Natl Ctr, Reston, VA 22092 USA.	zzhu@usgs.gov	Zhu, Zhiliang/I-2686-2018	Zhu, Zhiliang/0000-0002-6860-6936				Allen ST, 2019, FOREST ECOL MANAG, V432, P345, DOI 10.1016/j.foreco.2018.09.041; Anthoff D, 2009, ENVIRON RESOUR ECON, V43, P351, DOI 10.1007/s10640-009-9269-5; Archie KM, 2012, ECOL SOC, V17, DOI 10.5751/ES-05187-170420; Ballanti L, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9111919; Burnham K. P., 1998, MODEL SELECTION INFE; Cambardella CA, 2019, P 2018 2019 INT SOIL; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Dilling L., 2013, LAND USE CARBON CYCL, P455; Drexler JZ, 2019, RESTOR ECOL, V27, P1117, DOI 10.1111/rec.12941; Drexler JZ, 2013, WETLANDS, V33, P965, DOI 10.1007/s13157-013-0456-3; Gergely KJ., 2016, GEOLOGICAL SURVEY FA; Guzman JG, 2010, J ENVIRON QUAL, V39, P136, DOI 10.2134/jeq2009.0063; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hope C, 2008, ENERG ECON, V30, P1011, DOI 10.1016/j.eneco.2006.11.006; Ingraham MW, 2008, ECOL ECON, V67, P608, DOI 10.1016/j.ecolecon.2008.01.012; Interagency Working Group on Social Cost of Greenhouse Gases United States Government, 2016, TECHN SUPP DOC TECHN; Kroeger KD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12138-4; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; McGarvey JC, 2015, ECOLOGY, V96, P311, DOI 10.1890/14-1154.1; Merrill, 2018, US GEOLOGICAL SURVEY; Mickler RA, 2017, FIRE ECOL, V13, P34, DOI 10.4996/fireecology.1301034; Middleton B., 1999, WETLAND RESTORATION; Middleton BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226998; Middleton Beth A., 2005, Wetlands Ecology and Management, V13, P15, DOI 10.1007/s11273-003-5024-9; Nahlik AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13835; Parthum B, 2017, J ENVIRON MANAGE, V203, P375, DOI 10.1016/j.jenvman.2017.08.018; Pindilli E, 2018, ECOL ECON, V154, P145, DOI 10.1016/j.ecolecon.2018.08.002; Poulter B, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006455; Reddy AD, 2015, REMOTE SENS ENVIRON, V170, P306, DOI 10.1016/j.rse.2015.09.017; Richardson L., 2014, NPSNRSSEQDNRR2014880; SAS Institute Inc, 2012, SAS 9 3; Shoch DT, 2009, WETLANDS, V29, P535, DOI 10.1672/08-110.1; Sleeter BM, 2019, GLOBAL CHANGE BIOL, V25, P3334, DOI 10.1111/gcb.14677; Stackpoole S, 2011, GEOLOGICAL SURVEY FA; Stewart CE, 2009, SOIL BIOL BIOCHEM, V41, P357, DOI 10.1016/j.soilbio.2008.11.011; Stricker CA, 2019, J GEOPHYS RES-BIOGEO, V124, P2751, DOI 10.1029/2019JG005079; Tan ZX, 2015, P NATL ACAD SCI USA, V112, P12723, DOI 10.1073/pnas.1512542112; Tinling MA, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0093-4; U.S. Environmental Protection Agency (EPA), 2016, EPA FACT SHEET SOC C; U.S. Fish and Wildlife Service (USFWS), 2017, BIOL CARB SEQ ACC 20; United States Fish and Wildlife Service (USFWS), USFWS NAT CAD DAT; United States Fish and Wildlife Service (USFWS), USFWS NAT WILDL REF; US EPA, 2021, SOURC GREENH GAS EM; Vandegraff DL, 2005, GEOLOGICAL SURVEY OP; Ward S., 2015, ENV LAW I WASHINGTON, V36; Windham-Myers L, 2018, BLUE CARBON PRIMER S, DOI [10.1201/9780429435362, DOI 10.1201/9780429435362]; Zhu K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05132-5; Zhu Z., 2016, 1826 DEP INT GEOL SU, DOI [10.3133/pp1826, DOI 10.3133/PP1826]	48	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262218	10.1371/journal.pone.0262218	http://dx.doi.org/10.1371/journal.pone.0262218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020751	gold, Green Published			2022-12-26	WOS:000834207700036
J	Druedahl, LC; Sporrong, SK; Minssen, T; Hoogland, H; De Bruin, ML; van de Weert, M; Almarsdottir, AB				Druedahl, Louise C.; Sporrong, Sofia Kalvemark; Minssen, Timo; Hoogland, Hans; De Bruin, Marie Louise; van de Weert, Marco; Almarsdottir, Anna Birna			Interchangeability of biosimilars: A study of expert views and visions regarding the science and substitution	PLOS ONE			English	Article							QUALITATIVE RESEARCH; HEALTH; CHALLENGES; MEDICINES	Healthcare systems have reached a critical point regarding the question of whether biosimilar substitution should become common practice. To move the discussion forward, the study objective was to investigate the views of experts from medicines agencies and the pharmaceutical industry on the science underpinning interchangeability of biosimilars. We conducted an empirical qualitative study using semi-structured interviews informed by a cross-disciplinary approach encompassing regulatory science, law, and pharmaceutical policy. In total 25 individuals with experience within biologics participated during September 2018-August 2019. Eight participants were EU national medicines authority regulators, and 17 had pharmaceutical industry background: five from two originator-only companies, four from two companies with both biosimilar and originator products, and eight from seven biosimilar-only companies. Two analysts independently conducted inductive content analysis, resulting in data-driven themes capturing the meaning of the data. The participants reported that interchangeability was more than a scientific question of likeness between biosimilar and reference products: it also pertained to regulatory practices and trust. Participants were overall confident in the science behind exchanging biosimilar products for the reference products via switching, i.e., with physician involvement. However, their opinions differed regarding the scientific risk associated with biosimilar substitution, i.e., without physician involvement. Almost all participants saw no need for additional scientific data to support substitution. Moreover, the participants did not believe that switching studies, as required in the US, were appropriate for obtaining scientific certainty due to their small size. It is unclear why biosimilar switching is viewed as scientifically safer than substitution; therefore, we expect greater policy debate on biosimilar substitution in the near future. We urge European and UK policymakers and regulators to clarify their visions for biosimilar substitution; the positions of these two frontrunners are likely to influence other jurisdictions on the future of biosimilar use.	[Druedahl, Louise C.; De Bruin, Marie Louise] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Ctr Regulatory Sci CORS, Dept Pharm, Copenhagen, Denmark; [Druedahl, Louise C.; Sporrong, Sofia Kalvemark; Almarsdottir, Anna Birna] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Social & Clin Pharm, Copenhagen, Denmark; [Druedahl, Louise C.; Minssen, Timo] Univ Copenhagen, Fac Law, Ctr Adv Studies Biomed Innovat Law CeBIL, Copenhagen, Denmark; [Sporrong, Sofia Kalvemark] Uppsala Univ, Fac Pharm, Dept Pharm, Social Pharm, Uppsala, Sweden; [Hoogland, Hans] LEO Pharma AS, Ballerup, Denmark; [De Bruin, Marie Louise] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [van de Weert, Marco] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Drug Delivery & Biophys Biopharmaceut, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Uppsala University; LEO Pharma; Utrecht University; University of Copenhagen	Druedahl, LC (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Ctr Regulatory Sci CORS, Dept Pharm, Copenhagen, Denmark.; Druedahl, LC (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Social & Clin Pharm, Copenhagen, Denmark.; Druedahl, LC (corresponding author), Univ Copenhagen, Fac Law, Ctr Adv Studies Biomed Innovat Law CeBIL, Copenhagen, Denmark.	louise.druedahl@jur.ku.dk	van de Weert, Marco/AGR-7726-2022; De Bruin, Marie Louise (Marieke)/O-5349-2016; Almarsdottir, Anna Birna/R-5299-2017	Hoogland, Hans/0000-0002-1508-9277; De Bruin, Marie Louise (Marieke)/0000-0001-9197-7068; Druedahl, Louise C./0000-0002-8979-8666; Minssen, Timo/0000-0002-3286-4888; Almarsdottir, Anna Birna/0000-0002-5354-2976; Kalvemark Sporrong, Sofia/0000-0001-5848-8625	LEO Pharma A/S; Collaborative Research Program for Biomedical Innovation Law, a scientifically independent research program - Novo Nordisk Foundation [NNF17SA0027784]	LEO Pharma A/S(LEO Pharma); Collaborative Research Program for Biomedical Innovation Law, a scientifically independent research program - Novo Nordisk Foundation	At the time of the study, LCD was funded by a PhD fellowship grant to the University of Copenhagen from LEO Pharma A/S, but the company has no commercial interest in the research. LEO Pharma A/S was aware of but had no decisive role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TM's work and LCD's current work is supported by the Collaborative Research Program for Biomedical Innovation Law, a scientifically independent research program supported by the Novo Nordisk Foundation (grant NNF17SA0027784).	Allens, WHIT PAP BIOL MED BI; [Anonymous], 2012, OJ C, V326, P47; [Anonymous], 2019, WHAT IS BIOS MED; Aronson JK, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3141; Ascef BD, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00611-y; Barbier L, 2020, CLIN PHARMACOL THER, V108, P734, DOI 10.1002/cpt.1836; Chapman SR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016730; Cohen HP, 2018, DRUGS, V78, P463, DOI 10.1007/s40265-018-0881-y; Druedahl LC, 2020, NAT BIOTECHNOL, V38, P1253, DOI 10.1038/s41587-020-0717-7; Druedahl LC, 2020, J LAW MED ETHICS, V48, P579, DOI 10.1177/1073110520958884; Druedahl LC, 2019, BASIC CLIN PHARMACOL, V124, P431, DOI 10.1111/bcpt.13147; EMA, 2019, BIOS EU INF GUID HEA; European Commission, 2020, PHARM STRAT EUR; European Medicines Agency, 2020, EMA REGULATORY SCI 2; European Medicines Agency, 2014, CHMP43704REV1 EUR ME; European Medicines Agency, 2016, EUR REG SYST MED CON; Evens R, 2015, HEALTH AFFAIR, V34, P210, DOI 10.1377/hlthaff.2014.1023; Federal Agency for Medicines and Health Products, 2020, BIOSIMILARS; Ferrario A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l5444; Glintborg B, 2019, ANN RHEUM DIS, V78, P192, DOI 10.1136/annrheumdis-2018-213474; Greene JA, 2019, CLIN PHARMACOL THER, V105, P290, DOI 10.1002/cpt.1316; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Irvine A, 2013, QUAL RES, V13, P87, DOI 10.1177/1468794112439086; Jasanoff S., 2015, DREAMSCAPES MODERNIT, DOI DOI 10.7208/CHICAGO/9780226276663.003.0001; Jensen TB, 2020, JAMA INTERN MED, V180, P902, DOI 10.1001/jamainternmed.2020.0338; Jensen TB, 2020, EUR J CLIN PHARMACOL, V76, P35, DOI 10.1007/s00228-019-02765-3; Kitto SC, 2008, MED J AUSTRALIA, V188, P243, DOI 10.5694/j.1326-5377.2008.tb01595.x; Kurki P, 2021, DRUGS, V81, P1881, DOI 10.1007/s40265-021-01601-2; Kurki P, 2015, EXPERT REV CLIN PHAR, V8, P649, DOI 10.1586/17512433.2015.1071188; Mack A, 2015, GABI J, V4, P90, DOI 10.5639/gabij.2015.0402.018; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Medicines for Europe, 2019, SCI CONSIDERATIONS D; Medicines & Healthcare products Regulatory Agency, CONS DOC MHRA GUID L; Meuser M, 2009, RES METHODS SER, P17; O'Callaghan J, 2019, EUR J CLIN PHARMACOL, V75, P1, DOI 10.1007/s00228-018-2542-1; O'Callaghan J, 2017, REGUL TOXICOL PHARM, V88, P252, DOI 10.1016/j.yrtph.2017.06.013; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Rathore AS, 2022, EXPERT OPIN BIOL TH, V22, P133, DOI 10.1080/14712598.2021.1889511; Regulation (EC) No 726/2004 of the European Parliament and of the Council, 2013, OFFICIAL J EUROPEAN; Reiland JB, 2017, GABI J, V6, P61, DOI 10.5639/gabij.2017.0602.014; Sarnola K, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034183; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Teeple A, 2019, CURR MED RES OPIN, V35, P611, DOI 10.1080/03007995.2019.1571296; The Cancer Vanguard Project, 2017, BIOS AD PROC TIM; The Finnish Medicines Agency, 2019, AUT SUBST BIOL MED W; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tsiftsoglou AS, 2014, BIODRUGS, V28, P479, DOI 10.1007/s40259-014-0109-y; U.S. Food and Drug Administration, 2020, BIOS; US Food and Drug Administration,, 2019, CONSIDERATIONS DEMON; van Overbeeke E, 2017, BIODRUGS, V31, P447, DOI 10.1007/s40259-017-0244-3; Vondeling GT, 2018, APPL HEALTH ECON HEA, V16, P653, DOI 10.1007/s40258-018-0406-6; Vulto AG, 2017, RHEUMATOLOGY, V56, P14, DOI 10.1093/rheumatology/kex278; Walsh G, 2018, NAT BIOTECHNOL, V36, P1136, DOI 10.1038/nbt.4305	53	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262537	10.1371/journal.pone.0262537	http://dx.doi.org/10.1371/journal.pone.0262537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015783	Green Published, gold			2022-12-26	WOS:000814820600032
J	Pamphlett, R; Bishop, DP				Pamphlett, Roger; Bishop, David P.			Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson's disease and co-localises with Lewy bodies	PLOS ONE			English	Article							LOCUS-COERULEUS; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; METALS; MECHANISMS; BISMUTH; MICE; LOCALIZATION; NEUROMELANIN; FIBRILLATION	Objective Environmental toxicants are suspected to play a part in the pathogenesis of idiopathic Parkinson's disease (PD) and may underlie its increasing incidence. Mercury exposure in humans is common and is increasing due to accelerating levels of atmospheric mercury, and mercury damages cells via oxidative stress, cell membrane damage, and autoimmunity, mechanisms suspected in the pathogenesis of PD. We therefore compared the cellular distribution of mercury in the tissues of people with and without PD who had evidence of previous mercury exposure by mercury being present in their locus ceruleus neurons. Materials and methods Paraffin sections from the brain and general organs of two people with PD, two people without PD with a history of mercury exposure, and ten people without PD or known mercury exposure, were stained for inorganic mercury using autometallography, combined with immunostaining for alpha-synuclein and glial cells. All had mercury-containing neurons in locus ceruleus neurons. Laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) was used to confirm the presence of mercury and to look for other potentially toxic elements. Autometallography-stained locus ceruleus paraffin sections were examined to compare the frequency of previous mercury exposure between 20 PD and 40 non-PD individuals. Results In PD brains, autometallography-detected mercury was seen in neurons affected by the disease, such as those in the substantia nigra, motor cortex, striatum, thalamus, and cerebellum. Mercury was seen in oligodendrocytes in white and grey matter. Mercury often co-localised with Lewy bodies and neurites. A more restricted distribution of brain mercury was seen in people without PD (both with or without known mercury exposure), with no mercury present in the substantia nigra, striatum, or thalamus. The presence of autometallography-detected mercury in PD was confirmed with LA-ICP-MS, which demonstrated other potentially toxic metals in the locus ceruleus and high iron levels in white matter. Autometallography-detected mercury was found in locus ceruleus neurons in a similar proportion of PD (65%) and non-PD (63%) individuals. Conclusions In people with PD, mercury was found in neurons and oligodendrocytes in regions of the brain that are affected by the disease, and often co-localised with aggregated alpha-synuclein. Mercury in the motor cortex, thalamus and striatum could result in bradykinesia and rigidity, and mercury in the cerebellum could cause tremor. People without PD had a restricted uptake of mercury into the brain. The similar frequency of mercury in the locus ceruleus of people with and without PD suggests these two groups have had comparable previous mercury exposures but that PD brains have a greater predisposition to take up circulating mercury. While this post mortem study does not provide a direct link between mercury and idiopathic PD, it adds to the body of evidence that metal toxicants such as mercury play a role in the disease. A precautionary approach would be to reduce rising mercury levels in the atmosphere by limiting the burning of fossil fuels, which may be contributing to the increasing incidence of PD.	[Pamphlett, Roger] Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Bishop, David P.] Univ Technol Sydney, Sch Math & Phys Sci, Elemental Bioimaging Facil, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Technology Sydney	Pamphlett, R (corresponding author), Univ Sydney, Brain & Mind Ctr, Sydney Med Sch, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au	Bishop, David/F-2891-2019	Bishop, David/0000-0002-6533-4410				Aarsland D, 2017, NAT REV NEUROL, V13, P217, DOI 10.1038/nrneurol.2017.27; Ahmed Z, 2012, NEUROPATH APPL NEURO, V38, P4, DOI 10.1111/j.1365-2990.2011.01234.x; Ahn JS, 2018, J OCCUP HEALTH, V60, P89, DOI 10.1539/joh.16-0274-CS; Andrade V M, 2017, Adv Neurobiol, V18, P227, DOI 10.1007/978-3-319-60189-2_12; Andreoli V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010093; Ball N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00218; Bloem BR, 2021, LANCET, V397, P2284, DOI 10.1016/S0140-6736(21)00218-X; Bonuccelli U, 1999, PARKINSONISM RELAT D, V5, P49, DOI 10.1016/S1353-8020(99)00010-3; Bostan AC, 2018, NAT REV NEUROSCI, V19, P338, DOI 10.1038/s41583-018-0002-7; Cai ZL, 2019, AGING CLIN EXP RES, V31, P1035, DOI 10.1007/s40520-018-1086-7; Caudle WM, 2012, NEUROTOXICOLOGY, V33, P585, DOI 10.1016/j.neuro.2012.04.011; CHANG LW, 1972, EXP NEUROL, V35, P122, DOI 10.1016/0014-4886(72)90064-7; Chen JH, 2019, NEUROEPIDEMIOLOGY, V52, P181, DOI 10.1159/000496977; Chohan H, 2021, MOVEMENT DISORD, V36, P1420, DOI 10.1002/mds.28551; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Cobbina SJ, 2015, CHEMOSPHERE, V132, P79, DOI 10.1016/j.chemosphere.2015.03.013; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Danscher G, 2000, J HISTOCHEM CYTOCHEM, V48, P1503, DOI 10.1177/002215540004801107; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P219, DOI 10.1177/33.3.2579122; DANSCHER G, 1994, NEUROPATH APPL NEURO, V20, P454, DOI 10.1111/j.1365-2990.1994.tb00996.x; DANSCHER G, 1986, HISTOCHEM J, V18, P109, DOI 10.1007/BF01675364; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Dorsey ER, 2018, J PARKINSON DIS, V8, pS3, DOI 10.3233/JPD-181474; Dum RP, 2019, P NATL ACAD SCI USA, V116, P26321, DOI 10.1073/pnas.1902297116; Eraslan M, 2016, ACTA OPHTHALMOL, V94, pE68, DOI 10.1111/aos.12809; FAWER RF, 1983, BRIT J IND MED, V40, P204; Fellner L, 2013, MOL NEUROBIOL, V47, P575, DOI 10.1007/s12035-012-8340-3; Foffani G, 2018, NEURON, V99, P1116, DOI 10.1016/j.neuron.2018.07.028; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; Gironell A, 2018, PARKINSONS DIS-US, V2018, DOI 10.1155/2018/4327597; Goldman SM, 2014, ANNU REV PHARMACOL, V54, P141, DOI 10.1146/annurev-pharmtox-011613-135937; Gustin MS, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.139619; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; HARGREAVES RJ, 1988, NEUROPATH APPL NEURO, V14, P443, DOI 10.1111/j.1365-2990.1988.tb01336.x; HARIK SI, 1984, ANN NEUROL, V15, P568, DOI 10.1002/ana.410150609; Hassani OK, 2020, NEUROBIOL AGING, V85, P22, DOI 10.1016/j.neurobiolaging.2019.09.014; Hou LY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00162; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Kullmann JAP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122874; Lentini P, 2017, MOL MED REP, V15, P3413, DOI 10.3892/mmr.2017.6389; Levinthal DJ, 2012, J NEUROSCI, V32, P6726, DOI 10.1523/JNEUROSCI.0406-12.2012; Lockwood TE, 2021, ANAL CHEM, V93, P10418, DOI 10.1021/acs.analchem.1c02138; Louis ED, 2020, NAT REV NEUROL, V16, P69, DOI 10.1038/s41582-019-0302-1; Markesbery WR, 2009, J NEUROPATH EXP NEUR, V68, P816, DOI 10.1097/NEN.0b013e3181ac10a7; Martinez-Finley Ebany J, 2014, Curr Environ Health Rep, V1, P163, DOI 10.1007/s40572-014-0014-z; McGregor MM, 2019, NEURON, V101, P1042, DOI 10.1016/j.neuron.2019.03.004; Melendez-Flores JD, 2021, METAB BRAIN DIS, V36, P1, DOI 10.1007/s11011-020-00623-1; Munhoz RP, 2004, PARKINSONISM RELAT D, V10, P381, DOI 10.1016/j.parkreldis.2004.03.008; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Obrist D, 2018, AMBIO, V47, P116, DOI 10.1007/s13280-017-1004-9; Pamphlett R, 2000, NEUROTOXICOL TERATOL, V22, P559, DOI 10.1016/S0892-0362(00)00083-0; Pamphlett R, 1996, ACTA NEUROPATHOL, V92, P525, DOI 10.1007/s004010050556; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96359-8; Pamphlett R, 2021, TOXICS, V9, DOI 10.3390/toxics9030067; Pamphlett R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82483-y; Pamphlett R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241054; Pamphlett R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231870; Pamphlett R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220859; Pamphlett R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203627; Paredes-Rodriguez E, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00435; Pollard KM, 2019, BBA-GEN SUBJECTS, V1863, DOI 10.1016/j.bbagen.2019.02.001; Raj K, 2021, NEUROSCI LETT, V753, DOI 10.1016/j.neulet.2021.135873; Reinert A, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0507-7; Rektor I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0187939; Robbins CB, 2021, JAMA OPHTHALMOL, V139, P182, DOI 10.1001/jamaophthalmol.2020.5730; Ross JF, 1996, BRAIN RES, V725, P137; Sanchez-Gomez A, 2021, PARKINSONISM RELAT D, V89, P22, DOI 10.1016/j.parkreldis.2021.06.002; Satue M, 2018, CURR EYE RES, V43, P109, DOI 10.1080/02713683.2017.1370116; Schartup AT, 2019, NATURE, V572, P648, DOI 10.1038/s41586-019-1468-9; SHIPLEY MT, 1985, BRAIN RES, V329, P294, DOI 10.1016/0006-8993(85)90537-2; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Streets DG, 2011, ENVIRON SCI TECHNOL, V45, P10485, DOI 10.1021/es202765m; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; VAHTER ME, 1995, TOXICOL APPL PHARM, V134, P273, DOI 10.1006/taap.1995.1193; Warfvinge K, 1996, TOXICOLOGY, V107, P189, DOI 10.1016/0300-483X(95)03257-G; Wei X, 2021, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.610962; Wen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173731; Yamin G, 2003, J BIOL CHEM, V278, P27630, DOI 10.1074/jbc.M303302200; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4; Zecca L, 2002, J NEURAL TRANSM, V109, P663, DOI 10.1007/s007020200055; Zucca FA, 2006, J NEURAL TRANSM, V113, P757, DOI 10.1007/s00702-006-0453-2; Zucca FA, 2017, PROG NEUROBIOL, V155, P96, DOI 10.1016/j.pneurobio.2015.09.012	86	4	5	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262464	10.1371/journal.pone.0262464	http://dx.doi.org/10.1371/journal.pone.0262464			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015796	gold, Green Published			2022-12-26	WOS:000814820600025
J	Beczek, M; Ryzak, M; Mazur, R; Sochan, A; Polakowski, C; Bieganowski, A				Beczek, Michal; Ryzak, Magdalena; Mazur, Rafal; Sochan, Agata; Polakowski, Cezary; Bieganowski, Andrzej			Influence of slope incline on the ejection of two-phase soil splashed material	PLOS ONE			English	Article							DROP SIZE DISTRIBUTION; WATER EROSION; HEAVY-METALS; RAINFALL; DETACHMENT; WIND; IMPACT; ANGLE; INTENSITY; TRANSPORT	Soil splash is the first step in the process of water erosion, where impacting raindrops cause the detachment and transport of soil material. One of the factors that strongly influences the magnitude of soil splash is the incline of the surface (slope). The aim of this study was to investigate the effect of the slope on the course of the splash phenomenon caused by single-drop impact (one drop impact per soil sample), with respect to the mass and proportions of the ejected material, taking into account its division into solid and liquid phases i.e. soil and water. The investigation was carried out using three types of soil with different textures, in moistened (pressure head corresponding to -1.0 kPa) and air-dry (-1500 kPa) conditions. The soil samples were on three angles of slope, being 5 degrees, 15 degrees, and 30 degrees, respectively. After a single-drop impact with a diameter of 4.2 mm, the ejected material was collected using a splash cup. The following quantities of splashed material were measured: the total mass, the mass of the solid phase, and the mass of the liquid phase. Additionally, the distribution and proportions (soil/ water) of the splashed material were analysed in both the upslope and downslope directions. It was found that: (i) the change of slope had a variable influence on the measured quantities for different soils; (ii) in the case of moistened samples, the measured values were mainly influenced by the texture, while in the dry samples, by the angle of the slope; (iii) with the increase of slope, the splashed material was mostly ejected in the downslope direction (irrespective of moisture conditions); (iv) in the moistened samples, the ejected material consisted mostly of water, while in the dry samples it was soil-this occurred for material ejected both upslope and downslope. The obtained results are important for improving the physical description of the process of splash erosion. A more thorough understanding and better recognition of the mechanisms governing this phenomenon at all stages could contribute to the development of more effective methods for protecting soil against erosion.	[Beczek, Michal; Ryzak, Magdalena; Mazur, Rafal; Sochan, Agata; Polakowski, Cezary; Bieganowski, Andrzej] Polish Acad Sci, Inst Agrophys, Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Beczek, M (corresponding author), Polish Acad Sci, Inst Agrophys, Lublin, Poland.	m.beczek@ipan.lublin.pl	; Polakowski, Cezary/H-7294-2013	Bieganowski, Andrzej/0000-0002-3571-3241; Polakowski, Cezary/0000-0002-1658-8334; Sochan, Agata/0000-0002-1987-0220; Beczek, Michal/0000-0002-8851-0982; Ryzak, Magdalena/0000-0002-6400-5375	National Science Centre, Poland [2018/31/N/ST10/01757]; Statutory Research of Institute of Agrophysics Polish Academy of Sciences	National Science Centre, Poland(National Science Centre, Poland); Statutory Research of Institute of Agrophysics Polish Academy of Sciences	This research was partially financed by: 1) National Science Centre, Poland (https://www.ncn.gov.pl), in the frame of the project no. 2018/31/N/ST10/01757 headed by MB; 2) Statutory Research of Institute of Agrophysics Polish Academy of Sciences. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard SM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58671-7; An J, 2021, SOIL TILL RES, V209, DOI 10.1016/j.still.2021.104937; Ao C, 2020, CATENA, V189, DOI 10.1016/j.catena.2020.104473; Bai Y, 2021, ENVIRON SCI POLLUT R, V28, P21132, DOI 10.1007/s11356-020-11820-x; Banski J, 2007, PRZYRODNICZE UWARUNK, P9; Bartkowiak A, 2020, SOIL SCI ANNU, V71, P118, DOI 10.37501/soilsa/122402; Beczek M, 2021, GEODERMA, V396, DOI 10.1016/j.geoderma.2021.115087; Beczek M, 2019, GEODERMA, V347, P40, DOI 10.1016/j.geoderma.2019.03.028; Bieganowski A, 2018, ADV AGRON, V151, P215, DOI 10.1016/bs.agron.2018.04.003; Bird JC, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/063017; BRANDT CJ, 1989, CATENA, V16, P507, DOI 10.1016/0341-8162(89)90032-5; Brodowski R, 2013, CATENA, V105, P52, DOI 10.1016/j.catena.2013.01.006; Cerda A, 1997, CATENA, V30, P169, DOI 10.1016/S0341-8162(97)00019-2; Che ZZ, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.023032; De Ploey J, 1968, GEOMORPH NF, V12, P174; Drewnik M, 2019, SOIL SCI ANNU, V70, P225, DOI 10.2478/ssa-2019-0020; Duan J, 2021, J ENVIRON MANAGE, V278, DOI 10.1016/j.jenvman.2020.111537; EPEMA GF, 1983, CATENA, P1; Erpul G, 2008, CATENA, V72, P413, DOI 10.1016/j.catena.2007.07.008; Erpul G, 2002, CATENA, V47, P227, DOI 10.1016/S0341-8162(01)00182-5; Fernandez-Raga M, 2021, J ARID ENVIRON, V186, DOI 10.1016/j.jaridenv.2020.104419; Fernandez-Raga M, 2017, EARTH-SCI REV, V171, P463, DOI 10.1016/j.earscirev.2017.06.009; Froehlich W, 1986, Z FUER GEOMORPHOL, V60, P105; Fu SH, 2011, CATENA, V84, P29, DOI 10.1016/j.catena.2010.08.013; GARNAUT R, 1992, ECONOMIC REFORM AND INTERNATIONALISATION: CHINA AND THE PACIFIC REGION, P1; GHADIRI H, 1988, J SOIL SCI, V39, P563, DOI 10.1111/j.1365-2389.1988.tb01240.x; Ghahramani A, 2011, HYDROL PROCESS, V25, P2471, DOI 10.1002/hyp.8086; Ghahramani A, 2011, CATENA, V85, P34, DOI 10.1016/j.catena.2010.11.005; Gholami L, 2019, CATENA, V182, DOI 10.1016/j.catena.2019.104151; Giwangkara GG, 2020, J ADV CIV ENV ENG, V3, P58; Grigar J, 2020, CROP SOILS, V53, P47, DOI [10.1002/crso.20030, DOI 10.1002/CRSO.20030]; Grismer M, 2012, CALIF AGR, V66, P102, DOI 10.3733/ca.v066n03p102; Guerrero R, 2020, INT AGROPHYS, V34, P503, DOI 10.31545/intagr/131099; Hao HX, 2019, CATENA, V173, P494, DOI 10.1016/j.catena.2018.10.029; Hejduk L, 2017, J ECOL ENG, V18, P256, DOI 10.12911/22998993/67105; Hewelke E, 2016, LAND DEGRAD DEV, V27, P955, DOI 10.1002/ldr.2305; Hou TY, 2021, SOIL TILL RES, V207, DOI 10.1016/j.still.2020.104807; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Joniec J, 2017, INT AGROPHYS, V31, P465, DOI 10.1515/intag-2016-0078; Kukal S. S., 2011, Journal of the Indian Society of Soil Science, V59, P87; Leguedois S, 2004, EARTH SURF PROC LAND, V29, P1117, DOI 10.1002/esp.1106; Levia DF, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1225; Li HR, 2021, HYDROL PROCESS, V35, DOI 10.1002/hyp.14060; Liang GT, 2013, ACTA MECH, V224, P2993, DOI 10.1007/s00707-013-0910-6; Lima JLMR De, 1989, SOIL TECHNOL, V2, P71; Liu DD, 2015, CATENA, V128, P54, DOI 10.1016/j.catena.2015.01.022; Liu HePing, 2011, Acta Pedologica Sinica, V48, P479; Liu JF, 2021, EUR J SOIL SCI, V72, P2088, DOI 10.1111/ejss.13094; Luo J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21852-6; Marzen M, 2016, CATENA, V145, P47, DOI 10.1016/j.catena.2016.05.018; MATI BM, 1994, AGR WATER MANAGE, V26, P59, DOI 10.1016/0378-3774(94)90024-8; McFadden D, 2000, J APPL ECONOMET, V15, P447, DOI 10.1002/1099-1255(200009/10)15:5<447::AID-JAE570>3.0.CO;2-1; Meshesha DT, 2014, HYDROLOG SCI J, V59, P2203, DOI 10.1080/02626667.2013.865030; Mhaske SN, 2019, CATENA, V172, P408, DOI 10.1016/j.catena.2018.08.039; Mizugaki S, 2010, HYDROL PROCESS, V24, P576, DOI 10.1002/hyp.7552; Morgan RPC, 1981, P FLORENCE S; Nanko K, 2020, ECOL STUD-ANAL SYNTH, V240, P279, DOI 10.1007/978-3-030-26086-6_12; Nanko K, 2008, CATENA, V72, P348, DOI 10.1016/j.catena.2007.07.002; Panagos P, 2015, ENVIRON SCI POLICY, V54, P438, DOI 10.1016/j.envsci.2015.08.012; Parwada C, 2019, WATER SA, V45, P12, DOI 10.4314/wsa.v45i1.02; POESEN J, 1986, EARTH SURF PROCESSES, V11, P1, DOI 10.1002/esp.3290110103; QUANSAH C, 1981, J SOIL SCI, V32, P215, DOI 10.1111/j.1365-2389.1981.tb01701.x; Roisman IV, 2002, J FLUID MECH, V472, P373, DOI 10.1017/S0022112002002434; Roy S, 2017, RESOUR ENV, V7, P103, DOI [10.5923/j.re.20170704.03, DOI 10.5923/J.RE.20170704.03]; Ryzak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119269; Sadeghi SH, 2017, GEODERMA, V290, P100, DOI 10.1016/j.geoderma.2016.12.007; Sadeghi SH, 2013, HYDROLOG SCI J, V58, P1374, DOI 10.1080/02626667.2013.814917; SAVAT J, 1981, EARTH SURF PROC LAND, V6, P275, DOI 10.1002/esp.3290060308; Sedghi Marjan, 2019, Polish Journal of Soil Science, V52, P129, DOI [10.17951/pjss/2019.52.1.129, 10.17951/pjss.2019.52.1.129]; Seela BK, 2018, J GEOPHYS RES-ATMOS, V123, P11602, DOI 10.1029/2018JD028307; Van Dijk AIJM, 2003, HYDROL PROCESS, V17, P153, DOI 10.1002/hyp.1154; Wu J, 2016, SOIL WATER RES, V11, P83, DOI 10.17221/280/2014-SWR; Zachar D, 1982, DEV SOIL SCI, DOI [10.1016/0092-8674(82)90250-1, DOI 10.1016/0092-8674(82)90250-1]; Zambon N, 2021, CATENA, V196, DOI 10.1016/j.catena.2020.104827; Zambon N, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10124103; Zhang JQ, 2018, J SOIL SEDIMENT, V18, P1620, DOI 10.1007/s11368-017-1855-5; Zumr D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010157	77	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1								10.1371/journal.pone.0262203	http://dx.doi.org/10.1371/journal.pone.0262203			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6X0HY	34995324	gold, Green Published			2022-12-26	WOS:000896106100001
J	Hioki, M; Kanehira, N; Koike, T; Saito, A; Shimaoka, K; Sakakibara, H; Oshida, Y; Akima, H				Hioki, Maya; Kanehira, Nana; Koike, Teruhiko; Saito, Akira; Shimaoka, Kiyoshi; Sakakibara, Hisataka; Oshida, Yoshiharu; Akima, Hiroshi			Relationship between adiponectin and intramuscular fat content determined by ultrasonography in older adults	PLOS ONE			English	Article							INSULIN SENSITIVITY; VISCERAL ADIPOSITY; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; PLASMA-GLUCOSE; LEPTIN; INFLAMMATION; RESISTANCE; INFILTRATION; ASSOCIATIONS	Age-associated intramuscular adipose tissue (IntraMAT) deposition induces the development of insulin resistance and metabolic syndrome. However, the relationship between IntraMAT and biochemical parameters in older adults remains unclear. The purpose of this study, therefore, was to elucidate the relationship between adiponectin and echo intensity-estimated IntraMAT using ultrasonography in normal-weight older adults (men 9, women 13) and examine biochemical parameters. Blood tests were performed to determine fasting levels of glucose, insulin, hemoglobin A1c, total cholesterol (Total-C), high-density-lipoprotein cholesterol, low-density-lipoprotein cholesterol (LDL-C), free fatty acid, triglycerides (TGs), adiponectin, leptin, high-sensitivity C-reactive protein, and high-sensitivity tumor necrosis factor, and homoeostasis model assessment index of insulin resistance (HOMA-IR). Mean gray-scale echo intensity was calculated as the IntraMAT index of the vastus lateralis. Waist circumference was measured at the level of the navel as the visceral adipose tissue (VAT) index. Echo intensity was significantly inversely correlated with adiponectin or LDL-C, and that was significantly positively correlated with TG. Adiponectin level was inversely correlated with waist circumference. Partial correlation analysis with waist circumference as the control variable revealed that adiponectin was inversely correlated with echo intensity, independent of waist circumference, whereas no such correlation was observed after controlling for LDL-C and TG levels. When biochemical parameters were grouped in the principal component analysis, among men, Total-C, insulin, and HOMA-IR or hemoglobin A1c, and high-sensitivity tumor necrosis factor-alpha were grouped with the same distribution for factors 1 and 2. Among women, glucose, insulin, HOMA-IR, and Total-C or TGs were grouped with the same distribution for factors 1 and 2. These data suggest that adiponectin level is related to IntraMAT content, independent of VAT in normal-weight older adults. The dynamics of adiponectin might not be similar to those of other circulating biochemical parameters in older men and women.	[Hioki, Maya; Sakakibara, Hisataka] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan; [Kanehira, Nana] Tokaigakuen Univ, Dept Hlth & Nutr, Nagoya, Aichi, Japan; [Koike, Teruhiko; Oshida, Yoshiharu; Akima, Hiroshi] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan; [Saito, Akira] Kyushu Sangyo Univ, Ctr Hlth & Sports Sci, Fukuoka, Fukuoka, Japan; [Shimaoka, Kiyoshi] Tokaigakuen Univ, Dept Human Wellness, Miyoshi, Aichi, Japan; [Hioki, Maya] Fac Hlth Care & Med Sports, Dept Phys Therapy, Ichihara, Chiba, Japan; [Sakakibara, Hisataka] Ichinomiya Kenshin Coll Nursing, Ichinomiya, Aichi, Japan	Nagoya University; Nagoya University	Hioki, M (corresponding author), Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan.; Hioki, M (corresponding author), Fac Hlth Care & Med Sports, Dept Phys Therapy, Ichihara, Chiba, Japan.	maya@mri.biglobe.ne.jp			Ministry of Education, Culture, Sports and Science and technology Grant [23650432]; Descente and Ishimoto Memorial Foundation for the Promotion of Sport Science	Ministry of Education, Culture, Sports and Science and technology Grant; Descente and Ishimoto Memorial Foundation for the Promotion of Sport Science	HA, Challenging Exploratory research from the Ministry of Education, Culture, Sports and Science and technology Grant(23650432), https://www.jsps.go.jp/english/index.html NO. YO, Descente and Ishimoto Memorial Foundation for the Promotion of Sport Science (grant number N/A), https://www.descente.co.jp/ishimoto/NO.	Akima H, 2007, ACTA ASTRONAUT, V60, P728, DOI 10.1016/j.actaastro.2006.10.006; Akima H, 2016, MAGN RESON IMAGING, V34, P397, DOI 10.1016/j.mri.2015.12.038; Akima H, 2015, EUR J APPL PHYSIOL, V115, P1627, DOI 10.1007/s00421-015-3148-2; Bredella MA, 2011, OBESITY, V19, P911, DOI 10.1038/oby.2010.296; Cohen AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116489; Dornbush S., 2020, PHYSIOLOGY; Fang HJ, 2018, CURR OPIN CLIN NUTR, V21, P360, DOI 10.1097/MCO.0000000000000485; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Gadekar Tukaram, 2020, Med J Armed Forces India, V76, P41, DOI 10.1016/j.mjafi.2017.12.001; Hioki M, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04456-6; Hioki M, 2019, EUR J APPL PHYSIOL, V119, P113, DOI 10.1007/s00421-018-4005-x; Houde AA, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0174-1; Hu XB, 2007, ACTA BIOCH BIOPH SIN, V39, P131, DOI 10.1111/j.1745-7270.2007.00255.x; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jain SH, 2009, DIABETES CARE, V32, P903, DOI 10.2337/dc08-1733; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Kantartzis K, 2006, CLIN CHEM, V52, P1934, DOI 10.1373/clinchem.2006.067397; Khabour OF, 2010, AGING MALE, V13, P188, DOI 10.3109/13685531003657800; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kizer JR, 2010, J GERONTOL A-BIOL, V65, P1208, DOI 10.1093/gerona/glq122; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moller N, 1998, J CLIN ENDOCR METAB, V83, P931, DOI 10.1210/jc.83.3.931; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Nakamura Y, 2009, OBESITY, V17, P1269, DOI 10.1038/oby.2009.3; Rodrigo CP, 2015, NUTR HOSP, V31, P49, DOI 10.3305/nh.2015.31.sup3.8751; Perseghin G, 2002, AM J PHYSIOL-ENDOC M, V283, pE556, DOI 10.1152/ajpendo.00127.2002; Perseghin G, 2007, J CLIN ENDOCR METAB, V92, P4883, DOI 10.1210/jc.2007-0325; Pillen S, 2008, MUSCLE NERVE, V37, P679, DOI 10.1002/mus.21015; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Vella CA, 2017, MED SCI SPORT EXER, V49, P915, DOI 10.1249/MSS.0000000000001179; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; World Health Organization, 2008, WAIST CIRCUMFERENCE; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Zoico E, 2010, J GERONTOL A-BIOL, V65, P295, DOI 10.1093/gerona/glp155	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262271	10.1371/journal.pone.0262271	http://dx.doi.org/10.1371/journal.pone.0262271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982778	Green Published, gold			2022-12-26	WOS:000834805700025
J	Nakawuki, AW; Nekaka, R; Ssenyonga, LVN; Masifa, G; Nuwasiima, D; Nteziyaremye, J; Iramiot, JS				Nakawuki, Ashley Winfred; Nekaka, Rebecca; Ssenyonga, Lydia V. N.; Masifa, George; Nuwasiima, Dorreck; Nteziyaremye, Julius; Iramiot, Jacob Stanley			Bacterial colonization, species diversity and antimicrobial susceptibility patterns of indwelling urinary catheters from postpartum mothers attending a Tertiary Hospital in Eastern Uganda	PLOS ONE			English	Article							TRACT-INFECTIONS; RESISTANCE	BackgroundPostpartum urinary Catheter-Related Infections (CRIs) are a significant cause of maternal sepsis. Several studies done have reported the presence of mixed populations of bacteria with a significant increase in Extended-Spectrum Beta-Lactamase (ESBL) Enterobacteriaceae spps, Methicillin-Resistant Staphylococcus aureus (MRSA), Multi-Drug Resistant (MDR) bacteria in urine and blood cultures of catheterized patients despite the use of prophylactic antibiotics. This study aimed at determining the bacterial species diversity and susceptibility patterns of indwelling urinary catheters from postpartum mothers attending Mbale Regional Referral Hospital (MRRH). MethodsA cross-sectional study employing quantitative and qualitative was carried out in MRRH among postpartum mothers with urinary catheters and their care-takers. The purposive non-random sampling strategy was used to collect data using an interviewer-administered questionnaire for the quantitative data collection and in-depth interviews for qualitative data collection. All the data collection tools used were developed, pretested and validated. At the point of de-catheterization, Catheter tips from enrolled participants were cut about 2-3cm below the balloon aseptically into test-tube containing peptone water, sonication technique employed, and incubation done 24hours then cultured to ensure phenotypic identification. An antibiotic sensitivity test was performed using the disc diffusion method following Clinical and Laboratory Standards Institute (CLSI) guidelines. Quantitative data collected was entered in Microsoft Excel and then exported to STATA14 for statistical analysis. Thematic analysis was used to analyse and organise qualitative data by an inductive coding method using Nvivo 12 software. ResultsIn this study, 208 postpartum mothers participated, the majority of whom were caesarean section mothers of age range 20-24 years and 17 care-takers with a median age of 32 years. The prevalence of catheter tips bacterial colonisation was 98% despite 88.5% of the participants being on broad-spectrum antibiotics. The average duration of catheterisation was 2 days. All bacteria isolates were potential uro-pathogens with a mean occurrence of 2 bacteria species in each urinary catheter tip. The rates of MDR to commonly used antibiotics were high. The urinary catheter size of greater than F14 and duration of catheterization greater than 2 days were significantly associated with the number of bacterial species isolated from each sample. The maintenance care and knowledge of care-urinary catheter care among the care-takers was found sub-optimal. ConclusionThere was a high prevalence of catheter colonisation with bacterial spps diversity averaging 2 spps per sample despite use of broad spectrum antibiotics. The MDR rates were high, which calls for routine culture and sensitivity. Health workers practicing obstetric medicine need to pay attention to catheter sizes during catheterisation and its duration. Health education should be part of antenatal and postnatal care education.	[Nakawuki, Ashley Winfred; Ssenyonga, Lydia V. N.; Nuwasiima, Dorreck] Busitema Univ, Dept Nursing, Fac Hlth Sci, Mbale, Uganda; [Nekaka, Rebecca] Busitema Univ Sci, Fac Hlth, Dept Community & Publ Hlth, Mbale, Uganda; [Masifa, George] Mbale Clin Res Inst, Mbale, Uganda; [Nteziyaremye, Julius] Busitema Univ, Dept Obstet & Gynaecol, Fac Hlth Sci, Mbale, Uganda; [Iramiot, Jacob Stanley] Busitema Univ, Dept Microbiol & Immunol, Fac Hlth Sci, Mbale, Uganda		Iramiot, JS (corresponding author), Busitema Univ, Dept Microbiol & Immunol, Fac Hlth Sci, Mbale, Uganda.	jiramiot@gmail.com	Nekaka, Rebecca/GYQ-7546-2022	Nekaka, Rebecca/0000-0002-9199-7197; Iramiot, Jacob Stanley/0000-0002-9239-6641	Fogarty International Center of the National Institutes of Health; U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy (S/GAC); President's Emergency Plan for AIDS Relief (PEPFAR) [1R25TW011213]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy (S/GAC); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health, U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy (S/GAC), and President's Emergency Plan for AIDS Relief (PEPFAR) under Award Number 1R25TW011213.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."	Abdallah N. M. A., 2011, International Journal for Biotechnology and Molecular Biology Research, V2, P172; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Bardoloi V, 2017, J MED MICROBIOL, V66, P927, DOI 10.1099/jmm.0.000525; Bebell LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175456; Chadha T., 2014, J BACTERIOL PARASITO, V5, P5, DOI DOI 10.4172/2155-9597.1000190; Frank DN., 2009, CULTURE INDEPENDENT, V4, P1; Fredrick B., 2019, J ADV MED MED RES, V29, P1; Gould C V., 2019, GUIDELINE PREVENTION, V61; Health Protection Surveillance Centre, 2011, S A R I GUID PREV CA; Hooton TM., 2010, CHINESE J INFECT CHE, V10, P321; Hossain MD, 2014, TZU CHI MED J, V26, P127, DOI 10.1016/j.tcmj.2014.06.003; Hussein J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087378; Knowles SJ, 2015, BJOG-INT J OBSTET GY, V122, P663, DOI 10.1111/1471-0528.12892; Letica-Kriegel AS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022137; Lo E, 2014, INFECT CONT HOSP EP, V35, P464, DOI [10.1086/675718, 10.1017/S0899823X00193845]; Magiorakos A., EXPERT PROPOSAL STAN; Maharjan G, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/7624857; Manohar J, 2020, AM J INFECT CONTROL, V48, P178, DOI 10.1016/j.ajic.2019.08.005; Ministerio de Agricultura A. y M. A., 2013, REAL DECR 670 2013 6, P1; Musinguzi B., 2019, ADV INFECT DIS, V9, P183; Ngonzi J, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1891-1; Ngonzi J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0986-9; Nicolle LE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-23; Nteziyaremye J., 2020, E UGANDA, P1, DOI [10.1371/journal.pone.0230523, DOI 10.1371/JOURNAL.PONE.0230523]; Paterson DL, 2007, CLIN INFECT DIS, V45, P1179, DOI 10.1086/522287; Peerayeh SN, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.30593; Safdar N, 2016, AM J INFECT CONTROL, V44, pE23, DOI 10.1016/j.ajic.2015.10.011; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; SHAPIRO M, 1984, INFECT CONT HOSP EP, V5, P525, DOI 10.1017/S019594170006104X; Shrestha LB, 2019, INFECT DRUG RESIST, V12, P957, DOI 10.2147/IDR.S200988; Soma-Pillay P, 2016, CARDIOVASC J AFR, V27, P89, DOI 10.5830/CVJA-2016-021; Stanley IJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200093; Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678; Tolera Moti, 2018, Adv Med, V2018, P2127814, DOI 10.1155/2018/2127814; UBOS, 2016, UG DEM HLTH SURV; Wald HL, 2008, ARCH SURG-CHICAGO, V143, P551, DOI 10.1001/archsurg.143.6.551; WHO, 2011, WHO LIB CAT PUBL DAT; World Health Organization, 2015, HLTH 2015 MDGS MILL; Xu YJ, 2012, J CLIN MICROBIOL, V50, P3901, DOI 10.1128/JCM.01237-12; Zarb P, 2012, EUROSURVEILLANCE, V17, P4	40	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262414	10.1371/journal.pone.0262414	http://dx.doi.org/10.1371/journal.pone.0262414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007300	gold, Green Published			2022-12-26	WOS:000741060700008
J	Alkhaffaf, B; Metryka, A; Blazeby, JM; Glenny, AM; Williamson, PR; Bruce, IA				Alkhaffaf, Bilal; Metryka, Aleksandra; Blazeby, Jane M.; Glenny, Anne-Marie; Williamson, Paula R.; Bruce, Iain A.		GASTROS Int Working Grp	How are trial outcomes prioritised by stakeholders from different regions? Analysis of an international Delphi survey to develop a core outcome set in gastric cancer surgery	PLOS ONE			English	Article								Background International stakeholder participation is important in the development of core outcome sets (COS). Stakeholders from varying regions may value health outcomes differently. Here, we explore how region, health income and participant characteristics influence prioritisation of outcomes during development of a COS for gastric cancer surgery trials (the GASTROS study). Methods 952 participants from 55 countries participating in a Delphi survey during COS development were eligible for inclusion. Recruits were grouped according to region (East or West), country income classification (high and low-to-middle income) and other characteristics (e.g. patients; age, sex, time since surgery, mode of treatment, surgical approach and healthcare professionals; clinical experience). Groups were compared with respect to how they categorised 56 outcomes identified as potentially important to include in the final COS ('consensus in', 'consensus out', 'no consensus'). Outcomes categorised as 'consensus in' or 'consensus out' by all 3 stakeholder groups would be automatically included in or excluded from the COS respectively. Results In total, 13 outcomes were categorised 'consensus in' (disease-free survival, disease-specific survival, surgery-related death, recurrence of cancer, completeness of tumour removal, overall quality of life, nutritional effects, all-cause complications, intraoperative complications, anaesthetic complications, anastomotic complications, multiple organ failure, and bleeding), 13 'consensus out' and 31 'no consensus'. There was little variation in prioritisation of outcomes by stakeholders from Eastern or Western countries and high or low-to-middle income countries. There was little variation in outcome prioritisation within either health professional or patient groups. Conclusion Our study suggests that there is little variation in opinion within stakeholder groups when participant region and other characteristics are considered. This finding may help COS developers when designing their Delphi surveys and recruitment strategies. Further work across other clinical fields is needed before broad recommendations can be made.	[Alkhaffaf, Bilal] Salford Royal NHS Fdn Trust, Salford Royal Hosp, Dept Oesophago Gastr Surg, Manchester, Lancs, England; [Alkhaffaf, Bilal] Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci, Manchester, Lancs, England; [Metryka, Aleksandra; Bruce, Iain A.] Manchester Univ NHS Fdn Trust, Royal Manchester Childrens Hosp, Paediat ENT Dept, Manchester, Lancs, England; [Blazeby, Jane M.] Univ Bristol, Ctr Surg Res, Bristol, Avon, England; [Blazeby, Jane M.] Univ Bristol, Bristol NIHR Biomed Res Ctr, Bristol, Avon, England; [Glenny, Anne-Marie] Univ Manchester, Div Dent, Sch Med Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Williamson, Paula R.] Univ Liverpool, MRC North West Hub Trials Methodol Res, Liverpool, Merseyside, England; [Williamson, Paula R.] Liverpool Hlth Partners, Liverpool, Merseyside, England; [Bruce, Iain A.] Univ Manchester, Div Infect Immun & Resp Med, Fac Biol Med & Hlth, Manchester, Lancs, England	Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Royal Manchester Children's Hospital; University of Bristol; University of Bristol; University of Manchester; University of Liverpool; University of Manchester	Alkhaffaf, B (corresponding author), Salford Royal NHS Fdn Trust, Salford Royal Hosp, Dept Oesophago Gastr Surg, Manchester, Lancs, England.; Alkhaffaf, B (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci, Manchester, Lancs, England.	bilal.alkhaffaf@srft.nhs.uk	Bodur, Muhammed Selim/GXG-1718-2022; da Costa, Paulo Matos/ABD-1573-2021; /C-4324-2009	Bodur, Muhammed Selim/0000-0002-8168-623X; da Costa, Paulo Matos/0000-0002-7550-8285; Bruce, Iain/0000-0003-0831-4760; Blazeby, Jane/0000-0002-3354-3330; Metryka, Aleksandra/0000-0001-9871-5167; Glenny, Anne-Marie/0000-0003-4037-2899; /0000-0002-6518-5806; Alkhaffaf, Bilal/0000-0001-5751-1846; O'Neill, Linda/0000-0002-0109-9650	National Institute for Health Research (NIHR) [DRF2015-08-023]; National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This study is funded by the National Institute for Health Research (NIHR -www.nihr.ac.uk) Doctoral Research Fellowship Grant (DRF2015-08-023). The award was received by BA. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhaffaf B, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034782; Alkhaffaf B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021796; Alkhaffaf B, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2100-7; Bang YJ, 2014, ASIA-PAC J CLIN ONCO, V10, P38, DOI 10.1111/ajco.12112; Chan WL, 2019, CLIN ONCOL-UK, V31, P570, DOI 10.1016/j.clon.2019.05.012; Coulman KD, 2016, OBES SURG, V26, P2738, DOI 10.1007/s11695-016-2186-0; Dodd S, 2018, J CLIN EPIDEMIOL, V96, P84, DOI 10.1016/j.jclinepi.2017.12.020; Fish R, 2020, J CLIN EPIDEMIOL, V128, P118, DOI 10.1016/j.jclinepi.2020.09.028; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Kirkham JJ, 2019, J CLIN EPIDEMIOL, V115, P90, DOI 10.1016/j.jclinepi.2019.07.007; Messager M, 2016, EJSO-EUR J SURG ONC, V42, P116, DOI 10.1016/j.ejso.2015.09.017; Michalowski J., 2018, COMMISSIONED HEALTHC; Potter S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1591-y; Remus A, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-020-01197-3; Williamson PR, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1978-4; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Yamamoto M, 2015, J GASTROINTEST ONCOL, V6, P79, DOI 10.3978/j.issn.2078-6891.2014.097	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261937	10.1371/journal.pone.0261937	http://dx.doi.org/10.1371/journal.pone.0261937			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972165	Green Published, Green Submitted, gold			2022-12-26	WOS:000773555700070
J	Lin, L; Liu, WQ; Mu, J; Zhan, EM; Wei, H; Hong, SQ; Hua, ZY				Lin, Lu; Liu, Weiqin; Mu, Jing; Zhan, Enmei; Wei, Hong; Hong, Siqi; Hua, Ziyu			Effect of neonatal neuronal intensive care unit on neonatal encephalopathy	PLOS ONE			English	Article							CEREBRAL-PALSY; RISK-FACTORS; MULTIPLE BIRTHS; PREGNANCY	Prophylaxis of brain injury in newborns has been a main concern since the first neonatal neuronal intensive care unit (NNICU) was established in the world in 2008. The aim of this study was to outline and evaluate the unit's development by analyzing the demographics of the patients, the services delivered, the short-term outcomes before and after the establishment of NNICU. During the two investigation periods, 384 newborns were diagnosed or suspected as "neonatal encephalopathy", among which 185 patients admitted to NNICU between 2011.03.01 and 2012.09.30 before the establishment of NNICU were enrolled in the pre-NNICU group, another 199 neonates hospitalized during 2018.03.01 to 2019.09.30 were included in the post-NNICU group. Patients in the post-NNICU group were more likely to have seizures (P = 0.001), incomplete or absent primitive reflexes (P = 0.002), therapeutic hypothermia (P<0.001) and liquid control (P<0.001) in acute phase. Meanwhile, amplitude-integrated electro encephalogram (aEEG) monitoring (P<0.001) and cranial ultrasound (P<0.001) were more often used in NNICU. Both of the follow-up rate in brain MRI and the assessment of neurodevelopment at 3 months were higher in the post-NNICU group (P<0.001). In conclusion, the NNICU focused on the neonatal neurocritical care for the babies susceptible to NE with the guidance of evidence-based medicine, the establishment of NNICU is gradually improving and standardizing the neuroprotective therapy and clinical follow-up to improve neurodevelopmental prognosis of the NE patients in CHCMU.	[Lin, Lu; Liu, Weiqin; Mu, Jing; Zhan, Enmei; Wei, Hong; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Lin, Lu; Liu, Weiqin; Mu, Jing; Zhan, Enmei; Wei, Hong; Hong, Siqi; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Minist Educ Key Lab Child Dev & Disorders,Chongqi, Natl Clin Res Ctr Child Hlth & Disorders,China In, Chongqing, Peoples R China; [Hong, Siqi] Chongqing Med Univ, Childrens Hosp, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Minist Educ Key Lab Child Dev & Disorders,Chongqi, Natl Clin Res Ctr Child Hlth & Disorders,China In, Chongqing, Peoples R China.	h_ziyu@126.com			Clinical Research Project of Children's Hospital of Chongqing Medical University [YBXM 2019007]	Clinical Research Project of Children's Hospital of Chongqing Medical University	This study was supported by grants from the Clinical Research Project of Children's Hospital of Chongqing Medical University (YBXM 2019007), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Obstet Gynecol, V123, P896, DOI 10.1097/01.AOG.0000445580.65983.d2; [Anonymous], 2018, QUEENSLAND CLIN GUID; [Anonymous], 2019, CHINESE J PRACTICAL, V34, P126, DOI [10.19538/j.ek2019020615, DOI 10.19538/J.EK2019020615]; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Bonifacio SL, 2011, NAT REV NEUROL, V7, P485, DOI 10.1038/nrneurol.2011.119; Campbell SK, 2002, DEV MED CHILD NEUROL, V44, P263, DOI 10.1017/S0012162201002043; Campbell Suzann K, 2006, Pediatr Phys Ther, V18, P119, DOI 10.1097/01.pep.0000223108.03305.5d; Charon V, 2016, EUR J RADIOL, V85, P1366, DOI 10.1016/j.ejrad.2016.05.005; CLANCY RR, 1988, EPILEPSIA, V29, P256, DOI 10.1111/j.1528-1157.1988.tb03715.x; Dixon BJ, 2015, INT J MOL SCI, V16, P22368, DOI 10.3390/ijms160922368; Doyle LW, 2010, J PEDIATR-US, V156, P49, DOI 10.1016/j.jpeds.2009.07.013; Dunin-Wasowicz D, 2000, J CHILD NEUROL, V15, P417; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Ellis M, 2000, BMJ-BRIT MED J, V320, P1229, DOI 10.1136/bmj.320.7244.1229; Glass HC, 2016, CLIN PERINATOL, V43, P547, DOI 10.1016/j.clp.2016.04.011; Glass HC, 2015, ANESTH ANALG, V120, P1337, DOI 10.1213/ANE.0000000000000705; Glass HC, 2014, SEMIN PEDIATR NEUROL, V21, P241, DOI 10.1016/j.spen.2014.10.003; Glass HC, 2010, NEUROCRIT CARE, V12, P421, DOI 10.1007/s12028-009-9324-7; Hintz SR, 2015, PEDIATRICS, V135, pE32, DOI 10.1542/peds.2014-0898; Kovo M, 2016, J MATERN-FETAL NEO M, V29, P1462, DOI 10.3109/14767058.2015.1051024; Liu JM, 2000, INT J EPIDEMIOL, V29, P292, DOI 10.1093/ije/29.2.292; Liu WQ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00133; Malone A, 2009, EPILEPSIA, V50, P2097, DOI 10.1111/j.1528-1167.2009.02132.x; Mulkey SB, 2014, J CHILD NEUROL, V29, P31, DOI 10.1177/0883073812469051; Newman JE, 2012, J PEDIATR-US, V161, P1041, DOI 10.1016/j.jpeds.2012.05.048; Pascual-Castroviejo I, 2012, NEUROLOGIA, V27, P336, DOI 10.1016/j.nrl.2011.12.017; PETTERSON B, 1990, AM J MED GENET, V37, P346, DOI 10.1002/ajmg.1320370311; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shao XM ZC., 2011, CHINESE J EVIDENCE B, V6, P327, DOI [10.3969/j.issn.1673-5501.2011.05.003, DOI 10.3969/J.ISSN.1673-5501.2011.05.003]; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Van Meurs KP, 2018, AM J PERINAT, V35, P1197, DOI 10.1055/s-0038-1646954; Wieczorek AI, 2015, GINEKOL POL, V86, P137	33	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261837	10.1371/journal.pone.0261837	http://dx.doi.org/10.1371/journal.pone.0261837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972144	Green Published, gold			2022-12-26	WOS:000773555700060
J	Xiao, JY; Xie, BG; Zhou, KC; Shi, SN; Li, JH; Yang, MX; Liu, CC				Xiao, Jianyong; Xie, Binggeng; Zhou, Kaichun; Shi, Shana; Li, Junhan; Yang, Mingxia; Liu, ChangChang			Assessment of soil erosion in the Dongting Lake Basin, China: Patterns, drivers, and implications	PLOS ONE			English	Article							LAND-USE CHANGE; FOR-GREEN PROGRAM; LOESS PLATEAU; CLIMATE-CHANGE; USE/COVER CHANGE; WATER EROSION; CATCHMENT; IMPACTS; RUNOFF; CONSERVATION	Soil loss caused by erosion is a global problem. Therefore, the assessment of soil erosion and the its driving mechanism are of great significance to soil conservation. However, soil erosion is affected by both climate change and human activities, which have not been quantified, and few researchers studied the differences in the driving mechanisms of soil erosion depending on the land use type. Therefore, the spatiotemporal characteristics and changing trends of soil erosion in the Dongting Lake Basin were analyzed in this study. Geographic detectors were used to identify the dominant factors affecting soil erosion in different land use types. In this study, a sensitivity experiment was conducted to clarify the relative contributions of climate change and human activities to soil erosion changes. In addition, we studied the effects of different land use types and vegetation cover restoration on soil erosion. The results show that soil erosion in the Dongting Lake Basin decreased from 2000 to 2018. Human activities represented by land use types and vegetation coverage significantly contributed to the alleviation of soil erosion in the Dongting Lake Basin, whereas climate change represented by rainfall slightly aggravated soil erosion in the study area. The restoration of grassland vegetation and transfer of cultivated land to woodlands in the study area improved the soil erosion. The slope steepness is the key factor affecting the intensity of soil erosion in dry land, paddy fields, and unused land, whereas the vegetation coverage is the key factor affecting the intensity of soil erosion in woodland, garden land, and grassland. Detailed spatiotemporally mapping of soil erosion was used to determine the connections between soil erosion and potential drivers, which have important implications for vegetation restoration and the optimization of land use planning.	[Xiao, Jianyong; Xie, Binggeng; Zhou, Kaichun; Shi, Shana; Li, Junhan; Yang, Mingxia; Liu, ChangChang] Hunan Normal Univ, Sch Geog Sci, Changsha, Peoples R China	Hunan Normal University	Xie, BG (corresponding author), Hunan Normal Univ, Sch Geog Sci, Changsha, Peoples R China.	xbgyb1961@163.com			Joint Funds of the National Natural Science Foundation of China [U19A2051]	Joint Funds of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by Joint Funds of the National Natural Science Foundation of China (U19A2051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boardman J, 2006, CATENA, V68, P73, DOI 10.1016/j.catena.2006.03.007; Bochet E, 2006, EARTH SURF PROC LAND, V31, P536, DOI 10.1002/esp.1351; Cao YC., 2018, ECOLOGICAL EC, P111; Cao ZH, 2021, GEODERMA, V389, DOI 10.1016/j.geoderma.2021.114949; [陈海山 Chen Haishan], 2013, [大气科学, Chinese Journal of Atmospheric Sciences], V37, P1; [陈思旭 Chen Sixu], 2014, [资源科学, Resources Science], V36, P1288; de Almeida AQ, 2017, PESQUI AGROPECU BRAS, V52, P371, DOI [10.1590/s0100-204x2017000600001, 10.1590/S0100-204X2017000600001]; Deng C., 2021, INT SOIL WATER CONSE; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; [邓正苗 Deng Zhengmiao], 2018, [农业现代化研究, Research of Agricultural Modernization], V39, P994; Devaty J, 2019, LAND USE POLICY, V82, P674, DOI 10.1016/j.landusepol.2018.11.058; Duan J, 2020, J HYDROL, V582, DOI 10.1016/j.jhydrol.2019.124290; Edwards BL, 2019, J SOIL WATER CONSERV, V74, P405, DOI 10.2489/jswc.74.4.405; Ferreira V, 2014, ENVIRON MANAGE, V54, P67, DOI 10.1007/s00267-014-0281-3; Gao JB, 2019, CATENA, V172, P369, DOI 10.1016/j.catena.2018.08.035; Hao HX, 2020, LAND DEGRAD DEV, V31, P1851, DOI 10.1002/ldr.3579; Haregeweyn N, 2008, CATENA, V75, P65, DOI 10.1016/j.catena.2008.04.011; Issa OM, 2006, EARTH SURF PROC LAND, V31, P929, DOI 10.1002/esp.1303; Kijowska-Strugala M, 2018, LAND DEGRAD DEV, V29, P1871, DOI 10.1002/ldr.2936; [李佳蕾 Li Jialei], 2020, [生态学报, Acta Ecologica Sinica], V40, P3473; Liang SZX, 2021, J SOIL SEDIMENT, V21, P134, DOI 10.1007/s11368-020-02756-3; Liang Y, 2020, J HYDROL, V584, DOI 10.1016/j.jhydrol.2020.124694; Liu BY, 2020, INT SOIL WATER CONSE, V8, P430, DOI 10.1016/j.iswcr.2020.07.002; Liu JB, 2018, J GEOGR SCI, V28, P59, DOI 10.1007/s11442-018-1459-z; Liu Ming, 2008, Yingyong Shengtai Xuebao, V19, P1317; Liu YS, 2014, LAND USE POLICY, V40, P6, DOI 10.1016/j.landusepol.2013.03.013; Liu Y, 2020, CLEAN-SOIL AIR WATER, V48, DOI 10.1002/clen.201900195; Luo J, 2020, FORESTS, V11, DOI 10.3390/f11030329; Luo J, 2020, CATENA, V190, DOI 10.1016/j.catena.2020.104515; Ma WM, 2016, SOIL TILL RES, V155, P69, DOI 10.1016/j.still.2015.07.007; Mancino G, 2016, ECOL INDIC, V71, P544, DOI 10.1016/j.ecolind.2016.07.040; Miller ME, 2011, INT J WILDLAND FIRE, V20, P982, DOI 10.1071/WF09142; Mohammad AG, 2010, CATENA, V81, P97, DOI 10.1016/j.catena.2010.01.008; Ndayisaba F, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020129; Ni SM, 2020, J SOIL SEDIMENT, V20, P2997, DOI 10.1007/s11368-020-02665-5; Ouyang W, 2018, SCI TOTAL ENVIRON, V613, P798, DOI 10.1016/j.scitotenv.2017.09.173; Panagos P, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12091365; Patton NR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05743-y; Anh PTQ, 2014, GEODERMA, V232, P352, DOI 10.1016/j.geoderma.2014.05.011; Phinzi K, 2019, INT SOIL WATER CONSE, V7, P27, DOI 10.1016/j.iswcr.2018.12.002; Qi JY, 2020, J HYDROL, V581, DOI 10.1016/j.jhydrol.2019.124415; Qi Y, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106528; [钱庆欢 Qian Qinghuan], 2018, [地理学报, Acta Geographica Sinica], V73, P2135; Renard KG., 1997, AGR HDB, DOI DOI 10.1201/9780203739358-5; Runting RK, 2017, GLOBAL CHANGE BIOL, V23, P28, DOI 10.1111/gcb.13457; Safwan M, 2021, INT J SEDIMENT RES, V36, P207, DOI 10.1016/j.ijsrc.2020.06.005; Smith P, 2016, GLOBAL CHANGE BIOL, V22, P1008, DOI 10.1111/gcb.13068; Sun WY, 2014, CATENA, V121, P151, DOI 10.1016/j.catena.2014.05.009; Swarnkar S, 2018, HYDROL EARTH SYST SC, V22, P2471, DOI 10.5194/hess-22-2471-2018; Teng MJ, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134164; Vanwalleghem T, 2017, ANTHROPOCENE, V17, P13, DOI 10.1016/j.ancene.2017.01.002; [王国杰 WANG Guojie], 2006, [湖泊科学, Scientia Limnologica Sinica], V18, P470; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang X, 2016, CATENA, V137, P256, DOI 10.1016/j.catena.2015.10.004; Wei YH, 2018, EARTH SURF PROC LAND, V43, P1899, DOI 10.1002/esp.4364; Wen Z, 2021, LAND DEGRAD DEV, V32, P1127, DOI 10.1002/ldr.3646; Wuepper D, 2020, NAT SUSTAIN, V3, P51, DOI 10.1038/s41893-019-0438-4; Xiao Y, 2021, GEOMAT NAT HAZ RISK, V12, P103, DOI 10.1080/19475705.2020.1861112; Xu YQ, 2011, J GEOGR SCI, V21, P1138, DOI 10.1007/s11442-011-0906-x; Yan R, 2018, INT SOIL WATER CONSE, V6, P13, DOI 10.1016/j.iswcr.2017.12.002; Yu KK, 2017, EARTH SURF PROC LAND, V42, P1238, DOI 10.1002/esp.4071; Zare M, 2017, LAND USE POLICY, V67, P558, DOI 10.1016/j.landusepol.2017.06.028; Zhang SH, 2017, SCI TOTAL ENVIRON, V574, P34, DOI 10.1016/j.scitotenv.2016.09.024; Zhang Y, 2012, J SOIL WATER CONSERV, V67, P390, DOI 10.2489/jswc.67.5.390; Zhao GJ, 2013, LAND DEGRAD DEV, V24, P499, DOI 10.1002/ldr.2246	66	3	3	21	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261842	10.1371/journal.pone.0261842	http://dx.doi.org/10.1371/journal.pone.0261842			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972138	gold, Green Published			2022-12-26	WOS:000773555700061
J	Monga, J; Adrianto, I; Rogers, C; Gadgeel, S; Chitale, D; Alumkal, JJ; Beltran, H; Zoubeidi, A; Ghosh, J				Monga, Jitender; Adrianto, Indra; Rogers, Craig; Gadgeel, Shirish; Chitale, Dhananjay; Alumkal, Joshi J.; Beltran, Himisha; Zoubeidi, Amina; Ghosh, Jagadananda			Tribbles 2 pseudokinase confers enzalutamide resistance in prostate cancer by promoting lineage plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Enzalutamide, a second-generation antiandrogen, is commonly prescribed for the therapy of advanced prostate cancer, but enzalutamide-resistant, lethal, or incurable disease invariably develops. To understand the molecular mechanism(s) behind enzalutamide resistance, here, we comprehensively analyzed a range of prostate tumors and clinically relevant models by gene expression array, immunohistochemistry, and Western blot, which revealed that enzalutamideresistant prostate cancer cells and tumors overexpress the pseudokinase, Tribbles 2 (TRIB2). Inhibition of TRIB2 decreases the viability of enzalutamide-resistant prostate cancer cells, suggesting a critical role of TRIB2 in these cells. Moreover, the overexpression of TRIB2 confers resistance in prostate cancer cells to clinically relevant doses of enzalutamide, and this resistance is lost upon inhibition of TRIB2. Interestingly, we found that TRIB2 downregulates the luminal markers androgen receptor and cytokeratin 8 in prostate cancer cells but upregulates the neuronal transcription factor BRN2 (Brain 2) and the stemness factor SOX2 (SRY-box 2) to induce neuroendocrine characteristics. Finally, we show that inhibition of either TRIB2 or its downstream targets, BRN2 or SOX2, resensitizes resistant prostate cancer cells to enzalutamide. Thus, TRIB2 emerges as a potential new regulator of trans differentiation that confers enzalutamide resistance in prostate cancer cells via a mechanism involving increased cellular plasticity and lineage switching.	[Monga, Jitender; Rogers, Craig; Ghosh, Jagadananda] Henry Ford Hlth Syst, Vattikuti Urol Inst, Detroit, MI 48202 USA; [Adrianto, Indra] Henry Ford Hlth Syst, Publ Hlth Sci, Detroit, MI USA; [Rogers, Craig; Gadgeel, Shirish; Chitale, Dhananjay; Ghosh, Jagadananda] Henry Ford Hlth Syst, Henry Ford Canc Inst, Detroit, MI 48202 USA; [Chitale, Dhananjay] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI 48202 USA; [Alumkal, Joshi J.] Univ Michigan, Dept Internal Med, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Beltran, Himisha] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Beltran, Himisha] Harvard Med Sch, Boston, MA 02115 USA; [Zoubeidi, Amina] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada; [Zoubeidi, Amina] Vancouver Prostate Ctr, Vancouver, BC, Canada	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of British Columbia	Ghosh, J (corresponding author), Henry Ford Hlth Syst, Vattikuti Urol Inst, Detroit, MI 48202 USA.; Ghosh, J (corresponding author), Henry Ford Hlth Syst, Henry Ford Canc Inst, Detroit, MI 48202 USA.	jghosh1@hfhs.org	Monga, Jitender/ACW-9747-2022	Gadgeel, Shirish/0000-0001-5240-3811	Henry Ford Health System Internal Research Grant [A10203]; Dykstra Foundation [F60587]; Pacific Northwest Prostate Cancer SPORE/NCI [P50 CA097186]; Michigan Prostate SPORE/NCI through the NCI Drug Resistance and Sensitivity Network [P50 CA186786, P50 CA186786-07S1]; NCI [R01 CA251245];  [W81XWH-20-1-0405];  [P30 CA046592]	Henry Ford Health System Internal Research Grant; Dykstra Foundation; Pacific Northwest Prostate Cancer SPORE/NCI; Michigan Prostate SPORE/NCI through the NCI Drug Resistance and Sensitivity Network; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; 	This work was supported by the Henry Ford Health System Internal Research Grant (A10203) and by the Dykstra Foundation Grant (F60587) to J. G. This work was also partially supported by the W81XWH-20-1-0405, NCI R01 CA251245, the Pacific Northwest Prostate Cancer SPORE/NCI (P50 CA097186), the Michigan Prostate SPORE/NCI (P50 CA186786 and P50 CA186786-07S1 through the NCI Drug Resistance and Sensitivity Network), and P30 CA046592 to J. J. A.	Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; Akamatsu S, 2018, INT J UROL, V25, P345, DOI 10.1111/iju.13526; Alumkal JJ, 2020, P NATL ACAD SCI USA, V117, P12315, DOI 10.1073/pnas.1922207117; Armstrong AJ, 2019, J CLIN ONCOL, V37, P2974, DOI 10.1200/JCO.19.00799; Beltran H, 2019, CLIN CANCER RES, V25, P6916, DOI 10.1158/1078-0432.CCR-19-1423; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Bishop JL, 2017, CANCER DISCOV, V7, P54, DOI 10.1158/2159-8290.CD-15-1263; Bisoffi M, 2004, J UROLOGY, V172, P1145, DOI 10.1097/01.ju.0000135117.40086.fa; Chen WS, 2019, EUR UROL, V76, P562, DOI 10.1016/j.eururo.2019.03.020; Davies AH, 2018, NAT REV UROL, V15, P271, DOI 10.1038/nrurol.2018.22; Eyers PA, 2017, TRENDS CELL BIOL, V27, P284, DOI 10.1016/j.tcb.2016.11.002; Formaggio N, 2021, ONCOGENE, V40, P1205, DOI 10.1038/s41388-020-01598-0; Foulkes DM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7951; Gibbons JA, 2015, CLIN PHARMACOKINET, V54, P1057, DOI 10.1007/s40262-015-0283-1; Gibbons JA, 2015, CLIN PHARMACOKINET, V54, P1043, DOI 10.1007/s40262-015-0271-5; Handle F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50220-1; Hill R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14687; Kregel S, 2016, ONCOTARGET, V7, P26259, DOI 10.18632/oncotarget.8456; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Labrecque MP, 2019, J CLIN INVEST, V129, P4492, DOI 10.1172/JCI128212; Makino T, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9040414; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Miller KD, 2020, CA-CANCER J CLIN, V70, P443, DOI 10.3322/caac.21637; Monga J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62845-8; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Raj GV, 2019, CANC DRUG RESIST, V2, P189; Tiwari R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14184-0; Tucci M, 2018, ONCOTARGETS THER, V11, P7353, DOI 10.2147/OTT.S153764	28	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101556	10.1016/j.jbc.2021.101556	http://dx.doi.org/10.1016/j.jbc.2021.101556			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34973338	Green Published, gold			2022-12-26	WOS:000761395300007
J	Morla, S; Deguchi, H; Zilberman-Rudenko, J; Gruber, A; McCarty, OJT; Srivastava, P; Gailani, D; Griffin, JH				Morla, Shravan; Deguchi, Hiroshi; Zilberman-Rudenko, Jevgenia; Gruber, Andras; McCarty, Owen J. T.; Srivastava, Priyanka; Gailani, David; Griffin, John H.			Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN FRAGMENTS; POLYPHOSPHATE; GENERATION; EXERCISE	Skeletal muscle myosin (SkM) has been shown to possess procoagulant activity; however, the mechanisms of this coagulation-enhancing activity involving plasma coagulation pathways and factors are incompletely understood. Here, we discovered direct interactions between immobilized SkM and coagulation factor XI (FXI) using biolayer interferometry (Kd = 0.2 nM). In contrast, we show that prekallikrein, a FXI homolog, did not bind to SkM, reflecting the specificity of SkM for FXI binding. We also found that the anti-FXI monoclonal antibody, mAb 1A6, which recognizes the Apple (A) 3 domain of FXI, potently inhibited binding of FXI to immobilized SkM, implying that SkM binds FXI A3 domain. In addition, we show that SkM enhanced FXI activation by thrombin in a concentration-dependent manner. We further used recombinant FXI chimeric proteins in which each of the four A domains of the heavy chain (designated A1 through A4) was individually replaced with the corresponding A domain from prekallikrein to investigate SkM-mediated enhancement of thrombin-induced FXI activation. These results indicated that activation of two FXI chimeras with substitutions of either the A3 domains or A4 domains was not enhanced by SkM, whereas substitution of the A2 domain did not reduce the thrombininduced activation compared with wildtype FXI. These data strongly suggest that functional interaction sites on FXI for SkM involve the A3 and A4 domains. Thus, this study is the first to reveal and support the novel intrinsic blood coagulation thrombin.	[Morla, Shravan; Deguchi, Hiroshi; Zilberman-Rudenko, Jevgenia; Griffin, John H.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Zilberman-Rudenko, Jevgenia; Gruber, Andras; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Sch Med, Dept Biomed Engn, Portland, OR 97201 USA; [Srivastava, Priyanka; Gailani, David] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Srivastava, Priyanka; Gailani, David] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN USA; [Griffin, John H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	Scripps Research Institute; Oregon Health & Science University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego	Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.; Griffin, JH (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	jgriffin@scripps.edu		Morla, Shravan/0000-0002-2892-1253; Zilberman-Rudenko, Jevgenia/0000-0001-9862-9285	National Institutes of Health [R01HL142975, R01HL133728, R01HL101972, R37HL140025]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the National Institutes of Health for partial support: R01HL142975 and R01HL133728 (to J. H. G.), R01HL101972 (to O. M.), and R37HL140025 (to D. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asselta R, 2017, BLOOD, V130, pE1, DOI 10.1182/blood-2017-04-780148; Atilla B, 2019, EFORT OPEN REV, V4, P230, DOI 10.1302/2058-5241.4.180068; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Deguchi H, 2021, J THROMB HAEMOST, V19, P7, DOI 10.1111/jth.15097; Deguchi H, 2020, BRIT J HAEMATOL, V190, P783, DOI 10.1111/bjh.16613; Deguchi H, 2019, J BIOL CHEM, V294, P15176, DOI 10.1074/jbc.AC119.010236; Deguchi H, 2016, BLOOD, V128, P1870, DOI 10.1182/blood-2016-03-707679; Erlacher P, 2001, CLIN CHIM ACTA, V306, P27, DOI 10.1016/S0009-8981(01)00392-8; Geng Y, 2013, J THROMB HAEMOST, V11, P1374, DOI 10.1111/jth.12275; Gidley GN, 2018, BLOOD ADV, V2, P1076, DOI 10.1182/bloodadvances.2017015123; Guerrero M, 2008, BRIT J SPORT MED, V42, P581, DOI 10.1136/bjsm.2007.037945; Ivanov I, 2017, THROMB HAEMOSTASIS, V117, P671, DOI 10.1160/TH16-09-0691; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; LOFBERG M, 1995, ARCH NEUROL-CHICAGO, V52, P1210, DOI 10.1001/archneur.1995.00540360090020; MAIR J, 1995, INT J SPORTS MED, V16, P352, DOI 10.1055/s-2007-973019; MAIR J, 1992, J APPL PHYSIOL, V72, P656, DOI 10.1152/jappl.1992.72.2.656; Mohammed BM, 2018, THROMB RES, V161, P94, DOI 10.1016/j.thromres.2017.10.008; Morla S, 2021, BLOOD, V137, P1839, DOI 10.1182/blood.2020008580; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Novakovic VA, 2020, BLOOD, V136, P2469, DOI 10.1182/blood.2020005930; Onuoha GN, 1999, CLIN INVEST MED, V22, P180; Onuoha GN, 2001, ARCH MED RES, V32, P27, DOI 10.1016/S0188-4409(00)00256-3; Sorichter S, 2001, J SPORT SCI, V19, P687, DOI 10.1080/02640410152475810; Wheeler AP, 2016, EXPERT REV HEMATOL, V9, P629, DOI 10.1080/17474086.2016.1191944; Zadra G, 2008, HAEMATOLOGICA, V93, P715, DOI 10.3324/haematol.12180; Zilberman-Rudenko J, 2020, ARTERIOSCL THROM VAS, V40, P901, DOI 10.1161/ATVBAHA.120.313990; Zucker M, 2014, J THROMB HAEMOST, V12, P1121, DOI 10.1111/jth.12600	28	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101567	10.1016/j.jbc.2022.101567	http://dx.doi.org/10.1016/j.jbc.2022.101567			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35007530	Green Published, gold			2022-12-26	WOS:000761371500014
J	Uzarska, MA; Grochowina, I; Soldek, J; Jelen, M; Schilke, B; Marszalek, J; Craig, EA; Dutkiewicz, R				Uzarska, Marta A.; Grochowina, Igor; Soldek, Joanna; Jelen, Marcin; Schilke, Brenda; Marszalek, Jaroslaw; Craig, Elizabeth A.; Dutkiewicz, Rafal			During FeS cluster biogenesis, ferredoxin and frataxin use overlapping binding sites on yeast cysteine desulfurase Nfs1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN; BACTERIAL FRATAXIN; SCAFFOLD PROTEIN; ISD11; COMPLEX; CHAPERONES; ELECTRON; REDUCTASE; WEB	In mitochondria, cysteine desulfurase (Nfs1) plays a central role in the biosynthesis of iron-sulfur (FeS) clusters, cofactors critical for activity of many cellular proteins. Nfs1 functions both as a sulfur donor for cluster assembly and as a binding platform for other proteins functioning in the process. These include not only the dedicated scaffold protein (Isu1) on which FeS clusters are synthesized but also accessory FeS cluster biogenesis proteins frataxin (Yfh1) and ferredoxin (Yah1). Yfh1 has been shown to activate cysteine desulfurase enzymatic activity, whereas Yah1 supplies electrons for the persulfide reduction. While Yfh1 interaction with Nfs1 is well understood, the Yah1-Nfs1 interaction is not. Here, based on the results of biochemical experiments involving purified WT and variant proteins, we report that in Saccharomyces cerevisiae, Yah1 and Yfh1 share an evolutionary conserved interaction site on Nfs1. Consistent with this notion, Yah1 and Yfh1 can each displace the other from Nfs1 but are inefficient competitors when a variant with an altered interaction site is used. Thus, the binding mode of Yah1 and Yfh1 interacting with Nfs1 in mitochondria of S. cerevisiae resembles the mutually exclusive binding of ferredoxin and frataxin with cysteine desulfurase reported for the bacterial FeS cluster assembly system. Our findings are consistent with the generally accepted scenario that the mitochondrial FeS cluster assembly system was inherited from bacterial ancestors of mitochondria.	[Uzarska, Marta A.; Grochowina, Igor; Soldek, Joanna; Jelen, Marcin; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland; [Uzarska, Marta A.; Grochowina, Igor; Soldek, Joanna; Jelen, Marcin; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Med Univ Gdansk, Gdansk, Poland; [Schilke, Brenda; Marszalek, Jaroslaw; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Wisconsin System; University of Wisconsin Madison	Marszalek, J; Dutkiewicz, R (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland.; Marszalek, J; Dutkiewicz, R (corresponding author), Med Univ Gdansk, Gdansk, Poland.; Marszalek, J; Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	jaroslaw.marszalek@ug.edu.pl; ecraig@wisc.edu; rafal.dutkiewicz@ug.edu.pl	Dutkiewicz, Rafal/ABE-6979-2020	Dutkiewicz, Rafal/0000-0003-4150-0450; Grochowina, Igor/0000-0003-2825-5315; Soldek, Joanna/0000-0002-4536-1606; Marszalek, Jaroslaw/0000-0002-6978-1189; Craig, Elizabeth/0000-0002-9381-4307	Polish National Science Center [UMO-2015/19/B/NZ1/00237]; TEAM program [POIR.04.04.00-00-4114/17-00]; European Union under the European Regional Development Fund; National Institutes of Health [R35GM127009]	Polish National Science Center; TEAM program; European Union under the European Regional Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Polish National Science Center Grant UMO-2015/19/B/NZ1/00237 (to R. D.), and the work of M. A. U. and I. G. was supported by POIR.04.04.00-00-4114/17-00 project carried out within the TEAM program cofinanced by the European Union under the European Regional Development Fund (to J. M.) and by the National Institutes of Health R35GM127009 (to E. A. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Altenhoff AM, 2018, NUCLEIC ACIDS RES, V46, pD477, DOI 10.1093/nar/gkx1019; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Boniecki MT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01497-1; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Cai K, 2017, ACS CHEM BIOL, V12, P918, DOI 10.1021/acschembio.6b01005; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Cory SA, 2017, P NATL ACAD SCI USA, V114, pE5325, DOI 10.1073/pnas.1702849114; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delewski W, 2016, MOL BIOL EVOL, V33, P643, DOI 10.1093/molbev/msv254; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Dutkiewicz R, 2018, J BIOL INORG CHEM, V23, P569, DOI 10.1007/s00775-017-1504-x; Dutkiewicz R, 2017, METHOD ENZYMOL, V595, P161, DOI 10.1016/bs.mie.2017.07.004; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fox NG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09989-y; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3880, DOI 10.1021/bi5014497; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gervason S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11470-9; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Heller Kira, 2010, PLoS Biol, V8, pe1000353, DOI 10.1371/journal.pbio.1000353; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; Lill R, 2020, ANNU REV BIOCHEM, V89, P471, DOI 10.1146/annurev-biochem-013118-111540; Lin CW, 2020, J AM CHEM SOC, V142, P6018, DOI 10.1021/jacs.9b11454; Maio N, 2020, TRENDS BIOCHEM SCI, V45, P411, DOI 10.1016/j.tibs.2020.02.001; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Manicki M, 2014, J BIOL CHEM, V289, P30268, DOI 10.1074/jbc.M114.596726; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Tran NH, 2019, NAT METHODS, V16, P63, DOI 10.1038/s41592-018-0260-3; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Patra S, 2019, P NATL ACAD SCI USA, V116, P19421, DOI 10.1073/pnas.1909535116; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saha PP, 2015, J BIOL CHEM, V290, P25876, DOI 10.1074/jbc.M115.678508; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2012, BBA-MOL CELL RES, V1823, P484, DOI 10.1016/j.bbamcr.2011.11.002; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tomiczek B, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007913; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Van Vranken JG, 2018, MOL CELL, V71, P567, DOI 10.1016/j.molcel.2018.06.039; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Weiler BD, 2020, P NATL ACAD SCI USA, V117, P20555, DOI 10.1073/pnas.2003982117; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yan R, 2015, BBA-PROTEINS PROTEOM, V1854, P1113, DOI 10.1016/j.bbapap.2015.02.002; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	62	1	1	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101570	10.1016/j.jbc.2022.101570	http://dx.doi.org/10.1016/j.jbc.2022.101570			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35026224	gold, Green Published			2022-12-26	WOS:000761371500007
J	Liu, XY; Taylor, SA; Gromer, KD; Zhang, D; Hubchak, SC; LeCuyer, BE; Iwawaki, T; Shi, ZD; Rockey, DC; Green, RM				Liu, Xiaoying; Taylor, Sarah A.; Gromer, Kyle D.; Zhang, Danny; Hubchak, Susan C.; LeCuyer, Brian E.; Iwawaki, Takao; Shi, Zengdun; Rockey, Don C.; Green, Richard M.			Mechanisms of liver injury in high fat sugar diet fed mice that lack hepatocyte X-box binding protein 1	PLOS ONE			English	Article							OBESITY	Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of liver diseases in the United States and can progress to cirrhosis, end-stage liver disease and need for liver transplantation. There are limited therapies for NAFLD, in part, due to incomplete understanding of the disease pathogenesis, which involves different cell populations in the liver. Endoplasmic reticulum stress and its adaptative unfolded protein response (UPR) signaling pathway have been implicated in the progression from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH). We have previously shown that mice lacking the UPR protein X-box binding protein 1 (XBP1) in the liver demonstrated enhanced liver injury and fibrosis in a high fat sugar (HFS) dietary model of NAFLD. In this study, to better understand the role of liver XBP1 in the pathobiology of NAFLD, we fed hepatocyte XBP1 deficient mice a HFS diet or chow and investigated UPR and other cell signaling pathways in hepatocytes, hepatic stellate cells and immune cells. We demonstrate that loss of XBP1 in hepatocytes increased inflammatory pathway expression and altered expression of the UPR signaling in hepatocytes and was associated with enhanced hepatic stellate cell activation after HFS feeding. We believe that a better understanding of liver cell-specific signaling in the pathogenesis of NASH may allow us to identify new therapeutic targets.	[Liu, Xiaoying; Zhang, Danny; Hubchak, Susan C.; LeCuyer, Brian E.; Green, Richard M.] Northwestern Univ, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA; [Taylor, Sarah A.; Gromer, Kyle D.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Chicago, IL 60611 USA; [Iwawaki, Takao] Kanazawa Med Univ, Div Cell Med, Dept Life Sci, Med Res Inst, Kahoku, Ishikawa, Japan; [Shi, Zengdun; Rockey, Don C.] Med Univ South Carolina, Digest Dis Res Ctr, Charleston, SC 29425 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Kanazawa Medical University; Medical University of South Carolina	Liu, XY (corresponding author), Northwestern Univ, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA.	xiaoying-liu@northwestern.edu		Taylor, Sarah/0000-0002-3575-8386	Max Goldenberg Foundation; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition;  [2R01DK093807];  [R01DK121997];  [1K08DK121937];  [R01DK113159];  [P30DK123704]	Max Goldenberg Foundation; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; ; ; ; ; 	2R01DK093807(RMG), R01DK121997 (RMG), The Max Goldenberg Foundation (RMG), North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (SAT), 1K08DK121937 (SAT), R01DK113159 (DCR),P30DK123704 (DCR) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista-Gonzalez A, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02993; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Duwaerts CC, 2021, CELL DEATH DIFFER, V28, P1455, DOI 10.1038/s41418-020-00671-1; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lefere S, 2019, JHEP REP, V1, P30, DOI 10.1016/j.jhepr.2019.02.004; Liu Xiaoying, 2019, Liver Res, V3, P55, DOI 10.1016/j.livres.2019.01.002; Liu XY, 2017, J LIPID RES, V58, P504, DOI 10.1194/jlr.M071266; Liu XY, 2015, AM J PHYSIOL-GASTR L, V309, pG965, DOI 10.1152/ajpgi.00132.2015; Mogilenko DA, 2019, CELL, V178, P263, DOI 10.1016/j.cell.2019.06.017; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150; Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001; Shi ZD, 2010, J BIOL CHEM, V285, P32415, DOI 10.1074/jbc.M110.164863; So JS, 2015, MOL CELL BIOL, V35, P2761, DOI 10.1128/MCB.00215-15; Taylor SA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244743; Wang JM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4617	19	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261789	10.1371/journal.pone.0261789	http://dx.doi.org/10.1371/journal.pone.0261789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030194	gold, Green Published			2022-12-26	WOS:000812798500016
J	Asama, Y; Furutani, A; Fujioka, M; Ozawa, H; Takei, S; Shibata, S; Ogawa, K				Asama, Youji; Furutani, Akiko; Fujioka, Masato; Ozawa, Hiroyuki; Takei, Satoshi; Shibata, Shigenobu; Ogawa, Kaoru			Analysis of conductive olfactory dysfunction using computational fluid dynamics	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; AIR-FLOW; CLEFT; OBSTRUCTION; SURGERY; ANATOMY	Conductive olfactory dysfunction (COD) is caused by an obstruction in the nasal cavity and is characterized by changeable olfaction. COD can occur even when the olfactory cleft is anatomically normal, and therefore, the cause in these cases remains unclear. Herein, we used computational fluid dynamics to examine olfactory cleft airflow with a retrospective cohort study utilizing the cone beam computed tomography scan data of COD patients. By measuring nasal-nasopharynx pressure at maximum flow, we established a cut-off value at which nasal breathing can be differentiated from combined mouth breathing in COD patients. We found that increased nasal resistance led to mouth breathing and that the velocity and flow rate in the olfactory cleft at maximum flow were significantly reduced in COD patients with nasal breathing only compared to healthy olfactory subjects. In addition, we performed a detailed analysis of common morphological abnormalities associated with concha bullosa. Our study provides novel insights into the causes of COD, and therefore, it has important implications for surgical planning of COD, sleep apnea research, assessment of adenoid hyperplasia in children, and sports respiratory physiology.	[Asama, Youji; Furutani, Akiko] Asama ENT Clin, Asama Inst, Koga, Ibaraki, Japan; [Asama, Youji; Fujioka, Masato; Ozawa, Hiroyuki; Ogawa, Kaoru] Keio Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shinjuku Ku, Tokyo, Japan; [Asama, Youji; Furutani, Akiko; Shibata, Shigenobu] Waseda Univ, Res Org Nano & Life Innovat, Shinjyuku Ku, Tokyo, Japan; [Takei, Satoshi] Saitama City Hosp, Dept Otorhinolaryngol, Saitama, Japan	Keio University; Waseda University	Furutani, A (corresponding author), Asama ENT Clin, Asama Inst, Koga, Ibaraki, Japan.; Furutani, A (corresponding author), Waseda Univ, Res Org Nano & Life Innovat, Shinjyuku Ku, Tokyo, Japan.	a.furutani@kurenai.waseda.jp	OZAWA, HIROYUKI/AAG-4386-2021	OZAWA, HIROYUKI/0000-0002-0990-831X; Fujioka, Masato/0000-0002-5317-0885				Akkoca O, 2020, ENT-EAR NOSE THROAT, V99, P437, DOI 10.1177/0145561319881061; Alam S, 2019, AM J RHINOL ALLERGY, V33, P263, DOI 10.1177/1945892418816841; BOLGER WE, 1991, LARYNGOSCOPE, V101, P56; Bruning J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60755-3; Cherobin GB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207178; Cocuzza S, 2020, J BIOL REG HOMEOS AG, V34, P1203, DOI 10.23812/19-522-L-4; Damm M, 2002, CHEM SENSES, V27, P831, DOI 10.1093/chemse/27.9.831; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frank-Ito DO, 2019, CLIN BIOMECH, V61, P172, DOI 10.1016/j.clinbiomech.2018.12.014; Gelardi M, 2020, ACTA CYTOL, V64, P397, DOI 10.1159/000508768; Iannella G, 2021, EUR ARCH OTO-RHINO-L, V278, P883, DOI 10.1007/s00405-020-06316-w; Jacobowitz O, 2019, LARYNGOSCOPE INVEST, V4, P211, DOI 10.1002/lio2.247; Kanowitz SJ, 2008, ENT-EAR NOSE THROAT, V87, P578, DOI 10.1177/014556130808701012; Kukwa Andrzej, 2014, Otolaryngol Pol, V68, P112, DOI 10.1016/j.otpol.2013.10.008; LEOPOLD DA, 1988, LARYNGOSCOPE, V98, P1232; Lintermann A, 2019, FLOW TURBUL COMBUST, V102, P89, DOI 10.1007/s10494-017-9876-0; Maniaci A, 2021, EUR ARCH OTO-RHINO-L, V278, P1743, DOI 10.1007/s00405-021-06724-6; Manmadhachary A, 2016, J MANUF PROCESS, V21, P46, DOI 10.1016/j.jmapro.2015.11.006; OGURA JH, 1966, ARCHIV OTOLARYNGOL, V83, P135; Pfaar O, 2006, CHEM SENSES, V31, P27, DOI 10.1093/chemse/bjj002; Rotter Nicole, 2016, GMS Curr Top Otorhinolaryngol Head Neck Surg, V15, pDoc06, DOI 10.3205/cto000133; Scadding Glenis, 2011, Clin Transl Allergy, V1, P2, DOI 10.1186/2045-7022-1-2; Schneider S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040925; Seiden AM, 2001, LARYNGOSCOPE, V111, P9, DOI 10.1097/00005537-200101000-00002; Seyed Toutounchi Seyed Javad, 2018, Iran J Otorhinolaryngol, V30, P33; Soler ZM, 2015, INT FORUM ALLERGY RH, V5, P846, DOI 10.1002/alr.21552; STAMMBERGER H, 1990, EUR ARCH OTO-RHINO-L, V247, P63; Suzuki M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231262; Tsega E.G., 2019, J BIOMED ENG TECHNOL, V7, P1, DOI [10.12691/jbet-7-1-1, DOI 10.12691/JBET-7-1-1]; Usui N., 1976, OTORHINOLARYNGOLOGY, P19; WARREN DW, 1988, AM J ORTHOD DENTOFAC, V93, P289, DOI 10.1016/0889-5406(88)90158-8; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033; Zhao K, 2014, INT FORUM ALLERGY RH, V4, P298, DOI 10.1002/alr.21272	33	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262579	10.1371/journal.pone.0262579	http://dx.doi.org/10.1371/journal.pone.0262579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020767	gold, Green Published			2022-12-26	WOS:000834207700053
J	Watanabe, Y; Nakagawa, T; Fukai, K; Honda, T; Furuya, H; Hayashi, T; Tatemichi, M				Watanabe, Yuya; Nakagawa, Toru; Fukai, Kota; Honda, Toru; Furuya, Hiroyuki; Hayashi, Takeshi; Tatemichi, Masayuki			Descriptive study of chest x-ray examination in mandatory annual health examinations at the workplace in Japan	PLOS ONE			English	Article							DOSE COMPUTED-TOMOGRAPHY; LUNG-CANCER MORTALITY; PULMONARY TUBERCULOSIS; CLASSIC SYMPTOMS; CT; SPECIFICITY; SENSITIVITY; VALIDITY	The utility of chest x-ray examination (CXR) in mandatory annual health examinations for occupational health is debatable in Japan. This study aimed to provide basic data to consider future policies for mandatory annual health examinations in the workplace. A nationwide descriptive survey was performed to determine the rate of detection of tuberculosis, lung cancer, and other diseases through CXR in organizations associated with National Federation of Industrial Health Association. The rate of finding on CXR conducted during annual health examinations in FY2016 was evaluated. Data regarding diagnosis based on follow-up examination findings were obtained and compared with the national statistics. In addition, CXR findings were compared with the results of low-dose lung computed tomography performed at the Hitachi Health Care Center. From 121 surveyed institutions, 88 institutions with 8,669,403 workers were included. For all ages, 1.0% of examinees required follow-up examination. Among 4,764,985 workers with diagnosis data, the tuberculosis detection rate was 1.8-5.3 per 100,000 persons. For Lung cancer, 3,688,396 workers were surveyed, and 334 positive cases were detected. The lung cancer detection rate using CXR was 9.1-24.4 per 100,000 persons. From 164 cases with information regarding the clinical stage, 72 (43.9%) had Stage I lung cancer. From 40,045 workers who underwent low-dose computed tomography multiple times, 31 lung cancer cases, all with Stage I disease, were detected (detection rate: 77.4 per 100,000 persons). Our findings suggest that CXR plays a little role in the detection of active tuberculosis. With regard to LC screening, the detection rate of LC by CXR was lower, approximately 50%, than the expected rate (41.0 per 100,000 persons) of LC morbidity based on the age-sex distribution of this study population. However, the role of CXR for LC screening cannot be mentioned based on this result, because assessment of mortality reduction is essential to evaluate the role.	[Watanabe, Yuya; Nakagawa, Toru; Honda, Toru; Hayashi, Takeshi] Hitachi Hlth Care Ctr, Ibaraki, Japan; [Fukai, Kota; Furuya, Hiroyuki; Tatemichi, Masayuki] Tokai Univ, Dept Prevent Med, Sch Med, Hiratsuka, Kanagawa, Japan	Tokai University	Tatemichi, M (corresponding author), Tokai Univ, Dept Prevent Med, Sch Med, Hiratsuka, Kanagawa, Japan.	tatemichi@tokai-u.jp			Ministry of Health, Labour, and Welfare of Japan through an Industrial Disease Clinical Research Grants [170301]	Ministry of Health, Labour, and Welfare of Japan through an Industrial Disease Clinical Research Grants	This study was supported by the Ministry of Health, Labour, and Welfare of Japan through an Industrial Disease Clinical Research Grants (grant no. 170301). The Hitachi Health Care Center employs Y.W., T.N., T.Ho., and T.Ha. for conducting medical examinations, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], GUIDELINE LC SCREENI; [Anonymous], IND SAFETY HLTH ACT; BARNES PF, 1988, CHEST, V94, P316, DOI 10.1378/chest.94.2.316; Brawley OW, 2005, J CLIN ONCOL, V23, P293, DOI 10.1200/JCO.2005.06.107; Cancer Registry and Statistics. Cancer Information Service National Cancer Center Japan, MON CANC INC JAP MCI; Cohen R, 1996, CHEST, V109, P420, DOI 10.1378/chest.109.2.420; Dobler CC, 2016, CLINICOECONOMIC OUTC, V8, P335, DOI 10.2147/CEOR.S92244; Fu CP, 2016, CLIN RESPIR J, V10, P333, DOI 10.1111/crj.12222; Furin J, 2019, LANCET, V393, P1642, DOI 10.1016/S0140-6736(19)30308-3; Ghotbi Nader, 2005, Environmental Health and Preventive Medicine, V10, P213, DOI 10.1007/BF02897713; MacMahon H, 2017, RADIOLOGY, V284, P228, DOI 10.1148/radiol.2017161659; MARKEY AC, 1986, BRIT MED J, V292, P378, DOI 10.1136/bmj.292.6517.378; McAdams HP, 2006, RADIOLOGY, V241, P663, DOI 10.1148/radiol.2413051535; Ministry of Health Labor and Welfare, GUID HLTH ED FOC CAN; Ministry of Health Labor and Welfare, DOC 5 PURP US CHEST; Ministry of Health Labor and Welfare, DOC 6 NEC CHEST XRAY; National Cancer Center Japan, REC GRAD CANC SCREEN; Nawa T, 2002, CHEST, V122, P15, DOI 10.1378/chest.122.1.15; Nawa T, 2019, JPN J CLIN ONCOL, V49, P130, DOI 10.1093/jjco/hyy185; Nawa T, 2015, J THORAC IMAG, V30, P108, DOI 10.1097/RTI.0000000000000138; Nawa T, 2012, LUNG CANCER, V78, P225, DOI 10.1016/j.lungcan.2012.09.012; Nawa T, 2012, LUNG CANCER, V75, P197, DOI 10.1016/j.lungcan.2011.07.002; Oudkerk M, 2017, LANCET ONCOL, V18, pE754, DOI [10.1016/S1470-2045(17)30861-6, 10.1016/s1470-2045(17)30861-6]; Raffle AE, 2007, SCREENING EVIDENCE P; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; SOBUE T, 1991, JPN J CANCER RES, V82, P1069, DOI 10.1111/j.1349-7006.1991.tb01759.x; Tang X, 2019, REV ASSOC MED BRAS, V65, P1508, DOI 10.1590/1806-9282.65.12.1508; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; The Tuberculosis Research Institute, TUB SURV CTR; Toyoda Y, 2008, BRIT J CANCER, V98, P1602, DOI 10.1038/sj.bjc.6604351; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Weinrich JM, 2017, EUR RADIOL, V27, P3244, DOI 10.1007/s00330-016-4684-9; World Health Organization, GLOB STRAT TARG TUB	34	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262404	10.1371/journal.pone.0262404	http://dx.doi.org/10.1371/journal.pone.0262404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020766	gold, Green Published			2022-12-26	WOS:000834207700040
J	Irisarri-Gutierrez, MJ; Acosta, L; Parker, LA; Toledo, R; Bornay-Llinares, FJ; Esteban, JG; Munoz-Antoli, C				Jose Irisarri-Gutierrez, Maria; Acosta, Lucrecia; Anne Parker, Lucy; Toledo, Rafael; Jorge Bornay-Llinares, Fernando; Guillermo Esteban, Jose; Munoz-Antoli, Carla			Anemia and undernutrition in intestinally parasitized schoolchildren from Gakenke district, Northern Province of Rwanda	PLOS ONE			English	Article							HELMINTH INFECTIONS; GIARDIA-DUODENALIS; CHILDREN; SCHOOL; ASSOCIATION; GROWTH; ALBENDAZOLE; PREVALENCE; HOOKWORM; IMPACT	Background Rwanda is a sub-Saharan country, where intestinal parasite infections, anemia and undernutrition coexist. The purpose of this research is to study the relationship between intestinal parasite infections and undernutrition/anemia to clarify the priorities of intervention in the rural area of Gakenke district in the Northern Province of Rwanda. Materials and methods A total of 674 students from Nemba I School, participated in a cross-sectional study, in which their parasitological and nutritional status were analysed. Statistical analysis was performed by chi(2) test, univariate analysis and Odds ratios (OR). Results A total of 95.3% of children presented intestinal parasitism, most of whom (94.5%) infected by protozoa and 36.1% infected by soil-transmitted helminths (STH), with Trichuris trichiura (27.3%) being the most prevalent. Multiple infections were found to be high (83.8%), with protozoa and STH co-infections in 30.6%. STH infections were mainly of low/moderate intensity. Neither infection nor STH infection of any intensity profile, was significantly related to anemia. In addition, STH infection, regardless of the intensity profile, was not associated with stunting, underweight or thinness. There was no difference between genders nor among ages in odds of anemia and nutritional status in STH-infected schoolchildren. Conclusion Multiparasitism remains high among Rwandan schoolchildren and is likely to cause nutritional problems. This work emphasizes the importance of keeping up health programs to reduce the prevalence of infection.	[Jose Irisarri-Gutierrez, Maria; Toledo, Rafael; Guillermo Esteban, Jose; Munoz-Antoli, Carla] Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut & Parasitol, Area Parasitol, Valencia, Spain; [Acosta, Lucrecia; Jorge Bornay-Llinares, Fernando] Univ Miguel Hernandez Elche, Fac Farm, Dept Agroquim & Medioambiente, Area Parasitol, Alicante, Spain; [Acosta, Lucrecia] Sanatorio Fontilles, Lab Anal Clin, Alicante, Spain; [Anne Parker, Lucy] Univ Miguel Hernandez Elche, Dept Salud Publ Hist Ciencia & Ginecol, Alicante, Spain; [Anne Parker, Lucy] Ctr Invest Biomed Red CIBER Epidemiol & Salud Pub, Madrid, Spain; [Jose Irisarri-Gutierrez, Maria] Univ Europea Madrid, Fac Ciencias Biomed, Dept Ciencias Salud, Madrid, Spain	University of Valencia; Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; European University of Madrid	Munoz-Antoli, C (corresponding author), Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut & Parasitol, Area Parasitol, Valencia, Spain.	carla.munoz@uv.es	; Toledo, Rafael/G-6741-2016	Acosta Soto, Lucrecia/0000-0003-3989-0218; Irisarri Gutierrez, Maria Jose/0000-0001-7562-625X; Toledo, Rafael/0000-0003-2651-9794	Proyecto of Conselleria de Bienestar Social de la Generalitat Valenciana (Comunitat Valenciana, Spain) [3055/2009]; Centro de Cooperacion al Desarrollo y Voluntariado de la Universidad Miguel Hernandez de Elche (Alicante, Spain)	Proyecto of Conselleria de Bienestar Social de la Generalitat Valenciana (Comunitat Valenciana, Spain); Centro de Cooperacion al Desarrollo y Voluntariado de la Universidad Miguel Hernandez de Elche (Alicante, Spain)	This work was supported by Proyecto of Conselleria de Bienestar Social de la Generalitat Valenciana (Comunitat Valenciana, Spain) (Ref. 3055/2009) and by Centro de Cooperacion al Desarrollo y Voluntariado de la Universidad Miguel Hernandez de Elche (Alicante, Spain).	Ajjampur SSR, 2016, PARASITOL INT, V65, P772, DOI 10.1016/j.parint.2016.05.007; Al-Mekhlafi HM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002516; Ash LR., 1994, BENCH AIDS DIAGNOSIS; Butera E, 2019, PAN AFR MED J, V32, DOI 10.11604/pamj.2019.32.11.15949; Center for Infectious Diseases Control Rwanda, 2008, NAT PREV SURV SOIL T; Danquah I, 2014, TROP MED INT HEALTH, V19, P563, DOI 10.1111/tmi.12284; de Gier B, 2014, AM J CLIN NUTR, V99, P1499, DOI 10.3945/ajcn.113.069955; de Onis M, 2000, B WORLD HEALTH ORGAN, V78, P1222; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Degarege A, 2013, J INFECT PUBLIC HEAL, V6, P125, DOI 10.1016/j.jiph.2012.11.008; Demissie Fekadu, 2009, Ethiop Med J, V47, P153; Donahue Angel M, 2017, FOOD NUTR BULL, V38, P554, DOI 10.1177/0379572117723134; Dushimimana A, 2008, SITUATION NUTR INFEC; Gall S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005573; Gasana J, 2002, ENVIRON RES, V90, P76, DOI 10.1006/enrs.2002.4394; Geus D, 2019, TROP MED INT HEALTH, V24, P409, DOI 10.1111/tmi.13206; Girum Tadele, 2018, Open Nurs J, V12, P155, DOI 10.2174/1874434601812010155; Goverment of Rwanda, 2019, ENV MAN PLAN ESMP; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; Hailegebriel T, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3306-3; Heimer J, 2015, ACTA TROP, V145, P17, DOI 10.1016/j.actatropica.2015.01.011; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Karagiannis-Voules DA, 2015, LANCET INFECT DIS, V15, P74, DOI 10.1016/S1473-3099(14)71004-7; KNIGHT WB, 1976, AM J TROP MED HYG, V25, P818, DOI 10.4269/ajtmh.1976.25.818; Krucken J, 2017, INT J PARASITOL-DRUG, V7, P262, DOI 10.1016/j.ijpddr.2017.06.001; Molla Eshetu, 2018, BMC Res Notes, V11, P585, DOI 10.1186/s13104-018-3679-9; Montresor A., 1998, WORLD HLTH ORG; Munisi DZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167122; Munoz-Antoli C, 2018, AM J TROP MED HYG, V99, P1591, DOI 10.4269/ajtmh.18-0195; Mupfasoni D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000517; Northrop-Clewes CA, 2001, AM J CLIN NUTR, V73, P53; Osazuwa F, 2011, N AM J MED SCI, V3, P30, DOI 10.4297/najms.2011.330; PRITCHARD DI, 1991, T ROY SOC TROP MED H, V85, P235, DOI 10.1016/0035-9203(91)90038-Z; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; ROBERTSON LJ, 1992, T ROY SOC TROP MED H, V86, P654, DOI 10.1016/0035-9203(92)90176-D; Ruberanziza E, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4020093; Rujeni N, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0212-z; Staudacher O, 2014, TROP MED INT HEALTH, V19, P812, DOI 10.1111/tmi.12321; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Sur D, 2005, T ROY SOC TROP MED H, V99, P261, DOI 10.1016/j.trstmh.2004.08.005; TRAC Plus (Ministry of Health) and the Access Project, 2008, REP NAT SCH PREV SUR; WHO, 2001, IRON DEFICIENCY ANAE; WHO, 2006, WHO CHILD GROWTH STA; Yap PL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002983	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262361	10.1371/journal.pone.0262361	http://dx.doi.org/10.1371/journal.pone.0262361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990483	Green Published, gold			2022-12-26	WOS:000815783800032
J	Langen, G; Lohr, C; Ueberschar, O; Behringer, M				Langen, Georg; Lohr, Christine; Ueberschaer, Olaf; Behringer, Michael			Reproducibility of knee extensor and flexor contraction velocity in healthy men and women assessed using tensiomyography: A study protocol	PLOS ONE			English	Article							GASTROCNEMIUS MEDIALIS MUSCLE; TEST-RETEST RELIABILITY; SHORTENING VELOCITY; PHYSICAL-ACTIVITY; MEASUREMENT ERROR; FATIGUE; POWER; RECOVERY	Tensiomyography measures the radial displacement of a muscle during an electrically evoked twitch contraction. The rate of muscle displacement is increasingly reported to assess contractile properties. Several formulas currently exist to calculate the rate of displacement during the contraction phase of the maximal twitch response. However, information on the reproducibility of these formulas is scarce. Further, different rest intervals ranging from 10 s to 30 s are applied between consecutive stimuli during progressive electrical stimulation until the maximum twitch response. The effect of different rest intervals on the rate of displacement has not been investigated so far. The first aim of this study is to investigate the within and between-day reliability of the most frequently used formulas to calculate the rate of displacement. The second aim is to investigate the effect of changing the inter-stimulus interval on the rate of displacement. We will determine the rectus femoris and biceps femoris rate of displacement of twenty-four healthy subjects' dominant leg on two consecutive days. The maximum displacement curve will be determined two times within three minutes on the first day and a third time 24 h later. On day two, we will also apply three blocks of ten consecutive stimuli at a constant intensity of 50 mA. Inter-stimuli intervals will be 10 s, 20 s or 30 s in each block, respectively, and three minutes between blocks. The order of inter-stimulus intervals will be randomized. This study will allow a direct comparison between the five most frequently used formulas to calculate the rate of displacement in terms of their reproducibility. Our data will also inform on the effect of different inter-stimulus intervals on the rate of displacement. These results will provide helpful information on methodical considerations to determine the rate of displacement and may thus contribute to a standardized approach.	[Langen, Georg; Behringer, Michael] Goethe Univ Frankfurt, Dept Sports Med & Performance Physiol, Frankfurt, Germany; [Langen, Georg] Inst Appl Training Sci, Dept Tech Tact Sports, Leipzig, Germany; [Ueberschaer, Olaf] Magdeburg Stendal Univ Appl Sci, Dept Engn & Ind Design, Magdeburg, Germany; [Ueberschaer, Olaf] Inst Appl Training Sci, Dept Biomech, Leipzig, Germany; [Lohr, Christine] Osteopathiepraxis, Hamburg, Germany	Goethe University Frankfurt	Langen, G (corresponding author), Goethe Univ Frankfurt, Dept Sports Med & Performance Physiol, Frankfurt, Germany.; Langen, G (corresponding author), Inst Appl Training Sci, Dept Tech Tact Sports, Leipzig, Germany.	langen@sport.uni-frankfurt.de		Langen, Georg/0000-0003-4285-5253; Ueberschar, Olaf/0000-0002-6822-5201				Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ben-Shachar M., 2020, J OPEN SOURCE SOFTW, V5, P2815, DOI [10.21105/joss.02815, DOI 10.21105/JOSS.02815, https://doi.org/10.21105/joss.02815]; Blazevich AJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01359; Cheng AJ, 2010, MED SCI SPORT EXER, V42, P1651, DOI 10.1249/MSS.0b013e3181d6c5b5; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cumming G, 2017, INTRO NEW STAT ESTIM; Dahmane R, 2005, J BIOMECH, V38, P2451, DOI 10.1016/j.jbiomech.2004.10.020; Dahmane R, 2001, MED BIOL ENG COMPUT, V39, P51, DOI 10.1007/BF02345266; de Paula Simola RA., 2015, SPORTS TECHNOL, V8, P58, DOI DOI 10.1080/19346182.2015.1117475; Debold EP, 2016, MED SCI SPORT EXER, V48, P2270, DOI 10.1249/MSS.0000000000001047; Ditroilo M, 2013, J ELECTROMYOGR KINES, V23, P558, DOI 10.1016/j.jelekin.2013.01.014; Domaszewski P, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030815; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garcia-Garcia O, 2020, RES Q EXERCISE SPORT, V91, P460, DOI 10.1080/02701367.2019.1680789; Gasparini M, 2012, EUR J VASC ENDOVASC, V44, P170, DOI 10.1016/j.ejvs.2012.04.024; Hodgson M, 2005, SPORTS MED, V35, P585, DOI 10.2165/00007256-200535070-00004; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jones DA, 2006, J PHYSIOL-LONDON, V576, P913, DOI 10.1113/jphysiol.2006.116343; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Latella C, 2019, J ELECTROMYOGR KINES, V45, P26, DOI 10.1016/j.jelekin.2019.02.002; Lohr C, 2018, EUR J APPL PHYSIOL, V118, P1349, DOI 10.1007/s00421-018-3867-2; Loturco I, 2016, J SPORT SCI MED, V15, P483; Loturco I, 2015, J STRENGTH COND RES, V29, P1723, DOI 10.1519/JSC.0000000000000803; Lucas NP, 2010, J CLIN EPIDEMIOL, V63, P854, DOI 10.1016/j.jclinepi.2009.10.002; Macgregor LJ, 2016, J SPORT REHABIL, V25, P241, DOI [10-1123/jsr.2014-0325, 10.1123/jsr.2014-0325]; Garcia-Manso JM, 2011, AM J PHYS MED REHAB, V90, P356, DOI 10.1097/PHM.0b013e31820ff352; Martin-Rodriguez S, 2017, J STRENGTH COND RES, V31, P3524, DOI 10.1519/JSC.0000000000002250; Martin-San Agustin R, 2020, PEERJ, V8, DOI 10.7717/peerj.8674; Perotto AO., 2011, ANATOMICAL GUIDE ELE; Pisot R, 2008, EUR J APPL PHYSIOL, V104, P409, DOI 10.1007/s00421-008-0698-6; Raeder C, 2016, J STRENGTH COND RES, V30, P3412, DOI 10.1519/JSC.0000000000001427; Rey E, 2012, J STRENGTH COND RES, V26, P3081, DOI 10.1519/JSC.0b013e3182470d33; Rodriguez-Ruiz D, 2013, EUR REV AGING PHYS A, V10, P127, DOI 10.1007/s11556-013-0127-7; Sanchez-Sanchez J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35345-z; Sanchez-Urena B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00766; Simola RAD, 2015, J STRENGTH COND RES, V29, P1339, DOI 10.1519/JSC.0000000000000768; Simunic B, 2010, ANN KINESIOLOGIAE, V1, P61; Simunic B, 2019, J APPL PHYSIOL, V126, P815, DOI 10.1152/japplphysiol.00880.2018; Simunic B, 2018, J GERONTOL A-BIOL, V73, P1602, DOI 10.1093/gerona/gly069; Simunic B, 2011, MED SCI SPORT EXER, V43, P1619, DOI 10.1249/MSS.0b013e31821522d0; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; Tous-Fajardo J, 2010, J ELECTROMYOGR KINES, V20, P761, DOI 10.1016/j.jelekin.2010.02.008; Urbaniak G. C., RES RANDOMIZER VERSI; Valencic V, 1997, ARTIF ORGANS, V21, P240, DOI 10.1111/j.1525-1594.1997.tb04658.x; van Melick N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189876; Wagner JM, 2008, PHYS THER, V88, P652, DOI 10.2522/ptj.20070255; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Westerblad H, 1998, J PHYSIOL-LONDON, V510, P269, DOI 10.1111/j.1469-7793.1998.269bz.x; Wiewelhove T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207313; Wiewelhove T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139801; Wilson HV, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab1cef; Wilson HV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191965; Wilson MT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01493; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhiyong Z, 2021, WEBPOWER BASIC ADV S; Zubac D, 2017, J STRENGTH COND RES, V31, P1610, DOI 10.1519/JSC.0000000000001626	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262156	10.1371/journal.pone.0262156	http://dx.doi.org/10.1371/journal.pone.0262156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990494	Green Published, gold			2022-12-26	WOS:000815783800017
J	Hayat, S; Ashraf, A; Zubair, M; Aslam, B; Siddique, MH; Khurshid, M; Saqalein, M; Khan, AM; Almatroudi, A; Naeem, Z; Muzammil, S				Hayat, Sumreen; Ashraf, Asma; Zubair, Muhammad; Aslam, Bilal; Siddique, Muhammad Hussnain; Khurshid, Mohsin; Saqalein, Muhammad; Khan, Arif Muhammad; Almatroudi, Ahmad; Naeem, Zilursh; Muzammil, Saima			Biofabrication of ZnO nanoparticles using Acacia arabica leaf extract and their antibiofilm and antioxidant potential against foodborne pathogens	PLOS ONE			English	Article							ZINC-OXIDE NANOPARTICLES; SILVER NANOPARTICLES; GREEN SYNTHESIS; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL; BIOSYNTHESIS; INHIBITION; FUNGUS	Emergence of multidrug resistant pathogens is increasing globally at an alarming rate with a need to discover novel and effective methods to cope infections due to these pathogens. Green nanoparticles have gained attention to be used as efficient therapeutic agents because of their safety and reliability. In the present study, we prepared zinc oxide nanoparticles (ZnO NPs) from aqueous leaf extract of Acacia arabica. The nanoparticles produced were characterized through UV-Visible spectroscopy, scanning electron microscopy, and X-ray diffraction. In vitro antibacterial susceptibility testing against foodborne pathogens was done by agar well diffusion, growth kinetics and broth microdilution assays. Effect of ZnO NPs on biofilm formation (both qualitatively and quantitatively) and exopolysaccharide (EPS) production was also determined. Antioxidant potential of green synthesized nanoparticles was detected by DPPH radical scavenging assay. The cytotoxicity studies of nanoparticles were also performed against HeLa cell lines. The results revealed that diameter of zones of inhibition against foodborne pathogens was found to be 16-30 nm, whereas the values of MIC and MBC ranged between 31.25-62.5 mu g/ml. Growth kinetics revealed nanoparticles bactericidal potential after 3 hours incubation at 2 x MIC for E. coli while for S. aureus and S. enterica reached after 2 hours of incubation at 2 x MIC, 4 x MIC, and 8 x MIC. 32.5-71.0% inhibition was observed for biofilm formation. Almost 50.6-65.1% (wet weight) and 44.6-57.8% (dry weight) of EPS production was decreased after treatment with sub-inhibitory concentrations of nanoparticles. Radical scavenging potential of nanoparticles increased in a dose dependent manner and value ranged from 19.25 to 73.15%. Whereas cytotoxicity studies revealed non-toxic nature of nanoparticles at the concentrations tested. The present study suggests that green synthesized ZnO NPs can substitute chemical drugs against antibiotic resistant foodborne pathogens.	[Hayat, Sumreen; Aslam, Bilal; Khurshid, Mohsin; Saqalein, Muhammad; Naeem, Zilursh; Muzammil, Saima] Govt Coll Univ, Dept Microbiol, Faisalabad, Pakistan; [Ashraf, Asma] Govt Coll Univ, Dept Zool, Faisalabad, Pakistan; [Zubair, Muhammad; Siddique, Muhammad Hussnain] Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Khan, Arif Muhammad] Univ Sargodha, Dept Biotechnol, Sargodha, Pakistan; [Almatroudi, Ahmad] Qassim Univ, Dept Med Labs, Coll Appl Med Sci, Buraydah, Saudi Arabia	Government College University Faisalabad; Government College University Faisalabad; Government College University Faisalabad; University of Sargodha; Qassim University	Muzammil, S (corresponding author), Govt Coll Univ, Dept Microbiol, Faisalabad, Pakistan.	saimamuzammil83@gmail.com	ASLAM, BILAL/AAX-6227-2020; Khurshid, Mohsin/N-8135-2013; Zubair, Muhammad/HGA-4479-2022	ASLAM, BILAL/0000-0002-5568-5049; Khurshid, Mohsin/0000-0002-3196-2857; Siddique, Muhammad Hussnain/0000-0003-3700-0509; Zubair, Muhammad/0000-0003-4534-0968	Deanship of Scientific Research, Qassim University	Deanship of Scientific Research, Qassim University	The researchers would like to thank the Deanship of Scientific Research, Qassim University for funding the publication of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe GM, 2020, INT J MICROBIOL, V2020, DOI 10.1155/2020/1705814; Agarwal H, 2019, J DRUG DELIV SCI TEC, V53, DOI 10.1016/j.jddst.2019.101212; Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; Al-Shabib A, 2018, J NANOMATERIALS, P20181; Alekish M, 2018, VET WORLD, V11, P1428, DOI 10.14202/vetworld.2018.1428-1432; Arakha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09578; Atkinson A, 2009, CHEM REV, V109, P4708, DOI 10.1021/cr900006y; Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347; Azwanida N., 2015, MED AROMAT PLANTS, V4, P2167, DOI [10.4172/2167-0412.1000196, DOI 10.4172/2167-0412.1000196]; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; BAUMANN J, 1980, ARCH PHARM, V313, P330, DOI 10.1002/ardp.19803130409; Bharathi D, 2019, RES CHEM INTERMEDIAT, V45, P2065, DOI 10.1007/s11164-018-03717-9; Bisht Gunjan, 2016, Nanobiomedicine (Rij), V3, P9, DOI 10.5772/63437; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Cox SD, 2007, J APPL MICROBIOL, V103, P930, DOI 10.1111/j.1365-2672.2007.03353.x; Dalziel JM., 1956, USEFUL PLANTS W TROP, P101; Elumalai K, 2015, SPECTROCHIM ACTA A, V143, P158, DOI 10.1016/j.saa.2015.02.011; Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004; Imran M, 2021, J HAZARD MATER, V401, DOI 10.1016/j.jhazmat.2020.123338; Jacob V., 2019, ASIAN J PHARM CLIN R, V12, P200; Jadoun S, 2021, ENVIRON CHEM LETT, V19, P355, DOI 10.1007/s10311-020-01074-x; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kahsay M.H., 2018, OPEN NANO, V3, P28, DOI [10.1016/j.onano.2018.04, DOI 10.1016/J.ONANO.2018.04.001]; Kakati M., 2014, LETT APP NANOBIOSCIE, V9, P779; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kathiresan K, 2009, COLLOID SURFACE B, V71, P133, DOI 10.1016/j.colsurfb.2009.01.016; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Kubmarawa D, 2007, AFR J BIOTECHNOL, V6, P1690; Kulshrestha S, 2016, APPL MICROBIOL BIOT, V100, P1901, DOI 10.1007/s00253-015-7154-4; Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3; Liang SJ, 2018, APPL OPTICS, V57, P5657, DOI 10.1364/AO.57.005657; Loo YY, 2012, INT J NANOMED, V7, P4263, DOI 10.2147/IJN.S33344; Lorian V., 1991, ANTIBIOTICS LAB MED, V3, P493; Mahamuni PP, 2019, BIOCHEM BIOPHYS REP, V17, P71, DOI 10.1016/j.bbrep.2018.11.007; Moghaddam AB, 2017, MOLECULES, V22, DOI 10.3390/molecules22060872; Muzammil S, 2020, BIOFOULING, P1, DOI [10.1080/08927014.2019.1708334, DOI 10.1080/08927014.2019.1708334]; Naseer M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65949-3; Nithya K., 2019, OpenNano, V4, P15, DOI 10.1016/j.onano.2018.10.001; Pallavicini P, 2017, J COLLOID INTERF SCI, V498, P271, DOI 10.1016/j.jcis.2017.03.062; Peng XH, 2011, AQUAT TOXICOL, V102, P186, DOI 10.1016/j.aquatox.2011.01.014; Pirtarighat S, 2019, J NANOSTRUCTURE CHEM, V9, P1, DOI 10.1007/s40097-018-0291-4; Prabu K, 2019, J KING SAUD UNIV SCI, V31, P724, DOI 10.1016/j.jksus.2018.04.025; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Rao TN, 2019, SAUDI J BIOL SCI, V26, P1385, DOI 10.1016/j.sjbs.2019.09.005; Rehana D, 2017, BIOPROC BIOSYST ENG, V40, P943, DOI 10.1007/s00449-017-1758-2; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Salam HA, 2014, MATER LETT, V131, P16, DOI 10.1016/j.matlet.2014.05.033; Samat NA, 2013, CERAM INT, V39, pS545, DOI 10.1016/j.ceramint.2012.10.132; Seaman SJ, 2006, AM MINERAL, V91, P12, DOI 10.2138/am.2006.1765; Selim YA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60541-1; Siddique MH, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6398165; Siddique MH, 2018, BRIT FOOD J, V120, P1358, DOI 10.1108/BFJ-09-2017-0529; Thi TUD, 2020, RSC ADV, V10, P23899, DOI 10.1039/d0ra04926c; Vanaja M, 2013, J NANOSTRUCTURE CHEM, V3, DOI 10.1186/2193-8865-3-17; World Health Organization, 2014, IN EST GLOB BURD FOO, P108; Xia L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186434; Yang FG, 2017, SOFT MATTER, V13, P638, DOI 10.1039/c6sm02174c; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yuvakkumar R, 2015, SPECTROCHIM ACTA A, V137, P250, DOI 10.1016/j.saa.2014.08.022; Zare E, 2017, J MOL STRUCT, V1146, P96, DOI 10.1016/j.molstruc.2017.05.118; Zhang XL, 2011, CHEMOSPHERE, V82, P489, DOI 10.1016/j.chemosphere.2010.10.023	62	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0259190	10.1371/journal.pone.0259190	http://dx.doi.org/10.1371/journal.pone.0259190			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986148	Green Published, gold			2022-12-26	WOS:000765956200004
J	Yan, Y; Chen, HY; Sun, LP; Zhang, W; Lu, X; Li, ZP; Xu, JL; Ren, Q				Yan, Yi; Chen, Haiyan; Sun, Leping; Zhang, Wei; Lu, Xin; Li, Zhenpeng; Xu, Jialiang; Ren, Qing			The changes of microbial diversity and flavor compounds during the fermentation of millet Huangjiu, a traditional Chinese beverage	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; RICE WINE; TORULOPSIS-GLABRATA; SYNTHETIC BIOLOGY; AROMA COMPOUNDS; ACID SYNTHESIS; WHEAT QU; SP NOV.; PYRUVATE; OPTIMIZATION	Huangjiu is a national alcoholic beverage in China. Millet has congenital advantages in development and utilization of nutrient. Brewing Huangjiu with millet can increase the value of millet. Microbial community plays crucial roles in millet Huangjiu fermentation. Flavor compounds reflect the quality and health function of Huangjiu. The flavor compounds of Huangjiu are complex and their formation is closely associated with microorganisms, but the relationship between them during fermentation has been unknown. In this research, this relationship during millet Huangjiu fermentation were deeply investigated. Totally 86 volatile compounds were detected. Bacillus, Weissella, Paenibacillus, Klebsiella, Prevotella was investigated as the dominant microbes through high-throughput sequencing. 537 correlations between major flavor compounds and microbes were established to reflect the dynamic change during millet Huangjiu fermentation. The top five dominant genus of flavor producing microbes were Chryseobacterium, Sporolactobacillus, Psychrobacter, Sphingobium and Anoxybacillus. The content of malic acid and citric acid was gradually improved all through the millet Huangjiu fermentation. Malic acid and citric acid generated from millet Huangjiu fermentation shows healthy properties as liver protection and eliminating fatigue. Our research provides essential information on microbial community succession and the flavor formation during millet Huangjiu fermentation, and beneficial for development of Huangjiu products.	[Yan, Yi; Chen, Haiyan; Sun, Leping; Xu, Jialiang; Ren, Qing] Beijing Technol & Business Univ, Sch Light Ind, Beijing, Peoples R China; [Yan, Yi; Chen, Haiyan; Sun, Leping; Xu, Jialiang; Ren, Qing] Key Lab Brewing Mol Engn China Light Ind, Beijing, Peoples R China; [Zhang, Wei] Hebei Agr Univ, Coll Food Sci & Technol, Baoding, Peoples R China; [Lu, Xin; Li, Zhenpeng] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Beijing Technology & Business University; Hebei Agricultural University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, JL; Ren, Q (corresponding author), Beijing Technol & Business Univ, Sch Light Ind, Beijing, Peoples R China.; Xu, JL; Ren, Q (corresponding author), Key Lab Brewing Mol Engn China Light Ind, Beijing, Peoples R China.	xujialiang@btbu.edu.cn; renqing@th.btbu.edu.cn	Yan, Yi/GQH-0844-2022; Chen, Haiyan/HGB-6216-2022	Sun, Leping/0000-0001-9095-1878	Fundamental Research Funding of Beijing Technology and Business University [PXM2020_014213_000017]; coarse cereals and various beans processing project of modern agricultural industrial technology system of Hebei province [HBCT2018070206]	Fundamental Research Funding of Beijing Technology and Business University; coarse cereals and various beans processing project of modern agricultural industrial technology system of Hebei province	This study was supported by Y.Y., Fundamental Research Funding of Beijing Technology and Business University (PXM2020_014213_000017) and W.Z., the coarse cereals and various beans processing project of modern agricultural industrial technology system of Hebei province (HBCT2018070206).W.Z.; Funding Acquisition; W.Z. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi S, 2019, SORGHUM AND MILLETS: CHEMISTRY, TECHNOLOGY, AND NUTRITIONAL ATTRIBUTES, 2ND EDITION, P293, DOI 10.1016/B978-0-12-811527-5.00010-1; Amadou I., 2019, FERMENTED BEVERAGES, V5, P433, DOI [10.1016/B978-0-12-815271-3.00011-7, DOI 10.1016/B978-0-12-815271-3.00011-7]; [Anonymous], 2014, LIQUOR MAKING SCI TE; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Chandra P, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01428-8; Chen G-M, 2021, CURR OPIN FOOD SCI; Chen J., 2008, STUDY FACTORS SHAOXI; Chen S, 2018, FLAVOUR FRAG J, V33, P263, DOI 10.1002/ffj.3440; Chen T, 2020, J SCI FOOD AGR, V100, P3297, DOI 10.1002/jsfa.10343; Chen YF, 2016, J IND MICROBIOL BIOT, V43, P1261, DOI 10.1007/s10295-016-1795-x; Chethan S, 2007, FOOD CHEM, V105, P862, DOI 10.1016/j.foodchem.2007.02.012; Council CNLI, 2008, CHIN RIC WIN; Daviot L, 2019, CATALYSTS, V9, DOI 10.3390/catal9030272; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DICKINSON JR, 1993, FEBS LETT, V326, P29, DOI 10.1016/0014-5793(93)81754-N; Dong J, 2019, IRAN J BIOTECHNOL, V17, DOI 10.21859/ijb.1990; Dong Yan, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P559; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Etschmann MMW, 2002, APPL MICROBIOL BIOT, V59, P1, DOI 10.1007/s00253-002-0992-x; Fan GS, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.663744; Fan GS, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1470543; Fang RS, 2017, THESIS ZHEJIANG U; Fang RS, 2015, J FOOD SCI, V80, pM2265, DOI 10.1111/1750-3841.13018; Fu-Rong YE, 2013, LIQUOR MAKING, V40, P80; Gao X, 2018, BREWING TECHNOL, V1, P91; Gawas SD, 2016, APPL BIOCHEM BIOTECH, V180, P1428, DOI 10.1007/s12010-016-2177-6; Ghim CM, 2010, BIOTECHNOL BIOPROC E, V15, P11, DOI 10.1007/s12257-009-3065-5; Gil JV, 1996, J FOOD SCI, V61, P1247, DOI 10.1111/j.1365-2621.1996.tb10971.x; Goldenberger D, 2014, J CLIN MICROBIOL, V52, P3180, DOI 10.1128/JCM.00792-14; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HILU KW, 1978, BIOCHEM SYST ECOL, V6, P247, DOI 10.1016/0305-1978(78)90013-3; Hong XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep26621; Hu XL, 2016, APPL ENVIRON MICROB, V82, P2506, DOI 10.1128/AEM.03409-15; Hu YL, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.673670; Huang ZR, 2018, FOOD MICROBIOL, V76, P487, DOI 10.1016/j.fm.2018.07.014; Isar J, 2007, ANAEROBE, V13, P50, DOI 10.1016/j.anaerobe.2006.12.002; Ji ZW, 2018, INT J FOOD SCI TECH, V53, P1611, DOI 10.1111/ijfs.13743; Jiao JK, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.649611; Kalse S, 2016, DEV QUALITY EVALUATI, V7, P2; Karatas H, 2013, ANN MICROBIOL, V63, P45, DOI 10.1007/s13213-012-0443-6; Kariyawasam KMGMM, 2019, J DAIRY SCI, V102, P3887, DOI 10.3168/jds.2018-15360; Kawamura Y, 2015, SYST APPL MICROBIOL, V38, P104, DOI 10.1016/j.syapm.2014.11.004; Kumar MH, 2019, DRUG INVENT TODAY, V11, P2657; Li HH, 2019, FOOD CHEM, V284, P100, DOI 10.1016/j.foodchem.2019.01.102; Li LL, 2002, INT J PHARM, V237, P77, DOI 10.1016/S0378-5173(02)00029-7; Li Y, 2002, APPL MICROBIOL BIOT, V60, P101, DOI [10.1007/s0253-002-1064-y, 10.1007/s00253-002-1064-y]; Lilin S., 2021, CHINA BREWING, V40, P54; Lin H, 2020, FOOD SCI BIOTECHNOL, V29, P1037, DOI 10.1007/s10068-020-00757-z; Lin XJ, 2014, CHIN J CHROMATOGR, V32, P304, DOI 10.3724/SP.J.1123.2013.11023; Liu Jingke, 2009, Cereal & Feed Industry, P22; Liu SP, 2015, WORLD J MICROB BIOT, V31, P1907, DOI 10.1007/s11274-015-1931-1; Liu SP, 2019, INT J FOOD MICROBIOL, V303, P9, DOI 10.1016/j.ijfoodmicro.2019.05.001; Luo T, 2008, J I BREWING, V114, P172, DOI 10.1002/j.2050-0416.2008.tb00323.x; Luo W, 2016, RES IMPROVING ETHYL; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martinez-Ruiz A, 2018, BIORESOURCE TECHNOL, V265, P52, DOI 10.1016/j.biortech.2018.05.080; Miyata R, 1999, J BIOSCI BIOENG, V88, P173, DOI 10.1016/S1389-1723(99)80197-2; Ojediran J, 2021, SOME PHYS PROPERTIES, V6; Papagianni M, 2007, BIOTECHNOL ADV, V25, P244, DOI 10.1016/j.biotechadv.2007.01.002; PELEG Y, 1989, APPL MICROBIOL BIOT, V30, P176; Pines O, 1996, APPL MICROBIOL BIOT, V46, P393, DOI 10.1007/s002530050835; Rabinovitch-Deere CA, 2013, CHEM REV, V113, P4611, DOI 10.1021/cr300361t; Ran X., 2015, THESIS ZHEJIANG A F; Rayne S, 2007, J CHROMATOGR A, V1167, P195, DOI 10.1016/j.chroma.2007.08.049; Ren DQ, 2006, LIQUOR MAKING SCI TE, V144, P39; Ren Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40337-8; Robles A, 2019, TRAC-TREND ANAL CHEM, V120, DOI 10.1016/j.trac.2019.115630; Rong ZX, 2013, CHINA BREWING, V32, P28; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Shi H, 2007, STUDY NOURISHMENT HL; Song Y, SCI TECHNOLOGY FOOD, V37, P387; Song ZW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01294; Sun HL, 2020, FOOD CHEM, V317, DOI 10.1016/j.foodchem.2020.126420; Sun JX., 2012, MODERN FOOD SCI TECH, V28, P1541, DOI [10.13982/j.mfst.1673-9078.2012.11.033, DOI 10.13982/J.MFST.1673-9078.2012.11.033]; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; Takahashi T, 2017, J BIOSCI BIOENG, V123, P707, DOI 10.1016/j.jbiosc.2017.01.014; Teng W, 2016, J FOOD SCI, V35; Tomar A, 2003, APPL MICROBIOL BIOT, V62, P76, DOI 10.1007/s00253-003-1234-6; Tong J, 2010, INT J SYST EVOL MICR, V60, P1135, DOI 10.1099/ijs.0.011783-0; van Maris AJA, 2004, APPL ENVIRON MICROB, V70, P159, DOI 10.1128/AEM.70.1.159-166.2004; Vogel H, 1987, BIOTECHNOL BIOENG, V29; Wang J, 2020, FOOD RES INT, V134, DOI 10.1016/j.foodres.2020.109238; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xiao-Yu D, 2013, J DALIAN U; Xu JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23013-1; Xu YQ, 2021, FOOD CHEM, V338, DOI 10.1016/j.foodchem.2020.128025; Yang YJ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.580247; Yoda T, 2020, BIOMIMETICS-BASEL, V5, DOI 10.3390/biomimetics5020016; Yu HY, 2021, FOOD RES INT, V145, DOI 10.1016/j.foodres.2021.110421; Yu HY, 2015, J CHROMATOGR B, V997, P129, DOI 10.1016/j.jchromb.2015.05.037; Yu LJ, 2012, J I BREWING, V118, P114, DOI 10.1002/jib.13; Zhang Y, 2021, APPL OPTICS, V60, P5480, DOI 10.1364/AO.424015; Zhu J, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0221-9	98	4	4	28	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262353	10.1371/journal.pone.0262353	http://dx.doi.org/10.1371/journal.pone.0262353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986204	Green Published, gold			2022-12-26	WOS:000765956200046
J	Pecankova, K; Pecherkova, P; Gasova, Z; Sovova, Z; Riedel, T; Jaeger, E; Cermak, J; Majek, P				Pecankova, Klara; Pecherkova, Pavla; Gasova, Zdenka; Sovova, Zofie; Riedel, Tomas; Jaeger, Eliezer; Cermak, Jaroslav; Majek, Pavel			Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; WORLD-HEALTH-ORGANIZATION; OXIDATIVE STRESS; STROMAL CELLS; MEMBRANE-VESICLES; CLUSTERIN; EXOSOMES; MICROVESICLES; APOLIPOPROTEIN; CLASSIFICATION	BackgroundExtracellular vesicles are released into body fluids from the majority of, if not all, cell types. Because their secretion and specific cargo (e.g., proteins) varies according to pathology, extracellular vesicles may prove a rich source of biomarkers. However, their biological and pathophysiological functions are poorly understood in hematological malignancies. ObjectiveHere, we investigated proteome changes in the exosome-rich fraction of the plasma of myelodysplastic syndrome patients and healthy donors. MethodsExosome-rich fraction of the plasma was isolated using ExoQuick((TM)): proteomes were compared and statistically processed; proteins were identified by nanoLC-MS/MS and verified using the ExoCarta and QuickGO databases. Mann-Whitney and Spearman analyses were used to statistically analyze the data. 2D western blot was used to monitor clusterin proteoforms. ResultsStatistical analyses of the data highlighted clusterin alterations as the most significant. 2D western blot showed that the clusterin changes were caused by posttranslational modifications. Moreover, there was a notable increase in the clusterin proteoform in the exosome-rich fraction of plasma of patients with more severe myelodysplastic syndrome; this corresponded with a simultaneous decrease in their plasma. ConclusionsThis specific clusterin proteoform seems to be a promising biomarker for myelodysplastic syndrome progression.	[Pecankova, Klara; Pecherkova, Pavla; Gasova, Zdenka; Sovova, Zofie; Cermak, Jaroslav; Majek, Pavel] Inst Hematol & Blood Transfus, Prague, Czech Republic; [Riedel, Tomas; Jaeger, Eliezer] CAS, Inst Macromol Chem, Prague, Czech Republic	Institute of Hematology Prague; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences	Pecankova, K (corresponding author), Inst Hematol & Blood Transfus, Prague, Czech Republic.	klara.pecankova@uhkt.cz	Riedel, Tomáš/H-6777-2014; Jäger, Eliézer/D-8924-2016	Riedel, Tomáš/0000-0002-2971-6956; Jäger, Eliézer/0000-0001-9939-2355; Majek, Pavel/0000-0002-9946-3819	Ministry of Health of the Czech Republic [00023736]; Czech Science Foundation [20-10845S]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Ministry of Health of the Czech Republic project for the conceptual development of the research organization (Institute of Hematology and Blood Transfusion, 00023736) -KP, PP, ZG, ZS, JC, PM. This work was supported by the Czech Science Foundation (grant number 20-10845S) -KP, PP, JC, PM. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript for the infant's postnatal assessment.	Abello J, 2019, THERANOSTICS, V9, P2325, DOI 10.7150/thno.30030; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Aharon A, 2014, RAMBAM MAIMONIDES ME, V5, DOI 10.5041/RMMJ.10166; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Boyiadzis M, 2016, EXPERT REV MOL DIAGN, V16, P623, DOI 10.1080/14737159.2016.1174578; Breuza L, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav120; Brunning RD., 2001, WHO CLASSIFICATION T, V1st, P61; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chevallet M, 2008, PROTEOMICS, V8, P4853, DOI 10.1002/pmic.200800321; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Choi DS, 2011, PROTEOMICS, V11, P2745, DOI 10.1002/pmic.201100022; Corrado C, 2014, CANCER LETT, V348, P71, DOI 10.1016/j.canlet.2014.03.009; Crescitelli R, 2021, NAT PROTOC, V16, P1548, DOI 10.1038/s41596-020-00466-1; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Ghosh AK, 2010, BLOOD, V115, P1755, DOI 10.1182/blood-2009-09-242719; Giassafaki LPN, 2021, J CELL PHYSIOL, V236, P1529, DOI 10.1002/jcp.29991; Goncalves AC, 2015, FREE RADICAL RES, V49, P1081, DOI 10.3109/10715762.2015.1035268; Halim ATA, 2016, INFLAMMATION, V39, P1277, DOI 10.1007/s10753-016-0381-8; Hrustincova A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040794; Hussein MNA, 2007, THROMB HAEMOSTASIS, V98, P1096, DOI 10.1160/TH05-04-0231; Karimi N, 2018, CELL MOL LIFE SCI, V75, P2873, DOI 10.1007/s00018-018-2773-4; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kim JH, 2010, INVEST OPHTH VIS SCI, V51, P561, DOI 10.1167/iovs.09-3774; Kumar B, 2015, BLOOD, V126; Kumar B, 2016, BBA-MOL CELL RES, V1863, P464, DOI 10.1016/j.bbamcr.2015.09.017; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Lemansky P, 1999, EXP CELL RES, V251, P147, DOI 10.1006/excr.1999.4555; Lewin S, 2020, BIOCHEM SOC T, V48, P2335, DOI 10.1042/BST20200717; Looze C, 2009, BIOCHEM BIOPH RES CO, V378, P433, DOI 10.1016/j.bbrc.2008.11.050; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Majek P, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-56; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matukumalli SR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41235; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; O'Sullivan J, 2003, CELL DEATH DIFFER, V10, P914, DOI 10.1038/sj.cdd.4401254; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Onodi Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01479; Paggetti J, 2015, BLOOD, V126, P1106, DOI 10.1182/blood-2014-12-618025; Pandey KB, 2011, BIOMED PAP, V155, P131, DOI 10.5507/bp.2011.027; Panteleev MA, 2017, BIOCHEM MOSC SUPPL S, V11, P187, DOI 10.1134/S1990747817030060; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Ramacciotti E, 2010, THROMB RES, V125, pE269, DOI 10.1016/j.thromres.2010.01.019; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Robert Taylor JB., 2019, J CLIN TRANSL SCI, V3, P7, DOI [10.1017/cts.2019.20, DOI 10.1017/CTS.2019.20]; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Rodriguez-Pineiro AM, 2006, MOL CELL PROTEOMICS, V5, P1647, DOI 10.1074/mcp.M600143-MCP200; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; Sodar BW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24316; Soti C, 2005, CURR OPIN CELL BIOL, V17, P210, DOI 10.1016/j.ceb.2005.02.012; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trougakos IP, 2013, GERONTOLOGY, V59, P514, DOI 10.1159/000351207; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; Utleg AG, 2003, PROSTATE, V56, P150, DOI 10.1002/pros.10255; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Westerman M, 2016, BLOOD CELL MOL DIS, V59, P134, DOI 10.1016/j.bcmd.2016.04.003; Wilson MR, 2017, EXPERT OPIN THER TAR, V21, P201, DOI 10.1080/14728222.2017.1267142; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Yang CJ, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/573528; Yao Y, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-014-0082-4; Yoon YJ, 2014, BMB REP, V47, P531, DOI 10.5483/BMBRep.2014.47.10.164; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	79	3	3	9	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262484	10.1371/journal.pone.0262484	http://dx.doi.org/10.1371/journal.pone.0262484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007303	gold, Green Published			2022-12-26	WOS:000741060700010
J	Nightingale, G; Laxton, M; Illian, JB				Nightingale, Glenna; Laxton, Megan; Illian, Janine B.			How does the community COVID-19 level of risk impact on that of a care home?	PLOS ONE			English	Article							MODELS	Objectives To model the risk of COVID-19 mortality in British care homes conditional on the community level risk. Methods A two stage modeling process ("doubly latent") which includes a Besag York Mollie model (BYM) and a Log Gaussian Cox Process. The BYM is adopted so as to estimate the community level risks. These are incorporated in the Log Gaussian Cox Process to estimate the impact of these risks on that in care homes. Results For an increase in the risk at the community level, the number of COVID-19 related deaths in the associated care home would be increased by exp (0.833), 2. This is based on a simulated dataset. In the context of COVID-19 related deaths, this study has illustrated the estimation of the risk to care homes in the presence of background community risk. This approach will be useful in facilitating the identification of the most vulnerable care homes and in predicting risk to new care homes. Conclusions The modeling of two latent processes have been shown to be successfully facilitated by the use of the BYM and Log Gaussian Cox Process Models. Community COVID-19 risks impact on that of the care homes embedded in these communities.	[Nightingale, Glenna] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [Laxton, Megan; Illian, Janine B.] Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Nightingale, G (corresponding author), Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland.	glenna.evans@gmail.com		Laxton, Megan/0000-0002-5017-7395; Nightingale, Glenna/0000-0002-0110-3939				Bakka H, 2018, WILEY INTERDISCIP RE, V10, DOI 10.1002/wics.1443; Brix A, 2001, J R STAT SOC B, V63, P823, DOI 10.1111/1467-9868.00315; Burton JK, 2020, LANCET HEALTH LONGEV, V1, pE21, DOI 10.1016/S2666-7568(20)30012-X; Dutey-Magni PF, 2021, AGE AGEING, V50, P1019, DOI 10.1093/ageing/afab060; Emmerson C, 2021, INFLUENZA OTHER RESP, V15, P371, DOI 10.1111/irv.12831; Grabowski DC, 2020, JAMA-J AM MED ASSOC, V324, P23, DOI 10.1001/jama.2020.8524; Illian JB, 2012, ANN APPL STAT, V6, P1499, DOI 10.1214/11-AOAS530; J C.-H.A.a.Z., 2020, MORTALITY ASS COVID; Johnson O, 2019, STAT MED, V38, P4871, DOI 10.1002/sim.8339; Lindgren F., INLA FUNCTIONS WHICH; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Moraga P., 2019, GEOSPATIAL HLTH DATA; Moraga P, 2018, R J, V10, P495; Moraga P, 2012, COMPUT STAT DATA AN, V56, P1417, DOI 10.1016/j.csda.2011.11.011; NHS Services Scotland, 2020, VENTILATION WATER EN; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Salcher-Konrad M, 2020, COVID 19 RELATED MOR, DOI 10.1101/2020.06.09.20125237; Soriano-Redondo A, 2019, ECOGRAPHY, V42, P1092, DOI 10.1111/ecog.03771	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260051	10.1371/journal.pone.0260051	http://dx.doi.org/10.1371/journal.pone.0260051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972103	Green Accepted, Green Published, gold			2022-12-26	WOS:000773555700012
J	Shiraishi, M; Yamaguchi, A; Suzuki, K				Shiraishi, Manabu; Yamaguchi, Atsushi; Suzuki, Ken			Nrg1/ErbB signaling-mediated regulation of fibrosis after myocardial infarction	FASEB JOURNAL			English	Article						apoptosis; cardiac fibroblast; fibrosis; macrophage; myocardial infarction; senescence	CELLULAR SENESCENCE; EPITHELIAL-CELLS; HEART-FAILURE; PROLIFERATION; MACROPHAGES; APOPTOSIS; REPAIR; INFLAMMATION; FIBROBLASTS; METABOLISM	Appropriate fibrotic tissue formation after myocardial infarction (MI) is crucial to the maintenance of the heart's structure. M2-like macrophages play a vital role in post-MI fibrosis by activating cardiac fibroblasts. Because the mechanism by which post-MI cardiac fibrosis is regulated is not fully understood, we investigated, in vitro and in vivo, the cellular and molecular mechanisms of post-MI fibrotic tissue formation, especially those related to the regulation of cellular senescence and apoptosis. CD206(+)F4/80(+)CD11b(+) M2-like macrophages collected from mouse hearts on post-MI day 7 showed increased expression of neuregulin 1 (Nrg1). Nrg1 receptor epidermal growth factor receptors ErbB2 and ErbB4 were expressed on cardiac fibroblasts in the infarct area. M2-like macrophage-derived Nrg1 suppressed both hydrogen peroxide-induced senescence and apoptosis of fibroblasts, whereas blockade of ErbB function significantly accelerated both processes. M2-like macrophage-derived Nrg1/ErbB/PI3K/Akt signaling, shown to be related to anti-senescence, was activated in damaged cardiac fibroblasts. Interestingly, systemic blockade of ErbB function in MI model mice enhanced senescence and apoptosis of cardiac fibroblasts and exacerbated inflammation. Further, increased accumulation of M2-like macrophages resulted in excessive post-MI progression of fibrosis in mice hearts. The molecular mechanism underlying the regulation of fibrotic tissue formation in the infarcted myocardium was shown in part to be attenuation of apoptosis and senescence of cardiac fibroblasts by the activation of Nrg1/ErbB/PI3K/Akt signaling. M2-like macrophage-mediated regulation of Nrg1/ErbB signaling has a substantial effect on fibrotic tissue formation in the infarcted adult mouse heart and is critical for suppressing the progression of senescence and apoptosis of cardiac fibroblasts.	[Shiraishi, Manabu; Yamaguchi, Atsushi] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama 3300834, Japan; [Shiraishi, Manabu; Suzuki, Ken] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	Jichi Medical University; University of London; Queen Mary University London	Shiraishi, M (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama 3300834, Japan.	manabu@omiya.jichi.ac.jp		SHIRAISHI, MANABU/0000-0002-4491-7473	Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Public Trust Surgery Research Fund	Uehara Memorial Foundation(Uehara Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Public Trust Surgery Research Fund	Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Public Trust Surgery Research Fund	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Aden N, 2010, J INVEST DERMATOL, V130, P2191, DOI 10.1038/jid.2010.120; Alam P, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012089; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Baliga RR, 1999, AM J PHYSIOL-HEART C, V277, pH2026, DOI 10.1152/ajpheart.1999.277.5.H2026; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Choi JS, 2015, MUCOSAL IMMUNOL, V8, P1285, DOI 10.1038/mi.2015.19; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; ElZarrad MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079543; Farr L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01273; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Gould KE, 2002, AM J PHYSIOL-HEART C, V282, pH615, DOI 10.1152/ajpheart.00206.2001; Hayakawa K, 2003, CIRCULATION, V108, P104, DOI 10.1161/01.CIR.0000074225.62168.68; Hedhli N, 2011, CIRCULATION, V123, P2254, DOI 10.1161/CIRCULATIONAHA.110.991125; Ikeda N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat0207; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kirabo A, 2017, J MOL CELL CARDIOL, V105, P59, DOI 10.1016/j.yjmcc.2017.03.001; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; Leicht M, 2000, CARDIOVASC RES, V48, P274, DOI 10.1016/S0008-6363(00)00170-X; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Meyer D, 1997, DEVELOPMENT, V124, P3575; Moritz KE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09715-y; Morse C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02441-2018; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Pascual-Gil S, 2019, J DRUG TARGET, V27, P573, DOI 10.1080/1061186X.2018.1531417; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Saalbach A, 2019, FASEB J, V33, P6689, DOI 10.1096/fj.201802224R; Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shih H, 2011, J AM COLL CARDIOL, V57, P9, DOI 10.1016/j.jacc.2010.08.623; Shiiba M, 2015, INT J ONCOL, V46, P1978, DOI 10.3892/ijo.2015.2917; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Takemura G, 1998, CIRC RES, V82, P1130, DOI 10.1161/01.RES.82.11.1130; Tanol N, 2014, MOL THER, V22, P1864, DOI 10.1038/mt.2014.110; Uckelmann H, 2016, J EXP MED, V213, P1961, DOI 10.1084/jem.20151713; Uray IP, 2002, J HEART LUNG TRANSPL, V21, P771, DOI 10.1016/S1053-2498(02)00390-X; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vanheule V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00530; Vermeulen Z, 2017, AM J PHYSIOL-HEART C, V313, pH934, DOI 10.1152/ajpheart.00206.2017; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zhu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074535	65	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22150	10.1096/fj.202101428RR	http://dx.doi.org/10.1096/fj.202101428RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34997943				2022-12-26	WOS:000747987800025
J	Timmermans, S; Verhoog, NJD; Van Looveren, K; Dewaele, S; Hochepied, T; Eggermont, M; Gilbert, B; Boerema-de Munck, A; Vanderhaeghen, T; Vanden Berghe, J; Gonzalez, NG; Vandewalle, J; Bloch, Y; Provost, M; Savvides, SN; De Bosscher, K; Declercq, W; Rottier, RJ; Louw, A; Libert, C				Timmermans, Steven; Verhoog, Nicolette J. D.; Van Looveren, Kelly; Dewaele, Sylviane; Hochepied, Tino; Eggermont, Melanie; Gilbert, Barbara; Boerema-de Munck, Anne; Vanderhaeghen, Tineke; Vanden Berghe, Joke; Gonzalez, Natalia Garcia; Vandewalle, Jolien; Bloch, Yehudi; Provost, Mathias; Savvides, Savvas N.; De Bosscher, Karolien; Declercq, Wim; Rottier, Robbert J.; Louw, Ann; Libert, Claude			Point mutation I634A in the glucocorticoid receptor causes embryonic lethality by reduced ligand binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; DIMERIZATION; INFLAMMATION; MECHANISMS; RESISTANCE	The glucocorticoid (GC) receptor (GR) is essential for normal development and in the initiation of inflammation. Healthy GR(dim/dim) mice with reduced dimerization propensity due to a point mutation (A465T) at the dimer interface of the GR DNA-binding domain (DBD) (here GR(D/D)) have previously helped to define the functions of GR monomers and dimers. Since GR(D/D) retains residual dimerization capacity, here we generated the dimer-nullifying double mutant GR(D+L/D+L) mice, featuring an additional mutation (I634A) in the ligand-binding domain (LBD) of GR. These mice are perinatally lethal, as are GR(L/L) mice (these mice have the I634A mutation but not the A465T mutation), displaying improper lung and skin formation. Using embryonic fibroblasts, high and low doses of dexamethasone (Dex), nuclear translocation assays, RNAseq, dimerization assays, and ligand-binding assays (and K-d values), we found that the lethal phenotype in these mice is due to insufficient ligand binding. These data suggest there is some correlation between GR dimerization potential and ligand affinity. We conclude that even a mutation as subtle as I634A, at a position not directly involved in ligand interactions sensu stricto, can still influence ligand binding and have a lethal outcome.	[Timmermans, Steven; Van Looveren, Kelly; Dewaele, Sylviane; Hochepied, Tino; Eggermont, Melanie; Gilbert, Barbara; Vanderhaeghen, Tineke; Vanden Berghe, Joke; Gonzalez, Natalia Garcia; Vandewalle, Jolien; Bloch, Yehudi; Provost, Mathias; Savvides, Savvas N.; Declercq, Wim; Libert, Claude] VIB, VIB Ctr Inflammat Res, Ghent, Belgium; [Timmermans, Steven; Van Looveren, Kelly; Dewaele, Sylviane; Hochepied, Tino; Eggermont, Melanie; Gilbert, Barbara; Vanderhaeghen, Tineke; Vanden Berghe, Joke; Gonzalez, Natalia Garcia; Vandewalle, Jolien; Declercq, Wim; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Verhoog, Nicolette J. D.; Louw, Ann] Stellenbosch Univ, Dept Biochem, Stellenbosch, South Africa; [Boerema-de Munck, Anne; Rottier, Robbert J.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Surg, Rotterdam, Netherlands; [Boerema-de Munck, Anne; Rottier, Robbert J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Bloch, Yehudi; Provost, Mathias; Savvides, Savvas N.] Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium; [De Bosscher, Karolien] Univ Ghent, Dept Biochem, Ghent, Belgium; [De Bosscher, Karolien] VIB, Nucl Receptor Lab, Med Biotechnol Ctr, Receptor Res Labs, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Stellenbosch University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB)	Timmermans, S; Libert, C (corresponding author), VIB, VIB Ctr Inflammat Res, Ghent, Belgium.; Timmermans, S; Libert, C (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	steven.timmermans@irc.vib-ugent.be; claude.libert@ugent.be		Vanderhaeghen, Tineke/0000-0002-4227-2894; Garcia-Gonzalez, Natalia/0000-0002-0091-8570; Bloch, Yehudi/0000-0001-7924-3539; Verhoog, Nicolette/0000-0002-3786-6452; Provost, Mathias/0000-0002-7831-1170	Agency for Innovation of Science and Technology in Flanders (IWT); Research Council of Ghent University (GOA Program); Research Foundation Flanders (FWO-Vlaanderen); Flanders Institute for Biotechnology (VIB)	Agency for Innovation of Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Council of Ghent University (GOA Program); Research Foundation Flanders (FWO-Vlaanderen)(FWO); Flanders Institute for Biotechnology (VIB)	We wish to thank Prof. Jan Tuckermann for providing GR<SUP>D/D</SUP> and GR<SUP>-/-</SUP> mice. We are thankful to animal house caretakers for animal care. We acknowledge the VIB Nucleomics Core for the RNA sequencing. We would like to thank the VIB Bio-Imaging Core for training, support, and access to the instrument park. Research in the author's laboratories was funded by the Agency for Innovation of Science and Technology in Flanders (IWT) , the Research Council of Ghent University (GOA Program) , the Research Foundation Flanders (FWO-Vlaanderen) , and Flanders Institute for Biotechnology (VIB) .	Ballegeer M, 2018, J CLIN INVEST, V128, P3265, DOI 10.1172/JCI96636; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Bayo P, 2008, ENDOCRINOLOGY, V149, P1377, DOI 10.1210/en.2007-0814; Bird AD, 2015, MOL ENDOCRINOL, V29, P158, DOI 10.1210/me.2014-1362; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Buttgereit F, 2018, CLIN IMMUNOL, V186, P64, DOI 10.1016/j.clim.2017.07.023; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; De Bosscher K, 2016, TRENDS PHARMACOL SCI, V37, P4, DOI 10.1016/j.tips.2015.09.002; Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359; Gesina E, 2006, DIABETOLOGIA, V49, P2939, DOI 10.1007/s00125-006-0449-3; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hudson WH, 2013, NAT STRUCT MOL BIOL, V20, P53, DOI 10.1038/nsmb.2456; Jewell CM, 2012, MOL ENDOCRINOL, V26, P244, DOI 10.1210/me.2011-1116; Johnson TA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22234-9; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kino T, 2018, ENDOCRINOLOGY, V159, P2506, DOI 10.1210/en.2017-03254; Kleiman A, 2012, FASEB J, V26, P722, DOI 10.1096/fj.11-192112; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Louw A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01693; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; NORDEEN SK, 1990, MOL ENDOCRINOL, V4, P1866, DOI 10.1210/mend-4-12-1866; Oasa S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25393-w; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Overman RA, 2013, ARTHRIT CARE RES, V65, P294, DOI 10.1002/acr.21796; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; Presman DM, 2016, P NATL ACAD SCI USA, V113, P8236, DOI 10.1073/pnas.1606774113; Presman DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001813; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Robertson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064831; Rog-Zielinska EA, 2013, HUM MOL GENET, V22, P3269, DOI 10.1093/hmg/ddt182; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Silverman MN, 2013, MOL PSYCHIATR, V18, P1006, DOI 10.1038/mp.2012.131; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Timmermans S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01545; Van Looveren K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226753; Van Moortel L, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.559673; Vandevyver S, 2014, ENDOCR REV, V35, P671, DOI 10.1210/er.2014-1010; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Vitellius G, 2020, EUR J ENDOCRINOL, V182, pR15, DOI 10.1530/EJE-19-0811; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Wilkinson L, 2018, ENDOCR CONNECT, V7, pR328, DOI 10.1530/EC-18-0421; Xu M, 1999, MOL CELL ENDOCRINOL, V155, P85, DOI 10.1016/S0303-7207(99)00110-0	51	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101574	10.1016/j.jbc.2022.101574	http://dx.doi.org/10.1016/j.jbc.2022.101574			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1YB	35007536	Green Published, gold			2022-12-26	WOS:000761423400004
J	Coutinho, D; Goncalves, B; Folgado, H; Travassos, B; Santos, S; Sampaio, J				Coutinho, Diogo; Goncalves, Bruno; Folgado, Hugo; Travassos, Bruno; Santos, Sara; Sampaio, Jaime			Amplifying perceptual demands: How changes in the colour vests affect youth players performance during medium-sided games	PLOS ONE			English	Article							DECISION-MAKING; MOVEMENT BEHAVIOR; TACTICAL BEHAVIOR; TEAM; DYNAMICS; PROGRAM; DESIGN; SPORT	This study explored how manipulating the colour of training vests affects footballers' individual and collective performance during a Gk+6vs6+Gk medium-sided game. A total of 21 under-17 years old players were involved in three experimental conditions in a random order for a total of four days: i) CONTROL, two teams using two different colour vests; ii) SAME, both teams wearing blue vests; iii) MIXED, all 6 players per team wore different colour vests. Players' positional data was used to compute time-motion and tactical-related variables, while video analysis was used to collect technical variables. Further, these variables were synchronized with spatiotemporal data allowing to capture ball-related actions in a horizontal 2D plan. All variables were analysed from the offensive and defensive perspective. From the offensive perspective, players performed more and further shots to goal during the CONTROL than in SAME and MIXED (small effects) conditions, with a decreased distance to the nearest defender (small effects). While defending, results revealed lower distance to the nearest teammate (small effects) in the CONTROL than in the SAME and MIXED conditions, and higher team longitudinal synchronization (small effects). In addition, the CONTROL showed in general lower values of team width while defending than in the other 2 conditions. Overall, coaches may use the CONTROL condition to emphasize offensive performance and defensive behaviour over the longitudinal direction with increased physical demands. In turn, coaches may use the manipulation of players vests to emphasize defensive performance, as players seem to behave more cohesively under such scenarios.	[Coutinho, Diogo; Santos, Sara; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Dept Sports Sci Exercise & Hlth, Vila Real, Portugal; [Coutinho, Diogo; Travassos, Bruno; Santos, Sara; Sampaio, Jaime] Res Ctr Sports Sci Hlth Sci & Human Dev, CreativeLab Res Community, CIDESD, Vila Real, Portugal; [Coutinho, Diogo] Univ Inst Maia, ISMAI, Maia, Portugal; [Goncalves, Bruno; Folgado, Hugo] Univ Evora, Dept Desporto & Saude, Escola Saude & Desenvolvimento Humano, Evora, Portugal; [Goncalves, Bruno; Folgado, Hugo] Univ Evora, Comprehens Hlth Res Ctr CHRC, Evora, Portugal; [Goncalves, Bruno; Travassos, Bruno] Portuguese Football Federat, Portugal Football Sch, Oeiras, Portugal; [Travassos, Bruno] Univ Beira Interior, Dept Sports Sci, Covilha, Portugal	University of Tras-os-Montes & Alto Douro; Instituto Universitario da Maia (ISMAI); University of Evora; University of Evora; Universidade da Beira Interior	Coutinho, D (corresponding author), Univ Tras Os Montes & Alto Douro, Dept Sports Sci Exercise & Hlth, Vila Real, Portugal.; Coutinho, D (corresponding author), Res Ctr Sports Sci Hlth Sci & Human Dev, CreativeLab Res Community, CIDESD, Vila Real, Portugal.; Coutinho, D (corresponding author), Univ Inst Maia, ISMAI, Maia, Portugal.	diogoamcoutinho@gmail.com	Sampaio, Jaime/B-7392-2008; Santos, Sara/N-8806-2018; Travassos, Bruno/G-4478-2013; Sampaio, Jaime/GYD-3663-2022; Goncalves, Bruno/M-5361-2013; Folgado, Hugo/D-4501-2013	Sampaio, Jaime/0000-0003-2335-9991; Santos, Sara/0000-0002-4090-5790; Travassos, Bruno/0000-0002-2165-2687; Goncalves, Bruno/0000-0001-7874-4104; Folgado, Hugo/0000-0002-9432-1950	Portuguese Foundation for Science and Technology [UID/04045/2020]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by national funding through the Portuguese Foundation for Science and Technology, under the project UID/04045/2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar M, 2015, J SPORT SCI, V33, P1259, DOI 10.1080/02640414.2015.1022571; Aksum KM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.562995; Attrill MJ, 2008, J SPORT SCI, V26, P577, DOI 10.1080/02640410701736244; Balakrishnan G, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/301473; Barbero-Alvarez JC., 2015, J STRENGTH COND RES; Burnell L, 2021, PERCEPTION, V50, P615, DOI 10.1177/03010066211019370; Casamichana D, 2010, J SPORT SCI, V28, P1615, DOI 10.1080/02640414.2010.521168; Chow JiaYi., 2005, J PHYS ED NZ, V38, P17; Coutinho D, 2019, J SPORT SCI, V37, P741, DOI 10.1080/02640414.2018.1523671; Coutinho D, 2020, RES Q EXERCISE SPORT, V91, P15, DOI 10.1080/02701367.2019.1645938; Coutinho D, 2019, RES SPORTS MED, V27, P298, DOI 10.1080/15438627.2018.1544133; Davids K, 2013, EXERC SPORT SCI REV, V41, P154, DOI 10.1097/JES.0b013e318292f3ec; Duarte R, 2013, HUM MOVEMENT SCI, V32, P555, DOI 10.1016/j.humov.2013.01.011; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Fajen BR, 2005, PERCEPTION, V34, P717, DOI 10.1068/p5405; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Folgado H, 2019, J SPORT SCI, V37, P1064, DOI 10.1080/02640414.2018.1543834; Folgado H, 2015, J SPORT SCI, V33, P1238, DOI 10.1080/02640414.2015.1022576; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; GIBSON James J., 1979, ECOLOGICAL APPROACH; Goncalves B, 2016, J SPORT SCI, V34, P1346, DOI 10.1080/02640414.2016.1143111; Goncalves B., 2016, J STRENGTH COND RES; Goncalves B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221368; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Huttermanni S, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02614; Jordet G., 2013, MIT SLOAN SPORTS AN; Low B, 2020, SPORTS MED, V50, P343, DOI 10.1007/s40279-019-01194-7; Machado JC, 2019, RES Q EXERCISE SPORT, V90, P403, DOI 10.1080/02701367.2019.1612511; McGuckian TB, 2020, J SPORT SCI, V38, P658, DOI 10.1080/02640414.2020.1723375; McGuckian TB, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02520; Natsuhara T, 2020, PERCEPT MOTOR SKILL, V127, P468, DOI 10.1177/0031512519900057; ODonoghue P., 2010, RES METHODS SPORTS P; Pinder RA, 2011, J SPORT EXERCISE PSY, V33, P146, DOI 10.1123/jsep.33.1.146; Rikkert JO, 2015, J SPORT SCI, V33, P2166, DOI 10.1080/02640414.2015.1064156; Santos S, 2018, RES Q EXERCISE SPORT, V89, P11, DOI 10.1080/02701367.2017.1412063; Santos S, 2017, J SPORT SCI, V35, P1759, DOI 10.1080/02640414.2016.1236206; Seifert L, 2013, SPORTS MED, V43, P167, DOI 10.1007/s40279-012-0011-z; Silva P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1813-5; Sousa RBE, 2019, INT J PERF ANAL SPOR, V19, P999, DOI 10.1080/24748668.2019.1689751; Travassos B, 2013, PSYCHOL SPORT EXERC, V14, P211, DOI 10.1016/j.psychsport.2012.11.002; Travassos B, 2018, HUM MOVEMENT SCI, V61, P19, DOI 10.1016/j.humov.2018.06.017; Travassos B, 2012, J SPORT SCI, V30, P1447, DOI 10.1080/02640414.2012.712716; Vaeyens R, 2007, J SPORT EXERCISE PSY, V29, P147, DOI 10.1123/jsep.29.2.147; Vilar L, 2014, HUM MOVEMENT SCI, V33, P14, DOI 10.1016/j.humov.2013.08.012	45	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262245	10.1371/journal.pone.0262245	http://dx.doi.org/10.1371/journal.pone.0262245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030188	Green Published, gold			2022-12-26	WOS:000812798500033
J	Ferdouse, A; Agrawal, RR; Gao, MA; Jiang, HF; Blaner, WS; Clugston, RD				Ferdouse, Afroza; Agrawal, Rishi R.; Gao, Madeleine A.; Jiang, Hongfeng; Blaner, William S.; Clugston, Robin D.			Alcohol induced hepatic retinoid depletion is associated with the induction of multiple retinoid catabolizing cytochrome P450 enzymes	PLOS ONE			English	Article							CHRONIC ETHANOL-CONSUMPTION; VITAMIN-A DEPLETION; RAT-LIVER; ACID; METABOLISM; HEPATOTOXICITY; MICE; DISEASE; OBESITY; ESTERS	Chronic alcohol consumption leads to a spectrum of liver disease that is associated with significant global mortality and morbidity. Alcohol is known to deplete hepatic vitamin A content, which has been linked to the pathogenesis of alcoholic liver disease. It has been suggested that induction of Cytochrome P450 2E1 (CYP2E1) contributes to alcohol-induced hepatic vitamin A depletion, but the possible contributions of other retinoid-catabolizing CYPs have not been well studied. The main objective of this study was to better understand alcohol-induced hepatic vitamin A depletion and test the hypothesis that alcohol-induced depletion of hepatic vitamin A is due to CYP-mediated oxidative catabolism. This hypothesis was tested in a mouse model of chronic alcohol consumption, including wild type and Cyp2e1(-/-) mice. Our results show that chronic alcohol consumption is associated with decreased levels of hepatic retinol, retinyl esters, and retinoic acid. Moreover, the depletion of hepatic retinoid is associated with the induction of multiple retinoid catabolizing CYPs, including CYP26A1, and CYP26B1 in alcohol fed wild type mice. In Cyp2e1(-/-) mice, alcohol-induced retinol decline is blunted but retinyl esters undergo a change in their acyl composition and decline upon alcohol exposure like WT mice. In conclusion, the alcohol induced decline in hepatic vitamin A content is associated with increased expression of multiple retinoid-catabolizing CYPs, including the retinoic acid specific hydroxylases CYP26A1 and CYP26B1.	[Ferdouse, Afroza; Clugston, Robin D.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Agrawal, Rishi R.; Gao, Madeleine A.; Blaner, William S.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Gao, Madeleine A.; Blaner, William S.] Columbia Univ, Dept Med, New York, NY USA; [Jiang, Hongfeng] Capital Med Univ, Beijing Collaborat Innovat Ctr Cardiovasc Disorde, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis,Minist, Beijing, Peoples R China	University of Alberta; Columbia University; Columbia University; Capital Medical University	Clugston, RD (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	clugston@ualberta.ca	Clugston, Robin/ABC-8350-2020	Clugston, Robin/0000-0003-0264-9594; Agrawal, Rishi/0000-0002-5851-9978	Canadian Institutes of Health Research [PJT-156226]; National Institutes of Health [R01DK068437, R01-DK122071]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RDC was supported by the Canadian Institutes of Health Research (https://cihr-irsc.gc.ca/), PJT-156226. RDC was supported by the National Institutes of Health (https://www.nih.gov/), K99-AA022652. WSB was supported by National Institutes of Health (https://www.nih.gov/), R01DK068437 and R01-DK122071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Blaner WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43474; Blaner William S, 2016, Subcell Biochem, V81, P95; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Clugston RD, 2015, FASEB J, V29, P3654, DOI 10.1096/fj.14-266296; Clugston RD, 2014, J LIPID RES, V55, P239, DOI 10.1194/jlr.M041863; Clugston RD, 2013, BBA-MOL CELL BIOL L, V1831, P1276, DOI 10.1016/j.bbalip.2013.04.006; Clugston RD, 2012, NUTRIENTS, V4, P356, DOI 10.3390/nu4050356; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Dan Z, 2005, FASEB J, V19, P845, DOI 10.1096/fj.04-2809fje; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORKERT PG, 1991, CARCINOGENESIS, V12, P2259, DOI 10.1093/carcin/12.12.2259; Grucza RA, 2010, ARCH GEN PSYCHIAT, V67, P1301, DOI 10.1001/archgenpsychiatry.2010.155; Huang LS, 2018, ALCOHOL CLIN EXP RES, V42, P2298, DOI 10.1111/acer.13881; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kim YK, 2010, METHODS MOL BIOL, V652, P263, DOI 10.1007/978-1-60327-325-1_15; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; LEO MA, 1982, NEW ENGL J MED, V307, P597, DOI 10.1056/NEJM198209023071006; Leo MA, 1999, AM J CLIN NUTR, V69, P1071; Liu C, 2002, ALCOHOL CLIN EXP RES, V26, P1703, DOI 10.1097/01.ALC.0000037135.09289.69; Liu C, 2001, GASTROENTEROLOGY, V120, P179, DOI 10.1053/gast.2001.20877; Lu YK, 2011, DRUG METAB DISPOS, V39, P330, DOI 10.1124/dmd.110.035691; Mahli A, 2016, DIGEST DIS, V34, P32, DOI 10.1159/000447279; Molotkov A, 2002, J BIOL CHEM, V277, P22553, DOI 10.1074/jbc.M201603200; Oneta CM, 2002, J HEPATOL, V36, P47, DOI 10.1016/S0168-8278(01)00223-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RASMUSSEN M, 1985, J LIPID RES, V26, P1112; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; SATO M, 1982, ARCH BIOCHEM BIOPHYS, V213, P557, DOI 10.1016/0003-9861(82)90584-7; SATO M, 1981, J NUTR, V111, P2015, DOI 10.1093/jn/111.11.2015; Seitz HK, 2020, CHEM-BIOL INTERACT, V316, DOI 10.1016/j.cbi.2019.108918; Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; Wang XD, 1998, HEPATOLOGY, V28, P744, DOI 10.1002/hep.510280321; Wongsiriroj N, 2014, J LIPID RES, V55, P104, DOI 10.1194/jlr.M043844	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261675	10.1371/journal.pone.0261675	http://dx.doi.org/10.1371/journal.pone.0261675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030193	Green Published, gold			2022-12-26	WOS:000812798500012
J	Gan, FS; Liu, L; Zhou, QZ; Huang, WL; Huang, XW; Zhao, X				Gan, Fengshan; Liu, Liu; Zhou, Qingzhu; Huang, Wenli; Huang, Xinwei; Zhao, Xian			Effects of adipose-derived stromal cells and endothelial progenitor cells on adipose transplant survival and angiogenesis	PLOS ONE			English	Article							AUTOLOGOUS FAT TRANSPLANTATION; STEM-CELLS; ASSISTED LIPOTRANSFER; MYOCARDIAL-INFARCTION; MOUSE MODEL; REGENERATION; SECRETION; EFFICACY; NECROSIS; THERAPY	Background A paracrine mechanism is thought to mediate the proangiogenic capacity of adipose-derived stromal/stem cells (ASCs). However, the precise mechanism by which ASCs promote the formation of blood vessels by endothelial progenitor cells (EPCs) is unclear. Methods The EPCs-ASCs cocultures prepared in different ratios were subjected to tube formations assay to verify whether ASCs could directly participate in the tube genesis. The supernatant from cultured ASCs was used to stimulate EPCs to evaluate the effects on the angiogenic property of EPCs, as well as capacity for migration and invasion. A coculture model with transwell chamber were used to explore the regulation of angiogenesis markers expression in EPCs by ASCs. We then mixed ASCs with EPCs and transplanted them with adipose tissue into nude mice to evaluate the effects on angiogenesis in adipose tissue grafts. Results In the EPCs-ASCs cocultures, the tube formation was significantly decreased as the relative abundance of ASCs increased, while the ASCs was found to migrate and integrated into the agglomerates formed by EPCs. The supernatant from ASCs cultures promoted the migration and invasion of EPCs and the ability to form capillary-like structures. The expression of multiple angiogenesis markers in EPCs were significantly increased when cocultured with ASCs. In vivo, ASCs combined with EPC promoted vascularization in the fat transplant. Immunofluorescence straining of Edu and CD31 indicated that the Edu labeled EPC did not directly participate in the vascularization inside the fat tissue. Conclusions ADSC can participate in the tube formation of EPC although it cannot form canonical capillary structures. Meanwhile, Soluble factors secreted by ASCs promotes the angiogenic potential of EPCs. ASCs paracrine signaling appears to promote angiogenesis by increasing the migration and invasion of EPCs and simultaneously upregulating the expression of angiogenesis markers in EPCs. The results of in vivo experiments showed that ASCs combined with EPCs significantly promote the formation of blood vessels in the fat implant. Remarkably, EPCs may promote angiogenesis by paracrine regulation of endogenous endothelial cells (ECs) rather than direct participation in the formation of blood vessels.	[Gan, Fengshan; Liu, Liu; Zhou, Qingzhu; Huang, Wenli; Zhao, Xian] Kunming Med Univ, Dept Plast Surg, Kunming, Yunnan, Peoples R China; [Huang, Xinwei] Kuming Med Coll, Affiliated Hosp 2, Key Lab, Kunming, Yunnan, Peoples R China	Kunming Medical University	Zhao, X (corresponding author), Kunming Med Univ, Dept Plast Surg, Kunming, Yunnan, Peoples R China.; Huang, XW (corresponding author), Kuming Med Coll, Affiliated Hosp 2, Key Lab, Kunming, Yunnan, Peoples R China.	24864727@qq.com; 532768282@qq.com			National Natural Science Foundation of China [81460296, 81860343]; Yunnan Provincial Reserve Talents Fundation [H2016-31]; Yunnan Provincial Science and Technology Planning Project [2017FB121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Reserve Talents Fundation; Yunnan Provincial Science and Technology Planning Project	D This study was supported by National Natural Science Foundation of China (81460296, 81860343), The Yunnan Provincial Reserve Talents Fundation (H2016-31), and The Yunnan Provincial Science and Technology Planning Project (2017FB121).	Abe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082085; Amini AR, 2012, J ORTHOP RES, V30, P1507, DOI 10.1002/jor.22097; Cai JR, 2017, BIOCHEM BIOPH RES CO, V490, P560, DOI 10.1016/j.bbrc.2017.06.078; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang NJ, 2013, OSTEOARTHR CARTILAGE, V21, P1613, DOI 10.1016/j.joca.2013.07.016; Chen ZZ, 2008, NEUROSCI LETT, V445, P36, DOI 10.1016/j.neulet.2008.08.039; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Coleman SR, 2001, CLIN PLAST SURG, V28, P111; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Engel FB, 2016, STEM CELLS BIOL REG, P123, DOI 10.1007/978-3-319-25427-2_8; Fan WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045621; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Heo SC, 2011, J INVEST DERMATOL, V131, P1559, DOI 10.1038/jid.2011.64; Jeon O, 2007, J BIOMED SCI, V14, P323, DOI 10.1007/s11373-007-9145-7; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Leobon B, 2009, CARDIOVASC RES, V83, P757, DOI 10.1093/cvr/cvp167; Li ZF, 2013, CNS NEUROSCI THER, V19, P352, DOI 10.1111/cns.12086; Liao Han-Tsung, 2014, World J Stem Cells, V6, P288, DOI 10.4252/wjsc.v6.i3.288; Lin JY, 2018, PLAST RECONSTR SURG, V142, p665E, DOI 10.1097/PRS.0000000000004898; Luo TH, 2013, J TRAUMA ACUTE CARE, V74, P508, DOI 10.1097/TA.0b013e3182703420; Mazo M, 2012, CELL TRANSPLANT, V21, P1023, DOI 10.3727/096368911X623862; Mazzola RF, 2015, CLIN PLAST SURG, V42, P147, DOI 10.1016/j.cps.2014.12.002; Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Park JB, 2015, GENES GENOM, V37, P213, DOI 10.1007/s13258-014-0239-0; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rico ADG., 2014, BRIT J ORAL MAX SURG, V52, pe60; Simonacci F, 2016, ANN MED SURG, V12, P94, DOI 10.1016/j.amsu.2016.11.012; Strassburg S, 2013, TISSUE ENG PT A, V19, P166, DOI [10.1089/ten.tea.2011.0699, 10.1089/ten.TEA.2011.0699]; Tan Shaun S, 2016, J Cutan Aesthet Surg, V9, P152; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x; Yoshimura K, 2009, REGEN MED, V4, P265, DOI 10.2217/17460751.4.2.265; Yuan Y, 2015, ARCH DERMATOL RES, V307, P693, DOI 10.1007/s00403-015-1574-y; Yuan Y, 2013, CELL BIOL INT, V37, P547, DOI 10.1002/cbin.10068; Zhao LN, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0578-2; Zhao Yan Feng., 2015, CLIN EXPERIENCE AUTO, V24, P9; Zhou YW, 2016, PLAST RECONSTR SURG, V137, p44E, DOI 10.1097/PRS.0000000000001981	43	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261498	10.1371/journal.pone.0261498	http://dx.doi.org/10.1371/journal.pone.0261498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025920	Green Published, gold, Green Submitted			2022-12-26	WOS:000796264200017
J	Hurt, K; Kodym, P; Stejskal, D; Zikan, M; Mojhova, M; Rakovic, J				Hurt, Karel; Kodym, Petr; Stejskal, David; Zikan, Michal; Mojhova, Martina; Rakovic, Jakub			Toxoplasmosis impact on prematurity and low birth weight	PLOS ONE			English	Article							GONDII INFECTION	Background Toxoplasma gondii, one of the most common parasites, causes toxoplasmosis, one of the most frequent zoonotic diseases worldwide. T. gondii infects about one-third of the world's population. T. gondii infection is generally considered a major risk for spontaneous abortion, prematurity and low birth weight in the animal sphere. Less commonly, a toxoplasma serological profile is correlated with the particular data of delivery. Acute T. gondii infection during pregnancy often leads to spontaneous abortion and/or a severe injury of the eyes, brain, and other structures of the foetus. Latent T. gondii infection of pregnant women could lead to less obvious but important changes during pregnancy, including the end product of pregnancy and the timing of labour. This study aimed to contribute to the current knowledge by comparing serological T. gondii profiles of pregnant women with prematurity and low birth weights of newborns. Material and methods A retrospective study design was adopted. The study participants included a cohort of 1733 pregnant women who consecutively gave birth to their children and underwent regular antenatal biochemical screening between the 14th and 16th weeks of pregnancy. Prematurity was defined as the liveborn preterm delivery in gestational age of pregnancy <37 weeks. Low birth weight was defined as weight at birth of <= 2499 grams. The complement-fixation test (CFT) provided serological profiles for toxoplasmosis that expresses the overall levels of toxoplasma immunoglobulins of all classes. Enzyme-linked immunosorbent assay (ELISA) tests for IgG and IgM were used simultaneously. IgM positivity helped to differentiate acute from the latent stage of toxoplasmosis. Birth data, especially the week of delivery and fetal weight, were evaluated accordingly. Results Of the 1733 pregnant women, 25% were diagnosed as latent toxoplasma positive, and 75% as toxoplasma negative. There were 87 premature deliveries versus 1646 timely births. We observed 88 low birth weights and 1645 normal fetal weights. We found a statistically significant association between latent toxoplasmosis and prematurity, chi(2)(1) = 5.471, p = .019 and between latent toxoplasmosis and low birth weight of newborns, chi(2)(1) = 7.663, p = .006. There was a 1.707 times higher risk of prematurity for toxoplasma-positive women, while the risk for low birth weight was 1.861 times higher. The strength of both tests of association was mild. We tested the correlation between the levels of CFT titres and week of delivery and weight of newborns. No association was found between the level of latent toxoplasmosis and the week of delivery and fetal weight. Conclusion Latent toxoplasmosis was associated with premature birth rate and lower birth weight of newborns. The odds of premature delivery was 1.7 and low birth weight 1.9 times higher in women with latent toxoplasmosis compared to toxoplasma negative women. Even though the strength of the association in our large sample is relatively mild, the combination of latent toxoplasmosis with other adverse factors could cause serious harm. Whole CFT and specific IgG levels of latent toxoplasmosis are not linked to the severity of prematurity or low birth weight in newborns.	[Hurt, Karel; Zikan, Michal; Mojhova, Martina] Charles Univ Prague, Fac Med 1, Obstet & Gynaecol Dept, Prague, Czech Republic; [Kodym, Petr] Natl Inst Publ Hlth Prague, Prague, Czech Republic; [Stejskal, David] Gennet Genet Ctr, Prague, Czech Republic; [Rakovic, Jakub] OBGYN Dept Amedeana, Prague, Czech Republic	Charles University Prague; National Institute of Public Health (SZU) - Czech Republic	Hurt, K (corresponding author), Charles Univ Prague, Fac Med 1, Obstet & Gynaecol Dept, Prague, Czech Republic.	hurt@prahainfo.com	Hurt, Karel/L-8193-2017	Hurt, Karel/0000-0002-5373-2358; Stejskal, David/0000-0001-5515-7855				Andrade JV, 2018, SCI MED, V28, DOI 10.15448/1980-6108.2018.4.32169; Ayoade F, 2017, INT J STD AIDS, V28, P1150, DOI 10.1177/0956462417696216; Calero-Bernal R, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00054; Cutland CL, 2017, VACCINE, V35, P6492, DOI 10.1016/j.vaccine.2017.01.049; Freeman K, 2005, BJOG-INT J OBSTET GY, V112, P31, DOI 10.1111/j.1471-0528.2004.00299.x; Fricker-Hidalgo H, 2020, DIAGN MICR INFEC DIS, V96, DOI 10.1016/j.diagmicrobio.2020.114987; Garweg JG, 2005, KLIN MONATSBL AUGENH, V222, P721, DOI 10.1055/s-2005-858615; Gay J, 2019, TRANSPL INFECT DIS, V21, DOI 10.1111/tid.13154; Hurt K., 1999, NEONATOLOGY J, V5, P78; Kankova S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110878; Kasonga MK, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.115.14232; Fochi MML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132719; Martinot M, 2020, INFECTION, V48, P299, DOI 10.1007/s15010-019-01380-9; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Montoya JG, 2002, J INFECT DIS, V185, pS73, DOI 10.1086/338827; Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149; Pustorino G, 2017, NEUROL-CLIN PRACT, V7, P436, DOI 10.1212/CPJ.0000000000000364; Rico-Torres CP, 2016, EUR J CLIN MICROBIOL, V35, P1079, DOI 10.1007/s10096-016-2656-2; Roche AD, 2018, CASE REP NEUROL MED, V2018, DOI 10.1155/2018/9876514; Rougier S, 2017, TRENDS PARASITOL, V33, P93, DOI 10.1016/j.pt.2016.10.007; WHO: recommended definitions terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths, 1977, ACTA OBSTET GYNECOL, V56, P247, DOI DOI 10.3109/00016347709162009	22	1	1	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262593	10.1371/journal.pone.0262593	http://dx.doi.org/10.1371/journal.pone.0262593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025961	gold, Green Published			2022-12-26	WOS:000796264200090
J	Liu, YL; Ma, L; Hua, FL; Min, ZH; Zhan, YX; Zhang, W; Yao, JX				Liu, Yonglei; Ma, Li; Hua, Fanli; Min, Zhihui; Zhan, Yanxia; Zhang, Wei; Yao, Junxia			Exosomal circCARM1 from spheroids reprograms cell metabolism by regulating PFKFB2 in breast cancer	ONCOGENE			English	Article							STEM-CELLS; CIRCULAR RNA	Cancer stem cells (CSC) are the major obstacle for cancer therapy in clinic. Exosomes are one type of vesicles that containing circular RNA (circRNAs) involved in cell-cell communication. However, the roles of breast CSC (BCSC) exosomes are still unclear, and the purpose of the study was to investigate breast cancer cell metabolism reprogramming by circRNAs from BCSC exosomes. The circRNA array was performed in the exosomes secreted from spheroids of MDA-231 cells. circCARM1 was higher in BCSC exosomes than it in the parent breast cancer cells. Further investigation demonstrated that BCSC exosomes circCARM1 played an important role in breast cancer cell glycolysis by miR-1252-5p/PFKFB2. In a conclusion, BCSC exosome-derived circCARM1 played an important role in breast cancer cell glycolysis by sponging miR-1252-5p which regulated PFKFB2 expression.	[Liu, Yonglei; Ma, Li] Fudan Univ, Zhongshan Hosp, Med Res Ctr, Qingpu Branch, Shanghai, Peoples R China; [Hua, Fanli] Fudan Univ, Zhongshan Hosp, ChinaDept Hematol, Qingpu Branch, Shanghai, Peoples R China; [Min, Zhihui; Zhang, Wei] Fudan Univ, Zhongshan Hosp, Inst Clin Sci, Shanghai, Peoples R China; [Zhan, Yanxia] Fudan Univ, Zhongshan Hosp, Dept Pathol, Qingpu Branch, Shanghai, Peoples R China; [Yao, Junxia] Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Liu, YL (corresponding author), Fudan Univ, Zhongshan Hosp, Med Res Ctr, Qingpu Branch, Shanghai, Peoples R China.	yongleiliu@yeah.net			Shanghai Municipal Health Commission [202140454]; Shanghai Science and Technology Committee [19140901000]; National Natural Science Foundation of China [81502571]	Shanghai Municipal Health Commission; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Shanghai Municipal Health Commission (No: 202140454), Shanghai Science and Technology Committee (No: 19140901000), and National Natural Science Foundation of China (No: 81502571).	Al-Sowayan BS, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00384; Chung IM, 2020, CLIN CHIM ACTA, V500, P226, DOI 10.1016/j.cca.2019.10.022; Clara JA, 2020, NAT REV CLIN ONCOL, V17, P204, DOI 10.1038/s41571-019-0293-2; Clayton SM, 2020, STEM CELLS DEV, V29, P327, DOI 10.1089/scd.2019.0197; El-Sahli S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239125; Fanale D, 2018, ADV EXP MED BIOL, V1087, P109, DOI 10.1007/978-981-13-1426-1_9; Gabrusiewicz K, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1412909; Hardin H, 2018, LAB INVEST, V98, P1133, DOI 10.1038/s41374-018-0065-0; Hou J, 2018, CLIN TRANSL ONCOL, V20, P1109, DOI 10.1007/s12094-018-1839-y; Houles T, 2018, CANCER RES, V78, P2191, DOI 10.1158/0008-5472.CAN-17-2215; Hwang WL, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0699-4; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kristensen LS, 2018, ONCOGENE, V37, P555, DOI 10.1038/onc.2017.361; Li J, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0822-3; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; de Andres JL, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00966-3; Ozcan SC, 2020, MOL CELL BIOCHEM, V470, P115, DOI 10.1007/s11010-020-03751-5; Palacios-Ferrer JL, 2021, MOL ONCOL, V15, P407, DOI 10.1002/1878-0261.12823; Sharma A, 2018, INT J CANCER, V142, P1086, DOI 10.1002/ijc.31089; Taurin S, 2020, NEOPLASIA, V22, P663, DOI 10.1016/j.neo.2020.09.009; Wang L, 2020, J CELL MOL MED, V24, P6324, DOI 10.1111/jcmm.15274; Wang L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0997-z; Wang YX, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1041-z; Yang LQ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0110-5; Yang ZY, 2020, CELL ONCOL, V43, P123, DOI 10.1007/s13402-019-00476-6; Yu T, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0776-8; Zeng XB, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105320; Zhao SJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0419-y	28	4	4	3	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2012	2025		10.1038/s41388-021-02061-4	http://dx.doi.org/10.1038/s41388-021-02061-4		JAN 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35027669				2022-12-26	WOS:000742332100001
J	Benbenishty, A; Schneiderman, J				Benbenishty, Amit; Schneiderman, Jacob			Intraarterial anti-leptin therapy via ICA protects ipsilateral CA1 neurons subjected to ischemia and reperfusion	PLOS ONE			English	Article							NF-KAPPA-B; CEREBRAL-ISCHEMIA; ACTIVATION; RECEPTOR; INJURY; DAMAGE; DEGENERATION; HIPPOCAMPUS; METABOLISM; EXPRESSION	Background Brain reperfusion following an ischemic event is essential for tissue viability, however, it also involves processes that promote neuronal cell death. We have recently shown that local expression of the hormone leptin in cardiovascular organs drives deleterious remodeling. As cerebral ischemia-reperfusion (IR) lesions derive expression of both the leptin hormone and its receptor, we hypothesized that blocking leptin activity in the injured brain area will reduce the deleterious effects of IR injury. Methods C57BL6 male mice underwent bilateral common carotid artery and external carotid artery ligation. The right hemisphere was reperfused after 12 minutes, followed by intraarterial injection of either a low-dose leptin antagonist or saline solution via the ipsilateral ICA. The left common carotid artery remained ligated. Fifteen IR/leptin antagonist-injected and fourteen IR/saline-injected mice completed the experiment. Five days after surgery brains were collected and samples of the hippocampal CA1 region were analyzed for cell viability (H&E) and apoptosis (TUNEL and caspase3), for neuroinflammation (Iba1), and for signaling pathways of pSTAT3 and pSmad2. Results The right hemisphere hippocampal CA1 region subjected to IR and saline injection exhibited increased apoptosis and necrosis of pyramidal cells. Also, increased density of activated microglia/macrophages was evident around the CA1 region. Comparatively, leptin antagonist treatment at reperfusion reduced apoptosis and necrosis of pyramidal cells, as indicated by increased number of viable cells (p < 0.01), and reduced TUNEL (p < 0.001) and caspase3-positive cells (p<0.05). Furthermore, this treatment reduced the density of activated microglia/macrophages (p < 0.001) in the CA1 region. Signaling pathway analysis revealed that while pSTAT3 and pSmad2-positive cells were found surrounding the stratum pyramidal in saline-treated animals, pSTAT3 signal was undetected and pSmad2 was greatly reduced in this territory following leptin antagonist treatment (p < 0.01). Conclusions Inhibition of leptin activity in hemispheric IR injury preserved the viability of ipsilateral hippocampal CA1 neurons, likely by preventing apoptosis and local inflammation. These results indicate that intraarterial anti-leptin therapy may have clinical potential in reducing hemispheric brain IR injury.	[Benbenishty, Amit] Tel Aviv Univ, Segol Sch Neurosci, Tel Aviv, Israel; [Schneiderman, Jacob] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Vasc Surg, Tel Aviv, Israel	Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Schneiderman, J (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Vasc Surg, Tel Aviv, Israel.	jschneid@post.tau.ac.il		Benbenishty, Amit/0000-0003-4559-5821				Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Ambrosini G, 2002, J BIOL CHEM, V277, P34601, DOI 10.1074/jbc.M205172200; Amit B, 2017, BRAIN BEHAV IMMUN, V62, P265, DOI 10.1016/j.bbi.2017.02.012; [Anonymous], 1094539820211920424, DOI [10.1080/10945398.2021.1920424, DOI 10.1080/10945398.2021.1920424]; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; Ben-Zvi D, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003474; Cheng G, 2021, ANIM BIOTECHNOL, DOI 10.1080/10495398.2021.1920424; DIAZ FG, 1985, J NEUROSURG, V63, P200, DOI 10.3171/jns.1985.63.2.0200; Donkor ES, 2018, STROKE RES TREAT, V2018, DOI 10.1155/2018/3238165; Elinav E, 2009, ENDOCRINOLOGY, V150, P3083, DOI 10.1210/en.2008-1706; Fisch S, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014761; Gao Q, 2008, AM J PHYSIOL-ENDOC M, V294, pE817, DOI 10.1152/ajpendo.00733.2007; Ghantous CM, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/534320; Giacobini E, 2018, CURR ALZHEIMER RES, V15, P1077, DOI 10.2174/1567205015666180613111504; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Hosoi T, 2000, BIOCHEM BIOPH RES CO, V273, P312, DOI 10.1006/bbrc.2000.2937; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kadry H, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00230-3; Kain D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203902; L Lin, 2016, Biochem Pharmacol (Los Angel), V5, DOI 10.4172/2167-0501.1000213; Leyns CEG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0192-x; Liu FF, 2015, NEURAL REGEN RES, V10, P438, DOI 10.4103/1673-5374.153693; Liu GY, 2019, NEUROL RES, V41, P125, DOI 10.1080/01616412.2018.1544399; Matsui H, 2007, LIFE SCI, V80, P672, DOI 10.1016/j.lfs.2006.10.027; Mitsushima D, 2008, ENDOCRINOLOGY, V149, P802, DOI 10.1210/en.2007-0827; Mizuma A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00467; Moon JB, 2009, J VET MED SCI, V71, P1381, DOI 10.1292/jvms.001381; Nikonenko AG, 2009, ANAT REC, V292, P1914, DOI 10.1002/ar.20969; Onken M, 2012, J NEUROSCI METH, V204, P254, DOI 10.1016/j.jneumeth.2011.11.022; Paciaroni M, 2009, EUR NEUROL, V61, P321, DOI 10.1159/000210544; Pluta R, 2018, J ALZHEIMERS DIS, V66, P429, DOI 10.3233/JAD-180772; Rininger A, 2012, J NEUROSCI METH, V207, P181, DOI 10.1016/j.jneumeth.2012.04.010; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Schneiderman J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001727; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Soderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; Tao M, 2013, ARTERIOSCL THROM VAS, V33, P311, DOI 10.1161/ATVBAHA.112.300543; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Xiong BY, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00128; Yan BC, 2011, J NEUROL SCI, V303, P100, DOI 10.1016/j.jns.2010.12.025; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; Zhang JY, 2013, J CEREBR BLOOD F MET, V33, P567, DOI 10.1038/jcbfm.2012.202; Zhang WF, 2019, EXP THER MED, V17, P3282, DOI 10.3892/etm.2019.7377	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261644	10.1371/journal.pone.0261644	http://dx.doi.org/10.1371/journal.pone.0261644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015765	gold, Green Published			2022-12-26	WOS:000814820600005
J	Gar, C; Thorand, B; Herder, C; Sujana, C; Heier, M; Meisinger, C; Peters, A; Koenig, W; Rathmann, W; Roden, M; Stumvoll, M; Maalmi, H; Meitinger, T; Then, H; Seissler, J; Then, C				Gar, Christina; Thorand, Barbara; Herder, Christian; Sujana, Chaterina; Heier, Margit; Meisinger, Christa; Peters, Annette; Koenig, Wolfgang; Rathmann, Wolfgang; Roden, Michael; Stumvoll, Michael; Maalmi, Haifa; Meitinger, Thomas; Then, Holger; Seissler, Jochen; Then, Cornelia			Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study	PLOS ONE			English	Article							MIDREGIONAL PROADRENOMEDULLIN; SUBCLINICAL INFLAMMATION; METABOLIC SYNDROME; PROGNOSTIC VALUE; RISK-FACTORS; ADRENOMEDULLIN; PLASMA; PRO-ENDOTHELIN-1; ADIPONECTIN; DEFINITION	Background and aim Despite its vasodilatory effect, adrenomedullin and its surrogate mid-regional pro-adrenomedullin (MR-proADM) have been found to be positively associated with all-cause and cardiovascular mortality. However, the underlying mechanisms thereof remain unclear and the associations were mostly shown in geriatric cohorts or in patients with chronic diseases. Therefore, we aimed to investigate the possible involvement of abdominal obesity, selected adipokines, and biomarkers of subclinical inflammation in the association of MR-proADM with mortality in a population based study cohort. Methods Prospective analysis of the KORA F4 study; median follow-up 9.1 (8.8-9.4) years. Complete data on MR-proADM and mortality was available for 1551 participants, aged 56.9 +/- 12.9 years (mean +/- SD). Correlation and regression analyses of MR-proADM with overall (BMI) and abdominal obesity (waist circumference), selected adipokines and biomarkers of subclinical inflammation. Cox proportional hazard models on the association of MR-proADM with all-cause and cardiovascular mortality with adjustment for cardiovascular risk factors and selected biomarkers in study subgroups (n = 603-1551). Results MR-proADM associated with all-cause (HR (95%,CI): 2.37 (1.72-3.26) and 2.31 (1.67-3.20)) and cardiovascular mortality (4.28 (2.19-8.39) and 4.44 (2.25-8.76)) after adjustment for traditional cardiovascular risk factors including BMI or waist circumference, respectively. MR-proADM was further associated with four out of seven examined adipokines (leptin, retinol-binding protein-4, chemerin, and adiponectin) and with five out of eleven examined biomarkers of subclinical inflammation (high-sensitivity C-reactive protein, interleukin-6, myeloperoxidase, interleukin-22, and interleukin-1 receptor antagonist) after multivariable adjustment and correction for multiple testing. However, only IL-6 substantially attenuated the association of MR-proADM with all-cause mortality. Conclusions We found an association of MR-proADM with (abdominal) obesity, selected adipokines, and biomarkers of subclinical inflammation. However, the association of MR-proADM with mortality was independent of these parameters. Future studies should investigate the role of IL-6 and further characteristics of subclinical inflammation in the association between MR-proADM and all-cause mortality.	[Gar, Christina; Seissler, Jochen; Then, Cornelia] Ludwig Maximilians Univ Munchen, Dept Med 4, Univ Hosp, Munich, Germany; [Gar, Christina; Seissler, Jochen; Then, Cornelia] Ludwig Maximilians Univ Munchen, Clin Cooperat Grp Diabet, Munich, Germany; [Gar, Christina; Seissler, Jochen; Then, Cornelia] Helmholtz Zentrum Munchen, Munich, Germany; [Gar, Christina; Thorand, Barbara; Herder, Christian; Peters, Annette; Rathmann, Wolfgang; Roden, Michael; Maalmi, Haifa; Seissler, Jochen; Then, Cornelia] German Ctr Diabet Res DZD, Munich, Germany; [Thorand, Barbara; Sujana, Chaterina; Heier, Margit; Peters, Annette] German Res Ctr Environm Hlth GmbH, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Herder, Christian; Roden, Michael; Maalmi, Haifa] Heinrich Heine Univ Dusseldorf, German Diabet Ctr, Inst Clin Diabetol, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Herder, Christian; Roden, Michael] Heinrich Heine Univ Dusseldorf, Med Fac, Div Endocrinol & Diabetol, Dusseldorf, Germany; [Sujana, Chaterina] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometry & Epidemiol IBE, Munich, Germany; [Heier, Margit] Univ Hosp Augsburg, KORA Study Ctr, Augsburg, Germany; [Meisinger, Christa] German Res Ctr Environm Hlth GmbH, Independent Res Grp Clin Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Meisinger, Christa] Univ Hosp Augsburg, Chair Epidemiol, Augsburg, Germany; [Peters, Annette; Koenig, Wolfgang; Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Koenig, Wolfgang] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Rathmann, Wolfgang] Heinrich Heine Univ Dusseldorf, German Diabet Ctr, Inst Biometr & Epidemiol, Leibniz Inst, Dusseldorf, Germany; [Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Then, Holger] Freie Waldorfschule Augsburg, Augsburg, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University; German Heart Centre Munich; Technical University of Munich; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Leipzig University; Technical University of Munich	Gar, C (corresponding author), Ludwig Maximilians Univ Munchen, Dept Med 4, Univ Hosp, Munich, Germany.; Gar, C (corresponding author), Ludwig Maximilians Univ Munchen, Clin Cooperat Grp Diabet, Munich, Germany.; Gar, C (corresponding author), Helmholtz Zentrum Munchen, Munich, Germany.; Gar, C (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	christina.gar@med.uni-muenchen.de	; Thorand, Barbara/B-5349-2014	Sujana, Chaterina/0000-0002-0663-2557; Thorand, Barbara/0000-0002-8416-6440; Gar, Christina/0000-0002-4218-6945; Koenig, Wolfgang/0000-0002-2064-9603	Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Virtual Diabetes Institute (Helmholtz Zentrum Munchen); Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University Munchen; Helmholtz Zentrum Munchen; German Diabetes Center; Federal Ministry of Health (Berlin, Germany); Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany); Deutsche Diabetes Gesellschaft (DDG); German Research Foundation (DFG) [RA-45913/3-1]	Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Virtual Diabetes Institute (Helmholtz Zentrum Munchen); Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University Munchen; Helmholtz Zentrum Munchen(Helmholtz Association); German Diabetes Center; Federal Ministry of Health (Berlin, Germany); Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany); Deutsche Diabetes Gesellschaft (DDG); German Research Foundation (DFG)(German Research Foundation (DFG))	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. The study was supported by a research grant from the Virtual Diabetes Institute (Helmholtz Zentrum Munchen) and the Clinical Cooperation Group Diabetes, Ludwig-Maximilians-University Munchen and Helmholtz Zentrum Munchen, and by the German Diabetes Center. The German Diabetes Center was supported by the Federal Ministry of Health (Berlin, Germany) and the Ministry of Culture and Science of the state North Rhine Westphalia (Dusseldorf, Germany). Further support was obtained from the Deutsche Diabetes Gesellschaft (DDG). The KORA F4 study was partly funded by a grant from the German Research Foundation (DFG) (RA-45913/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Behnes M, 2008, CLIN CHEM LAB MED, V46, P204, DOI 10.1515/CCLM.2008.040; Beltowski J, 2004, POL J PHARMACOL, V56, P5; Brouwers FP, 2012, HEART, V98, P1348, DOI 10.1136/heartjnl-2012-302390; Calabro Paolo, 2007, Subcell Biochem, V42, P63; Carstensen-Kirberg M, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0591-x; Caruhel P, 2009, CLIN BIOCHEM, V42, P725, DOI 10.1016/j.clinbiochem.2009.01.002; Castellani G, 2016, CYTOKINE, V88, P136, DOI 10.1016/j.cyto.2016.09.003; D'Elia L, 2021, HYPERTENS RES, V44, P1444, DOI 10.1038/s41440-021-00718-x; Del Ry S, 2016, EUR J NUTR, V55, P1255, DOI 10.1007/s00394-015-0938-6; Dong YL, 2018, J CLIN ENDOCR METAB, V103, P3810, DOI 10.1210/jc.2018-00905; Ebert T, 2018, J CLIN ENDOCR METAB, V103, P1015, DOI 10.1210/jc.2017-02085; Eggers KM, 2013, INT J CARDIOL, V168, P3537, DOI 10.1016/j.ijcard.2013.05.005; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Herder C, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3000; Herder C, 2017, EUR J ENDOCRINOL, V177, P277, DOI 10.1530/EJE-17-0100; Herder C, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0498-6; Herder C, 2013, DIABETES CARE, V36, P3663, DOI 10.2337/dc13-0382; Huth C, 2019, EUR J EPIDEMIOL, V34, P409, DOI 10.1007/s10654-018-0475-8; Isumi Y, 1999, FEBS LETT, V463, P110, DOI 10.1016/S0014-5793(99)01615-4; Kang KW, 2020, J OBES METAB SYNDR, V29, P248, DOI 10.7570/jomes20120; Kato J, 2005, ARTERIOSCL THROM VAS, V25, P2480, DOI 10.1161/01.ATV.0000184759.91369.f8; Kistorp Caroline, 2014, BMC Obes, V1, P24, DOI 10.1186/s40608-014-0024-2; Koyama T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113968; Lee ES, 2013, INT J EPIDEMIOL, V42, P1029, DOI 10.1093/ije/dyt087; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2007, PEPTIDES, V28, P1129, DOI 10.1016/j.peptides.2007.03.005; Li YW, 2017, ATHEROSCLEROSIS, V259, P75, DOI 10.1016/j.atherosclerosis.2017.02.003; Lorubbio M, 2018, CLIN BIOCHEM, V53, P173, DOI 10.1016/j.clinbiochem.2018.01.003; Mandal J, 2019, PULM PHARMACOL THER, V56, P8, DOI 10.1016/j.pupt.2019.01.006; Masson S, 2010, EUR J HEART FAIL, V12, P338, DOI 10.1093/eurjhf/hfp206; Neumann JT, 2013, ATHEROSCLEROSIS, V228, P451, DOI 10.1016/j.atherosclerosis.2013.03.006; Odermatt J, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0605-3; Ohlsson T, 2019, J HYPERTENS, V37, P590, DOI 10.1097/HJH.0000000000001893; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Seissler J, 2012, EUR J ENDOCRINOL, V167, P847, DOI 10.1530/EJE-12-0472; Sinning C, 2017, CLIN RES CARDIOL, V106, P401, DOI 10.1007/s00392-016-1066-x; Unamuno X, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12997; Vila G, 2009, OBESITY, V17, P1184, DOI 10.1038/oby.2009.22; Wolf K, 2016, DIABETES, V65, P3314, DOI 10.2337/db15-1567; Wong HK, 2014, WORLD J DIABETES, V5, P364, DOI 10.4239/wjd.v5.i3.364; Wong HK, 2013, CLIN ENDOCRINOL, V79, P504, DOI 10.1111/cen.12078; Yang SL, 2002, CRIT CARE MED, V30, P2729, DOI 10.1097/00003246-200212000-00018; Yildirim NC, 2010, CLIN EXP IMMUNOL, V161, P171, DOI 10.1111/j.1365-2249.2010.04156.x; Zhou PH, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7201549; Zudaire E, 2003, REGUL PEPTIDES, V112, P121, DOI 10.1016/S0167-0115(03)00030-2	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262330	10.1371/journal.pone.0262330	http://dx.doi.org/10.1371/journal.pone.0262330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990470	Green Published, gold			2022-12-26	WOS:000815783800026
J	Ng' ombe, H; Simuyandi, M; Mwaba, J; Luchen, CC; Alabi, P; Chilyabanyama, ON; Mubanga, C; Hatyoka, LM; Muchimba, M; Bosomprah, S; Chilengi, R; Kwenda, G; Chisenga, CC				Ng' ombe, Harriet; Simuyandi, Michelo; Mwaba, John; Luchen, Charlie Chaluma; Alabi, Peter; Chilyabanyama, Obvious Nchimunya; Mubanga, Cynthia; Hatyoka, Luiza Miyanda; Muchimba, Mutinta; Bosomprah, Samuel; Chilengi, Roma; Kwenda, Geoffrey; Chisenga, Caroline Cleopatra			Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol (TM)) in adults residing in Lukanga Swamps of Zambia	PLOS ONE			English	Article								Introduction In cholera endemic areas, the periodicity of cholera outbreaks remains unpredictable, making it difficult to organize preventive efforts. Lack of data on duration of protection conferred by oral cholera vaccines further makes it difficult to determine when to deploy preemptive vaccination. We report on the immunogenicity and waning of immunity to Shanchol (TM) in Lukanga Swamps. Methods We enrolled a cohort of 223 participants aged between 18 and 65 years old from whom serum samples were collected at baseline, day 28 before administration of the second dose, and consecutively at 6, 12, 24, 30, 36, and 48 months. Vibriocidal antibody titres were measured and expressed as geometric mean titres. Box plots and 95% CI were computed at each visit for both Inaba and Ogawa. Seroconversion was defined as a four fold or greater increase in antibody titres compared to baseline titres. Results Overall, seroconversion against V. cholerae Inaba and Ogawa after 1st dose was 35/134 (26%) and 34/134 (25%) respectively. We observed a statistical difference in seroconversion between the two subgroups of baseline titres (low < 80 and high >= 80) for both Inaba (p = 0.02) and Ogawa (p<0.0001). From a baseline of 13.58, anti-Ogawa GMT increased to 21.95 after the first dose, but rapidly waned to 14.52, 13.13, and 12.78 at months 6, 12 and 24 respectively, and then increased to 13.21, 18.67 and 23.65 at months 30, 36 and 48 respectively. A similar trend was observed for anti-Inaba GMT across the same time points. Conclusion We found that Shanchol (TM) was immunogenic in our study population and that vibriocidal antibodies may not be a good marker for long-term immunity. The observed rise in titres after 36 months suggests natural exposure, and this may be a critical time window opening for natural transmission in an endemic areas. We recommend re-vaccination at this time point in high risk areas.	[Ng' ombe, Harriet; Simuyandi, Michelo; Mwaba, John; Luchen, Charlie Chaluma; Alabi, Peter; Chilyabanyama, Obvious Nchimunya; Mubanga, Cynthia; Hatyoka, Luiza Miyanda; Muchimba, Mutinta; Bosomprah, Samuel; Chilengi, Roma; Chisenga, Caroline Cleopatra] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Ng' ombe, Harriet; Mwaba, John; Kwenda, Geoffrey] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana	University of Zambia; University of Ghana	Ng' ombe, H (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.; Ng' ombe, H (corresponding author), Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.	Harriet.Ngombe@cidrz.org	Simuyandi, Michelo/I-5598-2018; Mubanga, Cynthia/GVS-5931-2022	Simuyandi, Michelo/0000-0002-7348-2835; 	European and Developing Countries Trials Partnership (EDCTP) [TMA2016CDF-1550]; Bill & Melinda Gates Foundation through the John Hopkins University Delivery of Oral Cholera Vaccine Effectively (DOVE) project [OPP1148763]	European and Developing Countries Trials Partnership (EDCTP); Bill & Melinda Gates Foundation through the John Hopkins University Delivery of Oral Cholera Vaccine Effectively (DOVE) project	This work was funded by European and Developing Countries Trials Partnership (EDCTP) through a fellowship grant given to Dr Caroline Cleopatra Chisenga with fellowship grant number: TMA2016CDF-1550 (www.edctp.org).This work was supported in part, by the Bill & Melinda Gates Foundation [OPP1148763] through the John Hopkins University Delivery of Oral Cholera Vaccine Effectively (DOVE) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2011, J INFECT DIS, V204, P912, DOI 10.1093/infdis/jir416; [Anonymous], 2018, WEEKLY EPIDEMIOLOGIC; Chandralekha C, 2011, Indian J Community Med, V36, P165, DOI 10.4103/0970-0218.84142; Charles RC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002828; Deen J, 2020, VACCINE, V38, pA31, DOI 10.1016/j.vaccine.2019.07.078; Desai SN, 2017, HUM VACC IMMUNOTHER, V13, P579, DOI 10.1080/21645515.2016.1245250; Desai SN, 2016, TROP MED INT HEALTH, V21, P194, DOI 10.1111/tmi.12641; Harris JB, 2018, J INFECT DIS, V218, pS141, DOI 10.1093/infdis/jiy414; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Iyer AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep35742; Kanungo S., 2014, PLOS ONE, V9, P1; Kanungo S., 2015, OPEN LABEL NONINFERI, P1; Kanungo S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003809; Kapata N, 2018, J INFECT DIS, V218, pS181, DOI 10.1093/infdis/jiy490; Lekshmi N, 2018, INDIAN J MED RES, V147, P133, DOI [10.4103/ijmr.IJMR_280_17, 10.4103/ijmr.ijmr_280_17]; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Murebwa-Chirambo R., 2017, ZNPHI HLTH PRESS ZAM, V1, P56; Mwaba J, 2021, VACCINE, V39, P4516, DOI 10.1016/j.vaccine.2021.06.034; Parker EPK, 2018, FUTURE MICROBIOL, V13, P97, DOI 10.2217/fmb-2017-0128; Saha A, 2011, VACCINE, V29, P8285, DOI 10.1016/j.vaccine.2011.08.108; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sinyange N, 2018, MMWR-MORBID MORTAL W, V67, P556, DOI 10.15585/mmwr.mm6719a5; Son MS., 2011, CURRENT PROTOCOLS MI; WASSERMAN SS, 1994, VACCINE, V12, P1000, DOI 10.1016/0264-410X(94)90335-2; WHO, 2017, WEEKLY EPIDEMIOLOGIC, V1, P533	26	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262239	10.1371/journal.pone.0262239	http://dx.doi.org/10.1371/journal.pone.0262239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986195	gold, Green Published			2022-12-26	WOS:000765956200029
J	Chauhan, BS; Manalil, S				Chauhan, Bhagirath Singh; Manalil, Sudheesh			Seedbank persistence of four summer grass weed species in the northeast cropping region of Australia	PLOS ONE			English	Article							CHLORIS-TRUNCATA; GERMINATION; EMERGENCE; MANAGEMENT; SURVIVAL; BIOLOGY; ECOLOGY; DEPTH; SOIL	Summer grass weed species are a particular problem in the northeast cropping region of Australia because they are prolific seeders and favor no-till systems. Information on weed seed persistence levels can be used for the development of effective and sustainable integrated weed management programs. A field study was conducted over 42 months to evaluate the seedbank persistence of Chloris truncata, C. virgata, Dactyloctenium radulans, and Urochloa panicoides as affected by burial depth (0, 2, and 10 cm). Regardless of species, buried seeds persisted longer than surface seeds and there was no difference in seed persistence between 2 and 10 cm depths. Surface seeds of C. truncata depleted completely in 12 months and buried seeds in 24 months. Similarly, C. virgata seeds placed on the soil surface depleted in 12 months. Buried seeds of this species took 18 months to completely deplete, suggesting that C. truncata seeds persist longer than C. virgata seeds. Surface seeds of D. radulans took 36 months to completely deplete, whereas about 7% of buried seeds were still viable at 42 months. U. panicoides took 24 and 42 months to completely exhaust the surface and buried seeds, respectively. These results suggest that leaving seeds on the soil surface will result in a more rapid depletion of the seedbank. Information on seed persistence will help to manage these weeds using strategic tillage operations.	[Chauhan, Bhagirath Singh; Manalil, Sudheesh] Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia; [Chauhan, Bhagirath Singh] Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia; [Manalil, Sudheesh] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia; [Manalil, Sudheesh] Amrita Vishwa Vidyapeetham, Coimbatore, Tamil Nadu, India	University of Queensland; University of Queensland; University of Western Australia; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Coimbatore	Chauhan, BS (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia.; Chauhan, BS (corresponding author), Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia.	b.chauhan@uq.edu.au	Manalil, Sudheesh/GQR-0450-2022		Grains Research and Development Corporation (GRDC), Australia [UA00156]	Grains Research and Development Corporation (GRDC), Australia(Grains R&D Corp)	This work was supported by a grant from Grains Research and Development Corporation (GRDC), Australia, under project UA00156. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DW, 1998, WEED RES, V38, P129, DOI 10.1046/j.1365-3180.1998.00083.x; [Anonymous], 2017, GROWNOTES, P1; Asaduzzaman M, 2019, WEED BIOL MANAG, V19, P85, DOI 10.1111/wbm.12183; BALLARE CL, 1988, ANN APPL BIOL, V112, P337, DOI 10.1111/j.1744-7348.1988.tb02070.x; Baskin CC, 2006, SEED SCI RES, V16, P165, DOI 10.1079/SSR2006247; Beckie HJ, 2018, WEED RES, V58, P177, DOI 10.1111/wre.12294; Borger CPD, 2011, CROP PASTURE SCI, V62, P678, DOI 10.1071/CP11018; Chauhan BS, 2006, WEED SCI, V54, P854, DOI 10.1614/WS-06-047R.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199949; Chauhan BS, 2019, WEBINAR AUSTR; Desai HS, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10091266; Douglas A., 2004, Weed management: balancing people, planet, profit. 14th Australian Weeds Conference, Wagga Wagga, New South Wales, Australia, 6-9 September 2004: papers and proceedings, P300; Fernando N, 2016, WEED SCI, V64, P605, DOI 10.1614/WS-D-15-00212.1; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Gill G., 2021, ECOLOGY MAJOR EMERGI; HATCH MD, 1988, ARCH BIOCHEM BIOPHYS, V261, P357, DOI 10.1016/0003-9861(88)90351-7; Heap I, INT SURVEY HERBICIDE; Korres NE, 2018, WEED SCI, V66, P446, DOI 10.1017/wsc.2018.27; KREMER RJ, 1993, ECOL APPL, V3, P42, DOI 10.2307/1941791; Llewellyn R, 2016, IMPACT WEEDS AUSTR G; Manalil S, 2020, CROP PASTURE SCI, V71, P916, DOI 10.1071/CP20092; Manalil S, 2017, CROP PASTURE SCI, V68, P773, DOI 10.1071/CP17116; Mohler CL, 1997, WEED RES, V37, P147, DOI 10.1046/j.1365-3180.1997.d01-21.x; Ngo TD, 2017, WEED SCI, V65, P413, DOI 10.1017/wsc.2016.33; Ngo TD, 2017, WEED SCI, V65, P395, DOI 10.1017/wsc.2017.5; Omami EN, 1999, WEED RES, V39, P345, DOI 10.1046/j.1365-3180.1999.00149.x; Taylor GB, 2005, AUST J AGR RES, V56, P645, DOI 10.1071/AR04284; Walker Steve, 2010, Plant Protection Quarterly, V25, P127	29	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262288	10.1371/journal.pone.0262288	http://dx.doi.org/10.1371/journal.pone.0262288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982794	gold, Green Published			2022-12-26	WOS:000834805700027
J	Hiramoto, S; Asano, H; Miyamoto, T; Takegami, M; Kawabata, A				Hiramoto, Shiori; Asano, Hajime; Miyamoto, Tomoyoshi; Takegami, Manabu; Kawabata, Atsufumi			Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan	PLOS ONE			English	Article							QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; DULOXETINE; BREAST; NEUROTOXICITY; GOSHAJINKIGAN; ASSOCIATION; CARBOPLATIN; IMPACT; OLDER	Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse reaction in cancer patients treated with several cytotoxic anticancer agents including paclitaxel. Duloxetine, an antidepressant known as a serotonin-noradrenalin reuptake inhibitor, is the only agent that has moderate evidence for the use to treat painful CIPN. The present retrospective cohort study aimed to analyze risk factors for paclitaxel-induced peripheral neuropathy (PIPN), and investigate ongoing prescription drug use for PIPN in Japan. Female breast and gynecologic cancer patients who underwent paclitaxel-based chemotherapy at a single center in Japan between January 2016 and December 2019 were enrolled in this study. Patients' information obtained from electronic medical records were statistically analyzed to test possible risk factors on PIPN diagnosis. Patients' age, total paclitaxel dose, the history of female hormone-related diseases, hypertension and body mass index (BMI), but not additional platinum agents, were significantly associated with increased PIPN diagnosis. Drugs prescribed for PIPN included duloxetine, pregabalin, mecobalamin and Goshajinkigan, a polyherbal medicine, regardless of poor evidence for their effectiveness against CIPN, and were greatly different between breast and gynecologic cancer patients diagnosed with PIPN at the departments of Surgery and Gynecology, respectively. Thus, older age, greater total paclitaxel dose, the history of estrogen-related diseases, hypertension and BMI are considered risk factors for PIPN in paclitaxel-based chemotherapy of female cancer patients. It appears an urgent need to establish a guideline of evidence-based pharmacotherapy for PIPN.	[Hiramoto, Shiori; Miyamoto, Tomoyoshi; Kawabata, Atsufumi] Kindai Univ, Fac Pharm, Div Pharmacol & Pathophysiol, Higashiosaka, Osaka, Japan; [Hiramoto, Shiori; Asano, Hajime; Takegami, Manabu] Kindai Univ Hosp, Div Pharm, Osakasayama, Japan	Kindai University (Kinki University)	Kawabata, A (corresponding author), Kindai Univ, Fac Pharm, Div Pharmacol & Pathophysiol, Higashiosaka, Osaka, Japan.	kawabata@phar.kindai.ac.jp						Alejandro LM, 2013, AM J CLIN ONCOL-CANC, V36, P331, DOI 10.1097/COC.0b013e318246b50d; Barginear M, 2019, ONCOLOGIST, V24, P617, DOI 10.1634/theoncologist.2018-0298; Chantalat E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082815; Dolan ME, 2017, CLIN CANCER RES, V23, P5757, DOI 10.1158/1078-0432.CCR-16-3224; Domoto R, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081881; Driessen CML, 2012, SUPPORT CARE CANCER, V20, P877, DOI 10.1007/s00520-011-1336-0; Fattori V, 2020, PAIN, V161, P1321, DOI 10.1097/j.pain.0000000000001832; Ghoreishi Z, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4869-5; Greenwald MK, 2019, CANCER-AM CANCER SOC, V125, P269, DOI 10.1002/cncr.31798; Hershman DL, 2016, J CLIN ONCOL, V34, P3014, DOI 10.1200/JCO.2015.66.2346; Hertz DL, 2021, CANCER TREAT REV, V99, DOI 10.1016/j.ctrv.2021.102241; Hirayama Y, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000053; Hirayama Y, 2015, INT J CLIN ONCOL, V20, P866, DOI 10.1007/s10147-015-0810-y; Hoshino N, 2018, INT J CLIN ONCOL, V23, P434, DOI 10.1007/s10147-017-1229-4; Jordan B, 2019, BREAST CARE, V14, P79, DOI 10.1159/000499599; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kono T, 2013, CANCER CHEMOTH PHARM, V72, P1283, DOI 10.1007/s00280-013-2306-7; Kuriyama A, 2018, SUPPORT CARE CANCER, V26, P1051, DOI 10.1007/s00520-017-4028-6; Liu ZM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00495; Loibl S, 2018, LANCET ONCOL, V19, P497, DOI 10.1016/S1470-2045(18)30111-6; Loprinzi CL, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.01399; Mielke S, 2005, CLIN CANCER RES, V11, P4843, DOI 10.1158/1078-0432.CCR-05-0298; Miyamoto T, 2021, J PHARMACOL SCI, V146, P49, DOI 10.1016/j.jphs.2021.03.001; Mols F, 2014, SUPPORT CARE CANCER, V22, P2261, DOI 10.1007/s00520-014-2255-7; Otake A, 2015, ANTICANCER RES, V35, P359; Salat K, 2020, PHARMACOL REP, V72, P486, DOI 10.1007/s43440-020-00109-y; Schloss JM, 2017, SUPPORT CARE CANCER, V25, P195, DOI 10.1007/s00520-016-3404-y; Schloss JM, 2015, SUPPORT CARE CANCER, V23, P1843, DOI 10.1007/s00520-015-2725-6; Sekiguchi F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010367; Sekiguchi F, 2018, NEUROPHARMACOLOGY, V141, P201, DOI 10.1016/j.neuropharm.2018.08.040; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Tew WP, 2014, J CLIN ONCOL, V32, P2553, DOI 10.1200/JCO.2014.55.3073; Tsubota M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1581-6; Xu JL, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6660087; Yang QW, 2016, REPROD SCI, V23, P163, DOI 10.1177/1933719115584449	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261473	10.1371/journal.pone.0261473	http://dx.doi.org/10.1371/journal.pone.0261473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972132	gold, Green Published			2022-12-26	WOS:000773555700036
J	Airik, M; McCourt, B; Ozturk, TT; Huynh, AB; Zhang, XY; Tometich, JT; Topaloglu, R; Ozen, H; Orhan, D; Nejak-Bowen, K; Monga, SP; Hand, TW; Ozaltin, F; Airik, R				Airik, Merlin; McCourt, Blake; Ozturk, Tugba Tastemel; Huynh, Amy B.; Zhang, Xiaoyi; Tometich, Justin T.; Topaloglu, Rezan; Ozen, Hasan; Orhan, Diclehan; Nejak-Bowen, Kari; Monga, Satdarshan P.; Hand, Timothy W.; Ozaltin, Fatih; Airik, Rannar			Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion	FASEB JOURNAL			English	Article						ANKS6; congenital liver fibrosis; inflammation; nephronophthisis	POLYCYSTIC KIDNEY-DISEASE; DUCT EPITHELIAL-CELLS; GROWTH-FACTOR; BILE-DUCTS; BILIARY; INFILTRATION; PATHOGENESIS; COMPARTMENT; HOMEOSTASIS; INHIBITION	Congenital hepatic fibrosis (CHF) is a developmental liver disease that is caused by mutations in genes that encode ciliary proteins and is characterized by bile duct dysplasia and portal fibrosis. Recent work has demonstrated that mutations in ANKS6 can cause CHF due to its role in bile duct development. Here, we report a novel ANKS6 mutation, which was identified in an infant presenting with neonatal jaundice due to underlying biliary abnormalities and liver fibrosis. Molecular analysis revealed that ANKS6 liver pathology is associated with the infiltration of inflammatory macrophages to the periportal fibrotic tissue and ductal epithelium. To further investigate the role of macrophages in CHF pathophysiology, we generated a novel liver-specific Anks6 knockout mouse model. The mutant mice develop biliary abnormalities and rapidly progressing periportal fibrosis reminiscent of human CHF. The development of portal fibrosis in Anks6 KO mice coincided with the accumulation of inflammatory monocytes and macrophages in the mutant liver. Gene expression and flow cytometric analysis demonstrated the preponderance of M1- over M2-like macrophages at the onset of fibrosis. A critical role for macrophages in promoting peribiliary fibrosis was demonstrated by depleting the macrophages with clodronate liposomes which effectively reduced inflammatory gene expression and fibrosis, and ameliorated tissue histology and biliary function in Anks6 KO livers. Together, this study demonstrates that macrophages play an important role in the initiation of liver fibrosis in ANKS6-deficient livers and their therapeutic elimination may provide an avenue to mitigate CHF in patients.	[Airik, Merlin; McCourt, Blake; Huynh, Amy B.; Airik, Rannar] Univ Pittsburgh, Dept Pediat, Div Nephrol, Pittsburgh, PA 15260 USA; [Ozturk, Tugba Tastemel; Topaloglu, Rezan; Ozaltin, Fatih] Hacettepe Univ, Dept Pediat, Div Pediat Nephrol, Ankara, Turkey; [Zhang, Xiaoyi] Univ Pittsburgh, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Tometich, Justin T.; Hand, Timothy W.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Dept Pediat,Div Infect Dis, Pittsburgh, PA 15260 USA; [Ozen, Hasan] Hacettepe Univ, Dept Pediat, Div Gastroenterol, Ankara, Turkey; [Orhan, Diclehan] Hacettepe Univ, Dept Pediat, Pediat Pathol Unit, Ankara, Turkey; [Nejak-Bowen, Kari; Monga, Satdarshan P.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Nejak-Bowen, Kari; Monga, Satdarshan P.] Univ Pittsburgh, Pittsburgh Liver Res Ctr, Pittsburgh, PA USA; [Nejak-Bowen, Kari; Monga, Satdarshan P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Ozaltin, Fatih] Hacettepe Univ, Dept Pediat, Div Pediat Nephrol, Nephrogenet Lab, Ankara, Turkey; [Airik, Rannar] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hacettepe University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hacettepe University; Hacettepe University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hacettepe University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Airik, R (corresponding author), UPMC Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	airikr@pitt.edu	Zhang, Xiaoyi/AGI-2976-2022	Zhang, Xiaoyi/0000-0002-4988-819X; Topaloglu, Rezan/0000-0002-6423-0927; McCourt, Blake/0000-0002-1488-2572	National Institutes of Health [DK099434, DK115403, P30DK079307]; Pittsburgh Liver Research Center [P30DK120531]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Liver Research Center	This research was supported by grants from the National Institutes of Health to R.A. (DK099434, DK115403, P30DK079307). The human disease samples were provided in part by the Pittsburgh Liver Research Center funded by P30DK120531 (SPM).	Airik M, 2020, HUM MOL GENET, V29, P3064, DOI 10.1093/hmg/ddaa197; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Beljaars L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00430; Bennett HW, 2020, MOL BIOL CELL, V31, P619, DOI 10.1091/mbc.E19-09-0499; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Best J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162286; Cadamuro M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00115; CHAPMAN RW, 1988, GUT, V29, P422, DOI 10.1136/gut.29.4.422; Czarnecki PG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7023; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; De Vito R, 2012, INT J MOL MED, V30, P49, DOI 10.3892/ijmm.2012.965; DESMET VJ, 1992, HEPATOLOGY, V16, P1069, DOI 10.1002/hep.1840160434; Desmet VJ, 1998, MAYO CLIN PROC, V73, P80; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guay-Woodford LM, 2014, J PEDIATR GENET, V3, P89, DOI 10.3233/PGE-14092; Guicciardi ME, 2018, J HEPATOL, V69, P676, DOI 10.1016/j.jhep.2018.05.018; Guillot A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI132305; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Jemail L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24825-x; Kaffe E, 2018, HEPATOLOGY, V67, P1903, DOI 10.1002/hep.29652; Katsumi T, 2019, AM J PHYSIOL-CELL PH, V317, pC788, DOI 10.1152/ajpcell.00250.2019; Kulkarni S, 2020, PEDIATR DEVEL PATHOL, V23, P235, DOI 10.1177/1093526619881541; Locatelli L, 2016, HEPATOLOGY, V63, P965, DOI 10.1002/hep.28382; Lu H, 2017, NAT GENET, V49, P1025, DOI 10.1038/ng.3871; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Moser M, 2005, HEPATOLOGY, V41, P1113, DOI 10.1002/hep.20655; Mousa HS, 2016, AUTOIMMUN REV, V15, P870, DOI 10.1016/j.autrev.2016.07.003; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Nakajima Y, 2018, KIDNEY INT, V93, P1108, DOI 10.1016/j.kint.2017.11.016; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Sasaki M, 2014, J CLIN PATHOL, V67, P470, DOI 10.1136/jclinpath-2013-201917; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sedlaczek N, 2001, AM J PATHOL, V158, P1239, DOI 10.1016/S0002-9440(10)64074-6; SPENGLER U, 1988, HEPATOLOGY, V8, P459, DOI 10.1002/hep.1840080304; Tan-Garcia A, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2019.11.006; Taskiran EZ, 2014, J AM SOC NEPHROL, V25, P1653, DOI 10.1681/ASN.2013060646; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Wu CT, 2003, HEPATOLOGY, V38, P1018, DOI 10.1053/jhep.2003.50407; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xi SJ, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.627927; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zimmerman KA, 2018, AM J PHYSIOL-GASTR L, V314, pG677, DOI 10.1152/ajpgi.00381.2017	49	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22157	10.1096/fj.202101387R	http://dx.doi.org/10.1096/fj.202101387R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032404				2022-12-26	WOS:000747987800018
J	Fan, XW; Wu, XX; De Lima, LTF; Stehbens, S; Punyadeera, C; Webb, R; Hamilton, B; Ayyapann, V; McLauchlan, C; Crawford, R; Zheng, MH; Xiao, Y; Prasadam, I				Fan, Xiwei; Wu, Xiaoxin; De Lima, Lucas Trevisan Franca; Stehbens, Samantha; Punyadeera, Chamindie; Webb, Richard; Hamilton, Brett; Ayyapann, Vijay; McLauchlan, Connor; Crawford, Ross; Zheng, Minghao; Xiao, Yin; Prasadam, Indira			The deterioration of calcified cartilage integrity reflects the severity of osteoarthritis-A structural, molecular, and biochemical analysis	FASEB JOURNAL			English	Article						calcified cartilage zone; microenvironment; osteoarthritis; osteochondral interface; proteomics	ARTICULAR-CARTILAGE; MASS-SPECTROMETRY; SUBCHONDRAL BONE; PATHWAYS; MATRIX; KNEE; CHONDROCYTES; PROGRESSION; INTERFACE; MODELS	The calcified cartilage zone (CCZ) is a thin interlayer between the hyaline articular cartilage and the subchondral bone and plays an important role in maintaining the joint homeostasis by providing biological and mechanical support from unmineralized cartilage to the underlying mineralized subchondral bone. The hallmark of CCZ characteristics in osteoarthritis (OA) is less well known. The aim of our study is to evaluate the structural, molecular, and biochemical composition of CCZ in tissues affected by primary knee OA and its relationship with disease severity. We collected osteochondral tissue samples stratified according to disease severity, from 16 knee OA patients who underwent knee replacement surgery. We also used meniscectomy-induced rat samples to confirm the pathophysiologic changes of human samples. We defined the characteristics of the calcified cartilage layer using a combination of morphological, biochemical, proteomic analyses on laser micro-dissected tissue. Our results demonstrated that the Calcium/Phosphate ratio is unchanged during the OA progression, but the calcium-binding protein and cadherin binding protein, as well as carbohydrate metabolism-related proteins, undergo significant changes. These changes were further accompanied by thinning of the CCZ, loss of collagen and proteoglycan content, the occurrence of the endochondral ossification, neovasculature, loss of the elastic module, loss of the collagen direction, and increase of the tortuosity indicating an altered structural and mechanical properties of the CCZ in OA. In conclusion, our results suggest that the calcified cartilage changes can reflect the disease progression.	[Fan, Xiwei; Wu, Xiaoxin; De Lima, Lucas Trevisan Franca; Punyadeera, Chamindie; Ayyapann, Vijay; McLauchlan, Connor; Crawford, Ross; Xiao, Yin; Prasadam, Indira] Queensland Univ Technol, Ctr Biomed Technol, Brisbane, Qld, Australia; [Wu, Xiaoxin] Cent South Univ, Xiangya Hosp 2, Dept Orthopaed Surg, Changsha, Peoples R China; [Stehbens, Samantha] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Punyadeera, Chamindie] Translat Res Inst, Brisbane, Qld, Australia; [Webb, Richard; Hamilton, Brett] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Crawford, Ross] Prince Charles Hosp, Brisbane, Qld, Australia; [Zheng, Minghao] Univ Western Australia, Med Sch, Perth, WA, Australia; [Xiao, Yin] Queensland Univ Technol, Australia China Ctr Tissue Engn & Regenerat Med, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Central South University; University of Queensland; University of Queensland; Prince Charles Hospital; University of Western Australia; Queensland University of Technology (QUT)	Prasadam, I (corresponding author), Queensland Univ Technol, Fac Engn, Ctr Biomed Technol, Q Block,60 Musk Ave, Brisbane, Qld 4059, Australia.	i.prasadam@qut.edu.au	; Stehbens, Sam/D-3512-2019	Punyadeera, Chamindie/0000-0001-9039-8259; Stehbens, Sam/0000-0002-8145-2708; Trevisan Franca de Lima, Lucas/0000-0002-4993-5945; Prasadam, Indira/0000-0001-5057-2427; Zheng, Minghao/0000-0003-1185-4768; Xiao, Yin/0000-0003-1785-3491	Prince Charles Hospital Research Foundation [RF-01, TM2017-05]; Cancer Australia [APP1145657]; NHMRC [APP1176298, APP2002576]	Prince Charles Hospital Research Foundation; Cancer Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The Prince Charles Hospital Research Foundation, Grant/Award Number: RF-01 and TM2017-05; NHMRC Investigator, Grant/Award Number: APP1176298 and APP2002576; Cancer Australia, Grant/Award Number: APP1145657	Aghajanian P, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0021-z; Akkiraju H, 2015, J DEV BIOL, V3, P177, DOI 10.3390/jdb3040177; Bellis DJ, 2006, J ANAL ATOM SPECTROM, V21, P948, DOI 10.1039/b603435g; BERRY JL, 1986, FOOT ANKLE, V7, P2, DOI 10.1177/107110078600700103; Boyde A, 2011, EUR CELLS MATER, V21, P470, DOI 10.22203/eCM.v021a35; BROWER TD, 1962, J BONE JOINT SURG AM, V44, P456, DOI 10.2106/00004623-196244030-00002; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Chen LZ, 2020, ANN RHEUM DIS, V79, P811, DOI 10.1136/annrheumdis-2020-216942; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Collins D, 1949, PATHOLOGY ARTICULAR; Dai GM, 2020, INT J MOL MED, V46, P167, DOI 10.3892/ijmm.2020.4576; Deng B, 2016, CURR RES TRANSL MED, V64, P149, DOI 10.1016/j.retram.2016.01.009; Eveque-Mourroux MR, 2020, J PROTEOMICS, V215, DOI 10.1016/j.jprot.2020.103637; Fan XW, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.659654; Ferguson VL, 2003, J ANAT, V203, P191, DOI 10.1046/j.1469-7580.2003.00193.x; Firner S, 2017, J HISTOCHEM CYTOCHEM, V65, P593, DOI 10.1369/0022155417729154; Furman BD, 2007, J ORTHOP RES, V25, P578, DOI 10.1002/jor.20331; Ghanbarian B, 2013, SOIL SCI SOC AM J, V77, P1461, DOI 10.2136/sssaj2012.0435; Goldring SR, 2016, NAT REV RHEUMATOL, V12, P632, DOI 10.1038/nrrheum.2016.148; Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011; HENEGHAN L, 2002, ECOLOGICAL RESTORATI, V20, P108, DOI DOI 10.3368/er.20.2.108; HONNER R, 1971, J BONE JOINT SURG AM, VA 53, P742, DOI 10.2106/00004623-197153040-00013; Hosseininia S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-18; Hsueh MF, 2014, MATRIX BIOL, V39, P56, DOI 10.1016/j.matbio.2014.08.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imhof H, 1999, Top Magn Reson Imaging, V10, P180, DOI 10.1097/00002142-199906000-00002; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Khanarian NT, 2014, J BONE MINER RES, V29, P2643, DOI 10.1002/jbmr.2284; Kourkoumelis N, 2012, J BIOL PHYS, V38, P279, DOI 10.1007/s10867-011-9247-3; Lord SJ, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202001064; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Lyons TJ, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-52; MAROUDAS A, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P166; MATTHEWSON MH, 1978, J BONE JOINT SURG BR, V60, P199, DOI 10.1302/0301-620X.60B2.659464; MEACHIM G, 1978, ARTHRITIS RHEUM, V21, P669, DOI 10.1002/art.1780210610; Mehana ESE, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116786; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Milovanovic P, 2012, EXP GERONTOL, V47, P154, DOI 10.1016/j.exger.2011.11.011; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720; Nanba Y, 1997, ACTA MED OKAYAMA, V51, P239; OGATA K, 1979, CLIN ORTHOP RELAT R, P273; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Poole AR, 2002, ANN RHEUM DIS, V61, P78, DOI 10.1136/ard.61.suppl_2.ii78; Prasadam I., 2009, CROSS TALK SUBCHONDR; Prasadam I, 2013, J MOL MED, V91, P369, DOI 10.1007/s00109-012-0953-5; Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.110777; Ruiz-Romero C, 2010, OSTEOARTHR CARTILAGE, V18, P500, DOI 10.1016/j.joca.2009.11.012; Schultz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120949; Sekar S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020509; Serrano RL, 2018, ARTHRITIS RHEUMATOL, V70, P1030, DOI 10.1002/art.40456; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepherd C, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1934-7; Steinberg J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09335-6; Suri S, 2012, BONE, V51, P204, DOI 10.1016/j.bone.2011.10.010; Tian J, 2020, PAIN RES MANAG, V2020, DOI 10.1155/2020/3428587; Wang FY, 2009, J STRUCT BIOL, V168, P359, DOI 10.1016/j.jsb.2009.08.010; Wang Fuyou, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P524; Wen CY, 2012, OSTEOARTHR CARTILAGE, V20, P916, DOI 10.1016/j.joca.2012.04.018; Woodell-May JE, 2020, J ORTHOP RES, V38, P253, DOI 10.1002/jor.24457; Zeng GQ, 2015, GENET MOL RES, V14, P14811, DOI 10.4238/2015.November.18.46; Zhai GJ, 2019, METABOLITES, V9, DOI 10.3390/metabo9010011; Zhang Y, 2012, INT J MED SCI, V9, P353, DOI 10.7150/ijms.4276; Zheng LL, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2020.101249; Zhong LL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071126; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553	69	5	5	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22142	10.1096/fj.202101449R	http://dx.doi.org/10.1096/fj.202101449R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032407				2022-12-26	WOS:000747987800011
J	Sun, CF; Wei, JC; Long, ZL; Zhao, WX; Qi, HF; Qi, X; Wang, BH; Wen, JM				Sun, Chengfang; Wei, Jingchao; Long, Zhilin; Zhao, Weixi; Qi Huangfu; Qi Xie; Wang, Bohan; Wen, Jiaming			Spindle pole body component 24 homolog potentiates tumor progression via regulation of SRY-box transcription factor 2 in clear cell renal cell carcinoma	FASEB JOURNAL			English	Article						clear cell renal cell carcinoma; metastasis; spindle pole body component 24 homolog; SRY-box transcription factor 2	CLINICAL-PRACTICE-GUIDELINES; EXTRACELLULAR-MATRIX; CANCER; SPC24; NDC80; DIAGNOSIS	Clear cell renal cell carcinoma (ccRCC) is the most common pathological subtype of human kidney cancer with a high probability of metastasis. To understand the molecular processing essential for ccRCC tumorigenicity, we conducted an integrative in silico analysis of The Cancer Genome Atlas (TCGA) ccRCC dataset and clustered randomly interspersed short palindromic repeats (CRISPR) screening dataset of ccRCC cell lines from Depmap. We identified spindle pole body component 24 homolog (SPC24) as an essential gene for ccRCC cell lines with prognostic significance in the TCGA database. Targeting SPC24 by CRISPR/Cas9-mediated gene knockout attenuated ccRCC proliferation, metastasis, and in vivo tumor growth. Furthermore, we found that SPC24 regulates metastasis genes expression in a SRY-box transcription factor 2 (SOX2)-dependent manner. The anti-proliferative effects of SPC24 knockout were strengthened with SOX2 knockdown. Collectively, our findings suggest SPC24 has a pivotal function in promoting ccRCC progression, providing a new insight for the treatment of ccRCC.	[Sun, Chengfang; Wei, Jingchao; Qi Huangfu; Wang, Bohan; Wen, Jiaming] Zhejiang Univ, Dept Urol, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Long, Zhilin; Zhao, Weixi; Qi Xie] Westlake Univ, Sch Life Sci, Key Lab Growth Regulat & Translat Res Zhejiang Pr, Hangzhou, Peoples R China; [Long, Zhilin; Zhao, Weixi; Qi Xie] Westlake Lab Life Sci & Biomed, Hangzhou, Peoples R China; [Long, Zhilin; Zhao, Weixi; Qi Xie] Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Peoples R China	Zhejiang University; Westlake University; Westlake University	Wang, BH; Wen, JM (corresponding author), Zhejiang Univ, Dept Urol, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China.	wangbohan@zju.edu.cn; wenjiaming@zju.edu.cn			National Natural Science Foundation of China [81871153, 82073268]; Westlake Education Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Westlake Education Foundation	This research was funded by the National Natural Science Foundation of China (No. 81871153 to Jiaming Wen, No. 82073268 to QiXie) and Westlake Education Foundation	Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bhattacharya S, 2019, STEM CELLS, V37, P417, DOI 10.1002/stem.2959; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bushweller JH, 2019, NAT REV CANCER, V19, P611, DOI 10.1038/s41568-019-0196-7; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen SX, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10355; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Clark DJ, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-2458; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Dempster J.M.R.J., 2019, BIORXIV, P720243, DOI [10.1101/720243, DOI 10.1101/720243]; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Dudani S, 2019, EUR UROL, V76, P861, DOI 10.1016/j.eururo.2019.07.048; Escudier B, 2019, ANN ONCOL, V30, P706, DOI 10.1093/annonc/mdz056; Escudier B, 2016, ANN ONCOL, V27, pv58, DOI 10.1093/annonc/mdw328; Francois M, 2020, SEMIN CELL DEV BIOL, V99, P12, DOI [10.1016/j.semedb.2018.07.019, 10.1016/j.semcdb.2018.07.019]; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Hsieh JJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.9; Huser L, 2018, EXPERT OPIN THER TAR, V22, P983, DOI 10.1080/14728222.2018.1538359; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Jiramongkol Y, 2020, CANCER METAST REV, V39, P681, DOI 10.1007/s10555-020-09883-w; Kotecha RR, 2019, NAT REV CLIN ONCOL, V16, P621, DOI 10.1038/s41571-019-0209-1; Lambert M, 2018, MOLECULES, V23, DOI 10.3390/molecules23061479; Linehan WM, 2019, NAT REV UROL, V16, P539, DOI 10.1038/s41585-019-0211-5; Ljungberg B, 2019, EUR UROL, V75, P799, DOI 10.1016/j.eururo.2019.02.011; Low JZB, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1974-4; Makhov P, 2018, MOL CANCER THER, V17, P1355, DOI 10.1158/1535-7163.MCT-17-1299; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Meng QC, 2015, AM J CANCER RES, V5, P1730; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Papavassiliou KA, 2016, J CELL BIOCHEM, V117, P2693, DOI 10.1002/jcb.25605; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Powles T, 2021, ANN ONCOL, V32, P422, DOI 10.1016/j.annonc.2020.11.016; Qu Y, 2014, J GASTROENTEROL, V49, P408, DOI 10.1007/s00535-013-0809-y; Rini BI, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0813-8; Sheng J, 2017, ONCOTARGET, V8, P105276, DOI 10.18632/oncotarget.22167; Sun ZY, 2020, J CANCER, V11, P2921, DOI 10.7150/jca.41834; Turajlic S, 2018, J EXP MED, V215, P2477, DOI 10.1084/jem.20181617; Wang Y, 2021, BIOCHEM BIOPH RES CO, V561, P80, DOI 10.1016/j.bbrc.2021.05.020; Xue DW, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1072-5; Yin HB, 2017, ONCOTARGET, V8, P21884, DOI 10.18632/oncotarget.15670; Zhang C, 2019, CLIN CANCER RES, V25, P6827, DOI 10.1158/1078-0432.CCR-19-0733; Zhou J, 2018, GENE, V675, P272, DOI 10.1016/j.gene.2018.07.017; Zhou J, 2017, ONCOTARGET, V8, P65469, DOI 10.18632/oncotarget.18971; Zhu PP, 2015, ONCOTARGET, V6, P41383, DOI 10.18632/oncotarget.5510	45	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22086	10.1096/fj.202101310R	http://dx.doi.org/10.1096/fj.202101310R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35028983				2022-12-26	WOS:000747987800038
J	Weber, S; Grande, PM; Blank, LM; Klose, H				Weber, Sophie; Grande, Philipp M.; Blank, Lars M.; Klose, Holger			Insights into cell wall disintegration of Chlorella vulgaris	PLOS ONE			English	Article							DISRUPTION METHODS; MICROALGAE; BIOMASS; EXTRACTION; PROTEIN; RELEASE; SUGAR; HYDROLYSIS; CONVERSION; DIGESTION	With their ability of CO2 fixation using sunlight as an energy source, algae and especially microalgae are moving into the focus for the production of proteins and other valuable compounds. However, the valorization of algal biomass depends on the effective disruption of the recalcitrant microalgal cell wall. Especially cell walls of Chlorella species proved to be very robust. The wall structures that are responsible for this robustness have been studied less so far. Here, we evaluate different common methods to break up the algal cell wall effectively and measure the success by protein and carbohydrate release. Subsequently, we investigate algal cell wall features playing a role in the wall's recalcitrance towards disruption. Using different mechanical and chemical technologies, alkali catalyzed hydrolysis of the Chlorella vulgaris cells proved to be especially effective in solubilizing up to 56 wt% protein and 14 wt% carbohydrates of the total biomass. The stepwise degradation of C. vulgaris cell walls using a series of chemicals with increasingly strong conditions revealed that each fraction released different ratios of proteins and carbohydrates. A detailed analysis of the monosaccharide composition of the cell wall extracted in each step identified possible factors for the robustness of the cell wall. In particular, the presence of chitin or chitin-like polymers was indicated by glucosamine found in strong alkali extracts. The presence of highly ordered starch or cellulose was indicated by glucose detected in strong acidic extracts. Our results might help to tailor more specific efforts to disrupt Chlorella cell walls and help to valorize microalgae biomass.	[Weber, Sophie; Grande, Philipp M.; Klose, Holger] Forschungszentrum Julich, Plantsci IBG 2, Inst Bio & Geosci, Julich, Germany; [Weber, Sophie] Rhein Westfal TH Aachen, Aachen, Germany; [Blank, Lars M.] Rhein Westfal TH Aachen, Inst Appl Microbiol, Aachen Biol & Biotechnol, Aachen, Germany; [Klose, Holger] Rhein Westfal TH Aachen, Inst Bot & Mol Genet, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Klose, H (corresponding author), Forschungszentrum Julich, Plantsci IBG 2, Inst Bio & Geosci, Julich, Germany.; Klose, H (corresponding author), Rhein Westfal TH Aachen, Inst Bot & Mol Genet, Aachen, Germany.	h.klose@fz-juelich.de	Klose, Holger/AAB-3936-2020	Klose, Holger/0000-0003-3804-0094	Bioeconomy International (BMBF) [FKZ: 031B0453A]	Bioeconomy International (BMBF)(Federal Ministry of Education & Research (BMBF))	The experimental work included here was partially financed by the Bioeconomy International (BMBF) Project Algnutrient-UrBioSol, FKZ: 031B0453A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou El-Souod GW, 2021, IRAN J SCI TECHNOL A, V45, P767, DOI 10.1007/s40995-021-01097-1; Alhattab M, 2019, J APPL PHYCOL, V31, P61, DOI 10.1007/s10811-018-1560-9; Allard B, 2000, PHYTOCHEMISTRY, V54, P369, DOI 10.1016/S0031-9422(00)00135-7; Arguelles ED, 2021, J APPL PHYCOL, V33, P1, DOI 10.1007/s10811-020-02126-z; BAILEY RW, 1958, BIOCHEM J, V68, P669, DOI 10.1042/bj0680669; Barbarino E, 2005, J APPL PHYCOL, V17, P447, DOI 10.1007/s10811-005-1641-4; Baudelet PH, 2017, ALGAL RES, V25, P333, DOI 10.1016/j.algal.2017.04.008; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canelli G, 2021, LWT-FOOD SCI TECHNOL, V143, DOI 10.1016/j.lwt.2021.111157; Canelli G, 2021, J AGR FOOD CHEM, V69, P2226, DOI 10.1021/acs.jafc.0c05032; Chen L, 2002, J AGR FOOD CHEM, V50, P5558, DOI 10.1021/jf020516x; Coelho D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41775-0; Dunker S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00719; Dwyer JH, 2001, CIRCULATION, V103, P2922, DOI 10.1161/01.CIR.103.24.2922; Ferreira AS, 2020, ALGAL RES, V45, DOI 10.1016/j.algal.2019.101757; Ferruzzi MG, 2007, NUTR RES, V27, P1, DOI 10.1016/j.nutres.2006.12.003; Fradique M, 2010, J SCI FOOD AGR, V90, P1656, DOI 10.1002/jsfa.3999; Fu CC, 2010, BIORESOURCE TECHNOL, V101, P8750, DOI 10.1016/j.biortech.2010.06.100; Fukuda H, 2001, J BIOSCI BIOENG, V92, P405, DOI 10.1016/S1389-1723(01)80288-7; Gerken HG, 2013, PLANTA, V237, P239, DOI 10.1007/s00425-012-1765-0; Gunerken E, 2015, BIOTECHNOL ADV, V33, P243, DOI 10.1016/j.biotechadv.2015.01.008; Halim R, 2012, BIOTECHNOL ADV, V30, P709, DOI 10.1016/j.biotechadv.2012.01.001; Hejazi MA, 2004, TRENDS BIOTECHNOL, V22, P189, DOI 10.1016/j.tibtech.2004.02.009; Huang GH, 2010, APPL ENERG, V87, P38, DOI 10.1016/j.apenergy.2009.06.016; Jeon BH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-37; KAPAUN E, 1995, PLANTA, V197, P577; Kim DY, 2016, BIORESOURCE TECHNOL, V199, P300, DOI 10.1016/j.biortech.2015.08.107; Kodner RB, 2009, ORG GEOCHEM, V40, P854, DOI 10.1016/j.orggeochem.2009.05.003; Kroger M, 2018, ENERGIES, V11, DOI 10.3390/en11020450; Largeau C, 1995, ADV MICROB ECOL, V14, P77; Laurens LML, 2015, GREEN CHEM, V17, P1145, DOI [10.1039/c4gc01612b, 10.1039/C4GC01612B]; Laurens LML, 2014, ANAL BIOCHEM, V452, P86, DOI 10.1016/j.ab.2014.02.009; Lee JY, 2010, BIORESOURCE TECHNOL, V101, pS75, DOI 10.1016/j.biortech.2009.03.058; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALISARAD S, 1980, PLANT CELL PHYSIOL, V21, P27; Martins LB, 2021, BIOMASS CONVERS BIOR, V11, P2485, DOI 10.1007/s13399-020-00661-w; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; McCann MC, 2015, J EXP BOT, V66, P4109, DOI 10.1093/jxb/erv267; Mendes-Pinto MM, 2001, J APPL PHYCOL, V13, P19, DOI 10.1023/A:1008183429747; Moretti R, 2008, ANAL BIOCHEM, V377, P251, DOI 10.1016/j.ab.2008.03.018; Motlagh SR., 2021, BIOMASS CONVERS BIOR; Mubarak M., 2016, Resource-Efficient Technologies, V2, P126, DOI 10.1016/j.reffit.2016.07.005; Mulder G. J., 1839, J PRAKT CHEMCHEM ZTG, V16, P129, DOI DOI 10.1002/PRAC.18390160137; Noda K, 1996, PLANTA MED, V62, P423, DOI 10.1055/s-2006-957931; Ogawa K., 2001, J APPL GLYCOSCI, V48, P325, DOI 10.5458/jag.48.325; Ometto F, 2014, WATER RES, V65, P350, DOI 10.1016/j.watres.2014.07.040; Pauly M., 2010, JOVE-J VIS EXP, V37, P1745, DOI [10.3791/1745, DOI 10.3791/1745]; Phusunti N, 2020, ALGAL RES, V48, DOI 10.1016/j.algal.2020.101918; Postma PR, 2017, BIORESOURCE TECHNOL, V224, P670, DOI 10.1016/j.biortech.2016.11.071; Prabakaran P, 2011, LETT APPL MICROBIOL, V53, P150, DOI 10.1111/j.1472-765X.2011.03082.x; Rokicka M, 2021, BIOENERG RES, V14, P752, DOI 10.1007/s12155-020-10202-y; SAEMAN JF, 1945, IND ENG CHEM, V37, P43, DOI 10.1021/ie50421a009; Safi C, 2015, ALGAL RES, V8, P61, DOI 10.1016/j.algal.2015.01.002; Safi C, 2014, ALGAL RES, V3, P55, DOI 10.1016/j.algal.2013.11.017; Safi C, 2014, RENEW SUST ENERG REV, V35, P265, DOI 10.1016/j.rser.2014.04.007; Singh A, 2011, BIORESOURCE TECHNOL, V102, P10, DOI 10.1016/j.biortech.2010.06.032; Skaloud P, 2014, FOTTEA, V14, P53, DOI 10.5507/fot.2014.004; TAKEDA H, 1984, PLANT CELL PHYSIOL, V25, P287; TAKEDA H, 1988, BIOCHEM SYST ECOL, V16, P367, DOI 10.1016/0305-1978(88)90027-0; TAKEDA H, 1993, PHYTOCHEMISTRY, V34, P1053, DOI 10.1016/S0031-9422(00)90712-X; Templeton DW, 2015, ALGAL RES, V11, P359, DOI 10.1016/j.algal.2015.07.013; Weidener D, 2018, CHEMSUSCHEM, V11, P2051, DOI 10.1002/cssc.201800653; Phong WN, 2018, BIOCHEM ENG J, V135, P83, DOI 10.1016/j.bej.2018.04.002; YAMADA T, 1982, ARCH MICROBIOL, V132, P10, DOI 10.1007/BF00690809	66	8	8	13	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262500	10.1371/journal.pone.0262500	http://dx.doi.org/10.1371/journal.pone.0262500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030225	gold, Green Published			2022-12-26	WOS:000812798500050
J	Zhang, C; Tang, M; Gao, XD; Ling, Q; Wu, PT				Zhang, Chao; Tang, Min; Gao, Xiaodong; Ling, Qiang; Wu, Pute			Sloping land use affects the complexity of soil moisture and temperature changes in the loess hilly region of China	PLOS ONE			English	Article							APPROXIMATE ENTROPY; SMALL CATCHMENT; PLATEAU; ORCHARD; EROSION; IMPACT; GROWTH	Various land use types have been implemented by the government in the loess hilly region of China to facilitate sustainable land use. Understanding the variability in soil moisture and temperature under various sloping land use types can aid the ecological restoration and sustainable utilization of sloping land resources. The objective of this study was to use approximate entropy (ApEn) to reveal the variations in soil moisture and temperature under different land use types, because ApEn only requires a short data series to obtain robust estimates, with a strong anti-interference ability. An experiment was conducted with four typical land use scenarios (i.e., soybean sloping field, maize terraced field, jujube orchard, and grassland) over two consecutive plant growing seasons (2014 and 2015), and the time series of soil moisture and temperature within different soil depth layers of each land use type were measured in both seasons. The results showed that the changing amplitude, degree of variation, and active layer of soil moisture in the 0-160 cm soil depth layer, as well as the changing amplitude and degree of variation of soil temperature in the 0-100 cm soil layer increased in the jujube orchard over the two growing seasons. The changing amplitude, degree of variation, and active layer of soil moisture all decreased in the maize terraced field, as did the changing amplitude and degree of variation of soil temperature. The ApEn of the soil moisture series was the lowest in the 0-160 cm soil layer in the maize terraced field, and the ApEn of the soil temperature series was the highest in the 0-100 cm layer in the jujube orchard in the two growing seasons. Finally, the jujube orchard soil moisture and temperature change process were more variable, whereas the changes in the maize terraced field were more stable, with a stable soil moisture and temperature. This work highlights the usefulness of ApEn for revealing soil moisture and temperature changes and to guide the management and development of sloping fields.	[Zhang, Chao; Tang, Min] Yangzhou Univ, Coll Hydraul Sci & Engn, Yangzhou, Jiangsu, Peoples R China; [Tang, Min; Gao, Xiaodong; Wu, Pute] Northwest Agr & Forestry Univ, Inst Water Saving Agr Arid Areas China, Yangling, Shaanxi, Peoples R China; [Ling, Qiang] Zhejiang Univ Water Resources & Elect Power, Coll Water Resources & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Yangzhou University; Northwest A&F University - China; Zhejiang University of Water Resources and Electric Power	Tang, M (corresponding author), Yangzhou Univ, Coll Hydraul Sci & Engn, Yangzhou, Jiangsu, Peoples R China.; Tang, M (corresponding author), Northwest Agr & Forestry Univ, Inst Water Saving Agr Arid Areas China, Yangling, Shaanxi, Peoples R China.	tangmin0511@126.com		Gao, Xiaodong/0000-0002-4954-8830	National Natural Science Foundation of China [51909228]; China Postdoctoral Science Foundation [2020M671623]; "Blue Project" of Yangzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); "Blue Project" of Yangzhou University	This research was funded by the National Natural Science Foundation of China (No. 51909228), China Postdoctoral Science Foundation (No. 2020M671623), and "Blue Project" of Yangzhou University.	Abdi H., 2010, ENCY RES DESIGN, V1, P169; Alizamir M, 2021, ARTIF INTELL REV, V54, P2863, DOI 10.1007/s10462-020-09915-5; An XL, 2017, P I MECH ENG E-J PRO, V231, P317, DOI 10.1177/0954408915595763; Baboshkina SV, 2020, SOIL ENVRON, V39, P211, DOI 10.25252/SE/2020/162260; Badia D, 2017, SCI TOTAL ENVIRON, V601, P1119, DOI 10.1016/j.scitotenv.2017.05.254; Bindajam AA, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11070762; Chen D, 2020, AGR WATER MANAGE, V227, DOI 10.1016/j.agwat.2019.105849; Chen HS, 2010, ENVIRON EARTH SCI, V61, P1105, DOI 10.1007/s12665-009-0428-3; Chen JunFeng, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P102; Figliola A, 1997, IEEE ENG MED BIOL, V16, P74, DOI 10.1109/51.585521; [高学睿 Gao Xuerui], 2020, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V51, P275; Ge J, 2020, HYDROL EARTH SYST SC, V24, P515, DOI 10.5194/hess-24-515-2020; [郝明德 Hao Mingde], 2003, [植物营养与肥料学报, Plant nutrition and fertitizer science], V9, P377; He YY, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/4/045603; Heinze J, 2017, J PLANT ECOL, V10, P808, DOI 10.1093/jpe/rtw097; Huang J, 2016, LAND DEGRAD DEV, V27, P946, DOI 10.1002/ldr.2281; Jayakumar GSDS, 2015, J RELIAB STAT STUD, V8, P39; Jia DY, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5350-x; Jimenez MN, 2017, CATENA, V152, P198, DOI 10.1016/j.catena.2017.01.021; Kader MA, 2019, AGR WATER MANAGE, V223, DOI 10.1016/j.agwat.2019.105707; Kader MA, 2020, IRRIG DRAIN, V69, P483, DOI 10.1002/ird.2431; Kaur A, 2020, TRAIT SIGNAL, V37, P279, DOI 10.18280/ts.370214; Li HC, 2016, SOLID EARTH, V7, P167, DOI 10.5194/se-7-167-2016; Li HC, 2018, J HYDROL, V558, P432, DOI 10.1016/j.jhydrol.2018.01.052; Mamat Z, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5394-y; da Silva DMN, 2016, BIOSCI J, V32, P11, DOI 10.14393/BJ-v32n1a2016-26241; Nishar A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00249; Obia A, 2020, SOIL TILL RES, V197, DOI 10.1016/j.still.2019.104521; Pan DL, 2018, SOIL SCI SOC AM J, V82, P447, DOI 10.2136/sssaj2017.10.0371; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ran QH, 2020, J HYDROL, V588, DOI 10.1016/j.jhydrol.2020.125045; Rong L, 2017, WATER-SUI, V9, DOI 10.3390/w9020092; Rosenbaum U, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011518; Savva Y, 2010, SOIL SCI SOC AM J, V74, P469, DOI 10.2136/sssaj2009.0107; Wanzeler RTS, 2016, ESTAC CIENT-UNIFAP, V6, P117, DOI 10.18468/estcien.2016v6n1.p117-124; Tang M, 2019, J SOIL WATER CONSERV, V74, P24, DOI 10.2489/jswc.74.1.24; Tang M, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10060774; Tang M, 2019, AGRON J, V111, P1506, DOI 10.2134/agronj2018.06.0405; Tibdewal MN, 2017, BIOMED SIGNAL PROCES, V38, P158, DOI 10.1016/j.bspc.2017.05.002; Wang HB, 2021, AGR WATER MANAGE, V244, DOI 10.1016/j.agwat.2020.106462; Wang L., 2014, STUDY COMPLEXITY SNO; Wang N, 2020, RESTOR ECOL, V28, pA5, DOI 10.1111/rec.13169; Wang Y, 2018, PLANT SOIL, V426, P33, DOI 10.1007/s11104-018-3596-7; Wang YM, 2020, AM J POTATO RES, V97, P405, DOI 10.1007/s12230-020-09791-3; Wen X, 2019, RESOUR CONSERV RECY, V151, DOI 10.1016/j.resconrec.2019.104474; Wu Lei, 2017, Fresenius Environmental Bulletin, V26, P7815; Wu L, 2016, FRESEN ENVIRON BULL, V25, P4506; [校亮 Xiao Liang], 2018, [生态学报, Acta Ecologica Sinica], V38, P646; Xue R, 2018, J SOIL SCI PLANT NUT, V18, P1; [颜萍 Yan Ping], 2016, [中国岩溶, Carsologica Sinica], V35, P557; Yan RQ, 2007, MECH SYST SIGNAL PR, V21, P824, DOI 10.1016/j.ymssp.2006.02.009; Yang F, 1997, Zhongguo Yi Liao Qi Xie Za Zhi, V21, P283; Yang Y, 2017, J HYDROL, V550, P466, DOI 10.1016/j.jhydrol.2017.05.026; Ye WJ, 2017, ROCK SOIL MECH, V38, P656, DOI 10.16285/j.rsm.2017.03.006; Yu BW, 2019, J SOIL SEDIMENT, V19, P1179, DOI 10.1007/s11368-018-2119-8; Yuan XF, 2019, J GEOGR SCI, V29, P779, DOI 10.1007/s11442-019-1627-9; Zhang CL, 2014, J HYDROL ENG, V19, DOI 10.1061/(ASCE)HE.1943-5584.0001015; Zhang YL, 2019, NONLINEAR DYNAM, V95, P617, DOI 10.1007/s11071-018-4586-2; Zhao XiNing, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P135; Zhou XY, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18090323	61	1	1	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262445	10.1371/journal.pone.0262445	http://dx.doi.org/10.1371/journal.pone.0262445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030231	gold, Green Published			2022-12-26	WOS:000812798500046
J	Mills, MG; Bruce, E; Huang, ML; Crothers, JW; Hyrien, O; Oura, CAL; Blake, L; Brown Jordan, A; Hester, S; Wehmas, L; Mari, B; Barby, P; Lacoux, C; Fassy, J; Vial, P; Vial, C; Martinez, JRW; Oladipo, OO; Inuwa, B; Shittu, I; Meseko, CA; Chammas, R; Santos, CF; Dionisio, TJ; Garbieri, TF; Parisi, VA; Mendes-Correa, MC; de Paula, AV; Romano, CM; Goes, LGB; Minoprio, P; Campos, AC; Cunha, MP; Vilela, APP; Nyirenda, T; Mkakosya, RS; Muula, AS; Dumm, RE; Harris, RM; Mitchell, CA; Pettit, S; Botten, J; Jerome, KR				Mills, Margaret G.; Bruce, Emily; Huang, Meei-Li; Crothers, Jessica W.; Hyrien, Ollivier; Oura, Christopher A. L.; Blake, Lemar; Brown Jordan, Arianne; Hester, Susan; Wehmas, Leah; Mari, Bernard; Barby, Pascal; Lacoux, Caroline; Fassy, Julien; Vial, Pablo; Vial, Cecilia; Martinez, Jose R. W.; Oladipo, Olusola Olalekan; Inuwa, Bitrus; Shittu, Ismaila; Meseko, Clement A.; Chammas, Roger; Santos, Carlos Ferreira; Dionisio, Thiago Jose; Garbieri, Thais Francini; Parisi, Viviane Aparecida; Mendes-Correa, Maria Cassia; de Paula, Anderson V.; Romano, Camila M.; Goes, Luiz Gustavo Bentim; Minoprio, Paola; Campos, Angelica C.; Cunha, Marielton P.; Vilela, Ana Paula P.; Nyirenda, Tonney; Mkakosya, Rajhab Sawasawa; Muula, Adamson S.; Dumm, Rebekah E.; Harris, Rebecca M.; Mitchell, Constance A.; Pettit, Syril; Botten, Jason; Jerome, Keith R.			An international, interlaboratory ring trial confirms the feasibility of an extraction-less "direct" RT-qPCR method for reliable detection of SARS-CoV-2 RNA in clinical samples	PLOS ONE			English	Article								Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is used worldwide to test and trace the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). "Extraction-less" or "direct" real time-reverse transcription polymerase chain reaction (RT-PCR) is a transparent and accessible qualitative method for SARS-CoV-2 detection from nasopharyngeal or oral pharyngeal samples with the potential to generate actionable data more quickly, at a lower cost, and with fewer experimental resources than full RT-qPCR. This study engaged 10 global testing sites, including laboratories currently experiencing testing limitations due to reagent or equipment shortages, in an international interlaboratory ring trial. Participating laboratories were provided a common protocol, common reagents, aliquots of identical pooled clinical samples, and purified nucleic acids and used their existing in-house equipment. We observed 100% concordance across laboratories in the correct identification of all positive and negative samples, with highly similar cycle threshold values. The test also performed well when applied to locally collected patient nasopharyngeal samples, provided the viral transport media did not contain charcoal or guanidine, both of which appeared to potently inhibit the RT-PCR reaction. Our results suggest that direct RT-PCR assay methods can be clearly translated across sites utilizing readily available equipment and expertise and are thus a feasible option for more efficient COVID-19 coronavirus disease testing as demanded by the continuing pandemic.	[Mills, Margaret G.; Huang, Meei-Li; Jerome, Keith R.] Univ Washington, Dept Lab Med & Pathol, Div Virol, Seattle, WA 98195 USA; [Bruce, Emily; Crothers, Jessica W.; Botten, Jason] Univ Vermont, Dept Med, Robert Larner MD Coll Med, Div Immunobiol, Burlington, VT 05405 USA; [Hyrien, Ollivier; Jerome, Keith R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Oura, Christopher A. L.; Blake, Lemar] Univ West Indies, Sch Vet Med, St Augustine, Trinidad Tobago; [Brown Jordan, Arianne] Minist Hlth, Port Of Spain, Trinidad Tobago; [Hester, Susan; Wehmas, Leah] US Environm Protect Agcy, Off Res & Dev, Res Triangle Pk, NC USA; [Mari, Bernard; Barby, Pascal; Lacoux, Caroline; Fassy, Julien] Univ Cote dAzur, CNRS, Inst Pharmacol Mol & Cellulaire, FHU OncoAge, Valbonne, France; [Vial, Pablo; Vial, Cecilia; Martinez, Jose R. W.] Clin Alemana Univ Desarrollo, Fac Med, Programa Hantavirus, Inst Ciencias & Innovac Med, Santiago, Chile; [Oladipo, Olusola Olalekan] Natl Inst Vet Res, Div Biochem, Vom, Nigeria; [Inuwa, Bitrus; Shittu, Ismaila; Meseko, Clement A.] Natl Inst Vet Res, Infect & Transboundary Anim Dis, Vom, Nigeria; [Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Ctr Invest Translac Oncol,Inst Canc Estado Sao Pa, Sao Paulo, Brazil; [Santos, Carlos Ferreira; Dionisio, Thiago Jose; Garbieri, Thais Francini; Parisi, Viviane Aparecida] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [Mendes-Correa, Maria Cassia; de Paula, Anderson V.; Romano, Camila M.] Inst Trop Med Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [Goes, Luiz Gustavo Bentim; Minoprio, Paola; Campos, Angelica C.; Cunha, Marielton P.; Vilela, Ana Paula P.] Univ Sao Paulo, Sci Platform Pasteur USP, Sao Paulo, Brazil; [Goes, Luiz Gustavo Bentim] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Nyirenda, Tonney; Mkakosya, Rajhab Sawasawa] Univ Malawi, Dept Pathol, Coll Med, Blantyre, Malawi; [Muula, Adamson S.] Univ Malawi, Dept Publ Hlth, Coll Med, Blantyre, Malawi; [Dumm, Rebekah E.; Harris, Rebecca M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Pettit, Syril] Hlth & Environm Sci Inst, Washington, DC USA; [Botten, Jason] Univ Vermont, Robert Larner MD Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA	University of Washington; University of Washington Seattle; University of Vermont; Fred Hutchinson Cancer Center; University West Indies Mona Jamaica; University West Indies Saint Augustine; United States Environmental Protection Agency; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universidad del Desarrollo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Malawi; University of Malawi; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Vermont	Jerome, KR (corresponding author), Univ Washington, Dept Lab Med & Pathol, Div Virol, Seattle, WA 98195 USA.; Botten, J (corresponding author), Univ Vermont, Dept Med, Robert Larner MD Coll Med, Div Immunobiol, Burlington, VT 05405 USA.; Jerome, KR (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Pettit, S (corresponding author), Hlth & Environm Sci Inst, Washington, DC USA.; Botten, J (corresponding author), Univ Vermont, Robert Larner MD Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA.	spettit@hesiglobal.org; jason.botten@uvm.med.edu; kjerome@uw.edu	Pessoa Vilela, Ana Paula/Q-7538-2018; Romano, Camila/ABC-2883-2020; Vial, Maria Cecilia/GVS-4266-2022; Chammas, Roger/A-8004-2011; Mari, Bernard/Q-5832-2019; Santos, Carlos Ferreira dos/B-7676-2012; Almeida Campos, Angelica Cristine/Z-6089-2019	Pessoa Vilela, Ana Paula/0000-0001-9030-0688; Romano, Camila/0000-0003-4550-1987; Chammas, Roger/0000-0003-0342-8726; Mari, Bernard/0000-0002-0422-9182; Brown Jordan, Arianne/0000-0002-4146-3920; Oladipo, Olusola/0000-0001-9498-1492; Parisi, Viviane Aparecida/0000-0002-0285-1322; Santos, Carlos Ferreira dos/0000-0002-0405-3500; Almeida Campos, Angelica Cristine/0000-0003-0425-7498; Vial, Cecilia/0000-0002-0399-6144; Garbieri, Thais Francini/0000-0003-4507-5148; Harris, Rebecca/0000-0002-1944-3747	Health and Environmental Sciences Institute; University of Vermont (UVM) Office of the Vice President for Research; Fondecyt [1201240]; National Institutes of Health National Institute of Allergy and Infectious Diseases [5R01AI129518, UM1AI068635]	Health and Environmental Sciences Institute; University of Vermont (UVM) Office of the Vice President for Research; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MM:A grant from the Health and Environmental Sciences Institute to the University of Washington supported preparation and shipment of Project A and B samples to Propagate partner laboratories. HESI scientific staff also served as authors on the study but were not involved in direct sample preparation or data analysis. www.hesiglobal.org JB: An award from the University of Vermont (UVM) Office of the Vice President for Research supported work in the Botten lab at UVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.uvm.edu/ovpr CV, PV: Fondecyt provided funding (grant 1201240) for the work of C. Vial and P. Vial. https://www.conicyt.cl/fondecyt/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KJ: Grants from the National Institutes of Health National Institute of Allergy and Infectious Diseases (5R01AI129518 and UM1AI068635) and a gift from the MJ Murdock Charitable Trust helped to support the work of University of Washington and Fred Hutchinson Cancer Research Center researchers. https://www.niaid.nih.gov/and https://murdocktrust.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. M.Ribeiro-dos-Santos, 2020, medRxiv, DOI 10.1101/2020.04.15.20064931; American Society for Microbiology, 2021, EXP COVID 19 TEST FR; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bruce Emily A, 2020, bioRxiv, DOI 10.1101/2020.03.20.001008; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dumm RE, 2021, J APPL LAB MED, V6, P1441, DOI 10.1093/jalm/jfab079; Eshghifar N, 2021, INT J GEN MED, V14, P435, DOI 10.2147/IJGM.S297762; Graham NR, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1189; Kirkland PD, 2020, PATHOLOGY, V52, P811, DOI 10.1016/j.pathol.2020.09.013; Kuiper JWP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241740; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Millan C, 2021, TEST SCARCITY MEANS; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Pettit SD, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012634; Smyrlaki I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18611-5; Soy A, 2021, LACK COVID 19 TESTIN; U.S. Centers for Disease Control and Prevention, 2021, CDC 2019 NOV COR 201; van Kampen JJA., 2020, MEDRXIV INTERNET; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; World Health Organization, 2020, INTERIM GUIDANCE 2 M; World Health Organization, 2020, COVID 19 STRAT UPD G	21	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261853	10.1371/journal.pone.0261853	http://dx.doi.org/10.1371/journal.pone.0261853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025926	Green Published, gold			2022-12-26	WOS:000796264200029
J	Tonelotto, V; Davini, A; Cardarelli, L; Calderone, M; Marin, P				Tonelotto, Valentina; Davini, Annamaria; Cardarelli, Laura; Calderone, Milena; Marin, Paola			Efficacy of Fluorecare SARS-CoV-2 Spike Protein Test Kit for SARS-CoV-2 detection in nasopharyngeal samples of 121 individuals working in a manufacturing company	PLOS ONE			English	Article								Objectives The aim of this study was to evaluate the clinical performance of the Fluorecare SARS-CoV-2 Spike Protein Test Kit, a rapid immunochromatographic assay for SARS-CoV-2 detection. Moreover, we sought to point out the strategy adopted by a local company to lift the lockdown without leading to an increase in the number of COVID-19 cases, by performing a precise and timely health surveillance. Methods The rapid Fluorecare SARS-CoV-2 Spike Protein Test was performed immediately after sampling following the manufacturer's instructions. RT-PCRs were performed within 24 hours of specimen collection. A total amount of 253 nasopharyngeal samples from 121 individuals were collected between March 16 and April 2, 2021 and tested. Results Of 253 nasopharyngeal samples, 11 (9.1%) were positive and 242 (90.9%) were negative for SARS-CoV-2 RNA by RT-PCR assays. The rapid SARS-CoV-2 antigen detection test's mean sensitivity and specificity were 84,6% (95% CI, 54.6-98.1%) and 100% (95% CI, 98.6-100%), respectively. Two false negative test results were obtained from samples with high RT-PCR cycle threshold (Ct). Conclusion Our study suggested that Fluorecare SARS-CoV-2 Spike Protein Test can be introduced into daily diagnostic practice, as its mean sensitivity and specificity follow the standards recommended by WHO and IFCC Task Force. In addition, we underlined how the strategy adopted by a local company to risk assessment and health surveillance was appropriate for infection containment. This real-life scenario gave us the possibility to experience potential approaches aimed to preserve public health and work activities.	[Tonelotto, Valentina; Davini, Annamaria; Calderone, Milena; Marin, Paola] CMSR Veneto Med Srl, Vicenza, Italy; [Cardarelli, Laura] RDI Rete Diagnost Italiana Srl, Lifebrain Srl, Grp Cerba HealthCare, Padua, Italy		Tonelotto, V (corresponding author), CMSR Veneto Med Srl, Vicenza, Italy.	valentina.tonelotto@gmail.com		Tonelotto, Valentina/0000-0001-7441-2700				Albert E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.11.004; [Anonymous], FIND SARS COV 2 DIAG; Bohn MK., 2021, CLIN CHEM LAB MED, V59, P1507, DOI [DOI 10.1515/cclm-2021-0455, 10.1515/cclm-2021-0455]; D'angelo D, 2021, SAFETY SCI, V134, DOI 10.1016/j.ssci.2020.105067; De Sanctis Vincenzo, 2020, Acta Biomed, V91, P184, DOI 10.23750/abm.v91i2.9543; Eis-Hubinger AM, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104381; Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759; European Agency for Safety and Health at Work (EU-OSHA), 2020, COVID 19 EU OSHA GUI; European Centre for Disease Prevention and Control (ECDC), 2020, GUID TECHN REP; Fenollar F, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02589-20; Iavicoli S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248874; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mathuria JP, 2020, J INFECT PUBLIC HEAL, V13, P901, DOI 10.1016/j.jiph.2020.06.005; Nguyen NNT, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10110905; Salvagno GL., 2021, ADV LAB MED MED LAB, V2, P409; Sheridan C, 2020, NAT BIOTECHNOL, V38, P515, DOI 10.1038/d41587-020-00010-2; Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624; WHO, 2020, ANTIGEN DETECTION DI	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262174	10.1371/journal.pone.0262174	http://dx.doi.org/10.1371/journal.pone.0262174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025944	gold, Green Published			2022-12-26	WOS:000796264200052
J	van der Elst, EM; Abuna, M; Agutu, C; Ogada, F; Galole, A; Shikuku, J; Oduor, T; Graham, SM; Sanders, EJ; Operario, D				van der Elst, Elise M.; Abuna, Mitchelle; Agutu, Clara; Ogada, Fred; Galole, Aisha; Shikuku, Joyce; Oduor, Tony; Graham, Susan M.; Sanders, Eduard J.; Operario, Don			"Facilitating HIV status adjustment: Qualitative insights from the Tambua Mapema proof-of-concept study in Kenya"	PLOS ONE			English	Article							INFECTION; ADULTS	Systematic efforts are needed to prepare persons newly diagnosed with acute or chronic HIV infection to cope. We examined how patients dealt with this news, looking at how readiness to accept an HIV diagnosis impacted treatment outcomes, prevention of transmission, and HIV status disclosure. We examined vulnerability and agency over time and considered implications for policy and practice. A qualitative sub-study was embedded in the Tambua Mapema ("Discover Early") Plus (TMP) study (NCT03508908), conducted in coastal Kenya between 2017 and 2020, which was a stepped wedge trial to evaluate an opt-out HIV-1 nucleic acid testing intervention diagnosing acute and chronic HIV infections. Diagnosed participants were offered antiretroviral therapy (ART), viral load monitoring, HIV partner notification services, and provision of pre-exposure prophylaxis (PrEP) to their uninfected partners. Data were analyzed using thematic approaches. Participants included 24 individuals who completed interviews at four time points (2 weeks and 3, 6, and 9 months after diagnosis), including 18 patients (11 women and 7 men) and 6 partners (1 woman, 5 men, of whom 4 men started PrEP). Acceptance of HIV status was often a long, individualized, and complex process, whereby participants' coping strategies affected day-to-day issues and health over time. Relationship status strongly impacted coping. In some instances, couples supported each other, but in others, couples separated. Four main themes impacted participants' sense of agency: acceptance of diagnosis and commitment to ART; positive feedback after attaining viral load suppression; recognition of partner supportive role and focus on sustained healthcare support whereby religious meaning was often key to successful transition. To support patients with acute or newly diagnosed chronic HIV, healthcare and social systems must be more responsive to the needs of the individual, while also improving quality of care, strengthening continuity of care across facilities, and promoting community support.	[van der Elst, Elise M.; Agutu, Clara; Ogada, Fred; Galole, Aisha; Shikuku, Joyce; Oduor, Tony; Sanders, Eduard J.] Kenya Med Res Inst Wellcome Trust Res Programme, Dept Clin Sci, Kilifi, Kenya; [Abuna, Mitchelle; Operario, Don] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Graham, Susan M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan M.] Univ Washington, Dept Global Hlth & Epidemiol, Seattle, WA 98195 USA; [Sanders, Eduard J.] Univ Oxford, Ctr Trop Med & Global Hlth, Headington, England	Kenya Medical Research Institute; Brown University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford	Sanders, EJ (corresponding author), Kenya Med Res Inst Wellcome Trust Res Programme, Dept Clin Sci, Kilifi, Kenya.; Sanders, EJ (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Headington, England.	esanders@kemri-wellcome.org		van der Elst, Elise/0000-0001-5106-0466; Abuna, Mitchelle/0000-0002-9431-3408; Sanders, Eduard/0000-0002-1062-8921; Agutu, Clara/0000-0003-1053-4463	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI124968]; DELTAS Africa Initiative grant [DEL-15-006]; Wellcome Trust [107752/Z/15/Z]; Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE)	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DELTAS Africa Initiative grant; Wellcome Trust(Wellcome Trust); Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE)	The National Institute of Allergy and Infectious Diseases (NIAID) grant #R01 AI124968. The Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) and DELTAS Africa Initiative grant #DEL-15-006. The Wellcome Trust grant #107752/Z/15/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzordor P, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01546-9; Agutu CA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246444; Agutu CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218369; COOPER DA, 1985, LANCET, V1, P537; Elliott T, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25419; Fiscus SA, 2007, J INFECT DIS, V195, P416, DOI 10.1086/510755; Graham SM, 2020, JMIR RES PROTOC, V9, DOI 10.2196/16198; Green J., 2018, QUALITATIVE METHODS, VFourth; Harrison SE, 2019, AIDS, V33, pS1, DOI 10.1097/QAD.0000000000002242; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Miles M.B., 1994, QUALITATIVE DATA ANA, DOI DOI 10.1016/0149-7189(96)88232-2; Rutstein SE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21579; Sanders EJ, 2022, HIV MED, V23, P16, DOI 10.1111/hiv.13157; Sanders EJ, 2015, AIDS, V29, pS221, DOI 10.1097/QAD.0000000000000924; Sanders EJ, 2011, AIDS, V25, P1219, DOI 10.1097/QAD.0b013e3283474ed5; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; TINDALL B, 1988, ARCH INTERN MED, V148, P945, DOI 10.1001/archinte.148.4.945; Trinh TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163594; Van der Elst EM, 2019, PSYCHOL HEALTH MED, V24, P631, DOI 10.1080/13548506.2018.1549736	19	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261255	10.1371/journal.pone.0261255	http://dx.doi.org/10.1371/journal.pone.0261255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025909	gold, Green Published			2022-12-26	WOS:000796264200014
J	Ghaddar, A; Khandaqji, S; Awad, Z; Kansoun, R				Ghaddar, Ali; Khandaqji, Sanaa; Awad, Zeinab; Kansoun, Rawad			Conspiracy beliefs and vaccination intent for COVID-19 in an infodemic	PLOS ONE			English	Article								Background The massive, free and unrestricted exchange of information on the social media during the Covid-19 pandemic has set fertile grounds for fear, uncertainty and the rise of fake news related to the virus. This "viral" spread of fake news created an "infodemic" that threatened the compliance with public health guidelines and recommendations. Objective This study aims to describe the trust in social media platforms and the exposure to fake news about COVID-19 in Lebanon and to explore their association with vaccination intent. Methods In this cross-sectional study conducted in Lebanon during July-August, 2020, a random sample of 1052 participants selected from a mobile-phone database responded to an anonymous structured questionnaire after obtaining informed consent (response rate = 40%). The questionnaire was conducted by telephone and measured socio-demographics, sources and trust in sources of information and exposure to fake news, social media activity, perceived threat and vaccination intent. Results Results indicated that the majority of participants (82%) believed that COVID-19 is a threat and 52% had intention to vaccinate. Exposure to fake/ unverified news was high (19.7% were often and 63.8% were sometimes exposed, mainly to fake news shared through Watsapp and Facebook). Trust in certain information sources (WHO, MoPH and TV) increased while trust in others (Watsapp, Facebook) reduced vaccination intent against Covid-19. Believing in the man-made theory and the business control theory significantly reduced the likelihood of vaccination intent (Beta = 0.43; p = 0.01 and Beta = -0.29; p = 0.05) respectively. Conclusion In the context of the infodemic, understanding the role of exposure to fake news and of conspiracy believes in shaping healthy behavior is important for increasing vaccination intent and planning adequate response to tackle the Covid-19 pandemic.	[Ghaddar, Ali; Khandaqji, Sanaa; Awad, Zeinab] Observ Publ Policies & Hlth, Beirut, Lebanon; [Ghaddar, Ali] Lebanese Int Univ, Dept Biomed Sci, Saida, Lebanon; [Khandaqji, Sanaa; Awad, Zeinab] Amer Univ Beirut, Dept Hlth Management & Policy, Beirut, Lebanon; [Kansoun, Rawad] Lebanese Int Univ, Dept Commun Arts, Beirut, Lebanon	American University of Beirut	Ghaddar, A (corresponding author), Observ Publ Policies & Hlth, Beirut, Lebanon.; Ghaddar, A (corresponding author), Lebanese Int Univ, Dept Biomed Sci, Saida, Lebanon.	ali.ghaddar@liu.edu.lb		Awad, Zeinab/0000-0001-5952-742X; Ghaddar, Ali/0000-0001-7261-347X				Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556; Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/19458; Ahorsu DK, 2022, HUM VACC IMMUNOTHER, V18, DOI 10.1080/21645515.2021.1993689; Ali K, 2019, SCI COMMUN, V41, P314, DOI 10.1177/1075547019846124; Alimoradi Z, 2021, ASIAN J SOC HEAL BEH, V4, P129, DOI 10.4103/shb.shb_100_21; Alvarez-Risco A, 2020, AM J TROP MED HYG, V103, P583, DOI 10.4269/ajtmh.20-0536; Aquino F, 2017, VACCINE, V35, P4494, DOI 10.1016/j.vaccine.2017.07.029; Bin Naeem S, 2021, HEALTH INFO LIBR J, V38, P143, DOI 10.1111/hir.12320; Campbell H, 2017, VACCINE, V35, P2979, DOI 10.1016/j.vaccine.2017.03.089; Casigliani V, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2672; Centers for Disease Control and Prevention, 2020, COVID 19; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; Department of Health and Social Care Department of Education, 2018, GOV RESP CONS TRANSF; Diegoli H, 2020, STROKE, V51, P2315, DOI 10.1161/STROKEAHA.120.030481; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Esaiasson P, 2021, EUR J POLIT RES, V60, P748, DOI 10.1111/1475-6765.12419; Fan CW, 2021, HUM VACC IMMUNOTHER, V17, P3413, DOI 10.1080/21645515.2021.1933687; Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569; Fridman I, 2020, JMIR PUBLIC HLTH SUR, V6, P398, DOI 10.2196/22060; Government of Canada, 2020, FLUWATCH ANN REP 201; Greene C., 2020, EVIDENCE STUDY COVID, DOI [10.31234/osf.io/qfnm3, DOI 10.31234/OSF.IO/QFNM3]; Harrison EA, 2020, EUR J EPIDEMIOL, V35, P325, DOI 10.1007/s10654-020-00634-3; Huang PC, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9091046; Imhoff R, 2020, SOC PSYCHOL PERS SCI, V11, P1110, DOI 10.1177/1948550620934692; Ireton C., 2018, JOURNALISM FAKE NEWS; Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255; Kukreti S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030246; Lin CY, 2020, INTERNET INTERV, V21, DOI 10.1016/j.invent.2020.100345; Melki J., 2020, MITIGATING INFODEMIC; Newton, 2020, VERGE, DOI 1263782/google-antitrust-case-attorneys-general-justice-partisan-politics.; Orso D, 2020, EUR J EMERG MED, V27, P327, DOI 10.1097/MEJ.0000000000000713; PAHO, 2020, UND INF MIS FIGHT CO; Palamenghi L, 2020, EUR J EPIDEMIOL, V35, P785, DOI 10.1007/s10654-020-00675-8; Pantaleon D, 2020, LIST N DIARIO; Patel MP, 2020, INDIAN J NEPHROL, V30, P188, DOI 10.4103/ijn.IJN_216_20; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Reza Zafarani, 2020, Arxiv, DOI arXiv:1812.00315; Rieger MO, 2021, ASIAN J SOC HEAL BEH, V4, P81, DOI 10.4103/shb.shb_7_21; Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356; Rosen G, 2020, FACEBOOK; Rovetta A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9884; Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Singh M, 2020, WHATSAPP INTRODUCES; Smallman S., 2015, J INT GLOBAL STUDIES; Spinney L., 2020, SCIENCEMAG; Statt N, 2020, VERGE; Strekalova YA, 2017, HEALTH EDUC BEHAV, V44, P332, DOI 10.1177/1090198116660310; Tangcharoensathien V, 2020, J MED INTERNET RES, V22, DOI 10.2196/19659; Tomljenovic H, 2020, PSYCHOL HEALTH, V35, P538, DOI 10.1080/08870446.2019.1673894; Trew B., 2020, INDEPENDENT; Ullah I, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.2370; UNITED NATIONS, 2020, UN TACKL INF MIS CYB; van Prooijen JW, 2018, EUR J SOC PSYCHOL, V48, P897, DOI 10.1002/ejsp.2530; Wang PW, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040380; Wang YX, 2019, SOC SCI MED, V240, DOI 10.1016/j.socscimed.2019.112552; WHO, 2020, MANAGING COVID 19 IN; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279; World Health Organization, 2020, MUN SEC C; World Health Organization (WHO), 2019, DIS OUTBREAK NE 0208; Yahaghi R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070684; Yang LJ, 2019, EUR J EPIDEMIOL, V34, P893, DOI 10.1007/s10654-019-00574-7; Yeh YC, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030297; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X	68	12	12	10	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261559	10.1371/journal.pone.0261559	http://dx.doi.org/10.1371/journal.pone.0261559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020721	Green Published, gold			2022-12-26	WOS:000834207700018
J	Reed, MS; Curtis, T; Gosal, A; Kendall, H; Andersen, SP; Ziv, G; Attlee, A; Fitton, RG; Hay, M; Gibson, AC; Hume, AC; Hill, D; Mansfield, JL; Martino, S; Olesen, AS; Prior, S; Rodgers, C; Rudman, H; Tanneberger, F				Reed, Mark S.; Curtis, Tom; Gosal, Arjan; Kendall, Helen; Andersen, Sarah Pyndt; Ziv, Guy; Attlee, Anais; Fitton, Richard G.; Hay, Matthew; Gibson, Alicia C.; Hume, Alex C.; Hill, David; Mansfield, Jamie L.; Martino, Simone; Olesen, Asger Strange; Prior, Stephen; Rodgers, Christopher; Rudman, Hannah; Tanneberger, Franziska			Integrating ecosystem markets to co-ordinate landscape-scale public benefits from nature	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; PAYMENTS; GOODS	Ecosystem markets are proliferating around the world in response to increasing demand for climate change mitigation and provision of other public goods. However, this may lead to perverse outcomes, for example where public funding crowds out private investment or different schemes create trade-offs between the ecosystem services they each target. The integration of ecosystem markets could address some of these issues but to date there have been few attempts to do this, and there is limited understanding of either the opportunities or barriers to such integration. This paper reports on a comparative analysis of eleven ecosystem markets in operation or close to market in Europe, based on qualitative analysis of 25 interviews, scheme documentation and two focus groups. Our results indicate three distinct types of markets operating from the regional to national scale, with different modes of operation, funding and outcomes: regional ecosystem markets, national carbon markets and green finance. The typology provides new insights into the operation of ecosystem markets in practice, which may challenge traditionally held notions of Payment for Ecosystem Services. Regional ecosystem markets, in particular, represent a departure from traditional models, by using a risk-based funding model and aggregating both supply and demand to overcome issues of free-riding, ecosystem service trade-offs and land manager engagement. Central to all types of market were trusted intermediaries, brokers and platforms to aggregate supply and demand, build trust and lower transaction costs. The paper outlines six options for blending public and private funding for the provision of ecosystem services and proposes a framework for integrating national carbon markets and green finance with regional ecosystem markets. Such integration may significantly increase funding for regenerative agriculture and conservation across multiple habitats and services, whilst addressing issues of additionality and ecosystem service trade-offs between multiple schemes.	[Reed, Mark S.; Kendall, Helen; Rudman, Hannah] Scotlands Rural Coll SRUC, Thriving Nat Capital Challenge Ctr, Dept Rural Econ, Edinburgh, Midlothian, Scotland; [Reed, Mark S.] Newcastle Univ, Ctr Rural Econ, Newcastle Upon Tyne, Tyne & Wear, England; [Reed, Mark S.] Newcastle Univ, Sch Nat & Environm Sci, Inst Agrifood Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England; [Curtis, Tom] 3Keel LLP, Fenlock Court, Long Hanborough, England; [Gosal, Arjan; Andersen, Sarah Pyndt] Inst European Environm Policy, Brussels, Belgium; [Ziv, Guy] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Attlee, Anais] Collingwood Investments Ltd, London, England; [Attlee, Anais] Project Maya CIC, London, England; [Fitton, Richard G.; Gibson, Alicia C.; Hume, Alex C.; Mansfield, Jamie L.] FinanceEarth, London, England; [Hay, Matthew] Forest Carbon Ltd, Abbey Rd Business Ctr, Durham, England; [Hill, David] Environm Bank Ltd, The Catalyst, York, N Yorkshire, England; [Martino, Simone; Prior, Stephen] Univ York, Dept Environm & Geog, York, N Yorkshire, England; [Olesen, Asger Strange] Forest Stewardship Council, Freiburg, Germany; [Rodgers, Christopher] Newcastle Univ, Sch Law, Windsor Terrace Law Sch 21 24, Newcastle Upon Tyne, Tyne & Wear, England; [Tanneberger, Franziska] Greifswald Univ, Partner Greifswald Mire Ctr, Greifswald, Germany	Scotland's Rural College; Newcastle University - UK; Newcastle University - UK; University of Leeds; University of York - UK; Newcastle University - UK	Reed, MS (corresponding author), Scotlands Rural Coll SRUC, Thriving Nat Capital Challenge Ctr, Dept Rural Econ, Edinburgh, Midlothian, Scotland.; Reed, MS (corresponding author), Newcastle Univ, Ctr Rural Econ, Newcastle Upon Tyne, Tyne & Wear, England.; Reed, MS (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Inst Agrifood Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England.	mark.reed@sruc.ac.uk		Gosal, Arjan/0000-0001-6782-0706; Reed, Mark/0000-0002-8958-8474; Rudman, Hannah/0000-0003-4502-3583	Global Food Security's 'Resilience of the UK Food System Programme'; BBSRC; ESRC; NERC; Scottish Government, as part of the Resilient Dairy Landscapes project [BB/R005680/1]; Integrated Catchment Solutions Programme (iCASP) - UK Natural Environment Research Council's Regional Impact from Science of the Environment scheme [NE/P011160/1]; European Commission's Directorate-General for Climate Action [340201/2018/789608/ETU/CLIMA.C.3]; NatureScot [117832]; British Academy [KF5210311]	Global Food Security's 'Resilience of the UK Food System Programme'; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government, as part of the Resilient Dairy Landscapes project; Integrated Catchment Solutions Programme (iCASP) - UK Natural Environment Research Council's Regional Impact from Science of the Environment scheme; European Commission's Directorate-General for Climate Action; NatureScot; British Academy	This research was funded by the Global Food Security's 'Resilience of the UK Food System Programme' with support from BBSRC, ESRC, NERC and Scottish Government, as part of the Resilient Dairy Landscapes project (grant BB/R005680/1), the Integrated Catchment Solutions Programme (iCASP) funded by the UK Natural Environment Research Council's Regional Impact from Science of the Environment scheme (grant NE/P011160/1), European Commission's Directorate-General for Climate Action (contract 340201/2018/789608/ETU/CLIMA.C.3), NatureScot (Project No. 117832) and the British Academy (grant KF5210311). Salary support was provided by 3Keel to TC, Forest Carbon Ltd to SP, Environment Bank Ltd to DH, Institute for European Environmental Policy to AG and SPA, Collingwood Investments Ltd to SA, Project Maya CIC to SA, Forest Stewardship Council to AO, Finance Earth to RF.	Adriaens T, 2015, MANAG BIOL INVASION, V6, P215, DOI 10.3391/mbi.2015.6.2.12; Aligica PD., 2019, PUBLIC GOVERNANCE CL; Artz RRE, 2013, DECISION SUPPORT TOO; Bailey R, 2020, IMPLICATIONS BOARDS; Bateman IJ, 2018, LAND USE POLICY, V79, P293, DOI 10.1016/j.landusepol.2018.08.022; Baumeister R.F., 1997, REV GEN PSYCHOL, V1, P311, DOI [10.1037/1089-2680.1.3.311, DOI 10.1037/1089-2680.1.3.311]; Bayon R., 2012, VOLUNTARY CARBON MAR; Benessaiah K, 2012, ECOL ECON, V77, P1, DOI 10.1016/j.ecolecon.2012.02.022; Braat L., 2008, EC BIODIVERSITY ECOS; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown MB, 2008, MINERVA, V46, P485, DOI 10.1007/s11024-008-9106-y; Calle A, 2020, ECOSYST SERV, V42, DOI 10.1016/j.ecoser.2020.101084; CCC, 2020, LAND US POL NET ZER; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Committe on Climate Change, 2019, NET ZERO UKS CONTRIB, P275; Coyne L., 2020, LAND USE POLICY, DOI [10.1016/j.landusepol.2020.105174%3C/italic%3E%3C/underline%3E, DOI 10.1016/J.LANDUSEPOL.2020.105174%3C/ITALIC%3E%3C/UNDERLINE%3E]; Credit Suisse McKinsey, 2016, CONS FIN NICH MAINST; Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666; de Lima LS, 2017, ECOSYST SERV, V27, P139, DOI 10.1016/j.ecoser.2017.09.005; de Sartre XA, 2019, ECOL SOC, V24, DOI 10.5751/ES-10711-240202; Defra, 2011, NAT CHOIC SEC VAL NA; Sagar Paul, 1992, Notornis, V39, P1, DOI 10.1145/143103.143108; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Environment Agency, 2020, GREEN FIN FUND ENV P; Esteves AM, 2012, IMPACT ASSESS PROJ A, V30, P34, DOI 10.1080/14615517.2012.660356; FAO, 2020, US; Gosal A., 2020, YORKSHIRE INTEGRATED, DOI [10.5518/100/48, DOI 10.5518/100/48]; Greenhalgh T, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12931; Hodge I, 2015, CONSERV BIOL, V29, P996, DOI 10.1111/cobi.12531; Johansen DF, 2020, MAR POLICY, V112, DOI 10.1016/j.marpol.2019.103783; Kendall H, UK DAIRY FARMER PERC; Kenney K, 2021, CARBON FARMING ORGAN; Lang S, 2019, CLIM POLICY, V19, P414, DOI 10.1080/14693062.2018.1556152; Martin-Ortega J, 2018, ECOL ECON, V154, P218, DOI 10.1016/j.ecolecon.2018.08.001; MARWELL G, 1979, AM J SOCIOL, V84, P1335, DOI 10.1086/226937; Mills J, 2017, AGR HUM VALUES, V34, P283, DOI 10.1007/s10460-016-9705-4; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Nelleman C., 2010, RAPID RESPONSE ASSES; Neumann RK, 2020, THESIS NEWCASTLE U; Panks S., 2019, BIODIVERSITY METRIC; Reed MS, 2017, GLOBAL ENVIRON CHANG, V43, P92, DOI 10.1016/j.gloenvcha.2016.12.009; Reed M.S., 2020, EMERALD OPEN RES SUS, V2, P57; Reed MS, 2020, FINAL REPORT NATURAL, DOI [10.13140/RG.2.2.23295.23208, DOI 10.13140/RG.2.2.23295.23208]; Ruggiero PGC, 2019, LAND USE POLICY, V82, P283, DOI 10.1016/j.landusepol.2018.11.054; Ruto E, 2009, J ENVIRON PLANN MAN, V52, P631, DOI 10.1080/09640560902958172; Securities Industry and Financial Market Association (SIFMA), 2020, 2019 FACT BOOK; Siebert R, 2006, SOCIOL RURALIS, V46, P318, DOI 10.1111/j.1467-9523.2006.00420.x; Sommerville MM, 2009, ECOL SOC, V14; STIGLER GJ, 1989, YALE LAW J, V99, P631, DOI 10.2307/796757; Vidal NG, 2010, J BUS ETHICS, V94, P553, DOI 10.1007/s10551-009-0281-z; Waylen KA, 2018, ECOSYST SERV, V29, P23, DOI 10.1016/j.ecoser.2017.11.007; WTW (Willis Towers Watson), 2020, GLOB EC RES FAC; Wunder S., 2009, Journal of Sustainable Forestry, V28, P576, DOI 10.1080/10549810902905669; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Wunder S, 2015, ECOL ECON, V117, P234, DOI 10.1016/j.ecolecon.2014.08.016; Young D., 2020, FINANCING UK NATURE	56	2	2	10	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0258334	10.1371/journal.pone.0258334	http://dx.doi.org/10.1371/journal.pone.0258334			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020743	gold, Green Published, Green Submitted			2022-12-26	WOS:000834207700006
J	Velez-Paez, JL; Legua, P; Velez-Paez, P; Irigoyen, E; Andrade, H; Jara, A; Lopez, F; Perez-Galarza, J; Baldeon, L				Luis Velez-Paez, Jorge; Legua, Pedro; Velez-Paez, Pablo; Irigoyen, Estefania; Andrade, Henry; Jara, Andrea; Lopez, Fernanda; Perez-Galarza, Jorge; Baldeon, Lucy			Mean platelet volume and mean platelet volume to platelet count ratio as predictors of severity and mortality in sepsis	PLOS ONE			English	Article							MEGAKARYOCYTE	Introduction Sepsis is a public health problem due to its high prevalence and mortality. Mean platelet volume (MPV), a biomarker reported in routine blood counts, has been investigated and shows promise for determining fatal outcomes in septic patients. Objective Evaluate whether the mean platelet volume (MPV) and mean platelet volume-to-platelet count (MPV/P) ratio are predictors of clinical severity and mortality in patients with sepsis. Methods A prospective population cohort of 163 patients aged 18-97 years was recruited at the Intensive Care Unit of Pablo Arturo Hospital, Quito, Ecuador from 2017-2019 and followed up for 28 days. Patients were diagnosed with sepsis based on SEPSIS-3 septic shock criteria; in which the MPV and the MPV/P ratio were measured on days 1, 2, and 3. Sequential organ failure assessment (SOFA) score and presence of septic shock assessed clinical severity. Mortality on day 28 was considered the fatal outcome. Results The average age of the patients was 61,15 years (SD 20,94) and female sex was predominant. MPV cutoff points at days 1, 2 and 3 were >9,45fL, >8,95fL and >8, 85fL; and (MPV/P) ratio >8, 18, >4, 12 y >3, 95, respectively. MPV at days 2 (9,85fL) and 3 (8,55fL) and (MPV/ P) ratio at days 1 (4,42), 2 (4,21), and 3 (8,55), were predictors of clinical severity assessed by septic shock, which reached significance in the ROC curves. MPV and (MPV/P) ratio or were also predictors of clinical severity determined by SOFA at days 1, 2, and 3, where higher values were observed in non-survivors reaching significance in all categories. MPV and MPV/P ratio at days 1, 2 and 3 were independent predictor factors of mortality using Cox proportional hazards model (HR 2,31; 95% CI 1,36-3,94), (HR 2,11; 95% CI 1,17-3,82), (HR 2,13; 95% CI 1,07-4,21) and (HR 2,38; 95% CI 1,38-4,12), (HR 2,15; 95% CI 1,14-4,06), (HR 4,43; 95% CI, 1,72-11,37) respectively. Conclusions MPV and the MPV/P ratio are predictors of clinical severity and mortality in sepsis. The MPV and its coefficient are indicators of the biological behavior of platelets in sepsis. They should be considered as a cost-effective and rapidly available tool that guides the treatment.	[Luis Velez-Paez, Jorge; Perez-Galarza, Jorge; Baldeon, Lucy] Univ Cent Ecuador, Fac Ciencias Med, Quito, Ecuador; [Luis Velez-Paez, Jorge; Irigoyen, Estefania] Hosp Pablo Arturo Suarez, Ctr Invest Clin Med Crit, Quito, Ecuador; [Legua, Pedro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Velez-Paez, Pablo] Ctr Invest Clin Med Crit, Quito, Ecuador; [Velez-Paez, Pablo; Andrade, Henry] Hosp Gen IESS Ibarra, Unidad Terapia Intens, Imbabura, Ecuador; [Jara, Andrea] Hosp Bas Machachi, Unidad Emergencia, Pichincha, Ecuador; [Lopez, Fernanda] Univ Cent Ecuador, Inst Posgrad Med Crit & Terapia Intens, Quito, Ecuador; [Perez-Galarza, Jorge; Baldeon, Lucy] Univ Cent Ecuador, Inst Invest Biomed, Quito, Ecuador	Universidad Central del Ecuador; Universidad Peruana Cayetano Heredia; Universidad Central del Ecuador; Universidad Central del Ecuador	Baldeon, L (corresponding author), Univ Cent Ecuador, Fac Ciencias Med, Quito, Ecuador.; Baldeon, L (corresponding author), Univ Cent Ecuador, Inst Invest Biomed, Quito, Ecuador.	lybaldeon@uce.edu.ec	Páez, Jorge Luis Vélez/AAQ-2469-2021; Baldeon, Lucy/AAE-6323-2022	Páez, Jorge Luis Vélez/0000-0002-6956-4475; Baldeon, Lucy/0000-0002-0447-0136				Ates S, 2015, SAUDI MED J, V36, P1186, DOI 10.15537/smj.2015.10.10718; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Dastjerd MS, 2006, HEMATOLOGY, V11, P317, DOI 10.1080/10245330600954163; Djordjevic Dragan, 2018, Mediators Inflamm, V2018, P3758068, DOI 10.1155/2018/3758068; Gao Yanxia, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P28, DOI 10.3760/cma.j.issn.2095-4352.2014.01.006; Greco E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102200; Guclu E, 2013, AFR HEALTH SCI, V13, P333, DOI 10.4314/ahs.v13i2.19; Kitazawa T, 2013, INTERNAL MED, V52, P1487, DOI 10.2169/internalmedicine.52.9555; Machlus KR, 2014, BRIT J HAEMATOL, V165, P227, DOI 10.1111/bjh.12758; Michelson AD, 2000, METHODS, V21, P259, DOI 10.1006/meth.2000.1006; Miliotis S, 2019, MITOCHONDRION, V48, P16, DOI 10.1016/j.mito.2019.02.002; Nishimura S, 2015, J CELL BIOL, V209, P453, DOI 10.1083/jcb.201410052; Oh GH, 2017, SHOCK, V47, P323, DOI 10.1097/SHK.0000000000000718; Rocke AS, 2018, THROMB HAEMOSTASIS, V118, P63, DOI 10.1160/TH17-02-0138; Rolfes V, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107615; Santillan-Santos D.A., 2019, REV ED INVESTIG EMER, DOI [10.24875/reie.19000008, DOI 10.24875/REIE.19000008]; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tajarernmuang P, 2016, CRIT CARE RES PRACT, V2016, DOI 10.1155/2016/4370834; Thon JN, 2012, J CELL BIOL, V198, P561, DOI 10.1083/jcb.201111136; Vardon-Bounes F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223553; Vélez-Páez Jorge Luis, 2021, Infect., V25, P153, DOI 10.22354/in.v25i3.939; Vélez-Paez Jorge Luis, 2020, Infect., V24, P162, DOI 10.22354/in.v24i3.861; Yalavarthi S., 2018, ANN PATHOL LAB MED, DOI [10.21276/apalm.1717, DOI 10.21276/APALM.1717]; Yun SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9060143; Zampieri FG, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0020-1; Zhang S, 2015, CHINESE MED J-PEKING, V128, P2012, DOI 10.4103/0366-6999.161346	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262356	10.1371/journal.pone.0262356	http://dx.doi.org/10.1371/journal.pone.0262356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990467	gold, Green Published			2022-12-26	WOS:000815783800030
J	Reinhart, JM; de Oliveira, GAR; Forsythe, L; Li, Z				Reinhart, Jennifer M.; de Oliveira, Gabriela A. R.; Forsythe, Lauren; Li, Zhong			Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs	PLOS ONE			English	Article							BIOAVAILABILITY; FORMULATIONS	Theophylline is an important drug for treatment of canine chronic bronchitis and bradyarrhythmias, but new products require validation since pharmacokinetics in dogs can vary by formulation. A new, 503B outsourcing facility-produced theophylline product (OFT) is available for veterinary use. Outsourcing facilities have many advantages over traditional compounding sources including current good manufacturing practice compliance. The purpose of this study was to establish the pharmacokinetics of OFT in dogs. Eight healthy dogs received 11 mg/kg intravenous aminophylline and 10 mg/kg oral OFT followed by serial blood sampling in a two-way, randomized, crossover design with 7-day washout. Plasma theophylline concentrations were quantified by liquid chromatography-mass spectrometry. Bioavailability, maximum concentration, time to maximum concentration, half-life and area under the curve were: 97 +/- 10%, 7.13 +/- 0.71 mu g/mL, 10.50 +/- 2.07 h, 9.20 +/- 2.87 h, and 141 +/- 37.6 mu g*h/mL, respectively. Steady-state predictions supported twice daily dosing of the OFT, but specific dosage recommendations are hindered by lack of a canine-specific therapeutic range for plasma theophylline concentration. These findings suggest that the OFT is well absorbed and can likely be dosed twice daily in dogs, but future pharmacodynamic and clinical studies are needed to establish a definitive therapeutic range for theophylline in this species.	[Reinhart, Jennifer M.; de Oliveira, Gabriela A. R.; Forsythe, Lauren] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA; [Li, Zhong] Univ Illinois, Metabol Lab, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Reinhart, JM (corresponding author), Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA.	jreinha2@illinois.edu		Reinhart, Jennifer/0000-0002-3021-5075	Epicur(R) Pharma	Epicur(R) Pharma	The authors declare that this study received funding from Epicur (R) Pharma (epicurpharma.com). The funder was allowed review of the manuscript prior to submission but was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	[Anonymous], FOOD DRUG LAW J; [Anonymous], 2021, CFR SECT, V21, P210; AUBIER M, 1983, AM REV RESPIR DIS, V127, P148; Bach JF, 2004, JAVMA-J AM VET MED A, V224, P1113, DOI 10.2460/javma.2004.224.1113; Cavett CL, 2019, J VET PHARMACOL THER, V42, P593, DOI 10.1111/jvp.12813; Fox PR., 1999, TXB CANINE FELINE CA, P495; Hawkins EC., 2014, CURRENT VET THERAPY, V15th ed, P622; KORITZ GD, 1986, J VET PHARMACOL THER, V9, P293, DOI 10.1111/j.1365-2885.1986.tb00044.x; KuKanich B, 2012, J VET PHARMACOL THER, V35, P275, DOI 10.1111/j.1365-2885.2011.01316.x; Kuusela E, 2000, J VET PHARMACOL THER, V23, P15, DOI 10.1046/j.1365-2885.2000.00245.x; Martin GJW, 1999, AUST VET J, V77, P250, DOI 10.1111/j.1751-0813.1999.tb11714.x; MCKIERNAN B C, 1981, Journal of Veterinary Pharmacology and Therapeutics, V4, P103, DOI 10.1111/j.1365-2885.1981.tb00718.x; McKiernan BC, 2000, VET CLIN N AM-SMALL, V30, P1267, DOI 10.1016/S0195-5616(00)06006-X; Mengozzi G, 1998, PHARMACOL RES, V38, P481, DOI 10.1006/phrs.1998.0394; MUNSIFF IJ, 1988, J VET PHARMACOL THER, V11, P381, DOI 10.1111/j.1365-2885.1988.tb00198.x; Pharmacia & Upjohn Co, 2019, ANTISEDAN ATIPAMEZOL; Reinhart JM., 2021, J VET PHARMACOL THER, V44, P724, DOI [10.1111/jvp.12979, DOI 10.1111/JVP.12979]; Riviere J. E., 2018, VET PHARM THERAPEUTI, V10th; U.S. FDA] U.S. Food and Drug Administration, 2021, CFR SECT; WEINBERGER M, 1984, J ALLERGY CLIN IMMUN, V73, P525, DOI 10.1016/0091-6749(84)90505-0	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262336	10.1371/journal.pone.0262336	http://dx.doi.org/10.1371/journal.pone.0262336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990472	Green Published, gold			2022-12-26	WOS:000815783800027
J	Garcia-Lamont, F; Alvarado, M; Cervantes, J				Garcia-Lamont, Farid; Alvarado, Matias; Cervantes, Jair			Systematic segmentation method based on PCA of image hue features for white blood cell counting	PLOS ONE			English	Article							CLASSIFICATION; LEUKOCYTES; ALGORITHM; SMEAR	Leukocyte (white blood cell, WBC) count is an essential factor that physicians use to diagnose infections and provide adequate treatment. Currently, WBC count is determined manually or semi-automatically, which often leads to miscounting. In this paper, we propose an automated method that uses a bioinspired segmentation mimicking the human perception of color. It is based on the claim that a person can locate WBCs in a blood smear image via the high chromatic contrast. First, by applying principal component analysis over RGB, HSV, and L*a*b* spaces, with specific combinations, pixels of leukocytes present high chromatic variance; this results in increased contrast with the average hue of the other blood smear elements. Second, chromaticity is processed as a feature, without separating hue components; this is different to most of the current automation that perform mathematical operations between hue components in an intuitive way. As a result of this systematic method, WBC recognition is computationally efficient, overlapping WBCs are separated, and the final count is more precise. In experiments with the ALL-IDB benchmark, the performance of the proposed segmentation was assessed by comparing the WBC from the processed images with the ground truth. Compared with previous methods, the proposed method achieved similar results in sensitivity and precision and approximately 0.2% higher specificity and 0.3% higher accuracy for pixel classification in the segmentation stage; as well, the counting results are similar to previous works.	[Garcia-Lamont, Farid; Cervantes, Jair] Univ Autonoma Estado Mexico, Ctr Univ UAEM Texcoco, Texcoco, Estado De Mexic, Mexico; [Alvarado, Matias] IPN, Dept Comp, Ctr Invest & Estudios Avanzados, Cdmx, Mexico		Garcia-Lamont, F (corresponding author), Univ Autonoma Estado Mexico, Ctr Univ UAEM Texcoco, Texcoco, Estado De Mexic, Mexico.	fgarcial@uaemex.mx	Garcia-Lamont, Farid/B-4009-2016	Garcia-Lamont, Farid/0000-0002-9739-3802; Alvarado, Matias/0000-0003-2853-7451	National Council of Research (CONACyT in Spanish abbreviation) [A1-S-20037]	National Council of Research (CONACyT in Spanish abbreviation)	Initials: M.A. (Matias Alvarado) Grant number:A1-S-20037 Funder name: National Council of Research (CONACyT in Spanish abbreviation) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhay E, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0912-y; Alomari YM, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/979302; Cao FL, 2019, NEURAL COMPUT APPL, V31, P6767, DOI 10.1007/s00521-018-3480-7; Cao FL, 2017, NEURAL COMPUT APPL, V28, pS503, DOI 10.1007/s00521-016-2391-8; Cao HC, 2018, BIOMED SIGNAL PROCES, V45, P10, DOI 10.1016/j.bspc.2018.05.010; Cheng HD, 2001, PATTERN RECOGN, V34, P2259, DOI 10.1016/S0031-3203(00)00149-7; Chung J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133489; Cuevas E, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/137392; Di Ruberto C, 2015, LECT NOTES COMPUT SC, V9279, P557, DOI 10.1007/978-3-319-23231-7_50; Di Ruberto C, 2015, LECT NOTES COMPUT SC, V9257, P415, DOI 10.1007/978-3-319-23117-4_36; Dorini LB, 2013, IEEE J BIOMED HEALTH, V17, P250, DOI 10.1109/TITB.2012.2207398; Garcia-Lamont F, 2018, NEUROCOMPUTING, V292, P1, DOI 10.1016/j.neucom.2018.01.091; Ghosh P, 2016, APPL SOFT COMPUT, V46, P629, DOI 10.1016/j.asoc.2015.12.038; Hegde RB, 2019, BIOCYBERN BIOMED ENG, V39, P382, DOI 10.1016/j.bbe.2019.01.005; Hegde RB, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0962-1; Jan Z, 2018, MULTIMED TOOLS APPL, V77, P9801, DOI 10.1007/s11042-017-4495-2; Janos A., 2007, CLUSTER ANAL DATA MI; Kutlu H, 2020, MED HYPOTHESES, V135, DOI 10.1016/j.mehy.2019.109472; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu H, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1185-9; Liu YH, 2017, IEEE J BIOMED HEALTH, V21, P1644, DOI 10.1109/JBHI.2016.2623421; Lopez-Puigdollers D, 2019, EXPERT SYST APPL, V115, P695, DOI 10.1016/j.eswa.2018.08.029; Mishra S, 2019, BIOMED SIGNAL PROCES, V47, P303, DOI 10.1016/j.bspc.2018.08.012; Nazlibilek S, 2014, MEASUREMENT, V55, P58, DOI 10.1016/j.measurement.2014.04.008; Prinyakupt J, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0037-1; Ruberto Cecilia, 2016, Machine Vision and Applications, V27, P1151, DOI 10.1007/s00138-016-0812-4; Safuan SNM, 2018, MEASUREMENT, V116, P543, DOI 10.1016/j.measurement.2017.11.002; Sayed GI, 2019, NEURAL COMPUT APPL, V31, P7633, DOI 10.1007/s00521-018-3597-8; Shahzad M, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/4015323; Sudha K, 2020, BIOCYBERN BIOMED ENG, V40, P639, DOI 10.1016/j.bbe.2020.02.005; Tsai MH, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0280-9; Zhao JW, 2017, MED BIOL ENG COMPUT, V55, P1287, DOI 10.1007/s11517-016-1590-x; Zheng X, 2018, MICRON, V107, P55, DOI 10.1016/j.micron.2018.01.010	33	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261857	10.1371/journal.pone.0261857	http://dx.doi.org/10.1371/journal.pone.0261857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972155	Green Published, gold			2022-12-26	WOS:000773555700063
J	Hansen, N; Bryant, A; McCormack, R; Johnson, H; Lindsay, T; Stelck, K; Bernards, MT				Hansen, Niko; Bryant, Adriana; McCormack, Roslyn; Johnson, Hannah; Lindsay, Travis; Stelck, Kael; Bernards, Matthew T.			Assessment of the performance of nonfouling polymer hydrogels utilizing citizen scientists	PLOS ONE			English	Article							BRUSHES; RESISTANCE; ADHESION; SCIENCE	To facilitate longer duration space travel, flight crew sickness and disease transmission amongst the crew must be eliminated. High contact surfaces within space vehicles provide an opportunity for bacterial adhesion, which can lead to biofilm formation or disease transmission. This study evaluates the performance of several nonfouling polymers using citizen science, to identify the best performing chemistry for future applications as bacteria resistant coatings. The specific polymer chemistries tested were zwitterionic sulfobetaine methacrylate (SBMA), and polyampholytes composed of [2-(acryloyloxy)ethyl] trimethylammonium chloride and 2-carboxyethyl acrylate (TMA/CAA), or TMA and 3-sulfopropyl methacrylate (TMA/SA). Each polymer chemistry is known to exhibit bacteria resistance, and this study provides a direct side-by-side comparison between the chemistries using a citizen science approach. Nearly 100 citizen scientists returned results comparing the performance of these polymers over repeat exposure to bacteria and 30 total days of growth. The results demonstrate that TMA/CAA polyampholyte hydrogels show the best long-term resistance to bacteria adhesion.	[Hansen, Niko; Bryant, Adriana; McCormack, Roslyn; Johnson, Hannah; Lindsay, Travis; Stelck, Kael; Bernards, Matthew T.] Univ Idaho, Dept Chem & Biol Engn, Moscow, ID 83843 USA	Idaho; University of Idaho	Bernards, MT (corresponding author), Univ Idaho, Dept Chem & Biol Engn, Moscow, ID 83843 USA.	mbernards@uidaho.edu		Bernards, Matthew/0000-0002-5234-1910	National Aeronautics and Space Administration (NASA) as part of the Student Payload Opportunity with Citizen Science (SPOCS) program [80NSSC17M0021]	National Aeronautics and Space Administration (NASA) as part of the Student Payload Opportunity with Citizen Science (SPOCS) program	This research was funded by the National Aeronautics and Space Administration (NASA) as part of the Student Payload Opportunity with Citizen Science (SPOCS) program under Federal Award No 80NSSC17M0021, as a subaward to the University of Idaho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves-Bueno E., 2017, B ECOL SOC AM, V98, P278, DOI DOI 10.1002/BES2.1336; Bernards M, 2014, J BIOMAT SCI-POLYM E, V25, P1479, DOI 10.1080/09205063.2014.938976; Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058; Davis JR., 2010, 22538 JSC NAT AER SP; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dobbins SC, 2012, J PHYS CHEM B, V116, P14346, DOI 10.1021/jp307588b; Grant DM, 2005, HEAT TRANSFER ENG, V26, P44, DOI 10.1080/01457630590890166; Haag SL, 2020, LANGMUIR, V36, P3292, DOI 10.1021/acs.langmuir.0c00114; Laschewsky A, 2014, POLYMERS-BASEL, V6, P1544, DOI 10.3390/polym6051544; Mi L, 2010, BIOMATERIALS, V31, P2919, DOI 10.1016/j.biomaterials.2009.12.038; Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4; Schroeder ME, 2013, BIOMACROMOLECULES, V14, P3112, DOI 10.1021/bm4007369; Tah T, 2012, COLLOID SURFACE B, V93, P195, DOI 10.1016/j.colsurfb.2012.01.004; Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wiggins A, 2019, AM J BIOETHICS, V19, P3, DOI 10.1080/15265161.2019.1619859; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65; Yang J, 2018, METHOD MICROBIOL, V45, P3, DOI 10.1016/bs.mim.2018.07.002	22	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261817	10.1371/journal.pone.0261817	http://dx.doi.org/10.1371/journal.pone.0261817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972139	Green Published, gold			2022-12-26	WOS:000773555700057
J	Lin, Q; Liu, Y; Peng, SM; Liu, CJ; Lv, T; Liao, LP; Li, YH; Wang, YZ; Fan, ZY; Wu, WG; Zeng, JG; Qiu, HJ; He, X; Dai, QZ				Lin, Qian; Liu, Yang; Peng, Simin; Liu, Chunjie; Lv, Tuo; Liao, Liping; Li, Yinghui; Wang, Yanzhou; Fan, Zhiyong; Wu, Weiguo; Zeng, Jianguo; Qiu, Huajiao; He, Xi; Dai, Qiuzhong			Magnolol additive improves growth performance of Linwu ducklings by modulating antioxidative status	PLOS ONE			English	Article							HEAT-STRESS IMPAIRS; OXIDATIVE STRESS; RNA EXPRESSION; HONOKIOL; COLISTIN; SUPPLEMENTATION; SYSTEM; MITOCHONDRIAL; PATHOGENESIS; METABOLISM	Magnolol is a bioactive polyphenolic compound commonly found in Magnolia officinalis. The aim of this study is to clarify the contribution of the magnolol additive on the growth performance of Linwu ducklings aging from 7 to 28 d, comparing to the effects of antibiotic additive (colistin sulphate). A total of 325, 7-d-old ducklings were assigned to 5 groups. Each group had 5 cages with 13 ducklings in each cage. The ducklings in different groups were fed with diets supplemented with 0, 100, 200 and 300 mg/kg magnolol additive (MA) (Control, MA100, MA200 and MA300) and 30 mg/kg colistin sulphate (CS30) for 3 weeks, respectively. Parameters regarding to the growth performance, intestinal mucosal morphology, serum biochemical indices, antioxidant and peroxide biomarkers and the expression levels of antioxidant-related genes were evaluated by one way ANOVA analysis. The results showed that 30 mg/kg colistin sulphate, 200 and 300 mg/kg magnolol additive improved the average final weight (P = 0.045), average daily body weight gain (P = 0.038) and feed/gain ratios (P = 0.001) compared to the control group. 200 and 300 mg/kg magnolol additive significantly increased the villus height/crypt depth ratio of ileum, compared to the control and CS30 groups (P = 0.001). Increased serum level of glucose (P = 0.011) and total protein (P = 0.006) were found in MA200 or MA300 group. In addition, comparing to the control and CS30 groups, MA200 or MA300 significantly increased the levels of superoxide dismutase (P = 0.038), glutathione peroxidase (P = 0.048) and reduced glutathione (P = 0.039) in serum. Moreover, the serum and hepatic levels of 8-hydroxy-2'-deoxyguanosine (P = 0.043 and 0.007, respectively) were lower in all MA groups compared to those of the control and CS30 group. The hepatic mRNA expression levels of superoxide dismutase-1, catalase and nuclear factor erythroid-2-related factor 2/erythroid-derived CNC-homology factor were also increased significantly in MA200 and MA300 groups (P < 0.05). Taken together, these data demonstrated that MA was an effective feed additive enhancing the growth performance of Linwu ducklings at 7 to 28 d by improving the antioxidant and intestinal mucosal status. It suggested that MA could be a potential ingredient to replace the colistin sulphate in diets.	[Lin, Qian; Liu, Chunjie; Lv, Tuo; Liao, Liping; Wang, Yanzhou; Zeng, Jianguo; Qiu, Huajiao; Dai, Qiuzhong] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Liu, Yang; Li, Yinghui; Fan, Zhiyong; He, Xi] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China; [Peng, Simin; Wu, Weiguo] Hunan Agr Univ, Coll Food Sci & Technol, Changsha, Hunan, Peoples R China; [Zeng, Jianguo] Hunan Agr Univ, Coll Hort, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Hunan Agricultural University; Hunan Agricultural University; Hunan Agricultural University	Qiu, HJ; Dai, QZ (corresponding author), Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China.; He, X (corresponding author), Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China.	qiuhuajiao@caas.cn; hexi111@126.com; daiqiuzhong@163.com		Liu, Yang/0000-0002-6579-3633	Hunan Natural Science Foundation [2019JJ50710]; National Key RD Program [2017YFD0500506]; Agricultural Science and Technology Innovation Program (ASTIP-IBFC); Modern Agricultural Technical System Foundation of China [CARS-42]	Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province); National Key RD Program; Agricultural Science and Technology Innovation Program (ASTIP-IBFC); Modern Agricultural Technical System Foundation of China	QL received Hunan Natural Science Foundation (2019JJ50710) founded by China Hunan Provincial Science & Technology Department (http://kjt.hunan.gov.cn/kjt/index.html), National Key R&D Program (2017YFD0500506) founded by Chinese Academy of Science (http://www.cas.cn), the Agricultural Science and Technology Innovation Program (ASTIP-IBFC) founded by Chinese Academy of Agricultural Sciences (http://www.caas.cn), Modern Agricultural Technical System Foundation of China (CARS-42) founded by Ministry of Agriculture and Rural Affairs of the People's Republic of China (http://www.kjs.moa.gov.cn/jgzn).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorati R, 2015, J ORG CHEM, V80, P10651, DOI 10.1021/acs.joc.5b01772; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Ceriello A, 1999, DIABETES NUTR METAB, V12, P42; Chang CP, 2003, CLIN EXP PHARMACOL P, V30, P387, DOI 10.1046/j.1440-1681.2003.03847.x; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Chen F, 2021, POULTRY SCI, V100, P835, DOI 10.1016/j.psj.2020.10.047; Chen L, 2017, ANIM GENET, V48, P358, DOI 10.1111/age.12540; Chen YP, 2013, BRIT POULTRY SCI, V54, P531, DOI 10.1080/00071668.2013.809402; Chen YH, 2009, ARCH PHARM RES, V32, P221, DOI 10.1007/s12272-009-1139-8; Choi SS, 2012, BIOFACTORS, V38, P372, DOI 10.1002/biof.1029; Council NR, 1994, NUTR REQ POULTR 9 RE; Dai CS, 2016, MOL NEUROBIOL, V53, P4685, DOI 10.1007/s12035-015-9396-7; Dai CS, 2014, ANTIMICROB AGENTS CH, V58, P4075, DOI 10.1128/AAC.00070-14; Dai Q., 2019, CROP RES, V33, P461; Ezeji E. U., 2012, AM J BIOCH, V2, P21, DOI 10.5923/j.ajb.20120203.01; Fiaccadori E, 2016, AM J KIDNEY DIS, V68, P296, DOI 10.1053/j.ajkd.2016.03.421; Hohtola E, 2002, COMP BIOCHEM PHYS A, V131, P733, DOI 10.1016/S1095-6433(02)00011-9; Horosova K, 2006, FOLIA MICROBIOL, V51, P278, DOI 10.1007/BF02931812; Huang C, 2015, J ANIM SCI, V93, P2144, DOI 10.2527/jas.2014-8739; Jiang JF, 2012, ASIAN AUSTRAL J ANIM, V25, P1445, DOI 10.5713/ajas.2012.12190; Khor TO, 2011, BIOCHEM PHARMACOL, V82, P1073, DOI 10.1016/j.bcp.2011.07.065; Kim YJ, 2013, MOL NUTR FOOD RES, V57, P1988, DOI 10.1002/mnfr.201300113; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Lee YS, 2015, FOOD SCI BIOTECHNOL, V24, P1467, DOI 10.1007/s10068-015-0189-6; Li H, 2019, TOXICOL APPL PHARM, V373, P48, DOI 10.1016/j.taap.2019.04.016; Li X., 2012, INT RES J PURE APPL, V2, P68, DOI DOI 10.9734/IRJPAC/2012/628; Li YZ, 2006, J ANIM SCI, V84, P212, DOI 10.2527/jas.2006-144; Lin Q, 2017, ANIM NUTR, V3, P132, DOI 10.1016/j.aninu.2017.03.004; Lin Qian, 2015, Chinese Journal of Animal Nutrition, V27, P2466; Lin Qian, 2014, Chinese Journal of Animal Nutrition, V26, P2101; Lin YF, 2005, J NUTR, V135, P2457, DOI 10.1093/jn/135.10.2457; Liu LL, 2014, POULTRY SCI, V93, P54, DOI 10.3382/ps.2013-03423; Liu YS, 2020, BRIT POULTRY SCI, V61, P599, DOI 10.1080/00071668.2020.1774511; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO YC, 1994, BIOCHEM PHARMACOL, V47, P549, DOI 10.1016/0006-2952(94)90187-2; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Ma XY, 2014, ANIM REPROD SCI, V145, P182, DOI 10.1016/j.anireprosci.2014.01.002; Mei C, 2016, J ZHEJIANG UNIV-SC B, V17, P413, DOI 10.1631/jzus.B1500261; Mishra B, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00060; Naghi Shokri A, 2017, ANIM SCI J, V88, P306, DOI 10.1111/asj.12629; Nation RL, 2015, LANCET INFECT DIS, V15, P225, DOI 10.1016/S1473-3099(14)70850-3; Ogata M, 1997, J AM OIL CHEM SOC, V74, P557, DOI 10.1007/s11746-997-0180-3; Qin S, 2016, MOL NUTR FOOD RES, V60, P1731, DOI 10.1002/mnfr.201501017; Rajgopal A, 2016, J ETHNOPHARMACOL, V193, P657, DOI 10.1016/j.jep.2016.10.016; Saleh AA, 2020, ANIM PROD SCI, V60, P1704, DOI 10.1071/AN19030; Saleh AA, 2014, VET MED-CZECH, V59, P536, DOI 10.17221/7818-VETMED; Saleh AA, 2018, ENVIRON SCI POLLUT R, V25, P14606, DOI 10.1007/s11356-018-1685-z; Shen JL, 2010, MOLECULES, V15, P6452, DOI 10.3390/molecules15096452; Sozer V, 2013, MINERVA MED, V104, P75; Wallace RJ, 2010, BRIT POULTRY SCI, V51, P461, DOI 10.1080/00071668.2010.506908; Wang W., 2015, INFLAMMATION, V281, P2543; Wu CL, 2014, INFLAMMATION, V37, P1957, DOI 10.1007/s10753-014-9928-8; Xia T, 2019, PHYTOTHER RES, V33, P1161, DOI 10.1002/ptr.6311; Xia XC, 2014, AFR J TRADIT COMPLEM, V11, P140, DOI 10.4314/ajtcam.v11i1.22; YASON CV, 1987, AM J VET RES, V48, P927; Yen HC, 2015, ANIM SCI J, V86, P99, DOI 10.1111/asj.12248; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Zeng Z, 2010, J VET PHARMACOL THER, V33, P408, DOI 10.1111/j.1365-2885.2009.01136.x; Zhao C, 2011, BIOCHIMIE, V93, P1755, DOI 10.1016/j.biochi.2011.06.012	59	1	2	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0259896	10.1371/journal.pone.0259896	http://dx.doi.org/10.1371/journal.pone.0259896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972101	gold, Green Published			2022-12-26	WOS:000773555700010
J	Possamai, D; Hanafi, LA; Bellemare-Pelletier, A; Hamelin, K; Thebault, P; Hebert, MJ; Gagnon, E; Leclerc, D; Lapointe, R				Possamai, David; Hanafi, Laila-Aicha; Bellemare-Pelletier, Angelique; Hamelin, Katia; Thebault, Pamela; Hebert, Marie-Josee; Gagnon, Etienne; Leclerc, Denis; Lapointe, Rejean			MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; ENDOGENOUS VIRAL-ANTIGENS; THYMIC EPITHELIAL-CELLS; DENDRITIC CELLS; MOLECULES; MACROAUTOPHAGY; VESICLES; EPITOPES; IMMUNITY	Nanoparticles made of the coat protein of papaya mosaic virus (PapMV) and a single-strand RNA were previously shown to be an efficient antigen presentation system for the trigger of cellular immunity. Engineering of PapMV nano with a cytotoxic T lymphocyte epitope was previously shown activating specific T lymphocytes through a proteasome-independent major histocompatibility complex class I (MHC-I) cross-presentation. In this study, we provide new insights into the mechanism of the MHC-I cross-presentation mediated by PapMV nanoparticles. We demonstrate that PapMV nanoparticles do not require the transporter associated with antigen presentation (TAP), but rather depend on lysosome acidification and cathepsin S protease activity for presentation of the T cell epitope. We have also linked the induction of autophagy with this vacuolar MHC-I cross-presentation process. Interestingly, autophagy is induced in antigen-presenting cells after PapMV nanoparticles exposure and inhibition of autophagy reduce MHC-I cross-presentation. This study demonstrates that autophagy is associated with TAP- and proteasome-independent MHC-I cross-presentation. A deeper understanding of the autophagy-dependent MHC-I cross-presentation will be useful in designing vaccination platforms that aim to trigger an efficient cytotoxic T lymphocyte response.	[Possamai, David; Hanafi, Laila-Aicha; Hamelin, Katia; Thebault, Pamela; Hebert, Marie-Josee; Lapointe, Rejean] Univ Montreal, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada; [Bellemare-Pelletier, Angelique; Gagnon, Etienne] Inst Rech Immunol & Cancerol, Montreal, PQ, Canada; [Bellemare-Pelletier, Angelique; Gagnon, Etienne] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Leclerc, Denis] Univ Quebec, Ctr Rech Infectiol, Ctr Hosp, Quebec City, PQ, Canada; [Leclerc, Denis] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Lapointe, Rejean] Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; University of Quebec; Laval University; Universite de Montreal	Lapointe, R (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada.; Lapointe, R (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada.	rejean.lapointe@umontreal.ca		Leclerc, Denis/0000-0002-9323-1638	Canadian Institutes of Health Research [CIHR MOP 89833]; Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN-2016-05376]; Fonds de la recherche du Quebec -sante (FRQ-S); Institut du cancer de Montreal	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche du Quebec -sante (FRQ-S); Institut du cancer de Montreal	This work was supported by grants from the Canadian Institutes of Health Research (CIHR MOP 89833; https://cihr-irsc.gc.ca) and the Natural Sciences and Engineering Research Council of Canada (NSERC RGPIN-2016-05376; https://www.nserc-crsng.gc.ca).RL and LAH are recipients of scholarships from the Fonds de la recherche du Quebec -sante (FRQ-S; https://frq.gouv.qc.ca).DP and LAH received Canderel scholarships from the Institut du cancer de Montreal (https://www.icm.qc.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Bhattacharjee S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0668-9; Blander JM, 2018, ANNU REV IMMUNOL, V36, P717, DOI 10.1146/annurev-immunol-041015-055523; Budida R, 2017, EUR J IMMUNOL, V47, P1819, DOI 10.1002/eji.201646908; Carignan D, 2018, NANOMED-NANOTECHNOL, V14, P2317, DOI 10.1016/j.nano.2017.10.015; Chen LY, 2004, EUR J IMMUNOL, V34, P952, DOI 10.1002/eji.200324359; Croft NP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000490; Dasari V, 2016, IMMUNOL CELL BIOL, V94, P964, DOI 10.1038/icb.2016.59; delaSalle H, 1997, J IMMUNOL, V158, P4555; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Di Bonito P, 2009, VIROLOGY, V395, P45, DOI 10.1016/j.virol.2009.09.012; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; English L, 2009, AUTOPHAGY, V5, P1026, DOI 10.4161/auto.5.7.9163; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Fiegl D, 2013, J IMMUNOL, V190, P2791, DOI 10.4049/jimmunol.1202741; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hanafi LA, 2010, VACCINE, V28, P5617, DOI 10.1016/j.vaccine.2010.06.024; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Herb M, 2020, SEMIN CELL DEV BIOL, V101, P68, DOI 10.1016/j.semcdb.2019.04.016; Lapointe R, 2003, CANCER RES, V63, P2836; Lebel ME, 2015, VACCINES-BASEL, V3, P620, DOI 10.3390/vaccines3030620; Leclerc D, 2007, J VIROL, V81, P1319, DOI 10.1128/JVI.01720-06; Loi M, 2016, CELL REP, V15, P1076, DOI 10.1016/j.celrep.2016.04.002; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Makarkov AI, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0111-y; Matheoud D, 2013, CELL HOST MICROBE, V14, P15, DOI 10.1016/j.chom.2013.06.003; MCCOY KL, 1988, IMMUNOL REV, V106, P129, DOI 10.1111/j.1600-065X.1988.tb00777.x; Menager J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089897; Moffat JM, 2013, VACCINE, V31, P2310, DOI 10.1016/j.vaccine.2013.02.042; Mohsen MO, 2020, WIRES NANOMED NANOBI, V12, DOI 10.1002/wnan.1579; Mohsen MO, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0587-z; Mohsen MO, 2017, SEMIN IMMUNOL, V34, P123, DOI 10.1016/j.smim.2017.08.014; Munz C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.628429; Oliveira CC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00298; Oliveira CC, 2013, MOL IMMUNOL, V55, P113, DOI 10.1016/j.molimm.2012.10.005; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Puleston DJ, 2014, IMMUNOLOGY, V141, P1, DOI 10.1111/imm.12165; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Ressing ME, 2013, MOL IMMUNOL, V55, P139, DOI 10.1016/j.molimm.2012.10.009; Rock KL, 2010, J IMMUNOL, V184, P9, DOI 10.4049/jimmunol.0903399; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Van Kaer L, 2019, MOL IMMUNOL, V113, P2, DOI 10.1016/j.molimm.2017.10.021; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; Wu CY, 2013, AUTOPHAGY, V9, P931, DOI 10.4161/auto.24374; Zehner M, 2013, MOL IMMUNOL, V55, P146, DOI 10.1016/j.molimm.2012.10.010; Zou LY, 2009, P NATL ACAD SCI USA, V106, P15801, DOI 10.1073/pnas.0905684106	54	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261987	10.1371/journal.pone.0261987	http://dx.doi.org/10.1371/journal.pone.0261987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972158	gold, Green Published			2022-12-26	WOS:000773555700081
J	Segreto, R; Bazafkan, H; Millinger, J; Schenk, M; Atanasova, L; Doppler, M; Buschl, C; Boeckstaens, M; Diaz, SS; Schreiner, U; Sillo, F; Balestrini, R; Schuhmacher, R; Zeilinger, S				Segreto, Rossana; Bazafkan, Hoda; Millinger, Julia; Schenk, Martina; Atanasova, Lea; Doppler, Maria; Bueschl, Christoph; Boeckstaens, Melanie; Diaz, Silvia Soto; Schreiner, Ulrike; Sillo, Fabiano; Balestrini, Raffaella; Schuhmacher, Rainer; Zeilinger, Susanne			The TOR kinase pathway is relevant for nitrogen signaling and antagonism of the mycoparasite Trichoderma atroviride	PLOS ONE			English	Article							PROTEIN S6 PHOSPHORYLATION; FISSION YEAST; AMINO-ACID; N-ACETYLGLUCOSAMINIDASE; TSC1-TSC2 COMPLEX; NPR1 KINASE; RHEB; RAPAMYCIN; GROWTH; GENE	Trichoderma atroviride (Ascomycota, Sordariomycetes) is a well-known mycoparasite applied for protecting plants against fungal pathogens. Its mycoparasitic activity involves processes shared with plant and human pathogenic fungi such as the production of cell wall degrading enzymes and secondary metabolites and is tightly regulated by environmental cues. In eukaryotes, the conserved Target of Rapamycin (TOR) kinase serves as a central regulator of cellular growth in response to nutrient availability. Here we describe how alteration of the activity of TOR1, the single and essential TOR kinase of T. atroviride, by treatment with chemical TOR inhibitors or by genetic manipulation of selected TOR pathway components affected various cellular functions. Loss of TSC1 and TSC2, that are negative regulators of TOR complex 1 (TORC1) in mammalian cells, resulted in altered nitrogen source-dependent growth of T. atroviride, reduced mycoparasitic overgrowth and, in the case of Delta tsc1, a diminished production of numerous secondary metabolites. Deletion of the gene encoding the GTPase RHE2, whose mammalian orthologue activates mTORC1, led to rapamycin hypersensitivity and altered secondary metabolism, but had an only minor effect on vegetative growth and mycoparasitic overgrowth. The latter also applied to mutants missing the npr1-1 gene that encodes a fungus-specific kinase known as TOR target in yeast. Genome-wide transcriptome analysis confirmed TOR1 as a regulatory hub that governs T. atroviride metabolism and processes associated to ribosome biogenesis, gene expression and translation. In addition, mycoparasitism-relevant genes encoding terpenoid and polyketide synthases, peptidases, glycoside hydrolases, small secreted cysteine-rich proteins, and G protein coupled receptors emerged as TOR1 targets. Our results provide the first in-depth insights into TOR signaling in a fungal mycoparasite and emphasize its importance in the regulation of processes that critically contribute to the antagonistic activity of T. atroviride.	[Segreto, Rossana; Bazafkan, Hoda; Millinger, Julia; Schenk, Martina; Schreiner, Ulrike; Zeilinger, Susanne] Univ Innsbruck, Dept Microbiol, Innsbruck, Austria; [Atanasova, Lea] Univ Nat Resources & Life Sci BOKU, Inst Food Technol, Vienna, Austria; [Doppler, Maria; Bueschl, Christoph; Schuhmacher, Rainer] Univ Nat Resources & Life Sci Vienna BOKU, Dept Agrobiotechnol IFA Tulin, Ctr Analyt Chem, Tulin, Austria; [Boeckstaens, Melanie; Diaz, Silvia Soto] Univ Libre Bruxelles, Dept Biol Mol, Lab Biol Membrane Transport, Belgium, Italy; [Sillo, Fabiano; Balestrini, Raffaella] IPSP, CNR, Turin, Italy	University of Innsbruck; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR)	Zeilinger, S (corresponding author), Univ Innsbruck, Dept Microbiol, Innsbruck, Austria.	Susanne.zeilinger@uibk.ac.at	; Sillo, Fabiano/K-5022-2016	Zeilinger, Susanne/0000-0003-3112-0948; Atanasova, Lea/0000-0002-1751-277X; Segreto, Rossana/0000-0002-2566-7042; Sillo, Fabiano/0000-0002-1218-9985; Boeckstaens, Melanie/0000-0003-1629-7403	Austrian Science Fund [P28248]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF; https://www.fwf.ac.at/; grant number P28248 to SZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasova L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-121; Atanasova L, 2010, J ZHEJIANG UNIV-SC B, V11, P151, DOI 10.1631/jzus.B1000007; Atkin J, 2014, J CELL SCI, V127, P1346, DOI 10.1242/jcs.146373; Baldin C, 2015, PROTEOMICS, V15, P2230, DOI 10.1002/pmic.201400584; Bastidas RJ, 2012, EUKARYOT CELL, V11, P270, DOI 10.1128/EC.05284-11; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Boeckstaens M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005382; Boeckstaens M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4101; Brito AS, 2019, ISCIENCE, V20, P415, DOI 10.1016/j.isci.2019.09.025; Brunner K, 2003, CURR GENET, V43, P289, DOI 10.1007/s00294-003-0399-y; Brunner K, 2008, CURR GENET, V54, P283, DOI 10.1007/s00294-008-0217-7; Bueschl C, 2017, ANAL CHEM, V89, P9518, DOI 10.1021/acs.analchem.7b02518; Bueschl C, 2014, METABOLOMICS, V10, P754, DOI 10.1007/s11306-013-0611-0; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Ceranic A, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00590-9; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Chowdhury T, 2015, MOL MICROBIOL, V98, P384, DOI 10.1111/mmi.13130; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gonzalez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120250; GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x; Hallett JEH, 2014, GENETICS, V198, P773, DOI 10.1534/genetics.114.168369; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Karlsson M, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0016-2016; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li LX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00501; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lopez-Berges MS, 2010, PLANT CELL, V22, P2459, DOI 10.1105/tpc.110.075937; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mach KE, 2000, GENETICS, V155, P611; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Matsumoto S, 2002, GENETICS, V161, P1053; Moran-Diez ME, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01120; Moreno-Ruiz D, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9100860; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Panepinto JC, 2003, INFECT IMMUN, V71, P2819, DOI 10.1128/IAI.71.5.2819-2826.2003; Panepinto JC, 2002, FUNGAL GENET BIOL, V36, P207, DOI 10.1016/S1087-1845(02)00022-1; Pang AP., 2021, BIOTECHNOL BIOFUELS, V14; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pfannmuller A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125487; Prouteau M, 2017, NATURE, V550, P265, DOI 10.1038/nature24021; R Core Team, 2020, R LANG ENV STAT COMP; Saikia S, 2014, INFECT IMMUN, V82, P839, DOI 10.1128/IAI.01357-13; Salas-Marina MA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00077; Sauerschnig C, 2018, METABOLITES, V8, DOI 10.3390/metabo8010001; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Schmoll M, 2016, MICROBIOL MOL BIOL R, V80, P205, DOI 10.1128/MMBR.00040-15; Seidl V, 2006, MICROBIOL-SGM, V152, P2003, DOI 10.1099/mic.0.28897-0; Seidl V, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-567; Seo J, 2002, COMPUTER, V35, P80; Serfontein J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000803; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tatebe H, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7040077; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Teichert S, 2006, EUKARYOT CELL, V5, P1807, DOI 10.1128/EC.00039-06; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tisch D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-613; Tsao CC, 2009, FUNGAL GENET BIOL, V46, P126, DOI 10.1016/j.fgb.2008.11.008; Tudzynski B, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00656; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200; VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845; Weisman R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0006-2016; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yerlikaya S, 2016, MOL BIOL CELL, V27, P397, DOI 10.1091/mbc.E15-08-0594; Yu FW, 2014, NEW PHYTOL, V203, P219, DOI 10.1111/nph.12776; Yu WJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26328-1; Zeilinger S, 2016, FUNGAL BIOL REV, V30, P74, DOI 10.1016/j.fbr.2016.05.001; Zeilinger S, 2007, GENE REGUL SYST BIO, V1, P227	98	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262180	10.1371/journal.pone.0262180	http://dx.doi.org/10.1371/journal.pone.0262180			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972198	Green Published, gold			2022-12-26	WOS:000773555700105
J	Luo, S; Wang, F; Chen, SY; Chen, AQ; Wang, ZM; Gao, XF; Kong, XQ; Zuo, GF; Zhou, WY; Gu, Y; Ge, Z; Zhang, JJ				Luo, Shuai; Wang, Feng; Chen, Siyu; Chen, Aiqun; Wang, Zhimei; Gao, Xiaofei; Kong, Xiangquan; Zuo, Guangfeng; Zhou, Wenying; Gu, Yue; Ge, Zhen; Zhang, Junjie			NRP2 promotes atherosclerosis by upregulating PARP1 expression and enhancing low shear stress-induced endothelial cell apoptosis	FASEB JOURNAL			English	Article						apoptosis; atherosclerosis; NRP2; PARP1; shear stress	NEUROPILIN-2; LYMPHANGIOGENESIS; MECHANISM; INFLAMMATION; HOMEOSTASIS; METASTASIS; RECEPTOR; GATA2; FLOW	Atherosclerosis-related cardiovascular diseases are leading causes of mortality worldwide, characterized by the development of endothelial cell dysfunction, increased oxidized low-density lipoprotein uptake by macrophages, and the ensuing formation of atherosclerotic plaque. Local blood flow patterns cause uneven atherosclerotic lesion distribution, and endothelial dysfunction caused by disturbed flow is an early step in the development of atherosclerosis. The present research aims to elucidate the mechanism underlying the regulation of Neuropilin 2 (NRP2) under low shear stress (LSS) in the atheroprone phenotype of endothelial cells. We observed that NRP2 expression was significantly upregulated in LSS-stimulated human umbilical vein endothelial cells (HUVECs) and in mouse aortic endothelial cells. Knockdown of NRP2 in HUVECs significantly ameliorated cell apoptosis induced by LSS. Conversely, overexpression of NRP2 had the opposite effect on HUVEC apoptosis. Animal experiments suggest that NRP2 knockdown markedly mitigated the development of atherosclerosis in Apoe(-/-) mice. Mechanistically, NRP2 knockdown and overexpression regulated PARP1 protein expression in the condition of LSS, which in turn affected the expression of apoptosis-related genes. Moreover, the upstream transcription factor GATA2 was found to regulate NRP2 expression in the progression of atherosclerosis. These findings suggest that NRP2 plays an essential proatherosclerotic role through the regulation of cell apoptosis, and the results reveal that NRP2 is a promising therapeutic target for the treatment of atherosclerotic disorders.	[Luo, Shuai; Wang, Feng; Chen, Siyu; Chen, Aiqun; Wang, Zhimei; Gao, Xiaofei; Kong, Xiangquan; Zuo, Guangfeng; Zhou, Wenying; Gu, Yue; Ge, Zhen; Zhang, Junjie] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210000, Peoples R China; [Gao, Xiaofei; Zhang, Junjie] Nanjing Heart Ctr, Dept Cardiol, Nanjing, Peoples R China	Nanjing Medical University	Zhang, JJ (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210000, Peoples R China.	jameszli@163.com		Wang, Feng/0000-0003-2771-5543	National Natural Science Foundation of China (NSFC) [81970307]; Six Talent Peaks Project in Jiangsu Province (Six Talent Peaks Project in Jiangsu Province of China) [2019-WSN-156]; Social Development Project of Jiangsu Province [BE2019616]; Jiangsu Commission of Health [H2019077]; Jiangsu Provincial Special Program of Medical Science [BE2019615]; Nanjing Commission of Health [ZKX19027]; Nanjing Health Youth Talent Training project [QRX17017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Six Talent Peaks Project in Jiangsu Province (Six Talent Peaks Project in Jiangsu Province of China); Social Development Project of Jiangsu Province; Jiangsu Commission of Health; Jiangsu Provincial Special Program of Medical Science; Nanjing Commission of Health; Nanjing Health Youth Talent Training project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81970307; Six Talent Peaks Project in Jiangsu Province (Six Talent Peaks Project in Jiangsu Province of China), Grant/Award Number: 2019-WSN-156; Social Development Project of Jiangsu Province, Grant/Award Number: BE2019616; Jiangsu Commission of Health, Grant/Award Number: H2019077; Jiangsu Provincial Special Program of Medical Science, Grant/Award Number: BE2019615; Nanjing Commission of Health, Grant/Award Number: ZKX19027; Nanjing Health Youth Talent Training project, Grant/Award Number: QRX17017	Alghamdi AAA, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00395; Ayari H, 2013, J BIOSCIENCES, V38, P311, DOI 10.1007/s12038-013-9310-2; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Caligiuri G, 2019, CARDIOVASC RES, V115, P1425, DOI 10.1093/cvr/cvz132; Campolo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090213; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Coma S, 2013, ANGIOGENESIS, V16, P939, DOI 10.1007/s10456-013-9370-9; DAVIS JB, 1990, AM SURGEON, V56, P47; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Hebbel RP, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016134; Hossain M, 2015, J IMMUNOL, V195, P2408, DOI 10.4049/jimmunol.1402225; Hu H, 2019, NUCLEIC ACIDS RES, V47, pD33, DOI 10.1093/nar/gky822; Ji T, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0359-4; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Lala PK, 2018, CANCER METAST REV, V37, P369, DOI 10.1007/s10555-018-9734-0; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Montero J, 2013, CELL DEATH DIFFER, V20, P1465, DOI 10.1038/cdd.2013.52; Mucka P, 2016, AM J PATHOL, V186, P2803, DOI 10.1016/j.ajpath.2016.07.022; Nakayama H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11789; Neiger JD, 2005, LIFE SCI, V76, P1895, DOI 10.1016/j.lfs.2004.11.004; Ou JJ, 2015, CANCER LETT, V358, P200, DOI 10.1016/j.canlet.2014.12.046; Paone S, 2019, CELL MOL LIFE SCI, V76, P1093, DOI 10.1007/s00018-018-2983-9; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pellet-Many C, 2015, CARDIOVASC RES, V108, P288, DOI 10.1093/cvr/cvv229; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Rizzolio S, 2018, CANCER RES, V78, P1058, DOI 10.1158/0008-5472.CAN-17-2020; Roy S, 2018, CANCER RES, V78, P5600, DOI 10.1158/0008-5472.CAN-18-0562; Schnittler HJ, 1998, BASIC RES CARDIOL, V93, P30; Schulz A, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01461; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Sun XL, 2016, P NATL ACAD SCI USA, V113, P769, DOI 10.1073/pnas.1524523113; Umesh A, 2006, J BIOL CHEM, V281, P34312, DOI 10.1074/jbc.M606765200; Venturini G, 2019, AM J PHYSIOL-CELL PH, V317, pC326, DOI 10.1152/ajpcell.00128.2018; Wang F, 2019, LIFE SCI, V224, P212, DOI 10.1016/j.lfs.2019.03.033; Wang JW, 2018, CANCER LETT, V418, P176, DOI 10.1016/j.canlet.2018.01.040; Xu SW, 2021, PHARMACOL REV, V73, P924, DOI 10.1124/pharmrev.120.000096; Xu SW, 2014, MED RES REV, V34, P644, DOI 10.1002/med.21300; Yamashiro Y, 2020, CLIN SCI, V134, P2399, DOI 10.1042/CS20190488; Yuan T, 2019, REDOX BIOL, V20, P247, DOI 10.1016/j.redox.2018.09.025; Zhong TT, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3426	45	4	4	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22079	10.1096/fj.202101250RR	http://dx.doi.org/10.1096/fj.202101250RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35028975				2022-12-26	WOS:000747987800019
J	Ma, GJ; Chen, F; Liu, YX; Zheng, LX; Jiang, XH; Tian, HL; Wang, XX; Song, XY; Yu, Y; Wang, DF				Ma, Guojing; Chen, Feng; Liu, Yixuan; Zheng, Lixia; Jiang, Xuehan; Tian, Huanlian; Wang, Xiaoxun; Song, Xiaoyu; Yu, Yang; Wang, Difei			Nur77 ameliorates age-related renal tubulointerstitial fibrosis by suppressing the TGF-beta/Smads signaling pathway	FASEB JOURNAL			English	Article						aging; Nur77; renal fibrosis; Smad7; TGF-beta/Smads signaling pathway	SMAD7; BETA; EXPRESSION	Nerve growth factor-induced gene B (Nur77) has been shown to ameliorate several biological processes in chronic diseases, including inflammatory response, cellular proliferation, and metabolism. Chronic kidney disease (CKD) is characterized by tubulointerstitial fibrosis for which no targeted therapies are available as yet. In this study, we performed in vivo and in vitro experiments to demonstrate that Nur77 targets fibrosis signals and attenuates renal tubulointerstitial fibrosis during the aging process. We observed that the TGF-beta/Smads signal pathway was significantly suppressed by Nur77, suggesting that Nur77 controlled the activation of key steps in TGF-beta/Smads signaling. We further showed that Nur77 interacted with Smad7, the main repressor of nuclear translocation of Smad 2/3, and stabilized Smad7 protein homeostasis. Nur77 deficiency resulted in Smad7 degradation, aggravating Smad2/3 phosphorylation, and promoting transcription of its downstream target genes, ACTA2 and collagen I. Our findings demonstrate that Nur77 is a potential therapeutic target for age-related kidney diseases including CKD. Maintenance of Nur77 may be an effective strategy for blocking renal tubulointerstitial fibrosis and improving renal function in the elderly.	[Ma, Guojing; Chen, Feng; Liu, Yixuan; Wang, Difei] China Med Univ, Dept Gerontol & Geriatr, Shengjing Hosp, Shenyang 110001, Liaoning, Peoples R China; [Ma, Guojing; Zheng, Lixia; Jiang, Xuehan; Song, Xiaoyu; Yu, Yang] China Med Univ, Inst Translat Med, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Zheng, Lixia; Jiang, Xuehan; Song, Xiaoyu; Yu, Yang] China Med Univ, Inst Hlth Sci, Shenyang 110122, Liaoning, Peoples R China; [Tian, Huanlian] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Peoples R China; [Wang, Xiaoxun] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Wang, DF (corresponding author), China Med Univ, Dept Gerontol & Geriatr, Shengjing Hosp, Shenyang 110001, Liaoning, Peoples R China.; Yu, Y (corresponding author), China Med Univ, Inst Hlth Sci, Shenyang 110122, Liaoning, Peoples R China.	youngf_0322@126.com; dfwang@cmu.edu.cn	Yu, Yang/GZG-4493-2022	Yu, Yang/0000-0002-2480-7306	Talent Project of Revitalizing Liaoning, People's Republic of China [XLYC1902013, XLYC1808036]; National Science Foundation of China [82000827]; Natural Science Foundation of Liaoning Province of China [2020-BS-087]	Talent Project of Revitalizing Liaoning, People's Republic of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province)	This work was supported by the Talent Project of Revitalizing Liaoning, People's Republic of China to D.F. Wang (grant number XLYC1902013, XLYC1808036), the National Science Foundation of China to Y. Yu (grant number 82000827), the Natural Science Foundation of Liaoning Province of China to Y. Yu (grant number 2020-BS-087)	Chen JH, 2021, J CELL PHYSIOL, V236, P495, DOI 10.1002/jcp.29877; Chen Y, 2015, DIABETES, V64, P2069, DOI 10.2337/db14-1206; Chen YT, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143645; Chou YH, 2021, AGING DIS, V12, P515, DOI 10.14336/AD.2020.0703; Chung ACK, 2013, MOL THER, V21, P388, DOI 10.1038/mt.2012.251; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Cortez-Toledo O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171268; Crean D, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.589770; DEMIGUEL MH, 1994, J AM SOC NEPHROL, V4, P1861; Dou F, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114079; Elliot SJ, 2006, J AM SOC NEPHROL, V17, P3315, DOI 10.1681/ASN.2006070799; Haub J, 2019, J INVEST DERMATOL, V139, P2144, DOI 10.1016/j.jid.2019.04.006; Hiwatashi N, 2017, LARYNGOSCOPE, V127, pE317, DOI 10.1002/lary.26678; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; Jung YS, 2019, INT J OBESITY, V43, P952, DOI 10.1038/s41366-018-0276-x; Kalantar-Zadeh K, 2021, LANCET, V398, P786, DOI 10.1016/S0140-6736(21)00519-5; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Lee SY, 2009, FREE RADICAL BIO MED, V47, P1591, DOI 10.1016/j.freeradbiomed.2009.09.004; Li XC, 2019, J MOL MED, V97, P1359, DOI 10.1007/s00109-019-01819-4; Li XM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0085-0; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Luo CW, 2018, J AM SOC NEPHROL, V29, P1238, DOI 10.1681/ASN.2017050574; Luo FB, 2021, FEBS J, V288, P1243, DOI 10.1111/febs.15459; Medzikovic L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041600; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miao JH, 2019, AGING CELL, V18, DOI 10.1111/acel.13004; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Nakao A, 2002, TRENDS MOL MED, V8, P361, DOI 10.1016/S1471-4914(02)02376-6; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; Palumbo-Zerr K, 2015, NAT MED, V21, P150, DOI 10.1038/nm.3777; Quan Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020402; Schroth J, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.564461; ShamsEldeen AM, 2021, CLIN EXP PHARMACOL P, V48, P1402, DOI 10.1111/1440-1681.13546; Venu VKP, 2021, AM J PHYSIOL-GASTR L, V321, pG280, DOI 10.1152/ajpgi.00338.2019; Wang QW, 2021, PHARM BIOL, V59, P106, DOI 10.1080/13880209.2020.1867197; Xie Y, 2018, KIDNEY INT, V94, P567, DOI 10.1016/j.kint.2018.04.011; Yan JQ, 2020, AGING-US, V12, P8107, DOI 10.18632/aging.103128; Yan XH, 2016, J BIOL CHEM, V291, P382, DOI 10.1074/jbc.M115.694281; Yin HM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.357; Zhang GL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29023-3; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	43	3	3	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22124	10.1096/fj.202101332R	http://dx.doi.org/10.1096/fj.202101332R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972249				2022-12-26	WOS:000747987800031
J	Chen, Q; Zhuang, SQ; Hong, YL; Yang, LT; Guo, P; Mo, PL; Peng, KS; Li, WG; Xiao, NM; Yu, CD				Chen, Qiang; Zhuang, Shuqing; Hong, Yilin; Yang, Lingtao; Guo, Peng; Mo, Pingli; Peng, Kesong; Li, Wengang; Xiao, Nengming; Yu, Chundong			Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling	ONCOGENE			English	Article							IFN-GAMMA; MECHANISMS; PROGRESSION; PATHWAY	Programmed death-ligand 1 (PD-L1) is an important immunosuppressive molecule highly expressed on the surface of cancer cells. IFN gamma triggered cancer cell immunosuppression against CD8(+) T cell surveillance via up-regulation of PD-L1. Histone demethylase JMJD2D promotes colorectal cancer (CRC) progression; however, the role of JMJD2D in cancer immune escape is unknown. Here, we report that both PD-L1 and JMJD2D are frequently overexpressed in human CRC specimens with a significant positive correlation. Genetic ablation of JMJD2D in CRC cells attenuated the expression of PD-L1 and stalled tumor growth in mice, accompanied by the elevated number and effector function of tumor infiltrating CD8(+) T cells. Mechanistically, JMJD2D coactivated SP-1 to promote the expression of IFNGR1, which elevated STAT3-IRF1 signaling and promoted PD-L1 expression. Again, JMJD2D is a major coactivator for STAT3-IRF1 axis to enhance PD-L1 transcription in a demethylation activity dependent manner. Furthermore, pharmacological inhibition of JMJD2D conduced to improve the anti-tumor efficacy of PD-L1 antibody as demonstrated by slower tumor growth and higher infiltration and function of CD8(+) T cells in the combination of JMJD2D inhibitor 5-c-8HQ and PD-L1 antibody group compared with monotherapy with either agent. These results demonstrate that JMJD2D promotes CRC immune escape by enhancing PD-L1 expression to inhibit the activation and tumor infiltration of CD8(+) T cells; targeting JMJD2D has the potential role in promoting the efficacy of anti-PD-1/PD-L1 immunotherapy.	[Chen, Qiang; Zhuang, Shuqing; Hong, Yilin; Yang, Lingtao; Guo, Peng; Mo, Pingli; Xiao, Nengming; Yu, Chundong] Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Peng, Kesong] Fudan Univ, Sch Basic Med Sci, Dept Cellular & Genet Med, Shanghai, Peoples R China; [Li, Wengang] Xiamen Univ, Canc Res Ctr, Sch Med, Xiamen, Peoples R China; [Li, Wengang] Xiamen Univ, Xiangan Hosp, Res Ctr Retroperitoneal Tumor Comm Oncol Soc, Chinese Med Assoc,Sch Med, Xiamen, Peoples R China	Xiamen University; Fudan University; Xiamen University; Xiamen University	Xiao, NM; Yu, CD (corresponding author), Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.; Peng, KS (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Cellular & Genet Med, Shanghai, Peoples R China.; Li, WG (corresponding author), Xiamen Univ, Canc Res Ctr, Sch Med, Xiamen, Peoples R China.; Li, WG (corresponding author), Xiamen Univ, Xiangan Hosp, Res Ctr Retroperitoneal Tumor Comm Oncol Soc, Chinese Med Assoc,Sch Med, Xiamen, Peoples R China.	kesongpeng@fudan.edu.cn; lwgang@xmu.edu.cn; nengming@xmu.edu.cn; cdyu@xmu.edu.cn		Peng, Kesong/0000-0001-9035-3421	National Natural Science Foundation of China [81970485, 81772942, 31570883, 81972223]; Scientific Research Foundation for Advanced Talents, Xiang'an Hospital of Xiamen University [PM20180917008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Advanced Talents, Xiang'an Hospital of Xiamen University	This work was supported by the National Natural Science Foundation of China (No. 81970485 and No. 81772942 to Chundong Yu, No. 31570883 to Nengming Xiao, No. 81972223 to Wengang Li); Scientific Research Foundation for Advanced Talents, Xiang'an Hospital of Xiamen University (No. PM20180917008 to Wengang Li).	Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101; Canedo P, 2008, GUT, V57, P1504, DOI 10.1136/gut.2007.143578; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Cha JH, 2019, MOL CELL, V76, P359, DOI 10.1016/j.molcel.2019.09.030; Chen CG, 2012, AM J PATHOL, V180, P661, DOI 10.1016/j.ajpath.2011.10.040; Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0; Deng SY, 2019, MOL CANCER THER, V18, P900, DOI 10.1158/1535-7163.MCT-18-1068; Doi T, 2017, ONCOL REP, V37, P1545, DOI 10.3892/or.2017.5399; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Du LY, 2020, J EXP MED, V217, DOI 10.1084/jem.20191115; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Guo R, 2019, CANCER SCI, V110, P1665, DOI 10.1111/cas.13989; Hogg SJ, 2017, CELL REP, V18, P2162, DOI 10.1016/j.celrep.2017.02.011; Kim EY, 2017, LUNG CANCER, V110, P63, DOI 10.1016/j.lungcan.2017.06.006; Lee HT, 2019, MOLECULES, V24, DOI 10.3390/molecules24061190; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lin CF, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0317-0; Lu CW, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw283; Luo N, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1438106; Mimura K, 2018, CANCER SCI, V109, P43, DOI 10.1111/cas.13424; Peng KS, 2020, ONCOGENE, V39, P7076, DOI 10.1038/s41388-020-01483-w; Peng KS, 2019, GASTROENTEROLOGY, V156, P1112, DOI 10.1053/j.gastro.2018.11.036; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sheng Q, 2020, CLIN EXP IMMUNOL, V200, P45, DOI 10.1111/cei.13406; Singh S, 2020, NAT CELL BIOL, V22, P591, DOI 10.1038/s41556-020-0495-y; Sun L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0988-9; Tannenbaum CS, 2000, SEMIN CANCER BIOL, V10, P113, DOI 10.1006/scbi.2000.0314; Tong ZW, 2015, J BIOL CHEM, V290, P18596, DOI 10.1074/jbc.M115.640490; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Walter MR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.606489; Wang Y, 2018, CELL CYCLE, V17, P1457, DOI 10.1080/15384101.2018.1489177; Wang YH, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0346-6; Woods DM, 2015, CANCER IMMUNOL RES, V3, P1375, DOI 10.1158/2326-6066.CIR-15-0077-T; Xiao G, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0784-9; Zhao YT, 2019, BIOCHEM BIOPH RES CO, V517, P201, DOI 10.1016/j.bbrc.2019.07.039; Zhu HR, 2016, CELL REP, V16, P2829, DOI 10.1016/j.celrep.2016.08.032; Zhuo MH, 2020, ONCOGENE, V39, P3336, DOI 10.1038/s41388-020-1219-2; Zingg D, 2017, CELL REP, V20, P854, DOI 10.1016/j.celrep.2017.07.007	39	3	3	9	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2022	41	10					1421	1433		10.1038/s41388-021-02173-x	http://dx.doi.org/10.1038/s41388-021-02173-x		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZN2JO	35027670				2022-12-26	WOS:000742332000001
J	Shagaro, SS; Gebabo, TF; Mulugeta, BT				Shagaro, Sewunet Sako; Gebabo, Teshale Fikadu; Mulugeta, Be'emnet Tekabe			Four out of ten married women utilized modern contraceptive method in Ethiopia: A Multilevel analysis of the 2019 Ethiopia mini demographic and health survey	PLOS ONE			English	Article								Background Modern contraceptive method is a product or medical procedure that interferes with reproduction from acts of sexual intercourse. Globally in 2019, 44% of women of reproductive age were using a modern method of contraception but it was 29% in sub-Saharan Africa. Therefore, the main aim of this analysis was to assess the prevalence of modern contraceptive utilization and associated factors among married women in Ethiopia. Method The current study used the 2019 Ethiopia mini demographic and health survey dataset. Both descriptive and multilevel mixed-effect logistic regression analysis were done using STATA version 14. A p-value of less than 0.05 and an adjusted odds ratio with a 95% confidence interval were used to report statistically significant factors with modern contraceptive utilization. Result The overall modern contraceptive utilization among married women in Ethiopia was 38.7% (95% CI: 37.3% to 40.0%). Among the modern contraceptive methods, injectables were the most widely utilized modern contraceptive method (22.82%) followed by implants (9.65%) and pills (2.71%). Maternal age, educational level, wealth index, number of living children, number of births in the last three years, number of under 5 children in the household, religion, and geographic region were independent predictors of modern contraceptive utilization. Conclusion In the current study only four out of ten married non-pregnant women of reproductive age utilized modern contraceptive methods. Furthermore, the study has identified both individual and community-level factors that can affect the utilization of modern contraceptive methods by married women in the country. Therefore, concerned bodies need to improve access to reproductive health services, empower women through community-based approaches, and minimize region wise discrepancy to optimize the utilization.	[Shagaro, Sewunet Sako; Mulugeta, Be'emnet Tekabe] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Informat, Arba Minch, Ethiopia; [Gebabo, Teshale Fikadu] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Publ Hlth, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University	Shagaro, SS (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Informat, Arba Minch, Ethiopia.	zesew1lalem@gmail.com	Shagaro, Sewunet Sako/AFS-0391-2022	Shagaro, Sewunet/0000-0003-0126-0165; Fikadu, Teshale/0000-0002-4177-9159				Abate MG, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0371-z; Adane AA, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8010327; Akinyemi JO., 2021, REPROD HLTH INTERNET, V18, P1, DOI [10.1186/s12978-020-01058-8, DOI 10.1186/S12978-020-01058-8]; Alemayehu GA, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0611-3; Alemayehu M, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0321-7; [Anonymous], 2016, REP INT AG EXP GROUP; [Anonymous], 2015, EPIDEMIOL OPEN ACCES, V05; Apanga PA, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.10.5301; Aviisah PA, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0634-9; Belda SS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2115-5; Beson P, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0649-2; Central Statistical Agency (CSA) (Ethiopia) and ICF, ETH DEM HLTH SURV 20; Croft TN, 2018, GUIDE DHS STAT; Debebe S, 2017, INT J REPROD BIOMED, V15, P367; Deloitte, 2018, EDITION WHATS NEW TH; Dey A.K., 2019, INT J COMMUNITY MED, V6, P738, DOI [10.18203/2394-6040.ijcmph20190200, DOI 10.18203/2394-6040.IJCMPH20190200]; Edition T., 2020, FEDERAL DEMOCRATIC R, VThird, P1; Endriyas M, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-016-0036-z; Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF, 2019, ETH MIN DEM HLTH SUR; Fertility World. and Planning Family, 2020, 2020 HIGHLIGHTS WORL; FMOH Performance report, 2012, FED MIN HLTH ETH PER, P487; Gebre MN, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00923-9; Geremew Alehegn Bishaw, 2018, Womens Midlife Health, V4, P13, DOI 10.1186/s40695-018-0044-z; Godfrey EM, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-5; Haq Iqramul, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040031; Hubacher D, 2015, CONTRACEPTION, V92, P420, DOI 10.1016/j.contraception.2015.08.008; Johnson OE, 2017, AFR J REPROD HEALTH, V21, P89, DOI 10.29063/ajrh2017/v21i3.8; Kassa GM, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0640-2; Kibria GMA., 2016, J MOL STUD MED RES, V2, P70, DOI [10.18801/jmsmr.020116.09, DOI 10.18801/JMSMR.020116.09]; Melash Belachew Asresie., 2020, HINDAWI ADV PUBLIC H; Mohammed A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-13; Njotang PN., 2017, BMC RES NOTES, V10, P4, DOI [10.1186/s13104-016-2343-5, DOI 10.1186/S13104-016-2343-5]; O'Regan A, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-017-0053-6; Oumer M, 2020, OPEN ACCESS J CONTR, V11, P53, DOI 10.2147/OAJC.S252970; Region M, 2020, HLTH GENDER, P4; Samuel Andualem., 2017, EC GYNAECOL, V6.2, P36; Schaapveld A, 2018, REPROD HEALTH, V2; Sheet F, 2018, CONTRACEPTIVE USE E, P1; TB Kassa GDZB., 2015, N W ETHIOP, V2, P507; Tekelab T, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0208-z; Tessema ZT, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247992; Tsegaye AT, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0649-6; World Health Organization, 2014, AD PREGN FACT SHEET; Zegeye B, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10252-7	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262431	10.1371/journal.pone.0262431	http://dx.doi.org/10.1371/journal.pone.0262431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030213	gold, Green Published			2022-12-26	WOS:000812798500045
J	Zhang, XH; Lauber, L; Liu, HJ; Shi, JQ; Xie, ML; Pan, YR				Zhang, Xinhuan; Lauber, Les; Liu, Hongjie; Shi, Junqing; Xie, Meili; Pan, Yuran			Travel time prediction of urban public transportation based on detection of single routes	PLOS ONE			English	Article								Improving travel time prediction for public transit effectively enhances service reliability, optimizes travel structure, and alleviates traffic problems. Its greater time-variance and uncertainty make predictions for short travel times (<= 35min) more subject to be influenced by random factors. It requires higher precision and is more complicated than long-term predictions. Effectively extracting and mining real-time, accurate, reliable, and low-cost multi-source data such as GPS, AFC, and IC can provide data support for travel time prediction. Kalman filter model has high accuracy in one-step prediction and can be used to calculate a large amount of data. This paper adopts the Kalman filter as a travel time prediction model for a single bus based on single-line detection: including the travel time prediction model of route (RTM) and the stop dwell time prediction model (DTM); the evaluation criteria and indexes of the models are given. The error analysis of the prediction results is carried out based on AVL data by case study. Results show that under the precondition of multi-source data, the public transportation prediction model can meet the accuracy requirement for travel time prediction and the prediction effect of the whole route is superior to that of the route segment between stops.	[Zhang, Xinhuan; Shi, Junqing; Xie, Meili; Pan, Yuran] Zhejiang Normal Univ, Inst Rd & Traff Engn, Jinhua, Zhejiang, Peoples R China; [Lauber, Les] Kansas Publ Employee Retirement Syst, Topeka, KS USA; [Liu, Hongjie] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Shanxi, Peoples R China	Zhejiang Normal University; Xi'an Jiaotong University	Zhang, XH (corresponding author), Zhejiang Normal Univ, Inst Rd & Traff Engn, Jinhua, Zhejiang, Peoples R China.; Liu, HJ (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Shanxi, Peoples R China.	zxh@zjnu.cn; hj.popel@stu.xjtu.edu	zhang, xinhuan/AHE-1003-2022	zhang, xinhuan/0000-0002-2156-7538	Zhejiang Provincial Natural Science Foundation of China [LY18G010009]; Zhejiang Provincial Educational Committee [Y201738488]; Scientific Research Foundation for the Returned Scholars, Ministry of Education of China [ZC304012027]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Educational Committee; Scientific Research Foundation for the Returned Scholars, Ministry of Education of China	This research was supported by Zhejiang Provincial Natural Science Foundation of China (General program) (Grant NO. LY18G010009),Zhejiang Provincial Educational Committee(Grant NO.Y201738488), the Scientific Research Foundation for the Returned Scholars, Ministry of Education of China(Grant NO.ZC304012027).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao J, 2018, PHYSICA A, V500, P222, DOI 10.1016/j.physa.2018.02.066; Chen CH, 2018, IEEE INTERNET THINGS, V5, P4231, DOI 10.1109/JIOT.2018.2863555; Chen EH, 2020, IEEE T INTELL TRANSP, V21, P1109, DOI 10.1109/TITS.2019.2902405; Chen Q, 2021, TRANSPORTMETRICA B, V9, P746, DOI 10.1080/21680566.2021.1950071; Cristina H., 2017, 2017 IEEE INT C SMAR, DOI [10.1109/SMARTCOMP.2017.7947031, DOI 10.1109/SMARTCOMP.2017.7947031]; Dhivyabharathi B, 2018, TRANSP LETT, V10, P75, DOI 10.1080/19427867.2016.1192016; Dhivyabharathi B, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION ENGINEERING (ICITE), P18, DOI 10.1109/ICITE.2016.7581300; Du MX, 2021, PHYSICA A, V578, DOI 10.1016/j.physa.2021.126108; Farooq MU, 2017, INT CONF FRONT INFO, P76, DOI 10.1109/FIT.2017.00021; Huang Z, 2019, IEEE ACCESS, V7, P106453, DOI 10.1109/ACCESS.2019.2932801; Huo JB, 2022, IEEE T INTELL TRANSP, V23, P10827, DOI 10.1109/TITS.2021.3096274; Jian Zhang, 2017, 2017 IEEE 2nd International Conference on Big Data Analysis (ICBDA), P296, DOI 10.1109/ICBDA.2017.8078828; Kumar BA, 2019, TRANSP LETT, V11, P362, DOI 10.1080/19427867.2017.1366120; Li JL, 2017, CHINA COMMUN, V14, P38, DOI 10.1109/CC.2017.7942193; Liu WP, 2016, INT CON DISTR COMP S, P529, DOI 10.1109/ICDCS.2016.31; Liu Y, 2021, TRANSPORT RES C-EMER, V126, DOI 10.1016/j.trc.2021.103070; Liu Y, 2021, IEEE T INTELL TRANSP, V22, P2349, DOI 10.1109/TITS.2020.3004254; Lu LL, 2021, IEEE INTEL TRANSP SY, DOI 10.1109/MITS.2021.3068416; Lu LL, 2021, J INTELL TRANSPORT S, V25, P501, DOI 10.1080/15472450.2020.1854093; Lu LL, 2018, IET INTELL TRANSP SY, V12, P2, DOI 10.1049/iet-its.2016.0356; Ma JM, 2019, TRANSPORT RES C-EMER, V105, P536, DOI 10.1016/j.trc.2019.06.008; Moridpour S, 2015, 3RD INTERNATIONAL CONFERENCE ON TRANSPORTATION INFORMATION AND SAFETY (ICTIS 2015), P264, DOI 10.1109/ICTIS.2015.7232119; Pang JB, 2019, IEEE T INTELL TRANSP, V20, P3283, DOI 10.1109/TITS.2018.2873747; Peng Z, 2018, NEURAL NETW WORLD, V28, P87, DOI 10.14311/NNW.2018.28.005; Petersen NC, 2019, EXPERT SYST APPL, V120, P426, DOI 10.1016/j.eswa.2018.11.028; Polson NG, 2017, TRANSPORT RES C-EMER, V79, P1, DOI 10.1016/j.trc.2017.02.024; Treethidtaphat W, 2017, IEEE INT C INTELL TR; Wu YK, 2018, TRANSPORT RES C-EMER, V90, P166, DOI 10.1016/j.trc.2018.03.001; Yang HF, 2017, IEEE T NEUR NET LEAR, V28, P2371, DOI 10.1109/TNNLS.2016.2574840; Yang M, 2016, NEURAL NETW WORLD, V26, P205, DOI 10.14311/NNW.2016.26.011; Yao BZ, 2017, COMPUT-AIDED CIV INF, V32, P154, DOI 10.1111/mice.12221; Zhang B, 2020, J TRANSP GEOGR, V82, DOI 10.1016/j.jtrangeo.2019.102568; Zhang HL, 2022, IEEE T INTELL TRANSP, V23, P2010, DOI 10.1109/TITS.2020.3030259; Zhang KP, 2019, TRANSPORT RES C-EMER, V108, P223, DOI 10.1016/j.trc.2019.09.019; Zhang KP, 2020, IEEE T INTELL TRANSP, V21, P1480, DOI 10.1109/TITS.2019.2909571; Zhang KP, 2020, NEUROCOMPUTING, V396, P438, DOI 10.1016/j.neucom.2018.10.097; Zheng L, 2018, IET INTELL TRANSP SY, V12, P474, DOI 10.1049/iet-its.2017.0059	37	0	0	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262535	10.1371/journal.pone.0262535	http://dx.doi.org/10.1371/journal.pone.0262535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030209	gold, Green Published			2022-12-26	WOS:000812798500053
J	van Rongen, S; Handgraaf, M; Benoist, M; de Vet, E				van Rongen, Sofie; Handgraaf, Michel; Benoist, Maaike; de Vet, Emely			The effect of personal relative deprivation on food choice: An experimental approach	PLOS ONE			English	Article							SUBJECTIVE SOCIOECONOMIC-STATUS; SOCIAL-CLASS; REWARD SENSITIVITY; INCOME INEQUALITY; ENERGY-INTAKE; HEALTH; RISK; EXPERIENCE; INCREASES; CRAVINGS	Growing evidence suggests that relative disadvantage is more relevant than absolute socioeconomic factors in explaining disparities in healthfulness of diet. In a series of pre-registered experiments, we tested whether personal relative deprivation (PRD), i.e. the sense that one is unfairly deprived of a deserved outcome relative to others, results in choosing more palatable, rewarding foods. Study 1 (N = 102) demonstrated the feasibility and effectiveness of a game for inducing real-time experiences of PRD. Study 2 (N = 287) showed no main effect of PRD condition on hypothetical food choices, but an interaction between chronic PRD and condition revealed that those in the PRD condition chose more rewarding foods when feeling chronically deprived. In Study 3 (N = 260) the hypothesized main effect was found on real, non-hypothetical food choices: those in the PRD condition chose more rewarding foods, controlling for sensitivity to palatable food. Our results provide preliminary indications that the experience of being relatively deprived, rather than the objective amount or resources, may result in a higher preference for high-caloric and palatable foods. It may be suggested that efforts to reduce societal disparities in healthfulness of diet may need to focus on perceptions of injustice beyond objective inequalities.	[van Rongen, Sofie; de Vet, Emely] Wageningen Univ & Res, Consumpt & Hlth Lifestyles Grp, Wageningen, Gelderland, Netherlands; [Handgraaf, Michel] Wageningen Univ & Res, Urban Econ Grp, Wageningen, Gelderland, Netherlands; [Benoist, Maaike] Wageningen Univ & Res, Human Nutr & Hlth Grp, Wageningen, Gelderland, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	van Rongen, S (corresponding author), Wageningen Univ & Res, Consumpt & Hlth Lifestyles Grp, Wageningen, Gelderland, Netherlands.	sofie.vanrongen13@gmail.com		van Rongen, Sofie/0000-0003-3207-439X	talent scheme of the Netherlands Organization for Scientific Research (NWO) [452-14-014]	talent scheme of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	YES. The research was financially supported by a personal grant from the talent scheme of the Netherlands Organization for Scientific Research (NWO) awarded to prof. dr. EWML de Vet, grant number 452-14-014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; [Anonymous], 2005, QUALTRICS QUALTRICS; Appelhans BM, 2012, AM J PREV MED, V42, P398, DOI 10.1016/j.amepre.2011.12.007; Appelhans BM, 2011, OBESITY, V19, P2175, DOI 10.1038/oby.2011.57; Bengers P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01932; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Beshai S, 2017, SOC SCI MED, V173, P18, DOI 10.1016/j.socscimed.2016.11.021; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Blechert J, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00307; Blechert J, 2016, APPETITE, V99, P254, DOI 10.1016/j.appet.2016.01.006; Boswell RG, 2016, OBES REV, V17, P159, DOI 10.1111/obr.12354; Bratanova B, 2016, APPETITE, V100, P162, DOI 10.1016/j.appet.2016.01.028; Briers B, 2006, PSYCHOL SCI, V17, P939, DOI 10.1111/j.1467-9280.2006.01808.x; Briers B, 2013, J MARKETING RES, V50, P767, DOI 10.1509/jmr.10.0513; Caldwell AE, 2019, APPETITE, V132, P238, DOI 10.1016/j.appet.2018.07.028; Callan MJ, 2008, PERS SOC PSYCHOL B, V34, P1514, DOI 10.1177/0146167208322956; Callan MJ, 2006, PERS SOC PSYCHOL B, V32, P1646, DOI 10.1177/0146167206292236; Callan MJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01415; Callan MJ, 2011, J PERS SOC PSYCHOL, V101, P955, DOI 10.1037/a0024778; Cardel MI, 2016, PHYSIOL BEHAV, V162, P93, DOI 10.1016/j.physbeh.2016.04.024; Cheon BK, 2018, FOOD QUAL PREFER, V68, P258, DOI 10.1016/j.foodqual.2018.03.010; Cheon BK, 2017, P NATL ACAD SCI USA, V114, P72, DOI 10.1073/pnas.1607330114; Claassen MA, 2019, SOCIAL PSYCHOLOGY OF INEQUALITY, P155, DOI 10.1007/978-3-030-28856-3_10; Clary C, 2017, HEALTH PLACE, V44, P1, DOI 10.1016/j.healthplace.2016.12.005; Daly M, 2015, HEALTH PSYCHOL, V34, P222, DOI 10.1037/hea0000098; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Davillas A, 2016, SOC SCI MED, V166, P223, DOI 10.1016/j.socscimed.2016.08.032; Davis Caroline, 2006, Eat Behav, V7, P266, DOI 10.1016/j.eatbeh.2005.09.006; Davis C, 2007, APPETITE, V48, P12, DOI 10.1016/j.appet.2006.05.016; de Graaf C, 2005, APPETITE, V44, P23, DOI 10.1016/j.appet.2004.08.008; Drewnowski A., 2009, FAT DETECTION TASTE, V23, P265; Dubois D, 2015, J PERS SOC PSYCHOL, V108, P436, DOI 10.1037/pspi0000008; Elgar FJ, 2016, SOC SCI MED, V152, P111, DOI 10.1016/j.socscimed.2016.01.039; Epstein LH, 2006, APPETITE, V46, P22, DOI 10.1016/j.appet.2005.04.006; Gardner MP, 2014, J CONSUM PSYCHOL, V24, P320, DOI 10.1016/j.jcps.2014.01.002; Herman C.P., 2004, HDB SELF REGULATION, P492, DOI DOI 10.1016/J.JESP.2006.05.004; Herman CP., 1980, RESTRAINED EATING; Hill SE, 2016, PSYCHOL SCI, V27, P354, DOI 10.1177/0956797615621901; Hilmers A, 2012, AM J PUBLIC HEALTH, V102, P1644, DOI 10.2105/AJPH.2012.300865; Hough G, 2015, FOOD QUAL PREFER, V40, P334, DOI 10.1016/j.foodqual.2014.05.003; Inglis V, 2009, APPETITE, V52, P273, DOI 10.1016/j.appet.2008.10.005; Jansen A, 2016, PHYSIOL BEHAV, V162, P174, DOI 10.1016/j.physbeh.2016.03.018; Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018; Kim H, 2018, J APPL SOC PSYCHOL, V48, P519, DOI 10.1111/jasp.12531; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Kringelbach ML, 2012, PHYSIOL BEHAV, V106, P307, DOI 10.1016/j.physbeh.2012.03.023; Kruger J, 2004, AM J PREV MED, V26, P402, DOI 10.1016/j.ampere.2004.02.001; Kulendran M, 2014, INT J OBESITY, V38, P507, DOI 10.1038/ijo.2013.198; Kulendran M, 2013, LANCET, V382, P55; Laran J, 2013, PSYCHOL SCI, V24, P167, DOI 10.1177/0956797612450033; Lerner M. J., 2002, JUSTICE MOTIVE EVERY, P10; LERNER MJ, 1977, J PERS, V45, P3; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Mellis AM, 2018, APPETITE, V129, P155, DOI 10.1016/j.appet.2018.06.032; Mercer ME, 1997, APPETITE, V29, P325, DOI 10.1006/appe.1997.0100; Mishra S, 2016, PERS INDIV DIFFER, V90, P22, DOI 10.1016/j.paid.2015.10.031; Mishra S, 2015, SOC SCI MED, V147, P144, DOI 10.1016/j.socscimed.2015.10.030; Mustonen S, 2007, APPETITE, V49, P159, DOI 10.1016/j.appet.2007.01.005; Olson James M., 1986, RELATIVE DEPRIVATION; Parra-Frutos I, 2014, BRIT J MATH STAT PSY, V67, P117, DOI 10.1111/bmsp.12011; Pavela G, 2017, CLIN OBES, V7, P316, DOI 10.1111/cob.12198; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Pickett KE, 2005, J EPIDEMIOL COMMUN H, V59, P670, DOI 10.1136/jech.2004.028795; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Recio-Roman A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030639; Rollins BY, 2010, APPETITE, V55, P420, DOI 10.1016/j.appet.2010.07.014; Salmon SJ, 2014, HEALTH PSYCHOL, V33, P103, DOI 10.1037/a0031785; Sim AY, 2018, APPETITE, V121, P268, DOI 10.1016/j.appet.2017.11.100; Smith HJ, 2012, PERS SOC PSYCHOL REV, V16, P203, DOI 10.1177/1088868311430825; Su DJ, 2012, J BIOSOC SCI, V44, P417, DOI 10.1017/S002193201100071X; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Vlismas Konstantinos, 2009, Central European Journal of Public Health, V17, P55; Wilkinson RG, 2009, ANNU REV SOCIOL, V35, P493, DOI 10.1146/annurev-soc-070308-115926	77	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261317	10.1371/journal.pone.0261317	http://dx.doi.org/10.1371/journal.pone.0261317			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025897	gold, Green Published			2022-12-26	WOS:000796264200015
J	Hibiya, K; Iwata, H; Kinjo, T; Shinzato, A; Tateyama, M; Ueda, S; Fujita, J				Hibiya, Kenji; Iwata, Hiroyoshi; Kinjo, Takeshi; Shinzato, Akira; Tateyama, Masao; Ueda, Shinichiro; Fujita, Jiro			Incidence of common infectious diseases in Japan during the COVID-19 pandemic	PLOS ONE			English	Article							HEPATITIS-E VIRUS; TRANSMISSION; TUBERCULOSIS; INFLUENZA	Recent reports indicate that respiratory infectious diseases were suppressed during the novel coronavirus disease-2019 (COVID-19) pandemic. COVID-19 led to behavioral changes aimed to control droplet transmission or contact transmission. In this study, we examined the incidence of common infectious diseases in Japan during the COVID-19 pandemic. COVID-19 data were extracted from the national data based on the National Epidemiological Surveillance of Infectious Diseases (NESID). Common infectious diseases were selected from notifiable infectious diseases under the NESID. The epidemic activity of the diseases during 2015-2020 was evaluated based on the Infectious Disease Weekly Reports published by the National Institute of Infectious Diseases. Each disease was then categorized according to the route of transmission. Many Japanese people had adopted hygienic activities, such as wearing masks and hand washing, even before the COVID-19 pandemic. We examined the correlation between the time-series of disease counts of common infectious diseases and COVID-19 over time using cross-correlation analysis. The weekly number of cases of measles, rotavirus, and several infections transmitted by droplet spread, was negatively correlated with the weekly number of cases of COVID-19 for up to 20 weeks in the past. According to the difference-in-differences analysis, the activity of influenza and rubella was significantly lower starting from the second week in 2020 than that in 2015-2019. Only legionellosis was more frequent throughout the year than in 2015-2019. Lower activity was also observed in some contact transmitted, airborne-transmitted, and fecal-oral transmitted diseases. However, carbapenem-resistant Enterobacteriaceae, exanthema subitum, showed the same trend as that over the previous 5 years. In conclusion, our study shows that public health interventions for the COVID-19 pandemic may have effectively prevented the transmission of most droplet-transmitted diseases and those transmitted through other routes.	[Hibiya, Kenji; Kinjo, Takeshi; Shinzato, Akira; Tateyama, Masao; Fujita, Jiro] Univ Ryukyus, Grad Sch Med, Dept Infect Resp & Digest Med, Nishihara Cho, Nishihara, Okinawa, Japan; [Hibiya, Kenji] Univ Ryukyus Hosp, Dept Diagnost Pathol, Nishihara, Okinawa, Japan; [Iwata, Hiroyoshi; Ueda, Shinichiro] Univ Ryukyus, Clin Pharmacol & Therapeut, Sch Med, Nishihara, Okinawa, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus	Hibiya, K (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Infect Resp & Digest Med, Nishihara Cho, Nishihara, Okinawa, Japan.; Hibiya, K (corresponding author), Univ Ryukyus Hosp, Dept Diagnost Pathol, Nishihara, Okinawa, Japan.	h2139517@med.u-ryukyu.ac.jp						AIDS Trends Committee, US; [Anonymous], 2015, THE JAPAN TIMES; [Anonymous], 2020, BBC NEWS 0227; [Anonymous], 2020, SPEECH STAT PRIM MIN; [Anonymous], 2020, THE JAPAN TIMES; [Anonymous], 2020, IASR, V41, P211; [Anonymous], 2019, IASR, V40, P127; [Anonymous], 2017, IASR, V38, P191; [Anonymous], 2015, IASR, V36, P147; [Anonymous], 2019, ANN SURVEILLANCE; [Anonymous], 2020, DECL STAT EM RESP NO; Apple Maps, COVID 19 MOB TRENDS; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Bennett JE., 2015, PRINCIPLES PRACTICE, V2; Bumpas B., 2020, COVID 19 IMPACTS FOO; CDC, 2021, NAT NOT DIS SURV SYS; Chia CC, 2021, SEX TRANSM INFECT, V97, P319, DOI 10.1136/sextrans-2020-054802; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Buckley RD, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa134; Dormitzer PR., 2015, PRINCIPLES PRACTICE, V2, P1854; Fear of catching, YOUGOV COVID 19 TRAC; Fujita J, 2021, RESPIR INVESTIG, V59, P5, DOI 10.1016/j.resinv.2020.11.002; Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117; Geme IIIJW, 2019, NELSON TXB PEDIAT, V19st, P914; Goodman Brenda, 2022, SOCIUS, DOI DOI 10.1177/2378023120948715; Harley D, 2001, Commun Dis Intell, V25, P9; Hepatitis E., 2014, IASR, V35, P1; Infectious Disease Surveillance Center, WEEKL REP; International Labour Organization [ILO], 2020, EMPL GUID WORK HOM R; Japan Student Services Organization (JASSO), 2021, RESULT ANN SURVEY IN; Komiya K, 2020, J INFECTION, V81, pE24, DOI 10.1016/j.jinf.2020.07.004; Lai CC, 2020, J INFECTION, V81, pE159, DOI 10.1016/j.jinf.2020.06.014; Latini A, 2021, SEX TRANSM INFECT, V97, P78, DOI 10.1136/sextrans-2020-054543; Li D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4232-8; Li H, 2020, J CELL MOL MED, V24, P6558, DOI 10.1111/jcmm.15364; Lin CF, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.604089; LocationMind xPop, DECR RAT VIS EACH PR; Maqbool A., 2011, NELSON TXB PEDIAT; Ministry of Health Labour and Welfare, LIST TUB OUTBR CAS; Ministry of Health Labour and Welfare Japan, NOV COR COVID 19; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Muto K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234292; National Institute of Infectious Disease, 2016, INFECT AGENTS SURVEI, V37, P185; National Institute of Infectious Disease, 2021, IASR, V42, P177; National Institute of Infectious Diseases, 2020, INFECT AGENTS SURVEI, V41, P53; National Institute of Infectious Diseases, 2016, IASR, V37, P239; Pennanen-Iire C, 2021, SEX MED REV, V9, P3, DOI 10.1016/j.sxmr.2020.10.004; Petri WA., 2015, PRINCIPLES PRACTICE, V2, P3047; Powell DA., 2019, NELSON TXB PEDIAT, V19st, P1029; Raoult D., 2015, PRINCIPLES PRACTICE, V2, P2225; Rodriguez Islay, 2021, Public Health Pract (Oxf), V2, P100072, DOI 10.1016/j.puhip.2020.100072; Sakamoto H, 2020, JAMA-J AM MED ASSOC, V323, P1969, DOI 10.1001/jama.2020.6173; Sekizuka T., MEDRXIV, DOI [10.1128/mSphere.00786-20, DOI 10.1128/MSPHERE.00786-20]; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Subires A, 2014, INT J FOOD MICROBIOL, V168, P47, DOI 10.1016/j.ijfoodmicro.2013.10.013; Sunagawa S, 2021, RESPIR INVESTIG, V59, P149, DOI 10.1016/j.resinv.2020.10.010; Surucuoglu S, 2018, MIKROBIYOL BUL, V52, P96, DOI 10.5578/mb.66237; Takahashi M, 2014, HEPATOL RES, V44, P43, DOI 10.1111/hepr.12175; Takahashi R., 2020, THE JAPAN TIMES; Tanaka S, 2019, HEPATOL RES, V49, P705, DOI 10.1111/hepr.13314; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; The Ministry of Health Labour and Welfare, MED EXP DAT; Tominaga A, 2012, HEPATOL RES, V42, P828, DOI 10.1111/j.1872-034X.2012.00988.x; True Data, REP PURCH BEH AN NOV; Tsukada R, 2019, JPN J INFECT DIS, V72, P44, DOI 10.7883/yoken.JJID.2018.279; Tuberculosis Surveillance Center, 2020, TUB JAP ANN REP 2020; Ujiie M, 2021, EMERG INFECT DIS, V27, P2969, DOI 10.3201/eid2711.211565; Walsh SR., 2015, PRINCIPLES PRACTICE, V2, P2131; West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9; WHO, 2020, MODES TRANSMISSION V; WHO, 2020, CRIT REL COVID 19 PA; William L., 2007, COLOR TXB PEDIAT DER, V4st ed, P113; Yasui S., 2021, 11 ADBI OECD ILO ROU	73	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261332	10.1371/journal.pone.0261332	http://dx.doi.org/10.1371/journal.pone.0261332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020724	Green Published, gold			2022-12-26	WOS:000834207700015
J	Liu, Y; Wang, LH; Yang, LB; Liu, XM				Liu, Yang; Wang, Li Hu; Yang, Li Bo; Liu, Xue Mei			Drought prediction based on an improved VMD-OS-QR-ELM model	PLOS ONE			English	Article							DECOMPOSITION; OPTIMIZATION; INDEX	To overcome the low accuracy, poor reliability, and delay in the current drought prediction models, we propose a new extreme learning machine (ELM) based on an improved variational mode decomposition (VMD). The model first redefines the output of the hidden layer of the ELM model with orthogonal triangular matrix decomposition (QR) to construct an orthogonal triangular ELM (QR-ELM), and then introduces an online sequence learning mechanism (OS) into the QR-ELM to construct an online sequence QR-ELM (OS-QR-ELM), which effectively improves the efficiency of the ELM model. The mutual information extension method was then used to extend both ends of the original signal to improve the VMD end effect. Finally, VMD and OS-QR-ELM were combined to construct a drought prediction method based on the VMD-OS-QR-ELM. The reliability and accuracy of the VMD-OS-QR-ELM model were improved by 86.19% and 93.20%, respectively, compared with those of the support vector regression model combined with empirical mode decomposition. Furthermore, the calculation efficiency of the OS-QR-ELM model was increased by 88.65% and 85.32% compared with that of the ELM and QR-ELM models, respectively.	[Liu, Yang; Wang, Li Hu; Yang, Li Bo; Liu, Xue Mei] North China Univ Water Resources & Elect Power, Sch Informat Engn, Zhengzhou, Henan, Peoples R China	North China University of Water Resources & Electric Power	Liu, Y (corresponding author), North China Univ Water Resources & Elect Power, Sch Informat Engn, Zhengzhou, Henan, Peoples R China.	ly_research@126.com			National Key Research and Development Project under Grant Strategic Research Projects in Key Area 16; Water Conservancy Science and Technology Research Project in Henan Province Grant [GG202042]	National Key Research and Development Project under Grant Strategic Research Projects in Key Area 16; Water Conservancy Science and Technology Research Project in Henan Province Grant	This work was supported in part by the National Key Research and Development Project under Grant Strategic Research Projects in Key Area 16 and the Water Conservancy Science and Technology Research Project in Henan Province Grant GG202042.	Afzal M, 2020, APPL WATER SCI, V10, DOI 10.1007/s13201-020-01293-1; Aghelpour P, 2021, STOCH ENV RES RISK A, V35, P2459, DOI 10.1007/s00477-021-02011-2; Aghelpour P, 2021, J HYDROL ENG, V26, DOI 10.1061/(ASCE)HE.1943-5584.0002059; Bai YL, 2021, APPL ENERG, V301, DOI 10.1016/j.apenergy.2021.117461; Basakin EE, 2021, MODEL EARTH SYST ENV, V7, P2363, DOI 10.1007/s40808-020-01010-6; Chen HL, 2020, APPL SOFT COMPUT, V86, DOI 10.1016/j.asoc.2019.105884; Cheng YJ, 2020, MULTIMED TOOLS APPL, V79, P30235, DOI 10.1007/s11042-020-09382-8; Dehghan S, 2020, J ARID LAND, V12, P318, DOI 10.1007/s40333-020-0095-5; Jimenez-Donaire MD, 2020, NAT HAZARD EARTH SYS, V20, P21, DOI [10.5194/nhess-20-21-2020,2020, 10.5194/nhess-20-21-2020]; Diao X, 2020, MECH SYST SIGNAL PR, V143, DOI 10.1016/j.ymssp.2020.106787; Feng SW, 2020, VIBROENGINEERING PRO, V35, P76, DOI [10.21595/vp.2020.21778, DOI 10.21595/VP.2020.21778]; Fung KF, 2020, J WATER CLIM CHANGE, V11, P1383, DOI 10.2166/wcc.2019.295; Hu HL, 2021, RENEW ENERG, V164, P729, DOI 10.1016/j.renene.2020.09.109; Kaur A, 2020, ECOL INFORM, V57, DOI 10.1016/j.ecoinf.2020.101067; Kaur A, 2020, J EXP THEOR ARTIF IN, V32, P273, DOI 10.1080/0952813X.2019.1647563; Khan MMH, 2020, J HYDROL, V590, DOI 10.1016/j.jhydrol.2020.125380; Khaymovich IM, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.070601; Li FH, 2019, MECH SYST SIGNAL PR, V116, P462, DOI 10.1016/j.ymssp.2018.06.055; Li GH, 2018, INFORMATION, V9, DOI 10.3390/info9070177; Li J, 2021, WATER RESOUR RES, V57, DOI 10.1029/2020WR029413; Liu C, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051523; Liu XY, 2020, KNOWL-BASED SYST, V195, DOI 10.1016/j.knosys.2020.105653; Liu YY, 2016, SIGNAL PROCESS, V125, P349, DOI 10.1016/j.sigpro.2016.02.011; Lv L, 2020, KNOWL-BASED SYST, V195, DOI 10.1016/j.knosys.2020.105648; Malik A, 2021, METEOROL ATMOS PHYS, V133, P891, DOI 10.1007/s00703-021-00787-0; Malik A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233280; Mohamadi S, 2020, NAT HAZARDS, V104, P537, DOI 10.1007/s11069-020-04180-9; Mouatadid S, 2018, ATMOS RES, V212, P130, DOI 10.1016/j.atmosres.2018.05.012; Rao WJ, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.054202; Roushangar K, 2021, HYDROL RES, V52, P1469, DOI 10.2166/nh.2021.028; Shamshirband S, 2020, ENG APPL COMP FLUID, V14, P339, DOI 10.1080/19942060.2020.1715844; Singh TP, 2021, MODEL EARTH SYST ENV, V7, P2005, DOI 10.1007/s40808-020-00947-y; Song XW, 2021, MEAS SCI TECHNOL, V32, DOI 10.1088/1361-6501/abcdc1; Tian ZD, 2020, WIND ENERGY, V23, P177, DOI 10.1002/we.2422; Wu CL, 2013, ENG APPL ARTIF INTEL, V26, P997, DOI 10.1016/j.engappai.2012.05.023; Xie T, 2019, J HYDROL, V577, DOI 10.1016/j.jhydrol.2019.123915; Xu WX, 2021, DIGIT SIGNAL PROCESS, V110, DOI 10.1016/j.dsp.2020.102936; Zhang X, 2018, MECH SYST SIGNAL PR, V108, P58, DOI 10.1016/j.ymssp.2017.11.029; Zhang YG, 2020, RENEW ENERG, V156, P1373, DOI 10.1016/j.renene.2019.12.047; Zhou Y, 2020, ENERGY, V204, DOI 10.1016/j.energy.2020.117894; Zhu Q, 2021, NAT HAZARDS, V105, P2161, DOI 10.1007/s11069-020-04394-x	41	0	0	9	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262329	10.1371/journal.pone.0262329	http://dx.doi.org/10.1371/journal.pone.0262329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990468	Green Published, gold			2022-12-26	WOS:000815783800025
J	Park, SY; Ha, HI; Lee, SM; Lee, IJ; Lim, HK				Park, Sun-Young; Ha, Hong Il; Lee, Sang Min; Lee, In Jae; Lim, Hyun Kyung			Comparison of diagnostic accuracy of 2D and 3D measurements to determine opportunistic screening of osteoporosis using the proximal femur on abdomen-pelvic CT	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ROUTINE ABDOMINAL CT; X-RAY ABSORPTIOMETRY; COMPUTED-TOMOGRAPHY; FRACTURE RISK; FEMORAL-NECK; DXA; HIP; CONTRAST; SEGMENTATION	Objectives To compare the osteoporosis-predicting ability of computed tomography (CT) indexes in abdomen-pelvic CT using the proximal femur and the reliability of measurements in two- and three-dimensional analyses. Methods Four hundred thirty female patients (age range, 50-96 years) who underwent dual-energy X-ray absorptiometry and abdominal-pelvic CT within 1 month were retrospectively selected. The volumes of interest (VOIs) from the femoral head to the lesser trochanter and the femoral neck were expressed as 3D(Femur). Round regions of interest (ROIs) of image plane drawn over the femoral neck touching the outer cortex were determined as 2D(coronal). In HU histogram analysis (HUHA), the percentages of HU histogram ranges related to the ROI or VOI were classified as HUHA(Fat) (<0 HU) and HUHA(Bone) (126 HU <=). Diagnostic performance, correlation analysis and measurement reliability were analyzed by receiver operating characteristic curves, correlation coefficient and interobserver correlation coefficient (ICC), respectively. Results AUCs of each HUHA and mean-HU measurement on 2D-ROI and 3D-VOI were 0.94 or higher (P < 0.001). Both 3D(Femur)-Mean-HU and 3D(Femur)-HUHA(Bone) showed the highest AUC (0.96). The cut-off value of 3D(Femur)-Mean-HU was 231HU or less, (sensitivity: 94.8%; specificity: 85.0%; correlation coefficient: -0.65; P<0.001) for diagnosis of osteoporosis. There was no superiority between AUCs in 2D-ROI and 3D-VOI measurements (P>0.05). Reliability of the 3D-VOI measurement showed perfect agreement (ICC >= 0.94), and 2D-ROI showed moderate to good agreement (ICC range: 0.63 similar to 0.84). Conclusions CT indexes on 3D-VOI for predicting femoral osteoporosis showed similar diagnostic accuracy with better reproducibility of measurement, compared with 2D-ROI.	[Park, Sun-Young; Ha, Hong Il; Lee, Sang Min; Lee, In Jae] Hallym Univ, Sacred Heart Hosp, Dept Radiol, Anyang Si, Gyeonggi Do, South Korea; [Lim, Hyun Kyung] Soonchunhyang Univ, Seoul Hosp, Dept Radiol, Seoul, South Korea	Hallym University; Soonchunhyang University	Ha, HI (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Radiol, Anyang Si, Gyeonggi Do, South Korea.	ha.hongil@gmail.com	Park, Sun/GSD-9620-2022	Park, Sun-Young/0000-0001-6500-3411				Alacreu E, 2017, OSTEOPOROSIS INT, V28, P983, DOI 10.1007/s00198-016-3804-3; Alberg AJ, 2004, J GEN INTERN MED, V19, P460, DOI 10.1111/j.1525-1497.2004.30091.x; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Amarnath ALD, 2015, J GEN INTERN MED, V30, P1733, DOI 10.1007/s11606-015-3349-8; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Buckens CF, 2015, EUR RADIOL, V25, P2074, DOI 10.1007/s00330-014-3584-0; Curtis JR, 2008, J BONE MINER RES, V23, P1061, DOI [10.1359/jbmr.080232, 10.1359/JBMR.080232]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dimai HP, 2017, BONE, V104, P39, DOI 10.1016/j.bone.2016.12.016; Fujii M, 2016, RADIOLOGY, V281, P933, DOI 10.1148/radiol.2016151657; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Jacobson JA, 2000, AM J ROENTGENOL, V174, P1699, DOI 10.2214/ajr.174.6.1741699; Jang S, 2019, RADIOLOGY, V291, P359, DOI 10.1148/radiol.2019181648; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; KOHRT WM, 1995, J BONE MINER RES, V10, P1303, DOI 10.1002/jbmr.5650100906; Lee SJ, 2016, OSTEOPOROSIS INT, V27, P1131, DOI 10.1007/s00198-015-3318-4; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Lim HK, 2019, EUR RADIOL, V29, P1831, DOI 10.1007/s00330-018-5728-0; Lindner C, 2013, IEEE T MED IMAGING, V32, P1462, DOI 10.1109/TMI.2013.2258030; Liu G, 1997, OSTEOPOROSIS INT, V7, P564, DOI 10.1007/BF02652563; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Mounach A, 2009, SEMIN ARTHRITIS RHEU, V38, P467, DOI 10.1016/j.semarthrit.2008.04.001; Pickhardt PJ, 2016, OSTEOPOROSIS INT, V27, P147, DOI 10.1007/s00198-015-3224-9; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; Pompe E, 2015, EUR RADIOL, V25, P283, DOI 10.1007/s00330-014-3408-2; Poole KES, 2017, BONE, V94, P124, DOI 10.1016/j.bone.2016.10.020; Poole KES, 2010, J BONE MINER RES, V25, P482, DOI 10.1359/jbmr.090734; Preda L, 2007, EUR RADIOL, V17, P2096, DOI 10.1007/s00330-006-0573-y; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sharma N, 2010, J MED PHYS, V35, P3, DOI 10.4103/0971-6203.58777; SINGH M, 1970, J BONE JOINT SURG AM, VA 52, P457, DOI 10.2106/00004623-197052030-00005; Sozen T, 2017, EUR J RHEUMATOL, V4, P46, DOI 10.5152/eurjrheum.2016.048; Thomas CDL, 2009, J BONE MINER RES, V24, P1808, DOI [10.1359/jbmr.090504, 10.1359/JBMR.090504]; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Ziemlewicz TJ, 2016, AM J ROENTGENOL, V206, P694, DOI 10.2214/AJR.15.15128	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262025	10.1371/journal.pone.0262025	http://dx.doi.org/10.1371/journal.pone.0262025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982780	gold, Green Published			2022-12-26	WOS:000834805700014
J	Dziwenka, M; Dolan, L; Mitchell, J				Dziwenka, Margitta; Dolan, Laurie; Mitchell, Jason			Toxicological safety of VOHO Hemp Oil; a supercritical fluid extract from the aerial parts of hemp	PLOS ONE			English	Article								VOHO Hemp Oil (Verdant Nature LLC (in collaboration with HempFusion)) is an extract of the aerial parts of hemp (Cannabis sativa L) manufactured using a supercritical CO2 extraction process. The results of four safety studies are reported here including a bacterial reverse mutation assay, an in vivo mammalian micronucleus study, a maximum tolerated dose study in rats and a 90-day repeat dose subchronic toxicity study in rats. VOHO Hemp oil can contain up to 30% phytocannabinoids and less than 0.2% is tetrahydrocannabinol (THC). VOHO Hemp Oil was found to be non-mutagenic in the bacterial reverse mutation assay and was negative for inducing micronuclei in the rat bone marrow micronucleus assay. The maximum tolerated dose in male and female Wistar rats was 2250 mg/kg bw/day. A 90-day repeat dose study was conducted in male and female Wistar rats according to OECD Guideline 408 and included a 21-day recovery period. The doses used in the study were 0, 25, 90 and 324 mg/kg bw per day in the main study, and in the recovery phase a control and 324 mg/kg bw/day group were included. One mortality was reported during the study, a high dose female, and test substance-related adverse clinical signs were reported in the high dose group. Other test substance-related changes noted in the high dose group included changes in body weights, activated partial thromboplastin time (APTT) values, and in absolute and relative organ weights. Based on the results of the study, the no observed adverse effect level (NOAEL) for VOHO Hemp Oil was determined to be 90 mg/kg bw/day in both male and female Wistar rats.	[Dziwenka, Margitta; Dolan, Laurie] GRAS Associates LLC, North Bethesda, MD 20852 USA; [Mitchell, Jason] HempFusion, Denver, CO USA		Dziwenka, M (corresponding author), GRAS Associates LLC, North Bethesda, MD 20852 USA.	dziwenka@gras-associates.com		Dziwenka, Margitta/0000-0003-4392-3473	Verdant Nature LLC; GRAS Associates LLC; Hempfusion	Verdant Nature LLC; GRAS Associates LLC; Hempfusion	Commercial companies: Verdant Nature LLC (funded study; https://verdantoasis.com/) and GRAS Associates LLC (funded 2 authors -MD and LD; http://www.nutrasource.ca/about/nutrasourcecompanies/) and Hempfusion (funded 1 author JM; https://www.hempfusion.com/).All named companies played a role in the decision to publish and Hempfusion and GRAS Associates were involved in the preparation of the manuscript.	[Anonymous], 2018, TEST 408 REP DOS 90; [Anonymous], 2009, ICH GUID M3 R2 NONCL; [Anonymous], 2001, GUIDANCE DOCUMENT AC; Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; Bonini SA, 2018, J ETHNOPHARMACOL, V227, P300, DOI 10.1016/j.jep.2018.09.004; Brenneisen Rudolf, 2007, P17, DOI 10.1007/978-1-59259-947-9_2; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Council NR, 2011, GUIDE CARE USE LAB A, VEighth; Dziwenka M, 2020, TOXICOL REP, V7, P376, DOI 10.1016/j.toxrep.2020.02.014; EU, 2008, COUNC REG EC 440 200; FDA, 2007, REDB 2000 GUID IND T; FDA, 2018, AGN RESP LETT GRAS N; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Lewis RW, 2002, TOXICOL PATHOL, V30, P66, DOI 10.1080/01926230252824725; Lopez HL, 2020, J DIET SUPPL, V17, P561, DOI 10.1080/19390211.2020.1765941; Marx TK, 2018, J TOXICOL-US, V2018, DOI 10.1155/2018/8143582; OECD, 2016, TEST 474 MAMM ER MIC; OECD, 2020, TEST 471 BACT REV MU; OECD, 1997, OECD SER PRINC GOOD; Redbook, 2000, GUID TOX STUD; WHO. WHO Expert Committee on Drug Dependence Pre-Review, 2018, EXTR TINCT CANN	21	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261900	10.1371/journal.pone.0261900	http://dx.doi.org/10.1371/journal.pone.0261900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972167	gold, Green Published			2022-12-26	WOS:000773555700067
J	de Goede, P; Wust, RCI; Schomakers, BV; Denis, S; Vaz, FM; Pras-Raves, ML; Weeghel, M; Yi, CX; Kalsbeek, A; Houtkooper, RH				de Goede, Paul; Wust, Rob C., I; Schomakers, Bauke, V; Denis, Simone; Vaz, Frederic M.; Pras-Raves, Mia L.; Weeghel, Michel; Yi, Chun-Xia; Kalsbeek, Andries; Houtkooper, Riekelt H.			Time-restricted feeding during the inactive phase abolishes the daily rhythm in mitochondrial respiration in rat skeletal muscle	FASEB JOURNAL			English	Article						lipidomics; metabolomics; mitochondrial respiration; soleus muscle; time-restricted feeding	OXIDATIVE CAPACITY; CIRCADIAN-RHYTHMS; GENE-EXPRESSION; CLOCK-GENES; SHIFT WORK; DYSFUNCTION; METABOLISM; DYNAMICS	Shift-workers show an increased incidence of type 2 diabetes mellitus (T2DM). A possible mechanism is the disruption of the circadian timing of glucose homeostasis. Skeletal muscle mitochondrial function is modulated by the molecular clock. We used time-restricted feeding (TRF) during the inactive phase to investigate how mistimed feeding affects muscle mitochondrial metabolism. Rats on an ad libitum (AL) diet were compared to those that could eat only during the light (inactive) or dark (active) phase. Mitochondrial respiration, metabolic gene expressions, and metabolite concentrations were determined in the soleus muscle. Rats on AL feeding or dark-fed TRF showed a clear daily rhythm in muscle mitochondrial respiration. This rhythm in mitochondrial oxidative phosphorylation capacity was abolished in light-fed TRF animals and overall 24h respiration was lower. The expression of several genes involved in mitochondrial biogenesis and the fission/fusion machinery was altered in light-fed animals. Metabolomics analysis indicated that light-fed animals had lost rhythmic levels of alpha-ketoglutarate and citric acid. Contrastingly, lipidomics showed that light-fed animals abundantly gained rhythmicity in levels of triglycerides. Furthermore, while the RER shifted entirely with the food intake in the light-fed animals, many measured metabolic parameters (e.g., activity and mitochondrial respiration) did not strictly align with the shifted timing of food intake, resulting in a mismatch between expected metabolic supply/demand (as dictated by the circadian timing system and light/dark-cycle) and the actual metabolic supply/demand (as dictated by the timing of food intake). These data suggest that shift-work impairs mitochondrial metabolism and causes metabolic inflexibility, which can predispose to T2DM.	[de Goede, Paul; Yi, Chun-Xia; Kalsbeek, Andries] Univ Amsterdam, Amsterdam Univ Med Ctr, Lab Endocrinol, Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam, Netherlands; [de Goede, Paul; Kalsbeek, Andries] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci NIN, Hypothalam Integrat Mech Grp, Amsterdam, Netherlands; [Wust, Rob C., I; Schomakers, Bauke, V; Denis, Simone; Vaz, Frederic M.; Pras-Raves, Mia L.; Weeghel, Michel; Houtkooper, Riekelt H.] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Cardiovasc Sci,Lab Genet Metab Dis, Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam, Netherlands; [Wust, Rob C., I] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Lab Myol, Amsterdam, Netherlands; [Schomakers, Bauke, V; Vaz, Frederic M.; Pras-Raves, Mia L.; Weeghel, Michel] Univ Amsterdam, Amsterdam Univ Med Ctr, Core Facil Metabol, Amsterdam, Netherlands; [Yi, Chun-Xia; Kalsbeek, Andries] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands	University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam	Houtkooper, RH (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Cardiovasc Sci,Lab Genet Metab Dis, Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam, Netherlands.	r.h.houtkooper@amsterdamumc.nl		Wust, Rob C.I./0000-0003-3781-5177; de Goede, Paul/0000-0003-4489-7422; Houtkooper, Riekelt/0000-0001-9961-0842; Kalsbeek, Andries/0000-0001-9606-8453	ZonMW TOP grant [91214047]	ZonMW TOP grant	P. de Goede was funded by a ZonMW TOP grant (#91214047).	Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Cela O, 2016, BBA-MOL CELL RES, V1863, P596, DOI 10.1016/j.bbamcr.2015.12.018; de Goede P, 2020, OBESITY, V28, pS68, DOI 10.1002/oby.22830; de Goede P, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00554; de Goede P, 2018, J MOL ENDOCRINOL, V60, pR115, DOI 10.1530/JME-17-0196; Deshmukh AS, 2016, HORM MOL BIOL CLIN I, V26, P13, DOI 10.1515/hmbci-2015-0041; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Fujimaki S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102147; Goede Paul de, 2018, Neurobiology of Sleep and Circadian Rhythms, V4, P24, DOI 10.1016/j.nbscr.2017.09.002; Gong CX, 2015, CHRONOBIOL INT, V32, P1254, DOI 10.3109/07420528.2015.1085388; Gordon JW, 2015, BIOCHEM CELL BIOL, V93, P452, DOI 10.1139/bcb-2015-0012; Grabner GF, 2020, J LIPID RES, V61, P995, DOI 10.1194/jlr.RA119000516; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Held NM, 2020, MOL METAB, V37, DOI 10.1016/j.molmet.2020.100989; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Heyde I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56323-z; Hodge BA, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0039-5; Honka MJ, 2018, EUR J ENDOCRINOL, V178, P523, DOI 10.1530/EJE-17-0882; Hoppeler H, 2002, J EXP BIOL, V205, P2143; Jacobi D, 2015, CELL METAB, V22, P709, DOI 10.1016/j.cmet.2015.08.006; Jordan SD, 2017, CELL METAB, V26, P243, DOI 10.1016/j.cmet.2017.06.002; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Knutsson A, 2014, CHRONOBIOL INT, V31, P1146, DOI 10.3109/07420528.2014.957308; Krishnaiah SY, 2017, CELL METAB, V25, P961, DOI 10.1016/j.cmet.2017.03.019; Kwak SH, 2010, J DIABETES INVEST, V1, P161, DOI 10.1111/j.2040-1124.2010.00047.x; Makrecka-Kuka M, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13430; Manella G, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00162; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Mehus AA, 2021, J NUTR BIOCHEM, V88, DOI 10.1016/j.jnutbio.2020.108531; Molenaars M, 2021, DIS MODEL MECH, V14, DOI 10.1242/dmm.047746; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Neufeld-Cohen A, 2016, P NATL ACAD SCI USA, V113, pE1673, DOI 10.1073/pnas.1519650113; Oliva-Ramirez J, 2014, IMMUNOLOGY, V143, P490, DOI 10.1111/imm.12329; Oosterman JE, 2020, OBESITY, V28, pS81, DOI 10.1002/oby.22832; Opperhuizen AL, 2016, EUR J NEUROSCI, V44, P2795, DOI 10.1111/ejn.13377; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Perrin L, 2018, ELIFE, V7, DOI 10.7554/eLife.34114; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Puig LS, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00452; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Scrima R, 2016, BBA-BIOENERGETICS, V1857, P1344, DOI 10.1016/j.bbabio.2016.03.035; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Simon N, 2003, CHRONOBIOL INT, V20, P451, DOI 10.1081/CBI-120021385; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211; van den Berg M, 2017, AM J RESP CRIT CARE, V196, P1544, DOI 10.1164/rccm.201703-0501OC; van Moorsel D, 2016, MOL METAB, V5, P635, DOI 10.1016/j.molmet.2016.06.012; Vetter C, 2018, DIABETES CARE, V41, P762, DOI 10.2337/dc17-1933; Wefers J, 2018, P NATL ACAD SCI USA, V115, P7789, DOI 10.1073/pnas.1722295115; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wust RCI, 2012, AM J PHYSIOL-HEART C, V302, pH402, DOI 10.1152/ajpheart.00653.2011; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	58	4	4	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22133	10.1096/fj.202100707R	http://dx.doi.org/10.1096/fj.202100707R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032416				2022-12-26	WOS:000747987800048
J	Lopez-Serrano, AL; Zamora-Cardenas, R; Arechiga-Figueroa, IA; Salazar-Fajardo, PD; Ferrer, T; Alamilla, J; Sanchez-Chapula, JA; Navarro-Polanco, RA; Moreno-Galindo, EG				Lopez-Serrano, Ana Laura; Zamora-Cardenas, Rodrigo; Arechiga-Figueroa, Ivan A.; Salazar-Fajardo, Pedro D.; Ferrer, Tania; Alamilla, Javier; Sanchez-Chapula, Jose A.; Navarro-Polanco, Ricardo A.; Moreno-Galindo, Eloy G.			Differential voltage-dependent modulation of the ACh-gated K+ current by adenosine and acetylcholine	PLOS ONE			English	Article							DOPAMINE D-2S RECEPTOR; MUSCARINIC RECEPTORS; DEACTIVATION KINETICS; INWARD RECTIFIER; POTASSIUM CURRENT; BINDING-SITE; RGS PROTEIN; SENSITIVITY; RELAXATION; ACTIVATION	Inhibitory regulation of the heart is determined by both cholinergic M-2 receptors (M2R) and adenosine A(1) receptors (A(1)R) that activate the same signaling pathway, the ACh-gated inward rectifier K+ (K-ACh) channels via G(i/o) proteins. Previously, we have shown that the agonist-specific voltage sensitivity of M2R underlies several voltage-dependent features of I-KACh, including the 'relaxation' property, which is characterized by a gradual increase or decrease of the current when cardiomyocytes are stepped to hyperpolarized or depolarized voltages, respectively. However, it is unknown whether membrane potential also affects A(1)R and how this could impact I-KACh. Upon recording whole-cell currents of guinea-pig cardiomyocytes, we found that stimulation of the A(1)R-G(i/o)-I-KACh pathway with adenosine only caused a very slight voltage dependence in concentration-response relationships (similar to 1.2-fold EC50 increase with depolarization) that was not manifested in the relative affinity, as estimated by the current deactivation kinetics (tau = 4074 +/- 214 ms at -100 mV and tau = 4331 +/- 341 ms at +30 mV; P = 0.31). Moreover, I-KACh did not exhibit relaxation. Contrarily, activation of the M2R-G(i/o)-I-KACh pathway with acetylcholine induced the typical relaxation of the current, which correlated with the clear voltage-dependent effect observed in the concentration-response curves (similar to 2.8-fold EC50 increase with depolarization) and in the I-KACh deactivation kinetics (tau = 1762 +/- 119 ms at -100 mV and tau = 1503 +/- 160 ms at +30 mV; P = 0.01). Our findings further substantiate the hypothesis of the agonist-specific voltage dependence of GPCRs and that the I-KACh relaxation is consequence of this property.	[Lopez-Serrano, Ana Laura; Zamora-Cardenas, Rodrigo; Salazar-Fajardo, Pedro D.; Ferrer, Tania; Sanchez-Chapula, Jose A.; Navarro-Polanco, Ricardo A.; Moreno-Galindo, Eloy G.] Univ Colima, Ctr Univ Invest Biomed, Colima, Col, Mexico; [Arechiga-Figueroa, Ivan A.] Univ Autonoma San Luis Potosi, Fac Med, CONACYT, San Luis Potosi, San Luis Potosi, Mexico; [Alamilla, Javier] Univ Colima, Ctr Univ Invest Biomed, CONACYT, Colima, Col, Mexico	Universidad de Colima; Universidad Autonoma de San Luis Potosi; Universidad de Colima	Moreno-Galindo, EG (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Colima, Col, Mexico.	eloy@ucol.mx		Moreno-Galindo, Eloy/0000-0001-7448-1239; ARECHIGA FIGUEROA, IVAN ARAEL/0000-0003-3124-7148	SEPCONACYT, Mexico [CB-2011-01-167109, CB-2013-01-220742]	SEPCONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by SEPCONACYT, Mexico. Grant No. CB-2011-01-167109 (to E.G.M-G.), and CB-2013-01-220742 (to R.A.NP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.581151; Barchad-Avitzur O, 2016, BIOPHYS J, V111, P1396, DOI 10.1016/j.bpj.2016.08.035; Beckmann C, 2008, CELL PHYSIOL BIOCHEM, V21, P259, DOI 10.1159/000129381; Ben Chaim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074354; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Ben-Chaim Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224367; Benavides-Haro DE, 2000, N-S ARCH PHARMACOL, V361, P311, DOI 10.1007/s002109900185; Benians A, 2003, P NATL ACAD SCI USA, V100, P6239, DOI 10.1073/pnas.1037595100; Brandts B, 2004, J PHARMACOL EXP THER, V308, P134, DOI 10.1124/jpet.103.057646; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Chen IS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05128-z; Chen IS, 2014, J PHYSIOL-LONDON, V592, P1237, DOI 10.1113/jphysiol.2013.269803; Corey S, 1998, J BIOL CHEM, V273, P5271, DOI 10.1074/jbc.273.9.5271; Dekel N, 2012, P NATL ACAD SCI USA, V109, P285, DOI 10.1073/pnas.1119424109; Dhein S, 2001, PHARMACOL RES, V44, P161, DOI 10.1006/phrs.2001.0835; Fujita S, 2000, J PHYSIOL-LONDON, V526, P341, DOI 10.1111/j.1469-7793.2000.00341.x; Ishii M, 2001, CIRC RES, V89, P1045, DOI 10.1161/hh2301.100815; Lopez-Serrano AL, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113961; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; Moreno-Galindo EG, 2016, MOL PHARMACOL, V90, P334, DOI 10.1124/mol.116.104950; Moreno-Galindo EG, 2016, PFLUG ARCH EUR J PHY, V468, P1207, DOI 10.1007/s00424-016-1812-y; Moreno-Galindo EG, 2011, J PHYSIOL-LONDON, V589, P1755, DOI 10.1113/jphysiol.2010.204115; Mustafa S Jamal, 2009, Handb Exp Pharmacol, P161, DOI 10.1007/978-3-540-89615-9_6; Navarro-Polanco RA, 2013, J PHYSIOL-LONDON, V591, P4273, DOI 10.1113/jphysiol.2013.255166; Navarro-Polanco RA, 2011, J PHYSIOL-LONDON, V589, P1741, DOI 10.1113/jphysiol.2010.204107; NOMA A, 1978, PFLUG ARCH EUR J PHY, V377, P193, DOI 10.1007/BF00584272; Ohana L, 2006, J BIOL CHEM, V281, P24204, DOI 10.1074/jbc.M513447200; Olcese R, 2011, J PHYSIOL-LONDON, V589, P1869, DOI 10.1113/jphysiol.2011.207951; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Rinne A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac7419; Rinne A, 2013, P NATL ACAD SCI USA, V110, P1536, DOI 10.1073/pnas.1212656110; Ruland JG, 2020, BRIT J PHARMACOL, V177, P3489, DOI 10.1111/bph.15070; Sahlholm K, 2008, BIOCHEM BIOPH RES CO, V374, P496, DOI 10.1016/j.bbrc.2008.07.052; Sahlholm K, 2012, BBA-BIOMEMBRANES, V1818, P3081, DOI 10.1016/j.bbamem.2012.07.027; Sahlholm K, 2011, BIOCHEM BIOPH RES CO, V415, P509, DOI 10.1016/j.bbrc.2011.10.106; Sahlholm K, 2011, NEUROPHARMACOLOGY, V61, P937, DOI 10.1016/j.neuropharm.2011.06.022; Sahlholm K, 2008, BIOCHEM BIOPH RES CO, V377, P1216, DOI 10.1016/j.bbrc.2008.10.117; Salazar-Fajardo PD, 2018, PFLUG ARCH EUR J PHY, V470, P1765, DOI 10.1007/s00424-018-2196-y; Wang XD, 2013, J CARDIOVASC PHARM, V62, P192, DOI 10.1097/FJC.0b013e3182965221	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261960	10.1371/journal.pone.0261960	http://dx.doi.org/10.1371/journal.pone.0261960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030226	gold, Green Published			2022-12-26	WOS:000812798500023
J	Brochot, E; Souplet, V; Follet, P; Ponthieu, P; Olivier, C; Even, G; Audebert, C; Malbec, R				Brochot, Etienne; Souplet, Vianney; Follet, Pauline; Ponthieu, Pauline; Olivier, Christophe; Even, Gael; Audebert, Christophe; Malbec, Remi			A multiplex serological assay for the characterization of IgG immune response to SARS-CoV-2	PLOS ONE			English	Article							CORONAVIRUS; KINETICS; TARGETS	In the fight against SARS-COV-2, the development of serological assays based on different antigenic domains represent a versatile tool to get a comprehensive picture of the immune response or differentiate infection from vaccination beyond simple diagnosis. Here we use a combination of the Nucleoprotein (NP), the Spike 1 (S1) and Spike 2 (S2) subunits, and the receptor binding domain (RBD) and N-terminal domain (NTD) of the Spike antigens from the CoViDiag((R)) multiplex IgG assay, to follow the immune response to SARS-CoV-2 infection over a long time period and depending on disease severity. Using a panel of 209 sera collected from 61 patients up to eight months after infection, we observed that most patients develop an immune response against multiple viral epitope, but anti-S2 antibodies seemed to last longer. For all the tested IgGs, we have found higher responses for hospitalized patients than for non-hospitalized ones. Moreover the combination of the five different IgG responses increased the correlation to the neutralizing antibody titers than if considered individually. Multiplex immunoassays have the potential to improve diagnostic performances, especially for ancient infection or mild form of the disease presenting weaker antibody responses. Also the combined detection of anti-NP and anti-Spike-derived domains can be useful to differentiate vaccination from viral infection and accurately assess the antibody potential to neutralize the virus.	[Brochot, Etienne] Amiens Univ, Dept Virol, Med Ctr, Amiens, France; [Brochot, Etienne] Jules Verne Univ Picardie, Agents Infect Resistance & Chimiothe, Amiens, France; [Souplet, Vianney; Follet, Pauline; Ponthieu, Pauline; Olivier, Christophe] Innobiochips, Loos, France; [Even, Gael; Audebert, Christophe; Malbec, Remi] GD Biotech, Douai, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Brochot, E (corresponding author), Amiens Univ, Dept Virol, Med Ctr, Amiens, France.; Brochot, E (corresponding author), Jules Verne Univ Picardie, Agents Infect Resistance & Chimiothe, Amiens, France.; Souplet, V (corresponding author), Innobiochips, Loos, France.	Brochot.Etienne@chu-amiens.fr; vianney.souplet@innobiochips.fr	BROCHOT, ETIENNE/I-5318-2012	BROCHOT, ETIENNE/0000-0002-8677-6349; AUDEBERT, Christophe/0000-0002-6509-7574	GD Biotech; Innobiochips	GD Biotech; Innobiochips	EB is employee of the Amiens University Hospital. RM, GE and CA are employees of GD Biotech, while PP, PF, VS and CO are employees of Innobiochips. GD Biotech and Innobiochips provided support in the form of salaries for authors RM, GE, CA, PP, PF, VS and CO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Innobiochips also provided the CoViDiag (R) assay kits for this study in the form research material.	Aubry A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10091815; Brochot E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.584251; Brochot E, 2020, J CLIN VIROL, V130, DOI 10.1016/j.jcv.2020.104569; Chaudhury S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252628; Coste AT, 2021, J CLIN VIROL, V134, DOI 10.1016/j.jcv.2020.104690; de Assis RR, 2021, NAT COMMUN, V12, DOI [10.1038/s41467-020-20095-2, 10.1101/2020.04.15.043364]; Gillot C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113752; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Grossberg AN, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21040-7; Komarov A, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010102; Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685; Lynch Kara L, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa979; Malbec R, 2020, J IMMUNOL METHODS, V483, DOI 10.1016/j.jim.2020.112808; Marien J, 2021, J VIROL METHODS, V288, DOI 10.1016/j.jviromet.2020.114025; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Sun B., 2020, NAT MED, V9, P940, DOI [DOI 10.1080/22221751.2020.1762515, 10.1080/22221751.2020.1762515, https://doi.org/10.1080/22221751.2020.1762515]; Tuaillon E, 2020, J INFECTION, V81, pE39, DOI 10.1016/j.jinf.2020.05.077; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262311	10.1371/journal.pone.0262311	http://dx.doi.org/10.1371/journal.pone.0262311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025936	Green Published, gold, Green Submitted			2022-12-26	WOS:000796264200058
J	de Oliveira, RAD; Silva, DRX; Silva, MGE				Dantas de Oliveira, Ricardo Antunes; Xavier Silva, Diego Ricardo; Goncalves e Silva, Mauricio			Geographical accessibility to the supply of antiophidic sera in Brazil: Timely access possibilities	PLOS ONE			English	Article							SUB-SAHARAN AFRICA	Snakebite accidents are considered category A neglected tropical diseases. Brazil stands out for snakebite accidents, mainly in the Amazon region. The best possible care after snakebite accidents is to obtain antiophidic sera on time. And the maximum ideal time to reach it is about 2 hours after an accident. Based on public health information and using a tool to analyze geographical accessibility, we evaluate the possibility of reaching Brazilian serum-providing health facilities from the relationship between population distribution and commuting time. In this exploratory descriptive study, the geographic accessibility of Brazilian population to health facilities that supply antiophidic serum is evaluated through a methodology that articulates several issues that influence the commuting time to health units (ACCESSMOD): population and facilities' distribution, transportation network and means, relief and land use, which were obtained in Brazilian and international sources. The relative importance of the population without the possibility of reaching a facility in two hours is highlighted for Macro-Regions, States and municipalities. About nine million people live in locations more than two hours away from serum-providing facilities, with relevant variations between regions, states, and municipalities. States like Mato Grosso, Para and MaranhAo had the most important participation of population with reaching time problems to those units. The most significant gaps are found in areas with a dispersed population and sometimes characterized by a high incidence of snakebites, such as in the North of the country, especially in the Northeastern Para state. Even using a 2010 population distribution information, because of the 2020 Census postponement, the tendencies and characteristics analyzed reveal challenging situations over the country. The growing availability of serum-providing health facilities, the enhanced possibilities of transporting accident victims, and even the availability of sera in other types of establishments are actions that would allow expanding the possibilities of access to serum supply.	[Dantas de Oliveira, Ricardo Antunes; Xavier Silva, Diego Ricardo] Oswaldo Cruz Fdn Fiocruz, Hlth Informat Lab, Inst Commun & Sci & Technol Informat Hlth Icict, Rio De Janeiro, RJ, Brazil; [Goncalves e Silva, Mauricio] Brazilian Inst Geog & Stat IBGE, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz	de Oliveira, RAD (corresponding author), Oswaldo Cruz Fdn Fiocruz, Hlth Informat Lab, Inst Commun & Sci & Technol Informat Hlth Icict, Rio De Janeiro, RJ, Brazil.	ricardo.dantas@icict.fiocruz.br	Dantas de Oliveira, Ricardo Antunes/C-2908-2019	Dantas de Oliveira, Ricardo Antunes/0000-0003-0144-7288	Inova Fiocruz Program [VPPCB-008-FIO-18-2-48]	Inova Fiocruz Program	RAD Oliveira have funding from Inova Fiocruz Program (https://portal.fiocruz.br/programa-inova-fiocruz), (Grant number: Inova Program VPPCB-008-FIO-18-2-48), a research support obtained in a selection occurred in 2018. The funds allowed the payment of scholarships to organize the datasets and the spatial information treatment, beyond the participation in congresses and seminars. The funding body had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GOOGL MAPS; Bochner R., 2014, Journal of Clinical Toxicology, V4, P194; Bochner Rosany, 2002, Cad. Saúde Pública, V18, P735, DOI [10.1590/S0102-311X2002000300022, 10.1590/S0102-311X2002000300017]; Bochner Rosany, 2003, Cad. Saúde Pública, V19, P07, DOI 10.1590/S0102-311X2003000100002; Brazil. Ministry of Health, CNESNATIONAL REG HLT; Brazil. Ministry of Health (MS), SINANN DIS INF SYST; Brazilian Institute of Geography and Statistics, 2020, POPULATION ESTIMATES; Brazilian Institute of Geography and Statistics (IBGE), 2016, 2010 DEM CENS STAT G; Brazilian Institute of Geography and Statistics (IBGE). Brazilian Digital National Atlas, 2018, THEM NOT 2018 GEOGR; Camara OF., 2020, J HUMAN GROWTH DEV, V30, P120, DOI [10.7322/jhgd.v30.9958, DOI 10.7322/JHGD.V30.9958]; Chippaux JP, 2011, TOXICON, V57, P586, DOI 10.1016/j.toxicon.2010.12.022; Citeli NQK., 2018, SINITOX NATL TOXIC P; de Oliveira RAD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00120718, 10.1590/0102-311X00120718]; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Fiszon Judith Tiomny, 2008, Rev. bras. epidemiol., V11, P114; Google, GOOGL STREET VIEW; Hansson E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002009; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Joint Comission on Accreditation of Healthcare Organizations-JCAHO, 1993, MEAS MAND ROAD PERF; Lira-da-Silva RM., 2009, GAZETA MED BAHIA, V79, P21; Longbottom J, 2018, LANCET, V392, P673, DOI 10.1016/S0140-6736(18)31224-8; McIntyre D, 2009, HEALTH ECON POLICY L, V4, P179, DOI 10.1017/S1744133109004836; Oliveira Evangelina X. G. de, 2004, Cad. Saúde Pública, V20, P386, DOI 10.1590/S0102-311X2004000200006; OPEN STREET MAP (OSM), OPEN STREET MAP; Oswaldo Cruz Foundation (FIOCRUZ). Institute of Communication and Scientific and Technological Information in Health, 2019, SINITOXNATIONAL TOXI; Ouma PO, 2018, LANCET GLOB HEALTH, V6, pE342, DOI 10.1016/S2214-109X(17)30488-6; Ray N, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-63; Ribeiro LA, 1995, REV SAUDE PUBL, V29, P380, DOI 10.1590/S0034-89101995000500007; SRTMGL3-verso 3, 2019, EARTH DATAOPEN ACC O; Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190; Vaz Vitor Hugo da Silva, 2020, Cad. saúde colet., V28, P409, DOI 10.1590/1414-462x202028030018; Vieira DS., 2019, REV PROUNIVERSUS, V10, P8, DOI [10.21727/rpu.v10i2.1896, DOI 10.21727/RPU.V10I2.1896]; World Health Organization, 2017, 10 M WHO STRAT TECHN; World Health Organization (WHO), ACC 5	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0260326	10.1371/journal.pone.0260326	http://dx.doi.org/10.1371/journal.pone.0260326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025873	Green Published, gold			2022-12-26	WOS:000796264200006
J	Tsantani, M; Podgajecka, V; Gray, KLH; Cook, R				Tsantani, Maria; Podgajecka, Vita; Gray, Katie L. H.; Cook, Richard			How does the presence of a surgical face mask impair the perceived intensity of facial emotions?	PLOS ONE			English	Article							EXPRESSION RECOGNITION; VISUAL-SEARCH; PERCEPTION; FEAR; SUNGLASSES; ACCURACY; SURPRISE; REVEALS; PEOPLE; EYES	The use of surgical-type face masks has become increasingly common during the COVID-19 pandemic. Recent findings suggest that it is harder to categorise the facial expressions of masked faces, than of unmasked faces. To date, studies of the effects of mask-wearing on emotion recognition have used categorisation paradigms: authors have presented facial expression stimuli and examined participants' ability to attach the correct label (e.g., happiness, disgust). While the ability to categorise particular expressions is important, this approach overlooks the fact that expression intensity is also informative during social interaction. For example, when predicting an interactant's future behaviour, it is useful to know whether they are slightly fearful or terrified, contented or very happy, slightly annoyed or angry. Moreover, because categorisation paradigms force observers to pick a single label to describe their percept, any additional dimensionality within observers' interpretation is lost. In the present study, we adopted a complementary emotion-intensity rating paradigm to study the effects of mask-wearing on expression interpretation. In an online experiment with 120 participants (82 female), we investigated how the presence of face masks affects the perceived emotional profile of prototypical expressions of happiness, sadness, anger, fear, disgust, and surprise. For each of these facial expressions, we measured the perceived intensity of all six emotions. We found that the perceived intensity of intended emotions (i.e., the emotion that the actor intended to convey) was reduced by the presence of a mask for all expressions except for anger. Additionally, when viewing all expressions except surprise, masks increased the perceived intensity of non-intended emotions (i.e., emotions that the actor did not intend to convey). Intensity ratings were unaffected by presentation duration (500ms vs 3000ms), or attitudes towards mask wearing. These findings shed light on the ambiguity that arises when interpreting the facial expressions of masked faces.	[Tsantani, Maria; Podgajecka, Vita; Cook, Richard] Birkbeck Univ London, Dept Psychol Sci, London, England; [Gray, Katie L. H.] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Cook, Richard] Univ York, Dept Psychol, York, N Yorkshire, England	University of London; Birkbeck University London; University of Reading; University of York - UK	Tsantani, M (corresponding author), Birkbeck Univ London, Dept Psychol Sci, London, England.	maria.tsantani@gmail.com		Tsantani, Maria/0000-0002-4118-0031	European Research Council [ERC2016-StG-715824]	European Research Council(European Research Council (ERC)European Commission)	RC is supported by a Starting Grant awarded by the European Research Council (ERC2016-StG-715824) https://erc.europa.eu/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Anwyl-Irvine AL, 2020, BEHAV RES METHODS, V52, P388, DOI 10.3758/s13428-019-01237-x; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Barrick E, 2020, PSYARXIV; Beaudry O, 2014, COGNITION EMOTION, V28, P416, DOI 10.1080/02699931.2013.833500; Blais C, 2012, NEUROPSYCHOLOGIA, V50, P2830, DOI 10.1016/j.neuropsychologia.2012.08.010; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bruce V., 1998, EYE BEHOLDER SCI FAC; Bunce C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80073-y; Calbi M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81780-w; Calvo MG, 2014, PSYCHOL RES-PSYCH FO, V78, P180, DOI 10.1007/s00426-013-0492-x; Carbon CC, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566886; Chamberland J, 2017, SOC NEUROSCI-UK, V12, P751, DOI 10.1080/17470919.2016.1251964; Cook R, 2013, PSYCHOL SCI, V24, P93, DOI 10.1177/0956797612452568; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; de Gelder B, 2006, PROG BRAIN RES, V155, P37, DOI 10.1016/S0079-6123(06)55003-4; Duncan J, 2017, J VISION, V17, DOI 10.1167/17.14.7; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Fischer AH, 2012, SOC PSYCHOL PERS SCI, V3, P266, DOI 10.1177/1948550611418534; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Gray KLH, 2020, PSYCHON B REV, V27, P62, DOI 10.3758/s13423-019-01684-9; Grundmann F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249792; Guarnera M, 2018, J GENET PSYCHOL, V179, P297, DOI 10.1080/00221325.2018.1509200; Hildebrandt A, 2012, COGNITION EMOTION, V26, P650, DOI 10.1080/02699931.2011.602046; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kotsia I, 2008, IMAGE VISION COMPUT, V26, P1052, DOI 10.1016/j.imavis.2007.11.004; Kret ME, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00110; Kuhn LK, 2017, EMOTION, V17, P912, DOI 10.1037/emo0000282; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; Marini M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84806-5; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Noyes E, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.201169; Office of National Statistics, 2021, COR SOC IMP LONG COV; ONS,, 2020, COR SOC IMP GREAT BR; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Over H, 2018, COGNITION, V170, P190, DOI 10.1016/j.cognition.2017.10.002; Park HB, 2015, ACTA PSYCHOL, V157, P185, DOI 10.1016/j.actpsy.2015.03.003; Pavlova MA, 2022, CEREB CORTEX, V32, P249, DOI 10.1093/cercor/bhab311; Poncet A, 2016, METHODOLOGY-EUR, V12, P61, DOI 10.1027/1614-2241/a000110; Richards A, 2002, EMOTION, V2, P273, DOI 10.1037/1528-3542.2.3.273; Roberson D, 2012, COGNITION, V125, P195, DOI 10.1016/j.cognition.2012.06.018; Roy-Charland A, 2014, COGNITION EMOTION, V28, P1214, DOI 10.1080/02699931.2013.878687; RUSSELL JA, 1986, SOC COGNITION, V4, P309, DOI 10.1521/soco.1986.4.3.309; Saumure C, 2018, J VISION, V18, DOI 10.1167/18.9.21; Saunders GH, 2021, INT J AUDIOL, V60, P495, DOI 10.1080/14992027.2020.1851401; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Tae J, 2020, COGNITION EMOTION, V34, P1171, DOI 10.1080/02699931.2020.1733933; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Vestner T, 2022, J EXP PSYCHOL GEN, V151, P161, DOI 10.1037/xge0001067; Vestner T, 2021, COGNITION, V214, DOI 10.1016/j.cognition.2021.104737; Vestner T, 2021, COGNITION, V208, DOI 10.1016/j.cognition.2020.104550; Vestner T, 2020, COGNITION, V200, DOI 10.1016/j.cognition.2020.104270; Wegrzyn M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177239; Woods AT, 2015, PEERJ, V3, DOI 10.7717/peerj.1058	61	16	16	15	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262344	10.1371/journal.pone.0262344	http://dx.doi.org/10.1371/journal.pone.0262344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025948	Green Accepted, Green Published, gold			2022-12-26	WOS:000796264200060
J	Ullah, S; Zhang, JZ; Xu, BY; Tegomo, AF; Sagada, G; Zheng, L; Wang, L; Shao, QJ				Ullah, Sami; Zhang, Jinzhi; Xu, Bingying; Tegomo, Arnaud Fabrice; Sagada, Gladstone; Zheng, Lu; Wang, Lei; Shao, Qingjun			Effect of dietary supplementation of lauric acid on growth performance, antioxidative capacity, intestinal development and gut microbiota on black sea bream (Acanthopagrus schlegelii)	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; DISEASE RESISTANCE; IMMUNE-RESPONSES; OXIDATIVE STRESS; MYRISTIC ACID; TRIGLYCERIDES; REQUIREMENT; PROTEIN; TRIACYLGLYCEROLS; DIGESTIBILITY	A feeding trial of eight weeks was conducted to examine the influence of food supplementation with lauric acid (LA) on Acanthopagrus schlegelii (juvenile black sea bream). A 24 percent fish meal baseline diet was created, while the other two diets were generated with dietary supplementation of graded points of LA at 0.1 percent and 0.8 percent, respectively. Each diet was given a triplicate tank with 20 fish weighing 6.22 +/- 0.19 g. In comparison with the control group, the weight gain rate, growth rate, as well as feed efficiency of fish fed of 0.1 percent diet of LA were considerably (P < 0.05) greater. The total body and dorsal muscle proximate compositions did not change significantly between groups (P > 0.05). Triglyceride (TG) content was considerably (P < 0.05) greater in the LA-supplemented meals eating group in comparison with the control group. In the group eating LA-supplemented meals, the height of villus and the number of goblet cells/villus were considerably (P < 0.05) larger. The microbial makeup of the gut was also studied. The differences in phyla, class, and family level were not statistically significant (P > 0.05). Firmicutes in the phylum, Betaproteobacteri, Gammaproteobacteria, and Clostridia in the class, and Clostridiaceae in the family were all substantially increased with higher levels of LA supplementation (P < 0.05). According to the findings of this study, an LA-supplemented diet improves fish development, antioxidative capability, gut microbiota and intestinal health.	[Ullah, Sami; Zhang, Jinzhi; Xu, Bingying; Sagada, Gladstone; Zheng, Lu; Wang, Lei; Shao, Qingjun] Zhejiang Univ, Coll Anim Sci, Hangzhou, Peoples R China; [Tegomo, Arnaud Fabrice] Zhejiang Univ, Ocean Coll, Zhoushan, Peoples R China; [Shao, Qingjun] Zhejiang Univ, Ocean Acad, Zhoushan, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Shao, QJ (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Peoples R China.; Shao, QJ (corresponding author), Zhejiang Univ, Ocean Acad, Zhoushan, Peoples R China.	qjshao@zju.edu.cn		Shao, Qingjun/0000-0002-4550-5139	Ministry of Science and Technology, China [2020YFD0900801]; Zhejiang Provincial Bureau of Science and Technology [2015C02020]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Zhejiang Provincial Bureau of Science and Technology	This work was funded by the Ministry of Science and Technology, China (Project No.: 2020YFD0900801) and the Zhejiang Provincial Bureau of Science and Technology (Project No.: 2015C02020).	Abd El Megid A, 2020, ECOTOX ENVIRON SAFE, V188, DOI 10.1016/j.ecoenv.2019.109876; Adil S., 2010, VET MED INT, V2010, P1, DOI [10.4061/2010/479485, DOI 10.4061/2010/479485, 10.4061/2010/479485.474, DOI 10.4061/2010/479485.295]; Askarian F, 2011, AQUACULT NUTR, V17, P488, DOI 10.1111/j.1365-2095.2010.00826.x; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Berges JA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1385, DOI 10.1016/B978-0-12-372522-6.00032-3; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bruce F., 2011, SCI EVIDENCE REGARDI; Piazzon MC, 2017, MICROBIOME, V5, DOI [10.1186/s40168-017-0390-3, 10.1186/S40168-017-0390-3]; CERA KR, 1988, J ANIM SCI, V66, P574; Cerezuela R, 2012, CELL TISSUE RES, V350, P477, DOI 10.1007/s00441-012-1495-4; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chwen LT, 2013, ASIAN AUSTRAL J ANIM, V26, P700, DOI 10.5713/ajas.2012.12561; Dayrit FM, 2015, J AM OIL CHEM SOC, V92, P1, DOI 10.1007/s11746-014-2562-7; Dierick NA, 2003, ARCH ANIM NUTR, V57, P49, DOI 10.1080/0003942031000086626; Dierick NA, 2002, LIVEST PROD SCI, V76, P1, DOI 10.1016/S0301-6226(01)00331-1; Dohme F, 2001, LETT APPL MICROBIOL, V32, P47, DOI 10.1046/j.1472-765x.2001.00863.x; Duarte-Silva E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.585857; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Estruch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136389; Food and Agriculture Organization (FAO), 2018, STAT WORLD FISH AQ 2; Gaber M., 2012, SCI REP-UK, V1, P1; Han D, 2011, AQUACULT NUTR, V17, pE741, DOI 10.1111/j.1365-2095.2010.00841.x; Hanczakowska E, 2011, J ANIM FEED SCI, V20, P556, DOI 10.22358/jafs/66213/2011; Hong SM, 2012, ASIAN AUSTRAL J ANIM, V25, P1003, DOI 10.5713/ajas.2011.11402; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Jiang LJ, 2018, DRUG DELIV, V25, P985, DOI 10.1080/10717544.2018.1461954; Kabara J. J., 2000, Indian Coconut Journal, V31, P2; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Kim SK, 2012, ADV FOOD NUTR RES, V65, P353, DOI 10.1016/B978-0-12-416003-3.00023-8; Kollanoor A, 2007, AQUAC RES, V38, P1293, DOI 10.1111/j.1365-2109.2007.01799.x; Kuang Y, 2015, ANIM FEED SCI TECH, V208, P145, DOI 10.1016/j.anifeedsci.2015.07.010; Li W, 2017, AQUACULT NUTR, V23, P1035, DOI 10.1111/anu.12471; Liu HT, 2017, FISH SHELLFISH IMMUN, V60, P326, DOI 10.1016/j.fsi.2016.12.003; Martinez-Vallespin B, 2016, CYTOTECHNOLOGY, V68, P1925, DOI 10.1007/s10616-016-0003-1; McCarty MF, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000467; Messens W, 2010, VET MICROBIOL, V141, P73, DOI 10.1016/j.vetmic.2009.08.002; Nagasaki H, 2012, FEBS LETT, V586, P368, DOI 10.1016/j.febslet.2012.01.001; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Ng WK., 2011, STANDARDS ACIDIFIERS, P49; Ngandzali BO, 2011, AQUACULT NUTR, V17, P526, DOI 10.1111/j.1365-2095.2010.00835.x; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Odle J, 1997, J NUTR, V127, P1061, DOI 10.1093/jn/127.6.1061; Rimoldi S, 2018, PEERJ, V6, DOI 10.7717/peerj.5355; Rocha TM, 2011, REV BRAS ZOOTECN, V40, P2776, DOI 10.1590/S1516-35982011001200023; ROTH JA, 1982, J AM VET MED ASSOC, V180, P894; Sava S, 2005, EFFECT BACTERIAL LOA, P1; Seneviratne KN, 2008, INT J FOOD SCI TECH, V43, P597, DOI 10.1111/j.1365-2621.2006.01493.x; Silberstein Tali, 2013, Isr Med Assoc J, V15, P156; Simo-Mirabet P, 2017, PEERJ, V5, DOI 10.7717/peerj.4001; Sithara K., 2008, Current Biotica, V2, P212; Soliva CR, 2004, BRIT J NUTR, V92, P689, DOI 10.1079/BJN20041250; STUBBS RS, 1985, AM J PHYSIOL, V248, pG347, DOI 10.1152/ajpgi.1985.248.3.G347; Suckow MA, 2012, AM COLL LAB, P1; TAKASE S, 1990, J NUTR, V120, P969, DOI 10.1093/jn/120.9.969; Tang M, 1999, J ANIM SCI, V77, P3191; Tezcan F, 2009, FOOD CHEM, V115, P873, DOI 10.1016/j.foodchem.2008.12.103; Van Wymelbeke V, 1998, AM J CLIN NUTR, V68, P226, DOI 10.1093/ajcn/68.2.226; Volatiana JA, 2020, AQUACULT NUTR, V26, P15, DOI 10.1111/anu.12984; Witcher KJ, 1996, CLIN DIAGN LAB IMMUN, V3, P10, DOI 10.1128/CDLI.3.1.10-13.1996; Yu W, 2018, FISH SHELLFISH IMMUN, V74, P649, DOI 10.1016/j.fsi.2018.01.024; Zeiger K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175693; Zeitz JO, 2015, POULTRY SCI, V94, P2404, DOI 10.3382/ps/pev191; Zentek J., 2011, Animal Health Research Reviews, V12, P83, DOI 10.1017/S1466252311000089; Zhang JZ, 2010, J WORLD AQUACULT SOC, V41, P151, DOI 10.1111/j.1749-7345.2010.00356.x; Zhou F, 2011, AQUACULT NUTR, V17, P469, DOI 10.1111/j.1365-2095.2010.00823.x; Zhou F, 2010, AQUACULT NUTR, V16, P194, DOI 10.1111/j.1365-2095.2009.00651.x; Zhou F, 2010, AQUAC RES, V41, pe418, DOI 10.1111/j.1365-2109.2009.02474.x	68	3	3	12	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262427	10.1371/journal.pone.0262427	http://dx.doi.org/10.1371/journal.pone.0262427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025934	Green Published, gold			2022-12-26	WOS:000796264200068
J	Trecarichi, A; Duggett, NA; Granat, L; Lo, S; Malik, AN; Zuliani-Alvarez, L; Flatters, SJL				Trecarichi, Annalisa; Duggett, Natalie A.; Granat, Lucy; Lo, Samantha; Malik, Afshan N.; Zuliani-Alvarez, Lorena; Flatters, Sarah J. L.			Preclinical evidence for mitochondrial DNA as a potential blood biomarker for chemotherapy-induced peripheral neuropathy	PLOS ONE			English	Article							COPY NUMBER; COLORECTAL-CANCER; PACLITAXEL; RISK; NEUROTOXICITY; PLATINUM; GENOME; HEAD	Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting side effect of several first-line chemotherapeutic agents including paclitaxel, oxaliplatin and bortezomib, for which no predictive marker is currently available. We have previously shown that mitochondrial dysfunction is associated with the development and maintenance of CIPN. The aim of this study was to evaluate the potential use of mitochondrial DNA (mtDNA) levels and complex I enzyme activity as blood biomarkers for CIPN. Real-time qPCR was used to measure mtDNA levels in whole blood collected from chemotherapy- and vehicle-treated rats at three key time-points of pain-like behaviour: prior to pain development, at the peak of mechanical hypersensitivity and at resolution of pain-like behaviour. Systemic oxaliplatin significantly increased mtDNA levels in whole blood prior to pain development. Furthermore, paclitaxel- and bortezomib-treated animals displayed significantly higher levels of mtDNA at the peak of mechanical hypersensitivity. Mitochondrial complex I activity in whole blood was assessed with an ELISA-based Complex I Enzyme Activity Dipstick Assay. Complex I activity was not altered by any of the three chemotherapeutic agents, either prior to or during pain-like behaviour. These data demonstrate that blood levels of mtDNA are altered after systemic administration of chemotherapy. Oxaliplatin, in particular, is associated with higher mtDNA levels before animals show any pain-like behaviour, thus suggesting a potential role for circulating mtDNA levels as non-invasive predictive biomarker for CIPN.	[Trecarichi, Annalisa; Duggett, Natalie A.; Granat, Lucy; Lo, Samantha; Zuliani-Alvarez, Lorena; Flatters, Sarah J. L.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Wolfson Ctr Age Related Dis, London, England; [Malik, Afshan N.] Kings Coll London, Sch Life Course Sci, Dept Diabet, London, England	University of London; King's College London; University of London; King's College London	Flatters, SJL (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Wolfson Ctr Age Related Dis, London, England.	sarah.flatters@kcl.ac.uk		Duggett, Natalie/0000-0003-0660-4190	Guys and St. Thomas' charity; Wellcome Trust [WT093335AIA]; British Pharmacological Society (Integrative Pharmacology Fund); British Journal of Anaesthesia/Royal College of Anaesthetists	Guys and St. Thomas' charity; Wellcome Trust(Wellcome Trust); British Pharmacological Society (Integrative Pharmacology Fund); British Journal of Anaesthesia/Royal College of Anaesthetists	AT was supported by a PhD studentship from Guys and St. Thomas' charity. These studies were supported by project grants awarded to SJLF from the British Journal of Anaesthesia/Royal College of Anaesthetists; The Wellcome Trust (WT093335AIA) and the British Pharmacological Society (Integrative Pharmacology Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2010, CHEM REV, V110, P3212, DOI 10.1021/cr900396q; Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; Barbosa MD, 2014, CANCER RES, V74, P5955, DOI 10.1158/0008-5472.CAN-14-2060; Boyette-Davis JA, 2012, CLIN CANCER RES, V18, P3180, DOI 10.1158/1078-0432.CCR-12-0205; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Chen EI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145816; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Cossarizza A, 2003, ANTIVIR THER, V8, P315; Diaz PL, 2018, BIOMARK MED, V12, P907, DOI 10.2217/bmm-2017-0427; Duggett NA, 2017, BRIT J PHARMACOL, V174, P4812, DOI 10.1111/bph.14063; Duggett NA, 2017, PAIN, V158, P1499, DOI 10.1097/j.pain.0000000000000939; Duggett NA, 2016, NEUROSCIENCE, V333, P13, DOI 10.1016/j.neuroscience.2016.06.050; Ellinger J, 2009, BJU INT, V104, P48, DOI 10.1111/j.1464-410X.2008.08289.x; Etienne-Grimaldi MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175998; Flatters SJL, 2017, BRIT J ANAESTH, V119, P737, DOI 10.1093/bja/aex229; Flatters SJL, 2015, PROG MOL BIOL TRANSL, V131, P119, DOI 10.1016/bs.pmbts.2014.12.004; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Gabriel CM, 2000, J NEUROL NEUROSUR PS, V69, P442, DOI 10.1136/jnnp.69.4.442; Girolimetti G, 2017, HUM MOL GENET, V26, P2961, DOI 10.1093/hmg/ddx186; Griffiths LA, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/8217613; Griffiths LA, 2015, J PAIN, V16, P981, DOI 10.1016/j.jpain.2015.06.008; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lunenburg CATC, 2016, EUR J CANCER, V54, P40, DOI 10.1016/j.ejca.2015.11.008; Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002; Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Malik Afshan N, 2009, Diabetes Res Clin Pract, V86, pe22, DOI 10.1016/j.diabres.2009.07.002; Marusich MF, 2009, INT J BIOCHEM CELL B, V41, P2081, DOI 10.1016/j.biocel.2009.05.009; Mehra N, 2007, CLIN CANCER RES, V13, P421, DOI 10.1158/1078-0432.CCR-06-1087; MICETICH KC, 1985, CANCER RES, V45, P4043; Oguri T, 2013, INT J CLIN PHARM TH, V51, P475, DOI 10.5414/CP201851; Podratz JL, 2011, NEUROBIOL DIS, V41, P661, DOI 10.1016/j.nbd.2010.11.017; Reddy SM, 2016, CLIN COLORECTAL CANC, V15, P37, DOI 10.1016/j.clcc.2015.07.001; Roldan CJ, 2018, PAIN PHYSICIAN, V21, pE419; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Serrano J, 1999, BBA-BIOENERGETICS, V1411, P201, DOI 10.1016/S0005-2728(99)00011-0; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Shi HH, 2009, INT J GYNECOL CANCER, V19, P423, DOI 10.1111/IGC.0b013e3181a19ff0; Sunder R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164319; Terrazzino S, 2015, J PERIPHER NERV SYST, V20, P15, DOI 10.1111/jns.12110; Trecarichi A, 2019, 7 INT C NEUROPATHIC; Trecarichi A, 2019, INT REV NEUROBIOL, V145, P83, DOI 10.1016/bs.irn.2019.05.001; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Wang XS, 2016, ONCOLOGY-BASEL, V90, P127, DOI 10.1159/000443377; Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009; Won HH, 2012, CANCER-AM CANCER SOC, V118, P2828, DOI 10.1002/cncr.26614; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Xu FX, 2012, DIABETIC MED, V29, pE47, DOI 10.1111/j.1464-5491.2011.03565.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	57	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262544	10.1371/journal.pone.0262544	http://dx.doi.org/10.1371/journal.pone.0262544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015774	gold, Green Published			2022-12-26	WOS:000814820600033
J	Yang, CM; Zhuo, QQ; Chen, JY; Fang, Z; Xu, YS				Yang, Chuanming; Zhuo, Qingqing; Chen, Junyu; Fang, Zhou; Xu, Yisong			Analysis of the spatio-temporal network of air pollution in the Yangtze River Delta urban agglomeration, China	PLOS ONE			English	Article							PM2.5; POLLUTANTS; TRANSPORT; CITIES	The complex correlation between regions caused by the externality of air pollution increases the difficulty of its governance. Therefore, analysis of the spatio-temporal network of air pollution (STN-AP) holds great significance for the cross-regional coordinated governance of air pollution. Although the spatio-temporal distribution of air pollution has been analyzed, the structural characteristics of the STN-AP still need to be clarified. The STN-AP in the Yangtze River Delta urban agglomeration (YRDUA) is constructed based on the improved gravity model and is visualized by UCINET with data from 2012 to 2019. Then, its overall-individual-clustering characteristics are analyzed through social network analysis (SNA) method. The results show that the STN-AP in the YRDUA was overall stable, and the correlation level gradually improved. The centrality of every individual city is different in the STN-AP, which reveals the different state of their interactive mechanism. The STN-AP could be subdivided into the receptive block, overflow block, bidirectional block and intermediary block. Shanghai, Suzhou, Hangzhou and Wuxi could be key cities with an all above degree centrality, betweenness centrality and closeness centrality and located in the overflow block of the STN-AP. This showed that these cities had a greater impact on the STN-AP and caused a more pronounced air pollution spillovers. The influencing factors of the spatial correlation of air pollution are further determined through the quadratic assignment procedure (QAP) method. Among all factors, geographical proximity has the strongest impact and deserves to be paid attention in order to prevent the cross-regional overflow of air pollution. Furthermore, several suggestions are proposed to promote coordinated governance of air pollution in the YRDUA.	[Yang, Chuanming; Zhuo, Qingqing; Chen, Junyu; Xu, Yisong] Suzhou Univ Sci & Technol, Sch Business, Suzhou, Jiangsu, Peoples R China; [Chen, Junyu] Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China; [Fang, Zhou] Hohai Univ, Business Sch, Nanjing, Jiangsu, Peoples R China	Suzhou University of Science & Technology; Tianjin University; Hohai University	Chen, JY (corresponding author), Suzhou Univ Sci & Technol, Sch Business, Suzhou, Jiangsu, Peoples R China.; Chen, JY (corresponding author), Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China.	jychen@usts.edu.cn	Fang, Zhou/GWU-6891-2022	Fang, Zhou/0000-0002-8441-0810; Chen, Junyu/0000-0002-9004-0887	Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province [2018SJZDI075]; Qinglan Project of Jiangsu Province [2018JSQL028]; Jiangsu social science fund [21GLC015]	Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province; Qinglan Project of Jiangsu Province; Jiangsu social science fund	The Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province (No. 2018SJZDI075) and the Qinglan Project of Jiangsu Province (No.2018JSQL028) received by Chuanming Yang would support our work. The Jiangsu social science fund (Grant NO. 21GLC015) received by Junyu Chen would also support our work.	Chang IC, 2019, AEROSOL AIR QUAL RES, V19, P2844, DOI 10.4209/aaqr.2019.11.0554; Du MZ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182010619; Feng HH, 2019, ECOL INDIC, V99, P251, DOI 10.1016/j.ecolind.2018.12.038; Feng YY, 2019, J ENVIRON MANAGE, V252, DOI 10.1016/j.jenvman.2019.109603; Guney S, 2019, AM J AGR ECON, V101, P541, DOI 10.1093/ajae/aay033; Jiang C, 2015, ATMOS CHEM PHYS, V15, P5803, DOI 10.5194/acp-15-5803-2015; Lasko K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196629; Lee MT, 2021, J ENERGY STORAGE, V41, DOI 10.1016/j.est.2021.102890; Li H, 2019, ENVIRON SCI POLLUT R, V26, P12136, DOI 10.1007/s11356-019-04682-5; Liu H., 2017, REV EC MANAG, V33, P57, DOI [10.13962/j.cnki.37-1486/f.2017.01.007, DOI 10.13962/J.CNKI.37-1486/F.2017.01.007]; Liu XF, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105713; Lu YL, 2019, J ENVIRON MANAGE, V249, DOI 10.1016/j.jenvman.2019.109377; Miller DJ, 2020, ENVIRON SCI TECHNOL, V54, P2133, DOI 10.1021/acs.est.9b05523; Morillas H, 2019, J CLEAN PROD, V226, P369, DOI 10.1016/j.jclepro.2019.04.063; Oetari PS, 2019, J ENVIRON MANAGE, V250, DOI 10.1016/j.jenvman.2019.109497; Pei, 2017, STAT RES, V34, P45, DOI DOI 10.19343/J.CNKI.11-1302/C.2017.03.004; Posch M, 2019, ENVIRON SCI TECHNOL, V53, P5062, DOI 10.1021/acs.est.8b06356; Saraswat A, 2016, ENVIRON SCI TECHNOL, V50, P3174, DOI 10.1021/acs.est.5b04975; Schioppo T, 2020, EPIDEMIOL PREV, V44, P228, DOI 10.19191/EP20.4.P228.052; Shan YJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237863; Shao JJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238547; Shen FZ, 2020, ENVIRON INT, V137, DOI 10.1016/j.envint.2020.105556; Squizzato S, 2018, ATMOS ENVIRON, V183, P209, DOI 10.1016/j.atmosenv.2018.03.045; Su Y, 2019, J CLEAN PROD, V213, P540, DOI 10.1016/j.jclepro.2018.12.121; Svistov PF, 2017, RUSS J GEN CHEM+, V87, P3173, DOI 10.1134/S1070363217130114; [汤放华 Tang Fanghua], 2013, [地理学报, Acta Geographica Sinica], V68, P1357; Tshehla C, 2019, S AFR J SCI, V115, DOI 10.17159/sajs.2019/6100; Wakeel M, 2017, J CLEAN PROD, V142, P3322, DOI 10.1016/j.jclepro.2016.10.138; Wang F, 2018, ENERGIES, V11, DOI 10.3390/en11102706; Wang JJ, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138134; Weaver JC, 1954, GEOGR REV, V44, P175, DOI 10.2307/212355; Wolfe AW, 1997, AM ETHNOL, V24, P219, DOI 10.1525/ae.1997.24.1.219; Xiao CC, 2020, J ENVIRON SCI, V87, P213, DOI 10.1016/j.jes.2019.05.024; Xu SC, 2019, J CLEAN PROD, V208, P340, DOI 10.1016/j.jclepro.2018.10.114; [杨传明 Yang Chuanming], 2020, [自然资源学报, Journal of Natural Resources], V35, P313; Yu XB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020587; Yu YP, 2019, POL J ENVIRON STUD, V28, P445, DOI 10.15244/pjoes/83730; Zeng D H., 2019, RES ENV SCI, V32, P1834; Zhang LY, 2020, CHEMOSPHERE, V253, DOI 10.1016/j.chemosphere.2020.126613; Zhang YL, 2019, SCI TOTAL ENVIRON, V684, P178, DOI 10.1016/j.scitotenv.2019.05.360	40	0	0	13	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262444	10.1371/journal.pone.0262444	http://dx.doi.org/10.1371/journal.pone.0262444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015793	gold, Green Published			2022-12-26	WOS:000814820600018
J	Giri, GR; Saxena, P				Giri, Gorkha Raj; Saxena, Priti			Mycobacterial MMAR_2193 catalyzes O-methylation of diverse polyketide cores	PLOS ONE			English	Article							ADENOSYL-L-METHIONINE; CRYSTAL-STRUCTURE; ISOLIQUIRITIGENIN 2-O-METHYLTRANSFERASE; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; SUBSTRATE-SPECIFICITY; BACTERIAL BIOFILMS; STRUCTURAL BASIS; METHYLTRANSFERASE; BIOSYNTHESIS	O-methylation of small molecules is a common modification widely present in most organisms. Type III polyketides undergo O-methylation at hydroxyl end to play a wide spectrum of roles in bacteria, plants, algae, and fungi. Mycobacterium marinum harbours a distinctive genomic cluster with a type III pks gene and genes for several polyketide modifiers including a methyltransferase gene, mmar_2193. This study reports functional analyses of MMAR_2193 and reveals multi-methylating potential of the protein. Comparative sequence analyses revealed conservation of catalytically important motifs in MMAR_2193 protein. Homology-based structure-function and molecular docking studies suggested type III polyketide cores as possible substrates for MMAR_2193 catalysis. In vitro enzymatic characterization revealed the capability of MMAR_2193 protein to utilize diverse polyphenolic substrates to methylate several hydroxyl positions on a single substrate molecule. High-resolution mass spectrometric analyses identified multi-methylations of type III polyketides in cell-free reconstitution assays. Notably, our metabolomics analyses identified some of these methylated molecules in biofilms of wild type Mycobacterium marinum. This study characterizes a novel mycobacterial O-methyltransferase protein with multi-methylating enzymatic ability that could be exploited to generate a palette of structurally distinct bioactive molecules.	[Giri, Gorkha Raj; Saxena, Priti] South Asian Univ, Fac Life Sci & Biotechnol, Chem Biol Grp, New Delhi, India; [Giri, Gorkha Raj] Tribhuvan Univ, Cent Dept Biotechnol, Kathmandu, Nepal	South Asian University (SAU); Tribhuvan University	Saxena, P (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, Chem Biol Grp, New Delhi, India.	psaxena@sau.ac.in		Giri, Gorkha Raj/0000-0001-6603-0526	Innovative Young Biotechnologist Award (IYBA), Department of Biotechnology (DBT); Ministry of Science and Technology, Government of India [CRG/2018/002229]; Science and Engineering Research Board (SERB); Department of Science and Technology (DST), Government of India; Startup Grant, South Asian University SAU	Innovative Young Biotechnologist Award (IYBA), Department of Biotechnology (DBT); Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India); Science and Engineering Research Board (SERB); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Startup Grant, South Asian University SAU	Financial support for the study was provided to PS by Innovative Young Biotechnologist Award (IYBA), Department of Biotechnology (DBT) (https://dbtindia.gov.in), Ministry of Science and Technology, Government of India, Core Research Grant (CRG/2018/002229), Science and Engineering Research Board (SERB) (http://www.serb.gov.in/home.php), Department of Science and Technology (DST), Government of India and Startup Grant, South Asian University SAU) (http://www.sau.int/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2015, MOL CELL, V60, P637, DOI 10.1016/j.molcel.2015.10.016; Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; Chakraborty P, 2019, MICROB CELL, V6, P105, DOI 10.15698/mic2019.02.667; Chatterjee T, 2015, ARCH BIOCHEM BIOPHYS, V583, P140, DOI 10.1016/j.abb.2015.08.001; Cho JH, 2008, J MOL BIOL, V382, P987, DOI 10.1016/j.jmb.2008.07.080; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Funa N, 2002, J BIOL CHEM, V277, P4628, DOI 10.1074/jbc.M110357200; Funabashi M, 2008, J BIOL CHEM, V283, P13983, DOI 10.1074/jbc.M710461200; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; Grocholski T, 2015, P NATL ACAD SCI USA, V112, P9866, DOI 10.1073/pnas.1501765112; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hou XW, 2007, J STRUCT BIOL, V159, P523, DOI 10.1016/j.jsb.2007.04.007; Ibdah M, 2003, J BIOL CHEM, V278, P43961, DOI 10.1074/jbc.M304932200; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Joshi CP, 1998, PLANT MOL BIOL, V37, P663, DOI 10.1023/A:1006035210889; Klimasauskas S, 2007, TRENDS BIOTECHNOL, V25, P99, DOI 10.1016/j.tibtech.2007.01.006; Law BJC, 2015, CHEM SCI, V6, P2885, DOI 10.1039/c5sc00164a; Lebe KE, 2019, RSC ADV, V9, P31527, DOI 10.1039/c9ra06412e; Lee S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44592-7; Liu CJ, 2006, PLANT CELL, V18, P3656, DOI 10.1105/tpc.106.041376; Ma QH, 2008, BIOCHIMIE, V90, P515, DOI 10.1016/j.biochi.2007.09.016; MAXWELL CA, 1992, ARCH BIOCHEM BIOPHYS, V293, P158, DOI 10.1016/0003-9861(92)90379-B; MAXWELL CA, 1993, PLANT J, V4, P971, DOI 10.1046/j.1365-313X.1993.04060971.x; Morishige T, 2010, P JPN ACAD B-PHYS, V86, P757, DOI 10.2183/pjab.86.757; Noel JP, 2003, RECENT ADV PHYTOCHEM, V37, P37; Oster LM, 2006, J MOL BIOL, V358, P546, DOI 10.1016/j.jmb.2006.02.004; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Parvez A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24980-1; Perez E, 2004, J BIOL CHEM, V279, P42584, DOI 10.1074/jbc.M406134200; Petronikolou N, 2018, CHEMBIOCHEM, V19, P784, DOI 10.1002/cbic.201700679; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; Scalliet G, 2008, P NATL ACAD SCI USA, V105, P5927, DOI 10.1073/pnas.0711551105; Schmidt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018184; Smith CD, 2002, PROTEIN SCI, V11, P625, DOI 10.1110/ps.37802; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wiens B, 2016, PHYTOCHEMISTRY, V132, P5, DOI 10.1016/j.phytochem.2016.10.004; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Wu SQ, 2003, J BIOSCI BIOENG, V96, P119, DOI 10.1016/S1389-1723(03)90113-7; Zheng YJ, 1997, J AM CHEM SOC, V119, P8137, DOI 10.1021/ja971019d; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	45	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262241	10.1371/journal.pone.0262241	http://dx.doi.org/10.1371/journal.pone.0262241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986163	Green Published, gold			2022-12-26	WOS:000765956200030
J	Lo Presti, S; Mattavelli, G; Canessa, N; Gianelli, C				Lo Presti, Sara; Mattavelli, Giulia; Canessa, Nicola; Gianelli, Claudia			Risk perception and behaviour during the COVID-19 pandemic: Predicting variables of compliance with lockdown measures	PLOS ONE			English	Article							EMERGENCY DECISION-MAKING; PROSPECT-THEORY; 5-FACTOR MODEL; SOCIAL-RESPONSIBILITY; PERSONALITY-TRAITS; HARM AVOIDANCE; LOSS AVERSION; NEURAL BASIS; LOCUS; TEMPERAMENT	The COVID-19 pandemic and the measures to counteract it have highlighted the role of individual differences in evaluating and reacting to emergencies, and the challenges inherent in promoting precautionary behaviours. We aimed to explore the psychological and cognitive factors modulating behaviour and intentions during the national lockdown in Italy. We administered an online questionnaire (N = 244) that included tests for assessing personality traits (Temperament and Character Inventory; Locus of Control of Behaviour) and moral judgment (Moral Foundations Questionnaire), alongside behavioural economics tasks addressing different facets of risk attitude (loss aversion, risk aversion and delay discounting). We then assessed the extent to which individual variations in these dimensions modulated participants' compliance with the lockdown norms. When assessing their joint contribution via multiple regressions, lockdown adherence was mostly predicted by internal locus of control, psycho-economic dimensions suggestive of long-sighted and loss-averse attitudes, as well as personality traits related to cautionary behaviour, such as harm avoidance, and the authority moral concern. These findings show that a multi-domain assessment of the factors underlying personal intentions, and thus driving compliance with government measures, can help predict individuals' actions during health emergencies. This evidence points to factors that should be considered when developing interventions and communication strategies to promote precautionary behaviours.	[Lo Presti, Sara; Mattavelli, Giulia; Canessa, Nicola; Gianelli, Claudia] Scuola Univ Super IUSS, IUSS Cognit Neurosci ICON Ctr, Pavia, Italy; [Mattavelli, Giulia; Canessa, Nicola; Gianelli, Claudia] Ist Clin Sci Maugeri IRCCS, Cognit Neurosci Lab, Pavia Inst, Pavia, Italy	IUSS PAVIA	Canessa, N (corresponding author), Scuola Univ Super IUSS, IUSS Cognit Neurosci ICON Ctr, Pavia, Italy.; Canessa, N (corresponding author), Ist Clin Sci Maugeri IRCCS, Cognit Neurosci Lab, Pavia Inst, Pavia, Italy.	nicola.canessa@iusspavia.it	Mattavelli, Giulia/K-5723-2016	Mattavelli, Giulia/0000-0003-2042-8947	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This research was partially supported by the "Ricerca Corrente" funding scheme of the Italian Ministry of Health. The authors wish to thank Maria Vittoria Fronda for language editing and the Third Mission Office of the Scuola Universitaria Superiore IUSS Pavia for the valuable support in recruiting participants.	Adan A, 2009, PERS INDIV DIFFER, V46, P687, DOI 10.1016/j.paid.2009.01.023; Amanzio M, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.685180; Bartoli M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18115847; Basinska MA, 2012, INT J ENDOCRINOL MET, V10, P537, DOI 10.5812/ijem.3932; Bengtsson MM, 2012, ISME J, V6, P2188, DOI 10.1038/ismej.2012.67; Betsch C, 2020, LANCET, V395, P1255, DOI 10.1016/S0140-6736(20)30729-7; Bobbio A., 2011, GIORNALE PSICOLOGIA, V5, P7, DOI DOI 10.1037/T65368-000; Bolton GE, 2015, EUR ECON REV, V74, P109, DOI 10.1016/j.euroecorev.2014.10.002; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Brown R, 2021, J PUBLIC HEALTH-HEID, DOI 10.1007/s10389-021-01543-9; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Campos-Mercade Pol, 2020, 346 U ZUR DEP EC, DOI [DOI 10.2139/SSRN.3604094, 10.2139/ssrn.3604094]; Canessa N, 2017, NEUROIMAGE, V146, P257, DOI 10.1016/j.neuroimage.2016.11.050; Canessa N, 2013, J NEUROSCI, V33, P14307, DOI 10.1523/JNEUROSCI.0497-13.2013; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; CHEBAT JC, 1986, J SOC PSYCHOL, V126, P559, DOI 10.1080/00224545.1986.9713626; Chua G, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063247; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802; CRAIG AR, 1984, BRIT J MED PSYCHOL, V57, P173, DOI 10.1111/j.2044-8341.1984.tb01597.x; Daugherty JR, 2010, PERS INDIV DIFFER, V48, P202, DOI 10.1016/j.paid.2009.10.007; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; Diaz R, 2022, COGNITION EMOTION, V36, P120, DOI 10.1080/02699931.2021.1941783; Ding YN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237626; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; European Centre for Disease Prevention and Control, 2020, EUROPEAN CTR DIS PRE; Farma T, 2001, RICERCA PSICO TERAPI, V1, P1; Flesia L., 2020, STABLE PSYCHOL TRAIT, DOI [10.31234/osf. io/yb2h8., DOI 10.3390/JCM9103350, DOI 10.31234/OSF.IO/YB2H8]; Fossati A, 2007, COMPR PSYCHIAT, V48, P380, DOI 10.1016/j.comppsych.2007.02.003; Franken IHA, 2008, PSYCHIAT RES, V158, P155, DOI 10.1016/j.psychres.2007.06.002; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Gachter S, 2009, J ECON BEHAV ORGAN, V70, P443, DOI 10.1016/j.jebo.2007.11.003; Graham J., 2008, MORAL FDN QUESTIONNA; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2008, PERSPECT PSYCHOL SCI, V3, P65, DOI 10.1111/j.1745-6916.2008.00063.x; Hameleers M., 2020, SOCARXIV, DOI [10.31235/osf.io/7pykj, DOI 10.31235/OSF.IO/7PYKJ]; Henderson RK, 2021, EVOL PSYCHOL-US, V19, DOI 10.1177/14747049211021524; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Hilbert M, 2012, PSYCHOL BULL, V138, P211, DOI 10.1037/a0025940; Iennaco D, 2018, 2018 9 IEEE INT C CO, DOI [10.1109/CogInfoCom, DOI 10.1109/COGINFOCOM]; Islam T, 2021, J RETAIL CONSUM SERV, V59, DOI 10.1016/j.jretconser.2020.102357; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kenis P, 2019, RISK HAZARDS CRISIS, V10, P275, DOI 10.1002/rhc3.12176; Kohut M, 2021, PERS INDIV DIFFER, V180, DOI 10.1016/j.paid.2021.110934; Kothari R., 2021, INT J INDIAN PSYCHOL, V9, P547; Krampe H, 2021, REVIEW, DOI [10.21203/rs.3.rs-479681/v1, DOI 10.21203/RS.3.RS-479681/V1]; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lanciano T, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.580053; Lawless L., 2013, AGR FOOD ECON, V1, P1, DOI DOI 10.1186/2193-7532-1-17; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135216; Linnemayr S, 2016, DISASTER MED PUBLIC, V10, P768, DOI 10.1017/dmp.2016.29; Linnemayr S, 2016, JAIDS-J ACQ IMM DEF, V72, pE50, DOI 10.1097/QAI.0000000000000972; Liu WJ, 2019, GRANULAR COMPUT, V4, P39, DOI 10.1007/s41066-018-0086-5; Lo Presti S, 2021, PERS INDIV DIFFER, V182, DOI 10.1016/j.paid.2021.111090; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; Misamer M, 2021, FRONT SOCIOL, V6, DOI 10.3389/fsoc.2021.705809; Mishra S., 2015, ECOPSYCHOLOGY, V7, P211, DOI [10.1089/eco.2015.0006, DOI 10.1089/ECO.2015.0006]; Mishra S, 2009, J PAC RIM PSYCHOL, V3, P11, DOI 10.1375/prp.3.1.11; Moreira D, 2019, EUR PSYCHOL, V24, P312, DOI 10.1027/1016-9040/a000360; Nafradi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186458; Nagatsuka M, 2015, SSRN ELECT J, DOI [10.2139/ssrn.2677487, DOI 10.2139/SSRN.2677487]; O'Grady T, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104331; O'Grady T, 2019, J RES PERS, V81, P224, DOI 10.1016/j.jrp.2019.06.008; Oliver A, 2018, J RISK UNCERTAINTY, V57, P29, DOI 10.1007/s11166-018-9284-4; Oosterhoff B, 2018, J RES PERS, V77, P47, DOI 10.1016/j.jrp.2018.09.008; PARKES KR, 1984, J PERS SOC PSYCHOL, V46, P655, DOI 10.1037/0022-3514.46.3.655; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; PHELPS ES, 1968, REV ECON STUD, V35, P185, DOI 10.2307/2296547; Pud D, 2004, EUR J PAIN, V8, P31, DOI 10.1016/S1090-3801(03)00065-X; Qian K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235883; Roddenberry A, 2010, CHILD PSYCHIAT HUM D, V41, P353, DOI 10.1007/s10578-010-0173-6; Rotter J.B, 1954, SOCIAL LEARNING CLIN, DOI 10.1037/10788-000; Shi R, 2020, PERS INDIV DIFFER, V159, DOI 10.1016/j.paid.2020.109828; Sigurvinsdottir R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17196985; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; Smillie LD, 2019, AUST J PSYCHOL, V71, P50, DOI 10.1111/ajpy.12229; Soofi M, 2020, APPL HEALTH ECON HEA, V18, P345, DOI 10.1007/s40258-020-00595-4; Stam CH, 2022, CURR PSYCHOL, V41, P3806, DOI 10.1007/s12144-020-00899-7; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van Baar JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09161-6; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Yang BJ, 2006, PSYCHOL REP, V98, P21, DOI 10.2644/PRO.98.1.21-22; Yang S, 2017, AM J INFECT CONTROL, V45, pE53, DOI 10.1016/j.ajic.2017.02.013; Yoshino A, 2005, BIOL PSYCHIAT, V57, P1, DOI 10.1016/j.biopsych.2004.09.027; Zaki J, 2020, TRENDS COGN SCI, V24, P587, DOI 10.1016/j.tics.2020.05.006; Zhang H, 2016, ENCY PERSONALITY IND, P1, DOI [10.1007/978-3-319-28099-8_1252-1, DOI 10.1007/978-3-319-28099-8_1252-1]; Zhang LW, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010064; Zhang ZX, 2018, INT J DISAST RISK SC, V9, P407, DOI 10.1007/s13753-018-0173-x	98	4	4	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262319	10.1371/journal.pone.0262319	http://dx.doi.org/10.1371/journal.pone.0262319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986209	gold, Green Published			2022-12-26	WOS:000765956200041
J	Fuchs, AA; Balne, PK; Giuliano, EA; Sinha, NR; Mohan, RR				Fuchs, Allison A.; Balne, Praveen K.; Giuliano, Elizabeth A.; Sinha, Nishant R.; Mohan, Rajiv R.			Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; EPIDERMAL-GROWTH-FACTOR; INTERMEDIATE-CONDUCTANCE; MITOMYCIN-C; INHIBITION; HAZE; VORINOSTAT; FIBROBLAST; APOPTOSIS; TARGET	Corneal injury and aberrant wound healing commonly result in corneal fibrosis and subsequent vision loss. Intermediate-conductance calmodulin/calcium-activated K+ channels (K(Ca)3.1) have been shown to promote fibrosis in non-ocular and ocular tissues via upregulation of transforming growth factor beta (TGF beta). TRAM-34 is a selective inhibitor of K(Ca)3.1 and reduces fibrosis by downregulation of TGF beta-induced transdifferentiation of stromal fibroblasts to myofibroblasts. Ascorbic acid has been demonstrated to be effective in promoting corneal re-epithelialization and reduction of neovascularization via anti-VEGF and anti-MMP mechanisms. This study evaluates tolerability and efficacy of a novel combination of TRAM-34 (25 mu M) and ascorbic acid (10%) topical treatment for corneal fibrosis using an established in vivo rabbit model and conducting clinical eye examinations. Markers of corneal fibrosis were evaluated in all corneas at study endpoint via histopathology, immunofluorescence, and quantitative real-time PCR. The eyedrop treated eyes showed significantly improved clinical outcomes based on modified McDonald Shadduck scores, reduction of clinical haze on Fantes scores, and reduction of central corneal thickness (CCT). At cellular and molecular levels, eyedrop treatment also significantly reduced expression of alpha smooth muscle actin (alpha-SMA) mRNA and protein, collagen III mRNA, and fibronectin mRNA compared to non-treated eyes. Our study suggests that a tested new bimodal eyedrop is well tolerated and effectively reduces corneal fibrosis/haze in rabbits in vivo.	[Fuchs, Allison A.; Balne, Praveen K.; Giuliano, Elizabeth A.; Sinha, Nishant R.; Mohan, Rajiv R.] Univ Missouri, Dept Vet Med, Coll Vet Med, Columbia, MO USA; [Fuchs, Allison A.; Balne, Praveen K.; Giuliano, Elizabeth A.; Sinha, Nishant R.; Mohan, Rajiv R.] Univ Missouri, Dept Surg, Coll Vet Med, Columbia, MO USA; [Fuchs, Allison A.; Balne, Praveen K.; Giuliano, Elizabeth A.; Sinha, Nishant R.; Mohan, Rajiv R.] Univ Missouri, Dept Biomed Sci, Coll Vet Med, Columbia, MO USA; [Balne, Praveen K.; Sinha, Nishant R.; Mohan, Rajiv R.] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Mohan, Rajiv R.] Univ Missouri, Mason Eye Inst, Sch Med, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia	Mohan, RR (corresponding author), Univ Missouri, Dept Vet Med, Coll Vet Med, Columbia, MO USA.; Mohan, RR (corresponding author), Univ Missouri, Dept Surg, Coll Vet Med, Columbia, MO USA.; Mohan, RR (corresponding author), Univ Missouri, Dept Biomed Sci, Coll Vet Med, Columbia, MO USA.; Mohan, RR (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.; Mohan, RR (corresponding author), Univ Missouri, Mason Eye Inst, Sch Med, Columbia, MO USA.	MohanR@health.missouri.edu	Balne, Praveen Kumar/X-7075-2019	Balne, Praveen Kumar/0000-0001-8365-9991; Mohan, Rajiv/0000-0002-1857-4200	University of Missouri Ruth M. Kraeuchi Endowed Chair Ophthalmology fund; American College of Veterinary Ophthalmologists Vision for Animals Foundation grant; NEI/NIH [R01EY030774, U01EY031650]; United States Department of Veterans Health Affairs [1I01BX00357, IK6BX005646]	University of Missouri Ruth M. Kraeuchi Endowed Chair Ophthalmology fund; American College of Veterinary Ophthalmologists Vision for Animals Foundation grant; NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); United States Department of Veterans Health Affairs	The work was mainly supported by the University of Missouri Ruth M. Kraeuchi Endowed Chair Ophthalmology fund (RRM) and the American College of Veterinary Ophthalmologists Vision for Animals Foundation grant (AAF); and partially by the NEI/NIH R01EY030774, NEI/NIH U01EY031650 and United States Department of Veterans Health Affairs 1I01BX00357 and IK6BX005646 grants (RRM).	Agarwal JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063028; Altmann S, 2010, INVEST OPHTH VIS SCI, V51, P4531, DOI 10.1167/iovs.09-5106; Anumanthan G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192145; Anumanthan G, 2018, EXP EYE RES, V167, P140, DOI 10.1016/j.exer.2017.12.003; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Berkowski WM, 2018, INVEST OPHTH VIS SCI, V59, P5509, DOI 10.1167/iovs.17-23085; Bosiack AP, 2012, VET OPHTHALMOL, V15, P291, DOI 10.1111/j.1463-5224.2011.00980.x; Bosiack AP, 2012, VET OPHTHALMOL, V15, P307, DOI 10.1111/j.1463-5224.2011.00985.x; Brown BM, 2020, ANNU REV PHARMACOL, V60, P219, DOI 10.1146/annurev-pharmtox-010919-023420; Buss DG, 2010, VET OPHTHALMOL, V13, P211, DOI 10.1111/j.1463-5224.2010.00782.x; Chen JL, 2017, STEM CELL TRANSL MED, V6, P1356, DOI 10.1002/sctm.16-0441; Choi K, 2012, MOL VIS, V18, P1010; Chowdhury S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070528; Dale E, 2016, GLIA, V64, P1733, DOI 10.1002/glia.22992; Donnelly KS, 2014, VET OPHTHALMOL, V17, P61, DOI 10.1111/vop.12129; Donnelly KS, 2014, VET OPHTHALMOL, V17, P162, DOI 10.1111/vop.12060; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Fink MK, 2015, VET OPHTHALMOL, V18, P242, DOI 10.1111/vop.12194; Freise C, 2015, LIVER INT, V35, P1244, DOI 10.1111/liv.12681; Freise C, 2014, PHARMACOL RES, V85, P6, DOI 10.1016/j.phrs.2014.04.013; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Gronkiewicz KM, 2016, EXP EYE RES, V143, P75, DOI 10.1016/j.exer.2015.09.010; Gronkiewicz KM, 2016, VET OPHTHALMOL, V19, P480, DOI 10.1111/vop.12331; Gupta R, 2011, VET OPHTHALMOL, V14, P304, DOI 10.1111/j.1463-5224.2011.00877.x; Gupta S, 2018, INVEST OPHTH VIS SCI, V59, P1045, DOI 10.1167/iovs.17-23308; Gupta S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172928; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Kasetsuwan N, 1999, ARCH OPHTHALMOL-CHIC, V117, P649; Koc M, 2017, J OCUL PHARMACOL TH, V33, P525, DOI 10.1089/jop.2017.0025; Lee MY, 2012, CORNEA, V31, P1165, DOI 10.1097/ICO.0b013e318241433b; Lim RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20841; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Mohan RR, 2019, EXP EYE RES, V180, P200, DOI 10.1016/j.exer.2019.01.001; Mohan RR, 2011, INVEST OPHTH VIS SCI, V52, P4833, DOI 10.1167/iovs.11-7357; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; MoSller-Pedersen T., 2009, CURR EYE RES, V17, P736; Netto MV, 2006, J REFRACT SURG, V22, P562; Netto MV, 2006, EXP EYE RES, V82, P788, DOI 10.1016/j.exer.2005.09.021; PFISTER RR, 1982, INVEST OPHTH VIS SCI, V22, P382; Roach KM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0022-0; Saika S, 2010, EYE CONTACT LENS, V36, P286, DOI 10.1097/ICL.0b013e3181eef01c; Sharma A, 2016, INVEST OPHTH VIS SCI, V57, P3381, DOI 10.1167/iovs.15-18750; Sharma A, 2009, INVEST OPHTH VIS SCI, V50, P2695, DOI 10.1167/iovs.08-2919; Tandon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066434; Tandon A, 2012, J REFRACT SURG, V28, P285, DOI 10.3928/1081597X-20120210-01; Torricelli AAM, 2016, EXP EYE RES, V142, P110, DOI 10.1016/j.exer.2014.09.012; Torricelli AAM, 2014, EXP EYE RES, V129, P151, DOI 10.1016/j.exer.2014.09.013; Wang LY, 2011, MOL VIS, V17, P2835; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Yang HK, 2013, EXP EYE RES, V110, P76, DOI 10.1016/j.exer.2013.02.015; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314	52	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262046	10.1371/journal.pone.0262046	http://dx.doi.org/10.1371/journal.pone.0262046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007294	gold, Green Published			2022-12-26	WOS:000741060700014
J	Carey, IM; Banchoff, E; Nirmalananthan, N; Harris, T; DeWilde, S; Chaudhry, UAR; Cook, DG				Carey, Iain M.; Banchoff, Emma; Nirmalananthan, Niranjanan; Harris, Tess; DeWilde, Stephen; Chaudhry, Umar A. R.; Cook, Derek G.			Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; AMYOTROPHIC-LATERAL-SCLEROSIS; DUCHENNE MUSCULAR-DYSTROPHY; MYASTHENIA-GRAVIS; INFLAMMATORY MYOPATHIES; EPIDEMIOLOGY; DISEASE; NATIONWIDE; METAANALYSIS; VALIDATION	Background In the UK, large-scale electronic primary care datasets can provide up-to-date, accurate epidemiological information on rarer diseases, where specialist diagnoses from hospital discharges and clinic letters are generally well recorded and electronically searchable. Current estimates of the number of people living with neuromuscular disease (NMD) have largely been based on secondary care data sources and lacked direct denominators. Objective To estimate trends in the recording of neuromuscular disease in UK primary care between 2000-2019. Methods The Clinical Practice Research Datalink (CPRD) database was searched electronically to estimate incidence and prevalence rates (per 100,000) for a range of NMDs in each year. To compare trends over time, rates were age standardised to the most recent CPRD population (2019). Results Approximately 13 million patients were actively registered in each year. By 2019, 28,230 active patients had ever received a NMD diagnosis (223.6), which was higher among males (239.0) than females (208.3). The most common classifications were Guillain-Barre syndrome (40.1), myasthenia gravis (33.7), muscular dystrophy (29.5), Charcot-Marie-Tooth (29.5) and inflammatory myopathies (25.0). Since 2000, overall prevalence grew by 63%, with the largest increases seen at older ages (>= 65-years). However, overall incidence remained constant, though myasthenia gravis incidence has risen steadily since 2008, while new cases of muscular dystrophy fell over the same period. Conclusions Lifetime recording of many NMDs on primary care records exceed current estimates of people living with these conditions; these are important data for health service and care planning. Temporal trends suggest this number is steadily increasing, and while this may partially be due to better recording, it cannot be simply explained by new cases, as incidence remained constant. The increase in prevalence among older ages suggests increases in life expectancy among those living with NMDs may have occurred.	[Carey, Iain M.; Banchoff, Emma; Harris, Tess; DeWilde, Stephen; Chaudhry, Umar A. R.; Cook, Derek G.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Nirmalananthan, Niranjanan] St Georges Hosp NHS Trust, Dept Neurol, London, England	St Georges University London; St Georges University London	Carey, IM (corresponding author), St Georges Univ London, Populat Hlth Res Inst, London, England.	sgjd450@sgul.ac.uk	Carey, Iain/O-6973-2014	Carey, Iain/0000-0003-1099-8460; Harris, Tess/0000-0002-8671-1553; Banchoff, Emma/0000-0003-3341-4878	Muscular Dystrophy UK [19GROE-PG24-0349-2]	Muscular Dystrophy UK	The study was funded from a research grant from Muscular Dystrophy UK (Grant Ref 19GROE-PG24-0349-2) awarded to Iain Carey as principal investigator. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hakem H, 2019, J NEUROL, V266, P440, DOI 10.1007/s00415-018-9151-x; Alkhawajah NM, 2013, MUSCLE NERVE, V48, P705, DOI 10.1002/mus.23964; All Party Parliamentary Group for Muscular Dystrophy, 2015, IMP NHS REF ACC NEUR; Barcelo MA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85395-z; Bhatt JM, 2016, NEUROL CLIN, V34, P999, DOI 10.1016/j.ncl.2016.06.017; Bragazzi NL, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02319-4; Breiner A, 2016, NEUROMUSCULAR DISORD, V26, P41, DOI 10.1016/j.nmd.2015.10.009; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; Cetin H, 2012, WIEN KLIN WOCHENSCHR, V124, P763, DOI 10.1007/s00508-012-0258-2; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Chiu ATG, 2021, EUR J NEUROL, V28, P2305, DOI 10.1111/ene.14852; Cho SK, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e55; Cole JA, 2016, PHARMACOEPIDEM DR S, V25, P103; Crisafulli S, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01430-8; de Jongh AD, 2021, NEUROLOGY, V96, pE1227, DOI 10.1212/WNL.0000000000011467; Deenen Johanna C W, 2015, J Neuromuscul Dis, V2, P73; Delannoy A, 2017, J PERIPHER NERV SYST, V22, P51, DOI 10.1111/jns.12202; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Foley C, 2012, J NEUROL NEUROSUR PS, V83, P573, DOI 10.1136/jnnp-2011-300285; Funch D, 2013, VACCINE, V31, P2075, DOI 10.1016/j.vaccine.2013.02.009; Green JD, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037909; Groft SC, 2010, ADV EXP MED BIOL, V686, P3, DOI 10.1007/978-90-481-9485-8_1; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hughes MI, 1996, NEUROMUSCULAR DISORD, V6, P69, DOI 10.1016/0960-8966(94)00017-4; Kontopantelis E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020738; Laura M, 2019, CURR OPIN NEUROL, V32, P641, DOI 10.1097/WCO.0000000000000735; Lefter S, 2017, NEUROLOGY, V88, P304, DOI 10.1212/WNL.0000000000003504; Levison LS, 2019, CLIN EPIDEMIOL, V11, P275, DOI 10.2147/CLEP.S199839; Barreto LCLS, 2016, NEUROEPIDEMIOLOGY, V46, P157, DOI 10.1159/000443706; Logroscino G, 2018, LANCET NEUROL, V17, P1083, DOI 10.1016/S1474-4422(18)30404-6; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; Mah JK, 2016, CAN J NEUROL SCI, V43, P163, DOI 10.1017/cjn.2015.311; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Marin B, 2017, INT J EPIDEMIOL, V46, P57, DOI 10.1093/ije/dyw061; McGrogan A, 2010, NEUROEPIDEMIOLOGY, V34, P171, DOI 10.1159/000279334; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Meyer A, 2015, RHEUMATOLOGY, V54, P50, DOI 10.1093/rheumatology/keu289; Muller KI, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.1948; Muscular Dystrophy Campaign, MUSCL DIS IMP INC PR; National Institute of Neurological Disorders and Stroke, 2018, GUILLAIN BARRE SYNDR; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Ohta A, 2014, MOD RHEUMATOL, V24, P477, DOI 10.3109/14397595.2013.844308; Pallaver F, 2011, NEUROEPIDEMIOLOGY, V36, P282, DOI 10.1159/000328863; Parkinson's UK, 2017, PREVALENCE INCIDENCE; Public Health England National Neurology Intelligence network and National End of life Care Intelligence Network, 2018, DEATHS ASS NEUR COND; Rodger S, 2015, J NEUROL, V262, P629, DOI 10.1007/s00415-014-7585-3; Rose L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210574; Rudant J, 2018, NEUROLOGY, V91, pE1220, DOI 10.1212/WNL.0000000000006246; Schorling E, 2019, NEUROLOGY, V92, pE2027, DOI 10.1212/WNL.0000000000007376; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sipila JOT, 2019, J NEUROL SCI, V407, DOI 10.1016/j.jns.2019.116520; Sipila JOT, 2017, J PERIPHER NERV SYST, V22, P440, DOI 10.1111/jns.12239; Sobieszczuk E, 2021, NEUROEPIDEMIOLOGY, V55, P62, DOI 10.1159/000512973; Springate DA, 2017, BRIT J DERMATOL, V176, P650, DOI 10.1111/bjd.15021; Svensson J, 2017, RHEUMATOLOGY, V56, P802, DOI 10.1093/rheumatology/kew503; Swain S, 2020, OSTEOARTHR CARTILAGE, V28, P792, DOI 10.1016/j.joca.2020.03.004; Theadom A, 2014, NEUROEPIDEMIOLOGY, V43, P259, DOI 10.1159/000369343; Tran TN., 2014, ANN RHEUM DIS, V71; Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005; Wakap SN, 2020, EUR J HUM GENET, V28, P165, DOI 10.1038/s41431-019-0508-0; Ward MM, 2005, EPIDEMIOLOGY, V16, P270, DOI 10.1097/01.ede.0000153643.88019.92; Westerberg E, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1819; Willett DL, 2018, APPL CLIN INFORM, V9, P667, DOI 10.1055/s-0038-1668090; Wolf A, 2019, INT J EPIDEMIOL, V48, P1740, DOI 10.1093/ije/dyz034; Xu L, 2020, J NEUROL, V267, P944, DOI 10.1007/s00415-019-09652-y; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Zghebi SS, 2017, DIABETES OBES METAB, V19, P1537, DOI 10.1111/dom.12964	70	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261983	10.1371/journal.pone.0261983	http://dx.doi.org/10.1371/journal.pone.0261983			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972157	Green Accepted, Green Published, gold			2022-12-26	WOS:000773555700080
J	Dembelu, M; Kote, M; Gilano, G; Mohammed, T				Dembelu, Maycas; Kote, Mesfin; Gilano, Girma; Mohammed, Temesgen			Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; PREVALENCE	Background Human immunodeficiency virus (HIV) infected individuals are prone to opportunistic infections (OIs) due to HIV mediated immune suppression. When opportunistic infections occur in the form of relapse or reinfection, it is said to be reoccurrence. This study was aimed to assess Incidence and predictors of reoccurrence of opportunistic infections among adult people living with HIV (PLHIV) attending ART clinics in Arba Minch Town, Southern Ethiopia Methods This retrospective cohort study was conducted on 450 HIV/AIDS patients attending anti-retro viral therapy (ART) clinics in Arba Minch town, southern Ethiopia. Simple random sampling technique was used. Kaplan-Meier graph and log rank test were used for group wise comparison. Bivariate and multivariable Cox Proportional Hazard Regression model were used to identify independent predictors of reoccurrence of opportunistic infection. Result One hundred nineteen HIV/AIDS patient had reoccurrence of opportunistic infection. The incidence rate was 11.5 per 1000 person months. The mean time of reoccurrence was 56 months. One of the most reoccurred OIs was pulmonary tuberculosis (PTB). Predictors that were associated significantly were recent cell differentiation 4 (CD4) count, recent body mass index (BMI), recent functional status, and duration on anti-retroviral therapy (ART). Conclusion Though the incidence rate of OIs decreased from previous findings, attention should be given to HIV patients with low CD4 count, low BMI and for those bedridden patients.	[Dembelu, Maycas] Mettu Univ, Fac Hlth Sci, Dept Nursing, Mettu, Ethiopia; [Kote, Mesfin; Gilano, Girma] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia; [Mohammed, Temesgen] Arba Minch Coll Hlth Sci, Dept Publ Hlth, Arba Minch, Ethiopia	Arba Minch University	Dembelu, M (corresponding author), Mettu Univ, Fac Hlth Sci, Dept Nursing, Mettu, Ethiopia.	MaycasDembelu27@gmail.com	Toma, Temesgen Mohammed/GZK-9176-2022; Gilano, Girma/AAU-4939-2021	Toma, Temesgen Mohammed/0000-0001-8849-6722; Gilano, Girma/0000-0002-5847-1425; Dembelu, Maycas/0000-0002-6620-8547				Achenbach CJ, 2012, CLIN INFECT DIS, V54, P424, DOI 10.1093/cid/cir802; Alemu G, 2018, ETHIOP J HEALTH SCI, V28, P147, DOI 10.4314/ejhs.v28i2.6; [Anonymous], 2011, EFF HAART INC TUB HI; [Anonymous], 2009, TRUTH STUDY TB RECUR, DOI [10.2147/IDR.S150644, DOI 10.2147/IDR.S150644]; [Anonymous], 2018, PREVALENCE OPPORTUNI; [Anonymous], 2018, HIV AIDS E SO AFRICA; Buchacz K, 2016, J INFECT DIS, V214, P862, DOI 10.1093/infdis/jiw085; Debasu DGYea., 2013, BMC RES NOTES, V6; Dereje N, 2019, HIV AIDS-RES PALLIAT, V11, P229, DOI 10.2147/HIV.S218213; HIV-AIDS, 2019, WHO MYANM WORLD AIDS; Kaplan Jonathan E., GUIDELINES PREVENTIO; Krishnaraj Raja, 2014, J Int Assoc Provid AIDS Care, V13, P15, DOI 10.1177/2325957413488170; Li XL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3991-6; Lokpo SY, 2020, AIDS RES TREAT, V2020, DOI 10.1155/2020/9247451; Maggi P, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4184-z; Mellie H., 2014, J AIDS CLIN RES, V03, DOI [10.4172/2155-6113.1000226, DOI 10.4172/2155-6113.1000226]; Naidoo K, 2018, INFECT DRUG RESIST, V11, P1413, DOI 10.2147/IDR.S150644; Nelson KCL., 2017, UGANDA COHORT STUDY, V23; Tanuma J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150781	19	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261454	10.1371/journal.pone.0261454	http://dx.doi.org/10.1371/journal.pone.0261454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972122	gold, Green Published			2022-12-26	WOS:000773555700033
J	Gilano, G; Hailegebreal, S; Seboka, BT				Gilano, Girma; Hailegebreal, Samuel; Seboka, Binyam Tariku			Geographical variation and associated factors of vitamin A supplementation among 6-59-month children in Ethiopia	PLOS ONE			English	Article							MORTALITY; COVERAGE	Introduction Vitamin A has been one of the most important micronutrients which are necessary for the health of the children. In developing countries, the supplementation of vitamins under a regular schedule had different constraints. Awareness, access, and resource limitations were usually the problem. In the current study, we analyzed the data from the demographic health survey (EDHS) 2016 to uncover the spatial distribution, predictors, and to provide additional information for policymaking and interventions. Methods In this analysis, we applied intra-community correlation to measure the random effect; global Moran's I to test the nature of variance in the null model; proportional change in variance to check the variance of null and neighborhood in subsequent models. We used STATA 15 for prediction; ArcGIS 10.7 for the spatial distribution of vitamin A supplementation; SaTscan 9.6.1 to specify location of clustering were the applied soft wares. After confirming that the traditional logistic regression cannot explore the variances, we applied multilevel logistic regression to examine predictors where p-value <0.25 was used to include variables into the model and p-value<0.05 was used to declare associations. We presented the result using means, standard deviations, numbers, and proportions or percent, and AOR with 95% CI. Result The vitamin A coverage was 4,029.22 (44.90%) in Ethiopia in 2016. The distribution followed some spatial geo-locations where Afar, Somali were severely affected (RR = 1.46, P-value < 0.001), some pockets of Addis Ababa (RR = 1.47, p-value <0.001), and the poor distribution also affected all other regions partially. Place of delivery 1.2(1-1.34), primary and secondary education 1.3 (1-1.6), media exposure 1.2(1.1-1.4), having work 1.4(1.2-1.5), and all visits of ANC were positively influenced the distribution. Conclusion The distribution of vitamin A coverage was not random as per the EDHS 2016 data. Regions like Afar, Somali, and some pocket areas in Addis inquires immediate interventions. Pastoralist, agrarian, and city administrations were all involved from severe to the lesser coverage in order. Since factors like Place of delivery, education, ANC, media exposure, and having work were showed positive associations, interventions considering awareness, access, and availability of service need more attention than ever.	[Gilano, Girma; Hailegebreal, Samuel] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Informat, Arba Minch, Ethiopia; [Seboka, Binyam Tariku] Dilla Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Informat, Dilla, Ethiopia	Arba Minch University; Dilla University	Gilano, G (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Informat, Arba Minch, Ethiopia.	gilanog@yahoo.com	Gilano, Girma/AAU-4939-2021; Seboka, Binyam Tariku/AAC-5370-2021	Gilano, Girma/0000-0002-5847-1425; Seboka, Binyam Tariku/0000-0002-8309-5986; Hailegebreal, Samuel/0000-0003-0887-7803				Adamu M. D., 2016, Annals of Nigerian Medicine, V10, P16, DOI 10.4103/0331-3131.189803; Aghaji AE., 2019, BMC PUBLIC HEALTH, V19, P1, DOI [10.1186/s12889-018-6343-3, DOI 10.1186/S12889-018-6343-3]; [Anonymous], 2021, UNICEF EV CHILD ETH, P1; Central statistical agency (CSA)[Ethiopia] and ICF, ETH DEM HLTH SURV; Chisti M. J., 2013, Food and Nutrition Sciences, V4, P150, DOI 10.4236/fns.2013.42021; Choi YJ, 2005, J HEALTH POPUL NUTR, V23, P156; Demissie T, 2010, FOOD NUTR BULL, V31, P234, DOI 10.1177/156482651003100206; ECSA, 2016, ETH DEM HLTH SURV, P161; Gatobu S, 2017, FOOD NUTR BULL, V38, P564, DOI 10.1177/0379572117708657; Gebremedhin S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-79; Haidar J., 2016, THE MAGAZINE; Hurt L, 2013, B WORLD HEALTH ORGAN, V91, P19, DOI 10.2471/BLT.11.100412; Janmohamed A, 2017, PUBLIC HEALTH NUTR, V20, P2016, DOI 10.1017/S1368980017000684; Kassa G, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09617-1; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Muche A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82755-7; Regional O., 2012, OROMIA REGIONAL HLTH; Rodriguez G, 2003, STATA J, V3, P32, DOI 10.1177/1536867X0300300102; Ross DA, 2002, J NUTR, V132, p2902S, DOI 10.1093/jn/132.9.2902S; Semba RD, 2008, J TROP PEDIATRICS, V54, P141, DOI 10.1093/tropej/fmm095; SOMMER A, 1986, LANCET, V1, P1169; Tariku Amare, 2016, BMC Res Notes, V9, P323, DOI 10.1186/s13104-016-2134-z; WHO, 2011, GUID VIT SUPPL INF C; Wilfred N. D., 2018, Food and Nutrition Sciences, V9, P247, DOI 10.4236/fns.2018.93019; World Bank Group, 2019, ETH NUTR PROJ PERF A, P9; World Health Organization & Centers for Disease Control and Prevention (U.S, 2014, METHODOLOGICAL APPRO; Zhang XY, 2020, FOODS, V9, DOI 10.3390/foods9020232	27	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261959	10.1371/journal.pone.0261959	http://dx.doi.org/10.1371/journal.pone.0261959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972168	gold, Green Published			2022-12-26	WOS:000773555700076
J	Fernando, S; Salagaras, T; Schwarz, N; Sandeman, L; Tan, JTM; Xie, JL; Zareh, J; Jensen, K; Williamson, A; Dimasi, C; Chhay, P; Toledo-Flores, D; Long, A; Manavis, J; Worthington, M; Fitridge, R; Di Bartolo, BA; Bursill, CA; Nicholls, SJ; Proud, CG; Psaltis, PJ				Fernando, Sanuja; Salagaras, Thalia; Schwarz, Nisha; Sandeman, Lauren; Tan, Joanne T. M.; Xie, Jianling; Zareh, Jonar; Jensen, Kirk; Williamson, Anna; Dimasi, Catherine; Chhay, Pich; Toledo-Flores, Deborah; Long, Aaron; Manavis, Jim; Worthington, Michael; Fitridge, Robert; Di Bartolo, Belinda A.; Bursill, Christina A.; Nicholls, Stephen J.; Proud, Christopher G.; Psaltis, Peter J.			Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36	FASEB JOURNAL			English	Article						atherosclerosis; CD36; eEF2K; foam cells; macrophages; protein translation	SCAVENGER RECEPTOR CD36; EXPRESSION; EEF2K; PHOSPHORYLATION; PROLIFERATION; HYPERTENSION; APOPTOSIS; MIGRATION; PROTECTS; SURVIVAL	Eukaryotic elongation factor 2 kinase (eEF2K) is an atypical protein kinase that controls protein synthesis in cells under stress. Although well studied in cancer, less is known about its roles in chronic inflammatory diseases. Here, we examined its regulation of macrophage cholesterol handling in the context of atherosclerosis. eEF2K mRNA expression and protein activity were upregulated in murine bone marrow-derived macrophages (BMDMs) exposed to oxidized low-density lipoprotein cholesterol (oxLDL). When incubated with oxLDL, BMDMs from eEF2K knockout (Eef2k(-/-)) mice formed fewer Oil Red O+ foam cells than Eef2k(+/+) BMDMs (12.5% +/- 2.3% vs. 32.3% +/- 2.0%, p < .01). Treatment with a selective eEF2K inhibitor, JAN-384, also decreased foam cell formation for C57BL/6J BMDMs and human monocyte-derived macrophages. Disabling eEF2K selectively decreased protein expression of the CD36 cholesterol uptake receptor, mediated by a reduction in the proportion of translationally active Cd36 mRNA. Eef2k(-/-) mice bred onto the Ldlr(-/-) background developed aortic sinus atherosclerotic plaques that were 30% smaller than Eef2k(+/+)-Ldlr(-/-) mice after 16 weeks of high cholesterol diet (p < .05). Although accompanied by a reduction in plaque CD36(+) staining (p < .05) and lower CD36 expression in circulating monocytes (p < .01), this was not associated with reduced lipid content in plaques as measured by oil red O staining. Finally, EEF2K and CD36 mRNA levels were higher in blood mononuclear cells from patients with coronary artery disease and recent myocardial infarction compared to healthy controls without coronary artery disease. These results reveal a new role for eEF2K in translationally regulating CD36 expression and foam cell formation in macrophages. Further studies are required to explore therapeutic targeting of eEF2K in atherosclerosis.	[Fernando, Sanuja; Salagaras, Thalia; Schwarz, Nisha; Sandeman, Lauren; Tan, Joanne T. M.; Zareh, Jonar; Williamson, Anna; Dimasi, Catherine; Chhay, Pich; Toledo-Flores, Deborah; Long, Aaron; Bursill, Christina A.; Nicholls, Stephen J.; Psaltis, Peter J.] Vasc Res Ctr, South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, Heart & Vasc Program, Level 6,POB 11060, Adelaide, SA 5001, Australia; [Fernando, Sanuja; Sandeman, Lauren; Tan, Joanne T. M.; Williamson, Anna; Manavis, Jim; Fitridge, Robert; Bursill, Christina A.; Psaltis, Peter J.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Xie, Jianling; Jensen, Kirk; Proud, Christopher G.] South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, Lifelong Hlth Nutr & Metab, Adelaide, SA, Australia; [Worthington, Michael] Royal Adelaide Hosp, Dept Cardiothorac Surg, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia; [Fitridge, Robert] Royal Adelaide Hosp, Dept Vasc Surg, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia; [Di Bartolo, Belinda A.] Univ Sydney, Kolling Inst, Sydney, NSW, Australia; [Nicholls, Stephen J.] Monash Univ, Monash Cardiovasc Res Ctr, Victoria, Australia; [Proud, Christopher G.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Psaltis, Peter J.] Royal Adelaide Hosp, Dept Cardiol, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Royal Adelaide Hospital; Royal Adelaide Hospital; University of Sydney; Kolling Institute of Medical Research; Monash University; University of Adelaide; Royal Adelaide Hospital	Psaltis, PJ (corresponding author), Vasc Res Ctr, South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, Heart & Vasc Program, Level 6,POB 11060, Adelaide, SA 5001, Australia.	peter.psaltis@sahmri.com		Fitridge, Robert/0000-0001-6258-5997; Tan, Joanne/0000-0003-1875-4882; Bursill, Christina/0000-0002-0682-8760; Dimasi, Catherine/0000-0001-9907-2909	National Health and Medical Research Council (NHMRC) [PG 1142794, CDF 1161506]; National Heart Foundation of Australia (Heart Foundation) [FLF 102056]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia (Heart Foundation)	National Health and Medical Research Council (NHMRC), Grant/Award Number: PG 1142794; CDF 1161506; National Heart Foundation of Australia (Heart Foundation), Grant/Award Number: FLF 102056	Ashour AA, 2014, APOPTOSIS, V19, P241, DOI 10.1007/s10495-013-0927-2; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chen JH, 2009, ARTERIOSCL THROM VAS, V29, P92, DOI 10.1161/ATVBAHA.108.174599; Chistiakov DA, 2016, J CELL MOL MED, V20, P17, DOI 10.1111/jcmm.12689; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Corpeleijn E, 2008, J PHYSIOL PHARMACOL, V59, P77; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Fu LL, 2014, APOPTOSIS, V19, P1527, DOI 10.1007/s10495-014-1019-7; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Kameshima S, 2015, AM J PHYSIOL-HEART C, V308, pH1298, DOI 10.1152/ajpheart.00864.2014; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Kenney JW, 2016, J NEUROCHEM, V136, P276, DOI 10.1111/jnc.13407; Kenney Justin W., 2014, Advances in Biological Regulation, V55, P15, DOI 10.1016/j.jbior.2014.04.003; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Martinet W, 2014, ATHEROSCLEROSIS, V233, P601, DOI 10.1016/j.atherosclerosis.2014.01.040; Moore CEJ, 2016, CELL SIGNAL, V28, P284, DOI 10.1016/j.cellsig.2016.01.005; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Nakata A, 1999, ARTERIOSCL THROM VAS, V19, P1333, DOI 10.1161/01.ATV.19.5.1333; Niculite CM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00680; Piechota M, 2012, PROTEIN J, V31, P511, DOI 10.1007/s10930-012-9431-8; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Portal VL, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1564-1; Proud CG, 2015, BIOCHEM SOC T, V43, P328, DOI 10.1042/BST20140323; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Taha E, 2020, CURR BIOL, V30, P3507, DOI 10.1016/j.cub.2020.06.061; Usui T, 2015, ACTA PHYSIOL, V213, P472, DOI 10.1111/apha.12354; Usui T, 2013, AM J PHYSIOL-HEART C, V305, pH756, DOI 10.1152/ajpheart.00373.2013; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang XM, 2017, CANCERS, V9, DOI 10.3390/cancers9120162; Wu Y, 2020, BIOCHEM J, V477, P4367, DOI 10.1042/BCJ20200697; Xie JL, 2019, J BIOL CHEM, V294, P7169, DOI 10.1074/jbc.AC119.008036; Xie JL, 2018, INT J CANCER, V142, P1865, DOI 10.1002/ijc.31210; Xie JL, 2015, MOL CELL BIOL, V35, P1805, DOI 10.1128/MCB.00012-15; Yan PK, 2011, INT J BIOL SCI, V7, P937, DOI 10.7150/ijbs.7.937; Yuasa-Kawase M, 2012, J ATHEROSCLER THROMB, V19, P263, DOI 10.5551/jat.10603; Zhang P, 2014, CAN J CARDIOL, V30, P1684, DOI 10.1016/j.cjca.2014.09.019; Zhu HC, 2017, RADIOTHER ONCOL, V124, P439, DOI 10.1016/j.radonc.2017.04.001	44	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22154	10.1096/fj.202101034R	http://dx.doi.org/10.1096/fj.202101034R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032419				2022-12-26	WOS:000747987800022
J	Forsdyke, DR				Forsdyke, Donald R.			When "doping" is OK: The importance not only of basic research, but how it is funded	FASEB JOURNAL			English	Editorial Material									[Forsdyke, Donald R.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Forsdyke, DR (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	forsdyke@queensu.ca	Forsdyke, Donald/A-1182-2012	Forsdyke, Donald/0000-0002-4844-1417				Anonymous,, 2021, IMMUNITY, V54, P2673; APIRION D, 1979, FED PROC, V38, P2649; Fauci AS, 2021, IMMUNITY, V54, P2676, DOI 10.1016/j.immuni.2021.10.018; FORSDYKE DR, 1993, FASEB J, V7, P619, DOI 10.1096/fasebj.7.8.8500686; FORSDYKE DR, 1991, FASEB J, V5, P2313, DOI 10.1096/fasebj.5.9.1860622; Forsdyke DR, PEER REV WEBPAGES PE; Forsdyke DR., 2000, TOMORROWS CURES TODA; Germain RN, 2015, CELL, V161, P1485, DOI 10.1016/j.cell.2015.05.052; Gibson EK, 2020, SCIENCE, V369, P258, DOI 10.1126/science.abb4913; Pederson T, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2110706118j1of3, 10.1073/pnas.2110706118]; Shapiro L, 2021, CELL, V184, P5271, DOI 10.1016/j.cell.2021.08.019; Wilkinson E, 2010, LANCET, V375, P185, DOI 10.1016/S0140-6736(10)60075-X	12	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22158	10.1096/fj.202101955	http://dx.doi.org/10.1096/fj.202101955			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35028966				2022-12-26	WOS:000747987800017
J	Kuwahara, M; Akasaki, Y; Kurakazu, I; Sueishi, T; Toya, M; Uchida, T; Tsutsui, T; Hirose, R; Tsushima, H; Teramura, T; Nakashima, Y				Kuwahara, Masanari; Akasaki, Yukio; Kurakazu, Ichiro; Sueishi, Takuya; Toya, Masakazu; Uchida, Taisuke; Tsutsui, Tomoaki; Hirose, Ryota; Tsushima, Hidetoshi; Teramura, Takeshi; Nakashima, Yasuharu			C10orf10/DEPP activates mitochondrial autophagy and maintains chondrocyte viability in the pathogenesis of osteoarthritis	FASEB JOURNAL			English	Article						autophagy; C10orf10; DEPP; chondrocyte; mitochondria; osteoarthritis	FOXO TRANSCRIPTION FACTORS; OXIDATIVE STRESS; CARTILAGE; HOMEOSTASIS; DEGRADATION; MECHANISMS; EXPRESSION; PROTEIN; GENES; BNIP3	Osteoarthritis (OA), the most prevalent joint disease, is characterized by the progressive loss of articular cartilage. Autophagy, a lysosomal degradation pathway, maintains cellular homeostasis, and autophagic dysfunction in chondrocytes is a hallmark of OA pathogenesis. However, the cause of autophagic dysfunction in OA chondrocytes remains incompletely understood. Recent studies have reported that decidual protein induced by progesterone (C10orf10/DEPP) positively regulates autophagic functions. In this study, we found that DEPP was involved in mitochondrial autophagic functions of chondrocytes, as well as in OA pathogenesis. DEPP expression decreased in human OA chondrocytes in the absence or presence of pro-inflammatory cytokines, and was induced by starvation, hydrogen peroxide (H2O2), and hypoxia (cobalt chloride). For functional studies, DEPP knockdown decreased autophagic flux induced by H2O2, whereas DEPP overexpression increased autophagic flux and maintained cell viability following H2O2 treatment. DEPP was downregulated by knockdown of forkhead box class O (FOXO) transcription factors and modulated the autophagic function regulated by FOXO3. In an OA mouse model by destabilization of the medial meniscus, DEPP-knockout mice exacerbated the progression of cartilage degradation with TUNEL-positive cells, and chondrocytes isolated from knockout mice were decreased autophagic flux and increased cell death following H2O2 treatment. Subcellular fractionation analysis revealed that mitochondria-located DEPP activated mitochondrial autophagy via BCL2 interacting protein 3. Taken together, our data demonstrate that DEPP is a major stress-inducible gene involved in the activation of mitochondrial autophagy in chondrocytes, and maintains chondrocyte viability during OA pathogenesis. DEPP represents a potential therapeutic target for enhancing autophagy in patients with OA.	[Kuwahara, Masanari; Akasaki, Yukio; Kurakazu, Ichiro; Sueishi, Takuya; Toya, Masakazu; Uchida, Taisuke; Tsutsui, Tomoaki; Hirose, Ryota; Tsushima, Hidetoshi; Nakashima, Yasuharu] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan; [Teramura, Takeshi] Kindai Univ, Inst Adv Clin Med, Div Cell Biol Regenerat Med, Fac Med, Osaka, Japan	Kyushu University; Kindai University (Kinki University)	Akasaki, Y (corresponding author), Kyushu Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	alcasaki.yukio.443@m.kyushu-u.ac.jp	Teramura, Takeshi/ELU-7591-2022	Kuwahara, Masanari/0000-0002-8621-4629; Akasaki, Yukio/0000-0002-3666-3952; Sueishi, Takuya/0000-0001-8799-0315	Japan Orthopaedics and Traumatology Foundation; Japan Society for the Promotion of Science [17H05097]	Japan Orthopaedics and Traumatology Foundation(Japan Orthopaedics and Traumatology Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Orthopaedics and Traumatology Foundation (JOTF); Japan Society for the Promotion of Science, Grant/Award Number: 17H05097	Akasaki Y, 2014, ARTHRITIS RHEUMATOL, V66, P3349, DOI 10.1002/art.38868; Alvarez-Garcia O, 2017, ARTHRITIS RHEUMATOL, V69, P1418, DOI 10.1002/art.40104; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Blanco FJ, 2020, OSTEOARTHR CARTILAGE, V28, P1003, DOI 10.1016/j.joca.2020.03.018; Carames B, 2015, ARTHRITIS RHEUMATOL, V67, P1568, DOI 10.1002/art.39073; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Chen SM, 2011, FEBS LETT, V585, P1796, DOI 10.1016/j.febslet.2011.04.024; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Duan R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.608388; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Kurakazu I, 2019, J BIOL CHEM, V294, P17555, DOI 10.1074/jbc.RA119.009409; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Li W, 2018, FASEB J, V32, P5459, DOI 10.1096/fj.201800357R; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Loeser RF, 2016, NAT REV RHEUMATOL, V12, P412, DOI 10.1038/nrrheum.2016.65; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; Mao K, 2014, AUTOPHAGY, V10, P652, DOI 10.4161/auto.27852; Matsuzaki T, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan0746; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Milner PJ, 2006, ARTHRITIS RHEUM-US, V54, P3523, DOI 10.1002/art.22209; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Salcher S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-224; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; Sasaki H, 2012, ARTHRITIS RHEUM-US, V64, P1920, DOI 10.1002/art.34323; Shin DH, 2005, DEV DYNAM, V233, P1589, DOI 10.1002/dvdy.20479; Stepp MW, 2014, BBA-MOL CELL RES, V1843, P1076, DOI 10.1016/j.bbamcr.2014.02.003; Sueishi T, 2020, ARTHRITIS RHEUMATOL, V72, P620, DOI 10.1002/art.41152; Sun K, 2021, AUTOPHAGY, V17, P2082, DOI 10.1080/15548627.2020.1822097; Vasheghani F, 2015, ANN RHEUM DIS, V74, P569, DOI 10.1136/annrheumdis-2014-205743; Vellai T, 2009, CELL DEATH DIFFER, V16, P94, DOI 10.1038/cdd.2008.126; Watanabe H, 2005, MOL HUM REPROD, V11, P471, DOI 10.1093/molehr/gah186; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Y, 2015, ANN RHEUM DIS, V74, P1432, DOI 10.1136/annrheumdis-2013-204599	47	2	2	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22145	10.1096/fj.202100896R	http://dx.doi.org/10.1096/fj.202100896R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34997944	Green Accepted			2022-12-26	WOS:000747987800006
J	Lim, SY; Yamaguchi, K; Itakura, M; Chikazawa, M; Matsuda, T; Uchida, K				Lim, Sei-Young; Yamaguchi, Kosuke; Itakura, Masanori; Chikazawa, Miho; Matsuda, Tomonari; Uchida, Koji			Unique B-1 cells specific for both N-pyrrolated proteins and DNA evolve with apolipoprotein E deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-M ANTIBODIES; GLYCATION END-PRODUCTS; ANTI-DNA; B-CELLS; GENE UTILIZATION; SEQUENCE; MURINE; MICE; REPERTOIRES; CDR3	Lysine N-pyrrolation, a posttranslational modification, which converts lysine residues to N-epsilon-pyrrole-L-lysine, imparts electronegative properties to proteins, causing them to mimic DNA. Apolipoprotein E (apoE) has been identified as a soluble receptor for pyrrolated proteins (pyrP), and accelerated lysine N-pyrrolation has been observed in apoE-deficient (apoE(-/-)) hyperlipidemic mice. However, the impact of pyrP accumulation consequent to apoE deficiency on the innate immune response remains unclear. Here, we investigated B-1a cells known to produce germline-encoded immunoglobulin M (IgM) from mice deficient in apoE and identified a particular cell population that specifically produces IgM antibodies against pyrP and DNA. We demonstrated an expansion of B-1a cells involved in IgM production in the peritoneal cavity of apoE(-/-) mice compared with wild-type mice, consistent with a progressive increase of IgM response in the mouse sera. We found that pyrP exhibited preferential binding to B-1a cells and facilitated the production of IgM. B cell receptor analysis of pyrP-specific B-1a cells showed restricted usage of gene segments selected from the germline gene set; most sequences contained high levels of non-templated-nucleotide additions (N-additions) that could contribute to junctional diversity of B cell receptors. Finally, we report that a subset of monoclonal IgM antibodies against pyrP/DNA established from the apoE(-/-) mice also contained abundant N-additions. These results suggest that the accumulation of pyrP due to apoE deficiency may influence clonal diversity in the pyrP-specific B cell repertoire. The discovery of these unique B-1a cells for pyrP/DNA provides a key link connecting covalent protein modification, lipoprotein metabolism, and innate immunity.	[Lim, Sei-Young; Yamaguchi, Kosuke; Itakura, Masanori; Chikazawa, Miho; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga, Japan; [Uchida, Koji] Japan Agcy Med Res & Dev, CREST, Tokyo, Japan	University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Uchida, K (corresponding author), Japan Agcy Med Res & Dev, CREST, Tokyo, Japan.	a-uchida@g.ecc.u-tokyo.ac.jp		Chikazawa, Miho/0000-0002-7447-8387	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [JP17H06170];  [JP20gm0910013]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported in part by a Grant-in-Aid for Scientific Research (S) (JP17H06170) (K. U.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This research was also supported by AMED-CREST from AMED (JP20gm0910013) (K. U.).	AHMED SA, 1989, J IMMUNOL, V142, P2647; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Bello-Gil D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01449; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Chikazawa M, 2020, J BIOL CHEM, V295, P7697, DOI 10.1074/jbc.RA120.013179; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; EILAT D, 1988, J IMMUNOL, V141, P1745; Endo R, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100648; Feeney A J, 1992, Int Rev Immunol, V8, P113, DOI 10.3109/08830189209055567; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Frohlich J, 2015, ARCH PHARM, V348, P589, DOI 10.1002/ardp.201500114; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hara Y, 2013, ANAL CHIM ACTA, V793, P107, DOI 10.1016/j.aca.2013.07.024; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021; HIDALGO FJ, 1995, CHEM PHYS LIPIDS, V77, P1; HIDALGO FJ, 1993, J BIOL CHEM, V268, P16190; Hirose S, 2019, J BIOL CHEM, V294, P11035, DOI 10.1074/jbc.RA118.006629; Holodick NE, 2014, J IMMUNOL, V192, P2432, DOI 10.4049/jimmunol.1300247; Huang CA, 1996, EUR J IMMUNOL, V26, P2537, DOI 10.1002/eji.1830261039; Hutchinson MA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.695220; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; Itakura K, 1998, J ORG CHEM, V63, P185, DOI 10.1021/jo971239+; Jethwa HS, 2000, J IMMUNOL, V165, P3890, DOI 10.4049/jimmunol.165.7.3890; Kantor A B, 1996, Semin Immunol, V8, P29, DOI 10.1006/smim.1996.0005; Krishnan MR, 1998, SCAND J IMMUNOL, V48, P223; Krishnan MR, 1996, J IMMUNOL, V157, P2430; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Ma ZJ, 2008, CLIN IMMUNOL, V127, P168, DOI 10.1016/j.clim.2008.01.002; MARNETT LJ, 1980, CANCER RES, V40, P276; MERCOLINO TJ, 1988, J EXP MED, V168, P687, DOI 10.1084/jem.168.2.687; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miyashita H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05343; Prohaska TA, 2018, J IMMUNOL, V200, P1702, DOI 10.4049/jimmunol.1700568; REES MS, 1993, SYNTHETIC COMMUN, V23, P757, DOI 10.1080/00397919308009836; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Salomon RG, 1997, CHEM RES TOXICOL, V10, P536, DOI 10.1021/tx960157y; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsuji N, 2020, J IMMUNOL, V205, P741, DOI 10.4049/jimmunol.1901302; Wang YH, 2012, BIOCHEM BIOPH RES CO, V423, P805, DOI 10.1016/j.bbrc.2012.06.044; Wloch MK, 1997, J IMMUNOL, V158, P4500; Wloch MK, 1996, EUR J IMMUNOL, V26, P2225, DOI 10.1002/eji.1830260939; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhou Y, 1999, BRAIN RES BULL, V49, P173, DOI 10.1016/S0361-9230(99)00052-0	63	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101582	10.1016/j.jbc.2022.101582	http://dx.doi.org/10.1016/j.jbc.2022.101582			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35031322	gold, Green Published			2022-12-26	WOS:000761371500012
J	Zhou, YZ; Zheng, R; Liu, SX; Disoma, C; Du, A; Li, SQ; Chen, ZP; Dong, ZJ; Zhang, YX; Li, SJ; Liu, PJ; Razzaq, A; Chen, X; Liao, YJ; Tao, SY; Liu, YX; Xu, LN; Zhang, QJ; Peng, J; Deng, X; Li, SN; Jiang, TJ; Xia, ZX				Zhou, Yuzheng; Zheng, Rong; Liu, Sixu; Disoma, Cyrollah; Du, Ashuai; Li, Shiqin; Chen, Zongpeng; Dong, Zijun; Zhang, Yongxing; Li, Sijia; Liu, Pinjia; Razzaq, Aroona; Chen, Xuan; Liao, Yujie; Tao, Siyi; Liu, Yuxin; Xu, Lunan; Zhang, Qianjun; Peng, Jian; Deng, Xu; Li, Shanni; Jiang, Taijiao; Xia, Zanxian			Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; PAPAIN-LIKE PROTEASE; SARS; APOPTOSIS; PATHOGENESIS; PNEUMONIA; TRANSMISSION; PROTEOLYSIS; EVOLUTION	With the outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), coronaviruses have begun to attract great attention across the world. Of the known human coronaviruses, however, Middle East respiratory syndrome coronavirus (MERS-CoV) is the most lethal. Coronavirus proteins can be divided into three groups: nonstructural proteins, structural proteins, and accessory proteins. While the number of each of these proteins varies greatly among different coronaviruses, accessory proteins are most closely related to the pathogenicity of the virus. We found for the first time that the ORF3 accessory protein of MERS-CoV, which closely resembles the ORF3a proteins of severe acute respiratory syndrome coronavirus and SARS-CoV-2, has the ability to induce apoptosis in cells in a dose-dependent manner. Through bioinformatics analysis and validation, we revealed that ORF3 is an unstable protein and has a shorter half-life in cells compared to that of severe acute respiratory syndrome coronavirus and SARS-CoV-2 ORF3a proteins. After screening, we identified a host E3 ligase, HUWE1, that specifically induces MERS-CoV ORF3 protein ubiquitination and degradation through the ubiquitin-proteasome system. This results in the diminished ability of ORF3 to induce apoptosis, which might partially explain the lower spread of MERS-CoV compared to other coronaviruses. In summary, this study reveals a pathological function of MERS-CoV ORF3 protein and identifies a potential host antiviral protein, HUWE1, with an ability to antagonize MERS-CoV pathogenesis by inducing ORF3 degradation, thus enriching our knowledge of the pathogenesis of MERS-CoV and suggesting new targets and strategies for clinical development of drugs for MERS-CoV treatment.	[Zhou, Yuzheng; Zheng, Rong; Liu, Sixu; Disoma, Cyrollah; Du, Ashuai; Li, Shiqin; Chen, Zongpeng; Zhang, Yongxing; Li, Sijia; Liu, Pinjia; Razzaq, Aroona; Chen, Xuan; Liao, Yujie; Tao, Siyi; Liu, Yuxin; Xu, Lunan; Li, Shanni; Xia, Zanxian] Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha, Peoples R China; [Dong, Zijun] Hunan Normal Univ, Sch Med, Dept Basic Med, Changsha, Peoples R China; [Zhang, Qianjun] Cent South Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha, Peoples R China; [Peng, Jian] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Peoples R China; [Deng, Xu] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha, Peoples R China; [Jiang, Taijiao] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Syst Med, Inst Basic Med Sci, Beijing, Peoples R China; [Xia, Zanxian] Cent South Univ, Hunan Key Lab Med Genet, Hunan Key Lab Anim Models Human Dis, Sch Life Sci, Changsha, Peoples R China; [Xia, Zanxian] Cent South Univ, Ctr Med Genet, Sch Life Sci, Changsha, Peoples R China	Central South University; Hunan Normal University; Central South University; Central South University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Central South University; Central South University	Xia, ZX (corresponding author), Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha, Peoples R China.; Xia, ZX (corresponding author), Cent South Univ, Hunan Key Lab Med Genet, Hunan Key Lab Anim Models Human Dis, Sch Life Sci, Changsha, Peoples R China.; Xia, ZX (corresponding author), Cent South Univ, Ctr Med Genet, Sch Life Sci, Changsha, Peoples R China.	xiazanxian@sklmg.edu.cn	Disoma, Cyrollah/ABC-7475-2020	Disoma, Cyrollah/0000-0002-7916-6606	National Key Research and Development Program of China [2021YFC2300103, 2016YFD0500300]; National Natural Science Foundation of China [U21A20384, 82072293]; Key Research and Development Program of Hunan Province [2020SK2054]; Zhejiang University special scientific research fund for COVID-19 prevention and control [2020XGZX033]; Changsha special scientific research fund for COVID-19 prevention and control [kq2001030]; Central South University Graduate Research Innovation Project [2018zzts387]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Hunan Province; Zhejiang University special scientific research fund for COVID-19 prevention and control; Changsha special scientific research fund for COVID-19 prevention and control; Central South University Graduate Research Innovation Project	This work was supported by the National Key Research and Development Program of China (2021YFC2300103 and 2016YFD0500300), the National Natural Science Foundation of China (U21A20384 and 82072293), the Key Research and Development Program of Hunan Province (2020SK2054), Zhejiang University special scientific research fund for COVID-19 prevention and control (2020XGZX033), Changsha special scientific research fund for COVID-19 prevention and control (kq2001030), and the Central South University Graduate Research Innovation Project (2018zzts387).	Aleidi SM, 2015, J BIOL CHEM, V290, P24604, DOI 10.1074/jbc.M115.675579; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bose R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17902-0; Burslem GM, 2020, CELL, V181, P102, DOI 10.1016/j.cell.2019.11.031; Chafekar A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020093; Chan CM, 2009, INT J BIOCHEM CELL B, V41, P2232, DOI 10.1016/j.biocel.2009.04.019; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chau TN, 2004, HEPATOLOGY, V39, P302, DOI 10.1002/hep.20111; Chu H, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf8577; COLLINS M, 1995, AM J RESP CRIT CARE, V152, pS20, DOI 10.1164/ajrccm/152.4_Pt_2.S20; Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; de Wispelaere M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11429-w; Dominguez Andres Ana, 2020, bioRxiv, DOI 10.1101/2020.08.18.256776; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fernandes MHV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00363; Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Garant KA, 2016, ONCOGENE, V35, P771, DOI 10.1038/onc.2015.136; Guan W. J., 2020, N ENGL; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Guo Y, 2020, J CLIN INVEST, V130, P6301, DOI 10.1172/JCI138234; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jensen SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02697; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Karuppannan AK, 2011, VIROLOGY, V410, P248, DOI 10.1016/j.virol.2010.11.009; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Le TM, 2007, FEBS J, V274, P4211, DOI 10.1111/j.1742-4658.2007.05947.x; Leung A, 2018, GENOME RES, V28, P1791, DOI 10.1101/gr.233585.117; Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074; Liu DX, 2014, ANTIVIR RES, V109, P97, DOI 10.1016/j.antiviral.2014.06.013; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Matthews KL, 2014, J GEN VIROL, V95, P874, DOI 10.1099/vir.0.062059-0; Menachery VD, 2017, MBIO, V8, DOI 10.1128/mBio.00665-17; Michel CJ, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01402-1; Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Oh SJ, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030530; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Redondo N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708264; Ren YJ, 2020, CELL MOL IMMUNOL, V17, P881, DOI 10.1038/s41423-020-0485-9; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Shi CS, 2014, J IMMUNOL, V193, P3080, DOI 10.4049/jimmunol.1303196; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Singh S, 2021, PHARMACOL THERAPEUT, V224, DOI 10.1016/j.pharmthera.2021.107809; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Strappazzon F, 2020, CELL DEATH DIFFER, V27, P1155, DOI 10.1038/s41418-019-0404-8; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Sui LY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.662989; Sun XY, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0101-6; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan YX, 2007, J VIROL, V81, P6346, DOI 10.1128/JVI.00090-07; Tao XR, 2013, J VIROL, V87, P9953, DOI 10.1128/JVI.01562-13; Tsoi H, 2014, BIOCHEM J, V464, P439, DOI 10.1042/BJ20131461; Verma R, 2020, MOL CELL, V77, P446, DOI 10.1016/j.molcel.2020.01.010; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2; Wong HH, 2018, VIROLOGY, V515, P165, DOI 10.1016/j.virol.2017.12.028; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Yamamoto SP, 2011, MICROBES INFECT, V13, P339, DOI 10.1016/j.micinf.2010.12.002; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17554; Yang Y, 2013, PROTEIN CELL, V4, P951, DOI 10.1007/s13238-013-3096-8; Yeung ML, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.4, 10.1038/nmicrobiol.2016.4]; Yu X, 2015, BIOCHEM BIOPH RES CO, V459, P270, DOI 10.1016/j.bbrc.2015.02.097; Yu Y., 2020, LANCET RESP MED, V8, P481; Yuen CK, 2020, EMERG MICROBES INFEC, V9, P1418, DOI 10.1080/22221751.2020.1780953; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17796-z; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	84	2	2	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101584	10.1016/j.jbc.2022.101584	http://dx.doi.org/10.1016/j.jbc.2022.101584			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1JE	35032548	gold, Green Published			2022-12-26	WOS:000761380200001
J	Capai, L; Piorkowski, G; Maestrini, O; Casabianca, F; Masse, S; de Lamballerie, X; Charrel, RN; Falchi, A				Capai, Lisandru; Piorkowski, Geraldine; Maestrini, Oscar; Casabianca, Francois; Masse, Shirley; de Lamballerie, Xavier; Charrel, Remi N.; Falchi, Alessandra			Detection of porcine enteric viruses (Kobuvirus, Mamastrovirus and Sapelovirus) in domestic pigs in Corsica, France	PLOS ONE			English	Article							MOLECULAR-DETECTION; GENETIC-CHARACTERIZATION; PIGLETS; ASTROVIRUSES; PREVALENCE; SEQUENCE; DIARRHEA; PROVINCE; SAMPLES; ACID	Many enteric viruses are found in pig farms around the world and can cause death of animals or important production losses for breeders. Among the wide spectrum of enteric viral species, porcine Sapelovirus (PSV), porcine Kobuvirus (PKoV) and porcine Astrovirus (PAstV) are frequently found in pig feces. In this study we investigated sixteen pig farms in Corsica, France, to evaluate the circulation of three enteric viruses (PKoV, PAstV-1 and PSV). In addition to the three viruses studied by RT-qPCR (908 pig feces samples), 26 stool samples were tested using the Next Generation Sequencing method (NGS). Our results showed viral RNA detection rates (i) of 62.0% [58.7-65.1] (n = 563/908) for PSV, (ii) of 44.8% [41.5-48.1] (n = 407/908) for PKoV and (iii) of 8.6% [6.8-10.6] (n = 78/908) for PAstV-1. Significant differences were observed for all three viruses according to age (P-value = 2.4e-13 for PAstV-1; 2.4e-12 for PKoV and 0.005 for PSV). The type of breeding was significantly associated with RNA detection only for PAstV-1 (P-value = 9.6e-6). Among the 26 samples tested with NGS method, consensus sequences corresponding to 10 different species of virus were detected. This study provides first insight on the presence of three common porcine enteric viruses in France. We also showed that they are frequently encountered in pigs born and bred in Corsica, which demonstrates endemic local circulation.	[Capai, Lisandru; Masse, Shirley; Falchi, Alessandra] Univ Corse, Lab Virol, UR 7310, Corte, France; [Piorkowski, Geraldine; de Lamballerie, Xavier; Charrel, Remi N.] Aix Marseille Univ IRD, Unite Virus Emergents UVE, Inserm 1207 190, Marseille, France; [Maestrini, Oscar; Casabianca, Francois] Inst Natl Rech Agr Alimentat & Environm INRAE, Lab Rech Sur Dev Elevage LRDE, Corte, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; INRAE	Capai, L; Falchi, A (corresponding author), Univ Corse, Lab Virol, UR 7310, Corte, France.	capai_l@univ-corse.fr; falchi_a@univ-corse.fr		Capai, Lisandru/0000-0002-3618-1582				Amimo JO, 2014, ARCH VIROL, V159, P1313, DOI 10.1007/s00705-013-1942-x; [Anonymous], 2017, PAN AGR CORS; Arruda PHE, 2017, TRANSBOUND EMERG DIS, V64, P311, DOI 10.1111/tbed.12621; Arya R, 2012, INDIAN J PEDIATR, V79, P1482, DOI 10.1007/s12098-012-0763-3; Barry AF, 2011, INFECT GENET EVOL, V11, P1811, DOI 10.1016/j.meegid.2011.06.020; BOURNE FJ, 1973, IMMUNOLOGY, V24, P157; Buitrago D, 2010, J VET DIAGN INVEST, V22, P763, DOI 10.1177/104063871002200519; Capai L, 2019, TRANSBOUND EMERG DIS, V66, P2462, DOI 10.1111/tbed.13304; Casabianca F., 2000, BUILDING STANDARD EL, P23; Charrier F, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00001; Chen JW, 2012, J VIROL, V86, P10898, DOI 10.1128/JVI.01799-12; Chen Q, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1001-z; Di Profio F, 2013, RES VET SCI, V95, P782, DOI 10.1016/j.rvsc.2013.06.020; Donin DG, 2014, TROP ANIM HEALTH PRO, V46, P523, DOI 10.1007/s11250-013-0523-z; ESTES MK, 1983, CURR TOP MICROBIOL, V105, P123; Holtz LR, 2011, EMERG INFECT DIS, V17, P2050, DOI 10.3201/eid1711.110496; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019206; ICTV, 2019, ICOTOV GEN KOB; Johnson C, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010022; Jori F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080236; Khamrin Pattara, 2014, VirusDisease, V25, P195, DOI 10.1007/s13337-014-0200-5; Khamrin P, 2010, INFECT GENET EVOL, V10, P950, DOI 10.1016/j.meegid.2010.06.001; Kim DS, 2016, J GEN VIROL, V97, P2566, DOI 10.1099/jgv.0.000571; Kim DS, 2016, J VIROL, V90, P4067, DOI 10.1128/JVI.02449-15; KLOBASA F, 1987, AM J VET RES, V48, P176; Krumbholz A, 2002, J VIROL, V76, P5813, DOI 10.1128/JVI.76.11.5813-5821.2002; Kumthip K, 2018, ARCH VIROL, V163, P1823, DOI 10.1007/s00705-018-3806-x; Lan DL, 2011, ARCH VIROL, V156, P1567, DOI 10.1007/s00705-011-1035-7; Liu GH, 2012, TROP ANIM HEALTH PRO, V44, P1335, DOI 10.1007/s11250-012-0138-9; Meng XJ, 2012, TRANSBOUND EMERG DIS, V59, P85, DOI 10.1111/j.1865-1682.2011.01291.x; MONROE SS, 1993, J VIROL, V67, P3611, DOI 10.1128/JVI.67.6.3611-3614.1993; Mor SK, 2012, J VET DIAGN INVEST, V24, P1064, DOI 10.1177/1040638712458781; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Ouyang T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020185; Park SJ, 2010, ARCH VIROL, V155, P1803, DOI 10.1007/s00705-010-0774-1; Piorkowski G, 2018, MICROBIOL RESOUR ANN, V7, DOI [10.1128/MRA.01049-18, 10.1128/mra.01049-18]; Ray PK, 2018, TRANSBOUND EMERG DIS, V65, P261, DOI 10.1111/tbed.12628; Reuter G, 2009, ARCH VIROL, V154, P101, DOI 10.1007/s00705-008-0288-2; Reuter G, 2008, EMERG INFECT DIS, V14, P1968, DOI 10.3201/eid1412.080797; Reuter G, 2011, ARCH VIROL, V156, P125, DOI 10.1007/s00705-010-0827-5; Saade G, 2020, VET RES, V51, DOI 10.1186/s13567-020-00807-8; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Salamunova S, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1640-8; Salines M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0207-y; Schock A, 2014, VET MICROBIOL, V172, P381, DOI 10.1016/j.vetmic.2014.06.001; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shan TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017292; Son KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107860; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; Westerman LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052281; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Xiao CT, 2013, J GEN VIROL, V94, P570, DOI 10.1099/vir.0.048744-0; Yang Z, 2014, ARCH VIROL, V159, P3407, DOI 10.1007/s00705-014-2204-2; Yu JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070137; Yu JM, 2011, ARCH VIROL, V156, P747, DOI 10.1007/s00705-010-0907-6; Zhang B, 2014, J GEN VIROL, V95, P1603, DOI 10.1099/vir.0.063743-0; Zhang Q, 2013, ARCH VIROL, V158, P1631, DOI 10.1007/s00705-013-1659-x; Zhou WG, 2016, VET MICROBIOL, V182, P75, DOI 10.1016/j.vetmic.2015.10.019	58	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0260161	10.1371/journal.pone.0260161	http://dx.doi.org/10.1371/journal.pone.0260161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030164	gold, Green Published, Green Submitted			2022-12-26	WOS:000812798500005
J	Rass, M; Gizler, L; Bayersdorfer, F; Irlbeck, C; Schramm, M; Schneuwly, S				Rass, Mathias; Gizler, Laura; Bayersdorfer, Florian; Irlbeck, Christoph; Schramm, Matthias; Schneuwly, Stephan			The Drosophila functional Smad suppressing element fuss, a homologue of the human Skor genes, retains pro-oncogenic properties of the Ski/Sno family	PLOS ONE			English	Article							HISTONE DEACETYLASE COMPLEX; CELL-PROLIFERATION; SKI; EYE; WINGLESS; DIFFERENTIATION; EXPRESSION; MORPHOGENESIS; REPRESSION; RECEPTOR	Over the years Ski and Sno have been found to be involved in cancer progression e.g. in oesophageal squamous cell carcinoma, melanoma, oestrogen receptor-positive breast carcinoma, colorectal carcinoma, and leukaemia. Often, their prooncogenic features have been linked to their ability of inhibiting the anti-proliferative action of TGF-beta signalling. Recently, not only pro-oncogenic but also anti-oncogenic functions of Ski/Sno proteins have been revealed. Besides Ski and Sno, which are ubiquitously expressed other members of Ski/Sno proteins exist which show highly specific neuronal expression, the SKI Family Transcriptional Corepressors (Skor). Among others Skor1 and Skor2 are involved in the development of Purkinje neurons and a mutation of Skor1 has been found to be associated with restless legs syndrome. But neither Skor1 nor Skor2 have been reported to be involved in cancer progression. Using overexpression studies in the Drosophila eye imaginal disc, we analysed if the Drosophila Skor homologue Fuss has retained the potential to inhibit differentiation and induce increased proliferation. Fuss expressed in cells posterior to the morphogenetic furrow, impairs photoreceptor axon pathfinding and inhibits differentiation of accessory cells. However, if its expression is induced prior to eye differentiation, Fuss might inhibit the differentiating function of Dpp signalling and might maintain proliferative action of Wg signalling, which is reminiscent of the Ski/Sno protein function in cancer.	[Rass, Mathias; Gizler, Laura; Bayersdorfer, Florian; Irlbeck, Christoph; Schramm, Matthias; Schneuwly, Stephan] Univ Regensburg, Inst Zool, Dept Dev Biol, Regensburg, Germany	University of Regensburg	Rass, M (corresponding author), Univ Regensburg, Inst Zool, Dept Dev Biol, Regensburg, Germany.	mathias.rass@ur.de		Rass, Mathias/0000-0001-7509-0336; Gizler, Laura/0000-0003-4710-5275; Irlbeck, Christoph/0000-0002-0097-5639				Arndt S, 2005, LAB INVEST, V85, P1330, DOI 10.1038/labinvest.3700344; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; Arndt S, 2011, AM J PATHOL, V178, P2622, DOI 10.1016/j.ajpath.2011.02.009; Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096; Bennett D, 2015, OCUL ONCOL PATHOL, V1, P190, DOI 10.1159/000370155; Bhandari P, 2001, ONCOGENE, V20, P6871, DOI 10.1038/sj.onc.1204849; Brunner E, 1999, DEV BIOL, V206, P178, DOI 10.1006/dbio.1998.9136; Buess M, 2004, NEOPLASIA, V6, P207, DOI 10.1593/neo.03442; Cadigan KM, 2002, DEVELOPMENT, V129, P3393; Chen R, 1999, DEVELOPMENT, V126, P935; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Cordero JB, 2007, DEVELOPMENT, V134, P1861, DOI 10.1242/dev.002972; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Enomoto M, 2015, DEV BIOL, V403, P162, DOI 10.1016/j.ydbio.2015.05.001; Fischer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042349; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Fu WM, 1998, DEVELOPMENT, V125, P2943; Heider TR, 2007, ANN SURG, V246, P61, DOI 10.1097/SLA.0b013e318070cafa; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Jahchan NS, 2012, DEVELOPMENT, V139, P3147, DOI 10.1242/dev.079616; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Johnson LN, 1999, J CHEM SOC PAKISTAN, V21, P185; Katanaev VL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77942-x; Kobayashi N, 2007, GENES CELLS, V12, P375, DOI 10.1111/j.1365-2443.2007.01052.x; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Lee JD, 2001, DEVELOPMENT, V128, P1519; Legent Kevin, 2008, V469, P141, DOI 10.1007/978-1-60327-469-2_12; Love MI, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007664; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Nakatani T, 2014, DEV BIOL, V388, P68, DOI 10.1016/j.ydbio.2014.01.016; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Pappu K, 2002, RES PRO CEL, V37, P5; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Piper MDW, 2018, BBA-MOL BASIS DIS, V1864, P2707, DOI 10.1016/j.bbadis.2017.09.016; Poser I, 2005, INT J ONCOL, V26, P1411; Rass Mathias, 2020, MicroPubl Biol, V2020, DOI 10.17912/micropub.biology.000230; Rass M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007940; Read RD, 2005, GENETICS, V171, P1057, DOI 10.1534/genetics.104.038018; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Royet J, 1997, DEVELOPMENT, V124, P4793; Sarayloo F, 2020, EUR J HUM GENET, V28, P1520, DOI 10.1038/s41431-020-0670-4; Schott S, 2017, DEVELOPMENT, V144, P3840, DOI 10.1242/dev.149807; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; STAVNEZER E, 1989, MOL CELL BIOL, V9, P4038, DOI 10.1128/MCB.9.9.4038; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Takaesu NT, 2012, DEVELOPMENT, V139, P3392, DOI 10.1242/dev.079442; Wang BP, 2011, DEVELOPMENT, V138, P4487, DOI 10.1242/dev.067264; Weasner BM, 2013, DEVELOPMENT, V140, P205, DOI 10.1242/dev.085423; Wiersdorff V, 1996, DEVELOPMENT, V122, P2153; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Yang HP, 2015, ONCOL REP, V34, P87, DOI 10.3892/or.2015.3961; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243; Yoshida S, 2005, DEVELOPMENT, V132, P4587, DOI 10.1242/dev.02040; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06; Zielke N, 2014, CELL REP, V7, P588, DOI 10.1016/j.celrep.2014.03.020	63	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262360	10.1371/journal.pone.0262360	http://dx.doi.org/10.1371/journal.pone.0262360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030229	gold, Green Published			2022-12-26	WOS:000812798500041
J	Harati, R; Hammad, S; Tlili, A; Mahfood, M; Mabondzo, A; Hamoudi, R				Harati, Rania; Hammad, Saba; Tlili, Abdelaziz; Mahfood, Mona; Mabondzo, Aloise; Hamoudi, Rifat			miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability	PLOS ONE			English	Article							IN-VITRO MODEL; WNT/BETA-CATENIN; CELL-LINE; INJURY; TRANSPORTER; DISRUPTION; MICRORNAS; CLAUDIN-5; PROTEINS; HCMEC/D3	Background The brain endothelial barrier permeability is governed by tight and adherens junction protein complexes that restrict paracellular permeability at the blood-brain barrier (BBB). Dysfunction of the inter-endothelial junctions has been implicated in neurological disorders such as multiple sclerosis, stroke and Alzheimer's disease. The molecular mechanisms underlying junctional dysfunction during BBB impairment remain elusive. MicroRNAs (miRNAs) have emerged as versatile regulators of the BBB function under physiological and pathological conditions, and altered levels of BBB-associated microRNAs were demonstrated in a number of brain pathologies including neurodegeneration and neuroinflammatory diseases. Among the altered micro-RNAs, miR-27a-3p was found to be downregulated in a number of neurological diseases characterized by loss of inter-endothelial junctions and disruption of the barrier integrity. However, the relationship between miR-27a-3p and tight and adherens junctions at the brain endothelium remains unexplored. Whether miR-27a-3p is involved in regulation of the junctions at the brain endothelium remains to be determined. Methods Using a gain-and-loss of function approach, we modulated levels of miR-27a-3p in an in-vitro model of the brain endothelium, key component of the BBB, and examined the resultant effect on the barrier paracellular permeability and on the expression of essential tight and adherens junctions. The mechanisms governing the regulation of junctional proteins by miR-27a-3p were also explored. Results Our results showed that miR-27a-3p inhibitor increases the barrier permeability and causes reduction of claudin-5 and occludin, two proteins highly enriched at the tight junction, while miR-27a-3p mimic reduced the paracellular leakage and increased claudin-5 and occludin protein levels. Interestingly, we found that miR-27-3p induces expression of claudin-5 and occludin by downregulating Glycogen Synthase Kinase 3 beta (GSK3 beta) and activating Wnt/beta-catenin signaling, a key pathway required for the BBB maintenance. Conclusion For the first time, we showed that miR-27a-3p is a positive regulator of key tight junction proteins, claudin-5 and occludin, at the brain endothelium through targeting GSK3 beta gene and activating Wnt/beta-catenin signaling. Thus, miR-27a-3p may constitute a novel therapeutic target that could be exploited to prevent BBB dysfunction and preserves its integrity in neurological disorders characterized by impairment of the barrier's function.	[Harati, Rania; Hammad, Saba] Univ Sharjah, Dept Pharm Practice & Pharmacotherapeut, Coll Pharm, Sharjah, U Arab Emirates; [Harati, Rania; Hammad, Saba] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Tlili, Abdelaziz; Mahfood, Mona] Univ Sharjah, Dept Appl Biol, Coll Sci, Sharjah, U Arab Emirates; [Mabondzo, Aloise] Univ Paris Saclay, Dept Med & Healthcare Technol, French Alternat Energies & Atom Energy Commiss, Gif Sur Yvette, France; [Hamoudi, Rifat] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates; [Hamoudi, Rifat] UCL, Div Surg & Intervent Sci, London, England	University of Sharjah; University of Sharjah; University of Sharjah; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Sharjah; University of London; University College London	Harati, R (corresponding author), Univ Sharjah, Dept Pharm Practice & Pharmacotherapeut, Coll Pharm, Sharjah, U Arab Emirates.; Harati, R (corresponding author), Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.	rharati@sharjah.ac.ae		Hammad, Saba/0000-0002-3016-495X; Harati, Rania/0000-0001-6672-2944	University of Sharjah [1701110321-P]	University of Sharjah	This work was supported by the University of Sharjah Competitive Grant (Grant no. 1701110321-P). R Harati received this funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Ban JJ, 2017, BIOCHEM BIOPH RES CO, V488, P316, DOI 10.1016/j.bbrc.2017.05.040; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bauer HC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00392; BENSON P F, 1961, Cereb Palsy Bull, V3, P510; Bernardo-Castro S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.594672; Cerutti C, 2017, SCI REP-UK, V7, DOI 10.1038/srep45284; Chen HJ, 2020, TECHNOL CANCER RES T, V19, DOI 10.1177/1533033820965576; Cucullo L, 2008, J CEREBR BLOOD F MET, V28, P312, DOI 10.1038/sj.jcbfm.9600525; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Enciu AM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/297512; Errede M, 2012, J NEUROPATH EXP NEUR, V71, P840, DOI 10.1097/NEN.0b013e31826ac110; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Frigerio CS, 2013, NEUROLOGY, V81, P2103, DOI 10.1212/01.wnl.0000437306.37850.22; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Greene C, 2018, MOL PSYCHIATR, V23, P2156, DOI 10.1038/mp.2017.156; Greene C., 2019, CLAUDIN 5 GATEKEEPER, P15; Greene C, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01054-3; Harati R, 2021, BREAST CANCER RES TR, V187, P695, DOI 10.1007/s10549-021-06255-y; Harati R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239292; Harati R, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13070144; Harati R, 2013, MOL PHARMACEUT, V10, P1566, DOI 10.1021/mp300334r; Harati R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-273; Laksitorini MD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56075-w; Lee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30875-y; Lengfeld JE, 2017, P NATL ACAD SCI USA, V114, pE1168, DOI 10.1073/pnas.1609905114; Li J, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000734; Liang T, 2020, ACTA BIOCH BIOPH SIN, V52, P363, DOI 10.1093/abbs/gmaa002; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu LM, 2014, NEUROCHEM INT, V75, P19, DOI 10.1016/j.neuint.2014.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Lv JJ, 2018, PROG NEUROBIOL, V161, P79, DOI 10.1016/j.pneurobio.2017.12.001; Maixner Dylan Warren, 2013, J Pharm Pharmacol (Los Angel), V1, P001; Marco S, 2006, NEUROSCI LETT, V401, P219, DOI 10.1016/j.neulet.2006.03.047; Ng L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080826; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Paul D, 2013, MICROVASC RES, V86, P1, DOI 10.1016/j.mvr.2012.12.001; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Ramirez SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055972; Reijerkerk A, 2013, J NEUROSCI, V33, P6857, DOI 10.1523/JNEUROSCI.3965-12.2013; Roig-Carles D, 2017, PROG INFLAMM RES SER, P153, DOI 10.1007/978-3-319-45514-3_7; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Romanitan MO, 2010, J CELL MOL MED, V14, P1088, DOI 10.1111/j.1582-4934.2009.00999.x; Santha P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00088; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Tran KA, 2016, CIRCULATION, V133, P177, DOI 10.1161/CIRCULATIONAHA.115.015982; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Watson CP, 2016, BRAIN RES, V1648, P232, DOI 10.1016/j.brainres.2016.07.026; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Wu RZ, 2020, CANCER MANAG RES, V12, P6241, DOI 10.2147/CMAR.S255419; Xi TY, 2018, J BIOL CHEM, V293, P20041, DOI 10.1074/jbc.RA118.001858; Xiao H, 2017, J NEUROCHEM, V142, P194, DOI 10.1111/jnc.14051; Yamazaki Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091965; Young JA, 2013, BLOOD, V122, P2911, DOI 10.1182/blood-2012-12-473017; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	62	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262152	10.1371/journal.pone.0262152	http://dx.doi.org/10.1371/journal.pone.0262152			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025943	Green Published, gold			2022-12-26	WOS:000796264200051
J	Tanaka, J; Ishikawa, F; Jinno, T; Miyakita, M; Miyamori, H; Sasaki, T; Yokokawa, T; Goto, T; Inoue, K; Matsumura, S				Tanaka, Jin; Ishikawa, Fuka; Jinno, Tomoki; Miyakita, Motoki; Miyamori, Haruka; Sasaki, Tsutomu; Yokokawa, Takumi; Goto, Tsuyoshi; Inoue, Kazuo; Matsumura, Shigenobu			Disruption of CRTC1 and CRTC2 in Sim1 cells strongly increases high-fat diet intake in female mice but has a modest impact on male mice	PLOS ONE			English	Article							CREB COACTIVATOR TORC2; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; NEURONS; HYPOTHALAMUS; ACTIVATION; EXPRESSION; PATHWAYS; GLUCOSE; CORTICOTROPIN	cAMP responsive element binding protein (CREB)-regulated transcription coactivators (CRTCs) regulate gene transcription in response to an increase in intracellular cAMP or Ca2+ levels. To date, three isoforms of CRTC have been identified in mammals. All CRTCs are widely expressed in various regions of the brain. Numerous studies have shown the importance of CREB and CRTC in energy homeostasis. In the brain, the paraventricular nucleus of the hypothalamus (PVH) plays a critical role in energy metabolism, and CRTC1 and CRTC2 are highly expressed in PVH neuronal cells. The single-minded homolog 1 gene (Sim1) is densely expressed in PVH neurons and in some areas of the amygdala neurons. To determine the role of CRTCs in PVH on energy metabolism, we generated mice that lacked CRTC1 and CRTC2 in Sim1 cells using Sim-1 cre mice. We found that Sim1 cell-specific CRTC1 and CRTC2 double-knockout mice were sensitive to high-fat diet (HFD)-induced obesity. Sim1 cell-specific CRTC1 and CRTC2 double knockout mice showed hyperphagia specifically for the HFD, but not for the normal chow diet, increased fat mass, and no change in energy expenditure. Interestingly, these phenotypes were stronger in female mice than in male mice, and a weak phenotype was observed in the normal chow diet. The lack of CRTC1 and CRTC2 in Sim1 cells changed the mRNA levels of some neuropeptides that regulate energy metabolism in female mice fed an HFD. Taken together, our findings suggest that CRTCs in Sim1 cells regulate gene expression and suppress excessive fat intake, especially in female mice.	[Tanaka, Jin; Ishikawa, Fuka; Jinno, Tomoki; Miyakita, Motoki; Miyamori, Haruka; Yokokawa, Takumi; Goto, Tsuyoshi; Inoue, Kazuo; Matsumura, Shigenobu] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Sasaki, Tsutomu] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Matsumura, Shigenobu] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Dept Clin Nutr, Osaka, Japan	Kyoto University; Osaka University; Osaka Metropolitan University	Matsumura, S (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan.; Matsumura, S (corresponding author), Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Dept Clin Nutr, Osaka, Japan.	smatsumara@rehab.osakafu-u.ac.jp		Matsumura, Shigenobu/0000-0002-7149-1375	Takeda Life Science foundation; JSPS Kakenhi	Takeda Life Science foundation; JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Takeda Life Science foundation and JSPS Kakenhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2006, OBESITY, V14, P222; Belgacem YH, 2017, ADV EXP MED BIOL, V1015, P19, DOI 10.1007/978-3-319-62817-2_2; Butler AA, 2002, NEUROPEPTIDES, V36, P77, DOI 10.1054/npep.2002.0890; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Chiappini F, 2011, J BIOL CHEM, V286, P8094, DOI 10.1074/jbc.M110.178186; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Elmquist JK, 2001, INT J OBESITY, V25, pS78, DOI 10.1038/sj.ijo.0801918; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Guo TT, 2020, NEUROSCI LETT, V714, DOI 10.1016/j.neulet.2019.134550; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kwon E, 2020, FRONT NEURAL CIRCUIT, V14, DOI 10.3389/fncir.2020.595783; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Li YQ, 2016, J CLIN INVEST, V126, P40, DOI 10.1172/JCI76348; Liu Y, 2011, J NEUROENDOCRINOL, V23, P216, DOI 10.1111/j.1365-2826.2010.02101.x; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsumura S, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqab076; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Okamoto S, 2018, CELL REP, V22, P706, DOI 10.1016/j.celrep.2017.11.102; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Pei HJ, 2014, MOL METAB, V3, P209, DOI 10.1016/j.molmet.2013.12.006; Qin C, 2018, ENDOCRINOLOGY, V159, P3458, DOI 10.1210/en.2018-00453; Ravnskjaer K, 2016, HANDB EXP PHARMACOL, V233, P29, DOI 10.1007/164_2015_32; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sohn JW, 2015, BMB REP, V48, P229, DOI 10.5483/BMBRep.2015.48.4.272; Sutton AK, 2016, ANNU REV PHYSIOL, V78, P207, DOI 10.1146/annurev-physiol-021115-105347; Sutton AK, 2014, J NEUROSCI, V34, P15306, DOI 10.1523/JNEUROSCI.0226-14.2014; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Watts AG, 2011, J NEUROENDOCRINOL, V23, P754, DOI 10.1111/j.1365-2826.2011.02178.x; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045167; Xi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036453; Zhu CJ, 2020, EMBO REP, DOI 10.15252/embr.201949210	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262577	10.1371/journal.pone.0262577	http://dx.doi.org/10.1371/journal.pone.0262577			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020776	Green Published, gold			2022-12-26	WOS:000834207700052
J	Ward, A; Sarraju, A; Lee, D; Bhasin, K; Gad, S; Beetel, R; Chang, S; Bonafede, M; Rodriguez, F; Dash, R				Ward, Andrew; Sarraju, Ashish; Lee, Donghyun; Bhasin, Kanchan; Gad, Sanchit; Beetel, Rob; Chang, Stella; Bonafede, Mac; Rodriguez, Fatima; Dash, Rajesh			COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; VALIDATION; CODES	Introduction Infection with SARS-CoV-2 is typically compared with influenza to contextualize its health risks. SARS-CoV-2 has been linked with coagulation disturbances including arterial thrombosis, leading to considerable interest in antithrombotic therapy for Coronavirus Disease 2019 (COVID-19). However, the independent thromboembolic risk of SARS-CoV-2 infection compared with influenza remains incompletely understood. We evaluated the adjusted risks of thromboembolic events after a diagnosis of COVID-19 compared with influenza in a large retrospective cohort. Methods We used a US-based electronic health record (EHR) dataset linked with insurance claims to identify adults diagnosed with COVID-19 between April 1, 2020 and October 31, 2020. We identified influenza patients diagnosed between October 1, 2018 and April 31, 2019. Primary outcomes [venous composite of pulmonary embolism (PE) and acute deep vein thrombosis (DVT); arterial composite of ischemic stroke and myocardial infarction (MI)] and secondary outcomes were assessed 90 days post-diagnosis. Propensity scores (PS) were calculated using demographic, clinical, and medication variables. PS-adjusted hazard ratios (HRs) were calculated using Cox proportional hazards regression. Results There were 417,975 COVID-19 patients (median age 57y, 61% women), and 345,934 influenza patients (median age 47y, 66% women). Compared with influenza, patients with COVID-19 had higher venous thromboembolic risk (HR 1.53, 95% CI 1.38-1.70), but not arterial thromboembolic risk (HR 1.02, 95% CI 0.95-1.10). Secondary analyses demonstrated similar risk for ischemic stroke (HR 1.11, 95% CI 0.98-1.25) and MI (HR 0.93, 95% CI 0.85-1.03) and higher risk for DVT (HR 1.36, 95% CI 1.19-1.56) and PE (HR 1.82, 95% CI 1.57-2.10) in patients with COVID-19. Conclusion In a large retrospective US cohort, COVID-19 was independently associated with higher 90-day risk for venous thrombosis, but not arterial thrombosis, as compared with influenza. These findings may inform crucial knowledge gaps regarding the specific thromboembolic risks of COVID-19.	[Ward, Andrew; Lee, Donghyun; Bhasin, Kanchan; Gad, Sanchit; Beetel, Rob; Dash, Rajesh] HealthPals Inc, Redwood City, CA USA; [Sarraju, Ashish; Rodriguez, Fatima; Dash, Rajesh] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Sarraju, Ashish; Rodriguez, Fatima; Dash, Rajesh] Stanford Univ, Cardiovasc Inst, Stanford, CA 94305 USA; [Chang, Stella; Bonafede, Mac] Veradigm, Chicago, IL USA	Stanford University; Stanford University	Sarraju, A (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.; Sarraju, A (corresponding author), Stanford Univ, Cardiovasc Inst, Stanford, CA 94305 USA.	asarraju@stanford.edu		Ward, Andrew/0000-0002-4692-1126; Sarraju, Ashish/0000-0003-1649-2110	American Heart Association [20SFRN35360178]; National Heart, Lung, and Blood Institute, National Institutes of Health [1K01HL144607]	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	HealthPals provided support for this study in the form of salary for AW, DL, KB, SG, and RB. Veradigm provided support for this study in the form of salary for SC and MB. AS received support from the American Heart Association (20SFRN35360178). FR received support from the National Heart, Lung, and Blood Institute, National Institutes of Health (1K01HL144607). The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Samkari H, 2021, JAMA-J AM MED ASSOC, V325, P1613, DOI 10.1001/jama.2021.4295; Ammann EM, 2018, PHARMACOEPIDEM DR S, V27, P398, DOI 10.1002/pds.4398; Ammann EM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009960; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bilaloglu S, 2020, JAMA-J AM MED ASSOC, V324, P799, DOI 10.1001/jama.2020.13372; Chan NC, 2016, CIRC RES, V118, P1409, DOI 10.1161/CIRCRESAHA.116.306925; Cheruiyot I, 2021, ANN VASC SURG, V70, P273, DOI 10.1016/j.avsg.2020.08.087; Cutrona SL, 2013, PHARMACOEPIDEM DR S, V22, P40, DOI 10.1002/pds.3310; Franklin JM, 2017, STAT MED, V36, P1946, DOI 10.1002/sim.7250; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Jevnikar M, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00116-2021; Katherine Yih W., 2020, MASTER PROTOCOL DEV; Katsoularis I, 2021, LANCET, V398, P599, DOI 10.1016/S0140-6736(21)00896-5; Lo Re V III., 2021, SENTINEL INITIATIVE; Lo Re V III., 2021, 2 SENT IN; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Piroth L, 2021, LANCET RESP MED, V9, P251, DOI 10.1016/S2213-2600(20)30527-0; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Stewart M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248128; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261786	10.1371/journal.pone.0261786	http://dx.doi.org/10.1371/journal.pone.0261786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020742	Green Published, Green Submitted, gold			2022-12-26	WOS:000834207700023
J	Wu, C; Xu, C; Mao, F; Xu, XL; Zhang, C				Wu, Chao; Xu, Cong; Mao, Feng; Xu, Xiaolin; Zhang, Chan			The impact of invisible-spreaders on COVID-19 transmission and work resumption	PLOS ONE			English	Article								The global impact of coronavirus disease 2019 (COVID-19) is unprecedented, and many control and prevention measures have been implemented to test for and trace COVID-19. However, invisible-spreaders, who are associated with nucleic acid detection and asymptomatic infections, have received insufficient attention in the current COVID-19 control efforts. In this paper, we analyze the time series infection data for Italy, Germany, Brazil, India and Sweden since the first wave outbreak to address the following issues through a series of experiments. We conclude that: 1) As of June 1, 2020, the proportion of invisible-spreaders is close to 0.4% in Sweden, 0.8% in early Italy and Germany, and 0.4% in the middle and late stages. However, in Brazil and India, the proportion still shows a gradual upward trend; 2) During the spread of this pandemic, even a slight increase in the proportion of invisible-spreaders could have large implications for the health of the community; and 3) On resuming work, the pandemic intervention measures will be relaxed, and invisible-spreaders will cause a new round of outbreaks.	[Wu, Chao; Xu, Cong] Zhejiang Univ, Sch Publ Affairs, Hangzhou, Peoples R China; [Wu, Chao] Imperial Coll London, Data Sci Inst, London, England; [Mao, Feng] Cardiff Univ, Sch Earth & Environm Sci, Cardiff, Wales; [Xu, Xiaolin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Biostat Bioinformat & Big Data,Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiaolin] Zhejiang Univ, Sch Med, Dept Big Data Hlth Sci, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiaolin] Natl Inst Data Sci Hlth & Med, Hangzhou, Zhejiang, Peoples R China; [Zhang, Chan] Zhejiang Univ, Coll Media & Int Culture, Hangzhou, Peoples R China	Zhejiang University; Imperial College London; Cardiff University; Zhejiang University; Zhejiang University; Zhejiang University	Wu, C (corresponding author), Zhejiang Univ, Sch Publ Affairs, Hangzhou, Peoples R China.; Wu, C (corresponding author), Imperial Coll London, Data Sci Inst, London, England.; Mao, F (corresponding author), Cardiff Univ, Sch Earth & Environm Sci, Cardiff, Wales.	chao.wu@zju.edu.cn; MaoF1@cardiff.ac.uk						[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], CORONAVIRUS ITALYS P; [Anonymous], CORONAVIRUS GERMANY; Apple Google., PRIV PRES CONT TRAC; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bailey NTJ, 1975, MATH THEORY INFECT D; BELLMAN R, 1957, J MATH MECH, V6, P679, DOI 10.1512/iumj.1957.6.56038; Benvenuto D, 2020, PATHOG GLOB HEALTH, V114, P64, DOI 10.1080/20477724.2020.1725339; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Ferguson N. M., 2020, REPORT 9 IMPACT NONP; Habib H, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2376; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Liao XL, 2020, INTENS CARE MED, V46, P357, DOI 10.1007/s00134-020-05954-2; Meijering E, 2002, P IEEE, V90, P319, DOI 10.1109/5.993400; West CP, 2020, MAYO CLIN PROC, V95, P1127, DOI 10.1016/j.mayocp.2020.04.004; Winichakoon P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00297-20; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Ye Zhen, 2020, IWEBCEE; Yun Gao, WUHAN IS SAFE 989 MI	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0252994	10.1371/journal.pone.0252994	http://dx.doi.org/10.1371/journal.pone.0252994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020722	gold, Green Published, Green Accepted			2022-12-26	WOS:000834207700004
J	Belakehal, F; Barth, SA; Menge, C; Mossadak, HT; Malek, N; Moser, I				Belakehal, Faiza; Barth, Stefanie A.; Menge, Christian; Mossadak, Hamdi T.; Malek, Naim; Moser, Irmgard			Evaluation of the discriminatory power of spoligotyping and 19-locus mycobacterial interspersed repetitive unit-variable number of tandem repeat analysis (MIRU-VNTR) of Mycobacterium bovis strains isolated from cattle in Algeria	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX BACTERIA; GENETIC DIVERSITY; LIVESTOCK; WILDLIFE; DIFFERENTIATION	Bovine tuberculosis (bTB) caused by Mycobacterium (M.) bovis and M. caprae is a transmissible disease of livestock, notifiable to the World Organization for Animal Health (OIE). BTB particularly affects cattle and small ruminants and can be transmitted to humans thereby posing a significant threat to veterinary and public health worldwide. M. bovis is the principal cause of bTB in Algeria. In order to better understand the route of spreading and elaborate an eradication program, isolation and characterization of mycobacteria from Algerian cattle was performed. Sixty strains belonging to the M. tuberculosis complex were analyzed by spoligotyping, thereof 42 by 19-locus-MIRU-VNTR-typing. Spoligotyping revealed 16 distinguishable patterns (Hunter-Gaston discriminatory index [HGDI] of 0.8294), with types SB0120 (n = 20) and SB0121 (n = 13) being the most frequent patterns, representing 55% of the strains. Analyses based on 19-locus-MIRU-VNTR yielded 32 different profiles, five clusters and one orphan pattern, showing higher discriminatory power (HGDI = 0.9779) than spoligotyping. Seven VNTR-loci [VNTR 577 (alias ETR C), 2163b (QU11b), 2165 (ETR A), 2461 (ETR B), 3007 (MIRU 27), 2163a (QUB11a) and 3232 (QUB 3232)] were the most discriminative loci (HGDI > 0.50). In conclusion, 19-locus-MIRU-VNTR yielded more information than spoligotyping concerning molecular differentiation of strains and better supports the elucidation of transmission routes of M. bovis between Algerian cattle herds.	[Belakehal, Faiza; Mossadak, Hamdi T.] Lab Food Hyg & Qual Insurance Syst, High Natl Vet Sch, El Alia, Oued Smar, Algeria; [Barth, Stefanie A.; Menge, Christian; Moser, Irmgard] Friedrich Loeffler Inst Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Berlin, Germany; [Barth, Stefanie A.; Moser, Irmgard] Friedrich Loeffler & Nstitut Fed Res Inst Anim Hl, Natl Reference Lab Bovine TB, Inst Mol Pathogenesis, Berlin, Germany; [Malek, Naim] Cent Mil Hosp, Dept Microbiol, Kouba, Algeria	Ecole Nationale Superieure Veterinaire; Friedrich Loeffler Institute	Belakehal, F (corresponding author), Lab Food Hyg & Qual Insurance Syst, High Natl Vet Sch, El Alia, Oued Smar, Algeria.; Barth, SA (corresponding author), Friedrich Loeffler Inst Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Berlin, Germany.; Barth, SA (corresponding author), Friedrich Loeffler & Nstitut Fed Res Inst Anim Hl, Natl Reference Lab Bovine TB, Inst Mol Pathogenesis, Berlin, Germany.	faiza.belakehal@gmail.com; stefanie.barth@fli.de	Barth, Stefanie/K-7053-2019	Barth, Stefanie/0000-0003-4921-5056	High National Veterinary School, Algeria, (ENSV) [000592]	High National Veterinary School, Algeria, (ENSV)	Parts of this work were funded by a travel and stay grant from the High National Veterinary School, Algeria, (ENSV, www.ensv.dz) (grant no. 000592) for Faiza Belakehal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, J OFFICIEL REPUBLIQU; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Asebe G, 2017, J MEDICAL DIAGNOSTIC, V06, P250, DOI [10.4172/2168-9784.1000250, DOI 10.4172/2168-9784.1000250]; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Biffa D, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-28; Bolado-Martinez E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/416479; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Boschiroli M.-L., 2015, B PID MIOL SANT ANIM, V70, P2; Bouklata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135695; Brites D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02820; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Couvin D, 2014, MISE PLACE BASES DON, V2014, P40; Cowie CE, 2016, EUR J WILDLIFE RES, V62, P51, DOI 10.1007/s10344-015-0973-x; Damene H, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008894; de la Fuente J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004232; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Djemal SE, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1314-y; Duignan A, 2012, REV SCI TECH OIE, V31, P845; Durr PA, 2000, REV SCI TECH OIE, V19, P675, DOI 10.20506/rst.19.3.1241; El Mrini M, 2016, EUR J WILDLIFE RES, V62, P479, DOI 10.1007/s10344-016-1022-0; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Ghavidel M, 2018, MICROB PATHOGENESIS, V118, P310, DOI 10.1016/j.micpath.2018.03.036; Haddad N, 2004, RES VET SCI, V76, P1, DOI 10.1016/S0034-5288(03)00078-X; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kao RR, 2016, REV SCI TECH OIE, V35, P241, DOI 10.20506/rst.35.1.2430; Katale BZ, 2017, TRANSBOUND EMERG DIS, V64, P815, DOI 10.1111/tbed.12445; Kent PT, 1985, PUBLIC HLTH MYCOBACT; Kohl TA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01573-20; Kohl TA, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00302-18, 10.1128/jcm.00302-18]; Lamine-Khemiri H, 2014, TROP ANIM HEALTH PRO, V46, P305, DOI 10.1007/s11250-013-0488-y; Loiseau C, 2020, EVOL MED PUBLIC HLTH, P49, DOI 10.1093/emph/eoaa005; Machado A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006147; Malama Sydney, 2014, Vet Med Int, V2014, P187842, DOI 10.1155/2014/187842; Marianelli C, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007546; Matos F, 2010, VET MED-CZECH, V55, P133, DOI 10.17221/137/2009-VETMED; Matos F, 2010, J CLIN MICROBIOL, V48, P4337, DOI 10.1128/JCM.01762-10; Mekonnen GA, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.553940; Muller B, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-26; Palisson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152578; Prodinger WM, 2005, J CLIN MICROBIOL, V43, P4984, DOI 10.1128/JCM.43.10.4984-4992.2005; Riviere J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183126; Rodriguez S, 2011, EMERG INFECT DIS, V17, P532, DOI 10.3201/eid1703.100618; Rodriguez-Campos S, 2014, RES VET SCI, V97, pS5, DOI 10.1016/j.rvsc.2014.02.009; Rodriguez-Campos S, 2013, J CLIN MICROBIOL, V51, P3658, DOI 10.1128/JCM.01271-13; Ruettger A, 2012, J CLIN MICROBIOL, V50, P2492, DOI 10.1128/JCM.00442-12; Sahraoui N, 2010, ANN BIOL CLIN-PARIS, V68, P449, DOI 10.1684/abc.2010.0459; Sahraoui N, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-4; Siala M, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007707; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2012, INFECT GENET EVOL, V12, P857, DOI 10.1016/j.meegid.2011.09.007; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tazerart F, 2021, EMERG INFECT DIS, V27, P972, DOI 10.3201/eid2703.191823; Tripathi K., 2014, INT J RECENT TRENDS, V10, P461; Yahyaoui-Azami H, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1165-6; Yang L, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0402-0	58	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262390	10.1371/journal.pone.0262390	http://dx.doi.org/10.1371/journal.pone.0262390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015775	Green Published, gold			2022-12-26	WOS:000814820600014
J	He, DD; Shang, XY; Wang, N; Wang, GX; He, KY; Wang, L; Han, ZG				He, Dan-Dan; Shang, Xue-Ying; Wang, Na; Wang, Guang-Xing; He, Kun-Yan; Wang, Lan; Han, Ze-Guang			BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage	ONCOGENE			English	Article							INACTIVATING MUTATIONS; SWI/SNF COMPLEXES; REPAIR; ARID2; CANCER; CELLS; VULNERABILITIES; RESISTANCE; BREAKS; ROLES	Hepatocellular carcinoma (HCC) has emerged as the third cause of cancer-related death owing to lacking effective systemic therapies. Genomic DNA sequencing revealed the high frequency of loss-of-function mutations in ARID2, which encodes a subunit of SWI/SNF chromatin remodeling complex, however, the therapeutic strategy for the HCC patients with ARID2 mutations is still completely unclear. In this study, we first performed a high-throughput screening approach using a compound library consisting of 2 180 FDA-approved drugs and other compounds, to elicit the potential drugs for synthetic lethality to target ARID2-deficient HCC cells. Interestingly, JQ1, a selective inhibitor of bromodomain protein BRD4, uniquely suppressed the growth of ARID2- deficient HCC cells. Next JQ1 is further confirmed to predominantly induce cell lethality upon ARID2 depletion through exacerbating DNA damage, especially double strand breaks (DSBs). Functional assays demonstrated that both BRD4 inhibition and ARID2 deficiency synergistically impede two main DNA damage repair pathways, homologous recombination (HR) and non-homologous end-joining (NHEJ), through attenuating the transcription of BRCA1, RAD51, and 53BP1, which encode the core molecules responsible for DSB repair. Mechanistically, both ARID2 and BRD4 exert a synergistic effect for maintaining transcriptional enhancer-promoter loops of these genes within chromatin conformation. However, as both ARID2 and BRD4 are disrupted, the expression of these DNA repair-related genes in response to DNA damage are hindered, resulting in DSB accumulation and cell apoptosis. Taken together, this study discloses that BRD4 inhibition may induce synthetic lethality in ARID2-deficient HCC cells, which might provide a potential therapeutic strategy for HCC patients with ARID2 mutations.	[He, Dan-Dan; Shang, Xue-Ying; Wang, Na; Wang, Guang-Xing; He, Kun-Yan; Wang, Lan; Han, Ze-Guang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Minist Educ, Shanghai 200240, Peoples R China; [Han, Ze-Guang] Hangzhou Innovat Inst Syst Oncol HIISCO, 3F Bldg 1,2636 Yuhangtang Rd, Hangzhou 311121, Zhejiang, Peoples R China	Shanghai Jiao Tong University	Han, ZG (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Minist Educ, Shanghai 200240, Peoples R China.; Han, ZG (corresponding author), Hangzhou Innovat Inst Syst Oncol HIISCO, 3F Bldg 1,2636 Yuhangtang Rd, Hangzhou 311121, Zhejiang, Peoples R China.	hanzg@sjtu.edu.cn		Han, Ze-Guang/0000-0002-1018-1752	National Natural Science Foundation of China [82073116, 81672772]; National Key Research and Development Program of China [2020YFC2002705]; Natural Science Foundation of Shanghai [19140902500]; National Science and Technology Major Project [2017ZX10203207]; Shanghai Jiao Tong University Scientific and Technological Innovation Funds [2019TPA09, ZH2018ZDA33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); National Science and Technology Major Project; Shanghai Jiao Tong University Scientific and Technological Innovation Funds	We thank all members of Han Lab for helpful discussions on the project. This work was supported by Grants from the National Natural Science Foundation of China (82073116 and 81672772 to ZH), National Key Research and Development Program of China (2020YFC2002705 to ZH), Natural Science Foundation of Shanghai (19140902500 to ZH), National Science and Technology Major Project (2017ZX10203207 to ZH) and Shanghai Jiao Tong University Scientific and Technological Innovation Funds (2019TPA09 and ZH2018ZDA33 to ZH).	Arnoult N, 2017, NATURE, V549, P548, DOI 10.1038/nature24023; Berns K, 2018, ONCOGENE, V37, P4611, DOI 10.1038/s41388-018-0300-6; Bhagwat AS, 2016, CELL REP, V15, P519, DOI 10.1016/j.celrep.2016.03.054; Bitler BG, 2017, NAT CELL BIOL, V19, P962, DOI 10.1038/ncb3582; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cajuso T, 2014, INT J CANCER, V135, P611, DOI 10.1002/ijc.28705; Caruso S, 2019, GASTROENTEROLOGY, V157, P760, DOI 10.1053/j.gastro.2019.05.001; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Centore RC, 2020, TRENDS GENET, V36, P936, DOI 10.1016/j.tig.2020.07.011; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; COLOMBO M, 1992, J HEPATOL, V15, P225, DOI 10.1016/0168-8278(92)90041-M; de Castro RO, 2017, J BIOL CHEM, V292, P8459, DOI 10.1074/jbc.M117.778183; de la Cruz FF, 2015, ANNU REV PHARMACOL, V55, P513, DOI 10.1146/annurev-pharmtox-010814-124511; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deribe YL, 2018, NAT MED, V24, P1627, DOI 10.1038/s41591-018-0173-9; Devaiah BN, 2016, NAT STRUCT MOL BIOL, V23, P540, DOI 10.1038/nsmb.3228; Donati B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0915-9; Doroshow DB, 2017, ANN ONCOL, V28, P1776, DOI 10.1093/annonc/mdx157; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Eustermann S, 2015, MOL CELL, V60, P742, DOI 10.1016/j.molcel.2015.10.032; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friend SH, 1998, NEW ENGL J MED, V338, P125, DOI 10.1056/NEJM199801083380211; Fujisawa T, 2017, NAT REV MOL CELL BIO, V18, P246, DOI 10.1038/nrm.2016.143; Gao QZ, 2017, CANCER SCI, V108, P1328, DOI 10.1111/cas.13277; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; He S, 2020, SCIENCE, V367, P875, DOI 10.1126/science.aaz9761; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Huang A, 2020, NAT REV DRUG DISCOV, V19, P23, DOI 10.1038/s41573-019-0046-z; Jiang H, 2020, P NATL ACAD SCI USA, V117, P4770, DOI 10.1073/pnas.1914937117; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kakarougkas A, 2014, MOL CELL, V55, P723, DOI 10.1016/j.molcel.2014.06.028; Kurimchak AM, 2016, CELL REP, V16, P1273, DOI 10.1016/j.celrep.2016.06.091; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li SJ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00358-6; Li XY, 2018, CELL REP, V22, P796, DOI 10.1016/j.celrep.2017.12.078; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Loesch R, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102152; Mashtalir N, 2018, CELL, V175, P1272, DOI 10.1016/j.cell.2018.09.032; Masliah-Planchon J, 2015, ANNU REV PATHOL-MECH, V10, P145, DOI 10.1146/annurev-pathol-012414-040445; Michel BC, 2018, NAT CELL BIOL, V20, P1410, DOI 10.1038/s41556-018-0221-1; Mittal P, 2020, NAT REV CLIN ONCOL, V17, P435, DOI 10.1038/s41571-020-0357-3; Nagarajan S, 2020, NAT GENET, V52, P187, DOI 10.1038/s41588-019-0541-5; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Oba A, 2017, J HEPATOL, V66, P942, DOI 10.1016/j.jhep.2016.12.026; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Schulze K, 2016, J HEPATOL, V65, P1031, DOI 10.1016/j.jhep.2016.05.035; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Shu SK, 2020, MOL CELL, V78, P1096, DOI 10.1016/j.molcel.2020.04.027; Slaughter MJ, 2018, J BIOL CHEM, V293, P13592, DOI 10.1074/jbc.RA118.003381; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Tai Y, 2018, INT J CLIN EXP PATHO, V11, P2931; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; Williamson CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13837; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Yang L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1645	65	5	5	4	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2022	41	10					1397	1409		10.1038/s41388-022-02176-2	http://dx.doi.org/10.1038/s41388-022-02176-2		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZN2JO	35017665				2022-12-26	WOS:000741240600001
J	Lee, JY; Kim, M; Oh, SB; Kim, HY; Kim, C; Kim, TY; Park, YH				Lee, Ji-Yeon; Kim, Mirinae; Oh, Su Bin; Kim, Hae-Young; Kim, Chongtae; Kim, Tae-Yoon; Park, Young-Hoon			Superoxide dismutase 3 prevents early stage diabetic retinopathy in streptozotocin-induced diabetic rat model	PLOS ONE			English	Article							RETINAL METABOLISM; OXIDATIVE STRESS; EXPERIMENTAL GALACTOSEMIA; ABNORMALITIES; EXPRESSION; PROTECTION; RECOVERIN; PERICYTES; DAMAGE	Purpose To identify the effects of superoxide dismutase (SOD)3 on diabetes mellitus (DM)-induced retinal changes in a diabetic rat model. Methods Diabetic models were established by a single intraperitoneal injection of streptozotocin (STZ) in Sprague-Dawley rats. After purification of the recombinant SOD3, intravitreal injection of SOD3 was performed at the time of STZ injection, and 1 and 2 weeks following STZ injection. Scotopic and photopic electroretinography (ERG) were recorded. Immunofluorescence staining with alpha-smooth muscle actin (SMA), glial fibrillary acidic protein (GFAP), pigment epithelium-derived factor (PEDF), Flt1, recoverin, parvalbumin, extracellular superoxide dismutase (SOD3), 8-Hydroxy-2'deoxyguanosine (8-OHdG) and tumor necrosis factor-alpha (TNF-alpha) were evaluated. Results In the scotopic ERG, the diabetic group showed reduced a- and b-wave amplitudes compared with the control group. In the photopic ERG, b-wave amplitude showed significant (p < 0.0005) reduction at 8 weeks following DM induction. However, the trend of a- and b-wave reduction was not evident in the SOD3 treated group. GFAP, Flt1, 8-OHdG and TNF-alpha immunoreactivity were increased, and alpha-SMA, PEDF and SOD3 immunoreactivity were decreased in the diabetic retina. The immunoreactivity of these markers was partially recovered in the SOD3 treated group. Parvalbumin expression was not decreased in the SOD3 treated group. In the diabetic retinas, the immunoreactivity of recoverin was weakly detected in both of the inner nuclear layer and inner plexiform layer compared to the control group but not in the SOD3 treated group. Conclusions SOD3 treatment attenuated the loss of a/b-wave amplitudes in the diabetic rats, which was consistent with the immunohistochemical evaluation. We also suggest that in rod-dominant rodents, the use of blue on green photopic negative response (PhNR) is effective in measuring the inner retinal function in animal models of diabetic retinopathy. SOD3 treatment ameliorated the retinal Muller cell activation in diabetic rats and pericyte dysfunction. These results suggested that SOD3 exerted protective effects on the development of diabetic retinopathy.	[Lee, Ji-Yeon; Kim, Mirinae; Oh, Su Bin; Kim, Chongtae; Park, Young-Hoon] Catholic Univ Korea, Coll Med, Catholic Inst Visual Sci, Seoul, South Korea; [Kim, Mirinae; Park, Young-Hoon] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; [Kim, Hae-Young; Kim, Tae-Yoon] Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Park, YH (corresponding author), Catholic Univ Korea, Coll Med, Catholic Inst Visual Sci, Seoul, South Korea.; Park, YH (corresponding author), Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	parkyh@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea [NRF-2020R1F1A1074898]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	Funding This study was supported by the Basic Science Research Program through the National Research Foundation of Korea under Grant [NRF-2020R1F1A1074898]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, REDOX REP, V15, P250, DOI 10.1179/135100010X12826446921662; Altobelli GG, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00183; [Anonymous], 2004, A BRADFORD BOOK; Bagnis A, 2012, EXP EYE RES, V103, P55, DOI 10.1016/j.exer.2012.07.011; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Carmona-Rodriguez L, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000432; Cecerska-Heryc E, 2021, CLIN BIOCHEM, V93, P1, DOI 10.1016/j.clinbiochem.2021.03.008; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Denat L, 2014, J INVEST DERMATOL, V134, P1512, DOI 10.1038/jid.2014.65; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Ferland-McCollough D, 2017, PHARMACOL THERAPEUT, V171, P30, DOI 10.1016/j.pharmthera.2016.11.008; Gong CY, 2013, INT J OPHTHALMOL-CHI, V6, P573, DOI 10.3980/j.issn.2222-3959.2013.05.03; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Ikelle L, 2019, ADV EXP MED BIOL, V1185, P335, DOI 10.1007/978-3-030-27378-1_55; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; KOWLURU R, 1994, CURR EYE RES, V13, P891, DOI 10.3109/02713689409015092; Kowluru RA, 1996, DIABETES, V45, P1233, DOI 10.2337/diabetes.45.9.1233; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; KUWABARA TOICHIRO, 1965, INVEST OPHTHALMOL, V4, P1049; Kwon MJ, 2012, J DERMATOL SCI, V67, P81, DOI 10.1016/j.jdermsci.2012.06.003; Liu YW, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5384909; Mohammedi K, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-014-0163-2; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; Naderi A, 2019, EXP EYE RES, V184, P213, DOI 10.1016/j.exer.2019.04.025; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Nozik-Grayck E, 2005, INT J BIOCHEM CELL B, V37, P2466, DOI 10.1016/j.biocel.2005.06.012; Ookawara T, 1998, AM J PHYSIOL-CELL PH, V275, pC840, DOI 10.1152/ajpcell.1998.275.3.C840; Park HS, 2008, ACTA NEUROPATHOL, V115, P241, DOI 10.1007/s00401-007-0314-6; Park SJ, 2018, EXP NEUROBIOL, V27, P210, DOI 10.5607/en.2018.27.3.210; Regan E, 2005, ARTHRITIS RHEUM, V52, P3479, DOI 10.1002/art.21387; Tan RJ, 2015, J AM SOC NEPHROL, V26, P2447, DOI 10.1681/ASN.2014060613; Wert KJ, 2018, FREE RADICAL BIO MED, V124, P408, DOI 10.1016/j.freeradbiomed.2018.06.024; Yamada H, 2005, DIABETOLOGIA, V48, P1663, DOI 10.1007/s00125-005-1809-0; Yoshida Y, 2009, DIABETES-METAB RES, V25, P678, DOI 10.1002/dmrr.1007; Yoshinaga A, 2021, ANTIOXID REDOX SIGN, V34, P1245, DOI 10.1089/ars.2019.8008; Yuki K, 2011, INVEST OPHTH VIS SCI, V52, P4143, DOI 10.1167/iovs.10-6294; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhao JS, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/8721379; Zhu XF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/580687	42	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262396	10.1371/journal.pone.0262396	http://dx.doi.org/10.1371/journal.pone.0262396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015779	gold, Green Published			2022-12-26	WOS:000814820600015
J	Zhang, HW; Jiao, B; Dong, FS; Liang, XX; Zhou, S; Wang, HB				Zhang, HongWei; Jiao, Bo; Dong, FuShuang; Liang, XinXia; Zhou, Shuo; Wang, Haibo			Genome-wide identification of CCT genes in wheat (Triticum aestivum L.) and their expression analysis during vernalization	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; FLOWERING-LOCUS-T; CIRCADIAN CLOCK; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; HEADING DATE; GATA FAMILY; CONSTANS; TIME; EVOLUTION	Numerous CCT genes are known to regulate various biological processes, such as circadian rhythm regulation, flowering, light signaling, plant development, and stress resistance. The CCT gene family has been characterized in many plants but remains unknown in the major cereal wheat (Triticum aestivum L.). Extended exposure to low temperature (vernalization) is necessary for winter wheat to flower successfully. VERNALIZATION2 (VRN2), a specific CCT-containing gene, has been proved to be strongly associated with vernalization in winter wheat. Mutation of all VRN2 copies in three subgenomes results in the eliminated demands of low temperature in flowering. However, no other CCT genes have been reported to be associated with vernalization to date. The present study screened CCT genes in the whole wheat genome, and preliminarily identified the vernalization related CCT genes through expression analysis. 127 CCT genes were identified in three subgenomes of common wheat through a hidden Markov model-based method. Based on multiple alignment, these genes were grouped into 40 gene clusters, including the duplicated gene clusters TaCMF6 and TaCMF8, each tandemly arranged near the telomere. The phylogenetic analysis classified these genes into eight groups. The transcriptome analysis using leaf tissues collected before, during, and after vernalization revealed 49 upregulated and 31 downregulated CCT genes during vernalization, further validated by quantitative real-time PCR. Among the differentially expressed and well-investigated CCT gene clusters analyzed in this study, TaCMF11, TaCO18, TaPRR95, TaCMF6, and TaCO16 were induced during vernalization but decreased immediately after vernalization, while TaCO1, TaCO15, TaCO2, TaCMF8, and TaPPD1 were stably suppressed during and after vernalization. These data imply that some vernalization related CCT genes other than VRN2 may exist in wheat. This study improves our understanding of CCT genes and provides a foundation for further research on CCT genes related to vernalization in wheat.	[Zhang, HongWei; Wang, Haibo] Hebei Agr Univ, Coll Agron, Baoding, Hebei, Peoples R China; [Zhang, HongWei; Jiao, Bo; Dong, FuShuang; Liang, XinXia; Zhou, Shuo; Wang, Haibo] Hebei Acad Agr & Forestry Sci, Inst Biotechnol & Food Sci, Plant Genet Engn Ctr Hebei Prov, Shijiazhuang, Hebei, Peoples R China	Hebei Agricultural University; Hebei Academy of Agricultural & Forestry Sciences	Wang, HB (corresponding author), Hebei Agr Univ, Coll Agron, Baoding, Hebei, Peoples R China.; Zhou, S; Wang, HB (corresponding author), Hebei Acad Agr & Forestry Sci, Inst Biotechnol & Food Sci, Plant Genet Engn Ctr Hebei Prov, Shijiazhuang, Hebei, Peoples R China.	zhoushuobio@163.com; nkywanghb@163.com		zhang, hong wei/0000-0003-0460-6125	HAAFS Agriculture Science and Technology Innovation Project [2019-4-8-06]; S&T Program of Hebei [20326306D]	HAAFS Agriculture Science and Technology Innovation Project; S&T Program of Hebei	This work was supported by the HAAFS Agriculture Science and Technology Innovation Project (grant number 2019-4-8-06), and the S&T Program of Hebei (grant number 20326306D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; [陈华夏 Chen Huaxia], 2010, [华中农业大学学报, Journal of Huazhong Agricultural University], V29, P669; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Deng WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6882; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Farre EM, 2013, CURR OPIN PLANT BIOL, V16, P621, DOI 10.1016/j.pbi.2013.06.015; Fu DL, 2007, MOL GENET GENOMICS, V277, P301, DOI 10.1007/s00438-006-0189-6; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; Liu HY, 2020, THEOR APPL GENET, V133, P1385, DOI 10.1007/s00122-020-03554-8; Liu H, 2019, J INTEGR PLANT BIOL, V61, P359, DOI 10.1111/jipb.12720; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991; Ma L, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9040513; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Murakami M, 2004, PLANT CELL PHYSIOL, V45, P645, DOI 10.1093/pcp/pch065; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, P822, DOI 10.1093/pcp/pcm056; Nakamichi N, 2009, PLANT CELL PHYSIOL, V50, P447, DOI 10.1093/pcp/pcp004; Niinuma K, 2008, PLANT BIOTECHNOL-NAR, V25, P165, DOI 10.5511/plantbiotechnology.25.165; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Qiao LY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00770; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Shaw LM, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008812; Shaw LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079459; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shim JS, 2017, PLANT PHYSIOL, V173, P5, DOI 10.1104/pp.16.01327; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Woods DP, 2016, PLANT PHYSIOL, V170, P2124, DOI 10.1104/pp.15.01279; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhan HS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100284; Zhang J, 2021, J INTEGR PLANT BIOL, V63, P913, DOI 10.1111/jipb.13013; Zhang J, 2017, J INTEGR AGR, V16, P2686, DOI 10.1016/S2095-3119(17)61724-6; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07663; Zheng XW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189333	63	1	1	13	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262147	10.1371/journal.pone.0262147	http://dx.doi.org/10.1371/journal.pone.0262147			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986172	gold, Green Published			2022-12-26	WOS:000765956200019
J	Sethu, S; Lawrenson, JG; Kekunnaya, R; Ali, R; Borah, RR; Suttle, C				Sethu, Sheeladevi; Lawrenson, John G.; Kekunnaya, Ramesh; Ali, Rahul; Borah, Rishi R.; Suttle, Catherine			Barriers and enablers to access childhood cataract services across India. A qualitative study using the Theoretical Domains Framework (TDF) of behaviour change	PLOS ONE			English	Article							HEALTH-CARE; DEVELOPING-COUNTRIES	Early presentation for childhood cataract surgery is an important first step in preventing related visual impairment and blindness. In the absence of neonatal eye screening programmes in developing countries, the early identification of childhood cataract remains a major challenge. The primary aim of this study was to identify potential barriers to accessing childhood cataract services from the perspective of parents and carers, as a critical step towards increasing the timely uptake of cataract surgery. In-depth interviews were conducted using a pre-designed topic guide developed for this study to seek the views of parents and carers in nine geographic locations across eight states in India regarding their perceived barriers and enablers to accessing childhood cataract services. A total of 35 in-depth interviews were conducted including 30 at the hospital premises and 5 in the participants' homes. All interviews were conducted in the local language and audio taped for further transcription and analysis. Data were organised using NVivo 11 and a thematic analysis was conducted utilising the Theoretical Domains Framework (TDF), an integrative framework of behavioural theories. The themes identified from interviews related to 11 out of 12 TDF domains. TDF domains associated with barriers included: 'Environmental context and resources', 'Beliefs about consequences' and 'Social influences'. Reported enablers were identified in three theoretical domains: 'Social influences', 'Beliefs about consequences' and 'Motivations and goals'. This comprehensive TDF approach enabled us to understand parents' perceived barriers and enablers to accessing childhood cataract services, which could be targeted in future interventions to improve timely uptake.	[Sethu, Sheeladevi; Lawrenson, John G.; Suttle, Catherine] City Univ London, Ctr Appl Vis Res, Div Optometry & Visual Sci, London, England; [Sethu, Sheeladevi; Ali, Rahul; Borah, Rishi R.] Orbis Int, Gurugram, India; [Kekunnaya, Ramesh] LV Prasad Eye Inst, Child Sight Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, India	City University London; L. V. Prasad Eye Institute	Sethu, S (corresponding author), City Univ London, Ctr Appl Vis Res, Div Optometry & Visual Sci, London, England.; Sethu, S (corresponding author), Orbis Int, Gurugram, India.	Sheeladevi.sethu@orbis.org		Sethu, Sheeladevi/0000-0001-6561-2882	School of Health Sciences, City University of London	School of Health Sciences, City University of London	This study was funded by School of Health Sciences, City University of London as a research scholarship for the primary author's PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Birch EE, 1998, INVEST OPHTH VIS SCI, V39, P1560; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; Burgess C, 2015, HEALTH EXPECT, V18, P2437, DOI 10.1111/hex.12212; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Dyson J., 2011, Journal of Infection Prevention, V12, P17, DOI 10.1177/1757177410384300; Ebeigbe Jennifer A, 2017, J Optom, V10, P104, DOI 10.1016/j.optom.2016.06.001; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Graham-Rowe E, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0309-2; Gray-Burrows KA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0416-4; Holloway E, 2018, DISABIL REHABIL, V40, P287, DOI 10.1080/09638288.2016.1250172; Lake AJ, 2017, J DIABETES COMPLICAT, V31, P997, DOI 10.1016/j.jdiacomp.2017.02.020; Lei L, 2017, SOC SCI MED, V179, P172, DOI 10.1016/j.socscimed.2017.02.028; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S., 2014, ABC BEHAV CHANGE THE; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Nasrin D, 2013, AM J TROP MED HYG, V89, P3, DOI 10.4269/ajtmh.12-0749; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Pillai R, 2003, SOC SCI MED, V57, P783, DOI 10.1016/S0277-9536(02)00448-3; Pokhrel S, 2004, HEALTH POLICY PLANN, V19, P218, DOI 10.1093/heapol/czh027; QSR-International, 2013, NVIVO QUAL DAT AN SO; Rimal RN, 2000, HEALTH COMMUN, V12, P219, DOI 10.1207/S15327027HC1203_01; Ritchie J., 2013, QUALITATIVE RES PRAC; Russell S, 1996, HEALTH POLICY PLANN, V11, P219, DOI 10.1093/heapol/11.3.219; Senthilkumar D, 2013, OPTOMETRY VISION SCI, V90, P1462, DOI 10.1097/OPX.0000000000000084; Sheeladevi S, 2018, EYE, V32, P1811, DOI 10.1038/s41433-018-0176-2; Taylor David, 2001, British Journal of Ophthalmology, V85, P1120, DOI 10.1136/bjo.85.9.1120; Tipping G., 1995, HLTH CARE SEEKING BE, P89; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261308	10.1371/journal.pone.0261308	http://dx.doi.org/10.1371/journal.pone.0261308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972107	Green Published, gold, Green Accepted			2022-12-26	WOS:000773555700029
J	Yu, LX; Chen, HM; Luo, WQ; Li, C				Yu, Linxing; Chen, Huaming; Luo, Wenqi; Li, Chang			Online public opinion evaluation through the functional resonance analysis method and deep analysis	PLOS ONE			English	Article							EVOLUTION; MODEL	A conventional model of public opinion analysis is no longer suitable when the internet is the primary arena of information dissemination. Thus, a more practical approach is urgently needed to deal with this dynamic and complicated phenomenon of propagating public opinion. This paper proposes that the outbreak of internet public opinion and its negative impacts, such as the occurrence of major security incidents, are a result of coupling and the complex interaction of many factors. The Functional Resonance Analysis Method model is composed of those factors and considers the stages of network information dissemination, the unique propagation rule, and textual sentiment resonance on the internet. Moreover, it is the first public opinion governance method that simultaneously highlights the complex system, functional identification, and functional resonance. It suggests a more effective method to shorten the dissipation time of negative public opinion and is a considerable improvement over previous models for risk-prediction. Based on resonance theory and deep learning, this study establishes public opinion resonance functions, which made it possible to analyze public opinion triggers and build a simulation model to explore the patterns of public opinion development through long-term data capture. The simulation results of the Functional Resonance Analysis Method suggest that the resonance in the model is consistent with the evolution of public opinion in real situations and that the components of the resonance of public opinion can be separated into eleven subjective factors and three objective factors. In addition, managing the subjective factors can significantly accelerate the dissipation of negative opinions.	[Yu, Linxing; Chen, Huaming; Luo, Wenqi] Sichuan Univ, Coll Literature & Journalism, Chengdu, Sichuan, Peoples R China; [Li, Chang] Sichuan Normal Univ, Coll Movie & Media, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan Normal University	Li, C (corresponding author), Sichuan Normal Univ, Coll Movie & Media, Chengdu, Sichuan, Peoples R China.	changli19870918@163.com			 [SC20B076]		This study was funded in part by the Research on network rumor identification and accurate management of major epidemic situations in the form of funds to HMC (SC20B076). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Bonzom V, 2012, PHYS LETT B, V711, P88, DOI 10.1016/j.physletb.2012.03.054; Chen HM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091535; China Internet Network Information Center (CNNIC), 2020, 46 CHIN INT NETW DEV; El Alaoui I, 2018, J BIG DATA-GER, V5, DOI 10.1186/s40537-018-0120-0; Elgazzar AS, 2003, PHYSICA A, V324, P402, DOI 10.1016/S0378-4371(02)01956-8; Ergasheva MP, 2019, THEORETICAL APPL SCI, P183, DOI [10.15863/TAS.2019.10.78.33, DOI 10.15863/TAS.2019.10.78.33]; Erik H., 2017, FRAM FUNCTIONAL RESO; Falegnami A, 2020, COGN TECHNOL WORK, V22, P877, DOI 10.1007/s10111-019-00612-0; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; Li ST, 2013, KNOWL-BASED SYST, V39, P23, DOI 10.1016/j.knosys.2012.10.005; Li TC, 2013, ANN PHYS-BERLIN, V525, P281, DOI 10.1002/andp.201200232; Luo QJ, 2017, TOURISM MANAGE, V62, P159, DOI 10.1016/j.tourman.2017.04.007; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; Patriarca R, 2017, ENVIRON IMPACT ASSES, V63, P72, DOI 10.1016/j.eiar.2016.12.002; Pekalski A, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.057104; Riccardo P, 2018, INT J RELIAB QUAL SA, V25, DOI 10.1142/S0218539318500018; Rosa LV, 2015, COGN TECHNOL WORK, V17, P559, DOI 10.1007/s10111-015-0337-z; Suchecki K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036132; Tomassini M, 2005, COMPLEX SYST, V15, P261; Wei-dong H, 2018, INT J COMPUT COMMUN, V13, P129, DOI 10.15837/ijccc.2018.1.3176; Zhang HQ, 2016, ENG APPL ARTIF INTEL, V47, P122, DOI 10.1016/j.engappai.2015.06.007	24	2	2	11	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261009	10.1371/journal.pone.0261009	http://dx.doi.org/10.1371/journal.pone.0261009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972099	gold, Green Published			2022-12-26	WOS:000773555700019
J	Berke, MS; Fensholdt, LKD; Hestehave, S; Kalliokoski, O; Abelson, KSP				Berke, Mie S.; Fensholdt, Louise K. D.; Hestehave, Sara; Kalliokoski, Otto; Abelson, Klas S. P.			Effects of buprenorphine on model development in an adjuvant-induced monoarthritis rat model	PLOS ONE			English	Article							CORTICOSTERONE LEVELS; POSTOPERATIVE PAIN; PLASMA-CORTICOSTERONE; LABORATORY RODENTS; NERVOUS-SYSTEM; GRIMACE SCALE; MELOXICAM; ANALGESIA; STRESS; HYPERALGESIA	Complete Freund's adjuvant (CFA)-induced arthritis in rats is a common animal model for studying chronic inflammatory pain. However, modelling of the disease is associated with unnecessary pain and impaired animal wellbeing, particularly in the immediate post-induction phase. Few attempts have been made to counteract these adverse effects with analgesics. The present study investigated the effect of buprenorphine on animal welfare, pain-related behaviour and model-specific parameters during the disease progression in a rat model of CFA-induced monoarthritis. The aim was to reduce or eliminate unnecessary pain in this model, in order to improve animal welfare and to avoid suffering, without compromising the quality of the model. Twenty-four male Sprague Dawley rats were injected with 20 mu l of CFA into the left tibio-tarsal joint to induce monoarthritis. Rats were treated with either buprenorphine or carprofen for 15 days during the disease development, and were compared to a saline-treated CFA-injected group or a negative control group. Measurements of welfare, pain-related behaviour and clinical model-specific parameters were collected. The study was terminated after 3 weeks, ending with a histopathologic analysis. Regardless of treatment, CFA-injected rats displayed mechanical hyperalgesia and developed severe histopathological changes associated with arthritis. However, no severe effects on general welfare were found at any time. Buprenorphine treatment reduced facial pain expression scores, improved mobility, stance and lameness scores and it did not supress the CFA-induced ankle swelling, contrary to carprofen. Although buprenorphine failed to demonstrate a robust analgesic effect on the mechanical hyperalgesia in this study, it did not interfere with the development of the intended pathology.	[Berke, Mie S.; Fensholdt, Louise K. D.; Kalliokoski, Otto; Abelson, Klas S. P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark; [Hestehave, Sara] UCL, Dept Cell & Dev Biol, London, England	University of Copenhagen; University of London; University College London	Berke, MS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark.	mibe@sund.ku.dk	Hestehave, Sara/AAZ-5283-2021; Kalliokoski, Otto/I-3828-2019	Hestehave, Sara/0000-0002-1837-521X; Kalliokoski, Otto/0000-0001-6531-3487; Abelson, Klas/0000-0002-4986-7882; Berke, Mie Schou/0000-0002-6197-3928	 [33010-NIFA-14-586]		KSPA received a grant from the Danish 3R-center (33010-NIFA-14-586). URL: https://en.3rcenter.dk/research/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott FV, 1997, VET REC, V140, P553, DOI 10.1136/vr.140.21.553; Abelson KSP, 2005, IN VIVO, V19, P815; Agha AM, 1999, PHARMACOL RES, V40, P385, DOI 10.1006/phrs.1999.0522; BAUMANS V, 1994, LAB ANIM-UK, V28, P97, DOI 10.1258/002367794780745308; Berke MS, 2020, SCAND J LAB ANIM SCI, V46, P39; BESSE D, 1992, EUR J PHARMACOL, V223, P123, DOI 10.1016/0014-2999(92)94830-O; Bolon B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569068; Brennan MP, 2009, LAB ANIMAL, V38, P87, DOI 10.1038/laban0309-87; Budsberg S., 2009, HDB VET PAIN MANAGEM, VSecond Edition, P183; BUTLER SH, 1992, PAIN, V48, P73, DOI 10.1016/0304-3959(92)90133-V; COWAN A, 1977, BRIT J PHARMACOL, V60, P537, DOI 10.1111/j.1476-5381.1977.tb07532.x; Crofford LJ, 2000, ARTHRITIS RHEUM-US, V43, P4, DOI 10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V; Curtin LI, 2009, COMPARATIVE MED, V59, P60; Deuis JR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00284; DONALDSON LF, 1993, J NEUROSCI METH, V49, P5, DOI 10.1016/0165-0270(93)90103-X; DOUGHERTY PM, 1992, BRAIN RES, V570, P109, DOI 10.1016/0006-8993(92)90570-Y; DUM J, 1981, EUR J PHARMACOL, V70, P293, DOI 10.1016/0014-2999(81)90163-1; Engelhardt G, 1995, INFLAMM RES, V44, P548, DOI 10.1007/BF01757360; Festing MFW., 2003, HDB LAB ANIMAL SCI V, V1, P327; Festing Michael F W, 2002, ILAR J, V43, P244; Flecknell P, 2000, PAIN MANAGEMENT ANIM; FLECKNELL PA, 1984, LAB ANIM, V18, P147, DOI 10.1258/002367784780891226; Flecknell P, 2009, LABORATORY ANIMAL ANAESTHESIA, 3RD EDITION, P109, DOI 10.1016/B978-0-12-369376-1.00004-6; Flecknell P, 2009, LABORATORY ANIMAL ANAESTHESIA, 3RD EDITION, P139, DOI 10.1016/B978-0-12-369376-1.00005-8; Gades NM, 2000, CONTEMP TOP LAB ANIM, V39, P8; Ganju P, 2001, EUR J PHARMACOL, V421, P191, DOI 10.1016/S0014-2999(01)01048-2; GARTNER J, 1980, DOC OPHTHALMOL, V49, P155; Goldkuhl R, 2008, EUR SURG RES, V41, P272, DOI 10.1159/000142372; Goldkuhl R, 2010, EUR SURG RES, V44, P117, DOI 10.1159/000264962; Goldkuhl R, 2010, LAB ANIM-UK, V44, P337, DOI 10.1258/la.2010.009115; Gomes RP, 2013, EINSTEIN-SAO PAULO, V11, P76, DOI 10.1590/S1679-45082013000100014; Grahm MJ, 1997, VET J, V153, P87, DOI 10.1016/S1090-0233(97)80013-5; Hampshire VA, 2001, LAB ANIM-UK, V35, P223, DOI 10.1258/0023677011911660; Hashmi JA, 2010, INFLAMM RES, V59, P667, DOI 10.1007/s00011-010-0179-3; Hedenqvist P., HDB LAB ANIMAL SCI, V12011; Hestehave S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188113; Jacobsen KR, 2013, COMPARATIVE MED, V63, P105; Jensen Troels S, 2014, Lancet Neurol, V13, P924, DOI 10.1016/S1474-4422(14)70102-4; Jessen L, 2007, LAB ANIM-UK, V41, P185, DOI 10.1258/002367707780378131; Kalliokoski O, 2012, IN VIVO, V26, P213; Kalliokoski O, 2010, IN VIVO, V24, P641; Kalliokoski O, 2011, VET J, V187, P251, DOI 10.1016/j.tvjl.2009.11.013; Kissin I, 1998, ANESTHESIOLOGY, V88, P224, DOI 10.1097/00000542-199801000-00031; Kyles AE, 1998, RES VET SCI, V65, P245, DOI 10.1016/S0034-5288(98)90151-5; Leach MC, 2010, LAB ANIM-UK, V44, P54, DOI 10.1258/la.2009.009029; Leung V, 2016, SCI REP-UK, V6, DOI 10.1038/srep31667; LEVINE JD, 1985, J NEUROSCI, V5, P1380; LILES JH, 1992, LAB ANIM, V26, P180, DOI 10.1258/002367792780740558; Magalhaes-Sant'Ana M, 2009, ANIM WELFARE, V18, P49; Martin LBE, 2001, COMPARATIVE MED, V51, P43; MCQUEEN DS, 1991, BRIT J PHARMACOL, V104, P178, DOI 10.1111/j.1476-5381.1991.tb12404.x; Mead R, 1988, DESIGN EXPT; Prunier A, 2005, J ANIM SCI, V83, P216; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Richardson CA, 2005, ATLA-ALTERN LAB ANIM, V33, P119, DOI 10.1177/026119290503300207; Roughan JV, 2002, LAB ANIM-UK, V36, P322, DOI 10.1258/002367702320162423; Sacerdote P, 2006, PALLIATIVE MED, V20, pS9, DOI 10.1191/0269216306pm1124oa; Shankarappa SA, 2012, P NATL ACAD SCI USA, V109, P17555, DOI 10.1073/pnas.1214634109; Shavit Y, 2005, BRAIN RES, V1047, P10, DOI 10.1016/j.brainres.2005.04.003; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stewart LSA, 2003, CONTEMP TOP LAB ANIM, V42, P28; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Sundbom R, 2011, IN VIVO, V25, P335; Walker JS, 1996, INFLAMM RES, V45, P557, DOI 10.1007/BF02342227; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	66	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0260356	10.1371/journal.pone.0260356	http://dx.doi.org/10.1371/journal.pone.0260356			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025864	Green Published, gold			2022-12-26	WOS:000796264200007
J	Karolak, A; Levatic, J; Supek, F				Karolak, Aleksandra; Levatic, Jurica; Supek, Fran			A framework for mutational signature analysis based on DNA shape parameters	PLOS ONE			English	Article							CANCER; PREDICTION; PATTERNS; REVEAL	The mutation risk of a DNA locus depends on its oligonucleotide context. In turn, mutability of oligonucleotides varies across individuals, due to exposure to mutagenic agents or due to variable efficiency and/or accuracy of DNA repair. Such variability is captured by mutational signatures, a mathematical construct obtained by a deconvolution of mutation frequency spectra across individuals. There is a need to enhance methods for inferring mutational signatures to make better use of sparse mutation data (e.g., resulting from exome sequencing of cancers), to facilitate insight into underlying biological mechanisms, and to provide more accurate mutation rate baselines for inferring positive and negative selection. We propose a conceptualization of mutational signatures that represents oligonucleotides via descriptors of DNA conformation: base pair, base pair step, and minor groove width parameters. We demonstrate how such DNA structural parameters can accurately predict mutation occurrence due to DNA repair failures or due to exposure to diverse mutagens such as radiation, chemical exposure, and the APOBEC cytosine deaminase enzymes. Furthermore, the mutation frequency of DNA oligomers classed by structural features can accurately capture systematic variability in mutagenesis of >1,000 tumors originating from diverse human tissues. A nonnegative matrix factorization was applied to mutation spectra stratified by DNA structural features, thereby extracting novel mutational signatures. Moreover, many of the known trinucleotide signatures were associated with an additional spectrum in the DNA structural descriptor space, which may aid interpretation and provide mechanistic insight. Overall, we suggest that the power of DNA sequence motif-based mutational signature analysis can be enhanced by drawing on DNA shape features.	[Karolak, Aleksandra; Levatic, Jurica; Supek, Fran] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Genome Data Sci, Barcelona, Spain; [Karolak, Aleksandra] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Karolak, Aleksandra] City Hope Natl Med Ctr, Beckman Res Inst, Dept Computat & Quantitat Med, Div Math Oncol, Duarte, CA USA; [Supek, Fran] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Karolak, Aleksandra] H Lee Moffitt Canc Ctr & Res Inst, Dept Machine Learning, Div Quantitat Sci, Tampa, FL USA	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; ICREA; H Lee Moffitt Cancer Center & Research Institute	Supek, F (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Genome Data Sci, Barcelona, Spain.; Supek, F (corresponding author), Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain.	fran.supek@irbbarcelona.org	Karolak, Aleksandra/L-7386-2017	Karolak, Aleksandra/0000-0001-8430-7138	European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020), under the Marie Sklodowska-Curie PROBIST grant [754510]; European Research Council (ERC) under the European Union [757700]; ICREA Research Professor program; Severo Ochoa Centres of Excellence program of the Spanish Ministry of Economy and Competitiveness; ERDF/Spanish Ministry of Science, Innovation and Universities-Spanish Research State Agency [BFU2017-89833-P, PID2020-118795GB-I00]	European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020), under the Marie Sklodowska-Curie PROBIST grant; European Research Council (ERC) under the European Union(European Research Council (ERC)); ICREA Research Professor program; Severo Ochoa Centres of Excellence program of the Spanish Ministry of Economy and Competitiveness; ERDF/Spanish Ministry of Science, Innovation and Universities-Spanish Research State Agency	This work has received funding from the European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020), under the Marie Sklodowska-Curie PROBIST grant agreement No. 754510 (to A.K. and J.L., PROBIST co-fund fellowship of the Barcelona Institute of Science and Technology) and by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 757700, to F.S). F.S. is funded by the ICREA Research Professor program. A.K., J.L. and F.S. acknowledge support of the Severo Ochoa Centres of Excellence program of the Spanish Ministry of Economy and Competitiveness to the IRB Barcelona. Work in the laboratory of F.S. was supported by the ERDF/Spanish Ministry of Science, Innovation and Universities-Spanish Research State Agency/RegioMut project (grant agreement No. BFU2017-89833-P) and REPAIRSCAPE project (PID2020-118795GB-I00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2015, CELL, V161, P307, DOI 10.1016/j.cell.2015.02.008; Aggarwala V, 2016, NAT GENET, V48, P349, DOI 10.1038/ng.3511; Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Behjati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12605; Berger MF, 2018, NAT REV CLIN ONCOL, V15, P353, DOI 10.1038/s41571-018-0002-6; Buisson R, 2019, SCIENCE, V364, P1251, DOI 10.1126/science.aaw2872; Cadet J, 2018, PHOTOCH PHOTOBIO SCI, V17, P1816, DOI 10.1039/c7pp00395a; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Carlson J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05936-5; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chiu TP, 2016, BIOINFORMATICS, V32, P1211, DOI 10.1093/bioinformatics/btv735; Dietlein F, 2020, NAT GENET, V52, P208, DOI 10.1038/s41588-019-0572-y; Duan CR, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1525-y; Fredriksson NJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006773; Fujii S, 2007, NUCLEIC ACIDS RES, V35, P6063, DOI 10.1093/nar/gkm627; Funnell T, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006799; Georgakopoulos-Soares I, 2018, GENOME RES, V28, P1264, DOI 10.1101/gr.231688.117; Glockzin Gabriel, 2016, World J Gastrointest Pharmacol Ther, V7, P343, DOI 10.4292/wjgpt.v7.i3.343; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Goto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11808; Gulhan DC, 2019, NAT GENET, V51, P912, DOI 10.1038/s41588-019-0390-2; Harmon Rhonda L, 2005, Int Semin Surg Oncol, V2, P3, DOI 10.1186/1477-7800-2-3; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Karolak A, 2016, J PHYS CHEM B, V120, P42, DOI 10.1021/acs.jpcb.5b09250; Karolak A, 2015, BIOPHYS CHEM, V203, P22, DOI 10.1016/j.bpc.2015.05.001; Karolak A, 2014, J COMPUT CHEM, V35, P2297, DOI 10.1002/jcc.23751; Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001; Lankas F, 2003, BIOPHYS J, V85, P2872, DOI 10.1016/S0006-3495(03)74710-9; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Levatic J., 2021, BIORXIV, DOI [10.1101/2021.05.19.444811, DOI 10.1101/2021.05.19.444811]; Li JS, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1145; Lim B, 2016, ONCOTARGET, V7, P8055, DOI 10.18632/oncotarget.6977; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Madakashira BP, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00076; Mao P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05064-0; Marquard AM, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0130-0; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Martinez-Fernandez L, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.21; Mas-Ponte D, 2020, NAT GENET, V52, P958, DOI 10.1038/s41588-020-0674-6; Mathelier A, 2016, CELL SYST, V3, P278, DOI 10.1016/j.cels.2016.07.001; Matsutani T, 2019, BIOINFORMATICS, V35, P4543, DOI 10.1093/bioinformatics/btz266; McMullen JRW, 2017, ONCOTARGET, V8, P43481, DOI 10.18632/oncotarget.16480; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Nakagawa H, 2018, CANCER SCI, V109, P513, DOI 10.1111/cas.13505; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Omichessan H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221235; Petljak M, 2019, CELL, V176, P1282, DOI 10.1016/j.cell.2019.02.012; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Poon SL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0161-3; Poulos RC, 2017, NUCLEIC ACIDS RES, V45, P7786, DOI 10.1093/nar/gkx463; R Core Team, 2020, R LANG ENV STAT COMP; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sahin IH, 2019, BRIT J CANCER, V121, P809, DOI 10.1038/s41416-019-0599-y; Salvadores M, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006953; Schrock AB, 2019, ANN ONCOL, V30, P1096, DOI 10.1093/annonc/mdz134; Seplyarskiy VB, 2021, SCIENCE, V373, P1030, DOI 10.1126/science.aba7408; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Shiraishi Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005657; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Staaf J, 2019, NAT MED, V25, P1526, DOI 10.1038/s41591-019-0582-4; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Volkova NV, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15912-7; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437	69	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262495	10.1371/journal.pone.0262495	http://dx.doi.org/10.1371/journal.pone.0262495			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015788	Green Published, Green Submitted, gold			2022-12-26	WOS:000814820600028
J	Arnaout, Y; Djelouadji, Z; Robardet, E; Cappelle, J; Cliquet, F; Touzalin, F; Jimenez, G; Hurstel, S; Borel, C; Picard-Meyer, E				Arnaout, Youssef; Djelouadji, Zouheira; Robardet, Emmanuelle; Cappelle, Julien; Cliquet, Florence; Touzalin, Frederic; Jimenez, Giacomo; Hurstel, Suzel; Borel, Christophe; Picard-Meyer, Evelyne			Genetic identification of bat species for pathogen surveillance across France	PLOS ONE			English	Article							REAL-TIME PCR; MOLECULAR PHYLOGENY; CHIROPTERA VESPERTILIONIDAE; POPULATION-GENETICS; MITOCHONDRIAL; EUROPE; PHYLOGEOGRAPHY; SYSTEMATICS; AMPLIFICATION; LYSSAVIRUSES	With more than 1400 chiropteran species identified to date, bats comprise one-fifth of all mammalian species worldwide. Many studies have associated viral zoonoses with 45 different species of bats in the EU, which cluster within 5 families of bats. For example, the Serotine bats are infected by European Bat 1 Lyssavirus throughout Europe while Myotis bats are shown infected by coronavirus, herpesvirus and paramyxovirus. Correct host species identification is important to increase our knowledge of the ecology and evolutionary pattern of bat viruses in the EU. Bat species identification is commonly determined using morphological keys. Morphological determination of bat species from bat carcasses can be limited in some cases, due to the state of decomposition or nearly indistinguishable morphological features in juvenile bats and can lead to misidentifications. The overall objective of our study was to identify insectivorous bat species using molecular biology tools with the amplification of the partial cytochrome b gene of mitochondrial DNA. Two types of samples were tested in this study, bat wing punches and bat faeces. A total of 163 bat wing punches representing 22 species, and 31 faecal pellets representing 7 species were included in the study. From the 163 bat wing punches tested, a total of 159 were genetically identified from amplification of the partial cyt b gene. All 31 faecal pellets were genetically identified based on the cyt b gene. A comparison between morphological and genetic determination showed 21 misidentifications from the 163 wing punches, representing similar to 12.5% of misidentifications of morphological determination compared with the genetic method, across 11 species. In addition, genetic determination allowed the identification of 24 out of 25 morphologically non-determined bat samples. Our findings demonstrate the importance of a genetic approach as an efficient and reliable method to identify bat species precisely.	[Arnaout, Youssef; Robardet, Emmanuelle; Cliquet, Florence; Picard-Meyer, Evelyne] ANSES, WHO Collaborating Ctr Res & Management Zoonoses C, Nancy Lab Rabies & Wildlife,OIE Reference Lab Rab, European Union Reference Lab Rabies,European Unio, Malzeville, France; [Arnaout, Youssef; Djelouadji, Zouheira] VetAgro Sup Lyon Lab Leptospira, Marcy Letoile, France; [Cappelle, Julien] Univ Montpellier, UMR ASTRE, CIRAD, INRAE, Montpellier, France; [Cappelle, Julien] INRAE, VetAgro Sup, UMR EPIA, Theix, France; [Touzalin, Frederic] Univ Coll Dublin, Sci Ctr West, Sch Biol & Environm Sci, Dublin, Ireland; [Jimenez, Giacomo; Borel, Christophe] CPEPESC Lorraine, Neuves Maisons, France; [Hurstel, Suzel] GEPMA, Strasbourg, France; [Hurstel, Suzel] LPO Alsace, Rosenwiller, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; CIRAD; INRAE; Universite de Montpellier; INRAE; VetAgro Sup; University College Dublin	Picard-Meyer, E (corresponding author), ANSES, WHO Collaborating Ctr Res & Management Zoonoses C, Nancy Lab Rabies & Wildlife,OIE Reference Lab Rab, European Union Reference Lab Rabies,European Unio, Malzeville, France.	evelyne.picard-meyer@anses.fr		Cappelle, Julien/0000-0001-7668-1971	French National Agency for Food, Environmental and Occupational Health & Safety and VetAgro Sup laboratory for Leptospira	French National Agency for Food, Environmental and Occupational Health & Safety and VetAgro Sup laboratory for Leptospira	This work was supported by the French National Agency for Food, Environmental and Occupational Health & Safety and VetAgro Sup laboratory for Leptospira.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Artyushin IV, 2009, ZOOTAXA, P40; Benda P, 2016, TURK J ZOOL, V40, P842, DOI 10.3906/zoo-1505-47; Benda Petr, 2012, Acta Societatis Zoologicae Bohemicae, V76, P163; Bogdanowicz W, 2009, ACTA CHIROPTEROL, V11, P289, DOI 10.3161/150811009X485530; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boston ESM, 2012, ACTA CHIROPTEROL, V14, P45, DOI 10.3161/150811012X654259; Chipps AS, 2020, PEERJ, V8, DOI 10.7717/peerj.10348; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Dietz C, 2009, HDB BATS EUROPE NW A; Dool SE, 2013, MOL ECOL, V22, P4055, DOI 10.1111/mec.12373; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Eggerbauer E, 2017, ADV VIRUS RES, V99, P199, DOI 10.1016/bs.aivir.2017.07.004; Falcon A, 2011, ARCH VIROL, V156, P1883, DOI 10.1007/s00705-011-1057-1; Fenton MB, 2010, CURR ZOOL, V56, P454, DOI 10.1093/czoolo/56.4.454; Hassanin A, 2016, CR BIOL, V339, P517, DOI 10.1016/j.crvi.2016.09.005; Heaney LR, 2012, ACTA CHIROPTEROL, V14, P265, DOI 10.3161/150811012X661602; Hulva P, 2012, MOL ECOL, V21, P6104, DOI 10.1111/mec.12078; Jones G, 2006, ACTA CHIROPTEROL, V8, P451, DOI 10.3161/1733-5329(2006)8[451:ECWSDA]2.0.CO;2; Juste J, 2018, ACTA CHIROPTEROL, V20, P285, DOI 10.3161/15081109ACC2018.20.2.001; Kawai K, 2003, MOL PHYLOGENET EVOL, V28, P297, DOI 10.1016/S1055-7903(03)00121-0; Kawai K, 2010, ACTA CHIROPTEROL, V12, P463, DOI 10.3161/150811010X538034; Kim HS, 2008, J CLIN MICROBIOL, V46, P2992, DOI 10.1128/JCM.00027-08; Korstian JM, 2016, CONSERV GENET RESOUR, V8, P27, DOI 10.1007/s12686-015-0509-4; Lei M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27726; Lopez-Oceja A, 2016, FORENSIC SCI INT-GEN, V23, P159, DOI 10.1016/j.fsigen.2016.05.001; McElhinney LM, 2013, ZOONOSES PUBLIC HLTH, V60, P35, DOI 10.1111/zph.12003; Ministere de l'Ecologie et du Developpement Durable, 2012, ARR AUT CAPT TRANSP, V3; Moussy C, 2015, HEREDITY, V115, P83, DOI 10.1038/hdy.2015.20; Muhldorfer K, 2010, EMERG INFECT DIS, V16, P578, DOI 10.3201/eid1603.091035; Nadin-Davis SA, 2012, OPEN J ZOOLOGY S1M5, V5, P27, DOI DOI 10.2174/1874336601205010027; Nadin-Davis S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005541; Pereira MR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639310; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; Puechmaille SJ, 2014, MAMMALIA, V78, P251, DOI 10.1515/mammalia-2013-0040; Puechmaille SJ, 2012, MAMM BIOL, V77, P224, DOI 10.1016/j.mambio.2011.11.004; Rebelo H, 2012, MOL ECOL, V21, P2761, DOI 10.1111/j.1365-294X.2012.05566.x; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Ruedi M, 2015, ZOOTAXA, V3920, P301, DOI 10.11646/zootaxa.3920.2.6; Ruedi M, 2013, MOL PHYLOGENET EVOL, V69, P437, DOI 10.1016/j.ympev.2013.08.011; Sakai T, 2003, GENES GENET SYST, V78, P179; Schlottau K, 2020, INFECT GENET EVOL, V78, DOI 10.1016/j.meegid.2019.104140; Shipley R, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4010031; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Stuckey MJ, 2017, EMERG INFECT DIS, V23, P539, DOI 10.3201/eid2303.160934; Sylvia B., 2018, ACTION PLAN CONSERVA, V86; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tian LX, 2004, FOLIA ZOOL, V53, P303; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; Troupin C, 2017, GENOME BIOL EVOL, V9, P3202, DOI 10.1093/gbe/evx236; Trujillo RG, 2009, J MAMMAL, V90, P548, DOI 10.1644/08-MAMM-A-239R2.1; Tsytsulina Katerina, 2012, Russian Journal of Theriology, V11, P1; Walker FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162342; Zhang GD, 2011, APPL ENVIRON MICROB, V77, P6495, DOI 10.1128/AEM.00520-11; Zhou ZM, 2009, J MAMMAL, V90, P57, DOI 10.1644/08-MAMM-A-048.1	61	1	1	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261344	10.1371/journal.pone.0261344	http://dx.doi.org/10.1371/journal.pone.0261344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982782	Green Published, gold			2022-12-26	WOS:000834805700008
J	Braunwarth, E; Schullian, P; Kummann, M; Reider, S; Putzer, D; Primavesi, F; Stattner, S; Ofner, D; Bale, R				Braunwarth, Eva; Schullian, Peter; Kummann, Moritz; Reider, Simon; Putzer, Daniel; Primavesi, Florian; Staettner, Stefan; Oefner, Dietmar; Bale, Reto			Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection	PLOS ONE			English	Article							LONG-TERM SURVIVAL; THERMAL ABLATION; HEPATOCELLULAR-CARCINOMA; MICROWAVE ABLATION; SURGICAL RESECTION; LIVER-RESECTION; MANAGEMENT; OUTCOMES; GEMCITABINE; CISPLATIN	Background To evaluate the efficacy, safety and overall clinical outcome of local treatment for recurrent intrahepatic cholangiocellular carcinoma after hepatic resection. Methods Between 2007 and 2019 72 consecutive patients underwent hepatic resection for primary intrahepatic cholangiocellular carcinoma. If amenable, recurrent tumors were aggressively treated by HR or stereotactic radiofrequency ablation with local curative intent. Endpoints consisted of morbidity and mortality, locoregional and de novo recurrence, disease free survival, and overall survival. Results After a median follow-up of 28 months, recurrence of intrahepatic cholangiocellular carcinoma was observed in 43 of 72 patients undergoing hepatic resection (60.3%). 16 patients were subsequently treated by hepatic resection (n = 5) and stereotactic radiofrequency ablation (n = 11) with local curative intention. The remaining 27 patients underwent palliative treatment for first recurrence. Overall survival of patients who underwent repeated aggressive liver-directed therapy was comparable to patients without recurrence (p = 0.938) and was better as compared to patients receiving palliative treatment (p = 0.018). The 5-year overall survival rates for patients without recurrence, the repeated liver-directed treatment group and the palliative treatment group were 54.3%, 47.7% and 12.3%, respectively. By adding stereotactic radiofrequency ablation as an alternative treatment option, the rate of curative re-treatment increased from 11.9% to 37.2%. Conclusion Repeated hepatic resection is often precluded due to patient morbidity or anatomical and functional limitations. Due to the application of stereotactic radiofrequency ablation in case of recurrent intrahepatic cholangiocellular carcinoma, the number of patients treated with curative intent can be increased. This leads to favorable clinical outcome as compared to palliative treatment of intrahepatic cholangiocellular carcinoma recurrence.	[Braunwarth, Eva; Oefner, Dietmar] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria; [Schullian, Peter; Kummann, Moritz; Putzer, Daniel; Bale, Reto] Med Univ Innsbruck, Dept Radiol Intervent Oncol Microinvas Therapy, Innsbruck, Austria; [Reider, Simon] Med Univ Innsbruck, Dept Internal Med 1, Gastroenterol Hepatol & Endocrinol, Innsbruck, Austria; [Primavesi, Florian; Staettner, Stefan] Salzkammergut Klinikum, Dept Gen Visceral & Vasc Surg, Vocklabruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Bale, R (corresponding author), Med Univ Innsbruck, Dept Radiol Intervent Oncol Microinvas Therapy, Innsbruck, Austria.	reto.bale@i-med.ac.at	Bale, Reto/AAS-1522-2020	Bale, Reto/0000-0003-0021-5792				Amini N, 2014, J SURG ONCOL, V110, P163, DOI 10.1002/jso.23605; [Anonymous], STATISTIK AUSTRIA; Atwell TD, 2005, CARDIOVASC INTER RAD, V28, P409, DOI 10.1007/s00270-004-4082-6; Bale R, 2019, CANCERS, V11, DOI 10.3390/cancers11091341; Bale R, 2012, EUR RADIOL, V22, P930, DOI 10.1007/s00330-011-2314-0; Bale R, 2011, CARDIOVASC INTER RAD, V34, P852, DOI 10.1007/s00270-010-9966-z; Bartolini I, 2020, RADIOL ONCOL, V54, P263, DOI 10.2478/raon-2020-0045; Bartsch F, 2019, WORLD J SURG, V43, P1105, DOI 10.1007/s00268-018-04876-x; Braunwarth E, 2018, EUR SURG, V50, P100, DOI 10.1007/s10353-018-0537-x; Buettner S, 2017, J SURG ONCOL, V116, P1085, DOI 10.1002/jso.24759; Butros SR, 2014, CLIN IMAG, V38, P490, DOI 10.1016/j.clinimag.2014.01.013; Carrafiello G, 2014, RADIOL MED, V119, P75, DOI 10.1007/s11547-013-0301-z; Choi SB, 2009, ANN SURG ONCOL, V16, P3048, DOI 10.1245/s10434-009-0631-1; Chun YS, 2017, CANCER CONTROL, V24, DOI 10.1177/1073274817729241; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Crocetti L, 2008, CANCER IMAGING, V8, P19, DOI 10.1102/1470-7330.2008.0004; Doussot A, 2016, J AM COLL SURGEONS, V223, P493, DOI 10.1016/j.jamcollsurg.2016.05.019; Doussot A, 2015, J AM COLL SURGEONS, V221, P452, DOI 10.1016/j.jamcollsurg.2015.04.009; Ebata T, 2017, LIVER CANCER, V6, P59, DOI 10.1159/000449493; Eckel F, 2009, ANN ONCOL, V20, P46, DOI 10.1093/annonc/mdp125; Ercolani G, 2010, ANN SURG, V252, P107, DOI 10.1097/SLA.0b013e3181e462e6; Fu Y, 2012, J VASC INTERV RADIOL, V23, P642, DOI 10.1016/j.jvir.2012.01.081; Haidu M, 2012, CARDIOVASC INTER RAD, V35, P1074, DOI 10.1007/s00270-011-0288-6; Hu LS, 2019, ANN SURG ONCOL, V26, P2549, DOI 10.1245/s10434-019-07353-4; Hyder O, 2013, SURGERY, V153, P811, DOI 10.1016/j.surg.2012.12.005; Inoue K, 2000, SURGERY, V127, P498, DOI 10.1067/msy.2000.104673; Kim JH, 2011, AM J ROENTGENOL, V196, pW205, DOI 10.2214/AJR.10.4937; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Lang H, 2009, J AM COLL SURGEONS, V208, P218, DOI 10.1016/j.jamcollsurg.2008.10.017; Lencioni R, 2015, TECH VASC INTERV RAD, V18, P135, DOI 10.1053/j.tvir.2015.06.003; Mavros MN, 2014, JAMA SURG, V149, P565, DOI 10.1001/jamasurg.2013.5137; Mizusawa J, 2016, JPN J CLIN ONCOL, V46, P385, DOI 10.1093/jjco/hyv213; Pang Yeung Yuk, 2002, HPB (Oxford), V4, P99, DOI 10.1080/136518202760378489; Park HM, 2016, ANN SURG ONCOL, V23, P4392, DOI 10.1245/s10434-016-5454-2; Primrose JN, 2019, LANCET ONCOL, V20, P663, DOI 10.1016/S1470-2045(18)30915-X; Putzer D, 2018, EUR SURG, V50, P117, DOI 10.1007/s10353-018-0521-5; Putzer D, 2019, INT J HYPERTHER, V36, P59, DOI 10.1080/02656736.2019.1647353; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Schullian P, 2020, J VASC INTERV RADIOL, V31, P943, DOI 10.1016/j.jvir.2019.12.794; Schullian P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58383-y; Schullian P, 2019, INT J HYPERTHER, V36, P876, DOI 10.1080/02656736.2019.1648886; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Si AF, 2017, SURGERY, V161, P897, DOI 10.1016/j.surg.2016.10.024; Souche R, 2016, AM J SURG, V212, P221, DOI 10.1016/j.amjsurg.2015.07.016; Spolverato G, 2016, ANN SURG ONCOL, V23, P235, DOI 10.1245/s10434-015-4642-9; Sulpice L, 2012, BRIT J SURG, V99, P1711, DOI 10.1002/bjs.8953; Tarchi P, 2018, SURGERY, V163, P698, DOI 10.1016/j.surg.2017.09.058; Thirunavukarasu P, 2016, SURG CLIN N AM, V96, P197, DOI 10.1016/j.suc.2015.11.001; Valle JW, 2016, ANN ONCOL, V27, pv28, DOI 10.1093/annonc/mdw324; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Waisberg DR, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2018.08.03; Wright GP, 2018, ANN SURG ONCOL, V25, P83, DOI 10.1245/s10434-017-6110-1; Xu HX, 2012, BRIT J RADIOL, V85, P1078, DOI 10.1259/bjr/24563774; Yamashita Y, 2017, ANN GASTROENT SURG, V1, P136, DOI 10.1002/ags3.12018; Yin T, 2017, CLIN RADIOL, V72, P136, DOI 10.1016/j.crad.2016.10.022; Zhang SJ, 2013, ANN SURG ONCOL, V20, P3596, DOI 10.1245/s10434-013-3035-1; Zhang XF, 2018, BRIT J SURG, V105, P848, DOI 10.1002/bjs.10676	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261136	10.1371/journal.pone.0261136	http://dx.doi.org/10.1371/journal.pone.0261136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982804	gold, Green Published			2022-12-26	WOS:000834805700007
J	Barajas, R; Hair, B; Lai, G; Rotunno, M; Shams-White, MM; Gillanders, EM; Mechanic, LE				Barajas, Rolando; Hair, Brionna; Lai, Gabriel; Rotunno, Melissa; Shams-White, Marissa M.; Gillanders, Elizabeth M.; Mechanic, Leah E.			Facilitating cancer systems epidemiology research	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TRANSDISCIPLINARY RESEARCH; HEALTH; SCIENCE; FUTURE; DISPARITIES; PREVENTION; OBESITY; IMPACT; CHALLENGES	Systems epidemiology offers a more comprehensive and holistic approach to studies of cancer in populations by considering high dimensionality measures from multiple domains, assessing the inter-relationships among risk factors, and considering changes over time. These approaches offer a framework to account for the complexity of cancer and contribute to a broader understanding of the disease. Therefore, NCI sponsored a workshop in February 2019 to facilitate discussion about the opportunities and challenges of the application of systems epidemiology approaches for cancer research. Eight key themes emerged from the discussion: transdisciplinary collaboration and a problem-based approach; methods and modeling considerations; interpretation, validation, and evaluation of models; data needs and opportunities; sharing of data and models; enhanced training practices; dissemination of systems models; and building a systems epidemiology community. This manuscript summarizes these themes, highlights opportunities for cancer systems epidemiology research, outlines ways to foster this research area, and introduces a collection of papers, "Cancer System Epidemiology Insights and Future Opportunities" that highlight findings based on systems epidemiology approaches.	[Barajas, Rolando; Lai, Gabriel; Rotunno, Melissa; Shams-White, Marissa M.; Gillanders, Elizabeth M.; Mechanic, Leah E.] NCI, Epidemiol & Genom Res Program, Div Canc Control & Populat Sci DCCPS, NIH, Bethesda, MD 20892 USA; [Hair, Brionna] NCI, DCCPS, NIH, Bethesda, MD 20892 USA; [Barajas, Rolando] Georgetown Univ, Sch Med, Washington, DC USA; [Hair, Brionna] NIH, Off Strateg Coordinat, Div Program Coordinat Planning & Strateg Initiat, Off Director, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; National Institutes of Health (NIH) - USA	Mechanic, LE (corresponding author), NCI, Epidemiol & Genom Res Program, Div Canc Control & Populat Sci DCCPS, NIH, Bethesda, MD 20892 USA.	mechanil@mail.nih.gov			Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI), National Institutes of Health (NIH)	Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI), National Institutes of Health (NIH)	This research was supported by the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI), National Institutes of Health (NIH). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Cancer Institute.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Alagoz O, 2018, MED DECIS MAKING, V38, p3S, DOI 10.1177/0272989X17737507; All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; Altman N, 2018, NAT METHODS, V15, P399, DOI 10.1038/s41592-018-0019-x; Bensyl DM, 2019, AM J EPIDEMIOL, V188, P830, DOI 10.1093/aje/kwz052; Bian J, 2014, J BIOMED INFORM, V52, P130, DOI 10.1016/j.jbi.2014.01.015; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Bures RM, 2014, AM J PUBLIC HEALTH, V104, P1156, DOI 10.2105/AJPH.2014.302082; Burke TA, 2017, ENVIRON HEALTH PERSP, V125, pA43, DOI 10.1289/EHP1465; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Centers for Disease Control, 2019, 1 YEAR GEOGR FOC END; Cerda M, 2019, AM J EPIDEMIOL, V188, P862, DOI 10.1093/aje/kwy262; Chatterjee N., 2020, DATA SCI; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Colditz GA, 2012, ANNU REV PUBL HEALTH, V33, P137, DOI 10.1146/annurev-publhealth-031811-124627; Collins T, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.0fdb85e1619f313a2a5a2ec3d7a8df9e; Cornelis Marilyn C, 2013, Curr Nutr Rep, V2, DOI 10.1007/s13668-013-0052-4; Dammann O, 2014, Online J Public Health Inform, V6, pe198, DOI 10.5210/ojphi.v6i3.5571; Department of Health and Human Services, 4 NATL REP HUM EXP E; Department of Health and Human Services Administration for Children and Families Children's Bureau, 2018, CHILD MALTREATMENT; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Fallah-Fini S, 2017, OBESITY, V25, P1809, DOI 10.1002/oby.21965; Frankhauser DE, 2021, WIRES MECH DIS, V13, DOI 10.1002/wsbm.1506; Franks PW, 2016, SCIENCE, V354, P69, DOI 10.1126/science.aaf5094; Gibbons MC, 2008, STUD HEALTH TECHNOL, V137, P265; Golembiewski EH, 2018, PUBLIC HEALTH REP, V133, P182, DOI 10.1177/0033354918754558; Hammond RA, 2009, PREV CHRONIC DIS, V6; Haring R, 2012, OMICS, V16, P231, DOI 10.1089/omi.2011.0108; Hiatt RA, 2014, CANCER EPIDEM BIOMAR, V23, P2078, DOI 10.1158/1055-9965.EPI-14-0403; Hu FB, 2011, CLIN CHEM, V57, P1224, DOI 10.1373/clinchem.2011.167056; Iorio A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3646-1; Jankowska MM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6501-2; Jayasekera J, 2018, JNCI-J NATL CANCER I, V110, P1370, DOI 10.1093/jnci/djy128; Jones AP, 2006, AM J PUBLIC HEALTH, V96, P488, DOI 10.2105/AJPH.2005.063529; Khurana Y., 2019, MEDIUM; Langellier BA, 2019, AM J PREV MED, V57, P273, DOI 10.1016/j.amepre.2019.03.017; Lee BY, 2018, AM J PREV MED, V54, P197, DOI 10.1016/j.amepre.2017.11.003; Lee BY, 2017, HEALTH AFFAIR, V36, P902, DOI 10.1377/hlthaff.2016.1315; Lee BY, 2017, NUTR REV, V75, P94, DOI 10.1093/nutrit/nuw049; Li Y, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150561; Lich KH, 2013, PREV SCI, V14, P279, DOI 10.1007/s11121-012-0285-2; Llewellyn N, 2020, EVAL HEALTH PROF, V43, P169, DOI 10.1177/0163278719839435; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Lund E, 2008, CANCER EPIDEM BIOMAR, V17, P2954, DOI 10.1158/1055-9965.EPI-08-0519; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; Mabry PL, 2013, HEALTH EDUC BEHAV, V40, p9S, DOI 10.1177/1090198113503469; Martin DN, 2016, CANCER EPIDEM BIOMAR, V25, P573, DOI 10.1158/1055-9965.EPI-15-1297; McGuire S, 2012, ADV NUTR, V3, P708, DOI 10.3945/an.112.002733; Mechanic LE, 2012, GENET EPIDEMIOL, V36, P22, DOI 10.1002/gepi.20652; National Cancer Institute, SURVEILLANCE EPIDEMI; National Institutes of Health, 2018, NIH STRAT PLAN DAT S; Nielsen J, 2017, CELL METAB, V25, P572, DOI 10.1016/j.cmet.2017.02.002; Orr MG, 2016, J EPIDEMIOL COMMUN H, V70, P862, DOI 10.1136/jech-2015-205621; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Paltoo DN, 2014, NAT GENET, V46, P934, DOI 10.1038/ng.3062; Patterson RE, 2013, CANCER CAUSE CONTROL, V24, P695, DOI 10.1007/s10552-013-0150-z; Pendergrass Sarah A, 2019, Curr Protoc Hum Genet, V100, pe80, DOI 10.1002/cphg.80; Peng B, 2019, BIOINFORMATICS, V35, P709, DOI 10.1093/bioinformatics/bty666; Pohl C., 2007, PRINCIPLES DESIGNING; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Powell-Wiley TM, 2017, OBESITY, V25, P2149, DOI 10.1002/oby.22040; Price ND, 2017, NAT BIOTECHNOL, V35, P747, DOI 10.1038/nbt.3870; Realmuto L, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2019.100373; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Sanna S, 2019, NAT GENET, V51, P600, DOI 10.1038/s41588-019-0350-x; Schmitz KH, 2016, CLIN CANCER RES, V22, P1565, DOI 10.1158/1078-0432.CCR-14-1214; Shams-White MM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250061; Spratt DE, 2016, JAMA ONCOL, V2, P1070, DOI 10.1001/jamaoncol.2016.1854; Susser M, 1996, AM J PUBLIC HEALTH, V86, P668, DOI 10.2105/AJPH.86.5.668; Swerdlow AJ, 2018, CANCER EPIDEM BIOMAR, V27, P1307, DOI 10.1158/1055-9965.EPI-18-0182; Tracy M, 2018, ANNU REV PUBL HEALTH, V39, P77, DOI 10.1146/annurev-publhealth-040617-014317; Wang K, 2017, NAT GENET, V49, P1319, DOI 10.1038/ng.3931; Washington University in St. Louis, 2021, SYST SCI SOC IMP SUM; Weed DL, 1998, AM J PUBLIC HEALTH, V88, P12, DOI 10.2105/AJPH.88.1.12; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18	76	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0255328	10.1371/journal.pone.0255328	http://dx.doi.org/10.1371/journal.pone.0255328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972102	Green Published, gold			2022-12-26	WOS:000773555700004
J	Diaz-Parga, P; de Alba, E				Diaz-Parga, Pedro; de Alba, Eva			Inflammasome regulation by adaptor isoforms, ASC and ASCb, via differential self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECK-LIKE PROTEIN; ACTIVATION; APOPTOSIS; KINETICS; NLRP3; POLYMERIZATION; MECHANISM; OLIGOMERIZATION; RECRUITMENT; GELATION	ASC is an essential adaptor of the inflammasome, a micrometer-size multiprotein complex that processes proinflammatory cytokines. Inflammasome formation depends on ASC self-association into large assemblies via homotypic interactions of its two death domains, PYD and CARD. ASCb, an alternative splicing isoform, activates the inflammasome to a lesser extent compared with ASC. Thus, it has been postulated that adaptor isoforms differentially regulate inflammasome function. At the amino acid level, ASC and ASCb differ only in the length of the linker connecting the two death domains. To understand inflammasome regulation at the molecular level, we investigated the self-association properties of ASC and ASCb using real-time NMR, dynamic light scattering (DLS), size-exclusion chromatography, and transmission electron microscopy (TEM). The NMR data indicate that ASC self association is faster than that of ASCb; a kinetic model for this oligomerization results in differing values for both the reaction order and the rate constants. Furthermore, DLS analysis indicates that ASC self-associates into more compact macrostructures compared with ASCb. Finally, TEM data show that ASCb has a reduced tendency to form densely packed filaments relative to ASC. Overall, these differences can only be explained by an effect of the linker length, as the NMR results show structural equivalence of the PYD and CARD in both proteins. The effect of linker length was corroborated by molecular docking with the procaspase-1 CARD domain. Altogether, our results indicate that ASC's faster and less polydisperse polymerization is more efficient, plausibly explaining inflammasome activation differences by ASC isoforms at the molecular level.	[Diaz-Parga, Pedro; de Alba, Eva] Univ Calif Merced, Sch Engn, Dept Bioengn, Merced, CA 95343 USA; [Diaz-Parga, Pedro] Univ Calif Merced, Quantitat Syst Biol PhD Program, Merced, CA USA	University of California System; University of California Merced; University of California System; University of California Merced	de Alba, E (corresponding author), Univ Calif Merced, Sch Engn, Dept Bioengn, Merced, CA 95343 USA.	edealbabastarrechea@ucmerced.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R15AI146780]; NSF-CREST: Center for Cellular and Biomol-ecular Machines at the University of California, Merced [NSF-HRD-1547848]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF-CREST: Center for Cellular and Biomol-ecular Machines at the University of California, Merced	This research was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R15AI146780 to E. d. A., and by the NSF-CREST: Center for Cellular and Biomol-ecular Machines at the University of California, Merced (NSF-HRD-1547848) to P. D-P. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Barry R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05321-2; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bryan NB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-23; Cavanagh J., 1995, PROTEIN NMR SPECTROS; de Alba E, 2007, BIOMOL NMR ASSIGM, V1, P135, DOI 10.1007/s12104-007-9036-x; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Dear AJ, 2020, P NATL ACAD SCI USA, V117, P12087, DOI 10.1073/pnas.1922267117; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diaz-Parga P, 2019, METHOD ENZYMOL, V625, P223, DOI 10.1016/bs.mie.2019.07.008; Duez H, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.630536; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; FERRONE FA, 1980, BIOPHYS J, V32, P361, DOI 10.1016/S0006-3495(80)84962-9; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Friker LL, 2020, CELL REP, V30, P3743, DOI 10.1016/j.celrep.2020.02.025; Gambin Y, 2018, J MOL BIOL, V430, P491, DOI 10.1016/j.jmb.2017.12.013; GOLDSTEIN RF, 1986, BIOPHYS J, V50, P583, DOI 10.1016/S0006-3495(86)83498-1; HOFRICHTER J, 1974, P NATL ACAD SCI USA, V71, P4864, DOI 10.1073/pnas.71.12.4864; Jin TC, 2015, APOPTOSIS, V20, P151, DOI 10.1007/s10495-014-1053-5; Kamihira M, 2000, PROTEIN SCI, V9, P867, DOI 10.1110/ps.9.5.867; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Malik A, 2017, J CELL SCI, V130, P3955, DOI 10.1242/jcs.207365; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Matsushita K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/287387; Meisl G, 2017, CHEM SCI, V8, P7087, DOI 10.1039/c7sc01965c; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nambayan RJT, 2019, J BIOL CHEM, V294, P439, DOI 10.1074/jbc.RA118.004407; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Oroz J, 2016, J BIOL CHEM, V291, P19487, DOI 10.1074/jbc.M116.741082; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pirzada RH, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020131; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sengupta I, 2017, J MOL BIOL, V429, P1852, DOI 10.1016/j.jmb.2017.05.006; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Sharma M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020872; THUSIUS D, 1975, J MOL BIOL, V94, P367, DOI 10.1016/0022-2836(75)90208-9; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001	51	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101566	10.1016/j.jbc.2022.101566	http://dx.doi.org/10.1016/j.jbc.2022.101566			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35007535	gold, Green Published			2022-12-26	WOS:000791267400016
J	Hashizume, M; Takashima, A; Iwasaki, M				Hashizume, Mei; Takashima, Ayako; Iwasaki, Masaharu			A small stem-loop-forming region within the 3 '-UTR of a nonpolyadenylated LCMV mRNA promotes translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; INTERGENIC REGION; LASSA FEVER; ARENAVIRUS; SEQUENCE; TRANSCRIPTION; NSP3; INHIBITOR	Mammalian arenavirus (mammarenavirus) mRNAs are characterized by 5'-capped and 3'-nonpolyadenylated untranslated regions (UTRs). We previously reported that the nonpolyadenylated 3'-UTR of viral mRNA (vmRNA), which is derived from the noncoding intergenic region (IGR), regulates viral protein levels at the posttranscriptional level. This finding provided the basis for the development of novel live-attenuated vaccines (LAVs) against human pathogenic mammarenaviruses. Detailed information about the roles of specific vmRNA 3'-UTR sequences in controlling translation efficiency will help in understanding the mechanism underlying attenuation by IGR manipulations. Here, we characterize the roles of cis-acting mRNA regulatory sequences of a prototypic mammarenavirus, lymphocytic choriomeningitis virus (LCMV), in modulating translational efficiency. Using in vitro transcribed RNA mimics encoding a reporter gene, we demonstrate that the 3'-UTR of nucleoprotein (NP) mRNA without a poly(A) tail promotes translation in a poly(A)-binding protein-independent manner. Comparison with the 3'-UTR of glycoprotein precursor mRNA, which is translated less efficiently, revealed that a 10-nucleotide sequence proximal to the NP open reading frame is essential for promoting translation. Modification of this 10-nucleotide sequence also impacted reporter gene expression in recombinant LCMV. Our findings will enable rational design of the 10-nucleotide sequence to further improve our mammarenavirus LAV candidates and to develop a novel LCMV vector capable of controlling foreign gene expression.	[Hashizume, Mei; Takashima, Ayako; Iwasaki, Masaharu] Osaka Univ, Int Res Ctr Infect Dis, Res Inst Microbial Dis, Lab Emerging Viral Dis, Suita, Osaka, Japan; [Iwasaki, Masaharu] Osaka Univ, Ctr Infect Dis Educ & Res CiDER, Suita, Osaka, Japan	Osaka University; Osaka University	Iwasaki, M (corresponding author), Osaka Univ, Int Res Ctr Infect Dis, Res Inst Microbial Dis, Lab Emerging Viral Dis, Suita, Osaka, Japan.; Iwasaki, M (corresponding author), Osaka Univ, Ctr Infect Dis Educ & Res CiDER, Suita, Osaka, Japan.	miwasaki@biken.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [18H06144, 19H03477]; Japan Agency for Medical Research and Development (AMED) [JP20fm0208101]; Tokyo Biochemical Research Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tokyo Biochemical Research Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	This research was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 18H06144 and 19H03477, to M. I.) and the Japan Agency for Medical Research and Development (AMED) (grant number JP20fm0208101, to M. I.), the Tokyo Biochemical Research Foundation (to M. I.), and the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (to M. I.).	Aviner R, 2021, NATURE, V596, P558, DOI 10.1038/s41586-021-03851-2; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; Barton LL, 2002, AM J OBSTET GYNECOL, V187, P1715, DOI 10.1067/mob.2002.126297; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bergeron E, 2012, J VIROL, V86, P10759, DOI 10.1128/JVI.01144-12; Blakqori G, 2009, J VIROL, V83, P3637, DOI 10.1128/JVI.02201-08; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Buchmeier M.J., 2013, FIELDS VIROLOGY, V6, P1283; Cai YY, 2020, MBIO, V11, DOI 10.1128/mBio.00186-20; Dusheiko G, 1996, J HEPATOL, V25, P591, DOI 10.1016/S0168-8278(96)80225-X; Eberhardt KA, 2019, INT J INFECT DIS, V87, P15, DOI 10.1016/j.ijid.2019.07.015; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Flatz L, 2006, P NATL ACAD SCI USA, V103, P4663, DOI 10.1073/pnas.0600652103; Golden JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04889-x; Haridhasapavalan KK, 2019, GENE, V686, P146, DOI 10.1016/j.gene.2018.11.069; IAPALUCCI S, 1991, VIROLOGY, V182, P269, DOI 10.1016/0042-6822(91)90670-7; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Iwasaki M, 2016, J VIROL, V90, P3187, DOI 10.1128/JVI.03145-15; Iwasaki M, 2015, J VIROL, V89, P12166, DOI 10.1128/JVI.02075-15; Kallert SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15327; Lee KJ, 2002, J VIROL, V76, P6393, DOI 10.1128/JVI.76.12.6393-6397.2002; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Martinez-Sobrido L, 2016, METHODS MOL BIOL, V1403, P313, DOI 10.1007/978-1-4939-3387-7_17; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; Peters CJ, 2006, NEW ENGL J MED, V354, P2208, DOI 10.1056/NEJMp068021; Pinschewer DD, 2005, J VIROL, V79, P4519, DOI 10.1128/JVI.79.7.4519-4526.2005; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; PONCET D, 1993, J VIROL, V67, P3159, DOI 10.1128/JVI.67.6.3159-3165.1993; Reguera J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005636; Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271; SINGH MK, 1987, VIROLOGY, V161, P448, DOI 10.1016/0042-6822(87)90138-3; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101576	10.1016/j.jbc.2022.101576	http://dx.doi.org/10.1016/j.jbc.2022.101576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35026225	gold, Green Published			2022-12-26	WOS:000761371500008
J	Bowers, JE; Tang, HB; Burke, JM; Paterson, AH				Bowers, John E.; Tang, Haibao; Burke, John M.; Paterson, Andrew H.			GC content of plant genes is linked to past gene duplications	PLOS ONE			English	Article							DIRECTED DNA METHYLATION; TRANSPOSABLE ELEMENTS; WHOLE-GENOME; HYBRID VIGOR; ARABIDOPSIS; EVOLUTION; DIVERSITY; DEMETHYLATION; CONSEQUENCES; EXPRESSION	The frequency of G and C nucleotides in genomes varies from species to species, and sometimes even between different genes in the same genome. The monocot grasses have a bimodal distribution of genic GC content absent in dicots. We categorized plant genes from 5 dicots and 4 monocot grasses by synteny to related species and determined that syntenic genes have significantly higher GC content than non-syntenic genes at their 5'-end in the third position within codons for all 9 species. Lower GC content is correlated with gene duplication, as lack of synteny to distantly related genomes is associated with past interspersed gene duplications. Two mutation types can account for biased GC content, mutation of methylated C to T and gene conversion from A to G. Gene conversion involves non-reciprocal exchanges between homologous alleles and is not detectable when the alleles are identical or heterozygous for presence-absence variation, both likely situations for genes duplicated to new loci. Gene duplication can cause production of siRNA which can induce targeted methylation, elevating mC -> T mutations. Recently duplicated plant genes are more frequently methylated and less likely to undergo gene conversion, each of these factors synergistically creating a mutational environment favoring AT nucleotides. The syntenic genes with high GC content in the grasses compose a subset that have undergone few duplications, or for which duplicate copies were purged by selection. We propose a "biased gene duplication / biased mutation" (BDBM) model that may explain the origin and trajectory of the observed link between duplication and genic GC bias. The BDBM model is supported by empirical data based on joint analyses of 9 angiosperm species with their genes categorized by duplication status, GC content, methylation levels and functional classes.	[Bowers, John E.; Burke, John M.; Paterson, Andrew H.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Bowers, John E.; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Tang, Haibao] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Haixia Appl Plant Syst Biol, Key Lab Minist Educ Genet Breeding & Multiple Uti, Ctr Genom & Biotechnol, Fuzhou, Fujian, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Fujian Agriculture & Forestry University	Bowers, JE (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.; Bowers, JE (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	jebowers@uga.edu	Burke, John/A-3502-2013	Burke, John/0000-0002-1412-5539; Bowers, John/0000-0001-5693-2796				Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; ANTEQUERA F, 1988, EMBO J, V7, P2295, DOI 10.1002/j.1460-2075.1988.tb03072.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Britten RJ, 2006, P NATL ACAD SCI USA, V103, P19027, DOI 10.1073/pnas.0608796103; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi KH, 2013, NAT GENET, V45, P1327, DOI 10.1038/ng.2766; Chu D, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6745-3; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Darracq A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4490-7; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Durand S, 2012, CURR BIOL, V22, P326, DOI 10.1016/j.cub.2011.12.054; Eichten SR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002372; Escudero M, 2020, NEW PHYTOL, V228, P805, DOI 10.1111/nph.16802; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gao L, 2019, NAT GENET, V51, P1044, DOI 10.1038/s41588-019-0410-2; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Glemin S, 2014, TRENDS GENET, V30, P263, DOI 10.1016/j.tig.2014.05.002; Gupta S, 2005, PLANT MOL BIOL, V57, P115, DOI 10.1007/s11103-004-6636-z; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hubner S, 2019, NAT PLANTS, V5, P54, DOI 10.1038/s41477-018-0329-0; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Kawanabe T, 2016, P NATL ACAD SCI USA, V113, pE6704, DOI 10.1073/pnas.1613372113; Knight RD, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-4-research0010; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Liu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048295; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2007, ORIGINS GENOME ARCHI; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Martinez de Alba AE, 2013, BBA-GENE REGUL MECH, V1829, P1300, DOI 10.1016/j.bbagrm.2013.10.005; Matzke MA, 2015, ANNU REV PLANT BIOL, V66, P243, DOI 10.1146/annurev-arplant-043014-114633; Mugal CF, 2015, G3-GENES GENOM GENET, V5, P441, DOI 10.1534/g3.114.015545; Muyle A, 2011, MOL BIOL EVOL, V28, P2695, DOI 10.1093/molbev/msr104; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Novoa EM, 2019, MOL BIOL EVOL, V36, P2328, DOI 10.1093/molbev/msz124; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Palidwor GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013431; Park K, 2016, P NATL ACAD SCI USA, V113, P15138, DOI 10.1073/pnas.1619047114; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Serres-Giardi L, 2012, PLANT CELL, V24, P1379, DOI 10.1105/tpc.111.093674; Shen YF, 2017, PLANT J, V91, P874, DOI 10.1111/tpj.13605; Singh R, 2016, TROP PLANT BIOL, V9, P136, DOI 10.1007/s12042-016-9165-4; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308; Turco GM, 2017, NEW PHYTOL, V214, P1213, DOI 10.1111/nph.14448; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wijnker E, 2013, ELIFE, V2, DOI 10.7554/eLife.01426; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Xie M, 2015, CURR GENOMICS, V16, P23, DOI 10.2174/1389202915666141128002211; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang B, 2016, P NATL ACAD SCI USA, V113, P12580, DOI 10.1073/pnas.1613910113; Zhao ZM, 2007, MOL BIOL EVOL, V24, P23, DOI 10.1093/molbev/msl156; Zhou WD, 2020, P NATL ACAD SCI USA, V117, P19359, DOI 10.1073/pnas.1921719117; Zhou ZP, 2016, P NATL ACAD SCI USA, V113, pE6117, DOI 10.1073/pnas.1606724113; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	87	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261748	10.1371/journal.pone.0261748	http://dx.doi.org/10.1371/journal.pone.0261748			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025913	gold, Green Published			2022-12-26	WOS:000796264200026
J	Craven, AJ; Pegram, C; Packer, RMA; Jarvis, S; McGreevy, PD; Warnes, C; Church, DB; Brodbelt, DC; O'Neill, DG				Craven, Annabel J.; Pegram, Camilla; Packer, Rowena M. A.; Jarvis, Susan; McGreevy, Paul D.; Warnes, Caroline; Church, David B.; Brodbelt, Dave C.; O'Neill, Dan G.			Veterinary drug therapies used for undesirable behaviours in UK dogs under primary veterinary care	PLOS ONE			English	Article							FLUOXETINE CHEWABLE TABLETS; SEPARATION ANXIETY; RISK-FACTORS; AGGRESSIVE-BEHAVIOR; TRAINING METHODS; NOISE PHOBIA; DOUBLE-BLIND; BREED; PREVALENCE; MANAGEMENT	Undesirable behaviours (UBs) in dogs are common and important issues with serious potential welfare consequences for both the dogs and their owners. This study aimed to investigate the usage of drug therapy for UBs in dogs and assess demographic risk factors for drug-prescribed UBs within the dog population under primary-care veterinary care in the UK in 2013. Dogs receiving drug therapy for UB were identified through the retrospective analysis of anonymised electronic patient records in VetCompass (TM). Risk factor analysis used multivariable logistic regression modelling. The study population comprised 103,597 dogs under veterinary care in the UK during 2013. There were 413 drug-prescribed UBs recorded among 404 dogs. The prevalence of dogs with at least one UB event treated with a drug in 2013 was 0.4%. Multivariable modelling identified 3 breeds with increased odds of drug-prescribed UB compared with crossbred dogs: Toy Poodle (OR 2.75), Tibetan Terrier (OR 2.68) and Shih-tzu (OR 1.95). Increasing age was associated with increased odds of drug-prescribed UB, with dogs >= 12 years showing 3.1 times the odds compared with dogs < 3 years. Neutered males (OR 1.82) and entire males (OR 1.50) had increased odds compared with entire females. The relatively low prevalence of dogs with at least one UB event that was treated with a drug in 2013 could suggest that opportunities for useful psychopharmaceutical intervention in UBs may be being missed in first opinion veterinary practice. While bodyweight was not a significant factor, the 3 individual breeds at higher odds of an UB treated with a behaviour modifying drug all have a relatively low average bodyweight. The current results also support previous research of a male predisposition to UBs and it is possible that this higher risk resulted in the increased likelihood of being prescribed a behaviour modifying drug, regardless of neuter status.	[Craven, Annabel J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Pegram, Camilla; Brodbelt, Dave C.; O'Neill, Dan G.] Royal Vet Coll, Pathobiol & Populat Sci, Hawkshead Lane, Hatfield, Herts, England; [Packer, Rowena M. A.; Church, David B.] Royal Vet Coll, Clin Sci & Serv, Hawkshead Lane, Hatfield, Herts, England; [Jarvis, Susan] Univ Edinburgh, Global Acad Agr & Food Secur, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [McGreevy, Paul D.] Univ New England, Sch Environm & Rural Sci, Fac Sci Agr Business & Law, Armidale, NSW, Australia	University of Edinburgh; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Edinburgh; University of New England	Craven, AJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	annabel_craven@hotmail.com	Brodbelt, David/C-6005-2009	Brodbelt, David/0000-0001-5628-4194	Kennel Club Charitable Trust	Kennel Club Charitable Trust	This study was supported at the RVC by an award from the Kennel Club Charitable Trust. Neither the Kennel Club Charitable Trust nor the Kennel Club had any input in the design of the study, the collection, analysis and interpretation of data or in writing the manuscript.	[Anonymous], 2020, NOAH COMPENDIUM; Arhant C, 2010, APPL ANIM BEHAV SCI, V123, P131, DOI 10.1016/j.applanim.2010.01.003; Bamberger M, 2006, JAVMA-J AM VET MED A, V229, P1591, DOI 10.2460/javma.229.10.1591; Barcelos AM, 2015, VET REC, V176, P466, DOI 10.1136/vr.102823; BLACKSHAW JK, 1991, APPL ANIM BEHAV SCI, V30, P351, DOI 10.1016/0168-1591(91)90140-S; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; BORCHELT PL, 1983, APPL ANIM ETHOL, V10, P45, DOI 10.1016/0304-3762(83)90111-6; Bowen J., 2005, BEHAV PROBLEMS SMALL; Boyd C, 2018, ANIM WELFARE, V27, P251, DOI 10.7120/09627286.27.3.251; Bradshaw JWS, 2002, VET REC, V151, P43, DOI 10.1136/vr.151.2.43; Buller K, 2020, J VET BEHAV, V37, P41, DOI 10.1016/j.jveb.2020.04.003; Christiansen FO, 2001, APPL ANIM BEHAV SCI, V72, P115, DOI 10.1016/S0168-1591(00)00202-1; Cracknell NR, 2008, VET J, V177, P80, DOI 10.1016/j.tvjl.2007.04.007; Crowell-Davis S.L., 2019, VET PSYCHOPHARMACOLO; Denenberg S, 2005, CURRENT ISSUES AND RESEARCH IN VETERINARY BEHAVIORAL MEDICINE, P56; Dinwoodie IR, 2021, J VET BEHAV, V43, P46, DOI 10.1016/j.jveb.2021.02.002; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Egenvall A, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-42; EPI INFO 7 CDC, 2020 CDCP US INTR EP; Erath JR, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00169; Fatjo J, 2007, J VET BEHAV, V2, P158, DOI 10.1016/j.jveb.2007.07.008; Fatjo J, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030383; Gaultier E, 2005, VET REC, V156, P533, DOI 10.1136/vr.156.17.533; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Martinez AG, 2011, J VET BEHAV, V6, P225, DOI 10.1016/j.jveb.2011.01.006; Guy NC, 2001, APPL ANIM BEHAV SCI, V74, P15, DOI 10.1016/S0168-1591(01)00153-8; Herron ME, 2008, JAVMA-J AM VET MED A, V233, P1420, DOI 10.2460/javma.233.9.1420; Hiby EF, 2004, ANIM WELFARE, V13, P63; Hobbs SL., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Horwitz D., 2002, BSAVA MANUAL CANINE, V1; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Ibanez M, 2009, J VET BEHAV, V4, P223, DOI 10.1016/j.jveb.2009.04.001; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Jokinen TS, 2015, J VET INTERN MED, V29, P1081, DOI 10.1111/jvim.12611; Karagiannis CI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0373-1; Katz MH., 2011, MULTIVARIABLE ANAL P, DOI [10.1017/CBO9780511974175, DOI 10.1017/CBO9780511974175]; King JN, 2000, APPL ANIM BEHAV SCI, V67, P255, DOI 10.1016/S0168-1591(99)00127-6; Kirkwood B. R., 2003, MED STAT; Landsberg G., 2012, BEHAV PROBLEMS DOG C, V3rd ed; Landsberg GM, 2008, J VET BEHAV, V3, P12, DOI 10.1016/j.jveb.2007.09.001; Fagundes ALL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00017; Lund JD, 1996, PREV VET MED, V28, P33, DOI 10.1016/0167-5877(96)01015-X; McGreevy P, 2017, VET J, V229, P1, DOI 10.1016/j.tvjl.2017.10.015; McGreevy PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080529; McLean A, 2013, P 9 INT EQUITATION S, P50; Menard S., 1995, APPL LOGISTIC REGRES; Mills DS, 2003, APPL ANIM BEHAV SCI, V81, P265, DOI 10.1016/S0168-1591(02)00286-1; Murray JK, 2015, VET REC, V177, DOI 10.1136/vr.103223; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Myers R., 1990, CLASSICAL AND MODERN; Bosch MN, 2012, CURR ALZHEIMER RES, V9, P298; O'Neill D, 2012, J SMALL ANIM PRACT, V53, P217, DOI 10.1111/j.1748-5827.2011.01190.x; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; O'Neill DG, 2013, J VET INTERN MED, V27, P814, DOI 10.1111/jvim.12090; O'Neill Dan G, 2018, Canine Genet Epidemiol, V5, P9, DOI 10.1186/s40575-018-0065-9; O'Neill DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090501; Overall K., 2013, MANUAL CLIN BEHAV ME; Overall K L, 1998, J Am Vet Med Assoc, V212, P1702; Overall KL, 2004, CLIN TECH SMALL AN P, V19, P250, DOI 10.1053/j.ctsap.2004.10.007; Overall KL, 2001, J AM VET MED ASSOC, V219, P467, DOI 10.2460/javma.2001.219.467; OVERALL KL, 1995, J AM VET MED ASSOC, V206, P629; Overall KL, 1997, CLIN BEHAV MED SMALL, V1; Packer RMA, 2018, APPL ANIM BEHAV SCI, V200, P106, DOI 10.1016/j.applanim.2017.11.008; Packer RMA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192182; Packer RMA, 2016, EPILEPSY BEHAV, V55, P62, DOI 10.1016/j.yebeh.2015.11.014; Pegram C, 2021, J SMALL ANIM PRACT, V62, P521, DOI 10.1111/jsap.13325; Pegram C, 2019, J SMALL ANIM PRACT, V60, P723, DOI 10.1111/jsap.13072; Powell L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87649-2; Radulescu SM, 2020, J VET INTERN MED, V34, P1993, DOI 10.1111/jvim.15869; Ramsey I., 2011, BSAVA SMALL ANIMAL F, V7; Ramsey I., 2014, BSAVA SMALL ANIMAL F, V8; Reisner IR, 2003, VET CLIN N AM-SMALL, V33, P303, DOI 10.1016/S0195-5616(02)00132-8; Roshier AL, 2013, VET REC, V172, DOI 10.1136/vr.101125; Salvin HE, 2010, VET J, V184, P277, DOI 10.1016/j.tvjl.2009.11.007; Scarlett J M, 1999, J Appl Anim Welf Sci, V2, P41, DOI 10.1207/s15327604jaws0201_4; Scott M, 2012, J SMALL ANIM PRACT, V53, P372, DOI 10.1111/j.1748-5827.2012.01231.x; Seksel K, 2001, AUST VET J, V79, P252, DOI 10.1111/j.1751-0813.2001.tb11976.x; Simpson BS, 2007, VET THER, V8, P18; Shihab N, 2011, EPILEPSY BEHAV, V21, P160, DOI 10.1016/j.yebeh.2011.03.018; Simpson BS, 2003, VET CLIN N AM-SMALL, V33, P365, DOI 10.1016/S0195-5616(02)00130-4; Sinn L, 2018, VET CLIN N AM-SMALL, V48, P457, DOI 10.1016/j.cvsm.2017.12.011; Stephens MJ, 2014, VET REC, V175, DOI 10.1136/vr.102431; Stone HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149403; Storengen LM, 2014, APPL ANIM BEHAV SCI, V159, P82, DOI 10.1016/j.applanim.2014.07.006; Takeuchi Y, 2001, APPL ANIM BEHAV SCI, V70, P297, DOI 10.1016/S0168-1591(00)00156-8; Takeuchi Y, 2000, J AM VET MED ASSOC, V217, P342, DOI 10.2460/javma.2000.217.342; The Kennel Club Limited 2021, BREED STAND; The VeNom Coding Group, 2020 VENOM VET NOM V; VANDERBORG JAM, 1991, APPL ANIM BEHAV SCI, V32, P237, DOI 10.1016/S0168-1591(05)80047-4; Waite MR, 2021, LEARN MOTIV, V74, DOI 10.1016/j.lmot.2021.101726; Watson Fraje, 2020, Vet Rec, V186, P93, DOI 10.1136/vr.105222; Wells DL, 2000, APPL ANIM BEHAV SCI, V69, P55, DOI 10.1016/S0168-1591(00)00118-0; WHITE RAS, 1989, VET REC, V125, P478, DOI 10.1136/vr.125.19.478; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; Winter J, 2018, VET REC, V182, DOI 10.1136/vr.104603; WRIGHT JC, 1987, APPL ANIM BEHAV SCI, V19, P169, DOI 10.1016/0168-1591(87)90213-9; Yu Y, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11020493	100	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261139	10.1371/journal.pone.0261139	http://dx.doi.org/10.1371/journal.pone.0261139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020726	Green Published, gold			2022-12-26	WOS:000834207700013
J	Ahring, KK; Dagnaes-Hansen, F; Bruel, A; Christensen, M; Jensen, E; Jensen, TG; Johannsen, M; Johansen, KS; Lund, AM; Madsen, JG; Brondum-Nielsen, K; Pedersen, M; Sorensen, LK; Kjolby, M; Moller, LB				Ahring, Kirsten K.; Dagnaes-Hansen, Frederik; Bruel, Annemarie; Christensen, Mette; Jensen, Erik; Jensen, Thomas G.; Johannsen, Mogens; Johansen, Karen S.; Lund, Allan M.; Madsen, Jesper G.; Brondum-Nielsen, Karen; Pedersen, Michael; Sorensen, Lambert K.; Kjolby, Mads; Moller, Lisbeth B.			The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model	PLOS ONE			English	Article							GENETIC MOUSE MODEL; PHENYLALANINE-HYDROXYLASE; SUPPORTS GROWTH; SPATIAL MEMORY; BARNES MAZE; BRAIN; PROTEIN; PKU; PLASMA; DIET	Introduction Management of phenylketonuria (PKU) is mainly achieved through dietary control with limited intake of phenylalanine (Phe) from food, supplemented with low protein (LP) food and a mixture of free synthetic (FS) amino acids (AA) (FSAA). Casein glycomacropeptide (CGMP) is a natural peptide released in whey during cheese making by the action of the enzyme chymosin. Because CGMP in its pure form does not contain Phe, it is nutritionally suitable as a supplement in the diet for PKU when enriched with specific AAs. Lacprodan (R) CGMP-20 (= CGMP) used in this study contained only trace amounts of Phe due to minor presence of other proteins/peptides. Objective The aims were to address the following questions in a classical PKU mouse model: Study 1, off diet: Can pure CGMP or CGMP supplemented with Large Neutral Amino Acids (LNAA) as a supplement to normal diet significantly lower the content of Phe in the brain compared to a control group on normal diet, and does supplementation of selected LNAA results in significant lower brain Phe level?. Study 2, on diet: Does a combination of CGMP, essential (non-Phe) EAAs and LP diet, provide similar plasma and brain Phe levels, growth and behavioral skills as a formula which alone consist of FSAA, with a similar composition?. Material and methods 45 female mice homozygous for the Pah(enu2 )mutation were treated for 12 weeks in five different groups; G1(N-CGMP), fed on Normal (N) casein diet (75%) in combination with CGMP (25%); G2 (N-CGMP-LNAA), fed on Normal (N) casein diet (75%) in combination with CGMP (19,7%) and selected LNAA (5,3% Leu, Tyr and Trp); G3 (N), fed on normal casein diet (100%); G4 (CGMP-EAA-LP), fed on CGMP (70,4%) in combination with essential AA (19,6%) and LP diet; G5 (FSAA-LP), fed on FSAA (100%) and LP diet. The following parameters were measured during the treatment period: Plasma AA profiles including Phe and Tyr, growth, food and water intake and number of teeth cut. At the end of the treatment period, a body scan (fat and lean body mass) and a behavioral test (Barnes Maze) were performed. Finally, the brains were examined for content of Phe, Tyr, Trp, dopamine (DA), 3,4dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT) and 5-hydroxyindole-acetic acid (5HIAA), and the bone density and bone mineral content were determined by dual-energy xray absorptiometry. Results Study 1: Mice off diet supplemented with CGMP (G1 (N-CGMP)) or supplemented with CGMP in combination with LNAA (G2 (N-CGMP-LNAA)) had significantly lower Phe in plasma and in the brain compared to mice fed only casein (G3 (N)). Extra LNAA (Tyr, Trp and Leu) to CGMP did not have any significant impact on Phe levels in the plasma and brain, but an increase in serotonin was measured in the brain of G2 mice compared to G1. Study 2: PKU mice fed with mixture of CGMP and EAA as supplement to LP diet (G4 (CGMP-EAA-LP)) demonstrated lower plasma-Phe levels but similar brain- Phe levels and growth as mice fed on an almost identical combination of FSAA (G5 (FSAA-LP)). Conclusion CGMP can be a relevant supplement for the treatment of PKU.	[Ahring, Kirsten K.; Brondum-Nielsen, Karen] Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Paediat,PKU Clin, Copenhagen, Denmark; [Ahring, Kirsten K.; Brondum-Nielsen, Karen] Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Clin Genet,PKU Clin, Copenhagen, Denmark; [Dagnaes-Hansen, Frederik; Bruel, Annemarie; Jensen, Thomas G.; Johansen, Karen S.; Madsen, Jesper G.; Kjolby, Mads] Aarhus Univ, Dept Biomed, Hlth, Aarhus, Denmark; [Christensen, Mette; Lund, Allan M.] Copenhagen Univ Hosp, Rigshosp, Dept Paediat, Ctr Inherited Metab Dis, Copenhagen, Denmark; [Christensen, Mette; Lund, Allan M.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Genet, Ctr Inherited Metab Dis, Copenhagen, Denmark; [Jensen, Erik] Arla Foods Ingredients Grp PS, Viby J, Denmark; [Johannsen, Mogens; Sorensen, Lambert K.] Aarhus Univ, Dept Forens Med, Aarhus, Denmark; [Pedersen, Michael] Aarhus Univ Hosp, Comparat Med Lab, Aarhus, Denmark; [Kjolby, Mads] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark; [Kjolby, Mads] Aarhus Univ Hosp, Dept Clin Pharmacol, Aarhus, Denmark; [Moller, Lisbeth B.] Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Clin Genet, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen	Ahring, KK (corresponding author), Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Paediat,PKU Clin, Copenhagen, Denmark.; Ahring, KK (corresponding author), Copenhagen Univ Hosp, Rigshosp, Kennedy Ctr, Dept Clin Genet,PKU Clin, Copenhagen, Denmark.	kirsten.kiaer.ahring@regionh.dk		Lund, Allan/0000-0002-6091-7879; Johannsen, Mogens/0000-0002-2548-7025; Bruel, Annemarie/0000-0003-4833-0888; Dagnaes-Hansen, Frederik/0000-0002-6622-0853; Moller, Lisbeth/0000-0002-9524-4301	AFI	AFI	The research was conducted as part of an lndustrial PhD program, which in Denmark is a three-year industrially focused PhD project where a student (Kirsten Ahring) is hired by a company (Arla Foods lngredients (AFI)) and enrolled at a university (Copenhagen University) at the same time. The industrial PhD program was managed by Innovation Fund Denmark and partly funded by AFI (https://ufm.dk/en/research-and-innovation/funding-proqrammesfor-research-and-innovation/find-danish-fundingprogrammes/programmesmanaged-byinnovation-fund-denmark/industrial-phd).AFI produces and commercialize the food ingredient; Casein glycomacropeptide which was used in the research.	Ahring K., EFFECT OFFERING PHEN; Aimutis WR, 2004, J NUTR, V134, p989S, DOI 10.1093/jn/134.4.989S; BENEVENGA NJ, 1994, J NUTR, V124, P451, DOI 10.1093/jn/124.3.451; BERRY HK, 1990, AM J DIS CHILD, V144, P539, DOI 10.1001/archpedi.1990.02150290033020; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Bruinenberg VM, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00233; Christensen R, 2005, EXP DERMATOL, V14, P535, DOI 10.1111/j.0906-6705.2005.00326.x; Demirdas S, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0232-y; Etzel MR, 2004, J NUTR, V134, p996S, DOI 10.1093/jn/134.4.996S; Giovannini M, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-7; Harding CO, 2014, J INHERIT METAB DIS, V37, P735, DOI 10.1007/s10545-013-9675-2; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; JOHANNIK K, 1994, MAGNET RESON MED, V31, P53, DOI 10.1002/mrm.1910310108; LOU HC, 1987, ACTA PAEDIATR SCAND, V76, P560, DOI 10.1111/j.1651-2227.1987.tb10521.x; LOU HC, 1985, EUR J PEDIATR, V144, P17, DOI 10.1007/BF00491918; MacDonald A, 2006, J INHERIT METAB DIS, V29, P526, DOI 10.1007/s10545-006-0234-y; Matalon R, 2007, J INHERIT METAB DIS, V30, P153, DOI 10.1007/s10545-007-0556-4; Matalon R, 2006, J INHERIT METAB DIS, V29, P732, DOI 10.1007/s10545-006-0395-8; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Miller DJ, 2004, J PHYSIOL-LONDON, V555, P585, DOI 10.1113/jphysiol.2004.060731; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; Moats RA, 2003, PEDIATRICS, V112, P1575; Nakano T, 2002, BIOTECHNOL PROGR, V18, P409, DOI 10.1021/bp010195u; Ney DM, 2008, J NUTR, V138, P316, DOI 10.1093/jn/138.2.316; Pascucci T, 2008, BRAIN RES, V1217, P232, DOI 10.1016/j.brainres.2008.04.006; Pascucci T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084697; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Peake RWA, 2013, CLIN CHIM ACTA, V423, P75, DOI 10.1016/j.cca.2013.03.036; Pritchett K, 2003, CONTEMP TOP LAB ANIM, V42, P53; Puglisi-Allegra S, 2000, NEUROREPORT, V11, P1361, DOI 10.1097/00001756-200004270-00042; Rocha JC, 2009, J INHERIT METAB DIS, V32, P472, DOI 10.1007/s10545-009-1132-x; Schindeler S, 2007, MOL GENET METAB, V91, P48, DOI 10.1016/j.ymgme.2007.02.002; Schuck PF, 2015, AGING DIS, V6, P390, DOI 10.14336/AD.2015.0827; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; Solverson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045165; Van Calcar SC, 2008, MOL GENET METAB, V93, P263; van Calcar SC, 2011, MOL GENET METAB, V102, P262; van Calcar SC, 2012, J ACAD NUTR DIET, V112, P1201, DOI 10.1016/j.jand.2012.05.004; van Calcar SC, 2009, AM J CLIN NUTR, V89, P1068, DOI 10.3945/ajcn.2008.27280; van Spronsen FJ, 2010, MOL GENET METAB, V99, pS90, DOI 10.1016/j.ymgme.2009.10.008; van Vliet D, 2016, AM J CLIN NUTR, V104, P1292, DOI 10.3945/ajcn.116.135996; van Vliet D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143833; van Wegberg AMJ, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0685-2; WHO, 2007, WHO TECH REP SER, V935, P1; Zaki OK, 2016, J NUTR METAB, V2016, DOI 10.1155/2016/2453027; Zimmermann M, 2012, MOL GENET METAB, V106, P264, DOI 10.1016/j.ymgme.2012.04.016	47	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261150	10.1371/journal.pone.0261150	http://dx.doi.org/10.1371/journal.pone.0261150			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015767	gold, Green Published			2022-12-26	WOS:000814820600002
J	Mascia, F; Mazo, I; Alterovitz, WL; Karagiannis, K; Wu, WW; Shen, RF; Beaver, JA; Rao, VA				Mascia, Francesca; Mazo, Ilya; Alterovitz, Wei-Lun; Karagiannis, Konstantinos; Wu, Wells W.; Shen, Rong-Fong; Beaver, Julia A.; Rao, V. Ashutosh			In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines	PLOS ONE			English	Article							MAMMALIAN AUTOPHAGY; GENES	Autophagy drives drug resistance and drug-induced cancer cell cytotoxicity. Targeting the autophagy process could greatly improve chemotherapy outcomes. The discovery of specific inhibitors or activators has been hindered by challenges with reliably measuring autophagy levels in a clinical setting. We investigated drug-induced autophagy in breast cancer cell lines with differing ER/PR/Her2 receptor status by exposing them to known but divergent autophagy inducers each with a unique molecular target, tamoxifen, trastuzumab, bortezomib or rapamycin. Differential gene expression analysis from total RNA extracted during the earliest sign of autophagy flux showed both cell- and drug-specific changes. We analyzed the list of differentially expressed genes to find a common, cell- and drug-agnostic autophagy signature. Twelve mRNAs were significantly modulated by all the drugs and 11 were orthogonally verified with Q-RT-PCR (Klh124, Hbp1, Crebrf, Ypel2, Fbxo32, Gdf15, Cdc25a, Ddit4, Psat1, Cd22, Ypel3). The drug agnostic mRNA signature was similarly induced by a mitochondrially targeted agent, MitoQ. In-silico analysis on the KM-plotter cancer database showed that the levels of these mRNAs are detectable in human samples and associated with breast cancer prognosis outcomes of Relapse-Free Survival in all patients (RSF), Overall Survival in all patients (OS), and Relapse-Free Survival in ER+ Patients (RSF ER+). High levels of Klh124, Hbpl, Crebrf, YpeIl2, CD22 and Ypel3 were correlated with better outcomes, whereas lower levels of Gdf15, Cdc25a, Ddit4 and Psat1 were associated with better prognosis in breast cancer patients. This gene signature uncovers candidate autophagy biomarkers that could be tested during preclinical and clinical studies to monitor the autophagy process.	[Mascia, Francesca; Rao, V. Ashutosh] US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, CDER, Silver Spring, MD 20993 USA; [Mazo, Ilya; Alterovitz, Wei-Lun; Karagiannis, Konstantinos] US FDA, HIVE Bioinformat Grp, Off Biostat & Epidemiol, CBER, Silver Spring, MD USA; [Wu, Wells W.; Shen, Rong-Fong] US FDA, Facil Biotechnol Resource, CBER, Silver Spring, MD USA; [Beaver, Julia A.] US FDA, Oncol Ctr Excellence, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, CDER, Silver Spring, MD 20993 USA.	ashutosh.rao@fda.hhs.gov		Karagiannis, Konstantinos/0000-0002-4776-5137				Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Biel TG, 2018, ONCOTARGET, V9, P995, DOI 10.18632/oncotarget.23171; Chen XX, 2020, DNA CELL BIOL, V39, P1595, DOI 10.1089/dna.2020.5667; Das CK, 2018, CANCER METAST REV, V37, P749, DOI 10.1007/s10555-018-9727-z; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Fullgrabe J, 2016, J CELL SCI, V129, P3059, DOI 10.1242/jcs.188920; Go Ma JY., 2021, AGEING, V13, P13684; Gonzalez Y, 2014, ONCOTARGET, V5, P1526, DOI 10.18632/oncotarget.1715; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Jegga AG, 2011, AUTOPHAGY, V7, P477, DOI 10.4161/auto.7.5.14811; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klionsky DJ, 2011, AUTOPHAGY, V7, P1, DOI 10.4161/auto.7.1.14130; Lai JG, 2020, J CELL MOL MED, V24, P9145, DOI 10.1111/jcmm.15551; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li XP, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.569318; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Pinto JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01207-3; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Santana-Quintero L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099033; Simonyan V, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141; Wu WW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4677-y; Zhou J, 2017, GENE, V627, P549, DOI 10.1016/j.gene.2017.06.053	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262134	10.1371/journal.pone.0262134	http://dx.doi.org/10.1371/journal.pone.0262134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990474	Green Published, gold			2022-12-26	WOS:000815783800016
J	Tabatabaei-Malazy, O; Moghaddam, SS; Masinaei, M; Rezaei, N; Fateh, SM; Dilmaghani-Marand, A; Abdolhamidi, E; Razi, F; Khashayar, P; Mahdavihezaveh, A; Samiee, SM; Larijani, B; Farzadfar, F				Tabatabaei-Malazy, Ozra; Moghaddam, Sahar Saeedi; Masinaei, Masoud; Rezaei, Nazila; Fateh, Sahar Mohammadi; Dilmaghani-Marand, Arezou; Abdolhamidi, Elham; Razi, Farideh; Khashayar, Patricia; Mahdavihezaveh, Alireza; Samiee, Siamak Mirab; Larijani, Bagher; Farzadfar, Farshad			Association between being metabolically healthy/unhealthy and metabolic syndrome in Iranian adults	PLOS ONE			English	Article							BODY-MASS INDEX; OBESE INDIVIDUALS; NORMAL-WEIGHT; HEALTHY; MORTALITY; RISK; PREVALENCE; PHENOTYPES; OVERWEIGHT	Introduction The prevalence of metabolically healthy obesity (MHO) varies based on different criteria. We assessed the prevalence of MHO and metabolic unhealthiness based on body mass index (BMI) and their association with metabolic syndrome (MetS) in a nation-wide study. Methods Data were taken from the STEPs 2016 study, from 18,459 Iranians aged >= 25 years. Demographic, metabolic, and anthropometric data were collected. Subjects were stratified by BMI, metabolic unhealthiness, and having MetS. The latter was defined based on National Cholesterol Education Program Adult Treatment Panel III 2004 (NCEP ATP III), was then assessed. Results The prevalence of MHO and metabolic unhealthiness in obese subjects was 7.5% (about 3.6 million) and 18.3% (about 8.9 million), respectively. Most of the metabolic unhealthy individuals were female (53.5%) or urban residents (72.9%). Low physical activity was significantly and positively associated (Odds Ratio: 1.18, 95% CI: 1.04-1.35) with metabolic unhealthiness, while being a rural residence (0.83, 0.74-0.93), and having higher education (0.47, 0.39-0.58) significantly but negatively affected it. Dyslipidemia was the most frequent MetS component with a prevalence rate of 46.6% (42.1-51.1), 62.2% (60.8-63.6), 76.3% (75.1-77.5), and 83.4% (82.1-84.6) among underweight, normal weight, overweight and obese phenotypes, respectively. Conclusion BMI aside, an additional set of criteria such as metabolic markers should be taken into account to identify normal weight but metabolically unhealthy individuals. Given the highest prevalence of dyslipidemia among obese subjects, further interventions are required to raise public awareness, promote healthy lifestyles and establish lipid clinics.	[Tabatabaei-Malazy, Ozra; Moghaddam, Sahar Saeedi; Masinaei, Masoud; Rezaei, Nazila; Fateh, Sahar Mohammadi; Dilmaghani-Marand, Arezou; Abdolhamidi, Elham; Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Tabatabaei-Malazy, Ozra; Fateh, Sahar Mohammadi; Larijani, Bagher; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Masinaei, Masoud] Univ Tehran Med Sci, Dept Epidemiol, Tehran, Iran; [Masinaei, Masoud] Univ Tehran Med Sci, Dept Biostat, Tehran, Iran; [Razi, Farideh] Univ Tehran Med Sci, Diabet Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Khashayar, Patricia] Univ Tehran Med Sci, Osteoporosis Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Khashayar, Patricia] Univ Ghent Belgium, Ctr Microsyst Technol, Imec & Ghent, Ghent, Belgium; [Mahdavihezaveh, Alireza] Minist Hlth & Med Educ, Hlth, Tehran, Iran; [Samiee, Siamak Mirab] Minist Hlth & Med Educ, Reference Hlth Lab, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ghent University; IMEC; Ministry of Health & Medical Education (MOHME); Ministry of Health & Medical Education (MOHME)	Farzadfar, F (corresponding author), Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.; Farzadfar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	f-farzadfar@tums.ac.ir	Masinaei, Masoud/AAE-2481-2022; Khashayar, Patricia/C-2738-2009; tabatabaei, ozra/E-3634-2013	Masinaei, Masoud/0000-0002-0145-7526; Khashayar, Patricia/0000-0001-7525-8418; Larijani, Bagher/0000-0001-5386-7597; tabatabaei, ozra/0000-0003-0188-9721	National Institute for Medical Research Development (NIMAD), Tehran, Iran; National Institute of Health Research	National Institute for Medical Research Development (NIMAD), Tehran, Iran; National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by National Institute for Medical Research Development (NIMAD), Tehran, Iran and National Institute of Health Research.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Aryan Z, 2018, J CLIN LIPIDOL, V12, P1471, DOI 10.1016/j.jacl.2018.08.001; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Djalalinia S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00042; Djalalinia S, 2017, ARCH IRAN MED, V20, P608, DOI 0172009/AIM.009; Djalalinia S, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.169075; Goncalves CG, 2016, NUTRITION, V32, P14, DOI 10.1016/j.nut.2015.07.010; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Gutierrez-Repiso C, 2014, NUTR METAB CARDIOVAS, V24, P947, DOI 10.1016/j.numecd.2014.04.019; Hwang YC, 2015, INT J OBESITY, V39, P1365, DOI 10.1038/ijo.2015.75; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kaur A, 2016, EUR J ENDOCRINOL, V175, P133, DOI 10.1530/EJE-16-0095; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Marques-Vidal P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-330; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364; Mohebi F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7592-5; Nematy M., 2014, J MOL GENET MED, VS1, P019, DOI [10.4172/1747-0862.S1-019, DOI 10.4172/1747-0862.S1-019]; Panagiotakos DB, 2004, AM HEART J, V147, P106, DOI 10.1016/S0002-8703(03)00442-3; Qorbani M, 2015, CLIN LIPIDOL, V10, P449, DOI 10.2217/clp.15.30; ROBERTS WC, 1988, AM J CARDIOL, V62, P345, DOI 10.1016/0002-9149(88)90248-2; Schroder H, 2014, EUR J NUTR, V53, P1345, DOI 10.1007/s00394-013-0635-2; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Soriguer F, 2004, EUR J EPIDEMIOL, V19, P33, DOI 10.1023/B:EJEP.0000013254.93980.97; Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253; Tabatabaei-Malazy O, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0241926; Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; who, STEPS MANUAL; WHO, NONCOMMUNICABLE DIS; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262246	10.1371/journal.pone.0262246	http://dx.doi.org/10.1371/journal.pone.0262246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990491	Green Published, gold			2022-12-26	WOS:000815783800021
J	Patel, SM; Shaik-Dasthagirisaheb, YB; Congdon, M; Young, RR; Patel, MZ; Mazhani, T; Boiditswe, S; Leburu, T; Lechiile, K; Arscott-Mills, T; Steenhoff, AP; Feemster, KA; Shah, SS; Cunningham, CK; Pelton, SI; Kelly, MS				Patel, Sweta M.; Shaik-Dasthagirisaheb, Yazdani B.; Congdon, Morgan; Young, Rebecca R.; Patel, Mohamed Z.; Mazhani, Tiny; Boiditswe, Sefelani; Leburu, Tirayaone; Lechiile, Kwana; Arscott-Mills, Tonya; Steenhoff, Andrew P.; Feemster, Kristen A.; Shah, Samir S.; Cunningham, Coleen K.; Pelton, Stephen I.; Kelly, Matthew S.			Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine	PLOS ONE			English	Article							CARRIAGE; CHILDREN	Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes. To describe pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine (PCV-13) in July 2012, we performed molecular serotyping of 268 pneumococcal strains isolated from 221 children between 2012 and 2017. The median (interquartile range) age of the children included in this analysis was 6 (3,12) months. Fifty-nine percent of the children had received at least one dose of PCV-13 and 35% were fully vaccinated with PCV-13. While colonization by vaccine serotypes steadily declined following PCV-13 introduction, 25% of strains isolated more than 3 years after vaccine introduction were PCV-13 serotypes. We also observed an increase in colonization by non-vaccine serotypes 21 and 23B, which have been associated with invasive pneumococcal disease and antibiotic resistance in other settings.	[Patel, Sweta M.] Duke Univ, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA; [Patel, Sweta M.; Kelly, Matthew S.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Shaik-Dasthagirisaheb, Yazdani B.; Pelton, Stephen I.] Boston Univ, Sch Med, Div Pediat Infect Dis, Boston, MA 02118 USA; [Congdon, Morgan; Arscott-Mills, Tonya; Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Young, Rebecca R.; Kelly, Matthew S.] Duke Univ, Div Pediat Infect Dis, Durham, NC USA; [Patel, Mohamed Z.; Mazhani, Tiny; Arscott-Mills, Tonya; Steenhoff, Andrew P.] Univ Botswana, Fac Med, Dept Paediat & Adolescent Hlth, Gaborone, Botswana; [Boiditswe, Sefelani; Leburu, Tirayaone; Lechiile, Kwana; Arscott-Mills, Tonya] Botswana Univ Pennsylvania Partnership, Gaborone, Botswana; [Steenhoff, Andrew P.; Feemster, Kristen A.] Childrens Hosp Philadelphia, Div Pediat Infect Dis, Philadelphia, PA USA; [Steenhoff, Andrew P.; Feemster, Kristen A.] Childrens Hosp Philadelphia, Dept Pediat, Global Hlth Ctr, Philadelphia, PA 19104 USA; [Shah, Samir S.] Cincinnati Childrens Med Ctr, Div Hosp Med, Cincinnati, OH USA; [Shah, Samir S.] Cincinnati Childrens Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Cunningham, Coleen K.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA	Duke University; Duke University; Boston University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; University of Botswana; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of California System; University of California Irvine	Patel, SM (corresponding author), Duke Univ, Div Pulm Allergy & Crit Care Med, Durham, NC 27708 USA.; Patel, SM (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	sweta.patel@duke.edu		Patel, Sweta M./0000-0001-7867-7706	Merck Investigator Studies Program Grant (MISP) [59310]; VECD Global Health Fellowship - Office of AIDS Research (OAR); Fogarty International Center (FIC) of the National Institutes of Health (NIH) [D43 TW009337]; Early Career Award from the Thrasher Research Fund; Burroughs Wellcome/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases; NIH Career Development Award [K23AI135090]; CIPHER grant from the International AIDS Society - ViiV Healthcare; NIH through the Duke Center for AIDS Research [P30-AI064518]; Children's Hospital of Philadelphia; Penn Center for AIDS Research, an NIH-funded program [P30AI045008]	Merck Investigator Studies Program Grant (MISP); VECD Global Health Fellowship - Office of AIDS Research (OAR); Fogarty International Center (FIC) of the National Institutes of Health (NIH); Early Career Award from the Thrasher Research Fund; Burroughs Wellcome/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases; NIH Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIPHER grant from the International AIDS Society - ViiV Healthcare; NIH through the Duke Center for AIDS Research; Children's Hospital of Philadelphia; Penn Center for AIDS Research, an NIH-funded program	This research was supported by a Merck Investigator Studies Program Grant (MISP #59310 to M.S.K; URL: https://engagezone.msd.com/misp.php).S.M.P.was supported by a VECD Global Health Fellowship, funded by the Office of AIDS Research (OAR) and the Fogarty International Center (FIC) of the National Institutes of Health (NIH; D43 TW009337; URL: https://www.vumc.org/vecd/home).M.S.K.was supported by an Early Career Award from the Thrasher Research Fund (URL: https://www.thrasherresearch.org/earlycareer-award?lang=eng), a Burroughs Wellcome/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases (URL: https://www.astmh.org/awardsfellowships-medals/awards-and-fellowships/burroughs-wellcome-fund-astmh-postdoctoralfellows), an NIH Career Development Award (K23AI135090; URL: https://www.niaid.nih.gov/grantscontracts/mentored-patient-oriented-research-career-development-award-k23), and a CIPHER grant from the International AIDS Society, supported by ViiV Healthcare (URL: https://www.iasociety.org/HIV-Programmes/Programmes/Paediatrics-CIPHER/CIPHER-Grant-Programme).The views expressed in this publication do not necessarily reflect the official policies of the International AIDS Society or ViiV Healthcare. M.S. K. and C.K.C. received financial support from the NIH through the Duke Center for AIDS Research (P30-AI064518; URL: https://cfar.duke.edu/).A.P.S and K.A.F received support from the Children's Hospital of Philadelphia and A.P.S. and T.A-M. through core services from the Penn Center for AIDS Research, an NIH-funded program (P30AI045008; URL https://www.med.upenn.edu/cfar/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bliss SJ, 2008, LANCET INFECT DIS, V8, P67, DOI 10.1016/S1473-3099(07)70242-6; Centers for Disease Control and Prevention, 2014, LIST OL PRIM US 41 C; CongdonM HH, 2020, CLIN INFECT DIS; Dube FS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30345-5; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Heinsbroek E, 2018, VACCINE, V36, P7369, DOI 10.1016/j.vaccine.2018.10.021; Kaplan SL, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0567; Kelly MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126593; Madhi SA, 2020, VACCINE, V38, P2350, DOI 10.1016/j.vaccine.2020.01.062; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Swarthout TD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15786-9; Turner P, 2020, CLIN INFECT DIS, V70, P1580, DOI 10.1093/cid/ciz481; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Voysey M, 2018, CLIN INFECT DIS, V66, P913, DOI 10.1093/cid/cix895; Weinberger DM, 2013, AM J EPIDEMIOL, V178, P1488, DOI 10.1093/aje/kwt156; Whelan Fiona J, 2014, Ann Am Thorac Soc, V11, P513, DOI 10.1513/AnnalsATS.201310-351OC; World Health Organization, 2020, UN REP TANZ MEASL VA; Wouters I, 2019, VACCINE, V37, P1080, DOI 10.1016/j.vaccine.2018.12.068	19	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262225	10.1371/journal.pone.0262225	http://dx.doi.org/10.1371/journal.pone.0262225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986196	gold, Green Published			2022-12-26	WOS:000765956200026
J	Mogaka, JN; Sharma, M; Temu, T; Masyuko, S; Kinuthia, J; Osoti, A; Zifodya, J; Nakanjako, D; Njoroge, A; Otedo, A; Page, S; Farquhar, C				Mogaka, Jerusha Nyabiage; Sharma, Monisha; Temu, Tecla; Masyuko, Sarah; Kinuthia, John; Osoti, Alfred; Zifodya, Jerry; Nakanjako, Damalie; Njoroge, Anne; Otedo, Amos; Page, Stephanie; Farquhar, Carey			Prevalence and factors associated with hypertension among adults with and without HIV in Western Kenya	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; BLOOD-PRESSURE; GUIDELINES; RISK	IntroductionThe burden of cardiovascular disease (CVD) is increasing in sub-Saharan Africa with untreated hypertension being a major contributing factor. Understanding the magnitude of the problem and risk factors associated with HIV and long-term antiretroviral therapy (ART) is critically important for designing effective programs for diagnosing and treating hypertension in Kenya. MethodsIn this cross-sectional study, we enrolled 300 persons with HIV (PWH) on long term ART (>= 6 months) and 298 HIV-negative adults seeking care at the Kisumu County Hospital between September 2017 and May 2018. Hypertension was defined as blood pressure of >= 140/90mmHg or a previous hypertension diagnosis. Multivariate regression was used to assess the association between hypertension and HIV adjusting for age, sex, and known CVD risk factors. ResultsOverall prevalence of hypertension was 22%. PWH had a lower prevalence of hypertension than HIV-negative persons (16% vs 27% respectively; p<0.002). In multivariate analyses, persons with HIV were 37% less likely to have hypertension compared to HIV-negative individuals (adjusted prevalence ratio 0.63; 95% confidence interval: 0.46-0.86). Other factors that were associated with hypertension in all participants included older age >40 years, body mass index (BMI) >25 kg/m(2) and low-density lipoproteins >= 130mg/dL. Among PWH, being older than 40 years and higher BMI >30 kg/m(2) were associated with hypertension. ConclusionPrevalence of hypertension was high, affecting nearly one in every 4 adults, and associated with older age, higher BMI and high low-density lipoproteins. PWH on long-term ART had significantly lower prevalence of hypertension compared to HIV-negative individuals, potentially due to increased access to healthcare services and interaction with prevention messaging. Interventions to increase screening for and prevention of hypertension in the community for all adults are warranted.	[Mogaka, Jerusha Nyabiage; Sharma, Monisha; Temu, Tecla; Masyuko, Sarah; Njoroge, Anne; Page, Stephanie; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Mogaka, Jerusha Nyabiage; Kinuthia, John] Kenyatta Natl Hosp, Dept Res & Programs, Nairobi, Kenya; [Masyuko, Sarah; Otedo, Amos] Minist Hlth, Nairobi, Kenya; [Osoti, Alfred] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [Osoti, Alfred] Univ Nairobi, Coll Hlth Sci, Dept Clin Med & Therapeut, Nairobi, Kenya; [Zifodya, Jerry] Tulane Univ, Sect Pulm Crit Care & Environm Med, Dept Med, New Orleans, LA USA; [Nakanjako, Damalie] Makerere Univ, Sch Med, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Page, Stephanie; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kenyatta National Hospital; University of Nairobi; University of Nairobi; Tulane University; Makerere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mogaka, JN (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Mogaka, JN (corresponding author), Kenyatta Natl Hosp, Dept Res & Programs, Nairobi, Kenya.	jerunyags@gmail.com		Nakanjako, Damalie/0000-0002-0935-2112; Mogaka, Jerusha/0000-0001-9913-9034; Temu, Tecla/0000-0002-0056-4143; Zifodya, Jerry/0000-0003-2742-5976; Sharma, Monisha/0000-0002-7599-1561	US National Institutes of Health (NIH) [R21 TW010459]; Fogarty International Center (FIC) [D43 TW009580]; NIMH [K01MH115789]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by US National Institutes of Health (NIH), R21 TW010459 and the Fogarty International Center (FIC) D43 TW009580. Monisha Sharma received support from NIMH K01MH115789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaney T, 2018, LANCET GLOB HEALTH, V6, pE736, DOI 10.1016/S2214-109X(18)30259-6; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Bull FC, 2020, BRIT J SPORT MED, V54, P1451, DOI 10.1136/bjsports-2020-102955; Chepchirchir A., 2018, INT J CYTOKINE EXPRE, DOI [10.1080/09540121.2017.1384533, DOI 10.1080/09540121.2017.1384533]; Dhungana RR, 2016, INT J HYPERTENS, V2016, P1, DOI 10.1155/2016/1656938; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gebrie A, 2018, SAGE OPEN MED, V6, DOI [10.1177/2050312118756663, 10.1177/2050312118774142]; Guwatudde D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2546-z; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Ibekwe RU, 2015, ANN MED HEALTH SCI R, V5, P71, DOI 10.4103/2141-9248.149793; IHME, 2020, GBD COMP VIZ HUB; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Kwarisiima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156309; Lubega G, 2021, PAN AFR MED J, V38, DOI 10.11604/pamj.2021.38.216.28034; Masenga SK, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0956-5; Masyuko SJ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020845; Ministry of Health; Kenyan National Bureau of Statistics; World Health Organization, 2015, PUBLIC HEALTH, V5, P8, DOI [10.1007/s11605-008-0794-2, DOI 10.1007/S11605-008-0794-2]; MoH-Kenya, 2018, KEN NAT GUID CARD DI; Mosha NR, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1321279; Nahimana MR, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4536-9; NASCOP K, KEN ARV GUID 2018 FI; Nduka CU, 2016, J HUM HYPERTENS, V30, P355, DOI 10.1038/jhh.2015.97; Ngatchou W, 2013, BLOOD PRESS MONIT, V18, P247, DOI 10.1097/MBP.0b013e328363ee43; Olack B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2610-8; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Ploth DW, 2018, KIDNEY INT REP, V3, P905, DOI 10.1016/j.ekir.2018.04.006; Pustil R., 2016, AIDS S4, V17, pS3, DOI 10.1073/pnas.86.15.5781; Trickey A, 2017, LANCET HIV, V4, pE349, DOI 10.1016/S2352-3018(17)30066-8; Whelton PK, 2018, JAMA-J AM MED ASSOC, V320, P1749, DOI 10.1001/jama.2018.16755; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2003, WHOCDSWHOPESGCDPP200, P43; World Health O, 2008, WAIST CIRCUMFERENCE, P8, DOI [10.1038/ejcn.2009.139, DOI 10.1038/EJCN.2009.139]; Yoruk A, 2018, AM J HYPERTENS, V31, P387, DOI 10.1093/ajh/hpx196	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262400	10.1371/journal.pone.0262400	http://dx.doi.org/10.1371/journal.pone.0262400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007291	gold, Green Published			2022-12-26	WOS:000741060700005
J	Boothe, MAS; Baltazar, CS; Sathane, I; Raymond, HF; Fazito, E; Temmerman, M; Luchters, S				Boothe, Makini A. S.; Baltazar, Cynthia Sema; Sathane, Isabel; Raymond, Henry F.; Fazito, Erika; Temmerman, Marleen; Luchters, Stanley			Young key populations left behind: The necessity for a targeted response in Mozambique	PLOS ONE			English	Article							RISK BEHAVIORS; HIV-INFECTION; SEX WORKERS; MEN; PEOPLE; DRUGS	Introduction The first exposure to high-risk sexual and drug use behaviors often occurs during the period of youth (15-24 years old). These behaviors increase the risk of HIV infection, especially among young key populations (KP)-men how have sex with men (MSM), female sex workers (FSW), and people who inject drugs (PWID). We describe the characteristics of young KP participants in the first Biobehavioral Surveillance (BBS) surveys conducted in Mozambique and examine their risk behaviors compared to adult KP. Methods Respondent-driven sampling (RDS) methodology was used to recruit KP in three major urban areas in Mozambique. RDS-weighted pooled estimates were calculated to estimate the proportion of young KP residing in each survey city. Unweighted pooled estimates of risk behaviors were calculated for each key population group and chi-square analysis assessed differences in proportions between youth (aged less than 24 years old) and older adult KP for each population group. Results The majority of MSM and FSW participants were young 80.7% (95% CI: 71.5-89.9%) and 71.9% (95% CI: 71.9-79.5%), respectively, although not among PWID (18.2%, 95% CI: 13.2-23.2%). Young KP were single or never married, had a secondary education level or higher, and low employment rates. They reported lower perception of HIV risk (MSM: 72.3% vs 56.7%, p<0.001, FSW: 45.3% vs 24.4%, p<0.001), lower HIV testing uptake (MSM: 67.5% vs 72.3%, p<0.001; FSW: 63.2% vs 80.6%; p<0.001, PWID: 53.3% vs 31.2%; p = 0.001), greater underage sexual debut (MSM: 9.6% vs 4.8%, p<0.001; FSW: 35.2% vs 22.9%, p<0.001), and greater underage initiation of injection drug use (PWID: 31.9% vs 7.0%, p<0.001). Young KP also had lower HIV prevalence compared to older KP: MSM: 3.3% vs 27.0%, p<0.001; FSW: 17.2% vs 53.7%, p<0.001; and PWID: 6.0% vs 55.0%, p<0.001. There was no significant difference in condom use across the populations. Conclusion There is an immediate need for a targeted HIV response for young KP in Mozambique so that they are not left behind. Youth must be engaged in the design and implementation of interventions to ensure that low risk behaviors are sustained as they get older to prevent HIV infection.	[Boothe, Makini A. S.; Baltazar, Cynthia Sema; Temmerman, Marleen; Luchters, Stanley] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, Ghent, Belgium; [Baltazar, Cynthia Sema] Natl Inst Hlth, Maputo, Mozambique; [Sathane, Isabel] Natl Directorate Publ Hlth, Natl STI HIV AIDS Control Program, Maputo, Mozambique; [Raymond, Henry F.] Rutgers State Univ, Sch Publ Hlth, Piscataway, NJ USA; [Fazito, Erika] Columbia Univ, ICAP, Pretoria, South Africa; [Temmerman, Marleen] Aga Khan Univ, Dept Obstet & Gynecol, Nairobi, Kenya; [Luchters, Stanley] Aga Khan Univ, Dept Populat Hlth, Nairobi, Kenya; [Luchters, Stanley] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia	Ghent University; Ghent University Hospital; Rutgers State University New Brunswick; Aga Khan University; Aga Khan University; Monash University	Boothe, MAS (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, Ghent, Belgium.	Makini.boothe@ugent.be		Luchters, Stanley/0000-0001-5235-5629; , Makini/0000-0002-5362-5106	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GPS001468]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	"This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of the Cooperative Agreement #U2GPS001468. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the CDC."The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], Adolescents and Youth Dashboard; Augusto AD, 2016, AIDS BEHAV, V20, P799, DOI 10.1007/s10461-015-1140-9; Baltazar CS, 2020, HARM REDUCT J, V17, DOI 10.1186/s12954-020-00363-6; Baltazar CS, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4655-2; Bekker LG, 2015, J INT AIDS SOC, V18, P1, DOI 10.7448/IAS.18.2.20027; Busza J, 2014, HEALTH PLACE, V28, P85, DOI 10.1016/j.healthplace.2014.04.002; Coetzee J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196759; Delany-Moretlwe S, 2015, J INT AIDS SOC, V18, P29, DOI 10.7448/IAS.18.2.19833; Demissie M, 2018, AJAR-AFR J AIDS RES, V17, P259, DOI 10.2989/16085906.2018.1511604; Fast-Track Cities, 2015, PLAN ESTR NAC RESP H; Harper GW, 2015, AIDS, V29, pS261, DOI 10.1097/QAD.0000000000000905; HIV/AIDS/STI UWG on G, 2012, STRAT LAB METH STREN; Instituto Nacional de Estatistica, POPULATION PROJECTIO; Instituto Nacional de Saude Centers for Disease Control and Prevention University of California San Francisco Pathfinder International and I-TECH, 2012, INT BIOL BEH SURV ME; Kim EJ, 2016, SEX TRANSM INFECT, V92, P240, DOI 10.1136/sextrans-2015-052034; Kounta CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212245; Kurth AE, 2015, JAIDS-J ACQ IMM DEF, V70, P420, DOI 10.1097/QAI.0000000000000769; Lancaster KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147662; Mavedzenge SN, 2011, J ADOLESCENT HEALTH, V49, P559, DOI 10.1016/j.jadohealth.2011.02.012; Milne J, 2020, AIDS BEHAV, V24, P2307, DOI 10.1007/s10461-020-02790-9; Ministerio da Saude, 2018, BREV CONS REL ESTR N; Ministerio da Saude, 2016, DIR INT SERV PREV C; Ministerio da Saude and Instituto Nacional de Saude, 2017, MOZ INT BIOL BEH SUR; Ministerio da Saude (MISAU) Instituto Nacional de Estatistica (INE) Com a Assistencia Tecnica de ICF., 2018, INQ IND IM MAL HIV S; Mmbaga EJ, 2020, ARCH SEX BEHAV, V49, P2045, DOI 10.1007/s10508-019-01529-5; Musyoki H, 2015, AIDS BEHAV, V19, pS46, DOI 10.1007/s10461-014-0919-4; Muzyamba C, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0067-6; Nala R, 2015, AIDS BEHAV, V19, P393, DOI 10.1007/s10461-014-0895-8; Needle R, 2008, SOC SCI MED, V67, P1447, DOI 10.1016/j.socscimed.2008.06.031; Okoboi S, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25269; Pantelic M, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001285; Pettifor A, 2015, J INT AIDS SOC, V18, P8, DOI 10.7448/IAS.18.2.19434; Rotheram-Borus MJ, 2018, CURR OPIN PEDIATR, V30, P131, DOI 10.1097/MOP.0000000000000580; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Tsang EYH, 2019, AM J MENS HEALTH, V13, DOI 10.1177/1557988318823883; Tun W, 2015, AIDS BEHAV, V19, pS24, DOI 10.1007/s10461-014-0936-3; UNAIDS, 2018, YOUTH BULG HIV; UNAIDS, 2016, END AIDS EP AD AD, P32, DOI [10.1080/09540121.2016.1139043, DOI 10.1080/09540121.2016.1139043]; UNAIDS, 2018, YOUTH HIV MAINSTR 3; United Nations, 2018, WORLD YOUTH REP YOUT, DOI [10.1186/s12884-018-1763-8, DOI 10.1186/S12884-018-1763-8]; United Nations General Assembly, 1996, ARES5081 UN GEN ASS; Vandepitte J, 2014, HIV OTHER SEXUALLY T, P17; Wirtz AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18742; World Health Organization, 2015, HIV YOUNG MEN WHO HA; World Health Organization, 2014, CONS GUID HIV PREV D; World Health Organization, 2015, TECHN BRIEF HIV YOUN	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261943	10.1371/journal.pone.0261943	http://dx.doi.org/10.1371/journal.pone.0261943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972172	Green Published, gold			2022-12-26	WOS:000773555700071
J	Fahmy, S; Kan, PF; Lewon, JW				Fahmy, Sarah; Kan, Pui-Fong; Lewon, Jen Walentas			The effects of theatre-based vocal empowerment on young Egyptian women's vocal and language characteristics	PLOS ONE			English	Article							FUNDAMENTAL-FREQUENCY; SPEECH PRACTICE; ENGLISH	This study investigates the impact of a theatre-based vocal empowerment program on the vocal and language characteristics and the self-perceptions of young bilingual Egyptian women. The program used applied theatre, a dramatic practice that promotes civic action by utilizing improvisational techniques to engage participants in exploring solutions to self-identified community concerns. These techniques supported participants' pursuit of vocal empowerment: the ability to comfortably express their intended content with a clear audible voice, accompanied by the belief that what they had to say was worthwhile. The program was implemented in Alexandria and Aswan, two Egyptian cities in different regions of the country, with distinct socio-economic profiles. Thirty-six young women from Aswan and nineteen from Alexandria participated. The program was facilitated in Arabic, for 90 minutes per day over twelve consecutive days in 2018. Participants in both groups spoke Arabic as a home language and studied English in school settings but differed in their educational experiences and English proficiency. The vocal and language characteristics of each participant were tested in Arabic and English pre- and post- program using a spontaneous speech task and a reading aloud task. Their self-perceptions were evaluated through a vocal self-perception survey. Results indicated that participants responded differently in each city. In Alexandria, participants showed significant improvement in language skills (e.g., mean length of utterance). In contrast, participants in Aswan showed a significant change in fundamental frequency. Overall, the self-surveys indicated that all participants experienced an increased sense of confidence, a stronger belief in self-authorship, and an increased desire to voice their opinions clearly in public; however, there were subtle differences between the groups. In analyzing these results, we conclude that to design effective vocal empowerment outreach programs internationally, it is necessary to consider participants' cultural backgrounds, language diversity, and socio-economic status.	[Fahmy, Sarah] Univ Colorado, Dept Theatre & Dance, Boulder, CO 80309 USA; [Kan, Pui-Fong; Lewon, Jen Walentas] Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Fahmy, S (corresponding author), Univ Colorado, Dept Theatre & Dance, Boulder, CO 80309 USA.	sarah.fahmy@colorado.edu	Kan, Pui Fong/AAL-7650-2020; Fahmy, Sarah/CAG-8336-2022	Kan, Pui Fong/0000-0001-8671-7755; Fahmy, Sarah/0000-0002-6702-9145	University of Colorado Boulder Office of Outreach and Engagement	University of Colorado Boulder Office of Outreach and Engagement	SF $2000 The University of Colorado Boulder Office of Outreach and Engagement https://www.colorado.edu/outreach/ooe/microgrants The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Hamid A., 2005, J READ LIT, V50, P15; Aboulfetouh M.., 2014, PARENTSATTITUDES THE; Abu-Al-Makarem A, 2007, PERCEPT MOTOR SKILL, V105, P572, DOI 10.2466/PMS.105.2.572-580; Altenberg EP, 2006, J VOICE, V20, P89, DOI 10.1016/j.jvoice.2005.01.005; Aravanis M.., 2020, EGYPTIAN STREETS; Aung T, 2020, CURR OPIN PSYCHOL, V33, P154, DOI 10.1016/j.copsyc.2019.07.028; Bassiouney R.., 2020, ARABIC SOCIOLINGUIST, VSecond; Boal A., 2002, AUGUSTO BOAL GAMES A; Boersma P., 2012, VERSION 6037; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Cantor-Cutiva LC, 2021, J VOICE, V35, P194, DOI 10.1016/j.jvoice.2019.08.009; Chakraborty R, 2008, J SPEECH LANG HEAR R, V51, P321, DOI 10.1044/1092-4388(2008/024); El Shimi R., 2013, AHRAM ONLINE 16 FEB; Elsirgany S., 2017, AHRAM ONLINE 5 NOV; Fahmy S., 2019, VOCAL EMPOWERMENT YO; Goy H, 2013, J VOICE, V27, P545, DOI 10.1016/j.jvoice.2013.03.002; Index Mundi, 2019, EGYPT DEMOGRAPHICS P; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kan PF, 2015, SEMIN SPEECH LANG, V36, P109, DOI 10.1055/s-0035-1549106; Kan PF, 2014, J SPEECH LANG HEAR R, V57, P929, DOI 10.1044/2013_JSLHR-L-13-0045; Kandil Y., 2015, Applied Theatre Research, V3, P237, DOI 10.1386/atr.3.3.237_1; Khattab M, 2016, COMP FEM STUD SER, P127, DOI 10.1057/978-1-137-50675-7_9; Kleinow J, 2006, DEV PSYCHOBIOL, V48, P275, DOI 10.1002/dev.20141; Lee B, 2017, SPEECH LANG HEARING, V20, P174, DOI 10.1080/2050571X.2016.1273572; Lev-Ari S, 2020, COGNITIVE SCI, V44, DOI 10.1111/cogs.12836; Linklater Kristin., 2018, VOICE SPEECH REV, V12, P211, DOI [10.1080/23268263.2018.1444558, DOI 10.1080/23268263.2018.1444558]; Mahrholz G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204991; Mattei A, 2019, EUR ANN OTORHINOLARY, V136, P151, DOI 10.1016/j.anorl.2019.02.010; MENA OECD, 2018, WOMENS POLITICAL PAR, P1; Miller J.F., 2017, SYSTEMATIC ANAL LANG; Nader N., 2017, N AFRICAN WOMEN ARAB, P211, DOI [10.1007/978-3-319-49926-0_11, DOI 10.1007/978-3-319-49926-0_11]; O'Connor P, 2009, RIDE-J APPL THEATRE, V14, P471, DOI 10.1080/13569780903285966; Osnes B., 2017, SPEAK; Osnes B, 2019, THEATR DANCE PERFORM, V10, P313, DOI 10.1080/19443927.2019.1637371; Pahwa S, 2019, TEXT PERFORM Q, V39, P56, DOI 10.1080/10462937.2018.1544375; Peterson M. A., 2011, CONNECTED CAIRO GROW; Sabbah SS, 2015, ARAB WORLD ENGL J, V6, P54, DOI 10.24093/awej/vol6no2.4; Shalaby M, 2016, COMP FEM STUD SER, P171, DOI 10.1057/978-1-137-55747-6_8; Siupsinskiene N, 2011, J VOICE, V25, pE177, DOI 10.1016/j.jvoice.2010.03.010; Smith A, 2006, J COMMUN DISORD, V39, P331, DOI 10.1016/j.jcomdis.2006.06.017; SUSSMAN JE, 1994, J VOICE, V8, P145, DOI 10.1016/S0892-1997(05)80306-6; Tahan S, 2011, READ WRIT, V24, P1061, DOI 10.1007/s11145-011-9301-3; Tower Jacob I, 2019, OTO Open, V3, p2473974X19866384, DOI 10.1177/2473974X19866384; Voniati L, 2016, J GREEK LINGUIST, V16, P117, DOI 10.1163/15699846-01601002; Waaramaa T, 2021, J VOICE, V35, DOI 10.1016/j.jvoice.2019.09.003; Worldometer, 2020, EGYPT POPULATION LIV	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261294	10.1371/journal.pone.0261294	http://dx.doi.org/10.1371/journal.pone.0261294			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972115	gold, Green Published			2022-12-26	WOS:000773555700028
J	Kim, H; Park, J; Choung, YH; Jang, JH; Ko, J				Kim, Hantai; Park, JaeYeon; Choung, Yun-Hoon; Jang, Jeong Hun; Ko, JeongGil			Predicting speech discrimination scores from pure-tone thresholds-A machine learning-based approach using data from 12,697 subjects	PLOS ONE			English	Article							HEMISPHERIC ASYMMETRIES; TEMPORAL RESOLUTION	Diagnostic tests for hearing impairment not only determines the presence (or absence) of hearing loss, but also evaluates its degree and type, and provides physicians with essential data for future treatment and rehabilitation. Therefore, accurately measuring hearing loss conditions is very important for proper patient understanding and treatment. In current-day practice, to quantify the level of hearing loss, physicians exploit specialized test scores such as the pure-tone audiometry (PTA) thresholds and speech discrimination scores (SDS) as quantitative metrics in examining a patient's auditory function. However, given that these metrics can be easily affected by various human factors, which includes intentional (or accidental) patient intervention, there are needs to cross validate the accuracy of each metric. By understanding a "normal" relationship between the SDS and PTA, physicians can reveal the need for re-testing, additional testing in different dimensions, and also potential malingering cases. For this purpose, in this work, we propose a prediction model for estimating the SDS of a patient by using PTA thresholds via a Random Forest-based machine learning approach to overcome the limitations of the conventional statistical (or even manual) methods. For designing and evaluating the Random Forest-based prediction model, we collected a large-scale dataset from 12,697 subjects, and report a SDS level prediction accuracy of 95.05% and 96.64% for the left and right ears, respectively. We also present comparisons with other widely-used machine learning algorithms (e.g., Support Vector Machine, Multi-layer Perceptron) to show the effectiveness of our proposed Random Forest-based approach. Results obtained from this study provides implications and potential feasibility in providing a practically-applicable screening tool for identifying patient-intended malingering in hearing loss-related tests.	[Kim, Hantai; Choung, Yun-Hoon; Jang, Jeong Hun] Ajou Univ Hosp, Suwon, South Korea; [Kim, Hantai; Choung, Yun-Hoon; Jang, Jeong Hun] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon, South Korea; [Park, JaeYeon; Ko, JeongGil] Yonsei Univ, Coll Engn, Sch Integrated Technol, Seoul, South Korea	Ajou University; Ajou University Hospital; Ajou University; Yonsei University	Jang, JH (corresponding author), Ajou Univ Hosp, Suwon, South Korea.; Jang, JH (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, Suwon, South Korea.; Ko, J (corresponding author), Yonsei Univ, Coll Engn, Sch Integrated Technol, Seoul, South Korea.	jhj@ajou.ac.kr; jeonggil.ko@yonsei.ac.kr	Ko, JeongGil/CAF-8134-2022	Kim, Hantai/0000-0002-5020-7814	National Research Foundation of Korea (NRF) - Korean Government (MSIT) [2021R1A2C4002380, ERC: 2015R1A5A1037668, KMDFPR202105270007202102]; Institute for Information and Communications Technology Planning and Evaluation [IITP-2020-2020-0-01461]	National Research Foundation of Korea (NRF) - Korean Government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Institute for Information and Communications Technology Planning and Evaluation	This study was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIT) in the form of funds to JGK [Basic Science Research Program:2021R1A2C4002380; ERC: 2015R1A5A1037668] and HK, YHC, and JHJ [KMDFPR202105270007202102]. This study was also supported by the Institute for Information and Communications Technology Planning and Evaluation to JGK [IITP-2020-2020-0-01461].	Adhikari Surabhi, 2020, 2020 International Conference on Electronics and Sustainable Communication Systems (ICESC). Proceedings, P975, DOI 10.1109/ICESC48915.2020.9155833; Ahn J, 2021, AD HOC NETW, V113, DOI 10.1016/j.adhoc.2020.102360; Ahn J, 2018, COMPUTER, V51, P68, DOI 10.1109/MC.2018.2381116; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Breiman L., 2001, MACH LEARN, V45, P5; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Brown S, 1997, PERCEPT PSYCHOPHYS, V59, P442, DOI 10.3758/BF03211910; Brown SD, 2009, COMPREHENSIVE CHEMOMETRICS: CHEMICAL AND BIOCHEMICAL DATA ANALYSIS, VOLS 1-4, P1; Mondelli MFCG, 2020, CODAS, V32, DOI 10.1590/2317-1782/20192018202; Crowson MG, 2020, LARYNGOSCOPE, V130, P45, DOI 10.1002/lary.27850; Cruz JA, 2006, CANCER INFORM, V2, P59; Dillon H., 2008, HEARING AIDS; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; FLETCHER H, 1950, Acta Otolaryngol Suppl, V90, P26; Flint PW., 2014, CUMMINGS OTOLARYNGOL; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Guan HY, 2013, INT J REMOTE SENS, V34, P5166, DOI 10.1080/01431161.2013.788261; He H, 2013, IMBALANCED LEARNING: FOUNDATIONS, ALGORITHMS, AND APPLICATIONS, P1, DOI 10.1002/9781118646106; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hodgson W., 1986, HEARING AID ASSESSME; Hong Seong Ah L., 2002, KOREAN J AUDIOL, V6, P128; HyeonJung Park, 2021, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V5, DOI 10.1145/3463498; Jaeyeon Park, 2020, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V4, DOI 10.1145/3411843; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Kaga K, 2016, AURIS NASUS LARYNX, V43, P10, DOI 10.1016/j.anl.2015.06.008; Kim H, 2021, DYES PIGMENTS, V193, DOI 10.1016/j.dyepig.2021.109492; Kim H, 2021, SENSOR ACTUAT B-CHEM, V329, DOI 10.1016/j.snb.2020.129248; Levene H, 1961, CONTRIBUTIONS PROBAB, P279; Liden G, 1969, J Laryngol Otol, V83, P507, DOI 10.1017/S0022215100070651; MARSHALL L, 1981, EAR HEARING, V2, P148, DOI 10.1097/00003446-198107000-00003; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Moturu ST, 2007, IEEE INT C BIOINFORM, P202, DOI 10.1109/BIBM.2007.54; MULLINS C J, 1957, Acta Otolaryngol, V47, P149, DOI 10.3109/00016485709130328; PAL SK, 1992, IEEE T NEURAL NETWOR, V3, P683, DOI 10.1109/72.159058; Park J, 2017, PROCEEDINGS OF THE 15TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS (SENSYS'17), DOI 10.1145/3131672.3131690; PAULER M, 1986, ARCH OTO-RHINO-LARYN, V243, P200, DOI 10.1007/BF00470622; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; RAFFIN MJM, 1980, J SPEECH HEAR RES, V23, P5, DOI 10.1044/jshr.2301.05; Royston P, 1992, STAT COMPUT, V2, P117, DOI [DOI 10.1007/BF01891203, 10.1007/BF01891203]; Shibata T, 2004, ACTA OTO-LARYNGOL, V124, P30, DOI 10.1080/03655230410018417; Sulakhe N, 2003, BRAIN COGNITION, V53, P372, DOI 10.1016/S0278-2626(03)00146-5; Tan Aik Choon, 2003, Appl Bioinformatics, V2, pS75; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; Van Dijk JE, 2000, ACTA OTO-LARYNGOL, V120, P627, DOI 10.1080/000164800750000450; Wilcoxon F., 1992, SPRINGER SERIES STAT, V1, P196, DOI DOI 10.2307/3001968; Yoon HJ, 2017, ACM T SENSOR NETWORK, V13, DOI 10.1145/3079764; YOSHIOKA P, 1980, J SPEECH HEAR RES, V23, P814, DOI 10.1044/jshr.2304.814; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	50	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261433	10.1371/journal.pone.0261433	http://dx.doi.org/10.1371/journal.pone.0261433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972151	Green Published, gold			2022-12-26	WOS:000773555700032
J	Kim, J; Cho, S; Park, Y; Lee, J; Park, J				Kim, Jiyoon; Cho, Siwoo; Park, Yonghyun; Lee, Jiyoul; Park, Jaesung			Evaluation of micro-RNA in extracellular vesicles from blood of patients with prostate cancer	PLOS ONE			English	Article							PCR DATA; CIRCULATING MICRORNAS; BIOMARKERS; SERUM; DIAGNOSIS; MIRNAS; NORMALIZATION; EXPRESSION; EXOSOMES; GENES	Extracellular vesicles (EVs) contain various types of molecules including micro-RNAs, so isolating EVs can be an effective way to analyze and diagnose diseases. A lot of micro-RNAs have been known in relation to prostate cancer (PCa), and we evaluate miR-21, miR-141, and miR-221 in EVs and compare them with prostate-specific antigen (PSA). EVs were isolated from plasma of 38 patients with prostate cancer and 8 patients with benign prostatic hyperplasia (BPH), using a method that showed the highest recovery of RNA. Isolation of EVs concentrated micro-RNAs, reducing the cycle threshold (Ct) value of RT-qPCR amplification of micro-RNA such as miR-16 by 5.12 and miR-191 by 4.65, compared to the values before EV isolation. Normalization of target micro-RNAs was done using miR-191. For miR-221, the mean expression level of patients with localized PCa was significantly higher than that of the control group, having 33.45 times higher expression than the control group (p < 0.01). Area under curve (AUC) between BPH and PCa for miR-221 was 0.98 (p < 0.0001), which was better than AUC for prostate-specific antigen (PSA) level in serum for the same patients. The levels of miR-21 and miR-141 in EVs did not show significant changes in patients with PCa compared to the control group in this study. This study suggests isolating EVs can be a helpful approach in analyzing micro-RNAs with regard to disease.	[Kim, Jiyoon; Park, Jaesung] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea; [Cho, Siwoo; Park, Jaesung] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, Gyeong Buk, South Korea; [Park, Yonghyun; Lee, Jiyoul] Catholic Univ Korea, Coll Med, Dept Urol, Seoul St Marys Hosp, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Seoul St. Mary's Hospital	Park, J (corresponding author), Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea.; Park, J (corresponding author), Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, Gyeong Buk, South Korea.	jpark@posteach.ac.kr		Kim, Ji Yoon/0000-0003-0975-9171	Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT) [1711137918, KMDF_PR_20200901_0018]; Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy) [1711137918, KMDF_PR_20200901_0018]; Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare) [1711137918, KMDF_PR_20200901_0018]; Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety) [1711137918, KMDF_PR_20200901_0018]	Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety)	The author who received the fund: JP -Grant number: 1711137918, KMDF_PR_20200901_0018 -Full name of funder: Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) -URL: https://www.kmdf.org/-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abak A, 2018, EUR REV MED PHARMACO, V22, P3094, DOI 10.26355/eurrev_201805_15069; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Castanares MA, 2016, PROSTATE, V76, P215, DOI 10.1002/pros.23115; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; El-Hefnawy T, 2004, CLIN CHEM, V50, P564, DOI 10.1373/clinchem.2003.028506; Fabris L, 2016, EUR UROL, V70, P312, DOI 10.1016/j.eururo.2015.12.054; Fernandez-Mercado M, 2015, J CELL MOL MED, V19, P2307, DOI 10.1111/jcmm.12625; Filella X, 2017, CLIN CHEM LAB MED, V55, P715, DOI 10.1515/cclm-2015-1073; Gharbi S, 2015, CELL J, V17, P494; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Keck B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061315; Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2; Kim J, 2017, J DENT RES, V96, P938, DOI 10.1177/0022034517702100; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kotb S, 2014, TUMOR BIOL, V35, P12613, DOI 10.1007/s13277-014-2584-7; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logozzi M, 2020, J ENZYM INHIB MED CH, V35, P280, DOI 10.1080/14756366.2019.1697249; Luu HN, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0206-6; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Neuhaus J, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8040068; Ryan D, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0948-z; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen J, 2013, CANCER LETT, V329, P125, DOI 10.1016/j.canlet.2012.11.001; Shin H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13103; Sun Z, 2018, J CELL MOL MED, V22, P3719, DOI 10.1111/jcmm.13676; Tamada T, 2011, AM J ROENTGENOL, V197, P664, DOI 10.2214/AJR.10.5923; Taylor MA, 2015, BIOMEDICINES, V3, DOI 10.3390/biomedicines3040270; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0086-0; Whiteside TL, 2016, ADV CLIN CHEM, V74, P103, DOI 10.1016/bs.acc.2015.12.005; Zedan AH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57101-7; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8	35	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262017	10.1371/journal.pone.0262017	http://dx.doi.org/10.1371/journal.pone.0262017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972164	Green Published, gold			2022-12-26	WOS:000773555700083
J	Wood, CL; Leslie, KL; Greene, A; Lam, LS; Basnett, B; Hamilton, SL; Samhouri, JF				Wood, Chelsea L.; Leslie, Katie L.; Greene, Alanna; Lam, Laurel S.; Basnett, Bonnie; Hamilton, Scott L.; Samhouri, Jameal F.			The weaker sex: Male lingcod (Ophiodon elongatus) with blue color polymorphism are more burdened by parasites than are other sex-color combinations	PLOS ONE			English	Article							FISH; INFECTIONS; NUTRITION; SELECTION; PIGMENTS; SCULPIN; HEALTH; WILD	The unusual blue color polymorphism of lingcod (Ophiodon elongatus) is the subject of much speculation but little empirical research; similar to 20% of lingcod individuals exhibit this striking blue color morph, which is discrete from and found within the same populations as the more common brown morph. In other species, color polymorphisms are intimately linked with host-parasite interactions, which led us to ask whether blue coloration in lingcod might be associated with parasitism, either as cause or effect. To test how color and parasitism are related in this host species, we performed parasitological dissection of 89 lingcod individuals collected across more than 26 degrees of latitude from Alaska, Washington, and California, USA. We found that male lingcod carried 1.89 times more parasites if they were blue than if they were brown, whereas there was no difference in parasite burden between blue and brown female lingcod. Blue individuals of both sexes had lower hepatosomatic index (i.e., relative liver weight) values than did brown individuals, indicating that blueness is associated with poor body condition. The immune systems of male vertebrates are typically less effective than those of females, due to the immunocompromising properties of male sex hormones; this might explain why blueness is associated with elevated parasite burdens in males but not in females. What remains to be determined is whether parasites induce physiological damage that produces blueness or if both blue coloration and parasite burden are driven by some unmeasured variable, such as starvation. Although our study cannot discriminate between these possibilities, our data suggest that the immune system could be involved in the blue color polymorphism-an exciting jumping-off point for future research to definitively identify the cause of lingcod blueness and a hint that immunocompetence and parasitism may play a role in lingcod population dynamics.	[Wood, Chelsea L.; Leslie, Katie L.; Greene, Alanna] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Greene, Alanna] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Lam, Laurel S.] NOAA, Pacific States Marine Fisheries Commiss, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Basnett, Bonnie; Hamilton, Scott L.] San Jose State Univ, Moss Landing Marine Labs, Moss Landing, CA USA; [Samhouri, Jameal F.] NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; San Jose State University; Moss Landing Marine Laboratories; National Oceanic Atmospheric Admin (NOAA) - USA	Wood, CL (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	chelwood@uw.edu		Basnett, Bonnie/0000-0001-9019-7270; Wood, Chelsea/0000-0003-2738-3139	NOAA NMFS Habitat Assessment Improvement Plan (HAIP) [NA15-NMF4550353]; National Science Foundation [OCE-1829509]; Sloan Research Fellowship from the Alfred P. Sloan Foundation; UW Innovation Award; UW Royalty Research Fund	NOAA NMFS Habitat Assessment Improvement Plan (HAIP); National Science Foundation(National Science Foundation (NSF)); Sloan Research Fellowship from the Alfred P. Sloan Foundation; UW Innovation Award; UW Royalty Research Fund	Funding for lingcod collections was provided by NOAA NMFS Habitat Assessment Improvement Plan (HAIP; #NA15-NMF4550353; https://www.st.nmfs.noaa.gov/Assets/science_ program/ecosystem-program-review/Habitat/HAIP_ES.pdf) to JFS and SLH. CLW was supported by a grant from the National Science Foundation (OCE-1829509; https://www.nsf.gov/geo/oce/programs/biores.jsp), a Sloan Research Fellowship from the Alfred P. Sloan Foundation (https://sloan.org/fellowships/), a UW Innovation Award (https://www.washington.edu/research/resources/fundingopportunities/the-university-of-washington-innovation-awards/), and the UW Royalty Research Fund (https://www.washington.edu/research/or/royalty-research-fund-rrf/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZPELLITERO P, 1993, J FISH BIOL, V42, P889, DOI 10.1111/j.1095-8649.1993.tb00398.x; Andrews KS, 2018, CONSERV GENET, V19, P865, DOI 10.1007/s10592-018-1060-0; Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; BADA JL, 1970, EXPERIENTIA, V26, P251, DOI 10.1007/BF01900075; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; Brunner FS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0128; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; Cornet S, 2014, J ANIM ECOL, V83, P256, DOI 10.1111/1365-2656.12113; Cote J, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0285; Ezenwa VO, 2004, INT J PARASITOL, V34, P535, DOI 10.1016/j.ijpara.2003.11.012; FANG LS, 1987, COMP BIOCHEM PHYS B, V88, P667; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Foo YZ, 2017, BIOL REV, V92, P551, DOI 10.1111/brv.12243; Galeotti P, 2003, J ZOOL, V261, P91, DOI 10.1017/S0952836903003960; Galloway AWE, 2021, MAR BIOL, V168, DOI 10.1007/s00227-021-03936-6; Gangoso L, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0839; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; Hair F., 1995, MULTIVARIATE DATA AN, V4th; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hamilton WJ, 1997, BEHAVIOUR, V134, P299, DOI 10.1163/156853997X00485; Huntington B.E., 2014, OREGON MARINE RESERV; KETTLEWELL H. B. D., 1955, HEREDITY, V9, P323, DOI 10.1038/hdy.1955.36; King JR, 2005, MOL ECOL, V14, P653, DOI 10.1111/j.1365-294X.2005.02438.x; Love M.S., 2011, CERTAINLY MORE YOU W; LOW PS, 1974, COMP BIOCHEM PHYSIOL, V47, P411, DOI 10.1016/0300-9629(74)90003-6; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Ludecke D., 2018, J OPEN SOURCE SOFTW, V3, P772, DOI [10.21105/joss.00772, DOI 10.21105/JOSS.00772]; Majerus Michael E.N., 2009, Evolution Education and Outreach, V2, P63, DOI 10.1007/s12052-008-0107-y; Manniste M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00004; Mikkola K, 2010, BIOL J LINN SOC, V99, P831, DOI 10.1111/j.1095-8312.2010.01398.x; Miller D.J., 1973, FISH B-NOAA, V158; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ponton F, 2013, J INSECT PHYSIOL, V59, P130, DOI 10.1016/j.jinsphys.2012.10.011; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Retschnig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085261; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rust M.B., 2003, FISH NUTR, P367; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; Venesky MD, 2015, J ZOOL, V295, P279, DOI 10.1111/jzo.12208; Wendt DE, 2009, MAR COAST FISH, V1, P315, DOI 10.1577/C08-054.1; WILLEY CH, 1957, J PARASITOL, V43, P324, DOI 10.2307/3274359; Wood CL, 2014, ECOLOGY, V95, P1929, DOI 10.1890/13-1270.1; YAMAGUCHI K, 1976, COMP BIOCHEM PHYS B, V55, P85, DOI 10.1016/0305-0491(76)90177-2; Zuk M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000267	46	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261202	10.1371/journal.pone.0261202	http://dx.doi.org/10.1371/journal.pone.0261202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972116	gold, Green Published			2022-12-26	WOS:000773555700026
J	Kapinos, A; Aghamalian, P; Capehart, E; Alag, A; Angel, H; Briseno, E; Perez, BC; Farag, E; Foster, H; Hakim, A; Hernandez-Casas, D; Huang, C; Lam, D; Mendez, M; Min, A; Nguyen, N; Omholt, AL; Ortiz, E; Saldivar, LS; Shannon, JA; Smith, R; Sridhar, MV; Ta, A; Theophilus, MC; Ngo, R; Torres, C; Reddi, K; Freise, AC; Moberg Parker, J				Kapinos, Andrew; Aghamalian, Pauline; Capehart, Erika; Alag, Anya; Angel, Heather; Briseno, Eddie; Perez, Byron Corado; Farag, Emily; Foster, Hilory; Hakim, Abbas; Hernandez-Casas, Daisy; Huang, Calvin; Lam, Derek; Mendez, Maya; Min, Ashley; Nguyen, Nikki; Omholt, Alexa L.; Ortiz, Emily; Saldivar, Lizbeth Shelly; Shannon, Jack Arthur; Smith, Rachel; Sridhar, Mihika V.; Ta, An; Theophilus, Malavika C.; Ngo, Ryan; Torres, Canela; Reddi, Krisanavane; Freise, Amanda C.; Moberg Parker, Jordan			Novel Cluster AZ Arthrobacter phages Powerpuff, Lego, and YesChef exhibit close functional relationships with Microbacterium phages	PLOS ONE			English	Article							PROTEIN TOPOLOGY; BACTERIOPHAGES; SOFTWARE; SERVER; TOOL	Bacteriophages exhibit a vast spectrum of relatedness and there is increasing evidence of close genomic relationships independent of host genus. The variability in phage similarity at the nucleotide, amino acid, and gene content levels confounds attempts at quantifying phage relatedness, especially as more novel phages are isolated. This study describes three highly similar novel Arthrobacter globiformis phages-Powerpuff, Lego, and YesChef-which were assigned to Cluster AZ using a nucleotide-based clustering parameter. Phages in Cluster AZ, Microbacterium Cluster EH, and the former Microbacterium singleton Zeta1847 exhibited low nucleotide similarity. However, their gene content similarity was in excess of the recently adopted Microbacterium clustering parameter, which ultimately resulted in the reassignment of Zeta1847 to Cluster EH. This finding further highlights the importance of using multiple metrics to capture phage relatedness. Additionally, Clusters AZ and EH phages encode a shared integrase indicative of a lysogenic life cycle. In the first experimental verification of a Cluster AZ phage's life cycle, we show that phage Powerpuff is a true temperate phage. It forms stable lysogens that exhibit immunity to superinfection by related phages, despite lacking identifiable repressors typically required for lysogenic maintenance and superinfection immunity. The ability of phage Powerpuff to undergo and maintain lysogeny suggests that other closely related phages may be temperate as well. Our findings provide additional evidence of significant shared phage genomic content spanning multiple actinobacterial host genera and demonstrate the continued need for verification and characterization of life cycles in newly isolated phages.	[Kapinos, Andrew; Aghamalian, Pauline; Capehart, Erika; Alag, Anya; Angel, Heather; Briseno, Eddie; Perez, Byron Corado; Farag, Emily; Foster, Hilory; Hakim, Abbas; Hernandez-Casas, Daisy; Huang, Calvin; Lam, Derek; Mendez, Maya; Min, Ashley; Nguyen, Nikki; Omholt, Alexa L.; Ortiz, Emily; Saldivar, Lizbeth Shelly; Shannon, Jack Arthur; Smith, Rachel; Sridhar, Mihika V.; Ta, An; Theophilus, Malavika C.; Ngo, Ryan; Torres, Canela; Reddi, Krisanavane; Freise, Amanda C.; Moberg Parker, Jordan] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Moberg Parker, Jordan] Kaiser Permanente Bernard J Tyson Sch Med, Dept Biomed Sci, Pasadena, CA 91101 USA	University of California System; University of California Los Angeles; Kaiser Permanente	Moberg Parker, J (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Moberg Parker, J (corresponding author), Kaiser Permanente Bernard J Tyson Sch Med, Dept Biomed Sci, Pasadena, CA 91101 USA.	jordan.p.parker@kp.org		Kapinos, Andrew/0000-0002-5353-5944; Huang, Calvin/0000-0002-6847-4611				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Camargo FAO, 2004, BIOL TRACE ELEM RES, V97, P183, DOI 10.1385/BTER:97:2:183; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Dedrick RM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.251; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Demo S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248418; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Hatfull GF, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.GPP3-0026-2018; Hatfull GF, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00389-16; Hatfull GF, 2015, J VIROL, V89, P8107, DOI 10.1128/JVI.01340-15; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jacobs-Sera D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234636; Kalatzis PG, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050122; Keen EC, 2015, BIOESSAYS, V37, P6, DOI 10.1002/bies.201400152; Klyczek KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180517; Koonin EV, 2003, SEQUENCE EVOLUTION F; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; O'Loughlin EJ, 1999, BIODEGRADATION, V10, P93, DOI 10.1023/A:1008309026751; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2017, MBIO, V8, DOI 10.1128/mBio.01069-17; Pratama AA, 2018, TRENDS MICROBIOL, V26, P649, DOI 10.1016/j.tim.2017.12.004; Russell DA, 2018, METHODS MOL BIOL, V1681, P109, DOI 10.1007/978-1-4939-7343-9_9; Russell DA, 2017, BIOINFORMATICS, V33, P784, DOI 10.1093/bioinformatics/btw711; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEA-PHAGES/Starterator, 2016, SEA PHAGES PROGR; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Westerberg K, 2000, INT J SYST EVOL MICR, V50, P2083, DOI 10.1099/00207713-50-6-2083; Yoon SH, 2017, ANTON LEEUW INT J G, V110, P1281, DOI 10.1007/s10482-017-0844-4; Yuan YH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00403	40	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262556	10.1371/journal.pone.0262556	http://dx.doi.org/10.1371/journal.pone.0262556			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025964	gold, Green Submitted, Green Published			2022-12-26	WOS:000796264200085
J	Otaki, Y; Fujishiro, N; Oyama, Y; Hata, N; Kato, D; Kawachi, S				Otaki, Yasuhiro; Fujishiro, Naofumi; Oyama, Yasuaki; Hata, Naoko; Kato, Daisuke; Kawachi, Shoji			The risk of fatal bleeding complications in jugular catheterization in patients with coagulopathy: A retrospective analysis of death cases in closed claims and the Medical Accident Investigating System in Japan	PLOS ONE			English	Article							MALPRACTICE CLAIMS; GUIDELINES; MANAGEMENT; ARTHRITIS; ERRORS	Background To prevent recurrence of medical accidents, the Medical Accident Investigating System was implemented in October 2015 by the Japan Medical Safety Research Organization (Medsafe Japan) to target deaths from medical care that were unforeseen by the administrator. Medsafe Japan analyzed the 10 cases of central venous catheterization-related deaths reported in the system and published recommendations in March 2017. However, the particular emphasis for the prevention of central venous catheterization-related deaths is unclear. Methods This study aimed to identify the recommendation points that should be emphasized to prevent recurrence of central venous catheterization-related deaths. We assessed central venous catheterization in 8530 closed-claim cases between January 2002 and December 2016 covered by the medical insurer Sompo-Japan. Moreover, we compared central venous catheterization-related death in closed-claim cases with death in reported cases. Results The background, error type, anatomic insertion site, and fatal complication data were evaluated for 37 closed-claim cases, of which 12 (32.4%) were death cases. Of the 12 closed-claim cases and 10 reported cases, 9 (75.0%) closed-claim cases and 9 (90.0%) reported cases were related to vascular access. Among these, 5 closed-claim cases (41.7%) and 7 reported cases (77.8%) were related to internal jugular vein catheterization (p = 0.28). Coagulopathy was observed in 3 (60.0%) of 5 closed-claim cases and 6 (85.7%) of 7 reported cases. Conclusions The risk of internal jugular catheterization in patients with coagulopathy must be carefully considered.	[Otaki, Yasuhiro; Fujishiro, Naofumi; Hata, Naoko; Kato, Daisuke; Kawachi, Shoji] Teikyo Univ, Gen Med Educ & Res Ctr, Tokyo, Japan; [Otaki, Yasuhiro; Kawachi, Shoji] Teikyo Univ Hosp, Safety Control Dept, Tokyo, Japan; [Oyama, Yasuaki] Sompo Japan Insurance Inc, Specialty Claims Dept, Tokyo, Japan	Teikyo University; Teikyo University	Otaki, Y (corresponding author), Teikyo Univ, Gen Med Educ & Res Ctr, Tokyo, Japan.; Otaki, Y (corresponding author), Teikyo Univ Hosp, Safety Control Dept, Tokyo, Japan.	y-otaki@med.teikyo-u.ac.jp		Otaki, Yasuhiro/0000-0002-8617-1120; Fujishiro, Naofumi/0000-0001-6573-9613	Japan Society for the Promotion of Science (JSPS) KAKENHI [18KT0099, 19K10542]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YO received the funding for this work from the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 18KT0099 and 19K10542, available from https://nrid.nii.ac.jp/ja/nrid/1000060464004/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Anesthesiologists, 2012, ANESTHESIOLOGY, V116, P539, DOI 10.1097/ALN.0b013e31823c9569; Ares G, 2017, CURR OPIN PEDIATR, V29, P340, DOI 10.1097/MOP.0000000000000485; Domino KB, 2004, ANESTHESIOLOGY, V100, P1411, DOI 10.1097/00000542-200406000-00013; Frykholm P, 2014, ACTA ANAESTH SCAND, V58, P508, DOI 10.1111/aas.12295; Ibeas Jose, 2017, Nefrologia, V37 Suppl 1, P1, DOI 10.1016/j.nefro.2017.11.004; Jaffray J, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00005; Japan Medical Safety Research Organization, RES QUEST REC CVC IN; Japan Medical Safety Research Organization, SEC MED SAF MED ACC; Joffe AM, 2019, ANESTHESIOLOGY, V131, P818, DOI 10.1097/ALN.0000000000002815; Lamperti M, 2012, INTENS CARE MED, V38, P1105, DOI 10.1007/s00134-012-2597-x; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Medical Accident Investigation and Support Center Japan Medical Safety Research Organization, 2017, AN DEATHS REL COMPL; Miki Tamotsu, 2011, Masui, V60 Suppl, pS25; Ministry of Health Labor and Welfare, MED ACC INV SYST; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Morley M, 2020, OPHTHALMOLOGY, V127, P852, DOI 10.1016/j.ophtha.2019.12.019; Nishiwaki K, 2020, J ANESTH, V34, P167, DOI 10.1007/s00540-019-02702-9; Norris LB, 2017, INT J ANTIMICROB AG, V50, P308, DOI 10.1016/j.ijantimicag.2017.06.013; Otaki Y, 2018, J CHIN MED ASSOC, V81, P236, DOI 10.1016/j.jcma.2017.06.023; Otaki Y, 2017, CHINESE MED J-PEKING, V130, P1454, DOI 10.4103/0366-6999.207479; Parienti JJ, 2015, NEW ENGL J MED, V373, P1220, DOI 10.1056/NEJMoa1500964; Schummer W, 2014, BRIT J ANAESTH, V113, P122, DOI 10.1093/bja/aeu049; Singh H, 2007, ARCH INTERN MED, V167, P2030, DOI 10.1001/archinte.167.19.2030; Stephens R, 2001, BRIT J ANAESTH, V87, P306, DOI 10.1093/bja/87.2.306; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Troianos CA, 2012, ANESTH ANALG, V114, P46, DOI 10.1213/ANE.0b013e3182407cd8; Vincent C, 2006, J EVAL CLIN PRACT, V12, P665, DOI 10.1111/j.1365-2753.2006.00634.x; Zengerink I, 2016, J ARTHROPLASTY, V31, P1890, DOI 10.1016/j.arth.2016.02.055	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261636	10.1371/journal.pone.0261636	http://dx.doi.org/10.1371/journal.pone.0261636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025900	Green Published, gold			2022-12-26	WOS:000796264200022
J	Thompson, JLM; West, DWD; Doering, TM; Budiono, BP; Lessard, SJ; Koch, LG; Britton, SL; Byrne, NM; Brown, MA; Ashton, KJ; Coffey, VG				Thompson, Jamie-Lee M.; West, Daniel W. D.; Doering, Thomas M.; Budiono, Boris P.; Lessard, Sarah J.; Koch, Lauren G.; Britton, Steven L.; Byrne, Nuala M.; Brown, Matthew A.; Ashton, Kevin J.; Coffey, Vernon G.			Effect of short-term hindlimb immobilization on skeletal muscle atrophy and the transcriptome in a low compared with high responder to endurance training model	PLOS ONE			English	Article							REGULATORY T-CELLS; TIME-COURSE; EXERCISE; RESISTANCE; DISUSE; ADAPTATIONS; EXPRESSION; RECOVERY; REPAIR	Skeletal muscle atrophy is a physiological response to disuse, aging, and disease. We compared changes in muscle mass and the transcriptome profile after short-term immobilization in a divergent model of high and low responders to endurance training to identify biological processes associated with the early atrophy response. Female rats selectively bred for high response to endurance training (HRT) and low response to endurance training (LRT; n = 6/group; generation 19) underwent 3 day hindlimb cast immobilization to compare atrophy of plantaris and soleus muscles with line-matched controls (n = 6/group). RNA sequencing was utilized to identify Gene Ontology Biological Processes with differential gene set enrichment. Aerobic training performed prior to the intervention showed HRT improved running distance (+60.6 +/- 29.6%), while LRT were unchanged (-0.3 +/- 13.3%). Soleus atrophy was greater in LRT vs. HRT (-9.0 +/- 8.8 vs. 6.2 +/- 8.2%; P<0.05) and there was a similar trend in plantaris (-16.4 +/- 5.6% vs. -8.5 +/- 7.4%; P = 0.064). A total of 140 and 118 biological processes were differentially enriched in plantaris and soleus muscles, respectively. Soleus muscle exhibited divergent LRT and HRT responses in processes including autophagy and immune response. In plantaris, processes associated with protein ubiquitination, as well as the atrogenes (Trim63 and Fbxo32), were more positively enriched in LRT. Overall, LRT demonstrate exacerbated atrophy compared to HRT, associated with differential gene enrichments of biological processes. This indicates that genetic factors that result in divergent adaptations to endurance exercise, may also regulate biological processes associated with short-term muscle unloading.	[Thompson, Jamie-Lee M.; Doering, Thomas M.; Ashton, Kevin J.; Coffey, Vernon G.] Bond Univ, Fac Hlth Sci & Med, Robina, Australia; [West, Daniel W. D.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [West, Daniel W. D.] Toronto Rehabil Inst, Toronto, ON, Canada; [West, Daniel W. D.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Doering, Thomas M.] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia; [Budiono, Boris P.] Charles Sturt Univ, Sch Community Hlth, Bathurst, NSW, Australia; [Lessard, Sarah J.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Lessard, Sarah J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Lessard, Sarah J.] Harvard Med Sch, Boston, MA 02115 USA; [Koch, Lauren G.] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Byrne, Nuala M.] Univ Tasmania, Sch Hlth Sci, Hobart, Tas, Australia; [Brown, Matthew A.] Kings Coll London, Natl Inst Hlth Res, Guys & St Thomas Biomed Res Ctr, London, England	Bond University; University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Central Queensland University; Charles Sturt University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of Tasmania; University of London; King's College London	Coffey, VG (corresponding author), Bond Univ, Fac Hlth Sci & Med, Robina, Australia.	vcoffey@bond.edu.au	Doering, Thomas/GXZ-8161-2022; Ashton, Kevin/R-2147-2016	Ashton, Kevin/0000-0001-6106-3425; Thompson, Jamie-Lee/0000-0003-3015-0854; Doering, Thomas Michael/0000-0002-6427-1067	Collaborative Research Network for Advancing Exercise and Sport Science - Department of Education and Training, Australia [CRN-AESS -201202]; Institute of Biomedical Innovation Collaborative Research Development scheme by Queensland University of Technology, Australia; National Institutes of Health [P40ODO21331]	Collaborative Research Network for Advancing Exercise and Sport Science - Department of Education and Training, Australia; Institute of Biomedical Innovation Collaborative Research Development scheme by Queensland University of Technology, Australia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Collaborative Research Network for Advancing Exercise and Sport Science (CRN-AESS -201202) scheme awarded by the Department of Education and Training, Australia, and the Institute of Biomedical Innovation Collaborative Research Development scheme by Queensland University of Technology, Australia. The LRT-HRT rat model is funded by the Office of Infrastructure Programs grant P40ODO21331 (to L.G.K and S.L.B) from the National Institutes of Health. These rat models for low and high exercise response to training are maintained as an international resource with support from the Department of Physiology & Pharmacology, The University of Toledo College of Medicine, Toledo, OH. Contact L.G.K(Lauren.Koch2@UToledo.edu) or S.L.B (brittons@umich.edu) for information on the rat models. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Baehr LM, 2017, J APPL PHYSIOL, V122, P1336, DOI 10.1152/japplphysiol.00703.2016; Baehr LM, 2016, AGING-US, V8, P127, DOI 10.18632/aging.100879; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brocca L, 2012, J PHYSIOL-LONDON, V590, P5211, DOI 10.1113/jphysiol.2012.240267; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Camera DM, 2010, MED SCI SPORT EXER, V42, P1843, DOI 10.1249/MSS.0b013e3181d964e4; Chun Y, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120278; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Conesa A., MASIGPRO SIGNIFICANT; Edwards SJ, 2020, AM J CLIN NUTR, V112, P1368, DOI 10.1093/ajcn/nqaa229; Figueiredo VC, 2021, J CACHEXIA SARCOPENI, V12, P130, DOI 10.1002/jcsm.12636; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Howard EE, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00087; Kelleher AR, 2015, AM J PHYSIOL-ENDOC M, V308, pE122, DOI 10.1152/ajpendo.00341.2014; Koch LG, 2013, PHYSIOL GENOMICS, V45, P606, DOI 10.1152/physiolgenomics.00021.2013; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; Kucera Mike, 2016, F1000Res, V5, P1717; Kuo IY, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006023; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lawrence MM, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13460; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lessard SJ, 2013, DIABETES, V62, P2717, DOI 10.2337/db13-0062; Li JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00585; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Neubauer O, 2014, J APPL PHYSIOL, V116, P274, DOI 10.1152/japplphysiol.00909.2013; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Phillips SM, 2014, J PHYSIOL-LONDON, V592, P5341, DOI 10.1113/jphysiol.2014.273615; Reid MB, 2014, J PHYSIOL-LONDON, V592, P5345, DOI 10.1113/jphysiol.2014.279406; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rudrappa SS, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00361; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2017, FEBS J, V284, P517, DOI 10.1111/febs.13827; Stokes T, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107980; Taillandier D, 2019, BIOCHIMIE, V166, P251, DOI 10.1016/j.biochi.2019.07.014; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; Vellers HL, 2018, MAMM GENOME, V29, P48, DOI 10.1007/s00335-017-9732-5; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; West DWD, 2021, EXP PHYSIOL, V106, P714, DOI 10.1113/EP089301; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	46	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261723	10.1371/journal.pone.0261723	http://dx.doi.org/10.1371/journal.pone.0261723			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025912	Green Accepted, gold, Green Published			2022-12-26	WOS:000796264200024
J	Xu, JH; Strasburg, GM; Reed, KM; Velleman, SG				Xu, Jiahui; Strasburg, Gale M.; Reed, Kent M.; Velleman, Sandra G.			Thermal stress affects proliferation and differentiation of turkey satellite cells through the mTOR/S6K pathway in a growth-dependent manner	PLOS ONE			English	Article							SKELETAL-MUSCLE HYPERTROPHY; FACTOR-I IGF-1; BREAST MUSCLE; MYOBLAST DIFFERENTIATION; BINDING PARTNER; GENE-EXPRESSION; SELF-RENEWAL; RAG GTPASES; HETEROGENEITY; RAPAMYCIN	Satellite cells (SCs) are stem cells responsible for post-hatch muscle growth through hypertrophy and in birds are sensitive to thermal stress during the first week after hatch. The mechanistic target of rapamycin (mTOR) signaling pathway, which is highly responsive to thermal stress in differentiating turkey pectoralis major (p. major) muscle SCs, regulates protein synthesis and the activities of SCs through a downstream effector, S6 kinase (S6K). The objectives of this study were: 1) to determine the effect of heat (43 degrees C) and cold (33 degrees C) stress on activity of the mTOR/S6K pathway in SCs isolated from the p. major muscle of one-week-old faster-growing modern commercial (NC) turkeys compared to those from slower-growing Randombred Control Line 2 (RBC2) turkeys, and 2) to assess the effect of mTOR knockdown on the proliferation, differentiation, and expression of myogenic regulatory factors of the SCs. Heat stress increased phosphorylation of both mTOR and S6K in both turkey lines, with greater increases observed in the RBC2 line. With cold stress, greater reductions in mTOR and S6K phosphorylation were observed in the NC line. Early knockdown of mTOR decreased proliferation, differentiation, and expression of myoblast determination protein 1 and myogenin in both lines independent of temperature, with the RBC2 line showing greater reductions in proliferation and differentiation than the NC line at 38 degrees and 43 degrees C. Proliferating SCs are more dependent on mTOR/S6K-mediated regulation than differentiating SCs. Thus, thermal stress can affect breast muscle hypertrophic potential by changing satellite cell proliferation and differentiation, in part, through the mTOR/S6K pathway in a growth-dependent manner. These changes may result in irreversible effects on the development and growth of the turkey p. major muscle.	[Xu, Jiahui; Velleman, Sandra G.] Ohio State Univ, Dept Anim Sci, Wooster, OH 43210 USA; [Strasburg, Gale M.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Reed, Kent M.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University System of Ohio; Ohio State University; Michigan State University; University of Minnesota System; University of Minnesota Twin Cities	Velleman, SG (corresponding author), Ohio State Univ, Dept Anim Sci, Wooster, OH 43210 USA.	velleman.1@osu.edu		Strasburg, Gale/0000-0002-3897-4340; Xu, Jiahui/0000-0003-2780-9267	Agriculture and Food Research Initiative from the United States Department of Agriculture [2020-67015-30827]	Agriculture and Food Research Initiative from the United States Department of Agriculture	This study was supported by the Agriculture and Food Research Initiative Competitive Grant No. 2020-67015-30827 from the United States Department of Agriculture to GMS, KMR, and SGV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153750; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNETTI A, 1990, J BIOL CHEM, V265, P5960; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; CARDASIS CA, 1975, J EXP ZOOL, V191, P347, DOI 10.1002/jez.1401910305; Clark DL, 2016, POULTRY SCI, V95, P934, DOI 10.3382/ps/pev437; Clark DL, 2018, COMP BIOCHEM PHYS A, V219, P58, DOI 10.1016/j.cbpa.2018.02.014; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Davis RVN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122525; Dransfield E, 1999, POULTRY SCI, V78, P743, DOI 10.1093/ps/78.5.743; DUNNINGTON EA, 1984, POULTRY SCI, V63, P1303, DOI 10.3382/ps.0631303; FELDMAN JL, 1991, DEV BIOL, V143, P320, DOI 10.1016/0012-1606(91)90083-F; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Goodman CA, 2014, REV PHYSIOL BIOCH P, V166, P43, DOI 10.1007/112_2013_17; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hadad Y, 2014, POULTRY SCI, V93, P1076, DOI 10.3382/ps.2013-03592; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Halevy O, 2001, AM J PHYSIOL-REG I, V281, pR302, DOI 10.1152/ajpregu.2001.281.1.R302; Halevy O, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00235; Han B, 2008, MOL REPROD DEV, V75, P810, DOI 10.1002/mrd.20832; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harding RL, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12770; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Havenstein GB, 2003, POULTRY SCI, V82, P1509, DOI 10.1093/ps/82.10.1509; He C, 2016, GEN COMP ENDOCR, V236, P24, DOI 10.1016/j.ygcen.2016.04.019; Hoving-Bolink AH, 2000, MEAT SCI, V56, P397, DOI 10.1016/S0309-1740(00)00071-1; Jin CL, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121549; Joiner KS, 2014, AVIAN DIS, V58, P377, DOI 10.1637/10733-112513-Reg.1; Khodabukus A, 2015, J CELL PHYSIOL, V230, P1750, DOI 10.1002/jcp.24848; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Konarzewski M, 2000, PHYSIOL BIOCHEM ZOOL, V73, P237, DOI 10.1086/316729; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; KORNOTH T, 1994, ANAT HISTOL EMBRYOL, V23, P21, DOI 10.1111/j.1439-0264.1994.tb00238.x; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagord C, 1998, CELL TISSUE RES, V291, P455, DOI 10.1007/s004410051015; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Liu C, 2006, POULTRY SCI, V85, P422, DOI 10.1093/ps/85.3.422; Ma BB, 2018, POULTRY SCI, V97, P4150, DOI 10.3382/ps/pey291; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McFarland Douglas C., 1995, Cytobios, V82, P229; MODREY P, 1992, J THERM BIOL, V17, P287, DOI 10.1016/0306-4565(92)90035-E; Moschella PC, 2013, CELL SIGNAL, V25, P1904, DOI 10.1016/j.cellsig.2013.05.001; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; MOZDZIAK PE, 1994, POULTRY SCI, V73, P547, DOI 10.3382/ps.0730547; Nader GA, 2005, AM J PHYSIOL-CELL PH, V289, pC1457, DOI 10.1152/ajpcell.00165.2005; NESTOR KE, 1969, POULTRY SCI, V48, P1944, DOI 10.3382/ps.0481944; NICOL CJ, 1990, APPL ANIM BEHAV SCI, V28, P57, DOI 10.1016/0168-1591(90)90046-G; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.017; Patael T, 2019, POULTRY SCI, V98, P3268, DOI 10.3382/ps/pez123; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Nguyen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142319; Piestun Y, 2017, POULTRY SCI, V96, P2877, DOI 10.3382/ps/pex065; Reed KM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00948; Reed KM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3740-4; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schiaffino Stefano, 2011, Skelet Muscle, V1, P4, DOI 10.1186/2044-5040-1-4; SCHULTZ E, 1974, ANAT RECORD, V180, P589, DOI 10.1002/ar.1091800405; Shinder D, 2007, POULTRY SCI, V86, P2200, DOI 10.1093/ps/86.10.2200; SMITH DP, 1988, POULTRY SCI, V67, P908, DOI 10.3382/ps.0670908; SMITH JH, 1963, POULTRY SCI, V42, P283, DOI 10.3382/ps.0420283; Sun KJ, 2016, J NUTR, V146, P2461, DOI 10.3945/jn.116.231266; Tierney MT, 2016, TRENDS CELL BIOL, V26, P434, DOI 10.1016/j.tcb.2016.02.004; Velleman SG, 2003, POULTRY SCI, V82, P1069, DOI 10.1093/ps/82.7.1069; Velleman SG, 2000, COMP BIOCHEM PHYS A, V125, P503, DOI 10.1016/S1095-6433(00)00178-1; Vignale K, 2015, J NUTR, V145, P855, DOI 10.3945/jn.114.207936; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; WILSON BW, 1990, POULTRY SCI, V69, P1553, DOI 10.3382/ps.0691553; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; WISKUS KJ, 1976, POULTRY SCI, V55, P562, DOI 10.3382/ps.0550562; Xu JH, 2021, COMP BIOCHEM PHYS A, V252, DOI 10.1016/j.cbpa.2020.110823; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yahav S, 2000, AVIAN POULT BIOL REV, V11, P81; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Yoshihara T, 2013, ACTA PHYSIOL, V207, P416, DOI 10.1111/apha.12040; You JS, 2019, FASEB J, V33, P4021, DOI 10.1096/fj.201801653RR; Yu ML, 2015, CELL BIOL INT, V39, P910, DOI 10.1002/cbin.10466; Yun Y, 1997, COMP BIOCHEM PHYS A, V117, P463, DOI 10.1016/S0300-9629(96)00404-5; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhang PP, 2015, BIOCHEM BIOPH RES CO, V463, P102, DOI 10.1016/j.bbrc.2015.05.032; Zhang RP, 2014, POULTRY SCI, V93, P3104, DOI 10.3382/ps.2014-04145; Zhang XF, 2008, MATRIX BIOL, V27, P619, DOI 10.1016/j.matbio.2008.06.002; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	96	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262576	10.1371/journal.pone.0262576	http://dx.doi.org/10.1371/journal.pone.0262576			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025965	Green Published, gold			2022-12-26	WOS:000796264200088
J	Turban, JL; King, D; Kobe, J; Reisner, SL; Keuroghlian, AS				Turban, Jack L.; King, Dana; Kobe, Julia; Reisner, Sari L.; Keuroghlian, Alex S.			Access to gender-affirming hormones during adolescence and mental health outcomes among transgender adults	PLOS ONE			English	Article							MINORITY STRESS; SUBSTANCE USE; VICTIMIZATION; POPULATIONS; YOUTH; CARE	Objective To examine associations between recalled access to gender-affirming hormones (GAH) during adolescence and mental health outcomes among transgender adults in the U.S. Methods We conducted a secondary analysis of the 2015 U.S. Transgender Survey, a cross-sectional non-probability sample of 27,715 transgender adults in the U.S. Using multivariable logistic regression adjusting for potential confounders, we examined associations between access to GAH during early adolescence (age 14-15), late adolescence (age 16-17), or adulthood (age >= 18) and adult mental health outcomes, with participants who desired but never accessed GAH as the reference group. Results 21,598 participants (77.9%) reported ever desiring GAH. Of these, 8,860 (41.0%) never accessed GAH, 119 (0.6%) accessed GAH in early adolescence, 362 (1.7%) accessed GAH in late adolescence, and 12,257 (56.8%) accessed GAH in adulthood. After adjusting for potential confounders, accessing GAH during early adolescence (aOR = 0.4, 95% CI = 0.2-0.6, p < .0001), late adolescence (aOR = 0.5, 95% CI = 0.4-0.7, p < .0001), or adulthood (aOR = 0.8, 95% CI = 0.7-0.8, p < .0001) was associated with lower odds of past-year suicidal ideation when compared to desiring but never accessing GAH. In post hoc analyses, access to GAH during adolescence (ages 14-17) was associated with lower odds of past-year suicidal ideation (aOR = 0.7, 95% CI = 0.6-0.9, p = .0007) when compared to accessing GAH during adulthood. Conclusion Access to GAH during adolescence and adulthood is associated with favorable mental health outcomes compared to desiring but not accessing GAH.	[Turban, Jack L.] Stanford Univ, Sch Med, Div Child & Adolescent Psychiat, Stanford, CA 94305 USA; [King, Dana; Kobe, Julia; Reisner, Sari L.; Keuroghlian, Alex S.] Fenway Inst, Boston, MA USA; [Reisner, Sari L.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 75 Francis St, Boston, MA 02115 USA; [Reisner, Sari L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Reisner, Sari L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Keuroghlian, Alex S.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Keuroghlian, Alex S.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Turban, JL (corresponding author), Stanford Univ, Sch Med, Div Child & Adolescent Psychiat, Stanford, CA 94305 USA.	jturban@stanford.edu		Keuroghlian, Alex/0000-0002-6624-8354	Arbor; Pfizer; National Institute of Mental Health [MH094612]; Sorensen Foundation; Health Resources and Services Administration Bureau of Primary Health Care [U30CS22742]	Arbor; Pfizer(Pfizer); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sorensen Foundation; Health Resources and Services Administration Bureau of Primary Health Care	JLT received a pilot research award for general psychiatry residents from The American Academy of Child & Adolescent Psychiatry, supported by Industry Sponsors (Arbor and Pfizer), an award from the National Institute of Mental Health (MH094612), and a fellowship from The Sorensen Foundation. ASK received a grant from Health Resources and Services Administration Bureau of Primary Health Care (U30CS22742). The sponsors of this research did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AACAP:https://www.aacap.org/AACAP/Press/Press_Releases/2019/Jack_Turban_Receives_AACAP_Pilot_ Research_Award_for_General_Psychiatry_ Residents_Supported_b.aspx#:~:text=Washington %2C%20DC%2C%20September%2030% 2C,2019%20Pilot%20Research%20Award%20for NIMH: nimh.nih.gov Sorensen Foundation: https://sorensenfellowship.org/Health Resources and Services Administration Bureau of Primary Health Care: https://bphc.hrsa.gov/	Achille C, 2020, INT J PEDIATR ENDOCR, V2020, DOI 10.1186/s13633-020-00078-2; Allen LR, 2019, CLIN PRACT PEDIAT PS, V7, P302, DOI 10.1037/cpp0000288; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; de Vries ALC, 2014, PEDIATRICS, V134, P696, DOI 10.1542/peds.2013-2958; Gilbert PA, 2018, DRUG ALCOHOL DEPEN, V186, P138, DOI 10.1016/j.drugalcdep.2018.01.016; Gill-Peterson J., 2018, HIST TRANSGENDER CHI; Hatchel T, 2019, J CHILD FAM STUD, V28, P2467, DOI 10.1007/s10826-018-1168-3; Hembree W. C., 2017, J CLIN ENDOCRINOL; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Hughes LD, 2022, ANN BEHAV MED, V56, P592, DOI 10.1093/abm/kaab063; James S. E., 2016, REPORT US TRANSGENDE; Johns MM, 2019, MMWR-MORBID MORTAL W, V68, P67, DOI 10.15585/mmwr.mm6803a3; Kaltiala R, 2020, NORD J PSYCHIAT, V74, P213, DOI 10.1080/08039488.2019.1691260; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Keuroghlian AS, 2015, DRUG ALCOHOL DEPEN, V152, P139, DOI 10.1016/j.drugalcdep.2015.04.008; Kidd KM, 2021, J ADOLESCENT HEALTH, V68, P1082, DOI 10.1016/j.jadohealth.2020.09.010; Klein A, 2016, LGBT HEALTH, V3, P193, DOI 10.1089/lgbt.2015.0111; Kuper LE, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-3006; de Lara DL, 2020, AN PEDIATR, V93, P41, DOI 10.1016/j.anpedi.2020.01.019; Mehringer JE, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-013300; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Olson-Kennedy J, 2018, JAMA PEDIATR, V172, P431, DOI 10.1001/jamapediatrics.2017.5440; Reisner SL, 2016, LANCET, V388, P412, DOI 10.1016/S0140-6736(16)00684-X; Turban JL, 2021, J ADOLESCENT HEALTH, V69, P991, DOI 10.1016/j.jadohealth.2021.06.001; Turban JL, 2021, JAMA-J AM MED ASSOC, V325, P2251, DOI 10.1001/jama.2021.7764; Turban JL, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-1725; Turban JL, 2020, JAMA PSYCHIAT, V77, P68, DOI 10.1001/jamapsychiatry.2019.2285; Turban JL, 2019, AM J PUBLIC HEALTH, V109, P1452, DOI 10.2105/AJPH.2019.305237; Turban JL, 2018, J CHILD PSYCHOL PSYC, V59, P1228, DOI 10.1111/jcpp.12833; Wiepjes CM, 2018, J SEX MED, V15, P582, DOI 10.1016/j.jsxm.2018.01.016	33	12	12	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261039	10.1371/journal.pone.0261039	http://dx.doi.org/10.1371/journal.pone.0261039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020719	gold, Green Published			2022-12-26	WOS:000834207700010
J	Byun, JY; Huang, K; Lee, JS; Huang, WJ; Hu, L; Zheng, XY; Tang, X; Li, FZ; Jo, DG; Song, XM; Huang, C				Byun, Joo-Yun; Huang, Kun; Lee, Jong Suk; Huang, Wenjie; Hu, Li; Zheng, Xuyu; Tang, Xin; Li, Fengzeng; Jo, Dong-Gyu; Song, Xinmao; Huang, Chuang			Targeting HIF-1 alpha/NOTCH1 pathway eliminates CD44(+) cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma	ONCOGENE			English	Article							HYPOXIA-INDUCIBLE FACTORS; EPITHELIAL-MESENCHYMAL TRANSITION; FACTOR 1-ALPHA; CHEMOTHERAPY RESISTANCE; BREAST-CANCER; EXPRESSION; PROGNOSIS; GROWTH; NOTCH; TH-302	Poor prognosis of head and neck squamous cell carcinomas (HNSCCs) results from resistance to chemotherapy and radiotherapy. To uncover the drivers of HNSCC resistance, including stemness and hypoxia, in this study, we compared the gene expression between CD44(+) and CD44(-) HNSCC cells and assessed the correlation of CD44 and hypoxia-inducible factor 1 alpha (HIF-1 alpha) expression with mouse features and outcomes of patients with HNSCC. We combined the knockdown or activation of HIF-1 alpha with in vitro and in vivo assays to evaluate effects on stemness and resistance of HNSCC cells. Analysis of clinical data showed that activation of HIF-1 alpha in CD44(+) patients with HNSCC was correlated with worse prognosis. Functional assays showed that HIF-1 alpha promoted stemness, resistance, and epithelial-mesenchymal transition in HNSCC CD44(+) cells. HIF-1 alpha activated NOTCH1 signaling in HNSCC stem-like cells characterized by CD44 expression. Moreover, inhibition of these signaling proteins using shRNA or Evofosfamide (Evo) development for cancer treatment, reversed chemoresistance in vitro and in vivo. Taken together, our results indicated that targeting HIF-1 alpha attenuated NOTCH1-induced stemness, which regulates responses to chemotherapy or radiotherapy and malignancy in CD44(+) HNSCCs. HIF-1 alpha/NOTCH1 signaling may represent a target for HNSCC treatment.	[Byun, Joo-Yun; Lee, Jong Suk; Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, Suwon 16419, South Korea; [Huang, Kun; Hu, Li; Zheng, Xuyu; Tang, Xin; Li, Fengzeng] Chongqing Med Univ, Dept Dermatol, Affiliated Hosp 1, Chongqing, Peoples R China; [Huang, Wenjie] Chongqing Med Univ, Key Lab Diagnost Med, Minist Educ, Chongqing, Peoples R China; [Song, Xinmao] Fudan Univ, Dept Radiat Oncol, Eye Ear Nose & Throat Hosp, Shanghai, Peoples R China; [Huang, Chuang] Chongqing Univ, Canc Hosp, Chongqing Key Lab Translat Res Canc Metastasis &, Chongqing, Peoples R China; [Huang, Chuang] Chongqing Canc Inst, Chongqing, Peoples R China; [Huang, Chuang] Chongqing Canc Hosp, Chongqing, Peoples R China	Sungkyunkwan University (SKKU); Chongqing Medical University; Chongqing Medical University; Fudan University; Chongqing University	Jo, DG (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon 16419, South Korea.; Song, XM (corresponding author), Fudan Univ, Dept Radiat Oncol, Eye Ear Nose & Throat Hosp, Shanghai, Peoples R China.; Huang, C (corresponding author), Chongqing Univ, Canc Hosp, Chongqing Key Lab Translat Res Canc Metastasis &, Chongqing, Peoples R China.; Huang, C (corresponding author), Chongqing Canc Inst, Chongqing, Peoples R China.; Huang, C (corresponding author), Chongqing Canc Hosp, Chongqing, Peoples R China.	jodg@skku.edu; muqinger@sina.com; huangchuang@126.com	Jo, Dong-Gyu/AAN-9278-2021; Song, Xinmao/AAP-9859-2021	Jo, Dong-Gyu/0000-0003-2271-1076; Song, Xinmao/0000-0002-4265-1851	MSKCC Senior Research Scientist Changhwan Yoon; National Natural Science Foundation grants of China [81972942]; Chongqing Science and Health Joint Medical Research Project [2020FYYX017]; Chongqing Innovative Support Program for Returned Overseas Chinese Scholars [cx2020103]; Natural Science Foundation grants of Chongqing [cstc2021jcyj-msxmX0009]; High-level Medical Reserved Personnel Training Project of Chongqing	MSKCC Senior Research Scientist Changhwan Yoon; National Natural Science Foundation grants of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Health Joint Medical Research Project; Chongqing Innovative Support Program for Returned Overseas Chinese Scholars; Natural Science Foundation grants of Chongqing; High-level Medical Reserved Personnel Training Project of Chongqing	We thank MSKCC Senior Research Scientist Changhwan Yoon for supporting Data and reviewing this manuscript. This study was supported by the National Natural Science Foundation grants of China (grant no. 81972942), the Chongqing Science and Health Joint Medical Research Project (grant no. 2020FYYX017), Chongqing Innovative Support Program for Returned Overseas Chinese Scholars (grant no. cx2020103), and the Natural Science Foundation grants of Chongqing (grant no. cstc2021jcyj-msxmX0009), and High-level Medical Reserved Personnel Training Project of Chongqing.	Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003; Aebersold DM, 2001, CANCER RES, V61, P2911; Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Arumugam TV, 2018, PROG NEUROBIOL, V165, P103, DOI 10.1016/j.pneurobio.2018.03.002; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Birner P, 2000, CANCER RES, V60, P4693; Birner P, 2001, CLIN CANCER RES, V7, P1661; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Cheng YL, 2015, PHARMACOL THERAPEUT, V147, P80, DOI 10.1016/j.pharmthera.2014.11.005; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Crowder Spencer W, 2014, Curr Pathobiol Rep, V2, P33; Duan JX, 2008, J MED CHEM, V51, P2412, DOI 10.1021/jm701028q; Fabbro D, 2020, CHIMIA, V74, P779, DOI 10.2533/chimia.2020.779; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Favier J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-139; Foster JG, 2014, FUTURE ONCOL, V10, P2659, DOI 10.2217/fon.14.201; Gammon L, 2016, J ORAL PATHOL MED, V45, P77, DOI 10.1111/jop.12327; Gao T, 2016, BIOMED PHARMACOTHER, V80, P393, DOI 10.1016/j.biopha.2016.02.044; Ghattass K, 2013, CURR CANCER DRUG TAR, V13, P670, DOI 10.2174/15680096113139990004; Guo M, 2006, APOPTOSIS, V11, P67, DOI 10.1007/s10495-005-3085-3; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Huang C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2448-6; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim NS, 2011, PATHOL ONCOL RES, V17, P493, DOI 10.1007/s12253-010-9327-x; Koukourakis MI, 2002, INT J RADIAT ONCOL, V53, P1192, DOI 10.1016/S0360-3016(02)02848-1; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee KE, 2012, CURR OPIN CELL BIOL, V24, P232, DOI 10.1016/j.ceb.2012.01.005; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Putra AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134496; Rawluszko-Wieczorek AA, 2014, MOL CANCER RES, V12, P1112, DOI 10.1158/1541-7786.MCR-14-0054; Rocco A, 2012, WORLD J GASTRO ONCOL, V4, P54, DOI 10.4251/wjgo.v4.i3.54; Saggar JK, 2014, INT J CANCER, V134, P2726, DOI 10.1002/ijc.28595; Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Sena JA, 2014, MOL CANCER RES, V12, P1233, DOI 10.1158/1541-7786.MCR-14-0149; Sindhu SK, 2019, ORAL MAXIL SURG CLIN, V31, P145, DOI 10.1016/j.coms.2018.09.003; Sivridis E, 2002, CANCER-AM CANCER SOC, V95, P1055, DOI 10.1002/cncr.10774; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun JD, 2012, CLIN CANCER RES, V18, P758, DOI 10.1158/1078-0432.CCR-11-1980; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Welander J, 2014, ENDOCR-RELAT CANCER, V21, P495, DOI 10.1530/ERC-13-0384; Yang CF, 2014, CANCER LETT, V344, P260, DOI 10.1016/j.canlet.2013.11.006; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yoon C, 2015, BRIT J CANCER, V113, P46, DOI 10.1038/bjc.2015.186; Yoon C, 2016, CLIN CANCER RES, V22, P971, DOI 10.1158/1078-0432.CCR-15-1356; Zhong H, 1999, CANCER RES, V59, P5830	55	4	5	3	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1352	1363		10.1038/s41388-021-02166-w	http://dx.doi.org/10.1038/s41388-021-02166-w		JAN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	35013621				2022-12-26	WOS:000741571100001
J	Jiangid, XF; Qin, JX; Gao, JG; Gossage, MG				Jiangid, Xiufang; Qin, Jianxiong; Gao, Jianguo; Gossage, Mollie G.			The mediation of perceived risk's impact on destination image and travel intention: An empirical study of Chengdu, China during COVID-19	PLOS ONE			English	Article							BEHAVIORAL INTENTION; TOURISM; PERCEPTIONS; RESIDENTS	Perceived risk clearly impacts travel behavior, including destination selection and satisfaction, but it is unclear how or why its effect is only significant in certain cases. This is because existing studies have undervalued the mediating factors of risk aversion, government initiatives, and media influence as well as the multiple forms or dimensions of risk that can mask its direct effect. This study constructs a structural equation model of perceived risk's impact on destination image and travel intention for a more nuanced model of the perceived risk mechanism in tourism, based on 413 e-questionnaires regarding travel to Chengdu, China during the COVID-19 pandemic, using the Bootstrap method to analyze suppressing effect. It finds that while perceived risk has a significant negative impact on destination image and travel intention, this is complexly mediated so as to appear insignificant. Furthermore, different mediating factors and dimensions of perceived risk operate differently according to their varied combinations in actual circumstances. This study is significant because it provides a theoretical interpretation of tourism risk, elucidates the mechanisms or paths by which perceived risk affects travel intention, and expands a framework for research on destination image and travel intention into the realms of psychology, political, and communication science. It additionally encourages people to pay greater attention to the negative impact of crises and focuses on the important role of internal and external responses in crisis management, which can help improve the effectiveness of crisis management and promote the sustainable development of the tourism industry.	[Jiangid, Xiufang] Southwest Minzu Univ, Coll Econ, Chengdu, Peoples R China; [Qin, Jianxiong] Southwest Minzu Univ, Coll Hist Culture & Tourism, Chengdu, Peoples R China; [Gao, Jianguo] Chengdu Univ Technol, Coll Earth Sci, Chengdu, Peoples R China; [Gossage, Mollie G.] Univ Wisconsin Madison, Dept Anthropol, Madison, WI USA	Southwest Minzu University; Southwest Minzu University; Chengdu University of Technology; University of Wisconsin System; University of Wisconsin Madison	Jiangid, XF (corresponding author), Southwest Minzu Univ, Coll Econ, Chengdu, Peoples R China.; Qin, JX (corresponding author), Southwest Minzu Univ, Coll Hist Culture & Tourism, Chengdu, Peoples R China.	15203656667@163.com; jx-qin@vip.163.com		Jiang, xiufang/0000-0002-8280-8606	Research project of the Key Research Base of Humanities and Social Sciences in Universities of Sichuan Province [GJGY2019-ZD002]; Innovative research project of Southwest Minzu University [CX2020BS20]	Research project of the Key Research Base of Humanities and Social Sciences in Universities of Sichuan Province; Innovative research project of Southwest Minzu University	This research was funded by Research project of the Key Research Base of Humanities and Social Sciences in Universities of Sichuan Province, grant number GJGY2019-ZD002(Q received the award); and was supported by "the Innovative research project of Southwest Minzu University", grant number CX2020BS20(J received the award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], QUESTIONNAIRE STAR; Bai K., 2009, TOURISM SCI, V23, P9, DOI [10.16323/j.cnki.lykx.2009.02.004, DOI 10.16323/J.CNKI.LYKX.2009.02.004]; Baloglu S., 1999, Journal of Travel Research, V38, P144, DOI 10.1177/004728759903800207; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauer R.A., 1960, P 43 NATL C AM MARK, P389, DOI DOI 10.4018/978-1-4666-7357-1.CH101; Bhatnagar Amit, CHEMOSPHERE, V157, P277, DOI [10.1016/j.cej.2010.01.007, DOI 10.1016/J.CHEMOSPHERE.2003.10.039, 10.1016/j.neubiorev.2012.11.002, DOI 10.1016/J.NEUBIOREV.2012.11.002]; Boksberger PE, 2007, J AIR TRANSP MANAG, V13, P90, DOI 10.1016/j.jairtraman.2006.10.003; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Cai LPA, 2002, ANN TOURISM RES, V29, P720, DOI 10.1016/S0160-7383(01)00080-9; Carr N, 2001, TOURISM MANAGE, V22, P565, DOI 10.1016/S0261-5177(01)00014-0; Cevik S, 2022, OPEN ECON REV, V33, P141, DOI 10.1007/s11079-021-09619-5; Chai SS, 2011, J OCEAN U CHINA SOCI, P55; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chew EYT, 2014, TOURISM MANAGE, V40, P382, DOI 10.1016/j.tourman.2013.07.008; Chi CGQ, 2008, TOURISM MANAGE, V29, P624, DOI 10.1016/j.tourman.2007.06.007; Cohen E, 2012, ANN TOURISM RES, V39, P2177, DOI 10.1016/j.annals.2012.07.009; Cui XJ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11010210; Edgell D., 2013, TOURISM POLICY PLANN, V2nd; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; Enright M. J., 2005, Journal of Travel Research, V43, P339, DOI 10.1177/0047287505274647; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Fang Z, 2007, REFORM EC SYSTEM, P173; FISCHER GW, 1991, RISK ANAL, V11, P303, DOI 10.1111/j.1539-6924.1991.tb00606.x; Fu H, 2016, TOURISM MANAGE, V55, P37, DOI 10.1016/j.tourman.2016.01.009; Fuchs G, 2011, TOURISM MANAGE, V32, P266, DOI 10.1016/j.tourman.2010.01.012; Gartner W. C., 1993, Journal of Travel & Tourism Marketing, V2, P191; Gibson H, 2002, ANN TOURISM RES, V29, P358, DOI 10.1016/S0160-7383(01)00037-8; Gunn CA, 1988, VACATIONSCAPE DESIGN; Hainan Provincial Bureau of Statistics, 2014, HAIN STAT YB; Hardeep Chahal, 2017, International Journal of Leisure and Tourism Marketing, V5, P100, DOI 10.1504/IJLTM.2017.084618; Heath R, 1998, SAFETY SCI, V30, P139, DOI 10.1016/S0925-7535(98)00042-3; Hsi-Tien Chen, 2012, Information Technology Journal, V11, P1357, DOI 10.3923/itj.2012.1357.1368; Huang YH, 2018, RESOURCE DEV MARKET, V34, P1327; Ivanov S, 2017, J POLICY RES TOUR LE, V9, P100, DOI 10.1080/19407963.2016.1209677; Jalilvand MR, 2012, J ISLAMIC MARK, V3, P175, DOI 10.1108/17590831211232573; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; Kapuscinski G, 2016, TOURISM MANAGE, V57, P234, DOI 10.1016/j.tourman.2016.06.017; Kenny DA, 2003, PSYCHOL METHODS, V8, P115, DOI 10.1037/1082-989X.8.2.115; Krajnak T, 2021, TOURISM ECON, V27, P1736, DOI 10.1177/1354816620938900; Laing JH, 2009, TOUR ANAL, V14, P187, DOI 10.3727/108354209789116547; Lee TH, 2018, J TRAVEL RES, V57, P792, DOI 10.1177/0047287517717350; Li S.R., 2021, P ENTER 2021 ET C CH, P490, DOI DOI 10.1007/978-3-030-65785-7_47; Li ZY, 2020, J DESTIN MARK MANAGE, V18, DOI 10.1016/j.jdmm.2020.100502; Liang XH, 2020, WORLD J CLIN CASES, V8, P2959, DOI 10.12998/wjcc.v8.i14.2959; Liu LL, 2013, JAFMS, V8, P23; Lo AS, 2011, J TRAVEL TOUR MARK, V28, P240, DOI 10.1080/10548408.2011.562851; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2009, CURR DIR PSYCHOL SCI, V18, P16, DOI 10.1111/j.1467-8721.2009.01598.x; Mercille J, 2005, ANN TOURISM RES, V32, P1039, DOI 10.1016/j.annals.2005.02.001; Merrilees B, 2013, J BUS RES, V66, P37, DOI 10.1016/j.jbusres.2011.07.021; Mohseni S, 2018, CURR ISSUES TOUR, V21, P616, DOI 10.1080/13683500.2016.1200539; Neuburger L, 2021, CURR ISSUES TOUR, V24, P1003, DOI 10.1080/13683500.2020.1803807; Noh J, 2013, CURR ISSUES TOUR, V16, P455, DOI 10.1080/13683500.2012.741576; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pan B, 2011, ANN TOURISM RES, V38, P132, DOI 10.1016/j.annals.2010.06.004; Parrey SH, 2019, INT J TOUR CITIES, V5, P90, DOI 10.1108/IJTC-02-2018-0019; Parrey Shakir Hussain, INT J TOUR CITIES, V5, P90, DOI [10.1108/IJTC-02-2018-0019, DOI 10.1108/IJTC-02-2018-0019]; Phillips W, 2017, AMBIVALENT INTERNET, DOI 10.1177/875697280603700102; Qi XueQing [Qi X. Q. C.], 2009, Journal of Sport Tourism, V14, P43, DOI 10.1080/14775080902847439; Rasoolimanesh SM, 2021, J DESTIN MARK MANAGE, V21, DOI 10.1016/j.jdmm.2021.100620; Rittichainuwat BN, 2009, TOURISM MANAGE, V30, P410, DOI 10.1016/j.tourman.2008.08.001; Roehl W. S., 1992, Journal of Travel Research, V30, P17, DOI 10.1177/004728759203000403; Rossello J, 2020, TOURISM MANAGE, V79, DOI 10.1016/j.tourman.2020.104080; Senbeto DL, 2020, CURR ISSUES TOUR, V23, P740, DOI 10.1080/13683500.2018.1546674; Sharma GD, 2021, TOUR MANAG PERSPECT, V37, DOI 10.1016/j.tmp.2020.100786; Sohn HK, 2016, J TRAVEL TOUR MARK, V33, P28, DOI 10.1080/10548408.2015.1024912; SPENCE HE, 1970, J MARKETING RES, V7, P364, DOI 10.2307/3150296; SPSSAU, FREQUENTLY ASKED QUE; Stepchenkova S, 2013, TOURISM MANAGE, V36, P590, DOI 10.1016/j.tourman.2012.08.006; Tavitiyaman P, 2021, J HOSP TOUR MANAG, V46, P476, DOI 10.1016/j.jhtm.2021.02.003; Tessitore T, 2014, TOURISM MANAGE, V42, P3, DOI 10.1016/j.tourman.2013.10.001; The National Congress of the People's Republic of China, 2007, EM RESP LAW PEOPL RE; U SC, 2020, TOUR MANAG PERSPECT, V33, DOI 10.1016/j.tmp.2019.100628; United Nations World Tourism Organization, 2021, WORST YEAR TOUR HIST; United Nations World Tourism Organization, 2003, BMC PLANT BIOL; Uriely N, 2006, ANN TOURISM RES, V33, P339, DOI 10.1016/j.annals.2005.10.009; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; WHHLY. SHANDONG. GOV. CN, 2018, SHANDONG STAT YB; Woosnam KM, 2015, TOURISM MANAGE, V46, P263, DOI 10.1016/j.tourman.2014.06.022; Wu M L, 2009, WENJUAN TONGJI FENXI; Xiang Z, 2010, TOURISM MANAGE, V31, P179, DOI 10.1016/j.tourman.2009.02.016; Zeng BX, 2014, TOUR MANAG PERSPECT, V10, P27, DOI 10.1016/j.tmp.2014.01.001; Zhang TF, 2006, MODERN COMMUNICATION, P12; Zhang Wen, 2005, Current Issues in Tourism, V8, P22, DOI 10.1080/13683500508668203; Zhao SR, 2010, CHINESE PUBLIC ADM, P119; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Zhu H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103514	87	2	2	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1							e0261851	10.1371/journal.pone.0261851	http://dx.doi.org/10.1371/journal.pone.0261851			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6E4LQ	34995317	Green Published, gold			2022-12-26	WOS:000883352700001
J	Li, H; Roy, M; Liang, L; Cao, WJ; Hu, B; Li, YA; Xiao, XJ; Wang, HQ; Ye, M; Sun, SM; Zhang, B; Liu, J				Li, Hui; Roy, Mridul; Liang, Long; Cao, Wenjie; Hu, Bin; Li, Yanan; Xiao, Xiaojuan; Wang, Haiqin; Ye, Mao; Sun, Shuming; Zhang, Bin; Liu, Jing			Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; APOPTOSIS; DISEASE; CELLS	Despite the establishment of novel therapeutic interventions, multiple myeloma (MM) remains invariably incurable due to development of drug resistance and subsequent relapse, which are attributed to activation of oncogenic pathways such as autophagy. Deubiquitinating enzymes (DUBs) are promising targets to overcome resistance to proteasome inhibitor-based treatment. Ubiquitin-specific protease-12 (USP12) is a DUB with a known prognostic value in several cancers. We found that USP12 protein levels were significantly higher in myeloma patient samples than in non-cancerous human samples. Depletion of USP12 suppressed cell growth and clonogenicity and inhibited autophagy. Mechanistic studies showed that USP12 interacted with, deubiquitylated and stabilized the critical autophagy mediator HMGB1 (high mobility group box-1) protein. Knockdown of USP12 decreased the level of HMGB1 and suppressed HMGB1-mediated autophagy in MM. Furthermore, basal autophagy activity associated with USP12/HMGB1 was elevated in bortezomib (BTZ)-resistant MM cell lines. USP12 depletion, concomitant with a reduced expression of HMGB1, suppressed autophagy and increased the sensitivity of resistant cells to BTZ. Collectively, our findings have identified an important role of the deubiquitylase USP12 in pro-survival autophagy and resultant BTZ resistance in MM by stabilizing HMGB1, suggesting that the USP12/HMGB1 axis might be pursued as a potential diagnostic and therapeutic target in human MM.	[Li, Hui; Roy, Mridul; Ye, Mao] Hunan Univ, Coll Biol, Coll Chem & Chem Engn,State Key Lab Chemo Biosens, Collaborat Innovat Ctr Chem & Mol Med,Mol Sci & B, Changsha 410082, Hunan, Peoples R China; [Li, Hui; Roy, Mridul; Hu, Bin; Li, Yanan; Xiao, Xiaojuan; Wang, Haiqin; Sun, Shuming; Liu, Jing] Cent South Univ, Ctr Med Genet, Sch Life Sci,Mol Biol Res Ctr, Hunan Prov Key Lab Basic & Appl Hematol, Changsha 410078, Peoples R China; [Li, Hui; Liang, Long] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha 410008, Hunan, Peoples R China; [Cao, Wenjie; Zhang, Bin] Cent South Univ, Xiangya Sch Med, Dept Histol & Embryol, Changsha 410013, Peoples R China	Hunan University; Central South University; Central South University; Central South University	Ye, M (corresponding author), Hunan Univ, Coll Biol, Coll Chem & Chem Engn,State Key Lab Chemo Biosens, Collaborat Innovat Ctr Chem & Mol Med,Mol Sci & B, Changsha 410082, Hunan, Peoples R China.; Sun, SM; Liu, J (corresponding author), Cent South Univ, Ctr Med Genet, Sch Life Sci,Mol Biol Res Ctr, Hunan Prov Key Lab Basic & Appl Hematol, Changsha 410078, Peoples R China.; Zhang, B (corresponding author), Cent South Univ, Xiangya Sch Med, Dept Histol & Embryol, Changsha 410013, Peoples R China.	goldleaf@hnu.edu.cn; sunshuming203@163.com; coolzhangbin22@163.com; jingliucsu@hotmail.com		Ye, Mao/0000-0002-4798-1825; Li, Hui/0000-0003-1086-0402; Cao, Wenjie/0000-0002-7877-4079	National Key Research and Development Program of China [2018YFA0107800]; National Natural Science Foundation of China [21890744, 81672760, 82003286, 81970195, 81920108004, 81772496, 82073099]; Natural Science Foundation of Hunan Province [2021JJ40054, 2019JJ40391]; China Postdoctoral Science Foundation [2020M672474, 2021T140195, 2018M630896]; Hunan Provincial Key Research and Development Plan [2018SK2128]; Changsha Municipal Natural Science Foundation [kq2014041, kq2014042, kq2001012]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hunan Provincial Key Research and Development Plan; Changsha Municipal Natural Science Foundation	This study was supported by grants from the National Key Research and Development Program of China (2018YFA0107800), the National Natural Science Foundation of China (Nos. 21890744, 81672760, 82003286, 81970195, 81920108004, 81772496 and 82073099), the Natural Science Foundation of Hunan Province (No. 2021JJ40054, 2019JJ40391), the China Postdoctoral Science Foundation (2020M672474, 2021T140195 and 2018M630896), the Hunan Provincial Key Research and Development Plan (2018SK2128), the Changsha Municipal Natural Science Foundation (kq2014041, kq2014042 and kq2001012).	Arnold J, 2016, CELL DEATH DIFFER, V23, P853, DOI 10.1038/cdd.2015.149; Aron R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05653-z; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Boutouja F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122541; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; D'Eliseo Donatella, 2017, Genes Cancer, V8, P426, DOI 10.18632/genesandcancer.131; Gao D, 2017, J CELL BIOCHEM, V118, P3341, DOI 10.1002/jcb.25987; Guo X, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0883-3; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hussain S, 2015, ONCOTARGET, V6, P40704, DOI 10.18632/oncotarget.5727; Inoue Y, 2013, THROMB RES, V132, P493, DOI 10.1016/j.thromres.2013.08.020; Jacomin AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143078; Jahan AS, 2016, P NATL ACAD SCI USA, V113, pE705, DOI 10.1073/pnas.1521763113; Jarauta V, 2016, CANCER LETT, V382, P1, DOI 10.1016/j.canlet.2016.08.019; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kumar SK, 2016, CLIN CANCER RES, V22, P5453, DOI 10.1158/1078-0432.CCR-16-0868; Liu J, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008215; Lu YC, 2018, CANCER SCI, V109, P2706, DOI 10.1111/cas.13711; Mah Li Yen, 2012, Cold Spring Harb Perspect Biol, V4, pa008821, DOI 10.1101/cshperspect.a008821; McClurg UL, 2018, ONCOGENE, V37, P4679, DOI 10.1038/s41388-018-0283-3; Milan E, 2016, J CLIN IMMUNOL, V36, pS18, DOI 10.1007/s10875-016-0254-9; Moretti J, 2012, J BIOL CHEM, V287, P29429, DOI 10.1074/jbc.M112.366807; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nayak TKS, 2017, BIOCHEM BIOPH RES CO, V483, P69, DOI 10.1016/j.bbrc.2017.01.004; Nomura S, 2018, J BLOOD MED, V9, P1, DOI 10.2147/JBM.S147743; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Pinto V, 2020, CANCERS, V12, DOI 10.3390/cancers12020407; Rajkumar SV, 2009, CURR PROB CANCER, V33, P7, DOI 10.1016/j.currproblcancer.2009.01.001; Roy M, 2016, THERANOSTICS, V6, P2209, DOI 10.7150/thno.15584; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Vogl DT, 2014, AUTOPHAGY, V10, P1380, DOI 10.4161/auto.29264; Xia JL, 2020, MOL ONCOL, V14, P763, DOI 10.1002/1878-0261.12641; Yuan SL, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00920-3; Zhang HM, 2018, ONCOL RES, V26, P421, DOI 10.3727/096504017X15049221237147; Zhang MJ, 2015, ONCOTARGET, V6, P8567, DOI 10.18632/oncotarget.3251; Zhang XD, 2014, MOL CELL BIOCHEM, V385, P265, DOI 10.1007/s11010-013-1835-z; Zhuang Y, 2017, LEUKEMIA RES, V59, P97, DOI 10.1016/j.leukres.2017.06.002	43	1	1	3	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2022	41	9					1298	1308		10.1038/s41388-021-02167-9	http://dx.doi.org/10.1038/s41388-021-02167-9		JAN 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZI1MQ	34997217				2022-12-26	WOS:000740148500001
J	Alghamdi, AG; El-Saeid, MH; Alzahrani, AJ; Ibrahim, HM				Alghamdi, Abdulaziz G.; El-Saeid, Mohamed H.; Alzahrani, Abdulhakim J.; Ibrahim, Hesham M.			Heavy metal pollution and associated health risk assessment of urban dust in Riyadh, Saudi Arabia	PLOS ONE			English	Article							ROAD DUST; MULTIVARIATE-ANALYSIS; TOXIC ELEMENTS; POULTRY MANURE; CONTAMINATION; CITY; ENRICHMENT; SEDIMENTS; ACCUMULATION; ADSORPTION	Depending on their particle size and concentration, heavy metals in urban dust pose a health hazard to humans. This study investigated the total concentration, health risk, integrated pollution load index (IPI), and enrichment factor (EF) of various heavy metals in urban dust at different locations in Riyadh City. Surface dust samples were collected from 50 different residential yards in the north, south, west, east, and central corners of the city and analyzed for cadmium (Cd), chromium (Cr), copper (Cu), manganese (Mn), nickel (Ni), lead (Pb), and zinc (Zn). With respect to concentrations heavy metals were in the following order Zn > Cu > Mn > Cr > Ni > Pb > Cd. The EF trends exposed repeated anthropogenic activities were responsible for Mn, Cr, and Ni, while Pb, Zn, and Cu appeared to come from Earth's crust. Since the heavy metal concentrations were lower than the threshold values, children and adults are exposed to lower health risk in investigated area. Also, there are no pollution of heavy metals in the dust with respect to IPI which is less than the critical limit (<1) with the exception of a sampling location in north side of the city with higher IPI showed unhealthy respiration conditions in particular areas. It was concluded that rapid industrialization and urbanization and their concentrations in dust may cause health problems in near future in north side as well as other sides of Riyadh City.	[Alghamdi, Abdulaziz G.; El-Saeid, Mohamed H.; Alzahrani, Abdulhakim J.; Ibrahim, Hesham M.] King Saud Univ, Coll Food & Agr Sci, Dept Soil Sci, Riyadh, Saudi Arabia; [Ibrahim, Hesham M.] Suez Canal Univ, Fac Agr, Dept Soils & Water, Ismailia, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Suez Canal University	Alghamdi, AG (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Soil Sci, Riyadh, Saudi Arabia.	agghamdi@ksu.edu.sa		Ibrahim, Hesham/0000-0002-0320-0943	Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia [RGP1440-050]	Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	This article was supported by Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia, research group no. RGP1440-050.	Adriano D.C., 2001, TRACE ELEMENTS TERRE, DOI 10.1007/978-0-387-21510-5; Aiman U, 2016, CHEMOSPHERE, V144, P2229, DOI 10.1016/j.chemosphere.2015.10.077; Al-Tayeb NT, 1993, P INDUSTERIAL AIR PO, P66; Alharbi BH, 2020, ENVIRON SCI POLLUT R, V27, P18475, DOI 10.1007/s11356-020-08362-7; Ali MU, 2017, CHEMOSPHERE, V181, P111, DOI 10.1016/j.chemosphere.2017.04.061; AlRajhi MA, 1996, ENVIRON INT, V22, P315, DOI 10.1016/0160-4120(96)00017-7; Batool S, 2020, ENVIRON RES, V181, DOI 10.1016/j.envres.2019.108955; Batool S, 2017, CHEM PHYS LETT, V689, P190, DOI 10.1016/j.cplett.2017.10.016; Castellanos D, 2014, POWDER TECHNOL, V254, P331, DOI 10.1016/j.powtec.2013.11.028; Chang CC, 2006, J TOXICOL ENV HEAL A, V69, P229, DOI 10.1080/15287390500227415; [陈丽旋 Chen Lixuan], 2005, [环境科学学报, Acta Scientiae Circumstantiae], V25, P409; Cheng VWS, 2018, JMIR MENT HEALTH, V5, DOI 10.2196/11068; Duong TTT, 2011, J ENVIRON MANAGE, V92, P554, DOI 10.1016/j.jenvman.2010.09.010; [方凤满 Fang Fengman], 2010, [地理研究, Geographical Research], V29, P1193; Forstner U, 1990, SEDIMENTS ENV GEOCHE, P311, DOI DOI 10.1007/978-3-642-75097-7_18; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Han Q, 2020, ECOTOX ENVIRON SAFE, V191, DOI 10.1016/j.ecoenv.2019.110157; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; Harikumar PS, 2009, INT J ENVIRON SCI TE, V6, P225; Hjortenkrans D, 2006, ENVIRON MONIT ASSESS, V117, P85, DOI 10.1007/s10661-006-7706-2; Ho HH, 2010, GEOL BELG, V13, P37; Idrees M, 2018, J MOL LIQ, V266, P373, DOI 10.1016/j.molliq.2018.06.049; Idrees M, 2016, SEP SCI TECHNOL, V51, P2307, DOI 10.1080/01496395.2016.1205093; Kamani H, 2015, B ENVIRON CONTAM TOX, V94, P382, DOI 10.1007/s00128-014-1453-9; Loska K, 2005, COMMUN SOIL SCI PLAN, V36, P1117, DOI 10.1081/CSS-200056880; MADANY IM, 1994, ENVIRON INT, V20, P483, DOI 10.1016/0160-4120(94)90197-X; Trujillo-Gonzalez JM, 2016, SCI TOTAL ENVIRON, V553, P636, DOI 10.1016/j.scitotenv.2016.02.101; Modaihsh AS, 2013, APCBEE PROC, V5, P50, DOI 10.1016/j.apcbee.2013.05.010; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; OSKARSSON A, 1995, ANALYST, V120, P765, DOI 10.1039/an9952000765; Rasmussen PE, 2001, SCI TOTAL ENVIRON, V267, P125, DOI 10.1016/S0048-9697(00)00775-0; Saw HY., 2013, CHEMECA CHALLENGING, V299; Shabbaj II, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010036; Shi GT, 2011, ATMOS ENVIRON, V45, P764, DOI 10.1016/j.atmosenv.2010.08.039; Soares HMVM, 1999, ENVIRON POLLUT, V105, P311, DOI 10.1016/S0269-7491(99)00048-2; Statistics Center of Iran, 2016, GEN POPULATION HOUSI; Sutherland RA, 2000, ARCH ENVIRON CON TOX, V38, P428, DOI 10.1007/s002449910057; USEPA, 2002, GUID DEV SOIL SCRE S; Van Pelt RS, 2007, ENVIRON MONIT ASSESS, V130, P3, DOI 10.1007/s10661-006-9446-8; WHO, 2000, WHO EUR SER; Wu QH, 2015, SCI TOTAL ENVIRON, V506, P217, DOI 10.1016/j.scitotenv.2014.10.121; Xing WQ, 2019, ECOTOX ENVIRON SAFE, V175, P192, DOI 10.1016/j.ecoenv.2019.03.062; Yang ZP, 2011, J GEOCHEM EXPLOR, V108, P27, DOI 10.1016/j.gexplo.2010.09.006; Zhao HJ, 2021, SCI TOTAL ENVIRON, V763, DOI 10.1016/j.scitotenv.2020.142979; Zheng N, 2010, SCI TOTAL ENVIRON, V408, P726, DOI 10.1016/j.scitotenv.2009.10.075	45	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261957	10.1371/journal.pone.0261957	http://dx.doi.org/10.1371/journal.pone.0261957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990460	gold, Green Published			2022-12-26	WOS:000815783800014
J	Imran, N; Naz, F; Sharif, MI; Liaqat, S; Riaz, M; Khawar, A; Azeem, MW				Imran, Nazish; Naz, Fauzia; Sharif, Muhammad Imran; Liaqat, Sumbul; Riaz, Musarrat; Khawar, Abida; Azeem, Muhammad Waqar			Multidimensional impacts of coronavirus pandemic in adolescents in Pakistan: A cross sectional research	PLOS ONE			English	Article							MENTAL-HEALTH; CHILDREN	Background COVID-19 has posed unique challenges for adolescents in different dimensions of their life including education, home and social life, mental and physical health. Whether the impact is positive or negative, its significance on the overall shaping of adolescents' lives cannot be overlooked. The aim of the present study was to explore impacts of the pandemic on the adolescents' everyday lives in Pakistan. Methods Following ethical approval, this cross-sectional study was conducted through September to December, 2020 via an online survey on 842 adolescents with the mean age of 17.14 +/- SD 1.48. Socio-demographic data and Epidemic Pandemic Impact Inventory-Adolescent Adaptation (EPII-A) was used to assess the multi-dimensional effects of the pandemic. Results Among the 842 participants, 84% were girls. Education emerged as the most negatively affected Pandemic domain (41.6-64.3%). Most of the adolescents (62.0-65.8%) had reported changes in responsibilities at home including increased time spent in helping family members. Besides, increase in workload of participants and their parents was prominent (41.8% & 47.6%). Social activities were mostly halted for approximately half (41-51%) of the participants. Increased screen time, decreased physical activity and sedentary lifestyle were reported by 52.7%, 46.3% and 40.7% respectively. 22.2-62.4% of the adolescents had a direct experience with quarantine, while 15.7% experienced death of a close friend or relative. Positive changes in their lives were endorsed by 30.5-62.4% respondents. Being male and older adolescents had significant association with negative impact across most domains (p<0.05). Conclusions Results have shown that COVID-19 exert significant multidimensional impacts on the physical, psycho-social, and home related domains of adolescents that are certainly more than what the previous researches has suggested.	[Imran, Nazish; Sharif, Muhammad Imran; Liaqat, Sumbul] King Edward Med Univ, Dept Child & Family Psychiat, Mayo Hosp, Lahore, Pakistan; [Naz, Fauzia] Govt Islamia Grad Coll, Lahore, Pakistan; [Riaz, Musarrat] Baqai Med Univ, Baqai Inst Diabetol & Endocrinol, Karachi, Pakistan; [Khawar, Abida] ZA Sch Syst, Lahore, Pakistan; [Azeem, Muhammad Waqar] Weill Cornell Med, Dept Psychiat, Sidra Med, Doha, Qatar	Baqai Medical University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Sidra Medical & Research Center	Imran, N (corresponding author), King Edward Med Univ, Dept Child & Family Psychiat, Mayo Hosp, Lahore, Pakistan.	nazishimrandr@gmail.com		Liaqat, Sumbul/0000-0001-7112-4471				Bates LC, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7090138; Bodla Z, 2020, ESCULAPIO, V16, P22; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cardenas MC, 2020, ACTA PAEDIATR, V109, P2187, DOI 10.1111/apa.15536; de Miranda DM, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101845; Duan L, 2020, J AFFECT DISORDERS, V275, P112, DOI 10.1016/j.jad.2020.06.029; Ellis WE, 2020, CAN J BEHAV SCI, V52, P177, DOI 10.1037/cbs0000215; Fegert JM, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00329-3; Glabska D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092640; Golberstein E, 2019, HEALTH ECON, V28, P955, DOI 10.1002/hec.3885; Grasso DJ., 2020, EPIDEMIC PANDEMIC IM; Imran N, 2020, PAK J MED SCI, V36, P1106, DOI 10.12669/pjms.36.5.3088; Imran N, 2020, PAK J MED SCI, V36, pS67, DOI 10.12669/pjms.36.COVID19-S4.2759; Khan KS, 2022, INT J MENT HEALTH AD, V20, P380, DOI 10.1007/s11469-020-00367-0; Laar RA, 2019, RELIGIONS, V10, DOI 10.3390/rel10110617; Saurabh K, 2020, INDIAN J PEDIATR, V87, P532, DOI 10.1007/s12098-020-03347-3; Zhang XX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207666; Zhou J, POSITIVE NEGATIVE PS; Zhu N, 2020, CHILD ADOL MENT H-UK, V25, P173, DOI 10.1111/camh.12408	19	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262325	10.1371/journal.pone.0262325	http://dx.doi.org/10.1371/journal.pone.0262325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986208	gold, Green Published			2022-12-26	WOS:000765956200042
J	Roggero, CM; Esser, V; Duan, LL; Rice, AM; Ma, SH; Raj, GV; Rosen, MK; Liu, ZP; Rizoi, J				Roggero, Carlos M.; Esser, Victoria; Duan, Lingling; Rice, Allyson M.; Ma, Shihong; Raj, Ganesh V.; Rosen, Michael K.; Liu, Zhi-Ping; Rizoi, Josep			Poly-glutamine-dependent self-association as a potential mechanism for regulation of androgen receptor activity	PLOS ONE			English	Article							PROSTATE-CANCER; TRANSACTIVATION DOMAIN; PHASE-TRANSITION; ACTIVATION; CONFORMATION; DEPRIVATION; RESISTANCE; BEHAVIOR; REPEATS; LENGTH	The androgen receptor (AR) plays a central role in prostate cancer. Development of castration resistant prostate cancer (CRPC) requires androgen-independent activation of AR, which involves its large N-terminal domain (NTD) and entails extensive epigenetic changes depending in part on histone lysine demethylases (KDMs) that interact with AR. The AR-NTD is rich in low-complexity sequences, including a polyQ repeat. Longer polyQ sequences were reported to decrease transcriptional activity and to protect against prostate cancer, although they can lead to muscular atrophy. However, the molecular mechanisms underlying these observations are unclear. Using NMR spectroscopy, here we identify weak interactions between the AR-NTD and the KDM4A catalytic domain, and between the AR ligand-binding domain and a central KDM4A region that also contains low-complexity sequences. We also show that the AR-NTD can undergo liquid-liquid phase separation in vitro, with longer polyQ sequences phase separating more readily. Moreover, longer polyQ sequences hinder nuclear localization in the absence of hormone and increase the propensity for formation of AR-containing puncta in the nucleus of cells treated with dihydrotestosterone. These results lead us to hypothesize that polyQ-dependent liquid-liquid phase separation may provide a mechanism to decrease the transcriptional activity of AR, potentially opening new opportunities to design effective therapies against CRPC and muscular atrophy.	[Roggero, Carlos M.; Esser, Victoria; Rice, Allyson M.; Rosen, Michael K.; Rizoi, Josep] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Roggero, Carlos M.; Esser, Victoria; Rizoi, Josep] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Roggero, Carlos M.; Esser, Victoria; Rizoi, Josep] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Duan, Lingling; Liu, Zhi-Ping] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Ma, Shihong; Raj, Ganesh V.] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Liu, Zhi-Ping] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Roggero, CM; Rizoi, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Roggero, CM; Rizoi, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Roggero, CM; Rizoi, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	Carlos.Roggero@UTSouthwestern.edu; Jose.Rizo-Rey@UTSouthwestern.edu			Cancer Prevention and Research Institute of Texas (CPRIT) [RP120717-P3, RP120717-AC, RP120717-P1]; Welch Foundation [I-1304]; NIH [RO1 CA215063]	Cancer Prevention and Research Institute of Texas (CPRIT); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.R. RP120717-P3 Cancer Prevention and Research Institute of Texas (CPRIT) https://www.cprit.state.tx.us/J.R.I-1304 Welch Foundation https://welch1.org/Z.P.L.RP120717-AC and RP120717-P1 Cancer Prevention and Research Institute of Texas (CPRIT) https://www.cprit.state.tx.us/Z.P.L.RO1 CA215063 NIH https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, Lancet, V346, P265; Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Bouchard JJ, 2018, MOL CELL, V72, P19, DOI 10.1016/j.molcel.2018.08.027; Cao SB, 2016, ENDOCR-RELAT CANCER, V23, pT199, DOI 10.1530/ERC-16-0298; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Charbonnier S, 2006, PROTEIN EXPRES PURIF, V50, P89, DOI 10.1016/j.pep.2006.06.010; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; De Mol E, 2018, STRUCTURE, V26, P145, DOI 10.1016/j.str.2017.11.007; De Mol E, 2016, ACS CHEM BIOL, V11, P2499, DOI 10.1021/acschembio.6b00182; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doesburg P, 1997, BIOCHEMISTRY-US, V36, P1052, DOI 10.1021/bi961775g; Duan LL, 2019, NUCLEIC ACIDS RES, V47, P11623, DOI 10.1093/nar/gkz1004; Eftekharzadeh B, 2016, BIOPHYS J, V110, P2361, DOI 10.1016/j.bpj.2016.04.022; Eisenberger MA, 1999, NEW ENGL J MED, V341, P1837, DOI 10.1056/NEJM199912093412409; Escobedo A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09923-2; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Huang WYC, 2019, SCIENCE, V363, P1098, DOI 10.1126/science.aau5721; Irvine RA, 2000, HUM MOL GENET, V9, P267, DOI 10.1093/hmg/9.2.267; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jochum T, 2012, BBA-MOL BASIS DIS, V1822, P1070, DOI 10.1016/j.bbadis.2012.02.006; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kumar R, 2011, LIFE SCI, V88, P565, DOI 10.1016/j.lfs.2011.01.021; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3360, DOI 10.1021/bi702221e; Lee DH, 2020, FASEB J, V34, P3461, DOI 10.1096/fj.201902584R; Lyon AS, 2021, NAT REV MOL CELL BIO, V22, P215, DOI 10.1038/s41580-020-00303-z; Martin EW, 2020, SCIENCE, V367, P694, DOI 10.1126/science.aaw8653; McEwan IJ, 2012, MOL BIOSYST, V8, P82, DOI 10.1039/c1mb05249g; Myung JK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.017413; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Oppong E, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020044; Peeples W, 2021, NAT CHEM BIOL, V17, P693, DOI 10.1038/s41589-021-00801-x; Peng Y, 2019, STRUCTURE, V27, P229, DOI 10.1016/j.str.2018.10.026; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Quayle SN, 2007, P NATL ACAD SCI USA, V104, P1331, DOI 10.1073/pnas.0606718104; Rizo J, 2012, J MOL CELL BIOL, V4, P270, DOI 10.1093/jmcb/mjs036; Roggero CM, 2021, ONCOGENE, V40, P1106, DOI 10.1038/s41388-020-01585-5; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shao C, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116768; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Stanford JL, 1997, CANCER RES, V57, P1194; Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18; Tibble RW, 2021, NAT CHEM BIOL, V17, P615, DOI 10.1038/s41589-021-00774-x; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; Wilson EM, 2011, METHODS MOL BIOL, V776, P113, DOI 10.1007/978-1-61779-243-4_8; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972	58	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0258876	10.1371/journal.pone.0258876	http://dx.doi.org/10.1371/journal.pone.0258876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986150	gold, Green Submitted, Green Published			2022-12-26	WOS:000765956200003
J	Stumpf, RP; Li, YZ; Kirkpatrick, B; Litaker, RW; Hubbard, KA; Currier, RD; Harrison, KK; Tomlinson, MC				Stumpf, Richard P.; Li, Yizhen; Kirkpatrick, Barbara; Litaker, R. Wayne; Hubbard, Katherine A.; Currier, Robert D.; Harrison, Katherine Kohler; Tomlinson, Michelle C.			Quantifying Karenia brevis bloom severity and respiratory irritation impact along the shoreline of Southwest Florida	PLOS ONE			English	Article							GULF-OF-MEXICO; HARMFUL ALGAL BLOOMS; RED-TIDE TOXINS; REMOTE-SENSING TECHNIQUES; WESTERN LAKE-ERIE; HUMAN HEALTH; CYANOBACTERIAL BLOOM; PSEUDO-NITZSCHIA; DOMOIC ACID; SHELF	Nearly all annual blooms of the toxic dinoflagellate Karenia brevis (K. brevis) pose a serious threat to coastal Southwest Florida. These blooms discolor water, kill fish and marine mammals, contaminate shellfish, cause mild to severe respiratory irritation, and discourage tourism and recreational activities, leading to significant health and economic impacts in affected communities. Despite these issues, we still lack standard measures suitable for assessing bloom severity or for evaluating the efficacy of modeling efforts simulating bloom initiation and intensity. In this study, historical cell count observations along the southwest Florida shoreline from 1953 to 2019 were used to develop monthly and annual bloom severity indices (BSI). Similarly, respiratory irritation observations routinely reported in Sarasota and Manatee Counties from 2006 to 2019 were used to construct a respiratory irritation index (RI). Both BSI and RI consider spatial extent and temporal evolution of the bloom, and can be updated routinely and used as objective criteria to aid future socioeconomic and scientific studies of K. brevis. These indices can also be used to help managers and decision makers both evaluate the risks along the coast during events and design systems to better respond to and mitigate bloom impacts. Before 1995, sampling was done largely in response to reports of discolored water, fish kills, or respiratory irritation. During this time-frame, lack of sampling during the fall, when blooms typically occur, generally coincided with periods of more frequent-than-usual offshore winds. Consequently, some blooms may have been undetected or under-sampled. As a result, the BSIs before 1995 were likely underestimated and cannot be viewed as accurately as those after 1995. Anomalies in the frequency of onshore wind can also largely account for the discrepancies between BSI and RI during the period from 2006 to 2019. These findings highlighted the importance of onshore wind anomalies when predicting respiratory irritation impacts along beaches.	[Stumpf, Richard P.; Tomlinson, Michelle C.] Natl Ocean Serv, NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD 20910 USA; [Li, Yizhen; Litaker, R. Wayne] Natl Ocean Serv, CSS Inc, NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD USA; [Kirkpatrick, Barbara; Currier, Robert D.; Harrison, Katherine Kohler] Texas A&M Univ, Gulf Mexico Coastal Ocean Observing Syst Reg Asso, Dept Oceanog, College Stn, TX USA; [Hubbard, Katherine A.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Texas A&M University System; Texas A&M University College Station; Florida Fish & Wildlife Conservation Commission	Stumpf, RP (corresponding author), Natl Ocean Serv, NOAA, Natl Ctr Coastal Ocean Sci, Silver Spring, MD 20910 USA.	Richard.stumpf@noaa.gov	Litaker, Richard Wayne/AAH-2036-2021	Litaker, Richard Wayne/0000-0001-6293-8000; Stumpf, Richard/0000-0001-5531-6860	National Aeronautics and Space Administration, Applied Sciences, ROSES Award [NNH16AC891, NN13ZDA001]; Center for Sponsored Coastal Ocean Research, the National Oceanic and Atmospheric Administration [NA20NOS4780194]	National Aeronautics and Space Administration, Applied Sciences, ROSES Award; Center for Sponsored Coastal Ocean Research, the National Oceanic and Atmospheric Administration	BK received funding from National Aeronautics and Space Administration, Applied Sciences, ROSES Award Number NN13ZDA001, https://appliedsciences.nasa.gov/what-we-do/health-air-quality.RS received funding from National Aeronautics and Space Administration, Applied Sciences, ROSES Award Number NNH16AC891, https://appliedsciences.nasa.gov/what-we-do/health-air-quality.BK received funding from Center for Sponsored Coastal Ocean Research, the National Oceanic and Atmospheric Administration, Award Number, NA20NOS4780194, https://coastalscience.noaa.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2015, IEEE GEOSCI REMOTE S, V12, P2080, DOI 10.1109/LGRS.2015.2448453; Amin R, 2009, OPT EXPRESS, V17, P9126, DOI 10.1364/OE.17.009126; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; Brand LE, 2007, HARMFUL ALGAE, V6, P232, DOI 10.1016/j.hal.2006.08.005; Cannizzaro JP, 2013, J COASTAL RES, V29, P1257, DOI 10.2112/JCOASTRES-D-12-00223.1; Carvalho GA, 2011, REMOTE SENS ENVIRON, V115, P1, DOI 10.1016/j.rse.2010.07.007; Chew F., 1955, EOS WASHINGTON DC, V36, P963; Clark S, 2019, HARMFUL ALGAE, V88, DOI 10.1016/j.hal.2019.101656; DAVIS CC, 1948, BOT GAZ, V109, P358, DOI 10.1086/335488; DiLeone AMG, 2019, ECOL MODEL, V392, P250, DOI 10.1016/j.ecolmodel.2018.11.022; Dixon LK, 2004, HARMFUL ALGAE 2002, P29; Duan HT, 2009, ENVIRON SCI TECHNOL, V43, P3522, DOI 10.1021/es8031852; Eberhart BTL, 2012, HARMFUL ALGAE, V19, P39, DOI 10.1016/j.hal.2012.05.005; ECOHAB. Ecology and oceanography of harmful algal blooms (ECOHAB), 2003, FIN REP ECOHAB FLOR; El-Habashi A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050377; Feinstein A., 1955, U MIAMI MARINE LAB R, P55; Feinstein A., 1956, B MAR SCI, V6, P209; FFWCC. Florida Fish and Wildlife Conservation Commission, 2021, KAR BREV ARCH STAT M; FFWCC. Florida Fish and Wildlife Conservation Commission (FFWCC), 100 YEARS RED TID OF, P2; Fire SE, 2015, MAR ECOL PROG SER, V526, P241, DOI 10.3354/meps11225; Fisher KM, 2005, 047 NOS COOPS NAT OC; Flaherty KE, 2011, ESTUAR COAST, V34, P417, DOI 10.1007/s12237-010-9350-x; Fleming LE, 2006, MAR POLLUT BULL, V53, P545, DOI 10.1016/j.marpolbul.2006.08.012; Fleming LE, 2005, ENVIRON HEALTH PERSP, V113, P650, DOI 10.1289/ehp.7500; Fleming LE, 2005, ENVIRON HEALTH PERSP, V113, P618, DOI 10.1289/ehp.7501; Fleming LE, 2007, CHEST, V131, P187, DOI 10.1378/chest.06-1830; Fleming LE, 2011, HARMFUL ALGAE, V10, P224, DOI 10.1016/j.hal.2010.08.006; Fleming LE, 2009, ENVIRON HEALTH PERSP, V117, P1095, DOI 10.1289/ehp.0900673; Florida Fish and Wildlife Conservation Commission, 2020, HAB MON DAT; Friedman MA, 2005, J INT NEUROPSYCH SOC, V11, P331, DOI 10.1017/S1355617705050381; Gilbes F, 2002, CONT SHELF RES, V22, P2479, DOI 10.1016/S0278-4343(02)00102-4; Gilbes F, 1996, CONT SHELF RES, V16, P1201, DOI 10.1016/0278-4343(95)00065-8; Hardison DR, 2012, J PHYCOL, V48, P844, DOI 10.1111/j.1529-8817.2012.01186.x; Hardison DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058545; Haywood AJ, 2004, J PHYCOL, V40, P165, DOI 10.1111/j.0022-3646.2004.02-149.x; Heil CA, 2014, HARMFUL ALGAE, V38, P127, DOI 10.1016/j.hal.2014.07.016; Heil CA, 2014, HARMFUL ALGAE, V38, P3, DOI 10.1016/j.hal.2014.07.015; Hoagland P, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00538; Hoagland P, 2009, ENVIRON HEALTH PERSP, V117, P1239, DOI 10.1289/ehp.0900645; Hu CM, 2015, SENSORS-BASEL, V15, P2873, DOI 10.3390/s150202873; Huang CC, 2014, ENVIRON EARTH SCI, V71, P3705, DOI 10.1007/s12665-013-2764-6; Kahru M, 2007, MAR ECOL PROG SER, V343, P15, DOI 10.3354/meps06943; Kahru M, 2014, BIOGEOSCIENCES, V11, P3619, DOI 10.5194/bg-11-3619-2014; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kirkpatrick B, 2008, SCI TOTAL ENVIRON, V402, P1, DOI 10.1016/j.scitotenv.2008.03.032; Kirkpatrick B, 2011, HARMFUL ALGAE, V10, P138, DOI 10.1016/j.hal.2010.08.005; Kirkpatrick B, 2010, HARMFUL ALGAE, V9, P186, DOI 10.1016/j.hal.2009.09.003; Kleindinst JL, 2014, DEEP-SEA RES PT II, V103, P277, DOI 10.1016/j.dsr2.2013.03.027; Kusek Kristen M., 1999, Contributions in Marine Science, V34, P1; Landsberg JH, 2009, HARMFUL ALGAE, V8, P598, DOI 10.1016/j.hal.2008.11.010; Lewitus AJ, 2012, HARMFUL ALGAE, V19, P133, DOI 10.1016/j.hal.2012.06.009; Liu YG, 2016, J GEOPHYS RES-OCEANS, V121, P5501, DOI 10.1002/2016JC011938; Magana HA, 2003, HARMFUL ALGAE, V2, P163, DOI 10.1016/S1568-9883(03)00026-X; Matthews MW, 2015, S AFR J SCI, V111, P77; Matthews MW, 2014, REMOTE SENS ENVIRON, V155, P161, DOI 10.1016/j.rse.2014.08.010; Maze G, 2015, HARMFUL ALGAE, V50, P1, DOI 10.1016/j.hal.2015.10.003; McKibben SM, 2015, HARMFUL ALGAE, V50, P32, DOI 10.1016/j.hal.2015.10.004; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Morgan KL, 2009, HARMFUL ALGAE, V8, P212, DOI 10.1016/j.hal.2008.05.002; NOAA. National Oceanographic and Atmospheric Administration, OCEANREPORTS OC BIOP; OSHEA TJ, 1991, MAR MAMMAL SCI, V7, P165, DOI 10.1111/j.1748-7692.1991.tb00563.x; Pierce RH, 2008, ECOTOXICOLOGY, V17, P623, DOI 10.1007/s10646-008-0241-x; Pierce RH, 2005, HARMFUL ALGAE, V4, P965, DOI 10.1016/j.hal.2004.11.004; Reich A, 2015, HARMFUL ALGAE, V43, P13, DOI 10.1016/j.hal.2014.12.003; Rounsefell GA, 1966, 535 US FISH WILDL SE; Sagarese SR, 2017, ECOL MODEL, V345, P75, DOI 10.1016/j.ecolmodel.2016.11.001; Sayers MJ, 2019, J GREAT LAKES RES, V45, P508, DOI 10.1016/j.jglr.2019.01.005; Smith J, 2018, HARMFUL ALGAE, V79, P87, DOI 10.1016/j.hal.2018.07.007; Soto IM, 2015, REMOTE SENS ENVIRON, V170, P239, DOI 10.1016/j.rse.2015.09.026; Steidinger KA, 2009, HARMFUL ALGAE, V8, P549, DOI 10.1016/j.hal.2008.11.009; Stumpf RP, 2008, CONT SHELF RES, V28, P189, DOI 10.1016/j.csr.2007.04.017; Stumpf RP, 2016, J GREAT LAKES RES, V42, P1174, DOI 10.1016/j.jglr.2016.08.006; Stumpf RP, 2016, HARMFUL ALGAE, V54, P160, DOI 10.1016/j.hal.2016.01.005; Stumpf RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042444; Stumpf RP, 2009, J MARINE SYST, V76, P151, DOI 10.1016/j.jmarsys.2008.05.016; Stumpf RP, 2003, HARMFUL ALGAE, V2, P147, DOI 10.1016/S1568-9883(02)00083-5; Stumpf RP, 2001, HUM ECOL RISK ASSESS, V7, P1363, DOI 10.1080/20018091095050; TBRPC, 2019, EC RIPPL EFF FLOR RE; Tester PA, 1997, LIMNOL OCEANOGR, V42, P1039, DOI 10.4319/lo.1997.42.5_part_2.1039; Tomlinson MC, 2009, REMOTE SENS ENVIRON, V113, P598, DOI 10.1016/j.rse.2008.11.003; Tomlinson MC, 2004, REMOTE SENS ENVIRON, V91, P293, DOI 10.1016/j.rse.2004.02.014; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P289, DOI 10.4319/lo.2009.54.1.0289; VARGO GA, 1987, LIMNOL OCEANOGR, V32, P762, DOI 10.4319/lo.1987.32.3.0762; Vargo GA, 2008, CONT SHELF RES, V28, P73, DOI 10.1016/j.csr.2007.04.008; Walsh JJ, 2001, J GEOPHYS RES-OCEANS, V106, P11597, DOI 10.1029/1999JC000123; Wynne TT, 2015, TOXINS, V7, P1649, DOI 10.3390/toxins7051649; Wynne TT, 2010, LIMNOL OCEANOGR, V55, P2025, DOI 10.4319/lo.2010.55.5.2025; Wynne TT, 2005, HARMFUL ALGAE, V4, P992, DOI 10.1016/j.hal.2005.02.004	88	4	4	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0260755	10.1371/journal.pone.0260755	http://dx.doi.org/10.1371/journal.pone.0260755			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986155	Green Published, gold			2022-12-26	WOS:000765956200007
J	Ashour, A; Phipps, DL; Ashcroft, DM				Ashour, Ahmed; Phipps, Denham L.; Ashcroft, Darren M.			Predicting dispensing errors in community pharmacies: An application of the Systematic Human Error Reduction and Prediction Approach (SHERPA)	PLOS ONE			English	Article							FAILURE MODE; RISK ANALYSIS; HEALTH-CARE; MEDICATION	Introduction The objective of this study was to use a prospective error analysis method to examine the process of dispensing medication in community pharmacy settings and identify remedial solutions to avoid potential errors, categorising them as strong, intermediate, or weak based on an established patient safety action hierarchy tool. Method Focus group discussions and non-participant observations were undertaken to develop a Hierarchical Task Analysis (HTA), and subsequent focus group discussions applied the Systematic Human Error Reduction and Prediction Approach (SHERPA) focusing on the task of dispensing medication in community pharmacies. Remedial measures identified through the SHERPA analysis were then categorised as strong, intermediate, or weak based on the Veteran Affairs National Centre for Patient Safety action hierarchy. Non-participant observations were conducted at 3 pharmacies, totalling 12 hours, based in England. Additionally, 7 community pharmacists, with experience ranging from 8 to 38 years, participated in a total of 4 focus groups, each lasting between 57 to 85 minutes, with one focus group discussing the HTA and three applying SHERPA. A HTA was produced consisting of 10 sub-tasks, with further levels of sub-tasks within each of them. Results Overall, 88 potential errors were identified, with a total of 35 remedial solutions proposed to avoid these errors in practice. Sixteen (46%) of these remedial measures were categorised as weak, 14 (40%) as intermediate and 5 (14%) as strong according to the Veteran Affairs National Centre for Patient Safety action hierarchy. Sub-tasks with the most potential errors were identified, which included 'producing medication labels' and 'final checking of medicines'. The most common type of error determined from the SHERPA analysis related to omitting a check during the dispensing process which accounted for 19 potential errors. Discussion This work applies both HTA and SHERPA for the first time to the task of dispensing medication in community pharmacies, detailing the complexity of the task and highlighting potential errors and remedial measures specific to this task. Future research should examine the effectiveness of the proposed remedial solutions to improve patient safety.	[Ashour, Ahmed; Phipps, Denham L.; Ashcroft, Darren M.] Univ Manchester, Fac Biol Med & Hlth, Ctr Pharmacoepidemiol & Drug Safety, Sch Hlth Sci,Div Pharm & Optometry, Manchester, Lancs, England; [Ashour, Ahmed; Ashcroft, Darren M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Greater Manchester Patient Safety Translat R, Manchester, Lancs, England; [Ashcroft, Darren M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Sch Primary Care Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Ashour, A (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Ctr Pharmacoepidemiol & Drug Safety, Sch Hlth Sci,Div Pharm & Optometry, Manchester, Lancs, England.; Ashour, A (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Greater Manchester Patient Safety Translat R, Manchester, Lancs, England.	ahmed.ashour@postgrad.manchester.ac.uk		Ashour, Ahmed/0000-0003-1645-1810	National Institute for Health Research (NIHR) through the Greater Manchester Patient Safety Translational Research Centre [PSTRC-2016-003]	National Institute for Health Research (NIHR) through the Greater Manchester Patient Safety Translational Research Centre(National Institute for Health Research (NIHR))	This work was funded by the National Institute for Health Research (NIHR) through the Greater Manchester Patient Safety Translational Research Centre (award number: PSTRC-2016-003). The views expressed are those of the author (s) and not necessarily those of the NIHR or the Department of Health and Social Care.	Annett J., 2004, HDB HUMAN FACTORS ER, P355; Ashley Laura, 2010, J Patient Saf, V6, P210, DOI 10.1097/PTS.0b013e3181fc98d7; Ashley L, 2010, JT COMM J QUAL PATIE, V36, P351, DOI 10.1016/S1553-7250(10)36053-3; Ashour A, 2021, APPL ERGON, V93, DOI 10.1016/j.apergo.2021.103372; Aspden P., 2006, I MED, P26; Bowie P, 2016, EDUC PRIM CARE, V27, P86, DOI 10.1080/14739879.2016.1152658; CIEHF, 2016, HUM FACT BARR MAN; Donaldson LJ, 2017, LANCET, V389, P1680, DOI 10.1016/S0140-6736(17)31047-4; Elliott RA, 2021, BMJ QUAL SAF, V30, P96, DOI 10.1136/bmjqs-2019-010206; Embrey D., 2014, PROC INT S HUM FACTO, V3, P246; Embrey DE., 1986, SHERPA SYSTEMATIC HU; Greenall J., 2007, CAN PHARM J REV PHAR, V140, P191, DOI [10.1177/171516350714000324, DOI 10.1177/171516350714000324]; Habraken MMP, 2009, ERGONOMICS, V52, P809, DOI 10.1080/00140130802578563; Harris D, 2005, AEROSP SCI TECHNOL, V9, P525, DOI 10.1016/j.ast.2005.04.002; Harvey J, 2015, RES SOC ADMIN PHARM, V11, P216, DOI 10.1016/j.sapharm.2014.06.005; Kessels-Habraken M, 2009, INT J QUAL HEALTH C, V21, P427, DOI 10.1093/intqhc/mzp043; Knudsen P, 2007, QUAL SAF HEALTH CARE, V16, P285, DOI 10.1136/qshc.2006.022053; Li YF, 2020, QUAL RELIAB ENG INT, V36, P1657, DOI 10.1002/qre.2652; Mandal S, 2015, EXPERT SYST APPL, V42, P7195, DOI 10.1016/j.eswa.2015.05.033; McLeod RW, 2017, PROCESS SAF ENVIRON, V110, P31, DOI 10.1016/j.psep.2017.01.012; Napier P, 2018, RES SOC ADMIN PHARM, V14, P382, DOI 10.1016/j.sapharm.2017.05.002; National Patient Safety Foundation, 2016, RCA2 IMPR ROOT CAUS; NHS Digital, 2019, GEN PHARM SERV ENGL; Panagioti M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4185; Phipps D, 2008, BRIT J ANAESTH, V100, P333, DOI 10.1093/bja/aem392; Phipps DL, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-158; Raduma-Tomas MA, 2012, BMJ QUAL SAF, V21, P211, DOI 10.1136/bmjqs-2011-000220; Roberts Alison S, 2005, Res Social Adm Pharm, V1, P546, DOI 10.1016/j.sapharm.2005.09.003; Shebl NA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-150; Shebl Nada Atef, 2009, J Patient Saf, V5, P86, DOI 10.1097/PTS.0b013e3181a6f040; Sheikh A, 2017, B WORLD HEALTH ORGAN, V95, P546, DOI 10.2471/BLT.17.198002; Stanton N.A., 2013, HUMAN FACTORS METHOD; Stojkovic T, 2021, J PATIENT SAF, V17, pe515, DOI 10.1097/PTS.0000000000000403; Stojkovic T, 2018, INT J HEALTH PLAN M, V33, pE320, DOI 10.1002/hpm.2479; Stojkovic T, 2017, RES SOC ADMIN PHARM, V13, P1159, DOI 10.1016/j.sapharm.2016.11.009; Sujan MA, 2020, RELIAB ENG SYST SAFE, V194, DOI 10.1016/j.ress.2018.06.017; Vosper Helen, 2018, Am J Pharm Educ, V82, P6184, DOI 10.5688/ajpe6184; Weir NM, 2020, RES SOC ADMIN PHARM, V16, P637, DOI 10.1016/j.sapharm.2019.08.029; Wetterneck TB, 2006, AM J HEALTH-SYST PH, V63, P1528, DOI 10.2146/ajhp050515; Wood LJ, 2020, INT J QUAL HEALTH C, V32, P438, DOI 10.1093/intqhc/mzaa068	40	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261672	10.1371/journal.pone.0261672	http://dx.doi.org/10.1371/journal.pone.0261672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982776	Green Published, gold			2022-12-26	WOS:000834805700011
J	Hendley, SA; Bhargava, A; Holland, CK; Wool, GD; Ahmed, O; Paul, JD; Bader, KB				Hendley, Samuel A.; Bhargava, Aarushi; Holland, Christy K.; Wool, Geoffrey D.; Ahmed, Osman; Paul, Jonathan D.; Bader, Kenneth B.			(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; PULSED FOCUSED ULTRASOUND; DEEP VENOUS THROMBOSIS; IN-VITRO; VEIN THROMBOSIS; HIGH-INTENSITY; CAVITATION; THERAPY; DEGRADATION; MECHANISMS	Deep vein thrombosis is a major source of morbidity and mortality worldwide. For acute proximal deep vein thrombosis, catheter-directed thrombolytic therapy is an accepted method for vessel recanalization. Thrombolytic therapy is not without risk, including the potential for hemorrhagic bleeding that increases with lytic dose. Histotripsy is a focused ultrasound therapy that generates bubble clouds spontaneously in tissue at depth. The mechanical activity of histotripsy increases the efficacy of thrombolytic therapy at doses consistent with current pharmacomechanical treatments for venous thrombosis. The objective of this study was to determine the influence of lytic dose on histotripsy-enhanced fibrinolysis. Human whole blood clots formed in vitro were exposed to histotripsy and a thrombolytic agent (recombinant tissue plasminogen activator, rt-PA) in a venous flow model perfused with plasma. Lytic was administered into the clot via an infusion catheter at concentrations ranging from 0 (control) to 4.54 mu g/mL (a common clinical dose for catheter-directed thrombolysis). Following treatment, perfusate samples were assayed for markers of fibrinolysis, hemolysis, and intact red blood cells and platelets. Fibrinolysis was equivalent between the common clinical dose of rt-PA (4.54 mu g/mL) and rt-PA at a reduction to one-twentieth of the common clinical dose (0.23 mu g/mL) when combined with histotripsy. Minimal changes were observed in hemolysis for treatment arms with or without histotripsy, potentially due to clot damage from insertion of the infusion catheter. Likewise, histotripsy did not increase the concentration of red blood cells or platelets in the perfusate following treatment compared to rt-PA alone. At the highest lytic dose, a refined histotripsy exposure scheme was implemented to cover larger areas of the clot. The updated exposure scheme improved clot mass loss and fibrinolysis relative to administration of lytic alone. Overall, the data collected in this study indicate the rt-PA dose can be reduced by more than a factor of ten and still promote fibrinolysis when combined with histotripsy.	[Hendley, Samuel A.; Bader, Kenneth B.] Univ Chicago, Comm Med Phys, Chicago, IL 60637 USA; [Bhargava, Aarushi; Ahmed, Osman; Bader, Kenneth B.] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Holland, Christy K.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA; [Holland, Christy K.] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH USA; [Wool, Geoffrey D.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Paul, Jonathan D.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Chicago; University of Chicago	Bader, KB (corresponding author), Univ Chicago, Comm Med Phys, Chicago, IL 60637 USA.; Bader, KB (corresponding author), Univ Chicago, Dept Radiol, Chicago, IL 60637 USA.	baderk@uchicago.edu			National Heart, Lung, and Blood Institute [R01 HL133334]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/), Grant Number R01 HL133334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia C, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816750; Bader KB, 2021, IEEE T BIO-MED ENG, V68, P1220, DOI 10.1109/TBME.2020.3023630; Bader KB, 2019, ULTRASOUND MED BIOL, V45, P1056, DOI 10.1016/j.ultrasmedbio.2018.10.035; Bader KB, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aab79b; Bader KB, 2016, PHYS MED BIOL, V61, P5253, DOI 10.1088/0031-9155/61/14/5253; Bader KB, 2016, ULTRASOUND MED BIOL, V42, P1701, DOI 10.1016/j.ultrasmedbio.2016.02.010; Bader KB, 2016, ADV EXP MED BIOL, V880, P339, DOI 10.1007/978-3-319-22536-4_19; Bader KB, 2015, ULTRASOUND MED BIOL, V41, P187, DOI 10.1016/j.ultrasmedbio.2014.08.018; Bajd Franci, 2012, Microcirculation, V19, P632, DOI 10.1111/j.1549-8719.2012.00198.x; Bajd F, 2010, THROMB RES, V126, P137, DOI 10.1016/j.thromres.2010.04.012; Bollen T, 2020, ULTRASOUND MED BIOL, V46, P336, DOI 10.1016/j.ultrasmedbio.2019.10.009; BRENNER B, 1990, CIRCULATION, V81, P1818, DOI 10.1161/01.CIR.81.6.1818; Chen JX, 2016, RADIOGRAPHICS, V36, P1565, DOI 10.1148/rg.2016150138; Coviello C, 2015, J ACOUST SOC AM, V137, P2573, DOI 10.1121/1.4916694; Czaplicki C, 2017, CARDIOVASC DIAGN THE, V7, pS186, DOI 10.21037/cdt.2017.11.05; Duck F.A., 1990, MED PHYS, V18; Go AS, 2013, CIRCULATION, V127, pE841, DOI 10.1161/CIR.0b013e31829ae08c; Goel L, 2021, ULTRASOUND MED BIOL, V47, P3231, DOI 10.1016/j.ultrasmedbio.2021.07.018; Goel L, 2021, MICROSYST NANOENG, V7, DOI 10.1038/s41378-020-00228-9; Graham SM, 2014, J CONTROL RELEASE, V178, P101, DOI 10.1016/j.jconrel.2013.12.016; Haworth KJ, 2017, IEEE T ULTRASON FERR, V64, P177, DOI 10.1109/TUFFC.2016.2620492; Haynes W., 2013, ENCY SYSTEMBIOL, P2354, DOI [10.1007/978-1-4419-9863-7_1185, DOI 10.1007/978-1-4419-9863-7_1185]; Hendley SA, 2021, IEEE T ULTRASON FERR, V68, P2942, DOI 10.1109/TUFFC.2021.3052393; Hilleman DE, 2008, J VASC INTERV RADIOL, V19, P377, DOI 10.1016/j.jvir.2007.10.027; Hitchcock KE, 2011, ULTRASOUND MED BIOL, V37, P1240, DOI 10.1016/j.ultrasmedbio.2011.05.011; Holland CK, 2008, THROMB RES, V121, P663, DOI 10.1016/j.thromres.2007.07.006; Jensen CT, 2017, J ULTRAS MED, V36, P1867, DOI 10.1002/jum.14220; Khokhlova VA, 2015, INT J HYPERTHER, V31, P145, DOI 10.3109/02656736.2015.1007538; Kieran K, 2007, J UROLOGY, V178, P672, DOI 10.1016/j.juro.2007.03.093; Kleven RT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83442-3; Kolbel T, 2008, J ENDOVASC THER, V15, P605, DOI 10.1583/08-2462.1; Lafond M, 2021, ULTRASOUND MED BIOL, V47, P693, DOI 10.1016/j.ultrasmedbio.2020.10.010; Li T, 2015, CANCER RES, V75, P3738, DOI 10.1158/0008-5472.CAN-15-0296; Lin KW, 2014, IEEE T ULTRASON FERR, V61, P1123, DOI 10.1109/TUFFC.2014.3012; Maxwell AD, 2022, IEEE T ULTRASON FERR, V69, P156, DOI 10.1109/TUFFC.2021.3113635; Maxwell AD, 2017, IEEE T ULTRASON FERR, V64, P1542, DOI 10.1109/TUFFC.2017.2739649; Maxwell AD, 2014, PHYS MED BIOL, V59, P4927, DOI 10.1088/0031-9155/59/17/4927; Maxwell AD, 2013, ULTRASOUND MED BIOL, V39, P449, DOI 10.1016/j.ultrasmedbio.2012.09.004; Maxwell AD, 2011, J ACOUST SOC AM, V130, P1888, DOI 10.1121/1.3625239; Maxwell AD, 2011, J VASC INTERV RADIOL, V22, P369, DOI 10.1016/j.jvir.2010.10.007; Mercado-Shekhar KP, 2018, ULTRASOUND MED BIOL, V44, P2710, DOI 10.1016/j.ultrasmedbio.2018.08.005; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Nyamekye I, 2012, PHLEBOLOGY, V27, P61, DOI 10.1258/phleb.2012.012S37; Rathbun S, 2009, CIRCULATION, V119, pE480, DOI 10.1161/CIRCULATIONAHA.108.841403; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sharafuddin MJA, 1998, J VASC INTERV RADIOL, V9, P15, DOI 10.1016/S1051-0443(98)70477-4; Shaw George J, 2009, BMC Res Notes, V2, P117, DOI 10.1186/1756-0500-2-117; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; TURI ZG, 1993, AM J CARDIOL, V71, P1009, DOI 10.1016/0002-9149(93)90564-S; Vedantham S, 2017, NEW ENGL J MED, V377, P2240, DOI 10.1056/NEJMoa1615066; Vedantham S, 2016, J THROMB THROMBOLYS, V41, P68, DOI 10.1007/s11239-015-1318-z; Virani SS, 2021, CIRCULATION, V143, pe254, DOI 10.1161/CIR.0000000000000950; Vlaisavljevich E, 2016, ULTRASOUND MED BIOL, V42, P931, DOI 10.1016/j.ultrasmedbio.2015.11.027; Vlaisavljevich E, 2014, PHYS MED BIOL, V59, P253, DOI 10.1088/0031-9155/59/2/253; Waheed SM., 2021, DEEP VEIN THROMBOSIS; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Wang TY, 2012, ULTRASOUND MED BIOL, V38, P753, DOI 10.1016/j.ultrasmedbio.2012.01.013; Wolf MF, 2021, J BIOMED MATER RES B, V109, P358, DOI 10.1002/jbm.b.34705; Wright CC, 2012, IEEE T BIO-MED ENG, V59, P842, DOI 10.1109/TBME.2011.2180904; Xu Z, 2021, INT J HYPERTHER, V38, P561, DOI 10.1080/02656736.2021.1905189; Zhang X, 2017, ULTRASOUND MED BIOL, V43, P1378, DOI 10.1016/j.ultrasmedbio.2017.01.028; Zhang X, 2015, IEEE T ULTRASON FERR, V62, P1342, DOI 10.1109/TUFFC.2015.007016	63	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0261567	10.1371/journal.pone.0261567	http://dx.doi.org/10.1371/journal.pone.0261567			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982784	gold, Green Published			2022-12-26	WOS:000834805700010
J	Watts, BD; Smith, FM; Hines, C; Duval, L; Hamilton, DJ; Keyes, T; Paquet, J; Pirie-Dominix, L; Rausch, J; Truitt, B; Winn, B; Woodard, P				Watts, Bryan D.; Smith, Fletcher M.; Hines, Chance; Duval, Laura; Hamilton, Diana J.; Keyes, Tim; Paquet, Julie; Pirie-Dominix, Lisa; Rausch, Jennie; Truitt, Barry; Winn, Brad; Woodard, Paul			The annual cycle for whimbrel populations using the Western Atlantic Flyway	PLOS ONE			English	Article							KNOTS CALIDRIS-CANUTUS; RED KNOTS; NUMENIUS-PHAEOPUS; MIGRATORY BIRDS; SHOREBIRDS; HABITAT; DECLINE; ARRIVAL; RATES; SANDPIPERS	Many long-distance migratory birds use habitats that are scattered across continents and confront hazards throughout the annual cycle that may be population-limiting. Identifying where and when populations spend their time is fundamental to effective management. We tracked 34 adult whimbrels (Numenius phaeopus) from two breeding populations (Mackenzie Delta and Hudson Bay) with satellite transmitters to document the structure of their annual cycles. The two populations differed in their use of migratory pathways and their seasonal schedules. Mackenzie Delta whimbrels made long (22,800 km) loop migrations with different autumn and spring routes. Hudson Bay whimbrels made shorter (17,500 km) and more direct migrations along the same route during autumn and spring. The two populations overlap on the winter grounds and within one spring staging area. Mackenzie Delta whimbrels left the breeding ground, arrived on winter grounds, left winter grounds and arrived on spring staging areas earlier compared to whimbrels from Hudson Bay. For both populations, migration speed was significantly higher during spring compared to autumn migration. Faster migration was achieved by having fewer and shorter stopovers en route. We identified five migratory staging areas including four that were used during autumn and two that were used during spring. Whimbrels tracked for multiple years had high (98%) fidelity to staging areas. We documented dozens of locations where birds stopped for short periods along nearly all migration routes. The consistent use of very few staging areas suggests that these areas are integral to the annual cycle of both populations and have high conservation value.	[Watts, Bryan D.; Smith, Fletcher M.; Hines, Chance; Duval, Laura] William & Mary, Ctr Conservat Biol, Williamsburg, VA 23185 USA; [Smith, Fletcher M.; Keyes, Tim] Georgia Dept Nat Resources, Wildlife Resources Div, Nongame Conservat Sect, Brunswick, GA USA; [Hamilton, Diana J.] Mt Allison Univ, Sackville, NB, Canada; [Paquet, Julie] Environm & Climate Change Canada, Canadian Wildlife Serv, Sackville, NB, Canada; [Pirie-Dominix, Lisa] Environm & Climate Change Canada, Canadian Wildlife Serv, Igaluit, NU, Canada; [Rausch, Jennie; Woodard, Paul] Environm & Climate Change Canada, Canadian Wildlife Serv, Yellowknife, NT, Canada; [Truitt, Barry] Nat Conservancys, Volgenau Virginia Coast Reserve, Nassawadox, VA USA; [Winn, Brad] Manoment Inc, Manomet, MA USA	Mount Allison University; Environment & Climate Change Canada; Canadian Wildlife Service; Environment & Climate Change Canada; Canadian Wildlife Service; Environment & Climate Change Canada; Canadian Wildlife Service; Nature Conservancy	Watts, BD (corresponding author), William & Mary, Ctr Conservat Biol, Williamsburg, VA 23185 USA.	bdwatt@wm.edu		Watts, Bryan/0000-0001-8244-6951; Smith, Fletcher/0000-0002-7617-8142	US Fish and Wildlife Service; National Fish and Wildlife Foundation's Atlantic Flyway Shorebird Initiative; The Nature Conservancy; Environmental Resources Network, (T.E.R.N.); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; New Brunswick Wildlife Trust Fund; Polar Continental Shelf Program; Cumulative Impacts Monitoring Program; Virginia Coastal Zone Management Program at the Department of Environmental Quality; Georgia Department of Natural Resources Non-game Section; Manomet Inc.	US Fish and Wildlife Service(US Fish & Wildlife Service); National Fish and Wildlife Foundation's Atlantic Flyway Shorebird Initiative; The Nature Conservancy; Environmental Resources Network, (T.E.R.N.); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Brunswick Wildlife Trust Fund; Polar Continental Shelf Program; Cumulative Impacts Monitoring Program; Virginia Coastal Zone Management Program at the Department of Environmental Quality; Georgia Department of Natural Resources Non-game Section; Manomet Inc.	This study and publication were completed with logistical support and/or funding provided by the US Fish and Wildlife Service, Environment and Climate Change Canada, the National Fish and Wildlife Foundation's Atlantic Flyway Shorebird Initiative, The Nature Conservancy, The Georgia Department of Natural Resources Non-game Section, Manomet Inc., the Environmental Resources Network, (T.E.R.N.), a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant, the New Brunswick Wildlife Trust Fund, the Polar Continental Shelf Program, the Cumulative Impacts Monitoring Program, and the Virginia Coastal Zone Management Program at the Department of Environmental Quality. No funders had any influence on the content of the submitted or published manuscript. No funders require approval of the final manuscript to be published.	Alves JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38154; Andres Brad A., 2012, Wader Study Group Bulletin, V119, P178; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Bent AC, 1929, US NATURAL MUSEUM B, V74; Burger J, 2007, J COASTAL RES, V23, P1159, DOI 10.2112/04-0393.1; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Duijns S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45862-0; Escudero G, 2012, AUSTRAL ECOL, V37, P355, DOI 10.1111/j.1442-9993.2011.02283.x; Fancy SG., 1998, US FISH WILDLIFE SER, V172; Finch T, 2014, BIODIVERS CONSERV, V23, P2427, DOI 10.1007/s10531-014-0731-5; Gates HR, 2013, AUK, V130, P372, DOI 10.1525/auk.2013.12052; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hijmans RJ., 2017, SPHERICAL TRIGONOMET, V1, P7; International Wader Study Group, 2003, WADER STUDY GROUP B, V101/102, P8; Johnson AS, 2016, J FIELD ORNITHOL, V87, P371, DOI 10.1111/jofo.12173; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Johnson DS, 2018, Zenodo, DOI 10.5281/zenodo.569569; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; La Sorte FA, 2017, J ANIM ECOL, V86, P273, DOI 10.1111/1365-2656.12624; Lank DB, 2003, J AVIAN BIOL, V34, P225, DOI 10.1034/j.1600-048X.2003.03250.x; Lindstrom A, 2019, NAT CLIM CHANGE, V9, P288, DOI 10.1038/s41558-019-0443-7; Mallory E.P., 1982, Wader Study Group Bulletin, P37; MCNEIL R, 1995, IBIS, V137, P169, DOI 10.1111/j.1474-919X.1995.tb03236.x; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; Morrison RIG, 2012, WATERBIRDS, V35, P120, DOI 10.1675/063.035.0112; Myers J.P., 1983, American Birds, V37, P23; Nagy-Macarthur A, 2016, THESIS MOUNT ALLISON; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norris DR, 2007, CONDOR, V109, P535; Prater A.J, 1977, GUIDE IDENTIFICATION; Pyle P, 2008, IDENTIFICATION GUIDE; R Core Team, 2020, R LANG ENV STAT COMP; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Reed ET, 2018, CONDOR, V120, P357, DOI 10.1650/CONDOR-17-127.1; Rosenberg KV, 2019, SCIENCE, V366, P120, DOI 10.1126/science.aaw1313; Sanzenbacher Peter M., 2000, Wader Study Group Bulletin, V91, P16; Schroder J., 2010, THESIS U GRONINGEN G; Skeel M. A., 2020, BIRDS OF THE WORLD, DOI [10.2173/bow.whimbr.01, DOI 10.2173/BOW.WHIMBR.01]; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; STODDARD PK, 1983, ANIM BEHAV, V31, P173, DOI 10.1016/S0003-3472(83)80186-9; Swift RJ, 2017, POLAR BIOL, V40, P1777, DOI 10.1007/s00300-017-2101-8; Taverner P. A., 1942, Wilson Bulletin, V54, P1; van Gils JA, 2006, ECOLOGY, V87, P1189, DOI 10.1890/0012-9658(2006)87[1189:FIATSE]2.0.CO;2; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Watts BD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92429-z; Watts BD, 2021, J AVIAN BIOL, V52, DOI 10.1111/jav.02629; Watts BD, 2019, CONDOR, V121, DOI 10.1093/condor/duy001; Watts Bryan D., 2015, Wader Study, V122, P37; Watts BD, 2011, WATERBIRDS, V34, P347, DOI 10.1675/063.034.0308; Watts Bryan D., 2008, Wader Study Group Bulletin, V115, P119; Wauchope HS, 2017, GLOBAL CHANGE BIOL, V23, P1085, DOI 10.1111/gcb.13404; Wetlands International, 2019, WATERBIRD POPULATION; WILLIAMS T C, 1977, American Birds, V31, P251; Yasue M, 2005, J ETHOL, V23, P199, DOI 10.1007/s10164-005-0152-8; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Ydenberg RC, 2017, OECOLOGIA, V183, P1101, DOI 10.1007/s00442-017-3835-2; ZWARTS L, 1990, ARDEA, V78, P257	58	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0260339	10.1371/journal.pone.0260339	http://dx.doi.org/10.1371/journal.pone.0260339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972114	Green Published, gold			2022-12-26	WOS:000773555700013
J	Evaristi, MF; Poirier, B; Chenede, X; Lefebvre, AM; Roccon, A; Gillot, F; Beeske, S; Corbier, A; Pruniaux-Harnist, MP; Janiak, P; Parkar, AA				Evaristi, Maria Francesca; Poirier, Bruno; Chenede, Xavier; Lefebvre, Anne-Marie; Roccon, Alain; Gillot, Florence; Beeske, Sandra; Corbier, Alain; Pruniaux-Harnist, Marie-Pierre; Janiak, Philip; Parkar, Ashfaq A.			A G-protein-biased S1P(1) agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; ENDOTHELIAL DYSFUNCTION; FIBROSIS; RECEPTOR	Aim Heart failure with preserved ejection fraction (HFpEF) is a major cause of death worldwide with no approved treatment. Left ventricular hypertrophy (LVH) and diastolic dysfunction represent the structural and functional components of HFpEF, respectively. Endothelial dysfunction is prevalent in HFpEF and predicts cardiovascular events. We investigated if SAR247799, a G-protein-biased sphingosine-1-phosphate receptor 1 (S1P(1)) agonist with endothelial-protective properties, could improve cardiac and renal functions in a rat model of metabolic syndrome LVH and diastolic function. Methods 31- and 65-week-old obese ZSF1 (Ob-ZSF1) rats, representing adult and aged animals with LVH and diastolic dysfunction, were randomized to a chow diet containing 0.025% (w/w) of SAR247799, or control (CTRL) chow for 4 weeks. Age-matched lean ZSF1 (Le-ZSF1) rats were fed control chow. Echocardiography, telemetry, biochemical and histological analysis were performed to evaluate the effect of SAR247799. Results Echocardiography revealed that Ob-ZSF1 rats, in contrast to Le-ZSF1 rats, developed progressive diastolic dysfunction and cardiac hypertrophy with age. SAR247799 blunted the progression of diastolic dysfunction in adult and aged animals: in adult animals E/e' was evaluated at 21.8 1.4 for Ob-ZSF1-CTRL, 19.5 +/- 1.2 for Ob-ZSF1-SAR247799 p<0.01, and 19.5 +/- 2.3 for Le-ZSF1-CTRL (median +/- IQR). In aged animals E/e' was evaluated at 23.15 +/- 4.45 for Ob-ZSF1-CTRL, 19.5 +/- 5 for Ob-ZSF1-SAR247799 p<0.01, and 16.69 +/- 1.7 for Le-ZSF1-CTRL, p<0.01 (median +/- IQR). In aged animals, SAR247799 reduced cardiac hypertrophy (g/mm mean +/- SEM of heart weight/tibia length 0.053 +/- 0.001 for Ob-ZSF1-CTRL vs 0.046 +/- 0.002 for Ob-ZSF1-SAR247799 p<0.01, Le-ZSF1-CTRL 0.035 +/- 0.001) and myocardial perivascular collagen content (p<0.001), independently of any changes in microvascular density. In adult animals, SAR247799 improved endothelial function as assessed by the very low frequency bands of systolic blood pressure variability (mean +/- SEM 67.8 +/- 3.41 for Ob-ZSF1-CTRL 55.8 +/- 4.27 or Ob-ZSF1-SAR247799, p<0.05 and 57.3 +/- 1.82 Le-ZSF1-CTRL), independently of any modification of arterial blood pressure. In aged animals, SAR247799 reduced urinary protein/creatinine ratio, an index of glomerular injury, (10.3 +/- 0.621 vs 8.17 +/- 0.231 for Ob-ZSF1-CTRL vs Ob-ZSF1-SAR247799, respectively, p<0.05 and 0.294 +/- 0.029 for Le-ZSF1-CTRL, mean +/- SEM) and the fractional excretion of electrolytes. Circulating lymphocytes were not decreased by SAR247799, confirming lack of S1P(1) desensitization. Conclusions These experimental findings suggest that S1P(1) activation with SAR247799 may be considered as a new therapeutic approach for LVH and diastolic dysfunction, major components of HFpEF.	[Evaristi, Maria Francesca; Poirier, Bruno; Chenede, Xavier; Gillot, Florence; Beeske, Sandra; Corbier, Alain; Pruniaux-Harnist, Marie-Pierre; Janiak, Philip] Sanofi R&D, Diabet & Cardiovasc Res, Chilly Mazarin, France; [Lefebvre, Anne-Marie] Sanofi R&D, Mol Histol & Bioimaging Translat Sci, Chilly Mazarin, France; [Roccon, Alain] Sanofi R&D, Translat Med & Early Dev, Biomarkers & Clin Bioanal, Montpellier, France; [Parkar, Ashfaq A.] Sanofi US Serv, Diabet & Cardiovasc Res, Bridgewater, NJ USA	Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Evaristi, MF (corresponding author), Sanofi R&D, Diabet & Cardiovasc Res, Chilly Mazarin, France.	maria-francesca.evaristi@sanoti.com		Evaristi, Maria Francesca/0000-0002-5188-4446; Lefebvre, Anne-Marie/0000-0001-5644-0441	Sanofi	Sanofi	This work was supported by Sanofi. The funder provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akiyama E, 2012, J AM COLL CARDIOL, V60, P1778, DOI 10.1016/j.jacc.2012.07.036; Anker SD, 2021, NEW ENGL J MED, V385, P1451, DOI 10.1056/NEJMoa2107038; Beldhuis IE, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003588; Bergougnan L, 2021, BRIT J CLIN PHARMACO, V87, P2303, DOI 10.1111/bcp.14632; Bergougnan L, 2021, BRIT J CLIN PHARMACO, V87, P598, DOI 10.1111/bcp.14422; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Cannavo A, 2013, CIRCULATION, V128, P1612, DOI 10.1161/CIRCULATIONAHA.113.002659; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; Dai ZH, 2012, J CARDIOL, V60, P416, DOI 10.1016/j.jjcc.2012.06.009; de Boer RA, 2019, EUR J HEART FAIL, V21, P272, DOI 10.1002/ejhf.1406; Desjardins F, 2008, CARDIOVASC RES, V79, P527, DOI 10.1093/cvr/cvn080; Ellison DH, 2017, ADV CHRONIC KIDNEY D, V24, P332, DOI 10.1053/j.ackd.2017.07.003; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Grailhe P, 2020, FEBS OPEN BIO, V10, P2010, DOI 10.1002/2211-5463.12951; Hamdani N, 2013, CIRC-HEART FAIL, V6, P1239, DOI 10.1161/CIRCHEARTFAILURE.113.000539; Li NJ, 2016, FRONT BIOSCI-LANDMRK, V21, P1296, DOI 10.2741/4458; Liu XX, 2020, J CELL MOL MED, V24, P2013, DOI 10.1111/jcmm.14900; Meyer M, 2018, HEART FAIL REV, V23, P499, DOI 10.1007/s10741-017-9660-1; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Mohanan A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/751513; Mottram PM, 2005, HEART, V91, P681, DOI 10.1136/hrt.2003.029413; Park SH, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-00997-7; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Perry HM, 2016, J AM SOC NEPHROL, V27, P3383, DOI 10.1681/ASN.2015080922; Pfeffer MA, 2019, CIRC RES, V124, P1598, DOI 10.1161/CIRCRESAHA.119.313572; Poirier B, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax8050; Polzin A, 2017, J MOL CELL CARDIOL, V110, P35, DOI 10.1016/j.yjmcc.2017.07.004; Schauer A, 2020, ESC HEART FAIL, V7, P2123, DOI 10.1002/ehf2.12915; Shah KS, 2017, J AM COLL CARDIOL, V70, P2476, DOI 10.1016/j.jacc.2017.08.074; Silverman Daniel N, 2019, Curr Treat Options Cardiovasc Med, V21, P20, DOI 10.1007/s11936-019-0709-4; Solomon SD, 2019, NEW ENGL J MED, V381, P1609, DOI 10.1056/NEJMoa1908655; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Swendeman SL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2722; ter Maaten JM, 2016, EUR J HEART FAIL, V18, P588, DOI 10.1002/ejhf.497; Tofovic SP, 2016, J PHARMACOL EXP THER, V356, P333, DOI 10.1124/jpet.115.228841; Vaisar T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192616; Valero-Munoz Maria, 2017, JACC Basic Transl Sci, V2, P770, DOI 10.1016/j.jacbts.2017.07.013; van Dijk CGM, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002760; Yoshimoto T, 2011, J PHYSIOL SCI, V61, P373, DOI 10.1007/s12576-011-0158-7	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0257929	10.1371/journal.pone.0257929	http://dx.doi.org/10.1371/journal.pone.0257929			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030174	Green Submitted, gold, Green Published			2022-12-26	WOS:000812798500002
J	Almulhem, M; Thayakaran, R; Hanif, S; Gooden, T; Thomas, N; Hazlehurst, J; Tahrani, AA; Hanif, W; Nirantharakumar, K				Almulhem, Munerah; Thayakaran, Rasiah; Hanif, Shahjehan; Gooden, Tiffany; Thomas, Neil; Hazlehurst, Jonathan; Tahrani, Abd A.; Hanif, Wasim; Nirantharakumar, Krishnarajah			Ramadan is not associated with increased infection risk in Pakistani and Bangladeshi populations: Findings from controlled interrupted time series analysis of UK primary care data	PLOS ONE			English	Article							REGRESSION; OUTCOMES	Background The effect of fasting on immunity is unclear. Prolonged fasting is thought to increase the risk of infection due to dehydration. This study describes antibiotic prescribing patterns before, during, and after Ramadan in a primary care setting within the Pakistani and Bangladeshi populations in the UK, most of whom are Muslims, compared to those who do not observe Ramadan. Method Retrospective controlled interrupted time series analysis of electronic health record data from primary care practices. The study consists of two groups: Pakistanis/Bangladeshis and white populations. For each group, we constructed a series of aggregated, daily prescription data from 2007 to 2017 for the 30 days preceding, during, and after Ramadan, respectively. Findings Controlling for the rate in the white population, there was no evidence of increased antibiotic prescription in the Pakistani/Bangladeshi population during Ramadan, as compared to before Ramadan (IRR: 0.994; 95% CI: 0.988-1.001, p = 0.082) or after Ramadan (IRR: 1.006; 95% CI: 0.999-1.013, p = 0.082). Interpretation In this large, population-based study, we did not find any evidence to suggest that fasting was associated with an increased susceptibility to infection.	[Almulhem, Munerah; Thayakaran, Rasiah; Gooden, Tiffany; Thomas, Neil; Nirantharakumar, Krishnarajah] Univ Birmingham, Inst Appl Hlth Res, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Hanif, Shahjehan] UCL, Life & Med Sci, London, England; [Hazlehurst, Jonathan] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Tahrani, Abd A.] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Hanif, Wasim] Univ Hosp Birmingham NHS Fdn Trust, Dept Diabet, Birmingham, W Midlands, England	University of Birmingham; University of London; University College London; University of Birmingham; University of Birmingham	Nirantharakumar, K (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Hanif, W (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Diabet, Birmingham, W Midlands, England.	K.Nirantharan@bham.ac.uk	, Tiffany/AAV-2407-2021	, Tiffany/0000-0002-3905-5477				Adawi M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01144; Ali NB, 2019, J HEALTH CARE POOR U, V30, P1360, DOI 10.1353/hpu.2019.0099; Almeneessier AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226034; Babineaux SM, 2015, DIABETIC MED, V32, P819, DOI 10.1111/dme.12685; BaHammam A, 2010, APPETITE, V54, P426, DOI 10.1016/j.appet.2010.01.011; Baicker K., 2019, ERN HYPOTHESIS TESTI; Beetz R, 2003, EUR J CLIN NUTR, V57, pS52, DOI 10.1038/sj.ejcn.1601902; Berbudi A, 2020, CURR DIABETES REV, V16, P442, DOI 10.2174/1573399815666191024085838; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Bernal JL, 2018, INT J EPIDEMIOL, V47, P2082, DOI 10.1093/ije/dyy135; Bragazzi NL, 2015, J INFECT DEV COUNTR, V9, P1186, DOI 10.3855/jidc.5815; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Communities and Local Government, UNDERSTANDING MUSLIM; Elbarsha A, 2018, ANN SAUDI MED, V38, P344, DOI 10.5144/0256-4947.2018.344; Faris Mo'ez A-Islam E, 2020, Ann Thorac Med, V15, P125, DOI 10.4103/atm.ATM_151_20; Faris MAIE, 2020, BRIT J NUTR, V123, P1, DOI 10.1017/S000711451900254X; Faris E, 2012, NUTR RES, V32, P947, DOI 10.1016/j.nutres.2012.06.021; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Ibarra-Coronado EG, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/678164; IDF and the DAR International Alliance, 2016, DIAB RAM PRACT GUID; International Diabetes Federation, 2021, IDF DIAB ATLAS2019; Jabbar A, 2017, DIABETES RES CLIN PR, V132, P19, DOI 10.1016/j.diabres.2017.07.014; Lahdimawan A., 2014, TUBERCULOSIS IOSR J, V9, P24; Latifynia Afshineh, 2009, J Ayub Med Coll Abbottabad, V21, P111; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Myles IA, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-61; Office for National Statistics, 2012, REL ENGL WAL 2011; Office for National Statistics, FULL STOR WHAT DOES; Oldroyd J, 2005, POSTGRAD MED J, V81, P486, DOI 10.1136/pgmj.2004.029124; Pew Research Center, 2015, FUT WORLD REL POP GR; Pew Research Center, 2020, WORLDS MUSL UN DIVER; Roky R, 2001, J SLEEP RES, V10, P319, DOI 10.1046/j.1365-2869.2001.00269.x; Salahuddin N, 2015, J PAK MED ASSOC, V65, pS65; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Tang YQ, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0086-y; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262530	10.1371/journal.pone.0262530	http://dx.doi.org/10.1371/journal.pone.0262530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025960	gold, Green Published			2022-12-26	WOS:000796264200079
J	Arana, C; Liang, CY; Brock, M; Zhang, B; Zhou, JC; Chen, L; Cantarel, B; SoRelle, J; Hooper, LV; Raj, P				Arana, Carlos; Liang, Chaoying; Brock, Matthew; Zhang, Bo; Zhou, Jinchun; Chen, Li; Cantarel, Brandi; SoRelle, Jeffrey; Hooper, Lora V.; Raj, Prithvi			A short plus long-amplicon based sequencing approach improves genomic coverage and variant detection in the SARS-CoV-2 genome	PLOS ONE			English	Article							MUTATIONS; EPIDEMIOLOGY; EVOLUTION; SPREAD	High viral transmission in the COVID-19 pandemic has enabled SARS-CoV-2 to acquire new mutations that may impact genome sequencing methods. The ARTIC.v3 primer pool that amplifies short amplicons in a multiplex-PCR reaction is one of the most widely used methods for sequencing the SARS-CoV-2 genome. We observed that some genomic intervals are poorly captured with ARTIC primers. To improve the genomic coverage and variant detection across these intervals, we designed long amplicon primers and evaluated the performance of a short (ARTIC) plus long amplicon (MRL) sequencing approach. Sequencing assays were optimized on VR-1986D-ATCC RNA followed by sequencing of nasopharyngeal swab specimens from fifteen COVID-19 positive patients. ARTIC data covered 94.47% of the virus genome fraction in the positive control and patient samples. Variant analysis in the ARTIC data detected 217 mutations, including 209 single nucleotide variants (SNVs) and eight insertions & deletions. On the other hand, long-amplicon data detected 156 mutations, of which 80% were concordant with ARTIC data. Combined analysis of ARTIC + MRL data improved the genomic coverage to 97.03% and identified 214 high confidence mutations. The combined final set of 214 mutations included 203 SNVs, 8 deletions and 3 insertions. Analysis showed 26 SARS-CoV-2 lineage defining mutations including 4 known variants of concern K417N, E484K, N501Y, P618H in spike gene. Hybrid analysis identified 7 nonsynonymous and 5 synonymous mutations across the genome that were either ambiguous or not called in ARTIC data. For example, G172V mutation in the ORF3a protein and A2A mutation in Membrane protein were missed by the ARTIC assay. Thus, we show that while the short amplicon (ARTIC) assay provides good genomic coverage with high throughput, complementation of poorly captured intervals with long amplicon data can significantly improve SARS-CoV-2 genomic coverage and variant detection.	[Arana, Carlos; Liang, Chaoying; Brock, Matthew; Zhang, Bo; Zhou, Jinchun; Hooper, Lora V.; Raj, Prithvi] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Arana, Carlos; Liang, Chaoying; Brock, Matthew; Zhou, Jinchun; Raj, Prithvi] Univ Texas Southwestern Med Ctr Dallas, Microbiome & Genom Core, Dallas, TX 75390 USA; [Chen, Li; SoRelle, Jeffrey] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Cantarel, Brandi] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Raj, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.; Raj, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Microbiome & Genom Core, Dallas, TX 75390 USA.	prithvi.raj@utsouthwestern.edu			Microbiome Research Laboratory at UT Southwestern Medical Center	Microbiome Research Laboratory at UT Southwestern Medical Center	Present study was supported by Microbiome Research Laboratory at UT Southwestern Medical Center.	Aleem A, 2021, STATPEARLS; Alteri C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20688-x; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Artesi M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01598-20; Ascoli CA, 2021, NAT BIOTECHNOL, V39, P274, DOI 10.1038/s41587-021-00845-3; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Charre C, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa075; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chen ZG, 2021, J VIROL METHODS, V289, DOI 10.1016/j.jviromet.2020.114032; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x; Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gohl DM, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07283-6; Hasan MR, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.03278-20; Hodcroft EB, 2021, NATURE, V595, P707, DOI [10.1038/s41586-021-03677-y, 10.1101/2020.10.25.20219063]; Itokawa K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239403; Kandeel M, 2020, J MED VIROL, V92, P660, DOI 10.1002/jmv.25754; Kurtzer GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177459; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Maurano MT, 2020, GENOME RES, V30, DOI 10.1101/gr.266676.120; McNamara RP, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108352; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Nasir JA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080895; Munnink BOB, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0997-y; Shah SA, 2021, LANCET DIGIT HEALTH, V3, pE539, DOI 10.1016/S2589-7500(21)00175-8; Singh D, 2021, EXP MOL MED, V53, P537, DOI 10.1038/s12276-021-00604-z; Tahan S, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00075-21; Tang JLW, 2021, J INFECTION, V82, pE27, DOI 10.1016/j.jinf.2020.12.024; Tyson JR., 2020, BIORXIV; Wang R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01754-6; Washington Nicole L, 2021, medRxiv, DOI 10.1101/2021.02.06.21251159; Weber S, 2020, VIRUS RES, V289, DOI 10.1016/j.virusres.2020.198170; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Xiao MF, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00751-4	41	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261014	10.1371/journal.pone.0261014	http://dx.doi.org/10.1371/journal.pone.0261014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025877	Green Published, gold, Green Submitted			2022-12-26	WOS:000796264200009
J	AbdelGhaffar, MM; Omran, D; Elgebaly, A; Bahbah, EI; Afify, S; AlSoda, M; El-Shiekh, M; ElSayed, ES; Shaaban, SS; AbdelHafez, S; Elkelany, K; Eltayar, AA; Ali, OS; Kamal, L; Heiba, AM; El Askary, A; Shousha, HI				AbdelGhaffar, Muhammad M.; Omran, Dalia; Elgebaly, Ahmed; Bahbah, Eshak, I; Afify, Shimaa; AlSoda, Mohamed; El-Shiekh, Mohamed; ElSayed, Enass S.; Shaaban, Soha S.; AbdelHafez, Samah; Elkelany, Khaled; Eltayar, Ayman A.; Ali, Omnia S.; Kamal, Lamiaa; Heiba, Ahmed M.; El Askary, Ahmad; Shousha, Hend Ibrahim			Prediction of mortality in hospitalized Egyptian patients with Coronavirus disease-2019: A multicenter retrospective study	PLOS ONE			English	Article							COVID-19; ANTICOAGULATION	We aimed to assess the epidemiological, clinical, and laboratory characteristics associated with mortality among hospitalized Egyptian patients with COVID-19. A multicenter, retrospective study was conducted on all polymerase chain reaction (PCR)-confirmed COVID-19 cases admitted through the period from April to July 2020. A generalized linear model was reconstructed with covariates based on predictor's statistical significance and clinically relevance. The odds ratio (OR) was calculated by using stepwise logistic regression modeling. A total of 3712 hospitalized patients were included; of them, 900 deaths were recorded (24.2%). Compared to survived patients, non-survived patients were more likely to be older than 60 years (65.7%), males (53.6%) diabetic (37.6%), hypertensive (37.2%), and had chronic renal insufficiency (9%). Non-survived patients were less likely to receive azithromycin (p <0.001), anticoagulants (p <0.001), and steroids (p <0.001). We found that age >= 60 years old (OR = 2.82, 95% CI 2.05-3.86; p <0.0001), diabetes mellitus (OR = 1.58, 95% CI 1.14-2.19; p = 0.006), hypertension (OR = 1.69, 95% CI 1.22-2.36; p = 0.002), chronic renal insufficiency (OR = 3.15, 95% CI 1.84-5.38; p <0.0001), tachycardia (OR = 1.65, 95% CI 1.22-2.23; p <0.001), hypoxemia (OR = 5.69, 95% CI 4.05-7.98; p <0.0001), GCS <13 (OR 515.2, 95% CI 148.5-1786.9; p <0.0001), the use of therapeutic dose of anticoagulation (OR = 0.4, 95% CI 0.22-0.74, p = 0.003) and azithromycin (OR = 0.16, 95% CI 0.09-0.26; p <0.0001) were independent negative predictors of mortality. In conclusion, age >60 years, comorbidities, tachycardia, hypoxemia, and altered consciousness level are independent predictors of mortality among Egyptian hospitalized patients with COVID-19. On the other hand, the use of anticoagulants and azithromycin is associated with reduced mortality.	[AbdelGhaffar, Muhammad M.; AbdelHafez, Samah; Heiba, Ahmed M.] Ahmed Maher Teaching Hosp, Gastroenterol & Infect Dis Dept, Cairo, Egypt; [AbdelGhaffar, Muhammad M.; Omran, Dalia; AlSoda, Mohamed] Gen Org Teaching Hosp & Inst GOTHI, Cairo, Egypt; [Omran, Dalia; Shousha, Hend Ibrahim] Cairo Univ, Fac Med, Endem Med Dept, Cairo, Egypt; [Elgebaly, Ahmed; Bahbah, Eshak, I] Al Azhar Univ, Fac Med, Cairo, Egypt; [Afify, Shimaa] Natl Hepatol & Trop Med Res Inst, Gastroenterol Dept, Cairo, Egypt; [El-Shiekh, Mohamed] Matareya Teaching Hosp, Chest Unit, Cairo, Egypt; [ElSayed, Enass S.] Ahmed Maher Teaching Hosp, Nephrol Dept, Cairo, Egypt; [Shaaban, Soha S.] El Matareya Educ Hosp, Rheumatol Dept, Cairo, Egypt; [Elkelany, Khaled] Shebin Elkom Teaching Hosp, Pediat Dept, Shibin Al Kawm, Egypt; [Eltayar, Ayman A.] Damanhour Teaching Hosp, Intens Care Dept, Damanhour, Egypt; [Ali, Omnia S.] Ahmed Maher Teaching Hosp, Clin & Chem Pathol Dept, Cairo, Egypt; [Kamal, Lamiaa] Sahel Gen Hosp, Clin & Chem Pathol Dept, Cairo, Egypt; [Heiba, Ahmed M.] Natl Res Ctr, Internal Med Dept, Cairo, Egypt; [El Askary, Ahmad] Taif Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Taif, Saudi Arabia	Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); Damanhour University; General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Taif University	Shousha, HI (corresponding author), Cairo Univ, Fac Med, Endem Med Dept, Cairo, Egypt.	hendshousha@yahoo.com	Bahbah, Eshak I/I-4504-2019; heiba, ahmed/GQI-1599-2022; Afify, Shimaa/AAB-6018-2021	Bahbah, Eshak I/0000-0002-6168-9134; Afify, Shimaa/0000-0001-5937-4240; Omran, Dalia/0000-0002-5513-6955; Heiba, Ahmed/0000-0002-5200-5458; Shousha, Hend Ibrahim/0000-0002-0928-4738; Elgebaly, Ahmed/0000-0002-8324-0960	Taif University, Taif, Saudi Arabia [TURSP-2020/82]	Taif University, Taif, Saudi Arabia	The authors acknowledge the support of Taif University Researchers Supporting Project number (TURSP-2020/82), Taif University, Taif, Saudi Arabia.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2020, EP UPD MONK MULT OUT; [Anonymous], 2020, US; [Anonymous], 2013, KIDNEY INT SUPPL, V3, P5, DOI [10.1038/kisup.2012.77, DOI 10.1038/KISUP.2012.77]; Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100169; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chen Y., 2020, PREPRINT, DOI [10.20944/preprints202002.0258.v2, DOI 10.20944/PREPRINTS202002.0258.V2]; Chen YY, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101205; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Cuker A., 2020, UPTODATE; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Fung SY, 2020, EMERG MICROBES INFEC, V9, P558, DOI 10.1080/22221751.2020.1736644; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Griesbeck M, 2015, J IMMUNOL, V195, P5327, DOI 10.4049/jimmunol.1501684; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harrison SL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003321; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096; Klein S, 2020, J CLIN INVEST, V130, P6141, DOI 10.1172/JCI142004; Kragholm K, 2021, CLIN INFECT DIS, V73, pE4025, DOI 10.1093/cid/ciaa924; Lee K, 2009, GLOB INST, P1; Lim S, 2021, NAT REV ENDOCRINOL, V17, P11, DOI 10.1038/s41574-020-00435-4; McBane RD, 2020, MAYO CLIN PROC, V95, P2467, DOI 10.1016/j.mayocp.2020.08.030; Middleton PM, 2012, AUSTRALAS EMERG NURS, V15, P170, DOI 10.1016/j.aenj.2012.06.002; Ministry of Health and Population, 2020, EG MAN PROT COVID 19; Nasiri MJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00459; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pawelec G, 2018, EXP GERONTOL, V105, P4, DOI 10.1016/j.exger.2017.10.024; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Singh S, 2020, GASTROENTEROLOGY, V159, P768, DOI 10.1053/j.gastro.2020.04.064; Tiwari NR, 2020, J CRIT CARE MED, V6, P217, DOI 10.2478/jccm-2020-0033; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Walker JL, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10427-2; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie P, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00189; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zhang BC, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00157; Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954	45	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262348	10.1371/journal.pone.0262348	http://dx.doi.org/10.1371/journal.pone.0262348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015782	Green Published, gold			2022-12-26	WOS:000814820600012
J	Shu, L; Chen, A; Li, LR; Yao, L; He, YD; Xu, JB; Gu, W; Li, Q; Wang, K; Zhang, TC; Liu, GQ				Shu, Le; Chen, Ao; Li, Linrui; Yao, Lun; He, Yiduo; Xu, Jianbo; Gu, Wei; Li, Qiang; Wang, Kun; Zhang, Tongcun; Liu, Guoquan			NRG1 regulates Fra-1 transcription and metastasis of triple-negative breast cancer cells via the c-Myc ubiquitination as manipulated by ERK1/2-mediated Fbxw7 phosphorylation	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; INVASIVENESS; EXPRESSION; HEREGULIN; MICROENVIRONMENT; PROTOONCOGENE; DEGRADATION; INDUCTION; MOTILITY; RNA	Neuregulin 1 (NRG1), an EGF family member, is expressed in most breast cancers. It promotes breast cancer growth and metastasis in HER2 receptor expressing breast cancer. However, its role in triple-negative breast cancer (TNBC) has not been extensively investigated. In this study, we observed that NRG1 knockdown resulted in the suppression of TNBC cells (MDA-MB-231 cell and MDA-MB-468 cell) metastasis and downregulation of Fra-1 (FOS-like 1, AP-1 transcription factor subunit, which is an overexpressed transcription factor in TNBC and acts as a coordinator of metastasis). In addition, the transcriptional regulation of Fra-1 by NRG1 was mediated by ERK1/2-induced recruitment of c-Myc (MYC proto-oncogene, transcription factor) to the promoter of Fra-1. Furthermore, c-Myc was targeted by an E3 ligase Fbxw7 and its ubiquitination and degradation by Fbxw7 was regulated by NRG1 expression and ERK1/2-mediated Fbxw7 phosphorylation that results in the dissociation and nuclear import of c-Myc. Taken together, the results of our study demonstrated that NRG1 regulates the Fra-1 expression to coordinate the TNBC metastasis via the novel ERK1/2-Fbxw7-c-Myc pathway and targeting NRG1 expression could be a potential therapeutic strategy for TNBC.	[Shu, Le; Gu, Wei; Li, Qiang; Liu, Guoquan] Bengbu Med Coll, Anhui Prov Key Lab Translat Canc Res, Bengbu 233030, Anhui, Peoples R China; [Chen, Ao; Zhang, Tongcun] Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Inst Biol & Med, Wuhan 430070, Hubei, Peoples R China; [Li, Linrui; Yao, Lun] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Wuhan 430070, Hubei, Peoples R China; [He, Yiduo; Xu, Jianbo] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Gu, Wei; Liu, Guoquan] Bengbu Med Coll, Sch Lab Med, Dept Biochem & Mol Biol, Bengbu 233030, Anhui, Peoples R China; [Li, Qiang] Bengbu Med Coll, Sch Biol Sci, Dept Cell Biol, Bengbu 233030, Anhui, Peoples R China; [Wang, Kun] Hubei Univ Med, Coll Biomed Engn, Shiyan 442000, Hubei, Peoples R China; [Zhang, Tongcun] Tianjin Univ Sci & Technol, Coll Biotechnol, Key Lab Ind Fermentat Microbiol, Minist Educ & Tianjin, Tianjin 300457, Peoples R China	Bengbu Medical College; Wuhan University of Science & Technology; Huazhong Agricultural University; Huazhong Agricultural University; Bengbu Medical College; Bengbu Medical College; Hubei University of Medicine; Tianjin University Science & Technology	Shu, L; Liu, GQ (corresponding author), Bengbu Med Coll, Anhui Prov Key Lab Translat Canc Res, Bengbu 233030, Anhui, Peoples R China.; Liu, GQ (corresponding author), Bengbu Med Coll, Sch Lab Med, Dept Biochem & Mol Biol, Bengbu 233030, Anhui, Peoples R China.	Leshu0101@163.com; guoquanliu@bbmc.edu.cn	Zhang, Tong/HGC-1090-2022	Chen, Ao/0000-0002-2330-0650	National Natural Science Foundation of China [31372418]; Bengbu Medical College Scientific and Technology Self-Innovation Foundation Program [BYKC2003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bengbu Medical College Scientific and Technology Self-Innovation Foundation Program	This study was partially supported financially by the National Natural Science Foundation of China (31372418, GL) and Bengbu Medical College Scientific and Technology Self-Innovation Foundation Program (No. BYKC2003, GL).	Adiseshaiah P, 2005, ONCOGENE, V24, P4193, DOI 10.1038/sj.onc.1208583; Adiseshaiah P, 2008, J CELL PHYSIOL, V216, P405, DOI 10.1002/jcp.21410; Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Bakiri L, 2015, CELL DEATH DIFFER, V22, P336, DOI 10.1038/cdd.2014.157; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheng FF, 2016, CANCER LETT, V375, P274, DOI 10.1016/j.canlet.2016.03.010; Cheng LS, 2009, CANCER LETT, V280, P50, DOI 10.1016/j.canlet.2009.02.007; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Debinski W, 2005, MOL CANCER RES, V3, P237; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Finigan JH, 2011, J BIOL CHEM, V286, P10660, DOI 10.1074/jbc.M110.208041; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Leconet W, 2017, CLIN CANCER RES, V23, P2806, DOI 10.1158/1078-0432.CCR-16-1316; Liu GQ, 2012, BLOOD, V120, P1942, DOI 10.1182/blood-2011-12-397430; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; Marino N, 2013, AM J PATHOL, V183, P1084, DOI 10.1016/j.ajpath.2013.06.012; Mizejewski G.J., 2019, J CANC METASTASIS TR, V5, P35, DOI [10.20517/2394-4722.2018.70, DOI 10.20517/2394-4722.2018.70]; Momeny M, 2015, ONCOTARGET, V6, P3932, DOI 10.18632/oncotarget.2846; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Ramos-Nino ME, 2003, CANCER RES, V63, P3539; Rattanasinchai C, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.44; Rothschild E, 2015, BREAST CANCER-BASIC, V9, P7, DOI 10.4137/BCBCR.S29423; Sundqvist A, 2020, ONCOGENE, V39, P4436, DOI 10.1038/s41388-020-1299-z; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Zhang PF, 2016, EMBO REP, V17, P1204, DOI 10.15252/embr.201642067; Zhao CY, 2014, CANCER RES, V74, P3983, DOI 10.1158/0008-5472.CAN-13-3396	34	3	3	5	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					907	919		10.1038/s41388-021-02142-4	http://dx.doi.org/10.1038/s41388-021-02142-4		JAN 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34992218				2022-12-26	WOS:000739823800002
J	Sirshar, M; Paracha, MFK; Akram, MU; Alghamdi, NS; Zaidi, SZY; Fatima, T				Sirshar, Mehreen; Paracha, Muhammad Faheem Khalil; Akram, Muhammad Usman; Alghamdi, Norah Saleh; Zaidi, Syeda Zainab Yousuf; Fatima, Tatheer			Attention based automated radiology report generation using CNN and LSTM	PLOS ONE			English	Article								The automated generation of radiology reports provides X-rays and has tremendous potential to enhance the clinical diagnosis of diseases in patients. A new research direction is gaining increasing attention that involves the use of hybrid approaches based on natural language processing and computer vision techniques to create auto medical report generation systems. The auto report generator, producing radiology reports, will significantly reduce the burden on doctors and assist them in writing manual reports. Because the sensitivity of chest X-ray (CXR) findings provided by existing techniques not adequately accurate, producing comprehensive explanations for medical photographs remains a difficult task. A novel approach to address this issue was proposed, based on the continuous integration of convolutional neural networks and long short-term memory for detecting diseases, followed by the attention mechanism for sequence generation based on these diseases. Experimental results obtained by using the Indiana University CXR and MIMIC-CXR datasets showed that the proposed model attained the current state-of-the-art efficiency as opposed to other solutions of the baseline. BLEU-1, BLEU-2, BLEU-3, and BLEU-4 were used as the evaluation metrics.	[Sirshar, Mehreen; Paracha, Muhammad Faheem Khalil; Akram, Muhammad Usman] Natl Univ Sci & Technol, Coll Elect & Mech, Dept Comp & Software Engn, Islamabad, Pakistan; [Alghamdi, Norah Saleh] Princess Nourah Bint Abdulrahman Univ, Coll Comp & Informat Sci, Riyadh, Saudi Arabia; [Zaidi, Syeda Zainab Yousuf] Bahria Univ, Dept Comp Sci, Islamabad, Pakistan; [Fatima, Tatheer] Pakistan Inst Med Sci, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan; Princess Nourah bint Abdulrahman University; Pakistan Institute of Medical Sciences	Paracha, MFK (corresponding author), Natl Univ Sci & Technol, Coll Elect & Mech, Dept Comp & Software Engn, Islamabad, Pakistan.	faheem.paracha18@ce.ceme.edu.pk		Khalil Paracha, Muhammad Faheem/0000-0002-6279-6193; , Norah/0000-0001-6421-6001	Deanship of Scientific Research, Princess Nourah bint Abdulrahman University, through the "Program of Research Project Funding After Publication" [42-PRFA-P-53]	Deanship of Scientific Research, Princess Nourah bint Abdulrahman University, through the "Program of Research Project Funding After Publication"(Princess Nourah bint Abdulrahman University)	This research project was funded by the Deanship of Scientific Research, Princess Nourah bint Abdulrahman University, through the "Program of Research Project Funding After Publication, grant No (42-PRFA-P-53)". https://www.pnu.edu.sa/en/Pages/home.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarghaly Omar, 2021, Informatics in Medicine Unlocked, V24, DOI 10.1016/j.imu.2021.100557; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2018, LARGE SCALE AUTOMATE; Brady Adrian, 2012, Ulster Med J, V81, P3; Bustos A, 2020, MED IMAGE ANAL, V66, DOI 10.1016/j.media.2020.101797; Chen Z., 2020, ARXIV PREPRINT ARXIV; Cho K., 2014, EMNLP, DOI 10.3115/v1/w14-4012; Delrue L., 2011, COMP INTERPRETATION, P27; Demner-Fushman D, 2016, J AM MED INFORM ASSN, V23, P304, DOI 10.1093/jamia/ocv080; Donahue J, 2014, PR MACH LEARN RES, V32; Donahue J, 2017, IEEE T PATTERN ANAL, V39, P677, DOI 10.1109/TPAMI.2016.2599174; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; Farhadi A, 2010, LECT NOTES COMPUT SC, V6314, P15, DOI 10.1007/978-3-642-15561-1_2; Gale W., 2018, ARXIV PREPRINT ARXIV; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hsu T.M.H., 2018, ARXIV PREPRINT ARXIV; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Jing B., 2017, ARXIV171108195; Kar C, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1134-8; Kingma DP., 2014, ADAM METHOD STOCHAST; Krause J, 2017, PROC CVPR IEEE, P3337, DOI 10.1109/CVPR.2017.356; Kulkarni G, 2013, IEEE T PATTERN ANAL, V35, P2891, DOI 10.1109/TPAMI.2012.162; Li Yuan, 2018, ADV NEURAL INFORM PR, P1530; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu Guanxiong, 2019, ARXIV PREPRINT ARXIV, P249; Miura Y., 2020, ARXIV PREPRINT ARXIV; Moradi M, 2018, LECT NOTES COMPUT SC, V11070, P449, DOI 10.1007/978-3-030-00928-1_51; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Papineni K, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P311, DOI 10.3115/1073083.1073135; Schlegl Thomas, 2015, Inf Process Med Imaging, V24, P437, DOI 10.1007/978-3-319-19992-4_34; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Shin HC, 2015, PROC CVPR IEEE, P1090, DOI 10.1109/CVPR.2015.7298712; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; Tanti M., 2019, ARXIV PREPRINT ARXIV; Vedantam R, 2015, PROC CVPR IEEE, P4566, DOI 10.1109/CVPR.2015.7299087; Wang X, 2016, ARXIV PREPRINT ARXIV; Wang XS, 2018, PROC CVPR IEEE, P9049, DOI 10.1109/CVPR.2018.00943; Wang YB, 2017, PROC CVPR IEEE, P2097, DOI 10.1109/CVPR.2017.226; Xu K, 2015, PR MACH LEARN RES, V37, P2048; You QZ, 2016, PROC CVPR IEEE, P4651, DOI 10.1109/CVPR.2016.503	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262209	10.1371/journal.pone.0262209	http://dx.doi.org/10.1371/journal.pone.0262209			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990477	gold, Green Published			2022-12-26	WOS:000815783800020
J	Ito, T; Kubiura-Ichimaru, M; Murakami, Y; Bogutz, AB; Lefebvre, L; Suetake, I; Tajima, S; Tada, M				Ito, Takamasa; Kubiura-Ichimaru, Musashi; Murakami, Yuri; Bogutz, Aaron B.; Lefebvre, Louis; Suetake, Isao; Tajima, Shoji; Tada, Masako			DNMT1 regulates the timing of DNA methylation by DNMT3 in an enzymatic activity-dependent manner in mouse embryonic stem cells	PLOS ONE			English	Article							DE-NOVO METHYLATION; METHYLTRANSFERASE DNMT1; SELF-RENEWAL; MAINTENANCE; LSH; TET; DEMETHYLATION; TRANSCRIPTION; ACTIVATION; BINDING	DNA methylation (DNAme; 5-methylcytosine, 5mC) plays an essential role in mammalian development, and the 5mC profile is regulated by a balance of opposing enzymatic activities: DNA methyltransferases (DNMTs) and Ten-eleven translocation dioxygenases (TETs). In mouse embryonic stem cells (ESCs), de novo DNAme by DNMT3 family enzymes, demethylation by the TET-mediated conversion of 5mC to 5-hydroxymethylation (5hmC), and maintenance of the remaining DNAme by DNMT1 are actively repeated throughout cell cycles, dynamically forming a constant 5mC profile. Nevertheless, the detailed mechanism and physiological significance of this active cyclic DNA modification in mouse ESCs remain unclear. Here by visualizing the localization of DNA modifications on metaphase chromosomes and comparing whole-genome methylation profiles before and after the mid-S phase in ESCs lacking Dnmt1 (1KO ESCs), we demonstrated that in 1KO ESCs, DNMT3-mediated remethylation was interrupted during and after DNA replication. This results in a marked asymmetry in the distribution of 5hmC between sister chromatids at mitosis, with one chromatid being almost no 5hmC. When introduced in 1KO ESCs, the catalytically inactive form of DNMT1 (DNMT1CI) induced an increase in DNAme in pericentric heterochromatin and the DNAme-independent repression of IAPEz, a retrotransposon family, in 1KO ESCs. However, DNMT1CI could not restore the ability of DNMT3 to methylate unmodified dsDNA de novo in S phase in 1KO ESCs. Furthermore, during in vitro differentiation into epiblasts, 1KO ESCs expressing DNMT1CI showed an even stronger tendency to differentiate into the primitive endoderm than 1KO ESCs and were readily reprogrammed into the primitive streak via an epiblast-like cell state, reconfirming the importance of DNMT1 enzymatic activity at the onset of epiblast differentiation. These results indicate a novel function of DNMT1, in which DNMT1 actively regulates the timing and genomic targets of de novo methylation by DNMT3 in an enzymatic activity-dependent and independent manner, respectively.	[Ito, Takamasa; Kubiura-Ichimaru, Musashi; Murakami, Yuri; Tada, Masako] Toho Univ, Fac Sci, Dept Biol, Stem Cells & Reprogramming Lab, Funabashi, Chiba, Japan; [Bogutz, Aaron B.; Lefebvre, Louis] Univ British Columbia, Life Sci Inst, Dept Med Genet, Vancouver, BC, Canada; [Suetake, Isao] Nakamura Gakuen Univ, Grad Sch Nutr Sci, Dept Nutr Sci, Fukuoka, Japan; [Suetake, Isao; Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka, Japan	Toho University; University of British Columbia; Osaka University	Tada, M (corresponding author), Toho Univ, Fac Sci, Dept Biol, Stem Cells & Reprogramming Lab, Funabashi, Chiba, Japan.	masako.tada@sci.toho-u.ac.jp	; Lefebvre, Louis/O-9309-2016	Ito, Takamasa/0000-0003-4220-3861; Tada, Masako/0000-0003-3641-3520; Lefebvre, Louis/0000-0001-5664-9480	JSPS [24613004, 2610904]; CIHR [PJT-165992]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CIHR(Canadian Institutes of Health Research (CIHR))	Funds from the JSPS supported this work to MT (Grant 24613004) and MK (DC1, 2610904) https://www-shinsei.jsps.go.jp/kaken/english/index.html; and from the CIHR (PJT-165992) to LL, https://cihr-irsc.gc.ca/e/37788.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barau J, 2016, SCIENCE, V354, P909, DOI 10.1126/science.aah5143; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Berrens RV, 2017, CELL STEM CELL, V21, P694, DOI 10.1016/j.stem.2017.10.004; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Dai HQ, 2016, NATURE, V538, P528, DOI 10.1038/nature20095; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Duymich CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11453; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Ferry L, 2017, MOL CELL, V67, P550, DOI 10.1016/j.molcel.2017.07.012; Garvilles RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137509; Gu TP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1464-7; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Haggerty C, 2021, NAT STRUCT MOL BIOL, V28, P594, DOI 10.1038/s41594-021-00603-8; Hagihara Y, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009646; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hata K, 2002, DEVELOPMENT, V129, P1983; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hervouet E, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0450-y; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jia YH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.7; Karg E, 2017, J MOL BIOL, V429, P3814, DOI 10.1016/j.jmb.2017.10.014; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kubiura M, 2012, CHROMOSOME RES, V20, P837, DOI 10.1007/s10577-012-9317-9; Kubiura-Ichimaru M, 2021, CHROMOSOME RES, V29, P145, DOI 10.1007/s10577-020-09645-y; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li T, 2018, NUCLEIC ACIDS RES, V46, P3218, DOI 10.1093/nar/gky104; Li YF, 2018, NATURE, V564, P136, DOI 10.1038/s41586-018-0751-5; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Ming X, 2020, CELL RES, V30, P980, DOI 10.1038/s41422-020-0359-9; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Nishiyama A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15006-4; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Oda M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003574; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Otani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082961; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Price FD, 2013, STEM CELLS, V31, P752, DOI 10.1002/stem.1321; Qin WH, 2015, CELL RES, V25, P911, DOI 10.1038/cr.2015.72; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ren JK, 2015, NUCLEIC ACIDS RES, V43, P1444, DOI 10.1093/nar/gku1371; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakaue M, 2010, CURR BIOL, V20, P1452, DOI 10.1016/j.cub.2010.06.050; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shirane K, 2020, NAT GENET, V52, P1088, DOI 10.1038/s41588-020-0689-z; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang QJ, 2020, NAT GENET, V52, P828, DOI 10.1038/s41588-020-0661-y; Weinberg DN, 2019, NATURE, V573, P281, DOI 10.1038/s41586-019-1534-3; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Xu QH, 2019, NAT GENET, V51, P844, DOI 10.1038/s41588-019-0398-7; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yan QS, 2003, MOL CELL BIOL, V23, P8416, DOI 10.1128/MCB.23.23.8416-8428.2003; Zeng Y, 2020, GENE DEV, V34, P1546, DOI 10.1101/gad.341925.120; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	84	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262277	10.1371/journal.pone.0262277	http://dx.doi.org/10.1371/journal.pone.0262277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986190	Green Published, gold			2022-12-26	WOS:000765956200034
J	Mwangi, FW; Suybeng, B; Gardiner, CP; Kinobe, RT; Charmley, E; Malau-Aduli, BS; Malau-Aduli, AEO				Mwangi, Felista W.; Suybeng, Benedicte; Gardiner, Christopher P.; Kinobe, Robert T.; Charmley, Edward; Malau-Aduli, Bunmi S.; Malau-Aduli, Aduli E. O.			Effect of incremental proportions of Desmanthus spp. in isonitrogenous forage diets on growth performance, rumen fermentation and plasma metabolites of pen-fed growing Brahman, Charbray and Droughtmaster crossbred beef steers	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; NEUTRAL DETERGENT FIBER; LEGUME-BASED PASTURES; RUMINAL FERMENTATION; METHANE PRODUCTION; ANIMAL PRODUCTION; FEEDING-BEHAVIOR; TROPICAL GRASS; DAIRY-COWS; DIGESTIBILITY	Desmanthus (Desmanthus spp.), a tropically adapted pasture legume, is highly productive and has the potential to reduce methane emissions in beef cattle. However, liveweight gain response to desmanthus supplementation has been inconclusive in ruminants. This study aimed to evaluate weight gain, rumen fermentation and plasma metabolites of Australian tropical beef cattle in response to supplementation with incremental levels of desmanthus forage legume in isonitrogenous diets. Forty-eight Brahman, Charbray and Droughtmaster crossbred beef steers were pen-housed and fed a basal diet of Rhodes grass (Chloris gayana) hay supplemented with 0, 15, 30 or 45% freshly chopped desmanthus forage on dry matter basis, for 140 days. Varying levels of lucerne (Medicago sativa) hay were added in the 0, 15 and 30% diets to ensure that all diets were isonitrogenous with the 45% desmanthus diet. Data were analyzed using the Mixed Model procedures of SAS software. Results showed that the proportion of desmanthus in the diet had no significant effect on steer liveweight, rumen volatile fatty acids molar proportions and plasma metabolites (P >= 0.067). Total bilirubin ranged between 3.0 and 3.6 mu mol/L for all the diet treatments (P = 0.67). All plasma metabolites measured were within the expected normal range reported for beef cattle. Rumen ammonia nitrogen content was above the 10 mg/dl threshold required to maintain effective rumen microbial activity and maximize voluntary feed intake in cattle fed low-quality tropical forages. The average daily weight gains averaged 0.5 to 0.6 kg/day (P = 0.13) and were within the range required to meet the target slaughter weight for prime beef markets within 2.5 years of age. These results indicate that desmanthus alone or mixed with other high-quality legume forages can be used to supplement grass-based diets to improve tropical beef cattle production in northern Australia with no adverse effect on cattle health.	[Mwangi, Felista W.; Suybeng, Benedicte; Gardiner, Christopher P.; Kinobe, Robert T.; Malau-Aduli, Aduli E. O.] James Cook Univ, Anim Genet & Nutr, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci,Vet Sci Discipline, Townsville, Qld, Australia; [Charmley, Edward] James Cook Univ, CSIRO Agr & Food, Private Mail Bag Aitkenvale, Australian Trop Sci & Innovat Precinct, Townsville, Qld, Australia; [Malau-Aduli, Bunmi S.] James Cook Univ, Div Trop Hlth & Med, Coll Med & Dent, Townsville, Qld, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; James Cook University	Malau-Aduli, AEO (corresponding author), James Cook Univ, Anim Genet & Nutr, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci,Vet Sci Discipline, Townsville, Qld, Australia.	aduli.malauaduli@jcu.edu.au	Malau-Aduli, Aduli Enoch Othniel/C-2419-2014; Malau-Aduli, Bunmi/J-9388-2014	Malau-Aduli, Aduli Enoch Othniel/0000-0002-3660-7862; Mwangi, Felista/0000-0002-4095-3098; Malau-Aduli, Bunmi/0000-0001-6054-8498; Kinobe, Robert/0000-0003-1166-0947	CRC-Projects; Meat & Livestock Australia	CRC-Projects; Meat & Livestock Australia(Meat and Livestock Australia)	The study reported herein received financial support from the CRC-Projects and Meat & Livestock Australia, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agle M, 2010, J DAIRY SCI, V93, P4211, DOI 10.3168/jds.2009-2977; Archer JA, 2000, LIVEST PROD SCI, V65, P47, DOI 10.1016/S0301-6226(99)00181-5; ARMENTANO LE, 1992, J NUTR, V122, P838, DOI 10.1093/jn/122.suppl_3.838; Asano K, 2017, ANIM SCI J, V88, P468, DOI 10.1111/asj.12665; AUFRERE J, 1988, ANIM FEED SCI TECH, V20, P203, DOI 10.1016/0377-8401(88)90044-2; Australian Government Bureau of Meteorology,, WOOLSH WEATH; Baloyi J. J., 2008, Tropical and Subtropical Agroecosystems, V8, P81; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Brandao RKC, 2018, TROP ANIM HEALTH PRO, V50, P105, DOI 10.1007/s11250-017-1408-3; Brandao VLN, 2019, TRANSL ANIM SCI, V3, P1064, DOI 10.1093/tas/txz019; Braun JP, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P485, DOI 10.1016/B978-0-12-370491-7.00016-7; CHANEY AL, 1962, CLIN CHEM, V8, P130; Cholongitas E, 2007, LIVER TRANSPLANT, V13, P523, DOI 10.1002/lt.20994; Coates DB, 1997, TROP GRASSLANDS, V31, P494; COCHRAN RC, 1994, FORAGE QUALITY, EVALUATION, AND UTILIZATION, P613; Commonwealth Scientific and Industrial Research Organization (CSIRO), 2007, NUTR REQUIREMENTS DO; Cook B., 1993, 17 INT GRASSL C ROCK, P2148; Molina-Botero IC, 2019, ANIM FEED SCI TECH, V251, P1, DOI 10.1016/j.anifeedsci.2019.01.011; Dal Pizzol JG, 2017, ANIM FEED SCI TECH, V228, P178, DOI 10.1016/j.anifeedsci.2017.04.020; Detmann E, 2009, LIVEST SCI, V126, P136, DOI 10.1016/j.livsci.2009.06.013; DIJKSTRA J, 1994, LIVEST PROD SCI, V39, P61, DOI 10.1016/0301-6226(94)90154-6; Dixon RM., 2005, RECENT ADV ANIM NUTR, V15, P65; Du WC, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9110983; Durmic Z, 2017, J SCI FOOD AGR, V97, P4075, DOI 10.1002/jsfa.8274; F. The Food and Agriculture Organization of the United Nations, 2020, FAOSTAT; Gagen EJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0314-3; Gardiner C., 2012, 2 AUSTR NZ SOC ANIMA; Gardiner C, 2013, TROP GRASSL-FORRAJES, V1, P78, DOI 10.17138/TGFT(1)78-80; Gebregiorgis F, 2012, TROP ANIM HEALTH PRO, V44, P511, DOI 10.1007/s11250-011-9927-9; Gemeda BS., 2018, APPROACHES POULTRY D, V2, P154, DOI [10.31031/APDV.2018.02.000538, DOI 10.31031/APDV.2018.02.000538]; Greenwood PL, 2018, ASIAN AUSTRAL J ANIM, V31, P992, DOI 10.5713/ajas.18.0090; Grev AM, 2020, AGRON J, V112, P406, DOI 10.1002/agj2.20011; Grunwaldt EG, 2005, TROP ANIM HEALTH PRO, V37, P527, DOI 10.1007/s11250-005-2474-5; Hart KJ, 2009, J ANIM SCI, V87, P3342, DOI 10.2527/jas.2009-1786; Hill JO, 2009, ANIM PROD SCI, V49, P983, DOI 10.1071/EA06331; IVORY DA, 1978, AUST J PLANT PHYSIOL, V5, P149, DOI 10.1071/PP9780149; Jancik F, 2008, CZECH J ANIM SCI, V53, P128, DOI 10.17221/2716-CJAS; Jones RJ, 2003, TROP GRASSLANDS, V37, P129; Kanani J, 2006, SMALL RUMINANT RES, V65, P1, DOI 10.1016/j.smallrumres.2005.04.028; Kaneko J. J., 1997, Clinical biochemistry of domestic animals., P45, DOI 10.1016/B978-012396305-5/50004-X; Kennedy PC, 2018, J AGR SCI-CAMBRIDGE, V156, P1005, DOI 10.1017/S0021859618000837; Kiro R., 2017, J DAIRY VET SCI, V2, P555588, DOI [10.19080/jdvs.2017.02.555588, DOI 10.19080/JDVS.2017.02.555588, 10.19080/JDVS.2017.02.555588]; Kurihara M, 1999, BRIT J NUTR, V81, P227, DOI 10.1017/S0007114599000422; LENG R A, 1990, Nutrition Research Reviews, V3, P277, DOI 10.1079/NRR19900016; Maasdorp BV, 1999, ANIM FEED SCI TECH, V77, P49, DOI 10.1016/S0377-8401(98)00232-6; Marsetyo DR., 2017, J AGR SCI TECH-IRAN, V7, P117, DOI [10.17265/2161-6256/2017.02.006, DOI 10.17265/2161-6256/2017.02.006]; McLennan S, 2015, NUTRIENT REQUIREMENT; McPherson R.A., 2016, HENRYS CLIN DIAGNOSI; Meat & Livestock Australia (MLA),, 2020, STAT IND REP; MILLER CP, 1991, TROP GRASSLANDS, V25, P98; Mwangi FW, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11082355; Ndlovu T, 2007, AFR J BIOTECHNOL, V6, P2727; NHMRC, 2013, AUSTR COD PRACT CAR; Norman HC, 2020, ANIM PROD SCI, V60, P1111, DOI 10.1071/AN19310; Ortiz-Rubio MA, 2007, ANIM FEED SCI TECH, V139, P143, DOI 10.1016/j.anifeedsci.2007.01.016; Otto F., 2000, ISR J VET MED, V55, P1; PARK KK, 1994, J ANIM SCI, V72, P478, DOI 10.2527/1994.722478x; Pearson RA, 2006, BRIT J NUTR, V95, P88, DOI 10.1079/BJN20051617; Pengelly BC, 2000, TROP GRASSLANDS, V34, P162; Popp JD, 2000, CAN J PLANT SCI, V80, P513, DOI 10.4141/P99-049; Poppi DP, 2018, REV BRAS ZOOTECN, V47, DOI 10.1590/rbz4720160419; Ramirez-Restrepo CA, 2005, ANIM FEED SCI TECH, V120, P179, DOI 10.1016/j.anifeedsci.2005.01.015; Rinne M, 2002, J ANIM SCI, V80, P1986; Rottman LW, 2015, J DAIRY SCI, V98, P4673, DOI 10.3168/jds.2014-8859; Sacks DB, 2002, CLIN CHEM, V48, P436; Sampaio CB, 2010, TROP ANIM HEALTH PRO, V42, P1471, DOI 10.1007/s11250-010-9581-7; Seymour WM, 2005, ANIM FEED SCI TECH, V119, P155, DOI 10.1016/j.anifeedsci.2004.10.001; SHIMIZU S, 1980, ANAL BIOCHEM, V107, P193, DOI 10.1016/0003-2697(80)90511-4; Suybeng B, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10112097; THOMAS RJ, 1995, PLANT SOIL, V174, P103, DOI 10.1007/BF00032243; THOMAS RJ, 1992, GRASS FORAGE SCI, V47, P133, DOI 10.1111/j.1365-2494.1992.tb02256.x; tMannetje L, 1997, TROP GRASSLANDS, V31, P81; Tomkins NW, 2015, ANIM FEED SCI TECH, V200, P25, DOI 10.1016/j.anifeedsci.2014.11.013; Vandermeulen S, 2018, CROP PASTURE SCI, V69, P797, DOI 10.1071/CP17279; Zanton GI., 2009, PROF ANIM SCI, V25, P393, DOI [10.15232/S1080-7446(15)30740-3, DOI 10.15232/S1080-7446(15)30740-3]	75	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0260918	10.1371/journal.pone.0260918	http://dx.doi.org/10.1371/journal.pone.0260918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982779	gold, Green Published, Green Accepted			2022-12-26	WOS:000834805700005
J	Shu, Y; Liang, DH				Shu, Yan; Liang, Donghui			Effect of tetracycline on nitrogen removal in Moving Bed Biofilm Reactor (MBBR) System	PLOS ONE			English	Article							WASTE-WATER TREATMENT; MICROBIAL COMMUNITY STRUCTURE; ANTIBIOTIC-RESISTANCE GENES; TREATMENT PLANTS; PERFORMANCE; SLUDGE; CARBON; DENITRIFICATION; NITRIFICATION; ENVIRONMENT	The effect of tetracycline (TC) on nitrogen removal in wastewater treatment plants has become a new problem. This study investigated the effects of TC on nitrogen removal using a Moving Bed Biofilm Reactor system. The results showed that there was no significant effect on nitrogen removal performance when the concentration of TC was 5 mg/L, and that the total nitrogen (TN) removal efficiency could reach 75-77%. However, when the concentration of TC increased to 10 mg/L, the denitrification performance was affected and the TN removal efficiency decreased to 58%. The abundance of denitrifying bacteria such as those in the genus Thauera decreased, and TC-resistant bacteria gradually became dominant. At a TC concentration of 10 mg/L, there were also increases and decreases, respectively, in the abundance of resistance and denitrification functional genes. The inhibitory effect of TC on denitrification was achieved mainly by the inhibition of nitrite-reducing bacteria.	[Shu, Yan; Liang, Donghui] South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Sch Environm & Energy, Guangzhou, Peoples R China; [Shu, Yan; Liang, Donghui] South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Minist Educ, Guangzhou, Peoples R China	South China University of Technology; South China University of Technology	Shu, Y (corresponding author), South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Sch Environm & Energy, Guangzhou, Peoples R China.; Shu, Y (corresponding author), South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Minist Educ, Guangzhou, Peoples R China.	scutshuyan@163.com						Adam M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-52; Bernier SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00020; Beyersmann PG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00784-7; Chen JF, 2018, BIORESOURCE TECHNOL, V270, P482, DOI 10.1016/j.biortech.2018.09.060; Chettri B, 2019, BIORESOURCE TECHNOL, V294, DOI 10.1016/j.biortech.2019.122190; Dai HT, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.573302; Fan ZZ, 2022, CHEMOSPHERE, V291, DOI 10.1016/j.chemosphere.2021.132681; Gao Y, 2012, J COLLOID INTERF SCI, V368, P540, DOI 10.1016/j.jcis.2011.11.015; Ge SJ, 2015, CHEMOSPHERE, V140, P85, DOI 10.1016/j.chemosphere.2015.02.004; Grabert R, 2018, BIORESOURCE TECHNOL, V267, P265, DOI 10.1016/j.biortech.2018.07.061; Guo HX, 2020, BIORESOURCE TECHNOL, V305, DOI 10.1016/j.biortech.2020.123073; He Y, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0051-0; Hou GY, 2016, BIORESOURCE TECHNOL, V212, P20, DOI 10.1016/j.biortech.2016.03.156; Hou J, 2016, ENVIRON SCI POLLUT R, V23, P1722, DOI 10.1007/s11356-015-5431-5; Huang MH, 2014, J ENVIRON SCI HEAL A, V49, P940, DOI 10.1080/10934529.2014.893794; Islam GM, 2019, J HAZARD MATER, V371, P130, DOI 10.1016/j.jhazmat.2019.02.032; Jia YT, 2020, CHEM ENG J, V400, DOI 10.1016/j.cej.2020.125905; Jia YT, 2019, BIORESOURCE TECHNOL, V294, DOI 10.1016/j.biortech.2019.122114; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Li TT, 2020, J TAIWAN INST CHEM E, V106, P99, DOI 10.1016/j.jtice.2019.10.004; Liao Q, 2021, SCI TOTAL ENVIRON, V757, DOI 10.1016/j.scitotenv.2020.143981; Liu H, 2018, BIORESOURCE TECHNOL, V256, P414, DOI 10.1016/j.biortech.2018.02.051; Meng FG, 2015, CHEM ENG J, V280, P448, DOI 10.1016/j.cej.2015.06.025; Meng YB, 2019, SCI TOTAL ENVIRON, V668, P379, DOI 10.1016/j.scitotenv.2019.02.389; Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027; Nzoughet JK, 2011, TOXICON, V58, P619, DOI 10.1016/j.toxicon.2011.09.012; Razavi M, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00418-20; Shu DT, 2015, BIORESOURCE TECHNOL, V186, P163, DOI 10.1016/j.biortech.2015.03.072; Sperfeld M, 2018, WATER RES, V132, P146, DOI 10.1016/j.watres.2017.12.040; Wan K, 2021, WATER RES, V190, DOI 10.1016/j.watres.2020.116744; Wan R, 2015, APPL MICROBIOL BIOT, V99, P2839, DOI 10.1007/s00253-014-6155-z; Wang LX, 2017, J ENVIRON MANAGE, V204, P152, DOI 10.1016/j.jenvman.2017.08.027; Wang QK, 2020, WATER RES, V185, DOI 10.1016/j.watres.2020.116300; Xu ZS, 2018, SCI TOTAL ENVIRON, V634, P195, DOI 10.1016/j.scitotenv.2018.03.348; Yang XH, 2020, AQUACULTURE, V529, DOI 10.1016/j.aquaculture.2020.735665; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039; Zhang JY, 2016, WATER RES, V91, P339, DOI 10.1016/j.watres.2016.01.010; Zhang YP, 2021, WATER RES, V207, DOI 10.1016/j.watres.2021.117834; Zhao RX, 2019, WATER RES, V151, P388, DOI 10.1016/j.watres.2018.12.034	39	3	3	8	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261306	10.1371/journal.pone.0261306	http://dx.doi.org/10.1371/journal.pone.0261306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007308	gold, Green Published			2022-12-26	WOS:000741060700015
J	Chen, TY; Li, XY; Goobie, GC; Hung, CH; Hung, TK; Hamilton, K; Bahudhanapati, H; Tan, JN; Kass, DJ; Zhang, YZ				Chen, Ting-Yun; Li, Xiaoyun; Goobie, Gillian C.; Hung, Ching-Hsia; Hung, Tin-Kan; Hamilton, Kyle; Bahudhanapati, Harinath; Tan, Jiangning; Kass, Daniel J.; Zhang, Yingze			Identification of a distal RXFP1 gene enhancer with differential activity in fibrotic lung fibroblasts involving AP-1	PLOS ONE			English	Article							PULMONARY-FIBROSIS; TRANSCRIPTION FACTORS; SYSTEMIC-SCLEROSIS; RELAXIN; EXPRESSION; RECEPTOR; PEPTIDE; PATHWAY	Relaxin/insulin-like family peptide receptor 1 (RXFP1) mediates relaxin's antifibrotic effects and has reduced expression in the lung and skin of patients with fibrotic interstitial lung disease (fILD) including idiopathic pulmonary fibrosis (IPF) and systemic sclerosis (SSc). This may explain the failure of relaxin-based anti-fibrotic treatments in SSc, but the regulatory mechanisms controlling RXFP1 expression remain largely unknown. This study aimed to identify regulatory elements of RXFP1 that may function differentially in fibrotic fibroblasts. We identified and evaluated a distal regulatory region of RXFP1 in lung fibroblasts using a luciferase reporter system. Using serial deletions, an enhancer upregulating pGL3-promoter activity was localized to the distal region between -584 to -242bp from the distal transcription start site (TSS). This enhancer exhibited reduced activity in IPF and SSc lung fibroblasts. Bioinformatic analysis identified two clusters of activator protein 1 (AP-1) transcription factor binding sites within the enhancer. Site-directed mutagenesis of the binding sites confirmed that only one cluster reduced activity (-358 to -353 relative to distal TSS). Co-expression of FOS in lung fibroblasts further increased enhancer activity. In vitro complex formation with a labeled probe spanning the functional AP-1 site using nuclear proteins isolated from lung fibroblasts confirmed a specific DNA/protein complex formation. Application of antibodies against JUN and FOS resulted in the complex alteration, while antibodies to JUNB and FOSL1 did not. Analysis of AP-1 binding in 5 pairs of control and IPF lung fibroblasts detected positive binding more frequently in control fibroblasts. Expression of JUN and FOS was reduced and correlated positively with RXFP1 expression in IPF lungs. In conclusion, we identified a distal enhancer of RXFP1 with differential activity in fibrotic lung fibroblasts involving AP-1 transcription factors. Our study provides insight into RXFP1 downregulation in fILD and may support efforts to reevaluate relaxin-based therapeutics alongside upregulation of RXFP1 transcription.	[Chen, Ting-Yun; Li, Xiaoyun; Goobie, Gillian C.; Hamilton, Kyle; Bahudhanapati, Harinath; Tan, Jiangning; Kass, Daniel J.; Zhang, Yingze] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Chen, Ting-Yun; Li, Xiaoyun; Goobie, Gillian C.; Hamilton, Kyle; Bahudhanapati, Harinath; Tan, Jiangning; Kass, Daniel J.; Zhang, Yingze] Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA; [Chen, Ting-Yun; Hung, Ching-Hsia] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan, Taiwan; [Goobie, Gillian C.] Univ British Columbia, Dept Med, Clinician Investigator Program, Vancouver, BC, Canada; [Goobie, Gillian C.; Zhang, Yingze] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Hung, Tin-Kan; Zhang, Yingze] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Cheng Kung University; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, YZ (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.; Zhang, YZ (corresponding author), Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA.; Zhang, YZ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.; Zhang, YZ (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15260 USA.	zhangyx@upmc.edu		Zhang, Yingze/0000-0001-6947-2901	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R21AR076024-01, 5P50AR060780-08]; Ministry of Science and Technology in Taiwan (MOST) [108IPFA0900005]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ministry of Science and Technology in Taiwan (MOST)	Funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R21AR076024-01 (YZ) and pilot grant from 5P50AR060780-08 (YZ); Ministry of Science and Technology in Taiwan (MOST) 108IPFA0900005 (TYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Bahudhanapati H, 2019, J BIOL CHEM, V294, P5008, DOI 10.1074/jbc.RA118.004910; Bathgate RAD, 2018, PHARMACOL THERAPEUT, V187, P114, DOI 10.1016/j.pharmthera.2018.02.008; Bejjani F, 2019, BBA-REV CANCER, V1872, P11, DOI 10.1016/j.bbcan.2019.04.003; Chen TY, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1194; Chiariello AM, 2022, FEBS J, V289, P1180, DOI 10.1111/febs.15762; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Corallo Claudio, 2019, Clin Exp Rheumatol, V37 Suppl 119, P69; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Giordano N, 2012, SCAND J RHEUMATOL, V41, P391, DOI 10.3109/03009742.2012.669496; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Khanna D, 2009, ARTHRITIS RHEUM-US, V60, P1102, DOI 10.1002/art.24380; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kusko RL, 2016, AM J RESP CRIT CARE, V194, P948, DOI 10.1164/rccm.201510-2026OC; Lam M, 2018, PHARMACOL THERAPEUT, V187, P61, DOI 10.1016/j.pharmthera.2018.02.004; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; McVicker BL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00318; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mortimer KM, 2020, RESPIRATION, V99, P108, DOI 10.1159/000504630; Ng HH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00501; Pini A, 2010, J PHARMACOL EXP THER, V335, P589, DOI 10.1124/jpet.110.170977; Rajasekaran S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041611; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Samuel CS, 2005, ANN NY ACAD SCI, V1041, P173, DOI 10.1196/annals.1282.025; Sasser JM, 2013, AM J PHYSIOL-REG I, V305, pR559, DOI 10.1152/ajpregu.00528.2012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Tan JN, 2016, AM J RESP CRIT CARE, V194, P1392, DOI 10.1164/rccm.201509-1865OC; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Ucero AC, 2019, J CLIN INVEST, V129, P3293, DOI 10.1172/JCI125366; Vierbuchen T, 2017, MOL CELL, V68, P1067, DOI 10.1016/j.molcel.2017.11.026; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Yu SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163277; Yu SB, 2013, BONE, V56, P234, DOI 10.1016/j.bone.2013.06.019; Zent J, 2018, CELL PHYSIOL BIOCHEM, V49, P848, DOI 10.1159/000493217; Zhang YZ, 2021, THORAX, V76, P335, DOI 10.1136/thoraxjnl-2020-215356	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0254466	10.1371/journal.pone.0254466	http://dx.doi.org/10.1371/journal.pone.0254466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972106	gold, Green Submitted, Green Published			2022-12-26	WOS:000773555700003
J	Tongununui, P; Kuriya, Y; Murata, M; Sawada, H; Araki, M; Nomura, M; Morioka, K; Ichie, T; Ikejima, K; Adachi, K				Tongununui, Prasert; Kuriya, Yuki; Murata, Masahiro; Sawada, Hideki; Araki, Michihiro; Nomura, Mika; Morioka, Katsuji; Ichie, Tomoaki; Ikejima, Kou; Adachi, Kohsuke			Mangrove crab intestine and habitat sediment microbiomes cooperatively work on carbon and nitrogen cycling	PLOS ONE			English	Article							EATING SESARMID CRABS; ORGANIC-MATTER; GUT MICROBIOTA; LEAF-LITTER; PHYLOGENETIC DIVERSITY; FEEDING ECOLOGY; FIXATION GENES; FOOD-INTAKE; SP NOV.; BACTERIA	Mangrove ecosystems, where litter and organic components are degraded and converted into detrital materials, support rich coastal fisheries resources. Sesarmid (Grapsidae) crabs, which feed on mangrove litter, play a crucial role in material flow in carbon-rich and nitrogen-limited mangrove ecosystems; however, the process of assimilation and conversion into detritus has not been well studied. In this study, we performed microbiome analyses of intestinal bacteria from three species of mangrove crab and five sediment positions in the mud lobster mounds, including the crab burrow wall, to study the interactive roles of crabs and sediment in metabolism. Metagenome analysis revealed species-dependent intestinal profiles, especially in Neosarmatium smithi, while the sediment microbiome was similar in all positions, albeit with some regional dependency. The microbiome profiles of crab intestines and sediments were significantly different in the MDS analysis based on OTU similarity; however, 579 OTUs (about 70% of reads in the crab intestinal microbiome) were identical between the intestinal and sediment bacteria. In the phenotype prediction, cellulose degradation was observed in the crab intestine. Cellulase activity was detected in both crab intestine and sediment. This could be mainly ascribed to Demequinaceae, which was predominantly found in the crab intestines and burrow walls. Nitrogen fixation was also enriched in both the crab intestines and sediments, and was supported by the nitrogenase assay. Similar to earlier reports, sulfur-related families were highly enriched in the sediment, presumably degrading organic compounds as terminal electron acceptors under anaerobic conditions. These results suggest that mangrove crabs and habitat sediment both contribute to carbon and nitrogen cycling in the mangrove ecosystem via these two key reactions.	[Tongununui, Prasert] Rajamangala Univ Technol Srivijaya, Fac Sci & Fisheries Technol, Dept Marine Sci & Environm, Amphur Sikao, Trang, Thailand; [Kuriya, Yuki; Murata, Masahiro; Araki, Michihiro] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Sawada, Hideki] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto, Japan; [Araki, Michihiro] Natl Inst Biomed Innovat Hlth & Nutr, Tokyo, Japan; [Nomura, Mika] Kagawa Univ, Fac Agr, Miki, Kagawa, Japan; [Morioka, Katsuji; Ichie, Tomoaki; Ikejima, Kou; Adachi, Kohsuke] Kochi Univ, Fac Agr & Marine Sci, Nankoku, Kochi, Japan	Rajamangala University of Technology Srivijaya; Kyoto University; Kyoto University; Kagawa University; Kochi University	Adachi, K (corresponding author), Kochi Univ, Fac Agr & Marine Sci, Nankoku, Kochi, Japan.	kohsukeadachi@kochi-u.ac.jp		Ichie, Tomoaki/0000-0002-1979-5806; Ikejima, Kou/0000-0003-3935-8475	JSPS KAKENHI [26520308]; Research Institute of Marine Invertebrate	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Institute of Marine Invertebrate	This work was partly supported by JSPS KAKENHI (Grant Number 26520308) and the Research Institute of Marine Invertebrate. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2012, FISHERIES SCI, V78, P1309, DOI 10.1007/s12562-012-0547-8; Adame MF, 2011, HYDROBIOLOGIA, V663, P23, DOI 10.1007/s10750-010-0554-7; Alfaro-Espinoza G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00445; Alongi D., CYCLING GLOBAL FLUXE; Alongi DM., 2020, NITROGEN, V1, P167, DOI [DOI 10.3390/NITROGEN1020014, 10.3390/nitrogen1020014]; Alongi DM, 2009, ENERGETICS MANGROVE; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Banba M, 2001, MOL PLANT MICROBE IN, V14, P173, DOI 10.1094/MPMI.2001.14.2.173; Barzkar N, 2020, APPL MICROBIOL BIOT, V104, P6873, DOI 10.1007/s00253-020-10692-y; Bertrand M, 2015, AGRON SUSTAIN DEV, V35, P553, DOI 10.1007/s13593-014-0269-7; Bomble YJ, 2017, CURR OPIN CHEM BIOL, V41, P61, DOI 10.1016/j.cbpa.2017.10.013; Booth JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40315-0; Borges AV, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017143; Bouillon S, 2008, J SEA RES, V59, P44, DOI 10.1016/j.seares.2007.05.001; Bouillon S, 2002, OECOLOGIA, V130, P441, DOI 10.1007/s004420100814; Brauman A, 2000, EUR J SOIL BIOL, V36, P117, DOI 10.1016/S1164-5563(00)01058-X; Breznak JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P209; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Bui THH, 2015, COMP BIOCHEM PHYS B, V179, P27, DOI 10.1016/j.cbpb.2014.09.004; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceja-Navarro JA, 2014, ISME J, V8, P6, DOI 10.1038/ismej.2013.134; Chen GC, 2010, MAR ECOL PROG SER, V419, P137, DOI 10.3354/meps08859; Cuellar-Gempeler C, 2018, ISME J, V12, P825, DOI 10.1038/s41396-017-0014-8; DENG SP, 1994, SOIL BIOL BIOCHEM, V26, P473, DOI 10.1016/0038-0717(94)90179-1; Dittmar T, 2001, MAR CHEM, V73, P253, DOI 10.1016/S0304-4203(00)00110-9; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; EMMERSON WD, 1992, J EXP MAR BIOL ECOL, V157, P41, DOI 10.1016/0022-0981(92)90073-J; GARDNER WS, 1987, LIMNOL OCEANOGR, V32, P1226, DOI 10.4319/lo.1987.32.6.1226; GIDDINS RL, 1986, MAR ECOL PROG SER, V33, P147, DOI 10.3354/meps033147; Gong X, 2018, SOIL BIOL BIOCHEM, V121, P120, DOI 10.1016/j.soilbio.2018.03.011; Goodenough AE, 2017, J ORNITHOL, V158, P233, DOI 10.1007/s10336-016-1371-1; Harada Y, 2016, ESTUAR COAST SHELF S, V174, P41, DOI 10.1016/j.ecss.2016.03.017; HOLGUIN G, 1992, FEMS MICROBIOL ECOL, V101, P207; Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Hongoh Y, 2006, APPL ENVIRON MICROB, V72, P6780, DOI 10.1128/AEM.00891-06; Igai K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31942; Ikejima K, 2003, ESTUAR COAST SHELF S, V56, P447, DOI 10.1016/S0272-7714(02)00194-4; Kawaida S, 2021, FOOD WEBS, V26, DOI 10.1016/j.fooweb.2020.e00180; Kawaida S, 2019, ESTUAR COAST SHELF S, V222, P43, DOI 10.1016/j.ecss.2019.04.004; Kawaida S, 2017, FISHERIES SCI, V83, P1007, DOI 10.1007/s12562-017-1139-4; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Klemm D., 1998, COMPREHENSIVE CELLUL, VVolume 1, DOI DOI 10.1002/3527601929; Kristensen DK, 2010, ESTUAR COAST SHELF S, V87, P583, DOI 10.1016/j.ecss.2010.02.016; Kristensen E, 2001, BEL BAR LIB, P369; Kristensen E, 2008, J SEA RES, V59, P30, DOI 10.1016/j.seares.2007.05.004; Kristensen E, 2017, LIMNOL OCEANOGR, V62, P2097, DOI 10.1002/lno.10553; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lee SY, 2008, J SEA RES, V59, P16, DOI 10.1016/j.seares.2007.05.002; Lee SG, 2017, MAT SCI ENG A-STRUCT, V697, P55, DOI 10.1016/j.msea.2017.04.115; Lee SY, 1997, MAR ECOL PROG SER, V159, P275, DOI 10.3354/meps159275; LEE SY, 1995, HYDROBIOLOGIA, V295, P203, DOI 10.1007/BF00029127; Lesser MP, 2007, MAR ECOL PROG SER, V346, P143, DOI 10.3354/meps07008; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Lin XL, 2019, MICROB ECOL, V78, P57, DOI 10.1007/s00248-018-1261-6; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucey KS, 2014, MOL ECOL, V23, P1531, DOI 10.1111/mec.12598; Maher DT, 2013, LIMNOL OCEANOGR, V58, P475, DOI 10.4319/lo.2013.58.2.0475; MALLEY DF, 1978, MAR BIOL, V49, P377, DOI 10.1007/BF00455032; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Tue NT, 2012, J SEA RES, V72, P14, DOI 10.1016/j.seares.2012.05.006; Nordhaus I, 2006, ESTUAR COAST SHELF S, V67, P239, DOI 10.1016/j.ecss.2005.11.022; Nordhaus I, 2011, J SEA RES, V65, P414, DOI 10.1016/j.seares.2011.03.006; Oakes JM, 2010, LIMNOL OCEANOGR, V55, P393, DOI 10.4319/lo.2010.55.1.0393; Odum WE, 1983, BASIC ECOLOGY; Odum WE, 1975, ESTUARINE RES, P265; Otani S, 2016, MICROB ECOL, V71, P207, DOI 10.1007/s00248-015-0692-6; PRESTWICH GD, 1980, OECOLOGIA, V46, P397, DOI 10.1007/BF00346270; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; Ravikumar S, 2004, J EXP MAR BIOL ECOL, V312, P5, DOI 10.1016/j.jembe.2004.05.020; ROBERTSON AI, 1989, OECOLOGIA, V78, P191, DOI 10.1007/BF00377155; Sarker SK, 2019, BIOL CONSERV, V236, P79, DOI 10.1016/j.biocon.2019.05.011; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; SENGUPTA A, 1991, OECOLOGIA, V87, P560, DOI 10.1007/BF00320420; Skov MW, 2002, OECOLOGIA, V131, P1, DOI 10.1007/s00442-001-0847-7; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Tanimura A, 2013, FISHERIES SCI, V79, P1, DOI 10.1007/s12562-012-0559-4; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Bui THH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089074; Thompson B. M., 2013, COMMUNITY ECOLOGY SI; Thongtham N, 2005, ESTUAR COAST SHELF S, V65, P213, DOI 10.1016/j.ecss.2005.05.014; Thongtham N, 2008, ESTUAR COAST SHELF S, V80, P573, DOI 10.1016/j.ecss.2008.09.017; TOLEDO G, 1995, CAN J MICROBIOL, V41, P1012, DOI 10.1139/m95-140; TRANVIK LJ, 1992, HYDROBIOLOGIA, V229, P107, DOI 10.1007/BF00006994; Twilley R.R., 2017, MANGROVE ECOSYSTEMS, P113, DOI DOI 10.1007/978-3-319-62206-4_5; Ue H, 2011, INT J SYST EVOL MICR, V61, P1322, DOI 10.1099/ijs.0.024299-0; Varon-Lopez M, 2014, ENVIRON MICROBIOL, V16, P845, DOI 10.1111/1462-2920.12237; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Weidenbach K, 2014, FEBS J, V281, P3507, DOI 10.1111/febs.12876; Werry J, 2005, MAR ECOL PROG SER, V293, P165, DOI 10.3354/meps293165; Yamada A, 2007, MOL ECOL, V16, P3768, DOI 10.1111/j.1365-294X.2007.03326.x; Yew WC, 2018, POLAR BIOL, V41, P269, DOI 10.1007/s00300-017-2189-x; Yi H, 2007, INT J SYST EVOL MICR, V57, P151, DOI 10.1099/ijs.0.64525-0; Zhang XY, 2018, SCI TOTAL ENVIRON, V633, P518, DOI 10.1016/j.scitotenv.2018.03.158; Zhu P, 2018, APPL SOIL ECOL, V130, P159, DOI 10.1016/j.apsoil.2018.06.003; Zilius M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70834-0	108	2	2	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261654	10.1371/journal.pone.0261654	http://dx.doi.org/10.1371/journal.pone.0261654			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972143	Green Published, gold			2022-12-26	WOS:000773555700043
J	Goh, BC; Xiang, XY; Lescar, J; Dedon, PC				Goh, Boon Chong; Xiang, Xinyu; Lescar, Julien; Dedon, Peter C.			Crystal structure and functional analysis of mycobacterial erythromycin resistance methyltransferase Erm38 reveals its RNA-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; MACROLIDE RESISTANCE; ANTIBIOTIC-RESISTANCE; PROTEIN; ERMC'; REQUIREMENTS; REFINEMENT; ABSCESSUS; RESIDUES; ERM(41)	Erythromycin resistance methyltransferases (Erms) confer resistance to macrolide, lincosamide, and streptogramin antibiotics in Gram-positive bacteria and mycobacteria. Although structural information for ErmAM, ErmC, and ErmE exists from Gram-positive bacteria, little is known about the Erms in mycobacteria, as there are limited biochemical data and no structures available. Here, we present crystal structures of Erm38 from Mycobacterium smegmatis in apoprotein and cofactor-bound forms. Based on structural analysis and mutagenesis, we identified several catalytically critical, positively charged residues at a putative RNA-binding site. We found that mutation of any of these sites is sufficient to abolish methylation activity, whereas the corresponding RNA-binding affinity of Erm38 remains unchanged. The methylation reaction thus appears to require a precise ensemble of amino acids to accurately position the RNA substrate, such that the target nucleotide can be methylated. In addition, we computationally constructed a model of Erm38 in complex with a 32-mer RNA substrate. This model shows the RNA substrate stably bound to Erm38 by a patch of positively charged residues. Furthermore, a pi-pi stacking interaction between a key aromatic residue of Erm38 and a target adenine of the RNA substrate forms a critical interaction needed for methylation. Taken together, these data provide valuable insights into Erm-RNA interactions, which will aid subsequent structure-based drug design efforts.	[Goh, Boon Chong; Lescar, Julien; Dedon, Peter C.] Singapore MIT Alliance Res & Technol Ctr, Antimicrobial Resistance Interdisciplinary Res Gr, Singapore, Singapore; [Goh, Boon Chong; Lescar, Julien] Nanyang Technol Univ, NTU Inst Struct Biol, Expt Med Bldg EMB, Singapore, Singapore; [Xiang, Xinyu; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Dedon, Peter C.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Xiang, Xinyu] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA	Singapore-MIT Alliance for Research & Technology Centre (SMART); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massachusetts Institute of Technology (MIT); Stanford University	Goh, BC; Lescar, J; Dedon, PC (corresponding author), Singapore MIT Alliance Res & Technol Ctr, Antimicrobial Resistance Interdisciplinary Res Gr, Singapore, Singapore.; Goh, BC; Lescar, J (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, Expt Med Bldg EMB, Singapore, Singapore.; Lescar, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Dedon, PC (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	boonchong@smart.mit.edu; pcdedon@mit.edu	; Goh, Boon Chong/L-2516-2016	Xiang, Xinyu/0000-0002-8358-2960; Goh, Boon Chong/0000-0002-0292-0922	National Research Foundation of Singapore through the Singapore-MIT Alliance for Research and Technology (SMART) Antimicrobial Resistance Interdisciplinary Research Group; SMART Innovation Centre [ING-000772 BIO IGN]; A*STAR BMRC Therapeutics Development Review [H19H0G1003/TOR 005-018]	National Research Foundation of Singapore through the Singapore-MIT Alliance for Research and Technology (SMART) Antimicrobial Resistance Interdisciplinary Research Group(National Research Foundation, SingaporeSingapore-MIT Alliance for Research & Technology Centre (SMART)); SMART Innovation Centre; A*STAR BMRC Therapeutics Development Review(Agency for Science Technology & Research (A*STAR))	We thank Yee Hwa Wong, Swathi Pasunooti, Abirami R, Fu Shan Sherlyn Chia, and Su Shan Khoh for their help at the initial stages of the project. We also thank the scientists in the NTU Protein Production Platform (https://proteins.sbs.ntu.edu.sg) for the cloning and expression tests of the protein constructs, the scientists, and beamline staff at the Proxima 2A, SOLEIL (Saint Aubin, France; Proposal 20180290) for their expert assistance, and the staff at the National Supercomputing Centre, Singapore (https://www.nscc.sg), for providing access to ASPIRE-1 for the MD simulations. This work was supported by grants from the National Research Foundation of Singapore through the Singapore-MIT Alliance for Research and Technology (SMART) Antimicrobial Resistance Interdisciplinary Research Group and the SMART Innovation Centre (ING-000772 BIO IGN), and by a grant from the A*STAR BMRC Therapeutics Development Review (H19H0G1003/TOR 005-018).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bhujbalrao R, 2019, J AM CHEM SOC, V141, P1425, DOI 10.1021/jacs.8b10277; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Brown-Elliott BA, 2015, J CLIN MICROBIOL, V53, P1211, DOI 10.1128/JCM.02950-14; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Bussiere DE, 1998, BIOCHEMISTRY-US, V37, P7103, DOI 10.1021/bi973113c; Carothers JM, 2006, J AM CHEM SOC, V128, P7929, DOI 10.1021/ja060952q; Chellat MF, 2016, ANGEW CHEM INT EDIT, V55, P6600, DOI 10.1002/anie.201506818; Ding YL, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1366-6; Duran D., 2013, Journal of Physics: Conference Series, V425, DOI 10.1088/1742-6596/425/1/012005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrow KA, 2002, ANTIMICROB AGENTS CH, V46, P1253, DOI 10.1128/AAC.46.5.1253-1261.2002; Feder M, 2008, CHEMMEDCHEM, V3, P316, DOI 10.1002/cmdc.200700201; Fyfe C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025395; Gorrec F, 2015, ACTA CRYSTALLOGR F, V71, P831, DOI 10.1107/S2053230X1500967X; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hofer Ursula, 2019, Nat Rev Microbiol, V17, P3, DOI 10.1038/s41579-018-0125-x; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaroensuk J, 2019, RNA, V25, P1481, DOI 10.1261/rna.066746.118; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Madsen CT, 2005, J BIOL CHEM, V280, P38942, DOI 10.1074/jbc.M505727200; Madsen CT, 2005, ANTIMICROB AGENTS CH, V49, P3803, DOI 10.1128/AAC.49.9.3803-3809.2005; Maravic G, 2003, NUCLEIC ACIDS RES, V31, P4941, DOI 10.1093/nar/gkg666; Moric I, 2010, J MED BIOCHEM, V29, P165, DOI 10.2478/v10011-010-0030-y; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Park AK, 2010, FEMS MICROBIOL LETT, V309, P151, DOI 10.1111/j.1574-6968.2010.02031.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rowe SJ, 2020, J BIOL CHEM, V295, P17476, DOI 10.1074/jbc.RA120.014280; Schluckebier G, 1999, J MOL BIOL, V289, P277, DOI 10.1006/jmbi.1999.2788; Schroeder MR, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00098; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Stsiapanava A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51174-0; Vester B, 1998, J MOL BIOL, V282, P255, DOI 10.1006/jmbi.1998.2024; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; Wang J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174116; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan YM, 2017, NUCLEIC ACIDS RES, V45, pW365, DOI 10.1093/nar/gkx407; Yu LP, 1997, NAT STRUCT BIOL, V4, P483, DOI 10.1038/nsb0697-483; ZHONG P, 1995, J BACTERIOL, V177, P4327, DOI 10.1128/jb.177.15.4327-4332.1995	50	0	0	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101571	10.1016/j.jbc.2022.101571	http://dx.doi.org/10.1016/j.jbc.2022.101571			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35007529	Green Published, gold			2022-12-26	WOS:000761371500015
J	Kielczewska, A; D'Angelo, I; Amador, MS; Wang, TN; Sudom, A; Min, XS; Rathanaswami, P; Pigott, C; Foltz, IN				Kielczewska, Agnieszka; D'Angelo, Igor; Amador, Maria Sheena; Wang, Tina; Sudom, Athena; Min, Xiaoshan; Rathanaswami, Palaniswami; Pigott, Craig; Foltz, Ian N.			Development of a potent high-affinity human therapeutic antibody via novel application of recombination signal sequence-based affinity maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOVO PROTEIN DESIGN; HEAVY-CHAIN GENES; COMPUTATIONAL DESIGN; MONOCLONAL-ANTIBODY; EXPRESSION; IDENTIFICATION; IMPROVEMENT; DIVERSITY; DISPLAY; CELLS	Therapeutic antibody development requires discovery of an antibody molecule with desired specificities and drug-like properties. For toxicological studies, a therapeutic antibody must bind the ortholog antigen with a similar affinity to the human target to enable relevant dosing regimens, and antibodies falling short of this affinity design goal may not progress as therapeutic leads. Herein, we report the novel use of mammalian recombination signal sequence (RSS)-directed recombination for complementarity-determining region-targeted protein engineering combined with mammalian display to close the species affinity gap of human interleukin (IL)-13 antibody 731. This fully human antibody has not progressed as a therapeutic in part because of a 400-fold species affinity gap. Using this nonhypothesis-driven affinity maturation method, we generated multiple antibody variants with improved IL-13 affinity, including the highest affinity antibody reported to date (34 fM). Resolution of a cocrystal structure of the optimized antibody with the cynomolgus monkey (or nonhuman primate) IL-13 protein revealed that the RSS-derived mutations introduced multiple successive amino acid substitutions resulting in a de novo formation of a pi-pi stacking-based protein-protein interaction between the affinity-matured antibody heavy chain and helix C on IL-13, as well as an introduction of an interface-distant residue, which enhanced the light chain-binding affinity to target. These mutations synergized binding of heavy and light chains to the target protein, resulting in a remarkably tight interaction, and providing a proof of concept for a new method of protein engineering, based on synergizing a mammalian display platform with novel RSS-mediated library generation.	[Kielczewska, Agnieszka; Amador, Maria Sheena; Wang, Tina; Rathanaswami, Palaniswami; Foltz, Ian N.] Amgen British Columbia, Therapeut Discovery, Burnaby, BC, Canada; [D'Angelo, Igor] Amgen Inc, Therapeut Discovery, Thousand Oaks, CA 91320 USA; [Sudom, Athena; Min, Xiaoshan] Amgen San Francisco, Therapeut Discovery, San Francisco, CA USA; [Pigott, Craig] Innovat Targeting Solut, Burnaby, BC, Canada	Amgen; Amgen	Kielczewska, A (corresponding author), Amgen British Columbia, Therapeut Discovery, Burnaby, BC, Canada.	akielcze@amgen.com		Sudom, Athena/0000-0002-7967-6411				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker D, 2019, PROTEIN SCI, V28, P678, DOI 10.1002/pro.3588; BALTIMORE D, 1974, NATURE, V248, P409, DOI 10.1038/248409a0; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischman S, 2018, CURR OPIN STRUC BIOL, V51, P156, DOI 10.1016/j.sbi.2018.04.007; Fujii Ikuo, 2004, Methods Mol Biol, V248, P345; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiyoshi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087099; Koepnick B, 2019, NATURE, V570, P390, DOI 10.1038/s41586-019-1274-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuroda D, 2018, METHODS MOL BIOL, V1827, P15, DOI 10.1007/978-1-4939-8648-4_2; KUROSAWA Y, 1981, NATURE, V290, P565, DOI 10.1038/290565a0; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee AI, 2003, PLOS BIOL, V1, P56, DOI 10.1371/journal.pbio.0000001; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Lou J, 2010, PROTEIN ENG DES SEL, V23, P311, DOI 10.1093/protein/gzq001; Mahajan SP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35464-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Nimrod G, 2018, CELL REP, V25, P2121, DOI 10.1016/j.celrep.2018.10.081; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Oh J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53756-4; Owyang AM, 2011, MABS-AUSTIN, V3, P49, DOI 10.4161/mabs.3.1.13989; Rathanaswami P, 2005, BIOCHEM BIOPH RES CO, V334, P1004, DOI 10.1016/j.bbrc.2005.07.002; Rathanaswami P, 2011, ANAL BIOCHEM, V414, P7, DOI 10.1016/j.ab.2011.02.034; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; SAKANO H, 1981, NATURE, V290, P562, DOI 10.1038/290562a0; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Tabasinezhad M, 2019, IMMUNOL LETT, V212, P106, DOI 10.1016/j.imlet.2019.06.009; Teplyakov A, 2017, PROTEIN ENG DES SEL, V30, P31, DOI 10.1093/protein/gzw059; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vsquez M, 2019, MABS-AUSTIN, V11, P803, DOI 10.1080/19420862.2019.1611172; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Zhu K, 2014, PROTEINS, V82, P1646, DOI 10.1002/prot.24551	45	0	0	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101533	10.1016/j.jbc.2021.101533	http://dx.doi.org/10.1016/j.jbc.2021.101533			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1TV	34973336	Green Published, gold			2022-12-26	WOS:000761412100004
J	Kihara, Y; Jonnalagadda, D; Zhu, YJ; Ray, M; Ngo, T; Palmer, C; Rivera, R; Chun, J				Kihara, Yasuyuki; Jonnalagadda, Deepa; Zhu, Yunjiao; Ray, Manisha; Ngo, Tony; Palmer, Carter; Rivera, Richard; Chun, Jerold			Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P(1)-selective modulation	FASEB JOURNAL			English	Article						GPCR; lysophospholipid; multiple sclerosis; neuroinflammation; sphingolipid	CUPRIZONE-INDUCED DEMYELINATION; MULTIPLE-SCLEROSIS; RECEPTOR MODULATOR; FTY720 FINGOLIMOD; ORAL FINGOLIMOD; BRAIN; FATIGUE; THERAPY; EXPRESSION; MECHANISM	Ponesimod is a sphingosine 1-phosphate (S1P) receptor (S1PR) modulator that was recently approved for treating relapsing forms of multiple sclerosis (MS). Three other FDA-approved S1PR modulators for MS-fingolimod, siponimod, and ozanimod-share peripheral immunological effects via common S1P(1) interactions, yet ponesimod may access distinct central nervous system (CNS) mechanisms through its selectivity for the S1P(1) receptor. Here, ponesimod was examined for S1PR internalization and binding, human astrocyte signaling and single-cell RNA-seq (scRNA-seq) gene expression, and in vivo using murine cuprizone-mediated demyelination. Studies confirmed ponesimod's selectivity for S1P(1) without comparable engagement to the other S1PR subtypes (S1P(2,3,4,5)). Ponesimod showed pharmacological properties of acute agonism followed by chronic functional antagonism of S1P(1). A major locus of S1P(1) expression in the CNS is on astrocytes, and scRNA-seq of primary human astrocytes exposed to ponesimod identified a gene ontology relationship of reduced neuroinflammation and reduction in known astrocyte disease-related genes including those of immediate early astrocytes that have been strongly associated with disease progression in MS animal models. Remarkably, ponesimod prevented cuprizone-induced demyelination selectively in the cingulum, but not in the corpus callosum. These data support the CNS activities of ponesimod through S1P(1), including protective, and likely selective, effects against demyelination in a major connection pathway of the brain, the limbic fibers of the cingulum, lesions of which have been associated with several neurologic impairments including MS fatigue.	[Kihara, Yasuyuki; Jonnalagadda, Deepa; Zhu, Yunjiao; Ray, Manisha; Ngo, Tony; Palmer, Carter; Rivera, Richard; Chun, Jerold] Sanford Burnham Prebys Med Discovery Inst, Translat Neurosci Initiat, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Palmer, Carter] Univ Calif San Diego, Biomed Sci Program, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Chun, J (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Translat Neurosci Initiat, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@sbpdiscovery.org			NIH | National Institute of Neurological Disorders and Stroke (NINDS) [R01NS103940]; Janssen Research & Development LLC	NIH | National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Janssen Research & Development LLC	NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS103940; Janssen Research & Development LLC	Al-Dalahmah O, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0880-6; Basu N, 2013, RHEUMATOLOGY, V52, P1429, DOI 10.1093/rheumatology/ket135; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bisecco A, 2016, MULT SCLER J, V22, P1676, DOI 10.1177/1352458516628331; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Bracht T, 2015, J AFFECT DISORDERS, V187, P45, DOI 10.1016/j.jad.2015.06.041; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2021, DRUGS, V81, P207, DOI 10.1007/s40265-020-01431-8; Chun J, 2019, ANNU REV PHARMACOL, V59, P149, DOI 10.1146/annurev-pharmtox-010818-021358; Chun J, 2011, DISCOV MED, V12, P213; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Clark AL, 2017, BRAIN IMAGING BEHAV, V11, P1548, DOI 10.1007/s11682-016-9594-6; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; D'Ambrosio D, 2016, THER ADV CHRONIC DIS, V7, P18, DOI 10.1177/2040622315617354; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; De Keyser J, 2003, ARCH NEUROL-CHICAGO, V60, P132, DOI 10.1001/archneur.60.1.132; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fourgeaud L, 2021, CENTRAL EFFECT PONES; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Grandjean J, 2016, NEUROIMAGE, V142, P544, DOI 10.1016/j.neuroimage.2016.08.013; Groves A, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0239-18.2018; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kang SY, 2020, J NEURAL TRANSM, V127, P301, DOI 10.1007/s00702-019-02130-9; Kappos L, 2021, JAMA NEUROL, V78, P558, DOI 10.1001/jamaneurol.2021.0405; Kappos L, 2018, LANCET, V391, P1263, DOI 10.1016/S0140-6736(18)30475-6; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kiray H, 2016, EXP NEUROL, V283, P541, DOI 10.1016/j.expneurol.2016.03.009; Koenig KA, 2015, MULT SCLER J, V21, P1794, DOI 10.1177/1352458515576983; Lee CW, 2010, ARCH PHARM RES, V33, P1567, DOI 10.1007/s12272-010-1008-5; LEE SC, 1990, J NEUROPATH EXP NEUR, V49, P122, DOI 10.1097/00005072-199003000-00005; Lees AJ, 2017, JAMA NEUROL, V74, P197, DOI 10.1001/jamaneurol.2016.4703; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Masiulionyte B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41974-9; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mizuno H, 2019, J LIPID RES, V60, P212, DOI 10.1194/jlr.D089938; Molina-Gonzalez I, 2019, NEUROSCI LETT, V713, DOI 10.1016/j.neulet.2019.134532; Morell P, 1998, MOL CELL NEUROSCI, V12, P220, DOI 10.1006/mcne.1998.0715; Nash B, 2011, J NEUROSCI, V31, P13028, DOI 10.1523/JNEUROSCI.1449-11.2011; Novo AM, 2018, NEUROL-CLIN PRACT, V8, P492, DOI 10.1212/CPJ.0000000000000545; Pardini M, 2015, MULT SCLER J, V21, P442, DOI 10.1177/1352458514546791; Pfeil EM, 2020, MOL CELL, V80, P940, DOI 10.1016/j.molcel.2020.10.027; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Provenzano D, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10070456; Radua J, 2014, NEUROPSYCHOPHARMACOL, V39, P1547, DOI 10.1038/npp.2014.5; Ray M, 2020, J LIPID RES, V61, P1244, DOI 10.1194/jlr.D120000880; Schmidt T, 2013, J MOL NEUROSCI, V49, P80, DOI 10.1007/s12031-012-9896-0; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Silvestroff L, 2010, J COMP NEUROL, V518, P2261, DOI 10.1002/cne.22330; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Sorensen A, 2008, GLIA, V56, P750, DOI 10.1002/glia.20650; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tansey FA, 1997, MOL CHEM NEUROPATHOL, V31, P161, DOI 10.1007/BF02815240; Tran JQ, 2020, ADV THER, V37, P4381, DOI 10.1007/s12325-020-01473-0; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Vidal-Jordana A, 2013, MULT SCLER J, V19, P1175, DOI 10.1177/1352458512473190; Werkman IL, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02045-3	67	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22132	10.1096/fj.202101531R	http://dx.doi.org/10.1096/fj.202101531R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34986275	Green Published			2022-12-26	WOS:000747987800050
J	Nakano, S; Nishikawa, M; Kobayashi, T; Harlin, EW; Ito, T; Sato, K; Sugiyama, T; Yamakawa, H; Nagase, T; Ueda, H				Nakano, Shun; Nishikawa, Masashi; Kobayashi, Tomoyo; Harlin, Eka Wahyuni; Ito, Takuya; Sato, Katsuya; Sugiyama, Tsuyoshi; Yamakawa, Hisashi; Nagase, Takahiro; Ueda, Hiroshi			The Rho guanine nucleotide exchange factor PLEKHG1 is activated by interaction with and phosphorylation by Src family kinase member FYN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; PROTEIN; GTPASES; RAC1; MECHANOTRANSDUCTION; PALMITOYLATION; REORIENTATION; ASSOCIATION; EXPRESSION; MIGRATION	Rho family small GTPases (Rho) regulate various cell motility processes by spatiotemporally controlling the actin cytoskeleton. Some Rho-specific guanine nucleotide exchange factors (RhoGEFs) are regulated via tyrosine phosphorylation by Src family tyrosine kinase (SFK). We also previously re-ported that PLEKHG2, a RhoGEF for the GTPases Rac1 and Cdc42, is tyrosine-phosphorylated by SRC. However, the de-tails of the mechanisms by which SFK regulates RhoGEFs are not well understood. In this study, we found for the first time that PLEKHG1, which has very high homology to the Dbl and pleckstrin homology domains of PLEKHG2, activates Cdc42 following activation by FYN, a member of the SFK family. We also show that this activation of PLEKHG1 by FYN requires interaction between these two proteins and FYN-induced tyrosine phosphorylation of PLEKHG1. We also found that the region containing the Src homology 3 and Src homology 2 domains of FYN is required for this interaction. Finally, we demonstrated that tyrosine phosphorylation of Tyr-720 and Tyr-801 in PLEKHG1 is important for the activation of PLEKHG1. These results suggest that FYN is a regulator of PLEKHG1 and may regulate cell morphology through Rho signaling via the interaction with and tyrosine phosphorylation of PLEKHG1.	[Nakano, Shun; Nishikawa, Masashi; Ueda, Hiroshi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Kobayashi, Tomoyo] Gifu Univ, Fac Engn, Gifu, Japan; [Harlin, Eka Wahyuni; Ito, Takuya; Ueda, Hiroshi] Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan; [Sato, Katsuya] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu, Japan; [Sugiyama, Tsuyoshi] Gifu Univ Med Sci, Fac Pharm, Kani, Gifu, Japan; [Yamakawa, Hisashi; Nagase, Takahiro] Kazusa DNA Res Inst, Chiba, Japan	Gifu University; Gifu University; Gifu University; Gifu University; Kazusa DNA Research Institute	Ueda, H (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan.; Ueda, H (corresponding author), Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan.	hueda@gifu-u.ac.jp		Sugiyama, Tsuyoshi/0000-0002-8517-9067	JSPS KAKENHI [23590073, 15K07927]; Division of Genomic Research of the Life Science Research Center at Gifu University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Division of Genomic Research of the Life Science Research Center at Gifu University	This study was supported by JSPS KAKENHI Grants Number 23590073 and 15K07927. The DNA sequence analysis was supported by the Division of Genomic Research of the Life Science Research Center at Gifu University.	Abiko H, 2015, J CELL SCI, V128, P1683, DOI 10.1242/jcs.157503; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chiu YJ, 2008, J CELL BIOL, V182, P753, DOI 10.1083/jcb.200801062; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Fujiwara S, 2019, GENES CELLS, V24, P390, DOI 10.1111/gtc.12682; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Gray KJ, 2018, HYPERTENSION, V72, P408, DOI 10.1161/HYPERTENSIONAHA.117.10688; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hansen K, 1997, BIOCHEM BIOPH RES CO, V241, P355, DOI 10.1006/bbrc.1997.7743; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Hunter ZR, 2014, BLOOD, V123, P1637, DOI 10.1182/blood-2013-09-525808; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Liang XQ, 2004, J BIOL CHEM, V279, P8133, DOI 10.1074/jbc.M311180200; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nakano S, 2019, MOL CELL BIOCHEM, V459, P83, DOI 10.1007/s11010-019-03552-5; Niediek V, 2012, EUR J CELL BIOL, V91, P118, DOI 10.1016/j.ejcb.2011.10.003; Nishikawa M, 2019, CELL SIGNAL, V61, P93, DOI 10.1016/j.cellsig.2019.04.016; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Reebye V, 2012, CELL SIGNAL, V24, P388, DOI 10.1016/j.cellsig.2011.10.003; Reinhard Nathalie R, 2021, Small GTPases, V12, P226, DOI 10.1080/21541248.2019.1658509; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SABE H, 1992, P NATL ACAD SCI USA, V89, P2190, DOI 10.1073/pnas.89.6.2190; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Sato K, 2014, CELL SIGNAL, V26, P691, DOI 10.1016/j.cellsig.2013.12.006; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Traylor M, 2019, NEUROLOGY, V92, pE749, DOI 10.1212/WNL.0000000000006952; Tse SW, 2005, GENE, V359, P63, DOI 10.1016/j.gene.2005.06.025; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Yu B., 2020, CELL DEATH DIS, V11, P1	45	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101579	10.1016/j.jbc.2022.101579	http://dx.doi.org/10.1016/j.jbc.2022.101579			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35031323	Green Published, gold			2022-12-26	WOS:000761371500013
J	Tupta, B; Stuehr, E; Sumi, MP; Sweeny, EA; Smith, B; Stuehr, DJ; Ghosh, A				Tupta, Blair; Stuehr, Eric; Sumi, Mamta P.; Sweeny, Elizabeth A.; Smith, Brandon; Stuehr, Dennis J.; Ghosh, Arnab			GAPDH is involved in the heme-maturation of myoglobin and hemoglobin	FASEB JOURNAL			English	Article						dimerization; GAPDH; globin; heme-maturation	SOLUBLE GUANYLATE-CYCLASE; 3-DIMENSIONAL FOURIER SYNTHESIS; GLOBIN GENE-EXPRESSION; SHOCK-PROTEIN 90; NITRIC-OXIDE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ALPHA-GLOBIN; MECHANISMS; CHAPERONE; HSP90	GAPDH, a heme chaperone, has been previously implicated in the incorporation of heme into iNOS and soluble guanylyl cyclase (sGC). Since sGC is critical for myoglobin (Mb) heme-maturation, we investigated the role of GAPDH in the maturation of this globin, as well as hemoglobins alpha, beta, and gamma. Utilizing cell culture systems, we found that overexpression of wild-type GAPDH increased, whereas GAPDH mutants H53A and K227A decreased, the heme content of Mb and Hb alpha and Hb beta. Overexpression of wild-type GAPDH fully recovered the heme-maturation inhibition observed with the GAPDH mutants. Partial rescue was observed by overexpression of sGC beta 1 but not by overexpression of a sGC Delta beta 1 deletion mutant, which is unable to bind the sGC alpha 1 subunit required to form the active sGC alpha 1 beta 1 complex. Wild type and mutant GAPDH was found to be associated in a complex with each of the globins and Hsp90. GAPDH at endogenous levels was found to be associated with Mb in differentiating C2C12 myoblasts, and with Hb gamma or Hb alpha in differentiating HiDEP-1 erythroid progenitor cells. Knockdown of GAPDH in C2C12 cells suppressed Mb heme-maturation. GAPDH knockdown in K562 erythroleukemia cells suppressed Hb alpha and Hb gamma heme-maturation as well as Hb dimerization. Globin heme incorporation was not only dependent on elevated sGC alpha 1 beta 1 heterodimer formation, but also influenced by iron provision and magnitude of expression of GAPDH, d-aminolevulinic acid, and FLVCR1b. Together, our data support an important role for GAPDH in the maturation of myoglobin and gamma, beta, and alpha hemoglobins.	[Tupta, Blair; Stuehr, Eric; Sumi, Mamta P.; Sweeny, Elizabeth A.; Smith, Brandon; Stuehr, Dennis J.; Ghosh, Arnab] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, E; Ghosh, A (corresponding author), Cleveland Clin, Dept Inflammat & Immun NC22, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org; ghosha3@ccf.org		GHOSH, ARNAB/0000-0002-7498-1994	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [R56HL139564, R01HL150049, K99 HL144921]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R01 GM130624]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R56HL139564, R01HL150049 and K99 HL144921; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01 GM130624	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Byon JCH, 2013, BLOOD, V122, P2903, DOI 10.1182/blood-2012-10-465104; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chiabrando D, 2014, HAEMATOLOGICA, V99, P973, DOI 10.3324/haematol.2013.091991; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Chiche J, 2015, LEUKEMIA, V29, P1163, DOI 10.1038/leu.2014.324; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; CONGIUCASTELLANO A, 1987, BIOCHEM BIOPH RES CO, V147, P31, DOI 10.1016/S0006-291X(87)80083-9; Dai Y, 2020, J BIOL CHEM, V295, P8145, DOI 10.1074/jbc.RA120.013802; Donegan RK, 2019, FREE RADICAL BIO MED, V133, P88, DOI 10.1016/j.freeradbiomed.2018.08.005; Echeverria PC, 2016, MOL CELL BIOL, V36, P1310, DOI 10.1128/MCB.01099-15; Fleischhacker AS, 2018, J BIOL CHEM, V293, P14569, DOI 10.1074/jbc.H118.005247; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Friebe A, 2022, BRIT J PHARMACOL, V179, P2328, DOI 10.1111/bph.15345; Friebe A, 2020, N-S ARCH PHARMACOL, V393, P287, DOI 10.1007/s00210-019-01779-z; Genest O, 2019, J BIOL CHEM, V294, P2109, DOI 10.1074/jbc.REV118.002806; Ghosh A, 2021, REDOX BIOL, V39, DOI 10.1016/j.redox.2020.101832; Ghosh A, 2019, FASEB J, V33, P9885, DOI 10.1096/fj.201802793RR; Ghosh A, 2018, P NATL ACAD SCI USA, V115, pE1117, DOI 10.1073/pnas.1717993115; Ghosh A, 2016, P NATL ACAD SCI USA, V113, pE2355, DOI 10.1073/pnas.1524398113; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Guo CM, 2013, CLIN TRANSL ONCOL, V15, P167, DOI 10.1007/s12094-012-0924-x; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Hannibal L, 2012, BIOCHEMISTRY-US, V51, P8514, DOI 10.1021/bi300863a; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hardison RC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011627; Huang Y, 2017, ARCH BIOCHEM BIOPHYS, V619, P54, DOI 10.1016/j.abb.2017.03.005; HUBBARD SR, 1990, J MOL BIOL, V213, P215, DOI 10.1016/S0022-2836(05)80181-0; Ikuta T, 2001, P NATL ACAD SCI USA, V98, P1847, DOI 10.1073/pnas.041599798; Kanatous SB, 2010, J EXP BIOL, V213, P2741, DOI 10.1242/jeb.041442; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Khandros E, 2010, HEMATOL ONCOL CLIN N, V24, P1071, DOI 10.1016/j.hoc.2010.08.013; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Longeville S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09146-9; Mercurio S, 2015, HAEMATOLOGICA, V100, P720, DOI 10.3324/haematol.2014.114488; Moras M, 2017, FRONT PHYSIOL, V8, DOI [10.3389/FPHYS.2017.01076, 10.3389/fphys.2017.01076]; Nakamura T, 2002, BIOCHEM BIOPH RES CO, V290, P858, DOI 10.1006/bbrc.2001.6271; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; PERUTZ M F, 1960, Brookhaven Symp Biol, V13, P165; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; PERUTZ MF, 1968, NATURE, V219, P131, DOI 10.1038/219131a0; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Ponka P, 1997, BLOOD, V89, P1; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; Sawicki KT, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001138; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Seo MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4724; Shimizu T, 2019, CHEM SOC REV, V48, P5624, DOI 10.1039/c9cs00268e; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Stuehr DJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100336; Sweeny EA, 2018, J BIOL CHEM, V293, P14557, DOI 10.1074/jbc.RA118.004169; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; Tittelmeier J, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.581374; Voon HPJ, 2008, HAEMATOL-HEMATOL J, V93, P1868, DOI 10.3324/haematol.13490; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; WELLER PA, 1986, MOL CELL BIOL, V6, P4539, DOI 10.1128/MCB.6.12.4539; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Yin T, 2015, J IMMUNOL, V194, P429, DOI 10.4049/jimmunol.1400643; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zhang JY, 2015, CANCER BIOL MED, V12, P10, DOI 10.7497/j.issn.2095-3941.2014.0019; Zhang J, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010064; Zhang K, 2017, ADV EXP MED BIOL, V977, P367, DOI 10.1007/978-3-319-55231-6_48; Zheng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14344	72	7	7	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22099	10.1096/fj.202101237RR	http://dx.doi.org/10.1096/fj.202101237RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34972240	Green Accepted			2022-12-26	WOS:000747987800049
J	Robitaille, MC; Byers, JM; Christodoulides, JA; Raphael, MP				Robitaille, Michael C.; Byers, Jeff M.; Christodoulides, Joseph A.; Raphael, Marc P.			Robust optical flow algorithm for general single cell segmentation	PLOS ONE			English	Article							TRACKING	Cell segmentation is crucial to the field of cell biology, as the accurate extraction of single-cell morphology, migration, and ultimately behavior from time-lapse live cell imagery are of paramount importance to elucidate and understand basic cellular processes. In an effort to increase available segmentation tools that can perform across research groups and platforms, we introduce a novel segmentation approach centered around optical flow and show that it achieves robust segmentation of single cells by validating it on multiple cell types, phenotypes, optical modalities, and in-vitro environments with or without labels. By leveraging cell movement in time-lapse imagery as a means to distinguish cells from their background and augmenting the output with machine vision operations, our algorithm reduces the number of adjustable parameters needed for manual optimization to two. We show that this approach offers the advantage of quicker processing times compared to contemporary machine learning based methods that require manual labeling for training, and in most cases achieves higher quality segmentation as well. This algorithm is packaged within MATLAB, offering an accessible means for general cell segmentation in a time-efficient manner.	[Robitaille, Michael C.; Byers, Jeff M.; Christodoulides, Joseph A.; Raphael, Marc P.] US Naval Res Lab, Mat Sci & Technol Div, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Raphael, MP (corresponding author), US Naval Res Lab, Mat Sci & Technol Div, Washington, DC 20375 USA.	Marc.Raphael@nrl.navy.mil		Raphael, Marc/0000-0003-1794-5193	National Research Council Research Associateship Program; Jerome and Isabella Karle Distinguished Scholar Fellowship Program; Office of Naval Research through the Naval Research Laboratory's Basic Research Program; Biological Technology Office of the Defense Advanced Research Program Agency	National Research Council Research Associateship Program; Jerome and Isabella Karle Distinguished Scholar Fellowship Program; Office of Naval Research through the Naval Research Laboratory's Basic Research Program(Office of Naval Research); Biological Technology Office of the Defense Advanced Research Program Agency	M.C.R. gratefully acknowledges support from the National Research Council Research Associateship Program and the Jerome and Isabella Karle Distinguished Scholar Fellowship Program. Funding for this project was provided by the Office of Naval Research through the Naval Research Laboratory's Basic Research Program and by the Biological Technology Office of the Defense Advanced Research Program Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1975, EXP CELL RES, V92, P57, DOI 10.1016/0014-4827(75)90636-9; Al-Kofahi Y, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2375-z; [Anonymous], 2019, NAT METHODS, V16, P1195, DOI 10.1038/s41592-019-0670-x; Asano Y, 2004, CELL MOTIL CYTOSKEL, V59, P17, DOI 10.1002/cm.20015; Baker M, 2010, NATURE, V466, P1137, DOI 10.1038/4661137a; Beauchemin SS, 1995, ACM COMPUT SURV, V27, P433, DOI 10.1145/212094.212141; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Buibas M, 2010, ANN BIOMED ENG, V38, P2520, DOI 10.1007/s10439-010-0005-7; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Chalfoun J, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0431-x; Christodoulides JA, 2018, MRS COMMUN, V8, P49, DOI 10.1557/mrc.2018.2; CLARK P, 1990, DEVELOPMENT, V108, P635; Delpiano J, 2012, MACH VISION APPL, V23, P675, DOI 10.1007/s00138-011-0362-8; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Falk T, 2019, NAT METHODS, V16, P67, DOI 10.1038/s41592-018-0261-2; Farneback G, 2003, LECT NOTES COMPUT SC, V2749, P363, DOI 10.1007/3-540-45103-x_50; Flores LR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40092-w; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Hilsenbeck O, 2017, BIOINFORMATICS, V33, P2020, DOI 10.1093/bioinformatics/btx107; Klein K, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-28; Lee RM, 2020, MOL BIOL CELL, V31, P1753, DOI 10.1091/mbc.E19-11-0614; Liu K, 2014, I S BIOMED IMAGING, P298, DOI 10.1109/ISBI.2014.6867868; Lucas B. D., 1981, IJCAI, P121, DOI DOI 10.5555/1623264.1623280; Lugagne JB, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007673; Masuzzo P, 2016, TRENDS CELL BIOL, V26, P88, DOI 10.1016/j.tcb.2015.09.003; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; Miao YC, 2017, NAT CELL BIOL, V19, P329, DOI 10.1038/ncb3495; Moller M, 2014, J VIS COMMUN IMAGE R, V25, P396, DOI 10.1016/j.jvcir.2013.12.002; Moshkov N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61808-3; Ounkomol C, 2018, NAT METHODS, V15, P917, DOI 10.1038/s41592-018-0111-2; Robitaille MC., MRS COMMUN, P1; Stringer C, 2021, NAT METHODS, V18, P100, DOI 10.1038/s41592-020-01018-x; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Tinevez JY, 2012, METHOD ENZYMOL, V506, P291, DOI 10.1016/B978-0-12-391856-7.00039-1; Tsai HF, 2019, SOFTWAREX, V9, P230, DOI 10.1016/j.softx.2019.02.007; Vicar T, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2880-8; Xu CC, 2018, MED IMAGE ANAL, V50, P82, DOI 10.1016/j.media.2018.09.001; Zhao TY, 2021, IEEE T MED IMAGING, V40, P2736, DOI 10.1109/TMI.2020.3046292	40	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261763	10.1371/journal.pone.0261763	http://dx.doi.org/10.1371/journal.pone.0261763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030184	Green Published, gold			2022-12-26	WOS:000812798500015
J	Lai, HF; Chau, IY; Lei, HJ; Chou, SC; Hsia, CY; Kao, YC; Chau, GY				Lai, Hon-Fan; Chau, Ivy Yenwen; Lei, Hao-Jan; Chou, Shu-Cheng; Hsia, Cheng-Yuan; Kao, Yi-Chu; Chau, Gar-Yang			Postoperative fever after liver resection: Incidence, risk factors, and characteristics associated with febrile infectious complication	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEPATIC RESECTION; CDC DEFINITIONS; GLOBULIN RATIO; SURGERY; MANAGEMENT; INDEX; ALBUMIN	Purpose To evaluate the incidence and risk factors of postoperative fever (POF) after liver resection. In patients with POF, predictors of febrile infectious complications were determined. Methods A total of 797 consecutive patients undergoing liver resection from January 2015 to December 2019 were retrospectively investigated. POF was defined as body temperature >= 38.0 degrees C in the postoperative period. POF was characterized by time of first fever, the highest temperature, and frequency of fever. The Institut Mutualiste Montsouris (IMM) classification was used to stratify surgical difficulty, from grade I (low), grade II (intermediate) to grade III (high). Postoperative leukocytosis was defined as a 70% increase of white blood cell count from the preoperative value. Multivariate analysis was performed to identify risk factors for POF and predictors of febrile infectious complications. Results Overall, 401 patients (50.3%) developed POF. Of these, 10.5% had the time of first fever > postoperative day (POD) 2, 25.9% had fever > 38.6 degrees C, and 60.6% had multiple fever spikes. In multivariate analysis, risk factors for POF were: IMM grade III resection (OR 1.572, p = 0.008), Charlson Comorbidity Index score > 3 (OR 1.872, p < 0.001), and serum albumin < 3.2 g/dL (OR 3.236, p = 0.023). 14.6% patients developed infectious complication, 21.9% of febrile patients and 7.1% of afebrile patients (p < 0.001). Predictors of febrile infectious complications were: fever > 38.6 degrees C (OR 2.242, p = 0.003), time of first fever > POD2 (OR 6.002, p < 0.001), and multiple fever spikes (OR 2.039, p = 0.019). Sensitivity, specificity, positive predictive value and negative predictive value for fever > 38.6 degrees C were 39.8%, 78.0%, 33.7% and 82.2%, respectively. A combination of fever > 38.6 degrees C and leukocytosis provided high specificity of 95.2%. Conclusion In this study, we found that IMM classification, CCI score, and serum albumin level related with POF development in patients undergone liver resection. Time of first fever > POD2, fever > 38.6 degrees C, and multiple fever spikes indicate an increased risk of febrile infectious complication. These findings may aid decision-making in patients with POF who require further diagnostic workup.	[Lai, Hon-Fan; Lei, Hao-Jan; Chou, Shu-Cheng; Hsia, Cheng-Yuan; Kao, Yi-Chu; Chau, Gar-Yang] Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Chau, Ivy Yenwen] Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lei, Hao-Jan; Hsia, Cheng-Yuan; Chau, Gar-Yang] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan	Taipei Veterans General Hospital; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University	Kao, YC; Chau, GY (corresponding author), Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.; Chau, GY (corresponding author), Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan.	gychau@vghtpe.gov.tw; yckao5@vghtpe.gov.tw			Taipei Veterans General Hospital [V109C-187]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	GYC received a grant from Taipei Veterans General Hospital (V109C-187) https://www.vghtpe.gov.tw/, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptndex.	Andres BM, 2003, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000093914.26658.55; Backemar L, 2020, ANN SURG ONCOL, V27, P2637, DOI 10.1245/s10434-020-08303-1; Bossink AWJ, 1999, CHEST, V116, P380, DOI 10.1378/chest.116.2.380; Braunwarth E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243539; Buvanendran A, 2003, JAMA-J AM MED ASSOC, V290, P2411, DOI 10.1001/jama.290.18.2411; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chau GY, 2014, WORLD J GASTROENTERO, V20, P12473, DOI 10.3748/wjg.v20.i35.12473; Chau GY, 2005, WORLD J SURG, V29, P1374, DOI 10.1007/s00268-005-7766-4; D'Amico D, 1999, J CHEMOTHERAPY, V11, P513, DOI 10.1179/joc.1999.11.6.513; Das UN, 2014, AM J SURG, V208, P157, DOI 10.1016/j.amjsurg.2013.08.055; de la Torre SH, 2003, AM J OBSTET GYNECOL, V188, P1642, DOI 10.1067/mob.2003.397; Dubray Q, 2021, SURG ENDOSC, V35, P1006, DOI 10.1007/s00464-020-08075-5; Elkholy S, 2019, ARCH MED SCI, V15, P656, DOI 10.5114/aoms.2019.84736; Elola-Olaso AM, 2012, HPB, V14, P136, DOI 10.1111/j.1477-2574.2011.00417.x; Feng F, 2017, ONCOTARGET, V8, P62622, DOI 10.18632/oncotarget.15979; Frank SM, 2000, ANESTHESIOLOGY, V93, P1426, DOI 10.1097/00000542-200012000-00014; FREISCHLAG J, 1983, SURGERY, V94, P358; GALICIER C, 1985, INFECT CONT HOSP EP, V6, P487, DOI 10.1017/S0195941700063608; GARIBALDI RA, 1985, INFECT CONT HOSP EP, V6, P273, DOI 10.1017/S0195941700061749; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hamaguchi Y, 2016, WORLD J SURG, V40, P1959, DOI 10.1007/s00268-016-3504-3; Hirokawa F, 2013, AM J SURG, V206, P8, DOI 10.1016/j.amjsurg.2012.08.016; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Huang XD, 2022, ASIAN J SURG, V45, P110, DOI 10.1016/j.asjsur.2021.03.024; Ishizawa T, 2009, ARCH SURG-CHICAGO, V144, P46, DOI 10.1001/archsurg.2008.511; Jian ZY, 2020, BMC UROL, V20, DOI 10.1186/s12894-020-00620-7; Jin S, 2013, WORLD J GASTROENTERO, V19, P7983, DOI 10.3748/wjg.v19.i44.7983; JORGENSEN FS, 1988, ANN CHIR GYNAECOL FE, V77, P47; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kawaguchi Y, 2020, BRIT J SURG, V107, P258, DOI 10.1002/bjs.11351; Kawaguchi Y, 2018, ANN SURG, V267, P13, DOI 10.1097/SLA.0000000000002176; Konstantinidis IT, 2016, J GASTROINTEST SURG, V20, P748, DOI 10.1007/s11605-015-3041-7; Kwon Y, 2021, WORLD J SURG, V45, P1178, DOI 10.1007/s00268-020-05912-5; Kyoden Y, 2010, J HEPATO-BIL-PAN SCI, V17, P186, DOI 10.1007/s00534-009-0161-z; Lesperance R, 2011, J SURG RES, V171, P245, DOI 10.1016/j.jss.2010.03.009; Li QS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171129; Lui Wing-Yiu, 1997, P533; LUI WY, 1995, ARCH SURG-CHICAGO, V130, P1090; Mayo BC, 2018, NEUROSPINE, V15, P154, DOI 10.14245/ns.1836026.013; McNally CG, 2000, J REPROD MED, V45, P572; MELLORS JW, 1988, AM SURGEON, V54, P558; MIHOLIC J, 1984, THORAC CARDIOV SURG, V32, P45, DOI 10.1055/s-2007-1023343; Miyawaki T, 1998, ORAL SURG ORAL MED O, V85, P146, DOI 10.1016/S1079-2104(98)90417-6; Moreira AD, 2008, DIS COLON RECTUM, V51, P508, DOI 10.1007/s10350-007-9183-2; Reddy SK, 2011, HPB, V13, P494, DOI 10.1111/j.1477-2574.2011.00330.x; Schmolders J, 2015, INT ORTHOP, V39, P1771, DOI 10.1007/s00264-015-2810-y; Schwandt A, 2001, AM J OBSTET GYNECOL, V184, P1066, DOI 10.1067/mob.2001.115227; Seo J, 2017, WORLD NEUROSURG, V103, P78, DOI 10.1016/j.wneu.2017.03.119; Ulyett S, 2017, PERIOPER MED-LONDON, V6, DOI 10.1186/s13741-017-0073-4; Vermeulen H, 2005, CLIN INFECT DIS, V40, P1404, DOI 10.1086/429621; Vigano L, 2019, ANN SURG, V270, P842, DOI 10.1097/SLA.0000000000003493; Walid MS, 2011, NEUROSURGERY, V68, P945, DOI 10.1227/NEU.0b013e318209c80a; Yan TT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015903; Yang T, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4832051; Yoo JH, 2017, INJURY, V48, P441, DOI 10.1016/j.injury.2016.12.013; Yoo JH, 2017, J ARTHROPLASTY, V32, P520, DOI 10.1016/j.arth.2016.09.025	56	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262113	10.1371/journal.pone.0262113	http://dx.doi.org/10.1371/journal.pone.0262113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025947	gold, Green Published			2022-12-26	WOS:000796264200045
J	Lee, C; Holroyd, TA; Gur-Arie, R; Sauer, M; Zavala, E; Paul, AM; Shattuck, D; Karron, RA; Limaye, RJ				Lee, Clarice; Holroyd, Taylor A.; Gur-Arie, Rachel; Sauer, Molly; Zavala, Eleonor; Paul, Alicia M.; Shattuck, Dominick; Karron, Ruth A.; Limaye, Rupali J.			COVID-19 vaccine acceptance among Bangladeshi adults: Understanding predictors of vaccine intention to inform vaccine policy	PLOS ONE			English	Article								Objectives The purpose of this study was to identify predictors of COVID-19 vaccine intention among Bangladeshi adults. Methods Secondary data from the COVID-19 Beliefs, Behaviors & Norms Survey conducted by the Massachusetts Institute of Technology (MIT) and Facebook were analyzed. Data were collected from 2,669 adult Facebook users in Bangladesh and was collected between February 15 and February 28, 2021. Binomial logistic regression examined the relationship between COVID-19 vaccination intent and demographic variables, risk perception, preventive behaviors, COVID-19 knowledge, and likelihood of future actions. Results Seventy-nine percent of respondents reported intent to get the COVID-19 vaccine when it becomes available. Intent to get vaccinated was highest among females, adults aged 71-80, individuals with college or graduate-level degrees, city dwellers, and individuals who perceived that they were in excellent health. Results of the binomial logistic regression indicated that predictors of vaccination intent include age (OR = 1.39), high risk perception of COVID-19 (OR = 1.47), and intent to practice social distancing (OR = 1.22). Discussion Findings suggest that age, perceived COVID-19 risk, and non-pharmaceutical COVID-19 interventions may predict COVID-19 vaccination intent among Bangladeshi adults. Findings can be used to create targeted messaging to increase demand for and uptake of COVID-19 vaccines in Bangladesh.	[Lee, Clarice; Holroyd, Taylor A.; Sauer, Molly; Zavala, Eleonor; Paul, Alicia M.; Karron, Ruth A.; Limaye, Rupali J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Lee, Clarice; Holroyd, Taylor A.; Sauer, Molly; Paul, Alicia M.; Limaye, Rupali J.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA; [Gur-Arie, Rachel] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Gur-Arie, Rachel] Oxford Johns Hopkins Global Infect Dis Ethics Col, Oxford, England; [Paul, Alicia M.; Limaye, Rupali J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Shattuck, Dominick] Johns Hopkins Univ, Ctr Commun Programs, JHU CCP, Baltimore, MD USA; [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD USA; [Limaye, Rupali J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Limaye, RJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Limaye, RJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA.; Limaye, RJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.; Limaye, RJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	rlimaye@jhu.edu		Shattuck, Dominick/0000-0002-8524-8149; Gur-Arie, Rachel/0000-0002-0868-7682; Sauer, Molly/0000-0002-5837-6997	Bill & Melinda Gates Foundation, Seattle, WA [INV016877]	Bill & Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA [INV016877]. https://www.gatesfoundation.org/The funder played no role in study design; in collection, analysis and interpretation of data; in writing of the report; or in the decision to submit the article for publication.	Abedin M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250495; AJMC Staff, 2021, TIM COVID 19 DEV 202; Al-Bari MAA, 2021, WORLD J RADIOL, V13, DOI 10.4329/wjr.v13.i1.1; Al-Masum Molla M., 2021, DAILY STAR; Ali M., 2021, BMJ OPEN, DOI [10.1136/bmjopen-2021-050303, DOI 10.1136/BMJOPEN-2021-050303]; [Anonymous], 2021, TIMES INDIA; [Anonymous], 2021, BUSINESS STANDARD; Bangladesh Ministry of Health and Family Welfare, 2021, COVID 19 VACC DASHB; Barkay N, 2020, WEIGHTS METHODOLOGY; Berkley S., 2020, COVAX EXPLAINED; Center for Systems Science and Engineering at Johns Hopkins University, 2021, NIG CDC COVID 19 DAS; Collis C., 2020, GLOBAL SURVEY COVID; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Government of India M of EA, 2021, COVID 19 UPD VACC SU; Hasan K., 2021, DHAKA TRIBUNE; Holder J, 2021, NEW YORK TIMES; Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0; Institute of Epidemiology DC and R, 2021, COV 19 STAT BANGL; Kabir R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050416; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Mahmud S., 2021, ACCEPTANCE COVID 19; Mamun S., 2021, DHAKA TRIBUNE 0421; Moehring A.V., 2021, SURFACING NORMS INCR, DOI 10.31234/osf.io/srv6t; Molla MMA, 2021, INT J HEALTH PLAN M, V36, P1014, DOI 10.1002/hpm.3156; National Institute of Population Research and Training (NIPORT) ICF, 2020, 2017 18 BANGL DEM HL; Opu MH, 2021, DHAKA TRIBUNE 0604; Our World in Data, 2021, OUR WORLD DAT; Paul, 2021, REUTERS; Saha S., 2021, COVID 19 RISE BANGLA; Sakib SN., 2021, BANGLADESH EXPORT LO; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; UNICEF, 2021, COVAX WORK GLOB EQ A; Wang W, 2015, INT J FORECASTING, V31, P980, DOI 10.1016/j.ijforecast.2014.06.001; Yeung MPS., 2016, FACTORS ASS UPTAKE S	34	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261929	10.1371/journal.pone.0261929	http://dx.doi.org/10.1371/journal.pone.0261929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025903	gold, Green Published			2022-12-26	WOS:000796264200035
J	Natalia, F; Young, JC; Afriliana, N; Meidia, H; Yunus, RE; Sudirman, S				Natalia, Friska; Young, Julio Christian; Afriliana, Nunik; Meidia, Hira; Yunus, Reyhan Eddy; Sudirman, Sud			Automated selection of mid-height intervertebral disc slice in traverse lumbar spine MRI using a combination of deep learning feature and machine learning classifier	PLOS ONE			English	Article							BOUNDARY DELINEATION; SEGMENTATION	Abnormalities and defects that can cause lumbar spinal stenosis often occur in the Intervertebral Disc (IVD) of the patient's lumbar spine. Their automatic detection and classification require an application of an image analysis algorithm on suitable images, such as mid-sagittal images or traverse mid-height intervertebral disc slices, as inputs. Hence the process of selecting and separating these images from other medical images in the patient's set of scans is necessary. However, the technological progress in making this process automated is still lagging behind other areas in medical image classification research. In this paper, we report the result of our investigation on the suitability and performance of different approaches of machine learning to automatically select the best traverse plane that cuts closest to the half-height of an IVD from a database of lumbar spine MRI images. This study considers images features extracted using eleven different pre-trained Deep Convolution Neural Network (DCNN) models. We investigate the effectiveness of three dimensionality-reduction techniques and three feature-selection techniques on the classification performance. We also investigate the performance of five different Machine Learning (ML) algorithms and three Fully Connected (FC) neural network learning optimizers which are used to train an image classifier with hyperparameter optimization using a wide range of hyperparameter options and values. The different combinations of methods are tested on a publicly available lumbar spine MRI dataset consisting of MRI studies of 515 patients with symptomatic back pain. Our experiment shows that applying the Support Vector Machine algorithm with a short Gaussian kernel on full-length image features extracted using a pre-trained DenseNet201 model is the best approach to use. This approach gives the minimum per-class classification performance of around 0.88 when measured using the precision and recall metrics. The median performance measured using the precision metric ranges from 0.95 to 0.99 whereas that using the recall metric ranges from 0.93 to 1.0. When only considering the L3/L4, L4/L5, and L5/S1 classes, the minimum F1-Scores range between 0.93 to 0.95, whereas the median F1-Scores range between 0.97 to 0.99.	[Natalia, Friska; Young, Julio Christian; Afriliana, Nunik; Meidia, Hira; Sudirman, Sud] Univ Multimedia Nusantara, Fac Engn & Informat, Serpong, Indonesia; [Yunus, Reyhan Eddy] Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Sudirman, Sud] Liverpool John Moores Univ, Sch Comp Sci & Math, Liverpool, Merseyside, England	Multimedia Nusantara University; University of Indonesia; Liverpool John Moores University	Sudirman, S (corresponding author), Liverpool John Moores Univ, Sch Comp Sci & Math, Liverpool, Merseyside, England.	s.sudirman@ljmu.ac.uk		Sudirman, Sud/0000-0003-4083-0810; Afriliana, Nunik/0000-0001-6314-6128	Indonesian Ministry of Research, Technology and Higher Education [9/E1/KPT/2020]	Indonesian Ministry of Research, Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	Grant Holder: FN Grant Number: 9/E1/KPT/2020 Funder: The Indonesian Ministry of Research, Technology and Higher Education. Funder URL: https://www.ristekbrin.go.id/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kafri AS, 2019, IEEE ACCESS, V7, P43487, DOI 10.1109/ACCESS.2019.2908002; Alomari RS., 2015, SPINAL IMAGING IMAGE, P193; Alomari RS, 2014, COMPUTATIONAL METHOD, P87, DOI DOI 10.1007/978-3-319-07269-2_8; Anthony G, 2007, ARXIV PREPR ARXIV071; Ardekani BA, 1997, IEEE T MED IMAGING, V16, P947, DOI 10.1109/42.650892; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Bagley Carlos, 2019, F1000Res, V8, DOI 10.12688/f1000research.16082.1; Baloch SH, 2007, IEEE T IMAGE PROCESS, V16, P317, DOI 10.1109/TIP.2006.888348; Barros RC, 2012, IEEE T SYST MAN CY C, V42, P291, DOI 10.1109/TSMCC.2011.2157494; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Bull AD, 2011, J MACH LEARN RES, V12, P2879; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Cournapeau D, SCIKIT LEARN; Davarpanah SH, 2017, INT J FUZZY SYST, V19, P591, DOI 10.1007/s40815-016-0247-0; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Fordellone M, 2019, STAT ANAL COMPLEX DA; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Ghosh S, 2014, COMPUT MED IMAG GRAP, V38, P639, DOI 10.1016/j.compmedimag.2014.03.005; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hartman J, 2019, CUREUS, V11, DOI 10.7759/cureus.4268; He K, 2017, P IEEE INT C COMPUTE, P29619; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He XX, 2017, MED IMAGE ANAL, V36, P22, DOI 10.1016/j.media.2016.10.009; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Huang GL, 2017, IEEE ICC; Huang JW, 2020, SPINE J, V20, P590, DOI 10.1016/j.spinee.2019.11.010; Hussain N, 2020, MULTIMED TOOLS APPL, DOI 10.1007/s11042-020-08852-3; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jovic A, 2015, 2015 8TH INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P1200, DOI 10.1109/MIPRO.2015.7160458; Khan MA, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11050811; Khan MA, 2021, CMC-COMPUT MATER CON, V68, P1041, DOI 10.32604/cmc.2021.016307; Khan MA, 2021, PATTERN RECOGN LETT, V143, P58, DOI 10.1016/j.patrec.2020.12.015; Khan MA, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10080565; Kingma DP., 2014, ADAM METHOD STOCHAST; Koh J, 2010, PROC SPIE, V7624, DOI 10.1117/12.844386; Koitka S, 2016, CLEF WORKING NOTES, P30417; Kornblith S, 2019, P IEEECVF C COMPUTER; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; LeCun Y, 1990, ADV NEURAL INFORM PR; Ma J, 2019, J VIS COMMUN IMAGE R, V63, DOI 10.1016/j.jvcir.2019.102578; Mattes D, 2003, IEEE T MED IMAGING, V22, P120, DOI 10.1109/TMI.2003.809072; Morid MA, 2021, COMPUT BIOL MED, V128, DOI 10.1016/j.compbiomed.2020.104115; Natalia F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241309; Natalia F, 2018, IEEE 20TH INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS / IEEE 16TH INTERNATIONAL CONFERENCE ON SMART CITY / IEEE 4TH INTERNATIONAL CONFERENCE ON DATA SCIENCE AND SYSTEMS (HPCC/SMARTCITY/DSS), P1449, DOI 10.1109/HPCC/SmartCity/DSS.2018.00239; No U, 2018, ARXIV PREPR ARXIV180; Paul CPL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191442; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Ruder S., 2016, ABS16090 CORR; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Simonyan K., 2015, PROC 3 INT C LEARN R; Song Y, 2013, IEEE T MED IMAGING, V32, P797, DOI 10.1109/TMI.2013.2241448; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Sudirman S, 2019, LUMBAR SPINE MRI DAT; Sudirman S, MENDELEY DATA, V2021; Szegedy C, 2016, ARXIV PREPR ARXIV160; Szegedy C, 2016, P IEEE C COMPUTER VI; Vapnik V., 2013, NATURE STAT LAERNING; Yang W, 2012, J COMPUT, V7, P161, DOI 10.4304/jcp.7.1.161-168; Zhang JP, 2019, MED IMAGE ANAL, V54, P10, DOI 10.1016/j.media.2019.02.010; Zhang Q, 2017, INT C INFORM PROCESS, P21022; Zou F, 2019, P IEEECVF C COMPUTER	68	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261659	10.1371/journal.pone.0261659	http://dx.doi.org/10.1371/journal.pone.0261659			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025904	Green Published, gold, Green Accepted			2022-12-26	WOS:000796264200023
J	Raisman, JC; Fiore, MA; Tomin, L; Adjei, JKO; Aswad, VX; Chu, J; Domondon, CJ; Donahue, BA; Masciotti, CA; McGrath, CG; Melita, J; Podbielski, PA; Schreiner, MR; Trumpore, LJ; Wengert, PC; Wrightstone, EA; Hudson, AO; Wadsworth, CB				Raisman, Jordan C.; Fiore, Michael A.; Tomin, Lucille; Adjei, Joseph K. O.; Aswad, Virginia X.; Chu, Jonathan; Domondon, Christina J.; Donahue, Ben A.; Masciotti, Claudia A.; McGrath, Connor G.; Melita, Jo; Podbielski, Paul A.; Schreiner, Madelyn R.; Trumpore, Lauren J.; Wengert, Peter C.; Wrightstone, Emalee A.; Hudson, Andre O.; Wadsworth, Crista B.			Evolutionary paths to macrolide resistance in a Neisseria commensal converge on ribosomal genes through short sequence duplications	PLOS ONE			English	Article							GENOMIC EPIDEMIOLOGY; GONORRHOEAE; MENINGITIDIS; AZITHROMYCIN; MUTATION; PROTEIN; SUSCEPTIBILITY; TRANSFORMATION; MECHANISMS; DIVERSITY	Neisseria commensals are an indisputable source of resistance for their pathogenic relatives. However, the evolutionary paths commensal species take to reduced susceptibility in this genus have been relatively underexplored. Here, we leverage in vitro selection as a powerful screen to identify the genetic adaptations that produce azithromycin resistance (>= 2 mu g/mL) in the Neisseria commensal, N. elongata. Across multiple lineages (n = 7/16), we find mutations that reduce susceptibility to azithromycin converge on the locus encoding the 50S ribosomal L34 protein (rpmH) and the intergenic region proximal to the 30S ribosomal S3 protein (rpsC) through short tandem duplication events. Interestingly, one of the laboratory evolved mutations in rpmH is identical (7LKRTYQ12), and two nearly identical, to those recently reported to contribute to high-level azithromycin resistance in N. gonorrhoeae. Transformations into the ancestral N. elongata lineage confirmed the causality of both rpmH and rpsC mutations. Though most lineages inheriting duplications suffered in vitro fitness costs, one variant showed no growth defect, suggesting the possibility that it may be sustained in natural populations. Ultimately, studies like this will be critical for predicting commensal alleles that could rapidly disseminate into pathogen populations via allelic exchange across recombinogenic microbial genera.	[Raisman, Jordan C.; Fiore, Michael A.; Tomin, Lucille; Adjei, Joseph K. O.; Aswad, Virginia X.; Chu, Jonathan; Domondon, Christina J.; Donahue, Ben A.; Masciotti, Claudia A.; McGrath, Connor G.; Melita, Jo; Podbielski, Paul A.; Schreiner, Madelyn R.; Trumpore, Lauren J.; Wengert, Peter C.; Wrightstone, Emalee A.; Hudson, Andre O.; Wadsworth, Crista B.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA	Rochester Institute of Technology	Wadsworth, CB (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	cbwsbi@rit.edu			RIT College of Science	RIT College of Science	The authors would like to acknowledge the generous support provided by the RIT College of Science for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma G, 2014, J BACTERIOL, V196, P3820, DOI 10.1128/JB.01896-14; Andrews S., 2010, FASTQC QUALITY CONTR; Arnold B, 2020, MOL BIOL EVOL, V37, P417, DOI 10.1093/molbev/msz225; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Castillo-Ramirez S, 2021, ENVIRON MICROBIOL, V23, P7271, DOI 10.1111/1462-2920.15841; Chamorro G, 2019, J MED MICROBIOL, V68, P1793, DOI 10.1099/jmm.0.001097; Chen ML, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01494-19; Chisholm SA, 2010, ANTIMICROB AGENTS CH, V54, P3812, DOI 10.1128/AAC.00309-10; Clinical and Laboratory Standards Institute, 2019, PERFORMANCE STANDARD, P1, DOI [10.1108/08876049410065598, DOI 10.1108/08876049410065598]; Corander J, 2012, J R SOC INTERFACE, V9, P1208, DOI 10.1098/rsif.2011.0601; de Block T, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10030384; Demczuk W, 2016, J CLIN MICROBIOL, V54, P1304, DOI 10.1128/JCM.03195-15; Diallo K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50203-2; Diallo K, 2016, J INFECTION, V72, P667, DOI 10.1016/j.jinf.2016.03.010; Dong HV, 2020, CLIN INFECT DIS, V70, P1169, DOI 10.1093/cid/ciz365; FEAVERS IM, 1992, MOL MICROBIOL, V6, P489, DOI 10.1111/j.1365-2958.1992.tb01493.x; Fifer H, 2020, INT J STD AIDS, V31, P4, DOI 10.1177/0956462419886775; Fiore MA, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9100656; Frye SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003458; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; Gong ZJ, 2016, ANTIMICROB AGENTS CH, V60, P2043, DOI 10.1128/AAC.00149-15; Goytia M, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10050538; Grad YH, 2016, J INFECT DIS, V214, P1579, DOI 10.1093/infdis/jiw420; HAGMAN KE, 1995, J BACTERIOL, V177, P4162, DOI 10.1128/jb.177.14.4162-4165.1995; HALTER R, 1989, EMBO J, V8, P2737, DOI 10.1002/j.1460-2075.1989.tb08415.x; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Harcourt BH, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv117; Jansen G, 2013, DRUG RESIST UPDATE, V16, P96, DOI 10.1016/j.drup.2014.02.002; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kim WJ, 2019, CELL HOST MICROBE, V26, P228, DOI 10.1016/j.chom.2019.07.003; Krone M, 2020, J ANTIMICROB CHEMOTH, V75, P984, DOI 10.1093/jac/dkz535; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laumen JGE, 2021, J ANTIMICROB CHEMOTH, V76, P1752, DOI 10.1093/jac/dkab084; Liu GY, 2015, MICROBIOL-SGM, V161, P1297, DOI 10.1099/mic.0.000086; Ma KC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19250-6; Ng LK, 2002, ANTIMICROB AGENTS CH, V46, P3020, DOI 10.1128/AAC.46.9.3020-3025.2002; Nji E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82693-4; Ohneck EA, 2011, MBIO, V2, DOI 10.1128/mBio.00187-11; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P2720, DOI 10.1128/AAC.00026-07; Papp JR, 2018, J MED MICROBIOL, V67, P68, DOI 10.1099/jmm.0.000651; R Core Team, 2021, R LANGUAGE ENV STAT; Retchless AC, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4560-x; Rouquette-Loughlin CE, 2018, MBIO, V9, DOI 10.1128/mBio.02281-18; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shoji S, 2011, J MOL BIOL, V413, P751, DOI 10.1016/j.jmb.2011.09.004; So M, 2019, MICROB CELL, V6, P544, DOI 10.15698/mic2019.12.701; SPRATT BG, 1992, J MOL EVOL, V34, P115; St Cyr S, 2020, MMWR-MORBID MORTAL W, V69, P1911, DOI 10.15585/mmwr.mm6950a6; Sukhum KV, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01699-20; Unemo M, 2011, CLIN MICROBIOL REV, V24, P447, DOI 10.1128/CMR.00040-10; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Vincent LR, 2018, MBIO, V9, DOI 10.1128/mBio.01905-17; von Wintersdorff CJH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00173; Wadsworth CB, 2018, MBIO, V9, DOI 10.1128/mBio.01419-18; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wu HM, 2009, NEW ENGL J MED, V360, P886, DOI 10.1056/NEJMoa0806414; Zarantonelli L, 2001, J ANTIMICROB CHEMOTH, V47, P651, DOI 10.1093/jac/47.5.651; ZHOU JJ, 1992, MOL MICROBIOL, V6, P2135, DOI 10.1111/j.1365-2958.1992.tb01387.x	59	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262370	10.1371/journal.pone.0262370	http://dx.doi.org/10.1371/journal.pone.0262370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025928	Green Published, gold			2022-12-26	WOS:000796264200064
J	Yoshihara, K; Takahashi, K				Yoshihara, Keisuke; Takahashi, Kei			A simple method for unsupervised anomaly detection: An application to Web time series data	PLOS ONE			English	Article							OUTLIER DETECTION	We propose a simple anomaly detection method that is applicable to unlabeled time series data and is sufficiently tractable, even for non-technical entities, by using the density ratio estimation based on the state space model. Our detection rule is based on the ratio of log-likelihoods estimated by the dynamic linear model, i.e. the ratio of log-likelihood in our model to that in an over-dispersed model that we will call the NULL model. Using the Yahoo S5 data set and the Numenta Anomaly Benchmark data set, publicly available and commonly used benchmark data sets, we find that our method achieves better or comparable performance compared to the existing methods. The result implies that it is essential in time series anomaly detection to incorporate the specific information on time series data into the model. In addition, we apply the proposed method to unlabeled Web time series data, specifically, daily page view and average session duration data on an electronic commerce site that deals in insurance goods to show the applicability of our method to unlabeled real-world data. We find that the increase in page view caused by e-mail newsletter deliveries is less likely to contribute to completing an insurance contract. The result also suggests the importance of the simultaneous monitoring of more than one time series.	[Yoshihara, Keisuke] Gunma Univ, Ctr Math & Data Sci, Maebashi, Gumma, Japan; [Takahashi, Kei] Fukuoka Inst Technol, Fac Informat Engn, Fukuoka, Japan; [Takahashi, Kei] Inst Stat Math, Sch Stat Thinking, Tokyo, Japan	Gunma University; Fukuoka Institute of Technology; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Yoshihara, K (corresponding author), Gunma Univ, Ctr Math & Data Sci, Maebashi, Gumma, Japan.	ksk0110@gmail.com		Yoshihara, Keisuke/0000-0002-3365-9755				Ahmad S, 2017, NEUROCOMPUTING, V262, P134, DOI 10.1016/j.neucom.2017.04.070; Amarbayasgalan T, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12081251; [Anonymous], YAHOO WEBSCOPE DATAS; Baragona R, 2007, NEURAL COMPUT, V19, P1962, DOI 10.1162/neco.2007.19.7.1962; Bozbura M., 2019, NEURAL NETWORKS, P217; Braei M., 2020, ANOMALY DETECTION UN; Daubener S., 2019, ICDM; FOX AJ, 1972, J ROY STAT SOC B, V34, P350; Galeano P, 2006, J AM STAT ASSOC, V101, P654, DOI 10.1198/016214505000001131; Hill DJ, 2010, ENVIRON MODELL SOFTW, V25, P1014, DOI 10.1016/j.envsoft.2009.08.010; Hundman K, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P387, DOI 10.1145/3219819.3219845; Lavin A, 2015, 2015 IEEE 14TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P38, DOI 10.1109/ICMLA.2015.141; Lu H, 2018, IEEE ACCESS, V6, P53593, DOI 10.1109/ACCESS.2018.2870151; Maciag PS, 2021, NEURAL NETWORKS, V139, P118, DOI 10.1016/j.neunet.2021.02.017; Manandhar K, 2014, IEEE T CONTROL NETW, V1, P370, DOI 10.1109/TCNS.2014.2357531; Munir M, 2019, IEEE ACCESS, V7, P1991, DOI 10.1109/ACCESS.2018.2886457; Nakano M, 2017, EXPERT SYST APPL, V73, P187, DOI 10.1016/j.eswa.2016.12.034; Papadimitriou Spiros, 2005, P 31 INT C VER LARG, P697; Petris G, 2009, USE R, P31, DOI 10.1007/b135794_2; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Shahriar MS, 2016, COMPUT ELECTRON AGR, V128, P20, DOI 10.1016/j.compag.2016.08.009; Soule A., 2005, Performance Evaluation Review, V33, P362, DOI 10.1145/1071690.1064259; Suh S, 2016, IEEE IJCNN, P1015, DOI 10.1109/IJCNN.2016.7727309; Thill M, 2017, 2017 EVOLVING ADAPTI, P1; Zhang Y, 2012, INT J GEOGR INF SCI, V26, P1373, DOI 10.1080/13658816.2012.654493; Zhou YS, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082628; Zhou YX, 2016, IEEE DECIS CONTR P, P6335, DOI 10.1109/CDC.2016.7799244	28	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262463	10.1371/journal.pone.0262463	http://dx.doi.org/10.1371/journal.pone.0262463			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015791	Green Published, gold			2022-12-26	WOS:000814820600024
J	Hendriksen, RB; van der Gaag, EJ				Hendriksen, Rosanne Barbra; van der Gaag, Ellen Jose			Effect of a dietary intervention including minimal and unprocessed foods, high in natural saturated fats, on the lipid profile of children, pooled evidence from randomized controlled trials and a cohort study	PLOS ONE			English	Article							TRANS-PALMITOLEIC ACID; CALCIUM INTAKE; ATHEROSCLEROSIS; METAANALYSIS; ASSOCIATION; OVERWEIGHT; OBESITY; ADULTS; MILK	Aim To study the possible effects of a dietary intervention with minimal and unprocessed foods, high in natural saturated fats on the lipid profile and body mass index of children. Method This study combines three intervention studies; one non-randomized retrospective cohort study and two randomized controlled trials, to a pooled analysis. The intervention group received a dietary intervention of minimal and unprocessed foods for three to six months, consisting of five times per week green vegetables, three times per week beef, daily 200300 mL whole cow's milk (3.4% fat) and whole dairy butter (80% fat) on each slice of bread. The control group continued their usual dietary habits. Raw data of the three intervention studies where combined into one single dataset for data analysis, using mixed effects analysis of covariance to test the effects of the dietary advice on the main study outcomes, which are measurements of the lipid profile. Results In total, 267 children aged 1 to 16 years were followed. 135 children were included in the intervention group and 139 children in the control group. Characteristics (age, gender and follow-up period) were equally distributed between the groups at baseline. In the intervention group HDL-cholesterol increased significantly from 1.22 mmol/L, 95% confidence interval (CI) 1.14-1.32 to 1.42 mmol/L 95% CI 1.30-1.65 (p = 0.007). The increase over time in HDL cholesterol in the intervention group was significantly different compared to the increase in the control group (from 1.26 mmol/L, 95% CI 1.19-1.35, to 1.30 mmol/L, 95% CI 1.26-1.37) (p = 0.04). Due to the increased HDL concentration in the intervention group, the total cholesterol/HDL cholesterol ratio decreased significantly from 3.70 mmol/L, 95% CI 3.38-3.87, to 3.25 mmol/L, 95% CI 2.96-3.31 (p = 0.05). Conclusion Consumption of minimal and unprocessed foods (high in natural saturated fats) has favourable effects on HDL cholesterol in children. Therefore, this dietary advice can safely be recommended to children.	[Hendriksen, Rosanne Barbra] Wageningen Univ & Res WUR, MSc Nutr & Hlth, Wageningen, Netherlands; [van der Gaag, Ellen Jose] Hosp Grp Twente ZGT, Dept Pediat, Hengelo, Netherlands	Wageningen University & Research	Hendriksen, RB (corresponding author), Wageningen Univ & Res WUR, MSc Nutr & Hlth, Wageningen, Netherlands.	rosannebh@gmail.com						Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Bhateja PK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/572013; Silverio RNC, 2019, DIABETES RES CLIN PR, V154, P9, DOI 10.1016/j.diabres.2019.06.005; Cornwell B, 2018, PUBLIC HEALTH NUTR, V21, P142, DOI 10.1017/S1368980017000891; Costa CS, 2019, NUTR METAB CARDIOVAS, V29, P177, DOI 10.1016/j.numecd.2018.11.003; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; Engel S, 2018, EUR J CLIN NUTR, V72, P249, DOI 10.1038/s41430-017-0042-5; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Gillman MW, 1997, JAMA-J AM MED ASSOC, V278, P2145, DOI 10.1001/jama.278.24.2145; Kohnke R, 2009, SCAND J GASTROENTERO, V44, P712, DOI 10.1080/00365520902803499; Kratz M, 2013, EUR J NUTR, V52, P1, DOI 10.1007/s00394-012-0418-1; Lee AK, 2014, CONSUMPTION LESS 10; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Liu XR, 2013, BRIT J NUTR, V109, P1695, DOI 10.1017/S0007114513000196; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mozaffarian D, 2004, AM J CLIN NUTR, V80, P1175, DOI 10.1093/ajcn/80.5.1175; Mozaffarian D, 2013, AM J CLIN NUTR, V97, P854, DOI 10.3945/ajcn.112.045468; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Ohlsson L, 2010, EUR J CLIN NUTR, V64, P1344, DOI 10.1038/ejcn.2010.164; Rauber F, 2015, NUTR METAB CARDIOVAS, V25, P116, DOI 10.1016/j.numecd.2014.08.001; Roberts JL, 2016, FOOD FUNCT, V7, P3337, DOI [10.1039/C6FO00051G, 10.1039/c6fo00051g]; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; SHRAPNEL WS, 1992, MED J AUSTRALIA, V156, pS9; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Skinner JD, 2003, J AM DIET ASSOC, V103, P1626, DOI 10.1016/j.jada.2003.09.020; UNICEF, VERL NAAR GEZ 2020; van der Gaag E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103689; van der Gaag E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010272; van der Gaag EJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050518; Vanderhout SM, 2020, AM J CLIN NUTR, V111, P266, DOI 10.1093/ajcn/nqz276; Vandevijvere S, 2019, EUR J NUTR, V58, P3267, DOI 10.1007/s00394-018-1870-3; Wang HF, 2011, OBESITY, V19, P2404, DOI 10.1038/oby.2011.234; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; World Health Organization, OB OV 2020; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0261446	10.1371/journal.pone.0261446	http://dx.doi.org/10.1371/journal.pone.0261446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986194	gold, Green Published			2022-12-26	WOS:000765956200010
J	Alem, AZ; Yeshaw, Y; Liyew, AM; Tesema, GA; Alamneh, TS; Worku, MG; Teshale, AB; Tessema, ZT				Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Liyew, Alemneh Mekuriaw; Tesema, Getayeneh Antehunegn; Alamneh, Tesfa Sewunet; Worku, Misganaw Gabrie; Teshale, Achamyeleh Birhanu; Tessema, Zemenu Tadesse			Timely initiation of antenatal care and its associated factors among pregnant women in sub-Saharan Africa: A multicountry analysis of Demographic and Health Surveys	PLOS ONE			English	Article							GLOBAL LEVELS; MORTALITY; TRENDS	BackgroundTimely initiation of antenatal care (ANC) is an important component of ANC services that improve the health of the mother and the newborn. Mothers who begin attending ANC in a timely manner, can fully benefit from preventive and curative services. However, evidence in sub-Saharan Africa (sSA) indicated that the majority of pregnant mothers did not start their first visit timely. As our search concerned, there is no study that incorporates a large number of sub-Saharan Africa countries. Thus, the objective of this study was to assess the prevalence of timely initiation of ANC and its associated factors in 36 sSA countries. MethodsThe Demographic and Health Survey (DHS) of 36 sSA countries were used for the analysis. The total weighted sample of 233,349 women aged 15-49 years who gave birth in the five years preceding the survey and who had ANC visit for their last child were included. A multi-level logistic regression model was used to examine the individual and community-level factors that influence the timely initiation of ANC. Results were presented using adjusted odds ratio (AOR) with 95% confidence interval (CI). ResultsIn this study, overall timely initiation of ANC visit was 38.0% (95% CI: 37.8-38.2), ranging from 14.5% in Mozambique to 68.6% in Liberia. In the final multilevel logistic regression model:- women with secondary education (AOR = 1.08; 95% CI: 1.06, 1.11), higher education (AOR = 1.43; 95% CI: 1.36, 1.51), women aged 25-34 years (AOR = 1.20; 95% CI: 1.17, 1.23), >= 35 years (AOR = 1.30; 95% CI: 1.26, 1.35), women from richest household (AOR = 1.19; 95% CI: 1.14, 1.22), women perceiving distance from the health facility as not a big problem (AOR = 1.05; 95%CI: 1.03, 1.07), women exposed to media (AOR = 1.29; 95%CI: 1.26, 1.32), women living in communities with medium percentage of literacy (AOR = 1.51; 95%CI: 1.40, 1.63), and women living in communities with high percentage of literacy (AOR = 1.56; 95%CI: 1.38, 1.76) were more likely to initiate ANC timely. However, women who wanted their pregnancy later (AOR = 0.84; 95%CI: 0.82, 0.86), wanted no more pregnancy (AOR = 0.80; 95%CI: 0.77, 0.83), and women residing in the rural area (AOR = 0.90; 95%CI: 0.87, 0.92) were less likely to initiate ANC timely. ConclusionEven though the WHO recommends all women initiate ANC within 12 weeks of gestation, sSA recorded a low overall prevalence of timely initiation of ANC. Maternal education, pregnancy intention, residence, age, wealth status, media exposure, distance from health facility, and community-level literacy were significantly associated with timely initiation of ANC. Therefore, intervention efforts should focus on the identified factors in order to improve timely initiation of ANC in sSA. This can be done through the providing information and education to the community on the timing and importance of attending antenatal care and family planning to prevent unwanted pregnancy, especially in rural settings.	[Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Liyew, Alemneh Mekuriaw; Tesema, Getayeneh Antehunegn; Alamneh, Tesfa Sewunet; Teshale, Achamyeleh Birhanu; Tessema, Zemenu Tadesse] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Sch Med, Dept Physiol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Worku, Misganaw Gabrie] Univ Gondar, Sch Med, Dept Human Anat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Alem, AZ (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	aduzeleke2201@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	Alemneh, Tesfa Sewunet/0000-0002-4830-931X; Yeshaw, Yigizie/0000-0003-4587-7925				Akhtar F, 2018, CUREUS, V10, DOI 10.7759/cureus.2078; Alemu Y, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0646-9; Aliyu Alhaji Abubakar, 2017, Pan Afr Med J, V26, P124, DOI 10.11604/pamj.2017.26.124.9861; Aung TZ., 2017, INT J COMMUNITY MED, V3, P900; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Banda I., 2012, MED J AUSTRALIA, V39, P29; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P137, DOI 10.4314/ejhs.v24i0.12S; Blackstone SR, 2019, WOMEN HEALTH, V59, P1141, DOI 10.1080/03630242.2019.1590496; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Branum AM, 2017, MATERN CHILD HLTH J, V21, P715, DOI 10.1007/s10995-016-2155-1; Chewe M. M., 2016, African Journal of Midwifery and Women's Health, V10, P169; Ejeta E, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.184.10926; Ekholuenetale M, 2020, J EGYPT PUBLIC HEAL, V95, DOI 10.1186/s42506-020-00041-2; Emiru AA, 2020, INT J WOMENS HEALTH, V12, P463, DOI 10.2147/IJWH.S250832; Ethiopian Central Statistics Agency (ECSA), 2016, ETH DEM HLTH SURV ED; Ewunetie AA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1748-7; Exavery A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-35; Gebrekidan K, 2017, PRAGMAT OBS RES, V8, P223, DOI 10.2147/POR.S140733; Gebresilassie B, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2490-5; Geta M. B., 2017, Advances in Public Health, V2017, P1624245, DOI 10.1155/2017/1624245; Gidey G, 2018, ASIAN J PHARM CLIN R, V11; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Gong E, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4369-6; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Gudayu TW, 2015, AFR J REPROD HEALTH, V19, P94; Haftu Abera, 2018, BMC Res Notes, V11, P872, DOI 10.1186/s13104-018-3987-0; Hanna G, TIMING 1 ANTENATAL C; Hug L, 2019, LANCET GLOB HEALTH, V7, pE710, DOI 10.1016/S2214-109X(19)30163-9; Institut National de la Statistique, 2011, ENQ DEM SANT IND MUL; Isawumi A, 2018, ONLINE J HLTH ALLIED, V7, P4; Jiwani SS, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010502; Kenya National Bureau of Statistics, 2014, KEN DEM HLTH SURV; Kisuule I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-121; Leshabari LK., 2020, EC GYNAECOL, V93, P01; Luginaah IN, 2016, SOC SCI MED, V160, P75, DOI 10.1016/j.socscimed.2016.05.019; Manyeh AK, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2738-0; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mgata S, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2576-0; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; Moore N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171136; Nigeria, 2014, NIG DEM HLTH SURV 20; Njiku F., 2017, PREVALENCE FACTORS A, V19, P1; Nwagwu AM, 2011, ANN LIBR INF STUD, V58, P270; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Ochako R, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0168-2; Pena-Rosas JP., 2017, COCHRANE DB SYST REV, V7; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Service AC., 2018, BMC PREGNANCY CHILDB, V19; Sinyange Nyambe, 2016, Pan Afr Med J, V25, P109, DOI 10.11604/pamj.2016.25.109.6873; Smith C, 2019, OBSTET GYNECOL, V134, P1234, DOI 10.1097/AOG.0000000000003557; Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374; Tekelab T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222566; Tesfaye G, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0412-4; Teshale AB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235538; Tessema ZT, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03669-w; Tolefac Paul Nkemtendong, 2017, Matern Health Neonatol Perinatol, V3, P29, DOI 10.1186/s40748-017-0067-8; Tolossa T, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01449-9; Turyasiima M, 2015, E AFR MED J, V91, P317; Weldearegawi GG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4789-8; WHO, 2016, WHO TECH REP SER, V997, P1; Wondemagegn AT, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0110-y; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2019, MAT DEATHS DECL SLOW; World Health Organization (WHO),S.a.r. health,, 2018, MOR WOM WORLDW REC E; WP. M, 2013, CAN J LIBR INF PR RE, V7, P19; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849; Zamawe COF, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0816-0; Zhao Qi, 2009, BMC Womens Health, V9, P5, DOI 10.1186/1472-6874-9-5	69	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262411	10.1371/journal.pone.0262411	http://dx.doi.org/10.1371/journal.pone.0262411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007296	Green Published, gold			2022-12-26	WOS:000741060700004
J	Huang, WC; Yen, JH; Sung, YW; Tung, SL; Chen, PM; Chu, PY; Shih, YC; Chi, HC; Huang, YC; Huang, SJ; Wang, LH				Huang, Wei-Chieh; Yen, Jia-Hau; Sung, Yu-Wen; Tung, Shiao-Lin; Chen, Po-Ming; Chu, Pei-Yi; Shih, Ya-Chi; Chi, Hsiang-Cheng; Huang, Yi-Ching; Huang, Shih-Jei; Wang, Lu-Hai			Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET	ONCOGENE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; C-MET; CELLS; EXPRESSION; RECEPTOR; OVARIAN; ICB-1; ONCOGENE; PATHWAYS; TARGETS	Triple negative breast cancer (TNBC) possesses poor prognosis mainly due to lack of effective endocrine or targeted therapies, aggressive nature and high rate of chemoresistance. Cancer stem cells (CSCs) are considered to play critical roles in cancer recurrence and chemoresistance. THEMIS2 was identified as the sole common elevated gene in three triple negative breast cancer (TNBC) and two ovarian CSC lines. We discovered an intrinsic signaling scaffold function of THEMIS2, which acts as a novel regulator of cancer stemness in promoting multiple cancer stemness properties including sphere formation, stemness markers expression, chemoresistance and tumorigenicity with low numbers of cancer cells implantation. For the first time, we demonstrated that THEMIS2 specifically enhanced MET activating phosphorylation by suppressing the association of protein-tyrosine phosphatases 1B (PTP1B) with p-MET and MET, which accounted mainly for THEMIS2-mediated effect on cancer stemness and chemoresistance. Increased THEMIS2 expression was associated with poor survival in TNBC patients and in patients from our breast cancer cohort. We found that non-cytotoxic dosages of cryptotanshinone (CPT) could potently inhibit cancer stemness, chemoresistance and tumorigenicity by suppressing expression of THEMIS2. Notably, stable overexpression of THEMIS2 is associated with enhanced sensitivity toward Capmatinib and CPT treatment. Expression levels of THEMIS2 and p-MET protein were positively correlated in the 465 breast cancer specimens. Our study revealed the novel oncogenic role of THEMIS2 and its underlying mechanism via suppressing PTP1B association with MET and thus leading to its activation. Our findings suggest that THEMIS2 could be a biomarker for MET targeted therapy and also provide a potential clinical application using low dosages of CPT for treatment of THEMIS2 positive TNBC.	[Huang, Wei-Chieh; Chen, Po-Ming; Shih, Ya-Chi; Chi, Hsiang-Cheng; Huang, Yi-Ching; Huang, Shih-Jei; Wang, Lu-Hai] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Huang, Wei-Chieh; Shih, Ya-Chi; Chi, Hsiang-Cheng; Huang, Shih-Jei; Wang, Lu-Hai] China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan; [Yen, Jia-Hau] China Med Univ Hosp, Res Canc Ctr Tradit Chinese Med, Dept Med Res, Taichung, Taiwan; [Sung, Yu-Wen] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Tung, Shiao-Lin] Ton Yen Gen Hosp, Dept Hematol & Oncol, Zhubei City, Hsinchu County, Taiwan; [Tung, Shiao-Lin] Hsin Sheng Jr Coll Med Care & Management, Dept Nursing, Taoyuan, Taiwan; [Chu, Pei-Yi] Show Chwan Mem Hosp, Dept Pathol, Chung Shang Rd, Changhua, Changhua County, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Show Chwan Memorial Hospital	Wang, LH (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.; Wang, LH (corresponding author), China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan.	luhaiwang@mail.cmu.edu.tw		Tung, Shiao-Lin/0000-0002-6241-6293	Ministry of Science and Technology, Taiwan [MOST 107-2320-B-039-059-MY3, MOST 107-2320-B-039-065, MOST 109-2320-B-039 -067, MOST 110-2320-B-039 -061]; China Medical University, Taiwan [CMU107-TU-11, CMU110-Z-06, CMU110-MF-26, CMU110-N-02]; "Chinese Medicine Research Center, China Medical University" from The Featured Areas Research Center Program within Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan [CMRC-CENTER-0]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University); "Chinese Medicine Research Center, China Medical University" from The Featured Areas Research Center Program within Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	This work were supported by the Ministry of Science and Technology, Taiwan (MOST 107-2320-B-039-059-MY3, MOST 107-2320-B-039-065, MOST 109-2320-B-039 -067, MOST 110-2320-B-039 -061), and China Medical University, Taiwan (CMU107-TU-11, CMU110-Z-06, CMU110-MF-26 and CMU110-N-02), and the "Chinese Medicine Research Center, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (CMRC-CENTER-0).	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Al Moustafa AE, 2013, CELL ADHES MIGR, V7, P424, DOI 10.4161/cam.26728; Bollmann J, 2008, J STEROID BIOCHEM, V109, P16, DOI 10.1016/j.jsbmb.2007.12.007; Chan SH, 2014, ONCOGENE, V33, P4496, DOI 10.1038/onc.2014.10; Cheng D, 2017, NAT IMMUNOL, V18, P205, DOI 10.1038/ni.3642; Cortazar P, 2019, LANCET, V393, P986; El Darsa Haidar, 2020, J Exp Pharmacol, V12, P349, DOI 10.2147/JEP.S242958; Firuzi O, 2019, CANCERS, V11, DOI 10.3390/cancers11050638; Garajova Ingrid, 2015, Transl Oncogenomics, V7, P13, DOI 10.4137/TOG.S30534; Hage C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.158; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Huang WC, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1091-5; Huang X, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00152; Kakazu A, 2008, INVEST OPHTH VIS SCI, V49, P2927, DOI 10.1167/iovs.07-0709; Karamboulas C, 2013, BBA-GEN SUBJECTS, V1830, P2481, DOI 10.1016/j.bbagen.2012.11.008; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Konwisorz A, 2010, ENDOCR-RELAT CANCER, V17, P147, DOI 10.1677/ERC-09-0095; Phi LTH, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5416923; Lee GD, 2017, J THORAC ONCOL, V12, P1233, DOI 10.1016/j.jtho.2017.04.031; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Liang H, 2020, ONCOTARGETS THER, V13, P2491, DOI 10.2147/OTT.S231257; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Luo Susan Y, 2013, Transl Respir Med, V1, P6, DOI 10.1186/2213-0802-1-6; Luvero D, 2014, THER ADV MED ONCOL, V6, P229, DOI 10.1177/1758834014544121; Matsumura A, 2013, INT J ONCOL, V42, P535, DOI 10.3892/ijo.2012.1728; Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; O'Conor CJ, 2018, BIOMARK MED, V12, P813, DOI 10.2217/bmm-2017-0398; O'Reilly EA, 2015, BBA CLIN, V3, P257, DOI 10.1016/j.bbacli.2015.03.003; Peirce MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011465; Riedmeier M, 2021, ARCH GYNECOL OBSTET, V304, P203, DOI 10.1007/s00404-020-05902-x; Sangwan V, 2011, J BIOL CHEM, V286, P45000, DOI 10.1074/jbc.M111.270934; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Treeck O, 2012, J CELL BIOCHEM, V113, P2979, DOI 10.1002/jcb.24175; Tung SL, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.25; Verma N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7064; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Wang H, 2017, ONCOL LETT, V14, P5890, DOI 10.3892/ol.2017.6959; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wolf J, 2020, NEW ENGL J MED, V383, P944, DOI 10.1056/NEJMoa2002787; Wu YL, 2021, CANCER TREAT REV, V95, DOI 10.1016/j.ctrv.2021.102173; Zagouri F, 2013, BRIT J CANCER, V108, P1100, DOI 10.1038/bjc.2013.31; Zhang Y, 2016, ONCOL LETT, V11, P3803, DOI 10.3892/ol.2016.4444	46	1	1	3	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2022	41	7					997	1010		10.1038/s41388-021-02136-2	http://dx.doi.org/10.1038/s41388-021-02136-2		JAN 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YX7EK	34974522	hybrid, Green Published			2022-12-26	WOS:000736941300001
J	Raza, M; Naveed, K; Akram, A; Salem, N; Afaq, A; Madni, HA; Khan, MAU; Mui-zzud-din				Raza, Mohsin; Naveed, Khuram; Akram, Awais; Salem, Nema; Afaq, Amir; Madni, Hussain Ahmad; Khan, Mohammad A. U.; Mui-zzud-din			DAVS-NET: Dense Aggregation Vessel Segmentation Network for retinal vasculature detection in fundus images	PLOS ONE			English	Article							BLOOD-VESSELS; DIABETIC-RETINOPATHY; SENSITIVITY	In this era, deep learning-based medical image analysis has become a reliable source in assisting medical practitioners for various retinal disease diagnosis like hypertension, diabetic retinopathy (DR), arteriosclerosis glaucoma, and macular edema etc. Among these retinal diseases, DR can lead to vision detachment in diabetic patients which cause swelling of these retinal blood vessels or even can create new vessels. This creation or the new vessels and swelling can be analyzed as biomarker for screening and analysis of DR. Deep learning-based semantic segmentation of these vessels can be an effective tool to detect changes in retinal vasculature for diagnostic purposes. This segmentation task becomes challenging because of the low-quality retinal images with different image acquisition conditions, and intensity variations. Existing retinal blood vessels segmentation methods require a large number of trainable parameters for training of their networks. This paper introduces a novel Dense Aggregation Vessel Segmentation Network (DAVS-Net), which can achieve high segmentation performance with only a few trainable parameters. For faster convergence, this network uses an encoder-decoder framework in which edge information is transferred from the first layers of the encoder to the last layer of the decoder. Performance of the proposed network is evaluated on publicly available retinal blood vessels datasets of DRIVE, CHASE_DB1, and STARE. Proposed method achieved state-of-the-art segmentation accuracy using a few number of trainable parameters.	[Raza, Mohsin] Bahria Univ, Dept Comp Sci, Islamabad, Pakistan; [Naveed, Khuram; Madni, Hussain Ahmad] COMSATS Univ Islamabad CUI, Dept Elect & Comp Engn, Islamabad, Pakistan; [Akram, Awais] Dept Primary & Secondary Healthcare, Lahore, Pakistan; [Salem, Nema; Khan, Mohammad A. U.] Effat Univ, Elect & Comp Engn Dept, Effat Coll Engn, Jeddah, Saudi Arabia; [Afaq, Amir] RMIT Univ, RF & Antenna Res Grp, Melbourne, Vic, Australia; [Khan, Mohammad A. U.] Namal Inst Mianwali, Dept Elect Engn, Mianwali, Pakistan; [Mui-zzud-din] Khwaja Fareed Univ Engn & Informat Technol, Dept Comp Sci, Rahim Yar Khan, Pakistan	COMSATS University Islamabad (CUI); Effat University; Royal Melbourne Institute of Technology (RMIT); Khwaja Fareed University of Engineering & Information Technology, Pakistan	Naveed, K (corresponding author), COMSATS Univ Islamabad CUI, Dept Elect & Comp Engn, Islamabad, Pakistan.	khurram.naveed@comsats.edu.pk	Raza, Mohsin/HDM-2483-2022; Salem, Nema/GRO-2185-2022	Salem, Nema/0000-0002-8440-4111; Naveed, Khuram/0000-0001-8286-6139				Arsalan M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091446; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Chen LCE, 2018, LECT NOTES COMPUT SC, V11211, P833, DOI 10.1007/978-3-030-01234-2_49; Cherukuri V, 2020, IEEE T IMAGE PROCESS, V29, P2552, DOI 10.1109/TIP.2019.2946078; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Demissie B, 2016, 2016 19TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P1; Fan Z, 2019, IEEE T IMAGE PROCESS, V28, P2367, DOI 10.1109/TIP.2018.2885495; Franklin SW, 2014, BIOCYBERN BIOMED ENG, V34, P117, DOI 10.1016/j.bbe.2014.01.004; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P600, DOI 10.1016/j.cmpb.2011.08.009; Gu ZW, 2019, IEEE T MED IMAGING, V38, P2281, DOI 10.1109/TMI.2019.2903562; Guan S, 2020, IEEE J BIOMED HEALTH, V24, P568, DOI 10.1109/JBHI.2019.2912935; Guo S, 2019, INT J MED INFORM, V126, P105, DOI 10.1016/j.ijmedinf.2019.03.015; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Huang GL, 2017, IEEE ICC; Imtiaz R, 2021, COMPUT ELECTR ENG, V91, DOI 10.1016/j.compeleceng.2021.107036; Irshad S, 2014, CAIRO INT BIOM ENG, P133, DOI 10.1109/CIBEC.2014.7020937; Jin QG, 2019, KNOWL-BASED SYST, V178, P149, DOI 10.1016/j.knosys.2019.04.025; Khan M, 2019, PEDIATR NEUROSURG, V54, P319, DOI 10.1159/000502360; Khan MAU, 2019, SIGNAL IMAGE VIDEO P, V13, P1667, DOI 10.1007/s11760-019-01515-3; Khan MAU, 2019, PATTERN ANAL APPL, V22, P1177, DOI 10.1007/s10044-018-0696-1; Khan MAU, 2019, PATTERN ANAL APPL, V22, P583, DOI 10.1007/s10044-017-0661-4; Khan Tariq M., 2021, Structural, Syntactic, and Statistical Pattern Recognition. Joint IAPR International Workshops, S+SSPR 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12644), P324, DOI 10.1007/978-3-030-73973-7_31; Khan T. M., 2020, NEURAL INFORM PROCES, P159; Khan TM, 2022, BIOMED SIGNAL PROCES, V71, DOI 10.1016/j.bspc.2021.103169; Khan TM, 2020, IEEE ACCESS, V8, P219275, DOI 10.1109/ACCESS.2020.3041719; Khan TM, 2017, IEEE T IMAGE PROCESS, V26, P2116, DOI 10.1109/TIP.2017.2671781; Khawaja A, 2019, IEEE ACCESS, V7, P164344, DOI 10.1109/ACCESS.2019.2953259; Khawaja A, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19224949; Li QL, 2016, IEEE T MED IMAGING, V35, P109, DOI 10.1109/TMI.2015.2457891; Liskowski P, 2016, IEEE T MED IMAGING, V35, P2369, DOI 10.1109/TMI.2016.2546227; Ma W, 2019, MED IMAGE COMPUTING; MAUKTMKMPNM Toufique Soomro, 2016, IEEE INT C DIG IM CO, P1; Mehmood M., 2019, PROCEDIA COMPUTER SC, V163, P370, DOI [10.1016/j.procs.2019.12.119, DOI 10.1016/J.PROCS.2019.12.119]; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Naveed K, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010114; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Rayudu M, 2012, I CONF SENS TECHNOL, P320, DOI 10.1109/ICSensT.2012.6461695; Ronneberger O., 2015, U NET CONVOLUTIONAL, P234; Simonyan K., 2015, PROC 3 INT C LEARN R; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Soomro TA., 2016, PROCEEDING INT C DIG, P1; Soomro TA, 2018, IEEE ACCESS, V6, P3524, DOI 10.1109/ACCESS.2018.2794463; Soomro TA, 2017, PATTERN ANAL APPL, V20, P927, DOI 10.1007/s10044-017-0630-y; Soomro T, 2017, SIGNAL IMAGE VIDEO P, V11, P1509, DOI 10.1007/s11760-017-1114-7; Srinidhi CL, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0719-2; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Tuba E., 2017, 27 INT C RADIOELEKTR, P1; Wang B, 2019, MED IMAGE COMPUTING; Wang DY, 2020, IEEE J BIOMED HEALTH, V24, P3384, DOI 10.1109/JBHI.2020.3002985; Wisaeng K., 2013, Applied Medical Informatics, V32, P33; Wu Y, 2019, VESSEL NET RETINAL V; Yin PS, 2020, IEEE ACCESS, V8, P116106, DOI 10.1109/ACCESS.2020.3002835; Zhang J, 2016, IEEE T MED IMAGING, V35, P2631, DOI 10.1109/TMI.2016.2587062	54	2	2	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261698	10.1371/journal.pone.0261698	http://dx.doi.org/10.1371/journal.pone.0261698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972109	gold, Green Published			2022-12-26	WOS:000773555700047
J	Luo, JS; De Pascali, F; Richmond, GW; Khojah, AM; Benovic, JL				Luo, Jiansong; De Pascali, Francesco; Richmond, G. Wendell; Khojah, Amer M.; Benovic, Jeffrey L.			Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL TAIL; DIFFERENTIATION; DESENSITIZATION; UBIQUITINATION; TRAFFICKING; KINASE; SITE	WHIM syndrome is a rare immunodeficiency disorder that is characterized by warts, hypogammaglobulinemia, infections, and myelokathexis. While several gain-of-function mutations that lead to C-terminal truncations, frame shifts and point mutations in the chemokine receptor CXCR4 have been identified in WHIM syndrome patients, the functional effect of these mutations are not fully understood. Here, we report on a new WHIM syndrome mutation that results in a frame shift within the codon for Ser339 (S339fs5) and compare the properties of S339fs5 with wild-type CXCR4 and a previously identified WHIM syndrome mutant, R334X. The S339fs5 and R334X mutants exhibited significantly increased signaling compared to wild-type CXCR4 including agonist-promoted calcium flux and extracellular-signal-regulated kinase activation. This increase is at least partially due to a significant decrease in agonist-promoted phosphorylation, beta-arrestin binding, and endocytosis of S339fs5 and R334X compared with wild-type CXCR4. Interestingly, there were also significant differences in receptor degradation, with S339fs5 having a very high basal level of degradation compared with that of R334X and wild-type CXCR4. In contrast to wild-type CXCR4, both R334X and S339fs5 were largely insensitive to CXCL12promoted degradation. Moreover, while basal and agonistpromoted degradation of wild-type CXCR4 was effectively inhibited by the CXCR4 antagonist TE-14016, this had no effect on the degradation of the WHIM mutants. Taken together, these studies identify a new WHIM syndrome mutant, CXCR4S339fs5, which promotes enhanced signaling, reduced phosphorylation, beta-arrestin binding and endocytosis, and a very high basal rate of degradation that is not protected by antagonist treatment.	[Luo, Jiansong; De Pascali, Francesco; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Richmond, G. Wendell] Rush Univ Med Ctr, Dept Med, Sect Allergy & Immunol, Chicago, IL USA; [Khojah, Amer M.] Ann & Robert Lurie Childrens Hosp Chicago, Div Allergy Immunol & Rheumatol, Chicago, IL USA	Jefferson University; Rush University; Ann & Robert H. Lurie Children's Hospital of Chicago	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu		khojah, amer/0000-0003-3357-4863; Khojah, Amer/0000-0002-4120-5307	Pennsylvania Department of Health; National Institutes of Health [R35 GM122541]	Pennsylvania Department of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded, in part, under a grant from the Pennsylvania Department of Health and by National Institutes of Health grant R35 GM122541 (to J. L. B.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachelerie F, 2010, DIS MARKERS, V29, P189, DOI [10.3233/DMA-2010-0736, 10.1155/2010/475104]; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Balabanian K, 2012, BLOOD, V119, P5722, DOI 10.1182/blood-2012-01-403378; Biajoux V, 2016, CELL REP, V17, P193, DOI 10.1016/j.celrep.2016.08.068; Britton C, 2021, FASEB J, V35, DOI 10.1096/fj.202001273R; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Caballero A, 2019, J BIOL CHEM, V294, P8023, DOI 10.1074/jbc.RA118.005991; Cao Y, 2015, LEUKEMIA, V29, P169, DOI 10.1038/leu.2014.187; Donthamsetti Prashant, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0214s70; Freitas C, 2017, J EXP MED, V214, P2023, DOI 10.1084/jem.20160806; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Heusinkveld LE, 2019, J CLIN IMMUNOL, V39, P532, DOI 10.1007/s10875-019-00665-w; Kaiser LM, 2021, LEUKEMIA, V35, P333, DOI 10.1038/s41375-020-01102-3; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Levy E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01262; Liu Q, 2016, J CLIN IMMUNOL, V36, P397, DOI 10.1007/s10875-016-0276-3; Liu Q, 2012, BLOOD, V120, P181, DOI 10.1182/blood-2011-12-395608; Luo JS, 2017, MOL PHARMACOL, V91, P554, DOI 10.1124/mol.116.106468; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; McDermott DH, 2011, J CELL MOL MED, V15, P2071, DOI 10.1111/j.1582-4934.2010.01210.x; Mueller W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064975; Nakai A, 2019, J EXP MED, V216, P1630, DOI 10.1084/jem.20181494; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Scala S, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020164; Tarrant TK, 2013, J LEUKOCYTE BIOL, V94, P1243, DOI 10.1189/jlb.0213097; Wang LQ, 2021, BMC MOL CELL BIOL, V22, DOI 10.1186/s12860-021-00347-9; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221	33	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101551	10.1016/j.jbc.2021.101551	http://dx.doi.org/10.1016/j.jbc.2021.101551			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1QM	34973340	Green Published, gold			2022-12-26	WOS:000761402800004
J	Vanselow, S; Neumann-Arnold, L; Wojciech-Moock, F; Seufert, W				Vanselow, Sven; Neumann-Arnold, Lea; Wojciech-Moock, Franziska; Seufert, Wolfgang			Stepwise assembly of the eukaryotic translation initiation factor 2 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INTELLECTUAL DISABILITY; BETA-SUBUNIT; TRANSFER-RNA; CELL-CYCLE; PROTEIN; EIF2-GAMMA; MECHANISM; GENES; IDENTIFICATION	The eukaryotic translation initiation factor 2 (eIF2) has key functions in the initiation step of protein synthesis. eIF2 guides the initiator tRNA to the ribosome, participates in scanning of the mRNA molecule, supports selection of the start codon, and modulates the translation of mRNAs in response to stress. eIF2 comprises a heterotrimeric complex whose assembly depends on the ATP-grasp protein Cdc123. Mutations of the eIF2 gamma subunit that compromise eIF2 complex formation cause severe neurological disease in humans. To this date, however, details about the assembly mechanism, step order, and the individual functions of eIF2 subunits remain unclear. Here, we quantified assembly intermediates and studied the behavior of various binding site mutants in budding yeast. Based on these data, we present a model in which a Cdc123-mediated conformational change in eIF2 gamma exposes binding sites for eIF2 alpha and eIF2 beta subunits. Contrary to an earlier hypothesis, we found that the associations of eIF2 alpha and eIF2 beta with the gamma-subunit are independent of each other, but the resulting heterodimers are nonfunctional and fail to bind the guanosine exchange factor eIF2B. In addition, levels of eIF2 alpha influence the rate of eIF2 assembly. By binding to eIF2 gamma, eIF2 alpha displaces Cdc123 and thereby completes the assembly process. Experiments in human cell culture indicate that the mechanism of eIF2 assembly is conserved between yeast and humans. This study sheds light on an essential step in eukaryotic translation initiation, the dysfunction of which is linked to human disease.	[Vanselow, Sven; Neumann-Arnold, Lea; Wojciech-Moock, Franziska; Seufert, Wolfgang] Univ Regensburg, Regensburg Ctr Biochem, Dept Genet, Regensburg, Germany	University of Regensburg	Seufert, W (corresponding author), Univ Regensburg, Regensburg Ctr Biochem, Dept Genet, Regensburg, Germany.	wolfgang.seufert@ur.de			Deutsche Forschungsgemeinschaft (DFG) [SFB960]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through a project grant to W. S. (SFB960, B10)	Adomavicius T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10167-3; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Borck G, 2012, MOL CELL, V48, P641, DOI 10.1016/j.molcel.2012.09.005; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Das S, 1997, J BIOL CHEM, V272, P31712, DOI 10.1074/jbc.272.50.31712; Dever T. E., 2016, GENETICS, V203, P65; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Gordiyenko Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10606-1; Hashem Y, 2018, ANNU REV BIOPHYS, V47, P125, DOI 10.1146/annurev-biophys-070816-034034; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2017, TRENDS BIOCHEM SCI, V42, P589, DOI 10.1016/j.tibs.2017.03.004; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoja MR, 2000, EXP CELL RES, V259, P239, DOI 10.1006/excr.2000.4948; Hussain T, 2014, CELL, V159, P597, DOI 10.1016/j.cell.2014.10.001; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Llacer JL, 2015, MOL CELL, V59, P399, DOI 10.1016/j.molcel.2015.06.033; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marintchev A, 2020, BIOCHEMISTRY-US, V59, P1299, DOI 10.1021/acs.biochem.0c00132; Moortgat S, 2016, AM J MED GENET A, V170, P2927, DOI 10.1002/ajmg.a.37792; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Naveau M, 2010, BIOCHEMISTRY-US, V49, P8680, DOI 10.1021/bi1009166; OHNO K, 1984, SOMAT CELL MOLEC GEN, V10, P17, DOI 10.1007/BF01534469; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Panvert M, 2015, STRUCTURE, V23, P1596, DOI 10.1016/j.str.2015.06.014; Perzlmaier AF, 2013, J BIOL CHEM, V288, P21537, DOI 10.1074/jbc.M113.472290; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Rojas M, 2014, P NATL ACAD SCI USA, V111, pE1344, DOI 10.1073/pnas.1400129111; Roll-Mecak A, 2004, J BIOL CHEM, V279, P10634, DOI 10.1074/jbc.M310418200; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; SIKORSKI RS, 1989, GENETICS, V122, P19; Sokabe M, 2006, P NATL ACAD SCI USA, V103, P13016, DOI 10.1073/pnas.0604165103; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870; Yatime L, 2006, STRUCTURE, V14, P119, DOI 10.1016/j.str.2005.09.020; Yatime L, 2005, BIOCHEMISTRY-US, V44, P8749, DOI 10.1021/bi050373i; Young-Baird SK, 2020, MOL CELL, V77, P875, DOI 10.1016/j.molcel.2019.11.008	43	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101583	10.1016/j.jbc.2022.101583	http://dx.doi.org/10.1016/j.jbc.2022.101583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35031321	Green Published, gold			2022-12-26	WOS:000761371500004
J	Kanda, S; Fujishiro, T; Omoto, T; Fujino, R; Ishii, K; Aihara, M				Kanda, Satoru; Fujishiro, Takashi; Omoto, Takashi; Fujino, Ryosuke; Ishii, Kiyoshi; Aihara, Makoto			The effects of antithrombotic therapy in ab interno trabeculotomy with a spatula-shaped microhook	PLOS ONE			English	Article							GLAUCOMA; IMPLANTATION; GONIOTOMY; SURGERY	To evaluate the effects of the discontinuation of antithrombotic drugs on intraocular pressure (IOP) reduction and complications from ab interno trabeculotomy for patients with glaucoma. We performed a retrospective chart review on the data of patients treated with antithrombotic agents who have undergone ab interno trabeculotomy through Tanito microhook combined with cataract surgery at the Asahi General Hospital and the Tokyo University Hospital, with 6 months of follow-up. The patients were classified into two groups depending on whether they discontinued (AT-) or continued (AT+) antithrombotic therapy during the perioperative phase. The demographics, pre- and postoperative IOP, medication score, best-corrected visual acuity (BCVA), and postoperative complications were analyzed preoperatively and postoperatively at 1 week and 1-6 months. The series included 44 eyes from 44 Japanese patients. The AT- and AT+ groups included 21 eyes from 21 patients and 23 eyes from 23 patients, respectively. The decrease in IOP from the baseline at 1 week postoperative was significantly different between the two groups (p = 0.009), but there were no significant differences observed in the other visits. Hyphema and IOP spikes exceeding 30 mmHg occurred in 10% and 10% of AT- participants, and in 43% and 26% of AT+ participants, respectively. Hyphema and spikes with hyphema occurred more frequently in the AT+ than in the AT- group (p = 0.02 and p = 0.05). The number of patients who had spikes was not significantly different (p = 0.27). In trabeculotomy using the Tanito microhook (R), discontinuing antithrombotic therapy had better IOP-lowering effects and less postoperative complications.	[Kanda, Satoru; Ishii, Kiyoshi] Saitama Red Cross Hosp, Dept Ophthalmol, Saitama, Saitama, Japan; [Kanda, Satoru; Fujishiro, Takashi; Omoto, Takashi; Fujino, Ryosuke; Aihara, Makoto] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kanda, S (corresponding author), Saitama Red Cross Hosp, Dept Ophthalmol, Saitama, Saitama, Japan.; Kanda, S; Fujishiro, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo, Japan.	rayc25.9063@gmail.com; fujishiro-tky@umin.ac.jp		Kanda, Satoru/0000-0002-9423-8532				Aihara M, 2019, JPN J OPHTHALMOL, V63, P402, DOI 10.1007/s10384-019-00682-7; Avar M, 2019, GRAEF ARCH CLIN EXP, V257, P997, DOI 10.1007/s00417-019-04259-5; Berdahl JP, 2018, ADV THER, V35, P2093, DOI 10.1007/s12325-018-0803-0; CAMPBELL DG, 1976, AM J OPHTHALMOL, V81, P441, DOI 10.1016/0002-9394(76)90299-3; Dorairaj SK, 2018, CLIN OPHTHALMOL, V12, P791, DOI 10.2147/OPTH.S158403; Ferguson TJ, 2016, J GLAUCOMA, V25, P896, DOI 10.1097/IJG.0000000000000529; Greenwood MD, 2017, J CATARACT REFR SURG, V43, P1197, DOI 10.1016/j.jcrs.2017.06.046; Hashimoto Y, 2019, JPN J OPHTHALMOL, V123, P815; Honjo M, 1996, J CATARACT REFR SURG, V22, P601, DOI 10.1016/S0886-3350(96)80017-4; Iwao K, 2011, AM J OPHTHALMOL, V151, P1047, DOI 10.1016/j.ajo.2010.11.028; Kerr NM, 2017, CLIN EXP OPHTHALMOL, V45, P393, DOI 10.1111/ceo.12888; Kobayashi K., 2019, CLIN OPHTHALMOL, V73, P865; MONTENEGRO MH, 1995, INT OPHTHALMOL CLIN, V35, P111, DOI 10.1097/00004397-199503510-00012; Mori S, 2020, BMJ OPEN OPHTHALMOL, V5, DOI 10.1136/bmjophth-2020-000446; Omoto T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245015; Omoto T, 2021, JPN J OPHTHALMOL, V65, P402, DOI 10.1007/s10384-020-00806-4; Omoto T, 2020, JPN J OPHTHALMOL, V64, P407, DOI 10.1007/s10384-020-00750-3; Tanito M, 2001, J GLAUCOMA, V10, P302, DOI 10.1097/00061198-200108000-00010; Tanito M, 2017, JPN J OPHTHALMOL, V61, P457, DOI 10.1007/s10384-017-0531-z; Tanito M, 2017, ACTA OPHTHALMOL, V95, pE354, DOI 10.1111/aos.13288; Xu J, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01422-z	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262548	10.1371/journal.pone.0262548	http://dx.doi.org/10.1371/journal.pone.0262548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025952	Green Published, gold			2022-12-26	WOS:000796264200082
J	Mokhayeri, Y; Nazemipour, M; Mansournia, MA; Naimi, AI; Kaufman, JS				Mokhayeri, Yaser; Nazemipour, Maryam; Mansournia, Mohammad Ali; Naimi, Ashley I.; Kaufman, Jay S.			Does weight mediate the effect of smoking on coronary heart disease? Parametric mediational g-formula analysis	PLOS ONE			English	Article							TIME-VARYING EXPOSURES; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; RISK; ATHEROSCLEROSIS; CESSATION; BIASES	Background In settings in which there are time-varying confounders affected by previous exposure and a time-varying mediator, natural direct and indirect effects cannot generally be estimated unbiasedly. In the present study, we estimate interventional direct effect and interventional indirect effect of cigarette smoking as a time-varying exposure on coronary heart disease while considering body weight as a time-varying mediator. Methods To address this problem, the parametric mediational g-formula was proposed to estimate interventional direct effect and interventional indirect effect. We used data from the Multi-Ethnic Study of Atherosclerosis to estimate effect of cigarette smoking on coronary heart disease, considering body weight as time-varying mediator. Results Over a 11-years period, smoking 20 cigarettes per day compared to no smoking directly (not through weight) increased risk of coronary heart disease by an absolute difference of 1.91% (95% CI: 0.49%, 4.14%), and indirectly decreased coronary heart disease risk by -0.02% (95% CI: -0.05%, 0.04%) via change in weight. The total effect was estimated as an absolute 1.89% increase (95% CI: 0.49%, 4.13%). Conclusion The overall absolute impact of smoking to incident coronary heart disease is modest, and we did not discern any important contribution to this effect relayed through changes to bodyweight. In fact, changes in weight because of smoking have no meaningful mediating effect on CHD risk.	[Mokhayeri, Yaser] Lorestan Univ Med Sci, Shahid Rahimi Hosp, Cardiovasc Res Ctr, Khorramabad, Iran; [Nazemipour, Maryam] Univ Tehran Med Sci, Osteoporosis Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Naimi, Ashley I.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Kaufman, Jay S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Fac Med, Montreal, PQ, Canada	Lorestan University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Emory University; McGill University	Mansournia, MA (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.	mansournia_ma@yahoo.com		Mansournia, Mohammad Ali/0000-0003-3343-2718	National Heart, Lung, and Blood Institute (NHLBI) [V02 1d20120806]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript was prepared using MESA Research Materials obtained from the National Heart, Lung, and Blood Institute (NHLBI); Research Materials Distribution Agreement (RMDA) V02 1d20120806. We would like to extend our thanks to the staff and coordinators of BioLINCC.	Aryaie M., 2020, AM J EPIDEMIOL; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Chen A, 2005, INT JOINT C ARTIFICI; Chen SM, 2021, NICOTINE TOB RES, V23, P85, DOI 10.1093/ntr/ntz165; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; DOYLE JT, 1959, NEW ENGL J MED, V261, P1096, DOI 10.1056/NEJM195911262612202; Etminan M, 2021, AM HEART J, V237, P62, DOI 10.1016/j.ahj.2021.03.008; Etminan M, 2021, GASTROENTEROLOGY, V160, P1443, DOI 10.1053/j.gastro.2020.11.053; Etminan M, 2020, CHEST, V158, pS21, DOI 10.1016/j.chest.2020.03.011; Feodoroff M, 2018, DIABETOLOGIA, V61, P2580, DOI 10.1007/s00125-018-4725-9; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; Lin SH, 2017, EPIDEMIOLOGY, V28, P266, DOI [10.1097/EDE.0000000000000609, 10.1097/ede.0000000000000609]; Luo JH, 2013, JAMA-J AM MED ASSOC, V310, P94, DOI 10.1001/jama.2013.6871; Mansournia MA, 2013, INT J EPIDEMIOL, V42, P860, DOI 10.1093/ije/dyt083; Mansournia MA, 2021, INT J EPIDEMIOL, V50, P1405, DOI 10.1093/ije/dyab157; Mansournia MA, 2021, BRIT J SPORT MED, V55, P1009, DOI 10.1136/bjsports-2020-103652; Mansournia MA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4587; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; Mansournia MA, 2017, EPIDEMIOLOGY, V28, P54, DOI 10.1097/EDE.0000000000000564; Mansournia MA, 2012, EPIDEMIOLOGY, V23, P631, DOI 10.1097/EDE.0b013e31824cc1c3; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Mokhayeri Y, 2019, STROKE, V50, P3286, DOI 10.1161/STROKEAHA.119.025749; Mucha Lisa, 2006, Gend Med, V3, P279, DOI 10.1016/S1550-8579(06)80216-0; Munafo MR, 2009, NICOTINE TOB RES, V11, P765, DOI 10.1093/ntr/ntp062; Naimi AI, 2017, INT J EPIDEMIOL, V46, P756, DOI 10.1093/ije/dyw323; Nettleton JA, 2008, AM J CLIN NUTR, V88, P185, DOI 10.1093/ajcn/88.1.185; Pearl J, 2012, PREV SCI, V13, P426, DOI 10.1007/s11121-011-0270-1; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; Robins JM, 1999, J AM STAT ASSOC, V94, P687, DOI 10.2307/2669978; Robins JM., 1997, P 13 C UNCERTAINTY A; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Shakiba M, 2017, AM J EPIDEMIOL; Sneve M, 2008, SCAND J PUBLIC HEALT, V36, P397, DOI 10.1177/1403494807088453; Tamura U, 2010, J ATHEROSCLER THROMB, V17, P12, DOI 10.5551/jat.1800; VanderWeele TJ, 2017, J R STAT SOC B, V79, P917, DOI 10.1111/rssb.12194; Vansteelandt S, 2009, EPIDEMIOLOGY, V20, P851, DOI 10.1097/EDE.0b013e3181b6f4c9; WARNER KE, 1978, J AM STAT ASSOC, V73, P314, DOI 10.2307/2286658; Woodward M, 1999, J Epidemiol Biostat, V4, P285	42	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262403	10.1371/journal.pone.0262403	http://dx.doi.org/10.1371/journal.pone.0262403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025942	Green Published, gold			2022-12-26	WOS:000796264200066
J	Zauner, J; Plischke, H; Strasburger, H				Zauner, Johannes; Plischke, Herbert; Strasburger, Hans			Spectral dependency of the human pupillary light reflex. Influences of pre-adaptation and chronotype	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MONOCHROMATIC LIGHT; MELANOPSIN; ILLUMINATION; CONE; SENSITIVITY; RESPONSES; ROD; COLOR; WAKE	Non-visual photoreceptors (ipRGCs) and rods both exert a strong influence on the human pupil, yet pupil models regularly use cone-derived sensitivity as their basis. This inconsistency is further exacerbated by the fact that circadian effects can modulate the wavelength sensitivity. We assessed the pupillary reaction to narrowband light stimuli in the mesopic range. Pupil size for eighty-three healthy participants with normal color vision was measured in nine experimental protocols with varying series of continuous or discontinuous light stimuli under Ganzfeld conditions, presented after 90 seconds of dark adaptation. One hundred and fifty series of stimulation were conducted across three experiments, and were analyzed for wavelength-dependency on the normalized pupillary constriction (nPC), conditional on experimental settings and individual traits. Traits were surveyed by questionnaire; color vision was tested by Ishihara plates or the Lanthony D15test. Data were analyzed with generalized additive mixed models (GAMM). The normalized pupillary constriction response is consistent with L+M-cone derived sensitivity when the series of light stimuli is continuous, i.e., is not interrupted by periods of darkness, but not otherwise. The results also show that a mesopic illuminance weighing led to an overall best prediction of pupillary constriction compared to other types of illuminance measures. IpRGC influence on nPC is not readily apparent from the results. When we explored the interaction of chronotype and time of day on the wavelength dependency, differences consistent with ipRGC influence became apparent. The models indicate that subjects of differing chronotype show a heightened or lowered sensitivity to short wavelengths, depending on their time of preference. IpRGC influence is also seen in the post-illumination pupil reflex if the prior light-stimulus duration is one second. However, shorter wavelengths than expected become more important if the light-stimulus duration is fifteen or thirty seconds. The influence of sex on nPC was present, but showed no interaction with wavelength. Our results help to define the conditions, under which the different wavelength sensitivities in the literature hold up for narrowband light settings. The chronotype effect might signify a mechanism for strengthening the individual's chronotype. It could also be the result of the participant's prior exposure to light (light history). Our explorative findings for this effect demand replication in a controlled study.	[Zauner, Johannes; Plischke, Herbert] Munich Univ Appl Sci, Munich, Germany; [Strasburger, Hans] Ludwig Maximilians Univ Munchen, Inst Med Psychol, Munich, Germany	University of Munich; University of Munich	Zauner, J (corresponding author), Munich Univ Appl Sci, Munich, Germany.	zauner@me.com		Strasburger, Hans/0000-0001-7156-5111; Zauner, Johannes/0000-0003-2171-4566; Plischke, Herbert/0000-0002-2132-6267	Hochschule Munchen University of Applied Sciences (MUAS); German Research Foundation (DFG)	Hochschule Munchen University of Applied Sciences (MUAS); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was financially supported by the Hochschule Munchen University of Applied Sciences (MUAS) and the German Research Foundation (DFG) through the "Open Access Publishing" program.	Adhikari P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33373; Adhikari P, 2015, SCI REP-UK, V5, DOI 10.1038/srep17610; Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Adrian Werner, 2003, Clin Exp Optom, V86, P235; ALPERN M, 1962, J PHYSIOL-LONDON, V164, P478, DOI 10.1113/jphysiol.1962.sp007033; Bonmati-Carrion MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162476; [Anonymous], 2021, SUPPORTING INFORM TH; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BESHARSE JC, 1983, SCIENCE, V219, P1341, DOI 10.1126/science.6828862; BOUMA H, 1962, NATURE, V193, P690, DOI 10.1038/193690a0; Brown TM, 2021, J PINEAL RES, V71, DOI 10.1111/jpi.12719; Chellappa SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13973-1; CIE, 2018, COS026E2018 CIE; CIE, 2005, 1652005 CIE; CIE, 2019, 1166412019E ISO CIE; CIE, 2004, ISO 235392005 E CO S; CIE, 2016, COTN0042016 CIE; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Daneault V, 2012, J BIOL RHYTHM, V27, P257, DOI 10.1177/0748730412441172; Danilenko KV, 2011, CHRONOBIOL INT, V28, P407, DOI 10.3109/07420528.2011.567425; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; DIN, 1982, 50313198203 DIN; DIN, 1982, 50312198203 DIN; EPEE, 2016, STRENGTH IND ENV QUA; Facer-Childs E, 2015, CURR BIOL, V25, P518, DOI 10.1016/j.cub.2014.12.036; Feigl B, 2012, ACTA OPHTHALMOL, V90, pe230, DOI 10.1111/j.1755-3768.2011.02226.x; Fischer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178782; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Goldstein D, 2007, PERS INDIV DIFFER, V42, P431, DOI 10.1016/j.paid.2006.07.008; Gooley JJ, 2012, J NEUROSCI, V32, P14242, DOI 10.1523/JNEUROSCI.1321-12.2012; Griefahn B., 2001, SOMNOLOGIE, V5, P71, DOI [10.1046/j.1439-054X.2001.01149.x, DOI 10.1046/J.1439-054X.2001.01149.X]; Guido ME, 2022, CELL MOL NEUROBIOL, V42, P59, DOI 10.1007/s10571-020-00997-x; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Hastie T., 1986, STAT SCI, V1, P297; Iadanza E, 2020, IEEE ACCESS, V8, P34949, DOI 10.1109/ACCESS.2020.2973747; Ishihara S, 1972, ISHIHARAS TESTS COLO; Joyce DS, 2016, INVEST OPHTH VIS SCI, V57, P5672, DOI 10.1167/iovs.16-19934; Kelbsch C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00129; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; LANTHONY P, 1978, DOC OPHTHALMOL, V46, P185; Lee SK, 2019, CELL REP, V29, P3349, DOI 10.1016/j.celrep.2019.11.024; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Lund D., 2012, COMPUTERIZED APPROAC; Martinez-Lozano N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73297-5; McDougal DH, 2015, COMPR PHYSIOL, V5, P439, DOI 10.1002/cphy.c140014; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; McHill AW, 2021, J PINEAL RES, V70, DOI 10.1111/jpi.12720; Morad Y, 2000, CURR EYE RES, V21, P535, DOI 10.1076/0271-3683(200007)21:1;1-Z;FT535; Mouland JW, 2019, CURR BIOL, V29, P4260, DOI 10.1016/j.cub.2019.10.028; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Okimura K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81540-w; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Pedersen EJ, 2019, PEERJ, V7, DOI 10.7717/peerj.6876; Prayag AS, 2019, CLOCKS SLEEP, V1, P193, DOI 10.3390/clockssleep1010017; Prigge CL, 2016, J NEUROSCI, V36, P7184, DOI 10.1523/JNEUROSCI.3500-15.2016; R Development Core Team, 2017, R LANG STAT COMP; Rao F, 2017, VISION RES, V137, P24, DOI 10.1016/j.visres.2017.02.010; Ringer RVC, 2021, I PERCEPTION; Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043; Roenneberg T, 2015, J BIOL RHYTHM, V30, P487, DOI 10.1177/0748730415603835; Roenneberg T, 2012, SLEEP BIOL RHYTHMS, V10, P75, DOI 10.1111/j.1479-8425.2012.00541.x; Rufiange M, 2007, J BIOL RHYTHM, V22, P454, DOI 10.1177/0748730407305375; Rukmini AV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00076; Rukmini AV, 2017, SCI REP-UK, V7, DOI 10.1038/srep43832; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simpson GL, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00149; Soskuthy M, 2017, ARXIV; Spitschan M, 2019, CURR BIOL, V29, pR1297, DOI 10.1016/j.cub.2019.11.031; Spitschan M, 2019, J VISION, V19, DOI 10.1167/19.9.5; Spitschan M, 2014, P NATL ACAD SCI USA, V111, P15568, DOI 10.1073/pnas.1400942111; Stone RA, 2013, EXP EYE RES, V114, P35, DOI 10.1016/j.exer.2013.01.001; Szabadi E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01069; Veitch JA, 2020, 0112020 CIE TN; Wagman IH, 1942, AM J PHYSIOL, V137, P0769, DOI 10.1152/ajplegacy.1942.137.4.769; Watson AB, 2012, J VISION, V12, DOI 10.1167/12.10.12; Webler FS, 2019, CURR OPIN BEHAV SCI, V30, P80, DOI 10.1016/j.cobeha.2019.06.006; Welbourne LE, 2015, CURR BIOL, V25, pR646, DOI 10.1016/j.cub.2015.06.030; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zandi B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67593-3; Zauner J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239553; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	92	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							0253030	10.1371/journal.pone.0253030	http://dx.doi.org/10.1371/journal.pone.0253030			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020744	gold, Green Submitted, Green Published			2022-12-26	WOS:000834207700005
J	Wolna, A; Durlik, J; Wodniecka, Z				Wolna, Agata; Durlik, Joanna; Wodniecka, Zofia			Pronominal anaphora resolution in Polish: Investigating online sentence interpretation using eye-tracking	PLOS ONE			English	Article							PRONOUN RESOLUTION; IMPLICIT-CAUSALITY; DISCOURSE; FOCUS; COHERENCE; SPEAKERS; SPANISH; NULL	The mechanism of anaphora resolution is subject to large cross-linguistic differences. The most likely reason for this is the different sensitivity of pronouns to the range of factors that determine their reference. In the current study, we explored the mechanism of anaphora resolution in Polish. First, we explored preferences in the interpretation of null and overt pronouns in ambiguous sentences. More specifically, we investigated whether Polish speakers prefer to relate overt pronouns to subject or object antecedents. Subsequently, we tested the consequences of violating this bias when tracing the online sentence-interpretation process using eye-tracking. Our results show that Polish speakers have a strong preference for interpreting null pronouns as referring to subject antecedents and interpreting overt pronouns as referring to object antecedents. However, in online sentence interpretation, only overt pronouns showed sensitivity to a violation of the speaker's preference for a pronoun-antecedent match. This suggests that null pronoun resolution is more flexible than overt pronoun resolution. Our results indicate that it is much easier for Polish speakers to shift the reference of a null pronoun than an overt one whenever a pronoun is forced to refer to a less-preferred antecedent. These results are supported by naturalness ratings, which showed that null pronouns are considered equally natural regardless of their reference, while overt pronouns referring to subject antecedents are rated as considerably less natural than those referring to object antecedents. To explain this effect, we propose that the interpretation of null and overt pronouns is sensitive to different factors which determine their reference.	[Wolna, Agata; Durlik, Joanna; Wodniecka, Zofia] Jagiellonian Univ, Inst Psychol, Psychol Language & Bilingualism Lab, Krakow, Poland	Jagiellonian University	Wolna, A (corresponding author), Jagiellonian Univ, Inst Psychol, Psychol Language & Bilingualism Lab, Krakow, Poland.	agata.wolna@doctoral.uj.edu.pl		Wolna, Agata/0000-0001-5822-104X	National Science Center Poland [2015/18/E/HS6/00428]; Polish National Science Centre [2018/28/T/HS6/00277]	National Science Center Poland(National Science Centre, Poland); Polish National Science Centre	This research was possible thanks to the grant SONATA BIS grant no 2015/18/E/HS6/00428 awarded to ZW by the National Science Center Poland (https://ncn.gov.pl/).During writing the paper JD was supported by Etiuda scholarship no 2018/28/T/HS6/00277 awarded by the Polish National Science Centre (https://ncn.gov.pl/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almor A, 1999, PSYCHOL REV, V106, P748, DOI 10.1037/0033-295X.106.4.748; Almor A., 2000, ARCHITECTURES MECH L, P341, DOI 10.3758/bf03209354; Alonso-Ovalle L., 2002, ITAL J LINGUIST, V14, P151; Arnold J.E., 1998, THESIS STANFORD U; Badecker W, 2002, J EXP PSYCHOL LEARN, V28, P748, DOI 10.1037//0278-7393.28.4.748; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Burkner PC, 2018, R J, V10, P395; CARMINATI M. N., 2002, THESIS U MASSACHUSET; Chamorro G, 2016, BILING-LANG COGN, V19, P520, DOI 10.1017/S1366728915000152; Chomsky N, 1982, SOME CONCEPTS CONSEQ; Clifton Charles Jr., 2007, P341, DOI 10.1016/B978-008044980-7/50017-3; Colonna S, 2015, LANG COGN NEUROSCI, V30, P1306, DOI 10.1080/23273798.2015.1066510; Colonna S, 2012, LINGUISTICS, V50, P991, DOI 10.1515/ling-2012-0031; Conklin K., 2018, EYE TRACKING GUIDE A, DOI [10.1017/9781108233279, DOI 10.1017/9781108233279]; Cowles HW, 2007, TOPOI-INT REV PHILOS, V26, P3, DOI 10.1007/s11245-006-9004-6; CRAWLEY RA, 1990, J PSYCHOLINGUIST RES, V19, P245, DOI 10.1007/BF01077259; de la Fuente I., 2016, EMPIRICAL PERSPECTIV, P11; Featherstone CR, 2010, Q J EXP PSYCHOL, V63, P3, DOI 10.1080/17470210903134344; Fernandes EG, 2018, J EXP PSYCHOL LEARN, V44, P1986, DOI 10.1037/xlm0000569; Filiaci F, 2014, LANG COGN NEUROSCI, V29, P825, DOI 10.1080/01690965.2013.801502; GERNSBACHER MA, 1988, J MEM LANG, V27, P699, DOI 10.1016/0749-596X(88)90016-2; GROSZ BJ, 1995, COMPUT LINGUIST, V21, P203; Hemforth B, 2010, COGNITION IN FLUX, P2218; Hobbs J. R., 1979, COGNITIVE SCI, V3, P67, DOI [10.1207/s15516709cog0301_4, DOI 10.1207/S15516709COG0301_4]; Hung YC, 2012, NEUROSCI LETT, V511, P59, DOI 10.1016/j.neulet.2012.01.013; Jarvikivi J, 2005, PSYCHOL SCI, V16, P260, DOI 10.1111/j.0956-7976.2005.01525.x; Kaiser E, 2008, LANG COGNITIVE PROC, V23, P709, DOI 10.1080/01690960701771220; Kaiser E, 2011, LANG COGNITIVE PROC, V26, P1625, DOI 10.1080/01690965.2010.523082; Kehler A., 2008, REFERENCE INTERDISCI; Kehler A, 2013, THEOR LINGUIST, V39, P1, DOI 10.1515/tl-2013-0001; Kehler A, 2008, J SEMANT, V25, P1, DOI 10.1093/jos/ffm018; Kleiman E., 2017, R PACKAGE VERSION 0; Koornneef AW, 2006, J MEM LANG, V54, P445, DOI 10.1016/j.jml.2005.12.003; Kwon N, 2013, LANG COGNITIVE PROC, V28, P377, DOI 10.1080/01690965.2011.645314; MATTHEWS A, 1988, J MEM LANG, V27, P245, DOI 10.1016/0749-596X(88)90053-8; MAZUKA R, 1991, J PSYCHOLINGUIST RES, V20, P215, DOI 10.1007/BF01067216; Patterson C., 2020, INFORM STRUCTURING D, P56; Patterson C, 2019, J PSYCHOLINGUIST RES, V48, P453, DOI 10.1007/s10936-018-9613-4; R Core Team, 2021, R LANG ENV STAT; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; Reinders-Machowska E., 1991, LONG DISTANCE ANAPHO, P137; Roberts L, 2008, STUD SECOND LANG ACQ, V30, P333, DOI 10.1017/S0272263108080480; Sanford AJ, 2007, Q J EXP PSYCHOL, V60, P171, DOI 10.1080/17470210600973390; Schumacher PB, 2017, LINGUA, V185, P25, DOI 10.1016/j.lingua.2016.07.004; Schumacher PB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01746; Sorace A, 2006, SECOND LANG RES, V22, P339, DOI 10.1191/0267658306sr271oa; Venditti JJ., 2001, RUCCSTR68, P1; Verissimo J., 2021, BILING-LANG COGN, P1	50	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262459	10.1371/journal.pone.0262459	http://dx.doi.org/10.1371/journal.pone.0262459			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015772	Green Published, Green Submitted, gold			2022-12-26	WOS:000814820600022
J	Rawal, LB; Sun, YW; Dahal, PK; Baral, SC; Khanal, S; Arjyal, A; Manandhar, S; Abdullah, A				Rawal, Lal B.; Sun, Yuewen; Dahal, Padam K.; Baral, Sushil C.; Khanal, Sudeepa; Arjyal, Abriti; Manandhar, Shraddha; Abdullah, Abu S.			Engaging Female Community Health Volunteers (FCHVs) for cardiovascular diseases risk screening in Nepal	PLOS ONE			English	Article							PREVENTION; INTERVENTION; BURDEN; INCOME; CARE	Introduction Non-Communicable Diseases (NCDs) have become the leading public health problems worldwide and the cardiovascular diseases (CVDs) is one of the major NCDs. Female Community Health Volunteers (FCHVs) in Nepal are the key drivers to implementing frontline health services. We explored the potential for engaging FCHVs for CVD risk screening at the community level in Nepal. Methods We used multiple approaches (quantitative and qualitative) for data collection. The trained FCHVs administered CVD risk screening questionnaire among 491 adults in rural and urban areas and calculated the CVD risk scores. To maintain consistency and quality, a registered medical doctor also, using the same risk scoring chart, independently calculated the CVD risk scores. Kappa statistics and concordance coefficient were used to compare these two sets of risk screening results. Sensitivity and specificity analyses were conducted. Two focus group discussions among the FCHVs were conducted to determine their experiences with CVD risk screening and willingness to engage with CVD prevention and control efforts. Results The mean level of agreement between two sets of risk screening results was 94.5% (Kappa = 0.77, P<0.05). Sensitivity of FCHV screening was 90.3% (95% CI: 0.801-0.964); and the specificity was 97% (95% CI: 0.948, 0.984). FCHVs who participated in the FGDs expressed a strong enthusiasm and readiness to using the CVD risk screening tools. Despite their busy workload, all FCHVs showed high level of motivation and willingness in using CVD risk screening tools and contribute to the prevention and control efforts of NCDs. The FCHVs recommended needs for providing additional training and capacity building opportunities. Conclusion We conclude that there is a potential for engaging FCHVs to use simple CVD risk screening tools at the community level. The findings are promising, however, further studies engaging larger number of FCHVs and larger population would warrant feasibility of such tools within the existing healthcare systems in Nepal.	[Rawal, Lal B.; Dahal, Padam K.] Cent Queensland Univ, Coll Sci & Sustainabil, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia; [Rawal, Lal B.] Cent Queensland Univ, Appleton Inst, Phys Act Res Grp, Rockhampton, Qld, Australia; [Rawal, Lal B.] Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia; [Rawal, Lal B.] Western Sydney Univ, Sch Social Sci, Penrith, NSW, Australia; [Sun, Yuewen; Abdullah, Abu S.] Duke Kunshan Univ, Global Hlth Inst, Suzhou, Jiangsu, Peoples R China; [Baral, Sushil C.; Khanal, Sudeepa; Arjyal, Abriti; Manandhar, Shraddha] HERD Int, Kathmandu, Nepal; [Khanal, Sudeepa] Bielefeld Univ, Sch Publ Hlth, Bielefeld, Germany; [Abdullah, Abu S.] Duke Univ, Durban, NC 27708 USA; [Abdullah, Abu S.] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA	Central Queensland University; Central Queensland University; Western Sydney University; Western Sydney University; Duke Kunshan University; University of Bielefeld; Duke University; Boston Medical Center; Boston University	Rawal, LB (corresponding author), Cent Queensland Univ, Coll Sci & Sustainabil, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia.; Rawal, LB (corresponding author), Cent Queensland Univ, Appleton Inst, Phys Act Res Grp, Rockhampton, Qld, Australia.; Rawal, LB (corresponding author), Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia.; Rawal, LB (corresponding author), Western Sydney Univ, Sch Social Sci, Penrith, NSW, Australia.; Abdullah, A (corresponding author), Duke Kunshan Univ, Global Hlth Inst, Suzhou, Jiangsu, Peoples R China.; Abdullah, A (corresponding author), Duke Univ, Durban, NC 27708 USA.; Abdullah, A (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA.	L.rawal@cqu.edu.au; abu.abdullah@duke.edu	Dahal, Padam/AAL-9920-2020; Manandhar, Shraddha/GZL-6574-2022	Dahal, Padam/0000-0002-5978-3762; Rawal, Lal/0000-0003-1106-0108				Abdullah A., 2019, WHO REG OFF SE NEW D; Advancing Partners & Communities, 2015, FEMALE COMMUNITY HLT; [Anonymous], 2016, WHO METHODS DATA SOU; Biswas T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167140; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Chicago Department of Public Health, 2019, HIV EPIDEMIOLOGY ANN; Crossan C, 2017, BRIT J GEN PRACT, V67, pE67, DOI 10.3399/bjgp16X687973; Dahal PK, 2019, AUST J PRIM HEALTH, V25, P526, DOI 10.1071/PY19007; Dhimal Meghnath, 2019, J Nepal Health Res Counc, V17, P394, DOI 10.33314/jnhrc.v17i3.2327; Dhital S. M., 2013, Regional Health Forum, V17, P44; Dhungana RR, 2016, INT J HYPERTENS, V2016, P1, DOI 10.1155/2016/1656938; Di Angelantonio E, 2019, LANCET GLOB HEALTH, V7, pE1332, DOI 10.1016/S2214-109X(19)30318-3; Eggleston K, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01850-0; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gauchan B, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0287-7; Gautam, 2013, HLTH PROSPECT, V11; Gaziano TA, 2015, LANCET GLOB HEALTH, V3, pE556, DOI 10.1016/S2214-109X(15)00143-6; Global Burden of Disease Collaborative Network, 2017, GLOB BURD DIS STUD 2; Government of Nepal, 2014, MULT ACT PLAN PREV C; Institute for Health Metrics and Evaluation (IHME), 2018, FIND GLOB BURD DIS S; Khatri RB, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00181; Koniak-Griffin D, 2015, INT J NURS STUD, V52, P75, DOI 10.1016/j.ijnurstu.2014.09.005; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mehata S, 2018, J HYPERTENS, V36, P1680, DOI [10.1097/HJH.0000000000001745, 10.1097/01.hjh.0000549242.70622.3e]; Meherali Salima, 2020, Health Lit Res Pract, V4, pe251, DOI 10.3928/24748307-20201118-01; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Mirelman AJ, 2016, HEALTH POLICY PLANN, V31, P785, DOI 10.1093/heapol/czv134; Mishra SR, 2016, LANCET DIABETES ENDO, V4, P979, DOI 10.1016/S2213-8587(16)30331-X; Neupane D, 2018, LANCET GLOB HEALTH, V6, pE66, DOI [10.1016/S2214-109X(17)30411-4, 10.1016/s2214-109x(17)30411-4]; Neupane D, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28254; Organization WH, 2018, NONCOMMUNICABLE DIS; Panday S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2567-7; Rawal LB, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040350; Rawal LB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205912; Rawal LB, 2012, INT J BEHAV MED, V19, P121, DOI 10.1007/s12529-011-9162-9; Rossello X, 2019, EUR J PREV CARDIOL, V26, P1534, DOI 10.1177/2047487319846715; Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; UNDP (United Nations Popul. Div.), 2017, AD YOUTH; Vaidya Abhinav, 2012, Indian Heart J, V64, P128, DOI 10.1016/S0019-4832(12)60045-5; van Schaik TM, 2017, NETH HEART J, V25, P446, DOI 10.1007/s12471-017-0963-6; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2010, PACK ESS NONC PEN DI; Xavier D, 2016, LANCET DIABETES ENDO, V4, P244, DOI 10.1016/S2213-8587(15)00480-5	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261518	10.1371/journal.pone.0261518	http://dx.doi.org/10.1371/journal.pone.0261518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990481	gold, Green Published			2022-12-26	WOS:000815783800009
J	Mishica, C; Kyrolalnen, H; Hynynen, E; NummelaID, A; Holmberg, HC; Linnamo, V				Mishica, Christina; Kyrolalnen, Heikki; Hynynen, Esa; NummelaID, Ari; Holmberg, Hans-Christer; Linnamo, Vesa			Evaluation of nocturnal vs. morning measures of heart rate indices in young athletes	PLOS ONE			English	Article							RATE-VARIABILITY; TRAINING LOAD; PERFORMANCE; EXERCISE; MONITOR; SLEEP; NIGHT	Purpose The purpose of this study was to compare heart rate (HR) and heart rate variability in young endurance athletes during nocturnal sleep and in the morning; and to assess whether changes in these values are associated with changes in submaximal running (SRT) and counter-movement jump (CMJ) performance. Methods During a three-week period of similar training, eleven athletes (16 +/- 1 years) determined daily HR and heart rate variability (RMSSD) during sleep utilizing a ballistocardiographic device (Emfit QS), as well as in the morning with a HR monitor (Polar V800). Aerobic fitness and power production were assessed employing SRT and CMJ test. Results Comparison of the average values for week 1 and week 3 revealed no significant differences with respect to nocturnal RMSSD (6.8%, P = 0.344), morning RMSSD (13.4%, P = 0.151), morning HR (-3.9 bpm, P = 0.063), SRT HR (-0.7 bpm, P = 0.447), SRT blood lactate (4.9%, P = 0.781), CMJ (-4.2%, P = 0.122) or training volume (16%, P = 0.499). There was a strong correlation between morning and nocturnal HRs during week 1 (r = 0.800, P = 0.003) and week 3 (r = 0.815, P = 0.002), as well as between morning and nocturnal RMSSD values (for week 1, r = 0.895, P<0.001 and week 3, r = 0.878, P = 0.001). Conclusion This study concluded that HR and RMSSD obtained during nocturnal sleep and in the morning did not differ significantly. In addition, weekly changes in training and performance were small indicating that fitness was similar throughout the 3-week period of observation. Consequently, daily measurement of HR indices during nocturnal sleep provide a potential tool for long-term monitoring of young endurance athletes.	[Mishica, Christina; Kyrolalnen, Heikki; Linnamo, Vesa] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Hynynen, Esa; NummelaID, Ari] KIHU Res Inst Olymp Sports, Jyvaskyla, Finland; [Holmberg, Hans-Christer] Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden	University of Jyvaskyla; Lulea University of Technology	Mishica, C (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.	christina.m.mishica@jyu.fi		Nummela, Ari/0000-0002-7965-3092; Kyrolainen, Heikki/0000-0003-3822-1733; Mishica, Christina/0000-0002-7232-5600	Amer Cultural Foundation of Finland	Amer Cultural Foundation of Finland	CM received funding for this work. The Amer Cultural Foundation of Finland supported funding for this project. The funder website is found at https://amerinkulttuurisaatio.emmi.fi/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Balsalobre-Fernandez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106066; BOSCO C, 1983, EUR J APPL PHYSIOL O, V51, P357, DOI 10.1007/BF00429072; Bosquet L, 2008, BRIT J SPORT MED, V42, P709, DOI 10.1136/bjsm.2007.042200; Bourdillon N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00456; Buchheit M, 2004, AM J PHYSIOL-HEART C, V287, pH2813, DOI 10.1152/ajpheart.00490.2004; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Camm AJ, 1996, EUR HEART J, V17, P354; Dupuy O, 2013, APPL PHYSIOL NUTR ME, V38, P200, DOI 10.1139/apnm-2012-0203; Fatisson J, 2016, HEART INT, V11, pE32, DOI 10.5301/heartint.5000232; Garrett JM, 2020, INT J SPORT PHYSIOL, V15, P68, DOI 10.1123/ijspp.2019-0150; Giles D, 2016, EUR J APPL PHYSIOL, V116, P563, DOI 10.1007/s00421-015-3303-9; Hamlin MJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00034; Hautala AJ, 2009, NEUROSCI BIOBEHAV R, V33, P107, DOI 10.1016/j.neubiorev.2008.04.009; Hedelin R, 2000, SCAND J MED SCI SPOR, V10, P298, DOI 10.1034/j.1600-0838.2000.010005298.x; Hynynen E, 2006, MED SCI SPORT EXER, V38, P313, DOI 10.1249/01.mss.0000184631.27641.b5; Hynynen E, 2011, EUR J APPL PHYSIOL, V111, P733, DOI 10.1007/s00421-010-1698-x; JEUKENDRUP AE, 1992, INT J SPORTS MED, V13, P534, DOI 10.1055/s-2007-1021312; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuipers H., 1996, RES Q EXERC SPORT, V67, pS, DOI [10.1080/02701367.1996.10608855, DOI 10.1080/02701367.1996.10608855]; Lamberts RP, 2004, J STRENGTH COND RES, V18, P641, DOI 10.1519/00124278-200408000-00044; Le Meur Y, 2013, MED SCI SPORT EXER, V45, P2061, DOI 10.1249/MSS.0b013e3182980125; Nummela A, 2010, INT J SPORTS MED, V31, P154, DOI 10.1055/s-0029-1243221; Ohtonen O, 2015, 3 INT C SCI NORDIC S; Pichot V, 2000, MED SCI SPORT EXER, V32, P1729, DOI 10.1097/00005768-200010000-00011; Pinheiro Eduardo, 2010, Open Biomed Eng J, V4, P201, DOI 10.2174/1874120701004010201; Plews DJ, 2017, INT J SPORT PHYSIOL, V12, P1324, DOI 10.1123/ijspp.2016-0668; Plews DJ, 2012, EUR J APPL PHYSIOL, V112, P3729, DOI 10.1007/s00421-012-2354-4; Schafer D, 2015, EUR J APPL PHYSIOL, V115, P2107, DOI 10.1007/s00421-015-3190-0; Schmitt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071588; Stanley J, 2013, SPORTS MED, V43, P1259, DOI 10.1007/s40279-013-0083-4; Taylor K., 2012, J AUST STRENGTH COND, V20, P12; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Vesterinen V., 2020, JMIR BIOMED ENG, V5, pe16620, DOI [10.2196/16620, DOI 10.2196/16620]; Waldeck Miriam R, 2003, J Sports Sci Med, V2, P133	36	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262333	10.1371/journal.pone.0262333	http://dx.doi.org/10.1371/journal.pone.0262333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986202	Green Published, gold			2022-12-26	WOS:000765956200043
J	Al-Haifi, AR; Al-Awadhi, BA; Al-Dashti, YA; Aljazzaf, BH; Allafi, AR; Al-Mannai, MA; Al-Hazzaa, HM				Al-Haifi, Ahmad R.; Al-Awadhi, Balqees A.; Al-Dashti, Yousef A.; Aljazzaf, Badriyah H.; Allafi, Ahmad R.; Al-Mannai, Mariam A.; Al-Hazzaa, Hazzaa M.			Prevalence of overweight and obesity among Kuwaiti adolescents and the perception of body weight by parents or friends	PLOS ONE			English	Article							MASS INDEX; DIVERSE SAMPLE; ASSOCIATION; COUNTRIES; HEALTH; TRENDS; DECADE; LIFE	Objective Recently, the State of Kuwait has witnessed a steady rise in the prevalence of obesity among children and adolescents. The present study aims to provide an update on the rate of overweight or obesity among Kuwaiti adolescents and examines the associations between adolescents' overweight/obesity levels and their perception of body weight as seen by parents or friends. Methods A cross-sectional study was conducted in Kuwaiti secondary schools and included adolescents between the ages of 15 and 18 years, using a multistage stratified random sampling method. Body weight and height were measured. A specifically designed self-report questionnaire was used to assess parents' and friends' perceptions of an adolescent's body weight. Results A total of 706 adolescents were included the study. The prevalence of overweight or obesity among Kuwaiti adolescents reached nearly 50%, with males (54.3%) having a significantly higher overweight or obesity percentage than females (44.6%). No significant difference in the prevalence of obesity relative to age, from 15 to 18 years, was found. In addition, logistic regression analysis, adjusted for age and gender, revealed that adolescents perceived their parents (p = 0.011 and p < 0.001) or friends (p = 0.002 and p < 0.001) as more likely to classify their weight as overweight or obese, respectively. Conclusion Overweight or obesity levels appear to be high among Kuwaiti adolescents, and appears to have reached a plateau recently. Efforts to combat obesity and promote physical activity and healthy nutrition are needed. Future studies should seek to identify important moderators of parental and social underestimation/overestimation of children's overweight or obesity.	[Al-Haifi, Ahmad R.; Al-Awadhi, Balqees A.; Al-Dashti, Yousef A.; Aljazzaf, Badriyah H.] PAAET, Dept Food & Nutr Sci, Coll Hlth Sci, Showaikh, Kuwait; [Allafi, Ahmad R.] Univ Kuwait, Coll Life Sci, Dept Food Sci & Nutr, Kuwait, Kuwait; [Al-Mannai, Mariam A.] Univ Bahrain, Dept Math, Sakheer, Bahrain; [Al-Hazzaa, Hazzaa M.] Princess Nourah Bint Abdulrahman Univ, Lifestyle & Hlth Res Ctr, Hlth Sci Res Ctr, Riyadh, Saudi Arabia	Public Authority for Applied Education & Training (PAAET) - Kuwait; Kuwait University; University of Bahrain; Princess Nourah bint Abdulrahman University	Al-Hazzaa, HM (corresponding author), Princess Nourah Bint Abdulrahman Univ, Lifestyle & Hlth Res Ctr, Hlth Sci Res Ctr, Riyadh, Saudi Arabia.	halhazzaa@hotmail.com	Al-Hazzaa, Hazzaa/R-6909-2019	Al-Hazzaa, Hazzaa/0000-0002-3099-0389	Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University through the Fast-track Research Funding Program	Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University through the Fast-track Research Funding Program(Princess Nourah bint Abdulrahman University)	For your information the corresponding author, Professor Hazzaa M. Al-Hazzaa's research has been funded by the Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University through the Fast-track Research Funding Program.	Al Hammadi Hanouf, 2019, BMC Obes, V6, P3, DOI 10.1186/s40608-018-0221-5; Al-Haifi Ahmad A, 2015, Glob J Health Sci, V8, P107, DOI 10.5539/gjhs.v8n1p107; Al-Hazzaa HM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-140; Al-Hazzaa HM., 2018, OBES OPEN ACCESS, V4, DOI [10.16966/2380-5528.136, DOI 10.16966/2380-5528.136]; Al-Hussaini A, 2019, SAUDI J GASTROENTERO, V25, P229, DOI 10.4103/sjg.SJG_617_18; Al-Isa AN, 2004, EUR J CLIN NUTR, V58, P1273, DOI 10.1038/sj.ejcn.1601961; Azar KMJ, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02038-4; Balantekin KN, 2014, APPETITE, V80, P190, DOI 10.1016/j.appet.2014.05.016; Bandura Albert, 1977, SOCIAL LEARNING THEO; Bauer KW, 2017, CHILD OBES, V13, P470, DOI 10.1089/chi.2017.0067; Bauer KW, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-45; Berge JM, 2015, BODY IMAGE, V15, P8, DOI 10.1016/j.bodyim.2015.04.006; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Eisenberg Marla, 2008, Int J Adolesc Med Health, V20, P155; Eisenberg ME, 2011, BODY IMAGE, V8, P12, DOI 10.1016/j.bodyim.2010.11.002; Gordon-Larsen P, 2010, OBESITY, V18, P1801, DOI 10.1038/oby.2009.451; Haines J, 2008, OBESITY, V16, pS18, DOI 10.1038/oby.2008.447; Hebebrand J, 2017, OBESITY FACTS, V10, P284, DOI 10.1159/000479208; Howe CJ, 2017, J PEDIATR NURS, V37, P57, DOI 10.1016/j.pedn.2017.06.005; Ievers-Landis CE, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091540; Kerkadi A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224428; Lissau I, 2004, ARCH PEDIAT ADOL MED, V158, P27, DOI 10.1001/archpedi.158.1.27; Lundahl A, 2014, PEDIATRICS, V133, pE689, DOI 10.1542/peds.2013-2690; Marks J, 2019, J RES ADOLESCENCE, V29, P710, DOI 10.1111/jora.12407; McCormack LA, 2011, J AM DIET ASSOC, V111, P431, DOI 10.1016/j.jada.2010.11.021; Moonesar IA., 2017, ADV OBES WEIGHT MANA, V6, P00150, DOI [10.15406/aowmc.2017.06.00150, DOI 10.15406/AOWMC.2017.06.00150]; Musaiger A. O., 2003, Nutrition & Food Science, V33, P145, DOI 10.1108/00346650310488480; Musaiger AO, 2014, J BIOSOC SCI, V46, P240, DOI 10.1017/S0021932013000278; Musaiger AO, 2014, APPETITE, V73, P197, DOI 10.1016/j.appet.2013.11.002; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Neumark-Sztainer D, 2002, INT J OBESITY, V26, P123, DOI 10.1038/sj.ijo.0801853; Oen G, 2018, INT J QUAL STUD HEAL, V13, DOI 10.1080/17482631.2018.1479581; Philippi ST, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00029817, 10.1590/0102-311X00029817]; Puhl RM, 2012, J YOUTH ADOLESCENCE, V41, P27, DOI 10.1007/s10964-011-9713-z; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Rey-Lopez JP, 2019, MINERVA PEDIATR, V71, P326, DOI 10.23736/S0026-4946.18.04911-3; Sirico F, 2020, HIGH BLOOD PRESS CAR, V27, P29, DOI 10.1007/s40292-019-00352-2; Steinberg L, 2001, ANNU REV PSYCHOL, V52, P83, DOI 10.1146/annurev.psych.52.1.83; Sweeting HN, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-1; Sweeting HN, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-32; Tantawy SA, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019950; Valois DD, 2019, BODY IMAGE, V29, P65, DOI 10.1016/j.bodyim.2019.02.009; van Geel M, 2014, INT J OBESITY, V38, P1263, DOI 10.1038/ijo.2014.117; Waly I.M., 2017, EC NUTR, V7, P3; World Health Organization, 2016, FACT SHEET OB OV; Yoon HK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145126	47	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262101	10.1371/journal.pone.0262101	http://dx.doi.org/10.1371/journal.pone.0262101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982787	gold, Green Published			2022-12-26	WOS:000834805700017
J	Kober, C; Manni, S; Wolff, S; Barnes, T; Mukherjee, S; Vogel, T; Hoenig, L; Vogel, P; Hahn, A; Gerlach, M; Vey, M; Widmer, E; Keiner, B; Schuetz, P; Roth, N; Kalina, U				Kober, Christina; Manni, Sandro; Wolff, Svenja; Barnes, Thomas; Mukherjee, Shatanik; Vogel, Thomas; Hoenig, Lea; Vogel, Peter; Hahn, Aaron; Gerlach, Michaela; Vey, Martin; Widmer, Eleonora; Keiner, Bjorn; Schuetz, Patrick; Roth, Nathan; Kalina, Uwe			IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools	PLOS ONE			English	Article								Analysis of convalescent plasma derived from individuals has shown that IgG3 has the most important role in binding to SARS-CoV-2 antigens; however, this has not yet been confirmed in large studies, and the link between binding and neutralization has not been confirmed. By analyzing plasma pools consisting of 247-567 individual convalescent donors, we demonstrated the binding of IgG3 and IgM to Spike-1 protein and the receptor-binding domain correlates strongly with viral neutralization in vitro. Furthermore, despite accounting for only approximately 12% of total immunoglobulin mass, collectively IgG3 and IgM account for approximately 80% of the total neutralization. This may have important implications for the development of potent therapies for COVID-19, as it indicates that hyperimmune globulins or convalescent plasma donations with high IgG3 concentrations may be a highly efficacious therapy.	[Kober, Christina; Wolff, Svenja; Mukherjee, Shatanik; Vogel, Thomas; Vogel, Peter; Hahn, Aaron; Gerlach, Michaela; Vey, Martin; Keiner, Bjorn; Kalina, Uwe] CSL Behring Innovat GmbH, Res & Dev, Marburg, Germany; [Manni, Sandro; Barnes, Thomas; Hoenig, Lea; Widmer, Eleonora; Schuetz, Patrick; Roth, Nathan] CSL Behring, Res & Dev, Bern, Switzerland	CSL	Kalina, U (corresponding author), CSL Behring Innovat GmbH, Res & Dev, Marburg, Germany.	Uwe.Kalina@cslbehring.com			CSL Behring GmbH	CSL Behring GmbH	The study was funded by CSL Behring GmbH. The funder provided support in the form of salaries for authors [Christina Kober, Sandro Manni, Svenja Wolff, Thomas Barnes, Shatanik Mukherjee, Thomas Vogel, Lea Hoenig, Peter Vogel, Aaron Hahn, Michaela Gerlach, Martin Vey, Eleonora Widmer, Bjorn Keiner, Patrick Schuetz, Nathan Roth, Uwe Kalina], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	A.Nadas, 2020, medRxiv, DOI 10.1101/2020.08.18.20177303; A. S.Buzzanco, 2020, medRxiv, DOI 10.1101/2020.05.15.20103341; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Bavli I, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4074; Chen YX, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008796; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Damelang T, 2019, TRENDS IMMUNOL, V40, P197, DOI 10.1016/j.it.2019.01.005; Gasser R, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108790; Goh YS, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100193; Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4; J. D. Herman, 2021, medRxiv, DOI 10.1101/2021.03.08.21253157; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kallolimath S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2107249118; Khatri I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.570018; Klasse PJ, 2020, ELIFE, V9, DOI 10.7554/eLife.57877; Liu XM, 2020, EMERG MICROBES INFEC, V9, P1269, DOI 10.1080/22221751.2020.1773324; Luo HL, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.632814; Maor Y, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100525; Mazzini L, 2021, J IMMUNOL METHODS, V489, DOI 10.1016/j.jim.2020.112937; MILES J, 1994, ANN CLIN BIOCHEM, V31, P245, DOI 10.1177/000456329403100305; Moura AD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95045-z; Muller L, 2021, EUR J CLIN MICROBIOL, V40, P1063, DOI 10.1007/s10096-021-04169-7; Munitz A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83019-0; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Prevost J, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100126; Rowntree LC, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1258; Sakoulas George, 2020, Crit Care Explor, V2, pe0280, DOI 10.1097/CCE.0000000000000280; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; Schwaiger J, 2020, J INFECT DIS, V222, P1960, DOI 10.1093/infdis/jiaa593; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Suthar MS., 2020, PREPRINT, DOI [10.1101/2020.05.03.20084442, DOI 10.1101/2020.05.03.20084442]; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Whitcombe AL, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1261; Yates JL, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100329; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	41	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262162	10.1371/journal.pone.0262162	http://dx.doi.org/10.1371/journal.pone.0262162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982806	gold, Green Published			2022-12-26	WOS:000834805700019
J	Schuetz, A; Kurz, K; Busch, G				Schuetz, Aurelia; Kurz, Katharina; Busch, Gesa			Virtual farm tours-Virtual reality glasses and tablets are suitable tools to provide insights into pig husbandry	PLOS ONE			English	Article							ANIMAL-WELFARE; PERCEPTION	Apart from improving husbandry conditions and animal welfare, there is a clear public demand to increase transparency in agricultural activities. Personal farm tours have shown to be appreciated by citizens but are limited in their impact because of hygiene requirements and accessibility. Virtual farm tours are a promising approach to overcome these limitations but evidence on their perceptions is missing. This study analyzes how a virtual farm tour is perceived by showing participants (n = 17) a 360-degree video of a conventional pig fattening pen on a tablet and via virtual reality (VR) glasses. Semi-structured in-depth interviews were conducted to analyze perceptions and level of immersion and to elicit differences between media devices. Participants' perception of the pig fattening pen was rather poor and depended on the recording perspective as well as on the media device. However, housing conditions were perceived more positively compared to the image participants had in mind prior to the study, and thus the stable was considered as a rather positive example. Participants described virtual farm tours as suitable tool to improve transparency and information transfer and to gain insights into husbandry conditions. They appreciated the comfortable and entertaining character of both media devices and named various possibilities for implementation. However, VR glasses were favored regarding the higher realistic and entertaining value, while the tablet was considered beneficial in terms of usability. The presentation of video sequences without additional explanations about the farm or the housing conditions were claimed insufficient to give an adequate understanding of the seen content.	[Schuetz, Aurelia; Kurz, Katharina; Busch, Gesa] Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Lower Saxony, Germany	University of Gottingen	Schuetz, A (corresponding author), Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Lower Saxony, Germany.	aurelia.schuetz@uni-goettingen.de		Schutz, Aurelia/0000-0003-2084-0296	Open Access Publication Funds of the Gottingen University	Open Access Publication Funds of the Gottingen University	We acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the Manuscript. Apart from the publication funding, the authors received no further funding for the study presented herein.	Ahn SJG, 2016, J COMPUT-MEDIAT COMM, V21, P399, DOI 10.1111/jcc4.12173; [Anonymous], 2019, VIRTUAL AUGMENTED RE, DOI [10.1007/978-3-662-58861-1, DOI 10.1007/978-3-662-58861-1]; Asani Emmanuel Oluwatobi, 2019, International Journal of Interactive Mobile Technologies, V13, P110, DOI 10.3991/ijim.v13i05.9119; Bailey J., 2012, P INT SOC PRES RES A, P24; Blokhuis HJ, 2003, ANIM WELFARE, V12, P445; Boogaard BK, 2011, LIVEST SCI, V140, P189, DOI 10.1016/j.livsci.2011.03.028; Busch G, 2015, SCHRIFTENREIHE RENTE, V31, P67; Busch G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211256; Busch G, 2017, GER J AGR ECON, V66, P65; Caracciolo F, 2016, J CLEAN PROD, V112, P121, DOI 10.1016/j.jclepro.2015.06.045; Crouch M, 2006, SOC SCI INFORM, V45, P483, DOI 10.1177/0539018406069584; Durnell Linda A, 2018, THESIS FIELDING GRAD; Ermann M., 2017, SCHRIFTEN GESELLSCHA, P45; European Commission, 2015, ATT EUR AN WELF SPEC; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; Gauly S., 2017, Diskussionspapiere - Department fur Agrarokonomie und Rurale Entwicklung, Universitat Gottingen; i.m.a.-Informationen.Medien-Agrar, 2003, IM DTSCH LANDW SICHT; Kisker J, 2021, PSYCHOL RES-PSYCH FO, V85, P68, DOI 10.1007/s00426-019-01244-9; Kletschke T, 2019, LIVE STREAM STALL SU; Krystallis A, 2009, LIVEST SCI, V126, P46, DOI 10.1016/j.livsci.2009.05.016; Lebensmittel Praxis, 2018, FLEISCH STAR 18; Liagkou V, 2019, PROC CIRP, V79, P712, DOI 10.1016/j.procir.2019.02.025; Markowitz DM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02364; Mayring P., 2010, HDB QUALITATIVE FORS, P601, DOI [DOI 10.1007/978-3-531-92052-8_42, 10.1007/978-3-531-92052-8_42]; Meehan M, 2002, ACM T GRAPHIC, V21, P645, DOI 10.1145/566570.566630; Mkwanazi MV, 2019, ASIAN AUSTRAL J ANIM, V32, P1, DOI 10.5713/ajas.17.0138; MOSTL A., 2016, KOMMUNIKATION LANDWI; Pasanen K, 2019, INFORMATION AND COMMUNICATION TECHNOLOGIES IN TOURISM 2019, P120, DOI 10.1007/978-3-030-05940-8_10; Radianti J, 2020, COMPUT EDUC, V147, DOI 10.1016/j.compedu.2019.103778; Ritchie J., 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.4135/9781452230108; Rizzo A, 2011, J CLIN PSYCHOL MED S, V18, P176, DOI 10.1007/s10880-011-9247-2; Rizzo A, 2017, NEUROPSYCHOLOGY, V31, P877, DOI 10.1037/neu0000405; Roche K, 2019, J NEUROLOGY PSYCHIAT; Schone B, 2019, CURR PSYCHOL, V38, P715, DOI 10.1007/s12144-017-9648-y; Spiller A., 2013, DLG MITTEILUNGEN, V1, P26; STEUER J, 1992, J COMMUN, V42, P73, DOI 10.1111/j.1460-2466.1992.tb00812.x; Stohlmann LK, 2019, THESIS OHIO STATE U; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; van Herpen E, 2016, APPETITE, V107, P196, DOI 10.1016/j.appet.2016.07.033; Vanhonacker F, 2008, LIVEST SCI, V116, P126, DOI 10.1016/j.livsci.2007.09.017; Ventura BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154733; Veres P., 2020, J ENG RES REPORTS, DOI [10.9734/jerr/2020/v13i217107, DOI 10.9734/JERR/2020/V13I217107]; Vierboom C., 2015, SCHRIFTENREIHE RENTE, V31, P67; Weible D, 2016, BRIT FOOD J, V118, P1994, DOI 10.1108/BFJ-12-2015-0458; Wells KT, 2019, THESIS LOWA STATE U; Wernsmann A, 2018, GER J AGR ECON, V67, P246; WILDRAUT C, 2015, MULTIMETHODISCHE BEW, V36; Wille SC, 2017, GER J AGR ECON, V66, P1; Zander K., 2013, ERWARTUNGEN GESELLSC	49	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261248	10.1371/journal.pone.0261248	http://dx.doi.org/10.1371/journal.pone.0261248			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007299	gold, Green Published			2022-12-26	WOS:000741060700009
J	Zhao, JL; Li, YF; Li, JM; Li, JX				Zhao, Jianlong; Li, Yanfeng; Li, Junmei; Li, Jiaxin			A study on the temperature profile of bifurcation tunnel fire under natural ventilation	PLOS ONE			English	Article							SMOKE TEMPERATURE; METRO TUNNEL; MOVEMENT; AREA; ROAD	This study simulated a series of bifurcation tunnel fire scenarios using the numerical code to investigate the temperature profile of bifurcation tunnel fire under natural ventilation. The bifurcation tunnel fire scenarios considered three bifurcation angles (30 degrees, 45 degrees, and 60 degrees) and six heat release rates (HRRs) (5, 10, 15, 20, 25, and 30 MW). According to the simulation results, the temperature profile with various HRRs and bifurcation angles was described. Furthermore, the effects of bifurcation angles and HRRs on the maximum temperature under the bifurcation tunnel ceiling and the temperature decay along the longitudinal direction of the branch were investigated. According to the theoretical analysis, two prediction models were proposed. These models can predict a bifurcation tunnel fire's maximum temperature and longitudinal temperature decay in the branch. The results of this study could be valuable for modelling a bifurcation tunnel fire and benefit the fire engineering design of bifurcation tunnels.	[Zhao, Jianlong; Li, Yanfeng; Li, Junmei; Li, Jiaxin] Beijing Univ Technol, Beijing Key Lab Green Built Environm & Energy Eff, Beijing, Peoples R China	Beijing University of Technology	Li, YF (corresponding author), Beijing Univ Technol, Beijing Key Lab Green Built Environm & Energy Eff, Beijing, Peoples R China.	liyanfeng@bjut.edu.cn		Zhao, Jianlong/0000-0003-1098-7868				ALPERT RL, 1975, COMBUST SCI TECHNOL, V11, P197, DOI 10.1080/00102207508946699; Chen CK, 2020, TUNN UNDERGR SP TECH, V104, DOI 10.1016/j.tust.2020.103522; Chen CK, 2020, TUNN UNDERGR SP TECH, V98, DOI 10.1016/j.tust.2019.103275; Chen CK, 2021, COMBUST SCI TECHNOL, V193, P2194, DOI 10.1080/00102202.2020.1732362; Chen LF, 2020, TUNN UNDERGR SP TECH, V98, DOI 10.1016/j.tust.2020.103295; Evers E., 1978, BUILD RES ESTABL FIR; Fan CG, 2016, APPL THERM ENG, V93, P405, DOI 10.1016/j.applthermaleng.2015.09.048; Feng S, 2020, TUNN UNDERGR SP TECH, V97, DOI 10.1016/j.tust.2019.103234; Gao Y, 2017, PROCEDIA ENGINEER, V205, P1850, DOI 10.1016/j.proeng.2017.10.260; Gao YJ, 2019, ADV STRUCT ENG, V22, P2089, DOI 10.1177/1369433219831485; Gong L, 2016, INT J THERM SCI, V102, P319, DOI 10.1016/j.ijthermalsci.2015.12.006; Haddad RK, 2020, J APPL FLUID MECH, V13, P1289, DOI 10.36884/jafm.13.04.30876; Hu LH, 2005, TUNN UNDERGR SP TECH, V20, P223, DOI 10.1016/j.tust.2004.08.007; Huang YB, 2020, TUNN UNDERGR SP TECH, V99, DOI 10.1016/j.tust.2020.103388; Huang YB, 2019, INT J THERM SCI, V145, DOI 10.1016/j.ijthermalsci.2019.105997; Huang YB, 2018, TUNN UNDERGR SP TECH, V72, P120, DOI 10.1016/j.tust.2017.11.021; Ingason H, 2010, FIRE SAFETY J, V45, P371, DOI 10.1016/j.firesaf.2010.07.004; Ji J, 2017, APPL THERM ENG, V118, P663, DOI 10.1016/j.applthermaleng.2017.03.026; Khoury GA, 2000, PROG STRUCT ENG MAT, V2, P429, DOI [10.1002/pse.51, DOI 10.1002/PSE.51, 10.1002/pse.51.URL]; Kurioka H, 2003, FIRE SAFETY J, V38, P319, DOI 10.1016/S0379-7112(02)00089-9; Lei P, 2021, INT J THERM SCI, V159, DOI 10.1016/j.ijthermalsci.2020.106631; Li JM, 2017, PROCEDIA ENGINEER, V205, P1858, DOI 10.1016/j.proeng.2017.10.262; Li YZ, 2018, TUNN UNDERGR SP TECH, V81, P568, DOI 10.1016/j.tust.2018.08.013; Li YZ, 2018, FIRE SAFETY J, V97, P85, DOI 10.1016/j.firesaf.2018.03.006; Li YS, 2021, TUNN UNDERGR SP TECH, V113, DOI 10.1016/j.tust.2021.103953; Li ZS, 2021, TUNN UNDERGR SP TECH, V112, DOI 10.1016/j.tust.2021.103893; Liu C, 2020, TUNN UNDERGR SP TECH, V97, DOI 10.1016/j.tust.2020.103296; Liu C, 2019, INT J THERM SCI, V138, P84, DOI 10.1016/j.ijthermalsci.2018.12.037; Liu C, 2017, APPL THERM ENG, V110, P382, DOI 10.1016/j.applthermaleng.2016.08.147; Lou B, 2017, J APPL FLUID MECH, V10, P1139, DOI 10.18869/acadpub.jafm.73.241.26529; Ma X, 2021, TUNN UNDERGR SP TECH, V107, DOI 10.1016/j.tust.2020.103674; McGrattan K., 2019, NIST SPEC PUBL, V1019; Tang F, 2020, INT J THERM SCI, V152, DOI 10.1016/j.ijthermalsci.2020.106294; Tomar MS, 2019, TUNN UNDERGR SP TECH, V85, P149, DOI 10.1016/j.tust.2018.12.018; Wang YF, 2016, APPL THERM ENG, V109, P344, DOI 10.1016/j.applthermaleng.2016.08.081; Wang ZY, 2020, INT J THERM SCI, V152, DOI 10.1016/j.ijthermalsci.2020.106272; Wang ZH, 2021, TUNN UNDERGR SP TECH, V109, DOI 10.1016/j.tust.2020.103752; Xu T, 2021, INDOOR BUILT ENVIRON, DOI 10.1177/1420326X211013080; Yan GF, 2020, INDOOR BUILT ENVIRON, V29, P1017, DOI 10.1177/1420326X19870313; Yang D, 2017, TUNN UNDERGR SP TECH, V61, P189, DOI 10.1016/j.tust.2016.10.009; Yao YZ, 2021, TUNN UNDERGR SP TECH, V108, DOI 10.1016/j.tust.2020.103672; Yao YZ, 2019, INDOOR BUILT ENVIRON, V28, P77, DOI 10.1177/1420326X17734906; Ye K, 2019, INT J THERM SCI, V142, P434, DOI 10.1016/j.ijthermalsci.2019.04.023; Yu L, 2021, TUNN UNDERGR SP TECH, V108, DOI 10.1016/j.tust.2020.103715; Zhang XL, 2021, TUNN UNDERGR SP TECH, V107, DOI 10.1016/j.tust.2020.103661; Zhao SZ, 2018, TUNN UNDERGR SP TECH, V73, P187, DOI 10.1016/j.tust.2017.12.002	46	0	0	15	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0262546	10.1371/journal.pone.0262546	http://dx.doi.org/10.1371/journal.pone.0262546			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007305	gold, Green Published			2022-12-26	WOS:000741060700007
J	Harlan, B; Park, HG; Spektor, R; Cummings, B; Brenna, JT; Soloway, PD				Harlan, Blaine; Park, Hui Gyu; Spektor, Roman; Cummings, Bethany; Brenna, J. Thomas; Soloway, Paul D.			Single-cell chromatin accessibility and lipid profiling reveals SCD1-dependent metabolic shift in adipocytes induced by bariatric surgery	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; VERTICAL SLEEVE GASTRECTOMY; HUMAN ADIPOSE-TISSUE; THERMOGENIC PROGRAM; GASTRIC BYPASS; PROTECTS MICE; FAT; DEFICIENCY; EXPRESSION; BROWN	Obesity promotes type 2 diabetes and cardiometabolic pathologies. Vertical sleeve gastrectomy (VSG) is used to treat obesity resulting in long-term weight loss and health improvements that precede weight loss; however, the mechanisms underlying the immediate benefits remain incompletely understood. Because adipose plays a crucial role in energy homeostasis and utilization, we hypothesized that VSG exerts its influences, in part, by modulating adipose functional states. We applied single-cell ATAC sequencing and lipid profiling to inguinal and epididymal adipose depots from mice that received sham surgery or VSG. We observed depot-specific cellular composition and chromatin accessibility patterns that were altered by VSG. Specifically, accessibility at Scd1, a fatty acid desaturase, was substantially reduced after VSG in mature adipocytes of inguinal but not epididymal depots. This was accompanied by reduced accumulation of SCD1-produced unsaturated fatty acids. Given these findings and reports that reductions in Scd1 attenuate obesity and insulin resistance our results suggest VSG exerts its beneficial effects through an inguinal depot-specific reduction of SCD1 activity.	[Harlan, Blaine; Spektor, Roman; Soloway, Paul D.] Cornell Univ, Dept Mol Biol & Genet, Field Genet Genom & Dev, Ithaca, NY 14850 USA; [Park, Hui Gyu; Brenna, J. Thomas] Univ Texas Austin, Dell Pediat Res Inst, Dept Pediat, Austin, TX USA; [Cummings, Bethany] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA USA; [Cummings, Bethany; Soloway, Paul D.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14850 USA; [Brenna, J. Thomas; Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14850 USA	Cornell University; University of Texas System; University of Texas Austin; University of California System; University of California Davis; Cornell University; Cornell University	Soloway, PD (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Field Genet Genom & Dev, Ithaca, NY 14850 USA.; Soloway, PD (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14850 USA.; Soloway, PD (corresponding author), Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14850 USA.	soloway@cornell.edu						Akama T, 2018, J BIOL CHEM, V293, P6603, DOI 10.1074/jbc.RA117.000456; Backdahl J, 2021, CELL METAB, V33, P1869, DOI 10.1016/j.cmet.2021.07.018; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Cereijo R, 2018, CELL METAB, V28, P750, DOI 10.1016/j.cmet.2018.07.015; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chi JY, 2018, CELL METAB, V27, P226, DOI 10.1016/j.cmet.2017.12.011; Cho DS, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900561; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Coulter AA, 2006, BIOCHEM BIOPH RES CO, V344, P1342, DOI 10.1016/j.bbrc.2006.04.071; Cummings BP, 2012, ENDOCRINOLOGY, V153, P3620, DOI 10.1210/en.2012-1131; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Ejarque M, 2019, INT J OBESITY, V43, P1256, DOI 10.1038/s41366-018-0219-6; Galanakis CG, 2015, WORLD J SURG, V39, P417, DOI 10.1007/s00268-014-2826-2; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; Garibay D, 2018, CELL REP, V23, P967, DOI 10.1016/j.celrep.2018.03.120; Gealekman O, 2011, CIRCULATION, V123, P186, DOI 10.1161/CIRCULATIONAHA.110.970145; Gleeson PA, 2014, SEMIN CELL DEV BIOL, V31, P64, DOI 10.1016/j.semcdb.2014.03.002; Granja JM, 2021, NAT GENET, V53, P403, DOI 10.1038/s41588-021-00790-6; Harris DA, 2020, AM J PHYSIOL-ENDOC M, V318, pE678, DOI 10.1152/ajpendo.00441.2019; Hartmann IB, 2016, SURG OBES RELAT DIS, V12, P1554, DOI 10.1016/j.soard.2016.04.016; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Jahansouz C, 2018, INT J OBESITY, V42, P139, DOI 10.1038/ijo.2017.197; Jiang YW, 2017, ELIFE, V6, DOI 10.7554/eLife.30329; Kelly AS, 2016, INT J OBESITY, V40, P275, DOI 10.1038/ijo.2015.174; Kwok KHM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.5; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Liu TY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16148-1; Liu WH, 2020, CELL CYCLE, V19, P895, DOI 10.1080/15384101.2020.1731644; Liu X, 2009, LOSS STEAROYL COA DE; McGavigan AK, 2017, DIS MODEL MECH, V10, P235, DOI 10.1242/dmm.027474; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Ng Y, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.144; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Ralston JC, 2014, INT J OBESITY, V38, P1449, DOI 10.1038/ijo.2014.35; Rinaldi VD, 2020, ELIFE, V9, DOI 10.7554/eLife.55474; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sanchez-Gurmaches J, 2015, STEM CELL REP, V4, P541, DOI 10.1016/j.stemcr.2015.02.008; Savu MK, 2009, SURG OBES RELAT DIS, V5, P172, DOI 10.1016/j.soard.2008.08.013; Schupp JC, 2020, BIORXIV; Schweitzer P., 2014, J BIOMOL TECH, V25, pS15; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sjogren P, 2008, DIABETOLOGIA, V51, P328, DOI 10.1007/s00125-007-0876-9; Sowers James R, 2008, Clin Cornerstone, V9, P32, DOI 10.1016/S1098-3597(08)60026-5; Spektor R, 2019, BIORXIV; Stine RR, 2016, MOL METAB, V5, P57, DOI 10.1016/j.molmet.2015.11.001; Sun W, 2019, MOL METAB, V28, P48, DOI 10.1016/j.molmet.2019.07.004; Toro-Ramos T, 2015, OBESITY, V23, P62, DOI 10.1002/oby.20932; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Velazquez-Villegas LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02068-0; Vijay J, 2020, NAT METAB, V2, P97, DOI 10.1038/s42255-019-0152-6; Wang WS, 2014, P NATL ACAD SCI USA, V111, P14466, DOI 10.1073/pnas.1412685111; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoon DY, 2007, ANZ J SURG, V77, P121, DOI 10.1111/j.1445-2197.2006.03990.x; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Zhang Y, 2014, OBES SURG, V24, P1617, DOI 10.1007/s11695-014-1258-2; Zhao Peng, 2013, JAKSTAT, V2, pe23092, DOI 10.4161/jkst.23092	66	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261783	10.1371/journal.pone.0261783	http://dx.doi.org/10.1371/journal.pone.0261783			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972124	Green Published, gold			2022-12-26	WOS:000773555700054
J	Midthassel, TC; Hansen, AH				Midthassel, Tiki Celine; Hansen, Anne Helen			Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study	PLOS ONE			English	Article							NUTRITION THERAPY; PHYSICAL-ACTIVITY; RISK-FACTOR; MORTALITY; ADULTS; INTERVENTIONS; PREDICTORS; TYPE-1	Background The prevalence of diabetes and the use of electronic health (eHealth) are increasing. Lifestyle changes in a positive direction may reduce morbidity and mortality in patients with diabetes. The main objective of this study was to test the association between lifestyle changes based on online information seeking and discussing the information with a doctor. Methods In this cross-sectional study we used e-mail survey data from 1250 members of The Norwegian Diabetes Association, collected in 2018. Included in the analyses were 847 men and women aged 18 to 89 years diagnosed with diabetes and who reported use of eHealth within the previous year. We used descriptive statistics to estimate lifestyle changes based on information from the internet. Logistic regressions were used to estimate the associations between lifestyle changes after online information seeking and discussing the information with a doctor. Analyses were adjusted for gender, age, education, and self-rated health. Results Lifestyle changes accomplished after online information seeking was reported by 46.9% (397/847) of the participants. The odds of changing lifestyle were more than doubled for those who had discussed information from the internet with a doctor (odds ratio 2.54, confidence interval 1.90-3.40). The odds of lifestyle changes were lower in the age groups 30-39 years and 60 years and over, compared to those aged 18-29 years (the reference group). Lifestyle changes were not associated with gender, education, or self-rated health. Conclusions Our findings indicate that health-care professionals can play an important role in lifestyle changes additional to health-advice found on the internet. This study underlines the importance of easily accessible high-quality online information, as well as the importance of making room for discussing lifestyle in the clinical encounter.	[Midthassel, Tiki Celine; Hansen, Anne Helen] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Hansen, Anne Helen] Univ Hosp North Norway, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Hansen, AH (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.; Hansen, AH (corresponding author), Univ Hosp North Norway, Tromso, Norway.	anne.h.hansen@uit.no		Hansen, Anne Helen/0000-0002-2731-6916				Afshin A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003058; Alvarez-Galvez J, 2020, INT J PUBLIC HEALTH, V65, P325, DOI 10.1007/s00038-020-01363-w; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS38, DOI 10.2337/dc18-S004; Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; [Anonymous], 2018, DIABETES CARE, V41, pS1, DOI [10.2337/dc18-Sint01, 10.2337/dc18-SINT01]; Beck F, 2014, J MED INTERNET RES, V16, P193, DOI 10.2196/jmir.2934; Brandt CJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017466; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Church TS, 2005, ARCH INTERN MED, V165, P2114, DOI 10.1001/archinte.165.18.2114; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Cooper John G, 2013, Tidsskr Nor Laegeforen, V133, P2257, DOI 10.4045/tidsskr.13.0153; Department of Information Science and Media Studies University of Bergen, MED NORW FACTS FIG N; Dutton GR, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0442-0; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Fox Susannah, 2013, PEW RES INTERNET PRO; Franz MJ, 2010, J AM DIET ASSOC, V110, P1852, DOI 10.1016/j.jada.2010.09.014; Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440; Hallan SI, 2011, KIDNEY INT, V80, P516, DOI 10.1038/ki.2011.157; Hansen AH, 2019, J MED INTERNET RES, V21, DOI 10.2196/13615; Hansen AH, 2018, J MED INTERNET RES, V20, DOI 10.2196/11322; Hong YA, 2017, J GERONTOL B-PSYCHOL, V72, P856, DOI 10.1093/geronb/gbw100; Hu G, 2005, DIABETES CARE, V28, P799, DOI 10.2337/diacare.28.4.799; International Diabetes Federation, 2019, IDF DIABETES ATLAS, V9th ed.; Jenssen TG, 2008, DIABETES RES CLIN PR, V80, P314, DOI 10.1016/j.diabres.2007.12.025; Joiner KL, 2017, PREV MED, V100, P194, DOI 10.1016/j.ypmed.2017.04.033; Kennedy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058861; Komkova Anastasija, 2019, JMIR Diabetes, V4, pe12140, DOI 10.2196/12140; Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117; Kummervold PE, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1023; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Li JH, 2016, HEALTH INFORM J, V22, P804, DOI 10.1177/1460458215595851; McCully SN, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2612; Medlock S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3749; Mouland G., 2014, DIABETES FASTLEGEPRA, V134, DOI [10.4045/tidsskr.13.0375, DOI 10.4045/TIDSSKR.13.0375]; Nolke L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1423-0; Norwegian Diabetes Association, 2018, VEIV GOD EG DIAB; Norwegian Directorate of Health, 2018, NASJONAL FAGLIG RETN; Norwegian Institute of Public Health, 2019, NORW PRESCR DAT; Norwegian Institute of Public Health, 2018, PUBL HLTH REP HLTH S; Norwegian Institute of Public Health, 2017, BURD DIS NORW 2015; Pinchevsky Y, 2015, CARDIOVASC J AFR, V26, P188, DOI 10.5830/CVJA-2015-050; Sandahl K, 2017, DIABETIC MED, V34, P380, DOI 10.1111/dme.13124; Sorensen T., 2014, PROSJEKTRAPPORT E HE; Statistics Norway, ICT US HOUS 2017; Statistics Norway, ED LEV POL 2020; Strom H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-520; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Tang J, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2857; The Norwegian Diabetes Association, 2018, ARSB 2017; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; van den Berg MH, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e26; Wangberg SC., 2015, USING INTERNET SUPPO, pe3; Wangberg S, 2009, SCAND J CARING SCI, V23, P691, DOI 10.1111/j.1471-6712.2008.00662.x; Wantland DJ, 2004, J MED INTERNET RES, V6, P67; Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376; World Health Organization, EHEALTH WHO; YUDKIN JS, 1993, BMJ-BRIT MED J, V306, P1313, DOI 10.1136/bmj.306.6888.1313	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261471	10.1371/journal.pone.0261471	http://dx.doi.org/10.1371/journal.pone.0261471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972136	gold, Green Published			2022-12-26	WOS:000773555700035
J	Ong, CE; Ahmad, R; Goh, YK; Azizan, KA; Baharum, SN; Goh, KJ				Ong, Cu Ean; Ahmad, Rafidah; Goh, You Keng; Azizan, Kamalrul Azlan; Baharum, Syarul Nataqain; Goh, Kah Joo			Growth modulation and metabolic responses of Ganoderma boninense to salicylic acid stress	PLOS ONE			English	Article							BASAL STEM ROT; PALM ELAEIS-GUINEENSIS; OIL PALM; ROOT INFECTION; CAUSAL AGENT; BIOSYNTHESIS; PATHWAYS; FUNGAL; DEGRADATION; VIRULENCE	Various phenolic compounds have been screened against Ganoderma boninense, the fungal pathogen causing basal stem rot in oil palms. In this study, we focused on the effects of salicylic acid (SA) on the growth of three G. boninense isolates with different levels of aggressiveness. In addition, study on untargeted metabolite profiling was conducted to investigate the metabolomic responses of G. boninense towards salicylic acid. The inhibitory effects of salicylic acid were both concentration- (P < 0.001) and isolate-dependent (P < 0.001). Also, growth-promoting effect was observed in one of the isolates at low concentrations of salicylic acid where it could have been utilized by G. boninense as a source of carbon and energy. Besides, adaptation towards salicylic acid treatment was evident in this study for all isolates, particularly at high concentrations. In other words, inhibitory effect of salicylic acid treatment on the fungal growth declined over time. In terms of metabolomics response to salicylic acid treatment, G. boninense produced several metabolites such as coumarin and azatyrosine, which suggests that salicylic acid modulates the developmental switch in G. boninense towards the defense mode for its survival. Furthermore, the liquid chromatography time-of-flight mass spectrometry (LC-TOF-MS) analysis showed that the growth of G. boninense on potato dextrose agar involved at least four metabolic pathways: amino acid metabolism, lipid pathway, tryptophan pathway and phenylalanine pathway. Overall, there were 17 metabolites that contributed to treatment separation, each with P<0.005. The release of several antimicrobial metabolites such as eudistomin I may enhance G. boninense's competitiveness against other microorganisms during colonisation. Our findings demonstrated the metabolic versatility of G. boninense towards changes in carbon sources and stress factors. G. boninense was shown to be capable of responding to salicylic acid treatment by switching its developmental stage.	[Ong, Cu Ean; Goh, You Keng; Goh, Kah Joo] Adv Agriecol Res Sdn Bhd, Petaling Jaya, Selangor, Malaysia; [Ahmad, Rafidah; Azizan, Kamalrul Azlan; Baharum, Syarul Nataqain] Univ Kebangsaan Malaysia, Inst Syst Biol INBIOSIS, Metabol Res Lab, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Ong, CE (corresponding author), Adv Agriecol Res Sdn Bhd, Petaling Jaya, Selangor, Malaysia.; Baharum, SN (corresponding author), Univ Kebangsaan Malaysia, Inst Syst Biol INBIOSIS, Metabol Res Lab, Bangi, Selangor, Malaysia.	ongce@aarsb.com.my; nataqain@ukm.edu.my		Ong, Cu Ean/0000-0003-2154-7139	Centre for Research and Instrumentation Management (CRIM), UKM; AAR [RB-2015-002]	Centre for Research and Instrumentation Management (CRIM), UKM; AAR	We acknowledge the Centre for Research and Instrumentation Management (CRIM), UKM for the Research Instrumentation Development Grants awarded in 2010 and 2013 (PIP-CRIM). The authors are grateful to AAR Principals, Boustead Plantations Berhad and Kuala Lumpur Kepong Berhad, for funding this research under the grant number RB-2015-002, and for their permission to publish the data presented in this paper.	Ahmad R., 2016, INT J PHARMACOGN PHY, V8, P1986; Ahmad R, 2020, MOLECULES, V25, DOI 10.3390/molecules25245965; Ahmed W, 2016, APPL ENVIRON MICROB, V82, P1316, DOI 10.1128/AEM.03765-15; Akone SH, 2016, TETRAHEDRON, V72, P6340, DOI 10.1016/j.tet.2016.08.022; Arasimowicz-Jelonek M, 2014, MOL PLANT PATHOL, V15, P406, DOI 10.1111/mpp.12095; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Beals KA, 2019, AM J POTATO RES, V96, P102, DOI 10.1007/s12230-018-09705-4; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Bivi M. R., 2012, African Journal of Biotechnology, V11, P13477; Bivi MSHR, 2016, PLANT PATHOLOGY J, V32, P396, DOI 10.5423/PPJ.OA.03.2016.0052; Bomprezzi R, 2015, THER ADV NEUROL DISO, V8, P20, DOI 10.1177/1756285614564152; Bubols GB, 2013, MINI-REV MED CHEM, V13, P318; Cheemanapalli S, 2018, BIOMED PHARMACOTHER, V108, P547, DOI 10.1016/j.biopha.2018.09.069; Chong K., 2010, ROLE PHENOLICS INTER; Chong KP, 2012, PLANT PATHOL, V61, P953, DOI 10.1111/j.1365-3059.2011.02577.x; Cooper R. M., 2011, Planter, V87, P515; Cooper RM, 1984, PLANT DIS INFECT DAM, P13; Corley RHV, 2016, WORLD AGRIC SER, P399; Costa TM, 2016, APPL MICROBIOL BIOT, V100, P6571, DOI 10.1007/s00253-016-7660-z; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Fiskesund R, 2010, PLANTA MED, V76, P1635, DOI 10.1055/s-0030-1250120; Garbe E, 2019, CURR CLIN MICROBIOL, V6, P108, DOI 10.1007/s40588-019-00124-5; Garzon CD, 2011, PLANT DIS, V95, P1233, DOI 10.1094/PDIS-09-10-0693; Georgiou CD, 2000, MYCOLOGIA, V92, P825, DOI 10.2307/3761577; Gnonlonfin GJB, 2012, CRIT REV PLANT SCI, V31, P47, DOI 10.1080/07352689.2011.616039; Goto K, 2018, BIOORGAN MED CHEM, V26, P3763, DOI 10.1016/j.bmc.2017.11.041; Haniff M. H., 2005, Asian Journal of Plant Sciences, V4, P438; Harborne J.B., 1984, PHYTOCHEMICAL METHOD, DOI [10.1007/978-94-009-5570-7_2, DOI 10.1007/978-94-009-5570-7_2]; Hyun Min Woo, 2011, Mycobiology, V39, P257, DOI 10.5941/MYCO.2011.39.4.257; INOUYE S, 1975, CHEM PHARM BULL, V23, P2669; IZAWA M, 1992, CANCER RES, V52, P1628; Jayawickrama GS, 2015, CURR MED CHEM, V22, P2902, DOI 10.2174/0929867322666150608094054; Jiang N., 2021, FRONT MICROBIOL, V12, P1; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Knabe N, 2013, EUKARYOT CELL, V12, P941, DOI 10.1128/EC.00355-12; Kok SM, 2013, MALAYS J MICROBIOL, V9, P33, DOI 10.21161/mjm.45212; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; Kunkel BN, 2018, J EXP BOT, V69, P245, DOI 10.1093/jxb/erx447; Laila Naher, 2013, Australian Journal of Crop Science, V7, P1723; Leung GSW, 2000, MOL GEN GENET, V262, P977, DOI 10.1007/PL00008666; Li E, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw198; Li X, 2015, J FLOW CHEM, V5, P82, DOI 10.1556/1846.2014.00043; Lim CK, 2018, SAINS MALAYS, V47, P3061, DOI 10.17576/jsm-2018-4712-16; Liu R, 2018, REDOX BIOL, V16, P388, DOI 10.1016/j.redox.2018.03.018; Lu X, 2015, NEW PHYTOL, V206, P295, DOI 10.1111/nph.13187; Miles E., 1987, BIOCH VITAMIN B6, P73; MISHRA AK, 1994, APPL ENVIRON MICROB, V60, P1101, DOI 10.1128/AEM.60.4.1101-1105.1994; Ntushelo Khayalethu, 2017, Pak J Biol Sci, V20, P278, DOI 10.3923/pjbs.2017.278.288; Ong Cu Ean, 2018, Archives of Phytopathology and Plant Protection, V51, P122, DOI 10.1080/03235408.2018.1439870; Paterson RRM, 2007, CROP PROT, V26, P1369, DOI 10.1016/j.cropro.2006.11.009; Patten CL, 2013, CRIT REV MICROBIOL, V39, P395, DOI 10.3109/1040841X.2012.716819; Perkin W. H. VI., 1868, J CHEM SOC, V21, P53, DOI [10.1039/JS8682100053, DOI 10.1039/JS8682100053]; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Qi G, 2018, MOL PLANT, V11, P1427, DOI 10.1016/j.molp.2018.10.002; Qi PF, 2012, FUNGAL BIOL-UK, V116, P413, DOI 10.1016/j.funbio.2012.01.001; Rabe F, 2013, MOL MICROBIOL, V89, P179, DOI 10.1111/mmi.12269; Ramzi AB, 2019, PEERJ, V7, DOI 10.7717/peerj.8065; Rees RW, 2007, PLANT PATHOL, V56, P862, DOI 10.1111/j.1365-3059.2007.01621.x; Rees RW, 2009, PLANT PATHOL, V58, P982, DOI 10.1111/j.1365-3059.2009.02100.x; RINEHART KL, 1987, J AM CHEM SOC, V109, P3378, DOI 10.1021/ja00245a031; Saito K, 2000, BIOSCI BIOTECH BIOCH, V64, P1321, DOI 10.1271/bbb.64.1321; Schulz H., 1888, PFLUGERS ARCH GES PH, V42, P517, DOI DOI 10.1007/BF01669373; Schulz H., 1887, VIRCHOWS ARCH, V108, P423, DOI [DOI 10.1007/BF02281473, 10.1515/9783112369043-025, DOI 10.1515/9783112369043-025]; SHINDOOKADA N, 1989, MOL CARCINOGEN, V2, P159, DOI 10.1002/mc.2940020309; SKIDMORE AM, 1976, T BRIT MYCOL SOC, V66, P57, DOI 10.1016/S0007-1536(76)80092-7; Southam CM, 1943, PHYTOPATHOLOGY, V33, P517; Surendran A, 2018, IND CROP PROD, V122, P358, DOI 10.1016/j.indcrop.2018.06.005; Sy-Cordero AA, 2012, J ANTIBIOT, V65, P541, DOI 10.1038/ja.2012.71; THOMPSON DP, 1989, MYCOLOGIA, V81, P151, DOI 10.2307/3759462; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; Tomas-Gallardo L, 2014, MICROB BIOTECHNOL, V7, P100, DOI 10.1111/1751-7915.12096; Turner, 1981, OIL PALM DIS DISORDE; Tzin V, 2010, MOL PLANT, V3, P956, DOI 10.1093/mp/ssq048; Umetrics M., 2002, USER GUIDE TO SIMCA, DOI [10.1023/a:1022450725545, DOI 10.1023/A:1022450725545]; Veeramohan R, 2018, DATA BRIEF, V18, P1212, DOI 10.1016/j.dib.2018.04.001; VILAMBI NRK, 1987, J ELECTROCHEM SOC, V134, P3074, DOI 10.1149/1.2100342; Wachtel-Galor S., 2011, HERBAL MED BIOMOLECU, V2nd; Ward G., 2004, Fungal biotechnology in agricultural, food, and environmental applications, P393; Weingart H, 2001, PHYTOPATHOLOGY, V91, P511, DOI 10.1094/PHYTO.2001.91.5.511; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wichrowska D, 2009, POL J ENVIRON STUD, V18, P487; Xiao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29026; Yamamoto T, 1999, J BIOCHEM-TOKYO, V126, P799, DOI 10.1093/oxfordjournals.jbchem.a022519; Ye LY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196287; Yeoh HockHin, 1996, Tropical Science, V36, P243; You BJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00281-x; You BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053616	88	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262029	10.1371/journal.pone.0262029	http://dx.doi.org/10.1371/journal.pone.0262029			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972183	gold, Green Published			2022-12-26	WOS:000773555700085
J	Sahile, Z; Perimal-Lewis, L; Arbon, P; Maeder, AJ				Sahile, Zekariyas; Perimal-Lewis, Lua; Arbon, Paul; Maeder, Anthony John			Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients	PLOS ONE			English	Article							ANTITUBERCULOSIS TREATMENT; ANTIRETROVIRAL THERAPY; TREATMENT NONADHERENCE; VALIDATION; MODEL	Background Non-adherence to Tuberculosis (TB) medication is a serious threat to TB prevention and control programs, especially in resource-limited settings. The growth of the popularity of mobile phones provides opportunities to address non-adherence, by facilitating direct communication more frequently between healthcare providers and patients through SMS texts and voice phone calls. However, the existing evidence is inconsistent about the effect of SMS interventions on TB treatment adherence. Such interventions are also seldom developed based on appropriate theoretical foundations. Therefore, there is a reason to approach this problem more rigorously, by developing the intervention systematically with evidence-based theory and conducting the trial with strong measurement methods. Methods This study is a single-blind parallel-group design individual randomized control trial. A total of 186 participants (93 per group) will be individually randomized into one of the two groups with a 1:1 allocation ratio by a computer-generated algorithm. Group one (intervention) participants will receive daily SMS texts and weekly phone calls concerning their daily medication intake and medication refill clinic visit reminder and group two (control) participants will receive the same routine standard treatment care as the intervention group, but no SMS text and phone calls. All participants will be followed for two months of home-based self-administered medication during the continuation phases of the standard treatment period. Urine test for the presence of isoniazid (INH) drug metabolites in urine will be undertaken at the random point at the fourth and eighth weeks of intervention to measure medication adherence. Medication adherence will also be assessed by self-report measurements using the AIDS Clinical Trial Group adherence (ACTG) and Visual Analogue Scales (VAS) questionnaires, and clinic appointment attendance registration. Multivariable regression model analysis will be employed to assess the effect of the Ma-MAS intervention at a significance level of P-value < 0.05 with a 95% confidence interval. Discussion For this trial, a mobile-assisted medication adherence intervention will first be developed systematically based on the Medical Research Council framework using appropriate behavioural theory and evidence. The trial will then evaluate the effect of SMS texts and phone calls on TB medication adherence. Evidence generated from this trial will be highly valuable for policymakers, program managers, and healthcare providers working in Ethiopia and beyond.	[Sahile, Zekariyas] Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia; [Sahile, Zekariyas; Maeder, Anthony John] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Flinders Digital Hlth Res Ctr, Adelaide, SA, Australia; [Perimal-Lewis, Lua] Flinders Univ S Australia, Coll Sci & Engn, Flinders Digital Hlth Res Ctr, Adelaide, SA, Australia; [Arbon, Paul] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia	Ambo University; Flinders University South Australia; Flinders University South Australia; Flinders University South Australia	Sahile, Z (corresponding author), Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia.; Sahile, Z (corresponding author), Flinders Univ S Australia, Coll Nursing & Hlth Sci, Flinders Digital Hlth Res Ctr, Adelaide, SA, Australia.	zekariyas.nezenega@flinders.edu.au		Sahile, Zekariyas/0000-0002-7215-9489; Arbon, Paul/0000-0002-5914-3300	Flinders University	Flinders University	This trial protocol is partially funded by Flinders University. The funder and sponsor had no role in trial design, and will not have a role in the trial implementation, analysis, and interpretation of the findings. All trial information is the responsibility of the authors.	Adane AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078791; Alipanah N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002595; Barclay E, 2009, LANCET, V373, P15, DOI 10.1016/S0140-6736(08)61938-8; Barkman C, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1337356; Bediang G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5502-x; Bleijenberg N, 2018, INT J NURS STUD, V79, P86, DOI 10.1016/j.ijnurstu.2017.12.001; Broomhead S, 2012, TELEMED E-HEALTH, V18, P24, DOI 10.1089/tmj.2011.0143; Central Statistical Agency, 2012, ETH DEM GRAPH HLTH S; Central statistical agency-CSA/Ethiopia ICF, 2017, ETH DEM HLTH SURV 20; Chen SQ, 2015, LANCET, V386, pS29, DOI 10.1016/S0140-6736(15)00867-3; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Davey Sanjeev, 2014, Indian J Community Med, V39, P178, DOI 10.4103/0970-0218.137160; Eticha T., 2014, ETHIOPIA, V6, P61; Fang XH, 2017, MED SCI MONITOR, V23, P2465, DOI 10.12659/MSM.904957; Fiseha D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1142-2; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Gashu KD, 2019, BMJ HEALTH CARE INFO, V26, DOI 10.1136/bmjhci-2019-100050; Goel S, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2688; Habteyes Hailu T., 2015, TUBERCULOSIS TREATME, V44, P1; Horne R., 2005, CONCORDANCE ADHERENC, V2005, P40; Kalichman Seth C, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P367, DOI 10.1177/1545109709352884; Kamath-Rayne BD, 2018, GLOB HEALTH-SCI PRAC, V6, P538, DOI 10.9745/GHSP-D-18-00147; Kanters S, 2017, LANCET HIV, V4, pE31, DOI 10.1016/S2352-3018(16)30206-5; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Kebede A, 2012, N AM J MED SCI, V4, P67, DOI 10.4103/1947-2714.93376; Kunawararak P, 2011, SE ASIAN J TROP MED, V42, P1444; Lester R, 2019, J CLIN TUBER OTH MYC, V16, DOI 10.1016/j.jctube.2019.100108; Liu Q, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006594.pub3; Liu XQ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001876; Mckay B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217219; Mekonnen Habtamu Sewunet, 2018, BMC Res Notes, V11, P691, DOI 10.1186/s13104-018-3789-4; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Mkopi A, 2014, INT J TUBERC LUNG D, V18, P804, DOI 10.5588/ijtld.13.0675; Mohammed H, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00753-9; Mohammed S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162944; Nezenega ZS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155626; Nglazi MD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-566; Ogundele OA., 2015, P 2015 ANN RES C S A; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Soobratty MR, 2014, EUR RESPIR J, V43, P1519, DOI 10.1183/09031936.00132613; Strathdee SA, 2012, ANN EPIDEMIOL, V22, P426, DOI 10.1016/j.annepidem.2012.04.002; Subbaraman R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001018; Tegegne T, 2011, IS MHEALTH VIABLE ET; Tesfahuneygn Gebrehiwet, 2015, BMC Res Notes, V8, P503, DOI 10.1186/s13104-015-1452-x; The Federal Ministry of Health, 2018, NAT GUID TB DR TB LE; Tola HH, 2019, INT J TUBERC LUNG D, V23, P741, DOI 10.5588/ijtld.18.0672; Tola HH, 2017, ETHIOP J HEALTH SCI, V27, P447, DOI 10.4314/ejhs.v27i5.2; Tola HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155147; Valencia S, 2017, EXPERT REV ANTI-INFE, V15, P157, DOI 10.1080/14787210.2017.1264270; van den Boogaard J, 2011, B WORLD HEALTH ORGAN, V89, P632, DOI 10.2471/BLT.11.086462; WHO, 2017, GUIDELINES TREATMENT; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378; Yew WW, 1999, CHEMOTHERAPY, V45, P26, DOI 10.1159/000048479; Zegeye A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210422	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261758	10.1371/journal.pone.0261758	http://dx.doi.org/10.1371/journal.pone.0261758			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972128	Green Published, gold			2022-12-26	WOS:000773555700052
J	Han, NR; Moon, PD; Nam, SY; Ko, SG; Park, HJ; Kim, HM; Jeong, HJ				Han, Na-Ra; Moon, Phil-Dong; Nam, Sun-Young; Ko, Seong-Gyu; Park, Hi-Joon; Kim, Hyung-Min; Jeong, Hyun-Ja			TSLP up-regulates inflammatory responses through induction of autophagy in T cells	FASEB JOURNAL			English	Article						autophagy; EL4 cells; inflammatory responses; thymic stromal lymphopoietin	THYMIC STROMAL LYMPHOPOIETIN; LIVER-INJURY; CYTOKINE PRODUCTION; PROTECTS MICE; MTOR; PHOSPHORYLATION; INTERLEUKIN-4; ACTIVATION; SEPSIS; STAT5	Thymic stromal lymphopoietin (TSLP), a type I cytokine belonging to the IL-2 cytokine family, promotes Th2-mediated inflammatory responses. The aim of this study is to investigate whether TSLP increases inflammatory responses via induction of autophagy using a murine T cell lymphoma cell line, EL4 cells, and lipopolysaccharide (LPS)-injected mice. TSLP increased expression levels of autophagy-related factors, such as Beclin-1, LC3-II, p62, Atg5, and lysosome associated membrane protein 1/2, whereas these factors increased by TSLP disappeared by neutralization of TSLP in EL4 cells. TSLP activated JAK1/JAK2/STAT5/JNK/PI3K, while the blockade of JAK1/JAK2/STAT5/JNK/PI3K signaling pathways reduced the expression levels of Beclin-1, LC3-II, and p62 in TSLP-stimulated EL4 cells. In addition, TSLP simultaneously increased levels of inflammatory cytokines via induction of autophagy by activation of JAK1/JAK2/STAT5/JNK/PI3K signaling pathways. In an LPS-induced acute liver injury (ALI) mouse model, exogenous TSLP increased expression levels of Beclin-1 and LC3-II, whereas functional deficiency of TSLP by TSLP siRNA resulted in lower expression of Beclin-1, LC3-II, and inflammatory cytokines, impairing their ability to form autophagosomes in ALI mice. Thus, our findings show a new role of TSLP between autophagy and inflammatory responses. In conclusion, regulating TSLP-induced autophagy may be a potential therapeutic strategy for inflammatory responses.	[Han, Na-Ra] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea; [Han, Na-Ra; Ko, Seong-Gyu] Kyung Hee Univ, Coll Korean Med, Korean Med Based Drug Repositioning Canc Res Ctr, Seoul, South Korea; [Moon, Phil-Dong] Kyung Hee Univ, Ctr Converging Humanities, Seoul, South Korea; [Nam, Sun-Young; Kim, Hyung-Min] Kyung Hee Univ, Coll Korean Med, Dept Pharmacol, Seoul, South Korea; [Ko, Seong-Gyu] Kyung Hee Univ, Coll Korean Med, Dept Prevent Med, Seoul, South Korea; [Park, Hi-Joon] Kyung Hee Univ, Coll Korean Med, Dept Anat & Informat Sci, Seoul, South Korea; [Jeong, Hyun-Ja] Hoseo Univ, Dept Food Sci & Technol, Asan, Chungnam, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Hoseo University	Kim, HM (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Pharmacol, Seoul, South Korea.; Jeong, HJ (corresponding author), Hoseo Univ, Dept Food Sci & Technol, Asan, Chungnam, South Korea.	hmkim@khu.ac.kr; hjjeong@hoseo.edu			National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03931625]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1A5A2019413]	National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Grant/Award Number: 2016R1D1A1B03931625; National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), Grant/Award Number: 2020R1A5A2019413	Abdelaziz DHA, 2015, IMMUNOL REV, V265, P194, DOI 10.1111/imr.12288; Allan S, 2008, NAT REV IMMUNOL, V8, P904, DOI 10.1038/nri2457; Alqahtani SA, 2020, UNITED EUR GASTROENT, V8, P509, DOI 10.1177/2050640620924157; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Botbol Y, 2016, EUR J IMMUNOL, V46, P1326, DOI 10.1002/eji.201545955; Botbol Y, 2015, AUTOPHAGY, V11, P1864, DOI 10.1080/15548627.2015.1089374; Caterino M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82426-7; Chapin CA, 2018, HEPATOLOGY, V68, P1087, DOI 10.1002/hep.29901; Cristofani R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0866-5; Desvaux E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254374; Dickinson JD, 2018, REDOX BIOL, V14, P272, DOI 10.1016/j.redox.2017.09.013; Dickinson JD, 2016, AUTOPHAGY, V12, P397, DOI 10.1080/15548627.2015.1056967; Dowaidar M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12747-z; Dreschers S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09359-8; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Han NR, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091350; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hewitt G, 2016, AUTOPHAGY, V12, P1917, DOI 10.1080/15548627.2016.1210368; Hsieh HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05639-x; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Jacquin E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01023; Jang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056433; Jesus TT, 2017, CRIT REV BIOCHEM MOL, V52, P235, DOI 10.1080/10409238.2017.1279120; Kadandale P, 2010, P NATL ACAD SCI USA, V107, P10502, DOI 10.1073/pnas.0914168107; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuethe JW, 2014, J SURG RES, V191, P19, DOI 10.1016/j.jss.2014.05.024; Kuperman DA, 2008, CURR MOL MED, V8, P384, DOI 10.2174/156652408785161032; Lee HC, 2013, HEPATOLOGY, V57, P1314, DOI 10.1002/hep.26128; Lee S, 2014, ANTIOXID REDOX SIGN, V20, P432, DOI 10.1089/ars.2013.5368; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Li H, 2021, BMC COMPLEMENT MED, V21, DOI 10.1186/s12906-020-03187-w; Li QR, 2018, INNATE IMMUN-LONDON, V24, P231, DOI 10.1177/1753425918771170; Li SL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129013; Lin CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102066; Lin SC, 2019, PEDIATR RES, V86, P181, DOI 10.1038/s41390-018-0239-x; Liu JN, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.38; Liu WJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2002-6; Lu LH, 2019, J INFECTION, V78, P178, DOI 10.1016/j.jinf.2018.12.003; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Matsumoto K, 2020, J ALLERGY CLIN IMMUN, V146, P55, DOI 10.1016/j.jaci.2020.05.017; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Miller K, 2020, AUTOPHAGY, V16, P2131, DOI 10.1080/15548627.2020.1817280; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Poon AH, 2012, J ALLERGY CLIN IMMUN, V129, P569, DOI 10.1016/j.jaci.2011.09.035; Proctor WR, 2014, HEPATOLOGY, V60, P1741, DOI 10.1002/hep.27169; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rochman Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8858; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Shen CC, 2011, INT J NANOMED, V6, P1229, DOI 10.2147/IJN.S21019; Shipkova M, 2012, CLIN CHIM ACTA, V413, P1338, DOI 10.1016/j.cca.2011.11.006; Takahashi N, 2016, CANCER RES, V76, P6241, DOI 10.1158/0008-5472.CAN-16-0992; Tvorogov D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3834; Vasilevskaya IA, 2016, MOL CANCER RES, V14, P753, DOI 10.1158/1541-7786.MCR-16-0035; Vomero M, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.569849; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2011, BLOOD, V117, P4273, DOI 10.1182/blood-2010-09-310888; Wesche-Soldato DE, 2007, AM J PATHOL, V171, P87, DOI 10.2353/ajpath.2007.061099; Wu YJ, 2018, MOL MED REP, V17, P8003, DOI 10.3892/mmr.2018.8831; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yang MH, 2013, BIOCHEM PHARMACOL, V86, P410, DOI 10.1016/j.bcp.2013.05.013; Yang R, 2019, J IMMUNOL, V203, P2020, DOI 10.4049/jimmunol.1900859; Yu J, 2018, RSC ADV, V8, P33338, DOI 10.1039/c8ra03720e; Yu XZ, 2012, CELL IMMUNOL, V279, P174, DOI 10.1016/j.cellimm.2012.10.005; Zhong J, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau007; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	77	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22148	10.1096/fj.202101447R	http://dx.doi.org/10.1096/fj.202101447R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34997949				2022-12-26	WOS:000747987800003
J	Alwan, N; Moss, SL; Davies, IG; Elliott-Sale, KJ; Enright, K				Alwan, Nura; Moss, Samantha L.; Davies, Ian G.; Elliott-Sale, Kirsty J.; Enright, Kevin			Weight loss practices and eating behaviours among female physique athletes: Acquiring the optimal body composition for competition	PLOS ONE			English	Article							RELATIVE ENERGY DEFICIENCY; IOC CONSENSUS STATEMENT; BODYBUILDERS; SPORTS; SYMPTOMATOLOGY; PREVALENCE; DISORDERS; EXERCISE; IMAGE	Little is known about weight loss practices and eating behaviours in female physique athletes. This study investigated the weight loss history, practices, and key influences during the pre-competition period in a large cohort of female physique athletes stratified by division and experience level. Eating attitudes and behaviours were assessed to identify whether athletes were at risk of developing an eating disorder. Using a cross-sectional research design, female physique athletes (n = 158) were recruited and completed an anonymous online self-reported survey consisting of two validated questionnaires: Rapid Weight Loss Questionnaire and Eating Attitudes Test-26. Irrespective of division or experience, female physique athletes used a combination of weight loss practices during the pre-competition phase. Gradual dieting (94%), food restriction (64%) and excessive exercise (84%), followed by body water manipulation via water loading (73%) were the most commonly used methods. Overall, 37% of female physique athletes were considered at risk of developing an eating disorder. Additionally, 42% of female physique athletes used two pathogenic weight control methods with 34% of Figure novice athletes indicating binge eating once a week or more. The coach (89%) and another athlete (73%) were identified as key influences on athletes' dieting practices and weight loss. The prevalence of athletes identified with disordered eating symptoms and engaging in pathogenic weight control methods is concerning. In future, female physique athletes should seek advice from registered nutritionists to optimise weight management practices and minimise the risk of developing an eating disorder.	[Alwan, Nura; Davies, Ian G.; Enright, Kevin] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England; [Alwan, Nura] Oxford Brookes Univ, Dept Sport & Hlth Sci, Oxford, England; [Moss, Samantha L.] Univ Chester, Dept Sport & Exercise Sci, Chester, Cheshire, England; [Elliott-Sale, Kirsty J.] Nottingham Trent Univ, Musculoskeletal Physiol Res Grp, Sport Hlth & Performance Enhancement Res Ctr, Nottingham, England	Liverpool John Moores University; Oxford Brookes University; University of Chester; Nottingham Trent University	Alwan, N (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England.; Alwan, N (corresponding author), Oxford Brookes Univ, Dept Sport & Hlth Sci, Oxford, England.	N.alwan@2016.ljmu.ac.uk	Davies, Ian/AAP-8249-2021; Enright, Kevin/A-5349-2011	Davies, Ian/0000-0003-3722-8466; Alwan, Nura/0000-0002-7033-6250; Enright, Kevin/0000-0003-1775-6392				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Alberga AS, 2018, J EAT DISORD, V6, DOI 10.1186/s40337-018-0227-x; Alwan N, 2019, INT J SPORT NUTR EXE, V29, P682, DOI 10.1123/ijsnem.2019-0037; Andersen RE., 1998, EAT DISORD, V6, P159; Artioli GG, 2010, MED SCI SPORT EXER, V42, P436, DOI 10.1249/MSS.0b013e3181ba8055; Chappell AJ, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0302-y; Chappell AJ, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0209-z; Chappell AJ, 2018, SPORTS, V6, DOI 10.3390/sports6040126; Dulloo AG, 2015, OBES REV, V16, P25, DOI 10.1111/obr.12253; Garigan TP, 1999, MIL MED, V164, P234, DOI 10.1093/milmed/164.3.234; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Gentil Paulo, 2017, Eur J Transl Myol, V27, P6247, DOI 10.4081/ejtm.2017.6247; Goldfield G. S., 1998, EATING DISORDERS, V6, P133, DOI DOI 10.1080/10640269808251249; Grogan S, 2004, J GENDER STUD, V13, P49, DOI 10.1080/0958923032000184970; Halliday TM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110740; Helms ER, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-20; Hoekstra R, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00137; Hulmi JJ, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00689; Hurst R, 2000, BRIT J SPORT MED, V34, P431, DOI 10.1136/bjsm.34.6.431; Khodaee M, 2015, CURR SPORT MED REP, V14, P435, DOI 10.1249/JSR.0000000000000206; Kong PL, 2015, J PSYCHOL, V149, P141, DOI 10.1080/00223980.2013.846291; Liamputtong, 2014, WOMEN SPORT PHYS ACT, V22, P24, DOI [10.1123/wspaj.2014-0008, DOI 10.1123/WSPAJ.2014-0008]; Longstrom Jaymes M, 2020, J Funct Morphol Kinesiol, V5, DOI 10.3390/jfmk5020027; Lowe MR, 2006, PHYSIOL BEHAV, V87, P487, DOI 10.1016/j.physbeh.2005.11.011; Mathisen TF, 2019, SPORTS, V7, DOI 10.3390/sports7110236; Mathisen TF, 2020, SCAND J MED SCI SPOR, V30, P135, DOI 10.1111/sms.13568; Mayr FB, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2011.06.029; Melin A, 2014, INT J SPORT NUTR EXE, V24, P450, DOI 10.1123/ijsnem.2014-0029; Miles-Chan JL, 2021, OBES REV, V22, DOI 10.1111/obr.13188; Mitchell L, 2017, SPORTS, V5, DOI 10.3390/sports5040076; Mitchell L, 2017, BODY IMAGE, V22, P1, DOI 10.1016/j.bodyim.2017.04.003; Money-Taylor E, 2022, SPORT SCI HLTH, V18, P67, DOI 10.1007/s11332-021-00775-2; Mountjoy M, 2018, BRIT J SPORT MED, V52, P687, DOI 10.1136/bjsports-2018-099193; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; Nolan D, 2022, J STRENGTH COND RES, V36, P405, DOI 10.1519/JSC.0000000000003488; Petrizzo J, 2017, INT J SPORT NUTR EXE, V27, P543, DOI 10.1123/ijsnem.2016-0313; Pickett TC, 2005, BRIT J SPORT MED, V39, P217, DOI 10.1136/bjsm.2004.012013; Reale R, 2018, INT J SPORT NUTR EXE, V28, P565, DOI 10.1123/ijsnem.2017-0183; Roberts BM, 2020, J HUM KINET, V71, P79, DOI 10.2478/hukin-2019-0096; Rohrig Brandon J, 2017, Int J Exerc Sci, V10, P301; Rosendahl J, 2009, SCAND J MED SCI SPOR, V19, P731, DOI 10.1111/j.1600-0838.2008.00821.x; SHEPHARD RJ, 1994, BRIT J SPORT MED, V28, P60, DOI 10.1136/bjsm.28.1.60-a; Sundgot-Borgen J, 2010, SCAND J MED SCI SPOR, V20, P112, DOI 10.1111/j.1600-0838.2010.01190.x; Sundgot-Borgen J, 2011, J SPORT SCI, V29, pS101, DOI 10.1080/02640414.2011.565783; SUNDGOTBORGEN J, 1993, INT J SPORT NUTR, V3, P29, DOI 10.1123/ijsn.3.1.29; Thiblin I, 2009, FORENSIC SCI INT, V184, pE7, DOI 10.1016/j.forsciint.2008.11.004; Tiggemann M, 2015, BODY IMAGE, V15, P61, DOI 10.1016/j.bodyim.2015.06.003; Tinsley GM, 2019, J STRENGTH COND RES, V33, P1823, DOI 10.1519/JSC.0000000000002758; Trexler ET, 2017, INT J SPORT NUTR EXE, V27, P458, DOI 10.1123/ijsnem.2017-0038; WALBERG JL, 1991, MED SCI SPORT EXER, V23, P30; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Whitehead J, 2020, EUR J SPORT SCI, V20, P1206, DOI 10.1080/17461391.2019.1698659	52	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262514	10.1371/journal.pone.0262514	http://dx.doi.org/10.1371/journal.pone.0262514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030218	gold, Green Accepted, Green Published			2022-12-26	WOS:000812798500051
J	Ahamed, MK; Ahmed, M; Karal, MA				Ahamed, Md. Kabir; Ahmed, Marzuk; Karal, Mohammad Abu Sayem			Quantification of pulsed electric field for the rupture of giant vesicles with various surface charges, cholesterols and osmotic pressures	PLOS ONE			English	Article							CELL-MEMBRANE ELECTROPERMEABILIZATION; INDUCED PORE FORMATION; TRANSIENT PORES; LIPID-BILAYERS; TENSION; ELECTROPORATION; PERMEABILIZATION; ELECTROCHEMOTHERAPY; TRANSITIONS; CAPACITANCE	Electropermeabilization is a promising phenomenon that occurs when pulsed electric field with high frequency is applied to cells/vesicles. We quantify the required values of pulsed electric fields for the rupture of cell-sized giant unilamellar vesicles (GUVs) which are prepared under various surface charges, cholesterol contents and osmotic pressures. The probability of rupture and the average time of rupture are evaluated under these conditions. The electric field changes from 500 to 410 Vcm(-1) by varying the anionic lipid mole fraction from 0 to 0.60 for getting the maximum probability of rupture (i.e., 1.0). In contrast, the same probability of rupture is obtained for changing the electric field from 410 to 630 Vcm(-1) by varying the cholesterol mole fraction in the membranes from 0 to 0.40. These results suggest that the required electric field for the rupture decreases with the increase of surface charge density but increases with the increase of cholesterol. We also quantify the electric field for the rupture of GUVs containing anionic mole fraction of 0.40 under various osmotic pressures. In the absence of osmotic pressure, the electric field for the rupture is obtained 430 Vcm(-1), whereas the field is 300 Vcm(-1) in the presence of 17 mOsmL(-1), indicating the instability of GUVs at higher osmotic pressures. These investigations open an avenue of possibilities for finding the electric field dependent rupture of cell-like vesicles along with the insight of biophysical and biochemical processes.	[Ahamed, Md. Kabir; Ahmed, Marzuk; Karal, Mohammad Abu Sayem] Bangladesh Univ Engn & Technol, Dept Phys, Dhaka, Bangladesh	Bangladesh University of Engineering & Technology (BUET)	Karal, MA (corresponding author), Bangladesh Univ Engn & Technol, Dept Phys, Dhaka, Bangladesh.	asayem221@phy.buet.ac.bd		Sayem Karal, Mohammad Abu/0000-0001-5288-2357; Ahmed, Marzuk/0000-0003-2322-7657; Ahamed, Md. Kabir/0000-0001-8245-8397	Ministry of Science and Technology, Bangladesh [39.00.0000.009.14.011.20-Phy's-566/1902]; Ministry of Education, Bangladesh [37.20.0000.004.033.020.2016.1053]; Information and Communication Technology Division (ICTD), (Ministry of Posts, Telecommunications and Information Technology), Bangladesh [56.00.0000.028.33.105.18-05]; Committee for Advanced Studies and Research (CASR) of Bangladesh University of Engineering and Technology (BUET), Bangladesh [DAERS/R01/CASR-339th/2021]	Ministry of Science and Technology, Bangladesh; Ministry of Education, Bangladesh; Information and Communication Technology Division (ICTD), (Ministry of Posts, Telecommunications and Information Technology), Bangladesh; Committee for Advanced Studies and Research (CASR) of Bangladesh University of Engineering and Technology (BUET), Bangladesh	This study was supported by the Ministry of Science and Technology, Bangladesh (No. 39.00.0000.009.14.011.20-Phy's-566/1902), Ministry of Education, Bangladesh (No. 37.20.0000.004.033.020.2016.1053), Information and Communication Technology Division (ICTD), (Ministry of Posts, Telecommunications and Information Technology), Bangladesh (No. 56.00.0000.028.33.105.18-05) and Committee for Advanced Studies and Research (CASR) of Bangladesh University of Engineering and Technology (BUET), Bangladesh (No. DAERS/R01/CASR-339th/2021) to Mohammad Abu Sayem Karal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ABIDOR IG, 1979, BIOELECTROCH BIOENER, V6, P37; Ahamed MK, 2020, EUR BIOPHYS J BIOPHY, V49, P371, DOI 10.1007/s00249-020-01440-1; Alwarawrah M, 2010, J PHYS CHEM B, V114, P7516, DOI 10.1021/jp101415g; Ambjornsson T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051916; Armstrong CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066162; Aronsson K, 2005, INT J FOOD MICROBIOL, V99, P19, DOI 10.1016/j.ijfoodmicro.2004.07.012; Aroush DRB, 2015, METHOD CELL BIOL, V125, P409, DOI 10.1016/bs.mcb.2014.11.005; Betterton MD, 1999, PHYS REV LETT, V82, P1598, DOI 10.1103/PhysRevLett.82.1598; Brown BH., 1998, MED PHYS BIOMEDICAL, V1st ed.; Cemazar M, 2010, CURR GENE THER, V10, P300, DOI 10.2174/156652310791823425; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; Chakraborty S, 2020, P NATL ACAD SCI USA, V117, P21896, DOI 10.1073/pnas.2004807117; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; CLARET B, 1973, J PHYSIOL-LONDON, V230, P87, DOI 10.1113/jphysiol.1973.sp010176; Cole KS, 1941, J GEN PHYSIOL, V24, P771, DOI 10.1085/jgp.24.6.771; Datta A, 2010, INTRO MODELING TRANS; de Meyer F, 2009, P NATL ACAD SCI USA, V106, P3654, DOI 10.1073/pnas.0809959106; Delemotte L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00097; Dimova R, 2009, SOFT MATTER, V5, P3201, DOI 10.1039/b901963d; Eid J, 2020, J PHYS CHEM B, V124, P6299, DOI 10.1021/acs.jpcb.0c04253; FREEMAN SA, 1994, BIOPHYS J, V67, P42, DOI 10.1016/S0006-3495(94)80453-9; Frey W, 2006, BIOPHYS J, V90, P3608, DOI 10.1529/biophysj.105.072777; Fricke H, 1925, J GEN PHYSIOL, V9, P153, DOI 10.1085/jgp.9.2.153; Golzio M, 2004, METHODS, V33, P126, DOI 10.1016/j.ymeth.2003.11.003; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Gowrishankar TR, 2003, P NATL ACAD SCI USA, V100, P3203, DOI 10.1073/pnas.0636434100; GROSSE C, 1992, BIOPHYS J, V63, P1632, DOI 10.1016/S0006-3495(92)81740-X; Heimburg T, 2012, BIOPHYS J, V103, P918, DOI 10.1016/j.bpj.2012.07.010; Hu Q, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032704; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P291, DOI 10.1016/B978-0-12-375182-9.10014-4; Ivorra A, 2010, PHYS CHEM CHEM PHYS, V12, P10055, DOI 10.1039/c004419a; Iwasa J., 2016, KARPS CELL MOL BIOL, V8 th ed.,; Jordan CA., 1989, ELECTROPORATION ELEC, DOI [10.1007/978-1-4899-2528-2, DOI 10.1007/978-1-4899-2528-2]; Karal MA, 2020, PROCEEDINGS OF 2020 11TH INTERNATIONAL CONFERENCE ON ELECTRICAL AND COMPUTER ENGINEERING (ICECE), P318, DOI 10.1109/ICECE51571.2020.9393089; Karal MA, 2019, EUR BIOPHYS J BIOPHY, V48, P731, DOI 10.1007/s00249-019-01398-9; Karal MA, 2019, EUR BIOPHYS J BIOPHY, V48, P349, DOI 10.1007/s00249-019-01363-6; Karal MA, 2016, PHYS CHEM CHEM PHYS, V18, P13487, DOI 10.1039/c6cp01184e; Karal MA, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012708; Karatekin E, 2003, BIOPHYS J, V84, P1734, DOI 10.1016/S0006-3495(03)74981-9; Kotnik T, 2019, ANNU REV BIOPHYS, V48, P63, DOI 10.1146/annurev-biophys-052118-115451; Laidler KJ., 1987, CHEM KINETICS, DOI [10.1016/s0076-6879(87)36008-2, DOI 10.1016/S0076-6879(87)36008-2]; Langus J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26409; Levadny V, 2013, LANGMUIR, V29, P3848, DOI 10.1021/la304662p; LITSTER JD, 1975, PHYS LETT A, VA 53, P193, DOI 10.1016/0375-9601(75)90402-8; Magarkar A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05005; Mahnic-Kalamiza S, 2014, J MEMBRANE BIOL, V247, P1279, DOI 10.1007/s00232-014-9737-x; Maton A, 1997, CELLS BUILDING BLOCK; Mir LM, 2006, EJC SUPPL, V4, P38, DOI 10.1016/j.ejcsup.2006.08.005; Mir LM, 1997, BRIT J CANCER, V76, P1617, DOI 10.1038/bjc.1997.606; Muralidharan A, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2020.183468; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; NEEDHAM D, 1989, BIOPHYS J, V55, P1001, DOI 10.1016/S0006-3495(89)82898-X; Portet T, 2012, J MEMBRANE BIOL, V245, P555, DOI 10.1007/s00232-012-9467-x; Portet T, 2010, BIOPHYS J, V99, P3264, DOI 10.1016/j.bpj.2010.09.032; Prathyusha KR, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.062413; Raicu V, 2015, DIELECTRIC RELAXATION IN BIOLOGICAL SYSTEMS: PHYSICAL PRINCIPLES, METHODS, AND APPLICATIONS, P1, DOI 10.1093/acprof:oso/9780199686513.001.0001; REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108; Rems L., 2017, ADV BIOMEMBRANES LIP, P1, DOI DOI 10.1016/BS.ABL.2017.06.001; Riske KA, 2005, BIOPHYS J, V88, P1143, DOI 10.1529/biophysj.104.050310; Riske KA, 2006, BIOPHYS J, V91, P1778, DOI 10.1529/biophysj.106.081620; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Saha SK, 2020, J PHYS CHEM B, V124, P5588, DOI 10.1021/acs.jpcb.0c03681; Sandre O, 1999, P NATL ACAD SCI USA, V96, P10591, DOI 10.1073/pnas.96.19.10591; Sarkar MK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251690; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Sens P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.128102; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Shibly SUA, 2016, BIOPHYS J, V111, P2190, DOI 10.1016/j.bpj.2016.09.043; Shoemaker SD, 2002, BIOPHYS J, V83, P2007, DOI 10.1016/S0006-3495(02)73962-3; Silve A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19957; Staykova M, 2008, SOFT MATTER, V4, P2168, DOI 10.1039/b811876k; Tamba Y, 2011, CHEM PHYS LIPIDS, V164, P351, DOI 10.1016/j.chemphyslip.2011.04.003; Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006; Teissie J., 2017, HDB ELECTROPORATION, P1, DOI DOI 10.1007/978-3-319-26779-1_77; Tsori Y, 2009, REV MOD PHYS, V81, P1471, DOI 10.1103/RevModPhys.81.1471; Uitert I van GacSL., 2010, SOFT MATTER, V6, P4420, DOI [10.1039/C0SM00181C, DOI 10.1039/C0SM00181C]; Usaj M, 2012, J MEMBRANE BIOL, V245, P583, DOI 10.1007/s00232-012-9470-2; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Weaver JC, 2012, BIOELECTROCHEMISTRY, V87, P236, DOI 10.1016/j.bioelechem.2012.02.007; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Zhao W, 2012, J AGR FOOD CHEM, V60, P12204, DOI 10.1021/jf304236h; ZHELEV DV, 1993, BIOCHIM BIOPHYS ACTA, V1147, P89, DOI 10.1016/0005-2736(93)90319-U; Zimmermann U., 1986, ELECT BREAKDOWN ELEC, V105, P175, DOI [10.1007/BFb0034499, DOI 10.1007/BFB0034499]; Zimmermann U., 1996, ELECTROMANIPULATION	85	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262555	10.1371/journal.pone.0262555	http://dx.doi.org/10.1371/journal.pone.0262555			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025973	Green Published, gold			2022-12-26	WOS:000796264200084
J	Bin Helayel, H; Ahmed, A; Ahmed, SK; Ahmad, A; Khan, R; Al-Swailem, SA				Bin Helayel, Halah; Ahmed, Anwar; Ahmed, Syed Khabir; Ahmad, Abeer; Khan, Ruhi; Al-Swailem, Samar A.			Quarantine-related traumatic stress, views, and experiences during the first wave of Coronavirus pandemic: A mixed-methods study among adults in Saudi Arabia	PLOS ONE			English	Article							HEALTH-CARE WORKERS; EAST RESPIRATORY SYNDROME; PSYCHOLOGICAL IMPACT; SARS; COVID-19; PERCEPTIONS; EPIDEMIC; OUTBREAK; TORONTO; EBOLA	Purpose Mental health is a significant problem following exposure to a traumatic event. This study aimed to examine quarantine-related experiences, traumatic stress, and coping strategies among adults quarantined in Saudi Arabia due to coronavirus disease 2019 (COVID-19) exposure or travel history. Methods Individuals aged >= 18 years who were quarantined in Saudi Arabia due to COVID-19 exposure or travel history were included. We used a sequential mixed methods design, using an online survey followed by in-depth individual telephonic interviews. The Impact of Event Scale-Revised (IES-R) was used to measure post-traumatic stress disorder (PTSD) symptoms after the quarantine. To identify factors associated with significant symptoms (IES-R score >= 33), prevalence ratios (PR) with 95% confidence intervals were computed using Poisson regression with robust error variance. In the next phase, a subset of the participants (n = 26) were interviewed to elicit their quarantine-related experiences and coping responses. Major themes and subthemes were identified. Results Of the 111 adults who completed the survey, 32 (28.8% [95% CI, 21.1-38.0%]) had significant PTSD symptoms (IES-R score >= 33) and 27 (24.3% [95% CI, 17.2-33.3%]) had severe symptoms (IES-R score > 37). Marital status was the only variable that was significantly associated with significant PTSD symptoms (P = 0.028). Significant symptoms were twice as prevalent in married adults than among other marital groups (PR 2.00, 95% CI, 1.08-3.72). Participants reported negative emotions such as overwhelming fear, helplessness, anxiety, and disgust. Participants utilized both problem-centered coping (e.g., use of social support) and emotion-centered coping (e.g., use of positive diversionary activities) during the quarantine period. Conclusion PTSD symptoms were present in one out of every four quarantined persons. The quarantine experience is viewed negatively. These findings highlight the need for increased awareness about stress-related disorders among quarantined individuals. Efforts are needed to detect and manage these symptoms early while making the quarantine experience more satisfying for the involved individuals and groups.	[Bin Helayel, Halah; Ahmed, Anwar; Ahmed, Syed Khabir; Ahmad, Abeer; Khan, Ruhi; Al-Swailem, Samar A.] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia	King Khaled Eye Specialist Hospital	Ahmed, A (corresponding author), King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia.	Anwarahmed991@gmail.com		Ahmed, Anwar/0000-0002-4797-8423; Ahmad, Khabir/0000-0002-1569-0628; HELAYEL, HALAH/0000-0003-2522-9234; Al-Swailem, Samar/0000-0002-1070-7232				Alkhamees AA, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152192; AlNajjar N S, 2017, East Mediterr Health J, V22, P817; Alshehri FS, 2020, SAUDI PHARM J, V28, P1666, DOI 10.1016/j.jsps.2020.10.013; Alsubaie S, 2019, J INFECT DEV COUNTR, V13, P920, DOI 10.3855/jidc.11753; Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Caleo G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5158-6; Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x; cdc, QUARANTINE ISOLATION; Chong MY, 2004, BRIT J PSYCHIAT, V185, P127, DOI 10.1192/bjp.185.2.127; Desclaux A, 2017, SOC SCI MED, V178, P38, DOI 10.1016/j.socscimed.2017.02.009; DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Fawaz M, 2020, INT J SOC PSYCHIATR, V66, P666, DOI 10.1177/0020764020932207; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Ifthikar Z, 2021, MIDDLE EAST CURR PSY, V28, DOI 10.1186/s43045-021-00127-3; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Kim EY, 2016, AM J INFECT CONTROL, V44, P1414, DOI 10.1016/j.ajic.2016.03.014; Kim HC, 2018, PSYCHIAT INVEST, V15, P355, DOI 10.30773/pi.2017.10.25.1; Lee Dong-Hun, 2016, [Korean Journal of Psychology: General, 한국심리학회지:일반], V35, P355, DOI 10.22257/kjp.2016.06.35.2.355; Lee S, 2005, SOC SCI MED, V61, P2038, DOI 10.1016/j.socscimed.2005.04.010; Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003; Mihashi M, 2009, HEALTH PSYCHOL, V28, P91, DOI 10.1037/a0013674; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; North Carol S, 2004, Ann Clin Psychiatry, V16, P209, DOI 10.1080/10401230490522034; North CS, 2004, J NERV MENT DIS, V192, P823, DOI 10.1097/01.nmd.0000146911.52616.22; Rattray J, 2007, J CLIN NURS, V16, P234, DOI 10.1111/j.1365-2702.2006.01573.x; Robertson E, 2004, CAN J PSYCHIAT, V49, P403; Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347; Temsah MH, 2020, J INFECT PUBLIC HEAL, V13, P877, DOI [10.1016/j.ijph.2020.05.021, 10.1016/j.jiph.2020.05.021]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wang YG, 2011, GEN HOSP PSYCHIAT, V33, P75, DOI 10.1016/j.genhosppsych.2010.11.001; Wester M, 2019, SCAND J PUBLIC HEALT, V47, P99, DOI 10.1177/1403494817753450; Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504; Xin MQ, 2020, AM PSYCHOL, V75, P607, DOI 10.1037/amp0000692	37	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261967	10.1371/journal.pone.0261967	http://dx.doi.org/10.1371/journal.pone.0261967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025910	Green Published, gold			2022-12-26	WOS:000796264200038
J	D'Ambrosi, F; Cesano, N; Iurlaro, E; Ronchi, A; Ramezzana, IG; Di Maso, M; Pietrasanta, C; Ronchi, A; Pugni, L; Ferrazzi, E				D'Ambrosi, Francesco; Cesano, Nicola; Iurlaro, Enrico; Ronchi, Alice; Ramezzana, Ilaria Giuditta; Di Maso, Matteo; Pietrasanta, Carlo; Ronchi, Andrea; Pugni, Lorenza; Ferrazzi, Enrico			Prelabor rupture of membranes at term: A possible hematological triage in addition to vagino-rectal beta-hemolytic streptococcus screening for early labor induction	PLOS ONE			English	Article							EXPECTANT MANAGEMENT; GUIDELINES; CHORIOAMNIONITIS; DIAGNOSIS	Introduction A potential complication of term prelabor rupture of membranes (term PROM) is chorioamnionitis with an increased burden on neonatal outcomes of chronic lung disease and cerebral palsy. The purpose of the study was to analyze the efficacy of a standing clinical protocol designed to identify women with term PROM at low risk for chorioamnionitis, who may benefit from expectant management, and those at a higher risk for chorioamnionitis, who may benefit from early induction. Material and methods This retrospective study enrolled all consecutive singleton pregnant women with term PROM. Subjects included women with at least one of the following factors: white blood cell count >= 15x100/mu L, C-reactive protein >= 1.5 mg/dL, or positive vaginal swab for beta-hemolytic streptococcus. These women comprised the high risk (HR) group and underwent immediate induction of labor by the administration of intravaginal dinoprostone. Women with none of the above factors and those with a low risk for chorioamnionitis waited for up to 24 hours for spontaneous onset of labor and comprised the low-risk (LR) group. Results Of the 884 consecutive patients recruited, 65 fulfilled the criteria for HR chorioamnionitis and underwent immediate induction, while 819 were admitted for expectant management. Chorioamnionitis and Cesarean section rates were not significantly different between the HR and LR groups. However, the prevalence of maternal fever (7.7% vs. 2.9%; p = 0.04) and meconium-stained amniotic fluid was significantly higher in the HR group than in LR group (6.1% vs. 2.2%; p = 0.04). This study found an overall incidence of 4.2% for chorioamnionitis, 10.9% for Cesarean section, 0.5% for umbilical artery blood pH < 7.10, and 1.9% for admission to the neonatal intensive care unit. Furthermore, no confirmed cases of neonatal sepsis were encountered. Conclusions A clinical protocol designed to manage, by immediate induction, only those women with term PROM who presented with High Risk factors for infection/inflammation achieved similar maternal and perinatal outcomes between such women and women without any risks who received expectant management. This reduced the need for universal induction of term PROM patients, thereby reducing the incidence of maternal and fetal complications without increasing the rate of Cesarean sections.	[D'Ambrosi, Francesco; Cesano, Nicola; Iurlaro, Enrico; Ronchi, Alice; Ramezzana, Ilaria Giuditta; Ferrazzi, Enrico] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Woman Child & Neonate, Obstert Unit, Milan, Italy; [Di Maso, Matteo] Univ Milan, Branch Med Stat Biometry & Epidemiol GA Maccacaro, Dept Clin Sci & Community Hlth, Milan, Italy; [Pietrasanta, Carlo; Ronchi, Andrea; Pugni, Lorenza] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neonatal Intens Care Unit, Milan, Italy; [Ferrazzi, Enrico] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	D'Ambrosi, F (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Woman Child & Neonate, Obstert Unit, Milan, Italy.	dambrosifr@gmail.com	Di Maso, Matteo/AAC-4816-2022	Di Maso, Matteo/0000-0002-6481-990X				[Anonymous], 2020, OBSTET GYNECOL, V135, pE80, DOI 10.1097/AOG.0000000000003700; Benitz WE, 2015, J PEDIATR-US, V166, P1070, DOI 10.1016/j.jpeds.2014.12.023; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Cahill AG, 2009, OBSTET GYNECOL, V114, P124, DOI 10.1097/AOG.0b013e3181aef106; Cotten CM, 2015, CLIN PERINATOL, V42, P195, DOI 10.1016/j.clp.2014.10.007; Davey MA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0869-0; Duff P, 1998, CLIN OBSTET GYNECOL, V41, P883, DOI 10.1097/00003081-199812000-00012; Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601; Higgins RD, 2016, OBSTET GYNECOL, V127, P426, DOI 10.1097/AOG.0000000000001246; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Krupa FD, 2005, BJOG-INT J OBSTET GY, V112, P1284, DOI 10.1111/j.1471-0528.2005.00700.x; Maqbool S., PAKISTAN J; MIDDLETON P, 2017, COCHRANE DB SYST REV; Ocviyanti D, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/4823404; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Romero R, 2019, J PERINAT MED, V47, P915, DOI 10.1515/jpm-2019-0297; Saccone G, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.034; SIGO, 2016, INDUZIONE TRAVAGLIO; Term Prelabour Rupture of Membranes (Term PROM), 2020, RANZCOG GUIDELINES; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003	21	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261906	10.1371/journal.pone.0261906	http://dx.doi.org/10.1371/journal.pone.0261906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025890	gold, Green Published			2022-12-26	WOS:000796264200033
J	Beraud, G; Timsit, JF; Leleu, H				Beraud, Guillaume; Timsit, Jean-Francois; Leleu, Henri			Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact	PLOS ONE			English	Article							FRANCE	Remdesivir and dexamethasone are the only drugs providing reductions in the lengths of hospital stays for COVID-19 patients. We assessed the impacts of remdesivir on hospital-bed resources and budgets affected by the COVID-19 outbreak. A stochastic agent-based model was combined with epidemiological data available on the COVID-19 outbreak in France and data from two randomized control trials. Strategies involving treating with remdesivir only patients with low-flow oxygen and patients with low-flow and high-flow oxygen were examined. Treating all eligible low-flow oxygen patients during the entirety of the second wave would have decreased hospital-bed occupancy in conventional wards by 4% [2%; 7%] and intensive care unit (ICU)-bed occupancy by 9% [6%; 13%]. Extending remdesivir use to high-flow-oxygen patients would have amplified reductions in ICU-bed occupancy by up to 14% [18%; 11%]. A minimum remdesivir uptake of 20% was required to observe decreases in bed occupancy. Dexamethasone had effects of similar amplitude. Depending on the treatment strategy, using remdesivir would, in most cases, generate savings (up to 722(sic)) or at least be cost neutral (an extra cost of 34(sic)). Treating eligible patients could significantly limit the saturation of hospital capacities, particularly in ICUs. The generated savings would exceed the costs of medications.	[Beraud, Guillaume] Univ Hosp Poitiers, Infect Dis Dept, Poitiers, France; [Timsit, Jean-Francois] Hop Xavier Bichat, APHP, Med & Infect Dis Intens Care Unit, Paris, France; [Timsit, Jean-Francois] Univ Paris Paris Diderot, IAME, UMR 1137, Paris, France; [Leleu, Henri] Publ Hlth Expertise, Paris, France	CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Beraud, G (corresponding author), Univ Hosp Poitiers, Infect Dis Dept, Poitiers, France.	beraudguillaume@gmail.com	Beraud, Guillaume/O-6062-2017	Beraud, Guillaume/0000-0002-4705-0916	GILEAD	GILEAD(Gilead Sciences)	HL is an employee of Public Health Expertise, which received funding from GILEAD for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence Technique de l'Information sur l'Hospitalisation, 2010, ET NAT COUTS; [Anonymous], REMDESIVIR COVID 19; Assurance Maladie, 2019, PERSONNES PRISES CHA; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bardet A., ESMO 2020 MIN OR SES; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bonaldi C, 2011, DIABETIC MED, V28, P583, DOI 10.1111/j.1464-5491.2011.03250.x; Chang R, 2020, MEDRXIV; Courtejoie N., 2020, DREES, P67; Efron B, 1998, INTRO BOOTSTRAP; Ferre A, 2012, RESP MED, V106, P467, DOI 10.1016/j.rmed.2011.12.002; FHF, 2 MILL EUR SUPPL ALL; GEODES, NUMB PERS HOSP COVID; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; GRENE-LEROUGE Nathalie, 2020, INSTRUCTION N DGSCOR; HAS, 2020, AV COMM TRANSP REMD; Hoertel N, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1001-6; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Insee, 2020, POPULATION TOTALE SE; INSERM, 2020, EPICOV; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kluge Stefan., 2020, AWMF; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Marijon E, 2020, LANCET PUBLIC HEALTH, V5, pE437, DOI 10.1016/S2468-2667(20)30117-1; NEULAT-ISARD Sabine, 2020, APM NEWS 0414; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Sante Publique France, 2020, COVIPREV; Sante Publique France, 2020, COVID 19 POINT EP HE; Schmidt M, 2021, INTENS CARE MED, V47, P60, DOI 10.1007/s00134-020-06294-x; Sprung CL, 2020, CRIT CARE MED, V48, P1196, DOI 10.1097/CCM.0000000000004410; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262462	10.1371/journal.pone.0262462	http://dx.doi.org/10.1371/journal.pone.0262462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020746	gold, Green Published, Green Submitted			2022-12-26	WOS:000834207700042
J	Horita, R; Nishio, A; Yamamoto, M				Horita, Ryo; Nishio, Akihiro; Yamamoto, Mayumi			Lingering effects of COVID-19 on the mental health of first-year university students in Japan	PLOS ONE			English	Article								Background The coronavirus disease 2019 (COVID-19) pandemic is continuing unabated in Japan, as of October 2021. We aimed to compare first-year university students' psychological distress before the pandemic in 2019, during the pandemic in 2020, and one year after the onset of the pandemic, in 2021. Methods The study conducted online surveys over three years from April to May each year. Participants were 400 first-year students in 2019, 766 in 2020, and 738 in 2021. We examined differences in scores on the Counseling Center Assessment of Psychological Symptoms- Japanese version (CCAPS-Japanese) between the three years using a one-way analysis of variance, and differences in the CCAPS-Japanese critical items using chi-squared test and residual analysis. Results The average scores on the Depression and Generalized Anxiety subscale in 2021 were significantly higher than those in 2020, but remained the same as in 2019. The Academic Distress subscale score in 2020 was the worst compared to 2019 and 2021. Meanwhile, the number of students who experienced severe suicidal ideation increased year by year from 2019 to 2021. Conclusion The mean mental health of first-year university students worsened after the onset of the COVID-19 pandemic, and recovered to the pre-pandemic level over the next two years. However, the number of high-risk students with suicidal ideation continued to increase. A system is required for early detection and support for students at high risk of mental health issues.	[Horita, Ryo; Nishio, Akihiro; Yamamoto, Mayumi] Gifu Univ, Hlth Adm Ctr, Gifu, Japan; [Horita, Ryo; Nishio, Akihiro; Yamamoto, Mayumi] Gifu Univ Hosp, Gifu, Japan; [Yamamoto, Mayumi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Gifu University; Gifu University; Gifu University	Horita, R (corresponding author), Gifu Univ, Hlth Adm Ctr, Gifu, Japan.; Horita, R (corresponding author), Gifu Univ Hosp, Gifu, Japan.	horita@gifu-u.ac.jp		Horita, Ryo/0000-0002-2922-9277	Japan Society for the Promotion of Science KAKENHI [JP19K14446]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant [grant number JP19K14446]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorsu DK, 2021, PSYCHOL RES BEHAV MA, V14, P1857, DOI 10.2147/PRBM.S333226; Arima M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043728; Cohen J.E., 1988, STAT POWER ANAL BEHA; Feng Y, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00587-y; Fruehwirth JC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247999; Fuse-Nagase Y, 2021, PSYCHIAT CLIN NEUROS, V75, P351, DOI 10.1111/pcn.13293; Fushimi M, 2021, PSYCHOL MED, DOI 10.1017/S0033291721001240; Hatabu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244350; Horita R, 2021, JPN PSYCHOL RES, DOI 10.1111/jpr.12345; Horita R, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113561; Horita R, 2020, CLIN PSYCHOL PSYCHOT, V27, P97, DOI 10.1002/cpp.2412; Japan's National Police Agency, 2021, NUMB SUIC VICT 2020; Lai AYK, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.584240; Locke BD, 2011, J COUNS PSYCHOL, V58, P97, DOI 10.1037/a0021282; Marashi MY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0239244; Marutani T, 2021, ASIAN J PSYCHIATR, V65, DOI 10.1016/j.ajp.2021.102803; Nishimura Y, 2021, J MED INTERNET RES, V23, DOI 10.2196/25232; Nomura K, 2021, ENVIRON HEALTH PREV, V26, DOI 10.1186/s12199-021-00953-1; Pirkis J, 2021, LANCET PSYCHIAT, V8, P579, DOI 10.1016/S2215-0366(21)00091-2; Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487; Sharma R, 2021, ASIAN J SOC HEAL BEH, V4, P98, DOI 10.4103/shb.shb_9_21; Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279; Tahara M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147245; Ueda M, 2022, J PUBLIC HEALTH-UK, V44, P541, DOI 10.1093/pubmed/fdab113; Villani L, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00680-w; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010	26	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262550	10.1371/journal.pone.0262550	http://dx.doi.org/10.1371/journal.pone.0262550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020752	Green Published, gold			2022-12-26	WOS:000834207700050
J	Tigabu, A; Beyene, Y; Getaneh, T; Chekole, B; Gebremaryam, T; Chanie, ES; Selomom, N; Alene, T; Aragie, G; Legas, G; Dessie, G				Tigabu, Agimasie; Beyene, Yeshiwork; Getaneh, Temesgen; Chekole, Bogale; Gebremaryam, Tigist; Chanie, Ermias Sisay; Selomom, Nigusie; Alene, Tamiru; Aragie, Getachew; Legas, Getasew; Dessie, Getnet			Incidence and predictors of anemia among adults on HIV care at South Gondar Zone Public General Hospital Northwest Ethiopia, 2020; retrospective cohort study	PLOS ONE			English	Article							PREVALENCE	Background Anemia is a major public health problem worldwide which accounts 24.8% of the population. Subsequently, anemia is a leading killer of people living with human immunodeficiency virus and many of these deaths occur in developing countries including Ethiopia. Cross sectional studies have done on anemia and human immunodeficiency virus. However, there is limited study on incidence of anemia and its predictors among adults on HIV care, especially no survival study has been conducted in the study area. Objective To assess incidence and predictors of anemia among adults on Human immunodeficiency virus care. Methods An institution-based retrospective cohort study was conducted among 434 adults on HIV care from January 1st 2015 to December 30th 2019 at Debre Tabor Referral Hospital. A computer-generated simple random sampling technique was employed to select the study participants. Ethical clearance was obtained from the Institutional Review Board of Bahir Dar University, and also, we got implied consent to review charts from the concerned bodies in the hospital. Data were entered using Epi-data version 3.1 and analyzed by using STATA version 14.0. A Kaplan Meier survival curve was utilized to estimate anemia free survival time. Bivariable and Multivariable Cox proportional hazards model were fitted to identify predictors of anemia. Results The overall incidence density rate of anemia was 6.27 (95% CI: 0.051, 0.077) per 100 person years. Clinical stage III/IV (AHR = 1.04; 95% CI = 1.02, 1.06), Body Mass Index less than 18.5 kg/m2 (AHR = 3.11; 95% CI = 1.56, 6.22), serum creatinine greater than 1.1 IU/L (AHR = 2.07; 95% CI = 1.12, 3.81) and fair/poor level of adherence(AHR = 1.05; 95% CI = 1.03, 1.07) were statistically significant predictors of anemia while increased anti-retroviral treatment duration (AHR = 0.98; 95% CI = 0.97, 0.99) decrease the risk of anemia at 95% confidence level. Conclusion The overall incidence density rate of anemia was high. Patients with clinical stage III/IV, body mass index < 18.5 kg/m(2), serum creatinine greater than 1.1 IU/L and fair/poor level of adherence were significant predictors of anemia while increased antiretroviral treatment duration had decreased the risk of anemia. Recommendation Even if the overall incidence rate of anemia was lower as compared to previous studies in Ethiopia, still the incidence of anemia was high. So, prevention measures should be taken beside with HIV care especially within 6-months ART initiation.	[Tigabu, Agimasie] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Adult Hlth Nursing, Nursing, Debre Tabor, Ethiopia; [Beyene, Yeshiwork; Dessie, Getnet] Bahir Dar Univ, Dept Adult Hlth Nursing, Sch Hlth Sci, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Getaneh, Temesgen] Debre Markos Univ, Dept Clin Midwife, Coll Med & Hlth Sci, Debre Markos, Ethiopia; [Chekole, Bogale] Wolkite Univ, Dept Pediat Nursing, Coll Med & Hlth Sci, Wolkite, Ethiopia; [Gebremaryam, Tigist] Debre Markos Univ, Dept Pediat Nursing, Coll Med & Hlth Sci, Debre Markos, Ethiopia; [Chanie, Ermias Sisay; Selomom, Nigusie; Aragie, Getachew] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Pediat Nursing, Debre Tabor, Ethiopia; [Alene, Tamiru] Wolaita Sodo Univ, Dept Pediat Nursing, Coll Med & Hlth Sci, Sodo, Ethiopia; [Legas, Getasew] Debre Tabor Univ, Dept Psychiat Nursing, Coll Med & Hlth Sci, Debre Tabor, Ethiopia	Bahir Dar University	Tigabu, A (corresponding author), Debre Tabor Univ, Coll Med & Hlth Sci, Dept Adult Hlth Nursing, Nursing, Debre Tabor, Ethiopia.	ethiomom23@gmail.com	Tibebu, Nigusie Selomon/AAH-6157-2021	Tibebu, Nigusie Selomon/0000-0002-5511-5812; Dessie, Getenet/0000-0001-7276-0891; Gebremaryam, Tigist/0000-0002-2191-435X; Tigabu, Agimasie/0000-0001-9085-9625; Legas, Getasew/0000-0002-1230-3952				Adamu AL, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0128-2; Ageru TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221853; Akilimali PZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140240; [Anonymous], 2011, BMC INFECT DIS, V11, P190; Assefa Muluken, 2015, BMC Hematol, V15, P6, DOI 10.1186/s12878-015-0024-6; Bhattad Dhiraj, 2013, J Assoc Physicians India, V61, P673; Brentlinger PE, 2016, AIDS RES HUM RETROV, V32, P12, DOI [10.1089/aid.2015.0030, 10.1089/AID.2015.0030]; De Benoist B, WORLDWIDE PREVALENCE; Denue Ballah Akawu, 2013, Infect Dis (Auckl), V6, P25, DOI 10.4137/IDRT.S10477; Federal Ministry of Health, 2017, NATL GUIDELINES COMP; Gebremedhin Ketema Bizuwork, 2019, Adv Hematol, V2019, P9614205, DOI 10.1155/2019/9614205; Gebreweld Angesom, 2018, Adv Hematol, V2018, P3942301, DOI 10.1155/2018/3942301; Gibellini Davide, 2013, World J Virol, V2, P91, DOI 10.5501/wjv.v2.i2.91; Gunda DW, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.26.8268; Ikunaiye N Y, 2018, Ann Ib Postgrad Med, V16, P115; Johannessen A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-190; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Llibre JM, 2015, AIDS REV, V17, P56; Manaye Y, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7901241; Martin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116263; Mata-Marin JA., 2017, NATL GUIDELINES COMP; Mata-Marin JA., 2016, WHO REVISED GUIDELIN; Mata-Marin Jose A, 2010, BMC Res Notes, V3, P230, DOI 10.1186/1756-0500-3-230; McClellan WM, 2005, EUR J CLIN INVEST, V35, P58, DOI 10.1111/j.1365-2362.2005.01532.x; Melese H, 2017, HIV AIDS-RES PALLIAT, V9, P25, DOI 10.2147/HIV.S121021; Mengesha Misganaw Birhaneselassie, 2019, BMC Hematol, V19, P1, DOI 10.1186/s12878-018-0133-0; Milkias H., 2013, J HIVAIDS INFECT DIS; Nabitaka VM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232419; Negesse Ayenew, 2018, BMC Hematol, V18, P32, DOI 10.1186/s12878-018-0127-y; Panwar Ajay., STUDY ANEMIA HUMAN I; Petraro P, 2016, AM J TROP MED HYG, V94, P384, DOI 10.4269/ajtmh.15-0587; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Ssali F., 2006, PREVALENCE INCIDENCE; Sullivan P, 2002, J INFECT DIS, V185, pS138, DOI 10.1086/340203; Tadesse S, J TROPICAL DIS; Takuva S, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/162950; Tamir Z, 2018, ETHIOP J HEALTH SCI, V28, P73, DOI 10.4314/ejhs.v28i1.9; Thai ACS, 2019, ANAEMIA ASSESSMENT C; who, DOLUTEGRAVIR DTG FIX; WHO, HEMOGLOBIN CONCENTRA; World Health Organisation (WHO), 2016, ANTIRETROVIRAL MED L; World Health Organization, 2016, GLOBAL HLTH SECTOR S; World Health Organization, 2013, CONSOLIDATED GUIDELI; Yesuf T, 2019, HIV AIDS-RES PALLIAT, V11, P211, DOI 10.2147/HIV.S209446; Zhou J., 2012, J INT AIDS SOC	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0259944	10.1371/journal.pone.0259944	http://dx.doi.org/10.1371/journal.pone.0259944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020736	gold, Green Published			2022-12-26	WOS:000834207700008
J	Przybyl, J; Spans, L; Ganjoo, K; Bui, N; Mohler, D; Norton, J; Poultsides, G; Debiec-Rychter, M; van de Rijn, M				Przybyl, Joanna; Spans, Lien; Ganjoo, Kristen; Bui, Nam; Mohler, David; Norton, Jeffrey; Poultsides, George; Debiec-Rychter, Maria; van de Rijn, Matt			Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma	PLOS ONE			English	Article								High-level amplification of MDM2 and other genes in the 12q13-15 locus is a hallmark genetic feature of well-differentiated and dedifferentiated liposarcomas (WDLPS and DDLPS, respectively). Detection of this genomic aberration in plasma cell-free DNA may be a clinically useful assay for non-invasive distinction between these liposarcomas and other retroperitoneal tumors in differential diagnosis, and might be useful for the early detection of disease recurrence. In this study, we performed shallow whole genome sequencing of cell-free DNA extracted from 10 plasma samples from 3 patients with DDLPS and 1 patient with WDLPS. In addition, we studied 31 plasma samples from 11 patients with other types of soft tissue tumors. We detected MDM2 amplification in cell-free DNA of 2 of 3 patients with DDLPS. By applying a genome-wide approach to the analysis of cell-free DNA, we also detected amplification of other genes that are known to be recurrently affected in DDLPS. Based on the analysis of one patient with DDLPS with longitudinal plasma samples available, we show that tracking MDM2 amplification in cell-free DNA may be potentially useful for evaluation of response to treatment. The patient with WDLPS and patients with other soft tissue tumors in differential diagnosis were negative for the MDM2 amplification in cell-free DNA. In summary, we demonstrate the feasibility of detecting amplification of MDM2 and other DDLPS-associated genes in plasma cell-free DNA using technology that is already routinely applied for other clinical indications. Our results may have clinical implications for improved diagnosis and surveillance of patients with retroperitoneal tumors.	[Przybyl, Joanna] McGill Univ, Dept Surg, Montreal, PQ, Canada; [Przybyl, Joanna] McGill Univ Hlth Ctr, Res Inst, Canc Res Program, Montreal, PQ, Canada; [Spans, Lien; Debiec-Rychter, Maria] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Spans, Lien; Debiec-Rychter, Maria] Univ Hosp Leuven, Leuven, Belgium; [Ganjoo, Kristen; Bui, Nam] Stanford Univ, Dept Med, Div Med Oncol, Stanford, CA 94305 USA; [Mohler, David] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Norton, Jeffrey; Poultsides, George] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [van de Rijn, Matt] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	McGill University; McGill University; KU Leuven; KU Leuven; University Hospital Leuven; Stanford University; Stanford University; Stanford University; Stanford University	Przybyl, J (corresponding author), McGill Univ, Dept Surg, Montreal, PQ, Canada.; Przybyl, J (corresponding author), McGill Univ Hlth Ctr, Res Inst, Canc Res Program, Montreal, PQ, Canada.	joanna.przybyl@mcgill.ca		van de Rijn, Matt/0000-0002-1909-9739; Przybyl, Joanna/0000-0002-8162-5226				Amant F, 2015, JAMA ONCOL, V1, P814, DOI 10.1001/jamaoncol.2015.1883; Bayindir B, 2015, EUR J HUM GENET, V23, P1286, DOI 10.1038/ejhg.2014.282; Binh MBN, 2007, AM J SURG PATHOL, V31, P1557, DOI 10.1097/PAS.0b013e31804b4109; Braig D, 2019, INT J CANCER, V145, P1148, DOI 10.1002/ijc.32216; Casadei L, 2019, CANCER RES, V79, P4911, DOI 10.1158/0008-5472.CAN-19-0203; Castriota G, 2007, CELL BIOL INT, V31, P586, DOI 10.1016/j.cellbi.2006.11.033; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Chibon F, 2004, GENE CHROMOSOME CANC, V40, P32, DOI 10.1002/gcc.20012; Coindre JM, 2010, VIRCHOWS ARCH, V456, P167, DOI 10.1007/s00428-009-0815-x; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Hemming ML, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00235; Lazar AJ, 2017, CELL, V171, P950, DOI 10.1016/j.cell.2017.10.014; Lee ATJ, 2018, J CLIN ONCOL, V36, P151, DOI 10.1200/JCO.2017.74.9598; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Matthyssens LE, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00004; Przybyl J, 2019, JCO PRECIS ONCOL, V3, DOI [10.1200/PO.18.00409, 10.1200/po.18.00409]; Przybyl J, 2018, CLIN CANCER RES, V24, P2688, DOI 10.1158/1078-0432.CCR-17-3704; Somaiah Neeta, 2018, Oncotarget, V9, P19891, DOI 10.18632/oncotarget.24924; Vandenberghe P, 2015, LANCET HAEMATOL, V2, pE55, DOI 10.1016/S2352-3026(14)00039-8	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262272	10.1371/journal.pone.0262272	http://dx.doi.org/10.1371/journal.pone.0262272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986184	gold, Green Published			2022-12-26	WOS:000765956200033
J	Sidhoum, AA; Dakpo, KH; Latruffe, L				Ait Sidhoum, Amer; Dakpo, K. Herve; Latruffe, Laure			Trade-offs between economic, environmental and social sustainability on farms using a latent class frontier efficiency model: Evidence for Spanish crop farms	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; TECHNICAL EFFICIENCY; DAIRY FARMS; CHEAP TALK; AGRICULTURE; IMPACT; TECHNOLOGY; BEHAVIOR; LEVEL; INEFFICIENCIES	This article studies trade-offs of farms in terms of economic sustainability (proxied here by technical efficiency), environmental sustainability (proxied here by farmers' commitment towards the environment) and social sustainability (proxied here by farmers' contribution to on farm well-being and communities' well-being). We use the latent class stochastic frontier model and create classes based on three separating variables, representing farms' environmental sustainability and social sustainability. The application to a sample of Spanish crop farms shows that more environmentally sustainable farms are likely to have lower levels of technical efficiency. However, improvements in social concerns, both towards own farm and the larger community, may lead to improved technical efficiency levels. In general, our study provides evidence of trade-offs for farms between economic sustainability and environmental sustainability, but also between environmental sustainability and social sustainability.	[Ait Sidhoum, Amer] Tech Univ Munich, Dept Agr Prod & Resource Econ, Freising Weihenstephan, Germany; [Ait Sidhoum, Amer] Nat Resources Inst Finland Luke, Business Econ, Helsinki, Finland; [Dakpo, K. Herve] Univ Paris Saclay, INRAE, AgroParisTech, Economie Publ, Thiverval Grignon, France; [Dakpo, K. Herve] Swiss Fed Inst Technol, Agr Econ & Policy Grp, Zurich, Switzerland; [Latruffe, Laure] Univ Bordeaux, INRAE, GREThA, Bordeaux, France	Technical University of Munich; Natural Resources Institute Finland (Luke); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux	Sidhoum, AA (corresponding author), Tech Univ Munich, Dept Agr Prod & Resource Econ, Freising Weihenstephan, Germany.; Sidhoum, AA (corresponding author), Nat Resources Inst Finland Luke, Business Econ, Helsinki, Finland.	amer.ait-sidhoum@luke.fi		AITSIDHOUM, Amer/0000-0001-7089-6242	Instituto Nacional de Investigaciones Agricolas (INIA) in Spain; European Regional Development Fund (ERDF), Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I + D + i) [RTA2012-00002-00-00]; Technical University of Munich (TUM)	Instituto Nacional de Investigaciones Agricolas (INIA) in Spain(Instituto de Investigacion Agropecuaria (INIA)); European Regional Development Fund (ERDF), Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I + D + i); Technical University of Munich (TUM)	The authors gratefully acknowledge financial support for data collection from Instituto Nacional de Investigaciones Agricolas (INIA) in Spain and from the European Regional Development Fund (ERDF), Plan Nacional de Investigacion Cienti ' fica, Desarrollo e Innovacion Tecnologica (I + D + i), Project Reference Number RTA2012-00002-00-00. This work is also supported by the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv A, 2006, EUR REV AGRIC ECON, V33, P49, DOI 10.1093/erae/jbi035; Aigner D., 1977, J ECONOMETRICS, V6, P21, DOI DOI 10.1016/0304-4076(77)90052-5; Allen P., 1991, American Journal of Alternative Agriculture, V6, P34, DOI 10.1017/S0889189300003787; Alvarez A, 2008, J DAIRY SCI, V91, P3693, DOI 10.3168/jds.2008-1123; Alvarez A, 2010, EUR REV AGRIC ECON, V37, P231, DOI 10.1093/erae/jbq015; [Anonymous], 2010, SUSTAINABLE AGR SYST, DOI DOI 10.17226/12832; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Battese G. E., 1995, EMPIR ECON, V20, P325, DOI DOI 10.1007/BF01205442; BATTESE GE, 1977, AUST J AGR ECON, V21, P169, DOI 10.1111/j.1467-8489.1977.tb00204.x; BATTESE GE, 1988, J ECONOMETRICS, V38, P387, DOI 10.1016/0304-4076(88)90053-X; Berre D, 2014, J ENVIRON MANAGE, V146, P235, DOI 10.1016/j.jenvman.2014.07.008; Bogetoft P, 2003, J PROD ANAL, V20, P243, DOI 10.1023/A:1027347616038; Bojnec S, 2008, IND MANAGE DATA SYST, V108, P258, DOI 10.1108/02635570810847617; Bostrom M, 2012, INT J SUST DEV WORLD, V19, P3, DOI 10.1080/13504509.2011.582891; BRAVOURETA BE, 1994, AGR ECON, V10, P27, DOI 10.1016/0169-5150(94)90037-X; Burton RJF, 2014, J ENVIRON MANAGE, V135, P19, DOI 10.1016/j.jenvman.2013.12.005; Chambers RG, 2018, EMPIR ECON, V54, P189, DOI 10.1007/s00181-016-1135-z; Chang HH, 2010, EUR REV AGRIC ECON, V37, P523, DOI 10.1093/erae/jbq032; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Chen Z, 2009, CHINA ECON REV, V20, P153, DOI 10.1016/j.chieco.2009.03.002; Chopin P, 2015, AGR SYST, V140, P26, DOI 10.1016/j.agsy.2015.08.006; Cillero MM, 2019, EUR REV AGRIC ECON, V46, P193, DOI 10.1093/erae/jby028; Cuesta RA, 2000, J PROD ANAL, V13, P139, DOI 10.1023/A:1017297831646; Cummings RG, 1999, AM ECON REV, V89, P649, DOI 10.1257/aer.89.3.649; Dakpo KH, 2021, J AGR ECON, V72, P760, DOI 10.1111/1477-9552.12422; Dempsey N, 2011, SUSTAIN DEV, V19, P289, DOI 10.1002/sd.417; Diazabakana A., REV FARM LEVEL INDIC; Dillard J., 2008, UNDERSTANDING SOCIAL; Duke JM, 2012, ECOL ECON, V74, P95, DOI 10.1016/j.ecolecon.2011.12.002; Edum-Fotwe FT, 2009, INT J PROJ MANAG, V27, P313, DOI 10.1016/j.ijproman.2008.04.003; Fare R., 1985, MEASUREMENT EFFICIEN, P1, DOI [10.1007/978-94-015-7721-2_1, DOI 10.1007/978-94-015-7721-2_1]; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Florax RJGM, 2005, EUR REV AGRIC ECON, V32, P441, DOI 10.1093/erae/jbi025; Garmendia E, 2010, ECOL ECON, V69, P1712, DOI 10.1016/j.ecolecon.2010.03.027; Govindan K, 2018, INT J PROD ECON, V200, P353, DOI 10.1016/j.ijpe.2016.09.003; Greene, 2002, ALTERNATIVE PANEL DA; Greene W, 2005, J ECONOMETRICS, V126, P269, DOI 10.1016/j.jeconom.2004.05.003; Guan ZF, 2006, AM J AGR ECON, V88, P644, DOI 10.1111/j.1467-8276.2006.00885.x; Guesmi B, 2012, SPAN J AGRIC RES, V10, P552, DOI 10.5424/sjar/2012103-462-11; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; Haggar J, 2017, ECOL INDIC, V79, P330, DOI 10.1016/j.ecolind.2017.04.023; Hansson H, 2020, EUR REV AGRIC ECON, V47, P1, DOI 10.1093/erae/jby042; Hensher DA, 2015, APPLIED CHOICE ANALYSIS, 2ND EDITION, P1, DOI 10.1017/CBO9781316136232; Huang HC, 2004, J PROD ANAL, V21, P277, DOI 10.1023/B:PROD.0000022094.39915.cf; Huijps K, 2010, EUR REV AGRIC ECON, V37, P553, DOI 10.1093/erae/jbq036; JONDROW J, 1982, J ECONOMETRICS, V19, P233, DOI 10.1016/0304-4076(82)90004-5; KALIRAJAN KP, 1994, OXFORD B ECON STAT, V56, P87; KALIRAJAN KP, 1990, J APPL ECONOM, V5, P75, DOI 10.1002/jae.3950050106; Kumbhakar, 2004, EMPIR ECON, V29, P169, DOI [10.1007/s00181-003-0184-2, DOI 10.1007/S00181-003-0184-2]; Lansink AO, 2002, EUR REV AGRIC ECON, V29, P51, DOI 10.1093/erae/29.1.51; Latruffe L, 2004, APPL ECON, V36, P1255, DOI 10.1080/0003684042000176793; Latruffe L., 2016, EU FP7 FLINT FARM LE, P1; Lebacq T, 2013, AGRON SUSTAIN DEV, V33, P311, DOI 10.1007/s13593-012-0121-x; Lusk JL, 2003, AM J AGR ECON, V85, P840, DOI 10.1111/1467-8276.00492; Manjunatha AV, 2013, LAND USE POLICY, V31, P397, DOI 10.1016/j.landusepol.2012.08.005; Mathijs E, 2001, REV ECON STAT, V83, P100, DOI 10.1162/003465301750160072; Mayen CD, 2010, AM J AGR ECON, V92, P181, DOI 10.1093/ajae/aap018; MEEUSEN W, 1977, INT ECON REV, V18, P435, DOI 10.2307/2525757; Mercade L., 2012, PRACTIQUES FERTILITZ; Michalos A.C., 2014, ENCY QUALITY LIFE RE; Murphy K., 2012, SCI PRACT POLICY, V8; Nielsen H.B., 2016, PACKAGE UCMINF; Phelan A, 2017, ECOL ECON, V131, P300, DOI 10.1016/j.ecolecon.2016.09.010; Pineiro V, 2020, NAT SUSTAIN, V3, P809, DOI 10.1038/s41893-020-00617-y; Rahman S, 2003, J ENVIRON MANAGE, V68, P183, DOI 10.1016/S0301-4797(03)00066-5; Roibas D, 2010, J DAIRY SCI, V93, P4366, DOI 10.3168/jds.2010-3135; Rosa-Schleich J, 2019, ECOL ECON, V160, P251, DOI 10.1016/j.ecolecon.2019.03.002; Sabiha NE, 2016, J ENVIRON MANAGE, V166, P84, DOI 10.1016/j.jenvman.2015.10.003; Sauer J., 2020, OECD FOOD AGR FISHER; Sauer J, 2013, APPL ECON, V45, P1461, DOI 10.1080/00036846.2011.617704; Seager T.P., 2008, BUS STRATEG ENVIRON, V17, P444, DOI [10.1002/bse.632, DOI 10.1002/BSE.632]; Serra T, 2009, J PROD ANAL, V31, P113, DOI 10.1007/s11123-008-0124-4; Sidhoum AA, 2020, EUR REV AGRIC ECON, V47, P200, DOI 10.1093/erae/jbz015; Spanish Ministry of Agriculture, 2010, BAL NITR AGR ESP AN; Ssebunya BR, 2019, ECOL ECON, V156, P35, DOI 10.1016/j.ecolecon.2018.09.004; Sydorovych O, 2009, RENEW AGR FOOD SYST, V24, P234, DOI 10.1017/S174217050999010X; Testa R, 2015, ECOL ENG, V83, P227, DOI 10.1016/j.ecoleng.2015.06.021; Upton M., 1987, European Review of Agricultural Economics, V14, P351, DOI 10.1093/erae/14.4.351; van Calker KJ, 2007, AGR SYST, V94, P205, DOI 10.1016/j.agsy.2006.08.006; Van Cauwenbergh N, 2007, AGR ECOSYST ENVIRON, V120, P229, DOI 10.1016/j.agee.2006.09.006; Vermeir I, 2008, ECOL ECON, V64, P542, DOI 10.1016/j.ecolecon.2007.03.007; Villalba D, 2019, AGR SYST, V173, P107, DOI 10.1016/j.agsy.2019.01.011; Yigitcanlar Tan, 2010, Sustainability, V2, P321, DOI 10.3390/su2010321; Zahm F, 2008, SUSTAIN DEV, V16, P271, DOI 10.1002/sd.380	84	2	2	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261190	10.1371/journal.pone.0261190	http://dx.doi.org/10.1371/journal.pone.0261190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007293	gold, Green Published			2022-12-26	WOS:000741060700002
J	Huang, K; Wang, CTRE; Vagts, C; Raguveer, V; Finn, PW; Perkins, DL				Huang, Kai; Wang, Catherine; Vagts, Christen; Raguveer, Vanitha; Finn, Patricia W.; Perkins, David L.			Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; INFLAMMASOMES; INFLAMMATION; PYROPTOSIS; REGULATORS	Hyperactive and damaging inflammation is a hallmark of severe rather than mild Coronavirus disease 2019 (COVID-19). To uncover key inflammatory differentiators between severe and mild COVID-19, we applied an unbiased single-cell transcriptomic analysis. We integrated two single-cell RNA-seq datasets with COVID-19 patient samples, one that sequenced bronchoalveolar lavage (BAL) cells and one that sequenced peripheral blood mononuclear cells (PBMCs). The combined cell population was then analyzed with a focus on genes associated with disease severity. The immunomodulatory long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 were highly differentially expressed between mild and severe patients in multiple cell types. Within those same cell types, the concurrent detection of other severity-associated genes involved in cellular stress response and apoptosis regulation suggests that the pro-inflammatory functions of these lncRNAs may foster cell stress and damage. Thus, NEAT1 and MALAT1 are potential components of immune dysregulation in COVID-19 that may provide targets for severity related diagnostic measures or therapy.	[Huang, Kai; Vagts, Christen; Finn, Patricia W.] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Dept Med, Chicago, IL USA; [Huang, Kai; Finn, Patricia W.; Perkins, David L.] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Wang, Catherine; Raguveer, Vanitha] Univ Illinois, Coll Med, Chicago, IL USA; [Finn, Patricia W.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Perkins, David L.] Univ Illinois, Div Nephrol, Dept Med, Chicago, IL USA; [Perkins, David L.] Univ Illinois, Dept Surg, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Finn, PW (corresponding author), Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Dept Med, Chicago, IL USA.; Finn, PW (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL USA.; Finn, PW (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA.	pwfinn@uic.edu		Finn, Patricia/0000-0001-6936-103X; Huang, Kai/0000-0003-2445-2696	National Heart, Lung, and Blood Institute [F30HL151182, T32HL144909, R01HL138628]; National Institute of Allergy and Infectious Diseases [U01AI132898]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Heart, Lung, and Blood Institute F30HL151182 (Kai Huang), T32HL144909 (Christen Vagts), R01HL138628 (Patricia W. Finn and David L. Perkins), and the National Institute of Allergy and Infectious Diseases U01AI132898 (David L. Perkins). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A., 2021, TOPGO ENRICHMENT ANA; Ali S, 2013, J IMMUNOL, V190, P3949, DOI 10.4049/jimmunol.1201015; Amodio N, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0606-4; Baller A, 2020, WHO2019NCOVCLINICAL2; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Biswas S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24907-w; Bittmann Stefan, 2020, J Clin Med Res, V12, P320, DOI 10.14740/jocmr4161; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cai LJ, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00656-8; Camper N, 2016, MUCOSAL IMMUNOL, V9, P669, DOI 10.1038/mi.2015.90; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Chang MY, 2017, AM J PHYSIOL-LUNG C, V313, pL1069, DOI 10.1152/ajplung.00353.2017; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Cui HC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124522; Du CX, 2016, INT J NANOMED, V11, P5871, DOI 10.2147/IJN.S114838; Evavold CL, 2018, J MOL BIOL, V430, P217, DOI 10.1016/j.jmb.2017.09.019; Farag NS, 2020, INT J BIOCHEM CELL B, V122, DOI 10.1016/j.biocel.2020.105738; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Freeman TL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01518; Garcia LF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01441; Gavin AL, 2018, NAT IMMUNOL, V19, P942, DOI 10.1038/s41590-018-0179-y; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Kapellos TS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02035; Laha S, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06395; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Li YH, 2020, OPEN MED-WARSAW, V15, P38, DOI 10.1515/med-2020-0007; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liu R, 2018, INT J MOL MED, V42, P2903, DOI 10.3892/ijmm.2018.3829; Masoumi F, 2019, J NEUROIMMUNOL, V328, P50, DOI 10.1016/j.jneuroim.2018.11.013; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; Menon MP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.569524; Meydan C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.590870; Mohr A, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1005; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Plowman T, 2021, NON-CODING RNA, V7, DOI 10.3390/ncrna7030054; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rodrigues AC, 2021, MOL ORAL MICROBIOL, V36, P291, DOI 10.1111/omi.12351; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Santofimia-Castano P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35020-3; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/NMETH.4612, 10.1038/nmeth.4612]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tang H, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.200; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Palomino DCT, 2015, EINSTEIN-SAO PAULO, V13, P469, DOI 10.1590/S1679-45082015RB3438; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van den Berg DF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01580; Vetter P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m627; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wang F, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02423-8; Wang L, 2019, J CELL PHYSIOL, V234, P5319, DOI 10.1002/jcp.27340; Wang L, 2019, CAN RESPIR J, V2019, DOI 10.1155/2019/1871394; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Wei L, 2019, MOL THER-NUCL ACIDS, V18, P285, DOI 10.1016/j.omtn.2019.05.009; Wei SB, 2019, INT J CLIN EXP PATHO, V12, P3311; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1101/2020.04.17.20069930, 10.1038/s41591-020-0944-y]; Yang QZ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.700184; Yap JKY, 2020, J IMMUNOL, V205, P307, DOI 10.4049/jimmunol.2000513; Yu SY, 2018, INT J CARDIOL, V254, P50, DOI 10.1016/j.ijcard.2017.10.071; Yue Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0917-y; Zaim S, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100618; Zhan JF, 2020, KIDNEY BLOOD PRESS R, V45, P589, DOI 10.1159/000508372; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x; Zhang PF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09482-6; Zhang XX, 2019, NUCLEIC ACIDS RES, V47, pD721, DOI 10.1093/nar/gky900; Zhao G, 2016, FEBS LETT, V590, P2884, DOI 10.1002/1873-3468.12315; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou Q, 2020, CYTOGENET GENOME RES, V160, P565, DOI 10.1159/000509811; Zietkiewicz E, 2019, AM J RESP CELL MOL, V61, P440, DOI 10.1165/rcmb.2018-0260OC; Zmijewski JW, 2020, ANESTH ANALG, V131, P989, DOI 10.1213/ANE.0000000000005140	86	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261242	10.1371/journal.pone.0261242	http://dx.doi.org/10.1371/journal.pone.0261242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007307	Green Published, gold, Green Submitted			2022-12-26	WOS:000741060700006
J	Berendam, SJ; Morgan-Asiedu, PK; Mangan, RJ; Li, SH; Heimsath, H; Luo, K; Curtis, AD; Eudailey, JA; Fox, CB; Tomai, MA; Phillips, B; Itell, HL; Kunz, E; Hudgens, M; Cronin, K; Wiehe, K; Alam, SM; Van Rompay, KKA; De Paris, K; Permar, SR; Moody, MA; Fouda, GG				Berendam, Stella J.; Morgan-Asiedu, Papa K.; Mangan, Riley J.; Li, Shuk Hang; Heimsath, Holly; Luo, Kan; Curtis, Alan D., II; Eudailey, Joshua A.; Fox, Christopher B.; Tomai, Mark A.; Phillips, Bonnie; Itell, Hannah L.; Kunz, Erika; Hudgens, Michael; Cronin, Kenneth; Wiehe, Kevin; Alam, S. Munir; Van Rompay, Koen K. A.; De Paris, Kristina; Permar, Sallie R.; Moody, M. Anthony; Fouda, Genevieve G.			Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS SIV; NEUTRALIZING ANTIBODIES; ANTIRETROVIRAL THERAPY; INFLUENZA VACCINE; ORAL CHALLENGE; IMMUNOGENICITY; SAFETY; WOMEN; TRIAL; ALVAC	Different HIV vaccine regimens elicit distinct plasma antibody responses in both human and nonhuman primate models. Previous studies in human and non-human primate infants showed that adjuvants influenced the quality of plasma antibody responses induced by pediatric HIV envelope vaccine regimens. We recently reported that use of the 3M052-SE adjuvant and longer intervals between vaccinations are associated with higher magnitude of antibody responses in infant rhesus macaques. However, the impact of different adjuvants in HIV vaccine regimens on the developing infant B cell receptor (BCR) repertoire has not been studied. This study evaluated whether pediatric HIV envelope vaccine regimens with different adjuvants induced distinct antigen-specific memory B cell repertoires and whether specific immunoglobulin (Ig) immunogenetic characteristics are associated with higher magnitude of plasma antibody responses in vaccinated infant rhesus macaques. We utilized archived preclinical pediatric HIV vaccine studies PBMCs and tissue samples from 19 infant rhesus macaques immunized either with (i) HIV Env protein with a squalene adjuvant, (ii) MVA-HIV and Env protein co-administered using a 3-week interval, (iii) MVA-HIV prime/protein boost with an extended 6-week interval between immunizations, or (iv) with HIV Env administered with 3M-052-SE adjuvant. Frequencies of vaccine-elicited HIV Env-specific memory B cells from PBMCs and tissues were similar across vaccination groups (frequency range of 0.06-1.72%). There was no association between vaccine-elicited antigen-specific memory B cell frequencies and plasma antibody titer or avidity. Moreover, the epitope specificity and Ig immunogenetic features of vaccine-elicited monoclonal antibodies did not differ between the different vaccine regimens. These data suggest that pediatric HIV envelope vaccine candidates with different adjuvants that previously induced higher magnitude and quality of plasma antibody responses in infant rhesus macaques were not driven by distinct antigen-specific memory BCR repertoires.	[Berendam, Stella J.; Morgan-Asiedu, Papa K.; Mangan, Riley J.; Li, Shuk Hang; Heimsath, Holly; Luo, Kan; Eudailey, Joshua A.; Itell, Hannah L.; Kunz, Erika; Cronin, Kenneth; Wiehe, Kevin; Alam, S. Munir; Permar, Sallie R.; Moody, M. Anthony; Fouda, Genevieve G.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Curtis, Alan D., II; Phillips, Bonnie; De Paris, Kristina] Univ N Carolina, Sch Med, Childrens Res Inst, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Curtis, Alan D., II; Phillips, Bonnie; De Paris, Kristina] Univ N Carolina, Sch Med, Ctr AIDS Res, Chapel Hill, NC 27515 USA; [Eudailey, Joshua A.; Permar, Sallie R.] Weill Cornell Coll Med, Dept Pediat, New York, NY USA; [Fox, Christopher B.] Infect Dis Res Inst IDRI, Seattle, WA USA; [Fox, Christopher B.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Tomai, Mark A.] 3 M Drug Delivery Syst, 3M Ctr, St Paul, MN USA; [Hudgens, Michael] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Washington; University of Washington Seattle; 3M; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis	Fouda, GG (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA.	genevieve.fouda@duke.edu		Morgan-Asiedu, Papa Kwadwo/0000-0001-5622-524X	National Institute of Allergy and Infectious Diseases (NIAID) [P01 AI117915]; Office of Research Infrastructure Program, Office of The Director, NIH [P51OD011107]; Interdisciplinary Research and Training Program in AIDS from NIAID [5T32AI007392-32]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research Infrastructure Program, Office of The Director, NIH; Interdisciplinary Research and Training Program in AIDS from NIAID	This work was supported by grant P01 AI117915 from the National Institute of Allergy and Infectious Diseases (NIAID) to KDP and SRP, and P51OD011107 (Office of Research Infrastructure Program, Office of The Director, NIH) to California National Primate Research Center (CNPRC). SJB is supported by the Interdisciplinary Research and Training Program in AIDS (5T32AI007392-32) to Duke University from NIAID.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Belshe RB, 2001, J INFECT DIS, V183, P1343, DOI 10.1086/319863; Bernat NV, 2021, IMMUNITY, V54, P355, DOI 10.1016/j.immuni.2020.12.018; Brochu HN, 2020, J IMMUNOL, V204, P3434, DOI 10.4049/jimmunol.1901256; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Dai KF, 2015, MBIO, V6, DOI 10.1128/mBio.01375-15; DOLIN R, 1991, ANN INTERN MED, V114, P119, DOI 10.7326/0003-4819-114-2-119; Dowling DJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91020; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Fouda GG, 2015, J INFECT DIS, V211, P508, DOI 10.1093/infdis/jiu444; Gao Y, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040167; Goo L, 2014, NAT MED, V20, P655, DOI 10.1038/nm.3565; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Holbrook BC, 2018, IMMUNOLOGY, V153, P357, DOI 10.1111/imm.12845; Holbrook BC, 2017, VACCINE, V35, P6137, DOI 10.1016/j.vaccine.2017.09.054; Holbrook BC, 2016, J IMMUNOL, V197, P555, DOI 10.4049/jimmunol.1600497; Johnson DC, 2005, J INFECT DIS, V192, P2129, DOI 10.1086/498163; Kaleebu P, 2014, JAIDS-J ACQ IMM DEF, V65, P268, DOI 10.1097/01.qai.0000435600.65845.31; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Kintu K, 2013, JAIDS-J ACQ IMM DEF, V63, P1, DOI 10.1097/QAI.0b013e31827f1c2d; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Luo K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88522; McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45; NIoHN, 2020, EXP HIV VACC REG IN; Organization WH, HIV AIDS 2019; Phillips B, 2018, J VIROL, V92, DOI 10.1128/JVI.01051-18; Phillips B, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00231-17; Ramesh A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01407; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Siberry GK, 2014, PEDIATR REV, V35, P268, DOI 10.1542/pir.35-7-268; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIS, 2016, PREV GAP REP; Van Rompay KKA, 2005, JAIDS-J ACQ IMM DEF, V38, P124, DOI 10.1097/00126334-200502010-00002; Van Rompay KKA, 2003, J VIROL, V77, P179, DOI 10.1128/JVI.77.1.179-190.2003; Vigdorovich V, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.42; Wiehe K, 2014, IMMUNITY, V41, P909, DOI 10.1016/j.immuni.2014.11.014; Wright PF, 1999, J INFECT DIS, V180, P1080, DOI 10.1086/314985; Zhang W, 2019, J IMMUNOL, V202, P1612, DOI 10.4049/jimmunol.1800342	43	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0256885	10.1371/journal.pone.0256885	http://dx.doi.org/10.1371/journal.pone.0256885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972105	Green Submitted, Green Published, gold			2022-12-26	WOS:000773555700005
J	Zoccolotti, JD; Cavalheiro, AJ; Tasso, CO; Ribas, BR; Ferrisse, TM; Jorge, JH				Zoccolotti, Jacqueline de Oliveira; Cavalheiro, Alberto Jose; Tasso, Camilla Olga; Ribas, Beatriz Ribeiro; Ferrisse, Tulio Morandin; Jorge, Janaina Habib			Antimicrobial efficacy and biocompatibility of extracts from Cryptocarya species	PLOS ONE			English	Article							DENTURE STOMATITIS; FLAVONOID GLYCOSIDES; ALKALOIDS; BIOFILMS; MANAGEMENT; ETIOLOGY; SUSCEPTIBILITY; STYRYLPYRONES; COLONIZATION; EPIDEMIOLOGY	This study evaluated the efficacy of Cryptocarya spp extracts on biofilm of Candida albicans and its biocompatibility. Mature biofilm of C. albicans was formed on denture base acrylic resin samples and the fungicidal effect of the extracts was evaluated by Alamar Blue (R) assay, counting colony-forming units (CFU/mL) and confocal laser scanning microscopy (CLSM). Cytotoxicity of extracts from Cryptocarya species was evaluated by AlamarBlue (R) assay, using normal oral keratinocytes (NOK) cells. In additional, Analysis of plant extracts by ultra-high-performance liquid chromatography-diode array detector-tandem mass spectrometry (UPLC-DAD-MS) was performed. The results showed significant reduction in the cellular metabolism and in the number of CFU/mL of C. albicans (p<0.05). The concentration of 0.045 g/mL completely inhibited the number of CFU/mL. Regarding cytotoxicity, all extracts decreased cell viability compared to the control group. CLSM analysis showed predominance of live cells, but with a great difference between the groups. Antimicrobial activity of extracts from Cryptocarya on C. albicans biofilm was confirmed. However, all extracts showed toxicity on NOK cells.	[Zoccolotti, Jacqueline de Oliveira; Tasso, Camilla Olga; Ribas, Beatriz Ribeiro; Ferrisse, Tulio Morandin; Jorge, Janaina Habib] Sao Paulo State Univ Unesp, Sch Dent, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil; [Cavalheiro, Alberto Jose] Sao Paulo State Univ Unesp, Inst Chem, Dept Biochem & Organ Chem, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Jorge, JH (corresponding author), Sao Paulo State Univ Unesp, Sch Dent, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil.	habib.jorge@unesp.br	Jorge, Janaina Habib/Q-2197-2019; Ferrisse, Túlio Morandin/ABB-5885-2020	Jorge, Janaina Habib/0000-0002-9135-3455; Ferrisse, Túlio Morandin/0000-0002-9933-2819; Ribas, Beatriz/0000-0001-6763-7258	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [88887.513643/2020-00]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The author Jacqueline de Oliveira Zoccolotti received a doctoral scholarship by the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Brasil (CAPES) -Finance Code 88887.513643/2020-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Brasil (CAPES) -Finance Code 88887.513643/2020-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awang K, 2008, FITOTERAPIA, V79, P308, DOI 10.1016/j.fitote.2007.11.025; Bandeira KF, 2009, CHROMATOGRAPHIA, V70, P1455, DOI 10.1365/s10337-009-1338-y; Belazi M, 2004, ORAL MICROBIOL IMMUN, V19, P347, DOI 10.1111/j.1399-302x.2004.00165.x; Calcaterra R, 2013, INT J IMMUNOPATH PH, V26, P239, DOI 10.1177/039463201302600125; Sugio CYC, 2020, J FUNGI, V6, DOI 10.3390/jof6020070; Cavalheiro AJ, 2000, PHYTOCHEMISTRY, V53, P811, DOI 10.1016/S0031-9422(99)00532-4; Chang HS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1073-5; Chang WT, 1998, PHYTOCHEMISTRY, V48, P119, DOI 10.1016/S0031-9422(97)01102-3; De Andrade PM, 2018, AN ACAD BRAS CIENC, V90, P2671, DOI 10.1590/0001-3765201820170332; Panariello BHD, 2016, AM J DENT, V29, P154; Dongari-Bagtzoglou A, 2009, ORAL MICROBIOL IMMUN, V24, P249, DOI 10.1111/j.1399-302X.2009.00505.x; DorockaBobkowska B, 1996, J ORAL PATHOL MED, V25, P411, DOI 10.1111/j.1600-0714.1996.tb00288.x; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Feng R, 2013, PHYTOCHEMISTRY, V90, P147, DOI 10.1016/j.phytochem.2013.01.009; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Giocondo M. P., 2009, Revista de Ciencias Farmaceuticas Basica e Aplicada, V30, P315; Gulati M, 2016, MICROBES INFECT, V18, P310, DOI 10.1016/j.micinf.2016.01.002; Hannah Victoria Elizabeth, 2017, Prim Dent J, V6, P46, DOI 10.1308/205016817822230175; Hellstein JW, 2019, HEAD NECK PATHOL, V13, P25, DOI 10.1007/s12105-019-01004-6; Hertiani T, 2019, PAK J PHARM SCI, V32, P1519; Hilgert JB, 2016, J AM GERIATR SOC, V64, P2539, DOI 10.1111/jgs.14399; Huang Hurng-Wern, 2014, ScientificWorldJournal, V2014, P180462, DOI 10.1155/2014/180462; Huang W, 2014, PLANTA MED, V80, P925, DOI 10.1055/s-0034-1368613; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; Lamfon H, 2005, FEMS MICROBIOL LETT, V242, P345, DOI 10.1016/j.femsle.2004.11.032; Lin FW, 2002, CHEM PHARM BULL, V50, P157, DOI 10.1248/cpb.50.157; Lin FW, 2001, CHEM PHARM BULL, V49, P1292, DOI 10.1248/cpb.49.1292; Maciel AJ, 2019, CHEM BIODIVERS, V16, DOI 10.1002/cbdv.201900204; Makarasen A, 2011, PLANTA MED, V77, P1519, DOI 10.1055/s-0030-1270743; Nasrullah AA, 2013, MOLECULES, V18, P8009, DOI 10.3390/molecules18078009; Nehme CJ, 2005, PHYTOCHEM ANALYSIS, V16, P93, DOI 10.1002/pca.818; Nehme CJ, 2008, BIOCHEM SYST ECOL, V36, P602, DOI 10.1016/j.bse.2008.05.001; Perlin DS, 2017, LANCET INFECT DIS, V17, pE383, DOI 10.1016/S1473-3099(17)30316-X; Queiroz MMF, 2014, PHYTOCHEM LETT, V10, pLXXXVIII, DOI 10.1016/j.phytol.2014.08.013; Reddy DK, 2010, EUR J MED CHEM, V45, P4657, DOI 10.1016/j.ejmech.2010.07.036; Ricardo MAG, 2004, ARKIVOC, P127, DOI 10.3998/ark.5550190.0005.616; Silva S, 2010, CURR MICROBIOL, V61, P534, DOI 10.1007/s00284-010-9649-7; Silva S, 2009, MED MYCOL, V47, P681, DOI 10.3109/13693780802549594; Toribio A, 2006, ORG LETT, V8, P3825, DOI 10.1021/ol061435f; Webb BC, 1998, AUST DENT J, V43, P160, DOI 10.1111/j.1834-7819.1998.tb00157.x; Webb BC, 1998, AUST DENT J, V43, P45, DOI 10.1111/j.1834-7819.1998.tb00152.x; Wu TS, 2001, J NAT PROD, V64, P1404, DOI 10.1021/np010258i; Xiong RQ, 2021, NAT PROD RES, V35, P1019, DOI 10.1080/14786419.2019.1611808; Zonaro VA., 2016, THESIS U ESTADUAL PA	45	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261884	10.1371/journal.pone.0261884	http://dx.doi.org/10.1371/journal.pone.0261884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972152	Green Published, gold			2022-12-26	WOS:000773555700065
J	Baradaran-Heravi, A; Bauer, CC; Pickles, IB; Hosseini-Farahabadi, S; Balgi, AD; Choi, K; Linley, DM; Beech, DJ; Roberge, M; Bon, RS				Baradaran-Heravi, Alireza; Bauer, Claudia C.; Pickles, Isabelle B.; Hosseini-Farahabadi, Sara; Balgi, Aruna D.; Choi, Kunho; Linley, Deborah M.; Beech, David J.; Roberge, Michel; Bon, Robin S.			Nonselective TRPC channel inhibition and suppression of aminoglycoside-induced premature termination codon readthrough by the small molecule AC1903	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE DILATION; NONSENSE MUTATIONS; CELLS; ANTIBIOTICS; POTENT; DISCOVERY; (-)-ENGLERIN; PERMEABILITY; SELECTIVITY; SKELETAL	Nonsense mutations, which occur in X11% of patients with genetic disorders, introduce premature termination codons (PTCs) that lead to truncated proteins and promote nonsense mediated mRNA decay. Aminoglycosides such as G418 permit PTC readthrough and so may be used to address this problem. However, their effects are variable between patients, making clinical use of aminoglycosides challenging. In this study, we tested whether TRPC nonselective cation channels contribute to the variable PTC readthrough effect of aminoglycosides by controlling their cellular uptake. Indeed, a recently reported selective TRPC5 inhibitor, AC1903, consistently suppressed G418 uptake and G418-induced PTC readthrough in the DMS114 cancer cell line and junctional epidermolysis bullosa (JEB) patient-derived keratinocytes. Interestingly, the effect of AC1903 in DMS-114 cells was mimicked by nonselective TRPC inhibitors, but not by well-characterized inhibitors of TRPC1/ 4/5 (Pico145, GFB-8438) or TRPC3/6/7 (SAR7334), suggesting that AC1903 may work through additional or undefined targets. Indeed, in our experiments, AC1903 inhibited multiple TRPC channels including TRPC3, TRPC4, TRPC5, TRPC6, TRPC4-C1, and TRPC5-C1, as well as endogenous TRPC1:C4 channels in A498 renal cancer cells, all with low micromolar IC50 values (1.8-18 mu M). We also show that AC1903 inhibited TRPV4 channels, but had weak or no effects on TRPV1 and no effect on the nonselective cation channel PIEZO1. Our study reveals that AC1903 has previously unrecognized targets, which need to be considered when interpreting results from experiments with this compound. In addition, our data strengthen the hypothesis that nonselective calcium channels are involved in aminoglycoside uptake.	[Baradaran-Heravi, Alireza; Hosseini-Farahabadi, Sara; Balgi, Aruna D.; Choi, Kunho; Roberge, Michel] Univ British Columbia, Life Sci Inst, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Bauer, Claudia C.; Pickles, Isabelle B.; Linley, Deborah M.; Beech, David J.; Bon, Robin S.] Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, Discovery & Translat Sci Dept, Leeds, W Yorkshire, England; [Pickles, Isabelle B.] Univ Leeds, Sch Chem, Leeds, W Yorkshire, England; [Bon, Robin S.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of British Columbia; University of Leeds; University of Leeds; University of Leeds	Baradaran-Heravi, A (corresponding author), Univ British Columbia, Life Sci Inst, Dept Biochem & Mol Biol, Vancouver, BC, Canada.; Bon, RS (corresponding author), Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, Discovery & Translat Sci Dept, Leeds, W Yorkshire, England.; Bon, RS (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	abara@mail.ubc.ca; r.bon@leeds.ac.uk		Bon, Robin/0000-0003-1733-3680	ERA-Net E-RARE grant funded by the Canadian Institute for Health Research [ERT-155725]; BBSRC [BB/P020208/1]; BHF [PG/19/2/34084]; Wellcome Trust [102174/B/13/Z]	ERA-Net E-RARE grant funded by the Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF(British Heart Foundation); Wellcome Trust(Wellcome Trust)	This work was supported by an ERA-Net E-RARE grant funded by the Canadian Institute for Health Research (ERT-155725 to M. R.) , the BBSRC (BB/P020208/1 to D. J. B. and R. S. B.) , the BHF (PG/19/2/34084 to D. J. B. and R. S. B.) , and a Wellcome Trust PhD studentship (102174/B/13/Z) to I. B. P.	A. D.Protopopova, 2020, bioRxiv, DOI 10.1101/2020.08.10.242008; Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Arakawa M, 2003, J BIOCHEM, V134, P751, DOI 10.1093/jb/mvg203; Arboit A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020365; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Baradaran-Heravi A., 2021, NUCLEIC ACIDS RES, V49, P3692, DOI DOI 10.1093/NAR/GKAB194; Baradaran-Heravi A, 2016, NUCLEIC ACIDS RES, V44, P6583, DOI 10.1093/nar/gkw638; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Baudel MASMA, 2020, J PHYSIOL-LONDON, V598, P3911, DOI 10.1113/JP279947; Bauer CC, 2020, RSC CHEM BIOL, V1, P436, DOI 10.1039/d0cb00126k; Bautista D, 2008, NAT NEUROSCI, V11, P528, DOI 10.1038/nn0508-528; Bean BP, 2015, NAT NEUROSCI, V18, P1534, DOI 10.1038/nn.4148; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Blum T, 2019, P NATL ACAD SCI USA, V116, P15236, DOI 10.1073/pnas.1905705116; Bon RS, 2022, ANNU REV PHARMACOL, V62, P427, DOI 10.1146/annurev-pharmtox-030121-122314; Bon RS, 2013, BRIT J PHARMACOL, V170, P459, DOI 10.1111/bph.12274; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; BURKE JF, 1985, NUCLEIC ACIDS RES, V13, P6265, DOI 10.1093/nar/13.17.6265; Cheung M, 2017, ACS MED CHEM LETT, V8, P549, DOI 10.1021/acsmedchemlett.7b00094; Cheung Sin Ying, 2018, Oncotarget, V9, P29634, DOI 10.18632/oncotarget.25659; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Du LT, 2013, MOL THER, V21, P1653, DOI 10.1038/mt.2013.150; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Elbaz Mohamad, 2018, Oncotarget, V9, P33459, DOI 10.18632/oncotarget.9663; Ferguson MW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216423; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; Gatti RA, 2012, ANN NY ACAD SCI, V1250, P33, DOI 10.1111/j.1749-6632.2012.06467.x; Guthrie OW, 2008, TOXICOLOGY, V249, P91, DOI 10.1016/j.tox.2008.04.015; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; Hashino E, 1997, BRAIN RES, V777, P75, DOI 10.1016/S0006-8993(97)00977-3; Hong C, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2019.118620; Hong C, 2015, BRAIN, V138, P3030, DOI 10.1093/brain/awv188; Just S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191225; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Lee JH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.25; Lepannetier S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00318; Li MF, 2015, NAT NEUROSCI, V18, P1577, DOI 10.1038/nn.4120; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Ludlow MJ, 2017, J BIOL CHEM, V292, P723, DOI 10.1074/jbc.M116.755678; Maier T, 2015, BRIT J PHARMACOL, V172, P3650, DOI 10.1111/bph.13151; Makabe A, 2020, JARO-J ASSOC RES OTO, V21, P137, DOI 10.1007/s10162-020-00746-3; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Martin N., 2018, ERJ OPEN RES, V4, P00080; Martorell L, 2020, HAEMATOLOGICA, V105, P508, DOI 10.3324/haematol.2018.212118; Minard A, 2019, BRIT J PHARMACOL, V176, P3924, DOI 10.1111/bph.14791; Minard A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060052; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Munns CH, 2015, J BIOL CHEM, V290, P5707, DOI 10.1074/jbc.M114.597435; Muraki K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17303-3; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Nabissi M, 2013, CARCINOGENESIS, V34, P48, DOI 10.1093/carcin/bgs328; Naylor J, 2016, BRIT J PHARMACOL, V173, P562, DOI 10.1111/bph.13387; Ningoo M., 2021, J BIOL CHEM, V296; Rode B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00429-3; Roden DM, 2019, LANCET, V394, P521, DOI 10.1016/S0140-6736(19)31276-0; Rubaiy HN, 2018, BRIT J PHARMACOL, V175, P3361, DOI 10.1111/bph.14379; Rubaiy HN, 2017, J BIOL CHEM, V292, P8158, DOI 10.1074/jbc.M116.773556; Sharma SH, 2019, BIOORG MED CHEM LETT, V29, P155, DOI 10.1016/j.bmcl.2018.12.007; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; SINGH A, 1979, NATURE, V277, P146, DOI 10.1038/277146a0; Song KC, 2021, ELIFE, V10, DOI 10.7554/eLife.63429; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Wang HB, 2020, PHARMACOL THERAPEUT, V209, DOI 10.1016/j.pharmthera.2020.107497; Wargo Kurt A, 2014, J Pharm Pract, V27, P573, DOI 10.1177/0897190014546836; Wright DJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01437-8; Yerna X, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051712; Yu ML, 2019, ACS MED CHEM LETT, V10, P1579, DOI 10.1021/acsmedchemlett.9b00430; Zhou Y, 2017, SCIENCE, V358, P1332, DOI 10.1126/science.aal4178; Zilberberg A, 2010, GUT, V59, P496, DOI 10.1136/gut.2008.169805; Zubcevic L, 2018, NAT STRUCT MOL BIOL, V25, P405, DOI 10.1038/s41594-018-0059-z	80	3	3	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101546	10.1016/j.jbc.2021.101546	http://dx.doi.org/10.1016/j.jbc.2021.101546			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1QM	34999117	gold, Green Published			2022-12-26	WOS:000761402800009
J	Sabui, S; Ramamoorthy, K; Romero, JM; Simoes, RD; Fleckenstein, JM; Said, HM				Sabui, Subrata; Ramamoorthy, Kalidas; Romero, Jose M.; Simoes, Rita D.; Fleckenstein, James M.; Said, Hamid M.			Hypoxia inhibits colonic uptake of the microbiota-generated forms of vitamin B1 via HIF-1 alpha-mediated transcriptional regulation of their transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIAMINE PYROPHOSPHATE; HIGH-AFFINITY; IN-VITRO; DEFICIENCY; EXPRESSION; DAMAGE; INFLAMMATION; REPRESSION; MECHANISM; DISORDER	Hypoxia exerts profound effects on cell physiology, but its effect on colonic uptake of the microbiota-generated forms of vitamin B1 (i.e., thiamin pyrophosphate [TPP] and free thiamine) has not been described. Here, we used human colonic epithelial NCM460 cells and human differentiated colonoid monolayers as in vitro and ex vivo models, respectively, and were subjected to either chamber (1% O-2, 5% CO2, and 94% N-2) or chemically (desferrioxamine; 250 mu M)-induced hypoxia followed by determination of different physiological-molecular parameters. We showed that hypoxia causes significant inhibition in TPP and free thiamin uptake by colonic NCM460 cells and colonoid monolayers; it also caused a significant reduction in the expression of TPP (SLC44A4) and free thiamin (SLC19A2 and SLC19A3) transporters and in activity of their gene promoters. Furthermore, hypoxia caused a significant induction in levels of hypoxia-inducible transcription factor (HIF)-1 alpha but not HIF-2 alpha. Knocking down HIF-1 alpha using gene-specific siRNAs in NCM460 cells maintained under hypoxic conditions, on the other hand, led to a significant reversal in the inhibitory effect of hypoxia on TPP and free thiamin uptake as well as on the expression of their transporters. Finally, a marked reduction in level of expression of the nuclear factors cAMP responsive element-binding protein 1 and gut-enriched Kruppel-like factor 4 (required for activity of SLC44A4 and SLC19A2 promoters, respectively) was observed under hypoxic conditions. In summary, hypoxia causes severe inhibition in colonic TPP and free thiamin uptake that is mediated at least in part via HIF-1 alpha-mediated transcriptional mechanisms affecting their respective transporters.	[Sabui, Subrata; Ramamoorthy, Kalidas; Said, Hamid M.] UCI, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Sabui, Subrata; Romero, Jose M.; Said, Hamid M.] VA Med Ctr, Dept Res, Long Beach, CA 90805 USA; [Romero, Jose M.; Said, Hamid M.] UCI, Dept Med, Irvine, CA 92697 USA; [Simoes, Rita D.; Fleckenstein, James M.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Fleckenstein, James M.] Vet Affairs Med Ctr, Dept Med Serv, St Louis, MO USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Washington University (WUSTL); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Said, HM (corresponding author), UCI, Dept Physiol & Biophys, Irvine, CA 92697 USA.; Said, HM (corresponding author), VA Med Ctr, Dept Res, Long Beach, CA 90805 USA.; Said, HM (corresponding author), UCI, Dept Med, Irvine, CA 92697 USA.	hmsaid@uci.edu			Department of Veterans Affairs [I01BX001142, 5I01BX001469-05]; National Institutes of Health [DK5606, AA018071, AI089894, AI126887]; National Institutes of Health Washington University Digestive Diseases Research Core Centers grant National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [P30 DK052574]	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Washington University Digestive Diseases Research Core Centers grant National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health	This work was supported by grants from the Department of Veterans Affairs (I01BX001142 to H. M. S. and 5I01BX001469-05 to J. M. F.) and the National Institutes of Health (DK5606 and AA018071 to H. M. S. and AI089894 and AI126887 to J. M. F. and by the National Institutes of Health Washington University Digestive Diseases Research Core Centers grant National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [grant no.: P30 DK052574]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albaugh VL, 2021, SURG OBES RELAT DIS, V17, P653, DOI 10.1016/j.soard.2020.11.032; Anandam KY, 2021, AM J PHYSIOL-GASTR L, V320, pG108, DOI 10.1152/ajpgi.00361.2020; Anandam KY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224234; Anwar A, 2016, FREE RADICAL RES, V50, pS85, DOI 10.1080/10715762.2016.1239821; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Choi S, 2017, FASEB J, V31, P1516, DOI 10.1096/fj.201601098R; Colgan SP, 2016, ANNU REV PATHOL-MECH, V11, P77, DOI 10.1146/annurev-pathol-012615-044231; Costantini A, 2013, J ALTERN COMPLEM MED, V19, P704, DOI 10.1089/acm.2011.0840; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; FERNANDEZBANARES F, 1989, AM J GASTROENTEROL, V84, P744; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/00008390-200310000-00008; GUERRANT N. B., 1932, Journal of Biological Chemistry, V98, P225; Hazell AS, 2009, ALCOHOL ALCOHOLISM, V44, P141, DOI 10.1093/alcalc/agn120; Hernandez-Vazquez AD, 2016, J NUTRIGENET NUTRIGE, V9, P287, DOI 10.1159/000456663; Jiang Y, 2005, LEUKEMIA, V19, P1239, DOI 10.1038/sj.leu.2403734; Kasper H, 1970, Am J Proctol, V21, P341; LEEVY CM, 1968, AM J CLIN NUTR, V21, P1325, DOI 10.1093/ajcn/21.11.1325; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnusdottir S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00148; Mallat J, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.32; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; MCLAREN DS, 1981, AM J CLIN NUTR, V34, P1031, DOI 10.1093/ajcn/34.6.1031; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Nabokina SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149255; Nabokina SM, 2015, AM J PHYSIOL-CELL PH, V308, pC750, DOI 10.1152/ajpcell.00381.2014; Nabokina SM, 2014, J BIOL CHEM, V289, P4405, DOI 10.1074/jbc.M113.528257; Nabokina SM, 2012, AM J PHYSIOL-GASTR L, V303, pG389, DOI 10.1152/ajpgi.00151.2012; Najjar VA, 1943, J AMER MED ASSOC, V123, P683, DOI 10.1001/jama.1943.02840460017005; Neufeld EJ, 2001, BLOOD CELL MOL DIS, V27, P135, DOI 10.1006/bcmd.2000.0356; Onishi Y, 2019, FEBS OPEN BIO, V9, P241, DOI 10.1002/2211-5463.12559; Ramamoorthy K, 2021, AM J PHYSIOL-GASTR L, V321, pG123, DOI 10.1152/ajpgi.00144.2021; Reidling JC, 2003, AM J PHYSIOL-CELL PH, V285, pC633, DOI 10.1152/ajpcell.00076.2003; Rindi G, 2000, P SOC EXP BIOL MED, V224, P246, DOI 10.1046/j.1525-1373.2000.22428.x; Said HM, 2018, COMPR PHYSIOL, V8, P1291, DOI 10.1002/cphy.c170054; Said HM, 2001, AM J PHYSIOL-GASTR L, V281, pG144, DOI 10.1152/ajpgi.2001.281.1.G144; Sasagawa T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35745-1; Shah Yatrik M, 2016, Mol Cell Pediatr, V3, P1, DOI 10.1186/s40348-016-0030-1; Sheikh A, 2020, P NATL ACAD SCI USA, V117, P29055, DOI 10.1073/pnas.2012480117; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; Sweet R, 2010, CANCER BIOL THER, V10, P1101, DOI 10.4161/cbt.10.11.13444; TALLAKSEN CME, 1992, ALCOHOL CLIN EXP RES, V16, P320, DOI 10.1111/j.1530-0277.1992.tb01384.x; Taylor CT, 2018, CELL MOL GASTROENTER, V5, P61, DOI 10.1016/j.jcmgh.2017.09.005; Thornalley P. J., 2007, DIABETOLOGIA, V125, P771; Todd KG, 1999, GLIA, V25, P190, DOI 10.1002/(SICI)1098-1136(19990115)25:2<190::AID-GLIA9>3.0.CO;2-B; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vemuganti R, 2006, EUR J NEUROSCI, V23, P1172, DOI 10.1111/j.1460-9568.2006.04651.x; Wong O. M., 1981, LARGE INTESTINE ITS, P157; Woolum JA, 2018, CRIT CARE MED, V46, P1747, DOI [10.1097/ccm.0000000000003311, 10.1097/CCM.0000000000003311]; Yoshii K, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00048; Zhao RB, 2001, BBA-GENE STRUCT EXPR, V1517, P320, DOI 10.1016/S0167-4781(00)00264-5; Zheng W, 2009, FASEB J, V23, P204, DOI 10.1096/fj.08-110221	53	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101562	10.1016/j.jbc.2022.101562	http://dx.doi.org/10.1016/j.jbc.2022.101562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34998824	Green Published, gold			2022-12-26	WOS:000761395300002
J	Poole, GC; Fogg, SK; O'Daniel, SJ; Amerson, BE; Reinhold, AM; Carlson, SP; Mohr, EJ; Oakland, HC				Poole, Geoffrey C.; Fogg, S. Kathleen; O'Daniel, Scott J.; Amerson, Byron E.; Reinhold, Ann Marie; Carlson, Samuel P.; Mohr, Elizabeth J.; Oakland, Hayley C.			Hyporheic hydraulic geometry: Conceptualizing relationships among hyporheic exchange, storage, and water age	PLOS ONE			English	Article							RESIDENCE TIME; ALLUVIAL AQUIFER; FLOW PATHS; RIVER; FLOODPLAIN; SURFACE; STREAMBEDS; FRAMEWORK; PATTERNS; SCIENCE	Hyporheic exchange is now widely acknowledged as a key driver of ecosystem processes in many streams. Yet stream ecologists have been slow to adopt nuanced hydrologic frameworks developed and applied by engineers and hydrologists to describe the relationship between water storage, water age, and water balance in finite hydrosystems such as hyporheic zones. Here, in the context of hyporheic hydrology, we summarize a well-established mathematical framework useful for describing hyporheic hydrology, while also applying the framework heuristically to visualize the relationships between water age, rates of hyporheic exchange, and water volume within hyporheic zones. Building on this heuristic application, we discuss how improved accuracy in the conceptualization of hyporheic exchange can yield a deeper understanding of the role of the hyporheic zone in stream ecosystems. Although the equations presented here have been well-described for decades, our aim is to make the mathematical basis as accessible as possible and to encourage broader understanding among aquatic ecologists of the implications of tailed age distributions commonly observed in water discharged from and stored within hyporheic zones. Our quantitative description of "hyporheic hydraulic geometry," associated visualizations, and discussion offer a nuanced and realistic understanding of hyporheic hydrology to aid in considering hyporheic exchange in the context of river and stream ecosystem science and management.	[Poole, Geoffrey C.; Fogg, S. Kathleen; Amerson, Byron E.; Reinhold, Ann Marie; Carlson, Samuel P.; Mohr, Elizabeth J.; Oakland, Hayley C.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Poole, Geoffrey C.; Reinhold, Ann Marie] Montana State Univ, Montana Inst Ecosyst, Bozeman, MT 59717 USA; [O'Daniel, Scott J.] Confederated Tribes Umatilla Indian Reservat, Pendleton, OR USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Poole, GC (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.; Poole, GC (corresponding author), Montana State Univ, Montana Inst Ecosyst, Bozeman, MT 59717 USA.	gpoole@montana.edu		Fogg, Katie/0000-0002-9164-1369; Carlson, Samuel/0000-0001-5233-5425; Mohr, Elizabeth/0000-0001-7178-981X; Reinhold, Ann Marie/0000-0003-0411-3486	US DOE Bonneville Power Administration Project [2007252-00]; National Science Foundation (BIO-DEB Award) [1945941]; USDA National Institute of Food and Agriculture [1015745]	US DOE Bonneville Power Administration Project; National Science Foundation (BIO-DEB Award)(National Science Foundation (NSF)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was funded by US DOE Bonneville Power Administration Project #2007252-00 (SJO; https://www.bpa.gov/Projects/Initiatives/Pages/Columbia-River-Treaty.aspx), and from the National Science Foundation (BIO-DEB Award 1945941) and the USDA National Institute of Food and Agriculture (Hatch Project 1015745) (GCP; https://nifa.usda.gov/program/hatch-act1887).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigoni AS, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006480; Arscott DB, 2001, CAN J FISH AQUAT SCI, V58, P2359, DOI 10.1139/cjfas-58-12-2359; Benettin P, 2017, WATER RESOUR RES, V53, P1864, DOI 10.1002/2016WR020117; Boano F, 2014, REV GEOPHYS, V52, P603, DOI 10.1002/2012RG000417; Botter G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047666; Boulton AJ, 2010, J N AM BENTHOL SOC, V29, P26, DOI 10.1899/08-017.1; Brunner P, 2012, GROUND WATER, V50, P170, DOI 10.1111/j.1745-6584.2011.00882.x; Cardenas MB, 2008, ADV WATER RESOUR, V31, P1382, DOI 10.1016/j.advwatres.2008.07.006; Cardenas MB, 2015, WATER RESOUR RES, V51, P3601, DOI 10.1002/2015WR017028; Cardenas MB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033753; Cardenas MB, 2004, WATER RESOUR RES, V40, DOI 10.1029/2004WR003008; Chen XB, 2015, WATER RESOUR RES, V51, P2923, DOI 10.1002/2014WR016848; Coker AK., 2001, MODELING CHEM KINETI; DANCKWERTS PV, 1953, CHEM ENG SCI, V2, P1, DOI 10.1016/0009-2509(53)80001-1; Drummond JD, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002019; Fanelli RM, 2008, GROUND WATER, V46, P671, DOI 10.1111/j.1745-6584.2008.00461.x; FINDLAY S, 1995, LIMNOL OCEANOGR, V40, P159, DOI 10.4319/lo.1995.40.1.0159; Frei S, 2019, WATER RESOUR RES, V55, P9808, DOI 10.1029/2019WR025540; Gesch D., 2009, 20093053 US GEOL SUR, DOI DOI 10.3133/FS20093053; Gomez JD, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012180; Gomez-Velez JD, 2015, NAT GEOSCI, V8, P941, DOI [10.1038/NGEO2567, 10.1038/ngeo2567]; Gomez-Velez JD, 2014, GEOPHYS RES LETT, V41, P6403, DOI 10.1002/2014GL061099; Gooseff MN, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004626; Gooseff MN, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003513; Gooseff MN, 2003, ADV WATER RESOUR, V26, P925, DOI 10.1016/S0309-1708(03)00105-2; Haggerty R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014743; Haggerty R, 2002, ERMS520308; Harman CJ, 2016, WATER RESOUR RES, V52, P7130, DOI 10.1002/2016WR018832; Harman CJ, 2015, WATER RESOUR RES, V51, P1, DOI 10.1002/2014WR015707; Harvey J, 2015, WATER RESOUR RES, V51, P6893, DOI 10.1002/2015WR017617; Hatch CE, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004787; Hauer FR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600026; Helton AM, 2015, J GEOPHYS RES-BIOGEO, V120, P693, DOI 10.1002/2014JG002832; Helton AM, 2014, GEOMORPHOLOGY, V205, P17, DOI 10.1016/j.geomorph.2012.01.004; Helton AM, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002025; Jones KL, 2008, HYDROL PROCESS, V22, P2105, DOI 10.1002/hyp.6810; Kasahara T, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001386; Krause S, 2011, ECOHYDROLOGY, V4, P481, DOI 10.1002/eco.176; Lee A, 2020, WATER RESOUR RES, V56, DOI 10.1029/2019WR026560; Lewandowski J, 2019, WATER-SUI, V11, DOI 10.3390/w11112230; Luce CH, 2013, WATER RESOUR RES, V49, P488, DOI 10.1029/2012WR012380; Magliozzi C, 2018, HYDROL EARTH SYST SC, V22, P6163, DOI 10.5194/hess-22-6163-2018; Magliozzi C, 2019, ENVIRON MODELL SOFTW, V111, P311, DOI 10.1016/j.envsoft.2018.09.006; Packman AI, 2003, HYDROBIOLOGIA, V494, P291, DOI 10.1023/A:1025403424063; Poole GC, 2008, RIVER RES APPL, V24, P1018, DOI 10.1002/rra.1099; Poole GC, 2006, J N AM BENTHOL SOC, V25, P288, DOI 10.1899/0887-3593(2006)25[288:MGDOGF]2.0.CO;2; R Core Team, 2021, R LANG ENV STAT; Rinaldo A, 2015, WATER RESOUR RES, V51, P4840, DOI 10.1002/2015WR017273; Rosenberry DO, 2008, J HYDROL, V359, P118, DOI 10.1016/j.jhydrol.2008.06.029; Runkel R.L., 1998, 984018 US GEOL SURV, V4018; Stanford J.A., 1994, P367; STANFORD JA, 1993, J N AM BENTHOL SOC, V12, P48, DOI 10.2307/1467685; Stonedahl SH, 2013, WATER RESOUR RES, V49, P5450, DOI 10.1002/wrcr.20400; Wroblicky GJ, 1998, WATER RESOUR RES, V34, P317, DOI 10.1029/97WR03285; Zarnetske JP, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/2011JG001730, 10.1029/2011J0001730]; Zarnetske JP, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001356	56	1	1	9	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262080	10.1371/journal.pone.0262080	http://dx.doi.org/10.1371/journal.pone.0262080			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030186	Green Published, gold			2022-12-26	WOS:000812798500028
J	Sanchez-Tocino, ML; Miranda-Serrano, B; Gracia-Iguacel, C; de-Alba-Penaranda, AM; Mas-Fontao, S; Lopez-Gonzalez, A; Villoria-Gonzalez, S; Pereira-Garcia, M; Ortiz, A; Gonzalez-Parra, E				Luz Sanchez-Tocino, M.; Miranda-Serrano, Blanca; Gracia-Iguacel, Carolina; Maria de-Alba-Penaranda, Ana; Mas-Fontao, Sebastian; Lopez-Gonzalez, Antonio; Villoria-Gonzalez, Silvia; Pereira-Garcia, Monica; Ortiz, Alberto; Gonzalez-Parra, Emilio			Sarcopenia assessed by 4-step EWGSOP2 in elderly hemodialysis patients: Feasibility and limitations	PLOS ONE			English	Article							MORTALITY; ASSOCIATION; PREVALENCE; PREDICTOR; CONSENSUS; DIALYSIS; FRAILTY; AGE	Background In 2019, EWGSOP2 proposed 4 steps to diagnose and assess sarcopenia. We aimed to quantify the prevalence of sarcopenia according to the EWGSOP2 diagnostic algorithm and to assess its applicability in elderly patients on hemodialysis. Methods Prospective study of 60 outpatients on chronic hemodialysis aged 75- to 95-years, sarcopenia was assessed according to the 4-step EWGSOP2: Find: Strength, Assistance walking, Rise from a chair, Climb stairs, and Falls (SARC-F); Assess: grip strength by dynamometry (GSD) and sit to stand to sit 5 (STS5); Confirm: appendicular skeletal muscle mass (ASM) by bioimpedance; Severity: gait speed (GS), Timed-Up and Go (TUG), and Short Physical Performance Battery (SPPB). Results The sequential four steps resulted in a prevalence of confirmed or severe sarcopenia of 20%. Most (97%) patients fulfilled at least one criterion for probable sarcopenia. The sensitivity of SARC-F for confirmed sarcopenia was low (46%). Skipping the SARC-F step increased the prevalence of confirmed and severe sarcopenia to 40% and 37%, respectively. However, 78% of all patients had evidence of dynapenia consistent with severe sarcopenia. Muscle mass (ASM) was normal in 60% of patients, while only 25% had normal muscle strength values (GSD). Conclusions According to the 4-step EWGSOP2, the prevalence of confirmed or severe sarcopenia was low in elderly hemodialysis patients. The diagnosis of confirmed sarcopenia underestimated the prevalence of dynapenia consistent with severe sarcopenia. Future studies should address whether a 2-step EWGSOP2 assessment (Assess-Severity) is simpler to apply and may provide better prognostic information than 4-step EWGSOP2 in elderly persons on hemodialysis.	[Luz Sanchez-Tocino, M.; Miranda-Serrano, Blanca; Villoria-Gonzalez, Silvia; Gonzalez-Parra, Emilio] Fdn Renal Inigo Aivarez de Toledo, Salamanca, Spain; [Gracia-Iguacel, Carolina; Ortiz, Alberto; Gonzalez-Parra, Emilio] IIS FJD UAM, Fdn Jimenez Diaz, Serv Nefrol & Hipertens, Madrid, Spain; [Maria de-Alba-Penaranda, Ana; Pereira-Garcia, Monica] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain; [Mas-Fontao, Sebastian] IIS Fdn Jimenez Diaz UAM, CIBERDEM, Madrid, Spain; [Lopez-Gonzalez, Antonio] Complejo Hosp Univ A Coruna, La Coruna, Spain	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Fundacion Jimenez Diaz; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna	Gonzalez-Parra, E (corresponding author), IIS FJD UAM, Fdn Jimenez Diaz, Serv Nefrol & Hipertens, Madrid, Spain.	egparra@fjd.es	; Ortiz Arduan, Alberto/Y-7582-2018	de Alba, Ana Maria/0000-0001-8262-2847; Mas, Sebastian/0000-0001-6604-3327; Sanchez-Tocino, M. Luz/0000-0002-2730-3242; Ortiz Arduan, Alberto/0000-0002-9805-9523	Ministerio de Economia, Industria y competitividad: FIS/Fondos FEDER [PI16/01298, PI17/00257, PI18/01386, PI19/00588, PI19/00815, PI20/00487, PI21/01430, KIDNEY ATTACK AC18/00064, PERSTIGAN AC18/00071, ISCIII-RETIC REDinREN RD016/0009]; Sociedad Espanola de Nefrologia, Comunidad de Madrid en Biomedicina [B2017/BMD-3686 CIFRA2-CM]; Fundacion Renal Inigo Alvarez de Toledo (FRIAT)	Ministerio de Economia, Industria y competitividad: FIS/Fondos FEDER; Sociedad Espanola de Nefrologia, Comunidad de Madrid en Biomedicina; Fundacion Renal Inigo Alvarez de Toledo (FRIAT)(Fonds de la Recherche Scientifique - FNRS)	This research received no external funding. EGP, SM and AO research groups are funded by Ministerio de Economia, Industria y competitividad: FIS/Fondos FEDER (PI16/01298, PI17/00257, PI18/01386, PI19/00588, PI19/00815, PI20/00487, PI21/01430, ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00064 and PERSTIGAN AC18/00071, ISCIII-RETIC REDinREN RD016/0009), and Sociedad Espanola de Nefrologi ' a, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM. All authors want to thank Fundacio ' n RenalI ' nigoA ' lvarez de Toledo (FRIAT) for it support to renal research in Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahat G, 2018, J NUTR HEALTH AGING, V22, P898, DOI 10.1007/s12603-018-1067-8; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bischoff HA, 2003, AGE AGEING, V32, P315, DOI 10.1093/ageing/32.3.315; Carrero JJ, 2016, KIDNEY INT, V90, P53, DOI 10.1016/j.kint.2016.02.025; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark BC, 2012, NUTRITION, V28, P495, DOI 10.1016/j.nut.2011.12.002; Conley KE, 2013, EXP PHYSIOL, V98, P768, DOI 10.1113/expphysiol.2012.067314; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Davenport A, 2010, NEPHRON CLIN PRACT, V114, pC60, DOI 10.1159/000245070; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; El-Kateb S, 2016, NUTR CLIN PRACT, V31, P375, DOI 10.1177/0884533615621549; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gracia-Iguacel C, 2013, NEFROLOGIA, V33, P495, DOI 10.3265/Nefrologia.pre2013.Apr.11979; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Jassal SV, 2009, NEW ENGL J MED, V361, P1612, DOI 10.1056/NEJMc0905289; Kalantar-Zadeh K, 2004, NEPHROL DIAL TRANSPL, V19, P1507, DOI 10.1093/ndt/gfh143; Kramer A, 2020, CLIN KIDNEY J, V13, P693, DOI 10.1093/ckj/sfaa048; Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048; McAdams-DeMarco MA, 2013, J AM GERIATR SOC, V61, P896, DOI 10.1111/jgs.12266; Moreno-Gonzalez R., 2020, BMC GERIATR, P20, DOI [10.1186/s12877-020-1421-7, DOI 10.1186/S12877-020-1421-7]; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Pavasini R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0763-7; Pereira RA, 2015, NEPHROL DIAL TRANSPL, V30, P1718, DOI 10.1093/ndt/gfv133; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Souweine J-S., 2020, NEPHROL DIAL TRANSPL; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Thompson S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211032; Zhu F, 2004, INT J ARTIF ORGANS, V27, P104, DOI 10.1177/039139880402700205	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261459	10.1371/journal.pone.0261459	http://dx.doi.org/10.1371/journal.pone.0261459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025892	Green Published, gold			2022-12-26	WOS:000796264200016
J	Rose, LJ; Houston, H; Martinez-Smith, M; Lyons, AK; Whitworth, C; Reddy, SC; Noble-Wang, J				Rose, Laura J.; Houston, Hollis; Martinez-Smith, Marla; Lyons, Amanda K.; Whitworth, Carrie; Reddy, Sujan C.; Noble-Wang, Judith			Factors influencing environmental sampling recovery of healthcare pathogens from non-porous surfaces with cellulose sponges	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; GRAM-NEGATIVE BACTERIA; ACINETOBACTER-BAUMANNII; CLOSTRIDIUM-DIFFICILE; VANCOMYCIN-RESISTANT; BIOFILM FORMATION; STAINLESS-STEEL; CELL-SURFACE; NOSOCOMIAL PATHOGENS	Results from sampling healthcare surfaces for pathogens are difficult to interpret without understanding the factors that influence pathogen detection. We investigated the recovery of four healthcare-associated pathogens from three common surface materials, and how a body fluid simulant (artificial test soil, ATS), deposition method, and contamination levels influence the percent of organisms recovered (%R). Known quantities of carbapenemase-producing KPC+ Klebsiella pneumoniae (KPC), Acinetobacter baumannii, vancomycin-resistant Enterococcus faecalis, and Clostridioides difficile spores (CD) were suspended in Butterfield's buffer or ATS, deposited on 323 cm(2) steel, plastic, and laminate surfaces, allowed to dry 1h, then sampled with a cellulose sponge wipe. Bacteria were eluted, cultured, CFU counted and %R determined relative to the inoculum. The %R varied by organism, from <1% (KPC) to almost 60% (CD) and was more dependent upon the organism's characteristics and presence of ATS than on surface type. KPC persistence as determined by culture also declined by >1 log(10) within the 60 min drying time. For all organisms, the %R was significantly greater if suspended in ATS than if suspended in Butterfield's buffer (p<0.05), and for most organisms the %R was not significantly different when sampled from any of the three surfaces. Organisms deposited in multiple droplets were recovered at equal or higher %R than if spread evenly on the surface. This work assists in interpreting data collected while investigating a healthcare infection outbreak or while conducting infection intervention studies.	[Rose, Laura J.; Houston, Hollis; Martinez-Smith, Marla; Lyons, Amanda K.; Whitworth, Carrie; Reddy, Sujan C.; Noble-Wang, Judith] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Noble-Wang, J (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Infect Dis, Atlanta, GA 30333 USA.	cux2@cdc.gov		Lyons, Amanda/0000-0003-4312-2481; Noble-Wang, Judith/0000-0001-5090-5025				ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90, DOI 10.1128/AEM.46.1.90-97.1983; Al-Nassir WN., 2008, COMP CLIN MICROBIOLO, V47, P62, DOI [10.1086/588293, DOI 10.1086/588293]; Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Arnold JW, 2000, POULTRY SCI, V79, P1839, DOI 10.1093/ps/79.12.1839; Barnes LM, 1999, APPL ENVIRON MICROB, V65, P4543; BENDINGER B, 1993, APPL ENVIRON MICROB, V59, P3973, DOI 10.1128/AEM.59.11.3973-3977.1993; Blanco N, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00790-17, 10.1128/aac.00790-17]; Bond WW., 2004, MICROBIOLOGICAL ASSA, P13; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Boyce JM, 2014, AM J INFECT CONTROL, V42, P326, DOI 10.1016/j.ajic.2013.09.009; BUGGY BP, 1983, J CLIN MICROBIOL, V18, P348, DOI 10.1128/JCM.18.2.348-352.1983; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980, DOI 10.1128/AEM.48.5.980-983.1984; Casey AL, 2010, J HOSP INFECT, V74, P72, DOI 10.1016/j.jhin.2009.08.018; Centers for Disease Control and Prevention, SURF SAMPL PROC BAC; Chai C, 2015, J MICROBIOL METH, V109, P20, DOI 10.1016/j.mimet.2014.12.001; Chowdhary D., 2018, J HOSP INFECT; Da Silva SM, 2011, APPL ENVIRON MICROB, V77, P2374, DOI 10.1128/AEM.01932-10; Denton M, 2004, J HOSP INFECT, V56, P106, DOI 10.1016/j.jhin.2003.10.017; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Dobbs TE, 2014, AM J INFECT CONTROL, V42, P731, DOI 10.1016/j.ajic.2014.03.007; Dolan A, 2011, J HOSP INFECT, V79, P227, DOI 10.1016/j.jhin.2011.05.011; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donskey CJ, 2000, J INFECT DIS, V181, P1830, DOI 10.1086/315428; Donskey CJ, 2013, AM J INFECT CONTROL, V41, pS12, DOI 10.1016/j.ajic.2012.12.010; EICKHOFF TC, 1974, HEALTH LAB SCI, V11, P73; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Evancho G., 2001, MICROBIOLOGICAL MONI, V4th ed, P25, DOI [10.1115/1.1389461, DOI 10.1115/1.1389461]; Fijan S, 2005, J HOSP INFECT, V61, P30, DOI 10.1016/j.jhin.2005.02.005; FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67, DOI 10.1128/AEM.37.1.67-72.1979; Fletcher M., 1996, BACTERIAL ADHESION M; Fletcher M., 1980, BACTERIAL ADHERENCE, P345; Gilchrist M., 1992, CLIN MICROBIOLOGY PR, P11; Greene C, 2015, AM J INFECT CONTROL, V43, P928, DOI 10.1016/j.ajic.2015.05.008; Griffith CJ, 2007, J HOSP INFECT, V66, P352, DOI 10.1016/j.jhin.2007.05.016; Hacek DM, 2000, J CLIN MICROBIOL, V38, P4646, DOI 10.1128/JCM.38.12.4646-4648.2000; Hasan JA, 2011, J AOAC INT, V94, P259; Havill NL, 2014, INFECT CONT HOSP EP, V35, P445, DOI 10.1086/675606; Head CB., 1982, COMP STUDY SELECTIVE, V16, P615, DOI [10.1128/jcm.16.4.615-621.19827153309, DOI 10.1128/JCM.16.4.615-621.19827153309]; Hilbert LR, 2003, INT BIODETER BIODEGR, V52, P175, DOI 10.1016/S0964-8305(03)00104-5; Hogan PG., 2015, ANN PUBLIC HLTH RES, V2; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; HUSMARK U, 1990, J APPL BACTERIOL, V69, P557, DOI 10.1111/j.1365-2672.1990.tb01548.x; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Krauter PA, 2012, APPL ENVIRON MICROB, V78, P846, DOI 10.1128/AEM.07403-11; LARSSON K, 1981, ACTA ODONTOL SCAND, V39, P79, DOI 10.3109/00016358109162263; Lemmen SW, 2001, INT J HYG ENVIR HEAL, V203, P245, DOI 10.1078/S1438-4639(04)70035-8; Li L., 2014, IMPORTANCE VIABLE NO, V5, P258; Lyons A., 2017, SURVIVAL HEALTHCARE; Lyons A RL., 2018, PERSISTENCE ANTIMICR; McDonald LC, 1998, PEDIATR INFECT DIS J, V17, P716, DOI 10.1097/00006454-199808000-00011; MCFETERS GA, 1995, J MICROBIOL METH, V21, P1, DOI 10.1016/0167-7012(94)00027-5; Michael K, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw236; Morgan DJ, 2012, CRIT CARE MED, V40, P1045, DOI 10.1097/CCM.0b013e31823bc7c8; Neely AN., 2000, SURVIVAL ENTEROCOCCI, V38, P724, DOI [10.1128/JCM.38.2.724-726.200010655374, DOI 10.1128/JCM.38.2.724-726.200010655374]; OHara LM., 2019, OPTIMIZING CONTACT P, V69, pS171, DOI [10.1093/cid/ciz621, DOI 10.1093/CID/CIZ621]; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Park GW, 2015, APPL ENVIRON MICROB, V81, P5987, DOI 10.1128/AEM.01657-15; Pembrey RS, 1999, APPL ENVIRON MICROB, V65, P2877; Perry KA., 2013, BIOSAFETY, V2013, DOI [10.4172/2167-0331.S1-002, DOI 10.4172/2167-0331.S1-002]; Peterson AE, 2013, AM J INFECT CONTROL, V41, P1298, DOI 10.1016/j.ajic.2013.05.015; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Prevention CfDCa, 2020, RED RISK SURF; Ramamurthy T., 2014, CURRENT PERSPECTIVES, V2, P103, DOI [10.3389/fpubh.2014.00103, DOI 10.3389/FPUBH.2014.00103]; Rawlinson S, 2019, J HOSP INFECT, V103, P363, DOI 10.1016/j.jhin.2019.07.015; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Rose LJ, 2011, APPL ENVIRON MICROB, V77, P8355, DOI 10.1128/AEM.05377-11; Rose LJ N-WJ., 2014, ASM MANUAL MICROBIOL, V4th; ROSZAK DB, 1987, APPL ENVIRON MICROB, V53, P2889, DOI 10.1128/AEM.53.12.2889-2893.1987; Rutala WA, 2016, AM J INFECT CONTROL, V44, pE69, DOI 10.1016/j.ajic.2015.10.039; Seahulster LM RL., 2012, HOSP EPIDEMIOLOGY IN, V4th ed, P1059; Sehulster L, 2003, MORBID MORTAL WKLY R, V52, P1; Shams AM, 2016, INFECT CONT HOSP EP, V37, P1426, DOI 10.1017/ice.2016.198; Shams AM., 2017, ASM MICROBE 0603; Suleyman G, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0620-2; USP, 2012, USP35 US PHAMACOPEIA; USP, 2015, USP 797 PHARM COMP S; van Loosdrecht M C, 1990, J Biomater Appl, V5, P91, DOI 10.1177/088532829000500202; van Merode AEJ, 2006, J BACTERIOL, V188, P2421, DOI 10.1128/JB.188.7.2421-2426.2006; VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75, DOI 10.1128/MMBR.54.1.75-87.1990; Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7; Watson SP, 1998, J BACTERIOL, V180, P1750, DOI 10.1128/JB.180.7.1750-1758.1998; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Wendt C, 1998, J CLIN MICROBIOL, V36, P3734, DOI 10.1128/JCM.36.12.3734-3736.1998; West-Deadwyler RM, 2020, INFECT CONT HOSP EP, V41, P226, DOI 10.1017/ice.2019.264; Wilson APR, 2016, J HOSP INFECT, V92, pS1, DOI 10.1016/j.jhin.2015.08.007	90	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261588	10.1371/journal.pone.0261588	http://dx.doi.org/10.1371/journal.pone.0261588			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025906	gold, Green Published			2022-12-26	WOS:000796264200020
J	Logeson, ZS; MacLennan, RJ; Abad, GKB; Methven, JM; Gradl, MR; Pinto, MD; Pinto, RS; Stock, MS				Logeson, Zachary S.; MacLennan, Rob J.; Abad, Gerard-Kyle B.; Methven, Johnathon M.; Gradl, Molly R.; Pinto, Matheus D.; Pinto, Ronei S.; Stock, Matt S.			The impact of skeletal muscle disuse on distinct echo intensity bands: A retrospective analysis	PLOS ONE			English	Article							BODY-COMPOSITION; ADAPTATIONS; FAT	Echo intensity (EI) is a novel tool for assessing muscle quality. El has traditionally been reported as the mean of the pixel histogram, with 0 and 255 arbitrary units (A.U.) representing excellent and poor muscle quality, respectively. Recent work conducted in youth and younger and older adults suggested that analyzing specific El bands, rather than the mean, may provide unique insights into the effectiveness of exercise and rehabilitation interventions. As our previous work showed deterioration of muscle quality after knee joint immobilization, we sought to investigate whether the increase in El following disuse was limited to specific El bands. Thirteen females (age = 21 yrs) underwent two weeks of left knee immobilization and ambulated via crutches. B-mode ultrasonography was utilized to obtain images of the immobilized vastus lateralis. The percentage of the total number of pixels within bands of 0-50, 51-100, 101-150, 151-200, and 201-255 A.U. was examined before and after immobilization. We also sought to determine if further subdividing the histogram into 25 A.U. bands (i.e., 0-25, 26-50, etc.) would be a more sensitive methodological approach. Immobilization resulted in a decrease in the percentage of pixels within the 0-50 A.U. band (-3.11 +/- 3.98%), but an increase in the 101-150 A.U. (2.94 +/- 2.64%) and 151-200 A.U. (0.93 +/- 1.42%) bands. Analyses of variance on the change scores indicated that these differences were large and significant ( %EI0-50VS. %EI101-150: p< .001, d= 1.243); %EI0-50 vs. %EI151-200: P = .043, d = 0.831). The effect size for the %EI51-100 versus %EI(101-150)comparison was medium/large (d= 0.762), but not statistically significant (p = .085). Further analysis of the 25 A.U. bands indicated that the percentage of pixels within the 25-50 A.U. band decreased (-2.97 +/- 3.64%), whereas the 101-125 (1.62 +/- 1.47%) and 126-150 A.U. (1.18 +/- 1.07%) bands increased. Comparison of the 50 A.U. and 25 A.U. band methods found that 25 A.U. bands offer little additional insight. Though studies are needed to ascertain the factors that may influence specific bands, changes in El during muscle disuse are not homogeneous across the pixel histogram. We encourage investigators to think critically about the robustness of data obtained from El histograms, rather than simply reporting the El(mean) value, in muscle quality research.	[Logeson, Zachary S.; Abad, Gerard-Kyle B.; Methven, Johnathon M.; Gradl, Molly R.; Stock, Matt S.] Univ Cent Florida, Inst Exercise Physiol & Rehabil Sci, Neuromuscular Plast Lab, Orlando, FL 32816 USA; [MacLennan, Rob J.] Oklahoma State Univ, Appl Neuromuscular Physiol Lab, Stillwater, OK 74078 USA; [Pinto, Matheus D.] Edith Cowan Univ, Ctr Exercise & Sport Sci Res CESSR, Sch Med & Hlth Sci, Joondalup, Australia; [Pinto, Ronei S.] Univ Fed Rio Grande do Sul, Phys Educ Physiotherapy & Dance Sch, Exercise Res Lab, Porto Alegre, RS, Brazil	State University System of Florida; University of Central Florida; Oklahoma State University System; Oklahoma State University - Stillwater; Edith Cowan University; Universidade Federal do Rio Grande do Sul	Stock, MS (corresponding author), Univ Cent Florida, Inst Exercise Physiol & Rehabil Sci, Neuromuscular Plast Lab, Orlando, FL 32816 USA.	matt.stock@ucf.edu	Stock, Matt S./G-8308-2018	Stock, Matt S./0000-0003-1156-1084; Daros Pinto, Matheus/0000-0002-2616-2492	De Luca Foundation; University of Central Florida's Office of Research; UCF College of Graduate Studies Open Access Publishing Fund	De Luca Foundation; University of Central Florida's Office of Research; UCF College of Graduate Studies Open Access Publishing Fund	Funding support for this project was provided to RJM by the De Luca Foundation and the University of Central Florida's Office of Research to MSS. Article processing charges were provided to ZSL in part by the UCF College of Graduate Studies Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2016, MAGN RESON IMAGING, V34, P397, DOI 10.1016/j.mri.2015.12.038; Arts IMP, 2012, MUSCLE NERVE, V45, P449, DOI 10.1002/mus.22254; Bali AU, 2020, EXP GERONTOL, V139, DOI 10.1016/j.exger.2020.111047; Burton AM, 2018, CLIN PHYSIOL FUNCT I, V38, P1062, DOI 10.1111/cpf.12532; Cohen J.E., 1988, STAT POWER ANAL BEHA; Deschenes MR, 2008, MED SCI SPORT EXER, V40, P856, DOI 10.1249/MSS.0b013e318164f4b6; Deschenes MR, 2009, EUR J APPL PHYSIOL, V105, P889, DOI 10.1007/s00421-008-0974-5; Giuliani HK, 2021, PHYSIOL MEAS, V42, DOI 10.1088/1361-6579/abea24; Hackney KJ, 2012, EUR J APPL PHYSIOL, V112, P9, DOI 10.1007/s00421-011-1971-7; Hioki M, 2020, EXP GERONTOL, V132, DOI 10.1016/j.exger.2020.110834; Komforti D, 2021, AGING CLIN EXP RES, V33, P921, DOI 10.1007/s40520-020-01596-y; Lopez P, 2019, ULTRASOUND MED BIOL, V45, P612, DOI 10.1016/j.ultrasmedbio.2018.10.010; Lopez P, 2017, MUSCLE NERVE, V55, P9, DOI 10.1002/mus.25168; MacLennan RJ, 2020, PEERJ, V8, DOI 10.7717/peerj.8224; Mota JA, 2018, AGING CLIN EXP RES, V30, P861, DOI 10.1007/s40520-017-0829-1; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Pinto RS, 2021, EXP GERONTOL, V145, DOI 10.1016/j.exger.2020.111179; Ruby L, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000023576; Ryan ED, 2016, APPL PHYSIOL NUTR ME, V41, P1104, DOI 10.1139/apnm-2016-0238; Schulze K, 2002, MED SCI SPORT EXER, V34, P303, DOI 10.1097/00005768-200202000-00019; Stevens J. P., 2012, APPL MULTIVARIATE ST; Stock MS, 2021, EUR J APPL PHYSIOL, V121, P369, DOI 10.1007/s00421-020-04556-6; Stokes T, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14683; Tesch PA, 2004, J APPL PHYSIOL, V96, P1451, DOI 10.1152/japplphysiol.01051.2003; Tesch PA, 2016, J APPL PHYSIOL, V120, P1207, DOI 10.1152/japplphysiol.01052.2015; Wong V, 2020, J ULTRASOUND, V23, P457, DOI 10.1007/s40477-019-00424-y; Young HJ, 2015, MUSCLE NERVE, V52, P963, DOI 10.1002/mus.24656	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262553	10.1371/journal.pone.0262553	http://dx.doi.org/10.1371/journal.pone.0262553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015790	Green Published, gold, Green Submitted			2022-12-26	WOS:000814820600034
J	Siewe, N; Friedman, A				Siewe, Nourridine; Friedman, Avner			Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; DENDRITIC CELLS; SIPULEUCEL-T; ANDROGEN DEPRIVATION; CASTRATION; CTLA-4; IMMUNOTHERAPY; RECEPTOR; SURVIVAL; CD8(+)	Metastatic castration resistant prostate cancer (mCRPC) is commonly treated by androgen deprivation therapy (ADT) in combination with chemotherapy. Immune therapy by checkpoint inhibitors, has become a powerful new tool in the treatment of melanoma and lung cancer, and it is currently being used in clinical trials in other cancers, including mCRPC. However, so far, clinical trials with PD-1 and CTLA-4 inhibitors have been disappointing. In the present paper we develop a mathematical model to assess the efficacy of any combination of ADT with cancer vaccine, PD-1 inhibitor, and CTLA-4 inhibitor. The model is represented by a system of partial differential equations (PDEs) for cells, cytokines and drugs whose density/concentration evolves in time within the tumor. Efficacy of treatment is determined by the reduction in tumor volume at the endpoint of treatment. In mice experiments with ADT and various combinations of PD-1 and CTLA-4 inhibitors, tumor volume at day 30 was always larger than the initial tumor. Our model, however, shows that we can decrease tumor volume with large enough dose; for example, with 10 fold increase in the dose of anti-PD-1, initial tumor volume will decrease by 60%. Although the treatment with ADT in combination with PD-1 inhibitor or CTLA-4 inhibitor has been disappointing in clinical trials, our simulations suggest that, disregarding negative effects, combinations of ADT with checkpoint inhibitors can be effective in reducing tumor volume if larger doses are used. This points to the need for determining the optimal combination and amounts of dose for individual patients.	[Siewe, Nourridine] Rochester Inst Technol, Sch Math Sci, Coll Sci, Rochester, NY 14623 USA; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	Rochester Institute of Technology; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Siewe, N (corresponding author), Rochester Inst Technol, Sch Math Sci, Coll Sci, Rochester, NY 14623 USA.	nourridine@aims.ac.za		Siewe, Nourridine/0000-0002-3005-8508	College of Science [15874]; Rochester Institute of Technology [16067]; Mathematical Biosciences Institute of The Ohio State University	College of Science; Rochester Institute of Technology; Mathematical Biosciences Institute of The Ohio State University	This research was supported by the Dean's Research Initiative Grant #15874 of the 390 College of Science, and the SEED Grant #16067, at Rochester Institute of Technology. 391 This work was also supported by the Mathematical Biosciences Institute of The Ohio 392 State University. There was no additional external funding received for this study.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Anassi Enock, 2011, P T, V36, P197; Ardiani A, 2013, CLIN CANCER RES, V19, P6205, DOI 10.1158/1078-0432.CCR-13-1026; Barnes MJ, 2013, MUCOSAL IMMUNOL, V6, P324, DOI 10.1038/mi.2012.75; Beer TM, 2017, J CLIN ONCOL, V35, P40, DOI 10.1200/JCO.2016.69.1584; Blank CU, 2015, INT IMMUNOL, V27, P3, DOI 10.1093/intimm/dxu076; Boettcher AN, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00884; Brady-Nicholls R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15424-4; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; Cai JJ, 2019, ONCOTARGETS THER, V12, P8437, DOI 10.2147/OTT.S221340; Cancer org, SURV RAT PROST CANC; Cancer org, KEY STAT PROST CANC; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Davis ID, 2019, NEW ENGL J MED, V381, P121, DOI 10.1056/NEJMoa1903835; de Almeida Daniel Vargas P, 2020, Am Soc Clin Oncol Educ Book, V40, P1, DOI 10.1200/EDBK_278853; Dennis KL, 2013, CURR OPIN ONCOL, V25, P637, DOI 10.1097/CCO.0000000000000006; Doersch KM, 2016, EXP BIOL MED, V241, P1900, DOI 10.1177/1535370216660212; Drake CG, 2005, CANCER CELL, V7, P239, DOI 10.1016/j.ccr.2005.01.027; DrugBank, NIV P T DRUG CREAT F; Du XX, 2018, CELL RES, V28, P416, DOI 10.1038/s41422-018-0011-0; Eikenberry SE, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-24; Erlandsson A, 2019, PROSTATE, V79, P363, DOI 10.1002/pros.23742; Fay AP, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.01.37; Fellner Chris, 2012, P T, V37, P503; Feng Q, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00858; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Fijak M, 2015, AM J REPROD IMMUNOL, V74, P12, DOI 10.1111/aji.12363; Friedman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192449; Friedman A, 2013, MATH BIOSCI ENG, V10, P591, DOI 10.3934/mbe.2013.10.591; Friedmen A, 2014, J MATH ANAL APPL, V412, P776, DOI 10.1016/j.jmaa.2013.11.017; Funt SA, 2014, ONCOLOGY-NY, V28, P6; Gamat M, 2017, ENDOCR-RELAT CANCER, V24, pT297, DOI 10.1530/ERC-17-0145; Gong JL, 2000, P NATL ACAD SCI USA, V97, P2715, DOI 10.1073/pnas.050587197; Graff JN, 2015, CORE EVID, V10, P1, DOI 10.2147/CE.S54712; Gupta R, 2010, DISCOV MED, V10, P52; Ha D, 2019, P NATL ACAD SCI USA, V116, P609, DOI 10.1073/pnas.1812186116; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; He JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13110; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hirata Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20788-1; Inc FP, 2008, TRADENAME DEG INJ LA; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Janco JMT, 2015, J IMMUNOL, V194, P2985, DOI 10.4049/jimmunol.1403134; Ji HH, 2019, CLIN DRUG INVEST, V39, P319, DOI 10.1007/s40261-018-0735-0; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaufman HL, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-11; Kim TJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155484; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Koh YT, 2009, PROSTATE, V69, P571, DOI 10.1002/pros.20906; Lai XL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231499; Lai XL, 2018, P NATL ACAD SCI USA, V115, P5534, DOI 10.1073/pnas.1721559115; Lai XL, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0446-9; Lai XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178479; Lamberti MJ, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12030256; Li CX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01234-1; Liechtenstein T., 2012, J CLIN CELL IMMUNO S, VS12, P006, DOI 10.4172/2155-9899.S12-006; Lin D, 2016, ASIAN J UROL, V3, P195, DOI 10.1016/j.ajur.2016.08.002; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Ma Y, 2013, J CANCER, V4, P36, DOI 10.7150/jca.5046; Mailliard RB, 2002, J EXP MED, V195, P473, DOI 10.1084/jem.20011662; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Mirlekar B, 2021, CANCERS, V13, DOI 10.3390/cancers13020167; Modena A, 2016, ONCOL REV, V10, DOI 10.4081/oncol.2016.293; Morse MD, 2010, HUM IMMUNOL, V71, P496, DOI 10.1016/j.humimm.2010.02.007; Muppidi M.R., 2015, J TARGET THER CANC, V4, P47; National Cancer Institute, 2021, NCI FACT SHEET; Ostroumov D, 2018, CELL MOL LIFE SCI, V75, P689, DOI 10.1007/s00018-017-2686-7; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Phan T, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10082721; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Recine F, 2015, TRANSL ANDROL UROL, V4, P355, DOI 10.3978/j.issn.2223-4683.2015.04.11; Rudd CE, 2009, EUR J IMMUNOL, V39, P687, DOI 10.1002/eji.200939261; Saenz R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-211; Saraon Punit, 2014, EJIFCC, V25, P42; SB, 2021, PD L1 PROT REC; Schalken J, 2016, BJU INT, V117, P215, DOI 10.1111/bju.13123; Sheikh NA, 2013, CANCER IMMUNOL IMMUN, V62, P137, DOI 10.1007/s00262-012-1317-2; Shen YC, 2018, PROSTATE CANCER P D, V21, P113, DOI 10.1038/s41391-017-0013-x; Shi L, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-74; Siewe N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252620; Simmons AD, 2007, CANCER IMMUNOL IMMUN, V56, P1653, DOI 10.1007/s00262-007-0315-2; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Sun GJ, 2019, FUTURE ONCOL, V15, P1167, DOI 10.2217/fon-2018-0619; Taghizadeh H, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1644109; Tang S, 2012, CANCER RES, V72, P1975, DOI 10.1158/0008-5472.CAN-11-2499; Tsukumo S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00101; US Food and Drug Administration, 2012, XTANDI C 12A005 ENZ; van der Burg SH, 2016, NAT REV CANCER, V16, P219, DOI 10.1038/nrc.2016.16; Vaz CV, 2016, J CANCER RES CLIN, V142, P5, DOI 10.1007/s00432-015-1992-4; Wang SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24249	91	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262453	10.1371/journal.pone.0262453	http://dx.doi.org/10.1371/journal.pone.0262453			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015785	gold, Green Published			2022-12-26	WOS:000814820600020
J	Mahbub, M; Srinivasan, S; Danciu, I; Peluso, A; Begoli, E; Tamang, S; Peterson, GD				Mahbub, Maria; Srinivasan, Sudarshan; Danciu, Ioana; Peluso, Alina; Begoli, Edmon; Tamang, Suzanne; Peterson, Gregory D.			Unstructured clinical notes within the 24 hours since admission predict short, mid & long-term mortality in adult ICU patients	PLOS ONE			English	Article							HOSPITAL MORTALITY	Mortality prediction for intensive care unit (ICU) patients is crucial for improving outcomes and efficient utilization of resources. Accessibility of electronic health records (EHR) has enabled data-driven predictive modeling using machine learning. However, very few studies rely solely on unstructured clinical notes from the EHR for mortality prediction. In this work, we propose a framework to predict short, mid, and long-term mortality in adult ICU patients using unstructured clinical notes from the MIMIC III database, natural language processing (NLP), and machine learning (ML) models. Depending on the statistical description of the patients' length of stay, we define the short-term as 48-hour and 4-day period, the mid-term as 7-day and 10-day period, and the long-term as 15-day and 30-day period after admission. We found that by only using clinical notes within the 24 hours of admission, our framework can achieve a high area under the receiver operating characteristics (AU-ROC) score for short, mid and long-term mortality prediction tasks. The test AU-ROC scores are 0.87, 0.83, 0.83, 0.82, 0.82, and 0.82 for 48-hour, 4-day, 7-day, 10-day, 15-day, and 30-day period mortality prediction, respectively. We also provide a comparative study among three types of feature extraction techniques from NLP: frequency-based technique, fixed embedding-based technique, and dynamic embedding-based technique. Lastly, we provide an interpretation of the NLP-based predictive models using feature-importance scores.	[Mahbub, Maria; Srinivasan, Sudarshan; Begoli, Edmon] Oak Ridge Natl Lab, Cyber Resilience & Intelligence Div, Oak Ridge, TN 37830 USA; [Danciu, Ioana; Peluso, Alina] Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN USA; [Tamang, Suzanne] Stanford Univ, Ctr Populat Hlth Sci, Palo Alto, CA 94304 USA; [Mahbub, Maria; Peterson, Gregory D.] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Stanford University; University of Tennessee System; University of Tennessee Knoxville	Mahbub, M (corresponding author), Oak Ridge Natl Lab, Cyber Resilience & Intelligence Div, Oak Ridge, TN 37830 USA.; Mahbub, M (corresponding author), Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA.	mmahbub@vols.utk.edu		Mahbub, Maria/0000-0002-3422-9650; Tamang, Suzanne/0000-0003-2077-4620	Office of Science of the U.S. Department of Energy [DE-AC05-00OR22725]; Department of Veterans Affairs Office of Information Technology Inter-Agency; Department of Energy [VA118-16-M-1062]; U.S. Department of Energy [DE-AC05-00OR22725]	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Department of Veterans Affairs Office of Information Technology Inter-Agency(US Department of Veterans Affairs); Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research used resources of the Knowledge Discovery Infrastructure at the Oak Ridge National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC05-00OR22725 and the Department of Veterans Affairs Office of Information Technology Inter-Agency Agreement with the Department of Energy under IAA No. VA118-16-M-1062. This manuscript has been in part co-authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the `author contributions' section.	Alsentzer E., 2019, PUBLICLY AVAILABLE C, P72; Anand Rajsavi S, 2018, AMIA Jt Summits Transl Sci Proc, V2017, P310; Auslander B, 2020, IEEE GLOBE WORK, DOI 10.1109/GCWkshps50303.2020.9367547; Awad A, 2017, INT J MED INFORM, V108, P185, DOI 10.1016/j.ijmedinf.2017.10.002; Bai ZX, 2021, COMPUT MATH METHOD M, V2021, DOI 10.1155/2021/7252280; Barlas G., 2020, IFIP INT C ART INT A, P255; Beaulieu-Jones BK, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00426-3; Biswas E, 2020, PROC IEEE INT CONF S, P162, DOI 10.1109/ICSME46990.2020.00025; Bojanowski Piotr, 2017, T ASSOC COMPUT LING, V5, P135, DOI 10.1162/tacl_a_00051; Breiman L., 2001, MACH LEARN, V45, P5; Caicedo-Torres W, 2019, J BIOMED INFORM, V98, DOI 10.1016/j.jbi.2019.103269; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cramer J.S, 2002, 20021194 TINB I, DOI [10.2139/ssrn.360300, DOI 10.2139/SSRN.360300]; Deschepper M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235117; Devlin Jacob, 2019, P ANN C N AM CHAPTER, V1, P4171; Ding N, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6638919; Doig G S, 1993, Proc Annu Symp Comput Appl Med Care, P361; Dybowski R, 1996, LANCET, V347, P1146, DOI 10.1016/S0140-6736(96)90609-1; Feng JY, 2020, PROCEEDINGS OF THE 2020 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING (EMNLP), P1478; FERYLEMONNIER E, 1995, INTENS CARE MED, V21, P356, DOI 10.1007/BF01705416; Ghassemi M, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P75, DOI 10.1145/2623330.2623742; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Haniffa R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1930-8; Hashir M, 2020, J BIOMED INFORM, V108, DOI 10.1016/j.jbi.2020.103489; Hernandez-Boussard T, 2019, J AM MED INFORM ASSN, V26, P1189, DOI 10.1093/jamia/ocz119; Hou NZ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02620-5; Johnson Alistair E W, 2017, AMIA Annu Symp Proc, V2017, P994; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Ke GL, 2017, ADV NEUR IN, V30; Kefi Z, 2019, INT J ADV COMPUT SC, V10, P583; Kingma D. P., 2014, P INT C LEARN REPR, P1, DOI DOI 10.1007/S11390-017-1754-7; Kocbek P, 2017, P SIKDD 2017 C DATA, V29, P31; Kong GL, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01271-2; Kong HJ, 2019, HEALTHC INFORM RES, V25, P1, DOI 10.4258/hir.2019.25.1.1; Krishnan GS, 2018, LECT NOTES COMPUT SC, V10859, P126, DOI 10.1007/978-3-319-91947-8_13; Lee J, 2020, BIOINFORMATICS, V36, P1234, DOI 10.1093/bioinformatics/btz682; Lin K, 2019, INT J MED INFORM, V125, P55, DOI 10.1016/j.ijmedinf.2019.02.002; Liu EQ, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/5948636; Lu ZQ, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.661710; Mahdavi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252384; Mikolov Tomas, 2013, P WORKSHOP ICLR; Parikh RB, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15997; Paszke A, 2019, ADV NEUR IN, V32; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng YF, 2019, SIGBIOMED WORKSHOP ON BIOMEDICAL NATURAL LANGUAGE PROCESSING (BIONLP 2019), P58; Radhachandran A, 2021, BIODATA MIN, V14, DOI 10.1186/s13040-021-00255-w; Sadeghi Reza, 2018, Smart Health (Amst), V9-10, P265, DOI 10.1016/j.smhl.2018.07.001; Sammut C., 2010, ENCY MACHINE LEARNIN, P986, DOI [10.1007/978-0-387-30164-8_832, DOI 10.1007/978-0-387-30164-8_832]; Sandfort V, 2019, J INTENSIVE CARE MED, V34, P622, DOI 10.1177/0885066618756828; Sazli MH., 2006, COMMUNICATIONS FACUL, V50; Tang CL, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0984-8; Tenney I, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P4593; Teo K, 2020, J MED IMAG HEALTH IN, V10, P2869, DOI 10.1166/jmihi.2020.3291; Theis J, 2022, IEEE J BIOMED HEALTH, V26, P388, DOI 10.1109/JBHI.2021.3092969; van Aken B, 2021, 16TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (EACL 2021), P881; Vaswani A., 2017, PROC ANN C NEURAL IN, V30, P5998; Wolf T, 2020, PROCEEDINGS OF THE 2020 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING: SYSTEM DEMONSTRATIONS, P38; Wu Y., 2016, ARXIV PREPRINT ARXIV; Ye JC, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01318-4; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu Gu, 2022, ACM Transactions on Computing and Healthcare, V3, DOI 10.1145/3458754; Yu K, 2020, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2020, P103; Yu Y, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2614; Zahid MAH., 2018, 2018 IEEE EMBS INT C, P226, DOI DOI 10.1109/BHI.2018.8333410; Zhu YB, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.662340; Zhu YK, 2015, IEEE I CONF COMP VIS, P19, DOI 10.1109/ICCV.2015.11	67	3	3	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262182	10.1371/journal.pone.0262182	http://dx.doi.org/10.1371/journal.pone.0262182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990485	Green Published, gold, Green Submitted			2022-12-26	WOS:000815783800018
J	Nguyen, JL; Benigno, M; Malhotra, D; Khan, F; Angulo, FJ; Hammond, J; Swerdlow, DL; Reimbaeva, M; Emir, B; McLaughlin, JM				Nguyen, Jennifer L.; Benigno, Michael; Malhotra, Deepa; Khan, Farid; Angulo, Frederick J.; Hammond, Jennifer; Swerdlow, David L.; Reimbaeva, Maya; Emir, Birol; McLaughlin, John M.			Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020	PLOS ONE			English	Article							COVID-19; ADMISSIONS; TRENDS; IMPACT	Background The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has substantially impacted healthcare utilization worldwide. The objective of this retrospective analysis of a large hospital discharge database was to compare all-cause and cause-specific hospitalizations during the first six months of the pandemic in the United States with the same months in the previous four years. Methods Data were collected from all hospitals in the Premier Healthcare Database (PHD) and PHD Special Release reporting hospitalizations from January through July for each year from 2016 through 2020. Hospitalization trends were analyzed stratified by age group, major diagnostic categories (MDCs), and geographic region. Results The analysis included 286 hospitals from all 9 US Census divisions. The number of allcause hospitalizations per month was relatively stable from 2016 through 2019 and then fell by 21% (57,281 fewer hospitalizations) between March and April 2020, particularly in hospitalizations for non-respiratory illnesses. From April onward there was a rise in the number of monthly hospitalizations per month. Hospitalizations per month, nationally and in each Census division, decreased for 20 of 25 MDCs between March and April 2020. There was also a decrease in hospitalizations per month for all age groups between March and April 2020 with the greatest decreases in hospitalizations observed for patients 50-64 and >= 65 years of age. Conclusions Rates of hospitalization declined substantially during the first months of the COVID-19 pandemic, suggesting delayed routine, elective, and emergency care in the United States. These lapses in care for illnesses not related to COVID-19 may lead to increases in morbidity and mortality for other conditions. Thus, in the current stage of the pandemic, clinicians and public-health officials should work, not only to prevent SARS-CoV-2 transmission, but also to ensure that care for non-COVID-19 conditions is not delayed.	[Nguyen, Jennifer L.; Benigno, Michael; Malhotra, Deepa] Pfizer Inc, Real World Evidence Ctr Excellence, New York, NY 10017 USA; [Nguyen, Jennifer L.; Khan, Farid; Angulo, Frederick J.; Swerdlow, David L.; McLaughlin, John M.] Pfizer Inc, Pfizer Vaccines, Med Dev & Sci Clin Affairs, Collegeville, PA 19426 USA; [Hammond, Jennifer] Pfizer Inc, Clin Dev Internal Med & Hosp, Pfizer Global Prod Dev, Collegeville, PA USA; [Reimbaeva, Maya] Pfizer Inc, Global Biometr & Data Management, Pfizer Global Prod Dev, Groton, CT 06340 USA; [Emir, Birol] Pfizer Inc, Pfizer Global Prod Dev, Global Biometr & Data Management, New York, NY USA	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	Nguyen, JL (corresponding author), Pfizer Inc, Real World Evidence Ctr Excellence, New York, NY 10017 USA.; Nguyen, JL (corresponding author), Pfizer Inc, Pfizer Vaccines, Med Dev & Sci Clin Affairs, Collegeville, PA 19426 USA.	Jennifer.Nguyen2@pfizer.com	Nguyen, Jennifer/GVS-4347-2022		Pfizer Inc.	Pfizer Inc.(Pfizer)	This work and the article processing charges were sponsored by Pfizer Inc. The funder provided support in the form of salaries for authors F.A, M.B, B.E, J.H, F.K, D.M, J.M, J.L.N, M.R, and D.L.S, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Argenziano MG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1996; Birkmeyer JD, 2020, HEALTH AFFAIR, V39, P2010, DOI 10.1377/hlthaff.2020.00980; Center for Systems Science and Engineering at Johns Hopkins University, COVID 19 DASHB 2020; Centers for Disease Control and Prevention, CDC COVID DATA TRACK, DOI [10.2196/1939932788148, DOI 10.2196/1939932788148]; Centers for Disease Control and Prevention, FRAM HEALTHC SYST PR; Centers for Disease Control and Prevention, EST DIS BURD COVID 1; Centers for Disease Control and Prevention, ICD 10 CM OFF COD RE; Centers for Medicare and Medicaid Services, ICD 10 CM PCS MS DRG; Centers for Medicare and Medicaid Services, 2020, ICD 10 MS DRGS VERS; Cowling BJ, 2020, J INFECT DIS, V221, P1749, DOI 10.1093/infdis/jiaa123; Cox C., 2020, HAVE HEALTHCARE UTIL; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1250, DOI 10.15585/mmwr.mm6936a4; de Pablo GS, 2020, J AFFECT DISORDERS, V275, P48, DOI 10.1016/j.jad.2020.06.022; De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Federal Government of the United States of America, 2020, PROCLAMATION DECLARI; Gallaway MS, 2020, MMWR-MORBID MORTAL W, V69, P1460, DOI 10.15585/mmwr.mm6940e3; Hartnett KP, 2020, MMWR-MORBID MORTAL W, V69, P699, DOI 10.15585/mmwr.mm6923e1; Hutchins HJ, 2020, MMWR-MORBID MORTAL W, V69, P1584, DOI 10.15585/mmwr.mm6943e4; Jewell JS, 2020, JMIR FORM RES, V4, DOI 10.2196/22043; Kadri SS, 2020, JAMA-J AM MED ASSOC, V324, P2553, DOI 10.1001/jama.2020.20323; Kim HS, 2020, ACAD EMERG MED, V27, P910, DOI 10.1111/acem.14099; Lai PH, 2020, JAMA CARDIOL, V5, P1154, DOI 10.1001/jamacardio.2020.2488; Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8; Moreland A, 2020, MMWR-MORBID MORTAL W, V69, P1198, DOI 10.15585/mmwr.mm6935a2; Olsen SJ, 2020, MMWR-MORBID MORTAL W, V69, P1305, DOI 10.15585/mmwr.mm6937a6; Oseran AS, 2020, AM J MANAG CARE, V26, P327, DOI 10.37765/ajmc.2020.43837; Oster AM, 2020, MMWR-MORBID MORTAL W, V69, P1127, DOI 10.15585/mmwr.mm6933e2; Pollard MS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22942; Premier Applied Sciences PI, 2020, PREM HEALTHC DAT COV; Prevention CfDCa, CDC COVID DAT TRACK; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Thompson CN, 2020, MMWR-MORBID MORTAL W, V69, P1725, DOI 10.15585/mmwr.mm6946a2; United Van Lines, 2020, ANN 2020 UN LIN NAT; US Census Bureau, CENS REG DIV US 2010; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013	37	9	9	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0262347	10.1371/journal.pone.0262347	http://dx.doi.org/10.1371/journal.pone.0262347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990489	Green Published, gold			2022-12-26	WOS:000815783800029
J	Dusadeemeelap, C; Rojasawasthien, T; Matsubara, T; Kokabu, S; Addison, WN				Dusadeemeelap, Chirada; Rojasawasthien, Thira; Matsubara, Takuma; Kokabu, Shoichiro; Addison, William N.			Inhibition of TET-mediated DNA demethylation suppresses osteoblast differentiation	FASEB JOURNAL			English	Article						DNA demethylation; DNA methylation; epigenetics; osteoblast; SP7; TET; TET inhibitors	OSTERIX OSX; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; TRANSCRIPTION; PROTEINS; SP7; 5-METHYLCYTOSINE; MINERALIZATION; HOMEOSTASIS	DNA methylation is an epigenetic modification critical for the regulation of chromatin structure and gene expression during development and disease. The ten-eleven translocation (TET) enzyme family catalyzes the hydroxymethylation and subsequent demethylation of DNA by oxidizing 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). Little is known about TET protein function due to a lack of pharmacological tools to manipulate DNA hydroxymethylation levels. In this study, we examined the role of TET-mediated DNA hydroxymethylation during BMP-induced C2C12 osteoblast differentiation using a novel cytosine-based selective TET enzyme inhibitor, Bobcat339 (BC339). Treatment of C2C12 cells with BC339 increased global 5mC and decreased global 5hmC without adversely affecting cell viability, proliferation, or apoptosis. Furthermore, BC339 treatment inhibited osteoblast marker gene expression and decreased alkaline phosphatase activity during differentiation. Methylated DNA immunoprecipitation and bisulfite sequencing showed that inhibition of TET with BC339 led to increased 5mC at specific CpG-rich regions at the promoter of Sp7, a key osteoblast transcription factor. Consistent with promoter 5mC marks being associated with transcriptional repression, luciferase activity of an Sp7-promoter-reporter construct was repressed by in vitro DNA methylation or BC339. Chromatin immunoprecipitation analysis confirmed that TET2 does indeed occupy the promoter region of Sp7. Accordingly, forced overexpression of SP7 rescued the inhibition of osteogenic differentiation by BC339. In conclusion, our data suggest that TET-mediated DNA demethylation of genomic regions, including the Sp7 promoter, plays a role in the initiation of osteoblast differentiation. Furthermore, BC339 is a novel pharmacological tool for the modulation of DNA methylation dynamics for research and therapeutic applications.	[Dusadeemeelap, Chirada; Rojasawasthien, Thira; Matsubara, Takuma; Kokabu, Shoichiro; Addison, William N.] Kyushu Dent Univ, Div Mol Signaling & Biochem, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan; [Dusadeemeelap, Chirada] Kyushu Dent Univ, Div Special Needs & Geriatr Dent, Kitakyushu, Fukuoka, Japan	Kyushu Dental University; Kyushu Dental University	Addison, WN (corresponding author), Kyushu Dent Univ, Div Mol Signaling & Biochem, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r19addison@fa.kyu-dent.ac.jp		Addison, William/0000-0002-8587-8028	NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation (Japan)) [20--018]; MEXT \ Japan Society for the Promotion of Science (JSPS) [19K24152]; Fukuoka Foundation for Sound Health	NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation (Japan)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health)	NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation (Japan)), Grant/Award Number: 20--018; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19K24152; Fukuoka Foundation for Sound Health	Addison WN, 2015, BONE, V71, P244, DOI 10.1016/j.bone.2014.11.003; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Barbuto R, 2013, J MOL ENDOCRINOL, V51, P99, DOI 10.1530/JME-12-0251; Cakouros D, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-018-0247-4; Carrio E, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00019; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Chua GNL, 2019, ACS MED CHEM LETT, V10, P180, DOI 10.1021/acsmedchemlett.8b00474; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fux C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh001; Gao J, 2016, PROTEIN CELL, V7, P351, DOI 10.1007/s13238-016-0267-4; Gao YG, 2004, GENE, V341, P101, DOI 10.1016/j.gene.2004.05.026; Hariri H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87608-x; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hojo H, 2016, DEV CELL, V37, P238, DOI 10.1016/j.devcel.2016.04.002; Hong SHH, 2009, J MOL ENDOCRINOL, V43, P197, DOI 10.1677/JME-09-0012; Hupkes M, 2011, BBA-MOL CELL RES, V1813, P839, DOI 10.1016/j.bbamcr.2011.01.022; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lee JY, 2006, MOL CELLS, V22, P182; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li X, 2016, P NATL ACAD SCI USA, V113, pE8267, DOI 10.1073/pnas.1617802113; Li XK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15903; Liu RJ, 2013, CIRCULATION, V128, P2047, DOI 10.1161/CIRCULATIONAHA.113.002887; Lopez-Moyado IF, 2019, P NATL ACAD SCI USA, V116, P16933, DOI 10.1073/pnas.1903059116; Montagner S, 2016, CELL REP, V15, P1566, DOI 10.1016/j.celrep.2016.04.044; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Pleyer L, 2015, DRUG METAB REV, V47, P252, DOI 10.3109/03602532.2014.995379; Rao LJ, 2016, INT J ORAL SCI, V8, P110, DOI 10.1038/ijos.2016.4; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Reppe S, 2015, CURR GENOMICS, V16, P384, DOI 10.2174/1389202916666150817202913; Sepulveda H, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00177-17; Singh AK, 2020, P NATL ACAD SCI USA, V117, P3621, DOI 10.1073/pnas.1910702117; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Taylor SEB, 2016, J BONE MINER RES, V31, P524, DOI 10.1002/jbmr.2711; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Thaler R, 2016, J BIOL CHEM, V291, P6754, DOI 10.1074/jbc.M115.678235; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; van Wijnen AJ, 2019, J ORTHOP RES, V37, P1465, DOI 10.1002/jor.24305; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Yang RL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04464-6; Yasuda K, 2021, BONE REP, V15, DOI 10.1016/j.bonr.2021.101114; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu Fangtang, 2017, Bone Rep, V6, P109, DOI 10.1016/j.bonr.2017.04.001; Zhong JN, 2017, NUCLEIC ACIDS RES, V45, P672, DOI 10.1093/nar/gkw919; Zhong X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43539; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	61	3	3	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22153	10.1096/fj.202101402R	http://dx.doi.org/10.1096/fj.202101402R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34997955				2022-12-26	WOS:000747987800023
J	Fan, S; Lv, GX; Feng, X; Wu, GT; Jin, YY; Yan, MC; Yang, ZY				Fan, Shuai; Lv, Guangxin; Feng, Xiao; Wu, Guangteng; Jin, Yuanyuan; Yan, Maocai; Yang, Zhaoyong			Structural insights into the specific interaction between Geobacillus stearothermophilus tryptophanyl-tRNA synthetase and antimicrobial Chuangxinmycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ANTIFUNGAL AGENT; ACTIVATION; MECHANISM; BINDING; RECOGNITION; RESOLUTION; REVEALS; POTENT; ENERGY	The potential antimicrobial compound Chuangxinmycin (CXM) targets the tryptophanyl-tRNA synthetase (TrpRS) of both Gram-negative and Gram-positive bacteria. However, the specific steric recognition mode and interaction mechanism between CXM and TrpRS is unclear. Here, we studied this interaction using recombinant GsTrpRS from Geobacillus stearothermophilus by X-ray crystallography and molecular dynamics (MD) simulations. The crystal structure of the recombinant GsTrpRS in complex with CXM was experimentally determined to a resolution at 2.06 angstrom. After analysis using a complex-structure probe, MD simulations, and site-directed mutation verification through isothermal titration calorimetry, the interaction between CXM and GsTrpRS was determined to involve the key residues M129, D132, I133, and V141 of GsTrpRS. We further evaluated binding affinities between GsTrpRS WT/mutants and CXM; GsTrpRS was found to bind CXM through hydrogen bonds with D132 and hydrophobic interactions between the lipophilic tricyclic ring of CXM and M129, I133, and V141 in the substrate-binding pockets. This study elucidates the precise interaction mechanism between CXM and its target GsTrpRS at the molecular level and provides a theoretical foundation and guidance for the screening and rational design of more effective CXM analogs against both Gram-negative and Gram-positive bacteria.	[Fan, Shuai; Lv, Guangxin; Feng, Xiao; Jin, Yuanyuan; Yang, Zhaoyong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing, Peoples R China; [Wu, Guangteng] ArNuXon Pharm Sci Co Ltd, Res & Dev Dept, Beijing, Peoples R China; [Yan, Maocai] Jining Med Univ, Sch Pharm, Rizhao, Shandong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jining Medical University	Yang, ZY (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing, Peoples R China.; Yan, MC (corresponding author), Jining Med Univ, Sch Pharm, Rizhao, Shandong, Peoples R China.	yanmaocai@126.com; zhaoyongy@imb.pumc.edu.cn			National Key Research and Development Program of China [2018YFA0901800]; National Natural Science Foundation of China [81761128016, 8187131584]; CAMS Innovation Fund for Medical Sciences [2019-I2M-1-005]; NSFC cultivation project of Jining Medical University [JYP2018KJ18]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences; NSFC cultivation project of Jining Medical University	This work was funded by the National Key Research and Development Program of China (No. 2018YFA0901800) , National Natural Science Foundation of China (Grants 81761128016 and 8187131584) , CAMS Innovation Fund for Medical Sciences (2019-I2M-1-005) , and NSFC cultivation project of Jining Medical University (JYP2018KJ18) . We thank Prof. Zhuorong Li (Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, China) for providing the Chuangxinmycin. We thank BL18U1 in Shanghai Synchrotron Radiation Facility (SSRF) for providing technical support and assistance in data collection and process. We also thank Mr Yi Han at the Institute of Biophysics Core-Facility for the support during in-house data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1977, SCI SINICA, V20, P106; Brown MJ, 2002, BIOORG MED CHEM LETT, V12, P3171, DOI 10.1016/S0960-894X(02)00604-2; Carter CW, 2021, ANNU REV BIOCHEM, V90, P349, DOI 10.1146/annurev-biochem-071620-021218; Carter CW, 2017, ANNU REV BIOPHYS, V46, P433, DOI 10.1146/annurev-biophys-070816-033811; Carter CW, 2017, STRUCT DYNAM-US, V4, DOI 10.1063/1.4974218; Carter CW, 2020, PROTEINS, V88, P710, DOI 10.1002/prot.25856; Case D. A., AMBER 2018; Chandrasekaran SN, 2017, STRUCT DYNAM-US, V4, DOI 10.1063/1.4976142; DOUBLIE S, 1995, STRUCTURE, V3, P17, DOI 10.1016/S0969-2126(01)00132-0; Elewski BE, 2015, J AM ACAD DERMATOL, V73, P62, DOI 10.1016/j.jaad.2015.04.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Ilyin VA, 2000, PROTEIN SCI, V9, P218; Kim DG, 2014, NAT CHEM BIOL, V10, P29, DOI [10.1038/nchembio.1381, 10.1038/NCHEMBIO.1381]; Kise Y, 2004, NAT STRUCT MOL BIOL, V11, P149, DOI 10.1038/nsmb722; Laowanapiban P, 2009, P NATL ACAD SCI USA, V106, P1790, DOI 10.1073/pnas.0812752106; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Retailleau P, 2001, ACTA CRYSTALLOGR D, V57, P1595, DOI 10.1107/S090744490101215X; Retailleau P, 2007, J MOL BIOL, V369, P108, DOI 10.1016/j.jmb.2007.01.091; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Shen N, 2008, NUCLEIC ACIDS RES, V36, P1288, DOI 10.1093/nar/gkm1153; Shen N, 2006, NUCLEIC ACIDS RES, V34, P3246, DOI 10.1093/nar/gkl441; Shi YY, 2018, ACTA PHARM SIN B, V8, P283, DOI 10.1016/j.apsb.2017.07.005; Sun LQ, 2019, FUTURE MED CHEM, V11, P2877, DOI 10.4155/fmc-2019-0209; Williams TL, 2016, J BIOL CHEM, V291, P255, DOI 10.1074/jbc.M115.690321; Xu XK, 2018, J NAT PROD, V81, P1060, DOI 10.1021/acs.jnatprod.7b00835; Yang XL, 2007, STRUCTURE, V15, P793, DOI 10.1016/j.str.2007.05.009; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774; Zhou MY, 2010, NUCLEIC ACIDS RES, V38, P3399, DOI 10.1093/nar/gkp1254	32	0	0	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101580	10.1016/j.jbc.2022.101580	http://dx.doi.org/10.1016/j.jbc.2022.101580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35031320	gold, Green Published			2022-12-26	WOS:000761371500003
J	Gheorghita, AA; Wolfram, F; Whitfield, GB; Jacobs, HM; Pfoh, R; Wong, SSY; Guitor, AK; Goodyear, MC; Berezuk, AM; Khursigara, CM; Parsek, MR; Howell, PL				Gheorghita, Andreea A.; Wolfram, Francis; Whitfield, Gregory B.; Jacobs, Holly M.; Pfoh, Roland; Wong, Steven S. Y.; Guitor, Allison K.; Goodyear, Mara C.; Berezuk, Alison M.; Khursigara, Cezar M.; Parsek, Matthew R.; Howell, P. Lynne			The Pseudomonas aeruginosa homeostasis enzyme AlgL clears the periplasmic space of accumulated alginate during polymer biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSOR KINASE KINB; ACTIVE-SITE; EXOPOLYSACCHARIDE ALGINATE; POLYSACCHARIDE SYNTHESIS; CRYSTAL-STRUCTURE; BIOFILM FORMATION; LYASE ALGL; DI-GMP; MECHANISM; PROTEIN	Pseudomonas aeruginosa is an opportunistic human pathogen and a leading cause of chronic infection in the lungs of individuals with cystic fibrosis. After colonization, P. aeruginosa often undergoes a phenotypic conversion to mucoidy, characterized by overproduction of the alginate exopolysaccharide. This conversion is correlated with poorer patient prognoses. The majority of genes required for alginate synthesis, including the alginate lyase, algL, are located in a single operon. Previous investigations of AlgL have resulted in several divergent hypotheses regarding the protein's role in alginate production. To address these discrepancies, we determined the structure of AlgL and, using multiple sequence alignments, identified key active site residues involved in alginate binding and catalysis. In vitro enzymatic analysis of active site mutants highlights R249 and Y256 as key residues required for alginate lyase activity. In a genetically engineered P. aeruginosa strain where alginate biosynthesis is under arabinose control, we found that AlgL is required for cell viability and maintaining membrane integrity during alginate production. We demonstrate that AlgL func- tions as a homeostasis enzyme to clear the periplasmic space of accumulated polymer. Constitutive expression of the AlgU/T sigma factor mitigates the effects of an algL deletion during alginate production, suggesting that an AlgU/T-regulated protein or proteins can compensate for an algL deletion. Together, our study demonstrates the role of AlgL in alginate biosynthesis, explains the discrepancies observed previously across other P. aeruginosa Delta algL genetic backgrounds, and clarifies the existing divergent data regarding the function of AlgL as an alginate degrading enzyme.	[Gheorghita, Andreea A.; Wolfram, Francis; Whitfield, Gregory B.; Pfoh, Roland; Wong, Steven S. Y.; Guitor, Allison K.; Howell, P. Lynne] Hosp Sick Children, Program Mol Med, Toronto, ON, Canada; [Gheorghita, Andreea A.; Whitfield, Gregory B.; Wong, Steven S. Y.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Jacobs, Holly M.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Goodyear, Mara C.; Berezuk, Alison M.; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Parsek, Matthew R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Whitfield, Gregory B.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Guitor, Allison K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Guitor, Allison K.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Berezuk, Alison M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Washington; University of Washington Seattle; University of Guelph; University of Washington; University of Washington Seattle; Universite de Montreal; McMaster University; McMaster University; University of British Columbia	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Med, Toronto, ON, Canada.; Howell, PL (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	howell@sickkids.ca		Jacobs, Holly/0000-0003-3250-8258; Guitor, Allison/0000-0002-6290-6233; Wong, Steven/0000-0003-1722-242X; Gheorghita, Andreea/0000-0001-9548-6549	Canadian Institutes of Health Research (CIHR) [MOP 43998, FDN154327, PJT 156111]; Tier I Canada Research Chair; Cystic Fibrosis Canada; Hospital for Sick Children Foundation Student Scholarship Program; Natural Sciences and Engineering Research Council of Canada; NIH [R01AI134895, R01AI077628, R01AI143916-01]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier I Canada Research Chair(Canada Research Chairs); Cystic Fibrosis Canada; Hospital for Sick Children Foundation Student Scholarship Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants from the Canadian Institutes of Health Research (CIHR) to P. L. H. (MOP 43998 and FDN154327), and C. M. K. (PJT 156111). P. L. H. was the recipient of a Tier I Canada Research Chair (2006-2020). This research has been supported by graduate scholarships from Cystic Fibrosis Canada (A. A. G. and G. B. W.); The Hospital for Sick Children Foundation Student Scholarship Program (A. A. G. and S. S. Y. W.) and the Natural Sciences and Engineering Research Council of Canada (G. B. W. and S. S. Y. W.). M. R. P. was supported by the NIH: R01AI134895, R01AI077628, and R01AI143916-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht MT, 2005, J BACTERIOL, V187, P3869, DOI 10.1128/JB.187.11.3869-3872.2005; Almblad H, 2015, J BACTERIOL, V197, P2190, DOI 10.1128/JB.00193-15; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker P, 2015, J BIOL CHEM, V290, P28374, DOI 10.1074/jbc.M115.674929; Baker P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004334; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Basu S, 2011, BIODEGRADATION, V22, P153, DOI 10.1007/s10532-010-9384-6; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; BOYD A, 1994, APPL ENVIRON MICROB, V60, P2355, DOI 10.1128/AEM.60.7.2355-2359.1994; BOYD A, 1993, GENE, V131, P1, DOI 10.1016/0378-1119(93)90662-M; Brandenburg KS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50003-8; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Campa C, 2004, BIOCHEM J, V381, P155, DOI 10.1042/BJ20031265; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHITNIS CE, 1990, J BACTERIOL, V172, P2894, DOI 10.1128/jb.172.6.2894-2900.1990; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; Coughlan LM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01641; Damron FH, 2012, J BACTERIOL, V194, P1317, DOI 10.1128/JB.06105-11; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DONLAN RM, 1994, WATER RES, V28, P1497, DOI 10.1016/0043-1354(94)90318-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; GERLT JA, 1992, J AM CHEM SOC, V114, P5928, DOI 10.1021/ja00041a004; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Green M.R., 2012, MOL CLONING LAB MANU; Harrison JJ, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008848; HERSHBERGER CD, 1995, P NATL ACAD SCI USA, V92, P7941, DOI 10.1073/pnas.92.17.7941; Highbarger LA, 1996, BIOCHEMISTRY-US, V35, P41, DOI 10.1021/bi9518306; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; Jain S., 2004, ALGINATE BIOSYNTHESI; Jennings LK, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108782; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Kaneko A, 2017, J BIOL CHEM, V292, P15681, DOI 10.1074/jbc.M117.793992; Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015; Kim W., 2013, PLOS ONE, V8, P1; Kim W, 2014, P NATL ACAD SCI USA, V111, pE1639, DOI 10.1073/pnas.1323632111; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Lee JY, 2001, NAT STRUCT BIOL, V8, P789, DOI 10.1038/nsb0901-789; Limoli DH, 2016, EUR J CLIN MICROBIOL, V35, P947, DOI 10.1007/s10096-016-2621-0; Limoli DH, 2017, MBIO, V8, DOI 10.1128/mBio.00186-17; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; MAI GT, 1993, INFECT IMMUN, V61, P559, DOI 10.1128/IAI.61.2.559-564.1993; Markel E, 2016, J BACTERIOL, V198, P2330, DOI 10.1128/JB.00276-16; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; MARTIN DW, 1994, J BACTERIOL, V176, P6688, DOI 10.1128/JB.176.21.6688-6696.1994; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; May Thomas B., 1994, Trends in Microbiology, V2, P151, DOI 10.1016/0966-842X(94)90664-5; Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagata T, 2004, ANTIMICROB AGENTS CH, V48, P2251, DOI 10.1128/AAC.48.6.2251-2259.2004; Nakagami G, 2008, WOUND REPAIR REGEN, V16, P30, DOI 10.1111/j.1524-475X.2007.00329.x; Naught LE, 2002, BIOCHEMISTRY-US, V41, P9637, DOI 10.1021/bi025862m; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Okuda K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00182; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Piper C, 2001, HEART, V85, P590, DOI 10.1136/heart.85.5.590; Price CE, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00559-19; Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x; Remminghorst U, 2006, FEBS LETT, V580, P3883, DOI 10.1016/j.febslet.2006.05.077; Riley LM, 2013, J BIOL CHEM, V288, P22299, DOI 10.1074/jbc.M113.484931; ROYCHOUDHURY S, 1989, J BIOL CHEM, V264, P9380; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Schofield M. C., 2020, PREPRINT, DOI [10.1101/2020.08.17.253617, DOI 10.1101/2020.08.17.253617]; Schofield MC, 2021, MOL MICROBIOL, V116, P550, DOI 10.1111/mmi.14732; Schurr MJ, 1996, J BACTERIOL, V178, P4997, DOI 10.1128/jb.178.16.4997-5004.1996; Seyedarabi A, 2010, BIOCHEMISTRY-US, V49, P539, DOI 10.1021/bi901503g; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tan JQ, 2014, ACTA CRYSTALLOGR D, V70, P2054, DOI 10.1107/S1399004714001850; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang HZ, 2012, ANTIMICROB AGENTS CH, V56, P2683, DOI 10.1128/AAC.06486-11; Wang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19477; Whitfield GB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00471; Whitney JC, 2015, J BIOL CHEM, V290, P12451, DOI 10.1074/jbc.M115.645051; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wolfram F, 2014, J BIOL CHEM, V289, P6006, DOI 10.1074/jbc.M113.533158; Wolfram F, 2012, ACTA CRYSTALLOGR F, V68, P584, DOI 10.1107/S1744309112012808; Wood LF, 2012, MBIO, V3, DOI 10.1128/mBio.00094-12; Wood LF, 2009, MOL MICROBIOL, V72, P183, DOI 10.1111/j.1365-2958.2009.06635.x; Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yanagihara K, 2000, J ANTIMICROB CHEMOTH, V46, P69, DOI 10.1093/jac/46.1.69; Yanagihara K, 1997, AM J RESP CRIT CARE, V155, P337, DOI 10.1164/ajrccm.155.1.9001333; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P366, DOI 10.1111/j.1574-695X.2012.00936.x; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; YU H, 1995, J BACTERIOL, V177, P3259, DOI 10.1128/jb.177.11.3259-3268.1995; Yu H, 1996, INFECT IMMUN, V64, P2774, DOI 10.1128/IAI.64.7.2774-2781.1996	114	3	3	7	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101560	10.1016/j.jbc.2021.101560	http://dx.doi.org/10.1016/j.jbc.2021.101560			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34990713	Green Published, gold			2022-12-26	WOS:000761395300001
J	Wang, XL; Yang, YF; Zhao, D; Zhang, S; Chen, Y; Chen, YL; Feng, K; Li, XJ; Han, JH; Iwakiri, Y; Duan, YJ; Yang, XX				Wang, Xiaolin; Yang, Yanfang; Zhao, Dan; Zhang, Shuang; Chen, Yi; Chen, Yuanli; Feng, Ke; Li, Xiaoju; Han, Jihong; Iwakiri, Yasuko; Duan, Yajun; Yang, Xiaoxiao			Inhibition of high-fat diet-induced obesity via reduction of ER-resident protein Nogo occurs through multiple mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BROWN ADIPOSE-TISSUE; SKELETAL-MUSCLE; METABOLIC SYNDROME; INFLAMMATION; STRESS; RECEPTOR; MICE; MACROPHAGES; SUPPRESSION	Obesity is a risk factor for insulin resistance, type 2 diabetes, and cardiovascular diseases. Reticulon-4 (Nogo) is an endo-plasmic reticulum-resident protein with unclear functions in obesity. Herein, we investigated the effect of Nogo on obesity and associated metabolic disorders. Human serum samples were collected to explore the relationship between circulating Nogo-B and body mass index value. Nogo-deficient and WT littermate control mice were fed normal chow or high-fat diet (HFD) for 14 weeks, and HFD-induced obese C57BL/6J mice were injected scrambled or Nogo siRNA for 2 weeks. We found that in human and mouse serum, Nogo-B was positively correlated to body mass index/bodyweight and lipid profiles. Reduced Nogo (by genetic deletion or siRNA transfection) protected mice against HFD-induced obesity and related metabolic disorders. We demonstrate that Nogo deficiency reversed HFD-induced whitening of brown adipose tissue, thereby increasing thermogenesis. It also ameliorated lipid accumulation in tissues by activating the adiponectin- adiponectin receptor 1-AMP-activated kinase alpha signaling axis. Finally, Nogo deficiency potently reduced HFD-induced serum proinflammatory cytokines and infiltration of macro-phages into metabolic organs, which is related to enhanced NF-kappa B p65 degradation via the lysosome pathway. Collectively, our study suggests that reduced levels of Nogo protect mice against HFD-induced obesity by increasing thermogenesis and energy metabolism while inhibiting NF-kappa B-mediated inflam-mation. Our results indicate that inhibition of Nogo may be a potential strategy for obesity treatment.	[Wang, Xiaolin; Yang, Yanfang; Zhao, Dan; Chen, Yi; Feng, Ke; Li, Xiaoju; Han, Jihong] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Key Lab Bioact Mat,Minist Educ, Tianjin, Peoples R China; [Zhang, Shuang; Chen, Yuanli; Han, Jihong; Duan, Yajun; Yang, Xiaoxiao] Hefei Univ Technol, Coll Food & Biol Engn, Key Lab Metab & Regulat Major Dis Anhui Higher Ed, Hefei, Peoples R China; [Iwakiri, Yasuko] Yale Univ, Sect Digest Dis, Sch Med, New Haven, CT USA	Nankai University; Hefei University of Technology; Yale University	Duan, YJ; Yang, XX (corresponding author), Hefei Univ Technol, Coll Food & Biol Engn, Key Lab Metab & Regulat Major Dis Anhui Higher Ed, Hefei, Peoples R China.	yduan@hfut.edu.cn; jangxiaoxiao@hfut.edu.cn	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	National Natural Science Foundation of China [81973316, 82173807]; China Postdoctoral Science Foundation [2020M681914]; Tianjin Municipal Science and Technology Commission of China [20JCZDJC00710]; Fundamental Research Funds for the Central Universities (Nankai University) [63211045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tianjin Municipal Science and Technology Commission of China; Fundamental Research Funds for the Central Universities (Nankai University)	This work was supported by the National Natural Science Foundation of China grants 81973316 (to J. H.) and 82173807 (to Y. D.); the China Postdoctoral Science Foundation grant 2020M681914 (to X. Y.); and Tianjin Municipal Science and Technology Commission of China grant 20JCZDJC00710 and the Fundamental Research Funds for the Central Universities (Nankai University) (grant no.: 63211045 to J. H.).	Allen JN, 2017, JOVE-J VIS EXP, DOI 10.3791/55445; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cereijo R, 2018, CELL METAB, V28, P750, DOI 10.1016/j.cmet.2018.07.015; Chen DG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03225-9; Chen Y, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100624; Fang C, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1962591; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Garcia D, 2019, CELL REP, V26, P192, DOI 10.1016/j.celrep.2018.12.036; Guo W, 2021, CELL MOL GASTROENTER, V12, P1599, DOI 10.1016/j.jcmgh.2021.07.002; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Kalinkovich A, 2017, AGEING RES REV, V35, P200, DOI 10.1016/j.arr.2016.09.008; Ke BL, 2015, DIABETES, V64, P3355, DOI 10.2337/db15-0242; Kuang E, 2006, EXP CELL RES, V312, P1983, DOI 10.1016/j.yexcr.2006.02.024; Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Liu ML, 2015, J BIOL CHEM, V290, P10143, DOI 10.1074/jbc.M115.645416; Liu ML, 2012, DIABETES, V61, P2776, DOI 10.2337/db12-0169; Mahanty S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1478-4; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Minegishi Y, 2015, AM J PHYSIOL-ENDOC M, V309, pE523, DOI 10.1152/ajpendo.00071.2015; Misaki Y, 2010, METABOLISM, V59, P1465, DOI 10.1016/j.metabol.2010.01.011; Okuno Y, 2018, DIABETES, V67, P1113, DOI 10.2337/db17-1032; Park JK, 2017, HEPATOLOGY, V65, P1720, DOI 10.1002/hep.29051; Rissanen A, 2012, DIABETES OBES METAB, V14, P1088, DOI 10.1111/j.1463-1326.2012.01637.x; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Scheja L, 2019, NAT REV ENDOCRINOL, V15, P507, DOI 10.1038/s41574-019-0230-6; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yang XX, 2016, J BIOL CHEM, V291, P15108, DOI 10.1074/jbc.M116.726737; Ying W, 2019, CELL METAB, V29, P457, DOI 10.1016/j.cmet.2018.12.003; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Zhang S, 2020, J HEPATOL, V73, P1482, DOI 10.1016/j.jhep.2020.07.034; Zhang S, 2020, BRIT J PHARMACOL, V177, P1041, DOI 10.1111/bph.14886; Zhao H, 2018, DIABETES, V67, P235, DOI 10.2337/db17-0356; Zhou XY, 2020, THERANOSTICS, V10, P8197, DOI 10.7150/thno.43968	44	2	2	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101561	10.1016/j.jbc.2022.101561	http://dx.doi.org/10.1016/j.jbc.2022.101561			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34998825	gold, Green Published			2022-12-26	WOS:000761395300003
J	Zhang, LJ; Li, YQ; Hu, YQ; Chen, M; Cen, CH; Lin, LM; Zhou, JJ; Wang, MY; Cui, XH; Tang, FC; Gao, F				Zhang, Lianjun; Li, Yaqiong; Hu, Yuqiong; Chen, Min; Cen, Changhuo; Lin, Limei; Zhou, Jingjing; Wang, Mengyue; Cui, Xiuhong; Tang, Fuchou; Gao, Fei			Somatic cell-derived BMPs induce premature meiosis in male germ cells during the embryonic stage by upregulating Dazl expression	FASEB JOURNAL			English	Article						BMP signaling pathway; Dazl; DNA methylation; meiosis initiation; beta-catenin activation	BETA-CATENIN; SUPPRESSES MEIOSIS; MEIOTIC INITIATION; DNA METHYLATION; MOUSE; FATE; SEX; PROTEIN; NANOS2; MICE	Although germ cell fate is believed to be determined by signaling factors from differentiated somatic cells, the molecular mechanism behind this process remains obscure. In this study, premature meiosis in male germ cells was observed during the embryonic stage by conditional activation of beta-catenin in Sertoli cells. Somatic and germ cell transcriptome results indicated that the BMP signaling pathway was enriched after beta-catenin activation. In addition, we observed a decreased DNA methylation within a reduction of DNMT3A in germ cells of beta-catenin activated testes and reversed increase after inhibiting BMP signaling pathway with LDN-193189. We also found that Dazl expression was increased in beta-catenin activated testes and decreased after LDN treatment. Taken together, this study demonstrates that male germ cells entered meiosis prematurely during the embryonic stage after beta-catenin activated in Sertoli cells. BMP signaling pathway involved in germ cell meiosis initiation by mediating DNA methylation to induce meiotic genes expression.	[Zhang, Lianjun; Li, Yaqiong; Chen, Min; Cen, Changhuo; Lin, Limei; Zhou, Jingjing; Wang, Mengyue; Cui, Xiuhong; Gao, Fei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Zhang, Lianjun; Li, Yaqiong; Chen, Min; Cen, Changhuo; Lin, Limei; Zhou, Jingjing; Wang, Mengyue; Gao, Fei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hu, Yuqiong; Tang, Fuchou] Peking Univ, Coll Life Sci, Beijing Adv Innovat Ctr Genom, Biomed Inst Pioneering Invest Via Convergence, Beijing 100871, Peoples R China; [Hu, Yuqiong; Tang, Fuchou] Biomed Pioneering Innovat Ctr, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China; [Cen, Changhuo; Zhou, Jingjing; Wang, Mengyue; Cui, Xiuhong; Gao, Fei] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Chinese Academy of Sciences	Gao, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Tang, FC (corresponding author), Peking Univ, Coll Life Sci, Beijing Adv Innovat Ctr Genom, Biomed Inst Pioneering Invest Via Convergence, Beijing 100871, Peoples R China.	tangfuchou@pku.edu.cn; gaof@ioz.ac.cn			National Key R&D Program of China [2018YFA0107702]; National Science Fund for Distinguished Young Scholars [81525011]; National Natural Science Foundation of China [31970785, 32170855, 32060171]	National Key R&D Program of China; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China, Grant/Award Number: 2018YFA0107702; National Science Fund for Distinguished Young Scholars, Grant/Award Number: 81525011; National Natural Science Foundation of China, Grant/Award Number: 31970785, 32170855 and 32060171	Adams IR, 2002, DEVELOPMENT, V129, P1155; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Coscioni AC, 2001, ANIM REPROD SCI, V67, P59, DOI 10.1016/S0378-4320(01)00116-6; Dong J, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1416-2; Fan XY, 2018, CELL RES, V28, P730, DOI 10.1038/s41422-018-0053-3; Fukuda K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007436; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hill PWS, 2018, NATURE, V555, P392, DOI 10.1038/nature25964; Kato Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11272; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Koubova J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004541; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Li L, 2021, CELL RES, V31, P463, DOI 10.1038/s41422-020-00401-9; Li YQ, 2017, J BIOL CHEM, V292, P17577, DOI 10.1074/jbc.M117.811349; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; MCLAREN A, 1991, BIOESSAYS, V13, P151, DOI 10.1002/bies.950130402; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; McLaren A, 2001, CELL STRUCT FUNCT, V26, P119, DOI 10.1247/csf.26.119; Miyauchi H, 2017, EMBO J, V36, P3100, DOI 10.15252/embj.201796875; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagaoka SI, 2020, SCIENCE, V367, P1089, DOI 10.1126/science.aaw4115; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Saga Y, 2010, CELL MOL LIFE SCI, V67, P3815, DOI 10.1007/s00018-010-0456-x; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Spiller C, 2017, STEM CELL RES, V24, P174, DOI 10.1016/j.scr.2017.07.016; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033558; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wu Q, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002553; Wu Q, 2013, DEVELOPMENT, V140, P291, DOI 10.1242/dev.087882; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yu C, 2016, CELL RES, V26, P275, DOI 10.1038/cr.2016.20; Zhang LJ, 2015, REPROD FERT DEVELOP, V27, P294, DOI 10.1071/RD13281	53	1	1	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22131	10.1096/fj.202101585R	http://dx.doi.org/10.1096/fj.202101585R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34985827				2022-12-26	WOS:000747987800051
J	Cibulkova, N; Dadova K; Maskova, K; Busch, A; Kobesova, A; Varekova J; Haspicova, M; Matoulek, M				Cibulkova, Natalie; Dadova, Klara; Maskova, Katerina; Busch, Andrew; Kobesova, Alena; Varekova, Jitka; Haspicova, Marcela; Matoulek, Martin			Bariatric surgery and exercise: A pilot study on postural stability in obese individuals	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT-LOSS; MUSCULAR STRENGTH; BALANCE CONTROL; FORCE PLATE; PRESSURE; CHILDREN; SWAY; MOVEMENT; BEHAVIOR	This study aimed to analyze the changes in postural stability of individuals with obesity after bariatric surgery, and the effect of three months of regular exercise on the static postural stability. Twenty-two subjects (7 females and 15 males) aged 31 to 68 years (Body mass index 35-55 kg.m(-2)) completed the study. Participants were divided into two groups: one group participated in an exercise program after the bariatric surgery (n = 10; age 48.9 +/- 7.5 years; Body mass index 42 +/- 5.6 kg.m(-2)) while the second group did not exercise at all after bariatric surgery (n = 12; age 44.7 +/- 13.6 years, Body mass index 42.6 +/- 6.0 kg.m(-2)). Static postural stability was measured using a Tekscan MobileMat pressure plate before and 4 months after the bariatric surgery. The exercise program included exercising three times a week including: one hour of strengthening, one hour of aerobic group exercise and at least one session of individual exercise at home. There were no significant differences in Center of force sway, Center of force ranges and average speed before and 4 months after bariatric surgery. Also, no effect of exercise was found. Post-pre differences of some parameters were negatively related to age (r from-0.46 to-0.72). Further studies are needed to explore this topic in depth.	[Cibulkova, Natalie; Dadova, Klara; Maskova, Katerina; Varekova, Jitka] Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic; [Cibulkova, Natalie; Matoulek, Martin] Gen Univ Hosp Prague, Dept Internal Med 3, Prague, Czech Republic; [Busch, Andrew] Ohio Wesleyan Univ, Hlth & Human Kinet, Delaware, OH 43015 USA; [Kobesova, Alena] Charles Univ Prague, Fac Med 2, Dept Rehabil & Sports Med, Prague, Czech Republic; [Kobesova, Alena] Univ Hosp Motol, Prague, Czech Republic; [Haspicova, Marcela] Med Ctr ORP Ctr, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Ohio Wesleyan University; Charles University Prague; Motol University Hospital	Cibulkova, N (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic.; Cibulkova, N (corresponding author), Gen Univ Hosp Prague, Dept Internal Med 3, Prague, Czech Republic.	nat.cibulkova@gmail.com	Daďová, Klára/AAO-4920-2020; Cibulkova, Natalie/R-1024-2017	Daďová, Klára/0000-0003-3164-2236; Cibulkova, Natalie/0000-0001-5350-5502; Busch, Andrew/0000-0003-1383-4410	Ministry of Health, Czech Republic [GJIH-1599-04-1-180, 64165]; General University Hospital in Prague, Czech Republic; Programme of the institutional support for science at Charles University [Q41]	Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); General University Hospital in Prague, Czech Republic; Programme of the institutional support for science at Charles University	This study was supported by Ministry of Health, Czech Republic (GJIH-1599-04-1-180) conceptual development of research organization 64165, General University Hospital in Prague, Czech Republic, and the Programme of the institutional support for science at Charles University Progress, No. Q41 Biological aspects of the investigation of human movement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AC, 2012, CLINICS, V67, P1433, DOI 10.6061/clinics/2012(12)14; Bankoff A.D.P., 2006, MOV PERCEPCA O ESPIR, V6, P55; Benetti FA, 2016, CLINICS, V71, P78, DOI 10.6061/clinics/2016(02)05; BERGER W, 1992, ACTA OTO-LARYNGOL, V112, P22, DOI 10.3109/00016489209100778; Berrigan F, 2006, INT J OBESITY, V30, P1750, DOI 10.1038/sj.ijo.0803342; Bickley C, 2019, GAIT POSTURE, V67, P91, DOI 10.1016/j.gaitpost.2018.08.012; Birtane M, 2004, CLIN BIOMECH, V19, P1055, DOI 10.1016/j.clinbiomech.2004.07.008; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Brenton-Rule A, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-21; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Cieslinska-Swider JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220962; Cousins SD, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-36; Cruz-Gomez NS, 2011, OBESITY FACTS, V4, P212, DOI 10.1159/000329408; Daniels P, 2018, J SPORT SCI, V36, P529, DOI 10.1080/02640414.2017.1322217; Dansk Selskab for Almen Medicin, 2010, KLIN VEJL ALM PRAKS; De Lorenzo A, 2016, WORLD J GASTROENTERO, V22, P681, DOI 10.3748/wjg.v22.i2.681; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Dutil M, 2013, AGE, V35, P883, DOI 10.1007/s11357-012-9386-x; Era P, 2006, GERONTOLOGY, V52, P204, DOI 10.1159/000093652; Fabunmi A A, 2008, Afr J Med Med Sci, V37, P321; Ferreira FPM, 2003, MONOGRAFIA U ESTADO; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Goetschius J, 2018, J SPORT REHABIL, V27, DOI 10.1123/jsr.2017-0152; Gonzalez M, 2020, J BIOMECH, V100, DOI 10.1016/j.jbiomech.2019.109585; Greve J, 2007, CLINICS, V62, P717, DOI 10.1590/S1807-59322007000600010; Handrigan G, 2010, INT J OBESITY, V34, P936, DOI 10.1038/ijo.2009.300; Handrigan GA, 2010, J BIOMECH, V43, P383, DOI 10.1016/j.jbiomech.2009.08.041; Hassannejad A, 2017, OBES SURG, V27, P2792, DOI 10.1007/s11695-017-2717-3; Herrera-Rangel A, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/787202; Hills AP, 2001, INT J OBESITY, V25, P1674, DOI 10.1038/sj.ijo.0801785; Horak S, 2017, CENT EUR J PUBL HEAL, V25, P326, DOI 10.21101/cejph.a4780; Hue O, 2008, OBES SURG, V18, P1112, DOI 10.1007/s11695-008-9597-5; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; King WC, 2016, JAMA-J AM MED ASSOC, V315, P1362, DOI 10.1001/jama.2016.3010; Losco L, 2022, J INVEST SURG, V35, P620, DOI 10.1080/08941939.2021.1912220; Maffiuletti NA, 2005, J ENDOCRINOL INVEST, V28, P2, DOI 10.1007/BF03345521; Matrangola SL, 2009, MED SCI SPORT EXER, V41, P1488, DOI 10.1249/MSS.0b013e31819bd4bd; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Menegoni F, 2009, OBESITY, V17, P1951, DOI 10.1038/oby.2009.82; Pagnotti GM, 2020, OBESITY FACTS, V13, P499, DOI 10.1159/000509163; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Rezaeipour M, 2018, MIDDLE E J REHABIL H, V5, DOI 10.5812/mejrh.81617; Riddiford-Harland DL, 2000, INT J OBESITY, V24, P541, DOI 10.1038/sj.ijo.0801192; Rogind H, 2003, CLIN PHYSIOL FUNCT I, V23, P171, DOI 10.1046/j.1475-097X.2003.00492.x; Rojhani-Shirazi Z, 2016, EUR SURG, V48, P105, DOI 10.1007/s10353-015-0379-8; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Son Sung Min, 2016, Osong Public Health Res Perspect, V7, P378, DOI 10.1016/j.phrp.2016.10.001; Tabesh MR, 2019, OBES SURG, V29, P3385, DOI 10.1007/s11695-019-04112-y; Teasdale N, 2007, INT J OBESITY, V31, P153, DOI 10.1038/sj.ijo.0803360; Tekscan, PRESS MAPP TECHN PRE; The WAVEWATCH III &REG;Development Group, 2016, SPORTS 2 0X US MAN R; Theriault-Proulx M, 2008, MED SCI SPORT EXER, V40, pS344, DOI 10.1249/01.mss.0000323377.84898.21; Vareka I, 2002, REHAB FYZ LEK, V9, P115; Vartanian LR, 2008, J HEALTH PSYCHOL, V13, P131, DOI 10.1177/1359105307084318; VEDEL JP, 1982, NEUROSCI LETT, V34, P289, DOI 10.1016/0304-3940(82)90190-2; Villarrasa-Sapina I, 2018, CLIN BIOMECH, V52, P1, DOI 10.1016/j.clinbiomech.2017.12.010; Villarrasa-Sapina I, 2017, CLIN BIOMECH, V41, P77, DOI 10.1016/j.clinbiomech.2016.12.008; Villarrasa-Sapina I, 2016, GAIT POSTURE, V49, P1, DOI 10.1016/j.gaitpost.2016.06.012; Wearing SC, 2006, OBES REV, V7, P13, DOI 10.1111/j.1467-789X.2006.00215.x; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Zemkova E, 2017, J BACK MUSCULOSKELET, V30, P353, DOI 10.3233/BMR-160585	62	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262651	10.1371/journal.pone.0262651	http://dx.doi.org/10.1371/journal.pone.0262651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030216	gold, Green Published			2022-12-26	WOS:000812798500062
J	Lee, JM; Park, HB; Song, JE; Kim, IC; Song, JH; Kim, H; Oh, J; Youn, JC; Hong, GR; Kang, SM				Lee, Jae-Man; Park, Hyun-Bin; Song, Jin-Eun; Kim, In-Cheol; Song, Ji-Hun; Kim, Hyungseop; Oh, Jaewon; Youn, Jong-Chan; Hong, Geu-Ru; Kang, Seok-Min			The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; EUROPEAN-SOCIETY; RISK STRATIFICATION; ATRIAL-FIBRILLATION; CARDIOLOGY; MANAGEMENT; MODEL; DETERMINANTS; PREVENTION; GUIDELINES	Background Sudden cardiac death (SCD) and stroke-related events accompanied by atrial fibrillation (AF) can affect morbidity and mortality in hypertrophic cardiomyopathy (HCM). This study sought to evaluate a scoring system predicting cardio-cerebral events in HCM patients using cardiopulmonary exercise testing (CPET). Methods We investigated the role of a previous prediction model based on CPET, the HYPertrophic Exercise-derived Risk score for Heart Failure-related events (HyperHF), which is derived from peak circulatory power ventilatory efficiency and left atrial diameter (LAD), for predicting a composite of SCD-related (SCD, serious ventricular arrhythmia, death from cardiac cause, heart failure admission) and stroke-related (new-onset AF, acute stroke) events. The Novel HyperHF risk model using left atrial volume index (LAVI) instead of LAD was proposed and compared with the previous HCM Risk-SCD model. Results A total of 295 consecutive HCM patients (age 59.9 +/- 13.2, 71.2% male) who underwent CPET was included in the present study. During a median follow-up of 742 days (interquartile range 384-1047 days), 29 patients (9.8%) experienced an event (SCD-related event: 14 patients (4.7%); stroke-related event: 17 patients (5.8%)). The previous model for SCD risk score showed fair prediction ability (AUC of HCM Risk-SCD 0.670, p = 0.002; AUC of HyperHF 0.691, p = 0.001). However, the prediction power of Novel HyperHF showed the highest value among the models (AUC of Novel HyperHF 0.717, p<0.001). Conclusions Both conventional HCM Risk-SCD score and CPET-derived HyperHF score were useful for prediction of overall risk of SCD-related and stroke-related events in HCM. Novel HyperHF score using LAVI could be utilized for a better prediction power.	[Lee, Jae-Man; Park, Hyun-Bin; Song, Jin-Eun; Kim, In-Cheol; Song, Ji-Hun; Kim, Hyungseop] Keimyung Univ, Coll Med, Cardiovasc Ctr, Dept Internal Med,Dongsan Hosp,Div Cardiol, Daegu, South Korea; [Oh, Jaewon; Hong, Geu-Ru; Kang, Seok-Min] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea; [Youn, Jong-Chan] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,Seoul St Marys Hosp, Seoul, South Korea	Keimyung University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, IC (corresponding author), Keimyung Univ, Coll Med, Cardiovasc Ctr, Dept Internal Med,Dongsan Hosp,Div Cardiol, Daegu, South Korea.	kimic@dsmc.or.kr		Song, Ji-Hun/0000-0003-2809-5032; Kim, In-Cheol/0000-0002-5751-2328; Jin Eun, Song/0000-0002-5939-9912	Bisa Research Grant of Keimyung University	Bisa Research Grant of Keimyung University	This research was supported by the Bisa Research Grant of Keimyung University in 2017.	Coats CJ, 2015, CIRC-HEART FAIL, V8, P1022, DOI 10.1161/CIRCHEARTFAILURE.114.002248; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Finocchiaro G, 2015, JACC-HEART FAIL, V3, P408, DOI 10.1016/j.jchf.2014.11.011; Fu M, 2020, CLIN EXP HYPERTENS, V42, P1, DOI 10.1080/10641963.2018.1557680; Garg L, 2019, HEART FAIL REV, V24, P189, DOI 10.1007/s10741-018-9752-6; Guttmann OP, 2015, EUR J HEART FAIL, V17, P837, DOI 10.1002/ejhf.316; Leong KMW, 2018, AM J CARDIOL, V121, P349, DOI 10.1016/j.amjcard.2017.10.027; Magri D, 2016, CIRC J, V80, P2204, DOI 10.1253/circj.CJ-16-0432; Magri D, 2016, HEART, V102, P602, DOI 10.1136/heartjnl-2015-308453; Magri D, 2014, INTERN EMERG MED, V9, P293, DOI 10.1007/s11739-012-0866-x; Maron BJ, 2018, NEW ENGL J MED, V379, P655, DOI 10.1056/NEJMra1710575; Maron BJ, 2016, JAMA CARDIOL, V1, P98, DOI 10.1001/jamacardio.2015.0354; Maron BJ, 2016, HEART RHYTHM, V13, P1155, DOI 10.1016/j.hrthm.2015.12.048; Maron BJ, 2016, CIRCULATION, V133, P62, DOI 10.1161/CIRCULATIONAHA.115.017633; Maron BJ, 2015, AM J CARDIOL, V116, P757, DOI 10.1016/j.amjcard.2015.05.047; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; Masri A, 2015, AM HEART J, V169, P684, DOI 10.1016/j.ahj.2015.02.006; O'Mahony C, 2014, EUR HEART J, V35, P2010, DOI 10.1093/eurheartj/eht439; Ommen SR, 2020, J AM COLL CARDIOL, V76, P3022, DOI 10.1016/j.jacc.2020.08.044; Rowin EJ, 2017, CIRCULATION, V136, P2420, DOI 10.1161/CIRCULATIONAHA.117.029267; Rowin EJ, 2017, JACC-CARDIOVASC IMAG, V10, P1374, DOI 10.1016/j.jcmg.2017.07.016; Rowin EJ, 2017, J AM COLL CARDIOL, V69, P761, DOI 10.1016/j.jacc.2016.11.063; Sharma S, 2000, AM J CARDIOL, V86, P162, DOI 10.1016/S0002-9149(00)00854-7; Siontis KC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001002; Tan BYQ, 2020, CEREBROVASC DIS, V49, P285, DOI 10.1159/000508211; Tani T, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-34; Vaidya K, 2017, HEART LUNG CIRC, V26, P975, DOI 10.1016/j.hlc.2017.05.116; Vriesendorp PA, 2015, CIRC-ARRHYTHMIA ELEC, V8, P829, DOI 10.1161/CIRCEP.114.002553	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0259638	10.1371/journal.pone.0259638	http://dx.doi.org/10.1371/journal.pone.0259638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030160	gold, Green Published			2022-12-26	WOS:000812798500004
J	Vendramini, THA; Olivindo, RFG; Zafalon, RVA; Rentas, MF; Zanini, LD; Amaral, AR; Pedrinelli, V; de Oliveira, VV; Risolia, LW; Teixeira, FA; Brunetto, MA				Annibale Vendramini, Thiago Henrique; Gomes Olivindo, Rodrigo Fernando; Amorim Zafalon, Rafael Vessecchi; Rentas, Mariana Fragoso; Zanini, Lucca Denuci; Amaral, Andressa Rodrigues; Pedrinelli, Vivian; de Oliveira, Vinicius Vasques; Risolia, Larissa Wunsche; Teixeira, Fabio Alves; Brunetto, Marcio Antonio			Profile qualitative variables on the dynamics of weight loss programs in dogs	PLOS ONE			English	Article							LIMITED FOOD-CONSUMPTION; OWNER-PERCEIVED OBESITY; RISK-FACTORS; VETERINARY PRACTICES; LEPTIN CONCENTRATIONS; PREVALENCE; OSTEOARTHRITIS; ASSOCIATION; NUTRITION; CATS	Obesity is the most common nutritional disorder in dogs and it is associated with many comorbidities. Some obesity risk factors have already been established, however, the evaluation of the effect of different individual variables on weight loss induced by calorie restriction, although very important, is still poorly explored. The weight loss protocol can be updated and improved by more precise and adjusted equations throughout the weight loss program in the clinical routine practice. Therefore, the objective of this study was to analyze weight loss program dynamics in groups according to reproductive status, age, body size, and breed, as well as to define more accurately the amount of calories per target metabolic weight throughout the program. Data of 1,053 cases, presented between 2012 and 2019 at the Veterinary Hospital of the School of Veterinary Medicine and Animal Science of the University of Sao Paulo (FMVZ-USP) were retrospectively analyzed. A total of 77 obese dogs (body condition scores 8/9 or 9/9) of different ages, breeds, sizes, and reproductive status were selected. These dogs did not have any concomitant illnesses and successfully completed the weight loss program. Statistical analysis was performed and values of p <= 0.05 were considered significant. The proposed weight loss program was based on an energy restriction protocol where daily energy intake (in kcal) was estimated as 70 kcal x target weight(0.)(75). The target weight (TW) was defined as 80% of the animal's current weight. The average calorie intake for weight loss (calories x target weight(0.75)) was lower for spayed females (62.36), differing from intact males (66.14) and neutered males (65.41), while intact females (63.66) showed intermediate values without differing between groups (p = 0.015). There were no differences between weight loss calories according to age (p = 0.473) or body size (p = 0.084), allowing the use of the same mathematical equation for intact and neutered dogs; for dogs older than 1 year and of different body sizes. Regarding the breed, the average calorie intake was lower (p = 0.002) in mixed breed dogs (61.54xTW(0.)(75)) when compared to obesity-prone purebred dogs (64.17xTW(0.)(75)) and other purebreds (65.27xTW(0.)(75)). It was concluded that spayed females and mixed breed dogs have greater difficulty in losing weight, that is, they need fewer calories per metabolic body weight for the weight loss program to succeed. A more accurate equation for energy requirement for weight loss can improve chances of success, therefore improving compliance and helping clinical management of obesity in dogs.	[Annibale Vendramini, Thiago Henrique; Amorim Zafalon, Rafael Vessecchi; Rentas, Mariana Fragoso; Zanini, Lucca Denuci; Risolia, Larissa Wunsche; Brunetto, Marcio Antonio] Univ Sao Paulo, Pet Nutrol Res Ctr, Nutr & Prod Dept, Sch Vet Med & Anim Sci, Pirassununga, Brazil; [Gomes Olivindo, Rodrigo Fernando; Amaral, Andressa Rodrigues; Pedrinelli, Vivian; de Oliveira, Vinicius Vasques; Teixeira, Fabio Alves; Brunetto, Marcio Antonio] Univ Sao Paulo, Vet Teaching Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Brunetto, MA (corresponding author), Univ Sao Paulo, Pet Nutrol Res Ctr, Nutr & Prod Dept, Sch Vet Med & Anim Sci, Pirassununga, Brazil.; Brunetto, MA (corresponding author), Univ Sao Paulo, Vet Teaching Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, Brazil.	mabrunetto@usp.br		Vendramini, Thiago/0000-0003-4457-8392	Grandfood Ind. Ltd.	Grandfood Ind. Ltd.	We would like to thank Grandfood Ind. Ltd. team for maintaining the Pet Nutrology Research Center and supporting the Veterinary Nutrology Service.	Montoya-Alonso JA, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00059; Vendramini THA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238638; Bach JF, 2007, AM J VET RES, V68, P670, DOI 10.2460/ajvr.68.6.670; Brooks D, 2014, J AM ANIM HOSP ASSOC, V50, P1, DOI 10.5326/JAAHA-MS-6331; Brown DC, 1996, VET COMP ORTHOPAED, V9, P75; Brunetto MA, 2011, BRIT J NUTR, V106, pS194, DOI 10.1017/S0007114511000870; Brunetto MA, 2011, CIENC RURAL, V41, P266, DOI 10.1590/S0103-84782011005000004; Carciofi Aulus Cavalieri, 2005, Cienc. Rural, V35, P1331, DOI 10.1590/S0103-84782005000600016; CHIKAMUNE T, 1995, J VET MED SCI, V57, P595, DOI 10.1292/jvms.57.595; Colliard L, 2006, J NUTR, V136, p1951S, DOI 10.1093/jn/136.7.1951S; Corbee RJ, 2013, J ANIM PHYSIOL AN N, V97, P904, DOI 10.1111/j.1439-0396.2012.01336.x; Couillard C, 1997, DIABETOLOGIA, V40, P1178, DOI 10.1007/s001250050804; Courcier EA, 2010, J SMALL ANIM PRACT, V51, P362, DOI 10.1111/j.1748-5827.2010.00933.x; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; Devito FC, 2020, VET ANIM SCI, V10, DOI 10.1016/j.vas.2020.100131; EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391; Flanagan J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184199; Freeman LM, 2012, J VET INTERN MED, V26, P3, DOI 10.1111/j.1939-1676.2011.00838.x; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; GARLAND T, 1991, EVOLUTION, V45, P1969, DOI 10.1111/j.1558-5646.1991.tb02703.x; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; German AJ, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.6; German AJ, 2011, BRIT J NUTR, V106, pS93, DOI 10.1017/S0007114511000584; Porsani MYH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70937-8; Hayek MG., 1998, J ANTI-AGING MED, V1, P117, DOI [10.1089/rej.1.1998.1.117, DOI 10.1089/REJ.1.1998.1.117]; HENDRICKS JC, 1992, VET CLIN N AM-SMALL, V22, P1145, DOI 10.1016/S0195-5616(92)50306-0; Hosgood G, 2007, J VET EMERG CRIT CAR, V8, P222, DOI DOI 10.1111/J.1476-4431.1998.TB00128.X; Jeusette IC, 2005, RES VET SCI, V79, P169, DOI 10.1016/j.rvsc.2004.11.012; Kealy RD, 2000, J AM VET MED ASSOC, V217, P1678, DOI 10.2460/javma.2000.217.1678; Kealy RD, 1997, J AM VET MED ASSOC, V210, P222; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Laflamme D, 1997, CANINE PRACT, V22, P10; Laflamme D, 2014, VET CLIN N AM-SMALL, V44, P761, DOI 10.1016/j.cvsm.2014.03.001; Larsen JA, 2014, VET CLIN N AM-SMALL, V44, P741, DOI 10.1016/j.cvsm.2014.03.003; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Mao JF, 2013, PREV VET MED, V112, P438, DOI 10.1016/j.prevetmed.2013.08.012; Mawby DI, 2004, J AM ANIM HOSP ASSOC, V40, P109, DOI 10.5326/0400109; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Neto GBP, 2010, PESQUI VET BRASIL, V30, P167, DOI 10.1590/S0100-736X2010000200012; NRC, 2006, NUTR REQ DOGS CATS, DOI [10.17226/10668, DOI 10.17226/10668]; O'Neill DG, 2014, VET J, V202, P286, DOI 10.1016/j.tvjl.2014.08.004; Park HJ, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-113; Pereira-Neto GB, 2018, J ANIM PHYSIOL AN N, V102, P1743, DOI 10.1111/jpn.12963; Pereira-Neto GB, 2014, PESQUI VET BRASIL, V34, P87, DOI 10.1590/S0100-736X2014001300016; Pianka ER, 2000, EVOL ECOL, V6th, DOI [10.2307/4645, DOI 10.2307/4645]; Piantedosi D, 2016, VET J, V216, P72, DOI 10.1016/j.tvjl.2016.07.002; Raffan E, 2016, CELL METAB, V23, P893, DOI 10.1016/j.cmet.2016.04.012; Robertson ID, 2003, PREV VET MED, V58, P75, DOI 10.1016/S0167-5877(03)00009-6; Sallander M, 2010, PREV VET MED, V96, P132, DOI 10.1016/j.prevetmed.2010.05.004; SANTEN RJ, 1980, AM J PHYSIOL, V239, pE109, DOI 10.1152/ajpendo.1980.239.2.E109; Schauf S, 2016, J ANIM SCI, V94, P4239, DOI 10.2527/jas.2015-0109; Tropf M, 2017, J VET INTERN MED, V31, P1000, DOI 10.1111/jvim.14775; Usui S, 2016, ASIAN PAC J TROP BIO, V6, P338, DOI 10.1016/j.apjtb.2016.01.011; Vendramini THA, 2020, NUTR RES REV, V33, P134, DOI 10.1017/S0954422419000271; Zoran DL, 2010, VET CLIN N AM-SMALL, V40, P221, DOI 10.1016/j.cvsm.2009.10.009	56	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261946	10.1371/journal.pone.0261946	http://dx.doi.org/10.1371/journal.pone.0261946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020762	Green Published, gold			2022-12-26	WOS:000834207700030
J	Lee, G; Yoon, SE; Shin, K				Lee, Geon; Yoon, Se-eun; Shin, Kijung			Simple epidemic models with segmentation can be better than complex ones	PLOS ONE			English	Article								Given a sequence of epidemic events, can a single epidemic model capture its dynamics during the entire period? How should we divide the sequence into segments to better capture the dynamics? Throughout human history, infectious diseases (e.g., the Black Death and COVID-19) have been serious threats. Consequently, understanding and forecasting the evolving patterns of epidemic events are critical for prevention and decision making. To this end, epidemic models based on ordinary differential equations (ODEs), which effectively describe dynamic systems in many fields, have been employed. However, a single epidemic model is not enough to capture long-term dynamics of epidemic events especially when the dynamics heavily depend on external factors (e.g., lockdown and the capability to perform tests). In this work, we demonstrate that properly dividing the event sequence regarding COVID-19 (specifically, the numbers of active cases, recoveries, and deaths) into multiple segments and fitting a simple epidemic model to each segment leads to a better fit with fewer parameters than fitting a complex model to the entire sequence. Moreover, we propose a methodology for balancing the number of segments and the complexity of epidemic models, based on the Minimum Description Length principle. Our methodology is (a) Automatic: not requiring any user-defined parameters, (b) Model-agnostic: applicable to any ODE-based epidemic models, and (c) Effective: effectively describing and forecasting the spread of COVID-19 in 70 countries.	[Lee, Geon; Shin, Kijung] Korea Adv Inst Sci & Technol, Kim Jaechul Grad Sch AI, Daejeon, South Korea; [Yoon, Se-eun; Shin, Kijung] Korea Adv Inst Sci & Technol, Sch Elect Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Shin, K (corresponding author), Korea Adv Inst Sci & Technol, Kim Jaechul Grad Sch AI, Daejeon, South Korea.; Shin, K (corresponding author), Korea Adv Inst Sci & Technol, Sch Elect Engn, Daejeon, South Korea.	kijungs@kaist.ac.kr			Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2019M3D7A1094364]; Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT) [2019-0-00075]	Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science and ICT(National Research Foundation of Korea); Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This research was supported by Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (No. 2019M3D7A1094364), and Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) (No. 2019-0-00075, Artificial Intelligence Graduate School Program (KAIST)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antulov-Fantulin N, 2013, INFORM SCIENCES, V239, P226, DOI 10.1016/j.ins.2013.03.036; Baranowski R, 2019, J R STAT SOC B, V81, P649, DOI 10.1111/rssb.12322; Bohm C., 2007, ACM T KNOWL DISCOV D, V1, P10, DOI [DOI 10.1145/1297332.1297334, 10.1145/1297332.1297334]; Chen RTQ., 2018, NEURAL ORDINARY DIFF; Dandekar R., 2020, MEDRXIV; Davidson I, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P194; Fang HP, 2005, P ANN INT IEEE EMBS, P7470; George Em Karniadakis, 2017, Arxiv, DOI arXiv:1703.10230; Guo WJ, 2018, INFORM SCIENCES, V467, P670, DOI 10.1016/j.ins.2018.03.054; Hethcote H.W., 1981, DIFFER EQUATIONS APP, P65; Hooi B, 2017, LECT NOTES ARTIF INT, V10535, P3, DOI 10.1007/978-3-319-71246-8_1; Jiang FY, 2021, J R STAT SOC B, DOI 10.1111/rssb.12453; Jiang Feiyu, 2023, J Econom, V232, P1, DOI 10.1016/j.jeconom.2020.07.039; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Mathioudakis M., 2010, WSDM; Matsubara Y., 2012, P 18 ACM SIGKDD INT, P6, DOI 10.1145/2339530.2339537; Matsubara Y, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P458, DOI 10.1145/3292500.3330947; Matsubara Y, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1045, DOI 10.1145/2939672.2939755; Matsubara Y, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P721, DOI 10.1145/2736277.2741092; Matsubara Y, 2014, SIGMOD'14: PROCEEDINGS OF THE 2014 ACM SIGMOD INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P193, DOI 10.1145/2588555.2588556; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Osemwinyen A, 2015, APPL COMPUT MATH, V4, P313, DOI [10.11648/j.acm.20150404.19, DOI 10.11648/j.acm.20150404.19]; Papadimitriou S., 2005, P 31 INT C VER LARG; Papadimitriou S., 2006, P 2006 ACM SIGMOD IN; Raissi M, 2018, J COMPUT PHYS, V357, P125, DOI 10.1016/j.jcp.2017.11.039; Rajkumar S., 2020, DAY LEVEL INFORM COV; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Schober M, 2014, ADV NEUR IN, V27; SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; Yang F, 2018, PROC INT CONF DATA, P65, DOI 10.1109/ICDE.2018.00016	31	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262244	10.1371/journal.pone.0262244	http://dx.doi.org/10.1371/journal.pone.0262244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020775	gold, Green Published			2022-12-26	WOS:000834207700038
J	Suzuki, Y; Iijima, H; Nakamura, M; Aoyama, T				Suzuki, Yusuke; Iijima, Hirotaka; Nakamura, Masatoshi; Aoyama, Tomoki			Rate of force development in the quadriceps of individuals with severe knee osteoarthritis: A preliminary cross-sectional study	PLOS ONE			English	Article							MUSCLE STRENGTH; RISK; WEAKNESS; DISEASE; PAIN; HIP	Knee osteoarthritis (KOA) is a leading cause of knee pain and disability due to irreversible cartilage degeneration. Previous studies have not identified modifiable risk factors for KOA. In this preliminary cross-sectional study, we aimed to test the following hypotheses: individuals with severe KOA would have a significantly lower quadriceps rate of force development (RFD) than individuals with early KOA, and the decrease in quadriceps RFD would be greater than the decrease in maximum quadriceps strength in individuals with severe KOA. The maximum isometric strength of the quadriceps was assessed in individuals with mild (Kellgren and Lawrence [K&L]grade 1-2) and severe KOA (K&L grade 3-4) using a handheld dynamometer. The RFD was analyzed at 200 ms from torque onset and normalized to the body mass and maximum voluntary isometric contraction torque. To test whether the quadriceps RFD was lowered and whether the lower in the quadriceps RFD was greater than the lower in maximum quadriceps strength in individuals with severe knee OA, the Mann-Whitney U-test and analysis of covariance were performed, respectively. The effect size (ES) based on Hedges' g with a 95% confidence interval (CI) was calculated for the quadriceps RFD and maximum quadriceps strength. Sixty-six participants were analyzed. Individuals with severe KOA displayed significantly lower quadriceps RFD (p = 0.009), the lower being greater than the lower in maximum quadriceps strength (between-group difference, ES: 0.88, -1.07 vs. 0.06, -0.22). Our results suggest that a decreased quadriceps RFD is a modifiable risk factor for progressive KOA. Our finding could help in the early detection and prevention of severe KOA.	[Suzuki, Yusuke; Nakamura, Masatoshi] Niigata Univ Hlth & Welf, Fac Rehabil, Dept Phys Therapy, Niigata, Japan; [Iijima, Hirotaka; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Human Hlth Sci, Kyoto, Japan; [Iijima, Hirotaka] Keio Univ, Fac Sci & Technol, Dept Syst Design Engn, Yokohama, Kanagawa, Japan	Niigata University; Kyoto University; Keio University	Suzuki, Y (corresponding author), Niigata Univ Hlth & Welf, Fac Rehabil, Dept Phys Therapy, Niigata, Japan.	yusuke-suzuki@nuhw.ac.jp		Suzuki, Yusuke/0000-0001-9595-2191	JSPS KAKENHI [20K19356]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI with grant number 20K19356 (Yusuke Suzuki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Amin S, 2009, ARTHRITIS RHEUM-US, V60, P189, DOI 10.1002/art.24182; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Ando R, 2019, HUM MOVEMENT SCI, V66, P285, DOI 10.1016/j.humov.2019.05.002; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Bierma-Zeinstra SMA, 2007, NAT CLIN PRACT RHEUM, V3, P78, DOI 10.1038/ncprheum0423; Callahan DM, 2015, EXP GERONTOL, V72, P16, DOI 10.1016/j.exger.2015.08.016; Callahan DM, 2014, J APPL PHYSIOL, V116, P1582, DOI 10.1152/japplphysiol.01362.2013; Culvenor AG, 2017, ARTHRIT CARE RES, V69, P649, DOI 10.1002/acr.23005; Fukutani N, 2016, CLIN RHEUMATOL, V35, P2307, DOI 10.1007/s10067-016-3251-8; Henriksen M, 2012, KNEE, V19, P392, DOI 10.1016/j.knee.2011.07.003; Hu B, 2018, ARCH PHYS MED REHAB, V99, P1352, DOI 10.1016/j.apmr.2017.12.027; Hurley MV, 1999, RHEUM DIS CLIN N AM, V25, P283, DOI 10.1016/S0889-857X(05)70068-5; Iijima Hirotaka, 2018, BMC Psychol, V6, P19, DOI 10.1186/s40359-018-0234-3; Jefferson R J, 1990, Proc Inst Mech Eng H, V204, P21, DOI 10.1243/PIME_PROC_1990_204_224_02; Kamo T, 2019, GAIT POSTURE, V72, P28, DOI 10.1016/j.gaitpost.2019.05.019; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; LaRoche DP, 2010, J ELECTROMYOGR KINES, V20, P482, DOI 10.1016/j.jelekin.2009.08.004; Mirkov DM, 2004, EUR J APPL PHYSIOL, V91, P147, DOI 10.1007/s00421-003-0946-8; Oiestad BE, 2015, OSTEOARTHR CARTILAGE, V23, P171, DOI 10.1016/j.joca.2014.10.008; Petterson SC, 2008, MED SCI SPORT EXER, V40, P422, DOI [10.1249/mss.0b013e31815ef285, 10.1249/MSS.0b013e31815ef285]; Suetta C, 2007, J APPL PHYSIOL, V102, P942, DOI 10.1152/japplphysiol.00067.2006; Suetta C, 2004, J APPL PHYSIOL, V97, P1954, DOI 10.1152/japplphysiol.01307.2003; van Leeuwen DLM, 2013, AGING CLIN EXP RES, V25, P561, DOI 10.1007/s40520-013-0110-1; Ventura A, 2019, J ELECTROMYOGR KINES, V44, P94, DOI 10.1016/j.jelekin.2018.11.010; Vickers Andrew J, 2006, J Soc Integr Oncol, V4, P194, DOI 10.2310/7200.2006.023; Vos T., 2012, LANCET, V380, P2163, DOI [10.1016/S0140-6736(12)61729-2, DOI 10.1016/S0140-6736(12)61729-2, 10.1016/S0140-6736(12)61729-2.Erratumin]; Wang CY, 2002, ARCH PHYS MED REHAB, V83, P811, DOI 10.1053/apmr.2002.32743; Winters JD, 2014, EUR J APPL PHYSIOL, V114, P273, DOI 10.1007/s00421-013-2759-8	29	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262508	10.1371/journal.pone.0262508	http://dx.doi.org/10.1371/journal.pone.0262508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015797	gold, Green Published, Green Submitted			2022-12-26	WOS:000814820600031
J	Woods, M; Koon, W; Brander, RW				Woods, Mark; Koon, William; Brander, Robert W.			Identifying risk factors and implications for beach drowning prevention amongst an Australian multicultural community	PLOS ONE			English	Article							CURRENT HAZARD; RIP CURRENTS; SAFETY; KNOWLEDGE; PERCEPTIONS; EDUCATION; STUDENTS; ABILITY	Multicultural communities in Australia are recognised as a priority area for drowning prevention, but no evidence-based study has addressed their knowledge of beach safety. This study used an online survey tool to identify and examine risk factors relating to swimming ability, beach visitation characteristics and behaviour, and beach safety knowledge of the Australian Southern Asian community to assist in the development of future beach safety interventions. Data was obtained through 249 online and in-person surveys of people aged > 18 years. Most respondents reported poor swimming ability (80%), often swam in in the absence of lifeguards (77%), did not understand the rip current hazard (58%), but reported that they entered the water (76%) when visiting beaches. Close to one-quarter (28%) had not heard, or didn't know the purpose, of the red and yellow beach flags, which identify lifeguard supervised areas on Australian beaches. Length of time living in Australia is an important beach safety consideration for this community, with minimal differences in terms of gender and age. Those who have lived < 10 years in Australia visit beaches more frequently and are less likely to have participated in swimming lessons, be able to swim, heard of the flags or swim between them, understand rip currents, or have participated in a beach safety program. Very few (3%) respondents received beach safety information from within their own community. The importance of beach safety education and swimming lessons within the Southern Asian community should be prioritised for new and recent migrants to Australia.	[Woods, Mark; Koon, William; Brander, Robert W.] UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Woods, Mark; Koon, William; Brander, Robert W.] UNSW Sydney, UNSW Beach Safety Res Grp, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Brander, RW (corresponding author), UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.; Brander, RW (corresponding author), UNSW Sydney, UNSW Beach Safety Res Grp, Sydney, NSW, Australia.	rbrander@unsw.edu.cn	Brander, Robert/GZH-3081-2022	Koon, William/0000-0003-4708-4347; Brander, Robert/0000-0002-7268-2587				Acharya M, 2018, SBS; Australian Bureau of Statistics (ABS), 2021, MIGRATION; Australian Bureau of Statistics (ABS), CENS 2016 COUNTR BIR; Australian Bureau of Statistics (ABS), CENS 2016 ANC BIRTHP; Australian Water Safety Council, 2021, AUSTR WAT SAF STRAT; Ballantyne R, 2005, TOURISM MANAGE, V26, P617, DOI 10.1016/j.tourman.2004.02.016; Batra R, 2016, ADV DEV HUM RESOUR, V18, P88, DOI 10.1177/1523422316630651; Beale-Tawfeeq A. K., 2018, International Journal of Aquatic Research and Education, V11, P8, DOI 10.25035/ijare.11.01.08; Beasley Intercultural, 2018, CULTR DIV DROWN PREV; Brander R, 2013, NAT HAZARD EARTH SYS, V13, P1687, DOI 10.5194/nhess-13-1687-2013; Brander RW., 2015, RIP CURRENTS, P335; Brannstrom C, 2015, APPL GEOGR, V56, P61, DOI 10.1016/j.apgeog.2014.10.011; Brannstrom C, 2014, NAT HAZARDS, V72, P1123, DOI 10.1007/s11069-014-1061-3; Brighton B, 2013, NAT HAZARD EARTH SYS, V13, P1069, DOI 10.5194/nhess-13-1069-2013; Caldwell N, 2013, NAT HAZARDS, V68, P1041, DOI 10.1007/s11069-013-0673-3; Castelle B, 2016, EARTH-SCI REV, V163, P1, DOI 10.1016/j.earscirev.2016.09.008; Clifford KM, 2018, TOURISM MANAGE, V69, P487, DOI 10.1016/j.tourman.2018.06.032; Cooney N., 2020, COASTAL SAFETY BRIEF; Della Bona M, 2019, INT J PUBLIC HEALTH, V64, P755, DOI 10.1007/s00038-018-1197-0; FAO, 2015, FISH AQ COUNTR PROF; Farmer N., 2016, ESTABLISHING BEACH S, P161; Golob M. I., 2013, International Journal of Aquatic Research and Education, V7, P39; Hatfield J, 2012, ACCIDENT ANAL PREV, V46, P45, DOI 10.1016/j.aap.2011.10.003; Houser C, 2017, NAT HAZARD EARTH SYS, V17, P1003, DOI 10.5194/nhess-17-1003-2017; Irwin CC., 2009, INT J AQUATIC RES ED, V3, P10, DOI [10.25035/ijare.03.01.03, DOI 10.25035/IJARE.03.01.03]; Kamstra P, 2020, INT J DISAST RISK RE, V47, DOI 10.1016/j.ijdrr.2020.101558; Koon W, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246034; Lawes JC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256202; Lawes JC, 2021, INJURY PREV, V27, P442, DOI 10.1136/injuryprev-2020-043969; Lawes JC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238317; Mackellar KM., 2015, INT J AQUATIC RES ED, V9, P348, DOI [10.25035/ijare.09.03.10, DOI 10.25035/IJARE.09.03.10]; Matthews B., 2012, INJURY PREV, V18, DOI [10.1136/injuryprev-2012-040590h.14, DOI 10.1136/INJURYPREV-2012-040590H.14]; Matthews B, 2014, SAFETY SCI, V62, P312, DOI 10.1016/j.ssci.2013.09.003; Metwally Y., 2018, SBS; Mitchell R., 2004, HEALTH PROMOT J AUST, V15, P38, DOI [10.1071/he04038, DOI 10.1071/HE04038]; Moran K., 2013, International Journal of Aquatic Research and Education, V7, P136; Multicultural NSW, PROF ENGL; Pasta DJ, 2009, LEARNING BE DISCRETE; Pitman SJ, 2021, NAT HAZARD EARTH SYS, V21, P115, DOI 10.5194/nhess-21-115-2021; Robitzsch A, 2020, FRONT EDUC, V5, DOI 10.3389/feduc.2020.589965; Savage M. A., 2015, International Journal of Aquatic Research and Education, V9, P241; Scarr J, 2019, ADDRESSING DROWNING; SES Multicultural Water Safety Committee (SESMWSC), 2018, S E SYDN WAT SAF DIR; Sherker S, 2008, J SCI MED SPORT, V11, P81, DOI 10.1016/j.jsams.2006.08.007; Sherker S, 2010, ACCIDENT ANAL PREV, V42, P1785, DOI 10.1016/j.aap.2010.04.020; Short A., 2007, BEACHES NEW S WALES; Siano CJ, 2010, ARCH PEDIAT ADOL MED, V164, P299, DOI 10.1001/archpediatrics.2009.296; Stanley T., 2018, J ED HUMAN DEV, V7, P82, DOI [10.1186/s13054-018-2052-7, DOI 10.1186/S13054-018-2052-7]; Stevenson L, 2021, AUST J FORENSIC SCI, V53, P535, DOI 10.1080/00450618.2020.1759686; Surf Life Saving Australia, 2020, NAT COAST SAF REP 20; White KM, 2010, ACCIDENT ANAL PREV, V42, P1831, DOI 10.1016/j.aap.2010.05.004; Wilks J, 2017, INT J INJ CONTROL SA, V24, P283, DOI 10.1080/17457300.2016.1170043; Willcox-Pidgeon S, 2021, AUST NZ J PUBL HEAL, V45, P255, DOI 10.1111/1753-6405.13102; Willcox-Pidgeon SM, 2021, HEALTH PROMOT J AUST, V32, P49, DOI 10.1002/hpja.407; Willcox-Pidgeon SM, 2020, INJURY PREV, V26, P279, DOI 10.1136/injuryprev-2019-043432; Williamson A, 2012, AUST NZ J PUBL HEAL, V36, P385, DOI 10.1111/j.1753-6405.2012.00888.x; Woodward E, 2013, J COASTAL RES, P850, DOI 10.2112/SI65-144.1	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262175	10.1371/journal.pone.0262175	http://dx.doi.org/10.1371/journal.pone.0262175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015768	Green Published, gold			2022-12-26	WOS:000814820600010
J	Rasouli-Dogaheh, S; Komarek, J; Chatchawan, T; Hauer, T				Rasouli-Dogaheh, Somayeh; Komarek, Jiri; Chatchawan, Thomrat; Hauer, Tomas			Thainema gen. nov. (Leptolyngbyaceae, Synechococcales): A new genus of simple trichal cyanobacteria isolated from a solar saltern environment in Thailand	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SPECIES DELIMITATION; SP.-NOV.; MOLECULAR CHARACTERIZATION; PHYLOGENETIC-RELATIONSHIPS; SECONDARY STRUCTURE; DIVERSITY; SEQUENCE; GENERA; EVOLUTIONARY	Simple trichal types constitute a group of cyanobacteria with an abundance of novel, often cryptic taxa. Here, we investigated material collected from wet surface-soil in a saline environment in Petchaburi Province, central Thailand. A morphological comparison of the isolated strain with similar known species, as well as its phylogenetic and species delimitation analyses based on the combined datasets of other related organisms, especially simple trichal cyanobacteria, revealed that the material of this study represented an independent taxon. Using a multifaceted method, we propose that this material represents a new genus, Thainema gen. nov., belonging to the family Leptolyngbyaceae, with the type species Thainema salinarum sp. nov. This novel taxon shares similar ecological habitats with strains previously placed in the same lineage.	[Rasouli-Dogaheh, Somayeh; Komarek, Jiri; Hauer, Tomas] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Chatchawan, Thomrat] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand; [Komarek, Jiri] Acad Sci Czech Republ, Inst Bot, Trebon, Czech Republic	University of South Bohemia Ceske Budejovice; Chiang Mai University; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Rasouli-Dogaheh, S (corresponding author), Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic.	somaye.rasooli1990@gmail.com	Hauer, Tomas/F-5089-2010	Hauer, Tomas/0000-0002-8005-5874	Ministry of Education of the CR [LTAUSA 180088]; TRF/BIOTEC Special Program for Biodiversity Research and Training Grant [BRT T_149014]; Ministry of Education [GACR 206/08/0318]	Ministry of Education of the CR(Ministry of Education, Youth & Sports - Czech Republic); TRF/BIOTEC Special Program for Biodiversity Research and Training Grant(Thailand Research Fund (TRF)); Ministry of Education	TH, TC, JK. -1.Ministry of Education of the CR project No. LTAUSA 180088 (TH) 2.TRF/BIOTEC Special Program for Biodiversity Research and Training Grant BRT T_149014 (TC) 3.GACR 206/08/0318 (JK) -Ministry of Education of the CR -https://www.msmt.cz/-NO: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2002, ARCH MICROBIOL, V177, P361, DOI 10.1007/s00203-001-0390-2; Adeolu M, 2013, ANTON LEEUW INT J G, V104, P1, DOI 10.1007/s10482-013-9920-6; Akagham SC, 2019, FOTTEA, V19, P1, DOI 10.5507/fot.2018.012; Becerra-Absalon I, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00937; Blank CE, 2016, ALGAL RES, V15, P152, DOI 10.1016/j.algal.2016.02.014; Bohunicka M, 2015, PHYTOTAXA, V197, P84, DOI 10.11646/phytotaxa.197.2.2; Bornet E, 1888, REVISION NOSTOCACEES; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Brito A, 2017, MOL PHYLOGENET EVOL, V111, P18, DOI 10.1016/j.ympev.2017.03.006; Caires TA, 2018, MOL PHYLOGENET EVOL, V120, P196, DOI 10.1016/j.ympev.2017.12.009; Casamatta DA, 2006, HYDROBIOLOGIA, V561, P13, DOI 10.1007/s10750-005-1602-6; CASTENHOLZ RW, 1992, J PHYCOL, V28, P737, DOI 10.1111/j.0022-3646.1992.00737.x; Castenholz RW, 2001, PHYLUM BX CYANOBACTE; Chakraborty S, 2019, PHYTOTAXA, V422, P58, DOI 10.11646/phytotaxa.422.1.4; Chatchawan T, 2011, FOTTEA, V11, P203, DOI 10.5507/fot.2011.019; DasSarma S., 2001, ELS, P1, DOI DOI 10.1038/NPG.ELS.0000394; Dennis PP, 1997, MICROBIOL MOL BIOL R, V61, P90, DOI 10.1128/.61.1.90-104.1997; Derkarabetian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104982; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dvorak P, 2017, MODERN TOPICS PHOTOT, P3, DOI [10.1007/978-3-319-46261-5, DOI 10.1007/978-3-319-46261-5]; Dvorak P, 2018, FOTTEA, V18, P130, DOI 10.5507/fot.2017.023; Dvorak P, 2015, BIODIVERS CONSERV, V24, P739, DOI 10.1007/s10531-015-0888-6; Eckert Ester M., 2015, Life-Basel, V5, P50, DOI 10.3390/life5010050; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Fourcans A, 2006, FEMS MICROBIOL ECOL, V57, P367, DOI 10.1111/j.1574-6941.2006.00124.x; Fucikova K, 2014, J PHYCOL, V50, P14, DOI 10.1111/jpy.12118; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gevers D, 2006, PHILOS T R SOC B, V361, P1911, DOI 10.1098/rstb.2006.1915; Giarla TC, 2014, MOL PHYLOGENET EVOL, V70, P137, DOI 10.1016/j.ympev.2013.09.019; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P3584, DOI 10.1128/jb.170.8.3584-3592.1988; Gonzalez-Resendiz L, 2019, J PHYCOL, V55, P898, DOI 10.1111/jpy.12867; Gupta RS, 2015, INT J SYST EVOL MICR, V65, P1050, DOI 10.1099/ijs.0.070136-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Johansen J. R., 2005, ALGOLOGICAL STUDIES, V116, P71, DOI [DOI 10.1127/1864-1318/2005/0117-0071, 10.1127/1864-1318/2005/0117-0071]; Johansen JR, 2011, NOVA HEDWIGIA, V92, P283, DOI 10.1127/0029-5035/2011/0092-0283; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Kilgore C, 2018, FOTTEA, V18, P150, DOI 10.5507/fot.2018.002; Komarek J, 2021, WORLD WIDE ELECT PUB; Komarek J., 2005, CYANOPROKARYOTA 2, V19; Komarek J, 1999, CYANOPROKARYOTA TEIL, V19; Komarek Jiri, 2006, Algae, V21, P349; Komarek J, 2014, PRESLIA, V86, P295; Komarkova J, 2013, FOTTEA, V13, P227, DOI 10.5507/fot.2013.018; Kosuthova A, 2020, BMC EVOL BIOL, V20, DOI 10.1186/s12862-020-01681-w; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lemes-Da-Silva NM, 2012, BRAZ J BOT, V35, P169, DOI 10.1590/S1806-99592012000200006; Li XC, 2016, PHYCOLOGIA, V55, P478, DOI 10.2216/15-149.1; Loren JG, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00770; Mai T, 2018, PHYTOTAXA, V365, P1, DOI 10.11646/phytotaxa.365.1.1; Malavasi V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151137; Vaz MGMV, 2015, INT J SYST EVOL MICR, V65, P298, DOI 10.1099/ijs.0.070110-0; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SR, 2000, APPL ENVIRON MICROB, V66, P4222, DOI 10.1128/AEM.66.10.4222-4229.2000; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Miscoe Laura H., 2016, V120, P75; Mishler BD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P44; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Osorio-Santos K, 2014, EUR J PHYCOL, V49, P450, DOI 10.1080/09670262.2014.976843; Palinska KA, 2014, HYDROBIOLOGIA, V740, P1, DOI 10.1007/s10750-014-1971-9; Parker CT, 2019, INT J SYST EVOL MICR, V69, pS7, DOI 10.1099/ijsem.0.000778; Perkerson RB, 2011, J PHYCOL, V47, P1397, DOI 10.1111/j.1529-8817.2011.01077.x; Pietrasiak N, 2019, J PHYCOL, V55, P976, DOI 10.1111/jpy.12897; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rambaut A, FIGTREE VERSION 1 4; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rehakova K, 2007, PHYCOLOGIA, V46, P481, DOI 10.2216/06-92.1; Rehakova K, 2014, FOTTEA, V14, P161, DOI 10.5507/fot.2014.013; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Rudi K, 1998, J BACTERIOL, V180, P3453, DOI 10.1128/JB.180.13.3453-3461.1998; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Satyanarayana T, 2005, CURR SCI INDIA, V89, P78; Sawana A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00429; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Seo PS, 2003, J GEN APPL MICROBIOL, V49, P191, DOI 10.2323/jgam.49.191; Sherwood AR, 2014, PHYCOLOGIA, V53, P579, DOI 10.2216/14-059.1; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2014, EVOLUTION, V68, P2901, DOI 10.1111/evo.12483; Taton A, 2011, POLAR BIOL, V34, P181, DOI 10.1007/s00300-010-0868-y; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Turland NJ, 2018, REGNUM VEG, V159, P1; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Turner S, 1997, PLANT SYST EVOL, P13; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Wilmotte A, 2001, BERGEYS MAN SYST BAC, P487; Xu X, 2017, ZOOL J LINN SOC-LOND, V181, P867, DOI 10.1093/zoolinnean/zlx024; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Zammit G, 2018, PHYCOLOGIA, V57, P481, DOI 10.2216/17-125.1; Zammit G, 2012, EUR J PHYCOL, V47, P341, DOI 10.1080/09670262.2012.717106; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zimba PV, 2017, J PHYCOL, V53, P188, DOI 10.1111/jpy.12490	104	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2022	17	1							e0261682	10.1371/journal.pone.0261682	http://dx.doi.org/10.1371/journal.pone.0261682			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Z7IO	34995289	Green Published, gold			2022-12-26	WOS:000880142700001
J	Arif, B; Arif, Z; Ahmad, J; Perveen, K; Bukhari, NA; Ashraf, JM; Moinuddin; Alam, K				Arif, Binish; Arif, Zarina; Ahmad, Jamal; Perveen, Kahkashan; Bukhari, Najat A.; Ashraf, Jalaluddin M.; Moinuddin; Alam, Khursheed			Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress	PLOS ONE			English	Article							NONENZYMATIC GLYCOSYLATION; LIPID-PEROXIDATION; OXIDATIVE STRESS; MECHANISM; GLYCATION; PROTEINS; MELLITUS; COMPLICATIONS; ALBUMIN; TYPE-1	The micro- and macro-complications in diabetes mellitus (DM) mainly arise from the damage induced by Amadori and advanced glycation end products, as well as the released free radicals. The primary goal of DM treatment is to reduce the risk of micro- and macro-complications. In this study, we looked at the efficacy of aminoguanidine (AG) to prevent the production of early glycation products in alloxan-diabetic rabbits. Type1 DM was induced in rabbits by a single intravenous injection of alloxan (90 mg/kg body weight). Another group of rabbits was pre-treated with AG (100 mg/kg body weight) prior to alloxan injection; this was followed by weekly treatment with 100 mg/kg of AG for eight weeks. Glucose, insulin, and early glycation products (HbA1C and fructosamine) were measured in control, diabetic and AG treated diabetic rabbits. The effects of hyperglycemia on superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (Gpx), reduced glutathione (rGSH), nitric oxide, lipid peroxides, and protein carbonyl were investigated. Alloxan-diabetic rabbits had lower levels of SOD, CAT, Gpx, and rGSH than control rabbits. Nitric oxide levels were considerably greater. AG administration restored the activities of SOD, CAT, Gpx enzymes up to 70-80% and ameliorated the nitric oxide production. HbA1c and fructosamine levels were considerably lower in AG-treated diabetic rabbits. The observed control of hyperglycemia and amadori adducts in alloxan-diabetic rabbits by AG may be attributed to decrease of stress and restoration of antioxidant defenses.	[Arif, Binish] Sherikashmir Inst Med Sci, Dept Clin Biochem, Srinagar, J&K, India; [Arif, Zarina; Moinuddin; Alam, Khursheed] Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Biochem, Aligarh, UP, India; [Ahmad, Jamal] Aligarh Muslim Univ, Fac Med, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, UP, India; [Perveen, Kahkashan; Bukhari, Najat A.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Ashraf, Jalaluddin M.] Jazan Univ, Fac Appl Med Sci, Dept Clin Biochem, Jazan, Saudi Arabia	Sher-i-Kashmir Institute of Medical Sciences; Aligarh Muslim University; Aligarh Muslim University; King Saud University; Jazan University	Alam, K (corresponding author), Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Biochem, Aligarh, UP, India.	kalam786@rediffmail.com	Perveen, Kahkashan/N-1679-2014; Ashraf, Dr. Jalaluddin M/P-5391-2014	Perveen, Kahkashan/0000-0002-9618-5876; Ashraf, Dr. Jalaluddin M/0000-0001-7885-2551; Alam, Khursheed/0000-0001-9729-9966	Deanship of Scientific Research at King Saud University [RGP-066]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors would like to extend their sincere appreciations to the Deanship of Scientific Research at King Saud University for funding to the Research Group No. RGP-066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; ARAI K, 1987, BIOCHIM BIOPHYS ACTA, V924, P292, DOI 10.1016/0304-4165(87)90025-0; Assmann TS, 2016, NITRIC OXIDE-BIOL CH, V61, P1, DOI 10.1016/j.niox.2016.09.009; BUCALA R, 1994, DRUG DEVELOP RES, V32, P77, DOI 10.1002/ddr.430320204; Ceriello A, 2000, METABOLISM, V49, P27, DOI 10.1016/S0026-0495(00)80082-7; Chaturvedi N, 2002, DIABETES CARE, V25, P2320, DOI 10.2337/diacare.25.12.2320; CHEN HJC, 1993, J CARBOHYD CHEM, V12, P731; Cohen MP, 2006, J LAB CLIN MED, V147, P211, DOI 10.1016/j.lab.2005.12.006; Csonka C, 2015, BRIT J PHARMACOL, V172, P1620, DOI 10.1111/bph.12832; CURTISS LK, 1983, J CLIN INVEST, V72, P1427, DOI 10.1172/JCI111099; Dunn JS, 1943, LANCET, V1, P484; El-Mahmoudy A, 2005, INT IMMUNOPHARMACOL, V5, P195, DOI 10.1016/j.intimp.2004.09.001; El-Missiry MA, 2000, ANN NUTR METAB, V44, P97, DOI 10.1159/000012829; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; GALLOU G, 1993, CLIN CHIM ACTA, V214, P227, DOI 10.1016/0009-8981(93)90114-J; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Harding JL, 2019, DIABETOLOGIA, V62, P3, DOI 10.1007/s00125-018-4711-2; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; HIRSCH J, 1995, CARBOHYD RES, V267, P17, DOI 10.1016/0008-6215(94)00285-N; Ighodaro OM, 2017, MEDICINA-LITHUANIA, V53, P365, DOI 10.1016/j.medici.2018.02.001; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Jakus V, 2000, Bratisl Lek Listy, V101, P541; Jaleel A, 2005, DIABETES CARE, V28, P645, DOI 10.2337/diacare.28.3.645; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kedziora-Kornatowska KZ, 1998, CLIN CHEM LAB MED, V36, P771; KENNEDY L, 1984, DIABETOLOGIA, V26, P93; KHATAMI M, 1988, LIFE SCI, V43, P1725, DOI 10.1016/0024-3205(88)90484-5; KIRSCHENBAUM DM, 1984, PEDIATR CLIN N AM, V31, P611; KURAHASHI M, 1993, DIABETES RES CLIN PR, V19, P39, DOI 10.1016/0168-8227(93)90143-S; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LEWIS BS, 1990, EXP EYE RES, V50, P463, DOI 10.1016/0014-4835(90)90033-Q; Magdaleno F, 2019, EXP THER MED, V18, P3125, DOI 10.3892/etm.2019.7921; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mironova R, 2005, MOL MICROBIOL, V55, P1801, DOI 10.1111/j.1365-2958.2005.04504.x; MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7; Nagai R, 2012, DIABETES, V61, P549, DOI 10.2337/db11-1120; Natarajan R, 2021, DIABETES, V70, P328, DOI 10.2337/dbi20-0030; Lima TFO, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1036360; Ozturk A, 2012, EXP DIABETES RES, DOI 10.1155/2012/721256; Pageon H, 2010, PATHOL BIOL, V58, P226, DOI 10.1016/j.patbio.2009.09.009; Parlakpinar H, 2004, UROL RES, V32, P278, DOI 10.1007/s00240-004-0399-5; Rabbani N, 2020, OXIDATIVE STRESS: EUSTRESS AND DISTRESS, P759, DOI 10.1016/B978-0-12-818606-0.00036-5; Schalkwijk CG, 1999, DIABETES, V48, P2446, DOI 10.2337/diabetes.48.12.2446; Sliman SM, 2010, MOL CELL BIOCHEM, V333, P9, DOI 10.1007/s11010-009-0199-x; STOCKS J, 1971, BRIT J HAEMATOL, V20, P95, DOI 10.1111/j.1365-2141.1971.tb00790.x; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Valeri C, 2004, DIABETES-METAB RES, V20, pS1, DOI 10.1002/dmrr.512; VELAZQUEZ E, 1991, DIABETIC MED, V8, P752, DOI 10.1111/j.1464-5491.1991.tb01695.x; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; YOSHIOKA T, 1979, AM J OBSTET GYNECOL, V135, P372, DOI 10.1016/0002-9378(79)90708-7	53	2	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262233	10.1371/journal.pone.0262233	http://dx.doi.org/10.1371/journal.pone.0262233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986201	gold, Green Published			2022-12-26	WOS:000765956200028
J	Kairys, P; Frese, T; Voigt, P; Horn, J; Girndt, M; Mikolajczyk, R				Kairys, Paul; Frese, Thomas; Voigt, Paul; Horn, Johannes; Girndt, Matthias; Mikolajczyk, Rafael			Development of the simulation-based German albuminuria screening model (S-GASM) for estimating the cost-effectiveness of albuminuria screening in Germany	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; CHRONIC KIDNEY-DISEASE; TYPE-2 DIABETES-MELLITUS; RECEPTOR ANTAGONISTS; RENAL OUTCOMES; PREVALENCE; HYPERTENSION; POPULATION; MORTALITY; ADULTS	Background Chronic kidney disease is often asymptomatic in its early stages but constitutes a severe burden for patients and causes major healthcare systems costs worldwide. While models for assessing the cost-effectiveness of screening were proposed in the past, they often presented only a limited view. This study aimed to develop a simulation-based German Albuminuria Screening Model (S-GASM) and present some initial applications. Methods The model consists of an individual-based simulation of disease progression, considering age, gender, body mass index, systolic blood pressure, diabetes, albuminuria, glomerular filtration rate, and quality of life, furthermore, costs of testing, therapy, and renal replacement therapy with parameters based on published evidence. Selected screening scenarios were compared in a cost-effectiveness analysis. Results Compared to no testing, a simulation of 10 million individuals with a current age distribution of the adult German population and a follow-up until death or the age of 90 shows that a testing of all individuals with diabetes every two years leads to a reduction of the lifetime prevalence of renal replacement therapy from 2.5% to 2.3%. The undiscounted costs of this intervention would be 1164.10(sic)/QALY (quality-adjusted life year). Considering saved costs for renal replacement therapy, the overall undiscounted costs would be-12581.95(sic)/QALY. Testing all individuals with diabetes or hypertension and screening the general population reduced the lifetime prevalence even further (to 2.2% and 1.8%, respectively). Both scenarios were cost-saving (undiscounted, - 7127.10(sic)/QALY and-5439.23(sci)/QALY). Conclusions The S-GASM can be used for the comparison of various albuminuria testing strategies. The exemplary analysis demonstrates cost savings through albuminuria testing for individuals with diabetes, diabetes or hypertension, and for population-wide screening.	[Kairys, Paul; Frese, Thomas; Voigt, Paul] Martin Luther Univ Halle Wittenberg, Med Fac, Inst Gen Practice & Family Med, Halle, Germany; [Horn, Johannes; Mikolajczyk, Rafael] Martin Luther Univ Halle Wittenberg, Med Fac, Inst Med Epidemiol Biometry & Informat IMEBI, Halle, Germany; [Girndt, Matthias] Martin Luther Univ Halle Wittenberg, Med Fac, Dept Internal Med 2, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Kairys, P (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fac, Inst Gen Practice & Family Med, Halle, Germany.	paul.kairys@student.uni-halle.de		Kairys, Paul/0000-0002-6111-1885; Mikolajczyk, Rafael/0000-0003-1271-7204; Girndt, Matthias/0000-0003-2823-0847				Adarkwah CC, 2011, EXPERT REV PHARM OUT, V11, P215, DOI [10.1586/erp.11.18, 10.1586/ERP.11.8]; Adarkwah CC, 2010, INT J TECHNOL ASSESS, V26, P62, DOI 10.1017/S0266462309990584; Adler C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2023-8; Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Alagoz O, 2010, MED DECIS MAKING, V30, P474, DOI 10.1177/0272989X09353194; [Anonymous], 2015, VERBAND PRIVATARZTLI; Balijepalli C, 2014, J HUM HYPERTENS, V28, P193, DOI 10.1038/jhh.2013.85; Bundesamt Statistisches, 2017, KRANKH GES BUND; Bundesamt Statistisches, 2019, STERB 2015 2017 PER; Centalus Media GmbH, PREISV RAM 100 ST 08; Chen TT, 2018, MED J AUSTRALIA, V209, P275, DOI 10.5694/mja18.00297; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; da Silva GB, 2018, REV ASSOC MED BRAS, V64, P1108, DOI 10.1590/1806-9282.64.12.1108; de Vries EF, 2016, NEPHRON, V133, P89, DOI 10.1159/000446548; DEGAM e.V, 2019, VERS PAT CHRON NICHT; Excellence N.I. f.H.a.C, 2020, CHTE METH REV DISC; Gandjour A, 2015, EXPERT REV PHARM OUT, V15, P341, DOI 10.1586/14737167.2015.972375; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gemeinsamer Bundesausschuss (GBA), 2020, DMP DIAB MELL TYP 1; Girndt M, 2016, DTSCH ARZTEBL INT, V113, P85, DOI 10.3238/arztebl.2016.0085; Go DS, 2019, NEPHROLOGY, V24, P56, DOI 10.1111/nep.13203; Gozzoli V, 2000, DEUT MED WOCHENSCHR, V125, P1154, DOI 10.1055/s-2000-7670; Gracchi V, 2016, NEPHROL DIAL TRANSPL, V31, P1686, DOI 10.1093/ndt/gfv407; Grams ME, 2017, AM J KIDNEY DIS, V70, P337, DOI 10.1053/j.ajkd.2017.01.050; Heerspink HJL, 2015, CLIN J AM SOC NEPHRO, V10, P1079, DOI 10.2215/CJN.11511114; Hemmelmann C, 2010, DEUT MED WOCHENSCHR, V135, P848, DOI 10.1055/s-0030-1253666; Icks A, 2011, NEPHROL DIAL TRANSPL, V26, P264, DOI 10.1093/ndt/gfq398; Icks A, 2010, NEPHROL DIAL TRANSPL, V25, P1647, DOI 10.1093/ndt/gfp672; Ku E, 2018, CLIN J AM SOC NEPHRO, V13, P693, DOI 10.2215/CJN.10360917; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7; Palmer AJ, 2006, DEUT MED WOCHENSCHR, V131, P1721, DOI 10.1055/s-2006-947822; Palmer AJ, 2004, DIABETES CARE, V27, P1897, DOI 10.2337/diacare.27.8.1897; Pereira BD, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0646-4; Postma MJ, 2008, NEPHROL DIAL TRANSPL, V23, P1103, DOI 10.1093/ndt/gfl756; R Core Team, 2020, R LANG ENV STAT COMP; Rathmann W, 2010, DIABETOLOGE, V6, P170, DOI 10.1007/s11428-009-0496-8; Sarganas G, 2016, AM J HYPERTENS, V29, P104, DOI 10.1093/ajh/hpv067; Schweitzer RD, 2007, J CARDIOVASC NURS, V22, P76, DOI 10.1097/00005082-200701000-00012; Squires David A, 2011, Issue Brief (Commonw Fund), V16, P1; Statistisches Bundesamt, 2019, BEV ERW 2016 BEV GRU; Strippoli GFM, 2004, BMJ-BRIT MED J, V329, P828, DOI 10.1136/bmj.38237.585000.7C; Sugrue DM, 2019, PHARMACOECONOMICS, V37, P1451, DOI 10.1007/s40273-019-00835-z; Tajima R, 2010, CLIN EXP NEPHROL, V14, P340, DOI 10.1007/s10157-010-0304-1; Wen CP, 2014, KIDNEY INT, V86, P819, DOI 10.1038/ki.2013.553; Wilke T, 2013, DEUT MED WOCHENSCHR, V138, P69, DOI 10.1055/s-0032-1327394; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wu HY, 2014, JAMA INTERN MED, V174, P1108, DOI 10.1001/jamainternmed.2014.1363; Wyld M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001307; Xie XF, 2016, AM J KIDNEY DIS, V67, P728, DOI 10.1053/j.ajkd.2015.10.011; Yarnoff BO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205530; Yarnoff BO, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0497-6; Zhuo M, 2020, KIDNEY INT REP, V5, P475, DOI 10.1016/j.ekir.2019.12.011	53	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262227	10.1371/journal.pone.0262227	http://dx.doi.org/10.1371/journal.pone.0262227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986199	gold, Green Published			2022-12-26	WOS:000765956200027
J	Sveinsdottir, HS; Decker, A; Christensen, C; Lucena, PB; Porsteinsson, H; Richert, E; Maier, VH; Cornell, R; Karlsson, K&AElig;				Sveinsdottir, Hildur Soley; Decker, Amanda; Christensen, Christian; Lucena, Pablo Botella; Porsteinsson, Haraldur; Richert, Elena; Maier, Valerie Helene; Cornell, Robert; Karlsson, Karl Aegir			Motility phenotype in a zebrafish vmat2 mutant	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; CELL-DEATH; EXPRESSION; SLEEP; BRAIN; SYSTEM; MODEL; MPTP	In the present study, we characterize a novel zebrafish mutant of solute carrier 18A2 (slc18a2), also known as vesicular monoamine transporter 2 (vmat2), that exhibits a behavioural phenotype partially consistent with human Parkinson's disease. At six days-post-fertilization, behaviour was analysed and demonstrated that vmat2 homozygous mutant larvae, relative to wild types, show changes in motility in a photomotor assay, altered sleep parameters, and reduced dopamine cell number. Following an abrupt lights-off stimulus mutant larvae initiate larger movements but subsequently inhibit them to a lesser extent in comparison to wild-type larvae. Conversely, during a lights-on period, the mutant larvae are hypomotile. Thigmotaxis, a preference to avoid the centre of a behavioural arena, was increased in homozygotes over heterozygotes and wild types, as was daytime sleep ratio. Furthermore, incubating mutant larvae in pramipexole or L-Dopa partially rescued the motor phenotypes, as did injecting glial cell-derived neurotrophic factor (GDNF) into their brains. This novel vmat2 model represents a tool for high throughput pharmaceutical screens for novel therapeutics, in particular those that increase monoamine transport, and for studies of the function of monoamine transporters.	[Sveinsdottir, Hildur Soley; Christensen, Christian; Porsteinsson, Haraldur; Karlsson, Karl Aegir] 3Z, Reykjavik, Iceland; [Decker, Amanda; Cornell, Robert] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Lucena, Pablo Botella; Richert, Elena; Karlsson, Karl Aegir] Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland; [Richert, Elena] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany; [Maier, Valerie Helene; Karlsson, Karl Aegir] Univ Iceland, Biomed Ctr, Reykjavik, Iceland; [Lucena, Pablo Botella] Hasselt Univ, Biomed Res Inst, Dept Neurosci, Hasselt, Belgium	University of Iowa; Reykjavik University; Carl von Ossietzky Universitat Oldenburg; University of Iceland; Hasselt University	Karlsson, K&AElig; (corresponding author), 3Z, Reykjavik, Iceland.; Karlsson, K&AElig; (corresponding author), Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland.; Karlsson, K&AElig; (corresponding author), Univ Iceland, Biomed Ctr, Reykjavik, Iceland.	karlsson@ru.is		Karlsson, Karl/0000-0002-5931-8422; Richert, Elena/0000-0003-0919-4879	National Institutes of Health [GM067841, AR062547]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is funded in part by grants from the National Institutes of Health GM067841 (RAC) and AR062547 (RAC). NO The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Barnhill LM, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8070197; Baronio D, 2022, ACTA PHYSIOL, V234, DOI 10.1111/apha.13725; Basnet RM, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7010023; Bohn MC, 2000, NOVART FDN SYMP, V231, P70, DOI 10.1002/0470870834.ch5; Bonito-Oliva A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00290; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen MK, 2008, J NEUROCHEM, V105, P78, DOI 10.1111/j.1471-4159.2007.05108.x; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Christensen C, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.623924; De Lazzari F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123911; Decker AR, 2015, TRPM7 FUNCTION ZEBRA; Drinkut A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.263; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; Harrington KA, 1996, MOL BRAIN RES, V36, P157, DOI 10.1016/0169-328X(95)00278-Z; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Ichise M, 2010, J NUCL MED, V51, P1001, DOI 10.2967/jnumed.109.068999; Jiang S, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00356; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Leung LC, 2019, NATURE, V571, P198, DOI 10.1038/s41586-019-1336-7; Levitas-Djerbi T, 2017, CURR OPIN NEUROBIOL, V44, P89, DOI 10.1016/j.conb.2017.02.017; Lohr KM, 2016, TOXICOL SCI, V153, P79, DOI 10.1093/toxsci/kfw106; Lohr KM, 2014, EXPERT REV NEUROTHER, V14, P1115, DOI 10.1586/14737175.2014.960399; Lohr KM, 2014, P NATL ACAD SCI USA, V111, P9977, DOI 10.1073/pnas.1402134111; Lulla A, 2016, ENVIRON HEALTH PERSP, V124, P1766, DOI 10.1289/EHP141; Ma K, 2019, BIOCHEM BIOPH RES CO, V513, P306, DOI 10.1016/j.bbrc.2019.03.159; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; Oo TF, 2003, J NEUROSCI, V23, P5141; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; PETER D, 1995, J NEUROSCI, V15, P6179; Pontone GM, 2019, NPJ PARKINSON DIS, V5, DOI 10.1038/s41531-019-0102-8; Rilstone JJ, 2013, NEW ENGL J MED, V368, P543, DOI 10.1056/NEJMoa1207281; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2009, J NEUROCHEM, V109, P403, DOI 10.1111/j.1471-4159.2009.05986.x; Schafer MKH, 2013, ADV PHARMACOL, V68, P319, DOI 10.1016/B978-0-12-411512-5.00015-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016; Semenova SA, 2014, HISTOCHEM CELL BIOL, V142, P619, DOI 10.1007/s00418-014-1240-z; Shen Y, 2018, CHINESE MED J-PEKING, V131, P974, DOI 10.4103/0366-6999.229889; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Sigurgeirsson B, 2013, BEHAV BRAIN RES, V256, P377, DOI 10.1016/j.bbr.2013.08.032; Sorribes A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00178; Taylor TN, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/124165; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Unal I, 2019, J CLIN NEUROSCI, V62, P1, DOI 10.1016/j.jocn.2019.01.015; Wang YL, 2016, BIOCHEM BIOPH RES CO, V470, P792, DOI 10.1016/j.bbrc.2016.01.079; Wen L, 2008, DEV BIOL, V314, P84, DOI 10.1016/j.ydbio.2007.11.012; Whone AL, 2019, J PARKINSON DIS, V9, P301, DOI 10.3233/JPD-191576; Wulliman MF, 1986, NEUROANATOMY ZEBRAFI; Xi YW, 2010, EUR J NEUROSCI, V31, P623, DOI 10.1111/j.1460-9568.2010.07091.x; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Zalsman G, 2011, J NEURAL TRANSM, V118, P1383, DOI 10.1007/s00702-011-0643-4	62	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0259753	10.1371/journal.pone.0259753	http://dx.doi.org/10.1371/journal.pone.0259753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986152	gold, Green Published			2022-12-26	WOS:000765956200005
J	Guo, F; Cheng, X; Jing, BP; Wu, HS; Jin, X				Guo, Feng; Cheng, Xiang; Jing, Boping; Wu, Heshui; Jin, Xin			FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression	ONCOGENE			English	Article							FACTOR-KAPPA-B; HEAT-SHOCK FACTORS; MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR; R PACKAGE; GENE; GEMCITABINE; GROWTH; CELLS	Pancreatic cancer is regarded as the most lethal solid tumor worldwide. Deregulated and constitutively activated NF-kappa B signaling is one of the major characteristics of pancreatic cancer. The total expression level and subcellular localization of RelA/p65 have been shown to determine the activation of canonical NF-kappa B signaling in pancreatic cancer. FGD3, which is involved in regulating the actin cytoskeleton and cell shape, has been reported to inhibit cancer cell migration and predict a favorable prognosis in multiple types of cancer. However, the specific role of FGD3 in pancreatic cancer is still unknown. In this study, we conducted a systematic investigation of the cancer-related role of FGD3 in pancreatic cancer. We demonstrated that FGD3 was abnormally downregulated in pancreatic cancer tissues and that low expression of FGD3 was associated with unfavorable prognosis in patients with pancreatic cancer. Then, we showed that FGD3 inhibited pancreatic cancer cell proliferation, invasion and metastasis in vivo and in vitro. Moreover, we revealed that FGD3 silencing activated the NF-kappa B signaling pathway by promoting HSF4 nuclear translocation and increasing p65 expression in pancreatic cancer cells. Therefore, our results identified a novel and targetable FGD3/HSF4/p65 signaling axis in pancreatic cancer cells.	[Guo, Feng; Wu, Heshui] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pancreat Surg, Wuhan 430022, Peoples R China; [Guo, Feng; Wu, Heshui] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Sino German Lab Personalized Med Pancreat Canc, Wuhan 430022, Peoples R China; [Cheng, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China; [Jing, Boping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasound, Wuhan 430022, Hubei, Peoples R China; [Jin, Xin] Cent South Univ, Xiangya Hosp 2, Dept Urol, Changsha 410011, Hunan, Peoples R China; [Jin, Xin] Cent South Univ, Urooncol Inst, Changsha 410011, Hunan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Central South University; Central South University	Wu, HS (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pancreat Surg, Wuhan 430022, Peoples R China.; Wu, HS (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Sino German Lab Personalized Med Pancreat Canc, Wuhan 430022, Peoples R China.; Jin, X (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Urol, Changsha 410011, Hunan, Peoples R China.; Jin, X (corresponding author), Cent South Univ, Urooncol Inst, Changsha 410011, Hunan, Peoples R China.	Heshuiwu@hust.edu.cn; jinxinxy2@csu.edu.cn		Jin, Xin/0000-0001-6461-6005; Guo, Feng/0000-0003-0882-5296; jing, boping/0000-0001-8664-201X	National Natural Science Foundation of China [82073178, 82073321]; Science Foundation of Ministry of Education of China [2172019kfyRCPY069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 82073178 (H.W.), Grant No. 82073321 (X.J.)) and Science Foundation of Ministry of Education of China (Grant No. 2172019kfyRCPY069 (X.J.)).	Abane R, 2010, FEBS J, V277, P4150, DOI 10.1111/j.1742-4658.2010.07830.x; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Azoitei N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-015-0490-2; Cable J, 2021, ANN NY ACAD SCI, V1489, P30, DOI 10.1111/nyas.14526; Chen R, 2011, ONCOGENE, V30, P2570, DOI 10.1038/onc.2010.623; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Cui XK, 2012, BBA-MOL BASIS DIS, V1822, P1308, DOI 10.1016/j.bbadis.2012.05.005; Dougan SK, 2017, CANCER J, V23, P321, DOI 10.1097/PPO.0000000000000288; Fan P, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1044-z; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898; Jin X, 2019, MOL CELL, V73, P22, DOI 10.1016/j.molcel.2018.10.034; Jin XJ, 2012, MOL CANCER RES, V10, P523, DOI 10.1158/1541-7786.MCR-11-0530; Jing BP, 2021, J NANOBIOTECHNOL, V19, DOI 10.1186/s12951-020-00746-8; Kabacaoglu D, 2019, CANCERS, V11, DOI 10.3390/cancers11070937; Khalaf N, 2021, CLIN GASTROENTEROL H, V19, P876, DOI 10.1016/j.cgh.2020.02.054; Kong R, 2010, CANCER LETT, V291, P90, DOI 10.1016/j.canlet.2009.10.001; Liao SJ, 2018, GENE, V655, P30, DOI 10.1016/j.gene.2018.02.033; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Ma C, 2019, BIOMARK MED, V13, P1399, DOI 10.2217/bmm-2019-0273; Ma P, 2020, LIVER INT, V40, P1211, DOI 10.1111/liv.14410; Makieva S, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.02.009; Matsuo Y, 2004, PANCREAS, V28, P344, DOI 10.1097/00006676-200404000-00025; Meng QC, 2020, THERANOSTICS, V10, P3967, DOI 10.7150/thno.40566; Nakanishi H, 2008, J CELL MOL MED, V12, P1169, DOI 10.1111/j.1582-4934.2008.00345.x; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Oshima T, 2010, BIOL PHARM BULL, V33, P35, DOI 10.1248/bpb.33.35; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Pasteris NG, 2000, GENE, V242, P237, DOI 10.1016/S0378-1119(99)00518-1; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Renda I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51766-w; Shi XH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-10; Susini T, 2020, ANTICANCER RES, V40, P3645, DOI 10.21873/anticanres.14353; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang L, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0627-6; Wang LL, 2017, CANCER LETT, V398, P24, DOI 10.1016/j.canlet.2017.04.001; Wang WX, 1999, CLIN CANCER RES, V5, P119; Willis S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00009; Wu J, 2021, DIGEST DIS SCI, V66, P359, DOI 10.1007/s10620-020-06183-9; Wu JM, 2017, TRENDS PHARMACOL SCI, V38, P226, DOI 10.1016/j.tips.2016.11.009; Wu W, 2020, THERANOSTICS, V10, P2859, DOI 10.7150/thno.41279; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yang YC, 2017, IUBMB LIFE, V69, P956, DOI 10.1002/iub.1692; Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	46	0	0	3	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					838	851		10.1038/s41388-021-02140-6	http://dx.doi.org/10.1038/s41388-021-02140-6		JAN 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34975151				2022-12-26	WOS:000737109100002
J	Bizuayew, H; Abebe, H; Mullu, G; Bewuket, L; Tsega, D; Alemye, T				Bizuayew, Hulubante; Abebe, Haimanot; Mullu, Getachew; Bewuket, Likinaw; Tsega, Daniel; Alemye, Tsegaw			Post-cesarean section surgical site infection and associated factors in East Gojjam zone primary hospitals, Amhara region, North West Ethiopia, 2020	PLOS ONE			English	Article							CESAREAN-SECTION; RISK-FACTORS; MORBIDITY; DELIVERY	Purpose Maternal surgical site infection after cesarean delivery is a clinical problem which contributes to significant morbidity and mortality. In Ethiopia admissions following cesarean section due to surgical site infection have been routine activities of health care institutions but there is limited scientific evidence on both the magnitude of the problem and factors associated with it making prevention mechanisms less effective. Therefore, this study aimed to assess magnitude and risk factors of post-cesarean section surgical site infection at primary hospitals of East Gojjam Zone, Northwest Ethiopia. Methods Institution-based cross sectional study with retrospective chart review was conducted from September 10-30 /2020 at 3 randomly selected primary hospitals of east Gojjam zone. The data were entered in Epi data version 3.1 and exported to Statistical Package for Social Science Software version 26. Post-cesarean section surgical site infection was measured based on disease classification and definition of the term by Center for Disease Control and Prevention. After checking for presence of multicollinarity, presence and degree of association of factors with outcome variable were computed through logistic regression analysis. Factors with P value <= 0.2 in bi-variable logistic regression analysis were included in the multivariable logistic regression analysis and those variables with P-value of <0.05 in multivariable analysis were considered statistically significant. Result From 622 medical records of women who underwent cesarean section, 77 (12.4%) of them developed surgical site infection. Rural residence [(AOR = 2.30, 95%CI: (1.29, 4.09)], duration of labor greater than 24hrs [(AOR = 3.48, 95%CI: (1.49, 8.09)], rupture of membrane>12hrs[(AOR = 4.61,95%CI:(2.34,9.09)], hypertension[(AOR = 3.14,95%CI:(1.29,7.59)] and preoperative Hematocrit <= 30%[(AOR = 3.22,95%CI:(1.25,8.31)] were factors significantly associated with post-cesarean section surgical site infections. Conclusion Magnitude of post-cesarean section surgical site infection was a significant problem in primary hospitals. Minimizing prolonged labor; minimize early rupture of membrane, properly managing patients with comorbidities like hypertension, strengthen prophylaxis and treatment for anemia during antenatal care and raising awareness for rural residents can reduce the problem. Zonal police makers should give emphasis to reduce its burden.	[Bizuayew, Hulubante; Alemye, Tsegaw] Mizan Aman Hlth Sci Coll, Dept Midwifery, Mizan, Ethiopia; [Abebe, Haimanot] Wolkite Univ, Dept Nursing, Wolkite, Ethiopia; [Mullu, Getachew; Bewuket, Likinaw] Debre Markos Univ, Dept Midwifery, Debre Markos, Ethiopia; [Tsega, Daniel] Wolkite Univ, Dept Midwifery, Wolkite, Ethiopia		Bizuayew, H (corresponding author), Mizan Aman Hlth Sci Coll, Dept Midwifery, Mizan, Ethiopia.	hbizuayew@gmail.com	Abebe, Haimanot Geletie/AGD-2238-2022	Kassa, Getachew Mullu/0000-0002-8095-7376				Adane F, 2019, PATIENT SAF SURG, V13, DOI 10.1186/s13037-019-0212-6; Alfouzan W., 2019, EPIDEMIOLOGY INFECT, V147; Allegranzi Benedetta, 2016, Lancet Infect Dis, V16, pe276, DOI 10.1016/S1473-3099(16)30398-X; Amenu D, 2011, ETHIOP J HEALTH SCI, V21, P91; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; [Anonymous], 2015, J PREG CHILD HLTH, DOI DOI 10.4172/2376-127X.1000169; Ansar A., 2013, PAK J SURG, V18, P2; Azeze GG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4325-x; Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bizimana JK., 2016, INT J CURRENT MICROB, V5, P631; Busarira M., 2011, J HIGH I PUBLIC HLTH, V41, P359; del Monte MCC, 2010, AM J INFECT CONTROL, V38, P467, DOI 10.1016/j.ajic.2009.10.008; Central Statistical Agency, 2007, STAT ABSTR; Chu K, 2015, WORLD J SURG, V39, P350, DOI 10.1007/s00268-014-2840-4; Dacho AM, 2018, J NURS CARE, V7, P1168; Daniel A, 2008, THESIS, V23; De Nardo P, 2016, J HOSP INFECT, V93, P355, DOI 10.1016/j.jhin.2016.02.021; Gong SP, 2012, J OBSTET GYNAECOL RE, V38, P509, DOI 10.1111/j.1447-0756.2011.01746.x; Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3; Grayi A., 2018, HLTH POLICY LEGISLAT, V21; Haque M, 2018, INFECT DRUG RESIST, V11, P2321, DOI 10.2147/IDR.S177247; Harrison Margo S, 2016, Matern Health Neonatol Perinatol, V2, P6, DOI 10.1186/s40748-016-0033-x; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Jabbar S, 2016, ANN ABBASI SHAHEED H, V21, P233; Jido TA, 2012, ANN MED HEALTH SCI R, V2, P33, DOI 10.4103/2141-9248.96934; Krieger Y, 2017, J MATERN-FETAL NEO M, V30, P8, DOI 10.3109/14767058.2016.1163540; Lijaemiro H, 2020, OBSTET GYNECOL INT, V2020, DOI 10.1155/2020/9714640; Mamo T, 2017, PATIENT SAF SURG, V11, DOI 10.1186/s13037-017-0138-9; Molla M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2442-0; Mpogoro FJ, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-25; Mulu W., 2013, NW ETHIOPIA, V2, P140; Ojiyi E. C., 2013, Orient Journal of Medicine, V25, P8; Onsrud M, 2011, INT J GYNECOL OBSTET, V114, P10, DOI 10.1016/j.ijgo.2011.01.018; Onyegbule O. A., 2015, British Journal of Medicine and Medical Research, V5, P767, DOI 10.9734/BJMMR/2015/10297; Organization WH., 2016, GLOB GUID PREV SURG; Saeed KBM, 2019, EUR J OBSTET GYN R B, V240, P256, DOI 10.1016/j.ejogrb.2019.07.020; Schneid-Kofman N, 2005, INT J GYNECOL OBSTET, V90, P10, DOI 10.1016/j.ijgo.2005.03.020; Shrestha S, 2016, Kathmandu Univ Med J (KUMJ), V14, P107; Smaill FM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007482.pub3; Solomokin J., 2017, SWITZERLAND LANCET I, V17, P262, DOI [10.1016/S1473-3099(17)30081-6, DOI 10.1016/S1473-3099(17)30081-6]; Tran TS, 2000, OBSTET GYNECOL, V95, P367, DOI 10.1016/S0029-7844(99)00540-2; Vijayan CP, 2016, INT J SCI STUDY, V3, P97, DOI 10.17354/ijss/2016/129; WAGER GP, 1980, AM J OBSTET GYNECOL, V138, P1028, DOI 10.1016/0002-9378(80)91102-3; Wendmagegn TA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2075-8; Wodajo S, 2017, ETHIOP J HEALTH SCI, V27, P283, DOI 10.4314/ejhs.v27i3.10; Worku M., 2018, ETHIOPIAN J REPROD H, V10	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261951	10.1371/journal.pone.0261951	http://dx.doi.org/10.1371/journal.pone.0261951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972176	Green Submitted, Green Published, gold			2022-12-26	WOS:000773555700072
J	Heikkila, K; Pulakka, A; Metsala, J; Alenius, S; Hovi, P; Gissler, M; Sandin, S; Kajantie, E				Heikkila, Katriina; Pulakka, Anna; Metsala, Johanna; Alenius, Suvi; Hovi, Petteri; Gissler, Mika; Sandin, Sven; Kajantie, Eero			Preterm birth and the risk of chronic disease multimorbidity in adolescence and early adulthood: A population-based cohort study	PLOS ONE			English	Article							BORN PRETERM; YOUNG-ADULTS; SURVIVAL; METAANALYSIS; DEFINITION; REGISTER; QUALITY; MODELS; ASTHMA	Background People who were born prematurely have high risks of many individual diseases and conditions in the early part of the life course. However, our knowledge of the burden of multiple diseases (multimorbidity) among prematurely born individuals is limited. We aimed to investigate the risk and patterns of chronic disease multimorbidity in adolescence and early adulthood among individuals born across the spectrum of gestational ages, comparing preterm and full-term born individuals. Methods and findings We used individual-level data from linked nationwide registers to examine the associations of gestational age at birth with specialised healthcare records of >= 2 chronic diseases (multimorbidity) in adolescence (age 10-17 years) and early adulthood (age 18-30 years). Our study population comprised 951,116 individuals (50.2% females) born alive in Finland between 1(st) January 1987 and 31(st) December 2006, inclusive. All individuals were followed from age 10 years to the onset of multimorbidity, emigration, death, or 31 December 2016 (up to age 30 years). We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for multimorbidity using flexible parametric survival models. During 6,417,903 person-years at risk (median follow-up: 7.9 years), 11,919 individuals (1.3%) had multimorbidity in adolescence (18.6 per 10,000 person-years). During 3,967,419 person-years at risk (median follow-up: 6.2 years), 15,664 individuals (1.7%) had multimorbidity in early adulthood (39.5 per 10,000 person-years). Adjusted HRs for adolescent multimorbidity, comparing preterm to full-term born individuals, were 1.29 (95% CI: 1.22 to 1.36) and 1.26 (95% CI: 1.18 to 1.35) in females and males, respectively. The associations of preterm birth with early adult multimorbidity were less marked, with the adjusted HRs indicating 1.18-fold risk in females (95% CI: 1.12 to 1.24) and 1.10-fold risk in males (95% CI: 1.04 to 1.17). We observed a consistent dose-response relationship between earlier gestational age at birth and increasing risks of both multimorbidity outcomes. Compared to full-term born males, those born at 37-38 weeks (early term) had a 1.06-fold risk of multimorbidity in adolescence (95% CI: 0.98 to 1.14) and this risk increased in a graded manner up to 6.85-fold (95% CI: 5.39 to 8.71) in those born at 23-27 weeks (extremely premature), independently of covariates. Among females, the same risks ranged from 1.16-fold (95% CI: 1.09 to 1.23) among those born at 37-38 weeks to 5.65-fold (95% CI: 4.45 to 7.18) among those born at 23-27 weeks. The corresponding risks of early adult multimorbidity were similar in direction but less marked in magnitude, with little difference in risks between males and females born at 36-37 weeks but up to 3-fold risks observed among those born at 23-27 weeks. Conclusions Our findings indicate that an earlier gestational age at birth is associated with increased risks of chronic disease multimorbidity in the early part of the life course. There are currently no clinical guidelines for follow-up of prematurely born individuals beyond childhood, but these observations suggest that information on gestational age would be a useful characteristic to include in a medical history when assessing the risk of multiple chronic diseases in adolescent and young adult patients.	[Heikkila, Katriina; Pulakka, Anna; Metsala, Johanna; Alenius, Suvi; Hovi, Petteri; Kajantie, Eero] Finnish Inst Hlth & Welf, Populat Hlth Unit, Helsinki, Finland; [Alenius, Suvi] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Alenius, Suvi] Helsinki Univ Hosp, Helsinki, Finland; [Gissler, Mika] Finnish Inst Hlth & Welf, Informat Serv Dept, Helsinki, Finland; [Gissler, Mika] Acad Primary Hlth Care Ctr, Reg Stockholm, Stockholm, Sweden; [Gissler, Mika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Sandin, Sven] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sandin, Sven] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Sandin, Sven] Seaver Autism Ctr Res & Treatment Mt Sinai, New York, NY USA; [Kajantie, Eero] Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Kajantie, Eero] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; University of Oulu; University of Oulu; Norwegian University of Science & Technology (NTNU)	Heikkila, K (corresponding author), Finnish Inst Hlth & Welf, Populat Hlth Unit, Helsinki, Finland.	katriina.heikkila@thl.fi	Sandin, Sven/L-5357-2015	Sandin, Sven/0000-0001-6994-4884	European Union Horizon 2020 [733280]; Academy of Finland [315690]; Foundation for Pediatric Research; Sigrid Juse' lius Foundation	European Union Horizon 2020; Academy of Finland(Academy of Finland); Foundation for Pediatric Research; Sigrid Juse' lius Foundation(Sigrid Juselius Foundation)	EK, SS and MG: European Union Horizon 2020 (grant no. 733280: RECAP: "Research on Children and Adults Born Preterm"), https://ec.europa.eu/programmes/horizon2020/en/home; Academy of Finland (grant no. 315690), https:// www.aka.fi/en.EK: Foundation for Pediatric Research, https://www.lastentautientutkimussaatio.fi; and Sigrid Juse ' lius Foundation https://www.sigridjuselius.fi/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilsteen JF, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6085; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bramham K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2301; Breeman LD, 2015, PEDIATRICS, V136, P415, DOI 10.1542/peds.2015-0608; Brylka A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041735; Buurman BM, 2016, EUR J INTERN MED, V27, P68, DOI 10.1016/j.ejim.2015.09.021; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Cornish RP, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-66; Crump C, 2019, JAMA-J AM MED ASSOC, V322, P1580, DOI 10.1001/jama.2019.15040; Crump C, 2019, JAMA PEDIATR, V173, P736, DOI 10.1001/jamapediatrics.2019.1327; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; Doyle LW, 2019, LANCET RESP MED, V7, P677, DOI 10.1016/S2213-2600(18)30530-7; Ekeus C, 2010, PEDIATRICS, V125, pE67, DOI 10.1542/peds.2008-3329; Eves R, 2021, JAMA PEDIATR, V175, DOI 10.1001/jamapediatrics.2021.1058; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Gill JV, 2017, ARCH DIS CHILD, V102, P194, DOI 10.1136/archdischild-2015-309584; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Heo JS, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062951; Hovi P, 2016, HYPERTENSION, V68, P880, DOI 10.1161/HYPERTENSIONAHA.116.08167; Howson CP, 2012, BORN TOO SOON GLOBAL; Jani BD, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1305-x; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Kajantie E, 2019, SEMIN FETAL NEONAT M, V24, P66, DOI 10.1016/j.siny.2018.11.001; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Li WL, 2019, EPILEPSY BEHAV, V97, P83, DOI 10.1016/j.yebeh.2019.05.016; Liao LH, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00405; Lowe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155229; Luu TM, 2016, CAN MED ASSOC J, V188, P736, DOI 10.1503/cmaj.150450; Markopoulou P, 2019, J PEDIATR-US, V210, P69, DOI 10.1016/j.jpeds.2019.02.041; Marleen S, 2018, EUR J OBSTET GYN R B, V230, P159, DOI 10.1016/j.ejogrb.2018.09.025; McBryde M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.2027; Mendonca M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6961; Morrison KM, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0515; Moutquin JM, 2003, BJOG-INT J OBSTET GY, V110, P30, DOI 10.1016/S1470-0328(03)00021-1; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Paquette K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210366; Persson M, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003207; Philips EM, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003182; Pierrat V, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n741; Raju TNK, 2017, ACTA PAEDIATR, V106, P1409, DOI 10.1111/apa.13880; Risnes K, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.32779; Robinson R, 2020, SEMIN FETAL NEONAT M, V25, DOI 10.1016/j.siny.2020.101113; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ruiz M, 2015, J EPIDEMIOL COMMUN H, V69, P826, DOI 10.1136/jech-2014-205387; Russell J, 2020, ACAD PEDIATR, V20, P619, DOI 10.1016/j.acap.2019.09.007; Ryan A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0355-9; de Mendonca ELSS, 2020, EARLY HUM DEV, V149, DOI 10.1016/j.earlhumdev.2020.105154; Savran O, 2018, INT J CHRONIC OBSTR, V13, P683, DOI 10.2147/COPD.S153555; Sciences AoM, 2018, MULT PRIOR GLOB HLTH; Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443; Stahlberg T, 2020, J AFFECT DISORDERS, V277, P85, DOI 10.1016/j.jad.2020.08.004; Stirland LE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m160; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tronnes H, 2013, PEDIAT ALLERG IMM-UK, V24, P782, DOI 10.1111/pai.12170; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; WHO WHO, 2018, WHO FACT SHEET PRET; Willadsen TG, 2016, SCAND J PRIM HEALTH, V34, P112, DOI 10.3109/02813432.2016.1153242; Xu XL, 2017, AGEING RES REV, V37, P53, DOI 10.1016/j.arr.2017.05.003	61	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261952	10.1371/journal.pone.0261952	http://dx.doi.org/10.1371/journal.pone.0261952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972182	Green Published, gold			2022-12-26	WOS:000773555700073
J	Issafras, H; Fan, SL; Tseng, CL; Cheng, YC; Lin, PH; Xiao, LS; Huang, YJ; Tu, CH; Hsiao, YC; Li, M; Chen, YH; Ho, CH; Li, O; Wang, YL; Chen, S; Ji, ZY; Zhang, E; Mao, YT; Liu, E; Yang, SM; Jiang, WD				Issafras, Hassan; Fan, Shilong; Tseng, Chi-Ling; Cheng, Yunchih; Lin, Peihua; Xiao, Lisa; Huang, Yun-Ju; Tu, Chih-Hsiang; Hsiao, Ya-Chin; Li, Min; Chen, Yen-Hsiao; Ho, Chien-Hsin; Li, Ou; Wang, Yanling; Chen, Sandra; Ji, Zhenyu; Zhang, Eric; Mao, Yi-Ting; Liu, Eugene; Yang, Shumin; Jiang, Weidong			Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy	PLOS ONE			English	Article							CELL; BLOCKADE; LIGAND	Cancer immunotherapies, such as checkpoint blockade of programmed cell death protein-1 (PD-1), represents a breakthrough in cancer treatment, resulting in unprecedented results in terms of overall and progression-free survival. Discovery and development of novel anti PD-1 inhibitors remains a field of intense investigation, where novel monoclonal antibodies (mAbs) and novel antibody formats (e.g., novel isotype, bispecific mAb and low-molecular-weight compounds) are major source of future therapeutic candidates. HLX10, a fully humanized IgG(4) monoclonal antibody against PD-1 receptor, increased functional activities of human T-cells and showed in vitro, and anti-tumor activity in several tumor models. The combined inhibition of PD-1/PDL-1 and angiogenesis pathways using anti-VEGF antibody may enhance a sustained suppression of cancer-related angiogenesis and tumor elimination. To elucidate HLX10's mode of action, we solved the structure of HLX10 in complex with PD-1 receptor. Detailed epitope analysis showed that HLX10 has a unique mode of recognition compared to the clinically approved PD1 antibodies Pembrolizumab and Nivolumab. Notably, HLX10's epitope was closer to Pembrolizumab's epitope than Nivolumab's epitope. However, HLX10 and Pembrolizumab showed an opposite heavy chain (HC) and light chain (LC) usage, which recognizes several overlapping amino acid residues on PD-1. We compared HLX10 to Nivolumab and Pembrolizumab and it showed similar or better bioactivity in vitro and in vivo, providing a rationale for clinical evaluation in cancer immunotherapy.	[Issafras, Hassan; Lin, Peihua; Li, Ou; Wang, Yanling; Mao, Yi-Ting; Jiang, Weidong] Hengenix Inc, Fremont, CA 94538 USA; [Fan, Shilong; Li, Min] Tsinghua Univ, Natl Prot Sci Facil, Beijing, Peoples R China; [Tseng, Chi-Ling; Cheng, Yunchih; Huang, Yun-Ju; Tu, Chih-Hsiang; Hsiao, Ya-Chin; Chen, Yen-Hsiao; Ho, Chien-Hsin] HanchorBio Inc Ltd, Taipei, Taiwan; [Xiao, Lisa; Ji, Zhenyu; Zhang, Eric; Yang, Shumin; Jiang, Weidong] Shanghai Henlius Biotech Inc, Shanghai, Peoples R China; [Chen, Sandra] Anwita Biosci, San Carlos, CA USA; [Liu, Eugene] Taipei Med Univ, Taipei, Taiwan	Tsinghua University; Taipei Medical University	Issafras, H (corresponding author), Hengenix Inc, Fremont, CA 94538 USA.; Fan, SL (corresponding author), Tsinghua Univ, Natl Prot Sci Facil, Beijing, Peoples R China.	hissafras@gmail.com; fanshilong@mail.tsinghua.edu.cn			Shanghai Henlius Biotech, Inc.	Shanghai Henlius Biotech, Inc.	The authors received funding in the form of salary for this work from Shanghai Henlius Biotech, Inc. Hassan Issafras, Chi-Ling Tseng, Yunchih Cheng, Peihua Lin, Lisa Xiao, Yun-Ju Huang, Chih-Hsiang Tu, Ya-Chin Hsiao, Yen-Hsiao Chen, Chien-Hsin Ho, Ou Li, Yanling Wang, Sandra Chen, Zhenyu Ji, Eric Zhang, Yi-Ting Mao, Eugen Liu, Shumin Yang and Weidong Jiang were employees of Shanghai Henlius Biotech, Inc., P. R. China and its US subsidiary Hengenix Inc. Fremont, CA, US. Shilong Fan and Min Li received funding from Shanghai Henlius Biotech, Inc. but were not salaried employees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. The role of the authors as articulated in the 'author contributions' section.	Ai LY, 2020, ADV EXP MED BIOL, V1248, P33, DOI 10.1007/978-981-15-3266-5_3; Arasanz H, 2017, ONCOTARGET, V8, P51936, DOI 10.18632/oncotarget.17232; Assessment Report, 2015, EMACHMP766882015, P24; Brown ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229206; Chen Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01088; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Curran MA, 2018, CANCER J, V24, P2, DOI 10.1097/PPO.0000000000000298; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Gong J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0316-z; Horita S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35297; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee WS, 2020, EXP MOL MED, V52, P1475, DOI 10.1038/s12276-020-00500-y; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Na ZK, 2017, CELL RES, V27, P147, DOI 10.1038/cr.2016.77; Patsoukis N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd2712; Patsoukis N, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0845-0; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Tam SH, 2017, ANTIBODIES, V6, DOI 10.3390/antib6030012; Tan SG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14369; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Yi M, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01045-x; Yi M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0974-6; Yu JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206223; Zak KM, 2017, STRUCTURE, V25, P1163, DOI 10.1016/j.str.2017.06.011; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010	26	3	3	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0257972	10.1371/journal.pone.0257972	http://dx.doi.org/10.1371/journal.pone.0257972			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972111	Green Published, gold			2022-12-26	WOS:000773555700007
J	Son, M; Lee, YS; Lee, MJ; Park, Y; Bae, HR; Lee, SY; Shin, MG; Yang, S				Son, Minkook; Lee, Ye Sung; Lee, Mahn Jae; Park, YongKeun; Bae, Hae-Rahn; Lee, Seung Yeob; Shin, Myung-Geun; Yang, Sung			Effects of osmolality and solutes on the morphology of red blood cells according to three-dimensional refractive index tomography	PLOS ONE			English	Article							HUMAN ERYTHROCYTES; IN-VITRO; SHAPE; VOLUME; HEMOLYSIS; DYNAMICS; GLUCOSE; SALINE; AREA	Phosphate-buffered saline (PBS) and Alsever's solution (AS) are frequently used as media in blood-related studies, while 0.9% normal saline (NS) is frequently used in transfusion medicine. Despite the frequent use, the effects of these solutions on the shape and volume of red blood cells (RBCs) have not been reported. We collected blood samples from five healthy adults and used three-dimensional refractive index tomography to investigate the changes in the morphology of RBCs caused by changes in osmolality and solutes at the single-cell level. After diluting 2 mu L of RBCs 200-fold with each solution (PBS, AS, and 0.9% NS), 40 randomly selected RBCs were microscopically observed. RBC shape was measured considering sphericity, which is a dimensionless quantity ranging from 0 (flat) to 1 (spherical). RBCs in plasma or AS showed a biconcave shape with a small sphericity, whereas those in 0.9% NS or PBS showed a spherical shape with a large sphericity. Moreover, we confirmed that sodium chloride alone could not elicit the biconcave shape of RBCs, which could be maintained only in the presence of an osmotic pressure-maintaining substance, such as glucose or mannitol. Although 0.9% NS solution is one of the most commonly used fluids in hematology and transfusion medicine, RBCs in 0.9% NS or PBS are not biconcave. Therefore, as the debate on the use of NS continues, future clinical studies or applications should consider the effect of glucose or mannitol on the shape of RBCs.	[Son, Minkook; Yang, Sung] Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea; [Lee, Ye Sung; Yang, Sung] Gwangju Inst Sci & Technol, Sch Mech Engn, Gwangju, South Korea; [Lee, Mahn Jae] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Park, YongKeun] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea; [Bae, Hae-Rahn] Dong A Univ, Dept Physiol, Coll Med, Busan, South Korea; [Lee, Seung Yeob] Jeonbuk Natl Univ, Dept Lab Med, Med Sch & Hosp, Jeonju, South Korea; [Shin, Myung-Geun] Chonnam Natl Univ, Dept Lab Med, Med Sch, Hwasun, South Korea; [Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Dong A University; Jeonbuk National University; Chonnam National University; Chonnam National University	Yang, S (corresponding author), Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea.; Yang, S (corresponding author), Gwangju Inst Sci & Technol, Sch Mech Engn, Gwangju, South Korea.	syang@gist.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIT) [2020R1A5A8018367]	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) [grant number 2020R1A5A8018367]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsever JB., 1941, NY STATE J MED, V41, P126; Blumberg N, 2018, TRANSFUS APHER SCI, V57, P127, DOI 10.1016/j.transci.2018.02.021; Briggs C, 2000, CLIN LAB HAEMATOL, V22, P345, DOI 10.1046/j.1365-2257.2000.00330.x; Campbell-Lee SA., 2007, PACKED RED BLOOD CEL, Vsecond, P250; Dagur Pradeep K, 2015, Curr Protoc Cytom, V73, DOI 10.1002/0471142956.cy0501s73; Diez-Silva M, 2010, MRS BULL, V35, P382, DOI 10.1557/mrs2010.571; Disbro Wendy L, 2017, Immunohematology, V33, P105; DORWART WV, 1975, CLIN CHEM, V21, P190; ELGSAETER A, 1991, BIOCHIM BIOPHYS ACTA, V1071, P273, DOI 10.1016/0304-4157(91)90017-Q; Fung YC., 1993, BIOMECHANICS MECH PR, P112; Garcia MJ., 2009, REV COLOMB ANESTESIO, V37, P106; GEDDE MM, 1995, BLOOD, V86, P1595, DOI 10.1182/blood.V86.4.1595.bloodjournal8641595; Goodhead LK, 2017, ADV PHYSIOL EDUC, V41, P298, DOI 10.1152/advan.00083.2016; Hess JR., 2007, RED BLOOD CELL METAB, Vsecond, P205; Hur J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08675-7; Jung J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31698; Kackov S, 2013, BIOCHEM MEDICA, V23, P326; Kim Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06659; Kim Y, 2014, OPT EXPRESS, V22, P10398, DOI 10.1364/OE.22.010398; Kirkley SA, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.3557.3557; Lee S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01036-4; Li H, 2016, J ZHEJIANG UNIV-SC B, V17, P181, DOI 10.1631/jzus.B1500201; Martincic I, 2008, Immunohematology, V24, P39; Masalunga C, 2007, J PERINATOL, V27, P380, DOI 10.1038/sj.jp.7211748; Park H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34257; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Popescu G, 2008, BLOOD CELL MOL DIS, V41, P10, DOI 10.1016/j.bcmd.2008.01.010; Rasia M, 1998, BBA-BIOMEMBRANES, V1372, P198, DOI 10.1016/S0005-2736(98)00057-1; Rasouli M, 2016, CLIN BIOCHEM, V49, P936, DOI 10.1016/j.clinbiochem.2016.06.001; Reinhart SA, 2015, CLIN HEMORHEOL MICRO, V60, P437, DOI 10.3233/CH-141899; Reinhart WH, 2015, TRANSFUSION, V55, P1872, DOI 10.1111/trf.13052; Reinhart WH, 2015, MICROVASC RES, V98, P102, DOI 10.1016/j.mvr.2015.01.010; Roma PMS, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.090505; Rous P, 1916, J EXP MED, V23, P219, DOI 10.1084/jem.23.2.219; SCHJERNINGTHIESEN K, 1953, ACTA PATHOL MIC SC, V32, P198; Tomaiuolo G, 2012, CYTOM PART A, V81A, P1040, DOI 10.1002/cyto.a.22215; TRAYKOV TT, 1987, INT J MICROCIRC, V6, P35; Viskupicova J, 2015, REDOX BIOL, V5, P381, DOI 10.1016/j.redox.2015.06.011; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298; Watson P, 2014, MED SCI SPORT EXER, V46, P52, DOI 10.1249/MSS.0b013e3182a0537b; WAUGH RE, 1992, BLOOD, V79, P1351; Weatherall DJ, 2011, NEW ENGL J MED, V364, P376, DOI 10.1056/NEJMcibr1012683; Yang P, 2014, TRANSFUSION, V54, P1146, DOI 10.1111/trf.12370	44	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262106	10.1371/journal.pone.0262106	http://dx.doi.org/10.1371/journal.pone.0262106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972199	gold, Green Published			2022-12-26	WOS:000773555700098
J	Zhuang, XH; Tran, T; Jin, D; Philip, R; Wu, CR				Zhuang, Xiaohua; Tran, Tam; Jin, Doris; Philip, Riya; Wu, Chaorong			Aging effects on contrast sensitivity in visual pathways: A pilot study on flicker adaptation	PLOS ONE			English	Article							GANGLION-CELLS; SAMPLING EFFICIENCY; GLAUCOMA; AMBLYOPIA; MODULATION; LUMINANCE; PARALLEL; DECLINE; VISION; LOSSES	Contrast sensitivity is reduced in older adults and is often measured at an overall perceptual level. Recent human psychophysical studies have provided paradigms to measure contrast sensitivity independently in the magnocellular (MC) and parvocellular (PC) visual pathways and have reported desensitization in the MC pathway after flicker adaptation. The current study investigates the influence of aging on contrast sensitivity and on the desensitization effect in the two visual pathways. The steady- and pulsed-pedestal paradigms were used to measure contrast sensitivity under two adaptation conditions in 45 observers. In the non-flicker adaptation condition, observers adapted to a pedestal array of four 1 degrees x1 degrees squares presented with a steady luminance; in the flicker adaptation condition, observers adapted to a square-wave modulated luminance flicker of 7.5 Hz and 50% contrast. Results showed significant age-related contrast sensitivity reductions in the MC and PC pathways, with a significantly larger decrease of contrast sensitivity for individuals older than 50 years of age in the MC pathway but not in the PC pathway. These results are consistent with the hypothesis that sensitivity reduction observed at the overall perceptual level likely comes from both the MC and PC visual pathways, with a more dramatic reduction resulting from the MC pathway for adults >50 years of age. In addition, a similar desensitization effect from flicker adaptation was observed in the MC pathway for all ages, which suggests that aging may not affect the process of visual adaptation to rapid luminance flicker.	[Zhuang, Xiaohua; Tran, Tam; Jin, Doris; Philip, Riya] Illinois Coll Optometry, Chicago, IL 60616 USA; [Wu, Chaorong] Univ Utah, Study Design & Biostat Ctr, Div Epidemiol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Zhuang, XH (corresponding author), Illinois Coll Optometry, Chicago, IL 60616 USA.	xzhuang@ico.edu			Illinois Society for the Prevention of Blindness Research Grant; American Academy of Optometry Foundation Beta Sigma Kappa Research Fellowship; ICO Internal Research Grant	Illinois Society for the Prevention of Blindness Research Grant; American Academy of Optometry Foundation Beta Sigma Kappa Research Fellowship; ICO Internal Research Grant	Supported to XZ from Illinois Society for the Prevention of Blindness Research Grant, American Academy of Optometry Foundation Beta Sigma Kappa Research Fellowship, and ICO Internal Research Grant.	AHMAD A, 1993, J COMP NEUROL, V334, P631, DOI 10.1002/cne.903340410; Benedek Gyorgy, 2016, Vision (Basel), V1, DOI 10.3390/vision1010007; Bennett PJ, 1999, J OPT SOC AM A, V16, P654, DOI 10.1364/JOSAA.16.000654; Bi W, 2016, INVEST OPHTH VIS SCI, V57, P387, DOI 10.1167/iovs.15-16481; Chatzistefanou KI, 2005, J AAPOS, V9, P468, DOI 10.1016/j.jaapos.2005.05.002; Conlon E, 2008, AGING NEUROPSYCHOL C, V15, P446, DOI 10.1080/13825580701878008; CROOK JM, 1988, J PHYSIOL-LONDON, V396, P205, DOI 10.1113/jphysiol.1988.sp016959; DEREFELDT G, 1979, ACTA OPHTHALMOL, V57, P679; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Dorr M, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00234; ELLIOTT D, 1990, VISION RES, V30, P541, DOI 10.1016/0042-6989(90)90066-T; ELLIOTT DB, 1987, OPHTHAL PHYSL OPT, V7, P415, DOI 10.1111/j.1475-1313.1987.tb00771.x; Elliott SL, 2010, J VISION, V10, DOI 10.1167/10.4.4; Elliott SL, 2009, J VISION, V9, DOI 10.1167/9.2.24; Glass JM, 2007, PSYCHOL AGING, V22, P233, DOI 10.1037/0882-7974.22.2.233; Habak C, 2000, VISION RES, V40, P943, DOI 10.1016/S0042-6989(99)00235-7; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Hathibelagal AR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232784; Ichhpujani P, 2020, J GLAUCOMA, V29, P71, DOI 10.1097/IJG.0000000000001379; Jammal AA, 2020, BRIT J OPHTHALMOL, V104, P1418, DOI 10.1136/bjophthalmol-2019-315273; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; KENDELL KR, 1995, INVEST OPHTH VIS SCI, V36, P200; KIM CBY, 1994, J OPT SOC AM A, V11, P1958, DOI 10.1364/JOSAA.11.001958; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lek JJ, 2014, INVEST OPHTH VIS SCI, V55, P3171, DOI 10.1167/iovs.13-13229; Luu CD, 2013, INVEST OPHTH VIS SCI, V54, P3560, DOI 10.1167/iovs.12-10465; McAnany JJ, 2020, ACTA OPHTHALMOL, V98, pE224, DOI 10.1111/aos.14241; McKendrick AM, 2007, INVEST OPHTH VIS SCI, V48, P2115, DOI 10.1167/iovs.06-1208; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Min SH, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.622729; Mohammadi A, 2019, J CURR OPHTHALMOL, V31, P72, DOI 10.1016/j.joco.2018.09.010; NAMEDA N, 1989, OPTOMETRY VISION SCI, V66, P760, DOI 10.1097/00006324-198911000-00007; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Owsley C, 2016, ANNU REV VIS SCI, V2, P255, DOI 10.1146/annurev-vision-111815-114550; Pardhan S, 2004, J OPT SOC AM A, V21, P169, DOI 10.1364/JOSAA.21.000169; Pardhan S, 1996, VISION RES, V36, P1641, DOI 10.1016/0042-6989(95)00214-6; Plainis S, 2005, PERCEPTION, V34, P933, DOI 10.1068/p5451; Pokorny J, 1997, J OPT SOC AM A, V14, P2477, DOI 10.1364/JOSAA.14.002477; Pokorny J, 2011, J VISION, V11, DOI 10.1167/11.5.7; Pramanik S, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05336; Resende AF, 2019, DOC OPHTHALMOL, V139, P185, DOI 10.1007/s10633-019-09707-5; Ridder A, 2017, PARKINSONISM RELAT D, V34, P15, DOI 10.1016/j.parkreldis.2016.10.006; Schubert CR, 2017, J GERONTOL A-BIOL, V72, P1087, DOI 10.1093/gerona/glx067; SEKULER R, 1982, AM J OPTOM PHYS OPT, V59, P961; SLOANE ME, 1988, J OPT SOC AM A, V5, P2181, DOI 10.1364/JOSAA.5.002181; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Thakur S, 2018, EYE, V32, P1392, DOI 10.1038/s41433-018-0099-y; TULUNAYKEESEY U, 1988, J OPT SOC AM A, V5, P2191, DOI 10.1364/JOSAA.5.002191; TYLER CW, 1989, J OPT SOC AM A, V6, P481, DOI 10.1364/JOSAA.6.000481; Yan FF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63053-0; Yuan Y, 2021, OPHTHALMIC RES, V64, P967, DOI 10.1159/000515599; Zele AJ, 2007, INVEST OPHTH VIS SCI, V48, P3622, DOI 10.1167/iovs.06-1207; Zhuang XH, 2015, VISION RES, V117, P41, DOI 10.1016/j.visres.2015.08.020; Zhuang XH, 2015, INVEST OPHTH VIS SCI, V56, P2901, DOI 10.1167/iovs.14-16067; Zhuang XH, 2012, J VISION, V12, DOI 10.1167/12.11.16	56	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261927	10.1371/journal.pone.0261927	http://dx.doi.org/10.1371/journal.pone.0261927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972163	Green Published, gold			2022-12-26	WOS:000773555700068
J	Coudevylle, N; Banas, B; Baumann, V; Schuschnig, M; Zawadzka-Kazimierczuk, A; Kozminski, W; Martens, S				Coudevylle, Nicolas; Banas, Bartlomiej; Baumann, Verena; Schuschnig, Martina; Zawadzka-Kazimierczuk, Anna; Kozminski, Wiktor; Martens, Sascha			Mechanism of Atg9 recruitment by Atg11 in the cytoplasm-to-vacuole targeting pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; RESONANCE ASSIGNMENT; SCAFFOLD PROTEIN; EARLY STEPS; CARGO; VESICLES; TRANSPORT; ACTIVATE; SYSTEM; KINASE	Autophagy is a lysosomal degradation pathway for the removal of damaged and superfluous cytoplasmic material. This is achieved by the sequestration of this cargo material within double-membrane vesicles termed autophagosomes. Autophagosome formation is mediated by the conserved autophagy machinery. In selective autophagy, this machinery including the transmembrane protein Atg9 is recruited to specific cargo material via cargo receptors and the Atg11/FIP200 scaffold protein. The molecular details of the interaction between Atg11 and Atg9 are unclear, and it is still unknown how the recruitment of Atg9 is regulated. Here we employ NMR spectroscopy of the N-terminal disordered domain of Atg9 (Atg9-NTD) to map its interaction with Atg11 revealing that it involves two short peptides both containing a PLF motif. We show that the Atg9-NTD binds to Atg11 with an affinity of about 1 mu M and that both PLF motifs contribute to the interaction. Mutation of the PLF motifs abolishes the interaction of the Atg9-NTD with Atg11, reduces the recruitment of Atg9 to the precursor aminopeptidase 1 (prApe1) cargo, and blocks prApe1 transport into the vacuole by the selective autophagy-like cytoplasm-to-vacuole (Cvt) targeting pathway while not affecting bulk autophagy. Our results provide mechanistic insights into the interaction of the Atg11 scaffold with the Atg9 transmembrane protein in selective autophagy and suggest a model where only clustered Atg11 when bound to the prApe1 cargo is able to efficiently recruit Atg9 vesicles.	[Coudevylle, Nicolas; Baumann, Verena; Schuschnig, Martina; Martens, Sascha] Univ Vienna, Max Perutz Labs, Vienna, Austria; [Banas, Bartlomiej; Zawadzka-Kazimierczuk, Anna; Kozminski, Wiktor] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland; [Baumann, Verena] Univ Vienna, Doctoral Sch, Vienna BioCtr, PhD Program, Vienna, Austria; [Baumann, Verena] Med Univ Vienna, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Warsaw; University of Vienna; Vienna Biocenter (VBC); Medical University of Vienna	Coudevylle, N; Martens, S (corresponding author), Univ Vienna, Max Perutz Labs, Vienna, Austria.	nicolas.coudevylle@univie.ac.at; sascha.martens@univie.ac.at	; Zawadzka-Kazimierczuk, Anna/J-9655-2012	Martens, Sascha/0000-0003-3786-8199; Baumann, Verena/0000-0002-9972-9285; Banas, Bartlomiej/0000-0002-2304-0983; Zawadzka-Kazimierczuk, Anna/0000-0002-1125-7923	ERC [646653]; FWF grant [P32814-B]; Polish National Science Centre [2015/18/A/ST4/00270]	ERC(European Research Council (ERC)European Commission); FWF grant(Austrian Science Fund (FWF)); Polish National Science Centre	This work has been funded by the ERC grant No.646653 and FWF grant (P32814-B) to S. M. and a grant from the Polish National Science Centre to W. K. (MAESTRO, 2015/18/A/ST4/00270) .	Chang CM, 2021, NAT CELL BIOL, V23, P450, DOI 10.1038/s41556-021-00669-y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gomez-Sanchez R, 2018, J CELL BIOL, V217, P2743, DOI 10.1083/jcb.201710116; Guardia CM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107837; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; Kamber RA, 2015, MOL CELL, V59, P372, DOI 10.1016/j.molcel.2015.06.009; Kazimierczuk K, 2010, PROG NUCL MAG RES SP, V57, P420, DOI 10.1016/j.pnmrs.2010.07.002; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Licheva M, 2022, AUTOPHAGY, V18, P104, DOI 10.1080/15548627.2021.1909407; Maeda S, 2020, NAT STRUCT MOL BIOL, V27, P1194, DOI 10.1038/s41594-020-00520-2; Maeda S, 2019, ELIFE, V8, DOI 10.7554/eLife.45777; Margolis HK, 2020, J MOL BIOL, V432, P5752, DOI 10.1016/j.jmb.2020.08.025; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matoba K, 2020, NAT STRUCT MOL BIOL, V27, P1185, DOI [10.1038/s41594-020-00518-w, 10.1038/s41594-020-00538-6]; Melia TJ, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202002085; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mochida K, 2014, FEBS LETT, V588, P3862, DOI 10.1016/j.febslet.2014.09.032; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Orii M, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202009194; Osawa T, 2019, NAT STRUCT MOL BIOL, V26, P281, DOI 10.1038/s41594-019-0203-4; Pfaffenwimmer T, 2014, EMBO REP, V15, P862, DOI 10.15252/embr.201438932; Rao YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10338; Sawa-Makarska J, 2020, SCIENCE, V369, P1206, DOI 10.1126/science.aaz7714; Schutter M, 2020, CELL, V180, P135, DOI 10.1016/j.cell.2019.12.005; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Stanek J, 2010, J BIOMOL NMR, V47, P65, DOI 10.1007/s10858-010-9411-2; Suzuki H, 2018, FEBS OPEN BIO, V8, P110, DOI 10.1002/2211-5463.12355; Suzuki SW, 2015, P NATL ACAD SCI USA, V112, P3350, DOI 10.1073/pnas.1421092112; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; Torggler R, 2016, MOL CELL, V64, P221, DOI 10.1016/j.molcel.2016.09.008; Turco E, 2020, J MOL BIOL, V432, P123, DOI 10.1016/j.jmb.2019.07.027; Turco E, 2019, MOL CELL, V74, P330, DOI 10.1016/j.molcel.2019.01.035; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Uversky VN, 2020, METHODS MOL BIOL, V2141, P895, DOI 10.1007/978-1-0716-0524-0_46; Valverde DP, 2019, J CELL BIOL, V218, P1787, DOI 10.1083/jcb.201811139; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004; Zawadzka-Kazimierczuk A, 2012, J BIOMOL NMR, V54, P81, DOI 10.1007/s10858-012-9652-3; Zawadzka-Kazimierczuk A, 2012, J BIOMOL NMR, V52, P329, DOI 10.1007/s10858-012-9613-x	45	0	0	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101573	10.1016/j.jbc.2022.101573	http://dx.doi.org/10.1016/j.jbc.2022.101573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35007534	gold, Green Published			2022-12-26	WOS:000761371500001
J	Frasse, PM; Miller, JJ; Polino, AJ; Soleimani, E; Zhu, JS; Jakeman, DL; Jez, JM; Goldberg, DE; John, ARO				Frasse, Philip M.; Miller, Justin J.; Polino, Alexander J.; Soleimani, Ebrahim; Zhu, Jian-She; Jakeman, David L.; Jez, Joseph M.; Goldberg, Daniel E.; John, Audrey R. Odom			Enzymatic and structural characterization of HAD5, an essential phosphomannomutase of malaria-causing parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; BLOOD-STAGE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS; PHOSPHONO-ANALOGS; MEMBRANE ANCHOR; LINKED GLYCANS; EGRESS; INHIBITION; INVASION	The malaria-causing parasite Plasmodium falciparum is responsible for over 200 million infections and 400,000 deaths per year. At multiple stages during its complex life cycle, P. falciparum expresses several essential proteins tethered to its surface by glycosylphosphatidylinositol (GPI) anchors, which are critical for biological processes such as parasite egress and reinvasion of host red blood cells. Targeting this pathway therapeutically has the potential to broadly impact parasite development across several life stages. Here, we characterize an upstream component of parasite GPI anchor biosynthesis, the putative phosphomannomutase (PMM) (EC 5.4.2.8), HAD5 (PF3D7_1017400). We confirmed the PMM and phosphoglucomutase activities of purified recombinant HAD5 by developing novel linked enzyme biochemical assays. By regulating the expression of HAD5 in transgenic parasites with a TetR-DOZIinducible knockdown system, we demonstrated that HAD5 is required for malaria parasite egress and erythrocyte reinvasion, and we assessed the role of HAD5 in GPI anchor synthesis by autoradiography of radiolabeled glucosamine and thin layer chromatography. Finally, we determined the three-dimensional X-ray crystal structure of HAD5 and identified a substrate analog that specifically inhibits HAD5 compared to orthologous human PMMs in a time-dependent manner. These findings demonstrate that the GPI anchor biosynthesis pathway is exceptionally sensitive to inhibition in parasites and that HAD5 has potential as a specific, multistage antimalarial target.	[Frasse, Philip M.; Polino, Alexander J.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Frasse, Philip M.; Polino, Alexander J.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, Div Infect Dis, St Louis, MO 63110 USA; [Miller, Justin J.; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Soleimani, Ebrahim; Zhu, Jian-She; Jakeman, David L.] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada; [Soleimani, Ebrahim] Razi Univ, Dept Chem, Kermanshah, Iran; [Jakeman, David L.] Dalhousie Univ, Dept Chem, Halifax, NS, Canada; [John, Audrey R. Odom] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Dalhousie University; Razi University; Dalhousie University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	John, ARO (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA.	johna3@chop.edu		Frasse, Philip/0000-0002-5529-3280; Miller, Justin/0000-0001-9400-8916; Odom John, Audrey/0000-0001-8395-8537; Polino, Alexander/0000-0003-2601-3638	NIH/NIAID [R01 AI103280, R21 AI123808, R21 AI130584, R61 DH105594]; Burroughs Wellcome Fund; NSERC [03893-2020]; CIHR [153332]	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	Funding and additional information-A. R. O. J. is supported by the NIH/NIAID R01 AI103280, R21 AI123808, R21 AI130584, and R61 DH105594 and is an investigator in the Pathogenesis of Infectious Diseases (PATH) of the Burroughs Wellcome Fund. D. L. J. is supported by NSERC (03893-2020) and CIHR (153332) . The con-tent is solely the responsibility of the authors and does not neces-sarily represent the official views of the National Institutes of Health.	ACCORSI A, 1989, PREP BIOCHEM, V19, P251, DOI 10.1080/10826068908544915; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Anderson AC, 2005, DRUG DISCOV TODAY, V10, P121, DOI 10.1016/S1359-6446(04)03308-2; Azema L., 2006, CURR ENZYME INHIB, V2, P61; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Beaton SA, 2009, CHEM COMMUN, P238, DOI 10.1039/b808078j; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Burrows JN, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1675-x; Bushkin GG, 2010, EUKARYOT CELL, V9, P228, DOI 10.1128/EC.00197-09; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Chandramohanadas R, 2014, J INFECT DIS, V210, P1616, DOI 10.1093/infdis/jiu296; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Cova M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0949-z; Dans MG, 2020, INT J PARASITOL, V50, P235, DOI 10.1016/j.ijpara.2020.01.002; Das S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005647; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; Datoo MS, 2021, LANCET, V397, P1809, DOI 10.1016/S0140-6736(21)00943-0; de Macedo CS, 2001, EUR J BIOCHEM, V268, P6221, DOI 10.1046/j.0014-2956.2001.02571.x; DOERING T L, 1990, Methods (Orlando), V1, P288, DOI 10.1016/S1046-2023(05)80330-5; Doering T. L., 2001, CURR PROTOC PROTEIN; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Dowse Timothy J., 2008, V47, P121; Dumont L, 2019, MBIO, V10, DOI 10.1128/mBio.02060-19; Edwards RL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07159-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Favuzza P, 2020, CELL HOST MICROBE, V27, P642, DOI 10.1016/j.chom.2020.02.005; FERONE R, 1977, B WORLD HEALTH ORGAN, V55, P291; Frasse Philip M, 2019, Microbiol Insights, V12, p1178636119848435, DOI 10.1177/1178636119848435; Ganesan SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10727; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Guggisberg AM, 2018, MBIO, V9, DOI 10.1128/mBio.01193-18; Guggisberg AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5467; Haldar K, 2018, NAT REV MICROBIOL, V16, P156, DOI 10.1038/nrmicro.2017.161; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hoppe CM, 2018, GLYCOBIOLOGY, V28, P333, DOI 10.1093/glycob/cwy013; Imada M, 2010, PARASITOL INT, V59, P206, DOI 10.1016/j.parint.2010.01.007; Istvan ES, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14240; Ji TY, 2018, BIOCHEMISTRY-US, V57, P3480, DOI 10.1021/acs.biochem.8b00223; Kapoor N, 2018, BIOCHEMISTRY-US, V57, P516, DOI 10.1021/acs.biochem.7b01099; KEPES F, 1988, J BIOL CHEM, V263, P9155; Kim SH, 2003, ARCH MICROBIOL, V180, P240, DOI 10.1007/s00203-003-0582-z; Kokkonda S, 2018, ACS OMEGA, V3, P9227, DOI 10.1021/acsomega.8b01573; Kurucz R., 2013, ENCY MALARIA; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Kuznetsova E, 2015, J BIOL CHEM, V290, P18678, DOI 10.1074/jbc.M115.657916; Laurens MB, 2020, HUM VACC IMMUNOTHER, V16, P480, DOI 10.1080/21645515.2019.1669415; Lee SM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2989-2; Li L, 2018, J MICROBIOL BIOTECHN, V28, P1293, DOI 10.4014/jmb.1804.04030; Lidumniece E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022696118; Lopaticki S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00571-y; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; Lopez-Gutierrez B, 2019, PARASITOLOGY, V146, P1767, DOI 10.1017/S0031182019001380; Lu W, 2005, CARBOHYD RES, V340, P1213, DOI 10.1016/j.carres.2005.02.013; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehta M, 2005, FEBS LETT, V579, P6151, DOI 10.1016/j.febslet.2005.09.088; Meibalan E, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025452; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moorthy V, 2021, LANCET, V397, P1782, DOI 10.1016/S0140-6736(21)01065-5; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moyo P, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13090251; Naik RS, 2003, J BIOL CHEM, V278, P2036, DOI 10.1074/jbc.M208976200; Naik RS, 2000, J BIOL CHEM, V275, P24506, DOI 10.1074/jbc.M002151200; Nasamu AS, 2017, SCIENCE, V358, P518, DOI 10.1126/science.aan1478; NICOTRA F, 1982, J ORG CHEM, V47, P4459, DOI 10.1021/jo00144a011; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Oesterhelt C, 1997, FEBS LETT, V401, P35, DOI 10.1016/S0014-5793(96)01425-1; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Park J, 2015, ACTA CRYSTALLOGR D, V71, P1824, DOI 10.1107/S1399004715012067; Polino AJ, 2020, ACS INFECT DIS, V6, P738, DOI 10.1021/acsinfecdis.9b00460; Pradel G, 2002, MOL MICROBIOL, V45, P637, DOI 10.1046/j.1365-2958.2002.03057.x; Reddy KS, 2015, P NATL ACAD SCI USA, V112, P1179, DOI 10.1073/pnas.1415466112; Rieckmann KH, 1996, T ROY SOC TROP MED H, V90, P568, DOI 10.1016/S0035-9203(96)90326-0; ROSE ZB, 1986, TRENDS BIOCHEM SCI, V11, P253, DOI 10.1016/0968-0004(86)90188-X; ROTH EF, 1982, BIOCHEM BIOPH RES CO, V109, P355, DOI 10.1016/0006-291X(82)91728-4; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Sanz S, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00238; Scaria PV, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0121-9; Schultz C, 2003, BIOORGAN MED CHEM, V11, P885, DOI 10.1016/S0968-0896(02)00552-7; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Sherling ES, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008049; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Soldati D, 2004, TRENDS PARASITOL, V20, P567, DOI 10.1016/j.pt.2004.09.009; Tan MSY, 2021, EMBO J, V40, DOI 10.15252/embj.2020107226; Toenhake CG, 2018, CELL HOST MICROBE, V23, P557, DOI 10.1016/j.chom.2018.03.007; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Vanaerschot M, 2020, CELL CHEM BIOL, V27, P806, DOI 10.1016/j.chembiol.2020.04.001; Veiga-da-Cunha M, 2008, J BIOL CHEM, V283, P33988, DOI 10.1074/jbc.M805224200; Verma M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13810-1; von Itzstein M, 2008, TRENDS PARASITOL, V24, P210, DOI 10.1016/j.pt.2008.02.007; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Williamson KC, 2003, PARASITE IMMUNOL, V25, P351, DOI 10.1046/j.1365-3024.2003.00643.x; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006; Yeung Shunmay, 2018, Pediatr Infect Dis J, V37, P367, DOI 10.1097/INF.0000000000001887; Yuan MC, 2018, EUR J MED CHEM, V143, P611, DOI 10.1016/j.ejmech.2017.11.019; Zhang BC, 2011, BIOCHEMISTRY-US, V50, P3570, DOI 10.1021/bi200113y; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847; Zhu JS, 2019, J ORG CHEM, V84, P9627, DOI 10.1021/acs.joc.9b01305; Zhu JS, 2019, ACS OMEGA, V4, P7029, DOI 10.1021/acsomega.9b00008	114	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101550	10.1016/j.jbc.2021.101550	http://dx.doi.org/10.1016/j.jbc.2021.101550			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1QM	34973333	Green Published, gold			2022-12-26	WOS:000761402800003
J	Gao, M; Qi, ZJ; Feng, WY; Huang, HY; Xu, ZJ; Dong, Z; Xu, M; Han, JX; Kloeber, JA; Huang, JZ; Lou, ZK; Liu, SJ				Gao, Ming; Qi, Zijuan; Feng, Wenya; Huang, Hongyang; Xu, Zhijie; Dong, Zheng; Xu, Ming; Han, Jinxiang; Kloeber, Jake A.; Huang, Jinzhou; Lou, Zhenkun; Liu, Sijin			m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOBEC3B; N6-METHYLADENOSINE; MECHANISMS	The cytidine deaminase APOBEC3B (A3B) is an endogenous inducer of somatic mutations and causes chromosomal instability by converting cytosine to uracil in single-stranded DNA. Therefore, identification of factors and mechanisms that mediate A3B expression will be helpful for developing therapeutic approaches to decrease DNA mutagenesis. Arsenic (As) is one well-known mutagen and carcinogen, but the mechanisms by which it induces mutations have not been fully elucidated. Herein, we show that A3B is upregulated and required for As-induced DNA damage and mutagenesis. We found that As treatment causes a decrease of N6methyladenosine (m6A) modification near the stop codon of A3B, consequently increasing the stability of A3B mRNA. We further reveal that the demethylase FTO is responsible for Asreduced m6A modification of A3B, leading to increased A3B expression and DNA mutation rates in a manner dependent on the m6A reader YTHDF2. Our in vivo data also confirm that A3B is a downstream target of FTO in As-exposed lung tissues. In addition, FTO protein is highly expressed and positively correlates with the protein levels of A3B in tumor samples from indicate a previously unrecognized role of A3B in As-triggered somatic mutation and might open new avenues to reduce DNA mutagenesis by targeting the FTO/m6A axis.	[Gao, Ming; Feng, Wenya; Dong, Zheng; Xu, Ming; Liu, Sijin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing, Peoples R China; [Gao, Ming; Feng, Wenya; Dong, Zheng; Xu, Ming; Liu, Sijin] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China; [Qi, Zijuan; Han, Jinxiang] Shandong First Med Univ, Dept Orthoped Surg, Affiliated Hosp 1, Jinan, Shandong, Peoples R China; [Huang, Hongyang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China; [Xu, Zhijie] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Pathol, Changsha, Hunan, Peoples R China; [Kloeber, Jake A.; Huang, Jinzhou; Lou, Zhenkun] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Kloeber, Jake A.] Mayo Clin, Mayo Clin Med Scientist Training Program, Rochester, MN USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Hong Kong; Central South University; Mayo Clinic; Mayo Clinic	Liu, SJ (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing, Peoples R China.; Liu, SJ (corresponding author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China.; Huang, JZ; Lou, ZK (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.	huang.jinzhou@mayo.edu; lou.zhenkun@mayo.edu; sjliu@rcees.ac.cn		han, jinxiang/0000-0002-2507-9611; Huang, Hongyang/0000-0002-5138-7781; Kloeber, Jake/0000-0002-6646-564X	National Natural Science Foundation of China [22076212]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB2004]; China National Key RD Program [2021YFA0719300]; Science Fund for Creative Research Groups of the National Natural Science Foundation of China [22021003]; Youth Innovation Promotion Association of CAS [2021040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China National Key RD Program; Science Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of CAS	This research was supported by the National Natural Science Foundation of China (Grant No. 22076212), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB2004), the China National Key R&D Program (2021YFA0719300), the Science Fund for Creative Research Groups of the National Natural Science Foundation of China (22021003), and the Youth Innovation Promotion Association of CAS (2021040).	Ackerman S., 2018, GREEN CHEM, P109, DOI 10.2016/B978-0-12-809270-5.00005-4; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Buisson R, 2017, CANCER RES, V77, P4567, DOI 10.1158/0008-5472.CAN-16-3389; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cescon DW, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1069-y; Chen XY, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1033-z; Cheung MK, 2013, INT J OBESITY, V37, P744, DOI 10.1038/ijo.2012.77; Chou WC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44089; Cui YH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22469-6; Du YD, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03622-x; Faulds KJ, 2018, J BIOL CHEM, V293, P10731, DOI 10.1074/jbc.RA117.001298; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gao M, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-017-0005-y; Green AM, 2019, DNA REPAIR, V83, DOI 10.1016/j.dnarep.2019.102700; He LE, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1109-9; Herbst RS, 2018, NATURE, V553, P446, DOI 10.1038/nature25183; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Huang HL, 2020, CANCER CELL, V37, P270, DOI 10.1016/j.ccell.2020.02.004; Huang Y, 2019, CANCER CELL, V35, P677, DOI 10.1016/j.ccell.2019.03.006; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Johnston HR, 2019, EMERY RIMOINS PRINCI, P359, DOI DOI 10.1016/B978-0-12-812537-3.00012-3; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Kanu N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1042-9; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Li J, 2019, BIOCHEM BIOPH RES CO, V512, P479, DOI 10.1016/j.bbrc.2019.03.093; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Mathiyalagan P, 2019, CIRCULATION, V139, P518, DOI 10.1161/CIRCULATIONAHA.118.033794; McInerney Peter, 2014, Mol Biol Int, V2014, P287430, DOI 10.1155/2014/287430; Mori S, 2015, BIOCHEM BIOPH RES CO, V460, P555, DOI 10.1016/j.bbrc.2015.03.068; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Periyasamy M, 2021, ONCOGENE, V40, P1077, DOI 10.1038/s41388-020-01583-7; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Serebrenik AA, 2020, CLIN CANCER RES, V26, P3397, DOI 10.1158/1078-0432.CCR-19-2786; Serebrenik AA, 2019, P NATL ACAD SCI USA, V116, P22158, DOI 10.1073/pnas.1904024116; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Soza-Ried C, 2019, CRIT REV ONCOL HEMAT, V139, P128, DOI 10.1016/j.critrevonc.2019.01.012; Tam LM, 2020, CHEM RES TOXICOL, V33, P709, DOI 10.1021/acs.chemrestox.9b00464; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Wang SX, 2018, ONCOGENE, V37, P3924, DOI 10.1038/s41388-018-0245-9; Wang YY, 2021, MOL CLIN ONCOL, V14, DOI 10.3892/mco.2021.2290; Wei SH, 2019, TOXICOL RES-UK, V8, P319, DOI 10.1039/c8tx00298c; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Xu YR, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.629560; Yi YC, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01233-2; Yu F, 2021, NUCLEIC ACIDS RES, V49, P5779, DOI 10.1093/nar/gkab415; Zhang CF, 2020, MOL CELL, V79, P425, DOI 10.1016/j.molcel.2020.06.017; Zhang Q, 2019, P NATL ACAD SCI USA, V116, P17980, DOI 10.1073/pnas.1905489116; Zhou C, 2017, CELL REP, V20, P2262, DOI 10.1016/j.celrep.2017.08.027	53	4	4	8	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101563	10.1016/j.jbc.2022.101563	http://dx.doi.org/10.1016/j.jbc.2022.101563			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34998823	Green Published, gold			2022-12-26	WOS:000761395300009
J	Nelson, AK; Cassidy, T; Duran, LT; Cox, V; Wedderburn, CJ; Giddy, J; Pieters, P; Cotton, MF; Mutseyekwa, T; Rorwana, B; Sibanda, B; Bernheimer, J; Matise, N; Isaakidis, P; Maritz, J				Nelson, Aurelie Kennedy; Cassidy, Tali; Duran, Laura Trivino; Cox, Vivian; Wedderburn, Catherine J.; Giddy, Janet; Pieters, Pauline; Cotton, Mark F.; Mutseyekwa, Tabitha; Rorwana, Bulelwa; Sibanda, Beryl; Bernheimer, Jonathan; Matise, Nopinky; Isaakidis, Petros; Maritz, Jean			An analysis of the HIV testing cascade of a group of HIV-exposed infants from birth to 18 months in peri-urban Khayelitsha, South Africa	PLOS ONE			English	Article							FOLLOW-UP; PROGRAM; WORKERS; IMPACT; WOMEN; CARE	Background Despite the reduction of HIV mother-to-child transmission, there are concerns regarding transmission rate in the breastfeeding period. We describe the routine uptake of 6 or 10 (6/10) weeks, 9 months and 18 months testing, with and without tracing, in a cohort of infants who received HIV PCR testing at birth (birth PCR) (with and without point of care (POC) testing) in a peri-urban primary health care setting in Khayelitsha, South Africa. Methods In this cohort study conducted between November 2014 and February 2018, HIV-positive mothers and their HIV-exposed babies were recruited at birth and all babies were tested with birth PCR. Results of routine 6/10 weeks PCR, 9 months and 18 months testing were followed up by a patient tracer. We compared testing at 6/10 weeks with a subgroup from historical cohort who was not tested with birth PCR. Results We found that the uptake of 6/10 weeks testing was 77%, compared to 82% with tracing. When including all infants in the cascade and comparing to a historical cohort without birth testing, we found that infants who tested a birth were 22% more likely to have a 6/10 weeks test compared to those not tested at birth. There was no significant difference between the uptake of 6/10 weeks testing after birth PCR POC versus birth PCR testing without POC. Uptake of 9 months and 18 months testing was 39% and 24% respectively. With intense tracing efforts, uptake increased to 45% and 34% respectively. Conclusion Uptake of HIV testing for HIV-exposed uninfected infants in the first 18 months of life shows good completion of the 6/10 weeks PCR but suboptimal uptake of HIV testing at 9 months and 18 months, despite tracing efforts. Birth PCR testing did not negatively affect uptake of the 6/10 weeks HIV test compared to no birth PCR testing.	[Nelson, Aurelie Kennedy; Cassidy, Tali; Duran, Laura Trivino; Mutseyekwa, Tabitha; Rorwana, Bulelwa; Sibanda, Beryl; Bernheimer, Jonathan; Matise, Nopinky] Medecins Sans Frontieres, Cape Town, South Africa; [Cassidy, Tali] Univ Cape Town, Sch Publ Hlth & Family Med, Div Publ Hlth Med, Cape Town, South Africa; [Cox, Vivian] Stellenbosch Univ, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Cape Town, South Africa; [Wedderburn, Catherine J.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Wedderburn, Catherine J.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Giddy, Janet; Pieters, Pauline] Western Cape Prov Dept Hlth, Khayelitsha & Eastern Substruct, Cape Town, South Africa; [Cotton, Mark F.] Stellenbosch Univ, Tygerberg Childrens Hosp, Family Ctr Res Ubuntu, Dept Paediat & Child Hlth, Cape Town, South Africa; [Isaakidis, Petros] Southern African Med Unit, Cape Town, South Africa; [Maritz, Jean] Stellenbosch Univ, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Maritz, Jean] PathCare Reference Lab, Cape Town, South Africa	University of Cape Town; Stellenbosch University; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; Stellenbosch University; University of Cape Town	Nelson, AK (corresponding author), Medecins Sans Frontieres, Cape Town, South Africa.	aurelie.haw1@gmail.com	Wedderburn, Catherine/GZA-8421-2022	Cotton, Mark/0000-0003-2559-6034; Nelson, Aurelie/0000-0001-8681-7377; Isaakidis, Petros/0000-0002-7881-1554	UNITAID [UNITAID/EB15/SSDP/2012/R3]; MSF	UNITAID; MSF	The authors received UNITAID grant on Early Infant Diagnosis. https://unitaid.org/ourprojects/grantees/#en UNITAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript UNITAID grant number was UNITAID/EB15/SSDP/2012/R3. MSF provided funding. Aurelie Kennedy Nelson, Tali Cassidy, Laura Trivino Duran, Vivian Cox, Catherine J Wedderburn, Tabitha Mutseyekwa, Bulelwa Rorwana, Beryl Sibanda, Jonathan Bernheimer, Nopinky Matise, Petros Isaakidis, were employed by MSF at the time of the study. MSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamo ST, 2013, AIDS BEHAV, V17, P274, DOI 10.1007/s10461-012-0199-9; [Anonymous], 2015, W CAP CONS GUID HIV; Bershetyn A, 2017, CLIN INFECT DIS, V64, P1547, DOI 10.1093/cid/cix191; Cassidy T., 2015, S AFRICAN HIV CLIN S, V8; Cataldo F, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-017-2826-7; City of Cape Town, 2013, 2011 CENS SUB KHAY, P1; Department of Health Republic of South Africa, 2015, W CAPE ANT SURV REP, P1; Dunning L, 2017, PEDIATR INFECT DIS J, V36, P1159, DOI 10.1097/INF.0000000000001677; Dzanibe S, 2019, J LEUKOCYTE BIOL, V105, P281, DOI 10.1002/JLB.MR0318-120R; Edwards RJ, 2019, GLOB PUBLIC HEALTH, V14, P1589, DOI 10.1080/17441692.2019.1622759; Essajee S, 2015, J INT AIDS SOC, V18, P14, DOI 10.7448/IAS.18.7.20299; Etoori D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5258-3; Francke JA, 2016, J INFECT DIS, V214, P1319, DOI 10.1093/infdis/jiw379; Gill MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190874; Gill MM, 2015, JAIDS-J ACQ IMM DEF, V68, pe33, DOI 10.1097/QAI.0000000000000481; Goga AE, 2015, J EPIDEMIOL COMMUN H, V69, P240, DOI 10.1136/jech-2014-204535; Hacking D., 2017, SA AIDS; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hennessey C., 2016, TOP ANTIVIR MED, V24, P441; Hosseinipour M, 2017, JAIDS-J ACQ IMM DEF, V75, pS149, DOI 10.1097/qai.0000000000001368; Innes S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18914; Johnson L., 2014, THEMBISA VERSION 4 3, P1; Kalk E, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25212; Kaplan SR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002407; Kuhn L, 2015, S AFR J HIV MED, V16, P87, DOI [10.4102/sajhivmed.v16i1.377, 10.4102/SAJHIVMED.V16I1.377]; Lancaster KE, 2016, AJAR-AFR J AIDS RES, V15, P377, DOI 10.2989/16085906.2016.1255652; Lauritsen J., 2003, COMPR TOOL VALID ENT; Lebelo K., 2020, AIDS C; Nelson A, 2017, TOP ANTIVIR MED, V25, P983; Nelson AK., 2018, AIDS C P; Nelson A, 2015, S AFR J HIV MED, V16, P70, DOI 10.4102/sajhivmed.v16i1.376; Omonaiye O, 2018, INT J INFECT DIS, V74, P71, DOI 10.1016/j.ijid.2018.07.004; Phelanyane F., 2020, AIDS; Pieters P, 2015, COMMUNICATION; Shroufi A, 2013, AIDS, V27, P1971, DOI 10.1097/QAD.0b013e32836149ea; South African National Department of Health, 2018, GUIDELINES IMPLEMENT; UNAIDS. Communities at the centre, 2019, DEFEND RIGHTS BREAK; Velloza J, 2020, AIDS BEHAV, V24, P1727, DOI 10.1007/s10461-019-02716-0; Western Cape Department of Health, 2014, CAP FARM MAPP; Western Cape Department of Health, 2015, W CAP CONS GUID HIV, P1; World Health Organization, 2015, POL BRIEF CONS GUID, P20	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262518	10.1371/journal.pone.0262518	http://dx.doi.org/10.1371/journal.pone.0262518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030227	Green Published, gold, Green Accepted			2022-12-26	WOS:000812798500052
J	Xie, HJ; Zhu, MD; Yu, YY; Zeng, XS; Tang, GH; Duan, YH; Wang, JL; Yu, YH				Xie, Hongjun; Zhu, Mingdong; Yu, Yaying; Zeng, Xiaoshan; Tang, Guohua; Duan, Yonghong; Wang, Jianlong; Yu, Yinghong			Comparative transcriptome analysis of the cold resistance of the sterile rice line 33S	PLOS ONE			English	Article							STRESS; TOLERANCE; GENE; OVEREXPRESSION; PATHWAY; PROTEIN; IDENTIFICATION	Rice (Oryza sativa L.) is one of the most important species for food production worldwide. Low temperature is a major abiotic factor that affects rice germination and reproduction. Here, the underlying regulatory mechanism in seedlings of a TGMS variety (33S) and a cold-sensitive variety (Nipponbare) was investigated by comparative transcriptome. There were 795 differentially expressed genes (DEGs) identified only in cold-treated 33S, suggesting that 33S had a unique cold-resistance system. Functional and enrichment analysis of these DEGs revealed that, in 33S, several metabolic pathways, such as photosynthesis, amino acid metabolism, secondary metabolite biosynthesis, were significantly repressed. Moreover, pathways related to growth and development, including starch and sucrose metabolism, and DNA biosynthesis and damage response/repair, were significantly enhanced. The expression of genes related to nutrient reserve activity were significantly up-regulated in 33S. Finally, three NAC and several ERF transcription factors were predicted to be important in this transcriptional reprogramming. This present work provides valuable information for future investigations of low-temperature response mechanisms and genetic improvement of cold-tolerant rice seedlings.	[Xie, Hongjun; Zhu, Mingdong; Yu, Yaying; Zeng, Xiaoshan; Tang, Guohua; Duan, Yonghong] Hunan Rice Res Inst, Key Lab Ind Rice Genet & Breeding Middle & Lower, Changsha, Peoples R China; [Wang, Jianlong] Hunan Agr Univ, Coll Agron, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Peoples R China; [Yu, Yinghong] Hunan Acad Agr Sci, Changsha, Peoples R China	Hunan Academy of Agricultural Sciences; Hunan Agricultural University; Hunan Academy of Agricultural Sciences	Wang, JL (corresponding author), Hunan Agr Univ, Coll Agron, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Peoples R China.; Yu, YH (corresponding author), Hunan Acad Agr Sci, Changsha, Peoples R China.	wjl9678@126.com; yyh30678@163.com			National Key R&D Program of China [2018YFD0301001]	National Key R&D Program of China	This work was funded by the National Key R&D Program of China (2018YFD0301001).	Al Abdallat AM, 2014, MOL BREEDING, V33, P401, DOI 10.1007/s11032-013-9958-1; Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Buti M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225662; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Ding YL, 2018, EMBO J, V37, DOI 10.15252/embj.201798228; Ding YL, 2015, DEV CELL, V32, P278, DOI 10.1016/j.devcel.2014.12.023; Du LM, 2007, GENOMICS, V89, P697, DOI 10.1016/j.ygeno.2007.02.001; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fujino K, 2004, EUPHYTICA, V136, P63, DOI 10.1023/B:EUPH.0000019519.43951.67; Geng JJ, 2019, TREE PHYSIOL, V39, P2045, DOI 10.1093/treephys/tpz081; Guo H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205089; Han YC, 2019, PLANT CELL REP, V38, P673, DOI 10.1007/s00299-019-02399-w; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Huang L, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0897-y; Ishida K, 2008, BIOSCI BIOTECH BIOCH, V72, P3025, DOI 10.1271/bbb.80402; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lim CW, 2013, PLANT PATHOLOGY J, V29, P471, DOI 10.5423/PPJ.NT.07.2013.0071; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu QQ, 2015, PLANT SOIL, V387, P323, DOI 10.1007/s11104-014-2290-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo BoXiang, 2012, Journal of Agricultural Biotechnology, V20, P30; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Muthuramalingam P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00759; Ning YS, 2011, PLANT SIGNAL BEHAV, V6, P1684, DOI 10.4161/psb.6.11.17916; Normile D, 2008, SCIENCE, V321, P330, DOI 10.1126/science.321.5887.330; Pavlu J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082450; Penfield S, 2005, CURR BIOL, V15, P1998, DOI 10.1016/j.cub.2005.11.010; Shinada H, 2013, BREEDING SCI, V63, P197, DOI 10.1270/jsbbs.63.197; Singh RB., 1994, RECENT PROGR TECHNOL; Su N, 2012, PLANT PHYSIOL, V159, P227, DOI 10.1104/pp.112.195081; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Wang J, 2020, PLANT PHYSIOL, V184, P1775, DOI 10.1104/pp.20.00984; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang YJ, 2003, THEOR APPL GENET, V107, P1402, DOI 10.1007/s00122-003-1378-x; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Wei KF, 2016, PLANT MOL BIOL REP, V34, P761, DOI 10.1007/s11105-015-0958-7; Xia CX, 2021, PLANT CELL ENVIRON, V44, P491, DOI 10.1111/pce.13938; Xie H., 2015, AGR SCI TECHNOL, V16, P719; Xu JH, 2016, PLANT PHYSIOL BIOCH, V109, P561, DOI 10.1016/j.plaphy.2016.11.002; Yang QK, 2007, PLANTA, V225, P321, DOI 10.1007/s00425-006-0353-6; Yao PF, 2018, PLANT PHYSIOL BIOCH, V125, P85, DOI 10.1016/j.plaphy.2018.01.028; Yu GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109399; Yuan L P, 1994, HYBRID RICE, V6, P1, DOI 10.16267/j.cnki.1005-3956.1994.06.001	54	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261822	10.1371/journal.pone.0261822	http://dx.doi.org/10.1371/journal.pone.0261822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030196	Green Published, gold			2022-12-26	WOS:000812798500017
J	Nomikos, PA; Hall, MC; Fuller, A; Ogollah, R; Valdes, AM; Doherty, M; Walsh, DA; das Nair, R; Abhishek, A				Nomikos, Polykarpos Angelos; Hall, Michelle C.; Fuller, Amy; Ogollah, Reuben; Valdes, Ana M.; Doherty, Michael; Walsh, David Andrew; das Nair, Roshan; Abhishek, Abhishek			Acceptability of a nurse-led non-pharmacological complex intervention for knee pain: Nurse and patient views and experiences	PLOS ONE			English	Article							PRIMARY-CARE; MANAGEMENT; BARRIERS; OLDER	Objectives The overall purpose of this research programme is to develop and test the feasibility of a complex intervention for knee pain delivered by a nurse, and comprising both non-pharmacological and pharmacological interventions. In this first phase, we examined the acceptability of the non-pharmacological component of the intervention; issues faced in delivery, and resolved possible challenges to delivery. Methods Eighteen adults with chronic knee pain were recruited from the community. The intervention comprised holistic assessment, education, exercise, weight-loss advice (where appropriate) and advice on adjunctive treatments such as hot/cold treatments, footwear modification and walking aids. After nurse training, the intervention was delivered in four sessions spread over five weeks. Participants had one to one semi-structured interview at the end of the intervention. The nurse was interviewed after the last visit of the last participant. These were audio recorded and transcribed verbatim. Themes were identified by one author through framework analysis of the transcripts, and cross-checked by another. Results Most participants found the advice from the nurse easy to follow and were satisfied with the package, though some felt that too much information was provided too soon. The intervention changed their perception of managing knee pain, learning that it can be improved with self-management. However, participants thought that the most challenging part of the intervention was fitting the exercise regime into their daily routine. The nurse found discussion of goal setting to be challenging. Conclusion The nurse-led package of care is acceptable within a research setting. The results are promising and will be applied in a feasibility randomised-controlled trial.	[Nomikos, Polykarpos Angelos; Fuller, Amy; Valdes, Ana M.; Doherty, Michael; Walsh, David Andrew; Abhishek, Abhishek] Univ Nottingham, Acad Rheumatol, Sch Med, Div Rheumatol Orthopaed & Rheumatol, Nottingham, England; [Nomikos, Polykarpos Angelos; Hall, Michelle C.; Fuller, Amy; Valdes, Ana M.; Doherty, Michael; Walsh, David Andrew; Abhishek, Abhishek] Univ Nottingham, NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Nomikos, Polykarpos Angelos; Hall, Michelle C.; Valdes, Ana M.; Doherty, Michael; Walsh, David Andrew; das Nair, Roshan; Abhishek, Abhishek] Univ Nottingham, Pain Ctr Versus Arthrit, Nottingham, England; [Hall, Michelle C.] Univ Nottingham, Sch Hlth Sci, Nottingham, England; [Ogollah, Reuben] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham, England; [das Nair, Roshan] Nottinghamshire Healthcare Fdn NHS Trust, Inst Mental Hlth, Nottingham, England; [das Nair, Roshan] Univ Nottingham, Sch Med, Div Psychiat & Appl Psychol, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Nomikos, PA (corresponding author), Univ Nottingham, Acad Rheumatol, Sch Med, Div Rheumatol Orthopaed & Rheumatol, Nottingham, England.; Nomikos, PA (corresponding author), Univ Nottingham, NIHR Nottingham Biomed Res Ctr, Nottingham, England.; Nomikos, PA (corresponding author), Univ Nottingham, Pain Ctr Versus Arthrit, Nottingham, England.	Polykarpos.nomikos@nottingham.ac.uk		Fuller, Amy/0000-0002-9669-1816; Nomikos, Polykarpos/0000-0001-6827-4938; Doherty, Michael/0000-0002-5763-8326; Hall, Michelle/0000-0003-2231-1507; Ogollah, Reuben/0000-0002-5777-4117	NIHR Nottingham Biomedical Research Centre; University of Nottingham, UK; Pain Centre Versus Arthritis	NIHR Nottingham Biomedical Research Centre; University of Nottingham, UK; Pain Centre Versus Arthritis	This work was supported and co-funded by the NIHR Nottingham Biomedical Research Centre and the Pain Centre Versus Arthritis (Internal funding 2017-2022).The views expressed are those of author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The study is sponsored by the University of Nottingham, UK.	Ayala GX, 2011, J PUBLIC HEALTH DENT, V71, pS69, DOI 10.1111/j.1752-7325.2011.00241.x; Becker WC, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0608-2; Bellamy N, 2002, WOMAC OSTEOARTHRITIS, V5; Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Cui AY, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100587; Denver EA, 2003, DIABETES CARE, V26, P2256, DOI 10.2337/diacare.26.8.2256; Doherty M, 2018, LANCET, V392, P1403, DOI 10.1016/S0140-6736(18)32158-5; Driscoll A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009889.pub2; Egerton T, 2017, OSTEOARTHR CARTILAGE, V25, P625, DOI 10.1016/j.joca.2016.12.002; Egerton T, 2018, BMC RHEUMATOL, V2, DOI 10.1186/s41927-018-0037-4; Fisher P, 2006, HOMEOPATHY, V95, P215, DOI 10.1016/j.homp.2006.07.006; Fuller A, 2020, RHEUMATOLOGY, V59, P575, DOI 10.1093/rheumatology/kez333; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gignac MAM, 2006, ARTHRIT RHEUM-ARTHR, V55, P905, DOI 10.1002/art.22338; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hall M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037760; Hommel KA, 2013, EUR J GASTROEN HEPAT, V25, P469, DOI 10.1097/MEG.0b013e32835c2a1b; Martinez-Gonzalez NA, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0049-8; Metzler K., 2014, INTRO QUALITATIVE RE, Vfifth ed; Michie S, 2008, NHS HLTH TRAINER HDB; Michie S., 2014, BEHAV CHANGE WHEEL B; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Millar B, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03195-4; National Institute for Health and Care Excellence, 2014, ANN DIAB CHECKS IND; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Nomikos PA, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045242; Porcheret M, 2007, RHEUMATOLOGY, V46, P1694, DOI 10.1093/rheumatology/kem232; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Sisk JE, 2006, ANN INTERN MED, V145, P273, DOI 10.7326/0003-4819-145-4-200608150-00007; Welch G, 2010, DIABETES RES CLIN PR, V88, P1, DOI 10.1016/j.diabres.2009.12.026	31	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262422	10.1371/journal.pone.0262422	http://dx.doi.org/10.1371/journal.pone.0262422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025935	Green Submitted, Green Published, gold			2022-12-26	WOS:000796264200067
J	Soria, MA; Cervantes, SA; Siemer, AB				Soria, Maria A.; Cervantes, Silvia A.; Siemer, Ansgar B.			Calmodulin binds the N-terminus of the functional amyloid Orb2A inhibiting fibril formation	PLOS ONE			English	Article							CREB PHOSPHORYLATION; DROSOPHILA ORB2; PEPTIDES; IDENTIFICATION; RECOGNITION; TRANSLATION; PERSISTENCE; SEQUENCES; CORE	The cytoplasmic polyadenylation element-binding protein Orb2 is a key regulator of long-term memory (LTM) in Drosophila. The N-terminus of the Orb2 isoform A is required for LTM and forms cross-beta fibrils on its own. However, this N-terminus is not part of the core found in ex vivo fibrils. We previously showed that besides forming cross-beta fibrils, the N-terminus of Orb2A binds anionic lipid membranes as an amphipathic helix. Here, we show that the Orb2A N-terminus can similarly interact with calcium activated calmodulin (CaM) and that this interaction prevents fibril formation. Because CaM is a known regulator of LTM, this interaction could potentially explain the regulatory role of Orb2A in LTM.	[Soria, Maria A.; Cervantes, Silvia A.; Siemer, Ansgar B.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA; [Soria, Maria A.] Fresno Pacific Univ, Fresno, CA USA	University of Southern California	Siemer, AB (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA.	asiemer@usc.edu		Siemer, Ansgar B./0000-0003-0901-011X	National Institutes of Health [F31NS105524]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.B.S. would like to acknowledge funding from the National Institutes of Health (www.nih.gov) award number R01GM110521. S.A.C. would like to acknowledge funding from the National Institutes of Health (www.nih.gov) award number F31NS105524. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi WA, 2017, PROTEINS, V85, P1724, DOI 10.1002/prot.25330; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Ashami K, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100804; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Burke KA, 2013, J BIOL CHEM, V288, P14993, DOI 10.1074/jbc.M112.446237; Cervantes SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38265; CIMLER BM, 1985, J BIOL CHEM, V260, P784; Cote S, 2015, BIOPHYS J, V108, P1187, DOI 10.1016/j.bpj.2015.02.001; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; Fonda BD, 2021, J AM CHEM SOC, V143, P6657, DOI 10.1021/jacs.1c02424; Hervas R, 2020, SCIENCE, V367, P1230, DOI 10.1126/science.aba3526; Hervas R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002361; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Khan MR, 2015, CELL, V163, P1468, DOI 10.1016/j.cell.2015.11.020; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; MALENCIK DA, 1982, BIOCHEMISTRY-US, V21, P3480, DOI 10.1021/bi00257a035; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Soria MA, 2017, BIOPHYS J, V113, P37, DOI 10.1016/j.bpj.2017.05.039; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Voropai E. S., 2003, Journal of Applied Spectroscopy, V70, P868, DOI 10.1023/B:JAPS.0000016303.37573.7e; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; White-Grindley E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001786; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0259872	10.1371/journal.pone.0259872	http://dx.doi.org/10.1371/journal.pone.0259872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025866	gold, Green Published			2022-12-26	WOS:000796264200005
J	Tanner, C; Linder, S; Sohn, M				Tanner, Carmen; Linder, Stefan; Sohn, Matthias			Does moral commitment predict resistance to corruption? experimental evidence from a bribery game	PLOS ONE			English	Article							HONESTY-HUMILITY; ORGANIZATIONAL CORRUPTION; COMPETITION; MODEL; PREFERENCES; PSYCHOLOGY; MANAGEMENT; RESOLUTION; ATTITUDES; BEHAVIOR	Corruption is ubiquitous in practice and has severe negative consequences for organizations and societies at large. Drawing on a laboratory experiment, we propose that individuals high in moral commitment are less likely to engage in corrupt behaviors and prefer foregoing financial benefits. Specifically, we posit that individuals refrain from corruption (i) the more they endorse integrity (incorruptibility) as a protected value and (ii) the higher their level of Honesty-Humility. The results of a two-step experiment largely support our expectations: people who treat compromises to integrity as unacceptable were less willing to accept bribes, and Honesty-Humility decreased bribe-giving. The findings are robust to demographic variables (e.g., age, gender, cultural background) and additional personal characteristics (e.g., risk tolerance, dispositional greed) and have important implications for ongoing theory-building efforts and business practice.	[Tanner, Carmen] Univ Zurich, Dept Banking & Finance, Zurich, Switzerland; [Tanner, Carmen] Zeppelin Univ Friedrichshafen, Chair Econ Psychol & Leadership Eth, Friedrichshafen, Germany; [Linder, Stefan] ESSEC Business Sch Paris, Chair Accounting & Management Control, Cergy Pontoise, France; [Sohn, Matthias] European Univ Viadrina, Chair Management Accounting, Frankfurt, Germany	University of Zurich; Zeppelin University; ESSEC Business School; European University Viadrina Frankfurt Oder	Tanner, C (corresponding author), Univ Zurich, Dept Banking & Finance, Zurich, Switzerland.; Tanner, C (corresponding author), Zeppelin Univ Friedrichshafen, Chair Econ Psychol & Leadership Eth, Friedrichshafen, Germany.	carmen.tanner@bf.uzh.ch		Sohn, Matthias/0000-0001-9306-1416; Tanner, Carmen/0000-0002-3925-0889	CERESSEC [043-263-1-8-05-P-1]	CERESSEC	CERESSEC supported this research by proving financial support under grant number 043-263-1-8-05-P-1 for running the study.	Abbink K, 2006, EXP ECON, V9, P103, DOI 10.1007/s10683-006-5385-z; Abbink K, 2012, RES EXP ECON, V15, P77, DOI 10.1108/S0193-2306(2012)0000015006; Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.241102; Acemoglu D, 2020, J POLIT ECON, V128, P3090, DOI 10.1086/707765; Ajzen I., 1980, UNDERSTANDING ATTITU; Aquino K, 2002, J PERS SOC PSYCHOL, V83, P1423, DOI 10.1037//0022-3514.83.6.1423; Armantier O, 2012, RES EXP ECON, V15, P117, DOI 10.1108/S0193-2306(2012)0000015007; Ashforth BE, 2003, RES ORGAN BEHAV, V25, P1, DOI 10.1016/S0191-3085(03)25001-2; Ashton MC, 2007, PERS SOC PSYCHOL REV, V11, P150, DOI 10.1177/1088868306294907; Atran S, 2007, SCIENCE, V317, P1039, DOI 10.1126/science.1144241; BANDURA A, 1986, J SOC CLIN PSYCHOL, V4, P359, DOI 10.1521/jscp.1986.4.3.359; Baron J, 1997, ORGAN BEHAV HUM DEC, V70, P1, DOI 10.1006/obhd.1997.2690; Barr A, 2010, J PUBLIC ECON, V94, P862, DOI 10.1016/j.jpubeco.2010.07.006; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Beets SD, 2005, J BUS ETHICS, V57, P65, DOI 10.1007/s10551-004-3824-3; Beugre CD, 2010, J BUS PSYCHOL, V25, P533, DOI 10.1007/s10869-010-9176-3; Bhattacherjee A, 2018, GOV INFORM Q, V35, P703, DOI 10.1016/j.giq.2018.07.006; Blake J., 1999, LOCAL ENVIRON, V4, P257, DOI [10.1080/13549839908725599, DOI 10.1080/13549839908725599]; BLASI A, 1980, PSYCHOL BULL, V88, P1, DOI 10.1037/0033-2909.88.1.1; Brown SP, 1998, J MARKETING, V62, P88, DOI 10.2307/1252289; Bryan CJ, 2013, J EXP PSYCHOL GEN, V142, P1001, DOI 10.1037/a0030655; Burroughs JE, 2002, J CONSUM RES, V29, P348, DOI 10.1086/344429; Cameron L, 2009, J PUBLIC ECON, V93, P843, DOI 10.1016/j.jpubeco.2009.03.004; Christ MH, 2013, J MANAG ACOUNT RES, V25, P169, DOI 10.2308/jmar-50443; Clark-Wilson A, 2017, COMM COM INF SC, V739, P3, DOI 10.1007/978-3-319-63184-4_1; Clarke GRG, 2004, J PUBLIC ECON, V88, P2067, DOI 10.1016/j.jpubeco.2003.07.002; Cohen TR, 2014, RES ORGAN BEHAV, V34, P43, DOI 10.1016/j.riob.2014.08.003; Cohen TR, 2012, CURR DIR PSYCHOL SCI, V21, P355, DOI 10.1177/0963721412454874; de Quidt J, 2018, AM ECON REV, V108, P3266, DOI 10.1257/aer.20171330; de Vries RE, 2015, PERS INDIV DIFFER, V86, P112, DOI 10.1016/j.paid.2015.06.008; Dimant E, 2018, J ECON SURV, V32, P335, DOI 10.1111/joes.12198; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Dong B, 2012, J ECON PSYCHOL, V33, P609, DOI 10.1016/j.joep.2011.12.001; Falk A, 2006, AM ECON REV, V96, P1611, DOI 10.1257/aer.96.5.1611; Fan CS, 2009, J PUBLIC ECON, V93, P14, DOI 10.1016/j.jpubeco.2008.09.001; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Fisar M, 2016, J BEHAV EXP ECON, V63, P69, DOI 10.1016/j.socec.2016.05.004; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fisman R, 2007, J POLIT ECON, V115, P1020, DOI 10.1086/527495; Folger R, 2001, RES SOC ISS MAN SER, P3; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; Gewirtz J., 1984, MORALITY MORAL BEHAV, P128; Gibson R., 2016, HDB VALUE PERSPECTIV, P223; Gibson R, 2013, AM ECON REV, V103, P532, DOI 10.1257/aer.103.1.532; Ginges J, 2007, P NATL ACAD SCI USA, V104, P7357, DOI 10.1073/pnas.0701768104; GLYNN TJ, 1986, J COMMUNITY PSYCHOL, V14, P341, DOI 10.1002/1520-6629(198610)14:4<341::AID-JCOP2290140403>3.0.CO;2-0; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Gorsira M, 2018, J BUS ETHICS, V151, P179, DOI 10.1007/s10551-016-3219-2; Graycar A, 2011, HANDBOOK OF GLOBAL RESEARCH AND PRACTICE IN CORRUPTION, P3; Hauser C, 2021, BUS SOC, V60, P1468, DOI 10.1177/0007650319898474; Hauser C, 2019, J BUS ETHICS, V159, P281, DOI 10.1007/s10551-018-3808-3; Heck DW, 2018, JUDGM DECIS MAK, V13, P356; Hilbig BE, 2015, J RES PERS, V57, P72, DOI 10.1016/j.jrp.2015.04.003; Hilbig BE, 2013, PERS INDIV DIFFER, V54, P598, DOI 10.1016/j.paid.2012.11.008; Hilbig BE, 2009, J RES PERS, V43, P516, DOI 10.1016/j.jrp.2009.01.003; Hossein AT., 2020, BUSINESS SOC, P1, DOI 10.1177%2F0007650320928502; Hunt J, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P323; JAWORSKI BJ, 1992, ACCOUNT ORG SOC, V17, P17, DOI 10.1016/0361-3682(92)90034-P; Kant Immanuel, 1797, METAPHYSIK SITTEN; Klein SA, 2020, J RES PERS, V88, DOI 10.1016/j.jrp.2020.104006; Klein SA, 2017, JUDGM DECIS MAK, V12, P563; Kleinlogel EP, 2018, PERS SOC PSYCHOL B, V44, P158, DOI 10.1177/0146167217733071; Kobis NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131830; Krekels G, 2015, PERS INDIV DIFFER, V74, P225, DOI 10.1016/j.paid.2014.10.036; Lambsdorff JG, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P3; Lange D, 2008, ACAD MANAGE REV, V33, P710; Lee K, 2004, MULTIVAR BEHAV RES, V39, P329, DOI 10.1207/s15327906mbr3902_8; Li Y, 2015, ASIA PAC J MANAG, V32, P311, DOI 10.1007/s10490-014-9406-8; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Montada L., 1998, SOCIAL JUSTICE RES, V11, P81, DOI [10.1023/A:1023299119352, DOI 10.1023/A:1023299119352]; Mudrack PE, 2012, J BUS ETHICS, V108, P347, DOI 10.1007/s10551-011-1094-4; Mussel P, 2015, SOC NEUROSCI-UK, V10, P126, DOI 10.1080/17470919.2014.965340; Nam T, 2018, GOV INFORM Q, V35, P273, DOI 10.1016/j.giq.2018.01.005; Olken BA, 2012, ANNU REV ECON, V4, P479, DOI 10.1146/annurev-economics-080511-110917; Palanski Michael E., 2007, European Management Journal, V25, P171, DOI 10.1016/j.emj.2007.04.006; Paldam M., 2002, EUR J POLIT ECON, V18, P215, DOI [10.1016/S0176-2680(02)00078-2, DOI 10.1016/S0176-2680(02)00078-2]; Perugini M, 2009, J RES PERS, V43, P747, DOI 10.1016/j.jrp.2009.03.015; Rabl T, 2008, J BUS ETHICS, V82, P477, DOI 10.1007/s10551-008-9898-6; Schlenker BR, 2008, J SOC CLIN PSYCHOL, V27, P1078, DOI 10.1521/jscp.2008.27.10.1078; Scigala KA, 2019, SOC PSYCHOL PERS SCI, V10, P1019, DOI 10.1177/1948550618813419; Serra D, 2012, RES EXP ECON, V15, P1, DOI 10.1108/S0193-2306(2012)0000015003; Seuntjens TG, 2019, PERS INDIV DIFFER, V138, P147, DOI 10.1016/j.paid.2018.09.027; Shu LL, 2011, PERS SOC PSYCHOL B, V37, P330, DOI 10.1177/0146167211398138; Sinnott-Armstrong W., 2008, MORAL PSYCHOL, P35; Skitka LJ, 2002, PERS SOC PSYCHOL B, V28, P1419, DOI 10.1177/014616702236873; Steidlmeier P, 1999, J BUS ETHICS, V20, P121, DOI 10.1023/A:1005960026519; Swamy A, 2001, J DEV ECON, V64, P25, DOI 10.1016/S0304-3878(00)00123-1; Tang TLP, 2008, MANAGE DECIS, V46, P243, DOI 10.1108/00251740810854140; Tanner C, 2004, PSYCHON B REV, V11, P185, DOI 10.3758/BF03206481; Tanner C, 2014, LIBR ETHICS APPL PHI, V32, P119, DOI 10.1007/978-3-319-01369-5_7; Tanner C, 2009, DIAGNOSTICA, V55, P174, DOI 10.1026/0012-1924.55.3.174; Tavits M, 2010, SOC FORCES, V88, P1257; Tetlock PE, 2000, J PERS SOC PSYCHOL, V78, P853, DOI 10.1037/0022-3514.78.5.853; Thielmann I, 2021, SOC PSYCHOL PERS SCI, V12, P363, DOI 10.1177/1948550620905218; Torgler B, 2010, CONTEMP ECON POLICY, V28, P554, DOI 10.1111/j.1465-7287.2009.00188.x; Van Lange PAM, 2013, ORGAN BEHAV HUM DEC, V120, P125, DOI 10.1016/j.obhdp.2012.11.003; Volkema R.J., 2001, BUSINESS SOC, V40, P7, DOI [DOI 10.1177/000765030104000103, 10.1177%2F000765030104000103, 10.1177/000765030104000103]; Vranka MA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01511; Zettler I, 2020, PERSPECT PSYCHOL SCI, V15, P723, DOI 10.1177/1745691619895036	99	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0262201	10.1371/journal.pone.0262201	http://dx.doi.org/10.1371/journal.pone.0262201			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015764	gold, Green Published			2022-12-26	WOS:000814820600011
J	King, RJ; Shukla, SK; He, CB; Vernucci, E; Thakur, R; Attri, KS; Dasgupta, A; Chaika, NV; Mulder, SE; Abrego, J; Murthy, D; Gunda, V; Pacheco, CG; Grandgenett, PM; Lazenby, AJ; Hollingsworth, MA; Yu, F; Mehla, K; Singh, PK				King, Ryan J.; Shukla, Surendra K.; He, Chunbo; Vernucci, Enza; Thakur, Ravi; Attri, Kuldeep S.; Dasgupta, Aneesha; Chaika, Nina V.; Mulder, Scott E.; Abrego, Jaime; Murthy, Divya; Gunda, Venugopal; Pacheco, Camila G.; Grandgenett, Paul M.; Lazenby, Audrey J.; Hollingsworth, Michael A.; Yu, Fang; Mehla, Kamiya; Singh, Pankaj K.			CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis	ONCOGENE			English	Article							TUMOR-GROWTH; TGF-BETA; ADENOSINE; PROMOTES; GEMCITABINE; GENERATION; TOLERANCE; ANTIBODY; IMMUNITY; BURDEN	Metabolic alterations regulate cancer aggressiveness and immune responses. Given the poor response of pancreatic ductal adenocarcinoma (PDAC) to conventional immunotherapies, we investigated the link between metabolic alterations and immunosuppression. Our metabolic enzyme screen indicated that elevated expression of CD73, an ecto-5'-nucleotidase that generates adenosine, correlates with increased aggressiveness. Correspondingly, we observed increased interstitial adenosine levels in tumors from spontaneous PDAC mouse models. Diminishing CD73 by genetic manipulations ablated in vivo tumor growth, and decreased myeloid-derived suppressor cells (MDSC) in orthotopic mouse models of PDAC. A high-throughput cytokine profiling demonstrated decreased GM-CSF in mice implanted with CD73 knockdowns. Furthermore, we noted increased IFN-gamma expression by intratumoral CD4(+) and CD8(+) T cells in pancreatic tumors with CD73 knockdowns. Depletion of CD4(+) T cells, but not CD8(+) T cells abrogated the beneficial effects of decreased CD73. We also observed that splenic MDSCs from Nt5e knockdown tumor-bearing mice were incompetent in suppressing T cell activation in the ex vivo assays. Replenishing GM-CSF restored tumor growth in Nt5e knockout tumors, which was reverted by MDSC depletion. Finally, anti-CD73 antibody treatment significantly improved gemcitabine efficacy in orthotopic models. Thus, targeting the adenosine axis presents a novel therapeutic opportunity for improving the anti-tumoral immune response against PDAC.	[King, Ryan J.; Shukla, Surendra K.; He, Chunbo; Vernucci, Enza; Thakur, Ravi; Attri, Kuldeep S.; Dasgupta, Aneesha; Chaika, Nina V.; Mulder, Scott E.; Abrego, Jaime; Murthy, Divya; Gunda, Venugopal; Pacheco, Camila G.; Grandgenett, Paul M.; Hollingsworth, Michael A.; Mehla, Kamiya; Singh, Pankaj K.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Mulder, Scott E.; Hollingsworth, Michael A.; Singh, Pankaj K.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Lazenby, Audrey J.; Hollingsworth, Michael A.; Singh, Pankaj K.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Yu, Fang] Univ Nebraska, Med Ctr, Dept Biostat, Omaha, NE 68198 USA; [Singh, Pankaj K.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Mehla, K; Singh, PK (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	kamiya.mehla@unmc.edu; pankaj.singh@unmc.edu	Thakur, Ravi/AGH-8433-2022	Thakur, Ravi/0000-0003-2505-9757; Singh, Pankaj/0000-0001-8903-0131; Shukla, Surendra K/0000-0003-4490-8013	National Institutes of Health [R01CA163649, R01CA210439, R01CA216853]; Specialized Programs of Research Excellence (SPORE) [2P50 CA127297]; PCDC [U01CA210240]; NCI Research Specialist award [5R50CA211462]; Fred & Pamela Buffett Cancer Center Support Grant [P30CA036727]; SPORE Career Development Award (NCI) [2P50 CA127297]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Programs of Research Excellence (SPORE); PCDC; NCI Research Specialist award; Fred & Pamela Buffett Cancer Center Support Grant; SPORE Career Development Award (NCI)	This work was supported in part by funding from the National Institutes of Health grant (R01CA163649, R01CA210439, and R01CA216853, NCI) to PKS; the Specialized Programs of Research Excellence (SPORE, 2P50 CA127297, NCI) to PKS and MAH; SPORE Career Development Award (2P50 CA127297, NCI) to KM; the PCDC U01CA210240 to MAH; NCI Research Specialist award (5R50CA211462) to PMG. We would also like to acknowledge the Fred & Pamela Buffett Cancer Center Support Grant (P30CA036727, NCI) for supporting shared resources.	Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bhat P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.67; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Condamine T, 2015, J LEUKOCYTE BIOL, V98, P913, DOI 10.1189/jlb.4RI0515-204R; Daniel SK, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0226-9; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dosch M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041222; Foley K, 2016, CANCER LETT, V381, P244, DOI 10.1016/j.canlet.2015.12.020; Gravett AM, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1438107; Gunda V, 2017, CLIN CANCER RES, V23, P5881, DOI 10.1158/1078-0432.CCR-17-1151; Gupta S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00068; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jackaman C, 2012, CANCER IMMUNOL IMMUN, V61, P2343, DOI 10.1007/s00262-012-1307-4; Jiang T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4073-7; Johnson BA, 2017, CLIN CANCER RES, V23, P1656, DOI 10.1158/1078-0432.CCR-16-2318; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; King RJ, 2017, ONCOTARGET, V8, P67152, DOI 10.18632/oncotarget.17934; Lee CR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030869; Li CX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01234-1; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; Looi CK, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1153-8; Lytle NK, 2019, CELL, V177, P572, DOI 10.1016/j.cell.2019.03.010; Ma N, 2017, INT J IMMUNOPATH PH, V30, P152, DOI 10.1177/0394632017711055; Masuda K, 2016, J EXP MED, V213, P605, DOI 10.1084/jem.20151289; Mauti LA, 2011, J CLIN INVEST, V121, P2794, DOI 10.1172/JCI41936; Molinier-Frenkel V, 2017, FEBS LETT, V591, P3135, DOI 10.1002/1873-3468.12784; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; O'Reilly EM, 2019, JAMA ONCOL, V5, P1431, DOI 10.1001/jamaoncol.2019.1588; O'Sullivan T, 2014, CELL REP, V7, P989, DOI 10.1016/j.celrep.2014.03.073; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ostrand-Rosenberg S, 2018, J IMMUNOL, V200, P422, DOI 10.4049/jimmunol.1701019; Plate JMD, 2005, CANCER IMMUNOL IMMUN, V54, P915, DOI 10.1007/s00262-004-0638-1; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rivadeneira DB, 2018, CLIN CANCER RES, V24, P2473, DOI 10.1158/1078-0432.CCR-17-0894; Salminen A, 2019, CELL MOL LIFE SCI, V76, P1901, DOI 10.1007/s00018-019-03048-x; Shukla SK, 2017, CANCER CELL, V32, P71, DOI 10.1016/j.ccell.2017.06.004; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Sugiura A, 2018, J IMMUNOL, V200, P400, DOI 10.4049/jimmunol.1701041; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Vigano S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00925; Vijayan D, 2017, NAT REV CANCER, V17, P709, DOI 10.1038/nrc.2017.86; Wang L, 2011, J CLIN INVEST, V121, P2371, DOI 10.1172/JCI45559; Wang R, 2017, ONCOTARGET, V8, P57327, DOI 10.18632/oncotarget.16905; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zarek PE, 2007, AUTOIMMUNITY, V40, P425, DOI 10.1080/08916930701464939; Zhang B, 2012, ONCOIMMUNOLOGY, V1, P67, DOI 10.4161/onci.1.1.18068; Zhao H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01578; Zhou LJ, 2019, J MOL MED, V97, P803, DOI 10.1007/s00109-018-01742-0	63	6	6	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2022	41	7					971	982		10.1038/s41388-021-02132-6	http://dx.doi.org/10.1038/s41388-021-02132-6		JAN 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YX7EK	35001076	Green Accepted			2022-12-26	WOS:000740643000001
J	Houskeeper, HF; Rosenthal, IS; Cavanaugh, KC; Pawlak, C; Trouille, L; Byrnes, JEK; Bell, TW; Cavanaugh, KC				Houskeeper, Henry F.; Rosenthal, Isaac S.; Cavanaugh, Katherine C.; Pawlak, Camille; Trouille, Laura; Byrnes, Jarrett E. K.; Bell, Tom W.; Cavanaugh, Kyle C.			Automated satellite remote sensing of giant kelp at the Falkland Islands (Islas Malvinas)	PLOS ONE			English	Article							MACROCYSTIS-PYRIFERA; CITIZEN SCIENCE; ENVIRONMENTAL CONTROLS; LAMINARIALES; PERSISTENCE; PHAEOPHYTA; EVOLUTION; PATTERNS; ECOTYPES; FRONDS	Giant kelp populations that support productive and diverse coastal ecosystems at temperate and subpolar latitudes of both hemispheres are vulnerable to changing climate conditions as well as direct human impacts. Observations of giant kelp forests are spatially and temporally uneven, with disproportionate coverage in the northern hemisphere, despite the size and comparable density of southern hemisphere kelp forests. Satellite imagery enables the mapping of existing and historical giant kelp populations in understudied regions, but automating the detection of giant kelp using satellite imagery requires approaches that are robust to the optical complexity of the shallow, nearshore environment. We present and compare two approaches for automating the detection of giant kelp in satellite datasets: one based on crowd sourcing of satellite imagery classifications and another based on a decision tree paired with a spectral unmixing algorithm (automated using Google Earth Engine). Both approaches are applied to satellite imagery (Landsat) of the Falkland Islands or Islas Malvinas (FLK), an archipelago in the southern Atlantic Ocean that supports expansive giant kelp ecosystems. The performance of each method is evaluated by comparing the automated classifications with a subset of expert-annotated imagery (8 images spanning the majority of our continuous timeseries, cumulatively covering over 2,700 km of coastline, and including all relevant sensors). Using the remote sensing approaches evaluated herein, we present the first continuous timeseries of giant kelp observations in the FLK region using Landsat imagery spanning over three decades. We do not detect evidence of long-term change in the FLK region, although we observe a recent decline in total canopy area from 2017-2021. Using a nitrate model based on nearby ocean state measurements obtained from ships and incorporating satellite sea surface temperature products, we find that the area of giant kelp forests in the FLK region is positively correlated with the nitrate content observed during the prior year. Our results indicate that giant kelp classifications using citizen science are approximately consistent with classifications based on a state-of-the-art automated spectral approach. Despite differences in accuracy and sensitivity, both approaches find high interannual variability that impedes the detection of potential long-term changes in giant kelp canopy area, although recent canopy area declines are notable and should continue to be monitored carefully.	[Houskeeper, Henry F.; Cavanaugh, Katherine C.; Pawlak, Camille; Cavanaugh, Kyle C.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA; [Rosenthal, Isaac S.] Univ Massachusetts, Sch Environm, Boston, MA USA; [Trouille, Laura] Adler Planetarium, Chicago, IL USA; [Byrnes, Jarrett E. K.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Bell, Tom W.] Woods Hole Oceanog Inst, Appl Ocean Phys & Engn, Woods Hole, MA USA	University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; Woods Hole Oceanographic Institution	Houskeeper, HF (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA.	hhouskee@g.ucla.edu	Houskeeper, Henry/ACE-6594-2022	Pawlak, Camille/0000-0003-0740-3956; Houskeeper, Henry/0000-0001-5848-5440	National Aeronautics and Space Administration as part of the Citizen Science for Earth Systems Program [80NSSC18M0103]; National Science Foundation through the Santa Barbara Coastal Long-Term Environmental Research [OCE 0620276, 1232779]	National Aeronautics and Space Administration as part of the Citizen Science for Earth Systems Program; National Science Foundation through the Santa Barbara Coastal Long-Term Environmental Research	This work was funded by the National Aeronautics and Space Administration as part of the Citizen Science for Earth Systems Program (https://earthdata.nasa.gov/esds/competitiveprograms/csesp) with grant #80NSSC18M0103 (awarded to JEKB), which also provided salary to HFH, and by the National Science Foundation through the Santa Barbara Coastal Long-Term Environmental Research (https://sbclter.msi.ucsb.edu) program with grants #OCE 0620276 and 1232779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NJ, 2014, NAT CLIM CHANGE, V4, P564, DOI [10.1038/nclimate2235, 10.1038/NCLIMATE2235]; Bayley D. T. I., 2021, One Ecosystem, V6, DOI 10.3897/oneeco.6.e62811; Beaton EC, 2020, POLAR BIOL, V43, P573, DOI 10.1007/s00300-020-02662-x; Bell TW, 2020, REMOTE SENS ENVIRON, V238, DOI [10.1016/j.rse.2018.06.03, 10.1016/j.rse.2018.06.039]; Bell TW, 2015, J BIOGEOGR, V42, P2010, DOI 10.1111/jbi.12550; Bennett S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10280; Berry HD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0229703; Bonney R, 2016, PUBLIC UNDERST SCI, V25, P2, DOI 10.1177/0963662515607406; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Caselle JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195167; Castorani MCN, 2015, ECOLOGY, V96, P3141, DOI 10.1890/15-0283.1; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; Finger DJI, 2021, REMOTE SENS ENVIRON, V254, DOI 10.1016/j.rse.2020.112243; Friedlander AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229259; Friedlander AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189930; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Graham MH, 2007, OCEANOGR MAR BIOL, V45, P39; Hamilton SL, 2020, ECOLOGY, V101, DOI 10.1002/ecy.3031; Hijmans R. J., 2015, PACKAGE RASTER; Hooker SB, 2021, CONT SHELF RES, V219, DOI 10.1016/j.csr.2021.104357; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; King NG, 2019, J EXP MAR BIOL ECOL, V514, P10, DOI 10.1016/j.jembe.2019.03.004; Kosmala M, 2016, FRONT ECOL ENVIRON, V14, P551, DOI 10.1002/fee.1436; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Kudela RM, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11182071; Lamy T, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2987; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; McPherson ML, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01827-6; Miller RJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI [10.1098/rspb.2017.2571, 10.1098/rspb.]; Mora-Soto A, 2021, J BIOGEOGR, V48, P2562, DOI 10.1111/jbi.14221; Mora-Soto A, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12040694; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Reed DC, 2016, MAR FRESHWATER RES, V67, P14, DOI 10.1071/MF14158; Regnauld H, 2008, GEOMORPHOLOGIE, P33; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Rogers-Bennett L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51114-y; Rosenthal IS, 2018, ARXIV PREPRINT ARXIV; Schiel DR, 2015, BIOL ECOLOGY GIANT K; Siegel DA, 2000, APPL OPTICS, V39, P3582, DOI 10.1364/AO.39.003582; Smale DA, 2020, NEW PHYTOL, V225, P1447, DOI 10.1111/nph.16107; Thomsen MS, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00084; Upton J, 2002, AQUAT CONSERV, V12, P15, DOI 10.1002/aqc.496; VANTUSSENBROEK BI, 1989, BRIT PHYCOL J, V24, P137, DOI 10.1080/00071618900650131; VANTUSSENBROEK BI, 1989, MAR BIOL, V102, P545, DOI 10.1007/BF00438357; VANTUSSENBROEK BI, 1989, PHYCOLOGIA, V28, P169, DOI 10.2216/i0031-8884-28-2-169.1; VANTUSSENBROEK BI, 1989, MAR BIOL, V100, P419, DOI 10.1007/BF00391158; Vihinen M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S2; Woodworth PL, 1996, MAR GEOD, V19, P1, DOI DOI 10.1080/; Young M, 2016, ECOL MONOGR, V86, P45, DOI 10.1890/15-0267.1	52	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0257933	10.1371/journal.pone.0257933	http://dx.doi.org/10.1371/journal.pone.0257933			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990455	Green Published, Green Submitted, gold			2022-12-26	WOS:000815783800003
J	Li, XJ; Ye, YC; Zhang, YS; Wu, JM				Li, Xiao-Jun; Ye, Yan-Cheng; Zhang, Yan-Shan; Wu, Jia-Ming			Empirical modeling of the percent depth dose for megavoltage photon beams	PLOS ONE			English	Article							RATIO	Introduction This study presents an empirical method to model the high-energy photon beam percent depth dose (PDD) curve by using the home-generated buildup function and tail function (buildup-tail function) in radiation therapy. The modeling parameters n and p of buildup-tail function can be used to characterize the Collimator Scatter Factor (So either in a square field or in the different individual upper jaw and lower jaw setting separately for individual monitor unit check. Methods and materials The PDD curves for four high-energy photon beams were modeled by the buildup and tail function in this study. The buildup function was a quadratic function in the form of d/root d(2)+n with the main parameter of d (depth in water) and n, while the tail function was in the form of e(-mu d) and was composed by an exponential function with the main parameter of d and mu. The PDD was the product of buildup and tail function, PDD = d/root d(2)+n . e(-mu d). The PDD of four-photon energies was characterized by the buildup-tail function by adjusting the parameters n and mu. The S-c of 6 MV and 10 MV can then be expressed simply by the modeling parameters n and mu. Results The main parameters n increases in buildup-tail function when photon energy increased. The physical meaning of the parameter n expresses the beam hardening of photon energy in PDD. The fitting results of parameters n in the buildup function are 0.17, 0.208, 0.495, 1.2 of four-photon energies, 4 MV, 6 MV, 10 MV, 18 MV, respectively. The parameter mu can be treated as attenuation coefficient in tail function and decreases when photon energy increased. The fitting results of parameters p in the tail function are 0.065, 0.0515, 0.0458, 0.0422 of four-photon energies, 4 MV, 6 MV, 10 MV, 18 MV, respectively. The values of n and mu obtained from the fitted buildup-tail function were applied into an analytical formula of S-c = n(E) (S)(0.63)mu to get the collimator to scatter factor S-c for 6 and 10 MV photon beam, while n(E), mu(E), S denotes n, mu at photon energy E of field size S, respectively. The calculated S-c were compared with the measured data and showed agreement at different field sizes to within +/- 1.5%. Conclusions We proposed a model incorporating a two-parameter formula which can improve the fitting accuracy to be better than 1.5% maximum error for describing the PDD in different photon energies used in clinical setting. This model can be used to parameterize the S-c factors for some clinical requirements. The modeling parameters n and mu can be used to predict the S-c in either square field or individual jaws opening asymmetrically for treatment monitor unit double-check in dose calculation. The technique developed in this study can also be used for systematic or random errors in the QA program, thus improves the clinical dose computation accuracy for patient treatment.	[Li, Xiao-Jun; Ye, Yan-Cheng; Zhang, Yan-Shan; Wu, Jia-Ming] Wuwei Canc Hosp, Heavy Ion Ctr, Wuwei City, Gansu, Peoples R China; [Li, Xiao-Jun; Ye, Yan-Cheng; Zhang, Yan-Shan; Wu, Jia-Ming] Gansu Wuwei Acad Med Sci, Wuwei City, Gansu, Peoples R China; [Li, Xiao-Jun; Ye, Yan-Cheng; Zhang, Yan-Shan; Wu, Jia-Ming] Gansu Wuwei Tumor Hosp, Wuwei City, Gansu, Peoples R China; [Wu, Jia-Ming] Chengde Med Univ, Dept Med Phys, Chengde City, Hebei, Peoples R China; [Wu, Jia-Ming] Yee Zen Gen Hosp, Dept Radiat Oncol, Taoyuan, Taiwan	Chengde Medical University	Li, XJ; Wu, JM (corresponding author), Wuwei Canc Hosp, Heavy Ion Ctr, Wuwei City, Gansu, Peoples R China.; Li, XJ; Wu, JM (corresponding author), Gansu Wuwei Acad Med Sci, Wuwei City, Gansu, Peoples R China.; Li, XJ; Wu, JM (corresponding author), Gansu Wuwei Tumor Hosp, Wuwei City, Gansu, Peoples R China.; Wu, JM (corresponding author), Chengde Med Univ, Dept Med Phys, Chengde City, Hebei, Peoples R China.; Wu, JM (corresponding author), Yee Zen Gen Hosp, Dept Radiat Oncol, Taoyuan, Taiwan.	anglweli@qq.com; jiaming.wu@chmsc.com		li, xiaojun/0000-0002-1885-4747	Key R&D plan of Science and Technology Program of Gansu Province, China [19YF3FH001]	Key R&D plan of Science and Technology Program of Gansu Province, China	This work was supported by the Funding: Key R&D plan of Science and Technology Program of Gansu Province, China. (19YF3FH001).	Brunckhorst E., 2008, IAEATECDOC1583, P1; Cashmore J, 2008, PHYS MED BIOL, V53, P1933, DOI 10.1088/0031-9155/53/7/009; Dutreix A, 1997, ESTRO PHYS CLIN RADI, V3; Garcia-Garduno OA, 2016, APPL RADIAT ISOTOPES, V107, P121, DOI 10.1016/j.apradiso.2015.09.016; Gibbons JP, 2014, MED PHYS, V41, DOI 10.1118/1.4864244; KASE KR, 1986, MED PHYS, V13, P530, DOI 10.1118/1.595857; Khan FM., 2010, PHYS RAD THERAPY, V4th ed, P140; Lewis D, 2012, MED PHYS, V39, P6339, DOI 10.1118/1.4754797; Niroomand-Rad A, 2020, MED PHYS, V47, P5986, DOI 10.1002/mp.14497; Padilla-Cabal F, 2015, J RADIOTHER PRACT, V14, P311, DOI 10.1017/S146039691500014X; Wang KKH, 2010, MED PHYS, V37, P5270, DOI 10.1118/1.3480480; Zhu TC, 2009, MED PHYS, V36, P5261, DOI 10.1118/1.3227367	12	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2022	17	1							e0261042	10.1371/journal.pone.0261042	http://dx.doi.org/10.1371/journal.pone.0261042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2J6SK	34990461	Green Published, gold			2022-12-26	WOS:000815783800005
J	Storms, SM; Lowe, JF				Storms, Suzanna M.; Lowe, James F.			Active environmental surveillance of SARS-CoV-2 in Midwestern United States meatpacking plants	PLOS ONE			English	Article							CORONAVIRUSES; VIRUS; SARS	This pilot project investigated environmental SARS-CoV-2 presence in seven Midwestern meatpacking plants from May 2020 to January 2021. This study investigated social distancing and infection control practices and incorporated environmental sampling of surfaces and air in employee common areas. All plants increased their social distancing efforts, increased the frequency of cleaning and disinfecting worker areas, and screened for symptomatic people to prevent entry into the workplace. 575 samples from common areas were collected and evaluated with RT-qPCR for the presence of SARS-CoV-2. 42/367 surface samples were positive, while no virus was detected in air samples. Case positive data from the counties surrounding each plant showed peak positive SARS-CoV-2 cases from 12-55 days before the virus was detected in the plant, indicating that environmental sampling is likely a lagging indicator of community and plant infection.	[Storms, Suzanna M.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA; [Lowe, James F.] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lowe, JF (corresponding author), Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA.	jlowe@illinois.edu		Storms, Suzanna/0000-0001-8505-876X	Illinois Pork Producers Association	Illinois Pork Producers Association	This research was funded in part by the Illinois Pork Producers Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://ilpork.com/.	Abdulkarim Abdulrahman, 2020, INFEZ MED, DOI [10.1101/2020.12.07.20245233, DOI 10.1101/2020.12.07.20245233]; Buchan BW, 2020, AM J CLIN PATHOL, V154, P479, DOI 10.1093/ajcp/aqaa133; Byambasuren O., 2020, J ASS MED MICROBIOL, V5, P223, DOI [10.3138/jammi-2020-0030, DOI 10.3138/JAMMI-2020-0030]; CDC, 2019, NOV COR; Colaneri M, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.05.009; Fischer J., LONGHORN VACCINES DI; Hung IFN, 2004, EMERG INFECT DIS, V10, P1550, DOI 10.3201/eid1009.040058; Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022; Krebs C. K., 2020, SECURITY USDOH; Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628; Lowe JF, 2020, PORK BEEF SLAUGHTER; Nissen K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76442-2; Otter JA, 2016, J HOSP INFECT, V92, P235, DOI 10.1016/j.jhin.2015.08.027; Spackman E, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-35; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]	15	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261704	10.1371/journal.pone.0261704	http://dx.doi.org/10.1371/journal.pone.0261704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972125	Green Published, gold			2022-12-26	WOS:000773555700048
J	Hodges, WT; Jarasvaraparn, C; Ferguson, D; Griffett, K; Gill, LE; Chen, YN; Ilagan, MXG; Hegazy, L; Elgendy, B; Cho, K; Patti, GJ; McCommis, KS; Finck, BN				Hodges, Wesley T.; Jarasvaraparn, Chaowapong; Ferguson, Daniel; Griffett, Kristine; Gill, Lauren E.; Chen, Yana; Ilagan, Ma Xenia G.; Hegazy, Lamees; Elgendy, Bahaa; Cho, Kevin; Patti, Gary J.; McCommis, Kyle S.; Finck, Brian N.			Mitochondrial pyruvate carrier inhibitors improve metabolic parameters in diet-induced obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN; GLUCONEOGENESIS; ZAPRINAST; TRANSPORT; DEFECTS; LEADS	The mitochondrial pyruvate carrier (MPC) is an inner mitochondrial membrane complex that plays a critical role in intermediary metabolism. Inhibition of the MPC, especially in liver, may have efficacy for treating type 2 diabetes mellitus. Herein, we examined the antidiabetic effects of zaprinast and 7ACC2, small molecules which have been reported to act as MPC inhibitors. Both compounds activated a bioluminescence resonance energy transfer-based MPC reporter assay (reporter sensitive to pyruvate) and potently inhibited pyruvatemediated respiration in isolated mitochondria. Furthermore, zaprinast and 7ACC2 acutely improved glucose tolerance in diet-induced obese mice in vivo. Although some findings were suggestive of improved insulin sensitivity, hyperinsulinemic- euglycemic clamp studies did not detect enhanced insulin action in response to 7ACC2 treatment. Rather, our data suggest acute glucose-lowering effects of MPC inhibition may be due to suppressed hepatic gluconeogenesis. Finally, we used reporter sensitive to pyruvate to screen a chemical library of drugs and identified 35 potentially novel MPC modulators. Using available evidence, we generated a pharmacophore model to prioritize which hits to pursue. Our analysis revealed carsalam and six quinolone antibiotics, as well as 7ACC1, share a common pharmacophore with 7ACC2. We validated that these compounds are novel inhibitors of the MPC and suppress hepatocyte glucose production and demonstrated that one quinolone (nalidixic acid) improved glucose tolerance in obese mice. In conclusion, these data demonstrate the feasibility of therapeutic targeting of the MPC for treating diabetes and provide scaffolds that can be used to develop potent and novel classes of MPC inhibitors.	[Hodges, Wesley T.; Jarasvaraparn, Chaowapong; Ferguson, Daniel; Chen, Yana; Ilagan, Ma Xenia G.; Cho, Kevin; Patti, Gary J.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Griffett, Kristine; Hegazy, Lamees; Elgendy, Bahaa] Washington Univ, Sch Med, Ctr Clin Pharmacol, St Louis, MO USA; [Griffett, Kristine; Hegazy, Lamees; Elgendy, Bahaa] Univ Hlth Sci & Pharm, St Louis, MO USA; [Gill, Lauren E.; Hegazy, Lamees; Elgendy, Bahaa] Univ Hlth Sci & Pharm, Dept Pharmaceut & Adm Sci, St Louis, MO USA; [McCommis, Kyle S.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	bfinck@wustl.edu	Griffett, Kristine/ABU-5754-2022; Elgendy, Bahaa/AAD-8587-2022	Griffett, Kristine/0000-0002-6747-2518; Elgendy, Bahaa/0000-0003-4800-7976; Finck, Brian/0000-0001-5411-3674; Cho, Kevin/0000-0002-3041-3506	NIH [R01 DK104735]; Diabetes Research Center [P30 DK020579]; Nutrition Obesity Research Center at the Washington University School of Medicine [P30 DK56341];  [R00 HL136658];  [R35 ES028365]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research Center; Nutrition Obesity Research Center at the Washington University School of Medicine; ; 	This work was funded by NIH grant R01 DK104735 (B. N. F.). The Core services of the Diabetes Research Center (P30 DK020579) and the Nutrition Obesity Research Center (P30 DK56341) at the Washington University School of Medicine also supported this work. K. S. M. was supported by R00 HL136658, and G. J. P. was supported by R35 ES028365. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams KJ, 2020, J PROTEOME RES, V19, P1447, DOI 10.1021/acs.jproteome.9b00640; Adams MD, 1998, BIOCHEM PHARMACOL, V55, P1915, DOI 10.1016/S0006-2952(98)00052-5; Aldred KJ, 2013, NUCLEIC ACIDS RES, V41, P4628, DOI 10.1093/nar/gkt124; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Berhe A, 2019, J MED CASE REP, V13, DOI 10.1186/s13256-019-2083-y; Bowman CE, 2016, MOL CELL BIOL, V36, P2089, DOI 10.1128/MCB.00166-16; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Colca JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061551; Compan V, 2015, MOL CELL, V59, P491, DOI 10.1016/j.molcel.2015.06.035; Corbet C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03525-0; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Draoui N, 2014, MOL CANCER THER, V13, P1410, DOI 10.1158/1535-7163.MCT-13-0653; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Elhammali A, 2014, CANCER DISCOV, V4, P828, DOI 10.1158/2159-8290.CD-13-0572; Fernandez-Caggiano M, 2020, NAT METAB, V2, P1223, DOI 10.1038/s42255-020-00276-5; Flores A, 2021, EXP DERMATOL, V30, P448, DOI 10.1111/exd.14307; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Genders AJ, 2011, AM J PHYSIOL-ENDOC M, V301, pE342, DOI 10.1152/ajpendo.00691.2010; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Harrison SA, 2020, J HEPATOL, V72, P613, DOI 10.1016/j.jhep.2019.10.023; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Kamm DR, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100807; Kelesidis T, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.07.022; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LUGNIER C, 1986, BIOCHEM PHARMACOL, V35, P1743, DOI 10.1016/0006-2952(86)90333-3; McCommis KS, 2020, NAT METAB, V2, P1232, DOI 10.1038/s42255-020-00296-1; McCommis KS, 2017, HEPATOLOGY, V65, P1543, DOI 10.1002/hep.29025; McCommis KS, 2016, MOL METAB, V5, P602, DOI 10.1016/j.molmet.2016.06.016; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; McCommis KS, 2015, BIOCHEM J, V466, P443, DOI 10.1042/BJ20141171; Nishimura Y, 1997, ACTA DIABETOL, V34, P206, DOI 10.1007/s005920050075; Panic V, 2020, ELIFE, V9, DOI 10.7554/eLife.52558; Patterson JN, 2014, J BIOL CHEM, V289, P13335, DOI 10.1074/jbc.M113.521666; Rauckhorst AJ, 2017, MOL METAB, V6, P1468, DOI 10.1016/j.molmet.2017.09.002; Sharma A, 2019, ELIFE, V8, DOI 10.7554/eLife.45873; Su XY, 2017, ANAL CHEM, V89, P5941, DOI 10.1021/acs.analchem.7b00396; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Veliova M, 2020, EMBO REP, V21, DOI 10.15252/embr.201949634; Vigueira PA, 2017, EXP PHYSIOL, V102, P985, DOI 10.1113/EP086380; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Zhang Y, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00288-1	43	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101554	10.1016/j.jbc.2021.101554	http://dx.doi.org/10.1016/j.jbc.2021.101554			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34973337	Green Published, gold			2022-12-26	WOS:000761395300005
J	Song, WL; Isaji, T; Nakano, M; Liang, CX; Fukuda, T; Gu, JG				Song, Wanli; Isaji, Tomoya; Nakano, Miyako; Liang, Caixia; Fukuda, Tomohiko; Gu, Jianguo			O-GlcNAcylation regulates beta 1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis	FASEB JOURNAL			English	Article						cell adhesion; GlcNAc branching; N-glycan biosynthesis; O-GlcNAcylation	ACETYLGLUCOSAMINYLTRANSFERASE-IVA; LINKED OLIGOSACCHARIDES; INSULIN-SECRETION; CELL-MIGRATION; POOR-PROGNOSIS; GLYCOSYLATION; ROLES; MECHANISMS; EXPRESSION; GLCNAC	N-Linked glycosylation and O-linked N-acetylglucosamine (O-GlcNAc) are important protein post-translational modifications that are orchestrated by a diverse set of gene products. Thus far, the relationship between these two types of glycosylation has remained elusive, and it is unclear whether one influences the other via UDP-GlcNAc, which is a common donor substrate. Theoretically, a decrease in O-GlcNAcylation may increase the products of GlcNAc-branched N-glycans. In this study, via examination by lectin blotting, HPLC, and mass spectrometry analysis, however, we found that the amounts of GlcNAc-branched tri-antennary N-glycans catalyzed by N-acetylglucosaminyltransferase IV (GnT-IV) and tetra-antennary N-glycans were significantly decreased in O-GlcNAc transferase knockdown cells (OGT-KD) compared with those in wild type cells. We examined this specific alteration by focusing on SLC35A3, which is the main UDP-GlcNAc transporter in mammals that is believed to modulate GnT-IV activation. It is interesting that a deficiency of SLC35A3 specifically leads to a decrease in the amounts of GlcNAc-branched tri- and tetra-antennary N-glycans. Furthermore, co-immunoprecipitation experiments have shown that SLC35A3 interacts with GnT-IV, but not with N-acetylglucosaminyltransferase V. Western blot and chemoenzymatic labeling assay have confirmed that OGT modifies SLC35A3 and that O-GlcNAcylation contributes to its stability. Furthermore, we found that SLC35A3-KO enhances cell spreading and suppresses both cell migration and cell proliferation, which is similar to the phenomena observed in the OGT-KD cells. Taken together, these data are the first to demonstrate that O-GlcNAcylation specifically governs the biosynthesis of tri- and tetra-antennary N-glycans via the OGT-SLC35A3-GnT-IV axis.	[Song, Wanli; Isaji, Tomoya; Liang, Caixia; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan	Tohoku Medical & Pharmaceutical University; Hiroshima University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp			Japan Society for the Promotion of Science [19H03184, 19K07049]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20H04909]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Japan Society for the Promotion of Science, Grant/Award Number: 19H03184 and 19K07049; Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant/Award Number: 20H04909	Toscanini MA, 2019, J BIOL CHEM, V294, P10042, DOI 10.1074/jbc.RA119.008827; Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Biwi J, 2018, MOLECULES, V23, DOI 10.3390/molecules23112858; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Copeland RJ, 2013, PROTEOM CLIN APPL, V7, P597, DOI 10.1002/prca.201300001; Edvardson S, 2013, J MED GENET, V50, P733, DOI 10.1136/jmedgenet-2013-101753; Fan JH, 2012, GLYCOCONJUGATE J, V29, P323, DOI 10.1007/s10719-012-9414-1; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Gabius HJ, 2018, BIOSYSTEMS, V164, P102, DOI 10.1016/j.biosystems.2017.07.003; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Ghosh SK, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00197; Gu YC, 2014, MOL MED REP, V10, P897, DOI 10.3892/mmr.2014.2269; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Guillard M, 2011, J PEDIATR-US, V159, P1041, DOI 10.1016/j.jpeds.2011.08.007; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Ide Y, 2006, BIOCHEM BIOPH RES CO, V341, P478, DOI 10.1016/j.bbrc.2005.12.208; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Kamigaito T, 2014, PROSTATE CANCER P D, V17, P18, DOI 10.1038/pcan.2013.56; Kao Shih-Han, 2015, Bio Protoc, V5, DOI 10.21769/BioProtoc.1374; Khoder-Agha F, 2019, CELL MOL LIFE SCI, V76, P1821, DOI 10.1007/s00018-019-03032-5; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liu CF, 2020, J BIOL CHEM, V295, P7341, DOI 10.1074/jbc.RA119.012401; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Maszczak-Seneczko D, 2015, J BIOL CHEM, V290, P15475, DOI 10.1074/jbc.M115.636670; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Niimi K, 2012, BRIT J CANCER, V107, P1969, DOI 10.1038/bjc.2012.496; Oguri S, 2006, GLYCOCONJUGATE J, V23, P473, DOI 10.1007/s10719-006-6216-3; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Peterson SB, 2016, CRIT REV BIOCHEM MOL, V51, P150, DOI 10.3109/10409238.2015.1135102; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; Rudman N, 2019, FEBS LETT, V593, P1598, DOI 10.1002/1873-3468.13495; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Simanek EE, 1998, J AM CHEM SOC, V120, P11567, DOI 10.1021/ja982312w; Soesanto Y, 2011, J BIOL CHEM, V286, P26118, DOI 10.1074/jbc.M111.249508; Sun SS, 2019, CLIN PROTEOM, V16, DOI 10.1186/s12014-019-9254-0; Szulc B, 2020, J BIOL CHEM, V295, P16445, DOI 10.1074/jbc.RA119.012362; Takamatsu Shinji, 2013, Methods Mol Biol, V1022, P283, DOI 10.1007/978-1-62703-465-4_21; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; Varki A, 2015, ESSENTIALS GLYCOBIOL, DOI DOI 10.1101/GLYCOBIOLOGY.3E.047; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Wiertelak W, 2020, ANAL BIOCHEM, V593, DOI 10.1016/j.ab.2020.113599; Xu DG, 2019, INT J CLIN EXP PATHO, V12, P1305; Xu ZW, 2019, J BIOL CHEM, V294, P3117, DOI 10.1074/jbc.RA118.005923; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yoshida Y, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00104; Yoshida Y, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700215; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zhao LH, 2018, MOLECULES, V23, DOI 10.3390/molecules23081967; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	70	3	3	8	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22149	10.1096/fj.202101520R	http://dx.doi.org/10.1096/fj.202101520R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	34981577	hybrid			2022-12-26	WOS:000747987800002
J	Vos, MR; Piraino, B; LaBreck, CJ; Rahmani, N; Trebino, CE; Schoenle, M; Peti, W; Camberg, JL; Page, R				Vos, Margaret R.; Piraino, Benjamin; LaBreck, Christopher J.; Rahmani, Negar; Trebino, Catherine E.; Schoenle, Marta; Peti, Wolfgang; Camberg, Jodi L.; Page, Rebecca			Degradation of the E. coli antitoxin MqsA by the proteolytic complex ClpXP is regulated by zinc occupancy and oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BINDING DOMAIN; PROTEASE; RECOGNITION; TRANSCRIPTION; SUBSTRATE; MEDIATE; TRANSLATION; INHIBITION; SYSTEMS	It is well established that the antitoxins of toxin-antitoxin (TA) systems are selectively degraded by bacterial proteases in response to stress. However, how distinct stressors result in the selective degradation of specific antitoxins remain unan-swered. MqsRA is a TA system activated by various stresses, including oxidation. Here, we reconstituted the Escherichia coli ClpXP proteolytic machinery in vitro to monitor degradation of MqsRA TA components. We show that the MqsA antitoxin is a ClpXP proteolysis substrate, and that its degradation is regulated by both zinc occupancy in MqsA and MqsR toxin binding. Using NMR chemical shift perturbation mapping, we show that MqsA is targeted directly to ClpXP via the ClpX substrate targeting N-domain, and ClpX mutations that disrupt N-domain binding inhibit ClpXP-mediated degradation in vitro. Finally, we discovered that MqsA contains a cryptic N-domain recognition sequence that is accessible only in the absence of zinc and MqsR toxin, both of which stabilize the MqsA fold. This recognition sequence is transplantable and sufficient to target a fusion protein for degradation in vitro and in vivo. Based on these results, we propose a model in which stress selectively targets nascent and zinc-free MqsA, resulting in exposure of the ClpX recognition motif for ClpXP-mediated degradation.	[Vos, Margaret R.; Page, Rebecca] Univ Connecticut, Dept Cell Biol, Hlth Ctr, Farmington, CT 06030 USA; [Vos, Margaret R.] Univ Connecticut, Grad Program Mol Biol & Biochem, Hlth Ctr, Farmington, CT USA; [Piraino, Benjamin; LaBreck, Christopher J.; Rahmani, Negar; Trebino, Catherine E.; Camberg, Jodi L.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Schoenle, Marta] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Peti, Wolfgang] Univ Connecticut, Hlth Ctr, Dept Mol Biol & Biophys, Farmington, CT USA	University of Connecticut; University of Connecticut; University of Rhode Island; University of Arizona; University of Connecticut	Page, R (corresponding author), Univ Connecticut, Dept Cell Biol, Hlth Ctr, Farmington, CT 06030 USA.; Camberg, JL (corresponding author), Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA.	cambergj@uri.edu; rpage@uchc.edu		Piraino, Benjamin/0000-0003-0823-9844	National Science Foundation [MCB-1817621]; National Science Foundation Graduate Research Fellowship Program [DGE-2136520]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant MCB-1817621 (to J. L. C. and R. P.) and the National Science Foundation Graduate Research Fellowship Program (DGE-2136520 to M. R. V.).	Abdelhakim AH, 2008, MOL CELL, V30, P39, DOI 10.1016/j.molcel.2008.02.013; Brown BL, 2013, J BIOL CHEM, V288, P1286, DOI 10.1074/jbc.M112.421008; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Cheverton AM, 2016, MOL CELL, V63, P86, DOI 10.1016/j.molcel.2016.05.002; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Donaldson LW, 2003, J BIOL CHEM, V278, P48991, DOI 10.1074/jbc.M307826200; Dubiel A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33726-y; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fraikin N, 2019, MBIO, V10, DOI 10.1128/mBio.02678-19; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; Goormaghtigh F, 2018, MBIO, V9, DOI 10.1128/mBio.00640-18; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Holden DW, 2018, MBIO, V9, DOI 10.1128/mBio.01574-18; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; LeRoux M, 2020, MOL CELL, V79, P280, DOI 10.1016/j.molcel.2020.05.028; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mureddu L, 2019, FEBS J, V286, P2035, DOI 10.1111/febs.14771; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Olivares AO, 2018, ANNU REV PHYSIOL, V80, P413, DOI 10.1146/annurev-physiol-021317-121303; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Papadopoulos E, 2012, BBA-PROTEINS PROTEOM, V1824, P1401, DOI 10.1016/j.bbapap.2012.06.016; Park EY, 2007, J MOL BIOL, V367, P514, DOI 10.1016/j.jmb.2007.01.003; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ruangprasert A, 2017, MOL MICROBIOL, V104, P65, DOI 10.1111/mmi.13641; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Viola MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170505; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Yakhnin AV, 1998, PROTEIN EXPRES PURIF, V14, P382, DOI 10.1006/prep.1998.0981; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904	45	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101557	10.1016/j.jbc.2021.101557	http://dx.doi.org/10.1016/j.jbc.2021.101557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1NP	34974059	Green Published, gold			2022-12-26	WOS:000761395300004
J	Gunay, S; Can, G				Gunay, Samet; Can, Gokberk			The source of financial contagion and spillovers: An evaluation of the covid-19 pandemic and the global financial crisis	PLOS ONE			English	Article							IMPULSE-RESPONSE ANALYSIS; EMPIRICAL-EVIDENCE; STRUCTURAL-CHANGE; ECONOMIC-GROWTH; STOCK MARKETS	This study investigates the reaction of stock markets to the Covid-19 pandemic and the Global Financial Crisis of 2008 (GFC) and compares their influence in terms of risk exposures. The empirical investigation is conducted using the modified ICSS test, DCC-GARCH, and Diebold-Yilmaz connectedness analysis to examine financial contagion and volatility spillovers. To further reveal the impact of these two crises, the statistical features of tranquil and crisis periods under different time intervals are also compared. The test results show that although the outbreak's origin was in China, the US stock market is the source of financial contagion and volatility spillovers during the pandemic, just as it was during the GFC. The propagation of shocks is considerably higher between developed economies compared to emerging markets. Additionally, the results show that the COVID-19 pandemic induced a more severe contagious effect and risk transmission than the GFC. The study provides an extensive examination of the COVID-19 pandemic and the GFC in terms of financial contagion and volatility spillovers. The results suggest the presence of strong co-movements of world stock markets with the US equity market, especially in periods of financial turmoil.	[Gunay, Samet] Amer Univ Middle East, Coll Business Adm, Finance Dept, Egaila, Kuwait; [Can, Gokberk] Amer Univ Middle East, Coll Business Adm, Accounting Dept, Egaila, Kuwait	American University of Middle East; American University of Middle East	Gunay, S (corresponding author), Amer Univ Middle East, Coll Business Adm, Finance Dept, Egaila, Kuwait.	samet.gunay@aum.edu.kw	Can, Gökberk/W-5070-2017; Gunay, Samet/HDN-4467-2022	Can, Gökberk/0000-0003-2158-7253; 				Aali-Bujari Ali, 2017, Contad. Adm, V62, P1427, DOI 10.1016/j.cya.2017.09.005; Abuzayed B, 2021, ECON ANAL POLICY, V71, P180, DOI 10.1016/j.eap.2021.04.010; Akhtaruzzaman M, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2019.101393; Akhtaruzzaman M, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101604; Ben Amar A, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101853; Aslam F, 2020, BORSA ISTANB REV, V20, pS49, DOI 10.1016/j.bir.2020.09.003; Balcilar M, 2019, ENERG POLICY, V134, DOI 10.1016/j.enpol.2019.110931; Banerjee AK, 2021, FINANC RES LETT, V43, DOI 10.1016/j.frl.2021.102018; Bank of England, 2021, POL OP RES; Belda PR., 2014, ESTUD ECON APL, V32, P789; Billio M, 2010, COMPUT STAT DATA AN, V54, P2443, DOI 10.1016/j.csda.2009.03.018; BOLLERSLEV T, 1990, REV ECON STAT, V72, P498, DOI 10.2307/2109358; Bouri E, 2022, ECON RES-EKON ISTRAZ, V35, P1967, DOI 10.1080/1331677X.2021.1929374; Bouri E, 2021, INT REV FINANC ANAL, V73, DOI 10.1016/j.irfa.2020.101646; Cakan E, 2015, BORSA ISTANB REV, V15, P37, DOI 10.1016/j.bir.2014.10.002; Chen M, 2003, LECT NOTES COMPUT SC, V2658, P90; Chevallier J, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13120309; CHIODO AJ, 2002, FEDERAL RESERVE BANK, V84, P7, DOI DOI 10.20955/R.84.7-18; Choong CK, 2010, JPN WORLD ECON, V22, P107, DOI 10.1016/j.japwor.2009.07.001; Chun D, 2020, ECON SYST, V44, DOI 10.1016/j.ecosys.2020.100788; Corbet S, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101554; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; Coskun Y, 2017, CENT BANK REV, V17, P19, DOI 10.1016/j.cbrev.2017.02.003; Cross J, 2016, ECON MODEL, V58, P34, DOI 10.1016/j.econmod.2016.04.021; Diebold FX, 2012, INT J FORECASTING, V28, P57, DOI 10.1016/j.ijforecast.2011.02.006; Diebold FX, 2009, ECON J, V119, P158, DOI 10.1111/j.1468-0297.2008.02208.x; Engle R, 2002, J BUS ECON STAT, V20, P339, DOI 10.1198/073500102288618487; Federal Reserve Bank of St. Louis, FIN CRIS TIM TIM; Gazdar K, 2015, BORSA ISTANB REV, V15, P137, DOI 10.1016/j.bir.2015.06.001; Gulzar S, 2019, ECON RES-EKON ISTRAZ, V32, P187, DOI 10.1080/1331677X.2018.1550001; Gunay S, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14040175; Gunay S, 2021, RES INT BUS FINANC, V56, DOI 10.1016/j.ribaf.2020.101377; Gunay S, 2021, RES INT BUS FINANC, V56, DOI 10.1016/j.ribaf.2020.101361; Gunay S, 2021, J CHIN ECON FOREIGN, V14, P3, DOI 10.1108/JCEFTS-08-2020-0053; Guo YH, 2021, INT REV FINANC ANAL, V73, DOI 10.1016/j.irfa.2020.101649; Huang YS, 2017, INT REV ECON FINANC, V48, P367, DOI 10.1016/j.iref.2017.01.001; INCLAN C, 1994, J AM STAT ASSOC, V89, P913, DOI 10.2307/2290916; International Monetary Fund, 2020, WORLD EC OUTL LONG D; Kapetanios G, 2005, J TIME SER ANAL, V26, P123, DOI 10.1111/j.1467-9892.2005.00393.x; Karoglou M, 2010, EUR J FINANC, V16, P79, DOI 10.1080/13518470902872343; Kim BH, 2015, INT REV ECON FINANC, V39, P192, DOI 10.1016/j.iref.2015.04.005; Koop G, 1996, J ECONOMETRICS, V74, P119, DOI 10.1016/0304-4076(95)01753-4; Leiss M, 2015, J ECON DYN CONTROL, V55, P1, DOI 10.1016/j.jedc.2015.03.005; Li XM, 2003, SCOT J POLIT ECON, V50, P341, DOI 10.1111/1467-9485.5003006; Mensi W, 2021, BORSA ISTANB REV, V21, P291, DOI 10.1016/j.bir.2020.12.003; Milani F, 2017, INT REV ECON FINANC, V49, P223, DOI 10.1016/j.iref.2017.01.028; Mirzad, 2017, J FINANC DATA SCI, V3, P20, DOI DOI 10.1016/J.JFDS.2017.06.001; MSCI, 2021, MSCI EUR IND USD; MSCI, 2021, MSCI WORLD IND USD; Pesaran HH, 1998, ECON LETT, V58, P17, DOI 10.1016/S0165-1765(97)00214-0; Pradhan RP, 2018, EURASIAN ECON REV, V8, P161, DOI 10.1007/s40822-018-0094-4; Quintos C, 2001, REV ECON STUD, V68, P633, DOI 10.1111/1467-937X.00184; Raiher AP, 2021, ESTUD ECON APL, V39, DOI 10.25115/eea.v39i2.3709; Sanso A., 2004, REV EC FINANC, V4, P32; Shahzad SJH, 2021, INT REV FINANC ANAL, V75, DOI 10.1016/j.irfa.2021.101754; Shahzad SJH, 2021, FINANC INNOV, V7, DOI 10.1186/s40854-021-00228-2; Shahzad SJH, 2021, FINANC INNOV, V7, DOI 10.1186/s40854-020-00210-4; Sharif A, 2020, INT REV FINANC ANAL, V70, DOI 10.1016/j.irfa.2020.101496; Szczygielski JJ, 2021, FINANC RES LETT, V43, DOI 10.1016/j.frl.2021.101945; Yong HEWA, 2021, INT REV FINANC ANAL, V76, DOI 10.1016/j.irfa.2020.101656; Yoshino N, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101695; Yousfi M, 2021, TECHNOL FORECAST SOC, V167, DOI 10.1016/j.techfore.2021.120710	62	3	3	13	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0261835	10.1371/journal.pone.0261835	http://dx.doi.org/10.1371/journal.pone.0261835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030202	gold, Green Published			2022-12-26	WOS:000812798500018
J	Elbehiry, A; Aldubaib, M; Al Rugaie, O; Marzouk, E; Abaalkhail, M; Moussa, I; El-Husseiny, MH; Abalkhail, A; Rawway, M				Elbehiry, Ayman; Aldubaib, Musaad; Al Rugaie, Osamah; Marzouk, Eman; Abaalkhail, Marwan; Moussa, Ihab; El-Husseiny, Mohamed H.; Abalkhail, Adil; Rawway, Mohammed			Proteomics-based screening and antibiotic resistance assessment of clinical and sub-clinical Brucella species: An evolution of brucellosis infection control	PLOS ONE			English	Article							SUSCEPTIBILITY; MELITENSIS	Brucellae are intracellular sneaky bacteria and they can elude the host's defensive mechanisms, resulting in therapeutic failure. Therefore, the goal of this investigation was to rapid identification of Brucella species collected from animals and humans in Saudi Arabia, as well as to evaluate their resistance to antibiotics. On selective media, 364 animal samples as well as 70 human blood samples were cultured. Serological and biochemical approaches were initially used to identify a total of 25 probable cultured isolates. The proteomics of Brucella species were identified using the MALDI Biotyper (MBT) system, which was subsequently verified using real-time polymerase chain reaction (real-time PCR) and microfluidic electrophoresis assays. Both Brucella melitensis (B. melitensis) and Brucella abortus (B. abortus) were tested for antimicrobial susceptibility using Kirby Bauer method and the E-test. In total, 25 samples were positive for Brucella and included 11 B. melitensis and 14 B. abortus isolates. Twenty-two out of 25 (88%) and 24/25 (96%) of Brucella strains were recognized through the Vitek 2 Compact system. While MBT was magnificently identified 100% of the strains at the species level with a score value more than or equal to 2.00. Trimethoprim-sulfamethoxazole, rifampin, ampicillin-sulbactam, and ampicillin resistance in B. melitensis was 36.36%, 31.82%, 27.27%, and 22.70%, respectively. Rifampin, trimethoprim-sulfamethoxazole, ampicillin, and ampicillin-sulbactam resistance was found in 35.71%, 32.14%, 32.14%, and 28.57% of B. abortus isolates, correspondingly. MBT confirmed by microfluidic electrophoresis is a successful approach for identifying Brucella species at the species level. The resistance of B. melitensis and B. abortus to various antibiotics should be investigated in future studies.	[Elbehiry, Ayman; Marzouk, Eman; Abalkhail, Adil] Qassim Univ, Dept Publ Hlth, Coll Publ Hlth & Hlth Informat, Al Bukairiyah, Saudi Arabia; [Elbehiry, Ayman] Univ Sadat City, Dept Bacteriol Mycol & Immunol, Fac Vet Med, Sadat City, Egypt; [Aldubaib, Musaad] Qassim Univ, Dept Vet Med, Coll Agr & Vet Med, Qasim, Saudi Arabia; [Al Rugaie, Osamah] Qassim Univ, Dept Basic Med Sci, Coll Med & Med Sci, Unaizah, Qassim, Saudi Arabia; [Abaalkhail, Marwan] King Fahad Med City, Dept Clin Microbiol, Riyadh, Saudi Arabia; [Moussa, Ihab] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia; [Moussa, Ihab] Cairo Univ, Dept Microbiol, Fac Vet Med, Giza, Egypt; [El-Husseiny, Mohamed H.] Agr Res Ctr, Anim Hlth Res Inst, Giza, Egypt; [Rawway, Mohammed] Jouf Univ, Dept Biol, Coll Sci, Sakaka, Saudi Arabia; [Rawway, Mohammed] AL Azhar Univ, Dept Bot & Microbiol, Fac Sci, Assiut, Egypt	Qassim University; Egyptian Knowledge Bank (EKB); University of Sadat City; Qassim University; Qassim University; King Fahad Medical City; King Saud University; Egyptian Knowledge Bank (EKB); Cairo University; Animal Health Research Institute (AHRI); Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Al Jouf University; Egyptian Knowledge Bank (EKB); Al Azhar University; Assiut University	Elbehiry, A (corresponding author), Qassim Univ, Dept Publ Hlth, Coll Publ Hlth & Hlth Informat, Al Bukairiyah, Saudi Arabia.; Elbehiry, A (corresponding author), Univ Sadat City, Dept Bacteriol Mycol & Immunol, Fac Vet Med, Sadat City, Egypt.; Moussa, I (corresponding author), King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia.; Moussa, I (corresponding author), Cairo Univ, Dept Microbiol, Fac Vet Med, Giza, Egypt.	aymanella2007@yahoo.com; imoussa1@ksu.edu.sa	Rawway, Mohammed/GQQ-9386-2022	Rawway, Mohammed/0000-0003-0864-5260; Abalkhail, Adil/0000-0002-2294-9837	Qassim University, Saudi Arabia [QUIF-1-4-2]; Ministry of Education	Qassim University, Saudi Arabia; Ministry of Education	The Deputyship for Research & Innovation, Ministry of Education and Qassim University, Saudi Arabia (the project number: QUIF-1-4-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Maksoud M., 2012, IN VITRO ANTIBIOTIC, V11, P1; Agunos A., 2016, REV NONFOODBORNE ZOO, V60, P553; Al Dahouk S., 2003, PART TECHNIQUES DIRE, V49, P487; Al Jindan R, 2021, SAUDI J BIOL SCI, V28, P272, DOI 10.1016/j.sjbs.2020.09.059; Alamian S., 2019, ANTIMICROBIAL SUSCEP, V11, P363; Algammal AM, 2022, AQUACULTURE, V548, DOI 10.1016/j.aquaculture.2021.737643; Algammal AM., 2021, EMERGING MDR MYCOBAC, V21, P1, DOI [10.1186/s12866-021-02287-y, DOI 10.1186/S12866-021-02287-Y]; Algammal AM., 2021, ATP GENE SEQUENCING, V11, P1; Algammal AM., 2020, VIRULENCE DETERMINAN, V10, P1; Algammal AM., 2020, PREVALENCE ANTIBIOGR, V10, P1; Alkahtani AM., 2020, SERO PREVALENCE RISK, V20, P1; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Asadi FT, 2017, JPN J INFECT DIS, V70, P235, DOI 10.7883/yoken.JJID.2016.133; Bagheri Nejad R., 2020, BRUCELLOSIS MIDDLE E, V14, pe0008071, DOI [10.1371/journal.pntd.0008071, DOI 10.1371/JOURNAL.PNTD.0008071]; Baily G., 1992, DETECTION BRUCELLA M, V95, P271; Banai M., 2018, PERSPECTIVES OUTCOME, V4, P234; Barbosa Pauletti R., 2015, REDUCED SUSCEPTIBILI, V10, pe0132532, DOI [10.1371/journal.pone.0132532, DOI 10.1371/JOURNAL.PONE.0132532]; Barua A, 2016, INDIAN J MED RES, V143, P652, DOI 10.4103/0971-5916.187115; Caces E., 1978, MICROBIOLOGY DIS SYS, DOI [10.1016/0147-9571(78)90017-6, DOI 10.1016/0147-9571(78)90017-6]; Charalampides S., 1981, ESTIMATION COMPLEMEN; Choudhary P., 2019, MALDI TOF MASS SPECT, V9, P27, DOI [10.5455/ijlr.20190413030405, DOI 10.5455/IJLR.20190413030405]; Christoforidou S., 2020, 1 MALDI TOF MASS SPE, V51, P101533, DOI [10.1016/j.mcp.2020.101533, DOI 10.1016/J.MCP.2020.101533]; Christoforidou S., 2018, 1 PCR RFLP ASSAY, V4, P172; Cooper CW., 1992, RISK FACTORS TRANSMI, V86, P206; Cunningham SA., 2013, IMPORTANCE USING BRU, V51, P1639; Cutler S., 2005, BRUCELLOSIS NEW ASPE, V98, P1270; de Figueiredo P., 2015, PATHOGENESIS IMMUNOB, V185, P1505; del Pozo JSG., 2015, TREATMENT HUMAN BRUC, P185, DOI 10.5772/61223; Elbehiry A., 2021, MULTIDRUG RESISTANT, V28, P2091; Elbehiry A., 2017, APPL MALDI TOF MS FI, V40, P269; Elbehiry A., 2014, EVALUATION DIAGNOSTI; Elbehiry A., 2016, PERFORMANCE MALDI BI, V5, P1061, DOI [10.1002/mbo3.389, DOI 10.1002/MBO3.389]; Enany ME., 2018, MOL TYPING EVALUATIO, V31; Ferreira L., 2010, FAST RELIABLE IDENTI, V5, pe14235, DOI [10.1371/journal.pone.0014235, DOI 10.1371/JOURNAL.PONE.0014235]; Gattringer KB, 2010, INT J ARTIF ORGANS, V33, P621, DOI 10.1177/039139881003300907; Gebeyehu E., 2015, NW ETHIOPIA, V10; Godeau P., 1984, TREATMENT HUMAN BRUC, V60, P5; Godfroid J., 2017, BRUCELLOSIS LIVESTOC, V75, P1; Golshani Maryam, 2017, Iranian Biomedical Journal, V21, P349; Grenga L., 2019, PATHOGEN PROTEOTYPIN, V14, P9; Hashim R., 2014, IDENTIFICATION IN VI, V2014; Hays JP., 2012, NUUTILA 3006 16 CHAP; Herman L., 1992, IDENTIFICATION BRUCE, V58, P2099; Hinic V, 2008, J MICROBIOL METH, V75, P375, DOI 10.1016/j.mimet.2008.07.002; Hsueh P-R., 2010, CONSENSUS STATEMENT, V43, P452; Ilhan Z., 2013, IN VITRO ANTIMICROBI, P12; Johansen TB., 2018, WHOLE GENOME SEQUENC, V8, P1; Jokhdar H., 2009, BRUCELLOSIS SAUDI AR, V77, P47, DOI [10.3899/jrheum.081320, DOI 10.3899/JRHEUM.081320]; Kaden R., 2017, NOVEL REAL TIME PCR, V17, P1; Karger A., 2013, INTERLABORATORY COMP, V51, P3123; Kasim K., 2018, SELF MEDICATION PROB, V10, P40; Kattar MM, 2007, DIAGN MICR INFEC DIS, V59, P23, DOI 10.1016/j.diagmicrobio.2007.04.002; Khan AU, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120603; Kosikowska U., 2020, PREVALENCE SUSCEPTIB, V10, P1; La Scola B., 2009, DIRECT IDENTIFICATIO, V4, pe8041; Landers TF., 2012, REV ANTIBIOTIC USE F, V127, P4; Leal-Klevezas D S, 1995, Arch Med Res, V26, P263; Leyla G., 2003, COMP POLYMERASE CHAI, V93, P53, DOI [10.1016/s0378-1135(02)00442-x, DOI 10.1016/S0378-1135(02)00442-X]; Lista F., 2011, RELIABLE IDENTIFICAT, V11, P1; Liu Z-g., 2018, IN VITRO ANTIMICROBI, V18, P1; Lopez G., 2006, DETECTION ANTIBODIES, V116, P232; Lopez-Merino A, 2004, SCAND J INFECT DIS, V36, P636, DOI 10.1080/00365540410020767; Makharita RR., 2020, ANTIBIOGRAM GENETIC, V13, P3991; Neha A., 2017, COMP EFFICACY SEROLO, V18, P279; Nielsen K., 1989, ENZYME LINKED IMMUNO, V50, P5; Pavlovic Melanie, 2013, Open Microbiol J, V7, P135, DOI 10.2174/1874285801307010135; Pierce CY., 2007, STRAIN PHASE IDENTIF, V583, P23; Qadri H., 1993, SUSCEPTIBILITY BRUCE, V39, P128; Rijpens NP., 1996, DIRECT DETECTION BRU, V62, P1683; Rychert J, 2019, J INFECTIOL EPIDEMIO, V2; Saadat S., 2017, DIAGNOSIS CATTLE BRU, V14, P881; Sali M., 2018, RAPID SAFE ONE STEP, V13, pe0197864; Seng P., 2009, ONGOING REVOLUTION B, V49, P543; Singhal N., 2015, MALDI TOF MASS SPECT, V6, P791; Suarez S., 2014, APPL MALDI TOF TECHN, V63, P43; Suarez-Esquivel M., 2020, BRUCELLA GENOMICS MA, V21, P7749; Wareth G., 2020, PROTEOMICS BRUCELLA, V8, P766; Wareth G., 2021, MOL CHARACTERIZATION, V13, P100255; Yagupsky P., 2019, LAB DIAGNOSIS HUMAN, V33, pe00073; Yagupsky P., 2005, LAB EXPOSURES BRUCEL, V11, P1180	80	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262551	10.1371/journal.pone.0262551	http://dx.doi.org/10.1371/journal.pone.0262551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025975	gold, Green Published			2022-12-26	WOS:000796264200083
J	Riedinger, C; Campbell, J; Klein, WMP; Ferrer, RA; Usher-Smith, JA				Riedinger, Christiane; Campbell, Jackie; Klein, William M. P.; Ferrer, Rebecca A.; Usher-Smith, Juliet A.			Analysis of the components of cancer risk perception and links with intention and behaviour: A UK-based study	PLOS ONE			English	Article							FEAR APPEALS; METAANALYSIS; MODEL; REASON; DONT	Risk perception refers to how individuals interpret their susceptibility to threats, and has been hypothesised as an important predictor of intentions and behaviour in many theories of health behaviour change. However, its components, optimal measurement, and effects are not yet fully understood. The TRIRISK model, developed in the US, conceptualises risk perception as deliberative, affective and experiential components. In this study, we aimed to assess the replicability of the TRIRISK model in a UK sample by confirmatory factor analysis (CFA), explore the inherent factor structure of risk perception in the UK sample by exploratory factor analysis (EFA), and assess the associations of EFA-based factors with intentions to change behaviour and subsequent behaviour change. Data were derived from an online randomised controlled trial assessing cancer risk perception using the TRIRISK instrument and intention and lifestyle measures before and after communication of cancer risk. In the CFA analysis, the TRIRISK model of risk perception did not provide a good fit for the UK data. A revised model developed using EFA consisted of two separate "numerical" and "self-reflective" factors of deliberative risk perception, and a third factor combining affective with a subset of experiential items. This model provided a better fit to the data when cross-validated. Using multivariable regression analysis, we found that the self-reflective and affective-experiential factors of the model identified in this study were reliable predictors of intentions to prevent cancer. There were no associations of any of the risk perception factors with behaviour change. This study confirms that risk perception is clearly a multidimensional construct, having identified self-reflective risk perception as a new distinct component with predictive validity for intention. Furthermore, we highlight the practical implications of our findings for the design of interventions incorporating risk perception aimed at behaviour change in the context of cancer prevention.	[Riedinger, Christiane; Usher-Smith, Juliet A.] Univ Cambridge, Dept Publ Hlth & Primary Care, Prevent Grp, Primary Care Unit,Clin Sch, Cambridge, England; [Campbell, Jackie] Univ Northampton, Fac Hlth Educ & Soc, Northampton, England; [Klein, William M. P.; Ferrer, Rebecca A.] NCI, Behav Res Program, Rockville, MD USA	University of Cambridge; University of Northampton; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Riedinger, C (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Prevent Grp, Primary Care Unit,Clin Sch, Cambridge, England.	cr426@medschl.cam.ac.uk		Campbell, Jackie/0000-0002-1456-7994; Riedinger, Christiane/0000-0002-9310-9894; Usher-Smith, Juliet/0000-0002-8501-2531	Cancer Research UK Prevention Fellowship [C55650/A21464]; NIHR Academic Clinical Fellowship - Cancer Research UK Prevention Fellowship [C55650/A21464]	Cancer Research UK Prevention Fellowship; NIHR Academic Clinical Fellowship - Cancer Research UK Prevention Fellowship	This study was funded by the Cancer Research UK Prevention Fellowship (C55650/A21464). CR was supported by an NIHR Academic Clinical Fellowship. JC, WMPK and RAF received no specific funding or this project. JAUS was funded by the Cancer Research UK Prevention Fellowship (C55650/A21464).	[Anonymous], 1974, Health Education Monograph, V2, P324; ASPINWALL LG, 1991, HEALTH PSYCHOL, V10, P432, DOI 10.1037/0278-6133.10.6.432; Beatty P, 1998, MEMORY, V6, P407; Bending GD, 2000, BIOL FERT SOILS, V31, P78, DOI 10.1007/s003740050627; Bontempo RN, 1997, RISK ANAL, V17, P479, DOI 10.1111/j.1539-6924.1997.tb00888.x; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; Falk R.F., 1992, PRIMER SOFT MODELING; Faries MD, 2016, AM J LIFESTYLE MED, V10, P322, DOI 10.1177/1559827616638017; Ferrer RA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191994; Ferrer RA, 2016, ANN BEHAV MED, V50, P653, DOI 10.1007/s12160-016-9790-z; Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; French DP, 2017, ANN BEHAV MED, V51, P718, DOI 10.1007/s12160-017-9895-z; Gottlieb N H, 1987, Am J Health Promot, V2, P37, DOI 10.4278/0890-1171-2.1.37; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Han PKJ, 2009, HEALTH EXPECT, V12, P4, DOI 10.1111/j.1369-7625.2008.00524.x; Hay JL, 2006, PREV MED, V42, P401, DOI 10.1016/j.ypmed.2006.03.002; Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102; Ijaz K, 2020, INT J HUM-COMPUT INT, V36, P1195, DOI 10.1080/10447318.2020.1726107; Islami F, 2018, CA-CANCER J CLIN, V68, P31, DOI 10.3322/caac.21440; Janssen E, 2011, BRIT J HEALTH PSYCH, V16, P92, DOI 10.1348/135910710X514120; Joreskog K, 2013, LISREL 8 STRUCTURAL; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Leventhal H., 1970, ADV EXP SOC PSYCHOL, V5, P119, DOI [https://doi.org/10.1016/S0065-2601(08)60091-X, DOI 10.1016/S0065-2601(08)60091-X]; Loewenstein G., 2003, ROLE AFFECT DECISION; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Masson G, 2020, PREV MED, V138, DOI 10.1016/j.ypmed.2020.106154; Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; Pituch K.A., 2015, APPL MULTIVARIATE ST, DOI DOI 10.4324/9781315814919; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; SHAFIR E, 1993, COGNITION, V49, P11, DOI 10.1016/0010-0277(93)90034-S; Sheeran P, 2016, SOC PERSONAL PSYCHOL, V10, P503, DOI 10.1111/spc3.12265; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Turner JR, 2013, ENCY BEHAV MED, P1689, DOI [DOI 10.1007/978-1-4419-1005-9_866, 10.1007/978-1-4419-1005-9_866]; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; Usher-Smith JA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5712-2; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; Wilson RS, 2019, RISK ANAL, V39, P777, DOI 10.1111/risa.13207; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276	47	2	2	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0262197	10.1371/journal.pone.0262197	http://dx.doi.org/10.1371/journal.pone.0262197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025940	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000796264200053
J	Hamamoto, Y; Suzuki, S; Sugiura, M				Hamamoto, Yumi; Suzuki, Shinsuke; Sugiura, Motoaki			Two components of body-image disturbance are differentially associated with distinct eating disorder characteristics in healthy young women	PLOS ONE			English	Article							SIZE OVER-ESTIMATION; ANOREXIA-NERVOSA; PERCEPTUAL COMPONENT; FIXATION PATTERNS; BULIMIA-NERVOSA; VALIDATION; INVENTORY; WEIGHT; SHAPE	Body-image disturbance comprises two components. The first is perceptual in nature, and is measured by a discrepancy between one's actual body and perceived self-image ("perceived-actual discrepancy"). The other component is affective, and is measured by a discrepancy between one's perceived self-image and ideal body image ("perceived-ideal discrepancy"). The present study evaluated the relationships between body-image disturbance and characteristics of eating disorders such as symptoms and related personality traits. In a psychophysiological experiment, female university students (mean +/- SD age = 21.0 +/- 1.38 years) were presented with silhouette images of their own bodies that were distorted in terms of width. The participants were asked whether each silhouette image was more overweight than their actual or ideal body images. Eating-disorder characteristics were assessed using six factors from the Japanese version of the Eating Disorder Inventory 2 (EDI2). We found that perceived-actual discrepancies correlated with negative self-evaluation (i.e., factor 3 of the EDI2), whereas perceived-ideal discrepancies correlated with dissatisfaction with one's own body (i.e., factor 2 of EDI2). These results imply that distinct psychological mechanisms underlie the two components of body-image disturbance.	[Hamamoto, Yumi] Tohoku Univ, Sch Med, Sendai, Miyagi, Japan; [Hamamoto, Yumi; Suzuki, Shinsuke; Sugiura, Motoaki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Suzuki, Shinsuke] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi, Japan; [Suzuki, Shinsuke] Univ Melbourne, Dept Finance, Brain Minds & Markets Lab, Carlton, Vic, Australia; [Sugiura, Motoaki] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; University of Melbourne; Tohoku University	Hamamoto, Y (corresponding author), Tohoku Univ, Sch Med, Sendai, Miyagi, Japan.; Hamamoto, Y (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan.	yumi.hamamoto.q2@dc.tohoku.ac.jp		Hamamoto, Yumi/0000-0002-7166-6059	Japan Society for the Promotion of Science [16H01873, 17H05933]; Division for Interdisciplinary Advanced Research and Education Selective Examination, Tohoku University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Division for Interdisciplinary Advanced Research and Education Selective Examination, Tohoku University	This study was supported by KAKENHI 16H01873 (MS) and 17H05933 (SS) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html).YH received the financial support from the Division for Interdisciplinary Advanced Research and Education Selective Examination, Tohoku University (http://www.iiare.tohoku.ac.jp/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspen V, 2013, COGNITION EMOTION, V27, P820, DOI 10.1080/02699931.2012.749777; Benninghoven D, 2007, BODY IMAGE, V4, P51, DOI 10.1016/j.bodyim.2006.12.002; BRUCH H, 1962, PSYCHOSOM MED, V24, P187, DOI 10.1097/00006842-196203000-00009; Burke MA, 2017, ECON HUM BIOL, V27, P198, DOI 10.1016/j.ehb.2017.06.002; Calzo JP, 2012, J ADOLESCENT HEALTH, V51, P517, DOI 10.1016/j.jadohealth.2012.02.021; Carey M, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00635; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Cornelissen KK, 2019, BODY IMAGE, V31, P35, DOI 10.1016/j.bodyim.2019.08.001; Cornelissen KK, 2016, INT J EAT DISORDER, V49, P507, DOI 10.1002/eat.22505; Cornelissen KK, 2015, BODY IMAGE, V13, P75, DOI 10.1016/j.bodyim.2015.01.001; Cornelissen PL, 2013, BODY IMAGE, V10, P103, DOI 10.1016/j.bodyim.2012.09.003; Fairburn CG, 2008, COGNITIVE BEHAV THER; Fan YO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-314; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fitzgibbon ML, 2003, INT J EAT DISORDER, V34, P83, DOI 10.1002/eat.10160; Franko DL, 1999, J ADOLESCENCE, V22, P389, DOI 10.1006/jado.1999.0230; Gardner RM, 1996, BRIT J PSYCHOL, V87, P327, DOI 10.1111/j.2044-8295.1996.tb02593.x; Garner D. M., 2004, PROFESSIONAL MANUAL; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Garner DM, 1991, EATING DISORDER INVE; Gaudio S, 2012, NEUROSCI BIOBEHAV R, V36, P1839, DOI 10.1016/j.neubiorev.2012.05.003; GLEGHORN AA, 1987, J PSYCHOPATHOL BEHAV, V9, P203, DOI 10.1007/BF00960575; Hamamoto Y, 2019, PSYCHOTHER PSYCHOSOM, V88, P53; Irvine KR, 2019, BODY IMAGE, V29, P31, DOI 10.1016/j.bodyim.2019.02.006; Irvinea KR, 2020, BODY IMAGE, V33, P232, DOI 10.1016/j.bodyim.2020.03.007; Keizer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163921; Kodama N, 2018, BIOPSYCHOSOC MED, V12, DOI 10.1186/s13030-018-0134-z; Legenbauer T, 2014, Z KINDER JUG-PSYCH, V42, P51, DOI 10.1024/1422-4917/a000269; Lewer M, 2016, EAT WEIGHT DISORD-ST, V21, P115, DOI 10.1007/s40519-015-0200-5; Mohr HM, 2010, PSYCHOL MED, V40, P1519, DOI 10.1017/S0033291709991826; Mohr HM, 2016, PERCEPTION, V45, P725, DOI 10.1177/0301006616633385; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Nevonen L, 2001, Eat Weight Disord, V6, P59; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Porras-Garcia B, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00956; Porras-Garcia B, 2020, EUR EAT DISORD REV, V28, P454, DOI 10.1002/erv.2730; Probst M, 1998, INT J EAT DISORDER, V24, P167, DOI 10.1002/(SICI)1098-108X(199809)24:2&lt;167::AID-EAT6&gt;3.0.CO;2-C; Racine SE, 2012, INT J EAT DISORDER, V45, P333, DOI 10.1002/eat.20941; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; SCHOEMAKER C, 1994, INT J EAT DISORDER, V15, P387, DOI 10.1002/eat.2260150409; Shimura M., 1994, JPN J BEHAV THER, V20, P8; Stice E, 2018, BEHAV RES THER, V105, P52, DOI 10.1016/j.brat.2018.03.005; Stice E, 2011, BEHAV RES THER, V49, P622, DOI 10.1016/j.brat.2011.06.009; Tazaki S, 2007, JAPANESE J HLTH PSYC, V20, P56; Thaler A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192152; Waldman A, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-17; WATTS S, 1980, J AFFECT DISORDERS, V2, P257, DOI 10.1016/0165-0327(80)90027-0	48	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262513	10.1371/journal.pone.0262513	http://dx.doi.org/10.1371/journal.pone.0262513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020770	gold, Green Published			2022-12-26	WOS:000834207700046
J	Monari, N; Orwa, J; Agwanda, A				Monari, Naomi; Orwa, James; Agwanda, Alfred			Adolescent fertility and its determinants in Kenya: Evidence from Kenya demographic and health survey 2014	PLOS ONE			English	Article								Background Adolescent fertility in Kenya is vital in the development and execution of reproductive health policies and programs. One of the specific objectives of the Kenyan Adolescent Sexual Reproductive Health (ASRH) policy developed in 2015 is to decrease early and unintended pregnancies in an attempt to reduce adolescent fertility. We aimed to establish determinants of adolescent fertility in Kenya. Methods The Kenya Demographic and Health Survey (KDHS) 2014 data set was utilized. Adolescent's number of children ever born was the dependent variable. The Chi-square test was utilized to determine the relationship between dependent and independent variables. A Proportional-odds model was performed to establish determinants of adolescent fertility at a 5% significance level. Results Over 40% of the adolescent girls who had sex below 17 years had given birth i.e, current age 15-17 years (40.9%) and <15 years (44.9%) had given birth. In addition, 70.7% of the married adolescents had given birth compared to 8.1% of the unmarried adolescents. Moreover, 65.1% of the adolescents who were using contraceptives had given birth compared to only 9% of the adolescents who were not using a contraceptive. Approximately 29.4% of the adolescents who had no education had given birth compared to 9.1% who had attained secondary education. Age at first sex (18-19 years: OR: 0.221, 95% CI: 0.124-0.392; 15-17 years: OR: 0.530, 95% CI: 0.379-0.742), current age (18-19 years: OR: 4.727, 95% CI: 3.318-6.733), current marital status (Not married: OR:0.212, 95% CI: 0.150-4.780), and current contraceptive use (Using: OR 3.138, 95% CI: 2.257-4.362) were associated with adolescent fertility. Conclusion The study established that age at first sex, current age, marital status, and contraceptive use are the main determinants of adolescent childbearing. The stated determinants should be targeted by the government to control the adolescent birth rate in Kenya. Consequently, delaying the age at first sex, discouraging adolescent marriage, and increasing secondary school enrollment among adolescent girls are recommended strategies to control adolescent fertility in Kenya.	[Monari, Naomi; Orwa, James; Agwanda, Alfred] Univ Nairobi, Populat Studies & Res Inst, Nairobi, Kenya	University of Nairobi	Monari, N (corresponding author), Univ Nairobi, Populat Studies & Res Inst, Nairobi, Kenya.	naomi.monari@gmail.com		MONARI, NAOMI/0000-0001-5295-8753				Alemayehu T, 2010, ETHIOP J HEALTH DEV, V24, P30; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J, 2013, FERTILITY BIOL BEHAV; DAVIS K, 1956, ECON DEV CULT CHANGE, V4, P211, DOI 10.1086/449714; Eyasu AM., 2016, OPEN ACCESS LIB J, V3, P1; Gupta N, 1999, INT FAM PLAN PERSPEC, V25, P125, DOI 10.2307/2991961; Huda FauziaAkhter., 2014, PREVELENCE UNINTENDE, DOI [10.31899/rh4.1050, DOI 10.31899/RH4.1050]; Kassa GM, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0745-4; Kenya National Bureau of Statistics (KNBS) and ICF Micro, 2014, KENYA DEMOGRAPHIC HL; Laelago T, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0677-x; Loaiza E., 2013, ADOLESCENT PREGNANCY; Mahy M., 2002, TRENDS DIFFERENTIALS; Nyarko SH, 2012, INT J SCI BASIC APPL, V5, P21; Obare F, 2016, ADOLESCENT SEXUAL RE; Olorinola IO., ADOLESCENT FERTILITY; Palamuleni ME., 2017, GEND BEHAV, V15, P10126; Raharjo BB, 2019, KEMAS JURNAL KESEHAT, V15, P141; United Nations Department of Economic and Social Affairs Population Division, 2020, INT MIGR STOCK 2020; United Nations (UN), 2013, AD FERT INT C POP DE; Westoff CF., 2006, STALL FERTILITY TRAN; World Health Organization, 2014, HIGH PRIOR TARG PROD; WorldAtlas, HIGH TEEN PREGN RAT	23	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262016	10.1371/journal.pone.0262016	http://dx.doi.org/10.1371/journal.pone.0262016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020765	gold, Green Published			2022-12-26	WOS:000834207700032
J	Reimann, MW; Riihimaki, H; Smith, JP; Pokorny, C; Levi, R; Zochowski, M				Reimann, Michael W.; Riihimaki, Henri; Smith, Jason P.; Pokorny, Christoph; Levi, Ran; Zochowski, Michal			Topology of synaptic connectivity constrains neuronal stimulus representation, predicting two complementary coding strategies	PLOS ONE			English	Article							VARIABILITY; DIVERSE	In motor-related brain regions, movement intention has been successfully decoded from invivo spike train by isolating a lower-dimension manifold that the high-dimensional spiking activity is constrained to. The mechanism enforcing this constraint remains unclear, although it has been hypothesized to be implemented by the connectivity of the sampled neurons. We test this idea and explore the interactions between local synaptic connectivity and its ability to encode information in a lower dimensional manifold through simulations of a detailed microcircuit model with realistic sources of noise. We confirm that even in isolation such a model can encode the identity of different stimuli in a lower-dimensional space. We then demonstrate that the reliability of the encoding depends on the connectivity between the sampled neurons by specifically sampling populations whose connectivity maximizes certain topological metrics. Finally, we developed an alternative method for determining stimulus identity from the activity of neurons by combining their spike trains with their recurrent connectivity. We found that this method performs better for sampled groups of neurons that perform worse under the classical approach, predicting the possibility of two separate encoding strategies in a single microcircuit.	[Reimann, Michael W.; Levi, Ran] Ecole Polytech Fed Lausanne EPFL, Blue Brain Project, Geneva, Switzerland; [Riihimaki, Henri; Smith, Jason P.; Pokorny, Christoph; Zochowski, Michal] Univ Aberdeen, Aberdeen, Scotland; [Smith, Jason P.] Nottingham Trent Univ, Nottingham, England; [Pokorny, Christoph] Univ Latvia, Riga, Latvia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Aberdeen; Nottingham Trent University; University of Latvia	Reimann, MW (corresponding author), Ecole Polytech Fed Lausanne EPFL, Blue Brain Project, Geneva, Switzerland.	michael.reimann@epfl.ch		Lazovskis, Janis/0000-0002-3285-7522	Swiss government's ETH Board of the Swiss Federal Institutes of Technology; EPSRC [EP/P025072, 832]; Ecole Polytechnique Federale de Lausanne	Swiss government's ETH Board of the Swiss Federal Institutes of Technology; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ecole Polytechnique Federale de Lausanne	This study was supported by funding to the Blue Brain Project, a research center of the Ecole polytechnique federale de Lausanne (EPFL), from the Swiss government's ETH Board of the Swiss Federal Institutes of Technology. RL is supported by an EPSRC grant EP/P025072/and a collaboration agreement 832 with Ecole Polytechnique Federale de Lausanne.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Allen WE, 2019, SCIENCE, V364, P253, DOI 10.1126/science.aav3932; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Chung F. R.-K., 1996, CBMS REGIONAL C SERI, V92; Chung F, 2005, ANN COMB, V9, P1, DOI 10.1007/s00026-005-0237-z; Conceicao P, 2021, ARXIV; Desbordes G, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00151; Diestel R., 2000, GRAPH THEORY; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Gal E, 2017, NAT NEUROSCI, V20, P1004, DOI 10.1038/nn.4576; Gallego JA, 2017, NEURON, V94, P978, DOI 10.1016/j.neuron.2017.05.025; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hatcher A., 2005, ALGEBRAIC TOPOLOGY; Iacaruso MF, 2017, NATURE, V547, P449, DOI 10.1038/nature23019; Lidl R., 1997, ENCY MATH ITS APPL, V20; Ling DSF, 1999, J NEUROPHYSIOL, V82, P1793, DOI 10.1152/jn.1999.82.4.1793; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Masulli P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2022-y; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Nolte M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11633-8; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; Ramaswamy S, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00044; Reimann MW, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00048; Reimann MW, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00120; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Reyes-Puerta V, 2015, CEREB CORTEX, V25, P2001, DOI 10.1093/cercor/bhu007; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Riihimaki H, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03659-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P509, DOI 10.1113/jphysiol.2002.022095; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stringer C, 2019, SCIENCE, V364, P255, DOI 10.1126/science.aav7893; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Vijaymeena MK., 2016, MACH LEARN APPL, V3, P19, DOI [10.5121/mlaij.2016.3103, DOI 10.5121/MLAIJ.2016.3103]; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11380	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0261702	10.1371/journal.pone.0261702	http://dx.doi.org/10.1371/journal.pone.0261702			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020728	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000834207700021
J	Vannini, I; Ferracin, M; Fabbri, F; Fabbri, M				Vannini, Ivan; Ferracin, Manuela; Fabbri, Francesco; Fabbri, Muller			Overexpression of ultraconserved region 83-induces lung cancer tumorigenesis	PLOS ONE			English	Article							LONG NONCODING RNAS; ELEMENTS; EXPRESSION	The expression of non-coding RNAs (ncRNAs) is dysregulated in human cancers. The transcribed ultraconserved regions (T-UCRs) express long ncRNAs involved in human carcinogenesis. T-UCRs are non-coding genomic sequence that are 100% conserved across humans, rats and mice. Conservation of genomic sequences across species intrinsically implies an essential functional role and so we considered the expression of T-UCRs in lung cancer. Using a custom microarray we analyzed the global expression of T-UCRs. Among these T-UCRs, the greatest variation was observed for antisense ultraconserved element 83 (uc.83-), which was upregulated in human lung cancer tissues compared with adjacent non cancerous tissues. Even though uc.83- is located within the long intergenic non-protein coding RNA 1876 (LINC01876) gene, we found that the transcribed uc.83- is expressed independently of LINC01876 and was cloned as a 1143-bp RNA gene. In this study, functional analysis confirmed important effects of uc.83-on genes involved in cell growth of human cells. siRNA against uc.83- decreased the growth of lung cancer cells while the upregulation through a vector overexpressing the uc.83- RNA increased cell proliferation. We also show the oncogenic function of uc.83- is mediated by the phosphorylation of AKT and ERK 1/2, two important biomarkers of lung cancer cell proliferation. Based on our findings, inhibition against uc.83- could be a future therapeutic treatment for NSCLC to achieve simultaneous blockade of pathways involved in lung carcinogenesis.	[Vannini, Ivan; Fabbri, Francesco] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Biosci Lab, Meldola, Italy; [Ferracin, Manuela] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy; [Fabbri, Muller] Childrens Natl Hosp, Ctr Canc & Immunol Res, Washington, DC USA	University of Bologna; Children's National Health System	Vannini, I (corresponding author), IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Biosci Lab, Meldola, Italy.	ivan.vannini@irst.emr.it	Vannini, Ivan/T-7226-2019; Ferracin, Manuela/K-2097-2016; Fabbri, Francesco/K-1751-2018	Vannini, Ivan/0000-0002-9279-1801; Ferracin, Manuela/0000-0002-1595-6887; Fabbri, Francesco/0000-0002-7885-3025	National Institutes of Health [R01CA215753, R01CA219024]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, R01CA215753, Professor Muller Fabbri National Institutes of Health, R01CA219024, Professor Muller Fabbrihttps://www.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bomben R, 2019, BRIT J HAEMATOL, V184, P1045, DOI 10.1111/bjh.15237; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chi YJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091015; Ciuffreda L, 2014, CURR PHARM DESIGN, V20, P3944, DOI 10.2174/13816128113196660763; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fernandes JCR, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010017; Gardiner EJ, 2006, J CHEM INF MODEL, V46, P753, DOI 10.1021/ci050384i; Honma R, 2017, GASTRIC CANCER, V20, P960, DOI 10.1007/s10120-017-0714-9; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kopp F, 2019, J GENE MED, V21, DOI 10.1002/jgm.3104; Olivieri M, 2016, ONCOTARGET, V7, P20636, DOI 10.18632/oncotarget.7833; Rossi S, 2008, MAMM GENOME, V19, P526, DOI 10.1007/s00335-008-9119-8; Sciamanna I, 2013, ONCOTARGET, V4, P2271, DOI 10.18632/oncotarget.1403; Sekino Y, 2019, ONCOL REP, V41, P3111, DOI 10.3892/or.2019.7039; Seo Danbi, 2020, Genomics & Informatics, V18, pe36, DOI 10.5808/GI.2020.18.4.e36; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Slack FJ, 2019, CELL, V179, P1033, DOI 10.1016/j.cell.2019.10.017; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Tan AC, 2020, THORAC CANCER, V11, P511, DOI 10.1111/1759-7714.13328; Vannini I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01562-9; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yang RX, 2008, CARCINOGENESIS, V29, P351, DOI 10.1093/carcin/bgm290; Zhou H, 2020, LIFE SCI, V261, DOI 10.1016/j.lfs.2020.118362	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2022	17	1							e0261464	10.1371/journal.pone.0261464	http://dx.doi.org/10.1371/journal.pone.0261464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2I2NI	35015757	Green Published, gold			2022-12-26	WOS:000814820600003
J	Greenhouse-Tucknott, A; Butterworth, JB; Wrightson, JG; Harrison, NA; Dekerle, J				Greenhouse-Tucknott, Aaron; Butterworth, Jake B.; Wrightson, James G.; Harrison, Neil A.; Dekerle, Jeanne			Effect of the subjective intensity of fatigue and interoception on perceptual regulation and performance during sustained physical activity	PLOS ONE			English	Article							MUSCLE FATIGUE; SELF-EFFICACY; EXERCISE TOLERANCE; FEEDBACK; BRAIN; RECOMMENDATIONS; SLEEPINESS; ANXIETY; CORTEX; HEART	Background The subjective experience of fatigue impairs an individual's ability to sustain physical endurance performance. However, precise understanding of the specific role perceived fatigue plays in the central regulation of performance remains unclear. Here, we examined whether the subjective intensity of a perceived state of fatigue, pre-induced through prior upper body activity, differentially impacted performance and altered perceived effort and affect experienced during a sustained, isometric contraction in lower body. We also explored whether (cardiac) interoception predicted the intensity of experienced perceptual and affective responses and moderated the relationships between constructs during physical activity. Methods Using a repeated-measures study design, thirty male participants completed three experimental conditions, with the intensity of a pre-induced state of fatigue manipulated to evoke moderate (MOD), severe (SEV) and minimal (control; CON) intensity of perceptions prior to performance of the sustained contraction. Results Performance of the sustained contraction was significantly impaired under a perceived state of fatigue, with reductions of 10% and 14% observed in the MOD and SEV conditions, respectively. Performance impairment was accompanied by greater perceived effort and more negative affective valence reported during the contraction. However, effects were limited to comparisons to CON, with no difference evident between the two experimental trials (i.e. MOD vs. SEV). Individuals' awareness of their accuracy in judging resting heartbeats was shown to predict the subjective intensity of fatigue experienced during the endurance task. However, interoception did not moderate the relationships evident between fatigue and both perceived effort and affective valence. Conclusions A perceived state of fatigue limits endurance performance, influencing both how effortful activity is perceived to be and the affective experience of activity. Though awareness of interoceptive representations of bodily states may be important to the subjective experience of fatigue, interoception does not modulate the relationships between perceived fatigue and other perceptual (i.e. effort) and affective constructs.	[Greenhouse-Tucknott, Aaron; Butterworth, Jake B.; Wrightson, James G.; Dekerle, Jeanne] Univ Brighton, Sch Sport & Hlth Sci, Fatigue & Exercise Lab, Brighton, E Sussex, England; [Wrightson, James G.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Harrison, Neil A.] Cardiff Univ, Cardiff Univ Brain Res Imaging Ctr CUBRIC, Cardiff, Wales; [Harrison, Neil A.] Univ Sussex, Brighton & Sussex Med Sch, Dept Neurosci, Brighton, E Sussex, England	University of Brighton; University of Calgary; Cardiff University; University of Brighton; University of Sussex	Greenhouse-Tucknott, A (corresponding author), Univ Brighton, Sch Sport & Hlth Sci, Fatigue & Exercise Lab, Brighton, E Sussex, England.	A.Greenhouse-Tucknott@brighton.ac.uk	Dekerle, Jeanne/M-8367-2019	Dekerle, Jeanne/0000-0002-4482-4576; Greenhouse-Tucknott, Aaron/0000-0002-9257-521X				Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Aboodarda SJ, 2020, J PHYSIOL-LONDON, V598, P285, DOI 10.1113/JP278943; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Amann M, 2013, J APPL PHYSIOL, V115, P355, DOI 10.1152/japplphysiol.00049.2013; Andre N, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00079; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Behm DG, 2021, SPORTS MED, V51, P1893, DOI 10.1007/s40279-021-01456-3; Bekrater-Bodmann R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.562016; Benoit CE, 2019, NEUROPSYCHOLOGIA, V123, P30, DOI 10.1016/j.neuropsychologia.2018.06.017; Borg G., 1998, BORGS PERCEIVED EXER; Borg G., 1986, PERCEPTION EXERTION, P3; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brick NE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00159; Smirmaul BDC, 2012, BRIT J SPORT MED, V46, P308, DOI 10.1136/bjsm.2010.071407; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Machado DGD, 2019, PHYSIOL BEHAV, V204, P234, DOI 10.1016/j.physbeh.2019.02.038; de Koning JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015863; de Morree H. M., 2015, HDB BIOBEHAVIORAL AP, P255, DOI [10.1007/978-1-4939-1236-0_17, DOI 10.1007/978-1-4939-1236-0_17]; Dimitrov GV, 2008, J ELECTROMYOGR KINES, V18, P35, DOI 10.1016/j.jelekin.2006.07.002; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Ede A, 2017, PSYCHOL SPORT EXERC, V28, P31, DOI 10.1016/j.psychsport.2016.10.002; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Frick RW, 1998, BEHAV RES METH INS C, V30, P690, DOI 10.3758/BF03209488; Gallucci M., 2019, GAMLJ GEN ANAL LINEA; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Garfinkel SN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0014; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Garfinkel SN, 2013, SOC COGN AFFECT NEUR, V8, P231, DOI 10.1093/scan/nss140; Green DM, 1966, SIGNAL DETECTION THE; Greenhouse-Tucknott A, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13602; Greenhouse-Tucknott A, 2020, UNITY PATHOLOGICAL E; Halper LR, 2016, PSYCHOL SPORT EXERC, V22, P170, DOI 10.1016/j.psychsport.2015.08.007; Halperin I, 2020, SPORTS MED, V50, P679, DOI 10.1007/s40279-019-01229-z; Halperin I, 2015, EUR J APPL PHYSIOL, V115, P2031, DOI 10.1007/s00421-015-3249-y; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Harris S, 2019, PSYCHOL SPORT EXERC, V44, P1, DOI 10.1016/j.psychsport.2019.04.005; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hockey G. R. J., 2011, COGNITIVE FATIGUE MU, P167, DOI [10.1037/12343-008, DOI 10.1037/12343-008]; Hockey R., 2013, PSYCHOL FATIGUE WORK; Hureau TJ, 2018, EUR J SPORT SCI, V18, P13, DOI 10.1080/17461391.2016.1252428; Hutchinson JC, 2008, J APPL SPORT PSYCHOL, V20, P457, DOI 10.1080/10413200802351151; Inzlicht M, 2018, TRENDS COGN SCI, V22, P337, DOI 10.1016/j.tics.2018.01.007; Iodice P, 2019, P NATL ACAD SCI USA, V116, P13897, DOI 10.1073/pnas.1821032116; Jacquet T, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.588253; Joffily M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003094; Johnson MA, 2015, J APPL PHYSIOL, V119, P840, DOI 10.1152/japplphysiol.00072.2015; KATKIN ES, 1983, PSYCHOPHYSIOLOGY, V20, P452; Kennedy A, 2013, EUR J APPL PHYSIOL, V113, P559, DOI 10.1007/s00421-012-2462-1; Kleckner IR, 2015, PSYCHOPHYSIOLOGY, V52, P1432, DOI 10.1111/psyp.12503; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Koller M, 2016, J STAT SOFTW, V75, P1, DOI 10.18637/jss.v075.i06; Koteles F, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13620; Krupp LB, 1996, CURR OPIN NEUROL, V9, P456, DOI 10.1097/00019052-199612000-00011; Kuppuswamy A, 2017, BRAIN, V140, P2240, DOI 10.1093/brain/awx153; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Marcora S, 2009, J APPL PHYSIOL, V106, P2060, DOI 10.1152/japplphysiol.90378.2008; Marcora SM, 2008, EUR J APPL PHYSIOL, V104, P929, DOI 10.1007/s00421-008-0818-3; Marcora SM, 2010, EUR J APPL PHYSIOL, V109, P763, DOI 10.1007/s00421-010-1418-6; Marcora SM., ENCY PERCEPTION, V2010, P380, DOI DOI 10.4135/9781412972000.N119; Massin O., 2017, MOTIV SCI, V3, P230, DOI [10.1037/, DOI 10.1037/MOT0000066]; McAuley E, 1999, HEALTH PSYCHOL, V18, P288, DOI 10.1037/0278-6133.18.3.288; McMorris T, 2018, NEUROSCI BIOBEHAV R, V93, P93, DOI 10.1016/j.neubiorev.2018.03.024; Micklewright D, 2017, SPORTS MED, V47, P2375, DOI 10.1007/s40279-017-0711-5; Morgan PT, 2019, AM J PHYSIOL-REG I, V317, pR346, DOI 10.1152/ajpregu.00084.2019; Motl RW, 2006, J PAIN, V7, P301, DOI 10.1016/j.jpain.2005.11.009; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pezzulo G, 2018, TRENDS COGN SCI, V22, P294, DOI 10.1016/j.tics.2018.01.009; Pigeon WR, 2003, J PSYCHOSOM RES, V54, P61, DOI 10.1016/S0022-3999(02)00542-1; Preston J., 2009, OXFORD HDB HUMAN ACT, P469; R Core Team, 2020, R LANG ENV STAT COMP; Robertson CV, 2016, J APPL PHYSIOL, V120, P464, DOI 10.1152/japplphysiol.00363.2015; Ryum T, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00924; Smith MR, 2019, J PSYCHOL, V153, P759, DOI 10.1080/00223980.2019.1611530; Staiano W, 2018, PROG BRAIN RES, V240, P175, DOI 10.1016/bs.pbr.2018.09.012; Steele J., 2021, WHAT IS PERCEPTION E, DOI [10.31234/osf.io/kbyhm, DOI 10.31234/OSF.IO/KBYHM]; Stephan KE, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00550; Tanaka M, 2014, BRAIN RES, V1542, P49, DOI 10.1016/j.brainres.2013.10.018; The Jamovi Project, 2020, JAMOVI; Venhorst A, 2018, SPORTS MED, V48, P2479, DOI 10.1007/s40279-018-0986-1; Weinberg R., 1979, J SPORT EXERC PSYCHO, V1, P320; Weinberg RS, 1981, J SPORT PSYCHOL, V3; Wiens S, 2001, BIOL PSYCHOL, V58, P159, DOI 10.1016/S0301-0511(01)00110-7; Zenon A, 2019, NEUROPSYCHOLOGIA, V123, P5, DOI 10.1016/j.neuropsychologia.2018.09.013	90	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262303	10.1371/journal.pone.0262303	http://dx.doi.org/10.1371/journal.pone.0262303			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZO8DB	34986186	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000765956200039
J	Mariac, C; Duponchelle, F; Miranda, G; Ramallo, C; Wallace, R; Tarifa, G; Garcia-Davila, C; Ortega, H; Pinto, J; Renno, JF				Mariac, Cedric; Duponchelle, Fabrice; Miranda, Guido; Ramallo, Camila; Wallace, Robert; Tarifa, Gabriel; Garcia-Davila, Carmen; Ortega, Hernan; Pinto, Julio; Renno, Jean-Francois			Unveiling biogeographical patterns of the ichthyofauna in the Tuichi basin, a biodiversity hotspot in the Bolivian Amazon, using environmental DNA	PLOS ONE			English	Article							CONSERVATION; EDNA; POPULATION; HYDROPOWER; DIVERSITY; PACKAGE; SURFACE; FUTURE; WATERS; ANDES	To date, more than 2400 valid fish species have been recorded in the Amazon basin. However, some regions remain poorly documented. This is the case in the Beni basin and in particular in one of its main sub-basins, the Tuichi, an Andean foothills rivers flowing through the Madidi National Park in the Bolivian Amazonia. The knowledge of its ichthyological diversity is, however, essential for the management and protection of aquatic ecosystems, which are threatened by the development of infrastructures (dams, factories and cities), mining and deforestation. Environmental DNA (eDNA) has been relatively little used so far in the Amazon basin. We sampled eDNA from water in 34 sites in lakes and rivers in the Beni basin including 22 sites in the Tuichi sub-basin, during the dry season. To assess the biogeographical patterns of the amazonian ichthyofauna, we implemented a metabarcoding approach using two pairs of specific primers designed and developed in our laboratory to amplify two partially overlapping CO1 fragments, one of 185bp and another of 285bp. We detected 252 fish taxa (207 at species level) among which 57 are newly identified for the Beni watershed. Species compositions are significantly different between lakes and rivers but also between rivers according to their hydrographic rank and altitude. Furthermore, the diversity patterns are related to the different hydro-ecoregions through which the Tuichi flows. The eDNA approach makes it possible to identify and complete the inventory of the ichthyofauna in this still poorly documented Amazon basin. However, taxonomic identification remains constrained by the lack of reference barcodes in public databases and does not allow the assignment of all OTUs. Our results can be taken into account in conservation and management strategies and could serve as a baseline for future studies, including on other Andean tributaries.	[Mariac, Cedric; Renno, Jean-Francois] Univ Montpellier, CIRAD, DIADE, IRD, Montpellier, France; [Mariac, Cedric; Duponchelle, Fabrice; Miranda, Guido; Garcia-Davila, Carmen; Renno, Jean-Francois] UAGRM, IRD, IIAP, Lab Mixte Int Evolut & Domesticat Ichtyofaune Ama, Paris, France; [Duponchelle, Fabrice] Univ Montpellier, CNRS, IFREMER, IRD,MARBEC, Montpellier, France; [Miranda, Guido; Ramallo, Camila; Wallace, Robert; Tarifa, Gabriel] Wildlife Conservat Soc, Bolivia Program, La Paz, Bolivia; [Miranda, Guido; Pinto, Julio] Univ Mayor San Andres, Inst Ecol, Unidad Limnol, La Paz, Bolivia; [Garcia-Davila, Carmen] Inst Invest Amazonia Peruana IIAP, Lab Biol & Genet Mol LBGM, Iquitos, Peru; [Ortega, Hernan] Univ Nacl Mayor San Marcos, Museo Hist Nat, Dept Ictiol, Lima, Peru	CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidad Mayor de San Andres; Universidad Nacional Mayor de San Marcos	Mariac, C (corresponding author), Univ Montpellier, CIRAD, DIADE, IRD, Montpellier, France.; Mariac, C (corresponding author), UAGRM, IRD, IIAP, Lab Mixte Int Evolut & Domesticat Ichtyofaune Ama, Paris, France.	cedric.mariac@ird.fr	MARIAC, Cedric/H-9868-2017	MARIAC, Cedric/0000-0001-6439-115X	Programa Nacional de Investigacion Cientifica y Estudios Avanzados (PROCIENCA) [017-2018-FONDECYT]; Gordon and Betty Moore Foundation [GBMF331.07]; Laboratoire Mixte International -Evolution et Domestication de l'Ichtyofaune Amazonienne	Programa Nacional de Investigacion Cientifica y Estudios Avanzados (PROCIENCA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Laboratoire Mixte International -Evolution et Domestication de l'Ichtyofaune Amazonienne	CGD has been supported by Programa Nacional de Investigacion Cientifica y Estudios Avanzados (PROCIENCA) [grant number 017-2018-FONDECYT]. GM, RW, GT, CR has been supported by Gordon and Betty Moore Foundation [grant number GBMF331.07]. CM, FD, JFR, CDG has been supported by Laboratoire Mixte International -Evolution et Domestication de l'Ichtyofaune Amazonienne (No grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1642; Anderson EP, 2011, CONSERV BIOL, V25, P30, DOI 10.1111/j.1523-1739.2010.01568.x; Guimaraes KLA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209430; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Boussarie G, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9661; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Cantera I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39399-5; Carvajal-Quintero JD, 2015, ECOL EVOL, V5, P2608, DOI 10.1002/ece3.1539; Carvajal-Vallejos FM., 2017, BASES TECNICAS MANEJ, DOI [10.1371/journal.pone.0170009, DOI 10.1371/JOURNAL.PONE.0170009]; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Cilleros K, 2019, MOL ECOL RESOUR, V19, P27, DOI 10.1111/1755-0998.12900; Civade R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157366; Curtis AN, 2021, DIVERS DISTRIB, V27, P1918, DOI 10.1111/ddi.13196; Deiner K, 2017, METHODS ECOL EVOL, V8, P1888, DOI 10.1111/2041-210X.12836; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Doble C.J., 2020, ENV DNA, V2, P24, DOI [10.1002/edn3.43, DOI 10.1002/EDN3.43]; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Doria CRC, 2018, REV FISH SCI AQUAC, V26, P494, DOI 10.1080/23308249.2018.1463511; Dougherty MM, 2016, J APPL ECOL, V53, P722, DOI 10.1111/1365-2664.12621; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duponchelle F, 2021, AQUAT CONSERV, V31, P1087, DOI 10.1002/aqc.3550; Elbrecht V, 2017, METHODS ECOL EVOL, V8, P622, DOI 10.1111/2041-210X.12687; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Forsberg BR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182254; Freeman MC, 2003, AM FISH S S, V35, P255; Froese R, 2010, FISHBASE WORLD WIDE; Galan M, 2018, MOL ECOL RESOUR, V18, P474, DOI 10.1111/1755-0998.12749; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Goulding M., 1980, P1; Handley LL., 2019, ENV DNA, V1, P26, DOI [10.1002/edn3.5, DOI 10.1002/EDN3.5]; Harrison JB, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1409; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Hugueny B, 2010, AM FISH S S, V73, P29; Hunter ME, 2018, ENDANGER SPECIES RES, V35, P101, DOI 10.3354/esr00880; Hurd LE, 2016, BIOL CONSERV, V195, P118, DOI 10.1016/j.biocon.2016.01.005; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Jackman J.M., 2021, ENV DNA, V3, P837, DOI [10.1002/edn3.191, DOI 10.1002/EDN3.191]; Jaramillo-Villa U, 2010, J FISH BIOL, V76, P2401, DOI 10.1111/j.1095-8649.2010.02629.x; Jerde CL, 2019, MOL ECOL RESOUR, V19, P19, DOI 10.1111/1755-0998.12929; Jezequel C, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0436-4; Jezequel C, 2020, CONSERV BIOL, V34, P956, DOI 10.1111/cobi.13466; Jo T., 2021, ENV DNA, V4, P271, DOI [10.1002/edn3.253, DOI 10.1002/EDN3.253]; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Lacoursiere-Roussel A, 2016, GENOME, V59, P991, DOI 10.1139/gen-2015-0218; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Leroy B, 2019, J BIOGEOGR, V46, P2407, DOI 10.1111/jbi.13674; Li J., 2019, ENV DNA, V1, P238, DOI [10.1002/edn3.24, DOI 10.1002/EDN3.24]; Linke S, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0300-6; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Manel S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14409-7; Maurice-Bourgoin L, 2003, J PHYS IV, V107, P855, DOI 10.1051/jp4:20030432; McDevitt AD, 2019, J FISH BIOL, V95, P679, DOI 10.1111/jfb.14053; McKnight D.T., 2019, ENV DNA, V1, P14, DOI [DOI 10.1002/EDN3.11, 10.1002/edn3.11]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Melo BF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00107; Miranda-Chumacero G, 2020, GLOB ECOL CONSERV, V24, DOI 10.1016/j.gecco.2020.e01309; Miranda-Chumacero G, 2012, BIOINVASIONS REC, V1, P129, DOI 10.3391/bir.2012.1.2.09; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ortega H., 2012, LISTA ANOTADA PECES; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pochardt M, 2020, MOL ECOL RESOUR, V20, P457, DOI 10.1111/1755-0998.13123; Pont D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28424-8; Prance G.T., 1981, BRITTONIA, V33, P257, DOI [10.2307/2806336, DOI 10.2307/2806336]; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; R Core Team, 2020, R LANG ENV STAT COMP; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Sales NG, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142096; Santana CDde., 2021, BIORXIV, DOI [10.1038/s41598-021-97128-3, DOI 10.1038/S41598-021-97128-3]; Sarmiento J, 2014, PECES BOLIVIA BOLIVI; Sasso T, 2017, EDNA METABARCODING P, P1755; Schneider A, 2017, GEOPHYS RES LETT, V44, P2773, DOI 10.1002/2016GL071844; Shaw JLA, 2016, BIOL CONSERV, V197, P131, DOI 10.1016/j.biocon.2016.03.010; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Toomey AH, 2020, CONSERV SOC, V18, P25, DOI 10.4103/cs.cs_18_115; Wallace R., 2019, INFORME CIENTIFICO 2; Wallace R, 2020, TROP CONSERV SCI, V13, DOI 10.1177/1940082920966470; Wallace Robert, 2017, Ecología en Bolivia, V52, P1; Wasson J. G., 2002, The ecohydrology of South American rivers and wetlands, P69; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zhao SL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S10-P16	92	0	0	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2022	17	1							e0262357	10.1371/journal.pone.0262357	http://dx.doi.org/10.1371/journal.pone.0262357			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3L5MO	34982802	Green Published, Green Submitted, gold			2022-12-26	WOS:000834805700031
J	Abawari, MJ; Amdisa, D; Birhanu, Z; Kebede, Y				Abawari, Mohammed Jemal; Amdisa, Demuma; Birhanu, Zewdie; Kebede, Yohannes			Response to self-care practice messages among patients with diabetes mellitus visiting Jimma University medical center facility based cross sectional design application of extended parallel process model	PLOS ONE			English	Article							FEAR APPEALS; MANAGEMENT; BEHAVIORS; KNOWLEDGE; FOOT	Objective To determine response to self-care practice message among patients with diabetes in Jimma University Medical center based on the Extended Parallel Process Model. Design A facility-based cross-sectional study was conducted. Setting Jimma University Medical Center is found in Jimma town. Participants A total of 343 patients with diabetes participated in the study; making a response rate of 93.9%. All patients with diabetes who were 18 years and above and who were on follow up and registered were included in the study and those with Gestational DM were excluded. Data analysis Multivariable logistic regression analysis. Result Responsive respondents scored high in self-care practice score as compared to other respondents. educational status, information sources, knowledge, and preferred message appeals were independent predictors of controlling the danger of diabetes. Conclusion There is a significant gap in controlling the danger of diabetes. Variables like the level of education, knowledge of diabetes mellitus, information sources, and message appeals were independent predictors of controlling the danger of diabetes. Designing message having higher efficacy while maintaining the level of threat is the best that fits the existing audience's message processing to bring about desired diabetic self-care Practice.	[Abawari, Mohammed Jemal; Amdisa, Demuma; Birhanu, Zewdie; Kebede, Yohannes] Jimma Univ, Fac Publ Hlth, Dept Hlth Behav & Soc, Jimma, Ethiopia	Jimma University	Abawari, MJ (corresponding author), Jimma Univ, Fac Publ Hlth, Dept Hlth Behav & Soc, Jimma, Ethiopia.	Mahirmohammed159@gmail.com		Kebede, Yohannes/0000-0003-3142-5266				Abate Teshager Weldegiorgis, 2018, BMC Res Notes, V11, P800, DOI 10.1186/s13104-018-3874-8; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; America Diabetes Association, 2019, IDF DIAB ATL 2019, pS15; [Anonymous], 2015, INT J CURR RES ACAD; [Anonymous], 2014, WORLD J MED MED SCI, DOI DOI 10.21203/RS.3.RS-104748/V1; Aschalew AY, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4630-4; Ayele K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035515; CACIOPPO JT, 1989, BASIC APPL SOC PSYCH, V10, P3, DOI 10.1207/s15324834basp1001_2; Chali Segni Wanna, 2018, BMC Res Notes, V11, P833, DOI 10.1186/s13104-018-3939-8; Dillard J., 1994, COMMUN MONOGR, V61; Gebre MW, 2013, ETHIOP J HEALTH DEV, V27, P249; Gould Gillian Sandra, 2015, Prev Med Rep, V2, P4, DOI 10.1016/j.pmedr.2014.10.004; Gould GS., 2017, EXPLORING ADAPTED RI, P1; Gurmu Y, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3448-4; Heisler M, 2009, AM J PREV MED, V37, pS270, DOI 10.1016/j.amepre.2009.08.016; Kilberenge W., 2010, PAN AFR MED J, V8688, P1; Lael-Monfared E, 2019, DIABETES METAB SYND, V13, P1535, DOI 10.1016/j.dsx.2019.03.008; Lanting LC, 2008, PATIENT EDUC COUNS, V72, P146, DOI 10.1016/j.pec.2008.03.008; Li R, 2014, Int J Nurs Sci, V1, P266, DOI 10.1016/j.ijnss.2014.05.023; McKay DL, 2004, HEALTH EDUC BEHAV, V31, P355, DOI 10.1177/1090198104263353; Popova L, 2012, HEALTH EDUC BEHAV, V39, P455, DOI 10.1177/1090198111418108; Roberto AJ, 2009, J HEALTH COMMUN, V14, P400, DOI 10.1080/10810730902873935; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Tesfaye T, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0150-6; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; WHO Global Report, 2016, GLOBAL REPORT DIABET, V978; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; Witte K, 1998, HEALTH EDUC BEHAV, V25, P571, DOI 10.1177/109019819802500505; Witte K, 2001, EFFECTIVE HLTH RISK; WRIGHT P, 1980, J CONSUM RES, V7, P151, DOI 10.1086/208804; Yemane T., 2007, ETHIOP J HEALTH SCI, V17, P107	33	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261836	10.1371/journal.pone.0261836	http://dx.doi.org/10.1371/journal.pone.0261836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972154	gold, Green Published			2022-12-26	WOS:000773555700059
J	Dent, SE; King, DP; Osterberg, VR; Adams, EK; Mackiewicz, MR; Weissman, TA; Unni, VK				Dent, Sydney E.; King, Dennisha P.; Osterberg, Valerie R.; Adams, Eleanor K.; Mackiewicz, Marilyn R.; Weissman, Tamily A.; Unni, Vivek K.			Phosphorylation of the aggregate-forming protein alpha-synuclein on serine-129 inhibits its DNA-bending properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; MALIGNANT-MELANOMA; NUCLEAR-LOCALIZATION; SELECTIVE BINDING; MUTATION; CANCER; DYNAMICS; SER-129; RELEASE; MODELS	Alpha-synuclein (aSyn) is a vertebrate protein, normally found within the presynaptic nerve terminal and nucleus, which is known to form somatic and neuritic aggregates in certain neurodegenerative diseases. Disease-associated aggre-gates of aSyn are heavily phosphorylated at serine-129 (pSyn), while normal aSyn protein is not. Within the nucleus, aSyn can directly bind DNA, but the mechanism of binding and the potential modulatory roles of phosphorylation are poorly un-derstood. Here we demonstrate using a combination of elec-trophoretic mobility shift assay and atomic force microscopy approaches that both aSyn and pSyn can bind DNA within the major groove, in a DNA length-dependent manner and with little specificity for DNA sequence. Our data are consistent with a model in which multiple aSyn molecules bind a single 300 base pair (bp) DNA molecule in such a way that stabilizes the DNA in a bent conformation. We propose that serine-129 phosphorylation decreases the ability of aSyn to both bind and bend DNA, as aSyn binds 304 bp circular DNA forced into a bent shape, but pSyn does not. Two aSyn paralogs, beta-and gamma-synuclein, also interact with DNA differently than aSyn, and do not stabilize similar DNA conformations. Our work suggests that reductions in aSyn's ability to bind and bend DNA induced by serine-129 phosphorylation may be important for modulating aSyn's known roles in DNA metabolism, including the regulation of transcription and DNA repair.	[Dent, Sydney E.; King, Dennisha P.; Osterberg, Valerie R.; Unni, Vivek K.] Oregon Hlth & Sci Univ, Dept Neurol, Jungers Ctr Neurosci Res, Portland, OR 97201 USA; [Adams, Eleanor K.; Mackiewicz, Marilyn R.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Weissman, Tamily A.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA; [Unni, Vivek K.] Oregon Hlth & Sci Univ, OHSU Parkinson Ctr, Portland, OR 97201 USA; [King, Dennisha P.] Univ Rochester, Neurosci Grad Program, Rochester, NY 14642 USA; [Adams, Eleanor K.] Univ Calif Davis Hlth, Sch Med, Sacramento, CA 95187 USA; [Mackiewicz, Marilyn R.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Oregon Health & Science University; Portland State University; Oregon Health & Science University; University of Rochester; Oregon State University	Unni, VK (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Jungers Ctr Neurosci Res, Portland, OR 97201 USA.; Unni, VK (corresponding author), Oregon Hlth & Sci Univ, OHSU Parkinson Ctr, Portland, OR 97201 USA.	unni@ohsu.edu		Weissman, Tamily/0000-0001-9361-6071; Mackiewicz, Marilyn/0000-0002-5669-8714	NIH [NS102227, NS096190]; David Johnson Family Foundation; Oregon Tax Checkoff Alzheimer's Research Fund; American Parkinson Disease Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Johnson Family Foundation; Oregon Tax Checkoff Alzheimer's Research Fund; American Parkinson Disease Association	Electron microscopy was performed at the Multiscale Microscopy Core (MMC) with the technical assistance of Dr Claudia Lopez. The MMC is a member of the OHSU University Shared Resource Cores. We would like to thank Nicole Owen and Irina Minko for technical assistance and helpful discussions, Amanda McCullough, R. Stephen Lloyd, Allison Schaser, Sydney Boutros, Teresa Stackhouse, Jon Savage, Ujwal Shinde, and Randall Woltjer for helpful discussions. Figure 8, A and B, Figs. S6 and S7 created with the PyMOL Molecular Graphics System, Version 2.0 Schrodinger, LLC. Figure 8C was created with BioRender.com . This work was supported in part by the NIH (grants NS102227, NS096190) , the David Johnson Family Foundation, the Oregon Tax Checkoff Alzheimer's Research Fund, and the American Parkinson Disease Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Baba M, 1998, AM J PATHOL, V152, P879; Bajaj A, 2010, CANCER CAUSE CONTROL, V21, P697, DOI 10.1007/s10552-009-9497-6; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Beach TG, 2008, ACTA NEUROPATHOL, V116, P277, DOI 10.1007/s00401-008-0409-8; Biebricher AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8304; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chung CY, 2017, CELL SYST, V4, P242, DOI 10.1016/j.cels.2017.01.002; Constantinescu R, 2014, MOVEMENT DISORD, V29, P263, DOI 10.1002/mds.25734; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Desplats P, 2012, J BIOL CHEM, V287, P31691, DOI 10.1074/jbc.M112.354522; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; DOSHI P, 1991, MOL BIOL EVOL, V8, P721; Elfarrash S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252635; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fiske M, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/392180; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Goers J, 2003, BIOCHEMISTRY-US, V42, P8465, DOI 10.1021/bi0341152; Goncalves S, 2013, MOL NEUROBIOL, V47, P1081, DOI 10.1007/s12035-013-8406-x; Hegde ML, 2003, ARCH BIOCHEM BIOPHYS, V418, P169, DOI 10.1016/j.abb.2003.08.015; Hegde ML, 2007, ARCH BIOCHEM BIOPHYS, V464, P57, DOI 10.1016/j.abb.2007.03.042; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jiang K, 2021, BIOCHEM BIOPH RES CO, V568, P43, DOI 10.1016/j.bbrc.2021.06.059; Jiang K, 2018, CHEM-EUR J, V24, P15685, DOI 10.1002/chem.201803933; Kareus SA, 2012, ARCH NEUROL-CHICAGO, V69, P1572, DOI 10.1001/archneurol.2012.2261; Khurana V, 2017, CELL SYST, V4, P157, DOI 10.1016/j.cels.2016.12.011; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim S, 2014, EXP NEUROL, V252, P63, DOI 10.1016/j.expneurol.2013.11.009; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee BR, 2013, J CELL SCI, V126, P696, DOI 10.1242/jcs.122093; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Ma KL, 2014, NEUROPHARMACOLOGY, V82, P132, DOI 10.1016/j.neuropharm.2013.07.035; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; Medeiros J, 2021, BIOMOL NMR ASSIGN, V15, P297, DOI 10.1007/s12104-021-10020-z; Mukherjee SK, 2021, RSC CHEM BIOL, V2, P1196, DOI 10.1039/d1cb00108f; Mukherjee SK, 2020, CHEM-EUR J, V26, P10987, DOI 10.1002/chem.202002119; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Olsen JH, 2006, EPIDEMIOLOGY, V17, P582, DOI 10.1097/01.ede.0000229445.90471.5e; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Pinho R, 2019, HUM MOL GENET, V28, P31, DOI 10.1093/hmg/ddy326; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Popova B, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009407; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Rugbjerg K, 2012, INT J CANCER, V131, P1904, DOI 10.1002/ijc.27443; Samuel F, 2016, J BIOL CHEM, V291, P4374, DOI 10.1074/jbc.M115.705095; Schaser AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47227-z; Schechter M, 2020, J BIOL CHEM, V295, P18076, DOI 10.1074/jbc.RA120.015319; Schell H, 2009, NEUROSCIENCE, V160, P796, DOI 10.1016/j.neuroscience.2009.03.002; Siddiqui A, 2012, FREE RADICAL BIO MED, V53, P993, DOI 10.1016/j.freeradbiomed.2012.05.024; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stellwagen NC, 2009, J CHROMATOGR A, V1216, P1917, DOI 10.1016/j.chroma.2008.11.090; Tawar U, 2003, BIOCHEMISTRY-US, V42, P13339, DOI 10.1021/bi034425k; Thibault T, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1034; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Vargas KJ, 2014, J NEUROSCI, V34, P9364, DOI 10.1523/JNEUROSCI.4787-13.2014; Vasquez V, 2017, J ALZHEIMERS DIS, V60, pS133, DOI 10.3233/JAD-170342; Vasudevaraju P, 2012, J PHARM BIOALLIED SC, V4, P112, DOI 10.4103/0975-7406.94811; Viennet T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0049-z; Wang LN, 2014, CURR BIOL, V24, P2319, DOI 10.1016/j.cub.2014.08.027; Welinder C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110804; Weston LJ, 2021, NEUROBIOL DIS, V152, DOI 10.1016/j.nbd.2021.105291; Weston LJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100273; Ye Q, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00060; Yu S, 2007, NEUROSCIENCE, V145, P539, DOI 10.1016/j.neuroscience.2006.12.028; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	75	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101552	10.1016/j.jbc.2021.101552	http://dx.doi.org/10.1016/j.jbc.2021.101552			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1QM	34973339	gold, Green Published			2022-12-26	WOS:000761402800010
J	Kljakic, O; Janickova, H; Skirzewski, M; Reichelt, A; Memar, S; El Mestikawy, S; Li, YL; Saksida, LM; Bussey, TJ; Prado, VF; Prado, MAM				Kljakic, Ornela; Janickova, Helena; Skirzewski, Miguel; Reichelt, Amy; Memar, Sara; El Mestikawy, Salah; Li, Yulong; Saksida, Lisa M.; Bussey, Timothy J.; Prado, Vania F.; Prado, Marco A. M.			Functional dissociation of behavioral effects from acetylcholine and glutamate released from cholinergic striatal interneurons	FASEB JOURNAL			English	Article						acetylcholine; dopamine; glutamate; striatum	BASAL GANGLIA; TRANSPORTER VGLUT3; DOPAMINE RELEASE; MICE DEFICIENT; ATTENTION; NEURONS; REWARD; MODEL; ABNORMALITIES; ACTIVATION	In the striatum, cholinergic interneurons (CINs) have the ability to release both acetylcholine and glutamate, due to the expression of the vesicular acetylcholine transporter (VAChT) and the vesicular glutamate transporter 3 (VGLUT3). However, the relationship these neurotransmitters have in the regulation of behavior is not fully understood. Here we used reward-based touchscreen tests in mice to assess the individual and combined contributions of acetylcholine/glutamate co-transmission in behavior. We found that reduced levels of the VAChT from CINs negatively impacted dopamine signalling in response to reward, and disrupted complex responses in a sequential chain of events. In contrast, diminished VGLUT3 levels had somewhat opposite effects. When mutant mice were treated with haloperidol in a cue-based task, the drug did not affect the performance of VAChT mutant mice, whereas VGLUT3 mutant mice were highly sensitive to haloperidol. In mice where both vesicular transporters were deleted from CINs, we observed altered reward-evoked dopaminergic signalling and behavioral deficits that resemble, but were worse, than those in mice with specific loss of VAChT alone. These results demonstrate that the ability to secrete two different neurotransmitters allows CINs to exert complex modulation of a wide range of behaviors.	[Kljakic, Ornela; Janickova, Helena; Skirzewski, Miguel; Reichelt, Amy; Memar, Sara; Saksida, Lisa M.; Bussey, Timothy J.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Translat Neurosci Grp, 1151 Richmond St North, London, ON N6A 5B7, Canada; [Kljakic, Ornela; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Skirzewski, Miguel; Memar, Sara; Saksida, Lisa M.; Bussey, Timothy J.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Reichelt, Amy; Saksida, Lisa M.; Bussey, Timothy J.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada; [El Mestikawy, Salah] McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [El Mestikawy, Salah] Sorbonne Univ, Neurosci Paris Seine Inst Biol Paris Seine NPS IB, CNRS, INSERM, Paris, France; [Li, Yulong] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing, Peoples R China	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Peking University	Prado, VF; Prado, MAM (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Translat Neurosci Grp, 1151 Richmond St North, London, ON N6A 5B7, Canada.	vprado@robarts.ca; mprado@robarts.ca	Janickova, Helena/Q-7211-2017	Janickova, Helena/0000-0003-0310-7893; Skirzewski, Miguel/0000-0002-0980-0878	Ontario Graduate Scholarship; Jonathan and Joshua Graduate Scholarship; Fondation Brain Canada (Brain Canada); Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [MOP 126000, MOP 136930, MOP 89919, PJT 162431, PJT 159781]; Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC) [402524-2013 RGPIN, 03592-2021 RGPIN]; Weston Brain Institute; Canada First Research Excellence Fund (CFREF)	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Jonathan and Joshua Graduate Scholarship; Fondation Brain Canada (Brain Canada); Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Weston Brain Institute; Canada First Research Excellence Fund (CFREF)	Ontario Graduate Scholarship; Jonathan and Joshua Graduate Scholarship; Fondation Brain Canada (Brain Canada); Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP 126000, MOP 136930, MOP 89919, PJT 162431 and PJT 159781; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: 402524-2013 RGPIN and 03592-2021 RGPIN; Weston Brain Institute; Canada First Research Excellence Fund CFREF)	Abudukeyoumu N, 2019, EUR J NEUROSCI, V49, P604, DOI 10.1111/ejn.13949; Aguilar JI, 2017, NEURON, V95, P1074, DOI 10.1016/j.neuron.2017.07.038; Al-Onaizi MA, 2017, CEREB CORTEX, V27, P1615, DOI 10.1093/cercor/bhv349; Aoki S, 2015, J NEUROSCI, V35, P9424, DOI 10.1523/JNEUROSCI.0490-15.2015; AYLWARD EH, 1994, AM J PSYCHIAT, V151, P687; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Beraldo FH, 2015, DIS MODEL MECH, V8, P1457, DOI 10.1242/dmm.022525; BERNARD V, 1992, J NEUROSCI, V12, P3591; Brunelin J, 2013, CURR MED CHEM, V20, P397; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Dautan D, 2014, J NEUROSCI, V34, P4509, DOI 10.1523/JNEUROSCI.5071-13.2014; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; Divito CB, 2015, J NEUROSCI, V35, P14983, DOI 10.1523/JNEUROSCI.2124-15.2015; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Fasano C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00140; Favier M, 2020, J CLIN INVEST, V130, P6616, DOI 10.1172/JCI138532; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Gangarossa G, 2016, NEUROBIOL DIS, V87, P69, DOI 10.1016/j.nbd.2015.12.010; GERFEN CR, 1988, J ELECTRON MICR TECH, V10, P265, DOI 10.1002/jemt.1060100305; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gonzales KK, 2015, ANN NY ACAD SCI, V1349, P1, DOI 10.1111/nyas.12762; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Guzman MS, 2013, J NEUROCHEM, V124, P658, DOI 10.1111/jnc.12128; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Heath Christopher J, 2016, Curr Protoc Neurosci, V74, DOI 10.1002/0471142301.ns0834s74; Helseth AR, 2021, SCIENCE, V372, P361, DOI 10.1126/science.abe1931; Higley MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019155; Janickova Helena, 2021, Curr Protoc, V1, pe268, DOI 10.1002/cpz1.268; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Joviano-Santos JV, 2021, FEBS J, V288, P5331, DOI 10.1111/febs.15825; Karcher NR, 2019, BIOL PSYCHIAT-COGN N, V4, P956, DOI 10.1016/j.bpsc.2019.05.017; Keeler JF, 2014, NEUROSCIENCE, V282, P156, DOI 10.1016/j.neuroscience.2014.07.021; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kharkwal G, 2016, NEURON, V91, P67, DOI 10.1016/j.neuron.2016.06.014; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kljakic O, 2017, J NEUROCHEM, V142, P90, DOI 10.1111/jnc.14003; Kolisnyk B, 2015, BRIT J PHARMACOL, V172, P4919, DOI 10.1111/bph.13260; Kolisnyk B, 2013, J NEUROSCI, V33, P14908, DOI 10.1523/JNEUROSCI.1933-13.2013; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; KOOB GF, 1992, ANN NY ACAD SCI, V654, P171, DOI 10.1111/j.1749-6632.1992.tb25966.x; Lebouc M, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105076; Lim Sean Austin O, 2014, Front Synaptic Neurosci, V6, P22, DOI 10.3389/fnsyn.2014.00022; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Martins-Silva C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017611; Martos YV, 2017, J NEUROSCI, V37, P2849, DOI 10.1523/JNEUROSCI.3460-16.2017; Nelson AB, 2014, J NEUROSCI, V34, P8772, DOI 10.1523/JNEUROSCI.0901-14.2014; Nithianantharajah J, 2013, NEUROBIOL LEARN MEM, V105, P13, DOI 10.1016/j.nlm.2013.06.006; Palmer D, 2016, BEHAV BRAIN RES, V311, P267, DOI 10.1016/j.bbr.2016.05.050; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Prado VF, 2017, NEUROSCIENCE, V345, P130, DOI 10.1016/j.neuroscience.2016.09.013; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Romberg C, 2013, NEUROBIOL AGING, V34, P731, DOI 10.1016/j.neurobiolaging.2012.08.006; Sakae DY, 2015, MOL PSYCHIATR, V20, P1448, DOI 10.1038/mp.2015.104; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Sherer LM, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008609; Silm K, 2019, NEURON, V102, P786, DOI 10.1016/j.neuron.2019.03.031; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Sun FM, 2020, NAT METHODS, V17, P1156, DOI 10.1038/s41592-020-00981-9; Tecuapetla F, 2016, CELL, V166, P703, DOI 10.1016/j.cell.2016.06.032; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Trudeau LE, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00113; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wassum KM, 2012, BIOL PSYCHIAT, V71, P846, DOI 10.1016/j.biopsych.2011.12.019; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2; Zhai SY, 2018, CURR OPIN NEUROBIOL, V48, P9, DOI 10.1016/j.conb.2017.08.004	76	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2022	36	2							e22135	10.1096/fj.202101425R	http://dx.doi.org/10.1096/fj.202101425R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	YO5NJ	35032355	hybrid, Green Published			2022-12-26	WOS:000747987800046
J	Park, Y; Stukey, GJ; Jog, R; Kwiatek, JM; Han, GS; Carman, GM				Park, Yeonhee; Stukey, Geordan J.; Jog, Ruta; Kwiatek, Joanna M.; Han, Gil-Soo; Carman, George M.			Mutant phosphatidate phosphatase Pah1-W637A exhibits altered phosphorylation, membrane association, and enzyme function in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; LIPID-SYNTHESIS; PHOSPHATIDYLSERINE SYNTHASE; MEDIATED REGULATION; ORTHOLOGUE PAH1P; ACID PHOSPHATASE; GLOBAL ANALYSIS; CROSS-TALK	The Saccharomyces cerevisiae PAH1-encoded phosphatidate (PA) phosphatase, which catalyzes the dephosphorylation of PA to produce diacylglycerol, controls the bifurcation of PA into triacylglycerol synthesis and phospholipid synthesis. Pah1 is inactive in the cytosol as a phosphorylated form and becomes active on the membrane as a dephosphorylated form by the Nem1-Spo7 protein phosphatase. We show that the conserved Trp-637 residue of Pah1, located in the intrinsically disordered region, is required for normal synthesis of membrane phospholipids, sterols, triacylglycerol, and the formation of lipid droplets. Analysis of mutant Pah1-W637A showed that the tryptophan residue is involved in the phosphorylation-mediated/dephosphorylation-mediated membrane association of the enzyme and its catalytic activity. The endogenous phosphorylation of Pah1-W637A was increased at the sites of the N-terminal region but was decreased at the sites of the C-terminal region. The altered phosphorylation correlated with an increase in its membrane association. In addition, membrane-associated PA phosphatase activity in vitro was elevated in cells expressing Pah1-W637A as a result of the increased membrane association of the mutant enzyme. How-ever, the inherent catalytic function of Pah1 was not affected by the W637A mutation. Prediction of Pah1 structure by Alpha-Fold shows that Trp-637 and the catalytic residues Asp-398 and Asp-400 in the haloacid dehalogenase-like domain almost lie in the same plane, suggesting that these residues are important to properly position the enzyme for substrate recognition at the membrane surface. These findings underscore the importance of Trp-637 in Pah1 regulation by phosphorylation, membrane association of the enzyme, and its function in lipid synthesis.	[Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08854 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08854 USA.	gcarman@rutgers.edu		Stukey, Geordan/0000-0003-2562-5130; Kwiatek, Joanna/0000-0001-8934-0922	National Institutes of Health [GM136128]; United States Public Health Service	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported, in whole or in part, by the National Institutes of Health Grant GM136128 from the United States Public Health Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carey J, 2000, METHOD ENZYMOL, V328, P499, DOI 10.1016/S0076-6879(00)28415-2; Carman GM, 2019, J LIPID RES, V60, P2, DOI 10.1194/jlr.S087452; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Corcoles-Saez I, 2016, BBA-MOL CELL BIOL L, V1861, P213, DOI 10.1016/j.bbalip.2015.12.014; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Dey P, 2020, J LIPID RES, V61, P1556, DOI 10.1194/jlr.R120001092; Dey P, 2019, J BIOL CHEM, V294, P15997, DOI 10.1074/jbc.RA119.010592; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dubots E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104194; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Gu WJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24929-5; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hassaninasab A, 2019, J BIOL CHEM, V294, P18256, DOI 10.1074/jbc.RA119.011314; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Khayyo VI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15124-z; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kwiatek JM, 2020, J LIPID RES, V61, P1232, DOI 10.1194/jlr.RA120000937; Kwiatek JM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.03.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanz MC, 2021, EMBO REP, V22, DOI 10.15252/embr.202051121; Li TY, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04363, 10.1038/s41467-018-04363-w]; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1990, J BIOL CHEM, V265, P166; Liu N, 2019, NEW PHYTOL, V223, P412, DOI 10.1111/nph.15748; Lussier M, 1997, GENETICS, V147, P435; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MacGilvray ME, 2020, J PROTEOME RES, V19, P3405, DOI 10.1021/acs.jproteome.0c00253; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Mirheydari M, 2020, J BIOL CHEM, V295, P11473, DOI 10.1074/jbc.RA120.014129; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Papagiannidis D, 2021, EMBO J, V40, DOI 10.15252/embj.2021107958; Park Y, 2017, J BIOL CHEM, V292, P19580, DOI 10.1074/jbc.M117.819375; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Romanauska A, 2018, CELL, V174, P700, DOI 10.1016/j.cell.2018.05.047; Rose MD., 1990, METHODS YEAST GENETI; Ruiz C, 1999, YEAST, V15, P1001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sherr GL, 2017, BIOCHEM BIOPH RES CO, V491, P693, DOI 10.1016/j.bbrc.2017.07.127; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8; Su WM, 2018, J BIOL CHEM, V293, P15801, DOI 10.1074/jbc.RA118.005348; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	117	2	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101578	10.1016/j.jbc.2022.101578	http://dx.doi.org/10.1016/j.jbc.2022.101578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35026226	Green Published, gold			2022-12-26	WOS:000761371500010
J	Bruce, C; Gearing, ME; DeMatteis, J; Levin, K; Mulcahy, T; Newsome, J; Wivagg, J				Bruce, Carol; Gearing, Maeve E.; DeMatteis, Jill; Levin, Kerry; Mulcahy, Timothy; Newsome, Jocelyn; Wivagg, Jonathan			Financial vulnerability and the impact of COVID-19 on American households	PLOS ONE			English	Article								In May 2020, Westat, in partnership with Stanford University School of Medicine, conducted a nationally-representative household survey of American attitudes and behaviors regarding COVID-19. In this article, we examine what the Coronavirus Attitudes and Behaviors Survey tells us about the impact of COVID-19 on financial status and how this impact varies by demographic characteristics, the presence of health risk factors, and financial status (including employment factors). The survey reveals significant inequality in financial impact, as those who were most financially vulnerable prior to the pandemic found themselves under greater financial strain, while those who were more financially secure have experienced a neutral or even positive impact of the pandemic on household finances. These findings have important implications for public policy as policymakers seek to target aid to those who need it most.	[Bruce, Carol; Gearing, Maeve E.; DeMatteis, Jill; Levin, Kerry; Mulcahy, Timothy; Newsome, Jocelyn; Wivagg, Jonathan] Westat Corp, Rockville, MD 20850 USA	Westat	Gearing, ME (corresponding author), Westat Corp, Rockville, MD 20850 USA.	MaeveGearing@westat.com			Westat	Westat	Westat provided funding in the form of salaries for CB, MG, JDM, KL, TM, JN, and JW. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderloni L, 2012, RES ECON, V66, P284, DOI 10.1016/j.rie.2012.03.001; Anderson A., 2020, PREPRINT; [Anonymous], COVID 19 CASE SURVEI; [Anonymous], 2020, REAL DISP PERS INC; Bachas N., 2020, PREPRINT; Baker S. R., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Bartik A. W., 2020, MEASURING LABOR MARK; Bauer L., 2020, 10 FACTS COVID 19 US; Bounie D., 2020, PREPRINT, DOI [10.2139/ssrn.3588373, DOI 10.2139/SSRN.3588373]; Cantor G., 2020, ARE MOST VULNERABLE; Carvalho VM., 2020, PREPRINT; Center on Budget and Policy Priorities (CBPP), 2020, TRACK COVID 19 REC E; Chetty R., 2020, PREPRINT; Coiboin O., 2020, PREPRINT; Despard Mathieu, 2020, COVID 19 JOB INCOME; Ganong P., 2020, PREPRINT; Hoffmann AOI, 2019, J CONSUM AFF, V53, P1630, DOI 10.1111/joca.12233; Lopez MarkHugo., 2020, FINANCIAL HLTH IMPAC, V5, P2020; National Foundation for Credit Counseling (NFCC), 2020, IMM FIN IMP COVID 19; Neel J., 2020, NPR; Pew Research Center, 2012, YOUNG AM READ LIB HA; Ricketts LR., 2020, WHICH FAMILIES ARE M	22	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262301	10.1371/journal.pone.0262301	http://dx.doi.org/10.1371/journal.pone.0262301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030175	Green Published, gold			2022-12-26	WOS:000812798500036
J	Worku, W; Desta, M; Menjetta, T				Worku, Woyinshet; Desta, Moges; Menjetta, Tadesse			High prevalence and antimicrobial susceptibility pattern of salmonella species and extended-spectrum beta-lactamase producing Escherichia coli from raw cattle meat at butcher houses in Hawassa city, Sidama regional state, Ethiopia	PLOS ONE			English	Article							RESISTANCE; SHOPS	Background Food-borne diseases related to the consumption of meat and its products had public health importance worldwide. The problem became worst in Ethiopia as the result of the tradition of eating raw cattle meat. Salmonella species and Escherichia coli are important food-borne pathogens associated with meat contamination. Hence the current study aimed to assess the prevalence and antimicrobial susceptibility of Salmonella species and Extended-spectrum beta-lactamase producing Escherichia coli from raw cattle meat at butcher houses in Hawassa city, Sidama regional state, Ethiopia. Method A cross-sectional study was done on the prevalence and antimicrobial susceptibility pattern of Salmonella species and Extended-spectrum beta-lactamase producing E.coli from raw cattle meat at butcher houses in Hawassa city from September to December 2020. Socio-demographic data were collected using a structured questionnaire and raw cattle meat and swab samples were collected from meat cutting equipment. The collected samples transported using icebox to Hawassa University College of Medicine and Health Sciences Microbiology Laboratory for identification. Samples were grown on different culture media and antimicrobial susceptibility tests were determined by using Kirby disc diffusion method. Data were entered and analyzed into SPSS version 23. Descriptive statistics were done and P-value < 0.05 was considered as statistically significant. Result The overall prevalence of salmonella and ESBL producing E.coli among 556 samples collected from 278 butcher houses was 36 (6.47%) (95% CI: 1.68-1.79) of which 13 (2.3%) were ESBL producing E.coli and 23(4.1%) were salmonella species. Poor hand washing practice (AOR = 2.208; 95% CI: 1.249-3.904) and touching birr while selling meat (AOR = 0.75; 95% CI: (0.433-1.299) were found to be significantly associated with the prevalence of salmonella species and E.coli on cattle meat. The isolates showed moderate levels of resistance (60-70%) against Amoxicillin/ clavulanic acid and high susceptibility (85-100%) against gentamicin, cotrimoxazole, ceftazidime, and tetracycline and the overall multidrug resistance was 33.3%. Conclusion This study revealed moderately high prevalence of salmonella and E.coli due to poor hygiene and sanitation practices in the butcher shops. Furthermore, the existence of ESBL producing E.coli isolates clearly indicate the possible threat to public health. Therefore, inspection by the right agencies must be implemented in order to prevent food-borne outbreaks and antimicrobial resistance.	[Worku, Woyinshet] Hawassa Coll Hlth Sci, Dept Med Lab Sci, Hawassa, Ethiopia; [Desta, Moges; Menjetta, Tadesse] Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia	Hawassa University	Menjetta, T (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia.	tademen2000@yahoo.com						Abayneh M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4554-6; Abebe E, 2020, J TROP MED-US, V2020, DOI 10.1155/2020/4674235; Algammal AM, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02287-y; Algammal AM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88861-w; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75914-9; Algammal AM, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01037-z; Bantawa, 2019, BMC RES NOTES, P12, DOI [10.1186/s13104-019-4050-5, DOI 10.1186/S13104-019-4050-5]; CLIS, 2014, SUMM MIN CLSI ANT SU, P34; CLSI, 2017, PERFORMANCE STANDARD; CLSI Clinical and Laboratory Standards Institute (CLSI), 2018, PERFORMANCE STANDARD, V28th, DOI DOI 10.1888/0333750888/6100; Cook A, 2009, J FOOD PROTECT, V72, P473, DOI 10.4315/0362-028X-72.3.473; Effendi M.H., 2020, INDIAN J PUBLIC HLTH, P11; Ekli R, 2019, IOP C SER EARTH ENV, V287, DOI 10.1088/1755-1315/287/1/012006; El Shamy HA, 2008, J EGYPT PUBLIC HEAL, V83, P133; Gebremedhin EZ, 2021, INT J MICROBIOL, V2021, DOI 10.1155/2021/6626373; Gutema FD, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052729; Jaffee S., 2018, WHO GLOBAL ESTIMATES; Jajere SM, 2019, VET WORLD, V12, P504, DOI 10.14202/vetworld.2019.504-521; Ketema L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9794869; Kim YJ, 2018, FOOD RES INT, V107, P158, DOI 10.1016/j.foodres.2017.12.023; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Makharita RR, 2020, INFECT DRUG RESIST, V13, P3991, DOI 10.2147/IDR.S276975; Mengistu S., 2017, J VET SCI TECHNOL, V8, P2; Mgaya FX, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10040343; Nagm, 2018, PREVALENCE SALMONELL; Saad, 2018, BENHA VET MED J, V34, P150; Sarowska J, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0290-0; Sebsibe MA, 2020, INFECT DRUG RESIST, V13, P3853, DOI 10.2147/IDR.S277890; Shrestha Anil, 2017, BMC Res Notes, V10, P574, DOI 10.1186/s13104-017-2917-x; Skurnik D, 2016, MOL BIOL EVOL, V33, P898, DOI 10.1093/molbev/msv280; Standardization I. O. F, 2007, AMENDMENT 1 ANNEX D; Tadesse H.A., 2020, PREVALENCE ANTIMICRO; Thung TY, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02697; Tola MA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258117; Zerabruk K, 2019, J FOOD QUALITY, V2019, DOI 10.1155/2019/3902690	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2022	17	1							e0262308	10.1371/journal.pone.0262308	http://dx.doi.org/10.1371/journal.pone.0262308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2F3FM	35030183	gold, Green Published			2022-12-26	WOS:000812798500037
J	Deshmukh, D; Ahmed, MR; Dominic, JA; Zaghloul, MS; Gupta, A; Achari, G; Hassan, QK				Deshmukh, Dhananjay; Ahmed, M. Razu; Dominic, John Albino; Zaghloul, Mohamed S.; Gupta, Anil; Achari, Gopal; Hassan, Quazi K.			Quantifying relations and similarities of the meteorological parameters among the weather stations in the Alberta Oil Sands region	PLOS ONE			English	Article							TEMPERATURE; NETWORK; PREDICTION; VARIABLES; AVERAGE; MODELS	Our objective was to quantify the similarity in the meteorological measurements of 17 stations under three weather networks in the Alberta oil sands region. The networks were for climate monitoring under the water quantity program (WQP) and air program, including Meteorological Towers (MT) and Edge Sites (ES). The meteorological parameters were air temperature (AT), relative humidity (RH), solar radiation (SR), barometric pressure (BP), precipitation (PR), and snow depth (SD). Among the various measures implemented for finding correlations in this study, we found that the use of Pearson's coefficient (r) and absolute average error (AAE) would be sufficient. Also, we applied the percent similarity method upon considering at least 75% of the value in finding the similarity between station pairs. Our results showed that we could optimize the networks by selecting the least number of stations (for each network) to describe the measure-variability in meteorological parameters. We identified that five stations are sufficient for the measurement of AT, one for RH, five for SR, three for BP, seven for PR, and two for SD in the WQP network. For the MT network, six for AT, two for RH, six for SR, and four for PR, and the ES network requires six for AT, three for RH, six for SR, and two for BP. This study could potentially be critical to rationalize/optimize weather networks in the study area.	[Deshmukh, Dhananjay; Ahmed, M. Razu; Dominic, John Albino; Zaghloul, Mohamed S.; Gupta, Anil; Achari, Gopal; Hassan, Quazi K.] Univ Calgary, Schulich Sch Engn, Calgary, AB, Canada; [Gupta, Anil] Univ Res Pk, Alberta Environm & Pk, Resource Stewardship Div, Calgary, AB, Canada	University of Calgary	Hassan, QK (corresponding author), Univ Calgary, Schulich Sch Engn, Calgary, AB, Canada.	qhassan@ucalgary.ca		Ahmed, M. Razu/0000-0002-4771-3353; Hassan, Quazi K./0000-0002-7034-359X	Oil Sands Monitoring (OSM) Program;  [19GRAEM25]	Oil Sands Monitoring (OSM) Program; 	This work was funded under the Oil Sands Monitoring (OSM) Program. It was independent of any position of the OSM Program. The fund was awarded to QKH having an agreement no. 19GRAEM25. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AM, 2022, INT J CLIMATOL, V42, P3253, DOI 10.1002/joc.6911; Alberta Environment and Parks, 2018, ACC FAC ROADS; Alberta Environment and Water, 2012, GROUNDW FLOW MOD ATH; Amorim AMT, 2012, INT J CLIMATOL, V32, P941, DOI 10.1002/joc.2317; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; [Anonymous], 2021, COEFFICIENT DETERMIN; Apogee Instruments, 2020, AFF ACC BAR PRESS SE; Belvederesi C, 2020, WATER-SUI, V12, DOI 10.3390/w12113049; Berndt C, 2018, J HYDROL-REG STUD, V15, P184, DOI 10.1016/j.ejrh.2018.02.002; BURN DH, 1991, J HYDROL, V122, P71, DOI 10.1016/0022-1694(91)90173-F; Colston JM, 2018, ENVIRON RES, V165, P91, DOI 10.1016/j.envres.2018.02.027; Consultants Hatfield., 2016, EDMONTON; DeGaetano AT, 2001, INT J CLIMATOL, V21, P791, DOI 10.1002/joc.645; Dewan A, 2021, APPL GEOGR, V135, DOI 10.1016/j.apgeog.2021.102533; Dewan A, 2021, SUSTAIN CITIES SOC, V71, DOI 10.1016/j.scs.2021.102926; Easterling DR., 1996, ORNLCDIAC87NDP019R3; Golmohammadi G, 2014, HYDROLOGY-BASEL, V1, P20, DOI 10.3390/hydrology1010020; Government of Alberta, 2020, ALB ENV MON SCI PROG; Government of Canada, 2021, 19812010 CLIM NORM A; Guttorp P., 1992, STAT ENV EARTH SCI, P39; Hassan QK, 2013, J PLANT ECOL, V6, P84, DOI 10.1093/jpe/rts010; Hinckley A, 2020, PYRANOMETERS WHAT YO; HUBBARD KG, 1994, AGR FOREST METEOROL, V68, P29, DOI 10.1016/0168-1923(94)90067-1; Hubbard KG., 2015, MICROMETEOROLOGY AGR, V47, P1, DOI [10.2134/agronmonogr47.c1, DOI 10.2134/AGRONMONOGR47.C1]; Janis MJ, 2004, J CLIMATE, V17, P151, DOI 10.1175/1520-0442(2004)017<0151:SDSFML>2.0.CO;2; Li L, 2018, SCI TOTAL ENVIRON, V615, P875, DOI 10.1016/j.scitotenv.2017.10.022; Mishra AK, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-311; Mishra AK, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000243; Montgomery K, 2006, J GEOGR, V105, P133, DOI 10.1080/00221340608978675; Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P1, DOI 10.1007/978-3-642-12541-6; National Snow & Ice Data Center, 2020, SNOW CLIM; Olabanji MF, 2020, PHYS CHEM EARTH, V120, DOI 10.1016/j.pce.2020.102939; Ouarda T, 1996, ONTARIO HYDROMETRIC; Ramesh K, 2015, SAINS MALAYS, V44, P1389; Rathod APS, 2016, 2016 INT C EM TRENDS, V2017, P1, DOI [10.1109/ETCT.2016.7882980, DOI 10.1109/ETCT.2016.7882980]; Ratner B., 2009, J TARGET MEAS ANAL M, V17, P139, DOI [10.1057/jt.2009.5, DOI 10.1057/JT.2009.5]; Schmiedeberg C, 2014, SOC INDIC RES, V117, P387, DOI 10.1007/s11205-013-0350-7; Shawky M, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11232840; Simundic AM, 2013, BIOCHEM MEDICA, V23, P12, DOI 10.11613/BM.2013.003; Smith J., 2007, INTRODUCTION, DOI [10.1017/S0014479708006893, DOI 10.1017/S0014479708006893]; St-Hilaire A, 2003, HYDROL PROCESS, V17, P3561, DOI 10.1002/hyp.1350; Tsintikidis D, 2002, J HYDROL ENG, V7, P175, DOI 10.1061/(ASCE)1084-0699(2002)7:2(175); Veiga VB, 2015, WATER-SUI, V7, P99, DOI 10.3390/w7010099; Vose RS, 2004, J CLIMATE, V17, P2961, DOI 10.1175/1520-0442(2004)017<2961:AMTDSD>2.0.CO;2; Wang LC, 2016, RENEW SUST ENERG REV, V61, P384, DOI 10.1016/j.rser.2016.04.024; West JB, 1996, J APPL PHYSIOL, V81, P1850, DOI 10.1152/jappl.1996.81.4.1850; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Wiston M, 2018, J CLIMATOL WEATHER F, P06, DOI [10.18332/tid/85067, DOI 10.18332/TID/85067]; Wood Buffalo Environmental Association, 2000, WBEA 2000 ANN REP; Wood Buffalo Environmental Association, 2020, WBEA 2019 ANN REP; World Meteorological Organization, 2018, GUID INSTR METH OBS; World Meteorological Organization, 2003, GUID CLIM OBS NETW S; World Meteorological Organization, 2017, MAN GLOB OBS SYST; World Meteorological Organization, 2012, MAN GLOB DAT PROC FO; World Meteorological Organization, 2018, GUID CLIM PRACT; World Meteorological Organization, 2010, GUID MET INSTR METH	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261610	10.1371/journal.pone.0261610	http://dx.doi.org/10.1371/journal.pone.0261610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025901	gold, Green Published			2022-12-26	WOS:000796264200021
J	Roy, P; van Peer, SE; de Witte, MM; Tytgat, GAM; Karim-Kos, HE; van Grotel, M; van de Ven, CP; Mavinkurve-Groothuis, AMC; Merks, JHM; Kuiper, RP; Hol, JA; Janssens, GOR; de Krijger, RR; Jongmans, MCJ; Drost, J; van der Steeg, AFW; Littooij, AS; Wijnen, MHWA; van Tinteren, H; van den Heuvel-Eibrink, MM				Roy, Prakriti; van Peer, Sophie E.; de Witte, Martin M.; Tytgat, Godelieve A. M.; Karim-Kos, Henrike E.; van Grotel, Martine; van de Ven, Cees P.; Mavinkurve-Groothuis, Annelies M. C.; Merks, Johannes H. M.; Kuiper, Roland P.; Hol, Janna A.; Janssens, Geert O. R.; de Krijger, Ronald R.; Jongmans, Marjolijn C. J.; Drost, Jarno; van der Steeg, Alida F. W.; Littooij, Annemieke S.; Wijnen, Marc H. W. A.; van Tinteren, Harm; van den Heuvel-Eibrink, Marry M.			Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year's experience of national centralization	PLOS ONE			English	Article							CLEAR-CELL SARCOMA; MALIGNANT RHABDOID TUMORS; WILMS-TUMOR; PEDIATRIC-ONCOLOGY; INTERNATIONAL-SOCIETY; INTERMEDIATE-RISK; CHILDHOOD-CANCER; SIOP; KIDNEY; SURVIVAL	Around 6% of all childhood malignancies represent renal tumors, of which a majority includes Wilms tumor (WT). Although survival rates have improved over the last decades, specific patients are still at risk for adverse outcome. In the Netherlands, since 2015, pediatric oncology care for renal tumors has been centralized in the Princess Maxima Center for Pediatric Oncology. Here, we describe experiences of the first 5 years of centralized care and explore whether this influences the epidemiological landscape by comparing data with the Netherlands Cancer Registry (NCR). We identified all patients <19 years with a renal mass diagnosed between 01-01-2015 and 31-12-2019 in the Princess Maxima Center. Epidemiology, characteristics and management were analyzed. We identified 164 patients (including 1 patient who refused consent for registration), in our center with a suspicion of a renal tumor. The remaining 163 cases included WT (n = 118)/cystic partially differentiated nephroblastoma (n = 2)/nephrogenic rests only (n = 6) and non-WT (n = 37). In this period, the NCR included 138 children, 1 17-year-old patient was not referred to the Princess Maxima Center. Central radiology review (before starting treatment) was performed in 121/163 patients, and central pathology review in 148/152 patients that underwent surgery. Treatment stratification, according to SIOP/EpSSG protocols was pursued based on multidisciplinary consensus. Preoperative chemotherapy was administered in 133 patients, whereas 19 patients underwent upfront surgery. Surgery was performed in 152 patients, and from 133 biomaterial was stored. Centralization of care for children with renal tumors led to referral of all but 1 new renal tumor cases in the Netherlands, and leads to referral of very rare subtypes not registered in the NCR, that benefit from high quality diagnostics and multidisciplinary decision making. National centralization of care led to enhanced development of molecular diagnostics and other innovation-based treatments for the future.	[Roy, Prakriti; van Peer, Sophie E.; de Witte, Martin M.; Tytgat, Godelieve A. M.; Karim-Kos, Henrike E.; van Grotel, Martine; van de Ven, Cees P.; Mavinkurve-Groothuis, Annelies M. C.; Merks, Johannes H. M.; Kuiper, Roland P.; Hol, Janna A.; Janssens, Geert O. R.; de Krijger, Ronald R.; Jongmans, Marjolijn C. J.; Drost, Jarno; van der Steeg, Alida F. W.; Littooij, Annemieke S.; Wijnen, Marc H. W. A.; van Tinteren, Harm; van den Heuvel-Eibrink, Marry M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Karim-Kos, Henrike E.] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands; [Kuiper, Roland P.; Jongmans, Marjolijn C. J.] Univ Med Ctr Utrecht UMCU, Dept Clin Genet, Utrecht, Netherlands; [Janssens, Geert O. R.] Univ Med Ctr Utrecht UMCU, Dept Radiat Oncol, Utrecht, Netherlands; [de Krijger, Ronald R.] Univ Med Ctr Utrecht UMCU, Dept Pathol, Utrecht, Netherlands; [Drost, Jarno] Oncode Inst, Utrecht, Netherlands; [Littooij, Annemieke S.] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Wilhelmina Childrens Hosp UMCU, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Roy, P (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.	p.roy-2@prinsesmaximacentrum.nl		Tytgat, Lieve/0000-0003-4452-0748; van de ven, Cornelis/0000-0001-8745-0626; Roy, Prakriti/0000-0003-0086-6691	Stichting Kinderen Kankervrij (KiKa), Amstelveen, The Netherlands [278]; Princess Maxima Center foundation	Stichting Kinderen Kankervrij (KiKa), Amstelveen, The Netherlands; Princess Maxima Center foundation	SP is (partly) funded by Stichting Kinderen Kankervrij (KiKa), Amstelveen, The Netherlands with grant number 278 and the Princess Maxima Center foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HU, 2007, LANCET ONCOL, V8, P730, DOI 10.1016/S1470-2045(07)70241-3; Amar AM, 2001, J PEDIAT HEMATOL ONC, V23, P105, DOI 10.1097/00043426-200102000-00007; Aquina CT, 2016, SURGERY, V159, P736, DOI 10.1016/j.surg.2015.09.021; Argani P, 2002, AM J SURG PATHOL, V26, P1553, DOI 10.1097/00000478-200212000-00003; Argani P, 2000, AM J SURG PATHOL, V24, P4, DOI 10.1097/00000478-200001000-00002; Biegel JA, 1999, CANCER RES, V59, P74; Broecker B, 2000, UROL CLIN N AM, V27, P463, DOI 10.1016/S0094-0143(05)70094-X; Bruder E, 2004, AM J SURG PATHOL, V28, P1117, DOI 10.1097/01.pas.0000131558.32412.40; Custers L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21675-6; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Furtwangler R, 2013, EUR J CANCER, V49, P3497, DOI 10.1016/j.ejca.2013.06.036; Gatta G, 2019, EJSO-EUR J SURG ONC, V45, P3, DOI 10.1016/j.ejso.2017.08.018; Geller JI, 2015, CANCER-AM CANCER SOC, V121, P2457, DOI 10.1002/cncr.29368; Gooskens SL, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26437; Gooskens SL, 2014, BRIT J CANCER, V111, P227, DOI 10.1038/bjc.2014.291; Gooskens SLM, 2012, EUR J CANCER, V48, P2219, DOI 10.1016/j.ejca.2012.04.009; Gutierrez JC, 2010, PEDIATR BLOOD CANCER, V55, P621, DOI 10.1002/pbc.22631; Hol JA, 2020, FAM CANCER, V19, P55, DOI 10.1007/s10689-019-00155-3; Hoot AC, 2004, AM J SURG PATHOL, V28, P1485, DOI 10.1097/01.pas.0000141390.14548.34; Janssens GO, 2020, LANCET CHILD ADOLESC, V4, P846, DOI 10.1016/S2352-4642(20)30183-8; JOSHI VV, 1986, ARCH PATHOL LAB MED, V110, P100; Kalapurakal JA, 2013, INT J RADIAT ONCOL, V85, P428, DOI 10.1016/j.ijrobp.2012.04.023; Karlsson J, 2016, GENE CHROMOSOME CANC, V55, P120, DOI 10.1002/gcc.22316; Knops RRG, 2013, ANN ONCOL, V24, P1749, DOI 10.1093/annonc/mds656; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; McDonald K, 2013, CLIN RADIOL, V68, P16, DOI 10.1016/j.crad.2012.05.006; Mul J, 2021, CLIN TRANSL RAD ONCO, V29, P20, DOI 10.1016/j.ctro.2021.04.007; Mul J, 2021, RADIOTHER ONCOL, V159, P249, DOI 10.1016/j.radonc.2021.04.005; Nakata K, 2020, INT J CANCER, V147, P3313, DOI 10.1002/ijc.33147; O'Meara E, 2012, J PATHOL, V227, P72, DOI 10.1002/path.3985; Pasqualini C, 2020, EUR J CANCER, V128, P38, DOI 10.1016/j.ejca.2020.01.001; Pastore G, 2006, EUR J CANCER, V42, P2103, DOI 10.1016/j.ejca.2006.05.010; Pritchard-Jones K, 2015, LANCET, V386, P1156, DOI 10.1016/S0140-6736(14)62395-3; Qureshi SS., 2020, J PEDIATR UROL, V16, pe1; Ray S, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28675; Rousseau-Merck MF, 1999, CANCER RES, V59, P3152; Samim A, 2017, PEDIATR RADIOL, V47, P1751, DOI 10.1007/s00247-017-3946-2; Segers H, 2011, EXPERT REV ANTICANC, V11, P1105, DOI [10.1586/era.11.76, 10.1586/ERA.11.76]; Seibel NL, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27450; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Ueno-Yokohata H, 2015, NAT GENET, V47, P861, DOI 10.1038/ng.3338; Van den Heuvel-Eibrink MM, 2008, PEDIATR BLOOD CANCER, V50, P1130, DOI 10.1002/pbc.21389; van den Heuvel-Eibrink MM, 2017, NAT REV UROL, V14, P743, DOI 10.1038/nrurol.2017.163; van den Heuvel-Eibrink MM, 2011, PEDIATR BLOOD CANCER, V56, P733, DOI 10.1002/pbc.22922; van der Beek JN, 2021, INT J CANCER, V148, P2724, DOI 10.1002/ijc.33476; van der Beek JN, 2020, CANCERS, V12, DOI 10.3390/cancers12071776; van Peer SE, 2021, CANCERS, V13, DOI 10.3390/cancers13050997; Vokuhl C, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26925; Vujanic GM, 2002, MED PEDIATR ONCOL, V38, P79, DOI 10.1002/mpo.1276; Vujanic GM, 2019, NAT REV UROL, V16, P563, DOI 10.1038/s41585-019-0191-5; Vujanic GM, 2018, NAT REV UROL, V15, P693, DOI 10.1038/s41585-018-0100-3; Vujanic GM, 2009, CANCER-AM CANCER SOC, V115, P1977, DOI 10.1002/cncr.24214; Wagner L, 2002, J PEDIAT HEMATOL ONC, V24, P385, DOI 10.1097/00043426-200206000-00012	53	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2022	17	1							e0261729	10.1371/journal.pone.0261729	http://dx.doi.org/10.1371/journal.pone.0261729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H0VF	35025887	gold, Green Published			2022-12-26	WOS:000796264200025
J	Chen, TH; Lucock, M				Chen, Tianhua; Lucock, Mike			The mental health of university students during the COVID-19 pandemic: An online survey in the UK	PLOS ONE			English	Article							DEPRESSION	Higher education students' mental health has been a growing concern in recent years even before the COVID-19 pandemic. The stresses and restrictions associated with the pandemic have put university students at greater risk of developing mental health issues, which may significantly impair their academic success, social interactions and their future career and personal opportunities. This paper aimed to understand the mental health status of University students at an early stage in the pandemic and to investigate factors associated with higher levels of distress. An online survey including demographics, lifestyle/living situations, brief mental well-being history, questions relating to COVID-19 and standardised measures of depression, anxiety, resilience and quality of life was completed by 1173 students at one University in the North of England. We found high levels of anxiety and depression, with more than 50% experiencing levels above the clinical cut offs, and females scoring significantly higher than males. The survey also suggested relatively low levels of resilience which we attribute to restrictions and isolation which reduced the opportunities to engage in helpful coping strategies and activities rather than enduring personality characteristics. Higher levels of distress were associated with lower levels of exercising, higher levels of tobacco use, and a number of life events associated with the pandemic and lockdown, such as cancelled events, worsening in personal relationships and financial concerns. We discuss the importance of longer-term monitoring and mental health support for university students.	[Chen, Tianhua] Univ Huddersfield, Sch Comp & Engn, Dept Comp Sci, Huddersfield, W Yorkshire, England; [Lucock, Mike] Univ Huddersfield, Ctr Appl Res Hlth, Sch Human & Hlth Sci, Huddersfield, W Yorkshire, England	University of Huddersfield; University of Huddersfield	Chen, TH (corresponding author), Univ Huddersfield, Sch Comp & Engn, Dept Comp Sci, Huddersfield, W Yorkshire, England.	T.Chen@hud.ac.uk		Chen, Tianhua/0000-0003-4495-1871				[Anonymous], HLTH MATTERS SMOKING; [Anonymous], 2020, CORONAVIRUS STUDENTS; [Anonymous], 2009, DEPR AD REC MAN CLIN; Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208438; Chaudhary Amar Prashad, 2021, JMIRx Med, V2, pe28158, DOI 10.2196/28158; Evans S, 2021, PSYCHIAT RES, V298, DOI 10.1016/j.psychres.2021.113819; Harper DJ, 2022, J CONSTR PSYCHOL, V35, P1, DOI 10.1080/10720537.2020.1773362; Henderson M., 2020, MENTAL HLTH LOCKDOWN; Hewitt R., STUDENTS VIEWS IMPAC; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hubble S., 2020, SUPPORT STUDENTS MEN; Johnstone L., IN PRESS, DOI [10.1177/0022167818793289, DOI 10.1177/0022167818793289]; Kecojevic A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239696; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; McManus S., 2016, MENTAL HLTH WELLBEIN; Rapanta C., 2020, POSTDIGITAL SCI EDUC, V2, P923, DOI [10.1007/s42438-020-00155-y, DOI 10.1007/S42438-020-00155-Y]; Saunders R, 2021, PSYCHOL MED, DOI 10.1017/S0033291721000957; Shah SGS, 2020, J MED INTERNET RES, V22, DOI 10.2196/22287; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sun Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249308; Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Tinsley B., 2020, CORONAVIRUS IMPACT S; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Zhang Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103722	30	31	32	17	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262562	10.1371/journal.pone.0262562	http://dx.doi.org/10.1371/journal.pone.0262562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020758	gold, Green Published			2022-12-26	WOS:000834207700051
J	Shiraishi, T; Tominaga, T; Nonaka, T; Hashimoto, S; Hamada, K; Araki, M; Sumida, Y; Takeshita, H; Fukuoka, H; Wada, H; To, K; Yamashita, M; Tanaka, K; Sawai, T; Nagayasu, T				Shiraishi, Toshio; Tominaga, Tetsuro; Nonaka, Takashi; Hashimoto, Shintaro; Hamada, Kiyoaki; Araki, Masato; Sumida, Yorihisa; Takeshita, Hiroaki; Fukuoka, Hidetoshi; Wada, Hideo; To, Kazuo; Yamashita, Mariko; Tanaka, Kenji; Sawai, Terumitsu; Nagayasu, Takeshi			Effect of hemodialysis on short-term outcomes after colon cancer surgery	PLOS ONE			English	Article							LAPAROSCOPIC SURGERY; COLORECTAL-CANCER; COMPLICATIONS; DIALYSIS; RISK	Background Hemodialysis patients who undergo surgery have a high risk of postoperative complications. The aim of this study was to determine whether colon cancer surgery can be safely performed in hemodialysis patients. Methods This multicenter retrospective study included 1372 patients who underwent elective curative resection surgery for colon cancer between April 2016 and March 2020. Results Of the total patients, 19 (1.4%) underwent hemodialysis, of whom 19 (100%) had poor performance status and 18 had comorbidities (94.7%). Minimally invasive surgery was performed in 78.9% of hemodialysis patients. The postoperative complication rate was significantly higher in hemodialysis than non-hemodialysis patients (36.8% vs. 15.5%, p = 0.009). All postoperative complications in the hemodialysis patients were infectious type. Multivariate analysis revealed a significant association of hemodialysis with complications (odds ratio, 2.9362; 95%CI, 1.1384-7.5730; p = 0.026). Conclusion Despite recent advances in perioperative management and minimally invasive surgery, it is necessary to be aware that short-term complications can still occur, especially infectious complications in hemodialysis patients.	[Shiraishi, Toshio; Tominaga, Tetsuro; Nonaka, Takashi; Sawai, Terumitsu; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki, Japan; [Shiraishi, Toshio] Sasebo Chuo Hosp, Dept Surg, Sasebo, Nagasaki, Japan; [Hashimoto, Shintaro; Hamada, Kiyoaki; Araki, Masato; Sumida, Yorihisa] Sasebo City Gen Hosp, Dept Surg, Sasebo, Nagasaki, Japan; [Takeshita, Hiroaki] Natl Hosp Org, Dept Surg, Nagasaki Med Ctr, Nagasaki, Japan; [Fukuoka, Hidetoshi] Isahaya Gen Hosp, Dept Surg, Nagasaki, Japan; [Wada, Hideo; To, Kazuo] Ureshino Med Ctr, Dept Surg, Ureshino, Saga, Japan; [Yamashita, Mariko; Tanaka, Kenji] Saiseikai Nagasaki Hosp, Dept Surg, Nagasaki, Japan	Nagasaki University	Tominaga, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki, Japan.	tetsuro.tominaga@nagasaki-u.ac.jp						Abe H, 2014, SURG TODAY, V44, P1906, DOI 10.1007/s00595-013-0828-6; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buia Alexander, 2015, World J Methodol, V5, P238, DOI 10.5662/wjm.v5.i4.238; Cherng YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058942; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Gajdos C, 2013, JAMA SURG, V148, P137, DOI 10.1001/2013.jamasurg.347; HAIMOV M, 1974, ANN SURG, V179, P863, DOI 10.1097/00000658-197406000-00008; Hu WH, 2015, INT J COLORECTAL DIS, V30, P1557, DOI 10.1007/s00384-015-2347-y; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; KHAN IH, 1993, KIDNEY INT, V43, pS143; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Obara N, 2021, ANTICANCER RES, V41, P993, DOI 10.21873/anticanres.14853; Palamuthusingam D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234402; Pierson DJ, 2006, RESP CARE, V51, P413; Queeley GL, 2018, AM HEALTH DRUG BENEF, V11, P118; Ris F, 2018, BRIT J SURG, V105, P1359, DOI 10.1002/bjs.10844; Rodrigues M, 2019, PHYSIOL REV, V99, P665, DOI 10.1152/physrev.00067.2017; Sciuto A, 2018, WORLD J GASTROENTERO, V24, P2247, DOI 10.3748/wjg.v24.i21.2247; VANHOLDER R, 1992, KIDNEY INT, V42, pS91	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2022	17	1							e0262531	10.1371/journal.pone.0262531	http://dx.doi.org/10.1371/journal.pone.0262531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K6TH	35020769	gold, Green Published			2022-12-26	WOS:000834207700049
J	Ramirez, A; Peyvandi, S; Cox, S; Gano, D; Xu, D; Tymofiyeva, O; McQuillen, PS				Ramirez, Alice; Peyvandi, Shabnam; Cox, Stephany; Gano, Dawn; Xu, Duan; Tymofiyeva, Olga; McQuillen, Patrick S.			Neonatal brain injury influences structural connectivity and childhood functional outcomes	PLOS ONE			English	Article							SUPERIOR LONGITUDINAL FASCICULUS; CONGENITAL HEART-DISEASE; NEURODEVELOPMENTAL OUTCOMES; THERAPEUTIC HYPOTHERMIA; CHILDREN; ADOLESCENTS; MICROSTRUCTURE; TRANSPOSITION; SEGMENTATION; OPTIMIZATION	Neonatal brain injury may impact brain development and lead to lifelong functional impairments. Hypoxic-ischemic encephalopathy (HIE) and congenital heart disease (CHD) are two common causes of neonatal brain injury differing in timing and mechanism. Maturation of whole-brain neural networks can be quantified during development using diffusion magnetic resonance imaging (dMRI) in combination with graph theory metrics. DMRI of 35 subjects with CHD and 62 subjects with HIE were compared to understand differences in the effects of HIE and CHD on the development of network topological parameters and functional outcomes. CHD newborns had worse 12-18 month language (P<0.01) and 30 month cognitive (P<0.01), language (P = 0.05), motor outcomes (P = 0.01). Global efficiency, a metric of brain integration, was lower in CHD (P = 0.03) than in HIE, but transitivity, modularity and small-worldness were similar. After controlling for clinical factors known to affect neurodevelopmental outcomes, we observed that global efficiency was highly associated with 30 month motor outcomes (P = 0.02) in both groups. To explore neural correlates of adverse language outcomes in CHD, we used hypothesis-based and data-driven approaches to identify pathways with altered structural connectivity. We found that connectivity strength in the superior longitudinal fasciculus (SLF) tract 2 was inversely associated with expressive language. After false discovery rate correction, a whole connectome edge analysis identified 18 pathways that were hypoconnected in the CHD cohort as compared to HIE. In sum, our study shows that neonatal structural connectivity predicts early motor development after HIE or in subjects with CHD, and regional SLF connectivity is associated with language outcomes. Further research is needed to determine if and how brain networks change over time and whether those changes represent recovery or ongoing dysfunction. This knowledge will directly inform strategies to optimize neurologic functional outcomes after neonatal brain injury.	[Ramirez, Alice; Peyvandi, Shabnam; Cox, Stephany; Gano, Dawn; McQuillen, Patrick S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Gano, Dawn; McQuillen, Patrick S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Xu, Duan; Tymofiyeva, Olga] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McQuillen, PS (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.; McQuillen, PS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	patrick.mcquillen@ucsf.edu	Xu, Duan/GMW-4195-2022; Gano, Dawn/GYU-8867-2022	Xu, Duan/0000-0003-0550-4235; Gano, Dawn/0000-0003-4192-2362	 [P01 NS082330];  [K23 NS099422]	; 	We would further like to emphasize that the funders [PSM: P01 NS082330 (https://www.ninds.nih.gov/) and SP: K23 NS099422 (https://www.ninds.nih.gov/)] had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almairac F, 2015, BRAIN STRUCT FUNCT, V220, P1983, DOI 10.1007/s00429-014-0773-1; Bain JS, 2019, HUM BRAIN MAPP, V40, P3695, DOI 10.1002/hbm.24626; Balsamo LM, 2006, NEUROIMAGE, V31, P1306, DOI 10.1016/j.neuroimage.2006.01.027; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; Bonifacio SL, 2012, AM J NEURORADIOL, V33, P2050, DOI 10.3174/ajnr.A3117; Cao M, 2017, TRENDS NEUROSCI, V40, P494, DOI 10.1016/j.tins.2017.06.003; Cao M, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00025; Clouchoux C, 2013, CEREB CORTEX, V23, P2932, DOI 10.1093/cercor/bhs281; d'Albis MA, 2018, BRAIN, V141, P3472, DOI 10.1093/brain/awy275; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Dimitropoulos A, 2013, NEUROLOGY, V81, P241, DOI 10.1212/WNL.0b013e31829bfdcf; Feldmann M, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa209; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Forbess JM, 2002, J THORAC CARDIOV SUR, V123, P631, DOI 10.1067/mtc.2002.119342; Fourdain S, 2019, EUR J PAEDIATR NEURO, V23, P491, DOI 10.1016/j.ejpn.2019.03.002; Holleran L, 2020, AM J PSYCHIAT, V177, P537, DOI 10.1176/appi.ajp.2019.19030225; Hyde C, 2021, BRAIN IMAGING BEHAV, V15, P727, DOI 10.1007/s11682-020-00280-z; INDER TE, 2018, VOLPES NEUROLOGY NEW, P510; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Latini F, 2017, BRAIN RES, V1675, P102, DOI 10.1016/j.brainres.2017.09.005; Limperopoulos C, 2010, CIRCULATION, V121, P26, DOI 10.1161/CIRCULATIONAHA.109.865568; Majnemer A, 2008, J PEDIATR-US, V153, P55, DOI 10.1016/j.jpeds.2007.12.019; Majnemer A, 2017, DEV MED CHILD NEUROL, V59, P1056, DOI 10.1111/dmcn.13520; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; McQuillen PS, 2010, PROG PEDIATR CARDIOL, V29, P79, DOI 10.1016/j.ppedcard.2010.06.011; McQuillen PS, 2010, ANN NY ACAD SCI, V1184, P68, DOI 10.1111/j.1749-6632.2009.05116.x; Miller SP, 2005, J PEDIATR-US, V146, P453, DOI 10.1016/j.jpeds.2004.12.026; Miller SP, 2007, NEW ENGL J MED, V357, P1928, DOI 10.1056/NEJMoa067393; Mosley PE, 2019, BRAIN, V142, P3917, DOI 10.1093/brain/awz327; Muktan D, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1660-y; Nagae LM, 2012, AM J NEURORADIOL, V33, P1720, DOI 10.3174/ajnr.A3037; Naigles LR, 2017, AUTISM RES, V10, P1107, DOI 10.1002/aur.1756; Natarajan G, 2016, SEMIN PERINATOL, V40, P549, DOI 10.1053/j.semperi.2016.09.007; Olsen M, 2011, CIRCULATION, V124, P1706, DOI 10.1161/CIRCULATIONAHA.110.002832; Panigrahy A, 2015, NEUROIMAGE-CLIN, V7, P438, DOI 10.1016/j.nicl.2015.01.013; Peyvandi S, 2018, J AM COLL CARDIOL, V71, P1986, DOI 10.1016/j.jacc.2018.02.068; Peyvandi S, 2018, J THORAC CARDIOV SUR, V155, P291, DOI 10.1016/j.jtcvs.2017.08.019; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rudolph AM, 2018, PEDIATR RES, V84, P348, DOI 10.1038/s41390-018-0094-9; Saygin ZM, 2013, J NEUROSCI, V33, P13251, DOI 10.1523/JNEUROSCI.4383-12.2013; Schaefer C, 2013, DEV MED CHILD NEUROL, V55, P1143, DOI 10.1111/dmcn.12242; Schmithorst VJ, 2018, HUM BRAIN MAPP, V39, P4593, DOI 10.1002/hbm.24308; Schmithorst VJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.504; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Skeide MA, 2016, NAT REV NEUROSCI, V17, P323, DOI 10.1038/nrn.2016.23; Spencer APC, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102582; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; Urger SE, 2015, J CHILD NEUROL, V30, P9, DOI 10.1177/0883073813520503; Vestergaard M, 2011, J COGNITIVE NEUROSCI, V23, P2135, DOI 10.1162/jocn.2010.21592; Wang R, DIFFUSION TOOLKIT SO, V1; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wilson S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023598118; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Ziv E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078824	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2022	17	1							e0262310	10.1371/journal.pone.0262310	http://dx.doi.org/10.1371/journal.pone.0262310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZO8DB	34986206	Green Published, gold			2022-12-26	WOS:000765956200040
J	Namba, H; Sugano, A; Murakami, T; Utsunomiya, H; Sato, H; Nishitsuka, K; Ishizawa, K; Kayama, T; Yamashita, H				Namba, Hiroyuki; Sugano, Akira; Murakami, Takanori; Utsunomiya, Hiroshi; Sato, Hidenori; Nishitsuka, Koichi; Ishizawa, Kenichi; Kayama, Takamasa; Yamashita, Hidetoshi			Ten-year longitudinal investigation of astigmatism: The Yamagata Study (Funagata)	PLOS ONE			English	Article							ELDERLY CHINESE POPULATION; HUMAN CORNEAL STROMA; REFRACTIVE ERRORS; RISK-FACTORS; JAPANESE POPULATION; VECTOR ANALYSIS; POWER VECTOR; ABERRATIONS; AGE; PREVALENCE	Despite numerous investigations into ocular or corneal astigmatism, the dynamic nature of astigmatism remains poorly understood. To reveal potential associations between age and astigmatism, 264 Japanese participants who underwent systemic and ophthalmological examinations in Funagata Town (Yamagata Prefecture, Japan) were evaluated over a 10-year period. Astigmatism was evaluated with regard to the cylinder power, cylinder axis, and vector analyses. Whereas the refractive cylinders showed age-related increases in patients in their 40s to 60s, the corneal cylinders did not change over 10 years. Nevertheless, cylindrical axis of the cornea demonstrated a continuous shift toward against-the-rule (ATR) astigmatism. Vector analyses revealed that the astigmatic shift toward ATR progressed continually after patients reached their 40s, although the shift did not accelerate with age. These novel insights may pave the way for the development of potential strategies for vision correction, including refractive surgeries, and vision-quality maintenance in the elderly.	[Namba, Hiroyuki; Murakami, Takanori; Utsunomiya, Hiroshi; Nishitsuka, Koichi; Yamashita, Hidetoshi] Yamagata Univ, Dept Ophthalmol & Visual Sci, Fac Med, Yamagata, Yamagata, Japan; [Sugano, Akira] Ideganka Hosp, Yamagata, Yamagata, Japan; [Murakami, Takanori] Yamagata Prefectural Cent Hosp, Dept Ophthalmol, Yamagata, Yamagata, Japan; [Sato, Hidenori] Yamagata Univ, Inst Promot Med Sci Res, Genome Informat Unit, Fac Med, Yamagata, Yamagata, Japan; [Ishizawa, Kenichi] Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata, Yamagata, Japan; [Kayama, Takamasa] Yamagata Univ, Dept Adv Med, Fac Med, Yamagata, Yamagata, Japan	Yamagata University; Yamagata Prefectural Central Hospital; Yamagata University; Yamagata University; Yamagata University	Namba, H (corresponding author), Yamagata Univ, Dept Ophthalmol & Visual Sci, Fac Med, Yamagata, Yamagata, Japan.	h-nanba@med.id.yamagata-u.ac.jp		Nishitsuka, Koichi/0000-0003-2394-9561				Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Alpins NA, 1997, J CATARACT REFR SURG, V23, P1503, DOI 10.1016/S0886-3350(97)80021-1; Artal P, 1998, OPT LETT, V23, P1713, DOI 10.1364/OL.23.001713; BALDWIN WR, 1981, AM J OPTOM PHYS OPT, V58, P206; CADERA W, 1992, J PEDIATR OPHTHALMOL, V29, P85; Cheng CY, 2003, INVEST OPHTH VIS SCI, V44, P4630, DOI 10.1167/iovs.03-0169; Daimon M, 2008, BIOCHEM BIOPH RES CO, V374, P576, DOI 10.1016/j.bbrc.2008.07.065; Daxer A, 1998, INVEST OPHTH VIS SCI, V39, P644; Diez Ajenjo Ma Amparo, 2015, J Optom, V8, P86, DOI 10.1016/j.optom.2014.07.006; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Faragher RGA, 1997, BRIT J OPHTHALMOL, V81, P814, DOI 10.1136/bjo.81.10.814; Guzowski M, 2003, OPHTHALMOLOGY, V110, P1364, DOI 10.1016/S0161-6420(03)00465-2; HAYASHI K, 1995, CORNEA, V14, P527; Jaffe NS., 1975, T AM ACAD OPHTHALMOL, V79, P615; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; Kawasaki R, 2006, OPHTHALMOLOGY, V113, P1378, DOI 10.1016/j.ophtha.2006.02.052; Liu YC, 2011, INVEST OPHTH VIS SCI, V52, P9651, DOI 10.1167/iovs.11-7641; MALIK NS, 1992, BIOCHIM BIOPHYS ACTA, V1138, P222, DOI 10.1016/0925-4439(92)90041-K; Moon NJ, 2006, J KOREAN MED SCI, V21, P131, DOI 10.3346/jkms.2006.21.1.131; Morlet N, 2001, BRIT J OPHTHALMOL, V85, P1127, DOI 10.1136/bjo.85.9.1127; NAESER K, 1990, J CATARACT REFR SURG, V16, P741, DOI 10.1016/S0886-3350(13)81018-8; Nagpal K M, 2000, Indian J Ophthalmol, V48, P213; Namba H, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012894; Namba H, 2018, CORNEA, V37, P53, DOI 10.1097/ICO.0000000000001418; Namba H, 2017, CORNEA, V36, pS34, DOI 10.1097/ICO.0000000000001386; Namba H, 2015, INVEST OPHTH VIS SCI, V56, P90, DOI 10.1167/iovs.14-15261; Nanavaty MA, 2006, J CATARACT REFR SURG, V32, P1091, DOI 10.1016/j.jcrs.2006.03.021; Nishitsuka K, 2011, OPHTHAL EPIDEMIOL, V18, P244, DOI 10.3109/09286586.2011.594206; Pesudovs K, 2003, BRIT J OPHTHALMOL, V87, P964, DOI 10.1136/bjo.87.8.964; Raju P, 2004, INVEST OPHTH VIS SCI, V45, P4268, DOI 10.1167/iovs.04-0221; Read SA, 2007, INVEST OPHTH VIS SCI, V48, P112, DOI 10.1167/iovs.06-0675; Reinstein DZ, 2014, J REFRACT SURG, V30, P654, DOI 10.3928/1081597X-20140903-01; Remon Laura, 2017, J Optom, V10, P141, DOI 10.1016/j.optom.2016.07.003; Rhim JW, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-019-1297-5; Rozema JJ, 2019, OPHTHAL PHYSL OPT, V39, P183, DOI 10.1111/opo.12616; Sanfilippo PG, 2015, ACTA OPHTHALMOL, V93, pE377, DOI 10.1111/aos.12644; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Tanabe Y, 2009, J HUM HYPERTENS, V23, P788, DOI 10.1038/jhh.2009.27; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Verzella F, 1993, Refract Corneal Surg, V9, P58; VIHLEN FS, 1983, INVEST OPHTH VIS SCI, V24, P1367; Vitalyos G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39234-x	44	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	1							e0261324	10.1371/journal.pone.0261324	http://dx.doi.org/10.1371/journal.pone.0261324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE3XC	35007309	gold, Green Published			2022-12-26	WOS:000741060700013
J	Anane-Fenin, B; Agbeno, EK; Osarfo, J; Anning, DAO; Boateng, AS; Ken-Amoah, S; Amanfo, AO; Derkyi-Kwarteng, L; Mouhajer, M; Amoo, SA; Ashong, J; Jeffery, E				Anane-Fenin, Betty; Agbeno, Evans Kofi; Osarfo, Joseph; Anning, Douglas Aninng Opoku; Boateng, Abigail Serwaa; Ken-Amoah, Sebastian; Amanfo, Anthony Ofori; Derkyi-Kwarteng, Leonard; Mouhajer, Mohammed; Amoo, Sarah Ama; Ashong, Joycelyn; Jeffery, Ernestina			A ten-year review of indications and outcomes of obstetric admissions to an intensive care unit in a low-resource country	PLOS ONE			English	Review							MATERNAL MORTALITY; PREGNANCY; AGE	Introduction Obstetric intensive care unit admission (ICU) suggests severe morbidity. However, there is no available data on the subject in Ghana. This retrospective review was conducted to determine the indications for obstetric ICU admission, their outcomes and factors influencing these outcomes to aid continuous quality improvement in obstetric care. Methods This was a retrospective review conducted in a tertiary hospital in Ghana. Data on participant characteristics including age and whether participant was intubated were collected from patient records for all obstetric ICU admissions from 1(st) January 2010 to 31(st) December 2019. Descriptive statistics were presented as frequencies, proportions and charts. Hazard ratios were generated for relations between obstetric ICU admission outcome and participant characteristics. A p-value <0.05 was deemed statistically significant. Results There were 443 obstetric ICU admissions over the review period making up 25.7% of all ICU admissions. The commonest indications for obstetric ICU admissions were hypertensive disorders of pregnancy (70.4%, n = 312/443), hemorrhage (14.4%, n = 64/443) and sepsis (9.3%, n = 41/443). The case fatality rates for hypertension, hemorrhage, and sepsis were 17.6%, 37.5%, and 63.4% respectively. The obstetric ICU mortality rate was 26% (115/443) over the review period. Age >= 25 years and a need for mechanical ventilation carried increased mortality risks following ICU admission while surgery in the index pregnancy was associated with a reduced risk of death. Conclusion Hypertension, haemorrhage and sepsis are the leading indications for obstetric ICU admissions. Thus, preeclampsia screening and prevention, as well as intensifying antenatal education on the danger signs of pregnancy can minimize obstetric complications. The establishment of an obstetric HDU in CCTH and the strengthening of communication between specialists and the healthcare providers in the lower facilities, are also essential for improved pregnancy outcomes. Further studies are needed to better appreciate the wider issues underlying obstetric ICU admission outcomes. Plain language summary This was a review of the reasons for admitting severely-ill pregnant women and women who had delivered within the past 42 days to the intensive care unit (ICU), the admission outcomes and risk factors associated with ICU mortality in a tertiary hospital in a low-resource country. High blood pressure and its complications, bleeding and severe infections were observed as the three most significant reasons for ICU admissions in decreasing order of significance. Pre-existing medical conditions and those arising as a result of, or aggravated by pregnancy; obstructed labour and post-operative monitoring were the other reasons for ICU admission over the study period. Overall, 26% of the admitted patients died at the ICU and maternal age of at least 25 years and the need for intubation were identified as risk factors for ICU deaths. Attention must be paid to high blood pressure during pregnancy.	[Anane-Fenin, Betty; Boateng, Abigail Serwaa; Ashong, Joycelyn] Cape Coast Teaching Hosp, Dept Obstet & Gynaecol, Cape Coast, Ghana; [Agbeno, Evans Kofi; Ken-Amoah, Sebastian; Amanfo, Anthony Ofori; Mouhajer, Mohammed] Univ Cape Coast, Dept Obstet & Gynaecol, Sch Med Sci, Cape Coast, Ghana; [Osarfo, Joseph] Univ Hlth & Allied Sci, Sch Med, Dept Community Med, Ho, Ghana; [Anning, Douglas Aninng Opoku] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana; [Derkyi-Kwarteng, Leonard] Univ Cape Coast, Dept Pathol, Sch Med Sci, Cape Coast, Ghana; [Amoo, Sarah Ama; Jeffery, Ernestina] Cape Coast Teaching Hosp, Intens Care Unit, Cape Coast, Ghana	University of Cape Coast; Kwame Nkrumah University Science & Technology; University of Cape Coast	Anane-Fenin, B (corresponding author), Cape Coast Teaching Hosp, Dept Obstet & Gynaecol, Cape Coast, Ghana.	oparebea81@gmail.com	Opoku, Douglas Aninng/CAF-0150-2022	Opoku, Douglas Aninng/0000-0003-2321-387X; Ken-Amoah, Sebastian/0000-0001-8293-6862; Anane-Fenin, Betty/0000-0003-3020-2159				Abiodun J., 2015, GLOB SCHOLAST RES J, V1; Adelaiye SM., 2016, TROP J OBSTET GYNAEC, V33, P44; Adeniran AS, 2015, MALAWI MED J, V27, P16, DOI 10.4314/mmj.v27i1.5; Adu-Bonsaffoh K, 2013, INT J GYNECOL OBSTET, V123, P110, DOI 10.1016/j.ijgo.2013.05.017; Ahinkorah BO, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9030272; Asseffa NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213240; Awoyesuku PA., 2020, J ADV MED MED RES, V32, P103; Bahadur BR., 2018, INT J REPROD CONTRAC, V7, P2909, DOI [10.18203/2320-1770.ijrcog20182905, DOI 10.18203/2320-1770.IJRCOG20182905]; Bas EK, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919922; Boafor TK, 2021, AFR J REPROD HEALTH, V25, P56, DOI 10.29063/ajrh2021/v25i1.7; Bosu W K, 2012, Ghana Med J, V46, P69; Cavazos-Rehg PA, 2015, MATERN CHILD HLTH J, V19, P1202, DOI 10.1007/s10995-014-1624-7; Chawla Sushil, 2013, Med J Armed Forces India, V69, P134, DOI 10.1016/j.mjafi.2012.08.033; Crozier TM, 2011, AUST NZ J OBSTET GYN, V51, P233, DOI 10.1111/j.1479-828X.2011.01303.x; de-Graft Aikins Ama, 2007, Ghana Med J, V41, P154; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; El-Abd H., 2011, CRIT CARE, V15, pP513, DOI [10.1186/cc9933, DOI 10.1186/CC9933]; Endeshaw Gezehagn, 2015, Int Sch Res Notices, V2015, P208043, DOI 10.1155/2015/208043; Ghosh G, 2014, ETHNIC DIS, V24, P283; Githae F., 2011, E AFR MED J, V88, P356; Jain Shruti, 2016, Indian J Public Health, V60, P159, DOI 10.4103/0019-557X.184575; Kumari N., 2016, IOSR J DENT MED SCI, V15, P55, DOI [10.9790/0853-1512085557, DOI 10.9790/0853-1512085557]; Maiden MJ, 2020, BJOG-INT J OBSTET GY, V127, P1558, DOI 10.1111/1471-0528.16285; Marshall JC, 2017, J CRIT CARE, V37, P270, DOI 10.1016/j.jcrc.2016.07.015; Mjahed K, 2006, J Obstet Gynaecol, V26, P418, DOI 10.1080/01443610600720188; Motiang M, 2017, SOUTH AFR J CRIT CAR, V33, P12, DOI 10.7196/SAJCC.2017.v33i1.279; Murthy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116949; Ntuli TS, 2015, SOUTH AFR J CRIT CAR, V31, P8, DOI 10.7196/SAJCC.164; Okafor UV, 2004, INT J OBSTET ANESTH, V13, P164, DOI 10.1016/j.ijoa.2004.04.002; Pollock W, 2010, INTENS CARE MED, V36, P1465, DOI 10.1007/s00134-010-1951-0; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Prin M, 2019, INT J OBSTET ANESTH, V39, P99, DOI 10.1016/j.ijoa.2019.03.004; Ramlakhan KP, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01396-0; Rudakemwa A, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03882-7; Sauer MV, 2015, FERTIL STERIL, V103, P1136, DOI 10.1016/j.fertnstert.2015.03.004; Siaw-Frimpong M, 2021, J CRIT CARE, V61, P76, DOI 10.1016/j.jcrc.2020.10.009; Sodhi K., 2018, J OBSTET ANAESTHESIA, V8, P73, DOI [10.4103/joacc.JOACC_57_17, DOI 10.4103/J0ACC.J0ACC_57_17]; Walker, 2016, DIS CONTROL PRIORITI, DOI DOI 10.1596/978-1-4648-0348-2_CH3; WHO, 2012, EV QUAL CAR SEV PREG; Witteveen T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1370-0; World Health Organization, 2012, EARL MARR AD YOUNG P; World Health Organization, 2019, MAT DEATHS DECL SLOW; Yi Hye Yeon, 2018, Obstet Gynecol Sci, V61, P209, DOI 10.5468/ogs.2018.61.2.209; Zieleskiewicz L, 2016, ANAESTH CRIT CARE PA, V35, pS51, DOI 10.1016/j.accpm.2016.06.005; Zwart JJ, 2010, INTENS CARE MED, V36, P256, DOI 10.1007/s00134-009-1707-x	45	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261974	10.1371/journal.pone.0261974	http://dx.doi.org/10.1371/journal.pone.0261974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972184	gold, Green Published			2022-12-26	WOS:000773555700078
J	Chan, A; Ayala, JM; Alvarez, F; Piccirillo, C; Dong, G; Langlais, D; Olivier, M				Chan, Aretha; Ayala, Jose-Mauricio; Alvarez, Fernando; Piccirillo, Ciriaco; Dong, George; Langlais, David; Olivier, Martin			The role of Leishmania GP63 in the modulation of innate inflammatory response to Leishmania major infection	PLOS ONE			English	Article							TARGETED GENE DELETION; CUTANEOUS LEISHMANIASIS; VIRULENCE; RESISTANCE; EXOSOMES; MACROPHAGES; EXPRESSION; INDUCTION; CYTOKINES; DONOVANI	Leishmaniasis is a disease caused by the protozoan parasite Leishmania and is known to affect millions of individuals worldwide. In recent years, we have established the critical role played by Leishmania zinc-metalloprotease GP63 in the modulation of host macrophage signalling and functions, favouring its survival and progression within its host. Leishmania major lacking GP63 was reported to cause limited infection in mice, however, it is still unclear how GP63 may influence the innate inflammatory response and parasite survival in an in vivo context. Therefore, we were interested in analyzing the early innate inflammatory events upon Leishmania inoculation within mice and establish whether Leishmania GP63 influences this initial inflammatory response. Experimentally, L. major WT (L. major(WT)), L. major GP63 knockout (L. major(KO)), or L. major GP63 rescue (L. major(R)) were intraperitoneally inoculated in mice and the inflammatory cells recruited were characterized microscopically and by flow cytometry (number and cell type), and their infection determined. Pro-inflammatory markers such as cytokines, chemokines, and extracellular vesicles (EVs, e.g. exosomes) were monitored and proteomic analysis was performed on exosome contents. Data obtained from this study suggest that Leishmania GP63 does not significantly influence the pathogen-induced inflammatory cell recruitment, but rather their activation status and effector function. Concordantly, internalization of promastigotes during early infection could be influenced by GP63 as fewer L. major(KO) amastigotes were found within host cells and appear to maintain in host cells over time. Collectively this study provides a clear analysis of innate inflammatory events occurring during L. major infection and further establish the prominent role of the virulence factor GP63 to provide favourable conditions for host cell infection.	[Chan, Aretha; Alvarez, Fernando; Piccirillo, Ciriaco; Dong, George; Langlais, David; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Chan, Aretha; Alvarez, Fernando; Piccirillo, Ciriaco; Dong, George; Olivier, Martin] McGill Univ, Infect Dis & Immun Global Hlth Program, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Ayala, Jose-Mauricio; Langlais, David] McGill Genome Ctr, Dept Human Genet, Montreal, PQ, Canada; [Ayala, Jose-Mauricio; Piccirillo, Ciriaco; Dong, George; Langlais, David; Olivier, Martin] McGill Res Ctr Complex Traits, Montreal, PQ, Canada; [Alvarez, Fernando; Piccirillo, Ciriaco; Olivier, Martin] FOCiS Ctr Excellence Translat Immunol, Montreal, PQ, Canada	McGill University; McGill University	Langlais, D; Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Olivier, M (corresponding author), McGill Univ, Infect Dis & Immun Global Hlth Program, Res Inst, Hlth Ctr, Montreal, PQ, Canada.	david.langlais@mcgill.ca; martin.olivier@mcgill.ca		Chan, Aretha/0000-0003-0841-6345	Canadian Institute of Health Research (CIHR) [PJT-159765]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2018-03849]; CIHR Ph.D. Scholarship; McGill University-CONACyT scholarship; Canada Foundation for Innovation John R. Evans Leaders Fund; Fonds de Recherche Quebec -Sante, ChercheurBoursier Junior 1 Award	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR Ph.D. Scholarship(Canadian Institutes of Health Research (CIHR)); McGill University-CONACyT scholarship; Canada Foundation for Innovation John R. Evans Leaders Fund; Fonds de Recherche Quebec -Sante, ChercheurBoursier Junior 1 Award	Work performed in the M.O. laboratory is supported by grants from the Canadian Institute of Health Research (CIHR) (PJT-159765) and the Natural Sciences and Engineering Research Council of Canada Discovery Grant (RGPIN-2018-03849). GD was a recipient of a CIHR Ph.D. Scholarship. MA was a recipient of a McGill University-CONACyT scholarship. DL was supported by a Canada Foundation for Innovation John R. Evans Leaders Fund and a Fonds de Recherche Quebec -Sante, ChercheurBoursier Junior 1 Award.	Atayde VD, 2016, CELL IMMUNOL, V309, P7, DOI 10.1016/j.cellimm.2016.07.013; Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 1998, EUR J IMMUNOL, V28, P1389, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1389::AID-IMMU1389&gt;3.0.CO;2-1; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; Castellano LR, 2009, HUM IMMUNOL, V70, P383, DOI 10.1016/j.humimm.2009.01.007; CHANG KP, 1978, J EXP MED, V147, P515, DOI 10.1084/jem.147.2.515; Coakley G, 2015, TRENDS PARASITOL, V31, P477, DOI 10.1016/j.pt.2015.06.009; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DESCOTEAUX A, 1992, J IMMUNOL, V149, P3008; Dowlati Y, 1996, CLIN DERMATOL, V14, P425, DOI 10.1016/0738-081X(96)00058-2; GARSIDE P, 1995, IMMUNOL TODAY, V16, P220, DOI 10.1016/0167-5699(95)80162-6; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Hassani K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002185; Himmelrich H, 2000, J IMMUNOL, V164, P4819, DOI 10.4049/jimmunol.164.9.4819; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Isnard A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00072; Isnard A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004776; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kanemoto S, 2016, BIOCHEM BIOPH RES CO, V480, P166, DOI 10.1016/j.bbrc.2016.10.019; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; LACKS SA, 1980, J BIOL CHEM, V255, P7467; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; LASKAY T, 1995, EUR J IMMUNOL, V25, P2220, DOI 10.1002/eji.1830250816; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liew FY, 1997, PHILOS T R SOC B, V352, P1311, DOI 10.1098/rstb.1997.0115; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; MELBY PC, 1994, INFECT IMMUN, V62, P837, DOI 10.1128/IAI.62.3.837-842.1994; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Miyazaki S, 2004, CLIN DIAGN LAB IMMUN, V11, P452, DOI 10.1128/CDLI.11.3.452-457.2004; Moskowitz NH, 1997, INFECT IMMUN, V65, P2448, DOI 10.1128/IAI.65.6.2448-2450.1997; MOSSER DM, 1985, J IMMUNOL, V135, P2785; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park AY, 2002, J IMMUNOL, V168, P5771, DOI 10.4049/jimmunol.168.11.5771; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; RUSSELL DG, 1987, EUR J BIOCHEM, V164, P213, DOI 10.1111/j.1432-1033.1987.tb11013.x; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Shio MT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003868; Soo CY, 2012, IMMUNOLOGY, V136, P192, DOI 10.1111/j.1365-2567.2012.03569.x; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002; Teixeira MJ, 2006, TRENDS PARASITOL, V22, P32, DOI 10.1016/j.pt.2005.11.010; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; Voth BR., 1998, MOL BIOCHEM PARASIT; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1	59	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0262158	10.1371/journal.pone.0262158	http://dx.doi.org/10.1371/journal.pone.0262158			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972189	gold, Green Published			2022-12-26	WOS:000773555700102
J	Gambo, A; Moodley, I; Babashani, M; Babalola, TK; Gqaleni, N				Gambo, Aisha; Moodley, Indres; Babashani, Musa; Babalola, Tesleem K.; Gqaleni, Nceba			A double-blind, randomized controlled trial to examine the effect of Moringa oleifera leaf powder supplementation on the immune status and anthropometric parameters of adult HIV patients on antiretroviral therapy in a resource-limited setting	PLOS ONE			English	Article							HIV/AIDS	Background People living with HIV (PLHIV) in resource-limited settings are vulnerable to malnutrition. Nutritional interventions aimed at improving food insecurity and malnutrition, together with antiretroviral therapy (ART), could improve treatment outcomes. In Nigeria, there is a high awareness of the nutraceutical benefits of Moringa oleifera. Thus, this study aimed to evaluate the effects of Moringa oleifera leaf supplementation on the CD4 counts, viral load and anthropometric of HIV-positive adults on ART. Methods This was a double-blind, randomized study. Two hundred HIV-positive patients were randomly allocated to either the Moringa Oleifera group (MOG) given Moringa oleifera leaf powder or the control group (COG) given a placebo. Changes in anthropometric parameters [weight; body mass index (BMI)] and CD4 cell counts were measured monthly for six months, while HIV-1 viral loads were measured at baseline and the end of the study for both groups. Results Over the study period, the treatment by time interaction shows a significant difference in CD4 counts by treatment group (p<0.0001). A further estimate of fixed effects showed that the CD4 counts among MOG were 10.33 folds greater than COG over the study period. However, the viral load (p = 0.9558) and all the anthropometric parameters (weight; p = 0.5556 and BMI; p = 0.5145) between the two groups were not significantly different over time. All tests were conducted at 95CI. Conclusion This study revealed that Moringa oleifera leaf supplementation was associated with increased CD4 cell counts of PLHIV on ART in a resource-limited setting. Programs in low-resource settings, such as Nigeria, should consider nutritional supplementation as part of a comprehensive approach to ensure optimal treatment outcomes in PLHIV.	[Gambo, Aisha; Moodley, Indres; Babalola, Tesleem K.] Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Babashani, Musa] Bayero Univ Kano, Dept Med, Kano, Kano State, Nigeria; [Babashani, Musa] Aminu Kano Teaching Hosp, Kano, Kano State, Nigeria; [Gqaleni, Nceba] Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Tradit Med, Durban, South Africa	University of Kwazulu Natal; Bayero University; University of Kwazulu Natal	Gambo, A (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.	gamboaishatu@yahoo.com	Gqaleni, Nceba/A-3609-2014	Gqaleni, Nceba/0000-0003-1946-3120; Gambo, Aisha/0000-0003-2605-4261	Department of Science and Innovation of South Africa [DST/CON 0196/2011]; College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa	Department of Science and Innovation of South Africa; College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa	This study was funded by the Department of Science and Innovation of South Africa (DST/CON 0196/2011) and the College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Addisu Tesfaw, 2018, Advances in Public Health, V2018, P6135482, DOI 10.1155/2018/6135482; Akwiwu U. N., 2019, Journal of Agriculture and Food Sciences, V16, P88, DOI 10.4314/jafs.v16i2.8; Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; ASPIRATA, 2017, NUTR AN MOR OL LEAV; Avert, 2019, HIV AIDS S AFRICA; Bahadoran Z, 2012, INT J FOOD SCI NUTR, V63, P767, DOI 10.3109/09637486.2012.665043; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colecraft E, 2008, P NUTR SOC, V67, P109, DOI 10.1017/S0029665108006095; Contri PV, 2011, CLINICS, V66, P997, DOI 10.1590/S1807-59322011000600013; Dhakad AK, 2019, PHYTOTHER RES, V33, P2870, DOI 10.1002/ptr.6475; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feleke DG., 2017, ETHIOPIA J AIDS CLIN, V8, P1, DOI [10.4172/2155-6113.1000688, DOI 10.4172/2155-6113.1000688]; Guerra EML., 2015, HLTH HIV INFECTED PE, V2, P367; Idohou-Dossou N., 2011, African Journal of Food, Agriculture, Nutrition and Development, V11, P4985; Mancini A, 2015, MOLECULES, V20, P17339, DOI 10.3390/molecules200917339; Merck, 2021, MERCK DISCONTINUES D; Mishra SP, 2012, BULL ENVIRON PHARMAC, V2, P28; Monera TG, 2008, J INFECT DEV COUNTR, V2, P379, DOI 10.3855/jidc.201; Nnyepi MS, 2009, S AFR J CLIN NUTR, V22, P89, DOI 10.1080/16070658.2009.11734224; Obiako RO., 2018, SUBSAHARAN AFR J MED, V6, P43; Ogbuagu EN, 2016, INT J INFECT DIS, V45, P267, DOI 10.1016/j.ijid.2016.02.595; Pandey A., 2012, MED AROMAT PLANTS, V1, P101, DOI [10.4172/2167-0412.1000101, DOI 10.4172/2167-0412.1000101]; RMRDC, 2010, P NAT SUMM MOR DEV; Roche, 2007, COBAS AMPLIPREP COBA; SANAS, 2017, S AFR NAT ACCR SYST; SOP Nigeria, HIV 1 VIRAL LOAD ASS; Tete-Benissan A., 2013, Journal of Applied Biosciences, V62, P4610; Thurber MD, 2009, ECOL FOOD NUTR, V48, P212, DOI 10.1080/03670240902794598; Toh HS, 2020, INT J INFECT DIS, V91, P44, DOI 10.1016/j.ijid.2019.11.010; Tshingani K, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1920-z; UNAIDS, 2019, START FREE STAY FREE; UNAIDS, UNAIDS2000; Vergara-Jimenez M, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040091; WHO UNICEF, 2018, ARS PRIM GUID INV MI, V3rd; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261935	10.1371/journal.pone.0261935	http://dx.doi.org/10.1371/journal.pone.0261935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972169	Green Published, gold			2022-12-26	WOS:000773555700069
J	Liu, Z; Mutukumira, AN; Shen, C				Liu, Zhe; Mutukumira, Anthony N.; Shen, Cong			Food safety knowledge, attitudes, and eating behavior in the advent of the global coronavirus pandemic	PLOS ONE			English	Article							CONSUMER ATTITUDES; POWER ANALYSIS; COVID-19; IMPACTS; PROGRAM; CRISIS; RISKS	The objective of this study was to evaluate the relationships of food safety knowledge, attitude and eating behavior of consumers during national lockdowns in the advent of the COVID-19 pandemic. A total of 157 respondents completed the online survey using a structured questionnaire worldwide. Overall, the respondents exhibited good attitude and good knowledge towards public health including food safety especially on the importance of social distancing, mask wearing, well-balanced diet, physical exercise and personal hygiene, such as hand washing during the pandemic lockdowns. A Structural Equation Modeling (SEM) was used to test the relationships among food safety knowledge, attitude and behavior under the pandemic conditions. Results showed that attitude towards food safety under the coronavirus pandemic and lockdowns positively affected the eating behavior of the respondents, which exhibited a high beta (0.686) among the variables tested (p<0.05). Food safety knowledge was apparently not affected by the food safety behavior of the respondents.	[Liu, Zhe; Shen, Cong] Henan Univ Technol, Sch Management, Zhengzhou, Henan, Peoples R China; [Mutukumira, Anthony N.] Massey Univ, Sch Food & Adv Technol, Auckland, New Zealand	Henan University of Technology; Massey University	Liu, Z (corresponding author), Henan Univ Technol, Sch Management, Zhengzhou, Henan, Peoples R China.	liuzhe168@163.com	Mutukumira, Tony N./CAH-8302-2022	Mutukumira, Tony N./0000-0003-3189-2120; Shen, Cong/0000-0001-8949-0349; LIU, ZHE/0000-0002-0934-4438	Henan Association for Science and Technology [HNKJZK-2021-12B]; National Social Science Foundation of China [21BGL052]; Humanities and Social Science Project of Education Department of Henan Province [2021-ZZJH-082]; Key Research Institute of Humanities and Social Sciences at Universities of Henan Province [2017JD-02]	Henan Association for Science and Technology; National Social Science Foundation of China; Humanities and Social Science Project of Education Department of Henan Province; Key Research Institute of Humanities and Social Sciences at Universities of Henan Province	The authors wish to acknowledge the funding from Henan Association for Science and Technology (HNKJZK-2021-12B) for the research upon which this paper is based. Also, this study was supported by National Social Science Foundation of China (21BGL052), Humanities and Social Science Project of Education Department of Henan Province (2021-ZZJH-082) and Key Research Institute of Humanities and Social Sciences at Universities of Henan Province (2017JD-02). The authors would like to thank all the respondents for their feedback and support during collection of the data.	Abdul-Mutalib NA, 2012, FOOD CONTROL, V27, P289, DOI 10.1016/j.foodcont.2012.04.001; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Ansari-Lari M, 2010, FOOD CONTROL, V21, P260, DOI 10.1016/j.foodcont.2009.06.003; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; BAGOZZI RP, 1980, J MARKETING RES, V17, P133, DOI 10.2307/3151129; Baser F, 2017, FOOD CONTROL, V73, P438, DOI 10.1016/j.foodcont.2016.08.032; Bolek S, 2021, ITAL J FOOD SCI, V33, P14, DOI 10.15586/ijfs.v33i3.2048; Bolek S, 2020, TRENDS FOOD SCI TECH, V102, P242, DOI 10.1016/j.tifs.2020.03.009; Bollen KA, 1989, STRUCTURAL EQUATIONS; BREWER MS, 1994, J FOOD SAFETY, V14, P63, DOI 10.1111/j.1745-4565.1994.tb00584.x; Brown RL, 1994, STRUCT EQU MODELING, V1, P287, DOI 10.1080/10705519409539983; BROWNE MW, 1995, HDB STAT MODELING SO, P311; Buccheri C, 2010, FOOD CONTROL, V21, P1367, DOI 10.1016/j.foodcont.2010.04.010; Cable J, 2021, ANN NY ACAD SCI, V1484, P3, DOI 10.1111/nyas.14482; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Ding L, 1995, STRUCT EQU MODELING, V2, P119, DOI 10.1080/10705519509540000; Djekic I, 2021, FOOD CONTROL, V122, DOI 10.1016/j.foodcont.2020.107800; Farsalinos Konstantinos, 2021, Toxicol Rep, V8, P1, DOI 10.1016/j.toxrep.2020.12.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254; Food and Agriculture Organization of the United Nations (FAO),World Health Organization (WHO), 1992, DECL PLAN ACT NUTR; Fox JP, 2010, STAT SOC BEHAV SC, P1, DOI 10.1007/978-1-4419-0742-4; Gorsuch R., 1983, FACTOR ANAL; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203; Hair Jr J.F., 2016, PRIMER PARTIAL LEAST; Han S, 2021, TRENDS FOOD SCI TECH, V109, P25, DOI 10.1016/j.tifs.2021.01.004; Hossain MB, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05799; International Food Infomation Council, COVID 19 PAND TRANSF; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Lee K, 2009, GLOB INST, P1; Lim TP, 2016, FOOD CONTROL, V60, P241, DOI 10.1016/j.foodcont.2015.07.042; Liu Peipei, 2020, Biosaf Health, V2, P199, DOI 10.1016/j.bsheal.2020.11.003; Ma NL, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110405; MCINTOSH WA, 1994, APPETITE, V22, P83, DOI 10.1006/appe.1994.1007; Meer RR, 2000, J FOOD PROTECT, V63, P1725, DOI 10.4315/0362-028X-63.12.1725; Meixner O, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187270; Memon M.A., 2020, J APPL STRUCT EQU MO, V4, P1, DOI [10.47263/JASEM.4(2)01, DOI 10.47263/JASEM.4(2)01, 10.47263/jasem.4(2)01]; Min S, 2020, J INTEGR AGR, V19, P2926, DOI 10.1016/S2095-3119(20)63388-3; Mistree D, 2021, SOC SCI MED, V276, DOI 10.1016/j.socscimed.2021.113846; MULAIK SA, 1987, MULTIVAR BEHAV RES, V22, P267, DOI 10.1207/s15327906mbr2203_3; Muthen LK., 2017, MPLUS, VEight; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Parthasarathy P, 2021, J INFECT PUBLIC HEAL, V14, P249, DOI 10.1016/j.jiph.2020.12.020; Raab C.A., 1997, INT J CONSUM STUD, V21, P117; Raykov T, 2004, BEHAV THER, V35, P299, DOI 10.1016/S0005-7894(04)80041-8; Ringle CM, 2020, INT J HUM RESOUR MAN, V31, P1617, DOI 10.1080/09585192.2017.1416655; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Schindler P.S., 2019, BUSINESS RES METHODS, Vthirteen, DOI [10.1016/j.ymeth.2019.06.012, DOI 10.1016/J.YMETH.2019.06.012]; SCHWARTZ NE, 1975, J AM DIET ASSOC, V66, P28; Siddiky NA., 2021, FOOD CONTROL; Tabachnick B, 2001, USING MULTIVARIATE A; Thomas MS, 2021, FOOD CONTROL, V130, DOI 10.1016/j.foodcont.2021.108279; Thomas MS, 2021, J FOOD PROTECT, V84, P1176, DOI 10.4315/JFP-21-006; TINSLEY HEA, 1987, J COUNS PSYCHOL, V34, P414, DOI 10.1037/0022-0167.34.4.414; Uttley J, 2019, LEUKOS, V15, P143, DOI 10.1080/15502724.2018.1533851; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; van der Linden WimJ., 2016, MODELS, V1; Wilcock A, 2004, TRENDS FOOD SCI TECH, V15, P56, DOI 10.1016/j.tifs.2003.08.004; World Health Organization, 2021, COVID 19 STRAT PREP; Yu CY, 2002, ANN C AM ED RES ASS; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	66	1	1	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261832	10.1371/journal.pone.0261832	http://dx.doi.org/10.1371/journal.pone.0261832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ9AO	34972145	gold, Green Published			2022-12-26	WOS:000773555700058
J	Lovfors, W; Ekstrom, J; Jonsson, C; Stralfors, P; Cedersund, G; Nyman, E				Lovfors, William; Ekstrom, Jona; Jonsson, Cecilia; Stralfors, Peter; Cedersund, Gunnar; Nyman, Elin			A systems biology analysis of lipolysis and fatty acid release from adipocytes in vitro and from adipose tissue in vivo	PLOS ONE			English	Article							INSULIN-RESISTANCE; MODEL; PHOSPHODIESTERASE; DESENSITIZATION; ACTIVATION; MECHANISM; OBESITY	Lipolysis and the release of fatty acids to supply energy fuel to other organs, such as between meals, during exercise, and starvation, are fundamental functions of the adipose tissue. The intracellular lipolytic pathway in adipocytes is activated by adrenaline and noradrenaline, and inhibited by insulin. Circulating fatty acids are elevated in type 2 diabetic individuals. The mechanisms behind this elevation are not fully known, and to increase the knowledge a link between the systemic circulation and intracellular lipolysis is key. However, data on lipolysis and knowledge from in vitro systems have not been linked to corresponding in vivo data and knowledge in vivo. Here, we use mathematical modelling to provide such a link. We examine mechanisms of insulin action by combining in vivo and in vitro data into an integrated mathematical model that can explain all data. Furthermore, the model can describe independent data not used for training the model. We show the usefulness of the model by simulating new and more challenging experimental setups in silico, e.g. the extracellular concentration of fatty acids during an insulin clamp, and the difference in such simulations between individuals with and without type 2 diabetes. Our work provides a new platform for model-based analysis of adipose tissue lipolysis, under both non-diabetic and type 2 diabetic conditions.	[Lovfors, William; Ekstrom, Jona; Cedersund, Gunnar; Nyman, Elin] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden; [Lovfors, William] Linkoping Univ, Dept Math, Linkoping, Sweden; [Jonsson, Cecilia; Stralfors, Peter] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University	Nyman, E (corresponding author), Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden.	elin.nyman@liu.se		Lovfors, William/0000-0002-9058-7049	Linkoping University; Swedish Diabetes Fund; Swedish Research Council; Swedish Research Council [2019-03767, 2018-05418, 2018-03319]; Heart and Lung Foundation; Ake Wibergs Stiftelse [M19-0449]; Swedish Foundation for Strategic Research [ITM17-0245]; SciLifeLab; KAW [2020.0182]; Horizon 2020 [777107]; CENIIT [15.09, 20.08]; ELLIIT; Swedish Fund for Research without Animal Experiments	Linkoping University; Swedish Diabetes Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Ake Wibergs Stiftelse; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); SciLifeLab; KAW; Horizon 2020; CENIIT; ELLIIT; Swedish Fund for Research without Animal Experiments	PS acknowledges support from Linkoping University, the Swedish Diabetes Fund (a 3-years program; https://www.diabetes.se/diabetesfonden/), and the Swedish Research Council (a 5-years program; https://www.vr.se/).EN acknowledges support from the Swedish Research Council (Dnr 2019-03767), the Heart and Lung Foundation (https://www.hjart-lungfonden.se/), CENIIT (20.08; http://ceniit.lith.liu.se/en/), and Ake Wibergs Stiftelse (M19-0449; https://akewiberg.se/).GC acknowledges support from the Swedish Research Council (Dnr 2018-05418, 2018-03319), Swedish Foundation for Strategic Research (ITM17-0245; https://strategiska.se/), SciLifeLab and KAW (2020.0182; https://www.scilifelab.se/), Horizon 2020 (PRECISE4Q, 777107; https://ec.europa.eu/programmes/horizon2020/), CENIIT (15.09), ELLIIT (https://www.lu.se/forskning/starka-forskningsmiljoer/strategiskaforskningsomraden/elliit), and the Swedish Fund for Research without Animal Experiments (https://forskautandjurforsok.se/swedish-fund-forresearch-without-animal-experiments/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmera I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.30; Arner P, 2015, OBESITY FACTS, V8, P147, DOI 10.1159/000381224; Arrestam O., 2021, DIGITAL TWIN PREDICT, DOI [10.1101/2021.11.04.467307, DOI 10.1101/2021.11.04.467307]; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Cedersund G, 2009, EUR J PHARM SCI, V36, P91, DOI 10.1016/j.ejps.2008.10.027; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Corral-Acero J, 2020, EUR HEART J, V41, P4556, DOI 10.1093/eurheartj/ehaa159; Dano S, 2006, FEBS J, V273, P4862, DOI 10.1111/j.1742-4658.2006.05485.x; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Egea JA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-136; Lopez-Palau NE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69629-0; ERIKSSON H, 1995, BBA-MOL CELL RES, V1266, P101, DOI 10.1016/0167-4889(94)00237-9; Golse N, 2021, J HEPATOL, V74, P661, DOI 10.1016/j.jhep.2020.10.036; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Herrgardh T, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.619254; HIGGINS J, 1964, P NATL ACAD SCI USA, V51, P989, DOI 10.1073/pnas.51.6.989; Jonsson C, 2019, BIOCHEM J, V476, P2883, DOI 10.1042/BCJ20190594; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kim J, 2008, J THEOR BIOL, V251, P523, DOI 10.1016/j.jtbi.2007.12.005; Lovfors W, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101221; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Marion-Latard F, 2001, AM J PHYSIOL-REG I, V280, pR166, DOI 10.1152/ajpregu.2001.280.1.R166; Murillo AL, 2019, MATH BIOSCI ENG, V16, P5765, DOI 10.3934/mbe.2019288; Nyman E, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0075; Nyman E, 2015, FEBS J, V282, P951, DOI 10.1111/febs.13194; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2012, TRENDS ENDOCRIN MET, V23, P107, DOI 10.1016/j.tem.2011.12.007; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; O'Donovan SD, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007400; Pratt AC, 2015, MATH BIOSCI, V262, P167, DOI 10.1016/j.mbs.2014.12.012; Rajan MR, 2016, J BIOL CHEM, V291, P15806, DOI 10.1074/jbc.M116.715763; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; SCHMITZPEIFFER C, 1992, CELL SIGNAL, V4, P37, DOI 10.1016/0898-6568(92)90006-T; Schwartz SM, 2020, FRONT COMP SCI-SWITZ, V2, DOI 10.3389/fcomp.2020.00031; SELKOV EE, 1968, EUR J BIOCHEM, V4, P79, DOI 10.1111/j.1432-1033.1968.tb00175.x; Shamanna P, 2020, DIABETES THER, V11, P2703, DOI 10.1007/s13300-020-00931-w; Sips FLP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135665; Smith JMD, 2009, OBESITY, V17, P632, DOI 10.1038/oby.2008.604; Stallknecht B, 1997, J PHYSIOL-LONDON, V500, P271, DOI 10.1113/jphysiol.1997.sp022017; Stich V, 2003, AM J PHYSIOL-ENDOC M, V285, pE599, DOI 10.1152/ajpendo.00502.2002; Wiener N., 1950, B AM ACAD ARTS SCI, V3, P2, DOI 10.2307/3822945	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2021	16	12							e0261681	10.1371/journal.pone.0261681	http://dx.doi.org/10.1371/journal.pone.0261681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ9AO	34972146	Green Published, gold, Green Submitted			2022-12-26	WOS:000773555700045
